data_1cf4_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1cf4 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.9 tpt . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.769 0.319 . . . . 0.0 111.3 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 62.25 134.04 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.448 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.503 HG23 ' CE1' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -107.39 -166.5 1.16 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.908 -179.158 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.437 ' CD1' HD11 ' A' ' 53' ' ' LEU . 4.9 pt -156.44 162.36 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.588 -179.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.12 99.41 4.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.437 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.3 m -78.25 103.25 8.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.518 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.1 t -135.15 112.57 14.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.327 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.434 ' CG1' ' HG3' ' A' ' 16' ' ' LYS . 0.2 OUTLIER -103.42 138.62 27.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.299 0.571 . . . . 0.0 111.203 -179.592 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.458 HG13 ' CE1' ' A' ' 78' ' ' PHE . 30.5 m -130.25 129.62 65.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.346 178.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 142.19 -172.42 24.2 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 119.867 -1.159 . . . . 0.0 112.7 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -96.5 27.48 3.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.779 0.323 . . . . 0.0 110.8 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.445 ' HA2' ' CD ' ' B' ' 537' ' ' ARG . . . -149.35 150.69 22.84 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.745 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.476 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -58.16 -54.56 45.55 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.551 0.215 . . . . 0.0 110.849 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.441 ' CG2' ' HB3' ' A' ' 81' ' ' CYS . 0.0 OUTLIER 44.62 -87.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.472 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 13' ' ' ALA . . . -102.32 23.13 35.31 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.242 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.434 ' HG3' ' CG1' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -84.34 -163.52 0.81 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.947 0.403 . . . . 0.0 110.945 -179.823 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.443 ' HB ' ' CG1' ' A' ' 21' ' ' ILE . 6.1 p -74.84 -28.6 60.75 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.029 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 53.3 t -41.47 -30.06 0.18 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.643 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.499 HD23 ' CE2' ' A' ' 169' ' ' PHE . 0.0 OUTLIER -62.83 -71.05 0.17 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.889 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.4 mt -70.07 -36.12 74.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.97 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.443 ' CG1' ' HB ' ' A' ' 17' ' ' THR . 4.5 mm -58.31 -71.2 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.418 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 25' ' ' THR . 24.5 m -55.22 -34.83 64.3 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 121.098 -0.241 . . . . 0.0 110.666 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.421 ' HB2' ' CD1' ' A' ' 165' ' ' LEU . 49.9 t80 -52.65 -35.12 54.36 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.97 -46.24 5.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.71 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.49 ' O ' ' CB ' ' A' ' 26' ' ' ASN . 6.7 t -177.83 -162.84 0.07 Allowed 'General case' 0 C--O 1.227 -0.082 0 CA-C-N 116.342 -0.39 . . . . 0.0 112.003 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.49 ' CB ' ' O ' ' A' ' 25' ' ' THR . 2.5 t30 97.6 -20.87 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.659 0.784 . . . . 0.0 110.616 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.6 mttp 60.06 146.67 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.963 0.411 . . . . 0.0 111.395 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.473 ' CD1' ' OH ' ' A' ' 32' ' ' TYR . 19.7 t80 -89.2 -47.69 0.41 Allowed Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.871 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 67.7 Cg_endo -88.29 58.14 2.71 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.793 2.328 . . . . 0.0 112.797 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.2 m -133.85 -85.53 0.43 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.823 0.344 . . . . 0.0 110.759 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -158.59 162.83 37.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.754 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.477 ' CD1' ' HB2' ' B' ' 532' ' ' TRP . 67.4 m-85 -135.22 103.56 5.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.971 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.44 ' HB ' ' CB ' ' B' ' 526' ' ' SER . 0.0 OUTLIER -165.31 -61.35 0.01 OUTLIER Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.341 -179.935 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.482 ' O ' ' CD1' ' A' ' 37' ' ' PHE . 86.7 Cg_exo -42.84 -28.49 1.18 Allowed 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.371 2.048 . . . . 0.0 112.528 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.2 t -57.44 -20.81 32.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.192 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.426 ' CG2' ' HB2' ' A' ' 61' ' ' LEU . 12.6 p -52.0 -21.18 2.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.521 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.482 ' CD1' ' O ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -83.02 46.9 1.15 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.66 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.439 ' CB ' ' HB2' ' A' ' 57' ' ' ASP . 5.0 p-10 -63.66 -158.29 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.645 0.259 . . . . 0.0 110.837 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 73.73 22.48 2.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.804 0.335 . . . . 0.0 111.006 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.487 ' CE2' ' HA ' ' B' ' 520' ' ' HIS . 1.8 m-30 -60.18 129.31 41.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.77 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.411 ' O ' HG12 ' B' ' 519' ' ' ILE . . . -95.51 119.61 34.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.582 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.416 ' CG1' ' O ' ' B' ' 517' ' ' SER . 17.5 m -117.74 159.82 17.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.986 0.422 . . . . 0.0 111.72 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.34 104.79 6.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.384 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.478 ' CG2' ' CG2' ' A' ' 52' ' ' THR . 10.4 m -149.04 -177.46 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.366 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.464 ' HE1' ' N ' ' A' ' 46' ' ' ILE . 4.7 tpt -99.07 96.62 7.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.342 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.464 ' N ' ' HE1' ' A' ' 45' ' ' MET . 1.3 mm -80.44 86.66 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-O 121.33 0.586 . . . . 0.0 109.695 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 42.74 -92.42 0.01 OUTLIER Glycine 0 CA--C 1.524 0.601 0 CA-C-N 115.537 -0.756 . . . . 0.0 113.71 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . -38.55 -91.59 0.01 OUTLIER Glycine 0 CA--C 1.52 0.39 0 N-CA-C 113.988 0.355 . . . . 0.0 113.988 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.431 ' C ' ' CE ' ' A' ' 45' ' ' MET . 1.3 pt-20 -125.88 152.47 72.73 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-O 120.693 0.282 . . . . 0.0 110.932 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.401 ' N ' ' SD ' ' A' ' 45' ' ' MET . 83.0 Cg_exo -43.28 105.55 0.06 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.51 2.14 . . . . 0.0 112.266 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.503 ' CE1' HG23 ' A' ' 3' ' ' THR . 8.8 t80 -172.02 159.21 4.93 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.303 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.478 ' CG2' ' CG2' ' A' ' 44' ' ' VAL . 6.5 p -136.09 153.2 51.39 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.146 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.437 HD11 ' CD1' ' A' ' 4' ' ' ILE . 0.0 OUTLIER -87.27 -179.19 6.37 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.919 179.807 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -128.54 103.51 0.62 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.627 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.66 97.38 10.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.807 0.336 . . . . 0.0 110.254 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -84.23 105.61 15.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.694 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.439 ' HB2' ' CB ' ' A' ' 38' ' ' ASP . 0.6 OUTLIER -90.75 137.05 32.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.061 -179.775 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.469 ' CB ' HD11 ' A' ' 67' ' ' LEU . 0.1 OUTLIER -99.03 143.38 29.37 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.278 179.807 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.425 ' CB ' HG22 ' A' ' 36' ' ' VAL . . . -153.14 177.4 10.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.923 0.392 . . . . 0.0 111.384 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' A' ' 65' ' ' ASP . . . -129.96 51.81 0.85 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.94 -0.647 . . . . 0.0 112.09 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.426 ' HB2' ' CG2' ' A' ' 36' ' ' VAL . 0.4 OUTLIER -120.82 -175.24 2.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.934 0.397 . . . . 0.0 111.199 -179.56 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -46.73 -40.24 13.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.347 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.417 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . 59.4 m-20 -47.25 -56.95 5.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.184 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.495 ' CD1' ' N ' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -166.8 93.34 0.47 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.837 -179.855 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.402 ' HA ' ' HA2' ' A' ' 60' ' ' GLY . 0.2 OUTLIER -86.33 -7.43 58.49 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.558 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.37 -20.63 20.87 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.473 HD22 ' CG ' ' A' ' 64' ' ' TYR . 4.5 pp -51.36 160.98 0.5 Allowed 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.783 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 20.6 ttp85 -178.18 62.82 0.16 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.012 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -84.79 -23.38 2.62 Favored 'Trans proline' 0 N--CA 1.461 -0.383 0 C-N-CA 122.859 2.373 . . . . 0.0 112.581 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.471 ' CD2' ' N ' ' B' ' 541' ' ' LEU . 0.1 OUTLIER -71.75 -6.16 39.32 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.448 -179.672 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -48.36 -71.25 0.07 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.86 0.362 . . . . 0.0 111.097 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -140.33 62.52 20.03 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.879 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -52.36 130.58 36.55 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.685 2.257 . . . . 0.0 112.284 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -86.15 10.27 14.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.499 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 15.3 t -50.82 174.6 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.806 0.336 . . . . 0.0 110.817 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -112.3 -25.73 9.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.882 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.436 ' CB ' ' HB2' ' A' ' 175' ' ' ALA . 8.2 p -126.57 99.14 5.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.172 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.458 ' CE1' HG13 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -80.89 176.58 9.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.61 179.826 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.465 ' HG ' ' N ' ' A' ' 15' ' ' GLY . 0.0 OUTLIER -127.83 108.74 10.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.077 -179.808 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.483 HG23 ' CD1' ' A' ' 110' ' ' PHE . 34.4 m -97.97 127.88 49.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.65 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.441 ' HB3' ' CG2' ' A' ' 14' ' ' VAL . 21.1 p -99.63 174.02 6.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.14 0.495 . . . . 0.0 111.632 -179.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.484 ' CZ ' ' HB1' ' A' ' 142' ' ' ALA . 8.3 p90 -179.63 -174.3 0.29 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.17 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.427 ' N ' ' CD2' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -156.08 149.89 25.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.752 0.31 . . . . 0.0 110.856 179.885 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.448 ' HB ' ' CB ' ' A' ' 120' ' ' ARG . 43.8 t -61.71 -41.84 92.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.345 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.439 ' CA ' HD23 ' A' ' 129' ' ' LEU . 17.6 m -59.64 114.8 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.365 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.412 ' N ' ' CD2' ' A' ' 129' ' ' LEU . 0.6 OUTLIER -152.02 117.47 3.08 Favored Pre-proline 0 C--N 1.329 -0.294 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.801 -179.57 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.425 ' O ' ' CB ' ' A' ' 132' ' ' ASN . 89.7 Cg_endo -94.01 53.28 0.33 Allowed 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.114 2.543 . . . . 0.0 111.288 179.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.425 ' HA ' ' HG3' ' A' ' 133' ' ' LYS . 0.2 OUTLIER 81.12 30.07 0.16 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.661 -179.253 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 73.9 m -97.2 -16.84 20.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.133 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.479 ' CZ ' HG21 ' A' ' 137' ' ' ILE . 0.1 OUTLIER -43.26 -42.11 4.22 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.869 0.366 . . . . 0.0 111.403 -179.919 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -63.41 -33.6 75.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.973 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.406 ' O ' ' N ' ' A' ' 96' ' ' LYS . 7.4 m120 -75.23 -52.98 9.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.095 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.417 ' CG2' ' HA ' ' A' ' 90' ' ' PHE . 7.4 m -49.71 -44.59 20.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.233 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.44 -49.78 67.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.899 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -82.57 7.34 14.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.671 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.406 ' N ' ' O ' ' A' ' 92' ' ' ASN . 4.8 tttt -115.3 -27.34 7.27 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.721 0.296 . . . . 0.0 111.036 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 1.7 m95 -94.31 -50.18 5.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.388 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.48 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 61.9 t -50.89 -46.01 87.42 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.962 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 95.3 Cg_endo -81.03 -11.21 12.38 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.377 2.051 . . . . 0.0 113.016 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -90.34 -57.0 2.99 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 120.906 0.384 . . . . 0.0 110.187 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 20.8 tt -57.34 -27.88 29.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.084 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 23.2 p -86.33 -29.66 22.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.75 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -58.62 -54.84 42.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.851 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 52.9 m170 -65.54 -42.04 92.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.79 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -125.87 124.02 24.71 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.669 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -50.98 89.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.414 2.076 . . . . 0.0 112.261 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 63.29 94.54 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.911 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -119.66 126.76 26.77 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.875 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -60.64 176.84 0.75 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.435 2.09 . . . . 0.0 112.236 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.484 ' CD1' ' HB3' ' A' ' 151' ' ' ALA . 32.7 p90 -165.93 176.39 7.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.852 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.426 ' CD1' HG13 ' A' ' 152' ' ' VAL . 1.1 tt -139.56 134.37 32.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.886 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.407 HD21 ' CG2' ' A' ' 80' ' ' VAL . 4.1 mm? -89.78 138.48 31.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.205 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.428 ' CG1' HG12 ' A' ' 168' ' ' VAL . 11.0 t -130.45 147.57 33.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.11 0.481 . . . . 0.0 112.064 -179.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -113.31 142.18 17.3 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.648 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.467 ' N ' HD12 ' A' ' 117' ' ' ILE . 0.8 OUTLIER -153.83 -61.53 0.14 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.853 0.359 . . . . 0.0 111.03 -179.622 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.445 ' N ' ' OG1' ' A' ' 115' ' ' THR . 10.5 mm100 -60.12 -20.4 58.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.026 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.467 HD12 ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -40.69 -29.13 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.867 -179.796 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -65.93 -42.19 90.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.812 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.432 HD22 ' CD2' ' A' ' 160' ' ' LEU . 0.1 OUTLIER -93.02 -48.16 6.64 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -179.327 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.448 ' CB ' ' HB ' ' A' ' 84' ' ' VAL . 1.4 mmt180 -48.15 -26.78 2.03 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.814 0.34 . . . . 0.0 111.024 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.06 -21.07 43.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.871 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.62 153.56 87.04 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.867 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -81.35 -2.68 11.73 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.997 2.465 . . . . 0.0 112.957 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 40.7 t -81.49 -69.98 0.57 Allowed 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 120.879 0.371 . . . . 0.0 110.49 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.416 ' CG2' HG12 ' A' ' 85' ' ' VAL . 8.4 m -51.46 -33.77 32.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.411 0.624 . . . . 0.0 109.6 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.461 ' HA ' ' CD1' ' A' ' 129' ' ' LEU . 0.1 OUTLIER -58.63 -42.85 86.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.449 179.021 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -57.3 -35.41 69.78 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.568 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.406 ' HB2' ' O ' ' A' ' 125' ' ' THR . 3.9 mptt -65.66 -33.15 75.22 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.461 ' CD1' ' HA ' ' A' ' 126' ' ' ILE . 9.0 mt -73.64 -36.61 65.44 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.404 ' HA ' ' HB3' ' A' ' 134' ' ' GLN . . . -49.15 -34.1 13.58 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.97 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 10.9 mmmm -47.58 -32.77 5.77 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.666 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.425 ' CB ' ' O ' ' A' ' 87' ' ' PRO . 43.4 m-80 -123.12 -31.22 3.63 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.281 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.512 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 9.3 mmtm -146.2 -95.05 0.09 Allowed 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 119.273 -0.394 . . . . 0.0 111.367 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.512 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 7.4 pt20 128.94 -21.17 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.482 1.113 . . . . 0.0 110.574 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.6 mttm -68.4 110.88 6.52 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.648 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.438 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 93.1 Cg_endo -82.86 130.15 5.69 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.67 2.246 . . . . 0.0 111.576 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.479 HG21 ' CZ ' ' A' ' 90' ' ' PHE . 1.1 mm -62.47 96.78 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.941 0.401 . . . . 0.0 110.748 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.7 p -67.69 156.11 89.8 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.888 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.494 ' HA ' ' CE1' ' A' ' 154' ' ' TYR . 10.3 Cg_endo -51.71 -23.23 14.99 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.657 2.238 . . . . 0.0 112.023 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -86.11 -26.41 25.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.587 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.8 m -63.35 -56.84 13.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.661 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.484 ' HB1' ' CZ ' ' A' ' 82' ' ' PHE . . . -52.5 -36.96 56.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.828 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.14 -36.04 82.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.709 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.15 -56.86 13.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.815 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 50.5 tp -65.17 -36.77 85.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.764 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -57.46 -51.09 70.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.943 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 -71.64 -24.51 61.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.857 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -50.24 -41.74 50.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.832 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.42 ' O ' ' CD ' ' A' ' 150' ' ' LYS . 1.3 mp -104.42 25.18 10.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.847 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.42 ' CD ' ' O ' ' A' ' 149' ' ' LEU . 0.0 OUTLIER 44.95 39.25 3.5 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.305 -179.971 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.484 ' HB3' ' CD1' ' A' ' 110' ' ' PHE . . . -62.26 -81.02 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.028 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.426 HG13 ' CD1' ' A' ' 111' ' ' LEU . 78.4 t -159.59 -75.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.023 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.428 ' HG3' ' N ' ' A' ' 154' ' ' TYR . 0.5 OUTLIER 170.13 146.06 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.746 -178.971 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.494 ' CE1' ' HA ' ' A' ' 139' ' ' PRO . 10.2 t80 -100.77 113.58 26.61 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.442 ' CG2' ' HA ' ' A' ' 168' ' ' VAL . 1.7 t -101.6 175.73 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.629 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -88.8 145.19 25.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.021 0.439 . . . . 0.0 111.073 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.431 ' CB ' HG12 ' A' ' 168' ' ' VAL . 2.8 t -169.93 151.22 4.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.257 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 2.4 t -160.23 123.47 3.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.072 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -92.74 20.56 6.35 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.953 179.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.432 ' CD2' HD22 ' A' ' 119' ' ' LEU . 0.3 OUTLIER -131.57 -44.06 1.0 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.575 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 15.3 t -107.06 -19.51 13.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.889 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 78.05 77.78 0.07 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.098 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 25.6 tptt -96.17 30.23 2.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.815 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 119.01 -58.09 0.54 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.516 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.44 ' CD2' ' HA ' ' A' ' 19' ' ' LEU . 0.7 OUTLIER 66.74 -73.58 0.07 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.787 0.327 . . . . 0.0 111.123 179.909 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.427 ' O ' ' N ' ' A' ' 170' ' ' ASP . 1.9 mtpt -56.9 -31.9 65.36 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.01 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -52.31 -71.71 0.06 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.291 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.442 ' HA ' ' CG2' ' A' ' 155' ' ' VAL . 13.6 p -57.06 -47.43 83.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.478 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.499 ' CE2' HD23 ' A' ' 19' ' ' LEU . 1.8 t80 -62.38 -25.79 68.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.59 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' A' ' 166' ' ' LYS . 28.4 t0 -71.58 -29.84 65.16 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.67 -29.84 62.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.845 179.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.422 ' HB1' ' CD2' ' A' ' 79' ' ' LEU . . . -67.44 -49.67 62.66 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.835 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 1.6 pp -72.49 -32.59 42.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.11 0.481 . . . . 0.0 110.414 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.429 ' CD2' ' HB2' ' B' ' 505' ' ' LEU . 10.1 tp -46.13 -44.47 15.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.175 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.436 ' HB2' ' CB ' ' A' ' 77' ' ' VAL . . . -57.0 -24.24 52.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.818 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.411 ' HB2' ' HB ' ' A' ' 4' ' ' ILE . . . -94.87 -31.72 13.57 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.104 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.46 ' CD2' ' HB ' ' B' ' 510' ' ' ILE . 2.5 tp -68.27 -26.13 65.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.676 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.439 ' CB ' ' CB ' ' B' ' 507' ' ' ALA . 1.0 OUTLIER 171.24 149.3 0.17 Allowed Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.687 179.808 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . 0.433 ' HD2' ' CG ' ' A' ' 178' ' ' GLU . 16.1 Cg_endo -57.48 107.71 0.32 Allowed 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.691 2.261 . . . . 0.0 112.272 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -80.53 171.88 14.14 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.664 2.242 . . . . 0.0 112.419 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -113.62 139.56 23.52 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.872 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -76.46 -165.28 0.3 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.68 2.253 . . . . 0.0 112.342 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 10.7 mttt -134.62 80.28 1.84 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.865 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.88 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.193 0 N-CA-C 112.525 -0.23 . . . . 0.0 112.525 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 503' ' ' SER . . . . . 0.43 ' HB3' ' CD1' ' B' ' 505' ' ' LEU . 37.5 m -64.14 -78.77 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.856 0.36 . . . . 0.0 110.844 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 504' ' ' GLY . . . . . 0.403 ' C ' ' CD1' ' B' ' 505' ' ' LEU . . . 87.82 109.69 0.99 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.414 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 505' ' ' LEU . . . . . 0.487 ' N ' ' CD2' ' B' ' 505' ' ' LEU . 0.0 OUTLIER -167.17 55.12 0.08 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.701 0.286 . . . . 0.0 111.137 -179.274 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 506' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 48.48 66.44 1.07 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.917 0.389 . . . . 0.0 110.613 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 507' ' ' ALA . . . . . 0.449 ' O ' ' HB3' ' B' ' 508' ' ' GLN . . . -175.5 53.42 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.79 -179.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 508' ' ' GLN . . . . . 0.449 ' HB3' ' O ' ' B' ' 507' ' ' ALA . 1.7 tt0 68.86 5.35 4.94 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.664 -178.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 509' ' ' ASP . . . . . . . . . . . . . 2.7 p30 51.54 47.1 25.45 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.449 0.643 . . . . 0.0 110.799 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 510' ' ' ILE . . . . . 0.46 ' HB ' ' CD2' ' A' ' 177' ' ' LEU . 80.3 mt -87.49 138.3 19.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.401 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 511' ' ' SER . . . . . . . . . . . . . 1.2 m -78.33 122.24 25.49 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.335 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 512' ' ' GLN . . . . . 0.474 ' HB2' ' HD2' ' B' ' 513' ' ' PRO . 0.0 OUTLIER -50.6 179.58 0.04 OUTLIER Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.893 179.265 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 513' ' ' PRO . . . . . 0.474 ' HD2' ' HB2' ' B' ' 512' ' ' GLN . 85.0 Cg_exo -46.12 92.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 121.78 1.653 . . . . 0.0 111.46 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 514' ' ' LEU . . . . . 0.448 ' N ' ' O ' ' B' ' 512' ' ' GLN . 0.0 OUTLIER -62.84 -168.33 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.27 -179.021 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 515' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -89.02 178.59 6.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.874 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 66.56 11.22 7.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.192 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 517' ' ' SER . . . . . 0.416 ' O ' ' CG1' ' A' ' 42' ' ' VAL . 3.4 p -100.9 65.48 1.12 Allowed 'General case' 0 N--CA 1.456 -0.139 0 CA-C-O 120.898 0.38 . . . . 0.0 110.759 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 518' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -158.06 91.86 1.14 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.644 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 519' ' ' ILE . . . . . 0.411 HG12 ' O ' ' A' ' 41' ' ' ALA . 3.5 mm -100.49 -19.02 6.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.581 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 520' ' ' HIS . . . . . 0.487 ' HA ' ' CE2' ' A' ' 40' ' ' TYR . 0.7 OUTLIER 72.91 103.12 0.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.866 0.365 . . . . 0.0 110.906 -179.737 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 521' ' ' THR . . . . . . . . . . . . . 3.2 m -143.86 57.6 1.35 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.825 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 522' ' ' GLY . . . . . . . . . . . . . . . -149.52 159.94 28.27 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.218 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 523' ' ' HIS . . . . . 0.436 ' CD2' ' C ' ' B' ' 523' ' ' HIS . 9.6 t-160 -98.68 -91.26 0.28 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.675 0.238 . . . . 0.0 110.959 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 524' ' ' GLY . . . . . 0.424 ' O ' ' CB ' ' B' ' 525' ' ' ASP . . . 45.52 -131.98 9.24 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.777 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 525' ' ' ASP . . . . . 0.424 ' CB ' ' O ' ' B' ' 524' ' ' GLY . 4.2 m-20 82.07 79.22 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.038 0.446 . . . . 0.0 111.02 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 526' ' ' SER . . . . . 0.44 ' CB ' ' HB ' ' A' ' 33' ' ' VAL . 0.4 OUTLIER -113.75 99.44 7.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.459 179.594 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 527' ' ' ASP . . . . . 0.409 ' HB2' ' HD2' ' B' ' 528' ' ' PRO . 0.4 OUTLIER -40.15 163.61 0.08 OUTLIER Pre-proline 0 N--CA 1.465 0.309 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.724 -179.703 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 528' ' ' PRO . . . . . 0.409 ' HD2' ' HB2' ' B' ' 527' ' ' ASP . 10.6 Cg_endo -51.08 112.05 0.7 Allowed 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 123.053 2.502 . . . . 0.0 111.988 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 529' ' ' ARG . . . . . . . . . . . . . 30.3 mtp180 -100.71 -54.1 2.91 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.258 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 530' ' ' HIS . . . . . . . . . . . . . 25.4 m-70 -137.68 10.29 2.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.587 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 3.9 m 44.99 -160.96 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.84 0.352 . . . . 0.0 111.286 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 532' ' ' TRP . . . . . 0.477 ' HB2' ' CD1' ' A' ' 32' ' ' TYR . 12.1 t-105 -132.34 92.29 3.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.867 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . -92.82 -48.87 2.82 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.526 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 534' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -106.87 140.21 21.15 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.658 0.266 . . . . 0.0 110.916 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -56.17 -158.16 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.518 2.146 . . . . 0.0 112.303 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 69.24 61.36 0.31 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.886 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 537' ' ' ARG . . . . . 0.445 ' CD ' ' HA2' ' A' ' 12' ' ' GLY . 0.0 OUTLIER -48.75 159.56 0.23 Allowed 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.0 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 538' ' ' ILE . . . . . 0.437 ' CG1' ' HB2' ' B' ' 542' ' ' TYR . 10.3 tp -81.72 141.33 15.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.482 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 539' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -45.5 161.16 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.883 0.373 . . . . 0.0 111.221 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 540' ' ' GLU . . . . . 0.433 ' O ' ' CG2' ' A' ' 58' ' ' THR . 0.4 OUTLIER -61.61 -14.89 34.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.555 -179.854 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 541' ' ' LEU . . . . . 0.471 ' N ' ' CD2' ' A' ' 70' ' ' LEU . 0.2 OUTLIER -66.22 -32.77 74.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.365 0.603 . . . . 0.0 110.062 179.708 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 542' ' ' TYR . . . . . 0.437 ' HB2' ' CG1' ' B' ' 538' ' ' ILE . 40.7 m-85 -104.9 -50.76 3.19 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.17 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 543' ' ' LEU . . . . . 0.428 ' CD1' ' O ' ' A' ' 58' ' ' THR . 0.5 OUTLIER 72.42 -68.02 0.24 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.931 -179.678 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . -117.44 164.02 12.61 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.493 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 545' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.888 179.988 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.518 ' CE ' ' CD1' ' A' ' 51' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.418 0 N-CA-C 111.529 0.196 . . . . 0.0 111.529 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.403 ' O ' ' HE3' ' A' ' 1' ' ' MET . 32.7 tp60 56.42 154.93 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.104 0.478 . . . . 0.0 111.556 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.444 ' HB ' ' CD2' ' A' ' 53' ' ' LEU . 0.3 OUTLIER -146.02 -168.97 3.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.034 179.991 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.447 ' CG2' ' HG ' ' A' ' 177' ' ' LEU . 0.1 OUTLIER -145.1 156.08 13.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.561 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 28.9 mttm -118.19 105.74 12.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.515 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.422 ' O ' ' N ' ' A' ' 56' ' ' PHE . 36.2 t -77.3 105.07 8.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.09 0.471 . . . . 0.0 111.934 -178.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 t -132.94 118.86 34.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.836 178.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.416 HG13 ' HG3' ' B' ' 540' ' ' GLU . 0.4 OUTLIER -96.69 143.41 12.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.315 0.579 . . . . 0.0 111.08 -179.235 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.41 HG22 ' CD2' ' A' ' 78' ' ' PHE . 12.6 m -140.88 129.75 24.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.482 178.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.43 -143.06 9.61 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.024 -1.084 . . . . 0.0 112.734 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -123.24 22.71 9.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.668 0.27 . . . . 0.0 110.953 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.434 ' CA ' ' O ' ' B' ' 536' ' ' ASP . . . -153.42 -172.45 21.62 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.406 -0.902 . . . . 0.0 113.364 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.69 -48.74 75.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.777 0.322 . . . . 0.0 111.462 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.433 ' CG1' ' HG ' ' A' ' 79' ' ' LEU . 61.5 t 68.37 -72.14 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.117 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.448 ' CA ' ' CD2' ' A' ' 19' ' ' LEU . . . -172.36 66.32 0.13 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.631 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.469 ' CD ' ' CD2' ' B' ' 543' ' ' LEU . 27.0 mttt -97.14 -97.56 0.2 Allowed 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 121.457 -0.097 . . . . 0.0 110.803 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.419 ' CG2' HG23 ' A' ' 35' ' ' THR . 58.3 p -98.22 -57.35 2.23 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-O 120.832 0.349 . . . . 0.0 111.177 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.8 p -36.17 -43.84 0.37 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.456 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.509 ' CD2' ' CD2' ' A' ' 169' ' ' PHE . 1.8 mp -46.41 -70.96 0.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.793 0.33 . . . . 0.0 111.284 -179.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.454 HD23 ' CD2' ' A' ' 169' ' ' PHE . 14.7 mt -61.96 -25.57 67.69 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.84 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.418 ' CG2' ' OG1' ' A' ' 25' ' ' THR . 15.2 mm -67.2 -70.36 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.666 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.412 ' HB2' ' CD1' ' A' ' 165' ' ' LEU . 3.4 m -47.79 -28.93 2.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.082 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -66.84 -68.18 0.39 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.833 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.02 -48.11 39.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.72 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.418 ' OG1' ' CG2' ' A' ' 21' ' ' ILE . 13.4 p -83.2 -152.29 0.12 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.424 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -160.11 33.46 0.17 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.821 0.343 . . . . 0.0 111.033 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 13.8 mmtt -121.32 101.71 7.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.408 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.463 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . 7.9 t80 -104.87 -60.11 0.06 OUTLIER Pre-proline 0 CA--C 1.537 0.444 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.124 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.463 ' HD3' ' HB3' ' A' ' 28' ' ' PHE . 95.1 Cg_endo -84.21 48.7 2.56 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.151 1.9 . . . . 0.0 112.608 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.84 -80.79 0.43 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.029 0.442 . . . . 0.0 110.656 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.432 ' HB2' ' NE ' ' B' ' 529' ' ' ARG . 12.9 pt-20 -158.34 140.98 14.51 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.63 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -130.21 100.91 5.57 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.514 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.441 ' CG2' ' HD3' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -165.28 -63.55 0.01 OUTLIER Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.157 -179.541 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.441 ' HD3' ' CG2' ' A' ' 33' ' ' VAL . 74.9 Cg_exo -38.75 -29.77 0.17 Allowed 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.745 2.296 . . . . 0.0 112.905 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.45 HG22 ' CD2' ' B' ' 543' ' ' LEU . 60.9 m -56.53 85.54 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.993 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.434 ' CG1' ' HB3' ' A' ' 59' ' ' ALA . 2.6 t -140.5 -40.42 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.282 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.457 ' CE2' ' OD1' ' A' ' 63' ' ' ASP . 0.3 OUTLIER -91.19 25.13 2.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.966 179.698 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.435 ' HB2' ' CB ' ' A' ' 57' ' ' ASP . 0.7 OUTLIER -57.78 -159.85 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.873 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 68.26 29.46 6.01 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.943 0.401 . . . . 0.0 110.46 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.414 ' CE1' ' O ' ' B' ' 521' ' ' THR . 0.7 OUTLIER -60.72 -160.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.852 -179.808 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.415 ' O ' ' CG1' ' B' ' 519' ' ' ILE . . . -122.97 123.27 40.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.466 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.3 t -106.76 121.7 59.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.64 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.423 ' O ' ' CG1' ' A' ' 44' ' ' VAL . 6.5 p -108.79 106.84 17.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.197 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.469 ' CG2' ' CG2' ' A' ' 52' ' ' THR . 27.3 m -159.46 -178.91 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.916 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.428 ' HG2' ' N ' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -98.37 103.39 15.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.844 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.486 ' O ' ' CG2' ' A' ' 46' ' ' ILE . 1.2 tt -95.2 106.29 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-O 121.529 0.681 . . . . 0.0 111.021 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.466 ' CA ' ' HA ' ' B' ' 510' ' ' ILE . . . 43.61 -93.19 0.01 OUTLIER Glycine 0 CA--C 1.517 0.178 0 C-N-CA 121.001 -0.619 . . . . 0.0 113.526 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.439 ' HA3' ' CB ' ' A' ' 1' ' ' MET . . . -39.2 -86.16 0.01 OUTLIER Glycine 0 C--N 1.334 0.458 0 C-N-CA 121.393 -0.432 . . . . 0.0 113.371 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.429 ' HB3' ' CD ' ' A' ' 50' ' ' PRO . 4.0 mt-10 -144.06 177.58 1.76 Allowed Pre-proline 0 C--N 1.331 -0.205 0 CA-C-O 120.671 0.272 . . . . 0.0 111.04 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.429 ' CD ' ' HB3' ' A' ' 49' ' ' GLU . 76.8 Cg_exo -51.23 92.98 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.551 2.167 . . . . 0.0 112.614 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.518 ' CD1' ' CE ' ' A' ' 1' ' ' MET . 2.8 t80 -173.29 125.96 0.42 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.386 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.469 ' CG2' ' CG2' ' A' ' 44' ' ' VAL . 0.1 OUTLIER -134.3 144.29 48.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.798 0.332 . . . . 0.0 111.161 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.444 ' CD2' ' HB ' ' A' ' 3' ' ' THR . 0.9 OUTLIER -87.69 -177.33 5.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.89 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -123.92 116.47 2.86 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.438 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.402 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 2.2 mp -50.77 139.13 17.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.874 0.369 . . . . 0.0 110.844 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.422 ' N ' ' O ' ' A' ' 6' ' ' CYS . 7.8 t80 -85.76 135.0 33.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.311 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.435 ' CB ' ' HB2' ' A' ' 38' ' ' ASP . 0.1 OUTLIER -150.54 131.88 14.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.372 179.558 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.433 ' O ' ' CD1' ' B' ' 543' ' ' LEU . 2.5 p -130.25 125.0 33.75 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.164 -179.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.434 ' HB3' ' CG1' ' A' ' 36' ' ' VAL . . . -144.19 99.68 3.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.7 179.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.09 75.79 0.25 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.684 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.431 ' CD1' ' HB2' ' A' ' 59' ' ' ALA . 4.6 mp -121.49 -95.89 0.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 121.312 -0.155 . . . . 0.0 111.207 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -99.36 -30.3 12.29 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 120.766 0.317 . . . . 0.0 111.487 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.457 ' OD1' ' CE2' ' A' ' 37' ' ' PHE . 29.7 t0 -80.57 -63.73 1.34 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.619 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.524 ' CD2' ' CD1' ' A' ' 67' ' ' LEU . 19.0 m-85 -88.27 144.53 26.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.917 0.389 . . . . 0.0 110.874 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -86.26 -62.04 1.61 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.831 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.29 -52.98 3.49 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -178.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.524 ' CD1' ' CD2' ' A' ' 64' ' ' TYR . 0.4 OUTLIER 64.78 -151.25 0.28 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 120.596 -0.442 . . . . 0.0 109.832 -179.566 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.499 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.1 OUTLIER 78.28 41.94 0.06 OUTLIER Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 179.5 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.499 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 88.3 Cg_endo -82.89 -21.95 4.55 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.302 2.002 . . . . 0.0 112.09 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.45 ' CD2' ' HA ' ' B' ' 541' ' ' LEU . 0.1 OUTLIER -60.52 -15.17 24.68 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.621 -179.677 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.33 -60.55 3.68 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.752 0.311 . . . . 0.0 110.968 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.01 65.07 74.47 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.923 0.392 . . . . 0.0 111.146 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.403 ' HD3' ' O ' ' A' ' 70' ' ' LEU . 83.6 Cg_endo -82.56 145.88 13.31 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.801 2.334 . . . . 0.0 112.189 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -96.64 10.25 39.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.48 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 11.5 t -53.05 -176.32 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.752 0.31 . . . . 0.0 110.878 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -136.5 7.35 3.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.553 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.421 ' CG2' ' HB2' ' A' ' 176' ' ' ALA . 4.8 t -139.03 86.76 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.725 0.298 . . . . 0.0 111.458 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.411 ' N ' ' O ' ' A' ' 109' ' ' PRO . 0.5 OUTLIER -80.85 172.01 14.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.084 179.351 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.433 ' HG ' ' CG1' ' A' ' 14' ' ' VAL . 9.8 tp -157.0 120.98 4.28 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.084 0.469 . . . . 0.0 111.812 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.476 ' HB ' ' CH2' ' A' ' 97' ' ' TRP . 0.7 OUTLIER -114.11 135.83 52.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.981 179.041 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.407 ' SG ' ' CG2' ' A' ' 14' ' ' VAL . 4.6 p -125.83 164.33 20.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.245 0.545 . . . . 0.0 112.283 -178.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.482 ' O ' ' CD1' ' A' ' 82' ' ' PHE . 11.3 p90 -169.36 135.61 1.64 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.131 179.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 50.2 p -88.41 144.66 26.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.816 0.341 . . . . 0.0 110.943 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.437 HG13 ' CB ' ' A' ' 120' ' ' ARG . 45.1 t -46.17 -63.14 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.56 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.3 m -45.47 110.02 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.698 0.285 . . . . 0.0 110.829 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.401 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 0.2 OUTLIER -151.6 131.46 6.94 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.827 -179.347 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.42 ' O ' ' CB ' ' A' ' 88' ' ' SER . 67.8 Cg_endo -92.58 53.33 0.55 Allowed 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 123.289 2.659 . . . . 0.0 111.837 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.43 ' CA ' ' HG3' ' A' ' 133' ' ' LYS . 1.0 OUTLIER 80.31 30.17 0.22 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.069 -179.745 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.22 -23.03 17.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.857 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.486 ' CZ ' HG23 ' A' ' 137' ' ' ILE . 0.8 OUTLIER -52.49 -58.41 6.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.93 179.924 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -58.22 -40.7 82.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.936 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -64.64 -59.21 4.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.886 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.479 HG12 ' CD1' ' A' ' 97' ' ' TRP . 47.1 t -51.22 -52.74 17.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.181 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.438 ' HG3' ' CD1' ' A' ' 145' ' ' LEU . 10.8 tmtt? -50.49 -50.43 52.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.901 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -54.25 -42.12 69.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.183 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.72 12.23 34.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.543 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.479 ' CD1' HG12 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -94.47 -53.16 4.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.744 0.307 . . . . 0.0 111.087 179.918 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.493 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 3.5 t -60.36 -44.94 97.31 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.896 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.493 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 16.4 Cg_exo -68.31 -33.72 23.14 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.539 2.159 . . . . 0.0 112.923 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -85.73 -35.7 20.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.649 -0.25 . . . . 0.0 111.437 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.454 HD13 ' CG ' ' A' ' 110' ' ' PHE . 12.7 tt -68.75 -25.98 31.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.755 0.312 . . . . 0.0 111.056 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 68.0 p -97.18 -26.85 14.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.046 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.47 ' CG ' ' O ' ' A' ' 99' ' ' PRO . 5.1 m170 -66.68 -41.84 87.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.047 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -76.68 -24.33 53.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.103 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.414 ' O ' ' N ' ' A' ' 107' ' ' LYS . 8.0 m -137.4 123.06 12.91 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.854 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.17 79.76 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.571 2.181 . . . . 0.0 112.234 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.414 ' N ' ' O ' ' A' ' 105' ' ' CYS . 2.6 mmmp? 61.39 91.41 0.06 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.917 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.413 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 0.1 OUTLIER -122.57 138.08 28.79 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.921 179.929 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 108' ' ' THR . 31.5 Cg_exo -60.28 138.02 78.49 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.618 2.212 . . . . 0.0 112.468 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.485 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 1.0 OUTLIER -142.25 147.18 36.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.715 179.656 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.475 ' CD1' ' CG1' ' A' ' 152' ' ' VAL . 0.9 OUTLIER -130.02 158.0 40.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.314 -179.678 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.477 ' CD2' ' CB ' ' A' ' 151' ' ' ALA . 3.0 mm? -97.19 161.35 13.85 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.667 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.44 ' HA ' ' CG2' ' A' ' 168' ' ' VAL . 18.2 t -135.03 138.69 48.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.049 0.452 . . . . 0.0 111.889 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.414 ' HA3' ' CZ ' ' A' ' 154' ' ' TYR . . . -123.26 107.31 1.08 Allowed Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.59 179.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 158' ' ' SER . 0.0 OUTLIER -130.81 -53.18 1.06 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.852 0.358 . . . . 0.0 110.704 -179.187 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.432 ' HG2' ' CD1' ' A' ' 119' ' ' LEU . 1.6 tt0 -79.89 53.8 1.74 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.274 179.008 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.427 ' O ' ' CG ' ' A' ' 120' ' ' ARG . 0.1 OUTLIER -99.12 -5.8 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.006 179.834 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -77.73 -27.43 50.51 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.936 0.398 . . . . 0.0 110.536 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.432 ' CD1' ' HG2' ' A' ' 116' ' ' GLN . 5.0 mp -76.69 -24.36 53.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.591 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.437 ' CB ' HG13 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -46.71 -29.38 1.86 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.811 179.783 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -83.79 -34.92 24.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.405 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.63 104.49 0.44 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.575 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.415 ' HA ' ' CG2' ' A' ' 126' ' ' ILE . 14.7 Cg_exo -69.06 -3.73 12.14 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.703 2.269 . . . . 0.0 113.106 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.03 -66.4 0.87 Allowed 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 121.109 0.48 . . . . 0.0 109.758 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.406 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 18.2 m -57.92 -37.92 74.94 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.465 ' HA ' ' CD1' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -54.85 -42.95 65.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.781 179.337 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -60.08 -35.1 74.45 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.86 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.406 ' HB2' ' O ' ' A' ' 125' ' ' THR . 0.0 OUTLIER -65.38 -30.91 71.79 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.071 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.465 ' CD1' ' HA ' ' A' ' 126' ' ' ILE . 7.4 mt -73.94 -35.59 64.59 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -46.25 -34.63 4.56 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.894 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 5.7 mmmt -47.51 -33.06 5.89 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.478 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.404 ' CB ' ' O ' ' A' ' 87' ' ' PRO . 55.7 m-80 -123.43 -31.4 3.53 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.451 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.523 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 16.7 mmtp -146.85 -97.49 0.09 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 119.208 -0.425 . . . . 0.0 111.662 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.523 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 9.2 pt20 128.99 -25.74 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.473 1.109 . . . . 0.0 110.331 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -69.36 110.63 6.64 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.761 -179.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.436 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 95.3 Cg_endo -79.53 136.97 12.71 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.514 2.143 . . . . 0.0 111.371 179.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.496 ' CD1' ' N ' ' A' ' 137' ' ' ILE . 0.8 OUTLIER -69.25 96.59 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.91 0.386 . . . . 0.0 110.953 -179.463 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.6 p -70.48 160.2 82.21 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.182 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.471 ' HA ' ' CE1' ' A' ' 154' ' ' TYR . 72.0 Cg_exo -48.14 -42.88 32.34 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.572 2.181 . . . . 0.0 112.213 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -67.44 -34.74 77.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.776 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 97.5 m -58.29 -55.32 36.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.904 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.511 ' CB ' ' CD2' ' A' ' 154' ' ' TYR . . . -50.9 -36.53 38.75 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.899 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -64.72 -42.59 95.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.833 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.55 -56.76 15.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.698 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.438 ' CD1' ' HG3' ' A' ' 94' ' ' LYS . 2.9 tt -67.92 -31.97 72.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.707 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.431 ' CB ' HD21 ' A' ' 112' ' ' LEU . . . -55.66 -66.02 0.49 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.931 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 16.1 mtp85 -63.52 -24.12 67.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.977 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -54.11 -40.95 67.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.2 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.408 HD13 ' CD2' ' A' ' 145' ' ' LEU . 0.5 OUTLIER -117.32 24.5 11.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.076 -179.862 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.79 59.06 2.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.786 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.477 ' CB ' ' CD2' ' A' ' 112' ' ' LEU . . . -94.22 27.92 2.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.118 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.475 ' CG1' ' CD1' ' A' ' 111' ' ' LEU . 92.8 t 68.94 -74.8 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.975 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.423 ' O ' ' CD2' ' A' ' 111' ' ' LEU . 0.2 OUTLIER 173.13 139.21 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.109 0.481 . . . . 0.0 111.394 -179.234 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.511 ' CD2' ' CB ' ' A' ' 142' ' ' ALA . 3.2 t80 -94.66 116.69 29.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.248 178.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 5.2 t -101.12 158.7 4.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.31 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -89.67 143.58 26.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.522 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.414 ' O ' HD13 ' A' ' 117' ' ' ILE . 25.3 p 178.9 179.25 0.41 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.012 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.426 ' OG ' ' N ' ' A' ' 163' ' ' LYS . 28.4 p -159.89 160.24 33.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.953 0.406 . . . . 0.0 111.308 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.422 ' CB ' HD13 ' A' ' 165' ' ' LEU . . . -113.8 -27.14 7.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.915 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.68 -37.39 41.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.782 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 7.7 t -116.59 -13.69 10.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.189 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.412 ' N ' ' OG ' ' A' ' 158' ' ' SER . 0.5 OUTLIER 71.56 82.02 0.15 Allowed 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.698 0.285 . . . . 0.0 111.254 179.827 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.426 ' N ' ' OG ' ' A' ' 158' ' ' SER . 5.5 mttm -101.92 22.15 13.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.053 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 105.2 44.23 1.51 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.442 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.422 HD13 ' CB ' ' A' ' 159' ' ' ALA . 2.3 mt -46.09 -31.7 2.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.783 0.325 . . . . 0.0 111.155 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.427 ' HG3' ' N ' ' A' ' 167' ' ' ASN . 0.1 OUTLIER -66.57 -28.62 68.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.902 179.825 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.427 ' N ' ' HG3' ' A' ' 166' ' ' LYS . 0.1 OUTLIER -57.48 -70.87 0.11 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.698 179.874 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.44 ' CG2' ' HA ' ' A' ' 113' ' ' VAL . 11.4 p -50.77 -44.27 25.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.914 0.388 . . . . 0.0 110.565 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.509 ' CD2' ' CD2' ' A' ' 19' ' ' LEU . 0.3 OUTLIER -63.85 -30.59 71.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.097 179.436 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.414 ' O ' HG13 ' A' ' 173' ' ' ILE . 20.4 t0 -70.65 -22.52 62.49 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.565 179.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -84.61 -35.1 22.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.248 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -67.28 -32.62 73.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.74 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.441 ' CG2' HG13 ' A' ' 4' ' ' ILE . 2.0 pp -82.52 -35.11 12.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.771 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.45 ' CD1' ' HB3' ' B' ' 505' ' ' LEU . 9.7 tp -52.83 -43.56 66.08 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.977 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -50.65 -23.48 2.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.642 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.44 ' CB ' HG21 ' A' ' 4' ' ' ILE . . . -96.72 -34.71 11.25 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.699 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.447 ' HG ' ' CG2' ' A' ' 4' ' ' ILE . 96.7 mt -68.76 -24.01 64.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.797 0.332 . . . . 0.0 110.729 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -179.92 154.33 0.68 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.926 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -68.1 108.8 1.81 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.603 2.202 . . . . 0.0 112.256 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.55 174.08 9.84 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.531 2.154 . . . . 0.0 112.449 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -145.64 144.47 22.64 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.781 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.3 -165.14 0.27 Allowed 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.598 2.198 . . . . 0.0 112.26 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 7.6 mttm -126.71 171.67 10.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.918 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 3.4 mtpt . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.192 -0.909 . . . . 0.0 110.867 -179.961 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 502' ' ' GLY . . . . . 0.425 ' CA ' ' O ' ' B' ' 509' ' ' ASP . . . . . . . . 0 N--CA 1.488 2.116 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 503' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.49 -75.29 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.797 0.332 . . . . 0.0 110.968 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 504' ' ' GLY . . . . . 0.471 ' CA ' ' HA ' ' B' ' 509' ' ' ASP . . . 147.22 -101.33 0.23 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.0 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 505' ' ' LEU . . . . . 0.45 ' HB3' ' CD1' ' A' ' 174' ' ' LEU . 0.5 OUTLIER 69.39 -61.77 0.43 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 179.244 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 506' ' ' SER . . . . . 0.424 ' CB ' ' O ' ' B' ' 505' ' ' LEU . 1.1 p 165.0 -45.71 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.722 0.296 . . . . 0.0 111.108 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 507' ' ' ALA . . . . . . . . . . . . . . . -36.92 -66.51 0.23 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.947 0.88 . . . . 0.0 111.43 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 508' ' ' GLN . . . . . 0.484 ' O ' ' CB ' ' B' ' 509' ' ' ASP . 7.3 mt-30 -160.48 -45.42 0.05 OUTLIER 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.02 -1.445 . . . . 0.0 107.841 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 509' ' ' ASP . . . . . 0.484 ' CB ' ' O ' ' B' ' 508' ' ' GLN . 3.3 p30 146.88 43.57 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 113.994 -1.457 . . . . 0.0 110.259 178.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 510' ' ' ILE . . . . . 0.466 ' HA ' ' CA ' ' A' ' 47' ' ' GLY . 2.3 mt -65.15 133.09 30.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.163 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 511' ' ' SER . . . . . 0.423 ' CB ' ' HG ' ' B' ' 514' ' ' LEU . 2.6 m -109.35 158.72 17.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.257 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 512' ' ' GLN . . . . . 0.484 ' CB ' ' HD3' ' B' ' 513' ' ' PRO . 0.7 OUTLIER -100.37 -65.43 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.724 179.562 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 513' ' ' PRO . . . . . 0.484 ' HD3' ' CB ' ' B' ' 512' ' ' GLN . 69.9 Cg_endo -83.81 53.49 4.11 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.549 2.166 . . . . 0.0 112.06 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 514' ' ' LEU . . . . . 0.423 ' HG ' ' CB ' ' B' ' 511' ' ' SER . 0.7 OUTLIER -61.75 -84.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.374 -179.468 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 515' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -78.91 -86.8 0.07 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.207 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -118.41 -32.32 4.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.779 0.323 . . . . 0.0 111.243 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 517' ' ' SER . . . . . 0.476 ' O ' ' CD1' ' B' ' 518' ' ' PHE . 0.4 OUTLIER 73.06 7.85 5.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.649 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 518' ' ' PHE . . . . . 0.476 ' CD1' ' O ' ' B' ' 517' ' ' SER . 6.5 m-85 -163.43 125.03 2.43 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.723 0.297 . . . . 0.0 110.901 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 519' ' ' ILE . . . . . 0.415 ' CG1' ' O ' ' A' ' 41' ' ' ALA . 40.1 mm -79.94 -34.37 15.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.214 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 520' ' ' HIS . . . . . 0.415 ' O ' ' CG2' ' B' ' 521' ' ' THR . 41.5 t-80 -163.25 -87.04 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.069 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 521' ' ' THR . . . . . 0.415 ' CG2' ' O ' ' B' ' 520' ' ' HIS . 0.1 OUTLIER 170.23 -172.43 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 120.848 0.356 . . . . 0.0 110.886 179.911 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 522' ' ' GLY . . . . . . . . . . . . . . . -93.23 -125.91 4.08 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.37 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 523' ' ' HIS . . . . . 0.434 ' CD2' ' C ' ' B' ' 523' ' ' HIS . 8.7 t-160 -157.47 -91.64 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.501 0.191 . . . . 0.0 110.767 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 524' ' ' GLY . . . . . . . . . . . . . . . 48.4 -178.23 0.01 OUTLIER Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.854 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 525' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 168.77 60.46 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.824 0.345 . . . . 0.0 110.809 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 526' ' ' SER . . . . . 0.42 ' OG ' ' CG1' ' A' ' 33' ' ' VAL . 12.2 t -92.34 97.01 10.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.012 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 527' ' ' ASP . . . . . 0.478 ' CB ' ' CD ' ' B' ' 528' ' ' PRO . 0.2 OUTLIER -52.72 -64.31 1.68 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.98 179.944 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 528' ' ' PRO . . . . . 0.478 ' CD ' ' CB ' ' B' ' 527' ' ' ASP . 12.8 Cg_endo -53.45 103.43 0.09 OUTLIER 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.97 2.447 . . . . 0.0 112.17 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 529' ' ' ARG . . . . . 0.432 ' NE ' ' HB2' ' A' ' 31' ' ' GLU . 13.7 mtt85 -100.59 -32.06 10.95 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.968 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 530' ' ' HIS . . . . . 0.503 ' CG ' ' O ' ' B' ' 530' ' ' HIS . 0.1 OUTLIER 70.5 6.47 5.82 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.116 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER 59.55 177.51 0.08 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.89 0.376 . . . . 0.0 111.034 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 532' ' ' TRP . . . . . 0.411 ' O ' ' CD2' ' B' ' 532' ' ' TRP . 72.4 t90 -75.28 73.03 2.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.844 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . -96.21 -19.0 29.52 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.491 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 534' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -88.67 156.02 50.38 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.78 0.324 . . . . 0.0 111.003 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -73.89 95.08 0.88 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.565 2.176 . . . . 0.0 112.362 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 536' ' ' ASP . . . . . 0.434 ' O ' ' CA ' ' A' ' 12' ' ' GLY . 35.4 m-20 62.97 46.91 4.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.019 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 537' ' ' ARG . . . . . . . . . . . . . 20.9 mmt-85 73.86 -173.89 0.14 Allowed 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.373 0.606 . . . . 0.0 111.518 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 538' ' ' ILE . . . . . 0.494 ' CD1' ' CB ' ' B' ' 542' ' ' TYR . 4.8 pt -106.66 -153.68 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.031 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 539' ' ' ASP . . . . . 0.402 ' N ' HG13 ' B' ' 538' ' ' ILE . 51.8 p30 -104.04 161.42 14.01 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.944 0.402 . . . . 0.0 111.35 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 540' ' ' GLU . . . . . 0.416 ' HG3' HG13 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -57.12 -23.79 49.6 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.801 179.634 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 541' ' ' LEU . . . . . 0.45 ' HA ' ' CD2' ' A' ' 70' ' ' LEU . 0.4 OUTLIER -60.09 -34.79 73.94 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.339 0.59 . . . . 0.0 109.884 179.794 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 542' ' ' TYR . . . . . 0.494 ' CB ' ' CD1' ' B' ' 538' ' ' ILE . 2.9 m-85 -102.66 -57.34 2.07 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.999 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 543' ' ' LEU . . . . . 0.469 ' CD2' ' CD ' ' A' ' 16' ' ' LYS . 0.2 OUTLIER 64.74 -71.41 0.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.915 179.865 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 544' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' B' ' 542' ' ' TYR . . . -62.87 165.66 24.92 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.349 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 545' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.276 -0.869 . . . . 0.0 111.018 -179.907 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.466 ' HE2' ' CD1' ' A' ' 51' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.323 0.106 . . . . 0.0 111.117 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.407 ' N ' ' SD ' ' A' ' 1' ' ' MET . 13.1 tp60 56.97 151.94 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.126 0.489 . . . . 0.0 111.58 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.486 ' OG1' ' CE1' ' A' ' 51' ' ' TYR . 0.3 OUTLIER -154.65 -158.69 0.87 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.247 179.919 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.455 ' CD1' ' N ' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -144.82 155.57 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 CA-C-O 121.189 0.519 . . . . 0.0 111.973 -179.514 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 36.3 mttt -134.45 116.61 15.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.704 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 45.7 t -138.38 154.22 48.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.364 0.602 . . . . 0.0 112.52 -178.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.426 ' CG1' ' OE2' ' B' ' 540' ' ' GLU . 11.9 t -128.37 150.35 34.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.208 178.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.466 ' CG2' ' HA ' ' A' ' 14' ' ' VAL . 2.8 p -83.8 121.65 36.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.307 0.575 . . . . 0.0 111.707 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 19.2 m -129.87 129.9 66.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.928 178.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.468 ' HA2' ' CZ2' ' A' ' 97' ' ' TRP . . . 137.49 -142.8 13.79 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.194 -1.003 . . . . 0.0 112.652 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.427 ' CB ' ' O ' ' B' ' 537' ' ' ARG . 0.4 OUTLIER -122.52 26.68 8.22 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.879 0.371 . . . . 0.0 110.633 179.915 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.425 ' O ' ' CB ' ' B' ' 537' ' ' ARG . . . -86.04 -176.2 49.96 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.765 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.428 ' CB ' ' HD3' ' B' ' 537' ' ' ARG . . . -89.39 4.82 47.76 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.466 ' HA ' ' CG2' ' A' ' 8' ' ' VAL . 8.7 t 81.24 107.18 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.066 0.46 . . . . 0.0 110.651 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.486 ' HA3' ' CE1' ' A' ' 169' ' ' PHE . . . -65.32 -9.29 41.96 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.723 -0.671 . . . . 0.0 113.423 -179.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.428 ' CD ' ' HB3' ' A' ' 55' ' ' LEU . 3.1 mmtt -77.07 -51.25 11.38 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 122.395 -0.473 . . . . 0.0 111.031 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.41 ' HB ' HG13 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -98.14 -44.36 6.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.596 -179.583 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.421 ' CB ' ' O ' ' A' ' 14' ' ' VAL . 44.0 t -36.12 -73.83 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.54 ' CD1' ' CE1' ' A' ' 169' ' ' PHE . 1.8 mp -56.53 -68.66 0.2 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.951 0.405 . . . . 0.0 111.583 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.9 mt -46.38 -61.45 1.79 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.201 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.41 HG13 ' HB ' ' A' ' 17' ' ' THR . 47.6 mm -49.35 -72.15 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.781 0.324 . . . . 0.0 111.191 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 27.7 t -51.2 -23.0 2.98 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.606 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -75.41 -68.07 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.731 0.3 . . . . 0.0 111.382 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.4 m -75.91 -34.69 59.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.31 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.402 ' OG1' ' O ' ' A' ' 21' ' ' ILE . 1.5 p -87.9 -156.12 0.34 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.882 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -151.41 21.13 0.73 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.089 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -108.59 123.51 49.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.869 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.473 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 0.4 OUTLIER -153.78 -68.25 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.411 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.632 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.473 ' CD ' ' CB ' ' A' ' 28' ' ' PHE . 74.0 Cg_endo -75.45 54.26 3.79 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.479 2.119 . . . . 0.0 112.939 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 33.9 t -145.96 -80.02 0.16 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.916 0.389 . . . . 0.0 110.976 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -158.34 159.02 35.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.45 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.413 ' CE1' ' O ' ' A' ' 28' ' ' PHE . 10.6 m-85 -128.44 93.36 3.62 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.065 0.46 . . . . 0.0 110.918 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.474 ' CG1' ' CB ' ' B' ' 526' ' ' SER . 1.9 t -108.45 -50.01 0.08 OUTLIER Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.545 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.419 ' HD3' ' HB ' ' A' ' 33' ' ' VAL . 77.6 Cg_exo -52.01 -22.14 13.88 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.009 1.806 . . . . 0.0 112.203 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.417 HG23 ' CD2' ' B' ' 543' ' ' LEU . 27.9 m -52.3 -24.33 7.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.545 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.425 ' CG1' ' HA2' ' B' ' 524' ' ' GLY . 5.6 p -57.98 -25.35 25.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.164 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.477 ' CD1' ' HA3' ' B' ' 522' ' ' GLY . 0.2 OUTLIER -125.79 53.36 1.59 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.963 0.411 . . . . 0.0 110.645 179.724 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.409 ' OD2' ' CB ' ' A' ' 16' ' ' LYS . 24.4 t70 -88.95 14.18 11.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.554 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -92.82 19.87 7.15 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.769 0.318 . . . . 0.0 110.905 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -61.95 -175.11 0.06 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.699 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -116.43 169.77 9.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.438 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.442 ' HA ' ' CG1' ' B' ' 519' ' ' ILE . 35.1 m -146.94 129.33 7.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.911 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.425 ' O ' ' CG1' ' A' ' 44' ' ' VAL . 16.4 p -87.5 105.61 17.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.554 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.499 ' CG2' ' CG2' ' A' ' 52' ' ' THR . 19.3 m -158.93 -177.09 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.53 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.479 ' HE1' ' N ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -124.85 107.54 11.01 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.795 0.295 . . . . 0.0 111.795 -179.639 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.456 ' CG2' HG21 ' B' ' 510' ' ' ILE . 5.1 mm -79.96 86.13 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 26.21 90.29 0.01 OUTLIER Glycine 0 CA--C 1.526 0.731 0 O-C-N 123.64 0.587 . . . . 0.0 114.449 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 140.39 -95.51 0.2 Allowed Glycine 0 N--CA 1.454 -0.156 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.448 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.479 ' N ' ' HE1' ' A' ' 45' ' ' MET . 0.0 OUTLIER -130.31 144.99 55.46 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.791 0.329 . . . . 0.0 110.638 179.347 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.41 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 68.8 Cg_exo -34.39 102.4 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.46 2.773 . . . . 0.0 113.446 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.486 ' CE1' ' OG1' ' A' ' 3' ' ' THR . 3.1 t80 -173.4 138.22 0.69 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.159 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.499 ' CG2' ' CG2' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -134.12 153.16 51.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.112 0.482 . . . . 0.0 111.402 179.495 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.435 HD11 ' CG1' ' A' ' 4' ' ' ILE . 0.4 OUTLIER -80.25 109.9 15.17 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.169 -179.616 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -62.95 107.61 1.75 Allowed Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.0 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.428 ' HB3' ' CD ' ' A' ' 16' ' ' LYS . 1.4 mp -63.59 116.88 6.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.836 0.35 . . . . 0.0 110.413 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -84.58 125.33 32.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.352 0.596 . . . . 0.0 111.751 -178.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -175.17 137.34 0.4 Allowed 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.457 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.455 ' OG1' ' CD2' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -155.07 160.02 40.69 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.483 -178.645 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.445 ' HB1' ' CD2' ' A' ' 61' ' ' LEU . . . -132.34 155.48 48.32 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.816 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -106.65 79.46 0.26 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.533 -0.841 . . . . 0.0 113.328 -179.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.445 ' CD2' ' HB1' ' A' ' 59' ' ' ALA . 0.1 OUTLIER -121.47 -87.76 0.63 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.72 0.295 . . . . 0.0 110.643 179.24 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -98.73 -26.52 14.32 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.99 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -89.4 -63.42 1.29 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.4 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.468 ' CB ' ' CD2' ' A' ' 67' ' ' LEU . 12.8 m-85 -96.85 146.54 24.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.958 0.409 . . . . 0.0 111.086 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -87.43 -58.5 2.56 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.402 ' O ' ' CB ' ' A' ' 67' ' ' LEU . 0.6 OUTLIER -98.35 -51.17 4.06 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -178.209 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.468 ' CD2' ' CB ' ' A' ' 64' ' ' TYR . 0.2 OUTLIER 76.4 87.74 0.08 Allowed 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -178.636 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.475 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 34.5 ptt180 -126.59 48.19 2.94 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.563 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.475 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 97.4 Cg_endo -79.0 -39.56 0.34 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.67 2.246 . . . . 0.0 111.875 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.47 ' CD2' ' CB ' ' B' ' 541' ' ' LEU . 0.1 OUTLIER -82.04 -8.45 59.67 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.038 179.959 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.4 ' O ' ' CD2' ' A' ' 104' ' ' HIS . 0.2 OUTLIER -51.8 -35.11 42.87 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.692 0.282 . . . . 0.0 111.14 -179.955 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.444 ' CZ ' ' O ' ' A' ' 104' ' ' HIS . 1.5 t80 -169.08 67.63 0.65 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.196 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.48 ' HG2' ' CE2' ' A' ' 78' ' ' PHE . 73.0 Cg_endo -75.75 142.66 25.9 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.641 2.227 . . . . 0.0 112.216 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 25.6 tp60 -101.42 10.8 40.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.608 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.2 t -47.46 167.78 0.02 OUTLIER 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.931 0.396 . . . . 0.0 111.211 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -91.49 -22.59 20.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.609 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 19.1 m -137.95 143.98 32.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.982 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.503 ' CE1' ' CG2' ' A' ' 108' ' ' THR . 3.7 m-85 -116.35 121.01 40.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.432 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.415 HD23 ' CE1' ' A' ' 169' ' ' PHE . 5.9 tp -82.38 108.18 15.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.887 0.375 . . . . 0.0 111.031 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 19.4 m -107.87 95.6 3.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.199 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 14.3 m -95.14 155.25 16.81 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.575 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -153.36 128.28 9.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.462 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.1 p -83.62 136.44 34.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.0 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.422 ' N ' ' OE1' ' A' ' 116' ' ' GLN . 58.7 t -45.32 -54.59 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.443 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.413 HG12 ' CG2' ' A' ' 125' ' ' THR . 28.8 m -49.52 112.97 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.682 0.277 . . . . 0.0 110.577 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.407 ' N ' HD21 ' A' ' 129' ' ' LEU . 18.4 m -151.37 122.36 3.76 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.665 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.412 ' O ' ' CB ' ' A' ' 88' ' ' SER . 87.1 Cg_endo -93.81 56.2 0.36 Allowed 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.228 2.619 . . . . 0.0 111.599 179.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.412 ' CB ' ' O ' ' A' ' 87' ' ' PRO . 0.9 OUTLIER 81.11 20.38 0.41 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.07 -179.449 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.418 ' O ' ' CG2' ' A' ' 93' ' ' VAL . 2.8 m -97.29 -27.29 14.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.827 0.346 . . . . 0.0 110.79 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -50.67 -53.86 27.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.016 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -50.18 -45.39 53.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.974 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.413 ' O ' ' N ' ' A' ' 96' ' ' LYS . 24.1 m120 -72.55 -44.58 61.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.872 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.418 ' CG2' ' O ' ' A' ' 89' ' ' SER . 62.0 t -51.34 -37.5 18.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.245 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.433 ' HG3' ' CD1' ' A' ' 145' ' ' LEU . 3.9 tttt -73.34 -49.96 24.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.886 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -82.87 6.98 16.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.562 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.413 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.1 OUTLIER -113.86 -28.47 7.39 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.713 0.292 . . . . 0.0 110.991 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.468 ' CZ2' ' HA2' ' A' ' 10' ' ' GLY . 3.1 m95 -94.32 -49.24 5.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.179 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.471 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 61.8 t -48.62 -47.48 70.72 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.662 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 71.9 Cg_endo -77.9 -16.75 14.24 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.242 1.961 . . . . 0.0 112.517 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.38 -47.0 8.31 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.729 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.414 HG13 ' N ' ' A' ' 102' ' ' THR . 2.0 pt -60.21 -26.71 37.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.026 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.414 ' N ' HG13 ' A' ' 101' ' ' ILE . 27.0 p -82.56 -39.66 21.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.867 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -54.16 -48.73 70.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.799 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.444 ' O ' ' CZ ' ' A' ' 72' ' ' TYR . 0.4 OUTLIER -70.06 -26.83 64.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.715 179.852 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -143.62 99.01 5.28 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.813 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_exo -43.03 99.02 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.6 2.2 . . . . 0.0 112.484 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.5 mmtm 57.61 102.62 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.869 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.503 ' CG2' ' CE1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -133.13 136.76 28.01 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.862 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.96 154.79 48.24 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.555 2.17 . . . . 0.0 112.292 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.42 ' CB ' ' O ' ' A' ' 78' ' ' PHE . 3.7 p90 -165.55 140.39 4.9 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.241 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.424 ' CD2' ' O ' ' A' ' 112' ' ' LEU . 1.8 tt -116.1 153.23 32.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.892 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.432 HD23 ' CB ' ' A' ' 146' ' ' ALA . 0.8 OUTLIER -98.01 161.53 13.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.833 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.431 ' CG1' HG11 ' A' ' 168' ' ' VAL . 10.6 t -140.53 143.59 28.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 121.08 0.467 . . . . 0.0 112.025 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -120.43 108.9 1.49 Allowed Glycine 0 C--N 1.332 0.34 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.625 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.88 5.28 3.08 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.879 0.325 . . . . 0.0 111.879 -178.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.422 ' OE1' ' N ' ' A' ' 84' ' ' VAL . 39.7 tt0 -118.32 -4.03 10.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.753 0.311 . . . . 0.0 110.459 179.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.452 ' CD1' ' O ' ' A' ' 157' ' ' CYS . 0.1 OUTLIER -44.88 -26.47 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.141 179.263 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -73.88 -31.5 63.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.292 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.408 ' N ' ' O ' ' A' ' 116' ' ' GLN . 3.9 mp -85.82 -23.7 27.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.359 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.435 ' CG ' ' O ' ' A' ' 117' ' ' ILE . 1.0 OUTLIER -49.63 -26.18 3.43 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.961 0.41 . . . . 0.0 110.684 179.818 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -85.46 -31.66 22.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.591 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.2 107.18 0.79 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.648 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.421 ' O ' ' CG ' ' A' ' 127' ' ' GLU . 43.1 Cg_endo -68.87 -5.91 16.76 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.493 2.129 . . . . 0.0 113.131 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.1 t -75.75 -67.22 0.69 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.413 ' CG2' HG12 ' A' ' 85' ' ' VAL . 3.1 m -57.81 -38.17 75.06 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.566 178.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.459 ' HA ' ' CD1' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -55.39 -46.36 78.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.81 179.407 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.421 ' CG ' ' O ' ' A' ' 123' ' ' PRO . 4.8 mm-40 -56.34 -35.43 67.6 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.924 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.406 ' HA ' ' CD ' ' A' ' 131' ' ' LYS . 6.0 mptt -65.36 -31.49 72.63 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.459 ' CD1' ' HA ' ' A' ' 126' ' ' ILE . 7.1 mt -73.87 -37.82 64.63 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -44.81 -37.97 4.19 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.224 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.406 ' CD ' ' HA ' ' A' ' 128' ' ' LYS . 0.1 OUTLIER -47.29 -32.6 4.82 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.933 179.816 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -123.12 -31.36 3.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.476 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.523 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 9.3 mmmt -146.98 -100.21 0.09 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 118.993 -0.527 . . . . 0.0 111.132 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.523 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 1.4 pt20 133.29 -21.16 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.281 1.032 . . . . 0.0 110.55 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 16.1 mmtp -68.44 110.95 6.67 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.705 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -85.48 122.27 2.37 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.832 2.355 . . . . 0.0 111.534 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.47 ' CD1' ' N ' ' A' ' 137' ' ' ILE . 1.2 mm -53.72 96.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.009 0.433 . . . . 0.0 110.664 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 33.8 p -68.66 155.82 92.19 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.908 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -50.59 -26.24 16.42 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.699 2.266 . . . . 0.0 111.875 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -81.46 -33.4 32.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.59 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.411 ' CG2' HG21 ' A' ' 137' ' ' ILE . 89.9 m -57.62 -49.17 77.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.636 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.485 ' HB1' ' CD1' ' A' ' 154' ' ' TYR . . . -55.17 -32.79 62.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.789 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -68.14 -40.68 82.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.621 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.59 -49.93 74.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.676 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.433 ' CD1' ' HG3' ' A' ' 94' ' ' LYS . 1.6 tt -70.08 -36.23 74.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.655 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.432 ' CB ' HD23 ' A' ' 112' ' ' LEU . . . -59.55 -58.1 10.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.965 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 38.1 mtt180 -67.86 -24.28 65.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.965 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -50.2 -36.11 29.29 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.785 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.64 23.6 7.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.86 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 37.0 mttt 45.57 59.75 3.45 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.126 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.438 ' O ' ' CG2' ' A' ' 152' ' ' VAL . . . -65.46 -82.39 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.212 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.438 ' CG2' ' O ' ' A' ' 151' ' ' ALA . 45.1 t -161.86 -72.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.653 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 12.4 tppt? -179.8 118.9 0.06 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.883 -178.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.485 ' CD1' ' HB1' ' A' ' 142' ' ' ALA . 63.1 t80 -89.86 110.85 21.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.372 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.438 ' CG2' ' HA ' ' A' ' 168' ' ' VAL . 2.6 t -101.61 167.46 2.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.739 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -106.58 119.06 38.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.123 0.487 . . . . 0.0 111.653 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.452 ' O ' ' CD1' ' A' ' 117' ' ' ILE . 14.8 p -140.19 -172.01 3.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.635 179.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -159.1 127.95 5.31 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.459 -0.497 . . . . 0.0 111.884 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -94.67 20.33 8.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.512 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.472 ' CD1' ' N ' ' A' ' 160' ' ' LEU . 0.0 OUTLIER -129.99 -44.19 1.18 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.327 179.925 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 8.3 t -113.25 -17.84 12.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.984 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 77.45 85.75 0.08 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.2 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 3.7 ttpp -107.82 22.71 15.56 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.051 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 115.44 40.73 0.84 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.793 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.438 HD23 ' CD2' ' A' ' 19' ' ' LEU . 9.2 mt -49.79 -42.79 47.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.77 0.319 . . . . 0.0 110.8 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.56 -32.02 72.5 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.423 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.22 -65.76 0.63 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.738 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.438 ' HA ' ' CG2' ' A' ' 155' ' ' VAL . 8.9 p -48.67 -43.64 13.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 121.081 0.467 . . . . 0.0 110.581 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.54 ' CE1' ' CD1' ' A' ' 19' ' ' LEU . 0.1 OUTLIER -69.3 -27.03 65.04 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.079 179.221 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.57 -29.98 70.37 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -77.9 -39.7 42.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.04 179.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -55.33 -48.22 74.5 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.579 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.429 HD13 ' CD1' ' A' ' 177' ' ' LEU . 1.4 pp -74.4 -33.69 34.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.843 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.434 ' CD1' ' HG ' ' B' ' 505' ' ' LEU . 21.7 tp -50.52 -68.73 0.15 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.928 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -54.44 -22.01 11.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.05 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.402 ' CB ' HG23 ' A' ' 4' ' ' ILE . . . -81.85 -45.84 14.97 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.281 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.446 ' CD2' HG21 ' B' ' 510' ' ' ILE . 2.1 mt -68.57 -25.01 64.68 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.864 0.364 . . . . 0.0 110.734 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.401 ' HB2' ' HA ' ' B' ' 507' ' ' ALA . 0.0 OUTLIER -159.57 151.63 17.17 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.727 179.928 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -53.03 139.07 62.07 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.534 2.156 . . . . 0.0 112.329 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.21 -168.71 0.59 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.546 2.164 . . . . 0.0 112.385 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -143.24 96.97 5.73 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.977 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.03 -165.0 0.26 Allowed 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.613 2.208 . . . . 0.0 112.207 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -116.33 121.03 40.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.945 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 16.4 mttp . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.884 179.979 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 502' ' ' GLY . . . . . 0.402 ' CA ' ' HB2' ' B' ' 511' ' ' SER . . . . . . . . 0 N--CA 1.49 2.272 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 503' ' ' SER . . . . . 0.402 ' N ' ' HB2' ' B' ' 511' ' ' SER . 18.5 m -77.77 -74.92 0.23 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.688 0.28 . . . . 0.0 110.908 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 504' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' B' ' 509' ' ' ASP . . . 105.43 110.08 3.47 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.388 -0.911 . . . . 0.0 112.316 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 505' ' ' LEU . . . . . 0.474 ' N ' ' CD2' ' B' ' 505' ' ' LEU . 1.4 pt? -179.93 44.89 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.755 0.312 . . . . 0.0 110.936 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 506' ' ' SER . . . . . . . . . . . . . 4.8 p 65.78 39.85 4.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.074 0.464 . . . . 0.0 110.48 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 507' ' ' ALA . . . . . 0.425 ' O ' ' HB2' ' B' ' 508' ' ' GLN . . . -144.25 37.56 1.26 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.657 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 508' ' ' GLN . . . . . 0.433 ' HB3' ' CD1' ' B' ' 510' ' ' ILE . 3.3 mt-30 70.04 4.29 4.75 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.09 -178.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 509' ' ' ASP . . . . . 0.404 ' HA ' ' HA2' ' B' ' 504' ' ' GLY . 52.1 t0 67.84 45.49 1.4 Allowed 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 121.012 0.434 . . . . 0.0 111.416 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 510' ' ' ILE . . . . . 0.456 HG21 ' CG2' ' A' ' 46' ' ' ILE . 1.7 mp -84.62 133.11 30.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.945 179.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 511' ' ' SER . . . . . 0.433 ' HB3' ' CG ' ' B' ' 514' ' ' LEU . 40.9 t -109.28 152.78 24.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.805 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 512' ' ' GLN . . . . . 0.488 ' CB ' ' HD3' ' B' ' 513' ' ' PRO . 0.0 OUTLIER -101.3 -57.91 0.11 Allowed Pre-proline 0 CA--C 1.529 0.155 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.426 179.271 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 513' ' ' PRO . . . . . 0.488 ' HD3' ' CB ' ' B' ' 512' ' ' GLN . 49.0 Cg_endo -93.89 63.12 0.39 Allowed 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.096 2.531 . . . . 0.0 112.169 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 514' ' ' LEU . . . . . 0.442 ' CD2' ' O ' ' A' ' 45' ' ' MET . 1.3 mp -70.54 -87.49 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.599 -179.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 515' ' ' GLN . . . . . . . . . . . . . 18.8 mm100 -78.82 -86.73 0.07 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.635 0.255 . . . . 0.0 111.233 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -118.08 -36.73 3.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.856 0.36 . . . . 0.0 110.835 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 517' ' ' SER . . . . . . . . . . . . . 7.3 m 60.73 27.68 17.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.816 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 518' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -163.58 113.09 1.28 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.401 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 519' ' ' ILE . . . . . 0.442 ' CG1' ' HA ' ' A' ' 42' ' ' VAL . 0.5 OUTLIER -137.36 111.34 8.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.124 179.483 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 80.3 m-70 60.64 174.47 0.1 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.012 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 521' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.1 136.8 28.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.812 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 522' ' ' GLY . . . . . 0.477 ' HA3' ' CD1' ' A' ' 37' ' ' PHE . . . -52.81 -174.96 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.474 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 523' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -64.0 -86.57 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.701 0.286 . . . . 0.0 110.871 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 524' ' ' GLY . . . . . 0.425 ' HA2' ' CG1' ' A' ' 36' ' ' VAL . . . 45.96 46.12 14.44 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.72 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 525' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -89.43 46.95 1.42 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.787 0.327 . . . . 0.0 110.958 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 526' ' ' SER . . . . . 0.474 ' CB ' ' CG1' ' A' ' 33' ' ' VAL . 0.5 OUTLIER -87.91 100.58 13.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.67 179.784 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 527' ' ' ASP . . . . . 0.462 ' CB ' ' HD2' ' B' ' 528' ' ' PRO . 0.4 OUTLIER -43.05 167.9 0.07 OUTLIER Pre-proline 0 N--CA 1.464 0.273 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.403 -179.848 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 528' ' ' PRO . . . . . 0.462 ' HD2' ' CB ' ' B' ' 527' ' ' ASP . 9.8 Cg_endo -48.91 102.37 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.925 2.416 . . . . 0.0 111.884 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 529' ' ' ARG . . . . . 0.422 ' CG ' ' O ' ' B' ' 527' ' ' ASP . 11.1 mtp85 -100.84 -55.04 2.67 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.602 -179.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 530' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -148.87 94.02 2.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.405 -179.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 1.8 m -54.24 -173.75 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.606 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 532' ' ' TRP . . . . . 0.494 ' CZ2' ' HG3' ' B' ' 537' ' ' ARG . 13.2 t-105 -107.99 163.17 13.37 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.945 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . 169.86 -30.98 0.15 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.473 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 534' ' ' PHE . . . . . 0.479 ' O ' ' CZ2' ' B' ' 532' ' ' TRP . 4.2 t80 -82.35 115.54 58.47 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.507 0.194 . . . . 0.0 110.745 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -45.25 151.74 0.83 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.48 2.12 . . . . 0.0 112.5 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 65.85 135.13 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.854 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 537' ' ' ARG . . . . . 0.494 ' HG3' ' CZ2' ' B' ' 532' ' ' TRP . 0.0 OUTLIER -99.34 176.25 5.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.107 0.479 . . . . 0.0 111.159 -179.962 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 538' ' ' ILE . . . . . 0.487 ' CD1' ' CB ' ' B' ' 542' ' ' TYR . 0.1 OUTLIER -118.71 139.37 46.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.556 179.649 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 539' ' ' ASP . . . . . 0.419 ' HB2' ' CD2' ' A' ' 70' ' ' LEU . 30.6 p30 -38.84 161.23 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.086 -178.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 540' ' ' GLU . . . . . 0.442 ' HG2' ' N ' ' B' ' 541' ' ' LEU . 0.9 OUTLIER -64.99 -33.44 76.05 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.056 -179.907 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 541' ' ' LEU . . . . . 0.47 ' CB ' ' CD2' ' A' ' 70' ' ' LEU . 4.4 tt -47.59 -29.69 3.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.105 0.479 . . . . 0.0 110.551 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 542' ' ' TYR . . . . . 0.487 ' CB ' ' CD1' ' B' ' 538' ' ' ILE . 6.2 m-85 -105.44 -17.08 14.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.626 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 543' ' ' LEU . . . . . 0.44 ' CD1' ' HA ' ' B' ' 540' ' ' GLU . 1.9 mp -40.11 136.54 1.15 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.89 0.376 . . . . 0.0 111.291 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 544' ' ' GLY . . . . . 0.435 ' HA2' ' CD2' ' A' ' 61' ' ' LEU . . . 157.8 101.68 0.18 Allowed Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.595 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 545' ' ' ASN . . . . . . . . . . . . . 16.3 p30 . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.265 -0.874 . . . . 0.0 111.008 -179.975 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.439 ' HE2' ' N ' ' A' ' 2' ' ' GLN . 7.8 tpt . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.828 0.347 . . . . 0.0 111.2 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.439 ' N ' ' HE2' ' A' ' 1' ' ' MET . 2.1 pt20 -155.44 111.25 3.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.898 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.532 ' CG2' ' CE1' ' A' ' 51' ' ' TYR . 1.3 t -96.37 178.42 5.37 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.536 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.5 ' CG2' ' O ' ' A' ' 3' ' ' THR . 0.3 OUTLIER -165.23 159.94 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.096 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 179.874 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.3 mtpt -111.65 137.47 49.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.329 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 39.8 t -121.55 142.91 49.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.041 0.448 . . . . 0.0 111.503 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.8 t -135.13 120.6 30.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.486 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.4 p -84.71 149.56 4.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.209 0.528 . . . . 0.0 111.051 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.3 m -143.43 130.2 17.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.902 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.67 -140.08 8.71 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.139 -1.029 . . . . 0.0 112.584 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -123.19 27.03 7.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.857 0.361 . . . . 0.0 110.647 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.427 ' CA ' ' HB2' ' B' ' 537' ' ' ARG . . . -120.13 171.42 14.54 Favored Glycine 0 C--N 1.331 0.25 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.651 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.412 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -93.84 -25.3 17.41 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.721 0.296 . . . . 0.0 111.403 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.469 ' CG2' ' CD2' ' A' ' 19' ' ' LEU . 4.1 p -41.52 94.6 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.355 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.432 ' O ' ' CD1' ' A' ' 19' ' ' LEU . . . -151.21 -103.16 0.25 Allowed Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.612 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.457 ' CD ' ' HA ' ' A' ' 38' ' ' ASP . 0.2 OUTLIER -97.93 -43.8 6.94 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 -179.547 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.456 ' O ' ' N ' ' A' ' 21' ' ' ILE . 2.6 p -94.93 -53.12 3.95 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 37.2 t -32.04 -69.62 0.08 Allowed 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -178.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.487 HD11 ' CZ ' ' A' ' 169' ' ' PHE . 0.5 OUTLIER -58.68 -68.09 0.3 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.393 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.423 ' O ' ' N ' ' A' ' 23' ' ' TYR . 2.9 mm? -61.05 -67.44 0.4 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -178.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.492 ' CG2' ' N ' ' A' ' 22' ' ' SER . 1.3 tp -37.08 -54.54 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -179.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.492 ' N ' ' CG2' ' A' ' 21' ' ' ILE . 0.4 OUTLIER -67.92 -30.21 69.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.791 0.329 . . . . 0.0 110.858 -179.557 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.423 ' N ' ' O ' ' A' ' 20' ' ' LEU . 27.3 t80 -53.79 -37.95 64.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.132 0.492 . . . . 0.0 109.987 179.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.49 -31.68 11.16 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.667 179.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.432 ' CG2' ' O ' ' A' ' 21' ' ' ILE . 3.3 t -136.82 79.79 1.78 Allowed 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.984 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.411 ' ND2' ' OG ' ' A' ' 22' ' ' SER . 1.4 m120 -66.6 79.28 0.11 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.298 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.4 mmtm -100.29 101.04 11.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.746 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.57 ' CE1' ' CZ2' ' B' ' 532' ' ' TRP . 0.1 OUTLIER -99.28 -53.61 0.19 Allowed Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.648 -179.67 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.404 ' HD3' ' HB3' ' A' ' 28' ' ' PHE . 84.7 Cg_endo -88.54 69.95 2.69 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.76 2.307 . . . . 0.0 112.981 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -144.8 -92.68 0.1 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.667 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -159.62 158.64 31.96 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.745 0.307 . . . . 0.0 110.818 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -133.07 99.98 4.73 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.406 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.451 ' HB ' ' CD ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -162.49 -63.46 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.866 -179.398 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.46 ' O ' ' N ' ' A' ' 36' ' ' VAL . 2.9 Cg_exo -36.07 -29.73 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.381 2.721 . . . . 0.0 113.012 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.429 HG22 ' CG2' ' A' ' 17' ' ' THR . 21.2 m -63.85 71.1 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.754 0.312 . . . . 0.0 110.886 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.482 HG11 ' CD1' ' A' ' 37' ' ' PHE . 10.2 p -130.55 -3.82 2.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.482 ' CD1' HG11 ' A' ' 36' ' ' VAL . 0.7 OUTLIER -84.22 50.05 1.78 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.742 0.306 . . . . 0.0 111.242 -179.793 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.457 ' HA ' ' CD ' ' A' ' 16' ' ' LYS . 5.5 m-20 -58.97 -21.43 58.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.158 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -86.98 -6.21 58.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.629 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.466 ' CD1' ' O ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -60.77 157.18 15.41 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.848 0.356 . . . . 0.0 110.913 179.935 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.4 ' HB1' HD13 ' B' ' 519' ' ' ILE . . . -108.07 175.72 5.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.35 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.455 ' CA ' HD11 ' B' ' 519' ' ' ILE . 12.8 m -140.57 121.71 14.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.167 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.421 ' O ' ' CG1' ' A' ' 44' ' ' VAL . 1.1 t -86.25 104.71 16.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.042 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.465 ' CG2' ' CG2' ' A' ' 52' ' ' THR . 24.9 m -158.19 -177.28 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.918 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.485 ' HE3' ' N ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -121.01 99.61 6.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.485 -179.523 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.454 HG23 ' CG2' ' B' ' 510' ' ' ILE . 0.7 OUTLIER -75.93 86.02 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 178.723 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.438 ' N ' ' HE2' ' A' ' 45' ' ' MET . . . 27.91 96.26 0.01 OUTLIER Glycine 0 C--N 1.337 0.616 0 CA-C-N 115.667 -0.697 . . . . 0.0 114.275 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.434 ' N ' ' HE3' ' A' ' 45' ' ' MET . . . 137.64 -92.32 0.21 Allowed Glycine 0 CA--C 1.518 0.262 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.024 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.485 ' N ' ' HE3' ' A' ' 45' ' ' MET . 0.7 OUTLIER -137.44 138.49 24.89 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-O 120.757 0.313 . . . . 0.0 111.222 -179.828 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.42 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 62.0 Cg_exo -35.77 95.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.315 2.677 . . . . 0.0 113.079 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.532 ' CE1' ' CG2' ' A' ' 3' ' ' THR . 2.5 t80 -173.0 105.2 0.14 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.307 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.465 ' CG2' ' CG2' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -124.06 153.64 41.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.473 -178.933 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.45 HD22 ' CA ' ' A' ' 4' ' ' ILE . 6.7 tp -102.73 146.7 27.83 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.75 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.89 -162.81 23.44 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.241 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.472 ' N ' ' CD2' ' A' ' 55' ' ' LEU . 1.2 mm? -121.88 114.17 20.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.813 0.34 . . . . 0.0 110.44 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -84.26 105.71 15.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.6 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -138.65 -176.33 4.44 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.088 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.441 ' HB ' ' CG ' ' A' ' 69' ' ' PRO . 0.1 OUTLIER -125.63 143.33 51.07 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.943 -179.647 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.456 ' CB ' ' HA ' ' A' ' 36' ' ' VAL . . . -147.78 100.7 3.24 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.936 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' B' ' 542' ' ' TYR . . . -75.66 80.9 1.01 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.63 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.424 ' CD1' HG11 ' A' ' 33' ' ' VAL . 3.1 mm? -121.3 -119.74 0.3 Allowed 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 110.577 -0.157 . . . . 0.0 110.577 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -98.53 -30.49 12.49 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-N 118.151 0.432 . . . . 0.0 111.075 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.34 -63.2 1.25 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.148 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.449 ' HB2' ' CD1' ' A' ' 67' ' ' LEU . 75.6 m-85 -87.67 146.34 25.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.037 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -86.5 -68.72 0.72 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.174 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.433 ' HD2' ' N ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -98.89 -50.33 4.24 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.924 -179.638 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.449 ' CD1' ' HB2' ' A' ' 64' ' ' TYR . 0.6 OUTLIER 65.35 114.95 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.629 0.252 . . . . 0.0 110.846 -179.753 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.492 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.5 OUTLIER -149.14 44.0 0.31 Allowed Pre-proline 0 C--N 1.329 -0.297 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 179.616 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.492 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 90.6 Cg_endo -83.08 -42.98 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.344 2.029 . . . . 0.0 112.269 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.455 ' CD2' ' HB2' ' B' ' 541' ' ' LEU . 0.2 OUTLIER -63.08 -16.34 59.62 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.322 -179.842 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 93.9 p -46.37 -56.3 6.07 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.854 0.359 . . . . 0.0 111.274 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -156.89 65.28 3.65 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.944 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.481 ' HB2' ' CZ ' ' A' ' 78' ' ' PHE . 35.0 Cg_exo -59.59 154.62 47.26 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.542 2.161 . . . . 0.0 112.233 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 7.4 mm-40 -98.5 10.33 41.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.309 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.1 m -56.7 161.36 2.84 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.818 0.342 . . . . 0.0 110.924 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.76 7.27 30.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.487 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -156.95 91.7 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.334 -0.084 0 CA-C-O 120.859 0.361 . . . . 0.0 111.219 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.481 ' CZ ' ' HB2' ' A' ' 73' ' ' PRO . 3.1 m-85 -80.88 -177.04 6.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.622 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.421 HD23 ' CG2' ' A' ' 113' ' ' VAL . 1.1 tt -149.83 114.19 5.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.972 0.415 . . . . 0.0 111.5 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.416 ' N ' HD21 ' A' ' 79' ' ' LEU . 2.1 t -98.6 156.4 3.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.285 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.437 ' CB ' HG13 ' A' ' 14' ' ' VAL . 1.8 p -152.04 153.08 33.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.086 0.47 . . . . 0.0 111.751 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.514 ' CE1' ' CE1' ' A' ' 90' ' ' PHE . 9.1 p90 -166.32 134.24 2.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.261 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.43 ' CB ' ' HG3' ' A' ' 116' ' ' GLN . 0.3 OUTLIER -85.34 141.72 29.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.942 -179.802 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.441 HG13 ' N ' ' A' ' 137' ' ' ILE . 57.8 t -44.47 -55.14 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.359 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.445 ' CA ' HD23 ' A' ' 129' ' ' LEU . 34.9 m -47.81 115.71 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.732 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.417 ' N ' HD23 ' A' ' 129' ' ' LEU . 5.1 p -150.94 129.78 6.26 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.584 -179.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.425 ' O ' ' CB ' ' A' ' 132' ' ' ASN . 87.4 Cg_endo -90.83 50.37 0.85 Allowed 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.043 2.495 . . . . 0.0 111.963 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.45 ' N ' ' HB3' ' A' ' 133' ' ' LYS . 0.3 OUTLIER 76.35 14.37 2.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.522 -179.785 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 8.4 t -97.39 -27.06 14.64 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.994 0.426 . . . . 0.0 110.583 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.514 ' CE1' ' CE1' ' A' ' 82' ' ' PHE . 59.3 t80 -51.14 -33.35 26.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.034 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.2 -48.51 28.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.191 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -69.1 -44.81 71.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.183 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.481 HG23 ' CZ3' ' A' ' 97' ' ' TRP . 11.6 p -58.84 -45.31 91.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.366 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.459 ' HE2' ' CE2' ' A' ' 82' ' ' PHE . 9.2 mmtt -59.62 -57.32 13.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.792 0.33 . . . . 0.0 110.997 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.423 ' O ' ' CG ' ' A' ' 99' ' ' PRO . 70.0 mm-40 -62.22 -18.5 61.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.259 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.8 tmtt? -101.49 -12.42 18.55 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.489 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.481 ' CZ3' HG23 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -84.27 -56.7 3.51 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.787 0.327 . . . . 0.0 111.124 -179.823 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.482 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 5.1 t -49.48 -46.6 78.41 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.643 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.482 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 82.1 Cg_exo -44.63 -41.23 14.47 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.458 2.105 . . . . 0.0 112.85 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.429 ' CG ' ' O ' ' A' ' 97' ' ' TRP . 2.1 pt-20 -79.51 -31.72 42.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.058 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.425 ' N ' ' HG3' ' A' ' 100' ' ' GLU . 23.0 mt -53.74 -41.71 48.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.018 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 23.1 p -93.81 -21.05 19.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.981 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -60.24 -31.46 70.22 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.936 0.398 . . . . 0.0 110.69 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 -88.64 -25.77 22.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.886 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -144.58 136.19 12.81 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.792 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -59.48 -15.28 29.52 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.598 2.199 . . . . 0.0 112.607 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -169.6 84.05 0.13 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.825 0.345 . . . . 0.0 110.906 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -108.79 101.82 45.52 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.813 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -60.4 155.17 48.31 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.493 2.128 . . . . 0.0 112.122 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.42 ' O ' ' CG2' ' A' ' 152' ' ' VAL . 32.1 p90 -155.99 169.4 24.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.188 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.474 ' CD1' ' CG1' ' A' ' 152' ' ' VAL . 0.7 OUTLIER -132.85 150.18 52.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.863 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.479 HD12 ' CE2' ' A' ' 82' ' ' PHE . 0.3 OUTLIER -98.93 161.57 13.56 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.113 -179.745 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.421 ' CG2' HD23 ' A' ' 79' ' ' LEU . 2.5 t -136.81 144.04 33.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.036 0.446 . . . . 0.0 111.805 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.479 ' HA3' ' CZ ' ' A' ' 154' ' ' TYR . . . -133.15 103.83 0.52 Allowed Glycine 0 C--N 1.33 0.233 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.697 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.406 ' HB ' ' HA ' ' A' ' 158' ' ' SER . 0.4 OUTLIER -125.01 -1.41 7.79 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -178.647 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.44 ' NE2' ' CD1' ' A' ' 119' ' ' LEU . 0.0 OUTLIER -99.2 -8.39 25.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.974 0.416 . . . . 0.0 110.011 178.78 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -49.25 -24.02 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.563 178.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -86.13 -20.51 28.54 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.562 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.44 ' CD1' ' NE2' ' A' ' 116' ' ' GLN . 4.2 pp -110.89 -12.84 14.21 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 9.1 ptt85 -50.88 -25.33 4.43 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.911 0.386 . . . . 0.0 110.72 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -72.24 -24.86 61.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.912 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -47.0 101.27 0.26 Allowed Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.838 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.418 ' O ' ' CG ' ' A' ' 127' ' ' GLU . 17.1 Cg_exo -67.4 -6.07 15.53 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.77 2.314 . . . . 0.0 113.021 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.7 t -84.67 -67.06 0.83 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.026 0.441 . . . . 0.0 110.001 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.9 m -52.47 -33.84 46.42 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.381 0.61 . . . . 0.0 109.358 178.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.477 ' HA ' ' CD1' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -60.03 -40.83 84.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.455 179.017 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.418 ' CG ' ' O ' ' A' ' 123' ' ' PRO . 3.7 mm-40 -56.13 -35.85 67.58 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.262 178.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -66.86 -32.71 74.16 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.477 ' CD1' ' HA ' ' A' ' 126' ' ' ILE . 7.3 mt -73.36 -41.55 63.28 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 177.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.458 ' HA ' ' HB3' ' A' ' 134' ' ' GLN . . . -48.88 -26.01 2.22 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.202 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 16.2 mmtp -65.6 -33.91 77.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.773 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.425 ' CB ' ' O ' ' A' ' 87' ' ' PRO . 39.1 m-80 -123.8 -30.6 3.54 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -179.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.492 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 0.0 OUTLIER -133.62 -72.53 0.5 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 120.991 -0.284 . . . . 0.0 111.424 -178.85 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.492 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 2.7 pt20 99.58 -37.4 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.959 0.903 . . . . 0.0 110.658 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.18 107.48 2.17 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.897 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.439 ' HG3' ' CD1' ' A' ' 126' ' ' ILE . 3.0 Cg_exo -80.65 134.96 10.06 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.823 2.349 . . . . 0.0 111.221 179.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.497 HG23 ' CZ ' ' A' ' 90' ' ' PHE . 0.8 OUTLIER -67.13 96.48 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.882 0.372 . . . . 0.0 110.817 -179.608 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 6.2 p -67.74 159.23 79.96 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.079 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -50.62 -28.99 23.76 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.636 2.224 . . . . 0.0 112.274 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -82.65 -26.72 31.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.701 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 8.7 m -66.66 -51.16 59.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.782 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.474 ' HB2' ' CD1' ' A' ' 154' ' ' TYR . . . -55.49 -37.98 68.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.924 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -66.54 -45.39 79.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.908 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp -54.22 -64.07 0.95 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.993 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.431 ' CD1' ' HG3' ' A' ' 94' ' ' LYS . 5.3 tt -60.6 -42.75 97.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.9 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.416 ' CB ' ' O ' ' A' ' 142' ' ' ALA . . . -48.99 -61.99 1.77 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.05 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.2 mtp85 -63.51 -23.14 67.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.861 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -50.16 -50.95 47.42 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.827 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -93.65 -72.14 0.62 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.673 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 170.26 60.44 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.516 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.454 ' O ' ' N ' ' A' ' 153' ' ' LYS . . . -94.81 27.46 3.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.535 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.474 ' CG1' ' CD1' ' A' ' 111' ' ' LEU . 75.8 t 61.11 -74.75 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.454 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.454 ' N ' ' O ' ' A' ' 151' ' ' ALA . 1.6 ttpt -176.41 121.74 0.16 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.829 -179.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.479 ' CZ ' ' HA3' ' A' ' 114' ' ' GLY . 13.2 t80 -84.97 112.38 20.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.688 179.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 3.2 t -101.28 156.11 4.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.181 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -94.19 127.58 40.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.584 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.415 ' HA ' ' HB3' ' A' ' 163' ' ' LYS . 1.1 p 178.62 125.12 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.305 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.406 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 37.1 m -104.53 155.76 18.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.959 0.409 . . . . 0.0 111.657 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.428 ' CB ' HD11 ' A' ' 165' ' ' LEU . . . -92.2 -52.65 4.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.592 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -48.3 -29.78 4.2 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.738 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.9 -21.97 10.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.914 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 69.19 62.46 0.3 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.804 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.415 ' HB3' ' HA ' ' A' ' 157' ' ' CYS . 0.1 OUTLIER -93.41 35.99 1.08 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.255 -179.75 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 95.21 46.56 2.79 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.21 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.445 ' CD1' ' HA ' ' A' ' 19' ' ' LEU . 0.4 OUTLIER -53.49 -29.88 38.31 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.988 0.423 . . . . 0.0 110.588 179.688 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 28.8 pttt -68.52 -24.54 64.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.763 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 30.7 t30 -58.25 -68.95 0.2 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.565 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 14.4 p -54.28 -45.81 68.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.565 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.487 ' CZ ' HD11 ' A' ' 19' ' ' LEU . 1.2 t80 -60.38 -41.02 92.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.501 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -54.91 -34.96 63.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.875 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -75.89 -26.47 57.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.174 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.85 -42.96 97.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.213 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.417 HD11 ' N ' ' A' ' 174' ' ' LEU . 0.0 OUTLIER -89.94 -23.45 6.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.633 -179.866 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.418 ' CD1' ' HB3' ' B' ' 505' ' ' LEU . 2.8 tp -49.05 -43.83 41.19 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.989 0.423 . . . . 0.0 110.41 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -62.14 -27.36 68.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.995 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.466 ' CB ' HG22 ' A' ' 4' ' ' ILE . . . -87.71 -39.41 14.99 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.636 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.475 ' CD1' HG13 ' A' ' 4' ' ' ILE . 0.6 OUTLIER -68.61 -26.39 65.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.518 179.628 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.436 ' CB ' ' HD2' ' A' ' 179' ' ' PRO . 0.5 OUTLIER -166.82 167.72 7.64 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.651 179.861 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . 0.436 ' HD2' ' CB ' ' A' ' 178' ' ' GLU . 18.9 Cg_endo -60.27 118.77 5.69 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.541 2.161 . . . . 0.0 112.229 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.87 153.96 63.59 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.527 2.151 . . . . 0.0 112.423 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -149.63 119.92 3.96 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.822 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.01 -164.89 0.25 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.429 2.086 . . . . 0.0 112.219 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 11.9 mmtt -105.0 83.41 1.98 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.958 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.16 -0.924 . . . . 0.0 110.819 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.221 0 N-CA-C 112.525 -0.23 . . . . 0.0 112.525 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 503' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.74 -49.32 3.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.751 0.31 . . . . 0.0 111.011 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 504' ' ' GLY . . . . . 0.437 ' O ' ' CD2' ' B' ' 505' ' ' LEU . . . 124.78 -93.52 0.45 Allowed Glycine 0 CA--C 1.508 -0.405 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.862 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 505' ' ' LEU . . . . . 0.487 ' CD1' ' N ' ' B' ' 505' ' ' LEU . 0.1 OUTLIER 74.17 0.28 3.56 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 179.45 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 506' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 52.93 23.79 3.04 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.022 0.439 . . . . 0.0 111.047 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 507' ' ' ALA . . . . . . . . . . . . . . . -107.86 -74.25 0.66 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.774 0.797 . . . . 0.0 109.506 179.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 508' ' ' GLN . . . . . 0.412 ' O ' ' HB3' ' B' ' 509' ' ' ASP . 0.0 OUTLIER -137.82 4.95 2.58 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.28 -1.327 . . . . 0.0 110.213 179.061 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 509' ' ' ASP . . . . . 0.412 ' HB3' ' O ' ' B' ' 508' ' ' GLN . 48.6 t0 72.47 38.85 0.78 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.587 0.708 . . . . 0.0 109.765 -178.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 510' ' ' ILE . . . . . 0.454 ' CG2' HG23 ' A' ' 46' ' ' ILE . 1.3 mt -66.34 143.72 15.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.847 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 511' ' ' SER . . . . . . . . . . . . . 47.2 t -109.44 148.0 31.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.498 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 512' ' ' GLN . . . . . 0.487 ' CB ' ' CD ' ' B' ' 513' ' ' PRO . 0.0 OUTLIER -98.62 -67.7 0.05 OUTLIER Pre-proline 0 CA--C 1.53 0.176 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.752 179.547 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 513' ' ' PRO . . . . . 0.487 ' CD ' ' CB ' ' B' ' 512' ' ' GLN . 88.1 Cg_endo -79.16 56.95 6.24 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.456 2.104 . . . . 0.0 111.917 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 514' ' ' LEU . . . . . 0.428 ' CD1' ' O ' ' A' ' 45' ' ' MET . 0.9 OUTLIER -64.1 -87.01 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.39 -179.568 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 515' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -93.07 -158.71 0.63 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.74 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 15.1 m-80 -50.37 -29.0 9.03 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.934 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 517' ' ' SER . . . . . 0.458 ' O ' ' CD1' ' B' ' 518' ' ' PHE . 0.9 OUTLIER 39.85 53.92 2.59 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.821 179.927 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 518' ' ' PHE . . . . . 0.458 ' CD1' ' O ' ' B' ' 517' ' ' SER . 6.1 m-85 -163.29 119.46 1.77 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.915 0.388 . . . . 0.0 111.438 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 519' ' ' ILE . . . . . 0.455 HD11 ' CA ' ' A' ' 42' ' ' VAL . 8.9 mt -126.83 82.49 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.058 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 41.8 p-80 -54.21 101.24 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.767 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 521' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.82 31.79 1.81 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.097 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 522' ' ' GLY . . . . . 0.471 ' HA3' ' CD1' ' A' ' 37' ' ' PHE . . . -111.12 -177.83 20.42 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.409 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 523' ' ' HIS . . . . . 0.455 ' CD2' ' N ' ' B' ' 524' ' ' GLY . 34.4 t60 -117.9 -85.64 0.64 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.744 0.306 . . . . 0.0 110.956 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 524' ' ' GLY . . . . . 0.455 ' N ' ' CD2' ' B' ' 523' ' ' HIS . . . 52.71 -144.4 21.87 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.604 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 525' ' ' ASP . . . . . . . . . . . . . 19.8 p30 -149.82 85.3 1.42 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.833 0.349 . . . . 0.0 110.933 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 526' ' ' SER . . . . . 0.405 ' CB ' ' HB3' ' A' ' 34' ' ' PRO . 2.4 m -74.92 95.64 3.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.662 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 527' ' ' ASP . . . . . . . . . . . . . 43.1 p-10 -153.97 150.58 22.99 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.919 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.36 100.98 0.94 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.72 2.28 . . . . 0.0 112.348 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 529' ' ' ARG . . . . . . . . . . . . . 39.7 mtp180 -100.41 -55.24 2.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.296 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 530' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -168.51 95.79 0.38 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.107 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 531' ' ' CYS . . . . . 0.412 ' O ' ' N ' ' B' ' 533' ' ' GLY . 18.3 t -49.79 130.64 21.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.014 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 532' ' ' TRP . . . . . 0.57 ' CZ2' ' CE1' ' A' ' 28' ' ' PHE . 0.0 OUTLIER 60.42 -81.84 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.933 179.893 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 533' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' B' ' 531' ' ' CYS . . . 92.3 -35.38 4.05 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.613 -0.804 . . . . 0.0 112.592 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 534' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -155.17 156.94 31.65 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.634 0.254 . . . . 0.0 110.846 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -53.21 -59.1 1.12 Allowed 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.749 2.299 . . . . 0.0 112.088 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -86.87 141.41 28.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.636 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 537' ' ' ARG . . . . . 0.427 ' HB2' ' CA ' ' A' ' 12' ' ' GLY . 25.4 mmt-85 -65.89 136.24 55.86 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.133 0.492 . . . . 0.0 111.214 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 538' ' ' ILE . . . . . 0.41 HG13 ' HB2' ' B' ' 542' ' ' TYR . 6.3 tp -59.57 143.22 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.208 179.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 539' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -44.13 143.41 1.18 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.874 0.369 . . . . 0.0 111.035 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 540' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -50.4 -24.39 3.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.014 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 541' ' ' LEU . . . . . 0.455 ' HB2' ' CD2' ' A' ' 70' ' ' LEU . 0.1 OUTLIER -55.3 -27.04 44.21 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 121.4 0.619 . . . . 0.0 109.77 179.07 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 542' ' ' TYR . . . . . 0.418 ' O ' ' N ' ' A' ' 60' ' ' GLY . 14.2 m-85 -104.23 -63.05 1.24 Allowed 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.903 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 543' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 49.73 103.86 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.318 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . 118.28 -100.99 0.87 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.529 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 545' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.919 -179.884 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.434 ' CE ' HG22 ' A' ' 46' ' ' ILE . 3.0 ptm . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.796 0.332 . . . . 0.0 111.21 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.427 ' N ' ' HG3' ' A' ' 1' ' ' MET . 0.0 OUTLIER 57.65 161.88 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.706 -179.891 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.505 HG23 ' CZ ' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -129.93 -177.41 4.28 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.333 -179.786 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.479 ' CG2' ' CD2' ' A' ' 177' ' ' LEU . 6.0 pt -153.89 148.22 13.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.758 -179.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.1 mttt -134.0 95.7 3.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.095 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -112.31 155.29 24.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.406 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -137.2 159.58 36.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.309 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.469 ' CG2' ' CB ' ' A' ' 16' ' ' LYS . 60.1 t -90.0 113.68 26.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.997 0.427 . . . . 0.0 111.299 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.452 ' CA ' ' HG2' ' B' ' 540' ' ' GLU . 93.5 t -130.65 129.48 64.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.673 179.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 138.73 -113.19 0.92 Allowed Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.014 -1.089 . . . . 0.0 113.013 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -110.61 -53.65 2.67 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.448 ' O ' ' CG1' ' A' ' 8' ' ' VAL . . . -140.06 -148.48 5.18 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.176 -1.011 . . . . 0.0 113.494 -179.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.427 ' O ' ' CG2' ' A' ' 14' ' ' VAL . . . -41.4 -31.97 0.28 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.433 HG21 HG11 ' A' ' 8' ' ' VAL . 6.3 m 48.08 25.52 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.966 0.412 . . . . 0.0 110.721 -178.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.462 ' HA2' ' CD1' ' A' ' 19' ' ' LEU . . . 83.36 26.53 43.16 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.951 -0.643 . . . . 0.0 112.723 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.484 ' HA ' ' CZ ' ' A' ' 169' ' ' PHE . 5.6 tptm -98.19 -72.91 0.63 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.776 0.322 . . . . 0.0 111.699 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.1 p -96.06 -58.32 2.12 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.456 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.406 ' HA ' ' CG1' ' A' ' 21' ' ' ILE . 12.0 t -42.34 -46.62 4.67 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.693 0.282 . . . . 0.0 111.64 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.462 ' CD1' ' HA2' ' A' ' 15' ' ' GLY . 0.7 OUTLIER -47.15 -49.74 21.79 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.886 0.374 . . . . 0.0 110.724 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.7 mt -64.75 -24.18 67.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.399 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.446 ' O ' ' N ' ' A' ' 25' ' ' THR . 14.2 mm -73.99 -70.52 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.19 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 59.8 p -48.26 -27.53 2.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.742 0.306 . . . . 0.0 111.048 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -70.44 -67.36 0.5 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.742 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 89.6 m -72.23 -48.58 41.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.647 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.446 ' N ' ' O ' ' A' ' 21' ' ' ILE . 20.6 p -85.58 -151.12 0.14 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.382 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -160.28 29.39 0.17 Allowed 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.859 0.361 . . . . 0.0 111.077 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.58 104.83 9.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.281 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.493 ' CD2' ' HD3' ' A' ' 29' ' ' PRO . 0.1 OUTLIER -110.34 -61.71 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.106 -179.977 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.493 ' HD3' ' CD2' ' A' ' 28' ' ' PHE . 91.5 Cg_endo -86.61 89.35 0.67 Allowed 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.369 2.046 . . . . 0.0 113.052 -179.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.3 p -163.94 -94.74 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.395 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.491 ' CG ' ' HA ' ' B' ' 530' ' ' HIS . 0.2 OUTLIER -160.25 121.87 3.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.716 0.293 . . . . 0.0 110.818 179.684 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -101.96 94.23 5.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.934 0.397 . . . . 0.0 110.809 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.409 ' CB ' ' HD3' ' A' ' 34' ' ' PRO . 0.6 OUTLIER -98.73 -51.97 0.2 Allowed Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.367 -179.757 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.409 ' HD3' ' CB ' ' A' ' 33' ' ' VAL . 7.0 Cg_exo -73.9 55.94 3.47 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.812 2.341 . . . . 0.0 112.44 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.7 t -116.77 -33.68 4.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.665 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.441 ' HB ' ' CD1' ' A' ' 61' ' ' LEU . 7.6 p -52.6 -27.1 11.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.802 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -93.97 40.08 1.08 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.535 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.61 36.17 1.1 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.978 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -123.77 18.15 9.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.142 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.411 ' CD2' ' HB ' ' B' ' 521' ' ' THR . 0.2 OUTLIER -75.74 -165.39 0.44 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.789 0.328 . . . . 0.0 110.71 179.973 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -96.18 161.76 13.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.164 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.407 ' CG1' ' O ' ' B' ' 517' ' ' SER . 7.6 m -149.47 129.44 3.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.147 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.0 t -87.9 106.13 17.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.632 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.46 ' HB ' ' CG2' ' A' ' 52' ' ' THR . 1.8 t -161.1 157.86 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.726 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.468 ' HE1' ' N ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -101.74 97.61 7.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.711 -179.481 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.451 HG21 ' CG2' ' B' ' 510' ' ' ILE . 3.0 mm -77.0 86.38 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.446 ' N ' ' HE3' ' A' ' 45' ' ' MET . . . 25.63 98.63 0.01 OUTLIER Glycine 0 C--N 1.339 0.73 0 CA-C-N 115.505 -0.77 . . . . 0.0 114.435 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.427 ' N ' ' HE1' ' A' ' 45' ' ' MET . . . 128.46 -89.89 0.32 Allowed Glycine 0 CA--C 1.519 0.281 0 C-N-CA 120.596 -0.811 . . . . 0.0 113.007 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.468 ' N ' ' HE1' ' A' ' 45' ' ' MET . 1.4 pt-20 -124.73 139.85 34.26 Favored Pre-proline 0 CA--C 1.53 0.202 0 CA-C-O 120.799 0.333 . . . . 0.0 111.233 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.453 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 78.9 Cg_exo -38.12 101.26 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 123.074 2.516 . . . . 0.0 112.822 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.505 ' CZ ' HG23 ' A' ' 3' ' ' THR . 2.2 t80 -172.98 154.69 2.89 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.436 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.46 ' CG2' ' HB ' ' A' ' 44' ' ' VAL . 0.1 OUTLIER -136.72 152.99 50.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.746 179.046 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.431 HD13 ' CD1' ' A' ' 4' ' ' ILE . 0.0 OUTLIER -74.94 161.53 29.42 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.002 -179.899 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -88.8 87.51 1.49 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.626 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.405 ' HG ' HD22 ' A' ' 53' ' ' LEU . 1.1 mp -58.37 99.9 0.05 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.844 0.354 . . . . 0.0 110.664 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -84.76 105.76 15.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.997 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -104.14 129.16 51.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.84 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.43 ' HA ' ' CD2' ' A' ' 67' ' ' LEU . 26.4 p -98.21 126.14 43.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.979 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.47 ' CB ' ' CD1' ' A' ' 61' ' ' LEU . . . -157.63 118.43 3.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.317 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.402 ' HA2' ' O ' ' A' ' 64' ' ' TYR . . . -69.36 73.85 0.42 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.286 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.47 ' CD1' ' CB ' ' A' ' 59' ' ' ALA . 6.7 mp -120.7 -117.26 0.31 Allowed 'General case' 0 CA--C 1.539 0.536 0 O-C-N 122.944 -0.151 . . . . 0.0 111.052 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -99.08 -31.3 11.85 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 118.069 0.395 . . . . 0.0 111.426 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.425 ' CB ' HG23 ' A' ' 36' ' ' VAL . 6.2 t0 -74.33 -63.26 1.27 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.311 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.454 ' CB ' ' CD2' ' A' ' 67' ' ' LEU . 0.2 OUTLIER -115.95 133.69 55.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.718 -179.759 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.95 -69.12 0.7 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.838 0.352 . . . . 0.0 111.146 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.404 ' O ' ' HB2' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -99.44 -34.99 10.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.33 -179.885 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.454 ' CD2' ' CB ' ' A' ' 64' ' ' TYR . 1.0 OUTLIER 70.15 123.88 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.978 -179.652 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.458 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 2.5 mpt_? -82.91 -49.26 0.77 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.147 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.458 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 83.0 Cg_exo -44.83 -58.37 1.59 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.588 2.192 . . . . 0.0 112.538 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.432 ' CD2' ' HA ' ' B' ' 541' ' ' LEU . 0.2 OUTLIER -51.08 -38.31 50.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.69 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.1 t -76.74 -53.78 7.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.906 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -114.32 61.57 1.12 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.638 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.428 ' N ' ' O ' ' A' ' 69' ' ' PRO . 52.1 Cg_endo -68.65 112.44 2.87 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.575 2.184 . . . . 0.0 112.466 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 15.2 tp60 -101.96 10.16 39.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.375 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.34 166.64 0.81 Allowed 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 120.802 0.334 . . . . 0.0 110.809 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -72.74 -26.02 61.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.707 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.3 p -164.4 116.31 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.132 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.52 ' CZ ' ' CG2' ' A' ' 108' ' ' THR . 0.0 OUTLIER -92.89 134.51 35.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.166 179.349 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.424 ' CD2' ' O ' ' A' ' 14' ' ' VAL . 7.5 tp -70.6 108.01 4.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.095 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.441 ' CG2' ' HB2' ' A' ' 110' ' ' PHE . 23.3 m -103.54 121.09 54.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.013 179.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.43 ' HB2' ' CB ' ' A' ' 14' ' ' VAL . 41.1 m -129.13 171.42 12.42 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.359 0.599 . . . . 0.0 112.493 -178.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.474 ' CE2' HG22 ' A' ' 137' ' ' ILE . 41.3 p90 -140.86 -174.04 3.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.88 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.3 p -134.66 122.74 22.68 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.808 0.337 . . . . 0.0 111.071 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.436 ' HA ' HG12 ' A' ' 137' ' ' ILE . 2.9 t -57.15 170.52 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.184 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.437 ' CG2' HD11 ' A' ' 119' ' ' LEU . 0.0 OUTLIER 61.09 105.57 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -179.287 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.448 ' N ' HD23 ' A' ' 129' ' ' LEU . 13.9 p -152.5 143.16 15.5 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-O 120.956 0.408 . . . . 0.0 112.039 -179.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.433 ' O ' ' CB ' ' A' ' 88' ' ' SER . 83.1 Cg_endo -90.84 53.36 1.01 Allowed 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.29 2.66 . . . . 0.0 111.585 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 87' ' ' PRO . 0.3 OUTLIER 84.29 25.62 0.1 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.663 -179.533 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.413 ' O ' ' CG2' ' A' ' 93' ' ' VAL . 2.8 p -97.23 -25.1 15.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.992 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.469 ' CE2' HG22 ' A' ' 141' ' ' THR . 19.4 t80 -53.86 -43.79 69.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.016 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -53.96 -61.71 2.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.929 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.419 ' O ' ' N ' ' A' ' 96' ' ' LYS . 30.0 m-80 -53.88 -42.31 68.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.941 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.413 ' CG2' ' O ' ' A' ' 89' ' ' SER . 60.1 t -47.47 -63.74 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.303 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.423 ' HG3' ' CG ' ' A' ' 145' ' ' LEU . 0.0 OUTLIER -51.04 -45.75 61.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.869 179.91 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -85.31 10.79 11.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.723 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.2 OUTLIER -111.04 -36.18 5.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.934 0.397 . . . . 0.0 110.976 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 33.4 m95 -94.36 -42.95 8.63 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.543 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.454 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 82.3 t -53.26 -47.3 96.53 Favored Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 77.9 Cg_endo -78.95 -18.52 11.44 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.237 1.958 . . . . 0.0 112.629 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -81.61 -40.18 23.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.923 0.392 . . . . 0.0 110.492 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.498 ' CD1' ' CD2' ' A' ' 110' ' ' PHE . 32.8 pt -69.49 -29.79 43.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.904 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.414 ' N ' HG13 ' A' ' 101' ' ' ILE . 70.5 p -78.2 -32.91 50.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.697 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 -63.21 -54.76 32.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.652 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 16.2 m80 -71.65 -24.28 61.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.79 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 1.6 t -143.85 95.96 5.64 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.866 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -47.63 112.07 0.5 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.654 2.236 . . . . 0.0 112.509 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.8 mttt 49.8 99.26 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.157 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.52 ' CG2' ' CZ ' ' A' ' 78' ' ' PHE . 8.7 m -139.24 144.34 40.04 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.03 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -60.67 159.29 28.93 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.762 2.308 . . . . 0.0 112.829 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.498 ' CD2' ' CD1' ' A' ' 101' ' ' ILE . 2.4 p90 -165.37 148.24 7.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.556 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.434 HD13 ' CG ' ' A' ' 171' ' ' GLU . 1.1 tt -120.05 154.79 34.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.168 -179.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.426 HD13 ' CA ' ' A' ' 146' ' ' ALA . 13.1 mt -111.73 146.43 37.57 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.799 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.467 ' CG1' ' CG2' ' A' ' 168' ' ' VAL . 21.9 t -130.87 149.69 33.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.15 0.5 . . . . 0.0 111.884 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -124.97 112.43 1.73 Allowed Glycine 0 N--CA 1.452 -0.247 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.407 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.404 ' N ' HD13 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -127.84 -54.82 1.31 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.839 0.352 . . . . 0.0 111.329 -179.009 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.414 ' HG2' ' CG ' ' A' ' 119' ' ' LEU . 2.0 tt0 -58.56 -17.65 23.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.26 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.416 ' CG2' HG23 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -44.81 -27.31 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 120.841 0.353 . . . . 0.0 111.592 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.41 ' N ' HG12 ' A' ' 117' ' ' ILE . 21.4 t0 -66.76 -35.37 79.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.688 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.437 HD11 ' CG2' ' A' ' 85' ' ' VAL . 3.8 pp -99.49 -3.89 32.54 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.434 ' CB ' HG11 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -52.37 -35.67 51.87 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.977 0.418 . . . . 0.0 110.481 179.583 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -62.48 -24.17 67.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.759 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -42.36 100.6 0.23 Allowed Pre-proline 0 N--CA 1.463 0.208 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.025 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.44 ' O ' ' CG ' ' A' ' 127' ' ' GLU . 37.7 Cg_endo -66.67 -8.99 22.83 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.434 2.089 . . . . 0.0 112.897 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.7 t -74.14 -67.52 0.61 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.08 0.467 . . . . 0.0 110.008 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.438 ' O ' ' N ' ' A' ' 128' ' ' LYS . 73.6 m -56.36 -47.15 79.44 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.462 ' O ' ' HB2' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -46.91 -40.46 4.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.959 179.413 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.44 ' CG ' ' O ' ' A' ' 123' ' ' PRO . 4.8 mm-40 -60.07 -39.11 84.93 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.438 ' N ' ' O ' ' A' ' 125' ' ' THR . 0.0 OUTLIER -68.67 -34.02 74.97 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.155 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.479 ' N ' HD13 ' A' ' 129' ' ' LEU . 9.8 mp -64.84 -37.75 88.66 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 177.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.445 ' HA ' ' HB2' ' A' ' 134' ' ' GLN . . . -43.58 -39.16 3.34 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 114.453 -1.249 . . . . 0.0 111.567 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 6.3 mmtm -58.65 -24.8 61.91 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.579 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.426 ' CB ' ' O ' ' A' ' 87' ' ' PRO . 11.1 m-80 -124.38 -31.52 3.27 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -179.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.431 ' HG2' ' CB ' ' A' ' 88' ' ' SER . 2.2 mmtt -156.41 -63.38 0.1 Allowed 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -178.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.445 ' HB2' ' HA ' ' A' ' 130' ' ' ALA . 2.0 tt0 80.9 14.18 0.69 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.208 -178.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 35.2 mmtt -97.87 96.54 3.45 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.634 0.254 . . . . 0.0 111.175 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -64.74 131.1 28.15 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.389 2.059 . . . . 0.0 111.738 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.474 HG22 ' CE2' ' A' ' 82' ' ' PHE . 1.6 mm -67.55 96.38 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.0 0.429 . . . . 0.0 110.749 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.4 ' O ' ' N ' ' A' ' 141' ' ' THR . 2.3 p -77.0 147.28 76.84 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.868 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.466 ' HA ' ' CE1' ' A' ' 154' ' ' TYR . 96.4 Cg_exo -43.0 -28.22 1.17 Allowed 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.584 2.189 . . . . 0.0 112.286 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -72.88 -36.55 67.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.865 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.469 HG22 ' CE2' ' A' ' 90' ' ' PHE . 16.6 m -54.57 -61.93 1.99 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.898 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.443 ' HB2' ' CE1' ' A' ' 82' ' ' PHE . . . -52.04 -40.81 61.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.066 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -51.18 -45.29 61.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.821 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.4 ttpp -64.06 -49.08 73.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.812 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.423 ' CG ' ' HG3' ' A' ' 94' ' ' LYS . 0.9 OUTLIER -61.43 -46.77 88.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.674 179.819 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.426 ' CA ' HD13 ' A' ' 112' ' ' LEU . . . -50.93 -45.52 60.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.98 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.57 -26.6 32.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.772 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -53.18 -38.4 62.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.766 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.4 ' HG ' HG13 ' A' ' 98' ' ' VAL . 2.9 mm? -114.48 21.25 14.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.926 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 48.16 51.3 14.99 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.037 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.442 ' O ' ' CG2' ' A' ' 152' ' ' VAL . . . -66.66 -82.86 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.978 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.442 ' CG2' ' O ' ' A' ' 151' ' ' ALA . 36.5 t -164.32 -69.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.244 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 176.65 135.76 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.134 -179.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.466 ' CE1' ' HA ' ' A' ' 139' ' ' PRO . 27.7 t80 -106.54 108.01 19.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.64 178.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -101.32 -171.89 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.89 0.376 . . . . 0.0 111.319 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -89.73 156.51 18.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.159 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.442 ' CB ' HG11 ' A' ' 168' ' ' VAL . 13.0 t 178.82 160.02 0.62 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.199 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 8.4 t -159.69 123.56 3.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.866 0.365 . . . . 0.0 111.19 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -92.3 20.25 6.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.073 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.428 ' CD1' ' N ' ' A' ' 160' ' ' LEU . 0.0 OUTLIER -133.11 -44.71 0.85 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.527 179.927 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 9.7 t -111.06 -16.08 13.57 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.993 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 75.9 85.41 0.09 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.84 0.352 . . . . 0.0 111.355 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 22.1 mmmt -111.12 45.77 1.14 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.52 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.436 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . 128.95 -63.22 0.63 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.106 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.439 HD13 ' CA ' ' A' ' 19' ' ' LEU . 0.2 OUTLIER 62.23 -74.46 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.711 0.291 . . . . 0.0 111.257 179.597 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.436 ' N ' ' O ' ' A' ' 164' ' ' GLY . 0.0 OUTLIER -69.76 -23.42 63.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.99 -179.961 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -56.02 -56.07 25.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.006 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.467 ' CG2' ' CG1' ' A' ' 113' ' ' VAL . 16.2 m -71.27 -36.74 63.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.582 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.484 ' CZ ' ' HA ' ' A' ' 16' ' ' LYS . 0.5 OUTLIER -75.03 -19.52 60.0 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.853 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.432 ' CB ' ' O ' ' A' ' 166' ' ' LYS . 28.7 t70 -83.06 -34.81 26.11 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.011 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.434 ' CG ' HD13 ' A' ' 111' ' ' LEU . 2.1 pt-20 -75.15 -31.66 61.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.912 0.387 . . . . 0.0 110.34 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.417 ' N ' HD13 ' A' ' 111' ' ' LEU . . . -73.09 -47.81 41.23 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.586 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 170' ' ' ASP . 1.7 pp -64.34 -38.63 83.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.756 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.44 ' HG ' ' CB ' ' B' ' 505' ' ' LEU . 3.3 tm? -52.3 -35.4 50.43 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.921 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -51.76 -24.31 5.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.984 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.434 ' CB ' ' HB ' ' A' ' 4' ' ' ILE . . . -95.05 -36.94 11.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.106 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.479 ' CD2' ' CG2' ' A' ' 4' ' ' ILE . 9.6 mt -68.82 -24.34 64.37 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.844 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -172.94 128.8 0.54 Allowed Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.908 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -57.19 115.75 2.72 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.559 2.172 . . . . 0.0 112.304 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -77.47 -166.44 0.39 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.451 2.101 . . . . 0.0 112.312 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -149.08 131.55 7.84 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.891 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -80.71 -165.47 0.34 Allowed 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.667 2.245 . . . . 0.0 112.326 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 29.3 mttt -133.98 170.85 15.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.894 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 2.3 mttm . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.184 -0.913 . . . . 0.0 110.905 -179.946 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.202 0 N-CA-C 112.428 -0.269 . . . . 0.0 112.428 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 503' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.5 -162.37 0.51 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.819 0.343 . . . . 0.0 110.849 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 504' ' ' GLY . . . . . 0.44 ' CA ' ' HA ' ' B' ' 509' ' ' ASP . . . 131.17 -101.89 0.5 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.321 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 505' ' ' LEU . . . . . 0.44 ' CB ' ' HG ' ' A' ' 174' ' ' LEU . 0.0 OUTLIER 58.96 18.08 5.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.563 0.22 . . . . 0.0 111.3 179.773 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 506' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 65.26 100.19 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.925 0.393 . . . . 0.0 110.649 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 507' ' ' ALA . . . . . 0.44 ' O ' ' CB ' ' B' ' 508' ' ' GLN . . . 169.15 -36.29 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.389 0.614 . . . . 0.0 110.44 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 508' ' ' GLN . . . . . 0.476 ' O ' ' CB ' ' B' ' 509' ' ' ASP . 0.5 OUTLIER 156.62 -26.36 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.394 -179.364 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 509' ' ' ASP . . . . . 0.476 ' CB ' ' O ' ' B' ' 508' ' ' GLN . 0.3 OUTLIER 98.07 32.4 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.975 0.91 . . . . 0.0 110.872 179.739 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 510' ' ' ILE . . . . . 0.451 ' CG2' HG21 ' A' ' 46' ' ' ILE . 3.3 mp -54.05 130.9 16.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.443 179.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 511' ' ' SER . . . . . 0.441 ' CB ' ' HG ' ' B' ' 514' ' ' LEU . 0.4 OUTLIER -109.09 154.48 22.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.261 -179.459 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 512' ' ' GLN . . . . . 0.452 ' CB ' ' HD3' ' B' ' 513' ' ' PRO . 0.0 OUTLIER -97.9 -57.69 0.17 Allowed Pre-proline 0 C--N 1.333 -0.149 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.799 179.575 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 513' ' ' PRO . . . . . 0.452 ' HD3' ' CB ' ' B' ' 512' ' ' GLN . 59.9 Cg_endo -90.85 42.4 0.43 Allowed 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.905 2.404 . . . . 0.0 112.043 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 514' ' ' LEU . . . . . 0.447 ' CD2' ' O ' ' A' ' 45' ' ' MET . 0.3 OUTLIER -46.49 -85.62 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.624 -179.388 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 515' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.09 -86.52 0.23 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.124 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -125.12 -37.15 2.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.218 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 517' ' ' SER . . . . . 0.407 ' O ' ' CG1' ' A' ' 42' ' ' VAL . 0.7 OUTLIER 63.79 29.57 14.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.962 -179.884 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 518' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -163.22 123.98 2.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.06 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 519' ' ' ILE . . . . . . . . . . . . . 12.1 mm -94.42 31.87 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.162 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 52.26 38.26 24.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.858 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 521' ' ' THR . . . . . 0.411 ' HB ' ' CD2' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -113.51 -172.11 2.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.845 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 522' ' ' GLY . . . . . . . . . . . . . . . 101.08 125.46 5.6 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.356 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 523' ' ' HIS . . . . . . . . . . . . . 26.4 t60 -117.86 -81.28 0.62 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.747 0.308 . . . . 0.0 110.98 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 524' ' ' GLY . . . . . . . . . . . . . . . 58.09 -106.05 0.74 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.648 -0.786 . . . . 0.0 112.619 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 525' ' ' ASP . . . . . . . . . . . . . 4.7 t0 57.77 73.77 0.45 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.754 0.311 . . . . 0.0 110.891 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 526' ' ' SER . . . . . 0.437 ' CB ' ' HB3' ' A' ' 61' ' ' LEU . 32.0 t -108.83 96.77 6.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.987 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 527' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 70.7 95.79 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.053 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -74.95 58.83 4.98 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.736 2.291 . . . . 0.0 112.472 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 529' ' ' ARG . . . . . 0.403 ' HB2' ' OD1' ' B' ' 545' ' ' ASN . 0.1 OUTLIER -53.31 -43.09 67.32 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.192 0.52 . . . . 0.0 110.122 179.519 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 530' ' ' HIS . . . . . 0.491 ' HA ' ' CG ' ' A' ' 31' ' ' GLU . 41.2 m170 64.74 51.05 1.93 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.931 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -155.99 132.1 9.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.16 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 532' ' ' TRP . . . . . 0.407 ' NE1' ' O ' ' B' ' 536' ' ' ASP . 6.6 t-105 -92.22 -22.22 19.92 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.887 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . 92.44 -136.59 13.29 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.447 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 534' ' ' PHE . . . . . 0.426 ' O ' ' N ' ' B' ' 536' ' ' ASP . 39.2 m-85 -81.42 165.5 43.95 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.655 0.264 . . . . 0.0 110.629 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -56.18 81.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.587 2.191 . . . . 0.0 112.377 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 536' ' ' ASP . . . . . 0.439 ' HA ' ' NH1' ' B' ' 537' ' ' ARG . 0.2 OUTLIER 171.45 -164.22 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.92 -180.0 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 537' ' ' ARG . . . . . 0.446 ' HG3' ' N ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER -125.47 155.88 39.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.148 0.499 . . . . 0.0 110.532 179.77 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 538' ' ' ILE . . . . . 0.428 ' CG2' ' HA ' ' B' ' 543' ' ' LEU . 6.7 tp -83.34 123.96 39.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.483 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 539' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -33.68 130.19 0.28 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.156 0.503 . . . . 0.0 112.115 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 540' ' ' GLU . . . . . 0.452 ' HG2' ' CA ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -41.79 -28.35 0.15 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.254 -179.29 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 541' ' ' LEU . . . . . 0.432 ' HA ' ' CD2' ' A' ' 70' ' ' LEU . 0.8 OUTLIER -40.91 -50.26 3.24 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.864 0.364 . . . . 0.0 111.319 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 542' ' ' TYR . . . . . 0.406 ' CD1' ' N ' ' B' ' 542' ' ' TYR . 0.1 OUTLIER -105.35 -63.37 1.24 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.234 179.949 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 543' ' ' LEU . . . . . 0.431 ' CD1' ' HA ' ' B' ' 540' ' ' GLU . 0.3 OUTLIER 72.83 166.68 0.3 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.474 -179.345 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . 116.47 156.97 10.86 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.655 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 545' ' ' ASN . . . . . 0.431 ' HB2' ' CB ' ' A' ' 31' ' ' GLU . 5.9 p30 . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.199 -0.905 . . . . 0.0 111.098 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.2 tpt . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.807 0.337 . . . . 0.0 111.252 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.23 144.61 57.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.49 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.51 HG22 ' CZ ' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -110.79 -173.82 2.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.535 -179.545 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.441 HD12 ' CG1' ' A' ' 173' ' ' ILE . 5.7 pt -154.92 127.29 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.16 -179.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.44 ' CB ' ' HB ' ' A' ' 75' ' ' THR . 5.6 mmtp -100.6 100.58 11.32 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.425 ' CB ' ' HB3' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -77.63 132.56 38.31 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.201 0.524 . . . . 0.0 112.061 -178.71 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.3 t -144.52 159.66 14.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.918 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.424 HG22 ' HG3' ' A' ' 16' ' ' LYS . 48.7 t -133.72 128.57 54.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.301 0.572 . . . . 0.0 112.143 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.436 ' HA ' ' CG ' ' B' ' 540' ' ' GLU . 3.3 m -134.06 129.38 54.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.267 -0.878 . . . . 0.0 109.694 178.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 134.98 -160.3 24.26 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.247 -0.978 . . . . 0.0 112.6 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.418 ' O ' ' N ' ' B' ' 537' ' ' ARG . 6.6 p30 -122.87 27.27 7.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.642 0.258 . . . . 0.0 111.047 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -104.59 174.59 21.96 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.823 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.413 ' CA ' ' HG3' ' B' ' 537' ' ' ARG . . . -95.16 -56.38 2.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.863 0.363 . . . . 0.0 111.1 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.445 HG23 ' CG1' ' A' ' 113' ' ' VAL . 14.7 p -53.61 105.93 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.047 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.444 ' HA2' ' CD1' ' A' ' 19' ' ' LEU . . . 153.01 -44.51 0.61 Allowed Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.069 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.424 ' HG3' HG22 ' A' ' 8' ' ' VAL . 9.8 mtmt -90.18 -95.24 0.11 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 120.368 0.127 . . . . 0.0 111.077 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 61.3 p -98.44 -49.6 4.6 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 120.939 0.4 . . . . 0.0 111.482 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.436 ' O ' ' CB ' ' A' ' 22' ' ' SER . 10.2 t -36.9 -41.32 0.33 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.447 -179.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.486 HD11 ' CD1' ' A' ' 169' ' ' PHE . 6.5 mt -49.84 -73.79 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.864 0.364 . . . . 0.0 111.557 -179.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.2 mt -74.74 -30.9 61.66 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.017 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.426 ' CG2' ' OG1' ' A' ' 25' ' ' THR . 16.2 mm -66.44 -69.44 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 178.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.439 ' O ' ' ND2' ' A' ' 26' ' ' ASN . 7.4 t -49.74 -25.8 3.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.594 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -65.37 -46.59 79.52 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.447 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.58 -55.01 3.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.478 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.426 ' OG1' ' CG2' ' A' ' 21' ' ' ILE . 30.1 p -88.38 76.4 8.31 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.439 ' ND2' ' O ' ' A' ' 22' ' ' SER . 0.6 OUTLIER -69.52 62.28 0.16 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.436 -178.742 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.2 mtmt -121.87 90.85 3.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.599 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.495 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 2.2 t80 -90.03 -44.95 0.41 Allowed Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.749 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 86.6 Cg_endo -85.78 13.56 2.71 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.5 2.133 . . . . 0.0 113.082 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.2 m -93.68 -93.7 0.17 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.631 -0.258 . . . . 0.0 110.845 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -158.99 145.52 16.95 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.789 0.328 . . . . 0.0 110.786 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.412 ' O ' ' ND2' ' B' ' 545' ' ' ASN . 11.9 m-85 -126.23 133.61 51.44 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.669 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.445 ' CB ' ' HD3' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -162.53 -56.55 0.01 OUTLIER Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.612 -179.537 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.445 ' HD3' ' CB ' ' A' ' 33' ' ' VAL . 51.5 Cg_exo -56.49 78.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.527 2.151 . . . . 0.0 112.686 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.463 ' CG2' ' CD2' ' B' ' 543' ' ' LEU . 29.2 m -121.57 -5.35 9.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.253 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.478 ' HA ' ' CB ' ' A' ' 59' ' ' ALA . 0.1 OUTLIER -89.69 -3.34 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -179.863 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -81.0 9.24 6.82 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -52.39 -174.12 0.0 OUTLIER 'General case' 0 C--O 1.231 0.101 0 CA-C-O 120.778 0.323 . . . . 0.0 111.052 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.418 ' ND2' ' OH ' ' A' ' 64' ' ' TYR . 9.8 p30 48.82 25.45 1.03 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.895 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.418 ' CB ' ' HB ' ' B' ' 521' ' ' THR . 8.8 p90 -65.16 -174.29 0.16 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.733 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.431 ' O ' ' CG1' ' B' ' 519' ' ' ILE . . . -122.93 152.01 41.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.272 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.432 ' CG2' ' HB ' ' A' ' 52' ' ' THR . 34.2 m -145.89 156.12 12.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.916 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.406 ' O ' ' CG1' ' A' ' 44' ' ' VAL . 0.1 OUTLIER -123.52 106.39 10.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.957 0.408 . . . . 0.0 111.239 -179.736 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.494 ' CG2' ' CG2' ' A' ' 52' ' ' THR . 10.7 m -156.5 -177.24 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.917 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.455 ' O ' ' CD1' ' B' ' 514' ' ' LEU . 4.8 tpt -107.01 96.1 6.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.303 -179.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.445 ' N ' ' HE1' ' A' ' 45' ' ' MET . 3.9 mm -76.79 86.85 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 121.036 0.446 . . . . 0.0 110.629 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.423 ' HA3' ' CG2' ' B' ' 510' ' ' ILE . . . 39.6 -92.73 0.01 OUTLIER Glycine 0 CA--C 1.521 0.454 0 CA-C-N 115.778 -0.647 . . . . 0.0 113.851 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . -35.59 -87.07 0.01 OUTLIER Glycine 0 C--N 1.334 0.457 0 N-CA-C 114.019 0.368 . . . . 0.0 114.019 -179.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.436 ' N ' ' HE3' ' A' ' 45' ' ' MET . 0.5 OUTLIER -133.32 159.16 73.68 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 120.705 0.288 . . . . 0.0 110.775 -179.693 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.403 ' N ' ' SD ' ' A' ' 45' ' ' MET . 86.1 Cg_exo -45.2 100.21 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.326 2.017 . . . . 0.0 112.161 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.51 ' CZ ' HG22 ' A' ' 3' ' ' THR . 8.8 t80 -167.21 153.78 8.29 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.442 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.494 ' CG2' ' CG2' ' A' ' 44' ' ' VAL . 1.8 p -136.86 153.37 50.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.037 0.446 . . . . 0.0 111.467 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.44 HD11 ' CD1' ' A' ' 4' ' ' ILE . 0.0 OUTLIER -83.38 167.99 17.02 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.844 179.637 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -105.21 -25.72 6.59 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.801 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.425 ' HB3' ' CB ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER 52.12 92.54 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.785 0.326 . . . . 0.0 111.038 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -84.95 105.57 15.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.365 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -105.95 165.99 10.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.109 0.48 . . . . 0.0 111.272 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.451 ' CG2' ' HB3' ' A' ' 70' ' ' LEU . 1.5 p -89.32 152.98 21.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.033 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.478 ' CB ' ' HA ' ' A' ' 36' ' ' VAL . . . -172.12 100.36 0.16 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.667 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' B' ' 543' ' ' LEU . . . -98.66 70.67 0.6 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.814 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.433 ' CD2' ' CB ' ' B' ' 526' ' ' SER . 6.5 mp -120.19 -107.69 0.36 Allowed 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 110.601 -0.148 . . . . 0.0 110.601 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -99.8 -24.67 14.61 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 120.775 0.322 . . . . 0.0 111.334 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.424 ' CB ' ' CG1' ' A' ' 36' ' ' VAL . 16.0 t0 -70.71 -63.41 1.1 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.676 -179.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.431 ' CD1' ' N ' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -151.66 116.25 5.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.848 0.356 . . . . 0.0 111.028 -179.54 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.67 -13.77 47.55 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.392 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.32 -50.7 4.23 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.651 0.262 . . . . 0.0 111.656 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.431 HD13 ' CG2' ' A' ' 58' ' ' THR . 13.5 mt 69.82 -148.18 0.1 Allowed 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 -179.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.418 ' CB ' ' CD ' ' A' ' 69' ' ' PRO . 3.8 mtt-85 -172.55 -61.38 0.0 OUTLIER Pre-proline 0 CA--C 1.528 0.102 0 C-N-CA 120.776 -0.369 . . . . 0.0 111.883 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.418 ' CD ' ' CB ' ' A' ' 68' ' ' ARG . 50.0 Cg_exo -35.99 -60.26 0.35 Allowed 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 123.059 2.506 . . . . 0.0 113.236 -179.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.451 ' HB3' ' CG2' ' A' ' 58' ' ' THR . 0.3 OUTLIER -46.88 -26.74 1.04 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.351 -179.777 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.5 t -74.6 -70.45 0.4 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.289 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -95.49 150.17 37.14 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.213 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.49 120.78 5.72 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.706 2.271 . . . . 0.0 112.531 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.415 ' NE2' ' O ' ' A' ' 69' ' ' PRO . 1.3 mp0 -102.03 -60.3 1.56 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.848 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.44 ' HB ' ' CB ' ' A' ' 5' ' ' LYS . 7.9 t -82.15 -178.71 7.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.053 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.405 ' O ' ' CG ' ' A' ' 109' ' ' PRO . 0.1 OUTLIER -104.3 7.7 35.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.382 179.899 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.412 ' CG1' ' O ' ' A' ' 77' ' ' VAL . 11.3 p -156.47 106.92 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.711 0.291 . . . . 0.0 111.24 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.481 ' CD1' HG21 ' A' ' 108' ' ' THR . 4.9 m-85 -83.59 -177.9 6.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.607 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.19 117.71 29.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.95 0.405 . . . . 0.0 111.427 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.522 ' CG2' ' CD1' ' A' ' 110' ' ' PHE . 1.8 t -111.35 100.32 10.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.367 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.426 ' CB ' HG13 ' A' ' 14' ' ' VAL . 2.3 p -109.57 137.74 46.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.04 0.448 . . . . 0.0 111.538 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.483 ' CE1' ' CE1' ' A' ' 90' ' ' PHE . 28.7 p90 -147.18 145.22 29.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.224 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.6 m -83.29 130.58 35.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.901 0.381 . . . . 0.0 111.269 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.445 ' HA ' ' HB ' ' A' ' 137' ' ' ILE . 97.2 t -45.93 -73.72 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.481 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.424 HG13 ' CD1' ' A' ' 119' ' ' LEU . 5.6 m -43.64 117.75 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.332 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.418 ' N ' HD21 ' A' ' 129' ' ' LEU . 0.4 OUTLIER -151.57 136.89 10.71 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.336 -179.798 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.421 ' O ' ' CB ' ' A' ' 88' ' ' SER . 68.2 Cg_endo -92.42 52.75 0.58 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 123.212 2.608 . . . . 0.0 111.816 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.426 ' OG ' ' CG ' ' A' ' 133' ' ' LYS . 0.1 OUTLIER 80.84 26.25 0.26 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.908 -179.499 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 43.3 t -96.78 -26.17 15.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.911 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.483 ' CE1' ' CE1' ' A' ' 82' ' ' PHE . 3.9 t80 -54.65 -46.97 74.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.983 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -52.3 -58.26 7.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.994 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.416 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.4 OUTLIER -54.39 -43.17 71.19 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.027 -179.947 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.449 HG11 ' CE2' ' A' ' 97' ' ' TRP . 60.5 t -54.35 -45.54 68.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.254 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.9 tttt -59.6 -55.12 38.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.056 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.8 0.14 24.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.741 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.416 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 2.0 tttt -112.22 -22.53 10.89 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.656 0.265 . . . . 0.0 111.072 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.474 ' CZ3' HG13 ' A' ' 80' ' ' VAL . 25.2 m0 -93.06 -55.13 3.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.111 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.48 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 61.1 t -43.68 -56.13 7.69 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.869 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 30.6 Cg_endo -62.67 -18.8 65.85 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.169 1.912 . . . . 0.0 112.381 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.29 -45.32 9.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.006 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 19.7 mm -52.58 -56.92 5.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.159 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.1 p -65.25 -22.3 66.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.238 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 22.3 t-160 -64.93 -68.74 0.34 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.892 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -75.54 -27.22 58.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.004 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.434 ' HB3' ' CB ' ' A' ' 108' ' ' THR . 8.3 m -122.64 75.16 45.48 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.024 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -57.08 131.96 48.56 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.642 2.228 . . . . 0.0 112.166 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 9.7 mmtp 50.31 39.16 19.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.824 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.481 HG21 ' CD1' ' A' ' 78' ' ' PHE . 46.0 m -108.3 101.69 43.31 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.95 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.405 ' CG ' ' O ' ' A' ' 76' ' ' ASP . 36.3 Cg_exo -60.19 171.78 2.91 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.632 2.221 . . . . 0.0 112.425 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.522 ' CD1' ' CG2' ' A' ' 80' ' ' VAL . 6.6 p90 -158.52 -177.55 6.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.711 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.463 ' CD1' ' CG1' ' A' ' 152' ' ' VAL . 3.1 tt -142.2 152.88 43.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.828 0.347 . . . . 0.0 111.245 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -101.52 161.15 13.85 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.559 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.445 ' CG1' HG23 ' A' ' 14' ' ' VAL . 2.5 t -138.74 155.5 27.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.007 0.432 . . . . 0.0 111.743 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' A' ' 157' ' ' CYS . . . -140.14 114.23 0.96 Allowed Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.327 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.438 ' CG2' ' HB3' ' A' ' 157' ' ' CYS . 0.1 OUTLIER -126.97 -49.14 1.47 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.919 0.39 . . . . 0.0 110.284 -179.676 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.405 ' HG3' ' CD2' ' A' ' 119' ' ' LEU . 0.7 OUTLIER -61.69 -16.28 47.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.634 179.284 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.432 HG12 ' N ' ' A' ' 118' ' ' ASP . 0.2 OUTLIER -40.58 -28.57 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 179.906 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.442 ' CB ' ' HB ' ' A' ' 161' ' ' THR . 2.3 p30 -66.9 -29.56 69.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.852 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.425 ' CD1' ' O ' ' A' ' 119' ' ' LEU . 3.6 pp -106.01 13.71 28.87 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.44 ' O ' ' CD1' ' A' ' 126' ' ' ILE . 1.8 ppt_? -66.86 -20.64 65.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.727 0.299 . . . . 0.0 110.696 179.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -85.47 -25.97 26.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.484 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -49.95 104.98 0.46 Allowed Pre-proline 0 C--N 1.332 -0.171 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.696 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.43 ' HA ' ' CG2' ' A' ' 126' ' ' ILE . 37.4 Cg_endo -66.32 -7.9 18.92 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.582 2.188 . . . . 0.0 113.174 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.38 -67.28 0.64 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.402 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 12.4 m -58.24 -39.41 79.04 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 178.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.456 HG13 HD12 ' A' ' 129' ' ' LEU . 0.1 OUTLIER -54.39 -44.68 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.684 179.176 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -57.84 -36.87 72.89 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.896 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 125' ' ' THR . 0.0 OUTLIER -63.31 -30.72 71.81 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.902 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.456 HD12 HG13 ' A' ' 126' ' ' ILE . 6.8 mt -74.54 -38.04 62.86 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 177.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -45.47 -33.15 2.51 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 114.867 -1.06 . . . . 0.0 111.048 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.2 mmtp -48.95 -34.89 13.82 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.512 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.419 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 2.7 m-80 -123.2 -31.23 3.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.362 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.524 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 36.8 mmtt -143.59 -100.67 0.12 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 119.092 -0.48 . . . . 0.0 111.478 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.524 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 4.5 pt20 131.33 -22.34 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.456 1.102 . . . . 0.0 110.45 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 5.9 mmpp? -68.57 110.6 6.14 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.739 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.425 ' HB3' ' CD1' ' A' ' 126' ' ' ILE . 90.6 Cg_endo -80.86 134.4 9.55 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.527 2.152 . . . . 0.0 111.656 179.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.525 ' CD1' ' N ' ' A' ' 137' ' ' ILE . 0.4 OUTLIER -64.34 96.6 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.323 -179.694 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.417 ' O ' ' N ' ' A' ' 141' ' ' THR . 2.9 p -68.78 145.72 97.05 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.888 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.427 ' O ' ' CE1' ' A' ' 154' ' ' TYR . 89.1 Cg_exo -43.19 -28.21 1.34 Allowed 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.573 2.182 . . . . 0.0 112.248 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -78.75 -36.7 42.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.676 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.417 ' N ' ' O ' ' A' ' 138' ' ' THR . 6.1 m -54.88 -56.06 23.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.714 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.509 ' CB ' ' CD2' ' A' ' 154' ' ' TYR . . . -53.02 -36.56 60.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.777 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.64 -38.82 90.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.667 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 17.2 tptt -63.41 -50.59 69.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.703 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.23 -33.99 72.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.593 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -67.69 -44.7 77.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.894 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 60.2 mtt180 -75.14 -23.18 57.8 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.793 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -56.14 -46.88 79.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.745 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -95.54 19.7 10.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.058 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.1 mtmp? 44.82 40.39 4.25 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.428 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.487 ' HB1' ' CD1' ' A' ' 110' ' ' PHE . . . -59.58 -81.72 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.866 0.365 . . . . 0.0 110.818 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.463 ' CG1' ' CD1' ' A' ' 111' ' ' LEU . 83.5 t -159.65 -73.82 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.833 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 4.1 tppt? 177.42 135.6 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.954 -179.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.509 ' CD2' ' CB ' ' A' ' 142' ' ' ALA . 3.3 t80 -98.06 112.49 24.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.154 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.431 ' CG2' ' HA ' ' A' ' 168' ' ' VAL . 0.3 OUTLIER -115.04 -172.84 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.637 -179.924 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.422 ' CB ' ' HG2' ' A' ' 163' ' ' LYS . 2.1 mp0 -89.58 163.3 15.24 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.868 0.366 . . . . 0.0 111.145 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.438 ' HB3' ' CG2' ' A' ' 115' ' ' THR . 0.1 OUTLIER -133.56 -172.73 3.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.987 -179.786 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.442 ' CB ' ' HB2' ' A' ' 165' ' ' LEU . 1.1 p -128.38 147.85 50.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.984 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . 169.58 -57.96 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.805 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.2 mp -100.39 -60.07 1.59 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.62 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.442 ' HB ' ' CB ' ' A' ' 118' ' ' ASP . 13.4 t -86.04 -26.4 25.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.474 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.426 ' HA ' ' HB2' ' A' ' 158' ' ' SER . 2.8 tt0 73.39 77.11 0.13 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.16 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.422 ' HG2' ' CB ' ' A' ' 156' ' ' GLU . 0.0 OUTLIER -88.19 -21.37 24.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.131 179.979 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 142.07 -36.07 1.7 Allowed Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.491 -0.861 . . . . 0.0 112.887 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.447 HD22 ' CD2' ' A' ' 19' ' ' LEU . 0.4 OUTLIER 68.37 -63.7 0.33 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.791 0.329 . . . . 0.0 111.064 -179.796 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.407 ' O ' ' CB ' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -48.49 -30.92 5.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.264 -179.848 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.403 ' ND2' HG11 ' A' ' 155' ' ' VAL . 0.2 OUTLIER -56.46 -71.5 0.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.313 -179.707 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.431 ' HA ' ' CG2' ' A' ' 155' ' ' VAL . 8.5 p -58.48 -46.77 89.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.823 0.344 . . . . 0.0 111.061 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.486 ' CD1' HD11 ' A' ' 19' ' ' LEU . 4.2 t80 -57.71 -37.39 73.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.187 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.407 ' CB ' ' O ' ' A' ' 166' ' ' LYS . 17.0 m-20 -58.83 -37.47 76.5 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -66.34 -32.29 73.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.785 179.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.5 -30.63 71.0 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.68 179.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.441 ' CG1' HD12 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -90.55 -26.15 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.097 -0.502 . . . . 0.0 109.763 179.256 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.442 ' CD2' HD12 ' B' ' 505' ' ' LEU . 1.2 mt -49.48 -46.81 48.63 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.01 0.434 . . . . 0.0 110.612 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.71 -22.68 64.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.098 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -97.09 -38.22 9.83 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.219 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.441 ' CD2' ' HB ' ' B' ' 510' ' ' ILE . 2.6 tp -68.71 -21.88 64.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.868 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.434 ' HB2' ' CB ' ' B' ' 507' ' ' ALA . 0.0 OUTLIER -174.06 158.08 2.72 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.788 179.905 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.65 110.68 3.06 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.654 2.236 . . . . 0.0 112.262 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -83.2 164.77 14.96 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.69 2.26 . . . . 0.0 112.472 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . 0.425 ' CG ' ' O ' ' A' ' 181' ' ' GLU . 9.5 pt-20 -113.11 110.11 51.49 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.551 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.66 -164.91 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.411 2.074 . . . . 0.0 112.278 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.66 86.21 1.64 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.874 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.872 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.224 0 N-CA-C 112.56 -0.216 . . . . 0.0 112.56 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 503' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -76.64 -82.44 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.735 0.302 . . . . 0.0 110.909 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 504' ' ' GLY . . . . . 0.403 ' HA2' ' HA ' ' B' ' 509' ' ' ASP . . . 93.55 104.23 1.7 Allowed Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.397 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 505' ' ' LEU . . . . . 0.442 HD12 ' CD2' ' A' ' 174' ' ' LEU . 0.1 OUTLIER -170.32 39.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.747 0.308 . . . . 0.0 110.982 -179.767 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 506' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 68.14 33.04 4.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.031 0.443 . . . . 0.0 110.486 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 507' ' ' ALA . . . . . 0.434 ' CB ' ' HB2' ' A' ' 178' ' ' GLU . . . -134.93 36.58 3.06 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.698 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 508' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 74.39 3.41 4.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.551 -178.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 509' ' ' ASP . . . . . 0.403 ' HA ' ' HA2' ' B' ' 504' ' ' GLY . 22.2 t70 70.49 43.62 0.77 Allowed 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 121.024 0.44 . . . . 0.0 110.985 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 510' ' ' ILE . . . . . 0.441 ' HB ' ' CD2' ' A' ' 177' ' ' LEU . 66.4 mt -95.25 139.0 19.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.579 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 511' ' ' SER . . . . . 0.418 ' N ' HG23 ' B' ' 510' ' ' ILE . 34.6 t -108.28 148.12 30.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.989 0.424 . . . . 0.0 112.039 -178.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 512' ' ' GLN . . . . . 0.471 ' HB3' ' HD3' ' B' ' 513' ' ' PRO . 11.8 tp60 -100.06 -69.08 0.04 OUTLIER Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.998 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 513' ' ' PRO . . . . . 0.471 ' HD3' ' HB3' ' B' ' 512' ' ' GLN . 85.3 Cg_endo -78.49 73.6 5.79 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.219 1.946 . . . . 0.0 110.934 178.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 514' ' ' LEU . . . . . 0.455 ' CD1' ' O ' ' A' ' 45' ' ' MET . 1.3 mp -80.38 -93.76 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -178.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 515' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.33 -83.7 0.03 OUTLIER 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.839 0.352 . . . . 0.0 111.914 -178.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 516' ' ' ASN . . . . . 0.413 ' ND2' ' O ' ' B' ' 518' ' ' PHE . 48.9 t30 -120.91 -37.11 3.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.485 -178.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 517' ' ' SER . . . . . 0.401 ' HA ' ' HB ' ' A' ' 42' ' ' VAL . 0.7 OUTLIER 55.87 26.0 9.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.854 -179.806 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 518' ' ' PHE . . . . . 0.413 ' O ' ' ND2' ' B' ' 516' ' ' ASN . 0.0 OUTLIER -162.98 106.89 1.07 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.054 -179.78 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 519' ' ' ILE . . . . . 0.431 ' CG1' ' O ' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -107.6 -84.97 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.991 179.851 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 13.7 t-160 -175.17 102.55 0.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.889 0.376 . . . . 0.0 110.899 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 521' ' ' THR . . . . . 0.418 ' HB ' ' CB ' ' A' ' 40' ' ' TYR . 0.2 OUTLIER -150.68 178.37 9.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.769 -179.964 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 522' ' ' GLY . . . . . . . . . . . . . . . 58.93 161.47 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.375 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 523' ' ' HIS . . . . . 0.427 ' NE2' ' HB2' ' B' ' 525' ' ' ASP . 16.3 t-160 -137.61 -84.92 0.31 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.704 0.288 . . . . 0.0 111.126 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 524' ' ' GLY . . . . . . . . . . . . . . . 92.37 -97.54 2.29 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.379 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 525' ' ' ASP . . . . . 0.427 ' HB2' ' NE2' ' B' ' 523' ' ' HIS . 2.7 t0 75.32 78.44 0.1 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.926 0.393 . . . . 0.0 111.279 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 526' ' ' SER . . . . . 0.434 ' O ' ' CG1' ' A' ' 33' ' ' VAL . 0.5 OUTLIER -117.4 98.19 6.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.723 179.545 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 527' ' ' ASP . . . . . 0.447 ' CB ' ' HD3' ' B' ' 528' ' ' PRO . 0.1 OUTLIER -44.32 -50.9 21.06 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.301 -179.807 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 528' ' ' PRO . . . . . 0.447 ' HD3' ' CB ' ' B' ' 527' ' ' ASP . 23.6 Cg_exo -68.08 118.65 5.77 Favored 'Trans proline' 0 CA--C 1.518 -0.305 0 C-N-CA 123.058 2.505 . . . . 0.0 112.108 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 529' ' ' ARG . . . . . 0.403 ' HA ' ' HB3' ' B' ' 545' ' ' ASN . 0.0 OUTLIER -100.92 -37.47 8.64 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.879 -179.162 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 530' ' ' HIS . . . . . 0.48 ' CG ' ' O ' ' B' ' 530' ' ' HIS . 0.0 OUTLIER 67.71 9.62 7.21 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.012 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 531' ' ' CYS . . . . . 0.465 ' O ' ' CD2' ' B' ' 530' ' ' HIS . 1.2 m 49.1 -174.45 0.02 OUTLIER 'General case' 0 C--N 1.334 -0.093 0 CA-C-O 120.87 0.367 . . . . 0.0 111.072 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 532' ' ' TRP . . . . . . . . . . . . . 23.0 t90 -65.44 -63.16 1.16 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.864 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . 95.52 -119.11 6.09 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.377 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 534' ' ' PHE . . . . . 0.418 ' O ' ' N ' ' B' ' 536' ' ' ASP . 11.3 m-85 -119.39 151.2 50.99 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.729 0.3 . . . . 0.0 110.892 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.48 83.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.586 2.191 . . . . 0.0 112.262 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 536' ' ' ASP . . . . . 0.418 ' N ' ' O ' ' B' ' 534' ' ' PHE . 1.0 OUTLIER 172.23 80.85 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.7 179.979 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 537' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' ' 11' ' ' ASP . 32.3 mmt-85 -51.78 132.92 31.81 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.116 0.484 . . . . 0.0 111.062 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 538' ' ' ILE . . . . . . . . . . . . . 3.1 tp -50.9 133.53 11.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.446 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 539' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -40.39 117.76 0.84 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.317 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 540' ' ' GLU . . . . . 0.436 ' CG ' ' HA ' ' A' ' 9' ' ' VAL . 2.8 pp20? -47.45 -24.87 0.91 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.116 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 541' ' ' LEU . . . . . 0.437 ' HA ' ' CD2' ' A' ' 70' ' ' LEU . 0.4 OUTLIER -38.53 -42.66 0.78 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.164 0.507 . . . . 0.0 111.012 179.435 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 542' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -105.3 -59.48 1.75 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.427 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 543' ' ' LEU . . . . . 0.463 ' CD2' ' CG2' ' A' ' 35' ' ' THR . 0.1 OUTLIER 59.98 122.88 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.881 -179.911 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 544' ' ' GLY . . . . . 0.402 ' HA2' ' CD1' ' A' ' 61' ' ' LEU . . . 164.3 105.21 0.19 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.538 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 545' ' ' ASN . . . . . 0.412 ' ND2' ' O ' ' A' ' 32' ' ' TYR . 10.0 m120 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.951 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.46 ' HE2' ' CD1' ' A' ' 51' ' ' TYR . 6.9 tpt . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.267 0.079 . . . . 0.0 111.082 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.43 ' N ' ' HG3' ' A' ' 1' ' ' MET . 5.7 tt0 42.22 100.08 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.294 0.568 . . . . 0.0 111.804 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.489 ' OG1' ' CE1' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -104.82 -159.48 0.71 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.652 -179.889 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.481 ' CG2' ' CB ' ' A' ' 176' ' ' ALA . 0.3 OUTLIER -156.37 163.18 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -178.653 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 16.2 mttp -134.45 102.36 5.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.876 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 32.3 m -103.07 156.2 17.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.225 0.536 . . . . 0.0 112.083 -178.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.7 t -139.11 159.87 29.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.248 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.433 ' CG1' HG22 ' A' ' 14' ' ' VAL . 65.4 t -106.89 141.5 21.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.239 0.542 . . . . 0.0 111.752 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.408 ' N ' HG11 ' A' ' 8' ' ' VAL . 98.0 t -156.51 129.96 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.855 179.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.55 -171.14 32.99 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 119.976 -1.107 . . . . 0.0 113.051 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -94.81 27.78 2.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.791 0.329 . . . . 0.0 110.852 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.43 ' HA2' ' CB ' ' B' ' 537' ' ' ARG . . . -170.04 -170.06 33.98 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.419 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -60.84 -30.17 69.95 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.953 0.406 . . . . 0.0 110.712 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.446 ' HA ' ' HB3' ' A' ' 81' ' ' CYS . 2.7 t 63.45 -71.21 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.584 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.467 ' O ' ' CE1' ' A' ' 169' ' ' PHE . . . 175.22 59.19 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.169 -1.015 . . . . 0.0 113.232 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.436 ' CD ' HD13 ' B' ' 543' ' ' LEU . 0.0 OUTLIER -97.85 -85.71 0.36 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.861 0.33 . . . . 0.0 110.217 178.75 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.438 ' HB ' ' CG1' ' A' ' 21' ' ' ILE . 45.9 p -99.5 -36.64 9.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.001 0.429 . . . . 0.0 111.116 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.405 ' O ' ' CB ' ' A' ' 22' ' ' SER . 30.0 p -40.28 -36.31 0.51 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.314 -179.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.483 HD21 ' CD1' ' A' ' 169' ' ' PHE . 0.0 OUTLIER -71.15 -69.3 0.38 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.926 0.393 . . . . 0.0 110.883 -179.68 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.415 HD22 ' N ' ' A' ' 20' ' ' LEU . 3.6 mt -55.98 -43.47 77.63 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.234 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.438 ' CG1' ' HB ' ' A' ' 17' ' ' THR . 42.4 mm -62.41 -66.9 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.864 0.364 . . . . 0.0 110.587 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.405 ' CB ' ' O ' ' A' ' 18' ' ' CYS . 52.3 p -46.18 -27.41 0.98 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.258 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -73.89 -68.14 0.54 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.954 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.91 -46.27 75.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.716 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.417 ' OG1' ' CG2' ' A' ' 21' ' ' ILE . 19.0 p -85.26 -149.1 0.12 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.308 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -161.18 30.11 0.14 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.746 0.307 . . . . 0.0 111.105 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.8 mttt -115.35 156.31 25.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.271 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.492 ' HA ' ' CE1' ' A' ' 32' ' ' TYR . 4.1 t80 -163.67 -62.15 0.01 OUTLIER Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.726 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.483 ' HD3' ' HB3' ' A' ' 28' ' ' PHE . 63.2 Cg_endo -85.07 -16.37 5.15 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.627 2.218 . . . . 0.0 112.989 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.2 m -50.61 -87.75 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.398 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -158.12 116.86 3.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.525 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.492 ' CE1' ' HA ' ' A' ' 28' ' ' PHE . 6.6 m-85 -111.56 94.14 4.82 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.108 0.48 . . . . 0.0 110.769 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.464 ' HB ' ' HD3' ' A' ' 34' ' ' PRO . 2.1 t -117.25 -52.22 0.04 OUTLIER Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.23 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.472 ' O ' ' CD1' ' A' ' 37' ' ' PHE . 5.1 Cg_exo -80.14 52.99 4.54 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.501 2.134 . . . . 0.0 112.245 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.9 t -98.88 -25.22 14.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.835 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.435 ' HB ' ' CD1' ' A' ' 61' ' ' LEU . 7.4 p -51.0 -27.63 5.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.326 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.472 ' CD1' ' O ' ' A' ' 34' ' ' PRO . 3.4 p90 -54.79 -21.15 10.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.965 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.436 ' HB3' ' CB ' ' A' ' 57' ' ' ASP . 59.2 t0 -44.71 -29.73 0.81 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.413 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -70.29 -30.75 67.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.167 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.515 ' CE1' ' CG2' ' B' ' 521' ' ' THR . 8.6 m-85 -60.68 -174.07 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.86 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -101.57 -179.63 4.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.087 0.47 . . . . 0.0 111.538 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.1 m -141.11 165.15 19.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.553 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.464 ' O ' ' CG1' ' A' ' 44' ' ' VAL . 0.7 OUTLIER -110.2 102.11 10.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.883 0.373 . . . . 0.0 111.649 -179.483 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.507 ' CG2' ' CG2' ' A' ' 52' ' ' THR . 30.1 m -164.81 -177.16 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.728 178.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.489 ' O ' ' HG3' ' A' ' 45' ' ' MET . 0.0 OUTLIER -128.53 101.12 6.03 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.54 0.686 . . . . 0.0 110.95 179.844 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.475 ' O ' ' N ' ' A' ' 48' ' ' GLY . 3.8 mm -55.49 101.6 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.478 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.454 ' O ' ' CE ' ' A' ' 45' ' ' MET . . . 29.48 -83.88 0.0 OUTLIER Glycine 0 C--N 1.337 0.626 0 N-CA-C 114.862 0.705 . . . . 0.0 114.862 178.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . -42.28 -77.32 0.08 OUTLIER Glycine 0 CA--C 1.519 0.311 0 C-N-CA 121.226 -0.511 . . . . 0.0 113.167 -179.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.409 ' HB3' ' HD2' ' A' ' 50' ' ' PRO . 2.0 mt-10 -143.57 164.28 31.52 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-O 120.807 0.337 . . . . 0.0 111.448 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.418 ' HA ' ' HB2' ' A' ' 45' ' ' MET . 4.2 Cg_endo -47.09 101.12 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.942 2.428 . . . . 0.0 112.309 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.489 ' CE1' ' OG1' ' A' ' 3' ' ' THR . 5.0 t80 -172.85 137.04 0.73 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.967 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.507 ' CG2' ' CG2' ' A' ' 44' ' ' VAL . 16.5 p -134.26 138.54 45.11 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.114 0.483 . . . . 0.0 111.369 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.421 ' CB ' ' O ' ' A' ' 4' ' ' ILE . 1.5 pp -74.04 178.07 5.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.752 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -111.89 86.91 0.44 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.071 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -47.62 116.81 1.58 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.854 0.359 . . . . 0.0 110.501 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -83.92 105.3 14.7 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.042 -179.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.436 ' CB ' ' HB3' ' A' ' 38' ' ' ASP . 0.1 OUTLIER -130.16 111.31 12.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.153 179.593 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.448 ' HB ' ' CD1' ' A' ' 67' ' ' LEU . 0.6 OUTLIER -86.28 129.78 34.73 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.748 -179.512 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.429 ' N ' HD11 ' A' ' 67' ' ' LEU . . . -135.99 114.75 12.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.909 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -67.48 63.8 0.27 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.775 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.436 ' CB ' ' HB2' ' B' ' 525' ' ' ASP . 9.7 mt -121.45 -171.72 2.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.834 0.349 . . . . 0.0 110.874 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.433 ' CB ' ' O ' ' B' ' 524' ' ' GLY . 0.1 OUTLIER -44.43 -45.53 9.08 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.51 -179.878 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.477 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . 5.3 m-20 -59.35 -62.99 1.47 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.163 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.477 ' CE1' ' HB3' ' A' ' 63' ' ' ASP . 0.1 OUTLIER -128.42 132.15 48.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.862 -179.68 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -86.68 -68.73 0.72 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.435 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.401 ' O ' ' HB2' ' A' ' 67' ' ' LEU . 11.1 mmt180 -98.41 -34.67 10.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.337 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.556 ' O ' ' CB ' ' A' ' 68' ' ' ARG . 1.2 mp 69.72 -80.07 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.058 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.556 ' CB ' ' O ' ' A' ' 67' ' ' LEU . 25.8 ttp180 113.83 -42.61 0.0 OUTLIER Pre-proline 0 N--CA 1.487 1.39 0 C-N-CA 123.89 0.876 . . . . 0.0 112.904 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 67.7 Cg_exo -41.61 -49.83 5.07 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.499 2.132 . . . . 0.0 113.182 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.524 ' CD2' ' CA ' ' B' ' 541' ' ' LEU . 0.1 OUTLIER -53.38 -26.23 18.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.78 0.324 . . . . 0.0 110.564 -179.924 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.412 ' CB ' ' O ' ' A' ' 68' ' ' ARG . 8.5 t -50.95 -67.68 0.23 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.081 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -147.14 73.57 12.03 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.012 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -56.47 164.78 5.13 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.58 2.187 . . . . 0.0 112.202 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 54.6 tp60 -95.02 -17.53 21.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.296 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.427 ' CG2' HG22 ' A' ' 77' ' ' VAL . 93.5 m -46.62 149.99 0.74 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.773 0.321 . . . . 0.0 111.201 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -90.43 -24.19 20.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.05 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.427 HG22 ' CG2' ' A' ' 75' ' ' THR . 1.2 m -103.83 91.6 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.135 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -80.98 122.09 26.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.17 109.65 12.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.013 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.408 HG21 ' HB2' ' A' ' 110' ' ' PHE . 1.8 m -106.75 121.4 59.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.379 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.446 ' HB3' ' HA ' ' A' ' 14' ' ' VAL . 9.0 p -95.37 161.43 14.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.319 0.581 . . . . 0.0 112.304 -178.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.523 ' CE1' ' CD2' ' A' ' 112' ' ' LEU . 14.3 p90 179.61 123.58 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.897 179.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.35 151.02 20.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.952 0.406 . . . . 0.0 111.341 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.435 ' CG2' ' HB3' ' A' ' 120' ' ' ARG . 1.5 m -52.52 -51.78 31.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.591 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.428 ' CG2' ' OE1' ' A' ' 116' ' ' GLN . 19.6 m -53.28 116.64 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.588 0.232 . . . . 0.0 110.615 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 6.4 m -151.14 129.2 5.89 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.455 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -91.17 51.39 0.81 Allowed 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.989 2.46 . . . . 0.0 111.684 179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.462 ' N ' ' CB ' ' A' ' 133' ' ' LYS . 0.1 OUTLIER 75.1 15.86 2.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.21 -179.626 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.4 ' O ' ' CG2' ' A' ' 93' ' ' VAL . 43.8 t -97.6 -22.4 16.52 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.121 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.487 ' CE2' ' CG2' ' A' ' 137' ' ' ILE . 12.0 t80 -47.07 -59.18 3.3 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.322 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -48.71 -47.18 41.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.967 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -69.89 -32.61 71.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.781 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.4 ' CG2' ' O ' ' A' ' 89' ' ' SER . 93.8 t -57.1 -68.51 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.964 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.437 ' CB ' HD11 ' A' ' 145' ' ' LEU . 6.9 mmtt -52.09 -52.86 48.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.745 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -57.44 -22.58 44.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.791 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -100.39 -12.38 19.46 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.355 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.421 ' O ' ' CG ' ' A' ' 100' ' ' GLU . 3.1 m0 -89.24 -56.27 3.34 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.628 0.252 . . . . 0.0 111.179 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.491 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 12.9 t -45.88 -45.44 37.57 Favored Pre-proline 0 C--N 1.329 -0.293 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.491 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 50.2 Cg_exo -54.14 -37.77 87.41 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.323 2.015 . . . . 0.0 112.523 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.438 ' HG3' ' N ' ' A' ' 101' ' ' ILE . 6.3 pt-20 -82.82 -32.53 27.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.078 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.438 ' N ' ' HG3' ' A' ' 100' ' ' GLU . 19.0 mm -53.86 -35.54 27.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.892 0.377 . . . . 0.0 110.648 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 43.9 p -95.93 -22.45 17.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.055 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 13.5 t-160 -66.02 -29.01 69.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.741 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 3.5 m170 -90.93 -25.22 19.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.799 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 1.1 m -145.33 142.2 17.98 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.886 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.51 90.48 0.22 Allowed 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.535 2.157 . . . . 0.0 112.207 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 58.9 90.83 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.743 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.93 116.07 30.29 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.969 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -60.14 156.32 40.49 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.575 2.184 . . . . 0.0 112.226 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.479 ' CE2' ' HB2' ' A' ' 151' ' ' ALA . 3.4 p90 -145.9 147.83 32.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.943 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.433 ' CD1' ' HB3' ' A' ' 171' ' ' GLU . 3.7 tt -108.45 141.38 40.4 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.011 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.523 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 25.1 mt -98.71 142.94 29.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.81 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.432 ' CG1' HG11 ' A' ' 168' ' ' VAL . 58.1 t -121.6 142.58 37.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.98 0.419 . . . . 0.0 111.775 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -117.43 121.74 5.21 Favored Glycine 0 N--CA 1.45 -0.375 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.449 ' CA ' HD13 ' A' ' 117' ' ' ILE . 1.3 p -136.63 -56.23 0.74 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.736 0.303 . . . . 0.0 111.134 -179.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.433 ' HG2' ' CG2' ' A' ' 84' ' ' VAL . 2.6 tt0 -59.36 -16.81 24.95 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.821 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.449 HD13 ' CA ' ' A' ' 115' ' ' THR . 0.4 OUTLIER -55.15 -16.05 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 179.912 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.426 ' N ' HD12 ' A' ' 117' ' ' ILE . 1.3 t0 -82.13 -19.99 38.92 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 120.732 0.301 . . . . 0.0 111.151 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.1 pp -121.35 1.72 10.21 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.908 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.435 ' HB3' ' CG2' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -50.05 -30.9 11.77 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.986 0.422 . . . . 0.0 110.647 179.88 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -59.84 -21.65 61.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.978 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -44.79 99.84 0.22 Allowed Pre-proline 0 N--CA 1.462 0.136 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.869 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.416 ' O ' ' CG ' ' A' ' 127' ' ' GLU . 15.1 Cg_exo -68.94 -4.68 13.92 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.711 2.274 . . . . 0.0 112.968 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.3 t -83.36 -64.7 1.12 Allowed 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.4 ' HA ' ' HD3' ' A' ' 128' ' ' LYS . 32.5 m -55.84 -36.43 67.51 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.436 ' O ' ' N ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -58.69 -39.39 76.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.945 179.24 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.416 ' CG ' ' O ' ' A' ' 123' ' ' PRO . 8.8 mm-40 -63.71 -29.28 70.52 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.776 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.4 ' HD3' ' HA ' ' A' ' 125' ' ' THR . 1.8 mptt -74.16 -58.34 3.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.789 179.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.425 ' HG ' ' HA ' ' A' ' 126' ' ' ILE . 3.6 pp -63.22 -25.89 68.54 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.483 ' HA ' ' CA ' ' A' ' 134' ' ' GLN . . . -52.61 -41.69 63.9 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.564 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 18.0 mmtm -46.22 -24.08 0.42 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.637 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -123.04 -30.23 3.79 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.478 ' CG ' ' N ' ' A' ' 134' ' ' GLN . 0.0 OUTLIER -132.21 -72.45 0.53 Allowed 'General case' 0 CA--C 1.534 0.331 0 O-C-N 122.097 -0.377 . . . . 0.0 111.871 -178.783 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.483 ' CA ' ' HA ' ' A' ' 130' ' ' ALA . 9.5 mt-30 98.63 -46.54 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.841 0.856 . . . . 0.0 110.945 -179.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 4.2 mtpp -73.77 109.1 5.9 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.42 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.06 -170.8 0.44 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.087 1.858 . . . . 0.0 110.764 179.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.487 ' CG2' ' CE2' ' A' ' 90' ' ' PHE . 1.2 mm -112.08 95.89 4.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.163 0.506 . . . . 0.0 111.057 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.412 ' O ' ' N ' ' A' ' 141' ' ' THR . 0.1 OUTLIER -71.57 150.03 93.52 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.76 -179.981 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -44.01 -28.85 2.37 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.698 2.265 . . . . 0.0 112.383 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -71.26 -31.26 67.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.85 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.412 ' N ' ' O ' ' A' ' 138' ' ' THR . 55.4 m -72.64 -50.58 24.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.905 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.456 ' HB1' ' CG ' ' A' ' 154' ' ' TYR . . . -50.28 -61.19 2.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.853 0.359 . . . . 0.0 110.792 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.45 -40.12 68.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.751 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -50.78 -61.24 2.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.705 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.437 HD11 ' CB ' ' A' ' 94' ' ' LYS . 3.6 tt -67.22 -34.0 76.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.568 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.411 ' CB ' HD11 ' A' ' 112' ' ' LEU . . . -57.2 -45.01 84.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.852 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 5.1 mtm180 -79.49 -25.6 41.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.843 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -58.24 -46.09 86.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.797 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.8 mt -102.05 24.18 10.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.804 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 39.07 55.14 2.13 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.758 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.479 ' HB2' ' CE2' ' A' ' 110' ' ' PHE . . . -67.04 -81.62 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.056 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.429 HG11 ' CD1' ' A' ' 111' ' ' LEU . 50.9 t -160.54 -74.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.81 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.16 114.9 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.11 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.456 ' CG ' ' HB1' ' A' ' 142' ' ' ALA . 45.7 t80 -90.55 109.9 21.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.048 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 3.6 t -101.67 161.43 3.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.393 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -89.7 140.33 29.68 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.098 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.408 ' SG ' ' CG1' ' A' ' 168' ' ' VAL . 1.8 p 178.71 -175.14 0.19 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.314 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' A' ' 115' ' ' THR . 4.5 t -160.28 163.75 33.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.109 0.48 . . . . 0.0 111.677 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.441 ' CB ' HD11 ' A' ' 165' ' ' LEU . . . -114.82 -42.15 3.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.09 179.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.43 -29.08 61.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.189 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -111.87 -26.4 8.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.659 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 73.52 70.57 0.12 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.232 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 12.3 mtmt -95.2 23.56 5.68 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.109 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 101.71 42.78 2.24 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.914 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.478 ' CD2' ' CD2' ' A' ' 19' ' ' LEU . 0.3 OUTLIER -52.29 -25.0 8.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.691 0.282 . . . . 0.0 111.042 179.911 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -69.04 -23.31 64.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.691 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.16 -70.33 0.24 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.707 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.445 ' CG1' ' N ' ' A' ' 169' ' ' PHE . 7.5 p -52.64 -46.78 50.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.114 0.483 . . . . 0.0 110.431 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.483 ' CD1' HD21 ' A' ' 19' ' ' LEU . 2.6 t80 -57.25 -32.55 66.68 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.111 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -71.22 -25.85 62.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.047 178.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.433 ' HB3' ' CD1' ' A' ' 111' ' ' LEU . 0.8 OUTLIER -74.16 -28.12 61.16 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.126 179.308 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.432 ' N ' HD11 ' A' ' 111' ' ' LEU . . . -75.44 -40.74 57.21 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.709 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.417 ' CD1' HD11 ' A' ' 177' ' ' LEU . 1.6 pp -80.89 -33.71 13.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.916 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.455 ' CD2' ' HB3' ' B' ' 505' ' ' LEU . 1.0 OUTLIER -55.42 -58.59 7.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.417 179.647 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.436 ' CB ' ' HG3' ' A' ' 180' ' ' PRO . . . -49.5 -25.85 2.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.791 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.481 ' CB ' ' CG2' ' A' ' 4' ' ' ILE . . . -87.8 -41.19 13.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.118 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.456 ' CD2' HG21 ' A' ' 4' ' ' ILE . 41.8 mt -68.82 -23.68 64.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.892 0.377 . . . . 0.0 110.614 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.43 ' CG ' ' HD2' ' A' ' 179' ' ' PRO . 24.8 tt0 -168.19 142.78 2.85 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.841 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . 0.43 ' HD2' ' CG ' ' A' ' 178' ' ' GLU . 93.3 Cg_exo -44.07 115.44 0.73 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.587 2.191 . . . . 0.0 112.405 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . 0.436 ' HG3' ' CB ' ' A' ' 175' ' ' ALA . 67.6 Cg_endo -73.08 -171.76 0.86 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.452 2.101 . . . . 0.0 112.358 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -148.83 151.59 35.45 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.787 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -59.45 -152.72 0.01 OUTLIER 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.706 2.271 . . . . 0.0 112.469 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.4 148.77 46.62 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.961 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.268 -0.872 . . . . 0.0 110.843 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.165 0 N-CA-C 112.514 -0.234 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 503' ' ' SER . . . . . . . . . . . . . 98.7 p -62.82 -170.9 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.843 0.354 . . . . 0.0 110.894 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 504' ' ' GLY . . . . . 0.405 ' N ' ' OD1' ' B' ' 509' ' ' ASP . . . -157.31 -106.63 0.24 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.396 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 505' ' ' LEU . . . . . 0.455 ' HB3' ' CD2' ' A' ' 174' ' ' LEU . 1.1 pt? 44.15 -171.77 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.114 0.483 . . . . 0.0 111.867 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 506' ' ' SER . . . . . . . . . . . . . 4.9 m -117.66 -15.69 10.14 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.106 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 507' ' ' ALA . . . . . 0.418 ' CB ' ' HB2' ' A' ' 178' ' ' GLU . . . -67.89 59.62 0.07 Allowed 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.087 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 508' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 69.86 3.17 4.18 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.608 -178.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 509' ' ' ASP . . . . . 0.406 ' HA ' ' HG ' ' B' ' 505' ' ' LEU . 15.7 t0 46.7 53.47 10.08 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.378 0.609 . . . . 0.0 111.094 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 510' ' ' ILE . . . . . 0.443 ' CG1' HG22 ' A' ' 46' ' ' ILE . 0.9 OUTLIER -50.6 107.78 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.352 179.561 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 511' ' ' SER . . . . . . . . . . . . . 48.2 m -61.87 86.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.91 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 512' ' ' GLN . . . . . 0.472 ' CB ' ' CD ' ' B' ' 513' ' ' PRO . 23.6 tp60 -50.89 -67.69 0.45 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.464 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 513' ' ' PRO . . . . . 0.472 ' CD ' ' CB ' ' B' ' 512' ' ' GLN . 98.3 Cg_endo -77.06 66.09 7.76 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.506 2.137 . . . . 0.0 112.13 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 514' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -73.69 138.78 44.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.847 0.356 . . . . 0.0 111.082 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 515' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.49 143.52 15.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.927 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 72.02 23.51 3.46 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.988 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 517' ' ' SER . . . . . 0.467 ' O ' ' CD1' ' B' ' 518' ' ' PHE . 3.1 m -82.75 53.79 2.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.185 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 518' ' ' PHE . . . . . 0.467 ' CD1' ' O ' ' B' ' 517' ' ' SER . 10.4 m-85 -163.63 94.98 0.8 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.603 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 519' ' ' ILE . . . . . 0.408 ' O ' ' HB2' ' B' ' 520' ' ' HIS . 13.2 mt -55.87 -100.16 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.316 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 520' ' ' HIS . . . . . 0.408 ' HB2' ' O ' ' B' ' 519' ' ' ILE . 15.7 t-160 179.22 40.14 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.763 0.316 . . . . 0.0 110.943 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 521' ' ' THR . . . . . 0.515 ' CG2' ' CE1' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -112.87 -177.1 3.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.262 -179.792 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 522' ' ' GLY . . . . . . . . . . . . . . . 71.58 97.33 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.265 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 523' ' ' HIS . . . . . 0.413 ' CD2' ' N ' ' B' ' 524' ' ' GLY . 15.8 p-80 -144.82 -45.77 0.23 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.821 0.343 . . . . 0.0 111.334 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 524' ' ' GLY . . . . . 0.433 ' O ' ' CB ' ' A' ' 62' ' ' GLU . . . -67.81 68.63 0.3 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.256 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 525' ' ' ASP . . . . . 0.436 ' HB2' ' CB ' ' A' ' 61' ' ' LEU . 0.2 OUTLIER 176.3 37.47 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.822 0.344 . . . . 0.0 110.549 -179.732 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 526' ' ' SER . . . . . 0.43 ' HA ' ' CG1' ' A' ' 33' ' ' VAL . 3.1 t -113.55 96.17 5.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.901 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 527' ' ' ASP . . . . . 0.52 ' CB ' ' CD ' ' B' ' 528' ' ' PRO . 0.4 OUTLIER -134.05 -70.67 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.831 179.518 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 528' ' ' PRO . . . . . 0.52 ' CD ' ' CB ' ' B' ' 527' ' ' ASP . 13.4 Cg_endo -53.97 90.07 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.671 2.247 . . . . 0.0 112.396 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 529' ' ' ARG . . . . . 0.415 ' CG ' HG21 ' A' ' 33' ' ' VAL . 0.5 OUTLIER -96.19 5.11 51.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.003 179.491 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 530' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -49.33 -53.8 20.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.751 0.31 . . . . 0.0 111.537 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER 71.23 -154.52 0.1 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.531 -179.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 532' ' ' TRP . . . . . 0.459 ' CD1' ' NH2' ' B' ' 537' ' ' ARG . 0.0 OUTLIER -41.9 142.06 0.75 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.962 0.411 . . . . 0.0 111.55 -179.86 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . -163.56 -40.45 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.308 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 534' ' ' PHE . . . . . 0.476 ' CZ ' HG22 ' B' ' 538' ' ' ILE . 4.5 p90 -133.17 161.16 65.45 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 120.679 0.276 . . . . 0.0 110.553 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 535' ' ' PRO . . . . . 0.405 ' HD2' ' HB2' ' B' ' 534' ' ' PHE . 91.0 Cg_exo -42.93 103.37 0.04 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.58 2.187 . . . . 0.0 112.49 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 1.8 t0 70.53 159.36 0.2 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.987 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 537' ' ' ARG . . . . . 0.459 ' NH2' ' CD1' ' B' ' 532' ' ' TRP . 0.0 OUTLIER -62.96 -165.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.301 0.572 . . . . 0.0 110.908 179.864 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 538' ' ' ILE . . . . . 0.476 HG22 ' CZ ' ' B' ' 534' ' ' PHE . 0.0 OUTLIER -105.5 -160.74 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.269 -0.878 . . . . 0.0 108.981 178.524 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 539' ' ' ASP . . . . . 0.475 ' N ' HG12 ' B' ' 538' ' ' ILE . 38.5 p-10 -79.83 153.13 29.32 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.329 -0.548 . . . . 0.0 111.014 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 540' ' ' GLU . . . . . 0.423 ' CG ' ' HB ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -52.57 -22.27 4.77 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.754 -179.389 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 541' ' ' LEU . . . . . 0.524 ' CA ' ' CD2' ' A' ' 70' ' ' LEU . 5.4 tp -54.84 -22.31 14.13 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.175 0.512 . . . . 0.0 110.853 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 542' ' ' TYR . . . . . 0.472 ' HB2' ' CG1' ' B' ' 538' ' ' ILE . 3.1 m-85 -104.91 -63.86 1.18 Allowed 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.708 -178.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 543' ' ' LEU . . . . . 0.436 HD13 ' CD ' ' A' ' 16' ' ' LYS . 0.1 OUTLIER 62.85 46.23 5.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.879 -179.566 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . 175.67 -70.2 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.465 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 545' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.274 -0.87 . . . . 0.0 110.887 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.421 ' HG2' ' CG ' ' A' ' 49' ' ' GLU . 2.4 ppp? . . . . . 0 N--CA 1.488 1.448 0 CA-C-O 120.842 0.353 . . . . 0.0 111.128 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 62.1 tp60 -161.14 125.21 3.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.313 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.443 ' CG2' ' HB2' ' A' ' 53' ' ' LEU . 13.1 t -123.65 -173.79 2.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.227 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.444 HG22 ' CB ' ' A' ' 176' ' ' ALA . 0.1 OUTLIER -153.39 156.11 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -178.983 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 16.3 pttm -124.9 95.52 4.54 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.044 179.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 8.3 m -95.61 156.5 16.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.99 0.424 . . . . 0.0 111.458 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.429 ' CG1' ' HB3' ' A' ' 56' ' ' PHE . 0.2 OUTLIER -120.12 159.65 21.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.471 179.704 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.434 ' CG2' ' N ' ' A' ' 15' ' ' GLY . 6.1 p -110.36 114.37 46.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.248 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.522 ' CG2' ' CE2' ' A' ' 78' ' ' PHE . 81.7 t -134.6 129.75 52.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.099 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 149.53 -150.01 22.05 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.186 -1.007 . . . . 0.0 112.917 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -118.81 -13.56 9.53 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.624 0.231 . . . . 0.0 111.624 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.434 ' O ' ' NH1' ' B' ' 537' ' ' ARG . . . -50.51 -101.22 0.01 OUTLIER Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.363 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -102.5 -19.08 15.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.79 0.329 . . . . 0.0 111.032 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.44 ' CG2' ' HB3' ' B' ' 537' ' ' ARG . 37.9 t 64.52 23.34 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.647 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.434 ' N ' ' CG2' ' A' ' 8' ' ' VAL . . . -153.9 134.53 4.38 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.632 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.487 ' HE2' ' CZ ' ' A' ' 169' ' ' PHE . 0.4 OUTLIER -86.54 7.55 25.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.75 0.309 . . . . 0.0 110.718 179.365 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.3 p -97.24 -45.03 6.67 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 120.938 0.399 . . . . 0.0 110.992 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 28.6 p -39.26 -45.96 1.46 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.307 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.52 ' CD2' ' CD1' ' A' ' 169' ' ' PHE . 1.4 mp -51.12 -50.0 59.67 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.923 0.392 . . . . 0.0 110.737 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.419 ' N ' HD21 ' A' ' 20' ' ' LEU . 3.0 mm? -73.02 -19.42 61.2 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.028 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.432 ' O ' ' N ' ' A' ' 25' ' ' THR . 17.4 mm -66.7 -71.04 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 CA-C-O 120.719 0.295 . . . . 0.0 110.7 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.3 t -61.22 -27.0 68.12 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.81 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -58.9 -62.94 1.5 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.916 0.388 . . . . 0.0 110.354 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 54.7 m -82.66 -46.53 13.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.403 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.432 ' N ' ' O ' ' A' ' 21' ' ' ILE . 14.2 p -101.23 -158.07 0.65 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.416 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -153.3 27.86 0.51 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.81 0.338 . . . . 0.0 111.114 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -96.17 73.15 2.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.046 0.45 . . . . 0.0 110.502 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.432 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . 0.3 OUTLIER -86.85 -53.1 0.41 Allowed Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.745 -179.745 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.432 ' HD3' ' HB3' ' A' ' 28' ' ' PHE . 84.0 Cg_endo -85.34 78.79 2.4 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.717 2.278 . . . . 0.0 112.757 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.417 ' O ' ' CB ' ' B' ' 531' ' ' CYS . 2.8 m -141.84 -96.18 0.13 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.815 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -159.39 133.56 7.61 Favored 'General case' 0 C--N 1.334 -0.083 0 CA-C-O 120.793 0.33 . . . . 0.0 110.977 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.468 ' OH ' ' CD1' ' B' ' 532' ' ' TRP . 3.0 m-30 -97.31 94.45 7.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.403 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.431 ' CG1' ' HG3' ' B' ' 529' ' ' ARG . 0.0 OUTLIER -134.2 -59.04 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.995 -179.521 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.429 ' HD3' ' CB ' ' A' ' 33' ' ' VAL . 77.7 Cg_exo -52.45 -21.53 14.17 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.107 1.871 . . . . 0.0 112.21 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 52.8 m -71.74 62.3 0.41 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.621 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.478 ' CG2' ' CB ' ' A' ' 59' ' ' ALA . 4.1 p -132.25 -39.86 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.559 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.475 ' CD2' ' HA ' ' A' ' 40' ' ' TYR . 5.6 t80 -41.13 -30.52 0.15 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.585 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.427 ' CB ' ' OH ' ' A' ' 64' ' ' TYR . 11.6 t0 66.55 -68.41 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.923 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.474 ' O ' ' CE2' ' A' ' 37' ' ' PHE . 0.7 OUTLIER -77.89 55.18 1.37 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.365 -179.928 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.475 ' HA ' ' CD2' ' A' ' 37' ' ' PHE . 6.7 m-85 -60.5 139.88 57.54 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.804 0.335 . . . . 0.0 110.464 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.437 ' O ' ' CG1' ' B' ' 519' ' ' ILE . . . -90.59 119.4 30.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.207 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.4 m -137.09 123.23 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.726 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.434 ' CG2' ' HB3' ' B' ' 516' ' ' ASN . 8.8 t -84.29 104.16 14.09 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.459 ' CG1' ' HB2' ' B' ' 514' ' ' LEU . 25.5 t -145.03 148.27 18.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.184 -178.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.464 ' HE1' ' N ' ' A' ' 49' ' ' GLU . 3.2 tpt -96.18 96.47 8.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.973 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.441 HG22 ' CG2' ' B' ' 510' ' ' ILE . 1.2 mm -83.25 85.76 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 120.718 0.294 . . . . 0.0 110.578 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.417 ' N ' ' HE3' ' A' ' 45' ' ' MET . . . 30.8 94.22 0.01 OUTLIER Glycine 0 CA--C 1.524 0.644 0 CA-C-N 115.694 -0.685 . . . . 0.0 114.035 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 135.27 -97.44 0.28 Allowed Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.83 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.464 ' N ' ' HE1' ' A' ' 45' ' ' MET . 0.2 OUTLIER -119.8 129.76 25.19 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.503 0.192 . . . . 0.0 110.551 179.701 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -37.14 96.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.914 2.41 . . . . 0.0 112.919 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.435 ' CD1' ' C ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -172.86 142.91 1.16 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.753 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.45 ' CG2' ' HB ' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -135.0 153.82 51.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.267 -178.982 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.443 ' HB2' ' CG2' ' A' ' 3' ' ' THR . 5.8 tp -95.67 136.17 36.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.768 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -64.99 142.07 44.41 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.453 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -76.33 134.98 39.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.842 0.353 . . . . 0.0 110.505 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.429 ' HB3' ' CG1' ' A' ' 7' ' ' VAL . 0.9 OUTLIER -84.59 108.74 17.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.912 0.387 . . . . 0.0 110.886 -179.875 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -140.41 142.07 35.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.138 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.454 ' HB ' ' CD1' ' A' ' 67' ' ' LEU . 43.4 p -101.28 -176.66 3.22 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.105 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.478 ' CB ' ' CG2' ' A' ' 36' ' ' VAL . . . -172.44 -162.58 0.2 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.886 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -148.78 43.11 0.81 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.295 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.439 ' CD2' ' HB3' ' B' ' 525' ' ' ASP . 0.4 OUTLIER -121.26 -160.03 0.83 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.922 0.391 . . . . 0.0 111.364 -179.732 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -48.71 -44.84 38.49 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.387 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.479 ' HB3' ' CD1' ' A' ' 64' ' ' TYR . 0.5 OUTLIER -45.97 -61.14 1.87 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.431 -179.651 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.479 ' CD1' ' HB3' ' A' ' 63' ' ' ASP . 0.1 OUTLIER -164.31 139.44 5.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.908 0.385 . . . . 0.0 111.021 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -86.73 -68.16 0.76 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.531 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.55 -32.17 19.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.634 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.454 ' CD1' ' HB ' ' A' ' 58' ' ' THR . 1.3 mp 71.16 -149.05 0.08 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.535 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.475 ' CB ' ' CD ' ' A' ' 69' ' ' PRO . 1.0 OUTLIER -159.05 -65.36 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.177 0 N-CA-C 111.717 0.265 . . . . 0.0 111.717 -179.831 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.475 ' CD ' ' CB ' ' A' ' 68' ' ' ARG . 46.1 Cg_exo -35.52 -60.26 0.33 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.039 2.493 . . . . 0.0 113.377 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.437 ' CD2' ' HA ' ' B' ' 541' ' ' LEU . 0.3 OUTLIER -46.62 -26.66 0.95 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.658 0.266 . . . . 0.0 111.473 -179.73 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.6 t -95.39 -6.81 40.1 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.401 ' O ' ' O ' ' A' ' 69' ' ' PRO . 23.7 m-85 -134.39 151.67 76.64 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-O 120.867 0.365 . . . . 0.0 111.474 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -80.1 51.37 3.88 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.749 2.299 . . . . 0.0 112.434 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.425 ' NE2' ' HB ' ' A' ' 75' ' ' THR . 4.1 pp0? -73.65 -30.44 62.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.0 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.425 ' HB ' ' NE2' ' A' ' 74' ' ' GLN . 12.1 t -70.61 -176.65 1.32 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.968 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -113.42 -21.77 10.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.904 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.8 t -150.74 112.87 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.041 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.522 ' CE2' ' CG2' ' A' ' 9' ' ' VAL . 0.1 OUTLIER -80.74 176.87 9.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.707 179.912 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.63 108.71 5.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.218 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.479 HG12 ' CH2' ' A' ' 97' ' ' TRP . 20.0 m -93.57 96.06 5.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.833 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 3.9 m -82.13 177.48 8.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.077 0.465 . . . . 0.0 111.458 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.459 ' CE1' ' O ' ' A' ' 113' ' ' VAL . 19.1 p90 -179.49 -173.47 0.26 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.011 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.82 134.66 18.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.783 0.325 . . . . 0.0 110.651 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.406 ' CG1' ' O ' ' A' ' 137' ' ' ILE . 2.2 m -45.36 -56.76 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.567 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 33.7 m -54.27 113.24 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.404 ' N ' HD21 ' A' ' 129' ' ' LEU . 4.1 m -151.24 125.49 4.49 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.684 0.278 . . . . 0.0 111.721 -179.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.433 ' O ' ' CB ' ' A' ' 88' ' ' SER . 87.5 Cg_endo -92.51 54.23 0.58 Allowed 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 123.177 2.585 . . . . 0.0 111.56 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 87' ' ' PRO . 0.1 OUTLIER 81.97 24.08 0.23 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.889 -179.413 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 6.1 t -97.21 -26.91 14.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.747 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.474 ' CE2' HG23 ' A' ' 137' ' ' ILE . 13.4 t80 -55.23 -41.34 71.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.89 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 19.2 mp0 -70.22 -38.84 75.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.028 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -67.6 -45.22 76.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.158 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.437 ' O ' ' N ' ' A' ' 97' ' ' TRP . 7.4 p -65.6 -48.98 80.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.488 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.432 ' N ' HG11 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -51.15 -63.18 1.21 Allowed 'General case' 0 C--O 1.235 0.31 0 CA-C-O 120.944 0.402 . . . . 0.0 110.766 179.851 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.425 ' O ' ' CD ' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -52.47 -39.73 61.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.583 179.864 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.404 ' O ' ' CG ' ' A' ' 96' ' ' LYS . 0.2 OUTLIER -88.6 9.17 24.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.274 179.753 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.479 ' CH2' HG12 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -93.06 -58.33 2.36 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.946 0.403 . . . . 0.0 110.877 -179.908 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.491 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 40.8 t -56.27 -44.07 99.56 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.383 -179.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.491 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 6.0 Cg_exo -74.3 -19.74 19.37 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.556 2.171 . . . . 0.0 112.921 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -90.46 -59.13 2.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.932 0.396 . . . . 0.0 111.174 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.446 ' CD1' ' HB3' ' A' ' 110' ' ' PHE . 11.5 tt -52.17 -26.22 8.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.709 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 73.7 p -94.54 -62.09 1.39 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.177 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.423 ' CB ' ' O ' ' A' ' 99' ' ' PRO . 7.9 t60 -48.33 -43.32 33.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.222 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 34.1 m-70 -85.1 -23.59 28.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.129 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 5.3 m -146.47 75.81 12.23 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.033 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -62.19 142.37 91.54 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.638 2.226 . . . . 0.0 112.259 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.8 mmtt 63.14 56.06 1.82 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.074 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -138.28 108.06 8.03 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.651 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.424 ' O ' ' N ' ' A' ' 78' ' ' PHE . 31.2 Cg_exo -60.26 164.07 13.44 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.488 2.125 . . . . 0.0 112.354 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.496 ' CD2' ' HB2' ' A' ' 151' ' ' ALA . 0.7 OUTLIER -154.42 139.59 17.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.024 179.955 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.419 HD13 ' CG1' ' A' ' 152' ' ' VAL . 5.8 tt -121.58 146.31 47.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.942 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -94.61 153.47 17.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.651 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.459 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 93.3 t -136.69 146.24 28.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.095 0.474 . . . . 0.0 111.614 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -126.01 104.01 0.72 Allowed Glycine 0 N--CA 1.452 -0.243 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.553 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.512 ' CA ' HD11 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -120.65 -50.94 2.18 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.978 0.418 . . . . 0.0 110.701 -179.037 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -67.3 -8.86 35.41 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.445 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.512 HD11 ' CA ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -44.6 -26.84 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-O 120.681 0.277 . . . . 0.0 111.332 -179.865 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -64.17 -25.22 67.99 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.779 0.323 . . . . 0.0 111.048 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' A' ' 122' ' ' ASP . 4.9 mp -95.64 -19.86 19.4 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.418 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.426 ' CG ' ' O ' ' A' ' 117' ' ' ILE . 5.7 ppt_? -49.43 -26.46 3.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.946 0.403 . . . . 0.0 110.684 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.37 -27.13 29.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.519 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.417 ' N ' ' O ' ' A' ' 119' ' ' LEU . 38.0 t0 -55.1 108.02 1.04 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.599 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -68.75 -3.9 12.18 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.715 2.277 . . . . 0.0 113.034 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.78 -67.76 0.75 Allowed 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 7.2 m -56.35 -35.39 67.59 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.457 178.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.444 ' HA ' ' CD1' ' A' ' 129' ' ' LEU . 0.1 OUTLIER -56.37 -42.02 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.772 179.348 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -60.74 -35.33 76.1 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.778 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.52 -31.66 72.97 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.444 ' CD1' ' HA ' ' A' ' 126' ' ' ILE . 8.0 mt -73.1 -35.74 66.64 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -46.2 -34.56 4.43 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.007 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -48.11 -32.95 7.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.531 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.412 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 6.2 m-80 -123.24 -31.24 3.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.416 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.521 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 17.3 mmtt -147.19 -97.96 0.09 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 119.115 -0.469 . . . . 0.0 111.399 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.521 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 7.2 pt20 130.52 -25.1 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.412 1.085 . . . . 0.0 110.297 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 60.5 mmtt -69.28 110.64 6.61 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.766 -179.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -80.17 150.96 20.5 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.565 2.177 . . . . 0.0 111.431 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.491 ' CD1' ' N ' ' A' ' 137' ' ' ILE . 1.1 mm -81.93 96.29 3.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.106 0.479 . . . . 0.0 110.83 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.3 p -72.02 151.06 92.71 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.031 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.491 ' HA ' ' CE2' ' A' ' 154' ' ' TYR . 79.7 Cg_exo -44.09 -37.83 10.02 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.496 2.13 . . . . 0.0 112.244 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -68.6 -33.71 74.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.773 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 24.6 m -63.56 -60.58 3.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.717 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -53.15 -38.14 62.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.893 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -59.77 -46.84 87.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.812 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 22.7 tttp -61.36 -47.8 84.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.836 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.403 HD12 ' CG ' ' A' ' 94' ' ' LYS . 32.8 tp -67.23 -36.09 80.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.73 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -60.45 -54.33 46.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.057 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 11.2 mtp85 -73.05 -26.89 61.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.776 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.66 -46.47 63.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.014 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.443 ' CD1' ' CG2' ' A' ' 98' ' ' VAL . 1.0 OUTLIER -93.36 19.61 8.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.049 -179.956 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 78.3 tttt 48.19 43.94 19.09 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.789 0.328 . . . . 0.0 110.984 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.496 ' HB2' ' CD2' ' A' ' 110' ' ' PHE . . . -72.36 -81.72 0.05 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.311 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.433 ' CG2' ' O ' ' A' ' 151' ' ' ALA . 69.4 t -160.18 -74.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.773 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt 175.84 139.65 0.06 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.776 -179.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.491 ' CE2' ' HA ' ' A' ' 139' ' ' PRO . 18.0 t80 -99.96 112.28 24.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.693 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.419 ' CG2' ' HA ' ' A' ' 168' ' ' VAL . 3.0 t -101.24 166.03 2.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.201 -179.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -89.51 150.23 22.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.12 0.486 . . . . 0.0 111.402 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.437 ' O ' HD11 ' A' ' 117' ' ' ILE . 1.6 p 178.52 -179.24 0.31 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.089 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -160.14 152.49 20.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.875 0.369 . . . . 0.0 111.179 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -109.99 -28.66 8.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.923 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.2 mp -83.78 -45.22 13.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.651 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -98.8 -24.31 15.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.587 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 75.34 76.9 0.1 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.108 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 2.8 tttm -94.82 34.21 1.38 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.698 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . 116.34 -62.32 0.38 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.589 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.417 ' CD1' ' O ' ' A' ' 19' ' ' LEU . 1.9 mt 67.55 -63.03 0.31 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.745 0.307 . . . . 0.0 111.05 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.418 ' O ' ' N ' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -55.49 -27.97 51.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.075 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -52.12 -72.63 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.858 0.361 . . . . 0.0 110.687 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.444 HG11 ' CG1' ' A' ' 113' ' ' VAL . 7.4 p -52.69 -46.22 49.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.173 0.511 . . . . 0.0 110.29 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.52 ' CD1' ' CD2' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -56.97 -29.32 63.13 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.744 179.225 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.453 ' O ' ' CD1' ' A' ' 173' ' ' ILE . 22.5 t0 -69.08 -29.47 67.58 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.494 178.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.414 ' CG ' HG21 ' A' ' 155' ' ' VAL . 28.8 mm-40 -75.91 -24.28 55.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.972 178.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.01 -54.91 9.55 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.381 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.453 ' CD1' ' O ' ' A' ' 170' ' ' ASP . 0.2 OUTLIER -67.64 -31.97 54.82 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-O 120.896 0.379 . . . . 0.0 110.666 -179.793 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.433 HD21 ' CD1' ' B' ' 505' ' ' LEU . 2.5 tm? -48.6 -33.65 10.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.742 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -74.53 -25.15 59.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.053 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.444 ' CB ' HG22 ' A' ' 4' ' ' ILE . . . -97.29 -32.41 11.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.646 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.453 ' CD1' ' HB ' ' B' ' 510' ' ' ILE . 14.4 mt -68.66 -11.23 59.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.223 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.426 ' HB2' ' CB ' ' B' ' 507' ' ' ALA . 0.0 OUTLIER 173.01 148.79 0.21 Allowed Pre-proline 0 C--N 1.332 -0.193 0 CA-C-O 120.768 0.318 . . . . 0.0 110.94 179.761 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -47.26 105.52 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.618 2.212 . . . . 0.0 112.305 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.97 171.85 14.97 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.581 2.188 . . . . 0.0 112.346 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -142.11 130.73 11.93 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.805 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.74 -164.95 0.23 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.546 2.164 . . . . 0.0 112.248 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.77 78.86 4.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.902 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.187 -0.911 . . . . 0.0 110.918 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 502' ' ' GLY . . . . . 0.423 ' CA ' ' OG ' ' B' ' 511' ' ' SER . . . . . . . . 0 N--CA 1.489 2.199 0 N-CA-C 112.539 -0.224 . . . . 0.0 112.539 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 503' ' ' SER . . . . . . . . . . . . . 26.7 t -58.83 -73.29 0.08 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.795 0.331 . . . . 0.0 110.855 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 504' ' ' GLY . . . . . 0.436 ' HA2' ' CB ' ' B' ' 509' ' ' ASP . . . 94.05 103.61 1.74 Allowed Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.393 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 505' ' ' LEU . . . . . 0.473 ' CD1' ' N ' ' B' ' 505' ' ' LEU . 0.1 OUTLIER -174.26 57.36 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.809 0.338 . . . . 0.0 110.741 -179.62 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 506' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 46.83 58.07 5.05 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.936 0.398 . . . . 0.0 110.66 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 507' ' ' ALA . . . . . 0.426 ' CB ' ' HB2' ' A' ' 178' ' ' GLU . . . -169.56 42.06 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.894 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 508' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 73.65 4.53 4.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.786 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 509' ' ' ASP . . . . . 0.436 ' CB ' ' HA2' ' B' ' 504' ' ' GLY . 3.0 p30 51.9 48.69 22.28 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 121.496 0.665 . . . . 0.0 110.673 -179.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 510' ' ' ILE . . . . . 0.453 ' HB ' ' CD1' ' A' ' 177' ' ' LEU . 37.5 mt -72.68 130.03 35.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.054 -0.975 . . . . 0.0 111.087 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 511' ' ' SER . . . . . 0.424 ' O ' ' CD1' ' B' ' 514' ' ' LEU . 16.5 m -77.2 135.79 38.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.3 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 512' ' ' GLN . . . . . 0.423 ' HB3' ' HD3' ' B' ' 513' ' ' PRO . 0.0 OUTLIER -97.91 -53.8 0.2 Allowed Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.092 179.744 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 513' ' ' PRO . . . . . 0.423 ' HD3' ' HB3' ' B' ' 512' ' ' GLN . 97.2 Cg_endo -90.56 59.39 1.46 Allowed 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.835 2.357 . . . . 0.0 112.231 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 514' ' ' LEU . . . . . 0.459 ' HB2' ' CG1' ' A' ' 44' ' ' VAL . 1.2 mp -75.21 -174.61 2.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.946 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 515' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -72.27 158.28 36.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.932 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 516' ' ' ASN . . . . . 0.434 ' HB3' ' CG2' ' A' ' 43' ' ' THR . 9.7 m120 59.89 24.04 13.09 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.885 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 517' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -41.08 -29.48 0.12 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.854 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 518' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -150.92 135.49 17.14 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.839 0.352 . . . . 0.0 111.409 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 519' ' ' ILE . . . . . 0.437 ' CG1' ' O ' ' A' ' 41' ' ' ALA . 2.7 pt -121.21 -37.02 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.845 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -120.04 -166.84 1.35 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.672 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 521' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -151.47 54.55 0.85 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.063 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 522' ' ' GLY . . . . . 0.451 ' CA ' ' CB ' ' A' ' 37' ' ' PHE . . . 45.52 -148.0 1.89 Allowed Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.529 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 523' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -173.1 -101.36 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.641 0.221 . . . . 0.0 111.037 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 524' ' ' GLY . . . . . . . . . . . . . . . 69.13 -63.0 0.54 Allowed Glycine 0 C--N 1.337 0.619 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.4 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 525' ' ' ASP . . . . . 0.439 ' HB3' ' CD2' ' A' ' 61' ' ' LEU . 24.2 t70 177.29 82.59 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.874 0.369 . . . . 0.0 110.719 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 526' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.51 95.99 5.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.801 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 527' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -146.1 158.57 48.09 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.915 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -68.62 97.56 0.54 Allowed 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.626 2.217 . . . . 0.0 112.328 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 529' ' ' ARG . . . . . 0.431 ' HG3' ' CG1' ' A' ' 33' ' ' VAL . 0.2 OUTLIER -100.53 -53.6 3.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.971 -179.998 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 530' ' ' HIS . . . . . 0.416 ' O ' ' CD2' ' B' ' 530' ' ' HIS . 12.4 t60 -166.76 95.16 0.51 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.492 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 531' ' ' CYS . . . . . 0.417 ' CB ' ' O ' ' A' ' 30' ' ' SER . 96.5 m -55.46 160.43 2.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.943 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 532' ' ' TRP . . . . . 0.468 ' CD1' ' OH ' ' A' ' 32' ' ' TYR . 88.5 t90 -55.12 139.46 41.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.832 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . -134.53 -123.69 2.38 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.594 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 534' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.84 147.43 89.51 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.745 0.307 . . . . 0.0 110.948 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_exo -51.61 -176.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.697 2.265 . . . . 0.0 112.351 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 3.5 t70 53.64 99.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.996 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 537' ' ' ARG . . . . . 0.44 ' HB3' ' CG2' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -75.57 179.02 5.57 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.299 0.571 . . . . 0.0 110.893 179.898 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 538' ' ' ILE . . . . . 0.424 ' O ' ' CG2' ' A' ' 14' ' ' VAL . 1.8 pt -74.87 -154.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.984 179.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 539' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -107.58 148.19 29.61 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.726 0.298 . . . . 0.0 110.419 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 540' ' ' GLU . . . . . 0.42 ' HA ' ' CG1' ' A' ' 14' ' ' VAL . 12.9 pm0 -48.11 -25.58 1.51 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.036 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 541' ' ' LEU . . . . . 0.437 ' HA ' ' CD2' ' A' ' 70' ' ' LEU . 11.0 mt -37.5 -45.29 0.72 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.523 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 542' ' ' TYR . . . . . 0.456 ' CD1' ' N ' ' B' ' 542' ' ' TYR . 1.4 m-30 -104.73 -63.12 1.25 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.879 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 543' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER 76.9 125.06 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.844 -179.853 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . 55.77 -159.08 7.56 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.483 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 545' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.207 -0.901 . . . . 0.0 110.925 179.983 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.435 ' CE ' HG22 ' A' ' 46' ' ' ILE . 5.4 tpt . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.889 0.376 . . . . 0.0 111.085 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.4 tm0? -81.78 144.1 31.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.635 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.514 HG22 ' CE1' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -93.82 -175.52 3.76 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.342 -179.639 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.471 ' CD1' ' CD2' ' A' ' 53' ' ' LEU . 5.2 pt -154.99 143.67 13.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.948 -179.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.2 ptpp? -134.33 95.57 3.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.131 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 80.5 m -118.87 153.34 34.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.059 0.457 . . . . 0.0 111.332 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.5 t -142.99 128.46 16.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.453 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.407 ' HB ' ' HA3' ' A' ' 15' ' ' GLY . 1.4 p -84.68 113.84 23.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.166 0.507 . . . . 0.0 111.192 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.3 m -114.74 129.75 70.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.443 178.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.477 ' HA2' ' CZ2' ' A' ' 97' ' ' TRP . . . 149.13 -170.11 29.48 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.098 -1.049 . . . . 0.0 112.808 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.435 ' O ' ' N ' ' B' ' 537' ' ' ARG . 0.4 OUTLIER -98.3 27.54 4.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.715 0.293 . . . . 0.0 110.691 179.91 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.425 ' CA ' ' HB2' ' B' ' 537' ' ' ARG . . . -126.34 170.62 18.15 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.684 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.435 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -98.27 -38.26 9.34 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.715 0.293 . . . . 0.0 111.344 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.418 ' HA ' HD12 ' A' ' 19' ' ' LEU . 2.1 m -43.94 91.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.481 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.483 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . . . -175.55 -71.43 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.934 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.423 ' CD ' ' HB3' ' A' ' 55' ' ' LEU . 8.8 mmtm -97.39 -80.67 0.44 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.007 0.432 . . . . 0.0 111.912 -179.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.471 ' CG2' ' CG2' ' A' ' 35' ' ' THR . 71.7 p -75.1 -69.57 0.47 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.547 -178.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.429 ' CB ' ' HB3' ' A' ' 13' ' ' ALA . 43.2 t -33.01 -43.35 0.1 Allowed 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -178.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.515 ' CD2' ' CG ' ' A' ' 169' ' ' PHE . 0.2 OUTLIER -60.71 -52.71 63.94 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.782 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -70.49 -24.42 62.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.842 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.416 ' O ' ' N ' ' A' ' 25' ' ' THR . 27.7 mm -57.81 -71.18 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.492 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.5 m -60.87 -23.37 65.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.128 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.458 ' CE2' ' HB2' ' B' ' 513' ' ' PRO . 41.5 t80 -65.19 -68.24 0.38 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.858 0.361 . . . . 0.0 110.284 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 96.9 m -75.87 -37.58 58.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.744 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.416 ' N ' ' O ' ' A' ' 21' ' ' ILE . 9.4 p -113.12 -166.8 1.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.684 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -142.0 19.08 2.12 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.12 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.8 mmtm -93.35 95.98 9.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.021 0.438 . . . . 0.0 110.566 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.45 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . 2.6 t80 -87.01 -50.6 0.45 Allowed Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.301 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.45 ' HD3' ' HB3' ' A' ' 28' ' ' PHE . 64.9 Cg_endo -88.66 46.04 1.01 Allowed 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.842 2.361 . . . . 0.0 112.475 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.5 p -83.7 -94.36 0.07 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.127 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -158.87 124.74 4.44 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.797 0.332 . . . . 0.0 111.17 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.407 ' CE2' ' HA ' ' B' ' 532' ' ' TRP . 4.6 m-30 -88.58 94.7 9.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.598 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.445 ' CB ' ' CD ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -165.03 -64.07 0.01 OUTLIER Pre-proline 0 N--CA 1.466 0.328 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.633 -179.804 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.445 ' CD ' ' CB ' ' A' ' 33' ' ' VAL . 10.3 Cg_endo -53.09 -16.98 7.25 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.889 2.393 . . . . 0.0 112.67 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.471 ' CG2' ' CG2' ' A' ' 17' ' ' THR . 45.4 m -36.18 -31.83 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.441 ' CG1' ' CB ' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -44.31 -28.37 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 120.685 0.279 . . . . 0.0 111.436 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.467 ' CG ' ' O ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -78.39 57.7 1.98 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.088 179.857 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -135.05 -47.46 0.72 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.845 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -63.96 -16.88 62.55 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.265 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.66 -157.5 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.932 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -90.76 162.6 14.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.068 0.461 . . . . 0.0 111.951 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.8 t -134.86 166.58 28.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.078 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.446 ' O ' ' CG1' ' A' ' 44' ' ' VAL . 9.4 t -143.82 103.8 4.1 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.508 ' CG2' ' CG2' ' A' ' 52' ' ' THR . 30.9 m -161.84 -177.46 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.017 178.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.454 ' HE2' ' N ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -105.63 100.01 9.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.61 0.243 . . . . 0.0 111.642 -179.479 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.443 HG21 ' CG2' ' B' ' 510' ' ' ILE . 5.1 mm -75.01 86.59 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 178.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.433 ' HA3' ' HA ' ' B' ' 510' ' ' ILE . . . 45.76 -95.61 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.689 -0.687 . . . . 0.0 113.401 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -38.04 -90.41 0.01 OUTLIER Glycine 0 CA--C 1.52 0.355 0 N-CA-C 113.992 0.357 . . . . 0.0 113.992 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.454 ' N ' ' HE2' ' A' ' 45' ' ' MET . 0.1 OUTLIER -123.14 159.12 55.69 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.789 0.328 . . . . 0.0 111.161 -179.181 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.416 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 2.7 Cg_endo -46.15 105.06 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.792 2.328 . . . . 0.0 112.356 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.514 ' CE1' HG22 ' A' ' 3' ' ' THR . 1.7 t80 -172.27 158.72 4.53 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.328 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.508 ' CG2' ' CG2' ' A' ' 44' ' ' VAL . 3.3 p -136.41 153.07 51.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.154 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.471 ' CD2' ' CD1' ' A' ' 4' ' ' ILE . 0.5 OUTLIER -78.76 -174.64 4.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.629 179.61 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -114.16 76.14 0.24 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.399 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.423 ' HB3' ' CD ' ' A' ' 16' ' ' LYS . 0.6 OUTLIER -52.56 114.62 1.44 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.938 0.399 . . . . 0.0 110.356 179.845 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -84.4 109.42 17.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.069 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -108.2 -175.76 2.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.652 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.426 ' HA ' ' CD1' ' A' ' 67' ' ' LEU . 16.8 p -135.83 170.38 16.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.093 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.441 ' CB ' ' CG1' ' A' ' 36' ' ' VAL . . . -171.82 167.01 6.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.111 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' B' ' 543' ' ' LEU . . . -146.14 33.73 1.46 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.306 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.22 -173.68 2.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.765 0.317 . . . . 0.0 110.817 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -44.52 -27.76 0.5 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.697 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.465 ' OD2' ' CE1' ' A' ' 64' ' ' TYR . 45.2 t0 -47.67 -63.44 1.06 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.223 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.465 ' CE1' ' OD2' ' A' ' 63' ' ' ASP . 0.0 OUTLIER 170.88 73.65 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.175 179.905 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -58.76 -19.9 44.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.101 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.14 -14.24 61.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.596 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.456 HD23 ' CD1' ' A' ' 64' ' ' TYR . 3.6 pp -47.69 135.51 11.56 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.839 0.352 . . . . 0.0 111.087 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.479 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -139.55 48.52 1.64 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.084 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 71.0 Cg_endo -74.17 -9.58 22.03 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.451 2.101 . . . . 0.0 112.484 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.477 ' O ' ' CD2' ' A' ' 72' ' ' TYR . 0.1 OUTLIER -78.78 1.04 24.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.641 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -55.13 -20.47 10.16 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.625 0.25 . . . . 0.0 111.437 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.477 ' CD2' ' O ' ' A' ' 70' ' ' LEU . 34.2 m-85 73.59 64.84 0.31 Allowed Pre-proline 0 C--N 1.332 -0.17 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.819 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.1 -150.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.581 2.188 . . . . 0.0 111.955 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -60.39 -16.17 32.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.374 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 55.3 m -42.12 133.06 3.15 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.871 0.367 . . . . 0.0 111.298 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.419 ' HA ' ' CG2' ' A' ' 108' ' ' THR . 0.4 OUTLIER -115.1 7.47 15.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.562 -179.82 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.429 HG23 ' CB ' ' A' ' 175' ' ' ALA . 7.9 p -145.21 79.95 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.881 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.493 ' CE2' ' HB ' ' A' ' 108' ' ' THR . 1.1 p90 -92.8 124.82 37.07 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 178.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.424 HD11 ' CG2' ' A' ' 113' ' ' VAL . 12.7 tp -70.37 108.65 4.34 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.78 -178.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.489 HG23 ' CD1' ' A' ' 110' ' ' PHE . 2.1 t -80.19 156.13 4.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.696 178.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 2.8 m -145.77 129.75 17.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.318 0.58 . . . . 0.0 112.363 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.47 ' O ' ' CD1' ' A' ' 82' ' ' PHE . 17.4 p90 -152.21 128.78 10.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.564 178.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -83.06 137.62 34.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.125 0.488 . . . . 0.0 111.76 -178.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.442 ' HA ' ' HB ' ' A' ' 137' ' ' ILE . 72.5 t -47.85 -78.73 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.246 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 29.6 m -42.8 113.95 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.086 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.429 ' N ' HD22 ' A' ' 129' ' ' LEU . 3.0 p -152.25 145.07 17.19 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.888 0.375 . . . . 0.0 111.909 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.424 ' O ' ' CB ' ' A' ' 88' ' ' SER . 76.9 Cg_endo -91.23 53.96 0.91 Allowed 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.226 2.618 . . . . 0.0 111.659 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.482 ' N ' ' CB ' ' A' ' 133' ' ' LYS . 0.7 OUTLIER 82.15 33.26 0.09 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.806 -179.455 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.412 ' O ' ' CG2' ' A' ' 93' ' ' VAL . 1.1 t -88.31 -24.75 23.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.023 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.499 ' CD1' HG13 ' A' ' 137' ' ' ILE . 2.1 t80 -51.07 -56.78 10.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.096 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -53.11 -41.9 65.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.131 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.422 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 1.8 t-20 -72.73 -53.16 12.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.975 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.412 ' CG2' ' O ' ' A' ' 89' ' ' SER . 46.5 t -49.81 -44.44 20.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.207 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.416 ' O ' ' CG2' ' A' ' 98' ' ' VAL . 30.4 tttt -62.23 -52.59 63.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.998 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 70.2 mt-10 -84.51 9.38 13.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.681 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.422 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 25.7 tttp -116.12 -37.75 3.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.729 0.3 . . . . 0.0 110.725 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.477 ' CZ2' ' HA2' ' A' ' 10' ' ' GLY . 0.8 OUTLIER -94.42 -46.85 6.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.34 -179.769 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.482 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 56.9 t -51.98 -46.07 92.89 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.654 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.482 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 92.0 Cg_endo -81.1 -12.37 11.82 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.342 2.028 . . . . 0.0 112.757 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -86.61 -49.17 7.72 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.861 0.362 . . . . 0.0 110.585 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 32.4 pt -66.55 -28.15 42.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.879 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 27.5 p -77.68 -33.25 53.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.579 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -64.12 -46.09 85.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.758 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 27.5 m170 -82.86 -24.15 33.37 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.758 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -142.94 95.8 6.13 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.665 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -68.81 133.13 26.51 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.594 2.196 . . . . 0.0 112.574 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 49.02 77.32 0.1 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.156 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.493 ' HB ' ' CE2' ' A' ' 78' ' ' PHE . 0.1 OUTLIER -139.29 115.09 8.35 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.878 179.857 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.404 ' HD2' ' O ' ' A' ' 76' ' ' ASP . 32.1 Cg_exo -59.42 162.78 13.91 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.639 2.226 . . . . 0.0 112.826 -179.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.49 ' HB3' ' CE1' ' A' ' 78' ' ' PHE . 37.0 p90 -161.69 165.05 28.73 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.549 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.426 ' CD1' HG13 ' A' ' 152' ' ' VAL . 0.9 OUTLIER -114.96 159.62 20.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.939 0.399 . . . . 0.0 111.635 -179.562 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.459 ' N ' ' CD2' ' A' ' 112' ' ' LEU . 2.4 mm? -119.48 161.14 21.07 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.575 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.425 HG12 ' CG2' ' A' ' 115' ' ' THR . 3.1 t -134.4 142.85 39.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.911 0.386 . . . . 0.0 111.694 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.456 ' HA3' ' CZ ' ' A' ' 154' ' ' TYR . . . -121.76 67.77 0.45 Allowed Glycine 0 C--N 1.331 0.28 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.989 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.425 ' CG2' HG12 ' A' ' 113' ' ' VAL . 1.4 p -92.38 26.55 2.55 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -178.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.435 ' HB2' ' CG2' ' A' ' 84' ' ' VAL . 2.9 mm-40 -131.88 23.85 4.62 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.199 0.523 . . . . 0.0 109.737 179.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.497 HD13 ' N ' ' A' ' 158' ' ' SER . 0.0 OUTLIER -67.68 -9.62 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.8 179.253 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -100.43 -40.59 7.39 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.144 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.423 ' CD1' ' HA ' ' A' ' 116' ' ' GLN . 3.5 mp -69.54 -33.79 73.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.313 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -47.25 -33.83 5.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.891 0.377 . . . . 0.0 110.984 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -80.13 -27.35 39.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.549 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' A' ' 119' ' ' LEU . 2.2 t70 -57.59 106.47 0.69 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.76 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -70.0 -3.83 12.95 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.643 2.229 . . . . 0.0 112.847 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.98 -67.27 0.77 Allowed 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.059 0.457 . . . . 0.0 110.0 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.408 ' O ' ' HB3' ' A' ' 128' ' ' LYS . 2.1 m -56.17 -43.58 78.51 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 178.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.455 ' HA ' ' CD1' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -48.28 -42.17 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.524 178.913 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -55.63 -49.44 72.84 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.006 178.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.408 ' HB3' ' O ' ' A' ' 125' ' ' THR . 0.1 OUTLIER -54.67 -32.89 59.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.2 179.017 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.455 ' CD1' ' HA ' ' A' ' 126' ' ' ILE . 7.5 mt -72.41 -42.0 65.62 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.459 ' HA ' ' CB ' ' A' ' 134' ' ' GLN . . . -42.51 -30.7 0.37 Allowed 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.106 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.9 mmmt -58.94 -39.56 81.97 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.247 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -125.16 -30.59 3.17 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.482 ' CB ' ' N ' ' A' ' 88' ' ' SER . 0.3 OUTLIER -130.51 -69.68 0.65 Allowed 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -177.719 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.467 ' N ' ' HG3' ' A' ' 133' ' ' LYS . 2.8 tt0 87.73 -37.23 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.428 ' CB ' ' HE3' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -69.03 111.23 7.82 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 120.733 0.301 . . . . 0.0 111.505 -179.137 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.431 ' HB3' ' CD1' ' A' ' 126' ' ' ILE . 74.2 Cg_endo -77.5 129.68 10.33 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.544 2.163 . . . . 0.0 112.019 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.51 ' CD1' ' N ' ' A' ' 137' ' ' ILE . 0.6 OUTLIER -59.42 96.9 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.94 179.904 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.42 ' O ' ' N ' ' A' ' 141' ' ' THR . 11.1 p -67.32 147.29 98.91 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.897 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_exo -40.88 -40.71 3.75 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.728 2.285 . . . . 0.0 112.318 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -69.24 -36.6 77.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.6 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.42 ' N ' ' O ' ' A' ' 138' ' ' THR . 90.6 m -55.31 -56.69 17.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.76 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.489 ' HB3' ' CD1' ' A' ' 154' ' ' TYR . . . -52.53 -39.57 61.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.81 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.98 -34.98 79.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.703 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.2 tptt -59.98 -58.63 7.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.783 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.407 ' HA ' ' HB2' ' A' ' 148' ' ' ASP . 24.1 tp -65.71 -35.98 82.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.761 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -58.11 -61.04 2.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.167 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 4.4 mtt85 -72.39 -25.44 61.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.012 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.407 ' HB2' ' HA ' ' A' ' 145' ' ' LEU . 1.8 m-20 -49.36 -41.87 40.31 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.036 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 5.9 mt -102.69 23.14 12.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.922 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 48.34 33.85 4.17 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.971 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.489 ' HB1' ' CD1' ' A' ' 110' ' ' PHE . . . -51.96 -81.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.187 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.431 ' CG2' ' O ' ' A' ' 151' ' ' ALA . 8.0 t -164.56 -69.21 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.894 0.378 . . . . 0.0 110.394 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 177.41 135.45 0.07 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.243 -179.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.489 ' CD1' ' HB3' ' A' ' 142' ' ' ALA . 24.7 t80 -106.75 114.7 28.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.728 178.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 2.8 t -101.24 151.99 5.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.733 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -99.12 118.58 36.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.4 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.436 ' CA ' HD13 ' A' ' 117' ' ' ILE . 0.9 OUTLIER 178.3 125.96 0.05 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.546 179.523 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.517 ' N ' ' HB2' ' A' ' 163' ' ' LYS . 40.2 t -118.61 151.57 37.66 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.076 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -72.06 -38.46 69.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.942 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.1 mp -52.6 -52.55 54.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.562 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 12.9 t -77.23 -42.62 36.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.562 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.404 ' O ' ' O ' ' A' ' 163' ' ' LYS . 3.1 tt0 176.71 -85.38 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.195 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.517 ' HB2' ' N ' ' A' ' 158' ' ' SER . 4.7 tttm 58.76 118.76 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.925 0.393 . . . . 0.0 110.726 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -71.12 -10.12 68.32 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.43 -0.89 . . . . 0.0 112.523 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.475 ' CD1' ' HA ' ' A' ' 19' ' ' LEU . 4.0 mm? 66.95 -63.73 0.26 Allowed 'General case' 0 CA--C 1.522 -0.097 0 CA-C-O 120.702 0.287 . . . . 0.0 110.474 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.436 ' O ' ' CB ' ' A' ' 170' ' ' ASP . 1.7 ptmt -57.04 -32.14 65.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.688 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.421 ' N ' ' HG2' ' A' ' 166' ' ' LYS . 0.1 OUTLIER -53.92 -72.17 0.06 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.764 0.316 . . . . 0.0 110.617 179.832 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 5.9 t -63.41 -43.06 98.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.244 0.545 . . . . 0.0 110.073 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.515 ' CG ' ' CD2' ' A' ' 19' ' ' LEU . 0.9 OUTLIER -58.57 -24.01 59.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.603 179.539 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.438 ' HA ' ' CG1' ' A' ' 173' ' ' ILE . 27.5 t0 -76.99 -41.53 42.5 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.879 0.371 . . . . 0.0 110.038 179.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -56.59 -33.76 66.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.185 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.42 ' N ' HD11 ' A' ' 111' ' ' LEU . . . -73.54 -58.22 3.46 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.129 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.438 ' CG1' ' HA ' ' A' ' 170' ' ' ASP . 1.3 pp -62.66 -39.93 86.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.23 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.444 HD22 ' CB ' ' B' ' 505' ' ' LEU . 5.0 tp -48.03 -43.18 29.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.194 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.429 ' CB ' HG23 ' A' ' 77' ' ' VAL . . . -52.59 -23.26 6.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.071 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.44 ' CB ' ' HB ' ' A' ' 4' ' ' ILE . . . -90.88 -36.5 14.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.394 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.449 ' CD2' ' CG2' ' A' ' 4' ' ' ILE . 80.7 mt -68.55 -23.02 64.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.816 0.341 . . . . 0.0 110.671 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.429 ' HG3' ' CA ' ' B' ' 507' ' ' ALA . 0.6 OUTLIER -169.96 167.22 5.08 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.799 179.878 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . 0.417 ' HD2' ' CB ' ' A' ' 178' ' ' GLU . 32.4 Cg_endo -64.17 124.58 13.67 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.576 2.184 . . . . 0.0 112.251 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -74.03 164.7 33.79 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.457 2.104 . . . . 0.0 112.455 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . 0.409 ' CG ' ' O ' ' A' ' 181' ' ' GLU . 0.7 OUTLIER -117.09 114.41 38.96 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.807 179.999 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.62 -165.04 0.25 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.567 2.178 . . . . 0.0 112.321 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.48 77.66 7.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.999 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.168 -0.92 . . . . 0.0 110.787 179.99 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.122 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 503' ' ' SER . . . . . . . . . . . . . 31.0 t -105.41 -71.93 0.73 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.78 0.324 . . . . 0.0 111.034 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 504' ' ' GLY . . . . . . . . . . . . . . . 111.93 122.49 4.14 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.126 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 505' ' ' LEU . . . . . 0.444 ' CB ' HD22 ' A' ' 174' ' ' LEU . 0.4 OUTLIER -173.92 -37.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.54 -179.572 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 506' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 171.46 -56.82 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.704 0.288 . . . . 0.0 110.913 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 507' ' ' ALA . . . . . 0.429 ' CA ' ' HG3' ' A' ' 178' ' ' GLU . . . -39.9 -43.74 1.55 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.688 0.756 . . . . 0.0 111.073 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 508' ' ' GLN . . . . . 0.48 ' O ' ' CB ' ' B' ' 509' ' ' ASP . 13.5 pt20 164.99 -39.22 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.362 -1.29 . . . . 0.0 108.226 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 509' ' ' ASP . . . . . 0.48 ' CB ' ' O ' ' B' ' 508' ' ' GLN . 7.6 p30 147.25 41.44 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 113.94 -1.482 . . . . 0.0 110.197 179.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 510' ' ' ILE . . . . . 0.443 ' CG2' HG21 ' A' ' 46' ' ' ILE . 13.7 mt -72.08 126.27 32.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.263 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 511' ' ' SER . . . . . . . . . . . . . 30.3 t -109.47 141.73 41.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.288 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 512' ' ' GLN . . . . . 0.46 ' CB ' ' CD ' ' B' ' 513' ' ' PRO . 4.3 tp60 -92.89 -67.68 0.1 OUTLIER Pre-proline 0 CA--C 1.532 0.27 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 513' ' ' PRO . . . . . 0.46 ' CD ' ' CB ' ' B' ' 512' ' ' GLN . 92.3 Cg_endo -80.3 74.31 5.6 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.451 2.101 . . . . 0.0 111.461 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 514' ' ' LEU . . . . . 0.444 ' CD2' ' O ' ' A' ' 45' ' ' MET . 2.3 mp -73.45 -86.7 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.488 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 515' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -79.25 -87.76 0.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.693 -0.231 . . . . 0.0 111.052 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -117.57 -29.67 5.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.803 0.335 . . . . 0.0 111.134 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 517' ' ' SER . . . . . 0.48 ' O ' ' CD1' ' B' ' 518' ' ' PHE . 2.6 m 72.01 22.27 3.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.964 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 518' ' ' PHE . . . . . 0.48 ' CD1' ' O ' ' B' ' 517' ' ' SER . 12.1 m-85 -150.13 130.44 13.73 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.027 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 519' ' ' ILE . . . . . . . . . . . . . 43.9 mm -63.62 -68.32 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.994 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -155.06 -67.41 0.13 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.061 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 521' ' ' THR . . . . . . . . . . . . . 11.2 m -163.88 157.63 18.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.101 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 522' ' ' GLY . . . . . . . . . . . . . . . -91.78 -92.08 1.39 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.333 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 523' ' ' HIS . . . . . 0.411 ' CD2' ' N ' ' B' ' 523' ' ' HIS . 0.1 OUTLIER 174.73 -98.81 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.475 0.137 . . . . 0.0 110.845 179.881 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 524' ' ' GLY . . . . . . . . . . . . . . . 42.35 -95.06 0.01 OUTLIER Glycine 0 C--N 1.338 0.658 0 C-N-CA 120.991 -0.623 . . . . 0.0 113.009 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 525' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' B' ' 523' ' ' HIS . 33.2 p-10 177.46 91.65 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.815 0.34 . . . . 0.0 111.088 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 526' ' ' SER . . . . . 0.43 ' CB ' ' HB3' ' A' ' 34' ' ' PRO . 9.2 t -80.04 95.71 6.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.724 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 527' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -144.6 147.91 37.93 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.816 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.55 99.92 0.65 Allowed 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.552 2.168 . . . . 0.0 112.323 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 529' ' ' ARG . . . . . . . . . . . . . 12.6 mtp180 -100.29 -54.88 2.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.004 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 530' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -158.72 96.85 1.4 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.836 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 27.8 p -68.76 112.13 5.29 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.955 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 532' ' ' TRP . . . . . 0.504 ' CD1' ' NH2' ' B' ' 537' ' ' ARG . 22.4 t90 66.74 -68.95 0.13 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.833 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . 61.39 -80.76 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.52 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 534' ' ' PHE . . . . . 0.416 ' O ' ' NH1' ' B' ' 537' ' ' ARG . 17.7 m-85 -105.54 149.86 38.35 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.685 0.279 . . . . 0.0 110.844 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.27 -12.72 30.26 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.502 2.135 . . . . 0.0 112.555 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -112.98 120.79 42.61 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.831 0.348 . . . . 0.0 111.003 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 537' ' ' ARG . . . . . 0.504 ' NH2' ' CD1' ' B' ' 532' ' ' TRP . 11.6 mmt-85 -71.57 138.51 48.86 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.156 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 538' ' ' ILE . . . . . . . . . . . . . 4.1 tp -56.46 139.03 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.941 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 539' ' ' ASP . . . . . . . . . . . . . 34.3 p-10 -42.64 126.03 3.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.862 0.363 . . . . 0.0 111.125 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 540' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -49.34 -22.58 1.15 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.077 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 541' ' ' LEU . . . . . 0.475 ' CD2' ' CD1' ' A' ' 70' ' ' LEU . 0.4 OUTLIER -35.26 -53.21 0.62 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.995 0.426 . . . . 0.0 111.62 179.81 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 542' ' ' TYR . . . . . 0.429 ' O ' ' N ' ' A' ' 59' ' ' ALA . 0.4 OUTLIER -104.8 -62.5 1.33 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.327 179.4 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 543' ' ' LEU . . . . . 0.425 ' O ' ' N ' ' A' ' 60' ' ' GLY . 3.4 tp 62.22 153.05 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.567 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . 103.26 82.73 1.65 Allowed Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.382 -0.913 . . . . 0.0 112.592 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 545' ' ' ASN . . . . . . . . . . . . . 1.1 m120 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.862 -179.932 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.437 ' HG2' ' CG ' ' A' ' 49' ' ' GLU . 5.5 tpt . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 120.861 0.363 . . . . 0.0 111.233 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.431 ' O ' ' CD2' ' A' ' 177' ' ' LEU . 5.8 pt20 -167.17 138.81 3.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.753 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.495 HG21 ' CE1' ' A' ' 51' ' ' TYR . 13.7 t -109.94 -139.67 0.38 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.26 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.467 HG22 ' CB ' ' A' ' 176' ' ' ALA . 0.2 OUTLIER -150.55 152.54 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -178.865 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 13.1 pttt -134.0 95.61 3.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.602 178.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.405 ' O ' ' CE ' ' A' ' 16' ' ' LYS . 25.1 m -102.03 154.35 19.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.188 0.518 . . . . 0.0 111.876 -178.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.6 t -133.12 150.21 32.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.164 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.464 ' HB ' ' CG ' ' B' ' 540' ' ' GLU . 53.5 t -97.3 143.75 12.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.267 0.556 . . . . 0.0 111.056 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.439 ' N ' HG13 ' A' ' 8' ' ' VAL . 6.7 m -161.67 129.95 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.853 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 148.59 -178.68 26.0 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 119.882 -1.151 . . . . 0.0 112.909 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -102.46 -27.16 12.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.89 0.376 . . . . 0.0 110.593 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.9 -129.56 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.211 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.418 ' HB3' ' NH2' ' B' ' 537' ' ' ARG . . . -102.42 -56.95 2.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.824 0.345 . . . . 0.0 111.258 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.438 ' HB ' ' CG1' ' A' ' 8' ' ' VAL . 2.8 t 43.38 29.06 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.461 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.51 89.49 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.802 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.435 ' HB2' ' CG2' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -52.59 -33.45 46.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.933 0.397 . . . . 0.0 110.273 179.675 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 39.2 p -81.15 -53.15 6.64 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.677 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.6 t -42.72 -38.54 2.11 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.265 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.52 ' CD2' ' CE1' ' A' ' 169' ' ' PHE . 0.0 OUTLIER -49.32 -58.67 4.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.545 179.668 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.59 -27.62 64.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.923 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.449 ' O ' ' N ' ' A' ' 25' ' ' THR . 37.3 mm -64.23 -71.43 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.242 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 9.6 t -50.0 -31.02 11.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.809 0.338 . . . . 0.0 110.717 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -63.54 -66.61 0.52 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.659 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.27 -54.63 6.77 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.73 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.449 ' N ' ' O ' ' A' ' 21' ' ' ILE . 27.4 p -78.47 -154.08 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.345 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.419 ' N ' ' ND2' ' A' ' 26' ' ' ASN . 0.1 OUTLIER -157.46 35.52 0.27 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.735 0.302 . . . . 0.0 111.088 -179.888 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -123.02 101.47 7.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.932 0.396 . . . . 0.0 111.525 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.488 ' CD2' ' HD3' ' A' ' 29' ' ' PRO . 0.4 OUTLIER -101.4 -70.04 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.726 178.92 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.488 ' HD3' ' CD2' ' A' ' 28' ' ' PHE . 95.7 Cg_endo -79.1 54.45 5.18 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.23 1.953 . . . . 0.0 111.518 178.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.02 -85.73 0.5 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.356 -179.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -147.54 118.53 7.68 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.196 0.522 . . . . 0.0 112.085 -179.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 4.2 m-30 -99.78 94.37 6.29 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.577 178.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.45 ' CG1' ' CB ' ' B' ' 526' ' ' SER . 0.0 OUTLIER -163.82 -63.85 0.01 OUTLIER Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.857 -179.177 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.436 ' HD2' HG23 ' A' ' 33' ' ' VAL . 8.8 Cg_endo -50.81 -20.43 6.78 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.781 2.321 . . . . 0.0 112.328 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.2 t -40.92 -29.66 0.11 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.501 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.476 ' CG1' ' CB ' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -43.63 -29.68 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-O 120.924 0.393 . . . . 0.0 111.016 179.648 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.493 ' O ' ' CG ' ' A' ' 40' ' ' TYR . 0.8 OUTLIER -55.36 -23.48 24.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.62 179.478 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.417 ' HA ' ' CE1' ' A' ' 40' ' ' TYR . 21.9 t70 -41.67 -28.29 0.14 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.121 -0.49 . . . . 0.0 112.122 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -72.79 -1.86 18.25 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.493 ' CG ' ' O ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -60.0 -176.48 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.767 0.318 . . . . 0.0 110.651 179.856 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.421 ' O ' ' CG1' ' B' ' 519' ' ' ILE . . . -112.84 144.54 42.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.455 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.434 ' CG1' ' O ' ' B' ' 517' ' ' SER . 0.8 OUTLIER -116.61 121.85 68.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.981 179.604 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.7 p -111.3 106.59 15.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.749 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.42 HG22 ' CD1' ' B' ' 514' ' ' LEU . 6.4 p -164.05 148.78 2.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.283 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.483 ' CE ' ' N ' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -74.56 104.38 5.23 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 178.773 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.489 ' HA ' ' CD1' ' B' ' 514' ' ' LEU . 7.8 tt -99.92 87.67 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.676 -179.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.411 ' N ' ' HE1' ' A' ' 45' ' ' MET . . . 75.77 -108.06 2.46 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.303 -0.862 . . . . 0.0 113.13 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -47.96 -88.88 0.01 OUTLIER Glycine 0 C--N 1.331 0.264 0 C-N-CA 121.184 -0.531 . . . . 0.0 113.342 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.473 ' N ' ' HE2' ' A' ' 45' ' ' MET . 5.0 pt-20 -126.16 170.89 8.71 Favored Pre-proline 0 CA--C 1.53 0.204 0 CA-C-O 120.627 0.251 . . . . 0.0 110.902 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.436 ' CD ' ' HB2' ' A' ' 49' ' ' GLU . 33.1 Cg_exo -60.28 107.48 0.42 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.684 2.256 . . . . 0.0 112.777 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.495 ' CE1' HG21 ' A' ' 3' ' ' THR . 6.2 t80 -172.87 104.72 0.14 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.402 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.6 128.92 51.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.844 0.354 . . . . 0.0 110.875 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.452 ' HG ' ' CG2' ' A' ' 3' ' ' THR . 11.3 mt -70.8 172.05 9.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.97 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -115.19 108.22 1.88 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.79 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.1 mp -48.73 114.55 1.0 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.842 0.353 . . . . 0.0 110.641 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -83.63 105.14 14.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.508 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.406 ' HB2' ' HB3' ' A' ' 38' ' ' ASP . 0.4 OUTLIER -99.53 -175.63 3.05 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.843 -179.87 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.438 ' CG2' HD11 ' A' ' 67' ' ' LEU . 1.2 p -136.05 167.84 20.47 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.784 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.476 ' CB ' ' CG1' ' A' ' 36' ' ' VAL . . . -171.2 179.99 2.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.184 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -151.48 31.24 0.94 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.293 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.45 -160.84 0.81 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.754 0.311 . . . . 0.0 110.815 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.6 mp0 -52.82 -27.11 16.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.184 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.404 ' C ' ' CG ' ' A' ' 64' ' ' TYR . 9.2 m-20 -50.49 -63.63 1.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.281 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.493 ' CD1' ' N ' ' A' ' 64' ' ' TYR . 0.0 OUTLIER 169.1 82.88 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.91 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -68.07 -22.32 64.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.086 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.92 -29.87 21.91 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.21 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.471 HD22 ' CD1' ' A' ' 64' ' ' TYR . 4.5 pp -48.39 140.28 7.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.957 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.465 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.1 OUTLIER -150.69 50.23 0.69 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 120.893 0.377 . . . . 0.0 110.893 -179.949 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 71.6 Cg_endo -76.79 -31.29 4.13 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.657 2.238 . . . . 0.0 112.647 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.458 ' CD2' ' HB2' ' B' ' 541' ' ' LEU . 0.1 OUTLIER -66.98 -25.19 66.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.842 0.354 . . . . 0.0 110.663 -179.914 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.449 ' OG ' ' CE2' ' A' ' 72' ' ' TYR . 13.9 t -59.89 -70.59 0.16 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.942 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.449 ' CE2' ' OG ' ' A' ' 71' ' ' SER . 3.5 m-85 -123.94 67.57 42.81 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.908 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.08 140.39 31.17 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.619 2.213 . . . . 0.0 112.282 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 9.8 tp60 -101.62 10.39 40.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.451 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 84.6 m -75.87 124.61 27.61 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.811 0.338 . . . . 0.0 110.982 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -79.3 -18.32 52.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.156 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.4 t -103.71 78.91 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.224 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -83.19 175.15 10.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.751 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 19.3 tp -147.63 108.9 4.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.99 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.408 ' CG2' ' O ' ' A' ' 80' ' ' VAL . 35.3 m -113.32 100.17 10.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.864 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.7 m -94.51 173.56 7.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.419 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.41 ' CE1' HG22 ' A' ' 137' ' ' ILE . 8.6 p90 -175.19 142.14 0.6 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.26 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.4 m -83.31 155.83 23.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.088 0.471 . . . . 0.0 111.543 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.474 ' CG1' ' N ' ' A' ' 137' ' ' ILE . 15.9 t -55.01 -51.71 51.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.518 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.438 HG11 ' CG2' ' A' ' 125' ' ' THR . 1.9 m -47.58 117.01 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.059 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.444 ' N ' HD21 ' A' ' 129' ' ' LEU . 0.1 OUTLIER -151.43 117.86 3.23 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.438 -179.741 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.423 ' O ' ' CB ' ' A' ' 88' ' ' SER . 78.3 Cg_endo -90.38 49.68 0.95 Allowed 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.981 2.454 . . . . 0.0 111.969 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.437 ' CB ' ' HG2' ' A' ' 133' ' ' LYS . 0.1 OUTLIER 81.56 28.34 0.17 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.694 -179.525 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 95.2 p -90.04 -15.94 30.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.256 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.486 ' CZ ' HG23 ' A' ' 137' ' ' ILE . 0.1 OUTLIER -46.29 -51.31 14.81 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.799 0.333 . . . . 0.0 111.157 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -62.46 -36.41 82.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.822 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -72.63 -57.89 3.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.467 HG12 ' CE2' ' A' ' 97' ' ' TRP . 24.2 t -52.11 -45.48 42.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.059 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.72 -50.49 73.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.811 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -82.87 6.9 16.9 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.633 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -117.15 -30.66 5.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.804 0.335 . . . . 0.0 110.971 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.467 ' CE2' HG12 ' A' ' 93' ' ' VAL . 23.3 m0 -94.01 -51.94 4.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.176 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.453 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 85.5 t -50.5 -57.6 12.62 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.612 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 29.8 Cg_endo -62.89 -15.51 47.88 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.197 1.931 . . . . 0.0 112.422 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -89.97 -54.48 4.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.878 0.37 . . . . 0.0 110.728 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.9 tt -55.17 -30.33 24.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.9 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 11.2 p -85.91 -25.29 26.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.774 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -60.71 -51.04 71.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.667 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 28.4 m80 -60.99 -38.53 86.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.69 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -137.53 126.52 14.91 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.734 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -49.79 89.14 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.461 2.108 . . . . 0.0 112.248 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 12.3 mttp 61.9 106.38 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.769 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.406 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 0.2 OUTLIER -127.95 137.19 30.27 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.9 -179.944 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 108' ' ' THR . 36.2 Cg_exo -60.24 156.02 42.67 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.485 2.123 . . . . 0.0 112.478 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.485 ' CE2' ' HB1' ' A' ' 151' ' ' ALA . 1.9 p90 -158.72 148.77 19.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.75 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.443 ' HG ' ' CG1' ' A' ' 152' ' ' VAL . 0.5 OUTLIER -111.18 148.54 32.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.482 -179.434 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.433 ' CD1' ' HB1' ' A' ' 146' ' ' ALA . 11.6 mt -103.98 158.07 16.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.824 179.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.444 ' CG1' HG11 ' A' ' 168' ' ' VAL . 14.3 t -146.1 150.73 15.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.399 0.619 . . . . 0.0 112.445 -179.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -131.31 124.65 4.17 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.86 179.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 158' ' ' SER . 0.9 OUTLIER -140.68 -58.51 0.52 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.908 0.354 . . . . 0.0 111.761 -178.694 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.45 ' HB3' ' CG ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -53.78 -21.84 8.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.853 0.358 . . . . 0.0 110.922 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.434 HG21 ' CG2' ' A' ' 84' ' ' VAL . 0.3 OUTLIER -41.81 -29.13 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.217 -179.859 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -63.81 -43.16 97.09 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -178.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.427 ' CD2' HD23 ' A' ' 160' ' ' LEU . 0.3 OUTLIER -118.47 14.71 13.73 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -178.537 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.45 ' CG ' ' HB3' ' A' ' 116' ' ' GLN . 0.8 OUTLIER -87.18 -20.32 27.15 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.096 179.585 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.01 -18.59 35.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.85 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -46.1 122.27 6.24 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.049 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.403 ' HA ' ' CG2' ' A' ' 126' ' ' ILE . 14.0 Cg_exo -68.74 -3.52 11.43 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.576 2.184 . . . . 0.0 113.028 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 29.8 t -76.85 -71.18 0.41 Allowed 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.027 0.441 . . . . 0.0 110.247 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.438 ' CG2' HG11 ' A' ' 85' ' ' VAL . 95.0 m -55.68 -35.15 65.71 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.536 ' HA ' ' CD1' ' A' ' 129' ' ' LEU . 0.1 OUTLIER -56.68 -39.18 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.722 179.087 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -64.04 -31.9 73.26 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.31 178.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.445 ' O ' ' HG3' ' A' ' 131' ' ' LYS . 0.0 OUTLIER -69.69 -24.79 63.64 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.843 178.92 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.536 ' CD1' ' HA ' ' A' ' 126' ' ' ILE . 3.2 mt -85.02 -28.86 25.43 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 177.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.463 ' HA ' ' HB3' ' A' ' 134' ' ' GLN . . . -48.0 -39.87 20.91 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.501 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.445 ' HG3' ' O ' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -44.85 -28.75 0.69 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.884 0.373 . . . . 0.0 110.724 179.882 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.441 ' N ' ' HD2' ' A' ' 131' ' ' LYS . 52.9 m-20 -123.55 -32.03 3.41 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.391 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.512 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 52.1 mmtt -151.25 -92.73 0.06 Allowed 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.512 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 6.5 pt20 120.09 -18.09 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.783 1.233 . . . . 0.0 110.821 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.99 111.15 7.55 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.215 -0.448 . . . . 0.0 112.204 -178.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.402 ' HB2' HG12 ' A' ' 84' ' ' VAL . 96.8 Cg_endo -79.61 129.89 8.55 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.645 2.23 . . . . 0.0 111.503 179.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.488 ' CD1' ' N ' ' A' ' 137' ' ' ILE . 0.8 OUTLIER -58.57 96.64 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.014 0.435 . . . . 0.0 111.616 -179.331 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 16.5 p -69.32 151.61 96.84 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.462 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.47 ' HA ' ' CE1' ' A' ' 154' ' ' TYR . 4.2 Cg_endo -47.06 -25.07 3.8 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 122.809 2.339 . . . . 0.0 112.33 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -81.38 -38.66 26.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.12 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.405 ' HB ' HG21 ' A' ' 137' ' ' ILE . 0.2 OUTLIER -57.38 -54.2 49.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.138 -179.812 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.474 ' HB2' ' CD2' ' A' ' 154' ' ' TYR . . . -47.85 -43.43 28.3 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.884 0.373 . . . . 0.0 110.99 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -59.44 -40.25 86.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.589 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -55.03 -55.81 26.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.59 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.73 -29.14 68.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.492 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.433 ' HB1' ' CD1' ' A' ' 112' ' ' LEU . . . -65.41 -41.24 93.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.793 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 9.0 mtp180 -85.63 -25.89 26.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.678 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -52.37 -32.62 39.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.739 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.401 ' CD1' HG22 ' A' ' 98' ' ' VAL . 3.5 mt -119.8 19.7 12.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.057 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 6.3 mttp 48.46 47.46 20.17 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.202 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.485 ' HB1' ' CE2' ' A' ' 110' ' ' PHE . . . -63.98 -81.51 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.879 0.371 . . . . 0.0 110.865 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.443 ' CG1' ' HG ' ' A' ' 111' ' ' LEU . 70.3 t -160.56 -75.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.778 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.43 ' HD3' ' N ' ' A' ' 154' ' ' TYR . 7.0 tppt? 173.65 116.91 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.278 -179.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.474 ' CD2' ' HB2' ' A' ' 142' ' ' ALA . 5.6 t80 -81.4 116.08 21.05 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 12.9 t -101.4 159.35 4.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.451 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -89.9 139.84 30.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.129 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.437 ' O ' ' HA ' ' A' ' 115' ' ' THR . 3.3 p 178.71 -174.54 0.18 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.416 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.459 ' HA ' ' HA ' ' A' ' 115' ' ' THR . 24.3 p -159.99 167.87 26.95 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.937 0.399 . . . . 0.0 111.164 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -116.6 -46.11 2.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.585 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.427 HD23 ' CD2' ' A' ' 119' ' ' LEU . 0.7 OUTLIER -63.81 -33.25 75.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.402 179.557 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 1.3 p -113.0 -22.83 10.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.807 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.415 ' N ' ' OG ' ' A' ' 158' ' ' SER . 1.3 tt0 74.58 71.81 0.1 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.022 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.43 ' N ' ' OG ' ' A' ' 158' ' ' SER . 0.2 OUTLIER -93.96 13.63 22.2 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.501 -179.816 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 121.08 34.48 0.89 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.345 -0.931 . . . . 0.0 113.2 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.422 ' CD2' HD13 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -49.58 -27.79 4.92 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.956 0.408 . . . . 0.0 110.515 179.697 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.412 ' O ' ' N ' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -73.67 -34.16 64.78 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.626 179.568 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.409 ' N ' ' HE2' ' A' ' 166' ' ' LYS . 0.6 OUTLIER -56.58 -67.61 0.29 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.421 179.601 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.444 HG11 ' CG1' ' A' ' 113' ' ' VAL . 14.2 p -50.63 -46.31 27.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.33 179.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.52 ' CE1' ' CD2' ' A' ' 19' ' ' LEU . 1.9 t80 -61.9 -31.26 71.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.732 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.412 ' N ' ' O ' ' A' ' 166' ' ' LYS . 4.6 t0 -57.42 -39.97 77.31 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.514 178.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -66.72 -35.35 79.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.612 178.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -59.83 -29.93 68.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.739 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.459 ' CD1' ' N ' ' A' ' 174' ' ' LEU . 0.0 OUTLIER -94.11 -43.88 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.438 179.633 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.459 ' N ' ' CD1' ' A' ' 173' ' ' ILE . 3.5 tm? -52.75 -27.79 19.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.953 0.406 . . . . 0.0 110.363 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -72.04 -29.78 64.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.744 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.467 ' CB ' HG22 ' A' ' 4' ' ' ILE . . . -80.84 -37.15 30.51 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.738 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.434 HD21 ' CG2' ' A' ' 4' ' ' ILE . 58.8 mt -70.76 -24.53 62.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.635 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 29.1 tp10 -165.2 137.05 3.33 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.526 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -49.8 141.65 27.58 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.376 2.05 . . . . 0.0 112.347 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.89 171.4 18.36 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.548 2.166 . . . . 0.0 112.222 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -154.24 151.31 24.0 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.055 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.48 -164.73 0.23 Allowed 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.669 2.246 . . . . 0.0 112.271 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 8.0 pttp -87.51 152.21 22.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.863 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.188 -0.911 . . . . 0.0 110.909 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.17 0 N-CA-C 112.449 -0.26 . . . . 0.0 112.449 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 503' ' ' SER . . . . . . . . . . . . . 75.3 m -96.18 -78.52 0.46 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.889 0.376 . . . . 0.0 110.857 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 504' ' ' GLY . . . . . . . . . . . . . . . 81.12 106.32 0.32 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.515 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 505' ' ' LEU . . . . . 0.478 ' CD1' ' N ' ' B' ' 505' ' ' LEU . 0.1 OUTLIER -166.58 99.27 0.58 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.93 0.395 . . . . 0.0 111.063 -179.947 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 506' ' ' SER . . . . . . . . . . . . . 13.3 p 59.76 -170.95 0.13 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.005 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 507' ' ' ALA . . . . . . . . . . . . . . . 59.31 -93.21 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.725 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 508' ' ' GLN . . . . . 0.426 ' O ' ' CB ' ' B' ' 509' ' ' ASP . 20.0 mt-30 -141.29 4.84 1.83 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.048 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 509' ' ' ASP . . . . . 0.426 ' CB ' ' O ' ' B' ' 508' ' ' GLN . 8.5 t70 81.83 35.39 0.08 Allowed 'General case' 0 C--N 1.341 0.238 0 CA-C-O 121.371 0.605 . . . . 0.0 109.704 -178.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 510' ' ' ILE . . . . . 0.451 ' CG2' HG12 ' A' ' 46' ' ' ILE . 87.4 mt -64.84 156.14 5.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.579 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 511' ' ' SER . . . . . 0.427 ' N ' HG21 ' B' ' 510' ' ' ILE . 8.7 t -109.54 167.39 10.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.098 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 512' ' ' GLN . . . . . 0.491 ' CB ' ' CD ' ' B' ' 513' ' ' PRO . 18.2 tt0 -114.2 -71.81 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.205 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 513' ' ' PRO . . . . . 0.491 ' CD ' ' CB ' ' B' ' 512' ' ' GLN . 93.5 Cg_endo -78.85 59.81 7.47 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.207 1.938 . . . . 0.0 111.29 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 514' ' ' LEU . . . . . 0.489 ' CD1' ' HA ' ' A' ' 46' ' ' ILE . 4.9 mt -53.31 -89.02 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.826 -178.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 515' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -92.99 -86.55 0.25 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.666 0.269 . . . . 0.0 111.255 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -127.57 -36.99 2.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.23 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 517' ' ' SER . . . . . 0.485 ' O ' ' CD1' ' B' ' 518' ' ' PHE . 6.4 m 72.01 22.8 3.64 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.047 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 518' ' ' PHE . . . . . 0.485 ' CD1' ' O ' ' B' ' 517' ' ' SER . 23.7 m-85 -140.99 91.79 2.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.79 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 519' ' ' ILE . . . . . 0.421 ' CG1' ' O ' ' A' ' 41' ' ' ALA . 7.3 mm -88.89 -11.06 10.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.667 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 72.56 104.75 0.07 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.84 0.353 . . . . 0.0 110.925 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 521' ' ' THR . . . . . . . . . . . . . 1.4 m -160.91 106.5 1.41 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.818 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 522' ' ' GLY . . . . . 0.473 ' O ' ' CZ ' ' A' ' 37' ' ' PHE . . . 143.2 178.67 19.24 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.349 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 523' ' ' HIS . . . . . . . . . . . . . 22.9 t60 -104.71 -83.42 0.5 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.745 0.307 . . . . 0.0 110.867 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 524' ' ' GLY . . . . . 0.444 ' CA ' HG23 ' A' ' 36' ' ' VAL . . . 49.68 -118.65 5.76 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.638 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 525' ' ' ASP . . . . . . . . . . . . . 1.2 p30 53.41 28.53 7.61 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 121.071 0.463 . . . . 0.0 110.498 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 526' ' ' SER . . . . . 0.45 ' CB ' ' CG1' ' A' ' 33' ' ' VAL . 3.9 m -57.15 100.1 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.207 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 527' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -37.44 162.08 0.05 OUTLIER Pre-proline 0 N--CA 1.467 0.381 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.227 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -53.75 104.79 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.195 2.597 . . . . 0.0 112.299 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 529' ' ' ARG . . . . . . . . . . . . . 2.3 mtt-85 -100.7 -42.42 6.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.073 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 530' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -153.32 -44.02 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.878 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 3.6 m 70.36 -160.53 0.15 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.876 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 532' ' ' TRP . . . . . . . . . . . . . 22.9 t90 -46.19 -65.0 0.62 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.159 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . 59.71 -87.13 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.622 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 534' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -116.56 152.67 48.52 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.698 0.285 . . . . 0.0 111.018 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -55.56 176.59 0.15 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.65 2.233 . . . . 0.0 112.456 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 59.92 92.86 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.082 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 537' ' ' ARG . . . . . 0.418 ' NH2' ' HB3' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -73.46 151.06 41.22 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.13 0.491 . . . . 0.0 110.844 179.829 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 538' ' ' ILE . . . . . 0.435 HG13 ' HB2' ' B' ' 542' ' ' TYR . 10.2 tp -61.18 157.22 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.262 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 539' ' ' ASP . . . . . 0.43 ' N ' HG13 ' B' ' 538' ' ' ILE . 2.3 m-20 -61.33 162.16 8.15 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.051 0.453 . . . . 0.0 111.126 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 540' ' ' GLU . . . . . 0.464 ' CG ' ' HB ' ' A' ' 8' ' ' VAL . 0.3 OUTLIER -48.22 -50.14 30.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.854 -179.633 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 541' ' ' LEU . . . . . 0.458 ' HB2' ' CD2' ' A' ' 70' ' ' LEU . 0.2 OUTLIER -39.99 -32.51 0.16 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.324 0.583 . . . . 0.0 111.063 -179.496 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 542' ' ' TYR . . . . . 0.435 ' HB2' HG13 ' B' ' 538' ' ' ILE . 35.3 m-85 -104.45 -59.21 1.77 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.896 -179.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 543' ' ' LEU . . . . . . . . . . . . . 2.0 tp 66.47 -67.68 0.15 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.061 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 544' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' B' ' 542' ' ' TYR . . . -89.02 139.41 15.25 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.485 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 545' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.945 179.979 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.484 ' CE ' ' CG2' ' A' ' 46' ' ' ILE . 1.3 tmt? . . . . . 0 N--CA 1.487 1.42 0 CA-C-O 120.84 0.352 . . . . 0.0 111.03 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 73.32 121.13 0.04 OUTLIER 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.994 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.445 HG22 ' CD1' ' A' ' 53' ' ' LEU . 0.3 OUTLIER -93.26 170.09 9.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.719 -179.345 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.462 ' HB ' ' CB ' ' A' ' 176' ' ' ALA . 0.1 OUTLIER -152.71 162.49 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -178.92 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.4 127.91 40.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.945 179.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 43.6 t -116.54 153.42 32.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.069 0.461 . . . . 0.0 111.906 -179.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.7 t -151.11 159.51 4.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.408 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.481 ' CG2' ' CG1' ' A' ' 14' ' ' VAL . 0.9 OUTLIER -110.91 155.77 12.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.323 0.582 . . . . 0.0 111.329 -179.848 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.425 HG12 ' CD1' ' A' ' 70' ' ' LEU . 66.9 t -159.17 129.91 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.042 179.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 138.44 -149.06 20.35 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.183 -1.008 . . . . 0.0 112.861 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' B' ' 537' ' ' ARG . 0.4 OUTLIER -110.8 27.15 9.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.938 0.399 . . . . 0.0 110.74 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -134.68 174.26 21.12 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.439 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.431 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -80.97 -57.63 3.45 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 123.063 -0.081 . . . . 0.0 111.195 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.481 ' CG1' ' CG2' ' A' ' 8' ' ' VAL . 13.8 p 23.96 44.61 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.443 ' CA ' HD12 ' A' ' 19' ' ' LEU . . . -125.39 -178.26 15.24 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.58 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.415 ' HB2' ' HG ' ' A' ' 55' ' ' LEU . 1.3 tmpt? -59.71 -17.68 36.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.585 0.231 . . . . 0.0 111.199 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.418 ' OG1' ' N ' ' A' ' 18' ' ' CYS . 34.1 p -79.58 -70.88 0.48 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.804 0.335 . . . . 0.0 111.463 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.418 ' N ' ' OG1' ' A' ' 17' ' ' THR . 16.5 t -62.49 -57.9 9.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.958 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.531 ' CD1' ' CE1' ' A' ' 169' ' ' PHE . 18.7 mt -47.87 -71.76 0.06 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -178.436 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.432 ' N ' ' CD2' ' A' ' 20' ' ' LEU . 2.5 mm? -56.74 -60.18 3.93 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -178.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.426 ' CG2' ' OG1' ' A' ' 25' ' ' THR . 50.0 mm -48.2 -70.52 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 120.936 -0.305 . . . . 0.0 111.189 -179.424 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.429 ' CB ' ' HB3' ' A' ' 159' ' ' ALA . 19.7 m -42.2 -29.3 0.24 Allowed 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 111.582 0.215 . . . . 0.0 111.582 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.482 ' CZ ' ' HG2' ' A' ' 166' ' ' LYS . 17.5 t80 -81.45 -68.72 0.67 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.856 0.36 . . . . 0.0 110.804 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.412 ' CG2' ' N ' ' A' ' 25' ' ' THR . 10.8 t -58.87 -46.75 87.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.128 0.489 . . . . 0.0 110.583 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.426 ' OG1' ' CG2' ' A' ' 21' ' ' ILE . 18.7 p -86.42 -153.46 0.2 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.431 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -150.03 55.5 0.94 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.658 0.266 . . . . 0.0 110.985 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.7 mttt -144.22 157.56 44.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.927 0.394 . . . . 0.0 111.252 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.492 ' CD2' ' HD3' ' A' ' 29' ' ' PRO . 0.5 OUTLIER -163.17 -64.64 0.01 OUTLIER Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.481 179.698 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.492 ' HD3' ' CD2' ' A' ' 28' ' ' PHE . 87.5 Cg_endo -81.77 57.87 6.51 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.62 2.213 . . . . 0.0 112.841 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.407 ' O ' ' N ' ' B' ' 532' ' ' TRP . 0.4 OUTLIER -131.45 -89.39 0.45 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.906 179.844 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.71 116.08 2.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.364 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -111.17 92.39 4.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.078 0.466 . . . . 0.0 111.188 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.496 ' N ' ' CD ' ' A' ' 34' ' ' PRO . 2.8 t -105.69 -33.55 0.19 Allowed Pre-proline 0 CA--C 1.544 0.731 0 N-CA-C 114.174 1.175 . . . . 0.0 114.174 -179.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.496 ' CD ' ' N ' ' A' ' 33' ' ' VAL . 46.6 Cg_exo -40.44 -26.5 0.22 Allowed 'Trans proline' 0 C--N 1.357 1.022 0 C-N-CA 122.361 2.041 . . . . 0.0 113.965 -178.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.48 ' CG2' ' CD2' ' B' ' 543' ' ' LEU . 51.4 m -54.07 88.38 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.625 0.25 . . . . 0.0 111.041 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.476 ' CG1' ' CA ' ' B' ' 524' ' ' GLY . 7.6 p 171.2 -32.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.7 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -108.06 23.44 14.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.904 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -61.23 -16.69 47.87 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.271 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -45.54 -27.25 0.71 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.717 0.294 . . . . 0.0 111.516 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.482 ' OH ' ' CE1' ' B' ' 518' ' ' PHE . 2.7 p90 -60.27 142.53 54.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.93 0.395 . . . . 0.0 110.72 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.41 ' C ' ' CD1' ' B' ' 519' ' ' ILE . . . -91.17 -178.75 5.25 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.972 -179.205 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.46 ' HA ' HG13 ' B' ' 519' ' ' ILE . 18.3 m -131.31 121.28 48.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.441 178.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.442 ' O ' ' CG1' ' A' ' 44' ' ' VAL . 5.0 t -86.24 104.61 15.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.422 -179.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.442 ' CG1' ' O ' ' A' ' 43' ' ' THR . 29.5 m -161.23 144.3 4.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.177 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.518 ' HE2' ' N ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -77.55 96.4 4.76 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.428 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.484 ' CG2' ' CE ' ' A' ' 1' ' ' MET . 5.9 tt -97.29 96.11 5.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.285 -179.125 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.452 ' N ' ' HE1' ' A' ' 45' ' ' MET . . . 101.91 -108.53 3.39 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.378 -0.828 . . . . 0.0 112.937 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.464 ' N ' ' HE2' ' A' ' 45' ' ' MET . . . -118.11 -22.78 3.75 Favored Glycine 0 CA--C 1.521 0.419 0 C-N-CA 120.511 -0.852 . . . . 0.0 113.375 -179.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.518 ' N ' ' HE2' ' A' ' 45' ' ' MET . 2.0 mt-10 -117.4 132.54 23.5 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.995 0.398 . . . . 0.0 111.148 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.434 ' HA ' ' HA ' ' A' ' 45' ' ' MET . 42.9 Cg_endo -68.65 90.26 0.42 Allowed 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.853 2.369 . . . . 0.0 113.839 -179.225 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.528 ' O ' ' CD1' ' A' ' 51' ' ' TYR . 2.3 p90 -173.41 132.18 0.47 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.728 178.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.401 ' HB ' ' CG2' ' A' ' 42' ' ' VAL . 0.1 OUTLIER -129.91 141.51 50.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.027 0.441 . . . . 0.0 111.354 -179.046 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.455 HD23 ' N ' ' A' ' 4' ' ' ILE . 2.1 tp -89.18 148.58 23.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.838 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -87.3 178.97 47.98 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.213 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.465 ' N ' ' CD2' ' A' ' 55' ' ' LEU . 0.4 OUTLIER -112.3 136.62 51.52 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.73 0.3 . . . . 0.0 110.54 179.758 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -84.38 116.34 22.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.918 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.409 ' OD2' ' N ' ' A' ' 36' ' ' VAL . 16.0 p-10 -119.3 167.74 11.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.057 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.435 ' CB ' HD23 ' A' ' 67' ' ' LEU . 0.6 OUTLIER -154.22 139.92 18.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.984 -179.826 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.423 ' CB ' ' HB3' ' B' ' 543' ' ' LEU . . . -171.07 136.08 1.05 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.807 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.77 73.1 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.613 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.425 ' CD2' ' HB2' ' B' ' 525' ' ' ASP . 0.3 OUTLIER -121.17 -175.41 3.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.918 0.389 . . . . 0.0 111.022 179.957 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -49.76 -39.51 37.92 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.028 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.407 ' HB3' ' CG2' ' A' ' 36' ' ' VAL . 11.2 t0 -64.11 -62.7 1.46 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.102 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.48 ' CD2' HD21 ' A' ' 67' ' ' LEU . 0.5 OUTLIER -120.07 140.53 50.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.78 -179.802 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.85 -69.08 0.7 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -179.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.428 ' O ' ' HB2' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -98.65 -46.51 5.68 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 -178.939 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.48 HD21 ' CD2' ' A' ' 64' ' ' TYR . 1.2 mp 69.37 131.43 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.06 -179.214 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.546 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 6.9 mtp180 -130.38 36.59 0.35 Allowed Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.961 178.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.546 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 61.1 Cg_endo -84.23 -39.93 0.1 Allowed 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 122.122 1.881 . . . . 0.0 112.044 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.454 ' CD2' ' HB2' ' B' ' 541' ' ' LEU . 0.1 OUTLIER -83.98 -7.84 59.31 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.156 -179.802 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.9 t -49.07 -64.11 0.9 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.745 0.307 . . . . 0.0 111.026 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -159.0 55.83 0.85 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.086 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.0 160.86 46.48 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.532 2.155 . . . . 0.0 112.209 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.05 10.24 34.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.462 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 69.3 m -50.73 117.86 2.75 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.828 0.347 . . . . 0.0 110.907 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -76.12 -20.07 57.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.061 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.434 ' CG2' ' HB3' ' A' ' 176' ' ' ALA . 43.1 t -103.93 72.53 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.897 0.379 . . . . 0.0 111.18 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -80.82 172.54 13.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.559 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.422 HD22 ' CG2' ' A' ' 14' ' ' VAL . 1.2 tt -152.61 108.73 3.37 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.853 0.359 . . . . 0.0 111.147 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.8 m -93.1 133.1 35.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.701 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.403 ' SG ' ' CG1' ' A' ' 14' ' ' VAL . 1.2 p -119.17 138.16 53.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.092 0.472 . . . . 0.0 111.36 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.469 ' CZ ' ' HB1' ' A' ' 142' ' ' ALA . 39.5 p90 -135.26 -174.12 3.53 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.008 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.1 m -145.81 139.08 26.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.745 0.307 . . . . 0.0 110.797 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.1 t -53.67 -67.6 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.302 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.9 m -48.62 108.65 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.737 0.304 . . . . 0.0 110.725 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -151.55 128.9 5.62 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.687 -179.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.411 ' O ' ' CB ' ' A' ' 88' ' ' SER . 74.0 Cg_endo -92.56 53.36 0.56 Allowed 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 123.272 2.648 . . . . 0.0 111.723 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.416 ' OG ' ' CG ' ' A' ' 133' ' ' LYS . 0.1 OUTLIER 81.95 39.21 0.05 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.823 -179.415 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.415 ' O ' ' CG2' ' A' ' 93' ' ' VAL . 0.1 OUTLIER -97.25 -34.89 10.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.804 179.862 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.497 ' CZ ' HG21 ' A' ' 137' ' ' ILE . 0.0 OUTLIER -51.83 -37.95 53.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.827 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -50.81 -57.41 8.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.661 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.427 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 4.1 p-10 -74.93 -43.57 53.44 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.676 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.469 HG11 ' CD2' ' A' ' 97' ' ' TRP . 57.4 t -52.31 -31.61 15.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.991 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.09 -50.92 10.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.915 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -82.75 6.31 18.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.648 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.427 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.6 OUTLIER -115.13 -27.81 7.18 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.754 0.312 . . . . 0.0 111.063 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.469 ' CD2' HG11 ' A' ' 93' ' ' VAL . 38.1 m0 -91.59 -44.81 8.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.02 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.472 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 64.4 t -53.48 -46.03 98.29 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.792 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 97.4 Cg_endo -80.61 -15.22 11.08 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.334 2.023 . . . . 0.0 112.781 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -85.8 -36.14 20.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.948 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.8 pt -79.14 -25.53 12.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.104 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 47.8 p -89.42 -31.63 17.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.038 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 74.5 t60 -72.8 -54.97 7.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.065 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -71.07 -25.84 62.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.047 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 28.5 m -132.31 95.37 21.21 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.9 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -50.2 110.69 0.41 Allowed 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.573 2.182 . . . . 0.0 112.263 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 7.6 mmpt? 50.8 92.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.906 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.59 113.04 12.92 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.85 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.15 133.62 51.02 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.584 2.189 . . . . 0.0 112.446 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.499 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 0.8 OUTLIER -134.92 142.81 46.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.96 179.923 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.434 ' CD1' HG11 ' A' ' 152' ' ' VAL . 5.0 tt -110.92 141.45 44.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.197 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.425 ' O ' ' CD2' ' A' ' 111' ' ' LEU . 3.6 mm? -89.8 158.38 17.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.627 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.431 ' CG2' HG22 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -137.84 150.42 25.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.123 0.487 . . . . 0.0 111.804 -179.554 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -129.59 134.92 8.12 Favored Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.525 179.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 158' ' ' SER . 0.0 OUTLIER -155.28 -41.49 0.08 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.859 0.33 . . . . 0.0 111.088 -179.279 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.443 ' HG2' ' CG ' ' A' ' 119' ' ' LEU . 10.5 tt0 -71.87 -9.09 57.82 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.322 178.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.449 HD12 ' N ' ' A' ' 117' ' ' ILE . 0.2 OUTLIER -54.39 -20.79 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.689 -179.848 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -75.55 -35.54 60.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.383 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.443 ' CG ' ' HG2' ' A' ' 116' ' ' GLN . 4.3 pp -97.02 14.21 26.38 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.626 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.403 ' O ' ' CD1' ' A' ' 126' ' ' ILE . 37.4 ptt85 -68.05 -27.29 66.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.951 0.405 . . . . 0.0 110.329 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -72.63 -25.68 61.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.827 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -47.58 101.63 0.27 Allowed Pre-proline 0 C--N 1.332 -0.169 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.703 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -67.83 -5.85 15.46 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.745 2.297 . . . . 0.0 113.049 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.46 -65.45 1.01 Allowed 'General case' 0 C--O 1.234 0.261 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.401 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 5.0 m -55.43 -38.94 69.65 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.449 ' HA ' ' CD1' ' A' ' 129' ' ' LEU . 0.1 OUTLIER -55.53 -47.41 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.713 179.179 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.413 ' N ' ' CG2' ' A' ' 126' ' ' ILE . 2.7 mm-40 -53.47 -35.77 60.91 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.02 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 125' ' ' THR . 1.7 mptp? -66.82 -32.09 73.14 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.449 ' CD1' ' HA ' ' A' ' 126' ' ' ILE . 6.2 mt -74.44 -36.8 63.39 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 177.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.464 ' HA ' ' HB2' ' A' ' 134' ' ' GLN . . . -43.98 -42.47 6.02 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.374 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.97 -26.38 10.41 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.365 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.408 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 29.5 m120 -124.61 -31.55 3.21 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -179.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.425 ' O ' ' HB2' ' A' ' 134' ' ' GLN . 6.4 mmpt? -152.06 -63.88 0.17 Allowed 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 -178.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.464 ' HB2' ' HA ' ' A' ' 130' ' ' ALA . 2.0 tt0 81.18 15.94 0.56 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.695 0.283 . . . . 0.0 110.97 -178.035 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 51.6 mttm -101.17 88.66 1.13 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.97 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -63.93 124.94 14.36 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.449 2.1 . . . . 0.0 111.859 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.497 HG21 ' CZ ' ' A' ' 90' ' ' PHE . 1.3 mm -60.14 97.25 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.106 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.9 p -74.34 153.83 88.05 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.807 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -47.14 -36.19 21.09 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.607 2.205 . . . . 0.0 112.324 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -67.9 -28.33 67.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.859 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 87.4 m -66.23 -53.55 35.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.841 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.469 ' HB1' ' CZ ' ' A' ' 82' ' ' PHE . . . -57.7 -36.66 72.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.898 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.98 -39.95 95.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.704 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 43.9 mttt -65.16 -51.61 60.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.862 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.16 -40.24 86.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.803 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -55.62 -44.81 77.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.037 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.25 -24.52 27.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.874 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -53.69 -31.57 48.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.855 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.428 ' CD1' HG21 ' A' ' 98' ' ' VAL . 2.1 mt -119.3 19.62 12.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.154 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 29.1 mmtm 48.06 42.42 16.85 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.784 0.326 . . . . 0.0 111.095 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.485 ' HB2' ' CE2' ' A' ' 110' ' ' PHE . . . -58.18 -81.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.913 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.434 HG11 ' CD1' ' A' ' 111' ' ' LEU . 47.6 t -160.73 -74.67 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.747 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 179.51 128.03 0.08 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.24 -179.057 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.462 ' CE2' ' HB3' ' A' ' 142' ' ' ALA . 38.3 t80 -100.19 112.49 24.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.755 178.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 2.8 t -101.52 154.58 4.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.416 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -90.55 120.13 31.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.94 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.404 ' O ' HD11 ' A' ' 117' ' ' ILE . 35.3 m -156.79 175.57 13.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.588 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.44 ' HA ' ' HA ' ' A' ' 115' ' ' THR . 4.6 t -158.07 145.16 17.96 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.089 0.471 . . . . 0.0 111.849 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.429 ' HB3' ' CB ' ' A' ' 22' ' ' SER . . . -104.72 -44.03 4.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.34 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.474 ' HB3' ' CE2' ' A' ' 28' ' ' PHE . 0.9 OUTLIER -62.94 -33.16 74.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.268 179.503 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -106.54 -21.74 12.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.565 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 77.9 60.48 0.03 OUTLIER 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.317 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.429 ' HB2' ' CB ' ' A' ' 158' ' ' SER . 0.5 OUTLIER -91.88 41.94 1.09 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.688 179.538 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.405 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . 104.09 -66.04 0.32 Allowed Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.719 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.451 ' CD2' ' HA ' ' A' ' 19' ' ' LEU . 0.5 OUTLIER 66.04 -66.77 0.16 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.724 0.297 . . . . 0.0 111.308 -179.914 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.482 ' HG2' ' CZ ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -50.09 -26.22 4.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.807 0.337 . . . . 0.0 110.872 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -62.22 -69.05 0.27 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.425 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.415 HG12 ' N ' ' A' ' 169' ' ' PHE . 14.0 p -54.41 -47.12 70.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.094 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.531 ' CE1' ' CD1' ' A' ' 19' ' ' LEU . 1.7 t80 -60.73 -31.86 71.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.338 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.442 ' O ' ' CD1' ' A' ' 173' ' ' ILE . 0.3 OUTLIER -62.48 -36.43 82.48 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.775 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -69.14 -28.77 66.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.633 178.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -61.04 -51.47 69.04 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.221 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.442 ' CD1' ' O ' ' A' ' 170' ' ' ASP . 0.1 OUTLIER -83.33 -23.65 8.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.031 -179.767 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.441 HD21 ' CD2' ' B' ' 505' ' ' LEU . 3.2 tm? -50.54 -48.53 57.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.048 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -51.02 -25.52 4.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.894 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.462 ' CB ' ' HB ' ' A' ' 4' ' ' ILE . . . -83.3 -42.77 16.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.11 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.434 ' CD1' HG23 ' B' ' 510' ' ' ILE . 8.3 mt -68.73 -17.54 64.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.991 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -171.79 145.11 1.62 Allowed Pre-proline 0 C--N 1.333 -0.109 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.746 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.9 127.99 28.62 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.619 2.212 . . . . 0.0 112.224 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.85 142.23 25.16 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.444 2.096 . . . . 0.0 112.242 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -113.99 141.48 26.33 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.92 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.3 -165.1 0.29 Allowed 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.639 2.226 . . . . 0.0 112.31 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 9.4 mttm -98.98 98.25 9.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.88 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.184 -0.913 . . . . 0.0 110.96 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.133 0 N-CA-C 112.509 -0.237 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 503' ' ' SER . . . . . 0.429 ' CB ' ' OD1' ' A' ' 170' ' ' ASP . 71.1 m -88.06 -81.55 0.25 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.79 0.329 . . . . 0.0 111.009 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 504' ' ' GLY . . . . . 0.419 ' N ' HD12 ' B' ' 505' ' ' LEU . . . 83.76 104.01 0.55 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.326 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 505' ' ' LEU . . . . . 0.5 ' N ' ' CD2' ' B' ' 505' ' ' LEU . 0.0 OUTLIER -148.38 90.44 1.8 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.911 0.386 . . . . 0.0 111.077 -179.137 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 506' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 55.57 -172.92 0.06 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.082 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 507' ' ' ALA . . . . . . . . . . . . . . . 63.86 -93.27 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.771 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 508' ' ' GLN . . . . . 0.423 ' O ' ' CB ' ' B' ' 509' ' ' ASP . 2.6 mt-30 -133.87 3.25 3.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.018 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 509' ' ' ASP . . . . . 0.423 ' CB ' ' O ' ' B' ' 508' ' ' GLN . 8.4 t70 80.61 36.67 0.1 Allowed 'General case' 0 CA--C 1.521 -0.165 0 CA-C-O 121.167 0.508 . . . . 0.0 109.915 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 510' ' ' ILE . . . . . 0.434 HG22 ' CG1' ' A' ' 46' ' ' ILE . 1.4 mp -53.75 128.59 13.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.162 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 511' ' ' SER . . . . . 0.438 ' HB2' ' CD2' ' B' ' 514' ' ' LEU . 11.5 m -109.33 158.57 17.76 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.16 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 512' ' ' GLN . . . . . 0.472 ' CB ' ' HD3' ' B' ' 513' ' ' PRO . 0.1 OUTLIER -103.24 -64.25 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.883 179.661 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 513' ' ' PRO . . . . . 0.472 ' HD3' ' CB ' ' B' ' 512' ' ' GLN . 67.7 Cg_endo -85.45 53.45 3.46 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.408 2.072 . . . . 0.0 112.202 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 514' ' ' LEU . . . . . 0.46 ' CD1' ' HA ' ' A' ' 46' ' ' ILE . 1.1 mp -62.62 -81.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.176 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 515' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -85.91 -85.0 0.16 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.897 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -120.66 -37.55 2.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.711 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 517' ' ' SER . . . . . 0.499 ' O ' ' CD1' ' B' ' 518' ' ' PHE . 0.9 OUTLIER 69.66 27.07 4.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.403 179.657 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 518' ' ' PHE . . . . . 0.499 ' CD1' ' O ' ' B' ' 517' ' ' SER . 24.9 m-85 -162.35 112.79 1.53 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.142 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 519' ' ' ILE . . . . . 0.46 HG13 ' HA ' ' A' ' 42' ' ' VAL . 31.3 mt -78.56 -30.09 15.04 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 CA-C-O 120.806 0.336 . . . . 0.0 110.703 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 63.39 94.45 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.885 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 521' ' ' THR . . . . . . . . . . . . . 2.2 t -167.93 47.65 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.844 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 522' ' ' GLY . . . . . . . . . . . . . . . -155.51 165.77 32.55 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.491 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 523' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -106.32 -84.83 0.51 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.737 0.303 . . . . 0.0 110.898 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 524' ' ' GLY . . . . . 0.476 ' CA ' ' CG1' ' A' ' 36' ' ' VAL . . . 75.97 21.34 76.47 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.619 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 525' ' ' ASP . . . . . 0.429 ' O ' ' CG1' ' A' ' 33' ' ' VAL . 26.2 m-20 50.93 56.74 7.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.842 0.353 . . . . 0.0 110.887 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 526' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.13 96.82 7.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.935 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 527' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -164.55 163.42 14.61 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.247 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -69.44 87.27 0.52 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 123.054 2.503 . . . . 0.0 111.734 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 529' ' ' ARG . . . . . . . . . . . . . 4.0 mtp180 -100.8 -45.67 5.39 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.527 -179.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 530' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -123.06 -42.76 2.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.057 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 3.7 m 72.72 138.81 0.05 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.924 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 532' ' ' TRP . . . . . 0.482 ' CZ2' ' HG3' ' B' ' 537' ' ' ARG . 11.2 t-105 -89.78 115.15 26.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.935 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . -110.46 -53.31 0.57 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.508 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 534' ' ' PHE . . . . . 0.475 ' O ' ' CZ2' ' B' ' 532' ' ' TRP . 32.2 m-85 -107.09 147.84 35.9 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.661 0.267 . . . . 0.0 110.881 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -67.61 -167.01 0.14 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.528 2.152 . . . . 0.0 112.298 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 70.14 102.51 0.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.945 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 537' ' ' ARG . . . . . 0.482 ' HG3' ' CZ2' ' B' ' 532' ' ' TRP . 0.0 OUTLIER -108.13 -177.11 3.24 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.391 0.615 . . . . 0.0 111.146 -179.991 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 538' ' ' ILE . . . . . 0.459 HG13 ' N ' ' B' ' 539' ' ' ASP . 11.4 pt -114.47 -156.05 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-N 114.999 -1.001 . . . . 0.0 109.749 179.295 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 539' ' ' ASP . . . . . 0.459 ' N ' HG13 ' B' ' 538' ' ' ILE . 0.3 OUTLIER -93.98 135.12 35.66 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.328 179.198 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 540' ' ' GLU . . . . . 0.437 ' HG3' ' CG1' ' A' ' 8' ' ' VAL . 1.4 mm-40 -41.33 -33.82 0.44 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.762 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 541' ' ' LEU . . . . . 0.485 HD23 ' CD1' ' B' ' 542' ' ' TYR . 2.4 tt -54.46 -34.36 61.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.117 0.484 . . . . 0.0 110.434 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 542' ' ' TYR . . . . . 0.485 ' CD1' HD23 ' B' ' 541' ' ' LEU . 89.4 m-85 -99.26 -6.55 27.85 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.923 -179.378 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 543' ' ' LEU . . . . . 0.48 ' CD2' ' CG2' ' A' ' 35' ' ' THR . 0.9 OUTLIER -50.17 167.03 0.06 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.789 0.328 . . . . 0.0 110.781 -179.786 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . 146.26 71.11 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.432 -0.89 . . . . 0.0 112.621 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 545' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.922 179.978 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.531 ' CE ' ' CD1' ' A' ' 51' ' ' TYR . 6.1 tpt . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.746 0.308 . . . . 0.0 111.263 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -100.04 150.88 22.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.022 0.439 . . . . 0.0 110.864 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.463 ' CG2' ' HB3' ' A' ' 53' ' ' LEU . 0.2 OUTLIER -93.46 -178.71 4.81 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.273 -179.538 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.479 ' CG2' ' CD2' ' A' ' 177' ' ' LEU . 3.8 pt -148.48 112.21 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.96 -179.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 44.8 mttt -94.85 95.83 8.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.191 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.523 ' CB ' ' CE2' ' A' ' 56' ' ' PHE . 4.0 m -121.35 136.99 54.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.666 -179.177 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.4 t -137.26 146.22 28.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.421 179.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.514 HG21 ' CD2' ' A' ' 56' ' ' PHE . 19.7 t -84.65 140.0 16.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.232 0.539 . . . . 0.0 111.668 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.41 ' N ' HG12 ' A' ' 8' ' ' VAL . 96.2 t -150.66 129.81 3.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.534 179.061 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 135.03 -148.8 19.71 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.089 -1.053 . . . . 0.0 112.63 -179.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -122.47 23.64 9.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.825 0.345 . . . . 0.0 110.721 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.401 ' HA2' ' HB2' ' B' ' 537' ' ' ARG . . . -142.28 148.9 20.71 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.451 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -98.79 4.76 47.7 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.447 ' CG2' ' CG1' ' A' ' 113' ' ' VAL . 6.8 p -43.69 -31.26 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 CA-C-O 120.692 0.282 . . . . 0.0 111.463 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.428 ' CA ' HD11 ' A' ' 19' ' ' LEU . . . -113.27 18.94 20.55 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.415 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.432 ' NZ ' HD21 ' B' ' 543' ' ' LEU . 2.3 tttm -97.52 -126.49 0.15 Allowed 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 119.949 -0.072 . . . . 0.0 110.851 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.434 ' HB ' ' CG1' ' A' ' 21' ' ' ILE . 3.3 p -97.34 -31.08 12.58 Favored 'General case' 0 C--N 1.34 0.172 0 O-C-N 122.041 -0.412 . . . . 0.0 111.435 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.441 ' O ' ' CB ' ' A' ' 22' ' ' SER . 15.6 p -42.08 -36.38 1.13 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.903 -179.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.494 HD22 ' CG ' ' A' ' 169' ' ' PHE . 2.8 mp -48.4 -72.79 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.322 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.6 mt -78.12 -40.71 37.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.875 0.369 . . . . 0.0 110.612 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.478 ' CD1' ' CZ ' ' B' ' 518' ' ' PHE . 24.3 mm -62.56 -69.35 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.209 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.441 ' CB ' ' O ' ' A' ' 18' ' ' CYS . 1.5 t -52.86 -46.33 67.8 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.558 -179.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.425 ' CB ' ' O ' ' A' ' 19' ' ' LEU . 28.6 t80 -48.99 -42.66 38.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.686 0.279 . . . . 0.0 111.414 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.1 m -100.51 -64.59 1.03 Allowed 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.423 ' N ' ' O ' ' A' ' 21' ' ' ILE . 97.8 m -100.55 164.64 11.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.933 0.396 . . . . 0.0 111.379 -179.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.416 ' ND2' ' O ' ' A' ' 31' ' ' GLU . 7.1 t-20 73.89 -60.67 0.52 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.079 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 74.4 174.13 0.27 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.821 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.488 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 8.1 t80 -86.71 -46.22 0.54 Allowed Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.645 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.488 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 87.1 Cg_endo -82.99 50.8 3.47 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.501 2.134 . . . . 0.0 112.792 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.3 m -143.18 -100.46 0.12 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.79 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.416 ' O ' ' ND2' ' A' ' 26' ' ' ASN . 1.2 pt-20 -159.69 163.2 34.99 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.902 0.382 . . . . 0.0 111.073 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -135.21 117.09 15.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.266 179.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.436 ' CG1' ' HG3' ' B' ' 529' ' ' ARG . 0.0 OUTLIER -163.39 -62.87 0.01 OUTLIER Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.686 -179.471 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.439 ' HB3' ' CB ' ' B' ' 526' ' ' SER . 29.0 Cg_endo -62.9 57.33 0.15 Allowed 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.816 2.344 . . . . 0.0 113.592 -179.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.0 t -122.74 22.45 9.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.846 0.355 . . . . 0.0 110.172 178.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.446 ' HA ' ' CB ' ' A' ' 59' ' ' ALA . 2.3 t -73.13 -45.64 53.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.751 -179.059 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.48 ' O ' ' CD2' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -85.5 48.77 1.64 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.786 0.327 . . . . 0.0 111.303 -179.731 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -69.75 -16.87 63.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.111 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -86.02 11.28 11.95 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.593 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.48 ' CD2' ' O ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -60.25 173.81 0.61 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.821 0.343 . . . . 0.0 110.725 179.874 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -92.16 147.43 22.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.174 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.408 HG13 ' HA ' ' B' ' 518' ' ' PHE . 6.7 m -134.91 147.05 29.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.887 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.423 ' N ' HD11 ' B' ' 519' ' ' ILE . 2.8 t -85.81 102.63 13.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.984 0.421 . . . . 0.0 109.911 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.455 HG22 ' N ' ' A' ' 45' ' ' MET . 1.1 p -165.77 145.61 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.872 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.455 ' N ' HG22 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -115.75 140.33 49.31 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.424 179.521 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.453 HG22 ' CG2' ' B' ' 510' ' ' ILE . 7.8 mm -95.38 115.46 34.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-O 120.947 0.403 . . . . 0.0 111.561 -179.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.423 ' O ' ' CE ' ' A' ' 45' ' ' MET . . . 33.18 -90.35 0.01 OUTLIER Glycine 0 C--N 1.336 0.552 0 CA-C-N 115.595 -0.73 . . . . 0.0 114.223 178.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . -41.14 -87.7 0.01 OUTLIER Glycine 0 C--N 1.332 0.315 0 C-N-CA 121.205 -0.522 . . . . 0.0 113.07 -179.435 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.413 ' HB3' ' HD2' ' A' ' 50' ' ' PRO . 1.1 mt-10 -143.51 165.36 25.53 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.406 0.103 . . . . 0.0 111.214 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.42 ' HA ' ' CB ' ' A' ' 45' ' ' MET . 39.2 Cg_exo -31.24 103.02 0.03 OUTLIER 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.619 2.879 . . . . 0.0 113.012 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.531 ' CD1' ' CE ' ' A' ' 1' ' ' MET . 8.7 t80 -172.53 120.67 0.41 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.772 -179.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.434 HG22 ' CG1' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -135.43 155.73 50.08 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.088 -178.741 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.463 ' HB3' ' CG2' ' A' ' 3' ' ' THR . 0.0 OUTLIER -115.55 156.3 26.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.186 179.973 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -62.26 109.85 2.87 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.6 -0.81 . . . . 0.0 111.875 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.22 -153.15 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.656 0.265 . . . . 0.0 110.895 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.523 ' CE2' ' CB ' ' A' ' 6' ' ' CYS . 9.0 m-85 -84.41 105.76 15.49 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 120.921 0.391 . . . . 0.0 111.127 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -120.74 113.06 19.64 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.939 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -154.21 125.77 7.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.87 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.446 ' CB ' ' HA ' ' A' ' 36' ' ' VAL . . . -172.52 119.86 0.39 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.992 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -95.18 75.45 0.89 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.445 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.43 ' CD1' ' CB ' ' A' ' 59' ' ' ALA . 3.5 mp -117.46 -115.09 0.33 Allowed 'General case' 0 CA--C 1.538 0.513 0 O-C-N 122.912 -0.17 . . . . 0.0 110.872 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -98.6 -29.55 12.99 Favored 'General case' 0 N--CA 1.455 -0.182 0 O-C-N 122.073 -0.392 . . . . 0.0 111.254 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.457 ' HB3' ' CD1' ' A' ' 64' ' ' TYR . 14.8 t0 -67.38 -63.25 1.1 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.066 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.457 ' CD1' ' HB3' ' A' ' 63' ' ' ASP . 0.2 OUTLIER -124.13 137.22 54.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.674 179.966 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -87.25 -62.5 1.49 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.897 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.476 ' N ' ' CD ' ' A' ' 66' ' ' ARG . 0.3 OUTLIER -98.68 -21.09 16.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.181 -179.777 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.425 ' CD2' ' HB2' ' A' ' 64' ' ' TYR . 1.7 mt 67.03 -135.38 0.13 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.297 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.467 ' CB ' ' CD ' ' A' ' 69' ' ' PRO . 1.2 mtt180 -166.06 -64.07 0.01 OUTLIER Pre-proline 0 CA--C 1.529 0.151 0 CA-C-N 118.28 0.491 . . . . 0.0 111.814 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.467 ' CD ' ' CB ' ' A' ' 68' ' ' ARG . 63.7 Cg_exo -36.96 -60.27 0.4 Allowed 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.965 2.443 . . . . 0.0 113.103 -179.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.406 ' CD1' ' C ' ' A' ' 70' ' ' LEU . 0.4 OUTLIER -50.08 -29.64 9.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.384 -179.752 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 68' ' ' ARG . 35.5 p -47.46 -64.76 0.7 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.759 0.314 . . . . 0.0 111.194 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.422 ' N ' ' OG ' ' A' ' 71' ' ' SER . 6.1 p90 -179.55 92.38 0.2 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.07 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.93 136.03 26.67 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.523 2.149 . . . . 0.0 112.313 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -87.4 10.91 15.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.512 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 11.7 t -70.13 -173.16 0.64 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.784 0.326 . . . . 0.0 110.933 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -124.31 7.69 8.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.431 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.404 ' O ' ' CG1' ' A' ' 77' ' ' VAL . 9.0 p -129.14 78.59 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.755 0.312 . . . . 0.0 111.388 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.526 ' CZ ' ' CG2' ' A' ' 108' ' ' THR . 7.6 m-30 -80.7 172.43 13.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.224 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.417 ' CD2' ' HA3' ' A' ' 15' ' ' GLY . 8.1 tp -143.83 108.55 4.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.876 0.37 . . . . 0.0 111.374 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.402 HG21 ' HB2' ' A' ' 110' ' ' PHE . 4.4 m -94.52 155.12 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.18 179.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 2.3 m -134.85 146.21 49.03 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.194 0.521 . . . . 0.0 111.92 -179.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -166.22 124.63 1.5 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.158 179.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.431 ' CB ' ' HG3' ' A' ' 116' ' ' GLN . 0.1 OUTLIER -90.24 139.26 30.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.014 0.435 . . . . 0.0 111.562 -179.244 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.451 HG21 ' CB ' ' A' ' 116' ' ' GLN . 10.2 m -63.26 -170.1 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.408 179.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.425 ' CG1' HD12 ' A' ' 129' ' ' LEU . 0.1 OUTLIER 56.19 102.11 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -179.282 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.431 ' CA ' HD23 ' A' ' 129' ' ' LEU . 0.2 OUTLIER -151.26 145.9 18.49 Favored Pre-proline 0 C--N 1.325 -0.465 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.923 -179.183 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.425 ' N ' HD22 ' A' ' 129' ' ' LEU . 83.6 Cg_endo -85.73 50.04 2.51 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 123.121 2.548 . . . . 0.0 111.654 179.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.463 ' N ' ' HB3' ' A' ' 133' ' ' LYS . 2.6 t 82.9 27.8 0.11 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.877 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 44.5 t -97.3 -24.16 15.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.848 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -49.56 -62.1 1.74 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.066 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -50.36 -31.16 13.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.873 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.424 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 1.4 t-20 -72.59 -63.22 1.2 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.859 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.43 HG12 ' N ' ' A' ' 94' ' ' LYS . 12.9 p -52.43 -41.74 36.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.039 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.436 ' HG3' ' CD1' ' A' ' 145' ' ' LEU . 0.8 OUTLIER -55.87 -62.27 1.81 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.699 179.93 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -78.32 2.81 17.34 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.782 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.481 ' HD3' ' CZ3' ' A' ' 97' ' ' TRP . 55.9 tttt -105.24 -38.43 6.53 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.869 0.366 . . . . 0.0 110.56 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.481 ' CZ3' ' HD3' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -74.8 -49.45 20.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.15 179.967 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.464 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 67.8 t -47.01 -52.3 34.57 Favored Pre-proline 0 CA--C 1.532 0.28 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.919 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 60.7 Cg_endo -72.22 -20.57 24.53 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.112 1.875 . . . . 0.0 112.385 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -84.89 -46.26 11.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.015 0.436 . . . . 0.0 110.622 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 5.9 tt -66.07 -26.11 37.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.906 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 60.3 p -91.55 -26.53 18.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.739 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.454 ' CG ' ' O ' ' A' ' 99' ' ' PRO . 1.9 m170 -67.52 -69.25 0.33 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.828 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -64.32 -42.93 96.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.634 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 4.5 m -112.59 149.21 40.79 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.603 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -49.21 162.31 0.5 Allowed 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.509 2.139 . . . . 0.0 112.269 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.43 56.21 2.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.801 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.526 ' CG2' ' CZ ' ' A' ' 78' ' ' PHE . 1.3 p -81.58 165.33 44.63 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.227 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -60.62 162.68 17.45 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.856 2.37 . . . . 0.0 112.323 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.427 ' O ' ' CB ' ' A' ' 151' ' ' ALA . 8.8 p90 -156.07 153.83 30.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.757 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.433 ' CD1' HG12 ' A' ' 152' ' ' VAL . 4.7 tt -113.81 142.95 45.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.408 -179.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.421 ' O ' ' CD2' ' A' ' 111' ' ' LEU . 3.8 mm? -99.14 158.68 15.51 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.387 179.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.477 ' CG1' ' CG1' ' A' ' 168' ' ' VAL . 2.6 t -141.94 146.95 22.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.166 0.507 . . . . 0.0 112.193 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.482 ' HA3' ' CZ ' ' A' ' 154' ' ' TYR . . . -122.49 92.02 0.47 Allowed Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.968 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.429 ' CG2' HG22 ' A' ' 14' ' ' VAL . 0.7 OUTLIER -114.34 6.76 16.18 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.281 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.451 ' CB ' HG21 ' A' ' 84' ' ' VAL . 2.3 mt-30 -110.22 25.86 11.31 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.301 0.572 . . . . 0.0 109.56 179.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.422 ' CD1' ' O ' ' A' ' 114' ' ' GLY . 0.0 OUTLIER -65.53 -10.45 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.501 179.008 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -96.9 -20.5 18.09 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.245 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.403 HD11 ' HA ' ' A' ' 116' ' ' GLN . 5.2 mp -89.02 -37.66 15.0 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.256 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -48.09 -31.56 5.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.828 0.347 . . . . 0.0 110.894 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -78.58 -37.06 43.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.485 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -47.97 104.24 0.4 Allowed Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.909 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.424 ' O ' ' CG ' ' A' ' 127' ' ' GLU . 55.4 Cg_endo -70.99 -6.17 18.61 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.444 2.096 . . . . 0.0 112.898 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.93 -66.58 0.77 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.401 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 17.2 m -57.51 -40.86 79.62 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.449 ' HA ' ' CD1' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -52.84 -46.56 52.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.805 179.231 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.424 ' CG ' ' O ' ' A' ' 123' ' ' PRO . 20.5 mm-40 -58.14 -33.69 69.46 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.9 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.432 ' HA ' ' CE ' ' A' ' 131' ' ' LYS . 9.9 mptt -68.99 -24.77 64.27 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 178.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.449 ' CD1' ' HA ' ' A' ' 126' ' ' ILE . 4.4 mt -79.43 -35.58 40.3 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 177.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.431 ' HA ' ' HB3' ' A' ' 134' ' ' GLN . . . -39.55 -39.1 0.67 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.033 -0.985 . . . . 0.0 112.391 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.432 ' CE ' ' HA ' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -69.88 -21.63 63.31 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.793 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.422 ' CB ' ' O ' ' A' ' 87' ' ' PRO . 17.5 m120 -124.01 -31.72 3.34 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -179.243 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.488 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 0.0 OUTLIER -139.63 -74.68 0.36 Allowed 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 -179.303 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.488 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 1.2 pt20 99.46 -41.21 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.075 0.95 . . . . 0.0 110.806 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.408 ' N ' ' HG2' ' A' ' 134' ' ' GLN . 0.8 OUTLIER -74.33 109.03 6.02 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.438 -179.648 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -68.28 -169.35 0.25 Allowed 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.253 1.968 . . . . 0.0 111.141 179.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.473 ' CD1' ' N ' ' A' ' 137' ' ' ILE . 1.0 OUTLIER -115.37 96.42 4.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.028 0.442 . . . . 0.0 110.585 179.877 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.415 ' O ' ' N ' ' A' ' 141' ' ' THR . 26.3 p -69.85 144.24 93.08 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.929 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.466 ' O ' ' CE1' ' A' ' 154' ' ' TYR . 1.8 Cg_endo -42.61 -46.07 8.22 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 122.893 2.395 . . . . 0.0 112.012 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -59.96 -32.66 71.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.417 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.415 ' N ' ' O ' ' A' ' 138' ' ' THR . 29.5 m -61.55 -53.17 59.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.686 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.526 ' CB ' ' CD2' ' A' ' 154' ' ' TYR . . . -51.91 -36.84 50.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.689 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -62.84 -40.88 98.8 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.492 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 37.4 tttp -59.38 -56.13 25.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.415 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.436 ' CD1' ' HG3' ' A' ' 94' ' ' LYS . 0.9 OUTLIER -62.15 -41.06 97.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.341 179.512 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -58.86 -53.19 61.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.739 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.06 -27.06 61.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.666 179.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -50.45 -45.08 55.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.709 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.11 20.73 18.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.926 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 18.9 mttt 48.67 63.55 2.05 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.091 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.433 ' O ' ' CG2' ' A' ' 152' ' ' VAL . . . -80.19 -82.29 0.11 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.959 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.433 ' CG2' ' O ' ' A' ' 151' ' ' ALA . 54.9 t -162.05 -75.6 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.794 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.17 120.14 0.12 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.855 -178.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.526 ' CD2' ' CB ' ' A' ' 142' ' ' ALA . 12.5 t80 -89.83 114.56 26.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.296 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 2.8 t -111.7 154.67 13.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.032 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -93.49 119.84 33.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.021 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 1.3 m -172.49 135.71 0.73 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.808 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.9 p -150.1 170.69 18.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.922 0.392 . . . . 0.0 111.153 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.39 -30.84 21.82 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.99 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.1 mt -51.38 -72.39 0.05 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.664 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 14.6 t -74.21 -16.81 60.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.086 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 71.07 50.84 0.3 Allowed 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.069 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -68.78 -21.02 64.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.969 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 139.05 -42.45 1.25 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.388 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.429 HD22 ' CD2' ' A' ' 19' ' ' LEU . 0.3 OUTLIER 68.15 -62.18 0.37 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.796 0.332 . . . . 0.0 111.079 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.426 ' O ' ' N ' ' A' ' 170' ' ' ASP . 0.1 OUTLIER -48.12 -25.52 1.49 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.388 -179.733 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -52.34 -71.64 0.06 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.798 0.332 . . . . 0.0 110.47 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.477 ' CG1' ' CG1' ' A' ' 113' ' ' VAL . 14.7 p -59.24 -29.92 42.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.266 0.555 . . . . 0.0 110.184 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.494 ' CG ' HD22 ' A' ' 19' ' ' LEU . 0.6 OUTLIER -67.53 -29.8 69.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.325 179.714 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 166' ' ' LYS . 68.9 m-20 -77.28 -27.72 53.17 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.191 179.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -75.5 -28.5 59.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.316 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.425 ' N ' HD13 ' A' ' 111' ' ' LEU . . . -75.02 -48.06 25.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.961 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 1.3 pp -65.72 -34.71 72.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.72 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.446 HD12 ' CD1' ' B' ' 505' ' ' LEU . 1.6 tp -48.86 -58.04 5.45 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.912 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -47.87 -26.46 1.69 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.136 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -77.29 -47.85 18.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.209 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.479 ' CD2' ' CG2' ' A' ' 4' ' ' ILE . 3.0 mt -68.53 -23.82 64.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.881 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.28 155.82 22.02 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.963 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.0 122.43 8.1 Favored 'Trans proline' 0 CA--C 1.529 0.253 0 C-N-CA 122.631 2.221 . . . . 0.0 112.18 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.53 175.82 5.64 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.434 2.09 . . . . 0.0 112.376 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 25.8 mp0 -144.63 96.72 5.12 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.887 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.23 -165.08 0.27 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.573 2.182 . . . . 0.0 112.235 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 5.8 mmtp -80.09 141.72 35.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.815 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.903 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.154 0 N-CA-C 112.521 -0.232 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 503' ' ' SER . . . . . . . . . . . . . 54.5 p -99.47 -160.49 0.81 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.745 0.307 . . . . 0.0 110.813 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 504' ' ' GLY . . . . . . . . . . . . . . . 149.23 95.81 0.15 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.331 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 505' ' ' LEU . . . . . 0.446 ' CD1' HD12 ' A' ' 174' ' ' LEU . 0.2 OUTLIER -157.43 146.51 19.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.057 0.456 . . . . 0.0 111.477 -179.698 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 506' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.05 81.83 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.728 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 507' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' B' ' 505' ' ' LEU . . . 170.82 43.71 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.486 -179.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 508' ' ' GLN . . . . . 0.444 ' HB2' ' CD1' ' B' ' 510' ' ' ILE . 0.0 OUTLIER 75.33 3.79 4.05 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.692 -177.385 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 509' ' ' ASP . . . . . . . . . . . . . 3.7 p30 45.9 53.16 9.23 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.164 0.507 . . . . 0.0 111.393 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 510' ' ' ILE . . . . . 0.453 ' CG2' HG22 ' A' ' 46' ' ' ILE . 1.2 mp -52.97 143.72 4.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.104 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 511' ' ' SER . . . . . 0.421 ' O ' ' CD1' ' B' ' 514' ' ' LEU . 22.8 t -108.67 153.74 23.0 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.889 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 512' ' ' GLN . . . . . 0.487 ' OE1' ' CD2' ' A' ' 169' ' ' PHE . 9.6 tt0 -102.46 -70.59 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.181 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 513' ' ' PRO . . . . . 0.487 ' CD ' ' CB ' ' B' ' 512' ' ' GLN . 87.5 Cg_endo -77.54 56.59 5.63 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.279 1.986 . . . . 0.0 111.617 179.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 514' ' ' LEU . . . . . 0.432 HD11 ' CG2' ' A' ' 44' ' ' VAL . 2.1 mp -60.72 -89.99 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.623 -179.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 515' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -84.15 -159.61 0.4 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.63 0.252 . . . . 0.0 110.792 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -48.12 -27.32 2.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.834 0.35 . . . . 0.0 110.733 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 517' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 39.57 33.75 0.13 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.724 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 518' ' ' PHE . . . . . 0.478 ' CZ ' ' CD1' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -163.51 106.72 1.0 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.371 -179.9 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 519' ' ' ILE . . . . . 0.423 HD11 ' N ' ' A' ' 43' ' ' THR . 3.6 mm -87.13 -37.31 10.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.906 0.384 . . . . 0.0 110.842 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -167.52 -170.75 1.5 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.668 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 521' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.27 157.54 19.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.849 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 522' ' ' GLY . . . . . 0.446 ' CA ' ' CB ' ' A' ' 37' ' ' PHE . . . -61.67 -126.52 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.32 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 523' ' ' HIS . . . . . 0.482 ' CD2' ' N ' ' B' ' 524' ' ' GLY . 41.1 t60 -165.05 -88.07 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.625 0.25 . . . . 0.0 111.065 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 524' ' ' GLY . . . . . 0.482 ' N ' ' CD2' ' B' ' 523' ' ' HIS . . . 42.49 -153.39 0.19 Allowed Glycine 0 C--N 1.334 0.418 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.841 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 525' ' ' ASP . . . . . 0.42 ' OD1' ' CD2' ' A' ' 61' ' ' LEU . 41.0 p-10 -83.29 65.81 8.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.902 0.382 . . . . 0.0 110.655 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 526' ' ' SER . . . . . 0.439 ' CB ' ' HB3' ' A' ' 34' ' ' PRO . 53.6 p -73.19 96.12 2.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.796 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 527' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -168.24 153.36 6.47 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.003 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.62 100.81 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.684 2.256 . . . . 0.0 112.069 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 529' ' ' ARG . . . . . 0.436 ' HG3' ' CG1' ' A' ' 33' ' ' VAL . 7.6 mtp85 -100.71 -55.34 2.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.286 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 530' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -162.94 98.33 0.95 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.123 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 19.2 t -46.81 95.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.887 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 532' ' ' TRP . . . . . 0.445 ' CE3' ' O ' ' B' ' 533' ' ' GLY . 21.0 t90 68.48 -67.36 0.2 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.948 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 533' ' ' GLY . . . . . 0.445 ' O ' ' CE3' ' B' ' 532' ' ' TRP . . . 87.34 -122.69 6.29 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.592 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 534' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -95.08 155.38 39.05 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 120.738 0.304 . . . . 0.0 110.87 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -64.54 166.38 17.77 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.619 2.213 . . . . 0.0 112.302 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 64.81 97.06 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.828 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 537' ' ' ARG . . . . . 0.401 ' HB2' ' HA2' ' A' ' 12' ' ' GLY . 0.2 OUTLIER -50.59 143.14 9.79 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.047 0.451 . . . . 0.0 111.054 -179.919 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 538' ' ' ILE . . . . . 0.439 ' CG2' ' HA ' ' B' ' 543' ' ' LEU . 6.1 tp -56.17 141.84 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.912 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 539' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -43.06 143.06 0.83 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.943 0.401 . . . . 0.0 111.387 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 540' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -54.15 -20.45 6.76 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.383 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 541' ' ' LEU . . . . . 0.406 ' HA ' HD13 ' A' ' 70' ' ' LEU . 3.9 mt -41.54 -57.9 2.09 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.878 0.37 . . . . 0.0 111.348 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 542' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -104.38 -63.54 1.2 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.804 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 543' ' ' LEU . . . . . 0.439 ' HA ' ' CG2' ' B' ' 538' ' ' ILE . 0.3 OUTLIER 67.21 152.93 0.08 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.754 -179.834 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . 120.25 -123.98 5.77 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.536 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 545' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.911 179.903 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.439 ' CE ' HG23 ' A' ' 46' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.788 0.328 . . . . 0.0 111.204 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.4 ' O ' ' CE ' ' A' ' 1' ' ' MET . 6.5 tt0 54.12 170.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.715 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.503 HG23 ' CE1' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -132.28 -172.46 2.9 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.317 -179.744 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.467 ' CG2' ' HG ' ' A' ' 177' ' ' LEU . 4.5 pt -153.14 132.06 3.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.526 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -91.45 95.78 10.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.575 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.43 ' CB ' HD11 ' A' ' 55' ' ' LEU . 1.1 m -80.37 98.64 7.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.273 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.1 t -126.25 159.43 35.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.478 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.4 t -128.97 117.62 44.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.039 0.447 . . . . 0.0 111.65 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 96.7 t -123.82 129.98 74.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.917 179.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 134.17 -164.91 24.48 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.205 -0.997 . . . . 0.0 112.612 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' B' ' 539' ' ' ASP . 1.2 m-20 -98.82 25.93 6.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.837 0.351 . . . . 0.0 110.572 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -138.27 150.01 20.78 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.645 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -89.83 -14.93 33.36 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.429 HG11 ' CG1' ' A' ' 113' ' ' VAL . 92.2 t -43.51 102.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-O 120.903 0.382 . . . . 0.0 111.29 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 142.12 -13.02 2.58 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.624 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.45 ' NZ ' ' CD2' ' B' ' 543' ' ' LEU . 77.0 mttt -97.61 -105.73 0.18 Allowed 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.645 0.222 . . . . 0.0 111.377 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.438 ' HB ' ' CG1' ' A' ' 21' ' ' ILE . 69.2 p -98.49 -39.32 8.81 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 -179.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.426 ' O ' ' CB ' ' A' ' 22' ' ' SER . 23.8 t -35.9 -34.19 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -179.021 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.486 HD13 ' CE2' ' A' ' 169' ' ' PHE . 0.0 OUTLIER -80.71 -70.31 0.54 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.761 0.315 . . . . 0.0 111.036 -179.746 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.406 ' CD2' ' O ' ' A' ' 16' ' ' LYS . 0.5 OUTLIER -50.84 -43.59 59.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.653 -179.908 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.464 ' CD1' ' CE2' ' B' ' 518' ' ' PHE . 32.5 mm -63.73 -64.05 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.171 179.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.426 ' CB ' ' O ' ' A' ' 18' ' ' CYS . 45.4 t -45.93 -30.17 1.67 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.958 0.408 . . . . 0.0 110.707 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -65.44 -45.24 84.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.412 179.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -87.39 -50.73 6.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.557 179.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.2 p -102.18 -158.55 0.68 Allowed 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.221 179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -159.33 38.45 0.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.005 0.431 . . . . 0.0 110.821 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.6 98.9 8.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.92 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.447 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . 9.4 t80 -97.56 -52.04 0.21 Allowed Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.024 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.447 ' HD3' ' HB3' ' A' ' 28' ' ' PHE . 65.3 Cg_endo -90.37 26.53 0.49 Allowed 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.782 2.321 . . . . 0.0 112.62 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.57 -87.32 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.129 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -158.13 115.86 2.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.844 0.354 . . . . 0.0 110.737 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 12.0 m-30 -105.83 119.5 39.32 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.759 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.475 ' CB ' ' HD3' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -161.86 -56.14 0.01 OUTLIER Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.145 179.863 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.48 ' O ' ' CD1' ' A' ' 37' ' ' PHE . 19.1 Cg_exo -66.22 -15.52 48.61 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.469 2.112 . . . . 0.0 112.558 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.0 t -41.94 -30.67 0.28 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.907 0.384 . . . . 0.0 111.387 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.445 ' CB ' HD12 ' A' ' 61' ' ' LEU . 12.3 p -51.29 -22.47 2.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.329 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.48 ' CD1' ' O ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -81.88 48.15 1.18 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.311 179.896 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.406 ' OD2' ' N ' ' A' ' 57' ' ' ASP . 14.6 p-10 -74.13 -2.6 25.29 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.498 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -83.94 11.11 8.26 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 111.603 0.223 . . . . 0.0 111.603 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 48.7 p90 -60.27 160.96 7.7 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.74 0.305 . . . . 0.0 110.616 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.423 ' O ' ' CG1' ' B' ' 519' ' ' ILE . . . -109.89 135.99 49.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.476 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.427 HG21 ' CG2' ' A' ' 52' ' ' THR . 13.5 m -114.57 121.68 67.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.824 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.43 ' O ' ' CG1' ' A' ' 44' ' ' VAL . 1.6 p -91.51 103.84 16.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.524 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.493 ' CG2' ' CG2' ' A' ' 52' ' ' THR . 29.2 m -159.26 -177.12 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.305 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.461 ' HE3' ' N ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -112.76 97.59 6.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.511 -179.58 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.442 ' O ' ' N ' ' A' ' 48' ' ' GLY . 1.6 mm -69.54 87.67 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.053 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 39.79 -90.59 0.01 OUTLIER Glycine 0 CA--C 1.521 0.466 0 CA-C-N 116.066 -0.516 . . . . 0.0 113.53 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . -38.38 -82.76 0.01 OUTLIER Glycine 0 C--N 1.334 0.467 0 C-N-CA 121.542 -0.361 . . . . 0.0 113.502 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.461 ' N ' ' HE3' ' A' ' 45' ' ' MET . 1.9 mt-10 -135.35 165.96 32.41 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-O 120.898 0.38 . . . . 0.0 111.581 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.415 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 51.4 Cg_exo -54.28 99.74 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.769 2.313 . . . . 0.0 113.032 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.503 ' CE1' HG23 ' A' ' 3' ' ' THR . 6.2 t80 -173.24 153.06 2.37 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.667 179.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.496 ' N ' ' CD1' ' A' ' 51' ' ' TYR . 0.8 OUTLIER -136.79 153.21 50.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.623 179.201 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.461 ' CD2' ' CD1' ' A' ' 4' ' ' ILE . 0.6 OUTLIER -80.93 -172.92 3.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.165 -179.879 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.408 ' O ' ' CE2' ' A' ' 56' ' ' PHE . . . -124.65 98.09 0.55 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.037 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.43 HD11 ' CB ' ' A' ' 6' ' ' CYS . 3.5 mm? -51.54 123.68 10.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.812 0.339 . . . . 0.0 111.053 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.408 ' CE2' ' O ' ' A' ' 54' ' ' GLY . 45.0 m-85 -113.6 118.75 35.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.786 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.41 ' HB2' ' CD ' ' A' ' 16' ' ' LYS . 35.6 p-10 -121.66 -176.57 3.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.119 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 75.7 p -124.52 130.83 53.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.923 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.43 ' CB ' HG22 ' A' ' 36' ' ' VAL . . . -140.93 -167.47 2.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.004 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.16 44.51 0.58 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.656 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.445 HD12 ' CB ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -121.33 -158.11 0.75 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.702 0.287 . . . . 0.0 110.898 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -62.84 -34.96 78.42 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.341 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.453 ' HB3' ' CD1' ' A' ' 64' ' ' TYR . 0.5 OUTLIER -47.37 -58.0 4.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.079 -179.848 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.453 ' CD1' ' HB3' ' A' ' 63' ' ' ASP . 0.1 OUTLIER -175.2 100.58 0.08 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.721 179.778 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.24 -21.91 39.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.158 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.42 ' HG2' ' N ' ' A' ' 67' ' ' LEU . 0.1 OUTLIER -88.29 -29.1 20.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.129 -179.852 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.42 ' N ' ' HG2' ' A' ' 66' ' ' ARG . 20.8 mt 51.86 -153.23 0.21 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.486 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.423 ' O ' ' N ' ' A' ' 71' ' ' SER . 0.3 OUTLIER 179.56 -56.87 0.0 OUTLIER Pre-proline 0 C--N 1.333 -0.152 0 CA-C-O 120.731 0.3 . . . . 0.0 111.427 -179.992 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -42.23 -27.99 0.81 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.673 2.249 . . . . 0.0 112.799 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.89 -31.18 22.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.903 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.423 ' N ' ' O ' ' A' ' 68' ' ' ARG . 35.0 t -47.45 -71.19 0.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.158 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.455 ' CD1' ' N ' ' A' ' 72' ' ' TYR . 0.0 OUTLIER 176.67 64.72 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.047 -179.855 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.98 172.9 11.99 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.51 2.14 . . . . 0.0 112.149 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 16.3 tp60 -87.98 10.2 19.71 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.495 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 12.3 t -52.35 161.13 0.7 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.783 0.325 . . . . 0.0 110.819 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -122.82 5.16 9.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.468 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.0 t -140.48 97.81 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.782 0.325 . . . . 0.0 111.117 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -95.59 -177.97 4.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.71 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.7 tp -147.35 108.8 4.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.255 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.0 m -95.09 131.02 43.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.359 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 2.6 m -127.08 134.67 50.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.922 0.391 . . . . 0.0 111.42 -179.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -148.06 132.47 17.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.546 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.421 ' CA ' ' HG3' ' A' ' 116' ' ' GLN . 0.5 OUTLIER -83.84 133.14 34.76 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.251 -179.675 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.446 HG12 ' N ' ' A' ' 137' ' ' ILE . 59.5 t -42.45 -67.75 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.566 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.435 ' CA ' HD22 ' A' ' 129' ' ' LEU . 28.5 m -37.03 111.17 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-O 120.75 0.31 . . . . 0.0 111.379 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.42 ' N ' HD22 ' A' ' 129' ' ' LEU . 0.1 OUTLIER -151.5 139.24 12.62 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.828 -179.064 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.426 ' O ' ' CB ' ' A' ' 132' ' ' ASN . 91.6 Cg_endo -91.02 53.19 0.93 Allowed 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 123.189 2.592 . . . . 0.0 111.681 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.451 ' CA ' ' HB2' ' A' ' 133' ' ' LYS . 0.1 OUTLIER 70.68 19.45 6.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.077 -179.521 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.4 m -97.23 -23.37 16.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.964 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -47.1 -48.48 22.87 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.183 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -51.94 -40.4 60.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.991 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -76.62 -36.55 57.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.933 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.473 ' O ' ' CG ' ' A' ' 97' ' ' TRP . 62.9 t -51.09 -57.25 3.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.291 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.432 ' HG2' ' CD1' ' A' ' 145' ' ' LEU . 3.8 mptp? -73.6 -32.35 64.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.118 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -64.72 -23.99 67.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.093 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 13.5 ptmt -108.35 -17.67 13.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.4 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.473 ' CG ' ' O ' ' A' ' 93' ' ' VAL . 34.0 m0 -76.83 -54.4 6.65 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.765 0.317 . . . . 0.0 111.078 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.492 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 42.6 t -47.18 -50.15 48.55 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.841 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.492 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 62.2 Cg_endo -72.98 -16.19 25.81 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.145 1.897 . . . . 0.0 112.549 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -85.5 -39.63 17.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.906 0.384 . . . . 0.0 110.933 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 40.8 pt -71.58 -32.93 47.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.05 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 11.0 p -80.26 -32.69 38.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.908 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -64.73 -50.09 68.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.685 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -76.03 -33.08 59.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.855 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 41.6 m -125.92 101.18 29.68 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.832 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -44.33 93.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.55 2.167 . . . . 0.0 112.49 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.2 mmmm 53.95 103.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.85 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.55 129.21 15.22 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.753 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -60.2 162.82 15.91 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.448 2.099 . . . . 0.0 112.25 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.479 ' CE2' ' HB2' ' A' ' 151' ' ' ALA . 7.6 p90 -162.9 150.57 13.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.947 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.429 ' CD1' HG11 ' A' ' 152' ' ' VAL . 9.7 tt -120.51 150.67 40.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.063 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.435 HD11 ' CB ' ' A' ' 146' ' ' ALA . 20.0 mt -108.03 156.19 19.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.813 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.431 ' CG1' HG13 ' A' ' 168' ' ' VAL . 3.8 t -130.92 148.82 33.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.913 0.387 . . . . 0.0 111.44 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.427 ' HA3' ' CZ ' ' A' ' 154' ' ' TYR . . . -123.54 84.85 0.37 Allowed Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.266 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.42 ' HB ' ' HA ' ' A' ' 158' ' ' SER . 0.7 OUTLIER -106.52 7.32 30.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.657 0.265 . . . . 0.0 111.667 -179.558 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.429 ' CB ' HG23 ' A' ' 84' ' ' VAL . 0.7 OUTLIER -98.07 -17.05 19.33 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.628 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.445 HD12 ' N ' ' A' ' 118' ' ' ASP . 0.2 OUTLIER -48.75 -24.11 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.831 179.238 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.445 ' N ' HD12 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -75.14 -22.14 58.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.163 -179.749 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.41 ' O ' ' N ' ' A' ' 122' ' ' ASP . 4.5 pp -122.45 -10.04 8.46 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.4 ' O ' ' CD1' ' A' ' 126' ' ' ILE . 0.7 OUTLIER -50.44 -27.18 5.99 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.942 0.401 . . . . 0.0 110.719 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -77.32 -26.62 52.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.529 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 119' ' ' LEU . 9.0 m-20 -50.81 103.92 0.4 Allowed Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.639 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -68.61 -3.99 12.24 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.8 2.334 . . . . 0.0 113.047 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 26.7 t -80.88 -67.42 0.78 Allowed 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.42 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 9.0 m -56.32 -32.74 64.92 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.408 0.623 . . . . 0.0 109.355 178.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.467 ' HA ' ' CD1' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -61.6 -43.33 96.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.466 179.196 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -56.2 -34.51 66.32 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.45 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 125' ' ' THR . 2.2 mptt -65.95 -32.95 74.74 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.467 ' CD1' ' HA ' ' A' ' 126' ' ' ILE . 6.8 mt -71.85 -39.3 69.79 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.449 ' HA ' ' HB3' ' A' ' 134' ' ' GLN . . . -48.01 -26.71 1.89 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.094 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.7 mmtp -64.69 -32.32 73.94 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.579 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.426 ' CB ' ' O ' ' A' ' 87' ' ' PRO . 47.8 m-80 -124.2 -30.99 3.38 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -179.186 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.492 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 0.0 OUTLIER -133.63 -73.16 0.49 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.345 -178.836 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.492 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 2.3 pt20 99.28 -33.42 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.866 0.866 . . . . 0.0 111.089 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -68.61 110.46 5.93 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.774 -178.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.436 ' HB3' ' CD1' ' A' ' 126' ' ' ILE . 72.4 Cg_endo -76.07 123.08 7.05 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.32 2.014 . . . . 0.0 111.355 179.049 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.446 ' N ' HG12 ' A' ' 84' ' ' VAL . 0.8 OUTLIER -57.38 96.36 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.549 -179.696 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.424 ' O ' ' N ' ' A' ' 141' ' ' THR . 0.5 OUTLIER -72.56 150.22 91.2 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.737 -179.808 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.442 ' HG3' ' CG2' ' A' ' 117' ' ' ILE . 97.8 Cg_exo -41.35 -38.34 3.61 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.682 2.255 . . . . 0.0 112.586 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -65.63 -33.36 75.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.004 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.427 ' CG2' HG21 ' A' ' 137' ' ' ILE . 58.5 m -60.15 -63.77 1.18 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.952 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.527 ' CB ' ' CD2' ' A' ' 154' ' ' TYR . . . -48.73 -48.16 40.78 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.807 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -58.98 -37.24 76.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.449 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -60.51 -58.38 8.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.48 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.432 ' CD1' ' HG2' ' A' ' 94' ' ' LYS . 0.5 OUTLIER -63.78 -33.32 75.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.393 179.574 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.435 ' CB ' HD11 ' A' ' 112' ' ' LEU . . . -65.05 -34.39 78.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.697 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -90.5 -25.31 20.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.655 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -57.01 -33.09 66.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.827 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.07 19.49 17.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.14 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt 47.91 40.31 12.58 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.196 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.479 ' HB2' ' CE2' ' A' ' 110' ' ' PHE . . . -58.4 -80.97 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.069 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.429 HG11 ' CD1' ' A' ' 111' ' ' LEU . 55.6 t -160.52 -75.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.744 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 176.07 126.82 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.773 -179.148 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.527 ' CD2' ' CB ' ' A' ' 142' ' ' ALA . 6.0 t80 -96.78 111.02 23.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.08 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 2.6 t -101.76 152.43 5.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.867 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -91.78 127.05 37.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.24 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.429 ' HA ' ' HB3' ' A' ' 163' ' ' LYS . 1.1 p 179.31 126.92 0.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.988 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.42 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 87.7 p -100.38 153.9 18.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.399 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.429 ' CB ' HD21 ' A' ' 165' ' ' LEU . . . -94.09 -35.58 12.49 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.828 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.2 mp -47.5 -41.74 21.54 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.641 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.0 t -112.97 -16.94 12.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.738 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.405 ' O ' ' NE2' ' A' ' 162' ' ' GLN . 0.8 OUTLIER 72.86 70.88 0.13 Allowed 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.837 179.983 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.429 ' HB3' ' HA ' ' A' ' 157' ' ' CYS . 2.1 tttm -87.84 -20.02 26.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.21 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 168.19 37.32 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.74 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.453 ' CD1' ' HA ' ' A' ' 19' ' ' LEU . 0.5 OUTLIER -47.82 -39.62 18.86 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.762 0.315 . . . . 0.0 110.914 179.966 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 13.8 pttp -72.61 -32.92 66.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.793 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -54.56 -70.3 0.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.597 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.431 HG13 ' CG1' ' A' ' 113' ' ' VAL . 7.7 p -53.7 -46.52 62.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.08 0.467 . . . . 0.0 110.358 179.525 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.486 ' CE2' HD13 ' A' ' 19' ' ' LEU . 0.8 OUTLIER -55.37 -34.09 64.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.239 179.324 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.423 ' HA ' ' CG1' ' A' ' 173' ' ' ILE . 52.5 t0 -62.13 -43.65 98.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.277 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -62.48 -28.99 70.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.367 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -78.73 -49.21 13.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.134 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.423 ' CG1' ' HA ' ' A' ' 170' ' ' ASP . 1.5 pp -72.05 -36.84 58.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.344 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -63.08 -32.67 74.1 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.969 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.69 -22.47 62.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.026 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -87.76 -31.41 19.65 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.102 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.481 ' CD1' ' CG2' ' B' ' 510' ' ' ILE . 0.3 OUTLIER -92.7 15.27 14.86 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.278 -179.87 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 176.92 98.11 0.11 Allowed Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.692 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -46.8 102.93 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.654 2.236 . . . . 0.0 112.547 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.26 170.88 19.37 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.59 2.193 . . . . 0.0 112.37 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -146.01 139.28 14.47 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.782 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -77.96 -165.27 0.32 Allowed 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.553 2.168 . . . . 0.0 112.332 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.9 153.95 32.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.879 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 2.3 mtpt . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.892 179.88 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.165 0 N-CA-C 112.458 -0.257 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 503' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.8 -86.62 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.714 0.292 . . . . 0.0 110.726 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 504' ' ' GLY . . . . . 0.464 ' HA2' ' N ' ' B' ' 510' ' ' ILE . . . 63.46 119.75 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.259 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 505' ' ' LEU . . . . . 0.483 ' N ' ' CD2' ' B' ' 505' ' ' LEU . 0.8 OUTLIER -173.66 115.59 0.23 Allowed 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 120.811 0.339 . . . . 0.0 111.818 -178.374 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 506' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 79.0 -74.11 0.06 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.615 179.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 507' ' ' ALA . . . . . 0.422 ' O ' ' CG ' ' B' ' 508' ' ' GLN . . . -35.26 -38.14 0.09 Allowed 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.436 0.636 . . . . 0.0 111.651 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 508' ' ' GLN . . . . . 0.519 ' O ' ' CB ' ' B' ' 509' ' ' ASP . 0.9 OUTLIER 159.47 -33.86 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.768 -1.105 . . . . 0.0 108.747 -179.677 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 509' ' ' ASP . . . . . 0.519 ' CB ' ' O ' ' B' ' 508' ' ' GLN . 27.0 t70 138.13 43.35 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 O-C-N 124.957 1.411 . . . . 0.0 109.704 179.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 510' ' ' ILE . . . . . 0.481 ' CG2' ' CD1' ' A' ' 177' ' ' LEU . 21.9 mm -60.4 107.63 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.701 179.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 511' ' ' SER . . . . . 0.431 ' CB ' ' HG ' ' B' ' 514' ' ' LEU . 3.9 m -101.89 130.07 48.28 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.949 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 512' ' ' GLN . . . . . 0.49 ' CB ' ' HD3' ' B' ' 513' ' ' PRO . 1.2 mm-40 -79.75 -66.87 0.25 Allowed Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.539 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 513' ' ' PRO . . . . . 0.49 ' HD3' ' CB ' ' B' ' 512' ' ' GLN . 79.0 Cg_endo -82.25 56.29 5.72 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.573 2.182 . . . . 0.0 111.84 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 514' ' ' LEU . . . . . 0.467 ' HB2' ' HB ' ' A' ' 44' ' ' VAL . 0.7 OUTLIER -55.53 -84.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.047 -179.583 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 515' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.62 -84.81 0.23 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.828 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -110.68 -36.8 5.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.538 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 517' ' ' SER . . . . . 0.417 ' HA ' ' HB ' ' A' ' 42' ' ' VAL . 15.4 m 52.58 27.23 4.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.205 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 518' ' ' PHE . . . . . 0.464 ' CE2' ' CD1' ' A' ' 21' ' ' ILE . 0.3 OUTLIER -163.54 91.59 0.68 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.365 -179.879 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 519' ' ' ILE . . . . . 0.423 ' CG1' ' O ' ' A' ' 41' ' ' ALA . 4.7 mm -101.35 131.82 48.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.858 0.361 . . . . 0.0 110.901 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -54.16 108.43 0.37 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.993 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 521' ' ' THR . . . . . . . . . . . . . 3.5 m -166.25 143.53 5.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.941 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 522' ' ' GLY . . . . . . . . . . . . . . . 128.47 179.06 15.67 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.552 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 523' ' ' HIS . . . . . . . . . . . . . 74.8 t60 -148.52 -84.12 0.1 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.808 0.337 . . . . 0.0 110.962 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 524' ' ' GLY . . . . . . . . . . . . . . . 57.81 -169.81 4.25 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.595 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 525' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -110.58 88.02 2.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.902 0.382 . . . . 0.0 110.86 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 526' ' ' SER . . . . . . . . . . . . . 35.6 p -77.44 95.59 4.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.786 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 527' ' ' ASP . . . . . 0.484 ' CB ' ' CD ' ' B' ' 528' ' ' PRO . 0.1 OUTLIER -174.32 -64.71 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.956 179.632 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 528' ' ' PRO . . . . . 0.484 ' CD ' ' CB ' ' B' ' 527' ' ' ASP . 20.3 Cg_endo -58.01 78.83 0.04 OUTLIER 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.971 2.447 . . . . 0.0 112.368 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 529' ' ' ARG . . . . . 0.448 ' HD3' ' CG2' ' A' ' 33' ' ' VAL . 7.0 mtt85 -82.8 -31.96 27.94 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.698 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 530' ' ' HIS . . . . . . . . . . . . . 9.4 m170 51.92 24.01 2.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.82 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 16.5 p 41.78 -163.8 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.377 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 532' ' ' TRP . . . . . 0.484 ' CZ2' ' HA ' ' B' ' 537' ' ' ARG . 34.9 t-105 -169.48 127.82 0.96 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.982 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . -159.62 35.4 0.47 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.234 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 534' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -109.66 161.62 23.45 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 120.708 0.289 . . . . 0.0 111.065 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -57.38 -57.44 1.26 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.622 2.215 . . . . 0.0 112.203 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -123.38 157.82 32.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.011 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 537' ' ' ARG . . . . . 0.484 ' HA ' ' CZ2' ' B' ' 532' ' ' TRP . 24.6 mmt180 -66.94 145.48 55.39 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.153 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 538' ' ' ILE . . . . . 0.445 ' CG2' HD12 ' B' ' 543' ' ' LEU . 5.8 tp -59.93 143.71 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.633 179.088 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 539' ' ' ASP . . . . . 0.453 ' O ' ' CD1' ' B' ' 543' ' ' LEU . 1.1 m-20 -42.7 128.33 4.08 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.812 0.339 . . . . 0.0 111.786 -179.05 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 540' ' ' GLU . . . . . 0.463 ' HA ' ' CD1' ' B' ' 543' ' ' LEU . 41.0 mm-40 -40.95 -24.47 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.27 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 541' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -31.12 -69.6 0.07 Allowed 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -179.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 542' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -104.45 -64.74 1.08 Allowed 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -178.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 543' ' ' LEU . . . . . 0.463 ' CD1' ' HA ' ' B' ' 540' ' ' GLU . 10.2 mp 58.37 179.5 0.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.739 0.304 . . . . 0.0 110.388 -178.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . -172.91 -54.84 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.503 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 545' ' ' ASN . . . . . . . . . . . . . 42.6 p30 . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.81 179.877 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.422 ' CE ' ' HB ' ' A' ' 46' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.873 0.368 . . . . 0.0 111.107 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.432 ' O ' ' CD2' ' A' ' 177' ' ' LEU . 5.4 tt0 -174.71 130.66 0.33 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.695 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.464 ' OG1' ' CD1' ' A' ' 51' ' ' TYR . 0.6 OUTLIER -116.86 -173.7 2.44 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.246 -179.591 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.512 ' CD1' ' N ' ' A' ' 4' ' ' ILE . 0.1 OUTLIER -151.38 163.27 2.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.769 -178.541 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.65 156.23 17.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.766 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.454 ' SG ' ' CZ ' ' A' ' 169' ' ' PHE . 0.0 OUTLIER -118.57 141.51 48.52 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.278 -179.755 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.1 t -148.34 159.77 7.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.669 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.432 HG13 ' N ' ' A' ' 9' ' ' VAL . 16.3 t -119.38 151.76 21.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.238 0.542 . . . . 0.0 111.753 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.432 ' N ' HG13 ' A' ' 8' ' ' VAL . 86.2 t -156.19 130.05 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.044 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.89 -140.52 14.74 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.197 -1.002 . . . . 0.0 112.836 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -123.23 27.85 7.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.657 0.265 . . . . 0.0 110.934 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -118.23 177.54 16.53 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.961 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.412 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -103.51 -26.85 12.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.775 0.322 . . . . 0.0 111.515 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.44 ' CG1' HG21 ' A' ' 113' ' ' VAL . 54.1 t -43.12 94.58 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 121.006 0.431 . . . . 0.0 111.418 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.447 ' HA2' ' CE1' ' A' ' 169' ' ' PHE . . . 132.89 -23.47 3.94 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.026 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.7 mttt -90.3 -159.13 0.58 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.767 0.318 . . . . 0.0 110.709 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.439 ' HB ' ' CG1' ' A' ' 21' ' ' ILE . 31.5 p -66.46 -44.91 81.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.392 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 43.3 t -33.26 -58.54 0.39 Allowed 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -179.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.526 ' CD1' ' CD1' ' A' ' 169' ' ' PHE . 13.8 mt -42.2 -67.93 0.23 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.718 -179.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.468 ' N ' ' CD2' ' A' ' 20' ' ' LEU . 1.5 mm? -72.43 -25.73 61.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.444 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.439 ' CG1' ' HB ' ' A' ' 17' ' ' THR . 20.7 mm -70.83 -68.2 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.765 0.317 . . . . 0.0 110.565 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 27.1 t -57.77 -25.74 60.92 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.983 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.429 ' HB2' ' CD1' ' A' ' 165' ' ' LEU . 4.4 t80 -80.1 -68.52 0.67 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.005 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 97.8 m -70.26 -48.64 55.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.031 0.444 . . . . 0.0 110.658 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.433 ' N ' ' O ' ' A' ' 21' ' ' ILE . 0.2 OUTLIER -77.48 -156.04 0.08 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.646 179.876 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -149.7 40.13 0.81 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.719 0.295 . . . . 0.0 110.805 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.4 mtmt -133.51 126.88 32.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.969 0.414 . . . . 0.0 111.369 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.488 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . 3.6 t80 -163.66 -53.44 0.01 OUTLIER Pre-proline 0 CA--C 1.536 0.437 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.947 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.488 ' HD3' ' HB3' ' A' ' 28' ' ' PHE . 5.7 Cg_exo -79.55 56.44 6.05 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.774 2.316 . . . . 0.0 112.418 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.7 m -143.54 -80.03 0.2 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.755 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -157.69 162.43 38.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.593 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.471 ' OH ' ' CD1' ' A' ' 28' ' ' PHE . 9.3 m-85 -131.55 94.6 3.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.967 0.413 . . . . 0.0 111.108 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.446 ' CG1' ' HG3' ' B' ' 529' ' ' ARG . 0.2 OUTLIER -133.05 -56.2 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.666 179.703 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.464 ' O ' ' CZ ' ' A' ' 37' ' ' PHE . 7.8 Cg_exo -72.17 59.08 2.99 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.346 2.031 . . . . 0.0 111.983 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.8 t -120.53 21.89 11.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.88 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.429 ' HA ' ' CB ' ' A' ' 59' ' ' ALA . 2.4 t -83.84 -4.75 8.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.648 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.464 ' CZ ' ' O ' ' A' ' 34' ' ' PRO . 4.2 m-85 -46.03 -27.7 1.0 Allowed 'General case' 0 N--CA 1.461 0.099 0 CA-C-O 120.813 0.34 . . . . 0.0 111.108 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.8 t0 69.26 33.07 3.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.642 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.422 ' CB ' ' O ' ' A' ' 55' ' ' LEU . 8.3 m120 52.01 87.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.609 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.475 ' OH ' ' CZ ' ' B' ' 518' ' ' PHE . 3.2 p90 -59.98 -175.73 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.707 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -90.77 160.5 15.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.055 0.455 . . . . 0.0 111.823 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.4 ' HA ' HG12 ' B' ' 519' ' ' ILE . 3.5 m -127.25 128.19 69.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.621 179.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.432 ' CG2' HD13 ' B' ' 519' ' ' ILE . 59.1 p -85.59 104.76 15.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.943 0.401 . . . . 0.0 111.17 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.468 ' CG2' ' CG2' ' A' ' 52' ' ' THR . 20.7 m -157.79 -177.7 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.859 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.477 ' HE3' ' CA ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -128.03 116.93 20.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.349 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.445 ' O ' ' N ' ' A' ' 48' ' ' GLY . 0.8 OUTLIER -81.98 87.65 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.676 0.274 . . . . 0.0 111.668 -179.865 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 56.87 -78.08 0.01 OUTLIER Glycine 0 C--N 1.333 0.374 0 CA-C-N 116.105 -0.498 . . . . 0.0 113.776 178.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . -54.0 -99.78 0.01 OUTLIER Glycine 0 C--N 1.331 0.285 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.979 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.477 ' CA ' ' HE3' ' A' ' 45' ' ' MET . 0.6 OUTLIER -119.72 164.26 22.99 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 120.878 0.37 . . . . 0.0 111.396 -179.617 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.76 100.93 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.699 2.266 . . . . 0.0 112.596 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.464 ' CD1' ' OG1' ' A' ' 3' ' ' THR . 12.3 t80 -172.84 106.61 0.16 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.361 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.468 ' CG2' ' CG2' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -124.43 153.78 41.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.939 0.399 . . . . 0.0 111.038 -179.92 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.446 HD13 ' CA ' ' A' ' 4' ' ' ILE . 82.7 mt -113.44 100.0 8.19 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.863 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -46.17 164.13 0.11 Allowed Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.396 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.422 ' O ' ' CB ' ' A' ' 39' ' ' ASN . 2.4 mp -79.66 152.87 29.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.71 0.29 . . . . 0.0 110.847 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.422 ' CB ' ' O ' ' A' ' 6' ' ' CYS . 0.3 OUTLIER -103.32 122.05 44.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.524 -179.52 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.65 167.0 17.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.36 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.446 ' HB ' ' CD2' ' A' ' 67' ' ' LEU . 0.2 OUTLIER -149.41 128.72 12.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.905 0.383 . . . . 0.0 111.122 -179.444 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.429 ' CB ' ' HA ' ' A' ' 36' ' ' VAL . . . -144.86 100.73 3.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.664 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.65 83.05 0.38 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.717 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.428 HD13 ' CG2' ' A' ' 36' ' ' VAL . 3.9 mp -121.5 -108.36 0.35 Allowed 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.564 0.182 . . . . 0.0 111.027 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -99.03 -30.02 12.57 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 120.827 0.346 . . . . 0.0 111.167 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.9 -63.32 1.19 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.442 -179.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.41 ' HB2' ' HB3' ' A' ' 67' ' ' LEU . 0.4 OUTLIER -107.62 120.6 42.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.94 -179.624 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -87.16 -53.39 4.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 112.029 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.21 8.8 44.28 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -178.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.446 ' CD2' ' HB ' ' A' ' 58' ' ' THR . 0.0 OUTLIER -47.46 110.68 0.33 Allowed 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 120.728 0.299 . . . . 0.0 110.667 179.625 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.404 ' HG2' HD21 ' B' ' 541' ' ' LEU . 0.0 OUTLIER -149.97 70.92 9.45 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.235 -179.788 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.412 ' CG ' HG23 ' A' ' 58' ' ' THR . 88.9 Cg_endo -81.02 -37.07 0.33 Allowed 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.591 2.194 . . . . 0.0 112.455 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.443 ' CD2' ' HB2' ' B' ' 541' ' ' LEU . 0.1 OUTLIER -58.83 -18.2 30.36 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.002 -179.939 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.472 ' HB3' ' CD2' ' A' ' 72' ' ' TYR . 0.3 OUTLIER -43.34 -50.44 6.7 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.389 -179.962 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.472 ' CD2' ' HB3' ' A' ' 71' ' ' SER . 5.6 p90 -165.2 70.9 1.39 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.289 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -70.01 153.36 67.85 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.881 2.387 . . . . 0.0 112.063 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 -102.42 10.28 39.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.568 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 14.1 t -57.49 178.63 0.07 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.844 0.354 . . . . 0.0 110.986 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -115.85 -18.74 10.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.282 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.5 m -118.94 91.1 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.755 0.312 . . . . 0.0 111.284 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -81.14 121.64 26.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.486 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.434 ' CD1' HG11 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -83.48 108.52 16.67 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.953 0.406 . . . . 0.0 111.236 -179.675 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.401 HG21 ' HB2' ' A' ' 110' ' ' PHE . 3.3 m -110.25 100.7 11.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.887 179.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.402 ' HB3' HG23 ' A' ' 14' ' ' VAL . 0.5 OUTLIER -113.37 146.94 38.65 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.536 -179.187 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.439 ' CD1' ' C ' ' A' ' 82' ' ' PHE . 6.3 p90 -155.48 143.05 19.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.216 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.96 133.4 35.3 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.112 0.482 . . . . 0.0 111.188 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.49 ' CG1' ' N ' ' A' ' 137' ' ' ILE . 89.2 t -48.5 -69.6 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.551 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.406 ' HB ' HG23 ' A' ' 125' ' ' THR . 16.0 m -40.84 110.45 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 120.742 0.306 . . . . 0.0 111.332 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.485 ' N ' ' CD2' ' A' ' 129' ' ' LEU . 52.4 p -154.36 134.03 7.69 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.772 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.408 ' O ' ' HB2' ' A' ' 133' ' ' LYS . 20.0 Cg_endo -61.21 -81.76 0.01 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 121.909 1.739 . . . . 0.0 111.408 179.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.9 t -144.87 24.55 1.49 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.832 0.349 . . . . 0.0 110.966 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.7 t -93.44 -21.88 19.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.176 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.439 ' CZ ' HG22 ' A' ' 137' ' ' ILE . 24.9 t80 -48.41 -49.01 36.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.178 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -57.84 -40.6 80.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.996 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 17.5 m-20 -67.42 -50.03 61.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.903 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.474 HG11 ' CE2' ' A' ' 97' ' ' TRP . 47.2 t -51.47 -52.37 20.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.193 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.3 tttp -52.31 -54.68 28.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.022 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -78.66 3.11 17.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.829 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.5 ttmm -115.2 -19.07 10.96 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.721 0.296 . . . . 0.0 111.184 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.474 ' CE2' HG11 ' A' ' 93' ' ' VAL . 27.9 m0 -93.74 -51.4 4.93 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.199 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.501 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 16.8 t -49.68 -44.98 78.71 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.706 -179.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.501 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 3.6 Cg_exo -74.88 -16.49 20.51 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.641 2.228 . . . . 0.0 112.612 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -90.19 -53.64 4.37 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.841 0.353 . . . . 0.0 110.976 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.514 ' CD1' ' CE2' ' A' ' 110' ' ' PHE . 1.0 OUTLIER -56.61 -24.2 18.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.151 179.997 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.7 p -88.8 -45.66 9.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.861 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -50.13 -32.68 16.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.959 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -79.52 -26.97 41.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.021 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -151.59 104.88 2.89 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.977 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -49.67 108.8 0.22 Allowed 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.397 2.065 . . . . 0.0 112.09 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 67.7 93.07 0.08 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.747 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.05 119.4 10.5 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.034 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -60.67 154.4 55.1 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.534 2.156 . . . . 0.0 112.438 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.514 ' CE2' ' CD1' ' A' ' 101' ' ' ILE . 1.2 p90 -151.53 147.85 27.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.864 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.424 HD12 ' N ' ' A' ' 172' ' ' ALA . 0.8 OUTLIER -110.38 160.67 16.37 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.417 -179.595 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -123.48 161.19 25.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.586 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.44 HG21 ' CG1' ' A' ' 14' ' ' VAL . 21.6 t -139.6 143.57 30.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.974 0.416 . . . . 0.0 111.912 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.442 ' O ' ' CD1' ' A' ' 117' ' ' ILE . . . -119.54 92.03 0.52 Allowed Glycine 0 C--N 1.331 0.297 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.005 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.25 9.51 13.48 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -178.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.454 ' HB2' ' CG2' ' A' ' 84' ' ' VAL . 1.9 mm-40 -114.74 11.97 16.94 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.879 0.371 . . . . 0.0 110.323 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.442 ' CD1' ' O ' ' A' ' 114' ' ' GLY . 0.1 OUTLIER -57.97 -17.37 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.718 179.043 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -100.13 -17.3 17.48 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.544 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.435 ' CD1' ' HA ' ' A' ' 116' ' ' GLN . 5.5 mp -91.79 -32.58 15.31 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.775 0.321 . . . . 0.0 110.992 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.415 ' CB ' ' HB2' ' A' ' 136' ' ' PRO . 1.0 OUTLIER -42.44 -52.42 4.66 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.361 -179.916 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.49 -42.59 98.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.58 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -45.37 102.79 0.31 Allowed Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.886 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.445 ' HA ' ' CG2' ' A' ' 126' ' ' ILE . 42.8 Cg_endo -68.6 -6.88 18.86 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.409 2.073 . . . . 0.0 112.947 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.34 -66.15 0.58 Allowed 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.045 0.45 . . . . 0.0 109.853 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.455 ' O ' ' N ' ' A' ' 128' ' ' LYS . 49.2 m -60.62 -49.37 77.79 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.445 ' CG2' ' HA ' ' A' ' 123' ' ' PRO . 0.0 OUTLIER -47.3 -36.98 4.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.001 179.566 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.59 -40.85 98.23 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.455 ' N ' ' O ' ' A' ' 125' ' ' THR . 0.2 OUTLIER -65.06 -33.73 76.74 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 177.992 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.488 HD11 ' N ' ' A' ' 129' ' ' LEU . 7.3 mp -68.83 -40.65 79.33 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 177.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -44.9 -31.37 1.23 Allowed 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.587 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -51.41 -27.27 9.63 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.986 179.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.468 ' O ' ' CG ' ' A' ' 133' ' ' LYS . 1.2 m-80 -123.3 -34.67 3.08 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.211 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.484 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 46.7 mttt -169.65 -86.21 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 O-C-N 123.107 0.255 . . . . 0.0 111.641 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.484 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 0.1 OUTLIER 102.49 106.7 0.01 OUTLIER 'General case' 0 C--N 1.351 0.638 0 C-N-CA 124.37 1.068 . . . . 0.0 110.38 -179.284 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.5 mmtm -159.38 92.44 1.84 Allowed Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.329 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.415 ' HB2' ' CB ' ' A' ' 120' ' ' ARG . 21.1 Cg_endo -62.12 103.22 0.29 Allowed 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 122.252 1.968 . . . . 0.0 112.306 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.49 ' N ' ' CG1' ' A' ' 84' ' ' VAL . 1.5 mm -45.31 106.56 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.443 179.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.421 ' O ' ' N ' ' A' ' 141' ' ' THR . 1.6 p -67.19 141.25 96.07 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.342 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -40.42 -29.77 0.42 Allowed 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.901 2.4 . . . . 0.0 112.015 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.35 -41.12 94.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.556 179.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.427 ' HB ' ' CG2' ' A' ' 137' ' ' ILE . 47.0 m -57.39 -66.61 0.43 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.009 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -47.7 -49.31 28.27 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.887 0.375 . . . . 0.0 110.919 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -64.16 -33.92 76.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.432 179.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 15.6 tttt -73.71 -46.63 44.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.631 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 14.5 tp -68.24 -39.91 82.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.208 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -62.11 -35.82 79.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.666 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.7 mtp180 -90.32 -29.86 17.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.666 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -50.79 -29.52 11.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.733 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.5 mt -123.02 21.09 9.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.91 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 45.5 mttt 48.08 52.24 13.45 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.943 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.471 ' O ' ' CG2' ' A' ' 152' ' ' VAL . . . -59.17 -83.37 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.032 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.471 ' CG2' ' O ' ' A' ' 151' ' ' ALA . 19.1 t -166.33 -68.38 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.285 179.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.04 144.04 2.06 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.144 0.497 . . . . 0.0 111.824 -179.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -135.96 102.57 5.08 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.434 ' HB ' ' CG2' ' A' ' 168' ' ' VAL . 2.3 t -105.93 167.87 3.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.328 -178.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -89.58 118.6 29.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.126 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.431 ' O ' ' CD1' ' A' ' 117' ' ' ILE . 17.9 p -144.92 -175.79 4.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.174 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.423 ' CB ' HG23 ' A' ' 161' ' ' THR . 3.1 m -159.61 158.29 31.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.965 0.412 . . . . 0.0 111.576 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -115.44 -33.41 5.27 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.464 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.19 -34.85 32.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.65 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.423 HG23 ' CB ' ' A' ' 158' ' ' SER . 5.0 t -113.0 -24.65 9.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.925 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 72.6 93.92 0.08 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.045 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -124.93 33.11 5.27 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.133 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 120.87 47.79 0.31 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.762 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.429 ' CD1' ' HB2' ' A' ' 23' ' ' TYR . 0.8 OUTLIER -56.52 -56.24 23.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.822 0.344 . . . . 0.0 110.745 179.838 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.403 ' O ' ' CB ' ' A' ' 170' ' ' ASP . 4.8 pttt -63.44 -29.14 70.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.805 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -51.54 -72.31 0.05 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.9 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.434 ' CG2' ' HB ' ' A' ' 155' ' ' VAL . 61.8 t -56.59 -53.36 42.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.994 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.526 ' CD1' ' CD1' ' A' ' 19' ' ' LEU . 3.2 t80 -53.24 -35.82 60.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.871 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.403 ' CB ' ' O ' ' A' ' 166' ' ' LYS . 5.3 m-20 -61.4 -40.34 94.02 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.915 0.388 . . . . 0.0 109.995 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -60.6 -34.89 74.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.163 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.424 ' N ' HD12 ' A' ' 111' ' ' LEU . . . -62.01 -65.0 0.76 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.68 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 1.4 pp -59.76 -41.53 85.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.985 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.436 HD23 ' N ' ' B' ' 505' ' ' LEU . 5.2 tp -60.37 -43.77 96.25 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.006 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -54.61 -22.33 13.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.943 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -86.49 -37.78 17.92 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.122 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.482 ' CD1' ' CG2' ' B' ' 510' ' ' ILE . 1.9 mt -72.94 -35.88 67.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.897 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -141.79 139.46 18.42 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.949 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.83 111.61 2.87 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.545 2.163 . . . . 0.0 112.286 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -64.35 167.05 15.55 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.355 2.036 . . . . 0.0 112.211 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -102.79 96.38 7.61 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.142 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -76.64 -164.93 0.28 Allowed 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.702 2.268 . . . . 0.0 112.208 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.53 83.16 4.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.901 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 14.6 mttm . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.892 179.967 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.174 0 N-CA-C 112.435 -0.266 . . . . 0.0 112.435 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 503' ' ' SER . . . . . . . . . . . . . 1.4 m -61.39 -177.23 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.812 0.339 . . . . 0.0 110.799 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 504' ' ' GLY . . . . . . . . . . . . . . . -99.78 65.27 0.62 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.387 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 505' ' ' LEU . . . . . 0.449 ' HA ' ' HB ' ' B' ' 510' ' ' ILE . 0.3 OUTLIER -108.92 159.89 16.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.05 0.453 . . . . 0.0 111.197 -179.971 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 506' ' ' SER . . . . . 0.401 ' HB3' HD12 ' A' ' 174' ' ' LEU . 11.3 t 165.8 -44.63 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.539 -179.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 507' ' ' ALA . . . . . . . . . . . . . . . -47.98 -28.31 2.68 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.159 178.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 508' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 167.17 -31.82 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.373 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 509' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 172.2 37.58 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.927 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 510' ' ' ILE . . . . . 0.482 ' CG2' ' CD1' ' A' ' 177' ' ' LEU . 46.9 mm -67.53 103.24 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.913 0.387 . . . . 0.0 111.286 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 511' ' ' SER . . . . . . . . . . . . . 2.1 m -101.43 131.79 47.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.921 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 512' ' ' GLN . . . . . 0.468 ' CB ' ' HD3' ' B' ' 513' ' ' PRO . 0.4 OUTLIER -93.41 -64.28 0.14 Allowed Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.144 -179.919 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 513' ' ' PRO . . . . . 0.468 ' HD3' ' CB ' ' B' ' 512' ' ' GLN . 89.4 Cg_endo -81.36 67.88 8.35 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.516 2.144 . . . . 0.0 112.521 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 514' ' ' LEU . . . . . 0.44 ' CD1' ' O ' ' A' ' 45' ' ' MET . 0.4 OUTLIER -81.16 -85.21 0.1 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.914 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 515' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -93.22 -158.9 0.64 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.671 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -46.97 -27.85 1.42 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.026 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 517' ' ' SER . . . . . . . . . . . . . 3.0 m 40.65 42.72 1.45 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.719 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 518' ' ' PHE . . . . . 0.475 ' CZ ' ' OH ' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -163.76 91.88 0.67 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.927 -179.951 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 519' ' ' ILE . . . . . 0.432 HD13 ' CG2' ' A' ' 43' ' ' THR . 6.2 mm -87.89 -33.74 6.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.748 0.309 . . . . 0.0 111.18 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 520' ' ' HIS . . . . . 0.457 ' HA ' ' CE2' ' A' ' 40' ' ' TYR . 0.7 OUTLIER 69.72 119.37 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.898 179.994 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 521' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -165.98 51.83 0.09 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.981 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 522' ' ' GLY . . . . . . . . . . . . . . . -138.26 157.62 24.51 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.445 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 523' ' ' HIS . . . . . . . . . . . . . 69.4 t60 -132.61 -84.74 0.47 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.662 0.268 . . . . 0.0 111.028 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 524' ' ' GLY . . . . . . . . . . . . . . . 66.22 176.67 7.14 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.465 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 525' ' ' ASP . . . . . 0.422 ' CB ' HD21 ' A' ' 61' ' ' LEU . 2.0 t0 -75.05 87.42 2.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.89 0.376 . . . . 0.0 110.837 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 526' ' ' SER . . . . . 0.419 ' CB ' ' HB3' ' A' ' 34' ' ' PRO . 1.1 m -89.62 95.98 10.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.884 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 527' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -159.13 145.71 12.58 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.939 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -68.83 105.59 1.35 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.705 2.27 . . . . 0.0 112.348 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 529' ' ' ARG . . . . . 0.446 ' HG3' ' CG1' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -100.31 -55.13 2.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.051 -179.885 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 530' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -165.89 97.63 0.64 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.846 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 95.5 m -46.27 171.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.121 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 532' ' ' TRP . . . . . 0.483 ' CZ2' ' HG3' ' B' ' 537' ' ' ARG . 0.0 OUTLIER -49.65 158.03 0.5 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.0 -179.886 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . -155.71 -56.82 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.534 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 534' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -94.35 142.73 25.25 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.742 0.306 . . . . 0.0 111.052 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.29 74.09 1.56 Allowed 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.63 2.22 . . . . 0.0 112.308 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 2.8 p30 172.73 143.56 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.671 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 537' ' ' ARG . . . . . 0.483 ' HG3' ' CZ2' ' B' ' 532' ' ' TRP . 2.0 mpt_? -92.85 179.93 5.32 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.203 0.525 . . . . 0.0 111.172 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 538' ' ' ILE . . . . . 0.438 HG13 ' HB2' ' B' ' 542' ' ' TYR . 5.0 tp -118.06 134.87 60.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.196 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 539' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -50.86 145.19 7.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.61 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 540' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -45.69 -44.72 13.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.454 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 541' ' ' LEU . . . . . 0.492 HD23 ' CE1' ' B' ' 542' ' ' TYR . 1.7 tt -48.43 -40.28 25.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.432 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 542' ' ' TYR . . . . . 0.492 ' CE1' HD23 ' B' ' 541' ' ' LEU . 63.2 m-85 -102.49 9.25 39.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.931 -179.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 543' ' ' LEU . . . . . . . . . . . . . 3.1 tp -58.64 95.74 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.781 0.324 . . . . 0.0 110.71 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . 176.23 89.09 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.506 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 545' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.854 179.935 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.45 ' CE ' HG22 ' A' ' 46' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.375 0 CA-C-O 120.761 0.315 . . . . 0.0 111.222 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -111.19 127.03 55.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.219 0.533 . . . . 0.0 110.948 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.483 HG23 ' N ' ' A' ' 4' ' ' ILE . 36.8 m -104.19 158.2 16.61 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.739 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.485 ' CD1' ' N ' ' A' ' 4' ' ' ILE . 0.1 OUTLIER -155.25 160.34 2.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.852 -179.587 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.04 140.43 46.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.631 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.4 p -138.11 124.53 20.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.908 0.385 . . . . 0.0 111.573 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.1 t -114.04 136.57 50.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.45 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.8 p -84.84 113.52 23.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.952 0.406 . . . . 0.0 111.125 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.0 p -117.69 129.57 73.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.893 178.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.485 ' HA2' ' CE2' ' A' ' 97' ' ' TRP . . . 133.57 -160.35 23.97 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.267 -0.968 . . . . 0.0 112.455 -179.289 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -92.9 21.99 5.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.726 0.298 . . . . 0.0 111.047 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.14 160.2 51.05 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.538 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.452 ' O ' ' HB ' ' A' ' 14' ' ' VAL . . . -53.27 -57.3 11.0 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.489 0.185 . . . . 0.0 111.296 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.452 ' HB ' ' O ' ' A' ' 13' ' ' ALA . 2.6 p 154.88 94.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 O-C-N 123.75 0.656 . . . . 0.0 109.908 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.435 ' HA2' ' CD1' ' A' ' 19' ' ' LEU . . . -47.82 -22.79 2.11 Favored Glycine 0 CA--C 1.519 0.305 0 CA-C-N 115.844 -0.616 . . . . 0.0 113.502 -179.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.406 ' HG2' ' HB2' ' A' ' 55' ' ' LEU . 1.6 tmtm? -70.68 -59.74 2.65 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 122.544 -0.386 . . . . 0.0 111.676 -179.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.428 ' CG2' HG23 ' A' ' 35' ' ' THR . 1.2 p -97.34 -39.43 9.22 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -178.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.426 ' CB ' ' O ' ' A' ' 14' ' ' VAL . 44.6 t -33.74 -73.49 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.182 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.494 HD11 ' CE1' ' A' ' 169' ' ' PHE . 0.3 OUTLIER -65.34 -68.22 0.38 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.827 -179.377 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.409 ' O ' ' N ' ' A' ' 23' ' ' TYR . 3.5 mt -49.0 -70.22 0.1 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.802 -179.043 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.426 ' HB ' ' O ' ' A' ' 17' ' ' THR . 1.1 tp -43.09 -48.49 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-O 120.817 0.341 . . . . 0.0 111.619 -179.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.422 ' OG ' ' ND2' ' A' ' 26' ' ' ASN . 35.2 t -62.48 -29.19 70.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.916 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.409 ' N ' ' O ' ' A' ' 20' ' ' LEU . 20.1 t80 -75.34 -37.43 60.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.949 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 10.1 t -87.23 -49.8 7.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.06 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 77.6 p -94.06 -61.77 1.47 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.88 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.422 ' ND2' ' OG ' ' A' ' 22' ' ' SER . 2.4 t-20 72.38 41.46 0.6 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.005 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -100.71 69.75 1.39 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.706 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.485 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 35.3 t80 -86.77 -45.59 0.54 Allowed Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.647 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.485 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 92.7 Cg_endo -82.22 73.41 5.66 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.354 2.036 . . . . 0.0 112.481 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.3 m -172.06 -85.34 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.982 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -158.29 164.57 36.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.016 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.484 ' OH ' ' CD1' ' A' ' 28' ' ' PHE . 10.2 m-85 -130.86 124.17 30.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.471 ' HB ' ' HD3' ' A' ' 34' ' ' PRO . 1.5 t -157.1 -53.61 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.772 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.471 ' HD3' ' HB ' ' A' ' 33' ' ' VAL . 5.4 Cg_exo -74.84 56.4 4.15 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.458 2.105 . . . . 0.0 112.292 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.428 HG23 ' CG2' ' A' ' 17' ' ' THR . 18.7 m -106.95 -20.64 13.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.844 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.489 ' CG1' ' CB ' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -42.38 -65.13 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.767 -0.197 . . . . 0.0 110.863 179.8 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.437 ' O ' ' N ' ' A' ' 39' ' ' ASN . 10.8 m-85 33.92 -88.4 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.684 0.615 . . . . 0.0 112.171 179.091 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.473 ' N ' ' O ' ' A' ' 36' ' ' VAL . 96.9 m-20 65.29 -65.46 0.16 Allowed 'General case' 0 CA--C 1.527 0.087 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.584 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.437 ' N ' ' O ' ' A' ' 37' ' ' PHE . 1.1 p-10 -71.7 -4.49 27.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.772 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.486 ' CZ ' HG22 ' B' ' 521' ' ' THR . 0.4 OUTLIER -59.78 95.36 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.925 0.393 . . . . 0.0 110.302 179.793 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.404 ' O ' HD12 ' B' ' 519' ' ' ILE . . . -90.36 -179.37 5.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.11 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.446 ' HA ' HD12 ' B' ' 519' ' ' ILE . 34.5 m -144.12 161.04 15.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.083 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.8 p -125.48 105.87 9.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.173 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.472 ' CG2' ' CG2' ' A' ' 52' ' ' THR . 19.2 m -156.32 -177.55 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.086 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.48 ' HE1' ' N ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -100.79 97.44 8.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.532 -179.486 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.45 HG22 ' CE ' ' A' ' 1' ' ' MET . 1.5 mm -70.91 91.08 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-O 120.824 0.345 . . . . 0.0 110.242 179.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 38.62 -91.81 0.01 OUTLIER Glycine 0 CA--C 1.519 0.337 0 CA-C-N 116.002 -0.545 . . . . 0.0 113.654 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . -39.85 -82.93 0.01 OUTLIER Glycine 0 C--N 1.333 0.374 0 C-N-CA 121.457 -0.402 . . . . 0.0 113.406 -179.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.48 ' N ' ' HE1' ' A' ' 45' ' ' MET . 2.7 mt-10 -133.99 165.7 34.75 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.786 0.327 . . . . 0.0 111.402 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.415 ' HD2' ' HB3' ' A' ' 49' ' ' GLU . 82.7 Cg_exo -48.36 104.69 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.6 2.2 . . . . 0.0 112.955 -179.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.509 ' CD1' ' N ' ' A' ' 52' ' ' THR . 14.1 t80 -172.46 155.59 3.48 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.275 179.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.509 ' N ' ' CD1' ' A' ' 51' ' ' TYR . 1.8 p -138.31 153.34 49.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.18 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.474 ' CD1' ' CD1' ' A' ' 4' ' ' ILE . 0.3 OUTLIER -110.47 99.36 8.37 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.835 179.716 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -50.97 -179.17 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.366 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.406 ' HB2' ' HG2' ' A' ' 16' ' ' LYS . 1.8 mp -139.72 97.65 3.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.853 0.359 . . . . 0.0 110.565 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -84.28 114.88 22.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.628 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -113.97 -175.56 2.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.376 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.413 ' CB ' ' O ' ' B' ' 540' ' ' GLU . 18.4 p -89.67 -175.73 4.76 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.617 -179.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.489 ' CB ' ' CG1' ' A' ' 36' ' ' VAL . . . -172.26 168.15 5.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.553 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -149.15 21.25 1.23 Allowed Glycine 0 C--N 1.329 0.189 0 C-N-CA 120.384 -0.912 . . . . 0.0 112.759 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.455 ' CG ' HG12 ' A' ' 36' ' ' VAL . 0.2 OUTLIER -121.34 -171.59 2.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.568 0.223 . . . . 0.0 110.777 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -38.24 -31.2 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.877 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.433 ' HB3' ' CD1' ' A' ' 64' ' ' TYR . 0.2 OUTLIER -45.28 -63.18 1.0 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.143 179.875 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.518 ' CD1' ' N ' ' A' ' 64' ' ' TYR . 0.0 OUTLIER 166.82 77.48 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.981 179.777 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -62.48 -22.22 66.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.059 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.45 -21.74 10.7 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.311 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.481 ' CD2' ' N ' ' A' ' 59' ' ' ALA . 3.4 pp -48.02 141.29 6.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.794 0.33 . . . . 0.0 111.058 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.467 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 1.1 ptm180 -158.84 49.58 0.33 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.035 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.467 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 61.4 Cg_endo -74.4 -48.49 0.2 Allowed 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.451 2.1 . . . . 0.0 112.386 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.51 ' CD2' ' N ' ' B' ' 541' ' ' LEU . 0.6 OUTLIER -51.27 -24.43 4.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.966 179.882 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 69.3 m -51.1 -30.13 15.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.854 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.433 ' N ' ' HD3' ' A' ' 73' ' ' PRO . 5.4 t80 177.3 65.04 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.821 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.433 ' HD3' ' N ' ' A' ' 72' ' ' TYR . 13.5 Cg_exo -69.3 154.62 69.3 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.706 2.271 . . . . 0.0 112.302 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.62 10.46 40.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.169 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.4 m -49.5 172.82 0.02 OUTLIER 'General case' 0 C--N 1.334 -0.108 0 CA-C-O 120.849 0.357 . . . . 0.0 110.897 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -113.89 -23.91 9.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.032 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.404 ' O ' ' CG1' ' A' ' 77' ' ' VAL . 7.2 p -130.22 92.38 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.283 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.512 ' CE1' ' CG2' ' A' ' 108' ' ' THR . 15.2 m-85 -80.78 167.32 20.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.623 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 38.8 tp -141.88 109.06 5.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.976 0.417 . . . . 0.0 111.297 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 29.1 m -96.93 126.51 49.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.583 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 1.6 m -116.77 158.95 23.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.161 0.505 . . . . 0.0 111.711 -179.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -147.15 -173.79 4.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.89 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.0 p -138.59 131.58 29.7 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.795 0.331 . . . . 0.0 111.116 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.408 ' O ' HG12 ' A' ' 137' ' ' ILE . 60.9 t -47.57 -72.06 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.186 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.43 HG21 ' NE2' ' A' ' 116' ' ' GLN . 32.6 m -46.58 106.85 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.81 0.338 . . . . 0.0 110.527 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -149.99 137.35 11.49 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.551 -179.175 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.416 ' O ' ' CB ' ' A' ' 88' ' ' SER . 85.1 Cg_endo -91.76 53.29 0.75 Allowed 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.214 2.61 . . . . 0.0 111.778 179.49 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.442 ' CB ' ' HG3' ' A' ' 133' ' ' LYS . 0.1 OUTLIER 81.09 30.65 0.15 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.79 -179.534 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -96.85 -25.94 15.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.063 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.483 ' CE2' HG22 ' A' ' 137' ' ' ILE . 6.4 t80 -50.74 -59.85 3.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.061 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -50.19 -57.88 6.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.9 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -51.35 -62.73 1.44 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.867 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 60.3 t -44.55 -47.12 2.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.414 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.418 ' O ' ' CG2' ' A' ' 98' ' ' VAL . 1.3 tmtt? -53.69 -51.01 64.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.705 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -84.0 6.59 21.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.486 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -110.52 -31.61 7.19 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.69 0.281 . . . . 0.0 111.021 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.485 ' CE2' ' HA2' ' A' ' 10' ' ' GLY . 0.5 OUTLIER -94.11 -44.93 7.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.372 -179.722 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.476 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 79.2 t -50.24 -46.41 83.21 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.575 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 97.5 Cg_endo -81.08 -15.13 10.53 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.288 1.992 . . . . 0.0 112.633 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -89.32 -44.96 9.85 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.872 0.368 . . . . 0.0 110.832 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 7.5 tt -66.48 -30.65 50.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.145 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 38.9 p -83.19 -26.52 30.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.931 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.09 -51.5 53.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.904 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.407 ' O ' ' CE1' ' A' ' 72' ' ' TYR . 27.7 m170 -69.5 -44.31 71.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.979 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.409 ' O ' ' N ' ' A' ' 107' ' ' LYS . 0.6 OUTLIER -111.95 126.65 28.1 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.834 -179.961 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -57.63 81.23 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.475 2.117 . . . . 0.0 112.269 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.409 ' N ' ' O ' ' A' ' 105' ' ' CYS . 0.1 OUTLIER 53.44 97.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.895 -179.993 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.512 ' CG2' ' CE1' ' A' ' 78' ' ' PHE . 0.1 OUTLIER -117.85 141.26 28.86 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.804 179.998 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.02 142.63 98.83 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.553 2.169 . . . . 0.0 112.412 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.476 ' CD2' ' HB3' ' A' ' 151' ' ' ALA . 1.9 p90 -147.78 136.27 21.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.816 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.426 HD13 ' CG1' ' A' ' 152' ' ' VAL . 4.8 tt -110.31 155.16 22.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.127 -179.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.414 ' O ' ' CD2' ' A' ' 111' ' ' LEU . 3.6 mm? -108.98 147.39 32.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.493 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.403 ' HA ' HG13 ' A' ' 168' ' ' VAL . 2.7 t -131.62 147.72 32.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.935 0.397 . . . . 0.0 111.855 -179.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.408 ' O ' ' CD1' ' A' ' 117' ' ' ILE . . . -125.55 100.64 0.6 Allowed Glycine 0 N--CA 1.453 -0.222 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.924 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -116.18 -45.05 2.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.994 0.426 . . . . 0.0 110.894 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.43 ' NE2' HG21 ' A' ' 85' ' ' VAL . 9.3 tt0 -64.96 -10.27 27.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.054 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.432 HG12 ' N ' ' A' ' 118' ' ' ASP . 0.2 OUTLIER -42.93 -27.74 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-O 120.717 0.294 . . . . 0.0 111.626 179.709 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.432 ' N ' HG12 ' A' ' 117' ' ' ILE . 1.7 m-20 -71.29 -30.16 65.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.36 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.8 mp -79.91 -23.18 41.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.129 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.417 ' CG ' ' O ' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -44.85 -29.22 0.76 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.934 0.397 . . . . 0.0 110.941 179.975 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.4 -38.69 34.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.549 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -46.47 103.37 0.35 Allowed Pre-proline 0 C--N 1.332 -0.192 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.918 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -69.7 -7.19 20.42 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.506 2.138 . . . . 0.0 112.934 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.3 t -77.92 -66.45 0.84 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.025 0.441 . . . . 0.0 109.945 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.407 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 5.0 m -56.73 -39.01 73.16 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.048 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.451 ' HA ' ' CD1' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -53.43 -45.45 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.854 179.309 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -57.44 -37.18 72.4 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.008 179.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.407 ' HB2' ' O ' ' A' ' 125' ' ' THR . 2.3 mptp? -63.67 -30.09 71.24 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.451 ' CD1' ' HA ' ' A' ' 126' ' ' ILE . 6.7 mt -74.89 -38.08 61.97 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.07 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -44.87 -33.64 2.03 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.948 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 9.1 mmtt -49.44 -34.42 16.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.506 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.408 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 0.6 OUTLIER -123.32 -30.92 3.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.514 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.526 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 6.7 mmtt -145.46 -101.21 0.1 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 119.109 -0.472 . . . . 0.0 111.317 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.526 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 0.9 OUTLIER 133.65 -26.2 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.331 1.052 . . . . 0.0 110.249 -179.858 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 8.9 mtpp -69.0 110.7 6.55 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.715 -179.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -80.34 133.72 9.81 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.682 2.254 . . . . 0.0 111.484 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.505 ' CD1' ' N ' ' A' ' 137' ' ' ILE . 0.8 OUTLIER -67.26 96.62 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.901 0.381 . . . . 0.0 110.871 -179.513 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.2 p -82.97 163.68 49.94 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.816 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.483 ' HA ' ' CE1' ' A' ' 154' ' ' TYR . 86.9 Cg_exo -46.15 -40.55 21.4 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.549 2.166 . . . . 0.0 112.275 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -57.56 -52.28 66.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.752 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 7.4 m -57.21 -52.09 66.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.76 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -54.01 -52.66 60.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.901 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -51.08 -32.52 22.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.682 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 7.4 ttpt -66.04 -61.3 2.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.76 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.407 ' O ' ' CD2' ' A' ' 145' ' ' LEU . 0.7 OUTLIER -60.75 -36.45 78.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.661 179.843 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -61.84 -41.54 97.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.973 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -87.59 -25.74 23.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.746 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -67.64 -42.21 82.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.961 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.05 16.37 12.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.258 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.7 mttm 46.88 35.02 2.94 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.768 0.318 . . . . 0.0 111.196 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.476 ' HB3' ' CD2' ' A' ' 110' ' ' PHE . . . -55.64 -82.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.09 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.438 ' CG2' ' O ' ' A' ' 151' ' ' ALA . 56.0 t -162.28 -75.67 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.711 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.417 ' HE3' ' N ' ' A' ' 154' ' ' TYR . 0.0 OUTLIER -176.56 113.54 0.1 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.801 -178.843 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.483 ' CE1' ' HA ' ' A' ' 139' ' ' PRO . 16.5 t80 -87.84 106.75 18.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.467 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.438 ' CB ' HG23 ' A' ' 168' ' ' VAL . 0.1 OUTLIER -101.74 177.07 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.448 179.745 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -99.48 118.76 36.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.8 0.333 . . . . 0.0 111.194 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.4 ' HB2' ' HA ' ' A' ' 165' ' ' LEU . 7.2 p -160.16 126.37 4.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.776 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.09 157.11 22.01 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.249 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -107.8 -33.39 7.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.698 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.64 -37.19 79.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.697 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 14.0 t -110.74 -18.78 13.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.012 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 75.76 66.54 0.06 Allowed 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 120.856 0.36 . . . . 0.0 110.975 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.26 38.1 1.0 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.244 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 89.48 48.89 3.59 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.97 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.457 ' CD1' ' HA ' ' A' ' 19' ' ' LEU . 4.3 mt -47.53 -31.6 4.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.77 0.319 . . . . 0.0 111.308 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.426 ' O ' ' N ' ' A' ' 170' ' ' ASP . 36.1 pttt -70.57 -29.67 66.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.3 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -52.09 -72.36 0.05 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.852 0.358 . . . . 0.0 110.94 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.438 HG23 ' CB ' ' A' ' 155' ' ' VAL . 57.4 t -57.69 -50.42 77.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.919 0.39 . . . . 0.0 110.584 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.494 ' CE1' HD11 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -54.32 -29.49 47.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.463 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 166' ' ' LYS . 6.1 m-20 -72.54 -29.28 63.43 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 178.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -73.94 -31.42 63.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.237 179.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -67.78 -48.13 67.23 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.796 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.424 HD12 ' CD2' ' B' ' 505' ' ' LEU . 1.1 pp -73.8 -31.82 32.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.625 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.402 HD12 ' HB3' ' B' ' 505' ' ' LEU . 4.6 tp -50.57 -53.98 26.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.789 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -50.91 -25.28 4.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.824 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.45 ' CB ' ' HB ' ' A' ' 4' ' ' ILE . . . -83.13 -48.68 10.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.166 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.472 ' CD2' ' CG2' ' B' ' 510' ' ' ILE . 1.0 OUTLIER -68.72 -23.62 64.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.867 179.955 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.418 ' CG ' ' HD2' ' A' ' 179' ' ' PRO . 2.4 tm-20 -152.14 142.63 15.2 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.807 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . 0.418 ' HD2' ' CG ' ' A' ' 178' ' ' GLU . 9.3 Cg_endo -52.76 117.84 4.12 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.724 2.283 . . . . 0.0 112.003 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -66.91 155.02 72.63 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.517 2.145 . . . . 0.0 112.487 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -148.01 98.13 3.83 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.804 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.21 -165.1 0.27 Allowed 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.713 2.275 . . . . 0.0 112.269 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -134.82 157.45 46.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.756 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.249 -0.882 . . . . 0.0 110.897 -179.999 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.311 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 503' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -104.65 -161.42 0.82 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.846 0.355 . . . . 0.0 110.886 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 504' ' ' GLY . . . . . . . . . . . . . . . -156.92 69.58 0.27 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.727 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 505' ' ' LEU . . . . . 0.463 ' O ' ' CB ' ' B' ' 506' ' ' SER . 1.3 mt -133.19 -56.91 0.91 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.642 0.258 . . . . 0.0 111.254 -179.13 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 506' ' ' SER . . . . . 0.463 ' CB ' ' O ' ' B' ' 505' ' ' LEU . 5.2 t 88.95 -20.57 0.16 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.404 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 507' ' ' ALA . . . . . . . . . . . . . . . -51.46 -79.99 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.331 0.586 . . . . 0.0 110.494 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 508' ' ' GLN . . . . . 0.443 ' HB2' ' CD1' ' B' ' 510' ' ' ILE . 5.8 mt-30 -130.91 3.55 4.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.418 179.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 509' ' ' ASP . . . . . 0.441 ' CB ' ' O ' ' B' ' 508' ' ' GLN . 25.5 t0 84.41 39.03 0.03 OUTLIER 'General case' 0 C--N 1.344 0.341 0 CA-C-O 120.98 0.419 . . . . 0.0 110.946 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 510' ' ' ILE . . . . . 0.472 ' CG2' ' CD2' ' A' ' 177' ' ' LEU . 1.8 mp -68.96 73.21 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.476 179.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 511' ' ' SER . . . . . 0.415 ' O ' ' CD1' ' B' ' 514' ' ' LEU . 14.9 t -60.12 140.78 56.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.904 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 512' ' ' GLN . . . . . 0.476 ' CB ' ' HD3' ' B' ' 513' ' ' PRO . 0.7 OUTLIER -89.84 -64.03 0.19 Allowed Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.735 179.803 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 513' ' ' PRO . . . . . 0.476 ' HD3' ' CB ' ' B' ' 512' ' ' GLN . 88.6 Cg_endo -82.37 49.94 3.27 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.638 2.225 . . . . 0.0 112.463 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 514' ' ' LEU . . . . . 0.44 ' CD1' ' O ' ' A' ' 45' ' ' MET . 0.4 OUTLIER -52.88 -89.3 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.784 -179.79 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 515' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -93.2 -157.67 0.55 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -48.7 -29.44 4.44 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.139 0.495 . . . . 0.0 110.316 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 517' ' ' SER . . . . . 0.435 ' O ' ' CG1' ' A' ' 42' ' ' VAL . 14.2 p 38.15 59.48 1.39 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.101 179.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 518' ' ' PHE . . . . . 0.485 ' CZ ' ' CE2' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -165.06 108.41 0.86 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.734 0.302 . . . . 0.0 111.393 179.485 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 519' ' ' ILE . . . . . 0.446 HD12 ' HA ' ' A' ' 42' ' ' VAL . 0.1 OUTLIER -151.1 152.16 11.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.171 179.246 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 70.33 76.0 0.2 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.825 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 521' ' ' THR . . . . . 0.486 HG22 ' CZ ' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -75.7 120.77 21.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.014 -179.951 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 522' ' ' GLY . . . . . . . . . . . . . . . -61.65 -158.26 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.389 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 523' ' ' HIS . . . . . 0.42 ' ND1' ' N ' ' B' ' 523' ' ' HIS . 0.4 OUTLIER -118.66 -83.97 0.65 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.788 0.327 . . . . 0.0 110.808 179.943 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 524' ' ' GLY . . . . . . . . . . . . . . . 67.71 122.13 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.714 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 525' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -142.0 57.91 1.48 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.777 0.323 . . . . 0.0 111.067 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 526' ' ' SER . . . . . 0.45 ' HB3' ' CG1' ' A' ' 33' ' ' VAL . 2.9 t -78.79 96.81 5.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.754 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 527' ' ' ASP . . . . . 0.466 ' CB ' ' HD3' ' B' ' 528' ' ' PRO . 1.7 t0 -43.93 -52.52 15.05 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.679 0.276 . . . . 0.0 111.019 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 528' ' ' PRO . . . . . 0.466 ' HD3' ' CB ' ' B' ' 527' ' ' ASP . 17.7 Cg_exo -70.82 134.06 24.96 Favored 'Trans proline' 0 CA--C 1.518 -0.306 0 C-N-CA 123.125 2.55 . . . . 0.0 111.726 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 529' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -101.06 -30.02 11.84 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.986 -179.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 530' ' ' HIS . . . . . 0.502 ' CG ' ' O ' ' B' ' 530' ' ' HIS . 0.1 OUTLIER 70.35 5.02 5.16 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.399 179.712 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 1.2 m 52.76 -88.08 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.637 0.256 . . . . 0.0 111.011 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 532' ' ' TRP . . . . . 0.434 ' N ' ' O ' ' B' ' 530' ' ' HIS . 15.6 t90 -154.27 -45.33 0.09 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.855 0.36 . . . . 0.0 110.685 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . 67.89 -143.08 41.08 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.572 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 534' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -65.86 150.83 96.02 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.791 0.329 . . . . 0.0 110.896 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -49.35 -49.74 14.76 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.614 2.21 . . . . 0.0 112.247 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.49 109.19 11.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.78 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 537' ' ' ARG . . . . . 0.44 ' NH2' ' CE2' ' A' ' 32' ' ' TYR . 0.2 OUTLIER -50.38 143.11 9.31 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 120.989 0.423 . . . . 0.0 111.006 179.998 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 538' ' ' ILE . . . . . 0.441 HG13 ' HB2' ' B' ' 542' ' ' TYR . 7.4 tp -58.69 146.78 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.148 179.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 539' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -46.37 140.52 4.1 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.914 0.388 . . . . 0.0 111.165 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 540' ' ' GLU . . . . . 0.413 ' O ' ' CB ' ' A' ' 58' ' ' THR . 14.0 mp0 -44.94 -27.68 0.57 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.357 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 541' ' ' LEU . . . . . 0.51 ' N ' ' CD2' ' A' ' 70' ' ' LEU . 0.9 OUTLIER -55.68 -32.06 62.94 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.351 0.596 . . . . 0.0 110.147 179.615 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 542' ' ' TYR . . . . . 0.441 ' HB2' HG13 ' B' ' 538' ' ' ILE . 11.1 m-85 -105.45 0.88 27.19 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.031 -0.986 . . . . 0.0 112.171 -178.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 543' ' ' LEU . . . . . . . . . . . . . 1.6 tp -49.23 117.64 2.26 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.814 0.34 . . . . 0.0 110.679 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . 135.09 -46.83 1.02 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.505 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 545' ' ' ASN . . . . . 0.408 ' ND2' ' HB3' ' B' ' 530' ' ' HIS . 72.9 m-20 . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.253 -0.879 . . . . 0.0 111.027 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.409 ' HE2' ' CD1' ' A' ' 51' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.375 0 CA-C-O 120.749 0.309 . . . . 0.0 111.216 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 57.66 160.54 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.715 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.513 HG21 ' CE1' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -119.52 -174.53 2.76 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.407 -179.632 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.475 ' CG2' ' CD2' ' A' ' 177' ' ' LEU . 25.7 pt -155.05 149.49 12.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.101 0.477 . . . . 0.0 111.991 -179.273 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 33.9 mttt -134.38 95.87 3.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.274 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -100.31 138.66 37.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.024 0.44 . . . . 0.0 111.491 -179.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.6 160.09 41.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.087 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.421 ' O ' ' CG1' ' A' ' 9' ' ' VAL . 47.3 t -111.69 137.64 43.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.289 0.566 . . . . 0.0 112.184 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.421 ' CG1' ' O ' ' A' ' 8' ' ' VAL . 19.3 m -161.44 130.04 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.862 179.232 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 149.37 -144.01 11.56 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.238 -0.982 . . . . 0.0 112.62 -179.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.5 p30 -122.15 25.3 9.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.938 0.399 . . . . 0.0 110.825 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.406 ' HA2' ' HB2' ' B' ' 537' ' ' ARG . . . -157.36 -160.24 10.03 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.324 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.41 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -79.11 -48.18 14.79 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.556 0.217 . . . . 0.0 110.836 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.521 ' CG2' ' N ' ' A' ' 15' ' ' GLY . 0.6 OUTLIER 65.59 -60.04 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.403 179.55 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.521 ' N ' ' CG2' ' A' ' 14' ' ' VAL . . . -165.83 30.31 0.21 Allowed Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.445 ' HA ' ' CB ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -91.01 -165.32 1.33 Allowed 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 121.232 0.539 . . . . 0.0 111.359 -179.313 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.424 HG22 ' CG2' ' A' ' 35' ' ' THR . 43.6 p -38.95 -65.85 0.33 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.478 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.431 ' O ' ' CB ' ' A' ' 22' ' ' SER . 23.6 t -32.42 -43.6 0.09 Allowed 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -178.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.45 ' CD2' ' HA2' ' A' ' 15' ' ' GLY . 2.5 mp -56.88 -71.74 0.09 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.73 0.3 . . . . 0.0 111.269 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.55 -50.3 14.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.192 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.479 HD11 ' CE1' ' B' ' 518' ' ' PHE . 10.9 mm -48.31 -55.79 2.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.403 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.467 ' HA ' ' CB ' ' A' ' 26' ' ' ASN . 3.1 t -64.03 -43.59 95.11 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 121.092 -0.243 . . . . 0.0 111.585 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.483 ' CE2' ' HB3' ' A' ' 165' ' ' LEU . 0.2 OUTLIER -45.79 -35.07 4.09 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.187 0.517 . . . . 0.0 110.16 179.6 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -101.67 -33.52 9.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.279 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.434 ' N ' ' O ' ' A' ' 21' ' ' ILE . 1.0 OUTLIER 173.46 127.14 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.722 0.296 . . . . 0.0 111.039 -178.98 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.467 ' CB ' ' HA ' ' A' ' 22' ' ' SER . 61.2 t30 178.56 -43.87 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.666 178.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.6 mtmm 65.1 142.17 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.734 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.46 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -86.68 -49.5 0.48 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.782 179.995 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.46 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 5.8 Cg_exo -79.35 52.15 4.16 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.933 2.422 . . . . 0.0 112.248 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 77.9 p -133.87 -108.74 0.23 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.679 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -159.57 118.75 2.89 Favored 'General case' 0 N--CA 1.457 -0.098 0 O-C-N 122.169 -0.332 . . . . 0.0 111.016 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -90.55 121.51 32.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.391 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.454 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 0.2 OUTLIER -160.99 -61.98 0.02 OUTLIER Pre-proline 0 N--CA 1.468 0.434 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.363 -179.415 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.473 ' HB3' ' CE2' ' A' ' 37' ' ' PHE . 3.0 Cg_exo -34.98 -28.57 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.649 2.899 . . . . 0.0 113.653 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.434 ' N ' ' O ' ' A' ' 33' ' ' VAL . 28.4 m -29.73 -38.46 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.468 ' CG2' ' CB ' ' A' ' 63' ' ' ASP . 11.5 p -50.4 -24.3 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.765 0.317 . . . . 0.0 111.373 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.473 ' CE2' ' HB3' ' A' ' 34' ' ' PRO . 7.1 m-30 -66.07 -10.02 36.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.576 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -46.26 172.62 0.01 OUTLIER 'General case' 0 C--O 1.231 0.102 0 CA-C-O 120.864 0.364 . . . . 0.0 111.159 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 75.37 5.43 4.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.303 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -60.38 -174.85 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.719 0.295 . . . . 0.0 110.607 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -110.11 124.18 51.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.586 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.423 ' HA ' HG12 ' B' ' 519' ' ' ILE . 24.0 m -118.44 124.88 73.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.014 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.72 104.82 16.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.934 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.478 ' CG2' ' CG2' ' A' ' 52' ' ' THR . 12.6 m -153.23 -177.24 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.931 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.457 ' HE1' ' N ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -111.96 103.71 11.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.651 -179.537 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.438 ' CG1' ' O ' ' A' ' 51' ' ' TYR . 2.7 mm -74.02 86.09 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.1 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.458 ' HA3' ' HA ' ' B' ' 510' ' ' ILE . . . 43.9 -94.13 0.01 OUTLIER Glycine 0 CA--C 1.519 0.313 0 CA-C-N 115.498 -0.774 . . . . 0.0 113.636 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -38.62 -87.44 0.01 OUTLIER Glycine 0 C--N 1.332 0.356 0 C-N-CA 121.607 -0.33 . . . . 0.0 113.626 -179.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.457 ' N ' ' HE1' ' A' ' 45' ' ' MET . 1.8 pt-20 -125.23 164.75 30.03 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 120.708 0.289 . . . . 0.0 111.024 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.432 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 52.0 Cg_exo -54.22 106.82 0.18 Allowed 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.653 2.235 . . . . 0.0 112.289 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.513 ' CE1' HG21 ' A' ' 3' ' ' THR . 4.4 t80 -172.53 147.92 1.92 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.498 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.478 ' CG2' ' CG2' ' A' ' 44' ' ' VAL . 0.3 OUTLIER -137.61 154.06 49.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.624 179.706 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.471 ' CD1' ' N ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -131.15 177.99 7.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.877 0.37 . . . . 0.0 111.305 -179.734 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -74.09 114.8 4.67 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.161 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.478 ' HB2' ' CD2' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -81.15 -62.97 1.5 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.019 0.437 . . . . 0.0 110.942 -179.785 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.478 ' CD2' ' HB2' ' A' ' 55' ' ' LEU . 1.9 p90 -142.94 128.89 19.55 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.185 -179.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -142.26 109.6 5.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.032 0.444 . . . . 0.0 110.847 179.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.432 ' OG1' ' CE ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -155.8 131.48 9.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.316 179.524 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.434 ' CB ' ' HA ' ' A' ' 36' ' ' VAL . . . -170.93 158.44 5.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.027 0.441 . . . . 0.0 111.613 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -131.01 19.63 4.9 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.149 179.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -86.22 -175.51 5.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.814 0.34 . . . . 0.0 110.779 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -46.58 -31.48 2.84 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.312 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.468 ' CB ' ' CG2' ' A' ' 36' ' ' VAL . 7.2 t0 -50.52 -62.09 1.8 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.06 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.504 ' CD1' ' N ' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -168.41 137.37 2.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.975 0.417 . . . . 0.0 111.154 -179.898 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.13 -66.23 0.92 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.786 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 17.1 mmt85 -73.22 -24.9 60.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.991 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.406 ' O ' ' CB ' ' A' ' 68' ' ' ARG . 1.1 mt 68.52 -94.73 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.114 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.424 ' CB ' ' HD3' ' A' ' 69' ' ' PRO . 0.0 OUTLIER 166.34 -53.9 0.0 OUTLIER Pre-proline 0 N--CA 1.465 0.287 0 CA-C-O 120.722 0.296 . . . . 0.0 111.128 179.822 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.424 ' HD3' ' CB ' ' A' ' 68' ' ' ARG . 52.8 Cg_exo -52.91 -60.41 0.73 Allowed 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.662 2.242 . . . . 0.0 112.727 -179.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.435 ' CD2' ' HA ' ' B' ' 541' ' ' LEU . 0.3 OUTLIER -58.7 -31.89 68.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.031 -179.847 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.8 t -54.6 -35.63 63.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.223 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 65.3 t80 175.39 81.57 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.669 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.492 ' HG2' ' CZ ' ' A' ' 78' ' ' PHE . 94.4 Cg_endo -81.17 136.42 10.17 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.604 2.203 . . . . 0.0 112.307 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? -90.79 10.25 26.82 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.349 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.4 t -57.74 178.45 0.08 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.808 0.337 . . . . 0.0 110.737 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -123.34 7.33 9.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.535 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.402 ' O ' ' CG1' ' A' ' 77' ' ' VAL . 8.9 p -152.76 101.05 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 CA-C-O 120.758 0.313 . . . . 0.0 111.321 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.492 ' CZ ' ' HG2' ' A' ' 73' ' ' PRO . 3.2 m-85 -80.61 177.65 8.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.393 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.447 ' CD2' HG23 ' A' ' 14' ' ' VAL . 5.9 tp -138.93 108.25 6.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.047 0.451 . . . . 0.0 111.042 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 19.7 m -111.04 127.01 68.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.243 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.441 ' HB3' ' CG1' ' A' ' 14' ' ' VAL . 13.6 p -108.21 177.19 4.88 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.604 0.716 . . . . 0.0 112.51 -178.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.49 ' CE1' HG23 ' A' ' 137' ' ' ILE . 2.1 p90 -176.54 124.45 0.17 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.607 -1.178 . . . . 0.0 109.467 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.4 m -87.89 143.65 27.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.831 0.348 . . . . 0.0 111.291 -179.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.43 ' CG1' ' N ' ' A' ' 137' ' ' ILE . 51.0 t -54.72 -53.08 35.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.748 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.406 ' CA ' HD23 ' A' ' 129' ' ' LEU . 34.3 m -52.09 110.1 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.225 179.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -151.46 128.38 5.44 Favored Pre-proline 0 C--N 1.33 -0.274 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.77 -179.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.401 ' HB2' ' HB2' ' A' ' 132' ' ' ASN . 82.5 Cg_endo -92.4 53.45 0.6 Allowed 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.299 2.666 . . . . 0.0 111.498 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.446 ' CA ' ' HG3' ' A' ' 133' ' ' LYS . 1.1 p 77.87 17.81 1.29 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.141 -179.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.0 p -97.28 -23.98 15.89 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.811 0.338 . . . . 0.0 111.066 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.491 ' CZ ' HG23 ' A' ' 137' ' ' ILE . 9.7 t80 -46.96 -46.77 21.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.186 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -50.77 -52.19 43.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.183 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.93 -40.38 83.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.168 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 62.1 t -48.36 -45.42 13.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.491 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.8 ptpp? -80.32 -36.81 33.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.107 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -74.61 -11.23 60.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.589 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.17 -20.49 12.33 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.58 0.228 . . . . 0.0 111.326 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.442 ' HA ' ' CE3' ' A' ' 97' ' ' TRP . 3.3 m95 -87.0 -51.61 5.92 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.712 0.291 . . . . 0.0 111.186 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.483 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 57.3 t -48.51 -47.79 69.02 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.598 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 73.4 Cg_endo -76.46 -13.65 18.39 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.169 1.913 . . . . 0.0 112.492 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -89.83 -49.17 6.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.885 0.374 . . . . 0.0 110.727 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 5.8 pt -56.84 -28.16 27.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.013 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 69.5 p -93.05 -25.89 17.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.93 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -63.5 -68.59 0.33 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.758 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 10.2 m80 -64.86 -51.1 63.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.795 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 2.9 m -101.57 141.15 22.01 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.811 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -51.24 155.21 6.89 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.591 2.194 . . . . 0.0 112.209 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 16.3 mttt -53.46 90.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.872 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.485 ' HB ' ' CD1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -115.65 152.43 47.26 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.918 -179.954 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -60.86 167.83 8.08 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.686 2.257 . . . . 0.0 112.415 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.472 ' CD2' ' HB1' ' A' ' 151' ' ' ALA . 1.8 p90 -155.8 159.39 39.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.738 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.44 ' CD1' ' CG1' ' A' ' 152' ' ' VAL . 4.2 tt -121.03 150.03 41.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.255 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -94.05 141.71 28.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.178 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.425 ' CG1' HG23 ' A' ' 168' ' ' VAL . 3.1 t -122.03 145.29 28.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.183 0.516 . . . . 0.0 112.07 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -130.51 125.78 4.71 Favored Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.093 179.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.402 ' HB ' ' HA ' ' A' ' 158' ' ' SER . 0.6 OUTLIER -144.27 -44.89 0.25 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.964 0.412 . . . . 0.0 110.752 -178.854 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.441 ' O ' ' N ' ' A' ' 119' ' ' LEU . 0.1 OUTLIER -71.33 -2.68 17.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.23 179.26 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.424 ' O ' ' CG ' ' A' ' 120' ' ' ARG . 0.1 OUTLIER -42.29 -28.44 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 179.935 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.18 -34.7 61.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.771 0.319 . . . . 0.0 111.131 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.466 ' CD2' ' N ' ' A' ' 119' ' ' LEU . 2.2 mm? -69.44 -31.78 70.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.083 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.424 ' CG ' ' O ' ' A' ' 117' ' ' ILE . 0.3 OUTLIER -46.11 -29.87 1.69 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.949 -179.884 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -83.84 -31.96 25.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.505 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 119' ' ' LEU . 3.5 t0 -56.54 106.86 0.74 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.618 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.415 ' O ' ' CG ' ' A' ' 127' ' ' GLU . 14.2 Cg_exo -69.19 -3.62 12.0 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.686 2.257 . . . . 0.0 112.975 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.83 -65.24 1.04 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 121.058 0.456 . . . . 0.0 109.865 179.543 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.404 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 4.1 m -56.65 -38.95 72.86 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.457 ' HA ' ' CD1' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -54.34 -43.1 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.753 179.203 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.415 ' CG ' ' O ' ' A' ' 123' ' ' PRO . 1.7 mm-40 -58.31 -37.7 75.61 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.833 179.25 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 125' ' ' THR . 2.7 mptt -63.11 -30.71 71.81 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.457 ' CD1' ' HA ' ' A' ' 126' ' ' ILE . 8.0 mt -74.88 -39.22 61.63 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -46.57 -31.49 2.84 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.85 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.0 mmtt -50.14 -34.31 21.79 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.391 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.401 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 5.0 m-80 -123.3 -31.36 3.56 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.359 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.512 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 7.6 mmtt -144.79 -98.96 0.1 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 119.15 -0.452 . . . . 0.0 111.326 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.512 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 0.0 OUTLIER 132.22 -22.79 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.401 1.08 . . . . 0.0 110.503 -179.809 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 4.5 mmtt -68.75 110.82 6.62 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.726 -179.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -81.6 123.4 4.27 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.534 2.156 . . . . 0.0 111.394 179.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.491 HG23 ' CZ ' ' A' ' 90' ' ' PHE . 1.1 mm -55.05 96.61 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.958 0.409 . . . . 0.0 110.893 -179.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 74.2 p -69.09 156.59 91.25 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.028 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.445 ' HA ' ' CE2' ' A' ' 154' ' ' TYR . 9.4 Cg_endo -50.75 -41.35 54.81 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.709 2.272 . . . . 0.0 112.085 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -58.85 -34.8 72.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.583 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 84.3 m -63.62 -46.49 85.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.677 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.488 ' HB1' ' CG ' ' A' ' 154' ' ' TYR . . . -55.6 -48.74 74.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.905 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -53.48 -43.95 68.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.73 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 6.8 mttt -54.1 -61.8 2.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.704 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.425 ' O ' ' CD2' ' A' ' 145' ' ' LEU . 0.8 OUTLIER -61.57 -37.98 85.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.649 179.748 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.45 -49.22 78.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.861 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 16.2 mtp180 -79.68 -25.14 41.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.826 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -56.93 -40.71 76.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.447 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.1 mt -109.95 26.11 11.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.667 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.469 ' N ' ' CD ' ' A' ' 150' ' ' LYS . 0.0 OUTLIER 37.84 57.0 1.54 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.671 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.472 ' HB1' ' CD2' ' A' ' 110' ' ' PHE . . . -73.76 -82.16 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.025 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.449 ' CG2' ' O ' ' A' ' 151' ' ' ALA . 55.5 t -161.96 -76.12 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.752 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.435 ' HG3' ' N ' ' A' ' 154' ' ' TYR . 1.9 ttpt -177.01 145.91 0.5 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.343 -178.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.488 ' CG ' ' HB1' ' A' ' 142' ' ' ALA . 61.3 t80 -105.66 114.48 28.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.551 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.409 ' CG2' ' OE2' ' A' ' 171' ' ' GLU . 11.4 t -112.91 157.94 13.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.803 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -97.79 118.29 34.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.065 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.442 ' HA ' ' CB ' ' A' ' 163' ' ' LYS . 22.9 m -160.63 126.42 3.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.673 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.424 ' OG ' ' CD1' ' A' ' 160' ' ' LEU . 0.4 OUTLIER -147.41 153.62 39.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.916 0.389 . . . . 0.0 111.745 -179.591 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -78.47 -22.07 48.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.664 179.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.424 ' CD1' ' OG ' ' A' ' 158' ' ' SER . 0.3 OUTLIER -67.39 -59.46 3.38 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.073 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 3.5 t -91.92 -22.49 20.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.222 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 72.13 69.86 0.15 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.865 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.442 ' CB ' ' HA ' ' A' ' 157' ' ' CYS . 10.3 mptt -90.81 19.37 5.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.32 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 119.13 -42.21 1.83 Allowed Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.634 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.483 ' HB3' ' CE2' ' A' ' 23' ' ' TYR . 1.0 OUTLIER 66.35 -66.24 0.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.783 0.325 . . . . 0.0 111.359 179.904 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.423 ' O ' ' N ' ' A' ' 170' ' ' ASP . 6.2 ptpp? -58.04 -26.08 62.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.752 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.401 ' CB ' ' SG ' ' A' ' 157' ' ' CYS . 0.2 OUTLIER -54.51 -69.46 0.13 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.814 0.34 . . . . 0.0 111.06 -179.717 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.437 ' O ' ' CG ' ' A' ' 171' ' ' GLU . 13.6 p -56.15 -44.77 79.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.142 0.496 . . . . 0.0 110.69 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.429 ' HB2' ' CD2' ' A' ' 19' ' ' LEU . 5.6 t80 -66.85 -17.23 64.79 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.979 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' A' ' 166' ' ' LYS . 2.8 m-20 -80.95 -38.66 27.36 Favored 'General case' 0 C--N 1.334 -0.068 0 CA-C-O 120.809 0.338 . . . . 0.0 110.699 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.437 ' CG ' ' O ' ' A' ' 168' ' ' VAL . 9.4 pt-20 -69.45 -27.81 65.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.936 0.398 . . . . 0.0 110.033 179.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.423 ' N ' HD13 ' A' ' 111' ' ' LEU . . . -75.69 -42.23 51.58 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.911 179.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 1.7 pp -81.58 -34.44 13.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.044 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -56.36 -44.62 80.3 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.859 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -51.22 -24.78 4.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.904 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.443 ' CB ' ' HB ' ' A' ' 4' ' ' ILE . . . -84.84 -39.27 18.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.163 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.475 ' CD2' ' CG2' ' A' ' 4' ' ' ILE . 31.4 mt -68.56 -24.06 64.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.869 0.366 . . . . 0.0 110.405 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.415 ' CG ' ' HD2' ' A' ' 179' ' ' PRO . 21.7 tt0 -165.52 139.27 3.76 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.543 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . 0.415 ' HD2' ' CG ' ' A' ' 178' ' ' GLU . 43.9 Cg_endo -68.36 108.58 1.83 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.564 2.176 . . . . 0.0 112.507 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -70.83 -159.51 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.734 2.29 . . . . 0.0 112.185 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -145.57 146.73 30.62 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.886 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.23 -165.32 0.3 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.686 2.258 . . . . 0.0 112.287 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.5 154.6 35.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.888 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 8.2 mttt . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.297 -0.858 . . . . 0.0 110.877 -179.967 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 112.45 -0.26 . . . . 0.0 112.45 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 503' ' ' SER . . . . . . . . . . . . . 5.7 m -74.03 -69.49 0.44 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.833 0.349 . . . . 0.0 110.782 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 504' ' ' GLY . . . . . . . . . . . . . . . 64.09 114.67 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.684 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 505' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.53 -52.41 0.18 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.845 0.355 . . . . 0.0 110.709 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 506' ' ' SER . . . . . 0.41 ' CB ' ' OE1' ' A' ' 178' ' ' GLU . 1.4 m -155.19 -161.11 1.13 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.778 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 507' ' ' ALA . . . . . . . . . . . . . . . 55.01 -90.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.001 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 508' ' ' GLN . . . . . 0.414 ' O ' ' CB ' ' B' ' 509' ' ' ASP . 9.9 mt-30 -132.1 3.9 4.05 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.875 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 509' ' ' ASP . . . . . 0.414 ' CB ' ' O ' ' B' ' 508' ' ' GLN . 7.8 t70 80.71 42.44 0.05 OUTLIER 'General case' 0 C--N 1.34 0.19 0 CA-C-O 121.221 0.534 . . . . 0.0 110.012 -179.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 510' ' ' ILE . . . . . 0.458 ' HA ' ' HA3' ' A' ' 47' ' ' GLY . 11.2 mt -65.3 145.28 14.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.554 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 511' ' ' SER . . . . . . . . . . . . . 27.9 t -109.37 149.2 29.86 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.205 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 512' ' ' GLN . . . . . 0.448 ' CB ' ' HD3' ' B' ' 513' ' ' PRO . 0.0 OUTLIER -93.69 -53.53 0.25 Allowed Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.406 179.387 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 513' ' ' PRO . . . . . 0.448 ' HD3' ' CB ' ' B' ' 512' ' ' GLN . 55.8 Cg_endo -97.73 74.79 0.08 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 123.33 2.687 . . . . 0.0 111.813 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 514' ' ' LEU . . . . . 0.44 ' CD1' ' O ' ' A' ' 45' ' ' MET . 0.7 OUTLIER -73.33 -88.28 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.6 -179.257 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 515' ' ' GLN . . . . . 0.405 ' HB2' HG12 ' A' ' 44' ' ' VAL . 0.3 OUTLIER -87.45 -159.88 0.56 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.777 0.322 . . . . 0.0 111.006 -179.669 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -54.48 -21.24 9.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.235 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 517' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 47.24 29.14 1.14 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.821 0.343 . . . . 0.0 111.129 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 518' ' ' PHE . . . . . 0.479 ' CE1' HD11 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -150.18 91.62 1.79 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.83 -179.749 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 519' ' ' ILE . . . . . 0.423 HG12 ' HA ' ' A' ' 42' ' ' VAL . 5.3 mm -97.79 -68.89 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.442 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -117.65 -170.0 1.78 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.946 0.403 . . . . 0.0 111.005 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 521' ' ' THR . . . . . 0.421 ' OG1' ' CG ' ' A' ' 37' ' ' PHE . 15.3 t -119.32 -159.86 0.79 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.909 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 522' ' ' GLY . . . . . . . . . . . . . . . -110.57 -92.37 2.15 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.364 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 523' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -115.41 -88.29 0.58 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.643 0.259 . . . . 0.0 111.02 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 524' ' ' GLY . . . . . 0.401 ' HA2' ' CE1' ' A' ' 37' ' ' PHE . . . 164.47 123.9 0.68 Allowed Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.491 -0.862 . . . . 0.0 112.643 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 525' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 177.28 46.17 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.99 0.424 . . . . 0.0 110.592 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 526' ' ' SER . . . . . 0.429 ' CB ' ' HD3' ' A' ' 34' ' ' PRO . 71.8 m -104.3 100.11 9.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.068 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 527' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -156.17 164.79 20.25 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.835 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -61.09 95.69 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.588 2.192 . . . . 0.0 112.133 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 529' ' ' ARG . . . . . . . . . . . . . 2.8 mtp85 -97.67 -49.77 4.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.105 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 530' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -168.8 -41.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.158 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 2.7 m 72.71 177.02 0.26 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.772 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 532' ' ' TRP . . . . . . . . . . . . . 37.1 t90 -53.01 92.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.796 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . -114.86 -61.39 0.38 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.548 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 534' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -78.11 139.16 60.71 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.644 0.259 . . . . 0.0 110.875 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.79 123.86 14.45 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.557 2.172 . . . . 0.0 112.438 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 70.31 126.8 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.027 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 537' ' ' ARG . . . . . 0.406 ' HB2' ' HA2' ' A' ' 12' ' ' GLY . 21.3 mmt180 -54.67 122.73 11.29 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.233 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 538' ' ' ILE . . . . . 0.404 ' CD1' ' C ' ' B' ' 538' ' ' ILE . 0.0 OUTLIER -48.17 151.05 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.152 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 539' ' ' ASP . . . . . 0.469 ' OD2' ' CD2' ' B' ' 542' ' ' TYR . 0.7 OUTLIER -38.52 104.62 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.218 0.532 . . . . 0.0 112.224 -178.58 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 540' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -45.25 -26.54 0.51 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.529 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 541' ' ' LEU . . . . . 0.435 ' HA ' ' CD2' ' A' ' 70' ' ' LEU . 42.1 mt -41.21 -35.18 0.57 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.953 0.406 . . . . 0.0 111.116 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 542' ' ' TYR . . . . . 0.469 ' CD2' ' OD2' ' B' ' 539' ' ' ASP . 4.1 m-30 -104.33 -57.25 2.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.525 179.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 543' ' ' LEU . . . . . 0.431 ' CD2' HG22 ' A' ' 35' ' ' THR . 0.2 OUTLIER 62.31 176.44 0.13 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.437 -179.884 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . 103.22 79.67 1.38 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.259 -0.972 . . . . 0.0 112.574 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 545' ' ' ASN . . . . . . . . . . . . . 2.5 m120 . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.955 179.921 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.431 ' HE1' ' HB2' ' A' ' 1' ' ' MET . 3.3 ppp? . . . . . 0 N--CA 1.488 1.472 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.421 ' N ' ' SD ' ' A' ' 1' ' ' MET . 50.4 tt0 61.93 132.84 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.893 0.377 . . . . 0.0 110.724 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.434 ' OG1' ' CE1' ' A' ' 51' ' ' TYR . 0.3 OUTLIER -133.36 -161.38 1.13 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.429 -179.679 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.512 ' CG2' ' CB ' ' A' ' 176' ' ' ALA . 0.3 OUTLIER -154.91 163.37 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -179.069 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 8.2 mtmt -111.29 136.59 50.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.041 179.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -108.32 138.73 44.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.063 0.459 . . . . 0.0 111.66 -179.356 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -151.11 160.41 3.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.098 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.3 m -143.24 139.95 26.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.845 0.355 . . . . 0.0 111.726 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.8 m -143.27 131.04 18.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.083 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.25 -110.11 3.92 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.623 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.73 -23.85 24.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.716 0.293 . . . . 0.0 110.92 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -49.43 150.56 4.32 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.617 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.446 ' O ' ' CG1' ' A' ' 14' ' ' VAL . . . -91.53 -56.35 3.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.549 0.214 . . . . 0.0 111.158 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.446 ' CG1' ' O ' ' A' ' 13' ' ' ALA . 0.0 OUTLIER 170.75 -56.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.788 179.584 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.47 ' HA3' ' CZ ' ' A' ' 169' ' ' PHE . . . 110.25 -16.29 29.85 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.419 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.438 ' HD3' ' CD2' ' A' ' 55' ' ' LEU . 15.4 tptm -93.44 -50.04 5.63 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.782 0.325 . . . . 0.0 111.076 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.447 ' O ' ' N ' ' A' ' 21' ' ' ILE . 0.6 OUTLIER -97.81 -71.2 0.69 Allowed 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.525 -179.516 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.417 ' SG ' ' CB ' ' A' ' 13' ' ' ALA . 0.1 OUTLIER -34.61 -74.18 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -178.823 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.486 ' CD2' ' CD1' ' A' ' 169' ' ' PHE . 7.8 mp -47.43 -39.21 15.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.058 -179.031 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.42 ' CD2' ' O ' ' A' ' 16' ' ' LYS . 3.1 mm? -76.9 -20.88 55.69 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.982 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.447 ' N ' ' O ' ' A' ' 17' ' ' THR . 9.1 mm -61.09 -69.64 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 74.8 m -56.55 -32.95 65.66 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.514 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.404 ' HB2' HD13 ' A' ' 165' ' ' LEU . 42.2 t80 -56.99 -68.38 0.23 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.026 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.3 m -76.65 -45.99 27.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.666 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.442 ' N ' ' O ' ' A' ' 21' ' ' ILE . 1.6 p -92.41 -155.91 0.44 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.435 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.414 ' N ' ' ND2' ' A' ' 26' ' ' ASN . 0.1 OUTLIER -155.75 23.8 0.39 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.776 0.322 . . . . 0.0 111.098 -179.908 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.33 100.22 9.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.947 0.403 . . . . 0.0 111.39 -179.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.488 ' CD2' ' HD3' ' A' ' 29' ' ' PRO . 0.1 OUTLIER -87.86 -64.95 0.2 Allowed Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.095 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.488 ' HD3' ' CD2' ' A' ' 28' ' ' PHE . 93.0 Cg_endo -81.72 54.16 4.96 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.597 2.198 . . . . 0.0 111.983 179.341 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.401 ' O ' ' HG3' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -97.17 -84.96 0.36 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.864 -179.64 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' B' ' 531' ' ' CYS . 27.0 mt-10 -149.52 126.49 11.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.041 0.448 . . . . 0.0 111.873 -179.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -105.15 93.34 4.64 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.591 178.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.443 ' CB ' ' CD ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -165.81 -64.56 0.01 OUTLIER Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.253 -179.177 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.443 ' CD ' ' CB ' ' A' ' 33' ' ' VAL . 55.2 Cg_endo -70.78 56.7 1.86 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.599 2.199 . . . . 0.0 112.891 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.3 t -121.75 26.35 8.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.993 0.425 . . . . 0.0 110.52 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.435 HG22 ' CB ' ' A' ' 61' ' ' LEU . 1.8 t -80.46 -5.66 8.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.888 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.437 ' HB3' ' N ' ' B' ' 522' ' ' GLY . 29.5 p90 -93.98 26.54 3.17 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.785 0.326 . . . . 0.0 111.142 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.1 p30 -70.3 -19.25 63.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.12 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -100.11 11.12 40.11 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.514 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.457 ' CE1' ' HA2' ' B' ' 522' ' ' GLY . 1.0 OUTLIER -60.66 -159.42 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 120.685 0.278 . . . . 0.0 110.664 179.894 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -117.82 156.26 28.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.543 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -140.56 126.13 20.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.883 179.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.42 ' O ' ' CG2' ' A' ' 44' ' ' VAL . 9.9 t -85.51 104.49 15.34 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.929 0.395 . . . . 0.0 110.592 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.459 ' CG1' ' CD1' ' B' ' 514' ' ' LEU . 2.8 t -164.63 158.1 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.818 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.456 ' HG3' HD23 ' B' ' 514' ' ' LEU . 0.0 OUTLIER -112.75 118.83 36.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.599 178.758 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.466 ' O ' ' N ' ' A' ' 48' ' ' GLY . 1.4 mm -79.65 86.81 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.441 -179.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 54.68 -76.16 0.01 OUTLIER Glycine 0 CA--C 1.521 0.464 0 CA-C-N 115.678 -0.692 . . . . 0.0 114.353 178.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . -57.55 -95.91 0.01 OUTLIER Glycine 0 CA--C 1.518 0.272 0 C-N-CA 121.099 -0.572 . . . . 0.0 113.559 -179.042 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.412 ' HB2' ' HD2' ' A' ' 50' ' ' PRO . 0.3 OUTLIER -115.93 163.83 19.84 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-O 120.736 0.303 . . . . 0.0 111.311 -179.154 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.412 ' HD2' ' HB2' ' A' ' 49' ' ' GLU . 57.8 Cg_exo -51.6 100.38 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.483 2.122 . . . . 0.0 112.39 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.434 ' CE1' ' OG1' ' A' ' 3' ' ' THR . 3.5 t80 -172.2 118.61 0.39 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.227 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.459 ' CG2' ' HB ' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -113.95 138.64 50.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.49 179.807 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.438 ' CB ' ' O ' ' A' ' 4' ' ' ILE . 0.3 OUTLIER -70.7 109.07 4.71 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.375 -179.463 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -61.22 94.73 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.613 179.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.438 ' CD2' ' HD3' ' A' ' 16' ' ' LYS . 0.9 OUTLIER -41.56 110.95 0.19 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.853 0.359 . . . . 0.0 111.179 -179.398 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -83.74 104.97 14.28 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.884 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.423 ' CB ' ' OE1' ' B' ' 540' ' ' GLU . 17.1 m-20 -131.56 174.89 9.64 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.001 -179.322 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.442 ' HB ' ' CG ' ' A' ' 67' ' ' LEU . 0.1 OUTLIER -144.77 143.92 30.91 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.935 -179.395 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.43 ' CB ' HD23 ' A' ' 61' ' ' LEU . . . -140.66 125.46 18.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.046 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -75.66 66.19 2.41 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.728 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.435 ' CB ' HG22 ' A' ' 36' ' ' VAL . 3.0 mm? -121.23 -176.98 3.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.905 0.383 . . . . 0.0 110.978 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -52.79 -45.93 67.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.012 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.402 ' HB3' ' CE2' ' A' ' 64' ' ' TYR . 0.2 OUTLIER -50.68 -38.01 44.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.951 -179.959 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.438 ' CB ' ' HB3' ' A' ' 67' ' ' LEU . 1.4 m-85 -145.02 97.13 2.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.788 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -86.02 -37.54 18.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.211 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -97.51 4.27 50.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.781 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.442 ' CG ' ' HB ' ' A' ' 58' ' ' THR . 0.0 OUTLIER -62.15 133.66 55.53 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.764 0.316 . . . . 0.0 110.266 179.672 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -174.84 60.05 0.22 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.249 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.43 ' HG2' ' CG2' ' A' ' 58' ' ' THR . 62.4 Cg_endo -73.18 -23.23 18.24 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.567 2.178 . . . . 0.0 112.03 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.24 -20.19 52.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.096 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.9 p -50.77 -42.89 58.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.169 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -160.68 69.91 2.76 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.031 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.19 149.58 36.14 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.653 2.235 . . . . 0.0 112.32 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.49 10.48 40.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.42 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.3 t -48.96 176.01 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.864 0.364 . . . . 0.0 110.897 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -109.39 -24.16 11.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.985 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.0 p -134.26 143.34 38.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.278 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.84 174.48 8.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.627 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 46.4 tp -146.51 109.28 4.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.892 0.377 . . . . 0.0 111.238 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.427 ' CG2' ' HB2' ' A' ' 110' ' ' PHE . 31.1 m -98.79 115.36 39.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.633 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 3.6 m -108.29 168.07 9.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.094 0.473 . . . . 0.0 111.655 -179.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.446 ' CE1' HG23 ' A' ' 137' ' ' ILE . 10.8 p90 -169.75 135.9 1.53 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.353 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.421 ' CB ' ' OE1' ' A' ' 116' ' ' GLN . 4.9 p -83.17 141.17 32.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.035 0.445 . . . . 0.0 111.562 -179.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.441 ' CG1' ' O ' ' A' ' 137' ' ' ILE . 16.4 m -57.05 -31.47 37.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.243 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.434 HG22 ' CB ' ' B' ' 535' ' ' PRO . 9.5 m -78.02 117.23 22.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.235 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.435 ' N ' HD22 ' A' ' 129' ' ' LEU . 0.4 OUTLIER -151.71 142.83 15.49 Favored Pre-proline 0 C--N 1.333 -0.151 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -179.141 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -92.45 53.93 0.59 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 123.406 2.737 . . . . 0.0 111.614 179.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.421 ' CB ' ' HB2' ' A' ' 133' ' ' LYS . 0.3 OUTLIER 71.0 19.77 5.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.99 -179.297 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 58.8 m -97.2 -21.59 17.21 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.741 0.305 . . . . 0.0 111.115 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.495 ' CZ ' HG23 ' A' ' 137' ' ' ILE . 17.4 t80 -47.48 -58.87 3.7 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.169 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.7 -39.29 36.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.868 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.419 ' O ' ' CD ' ' A' ' 96' ' ' LYS . 1.0 OUTLIER -72.52 -43.22 63.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.759 179.795 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 77.0 t -50.21 -63.47 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.051 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.433 ' CB ' HD11 ' A' ' 145' ' ' LEU . 0.0 OUTLIER -58.3 -39.32 79.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.913 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -65.81 -25.33 67.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.977 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.419 ' CD ' ' O ' ' A' ' 92' ' ' ASN . 1.4 mtpm? -100.06 -24.27 14.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.0 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.436 ' HA ' ' CE3' ' A' ' 97' ' ' TRP . 0.0 OUTLIER -67.18 -58.73 4.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.05 -179.853 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.47 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 95.4 t -45.57 -53.5 19.01 Favored Pre-proline 0 CA--C 1.532 0.26 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.814 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 51.9 Cg_endo -68.66 -14.43 39.35 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.173 1.915 . . . . 0.0 112.628 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -86.66 -35.66 19.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.87 0.367 . . . . 0.0 111.054 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.421 ' CD1' HG13 ' A' ' 80' ' ' VAL . 30.3 mt -78.31 -33.01 17.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.284 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 22.9 p -84.76 -21.69 29.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.215 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 19.9 t-80 -87.63 -51.62 5.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.815 0.34 . . . . 0.0 110.96 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -80.54 -29.76 37.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.093 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -117.11 147.27 39.92 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.924 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.48 60.58 2.07 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.514 2.143 . . . . 0.0 112.288 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 59.12 67.56 0.9 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.966 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -90.84 146.79 34.6 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.744 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -60.7 169.17 5.89 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.505 2.137 . . . . 0.0 112.314 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.489 ' CD2' ' HB1' ' A' ' 151' ' ' ALA . 2.9 p90 -162.2 134.63 5.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.877 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.434 HD21 ' N ' ' A' ' 112' ' ' LEU . 8.5 tt -119.93 154.53 34.3 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.997 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.434 ' N ' HD21 ' A' ' 111' ' ' LEU . 2.9 mm? -100.69 137.3 39.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.685 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.426 ' CG1' HG21 ' A' ' 168' ' ' VAL . 49.9 t -120.76 148.02 24.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.989 0.423 . . . . 0.0 111.373 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 157' ' ' CYS . . . -130.09 107.74 0.8 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.765 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.444 HG23 ' CB ' ' A' ' 157' ' ' CYS . 0.0 OUTLIER -125.01 -41.14 2.11 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.909 0.385 . . . . 0.0 110.595 -179.106 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.421 ' OE1' ' CB ' ' A' ' 83' ' ' SER . 2.1 tt0 -78.28 1.96 19.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.127 179.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.435 HD12 ' CA ' ' A' ' 115' ' ' THR . 0.0 OUTLIER -46.55 -26.23 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.094 0 CA-C-O 120.775 0.322 . . . . 0.0 111.562 179.929 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -75.52 -25.88 57.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.492 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.414 ' CD1' HD22 ' A' ' 160' ' ' LEU . 3.9 mp -83.95 -25.61 29.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.124 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.432 ' O ' ' CD1' ' A' ' 126' ' ' ILE . 5.8 ppt_? -50.36 -25.52 3.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.978 0.418 . . . . 0.0 110.629 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -87.79 -25.82 23.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.574 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -61.33 112.19 5.5 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.767 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.401 ' O ' HG22 ' A' ' 126' ' ' ILE . 40.0 Cg_endo -67.92 -6.27 16.59 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.513 2.142 . . . . 0.0 113.114 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -77.39 -68.49 0.61 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.024 0.44 . . . . 0.0 109.929 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.417 ' CG2' HG11 ' A' ' 85' ' ' VAL . 4.8 m -56.71 -35.41 68.49 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.31 0.576 . . . . 0.0 109.556 179.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.491 ' HA ' ' CD1' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -57.53 -44.04 84.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.55 179.231 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -55.69 -36.85 67.61 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.469 179.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 125' ' ' THR . 0.0 OUTLIER -64.04 -31.3 72.44 Favored 'General case' 0 CA--C 1.518 -0.25 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.554 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.491 ' CD1' ' HA ' ' A' ' 126' ' ' ILE . 7.6 mt -74.0 -42.06 60.95 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.474 ' HA ' ' HB3' ' A' ' 134' ' ' GLN . . . -47.21 -28.97 2.09 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.956 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 31.4 mmtt -56.54 -34.12 66.75 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.753 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -124.36 -31.33 3.3 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.508 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 0.0 OUTLIER -137.42 -75.6 0.41 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 121.037 -0.265 . . . . 0.0 111.306 -179.009 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.508 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 3.0 pt20 111.53 -45.21 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.607 1.163 . . . . 0.0 111.016 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.5 mttp -69.81 111.06 7.8 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.91 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -72.43 -169.89 0.52 Allowed 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.353 2.036 . . . . 0.0 111.218 178.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.495 HG23 ' CZ ' ' A' ' 90' ' ' PHE . 1.1 mm -114.03 97.03 5.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.904 0.383 . . . . 0.0 110.99 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 3.0 p -67.3 155.63 90.27 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.943 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.468 ' HA ' ' CE2' ' A' ' 154' ' ' TYR . 10.2 Cg_endo -51.66 -38.68 66.34 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.747 2.298 . . . . 0.0 112.098 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.426 ' HG3' ' N ' ' A' ' 141' ' ' THR . 0.0 OUTLIER -64.73 -25.96 68.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.664 179.69 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.426 ' N ' ' HG3' ' A' ' 140' ' ' GLU . 45.5 m -71.82 -47.4 53.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.787 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.406 ' HB2' ' CG ' ' A' ' 154' ' ' TYR . . . -55.21 -39.2 69.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.877 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -68.04 -41.96 81.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.818 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -53.25 -60.6 3.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.867 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.433 HD11 ' CB ' ' A' ' 94' ' ' LYS . 1.6 tt -66.91 -39.8 87.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.64 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -48.94 -50.37 35.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.927 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 19.2 mtp180 -78.76 -24.14 44.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.704 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -49.62 -34.78 19.03 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.88 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.6 mt -121.5 21.78 10.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.893 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.1 mttp 47.84 57.5 5.95 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.059 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.489 ' HB1' ' CD2' ' A' ' 110' ' ' PHE . . . -70.58 -82.69 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.214 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.443 ' CG2' ' O ' ' A' ' 151' ' ' ALA . 72.9 t -161.81 -73.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.842 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 179.5 146.35 0.2 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.61 -178.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.468 ' CE2' ' HA ' ' A' ' 139' ' ' PRO . 65.0 t80 -112.79 103.69 11.7 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.305 179.396 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -102.99 -179.96 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.744 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.442 ' CB ' ' HE3' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -89.6 151.3 21.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.921 0.391 . . . . 0.0 111.099 -179.797 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.457 ' N ' ' O ' ' A' ' 114' ' ' GLY . 1.9 t -128.97 169.22 14.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.883 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.426 ' CB ' ' HA ' ' A' ' 162' ' ' GLN . 2.2 t -106.99 151.46 25.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.203 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.405 ' O ' ' CD1' ' A' ' 160' ' ' LEU . . . 172.68 -33.96 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.77 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.433 ' N ' HD23 ' A' ' 160' ' ' LEU . 0.2 OUTLIER -131.09 -44.35 1.04 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.7 179.753 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 9.7 t -100.08 -21.69 15.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.091 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.426 ' HA ' ' CB ' ' A' ' 158' ' ' SER . 1.9 tt0 72.89 77.7 0.14 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.955 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.442 ' HE3' ' CB ' ' A' ' 156' ' ' GLU . 0.0 OUTLIER -97.35 10.44 39.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.569 -179.948 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.406 ' O ' ' CB ' ' A' ' 165' ' ' LEU . . . 116.25 -50.85 0.76 Allowed Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.428 -0.892 . . . . 0.0 113.336 179.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.428 ' CD2' ' HB3' ' A' ' 19' ' ' LEU . 0.2 OUTLIER 79.54 -56.6 0.4 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.8 0.333 . . . . 0.0 110.8 -179.433 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -56.8 -21.32 27.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.791 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -55.32 -72.18 0.07 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.014 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.426 HG21 ' CG1' ' A' ' 113' ' ' VAL . 29.0 m -57.9 -40.79 77.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.036 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.486 ' CD1' ' CD2' ' A' ' 19' ' ' LEU . 1.4 t80 -63.58 -34.67 78.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.734 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.403 ' HA ' ' CG1' ' A' ' 173' ' ' ILE . 13.2 m-20 -74.64 -24.89 58.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.659 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -79.41 -33.41 42.69 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.59 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -73.23 -35.25 66.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.685 179.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.403 ' CG1' ' HA ' ' A' ' 170' ' ' ASP . 1.4 pp -82.78 -32.51 9.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.891 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.487 ' CD1' ' CB ' ' B' ' 505' ' ' LEU . 13.6 tp -54.68 -47.34 73.75 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.211 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -47.5 -26.89 1.54 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.113 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.512 ' CB ' ' CG2' ' A' ' 4' ' ' ILE . . . -93.9 -37.12 11.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.173 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.48 ' CD2' HG21 ' A' ' 4' ' ' ILE . 43.3 mt -68.71 -24.2 64.46 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.663 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -160.52 128.74 2.89 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.684 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.69 106.9 0.19 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.44 2.093 . . . . 0.0 112.333 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.19 176.48 9.89 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.557 2.171 . . . . 0.0 112.248 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -139.79 141.89 29.26 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.966 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.35 -165.04 0.29 Allowed 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.718 2.279 . . . . 0.0 112.227 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.08 173.87 1.01 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.018 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.289 -0.862 . . . . 0.0 110.882 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.153 0 N-CA-C 112.421 -0.272 . . . . 0.0 112.421 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 503' ' ' SER . . . . . 0.403 ' HB2' ' HA ' ' B' ' 511' ' ' SER . 0.5 OUTLIER -87.4 -80.66 0.25 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.809 0.338 . . . . 0.0 110.908 179.943 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 504' ' ' GLY . . . . . 0.41 ' HA2' ' HA ' ' B' ' 509' ' ' ASP . . . 102.6 113.09 3.72 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.541 -0.838 . . . . 0.0 111.941 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 505' ' ' LEU . . . . . 0.487 ' CB ' ' CD1' ' A' ' 174' ' ' LEU . 0.1 OUTLIER -139.03 -42.28 0.47 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 121.053 -0.259 . . . . 0.0 111.681 -179.195 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 506' ' ' SER . . . . . 0.435 ' CB ' ' O ' ' B' ' 505' ' ' LEU . 0.4 OUTLIER 162.74 -44.98 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.668 0.27 . . . . 0.0 110.741 -179.678 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 507' ' ' ALA . . . . . . . . . . . . . . . -37.58 -35.23 0.12 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.627 0.727 . . . . 0.0 111.109 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 508' ' ' GLN . . . . . 0.472 ' O ' ' CB ' ' B' ' 509' ' ' ASP . 7.3 pt20 165.79 -37.94 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.555 -1.202 . . . . 0.0 108.634 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 509' ' ' ASP . . . . . 0.472 ' CB ' ' O ' ' B' ' 508' ' ' GLN . 13.7 t0 148.21 44.92 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 114.201 -1.363 . . . . 0.0 109.394 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 510' ' ' ILE . . . . . 0.444 ' CB ' HD12 ' A' ' 177' ' ' LEU . 19.9 mm -55.18 133.65 18.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.406 -179.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 511' ' ' SER . . . . . 0.403 ' HA ' ' HB2' ' B' ' 503' ' ' SER . 30.2 t -109.59 134.82 51.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.836 179.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 512' ' ' GLN . . . . . 0.428 ' CB ' ' HD3' ' B' ' 513' ' ' PRO . 0.0 OUTLIER -99.47 -53.65 0.18 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.134 179.735 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 513' ' ' PRO . . . . . 0.428 ' HD3' ' CB ' ' B' ' 512' ' ' GLN . 91.0 Cg_endo -94.91 78.19 0.15 Allowed 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 123.152 2.568 . . . . 0.0 112.525 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 514' ' ' LEU . . . . . 0.459 ' CD1' ' CG1' ' A' ' 44' ' ' VAL . 4.7 mp -89.23 -89.88 0.14 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.227 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 515' ' ' GLN . . . . . 0.524 ' O ' ' HB3' ' B' ' 516' ' ' ASN . 6.4 mt-30 -93.4 47.31 1.24 Allowed 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 116.744 -0.207 . . . . 0.0 111.13 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 516' ' ' ASN . . . . . 0.524 ' HB3' ' O ' ' B' ' 515' ' ' GLN . 29.2 t30 77.7 -38.23 0.26 Allowed 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 517' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 61.24 54.33 3.27 Favored 'General case' 0 C--O 1.232 0.15 0 O-C-N 122.24 -0.287 . . . . 0.0 111.452 179.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 518' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -163.54 92.73 0.72 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.894 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 519' ' ' ILE . . . . . . . . . . . . . 22.4 mm -71.16 -69.13 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.089 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -160.47 -170.44 2.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.94 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 521' ' ' THR . . . . . 0.454 ' O ' ' CZ ' ' A' ' 40' ' ' TYR . 13.8 t -77.32 -168.37 1.12 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.058 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 522' ' ' GLY . . . . . 0.457 ' HA2' ' CE1' ' A' ' 40' ' ' TYR . . . -121.41 -75.12 0.37 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.38 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 523' ' ' HIS . . . . . 0.439 ' CD2' ' C ' ' B' ' 523' ' ' HIS . 9.4 t-160 178.98 -88.21 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.555 0.217 . . . . 0.0 110.902 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 524' ' ' GLY . . . . . 0.415 ' HA3' ' CG2' ' A' ' 36' ' ' VAL . . . 46.77 -139.5 7.53 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.778 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 525' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -137.99 82.85 1.94 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.837 0.351 . . . . 0.0 110.784 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 526' ' ' SER . . . . . 0.442 ' CB ' ' HB3' ' A' ' 34' ' ' PRO . 6.5 m -72.17 95.75 1.7 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.757 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 527' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -145.96 142.42 17.78 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.016 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.21 105.29 2.0 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.671 2.248 . . . . 0.0 112.113 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 529' ' ' ARG . . . . . . . . . . . . . 2.3 mtt-85 -100.27 -55.38 2.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.307 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 530' ' ' HIS . . . . . 0.418 ' O ' ' CB ' ' B' ' 531' ' ' CYS . 0.0 OUTLIER -130.57 -38.12 1.34 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.486 -179.592 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 531' ' ' CYS . . . . . 0.418 ' CB ' ' O ' ' B' ' 530' ' ' HIS . 4.0 m 79.49 28.74 0.34 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.988 0.423 . . . . 0.0 110.604 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 532' ' ' TRP . . . . . 0.421 ' CH2' ' HG3' ' B' ' 537' ' ' ARG . 1.7 t-105 59.28 103.28 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.035 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . -114.55 -24.31 4.42 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.278 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 534' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -133.47 130.97 21.2 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.489 0.185 . . . . 0.0 110.597 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 535' ' ' PRO . . . . . 0.434 ' CB ' HG22 ' A' ' 85' ' ' VAL . 51.4 Cg_exo -54.49 -170.03 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.458 2.106 . . . . 0.0 112.504 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 68.22 120.86 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.004 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 537' ' ' ARG . . . . . 0.421 ' HG3' ' CH2' ' B' ' 532' ' ' TRP . 0.0 OUTLIER -106.23 -179.32 3.91 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 121.599 0.714 . . . . 0.0 111.259 179.916 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 538' ' ' ILE . . . . . 0.418 HG12 ' HB2' ' B' ' 542' ' ' TYR . 1.2 tt -116.02 174.47 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 CA-C-N 114.594 -1.184 . . . . 0.0 109.891 179.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 539' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.8 162.3 28.14 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.482 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 540' ' ' GLU . . . . . 0.427 ' CB ' ' OG1' ' A' ' 58' ' ' THR . 2.4 mt-10 -40.38 -49.08 2.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.841 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 541' ' ' LEU . . . . . . . . . . . . . 1.1 tt -42.28 -67.91 0.23 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.797 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 542' ' ' TYR . . . . . 0.418 ' HB2' HG12 ' B' ' 538' ' ' ILE . 59.2 m-85 -84.57 9.62 13.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.981 -179.17 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 543' ' ' LEU . . . . . 0.427 ' CD2' HG13 ' A' ' 14' ' ' VAL . 16.5 tp -44.92 -28.47 0.67 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.834 0.35 . . . . 0.0 111.283 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . -72.52 77.91 0.74 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.548 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 545' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.975 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.411 ' HB3' ' N ' ' A' ' 49' ' ' GLU . 2.6 ppp? . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.828 0.347 . . . . 0.0 111.264 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.4 ' CG ' ' CD1' ' B' ' 510' ' ' ILE . 0.2 OUTLIER -129.44 141.17 51.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.52 179.464 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.524 HG22 ' CZ ' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -94.06 168.78 10.72 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.983 -179.815 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.47 ' CG2' ' CD2' ' A' ' 177' ' ' LEU . 2.3 pt -151.03 154.39 8.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.659 -179.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -121.03 110.38 16.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.397 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 40.1 m -91.61 107.4 19.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.004 0.43 . . . . 0.0 111.589 -179.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.407 ' CG2' ' CZ ' ' A' ' 56' ' ' PHE . 2.9 t -138.0 113.65 10.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.254 179.334 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.49 ' CG2' ' CG2' ' A' ' 14' ' ' VAL . 2.4 p -87.24 150.14 3.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.308 0.575 . . . . 0.0 111.436 -179.445 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.53 ' CG2' ' CE1' ' A' ' 78' ' ' PHE . 72.5 t -155.06 130.23 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.637 179.132 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.72 148.13 4.75 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.131 -1.033 . . . . 0.0 112.711 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -58.17 -42.18 85.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.893 0.378 . . . . 0.0 110.394 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.26 -149.94 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.701 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.446 ' HA ' ' HB2' ' B' ' 537' ' ' ARG . . . -103.1 -55.86 2.33 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.274 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.49 ' CG2' ' CG2' ' A' ' 8' ' ' VAL . 3.5 t 84.13 -51.52 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.264 -0.425 . . . . 0.0 109.949 -178.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.428 ' O ' ' CB ' ' A' ' 19' ' ' LEU . . . 90.49 25.48 25.67 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.857 -0.687 . . . . 0.0 113.045 179.041 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.434 ' HB2' ' CG1' ' A' ' 8' ' ' VAL . 0.7 OUTLIER -38.58 -43.2 0.85 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.11 0.481 . . . . 0.0 111.017 179.749 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.406 ' O ' HG12 ' A' ' 21' ' ' ILE . 81.9 p -98.47 -60.98 1.44 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.278 178.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.446 ' HA ' ' HB ' ' A' ' 21' ' ' ILE . 29.7 t -46.51 -32.65 3.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.014 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.532 ' CD1' ' CE2' ' A' ' 169' ' ' PHE . 3.3 mt -45.68 -71.99 0.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -178.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.409 ' CD2' ' CE2' ' A' ' 169' ' ' PHE . 3.0 mm? -64.64 -23.67 67.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.951 -179.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.446 ' HB ' ' HA ' ' A' ' 18' ' ' CYS . 14.6 mm -61.05 -70.95 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.945 0.403 . . . . 0.0 110.486 179.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.498 ' HA ' ' HA ' ' A' ' 26' ' ' ASN . 2.4 t -51.76 -34.42 39.38 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.162 -179.075 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.485 ' CZ ' ' HD3' ' A' ' 166' ' ' LYS . 27.5 t80 -55.93 -45.11 78.84 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.968 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.62 -64.42 1.05 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.543 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 79.9 p -66.27 -37.47 85.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.582 -179.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.498 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 1.5 t-20 67.08 56.91 0.63 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.941 -179.15 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.0 mmtt -132.91 83.25 2.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.134 0.492 . . . . 0.0 110.961 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.468 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 40.5 t80 -92.35 -45.56 0.34 Allowed Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.082 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.468 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 62.6 Cg_endo -94.86 90.22 0.11 Allowed 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.955 2.436 . . . . 0.0 112.939 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.429 ' O ' ' CB ' ' B' ' 531' ' ' CYS . 0.4 OUTLIER -150.47 -89.2 0.07 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.627 0.251 . . . . 0.0 110.855 179.616 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -159.12 126.26 4.76 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.627 -0.261 . . . . 0.0 110.427 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.512 ' CG ' ' NH2' ' B' ' 537' ' ' ARG . 3.8 m-85 -111.55 121.87 46.31 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.194 0.521 . . . . 0.0 111.283 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.436 ' CB ' ' CD ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -165.42 -64.55 0.01 OUTLIER Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.433 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.436 ' CD ' ' CB ' ' A' ' 33' ' ' VAL . 50.5 Cg_endo -69.9 58.37 1.62 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.385 2.057 . . . . 0.0 112.428 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.2 t -87.64 10.47 17.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.737 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.412 HG11 ' CB ' ' A' ' 59' ' ' ALA . 3.3 m -76.0 -30.03 20.33 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-O 120.865 0.364 . . . . 0.0 110.84 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.409 ' O ' ' CG ' ' A' ' 40' ' ' TYR . 0.2 OUTLIER -50.87 -25.01 4.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.017 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -50.34 -28.29 7.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.971 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -88.99 14.52 10.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.165 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.473 ' CE1' HG13 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -71.59 -169.99 0.49 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.787 0.327 . . . . 0.0 110.911 179.809 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -112.16 119.92 40.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.316 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.473 HG13 ' CE1' ' A' ' 40' ' ' TYR . 2.5 m -122.71 121.71 64.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.023 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.4 t -104.69 128.79 52.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.9 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.483 ' CG1' ' CG2' ' A' ' 52' ' ' THR . 1.0 OUTLIER -164.54 -177.45 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.871 179.895 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.482 ' HE1' ' N ' ' A' ' 49' ' ' GLU . 5.9 tpt -101.4 96.13 6.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.012 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.462 ' O ' ' N ' ' A' ' 48' ' ' GLY . 1.6 mm -74.86 86.9 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 120.841 0.353 . . . . 0.0 110.219 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.436 ' HA3' ' HA ' ' B' ' 510' ' ' ILE . . . 33.71 -87.72 0.01 OUTLIER Glycine 0 CA--C 1.523 0.549 0 CA-C-N 115.676 -0.693 . . . . 0.0 114.327 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . -37.72 -79.17 0.04 OUTLIER Glycine 0 C--N 1.333 0.392 0 N-CA-C 113.899 0.319 . . . . 0.0 113.899 -179.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.482 ' N ' ' HE1' ' A' ' 45' ' ' MET . 2.7 mt-10 -140.52 156.34 69.42 Favored Pre-proline 0 C--N 1.332 -0.162 0 CA-C-O 120.808 0.337 . . . . 0.0 111.621 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' A' ' 49' ' ' GLU . 1.7 Cg_endo -43.2 101.01 0.04 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 123.137 2.558 . . . . 0.0 112.838 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.524 ' CZ ' HG22 ' A' ' 3' ' ' THR . 17.8 t80 -172.68 153.62 2.81 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.368 179.221 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.483 ' CG2' ' CG1' ' A' ' 44' ' ' VAL . 0.8 OUTLIER -136.88 154.11 50.57 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.961 179.53 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.46 ' HG ' ' CG1' ' A' ' 4' ' ' ILE . 0.0 OUTLIER -99.56 166.57 11.08 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.984 179.772 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 56' ' ' PHE . . . -115.17 87.56 0.44 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.42 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.34 82.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.781 0.324 . . . . 0.0 110.538 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.464 ' CG ' ' O ' ' A' ' 56' ' ' PHE . 37.4 p90 -84.36 105.5 15.24 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.571 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 56.6 p30 -98.19 -177.88 3.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.761 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.421 HG21 ' CD2' ' A' ' 70' ' ' LEU . 73.6 p -94.39 161.54 14.19 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.816 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.418 ' CA ' ' O ' ' B' ' 542' ' ' TYR . . . -170.84 179.84 3.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.172 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -150.97 34.66 0.93 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.463 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -95.71 -173.18 2.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.863 0.363 . . . . 0.0 110.917 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -51.02 -25.54 4.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.734 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.95 -54.79 34.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.798 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -132.53 152.07 51.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.774 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -85.88 -68.27 0.75 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.205 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.8 -52.27 4.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.224 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.406 HD22 ' CD ' ' A' ' 69' ' ' PRO . 7.2 tt 55.42 98.61 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.484 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.0 mmm180 -132.88 58.93 39.26 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.128 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.406 ' CD ' HD22 ' A' ' 67' ' ' LEU . 83.5 Cg_endo -83.68 -21.72 4.04 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.827 2.351 . . . . 0.0 112.172 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.466 ' CD1' ' HA ' ' B' ' 541' ' ' LEU . 1.1 pt? -85.69 1.32 49.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.721 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 46.3 t -70.59 -71.16 0.26 Allowed 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.728 0.299 . . . . 0.0 111.065 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -121.85 72.55 32.76 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.861 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -78.71 140.87 16.85 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.713 2.275 . . . . 0.0 112.457 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.8 tp60 -102.11 10.39 39.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.349 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 13.6 t -59.55 -173.75 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.866 0.365 . . . . 0.0 111.055 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -136.22 7.83 3.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.503 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.434 ' CG1' ' HB2' ' A' ' 175' ' ' ALA . 64.0 t -151.14 101.15 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 CA-C-O 120.788 0.328 . . . . 0.0 111.249 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.53 ' CE1' ' CG2' ' A' ' 9' ' ' VAL . 0.1 OUTLIER -102.08 -177.85 3.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.645 179.785 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 21.7 tp -154.13 114.59 3.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.831 0.348 . . . . 0.0 111.633 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.9 m -94.61 156.22 3.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.486 179.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.434 ' HB3' ' CG2' ' A' ' 14' ' ' VAL . 22.3 p -128.98 168.93 15.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.237 0.541 . . . . 0.0 112.178 -179.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.48 ' O ' ' CD1' ' A' ' 82' ' ' PHE . 46.9 p90 179.27 123.51 0.06 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.926 179.273 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 98.8 p -93.61 146.27 23.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.881 0.372 . . . . 0.0 111.44 -179.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.436 ' CG1' ' HG2' ' A' ' 120' ' ' ARG . 58.1 t -51.3 -73.95 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.366 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.1 m -43.27 105.76 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 120.756 0.313 . . . . 0.0 110.968 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.424 ' N ' HD22 ' A' ' 129' ' ' LEU . 87.6 p -151.33 138.65 12.19 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.62 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.407 ' O ' ' CB ' ' A' ' 88' ' ' SER . 80.3 Cg_endo -91.65 53.93 0.8 Allowed 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.305 2.67 . . . . 0.0 112.026 179.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.447 ' CB ' ' CG ' ' A' ' 133' ' ' LYS . 0.1 OUTLIER 81.42 30.33 0.14 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.84 -179.611 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 11.1 t -88.18 -24.42 23.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.697 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.464 ' CZ ' ' CG2' ' A' ' 137' ' ' ILE . 0.4 OUTLIER -50.89 -64.41 0.82 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.871 179.901 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -51.83 -37.58 52.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.936 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.413 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 3.3 m120 -67.96 -64.2 0.91 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.917 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 50.7 t -49.26 -46.7 18.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.368 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.436 ' HB2' ' CD1' ' A' ' 145' ' ' LEU . 4.5 ttpt -54.19 -59.08 5.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.276 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -83.46 9.9 10.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.869 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.413 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 13.7 tttt -116.86 -33.09 4.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.724 0.297 . . . . 0.0 111.067 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -94.35 -45.31 7.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.459 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.493 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 43.8 t -53.09 -44.44 97.13 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 -179.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.493 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 2.7 Cg_exo -76.01 -24.48 11.24 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.609 2.206 . . . . 0.0 112.641 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -88.73 -49.69 6.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.016 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.9 tt -51.16 -24.55 3.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.157 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 59.3 p -97.22 -28.72 13.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.006 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 54.1 t60 -72.82 -69.29 0.42 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.926 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -62.88 -42.15 99.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.733 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 17.0 m -111.03 148.41 38.58 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.739 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -49.29 167.7 0.15 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.502 2.135 . . . . 0.0 112.21 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.6 tmtt? -83.01 54.98 2.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.799 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.4 p -76.88 156.81 82.33 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.031 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -60.45 166.52 9.43 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.653 2.235 . . . . 0.0 112.238 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.482 ' CE2' ' HB1' ' A' ' 151' ' ' ALA . 9.1 p90 -163.11 142.44 8.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.925 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.434 ' CD1' HG13 ' A' ' 152' ' ' VAL . 0.9 OUTLIER -108.56 159.7 16.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.983 -179.721 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.43 ' CD2' ' HB3' ' A' ' 146' ' ' ALA . 3.1 mm? -106.15 128.03 53.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.659 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 43.8 t -89.96 128.45 41.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.134 0.492 . . . . 0.0 111.555 -179.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.494 ' HA2' ' CE2' ' A' ' 154' ' ' TYR . . . -112.36 103.62 1.49 Allowed Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.253 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.433 ' OG1' ' N ' ' A' ' 116' ' ' GLN . 0.4 OUTLIER -144.1 -153.65 0.48 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.826 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.433 ' N ' ' OG1' ' A' ' 115' ' ' THR . 0.4 OUTLIER 39.39 29.95 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.065 0.459 . . . . 0.0 111.329 179.333 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.432 ' CD1' ' HA ' ' A' ' 115' ' ' THR . 0.0 OUTLIER -74.37 -4.3 5.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.711 179.376 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -100.28 -22.01 15.26 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.11 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.476 ' CD2' ' N ' ' A' ' 119' ' ' LEU . 2.1 mm? -72.85 -29.65 63.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.097 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.436 ' HG2' ' CG1' ' A' ' 84' ' ' VAL . 25.7 mtp180 -47.32 -35.5 8.12 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.917 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -76.32 -42.55 44.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.794 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -46.93 100.52 0.24 Allowed Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.89 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.425 ' O ' ' CG ' ' A' ' 127' ' ' GLU . 10.5 Cg_exo -71.57 -3.76 13.7 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.737 2.291 . . . . 0.0 112.675 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.3 t -79.45 -64.11 1.26 Allowed 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.404 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 11.0 m -58.92 -40.14 83.68 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 178.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.441 ' HA ' ' CD1' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -53.78 -45.73 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.777 179.217 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.425 ' CG ' ' O ' ' A' ' 123' ' ' PRO . 3.2 mm-40 -57.54 -36.08 71.15 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.068 179.385 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 125' ' ' THR . 1.4 mptt -64.75 -30.66 71.67 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.144 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.441 ' CD1' ' HA ' ' A' ' 126' ' ' ILE . 5.3 mt -74.16 -40.8 62.34 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.09 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.424 ' HA ' ' HB3' ' A' ' 134' ' ' GLN . . . -42.91 -36.97 1.69 Allowed 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.438 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.3 mmtp -50.6 -29.06 9.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.974 0.416 . . . . 0.0 110.364 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -123.88 -31.09 3.45 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.732 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.516 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 4.0 mmpt? -148.86 -90.81 0.08 Allowed 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.516 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 1.2 pt20 122.24 -25.18 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.713 1.205 . . . . 0.0 110.314 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 4.5 ptmm? -69.21 110.71 6.7 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.716 -179.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.411 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 88.2 Cg_endo -82.01 127.69 5.5 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.574 2.182 . . . . 0.0 111.302 179.084 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.482 ' CD1' ' N ' ' A' ' 137' ' ' ILE . 0.9 OUTLIER -58.65 96.75 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.916 0.389 . . . . 0.0 110.792 -179.423 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.407 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 7.2 p -70.24 155.96 92.62 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.042 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.436 ' CD ' ' CZ ' ' A' ' 120' ' ' ARG . 10.3 Cg_endo -51.23 -24.37 15.16 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.653 2.235 . . . . 0.0 112.175 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -79.79 -46.36 17.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.551 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 6.8 m -56.2 -45.3 79.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.669 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.497 ' HB2' ' CD2' ' A' ' 154' ' ' TYR . . . -51.76 -51.49 55.82 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.847 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -53.97 -39.42 65.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.744 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.26 -55.81 24.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.701 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.436 ' CD1' ' HB2' ' A' ' 94' ' ' LYS . 1.6 tt -69.43 -36.96 77.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.572 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.43 ' HB3' ' CD2' ' A' ' 112' ' ' LEU . . . -54.42 -71.9 0.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.051 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.421 ' CZ ' ' HE3' ' A' ' 183' ' ' LYS . 10.0 mtt180 -61.35 -23.16 65.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.098 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -49.98 -37.16 31.18 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.855 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.77 20.59 16.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.087 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.3 mttt 47.89 49.09 17.3 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.144 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.482 ' HB1' ' CE2' ' A' ' 110' ' ' PHE . . . -65.25 -81.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.956 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.434 HG13 ' CD1' ' A' ' 111' ' ' LEU . 49.1 t -161.56 -75.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.732 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.75 131.18 0.26 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.923 -178.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.497 ' CD2' ' HB2' ' A' ' 142' ' ' ALA . 11.1 t80 -104.47 103.71 13.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.15 179.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.433 ' HB ' ' CG2' ' A' ' 168' ' ' VAL . 1.4 t -102.16 164.64 3.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.141 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -89.86 135.78 33.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.82 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.418 ' N ' ' O ' ' A' ' 114' ' ' GLY . 20.4 p -178.59 129.51 0.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.922 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.417 ' O ' ' CA ' ' A' ' 162' ' ' GLN . 0.1 OUTLIER -125.74 140.4 52.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.172 -179.906 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.409 ' N ' HD12 ' A' ' 165' ' ' LEU . . . -84.19 -44.32 14.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.072 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -47.77 -34.97 9.21 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.763 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.6 t -116.02 -15.87 11.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.118 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.417 ' CA ' ' O ' ' A' ' 158' ' ' SER . 1.5 tt0 70.33 66.8 0.21 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.812 0.339 . . . . 0.0 110.68 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -93.81 22.79 5.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.254 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 102.36 41.98 2.28 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.48 -0.867 . . . . 0.0 113.111 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.459 ' CD2' ' HA ' ' A' ' 19' ' ' LEU . 1.7 tp -50.4 -25.07 3.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.864 0.364 . . . . 0.0 110.691 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.485 ' HD3' ' CZ ' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -68.54 -26.08 65.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.842 179.514 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -58.33 -72.29 0.1 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.827 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.433 ' CG2' ' HB ' ' A' ' 155' ' ' VAL . 91.3 t -52.44 -43.63 41.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.967 0.413 . . . . 0.0 110.461 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.532 ' CE2' ' CD1' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -62.77 -33.66 75.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.277 179.681 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 166' ' ' LYS . 27.1 t0 -69.82 -25.61 63.84 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.599 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -78.75 -29.15 44.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.132 179.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.426 ' N ' HD12 ' A' ' 111' ' ' LEU . . . -75.1 -43.51 52.53 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.888 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 1.6 pp -68.75 -36.11 72.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.838 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.422 ' CD2' ' HB3' ' B' ' 505' ' ' LEU . 26.0 tp -55.13 -42.95 73.68 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.776 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.434 ' HB2' ' CG1' ' A' ' 77' ' ' VAL . . . -48.17 -27.01 2.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.775 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.432 ' CB ' ' HB ' ' A' ' 4' ' ' ILE . . . -86.7 -43.75 12.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.845 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.47 ' CD2' ' CG2' ' A' ' 4' ' ' ILE . 56.3 mt -68.73 -26.94 65.51 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.957 0.408 . . . . 0.0 110.255 179.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.428 ' HG3' ' N ' ' B' ' 507' ' ' ALA . 0.1 OUTLIER -174.14 92.6 0.33 Allowed Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.721 179.788 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -47.74 106.04 0.1 OUTLIER 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.645 2.23 . . . . 0.0 112.428 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.22 171.99 10.69 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.47 2.114 . . . . 0.0 112.205 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -110.19 137.79 20.67 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.979 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -79.42 -165.17 0.32 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.576 2.184 . . . . 0.0 112.272 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.421 ' HE3' ' CZ ' ' A' ' 147' ' ' ARG . 0.0 OUTLIER -135.97 97.33 3.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.925 179.992 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.166 -0.921 . . . . 0.0 110.921 -179.985 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 503' ' ' SER . . . . . . . . . . . . . 3.3 m -90.41 -75.97 0.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.744 0.307 . . . . 0.0 110.918 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 504' ' ' GLY . . . . . 0.422 ' O ' ' CD1' ' B' ' 505' ' ' LEU . . . 144.16 -116.84 0.99 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.368 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 505' ' ' LEU . . . . . 0.422 ' CD1' ' O ' ' B' ' 504' ' ' GLY . 0.1 OUTLIER 64.99 -70.6 0.09 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.786 0.327 . . . . 0.0 111.204 179.823 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 506' ' ' SER . . . . . 0.42 ' N ' ' O ' ' B' ' 504' ' ' GLY . 0.1 OUTLIER -171.92 -159.77 0.15 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.546 -179.973 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 507' ' ' ALA . . . . . 0.428 ' N ' ' HG3' ' A' ' 178' ' ' GLU . . . 62.97 -95.71 0.05 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.469 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 508' ' ' GLN . . . . . 0.462 ' O ' ' CB ' ' B' ' 509' ' ' ASP . 28.6 mt-30 -137.28 4.04 2.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.875 179.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 509' ' ' ASP . . . . . 0.462 ' CB ' ' O ' ' B' ' 508' ' ' GLN . 0.1 OUTLIER 92.36 29.7 0.01 OUTLIER 'General case' 0 C--N 1.345 0.406 0 CA-C-O 121.461 0.648 . . . . 0.0 109.864 -179.127 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 510' ' ' ILE . . . . . 0.44 ' CG2' HG23 ' A' ' 46' ' ' ILE . 43.0 mt -61.58 149.48 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.393 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 511' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.23 146.62 33.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.291 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 512' ' ' GLN . . . . . 0.494 ' CB ' ' CD ' ' B' ' 513' ' ' PRO . 1.5 pm0 -57.79 -176.2 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.35 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 513' ' ' PRO . . . . . 0.494 ' CD ' ' CB ' ' B' ' 512' ' ' GLN . 50.9 Cg_exo -55.52 82.37 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.492 2.128 . . . . 0.0 111.694 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 514' ' ' LEU . . . . . 0.455 ' CD1' HG13 ' A' ' 44' ' ' VAL . 1.8 mp -46.38 171.96 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.003 -179.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 515' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -94.26 -168.65 1.89 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.766 179.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 66.22 10.49 7.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.589 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 517' ' ' SER . . . . . 0.45 ' CB ' ' HB ' ' A' ' 44' ' ' VAL . 72.5 p -133.47 80.77 1.89 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.912 0.387 . . . . 0.0 111.02 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 518' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -140.45 91.69 2.46 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.897 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 519' ' ' ILE . . . . . . . . . . . . . 3.0 mm -84.97 138.12 19.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.046 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -41.89 -88.86 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.409 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 521' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 47.86 -161.59 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.873 0.368 . . . . 0.0 111.009 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 522' ' ' GLY . . . . . . . . . . . . . . . 55.24 170.33 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.47 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 523' ' ' HIS . . . . . . . . . . . . . 22.7 t60 -156.6 -77.45 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.787 0.327 . . . . 0.0 110.876 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 524' ' ' GLY . . . . . . . . . . . . . . . 46.68 -144.62 4.33 Favored Glycine 0 N--CA 1.454 -0.164 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.722 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 525' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -119.24 81.47 1.72 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.826 0.346 . . . . 0.0 110.842 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 526' ' ' SER . . . . . 0.433 ' CA ' ' HB3' ' A' ' 34' ' ' PRO . 0.7 OUTLIER -88.43 96.25 10.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.785 179.968 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 527' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -162.08 141.28 7.28 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.795 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -57.52 97.61 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.677 2.251 . . . . 0.0 112.072 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 529' ' ' ARG . . . . . 0.429 ' CD ' HG11 ' A' ' 33' ' ' VAL . 10.4 mtp180 -100.23 -54.74 2.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.099 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 530' ' ' HIS . . . . . 0.487 ' CE1' ' HB3' ' B' ' 545' ' ' ASN . 6.2 p80 -165.47 97.45 0.68 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.831 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 531' ' ' CYS . . . . . 0.429 ' CB ' ' O ' ' A' ' 30' ' ' SER . 18.8 p -53.49 -171.65 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.068 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 532' ' ' TRP . . . . . . . . . . . . . 87.4 t90 -49.06 103.78 0.05 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.013 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . -116.39 -57.47 0.32 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.496 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 534' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -68.38 155.97 91.38 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 120.705 0.288 . . . . 0.0 110.872 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -63.34 -19.52 68.39 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.633 2.222 . . . . 0.0 112.485 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -151.66 139.01 19.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.929 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 537' ' ' ARG . . . . . 0.512 ' NH2' ' CG ' ' A' ' 32' ' ' TYR . 0.1 OUTLIER -48.07 152.23 0.85 Allowed 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.114 179.921 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 538' ' ' ILE . . . . . 0.41 ' CG2' ' HA ' ' B' ' 543' ' ' LEU . 5.6 tp -63.42 140.77 19.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.139 179.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 539' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -44.61 147.39 0.61 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.733 0.301 . . . . 0.0 111.162 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 540' ' ' GLU . . . . . 0.404 ' O ' HG21 ' A' ' 58' ' ' THR . 49.8 mm-40 -60.14 -15.86 27.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.613 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 541' ' ' LEU . . . . . 0.466 ' HA ' ' CD1' ' A' ' 70' ' ' LEU . 2.9 mm? -41.31 -59.59 1.5 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.99 0.424 . . . . 0.0 110.897 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 542' ' ' TYR . . . . . 0.44 ' CD1' ' HB3' ' B' ' 541' ' ' LEU . 0.1 OUTLIER -105.84 -53.63 2.61 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.578 179.41 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 543' ' ' LEU . . . . . 0.41 ' HA ' ' CG2' ' B' ' 538' ' ' ILE . 6.8 tp 57.01 31.94 20.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.936 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . -119.13 83.6 0.35 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.468 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 545' ' ' ASN . . . . . 0.487 ' HB3' ' CE1' ' B' ' 530' ' ' HIS . 3.6 m120 . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.211 -0.9 . . . . 0.0 110.851 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.405 ' N ' ' OE1' ' B' ' 508' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.796 0.331 . . . . 0.0 111.255 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.81 144.4 47.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.388 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.497 HG22 ' CE1' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -93.86 176.34 6.38 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.925 -179.948 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.449 HG13 ' CD1' ' A' ' 53' ' ' LEU . 4.0 pt -152.27 146.36 15.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.009 0.433 . . . . 0.0 112.115 -178.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.427 ' O ' ' CB ' ' A' ' 75' ' ' THR . 13.1 tptp -134.44 95.73 3.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.399 179.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -110.08 119.74 40.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.979 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.426 ' HA ' ' HB3' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -104.79 145.55 13.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.14 0.495 . . . . 0.0 111.301 179.772 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.49 HG11 ' CG ' ' A' ' 56' ' ' PHE . 2.6 p -91.63 113.55 27.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.268 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 30.1 m -134.9 150.33 29.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.081 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 127.93 -144.46 15.22 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.508 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -103.25 -21.34 13.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.72 0.295 . . . . 0.0 110.956 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -105.02 156.33 16.87 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.611 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.427 ' O ' HG21 ' A' ' 14' ' ' VAL . . . -82.47 4.78 22.93 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.427 HG21 ' O ' ' A' ' 13' ' ' ALA . 1.9 m 40.99 31.07 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 120.985 0.422 . . . . 0.0 111.37 -179.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.435 ' O ' ' CG ' ' A' ' 19' ' ' LEU . . . 56.96 24.93 52.22 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.407 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.54 ' CB ' ' CE1' ' A' ' 56' ' ' PHE . 9.6 ptmt -38.31 -45.43 0.99 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.809 0.338 . . . . 0.0 111.628 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.427 ' CG2' HG13 ' A' ' 21' ' ' ILE . 0.2 OUTLIER -97.46 -57.43 2.25 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.49 179.341 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.447 ' O ' ' CB ' ' A' ' 22' ' ' SER . 46.8 m -47.65 -32.06 5.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.245 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.522 ' CD1' ' CD1' ' A' ' 169' ' ' PHE . 9.6 mt -47.35 -71.32 0.07 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.026 0.441 . . . . 0.0 111.079 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.08 -27.47 23.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.947 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.458 ' CG2' ' CG ' ' A' ' 27' ' ' LYS . 46.8 mm -68.44 -52.96 31.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 179.051 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.447 ' CB ' ' O ' ' A' ' 18' ' ' CYS . 2.3 t -69.73 -37.61 76.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.519 179.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -51.87 -45.9 64.26 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.575 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.1 m -94.03 -48.58 6.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.566 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.441 ' N ' ' O ' ' A' ' 21' ' ' ILE . 1.3 p -96.4 -146.19 0.29 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.228 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.44 ' N ' ' ND2' ' A' ' 26' ' ' ASN . 0.1 OUTLIER -163.2 34.64 0.09 Allowed 'General case' 0 C--O 1.232 0.139 0 O-C-N 122.341 -0.225 . . . . 0.0 111.365 -179.746 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.458 ' CG ' ' CG2' ' A' ' 21' ' ' ILE . 0.1 OUTLIER -86.42 127.41 34.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.926 0.393 . . . . 0.0 111.067 -179.896 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.511 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . 89.0 t80 -164.04 -50.71 0.01 OUTLIER Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.035 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.511 ' HD3' ' HB3' ' A' ' 28' ' ' PHE . 88.1 Cg_endo -93.03 33.06 0.24 Allowed 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.171 1.914 . . . . 0.0 112.65 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.43 -84.8 0.58 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.772 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -159.04 147.59 18.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.697 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -126.02 124.04 39.8 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.675 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.443 ' CG2' ' HD3' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -165.17 -61.76 0.01 OUTLIER Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.112 -179.763 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.479 ' O ' ' CD1' ' A' ' 37' ' ' PHE . 79.5 Cg_exo -46.36 -25.78 3.5 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.382 2.054 . . . . 0.0 112.329 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.429 HG22 ' N ' ' A' ' 36' ' ' VAL . 6.5 t -40.54 -29.51 0.09 Allowed 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.893 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.43 ' CG1' HD11 ' A' ' 61' ' ' LEU . 12.0 p -51.95 -22.25 2.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.607 -0.269 . . . . 0.0 111.394 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.479 ' CD1' ' O ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -88.68 18.34 4.76 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.494 179.899 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.403 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 25.6 t0 -58.74 -18.02 27.94 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.223 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -86.57 13.56 8.31 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.546 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.466 ' CD1' ' N ' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -60.8 179.09 0.19 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.819 0.342 . . . . 0.0 110.946 179.91 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -98.05 124.94 42.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.143 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.414 ' CG1' ' O ' ' B' ' 517' ' ' SER . 2.8 t -119.1 146.63 23.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.737 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.4 p -129.13 112.02 13.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.867 0.365 . . . . 0.0 111.566 -179.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.501 ' CG2' ' CG2' ' A' ' 52' ' ' THR . 4.1 m -153.1 -176.97 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.652 179.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.479 ' HE2' ' N ' ' A' ' 46' ' ' ILE . 4.4 tpt -100.65 95.94 7.01 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.658 -179.099 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.479 ' N ' ' HE2' ' A' ' 45' ' ' MET . 1.2 mm -82.23 87.32 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-O 121.382 0.61 . . . . 0.0 109.913 178.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 46.23 -90.69 0.01 OUTLIER Glycine 0 CA--C 1.522 0.494 0 CA-C-N 115.488 -0.778 . . . . 0.0 113.647 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . -36.5 -96.39 0.01 OUTLIER Glycine 0 C--N 1.335 0.477 0 N-CA-C 113.997 0.359 . . . . 0.0 113.997 -179.076 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.448 ' N ' ' HE1' ' A' ' 45' ' ' MET . 1.6 pt-20 -125.66 158.85 63.54 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 120.539 0.209 . . . . 0.0 110.555 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -40.2 101.07 0.03 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.595 2.196 . . . . 0.0 112.542 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.498 ' CG ' ' N ' ' A' ' 52' ' ' THR . 5.6 t80 -172.24 162.43 5.59 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.422 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.501 ' CG2' ' CG2' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -136.62 145.82 45.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.07 179.377 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.449 ' CD1' HG13 ' A' ' 4' ' ' ILE . 0.8 OUTLIER -83.54 179.57 7.6 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.848 179.847 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -103.14 109.93 3.59 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.236 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.38 -159.26 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.801 0.334 . . . . 0.0 110.76 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.54 ' CE1' ' CB ' ' A' ' 16' ' ' LYS . 0.1 OUTLIER -104.3 166.27 10.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.053 0.454 . . . . 0.0 111.091 -179.909 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.403 ' OD1' ' N ' ' A' ' 38' ' ' ASP . 31.0 t70 -167.63 111.2 0.66 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.444 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.434 ' HB ' ' CD2' ' A' ' 67' ' ' LEU . 22.5 p -144.96 126.43 14.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.044 -179.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -171.16 126.2 0.66 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.094 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -74.92 65.35 2.23 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.478 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.43 HD11 ' CG1' ' A' ' 36' ' ' VAL . 55.9 mt -115.88 172.97 6.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.802 0.334 . . . . 0.0 110.911 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -52.27 -37.04 54.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.815 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.449 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 1.0 OUTLIER -58.19 -62.42 1.84 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.798 179.866 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.449 ' CD2' ' HB3' ' A' ' 63' ' ' ASP . 0.3 OUTLIER -136.16 77.31 1.65 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.594 179.969 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -86.05 -16.04 39.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.491 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -83.45 -53.22 5.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.581 0.229 . . . . 0.0 111.478 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.434 ' CD2' ' HB ' ' A' ' 58' ' ' THR . 1.6 mp 49.6 -179.73 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.487 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 168.25 -57.33 0.0 OUTLIER Pre-proline 0 N--CA 1.465 0.3 0 CA-C-O 120.688 0.28 . . . . 0.0 111.354 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.412 ' O ' ' NE2' ' A' ' 74' ' ' GLN . 68.0 Cg_exo -38.12 -47.77 2.26 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.981 2.454 . . . . 0.0 113.039 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.422 ' CD2' ' O ' ' B' ' 541' ' ' LEU . 0.3 OUTLIER -48.06 -26.9 2.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.164 -179.757 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.64 -31.75 12.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.812 0.339 . . . . 0.0 111.448 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -82.66 143.29 46.88 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.116 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.37 100.41 0.89 Allowed 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.646 2.231 . . . . 0.0 111.977 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.412 ' NE2' ' O ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -102.19 -67.55 0.87 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.514 -179.461 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.427 ' CB ' ' O ' ' A' ' 5' ' ' LYS . 12.4 t -84.26 -164.67 0.98 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.706 -179.281 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.413 ' O ' ' HD2' ' A' ' 109' ' ' PRO . 4.2 p30 -124.74 8.33 8.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.238 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 39.3 t -141.55 91.18 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 CA-C-O 120.758 0.313 . . . . 0.0 111.157 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.48 ' CD1' HG21 ' A' ' 108' ' ' THR . 2.9 m-30 -80.79 -177.7 6.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.6 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.417 ' CD2' HG23 ' A' ' 14' ' ' VAL . 8.1 tp -143.34 108.46 4.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.262 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.48 HG22 ' CD2' ' A' ' 110' ' ' PHE . 21.5 m -105.61 135.09 45.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.02 179.088 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.403 ' HB2' HG12 ' A' ' 14' ' ' VAL . 9.6 m -137.38 170.7 15.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.212 0.529 . . . . 0.0 111.968 -179.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.526 ' CZ ' ' CE1' ' A' ' 90' ' ' PHE . 15.0 p90 -167.77 137.29 2.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.439 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 57.4 p -83.68 139.4 32.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.725 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.443 ' HA ' HG12 ' A' ' 137' ' ' ILE . 65.6 t -48.48 -63.78 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.22 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.422 HG13 ' CD1' ' A' ' 119' ' ' LEU . 30.4 m -45.35 111.85 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-O 120.61 0.243 . . . . 0.0 110.518 179.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.409 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 3.4 p -149.0 140.76 14.56 Favored Pre-proline 0 C--N 1.33 -0.24 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -178.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.436 ' CA ' ' HB2' ' A' ' 132' ' ' ASN . 72.3 Cg_endo -93.07 54.3 0.44 Allowed 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 123.381 2.721 . . . . 0.0 111.797 179.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.433 ' CB ' ' HB2' ' A' ' 133' ' ' LYS . 0.5 OUTLIER 72.93 21.73 3.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.043 -179.554 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 43.3 p -97.48 -17.8 19.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.264 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.526 ' CE1' ' CZ ' ' A' ' 82' ' ' PHE . 8.5 t80 -45.68 -72.86 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.743 0.306 . . . . 0.0 111.302 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -53.64 -31.2 46.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.812 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.41 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 8.3 t-20 -66.8 -58.18 5.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.953 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.432 HG11 ' N ' ' A' ' 94' ' ' LYS . 12.3 p -62.42 -41.3 91.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.256 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.432 ' N ' HG11 ' A' ' 93' ' ' VAL . 0.8 OUTLIER -55.65 -75.33 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.832 179.951 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.423 ' O ' ' CG ' ' A' ' 99' ' ' PRO . 24.3 mm-40 -52.24 -24.01 6.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.913 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.41 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 57.4 tttt -83.62 -22.51 32.2 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.114 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.457 ' HA ' ' CE3' ' A' ' 97' ' ' TRP . 0.0 OUTLIER -82.09 -55.49 4.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.58 -179.79 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.472 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 5.0 t -41.49 -46.63 8.55 Favored Pre-proline 0 N--CA 1.466 0.358 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -179.001 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 13.7 Cg_exo -69.96 -35.02 12.81 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.72 2.28 . . . . 0.0 112.354 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.415 ' OE1' ' N ' ' A' ' 100' ' ' GLU . 1.3 mp0 -76.73 -37.63 55.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.78 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 54.8 mt -65.93 -25.36 35.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.001 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 25.1 p -93.52 -26.93 16.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.858 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -66.09 -68.04 0.4 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.816 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -59.56 -34.76 73.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.696 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 89.3 m -127.4 103.58 22.48 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.756 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.68 106.72 0.64 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.439 2.093 . . . . 0.0 112.193 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.71 82.85 0.15 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.949 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.48 HG21 ' CD1' ' A' ' 78' ' ' PHE . 0.1 OUTLIER -131.59 100.12 16.63 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.853 179.98 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.413 ' HD2' ' O ' ' A' ' 76' ' ' ASP . 31.3 Cg_exo -59.69 158.54 27.87 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.677 2.251 . . . . 0.0 112.251 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.481 ' CD2' ' HB2' ' A' ' 151' ' ' ALA . 24.8 p90 -150.62 -176.62 5.57 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.092 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.446 ' CD1' ' CG1' ' A' ' 152' ' ' VAL . 4.4 tt -146.27 147.63 31.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.863 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.42 ' O ' ' CD2' ' A' ' 111' ' ' LEU . 4.2 mm? -93.43 156.8 16.56 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.626 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.439 ' CG1' HG23 ' A' ' 168' ' ' VAL . 11.0 t -143.21 150.68 17.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.091 0.472 . . . . 0.0 112.227 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.419 ' O ' ' CD1' ' A' ' 117' ' ' ILE . . . -124.46 100.15 0.62 Allowed Glycine 0 C--N 1.331 0.272 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.509 179.387 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.438 ' CG2' HG13 ' A' ' 113' ' ' VAL . 1.3 p -122.97 -2.47 8.7 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -178.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.43 ' HG3' ' CD1' ' A' ' 119' ' ' LEU . 1.6 tp-100 -111.66 10.23 21.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.115 0.483 . . . . 0.0 109.86 178.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.419 ' CD1' ' O ' ' A' ' 114' ' ' GLY . 0.1 OUTLIER -64.36 -11.63 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.948 179.018 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -80.34 -43.22 21.54 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.852 -179.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.43 ' CD1' ' HG3' ' A' ' 116' ' ' GLN . 4.0 pp -99.43 0.52 42.8 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -179.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.422 ' O ' ' CD1' ' A' ' 126' ' ' ILE . 0.3 OUTLIER -54.71 -27.63 41.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.002 0.429 . . . . 0.0 110.017 179.245 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -80.85 -23.91 38.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.306 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -51.27 104.65 0.44 Allowed Pre-proline 0 C--N 1.332 -0.162 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.501 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.432 ' HA ' ' CG2' ' A' ' 126' ' ' ILE . 14.3 Cg_exo -69.31 -3.52 11.88 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 122.739 2.293 . . . . 0.0 112.978 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 10.3 t -72.56 -69.36 0.41 Allowed 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 120.914 0.388 . . . . 0.0 109.969 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.436 HG21 ' CD1' ' A' ' 129' ' ' LEU . 17.2 m -58.31 -44.27 88.51 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.432 ' CG2' ' HA ' ' A' ' 123' ' ' PRO . 0.0 OUTLIER -50.09 -33.93 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.093 179.694 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.426 ' CG ' ' O ' ' A' ' 123' ' ' PRO . 3.9 mm-40 -70.88 -35.19 72.25 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.433 ' N ' ' O ' ' A' ' 125' ' ' THR . 0.1 OUTLIER -68.44 -34.85 76.71 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 177.934 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.476 HD12 ' N ' ' A' ' 129' ' ' LEU . 9.2 mp -60.76 -42.54 97.65 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.473 ' HA ' ' HB3' ' A' ' 134' ' ' GLN . . . -42.52 -36.33 1.32 Allowed 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 114.602 -1.181 . . . . 0.0 111.503 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm -55.1 -29.44 57.62 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.859 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.436 ' HB2' ' CA ' ' A' ' 87' ' ' PRO . 29.8 m-80 -124.44 -32.49 3.14 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -179.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.512 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 1.3 ttpt -142.69 -83.13 0.18 Allowed 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 122.332 -0.23 . . . . 0.0 111.083 -179.047 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.512 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 9.9 pt20 114.94 -42.1 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.682 1.193 . . . . 0.0 111.077 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.2 mptt -68.61 110.1 5.3 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.112 -0.494 . . . . 0.0 112.235 -178.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.25 148.11 33.92 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.494 2.129 . . . . 0.0 111.209 178.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.518 ' CD1' ' N ' ' A' ' 137' ' ' ILE . 0.7 OUTLIER -76.87 96.8 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.898 0.38 . . . . 0.0 111.053 -179.31 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 3.3 p -68.79 148.78 98.01 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.736 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.431 ' HA ' ' CE2' ' A' ' 154' ' ' TYR . 83.3 Cg_exo -45.56 -26.92 3.15 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.607 2.205 . . . . 0.0 112.382 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -77.48 -32.39 54.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.816 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.2 m -64.25 -57.55 9.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.89 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -51.11 -44.15 61.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.063 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -56.14 -44.12 78.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.949 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.6 mttt -56.92 -62.91 1.41 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.786 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.422 ' CD1' ' HG3' ' A' ' 94' ' ' LYS . 1.0 OUTLIER -60.2 -35.9 76.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.775 179.833 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -51.55 -60.86 2.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.863 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 22.2 mtt180 -67.29 -22.32 65.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.885 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -50.25 -48.81 54.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.695 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -92.89 17.43 10.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.084 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 9.9 mttt 47.6 51.44 13.86 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.787 0.327 . . . . 0.0 111.021 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.481 ' HB2' ' CD2' ' A' ' 110' ' ' PHE . . . -75.73 -82.2 0.07 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.176 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.446 ' CG1' ' CD1' ' A' ' 111' ' ' LEU . 69.8 t -160.42 -74.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.928 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.403 ' HG3' ' N ' ' A' ' 154' ' ' TYR . 0.2 OUTLIER -177.52 144.43 0.39 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.65 -179.042 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.431 ' CE2' ' HA ' ' A' ' 139' ' ' PRO . 18.3 t80 -105.75 109.59 21.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.186 179.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 3.1 t -101.64 158.81 4.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.998 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -100.49 126.18 46.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.016 0.436 . . . . 0.0 111.666 -179.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.402 ' HA ' ' HB3' ' A' ' 163' ' ' LYS . 1.4 p 178.51 126.07 0.05 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.548 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.413 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 15.4 m -112.5 167.99 10.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.943 0.402 . . . . 0.0 111.427 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.44 ' CB ' ' HB3' ' A' ' 18' ' ' CYS . . . -98.77 -33.53 10.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.843 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -51.14 -38.69 53.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.448 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.0 t -117.33 -12.91 10.42 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.163 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 64.65 72.48 0.44 Allowed 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.818 0.342 . . . . 0.0 110.892 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.408 ' CG ' ' O ' ' A' ' 163' ' ' LYS . 68.1 tttt -97.17 22.82 8.07 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.19 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 107.82 41.0 1.63 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.161 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.443 ' CD1' ' HA ' ' A' ' 19' ' ' LEU . 0.4 OUTLIER -49.26 -30.82 7.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.089 0.471 . . . . 0.0 110.632 179.596 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 22.9 pttm -68.79 -31.66 70.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.657 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -52.59 -69.28 0.12 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.546 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.439 HG23 ' CG1' ' A' ' 113' ' ' VAL . 12.3 p -50.29 -44.19 23.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.059 0.457 . . . . 0.0 110.441 179.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.522 ' CD1' ' CD1' ' A' ' 19' ' ' LEU . 2.2 t80 -59.85 -34.32 72.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.12 179.306 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.423 ' HA ' ' CG1' ' A' ' 173' ' ' ILE . 0.6 OUTLIER -60.7 -34.87 75.01 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.837 179.236 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.12 -30.46 63.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.2 179.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.424 ' N ' HD12 ' A' ' 111' ' ' LEU . . . -76.39 -42.39 44.63 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.648 179.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.423 ' CG1' ' HA ' ' A' ' 170' ' ' ASP . 1.5 pp -76.97 -32.62 19.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.423 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.423 ' CD2' HD23 ' B' ' 505' ' ' LEU . 22.8 tp -53.37 -49.34 67.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.551 179.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.84 -22.29 62.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.783 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.433 ' CB ' ' HB ' ' A' ' 4' ' ' ILE . . . -85.4 -41.82 15.08 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.058 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.448 ' CD1' ' HB ' ' B' ' 510' ' ' ILE . 32.6 mt -68.78 -23.18 64.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.819 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.4 ' HB2' ' CB ' ' B' ' 507' ' ' ALA . 0.0 OUTLIER -168.3 153.56 6.5 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.784 179.934 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -52.72 124.01 14.32 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.621 2.214 . . . . 0.0 112.313 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.53 -178.43 3.37 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.538 2.159 . . . . 0.0 112.404 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -144.42 99.53 4.89 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.858 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -88.47 35.43 0.4 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 123.197 2.598 . . . . 0.0 113.038 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 17.4 pttt -56.36 157.35 5.04 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.878 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 7.2 mttm . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.898 -179.978 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.204 0 N-CA-C 112.506 -0.238 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 503' ' ' SER . . . . . . . . . . . . . 22.3 m -67.35 -78.93 0.05 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.805 0.336 . . . . 0.0 110.814 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 504' ' ' GLY . . . . . 0.418 ' CA ' ' OD2' ' B' ' 509' ' ' ASP . . . 92.71 103.53 1.54 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.278 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 505' ' ' LEU . . . . . 0.423 HD23 ' CD2' ' A' ' 174' ' ' LEU . 0.2 OUTLIER -164.36 47.56 0.11 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.792 0.329 . . . . 0.0 111.31 -179.614 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 506' ' ' SER . . . . . . . . . . . . . 4.9 m 59.31 87.86 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.975 0.417 . . . . 0.0 110.022 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 507' ' ' ALA . . . . . 0.446 ' O ' ' CB ' ' B' ' 508' ' ' GLN . . . 173.75 -37.68 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.242 -179.083 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 508' ' ' GLN . . . . . 0.487 ' CB ' ' CD1' ' B' ' 510' ' ' ILE . 1.3 mt-30 155.48 -20.85 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.7 -1.136 . . . . 0.0 109.994 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 509' ' ' ASP . . . . . 0.455 ' CB ' ' O ' ' B' ' 508' ' ' GLN . 8.4 t70 90.03 38.67 0.01 OUTLIER 'General case' 0 C--N 1.343 0.323 0 CA-C-O 121.309 0.576 . . . . 0.0 110.6 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 510' ' ' ILE . . . . . 0.487 ' CD1' ' CB ' ' B' ' 508' ' ' GLN . 1.9 mp -68.99 136.39 26.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.346 179.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 511' ' ' SER . . . . . 0.437 ' HB2' ' CD2' ' B' ' 514' ' ' LEU . 4.1 m -109.23 153.98 23.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.061 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 512' ' ' GLN . . . . . 0.49 ' CB ' ' CD ' ' B' ' 513' ' ' PRO . 1.8 mm-40 -98.53 -68.37 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.82 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 513' ' ' PRO . . . . . 0.49 ' CD ' ' CB ' ' B' ' 512' ' ' GLN . 90.4 Cg_endo -78.64 59.55 7.27 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.4 2.067 . . . . 0.0 111.781 179.384 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 514' ' ' LEU . . . . . 0.451 ' CD1' ' O ' ' A' ' 45' ' ' MET . 1.1 mt -73.34 -86.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.751 -179.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 515' ' ' GLN . . . . . 0.406 ' CB ' HG12 ' A' ' 44' ' ' VAL . 0.5 OUTLIER -88.1 -10.31 50.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.649 -179.529 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 53.59 24.52 4.23 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.936 0.398 . . . . 0.0 110.379 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 517' ' ' SER . . . . . 0.414 ' O ' ' CG1' ' A' ' 42' ' ' VAL . 75.4 m -68.28 58.8 0.08 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.618 -179.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 518' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -78.28 91.48 4.42 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.42 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 519' ' ' ILE . . . . . . . . . . . . . 3.5 mm -76.28 157.47 5.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.251 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -101.57 119.59 39.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.903 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 521' ' ' THR . . . . . . . . . . . . . 18.7 p -133.93 -61.99 0.78 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.829 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 522' ' ' GLY . . . . . . . . . . . . . . . -55.74 119.56 14.62 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.564 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 523' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -59.05 -83.76 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.772 0.32 . . . . 0.0 110.882 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 524' ' ' GLY . . . . . 0.426 ' HA3' ' CG1' ' A' ' 36' ' ' VAL . . . 67.88 167.86 4.04 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.492 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 525' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.28 83.19 8.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.83 0.348 . . . . 0.0 110.94 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 526' ' ' SER . . . . . 0.436 ' CB ' ' HG3' ' A' ' 34' ' ' PRO . 6.4 t -83.58 95.79 8.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.694 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 527' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -177.52 147.36 0.66 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.995 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.74 101.56 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.685 2.257 . . . . 0.0 112.109 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 529' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.16 -55.3 2.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.352 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 530' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -142.3 -47.21 0.34 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.025 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 3.0 m 72.94 -172.1 0.14 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.806 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 532' ' ' TRP . . . . . . . . . . . . . 24.1 t90 -62.06 102.74 0.31 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.962 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . -122.02 -38.46 0.6 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.481 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 534' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -105.61 154.86 38.9 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 120.731 0.301 . . . . 0.0 110.932 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -67.18 125.51 13.65 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.641 2.228 . . . . 0.0 112.085 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 1.3 t0 70.84 141.35 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.768 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 537' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -70.8 144.6 50.76 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.25 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 538' ' ' ILE . . . . . 0.45 ' CG2' HD12 ' B' ' 543' ' ' LEU . 6.2 tp -58.16 145.17 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 539' ' ' ASP . . . . . 0.449 ' O ' ' CD1' ' B' ' 543' ' ' LEU . 20.5 t0 -41.38 132.85 2.6 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.969 0.414 . . . . 0.0 112.028 -178.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 540' ' ' GLU . . . . . 0.473 ' HA ' ' CD1' ' B' ' 543' ' ' LEU . 0.8 OUTLIER -40.55 -27.27 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.047 179.702 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 541' ' ' LEU . . . . . 0.444 ' HB3' ' CD1' ' B' ' 542' ' ' TYR . 5.3 mt -31.93 -69.24 0.08 Allowed 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 542' ' ' TYR . . . . . 0.444 ' CD1' ' HB3' ' B' ' 541' ' ' LEU . 0.1 OUTLIER -103.36 -63.78 1.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.317 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 543' ' ' LEU . . . . . 0.473 ' CD1' ' HA ' ' B' ' 540' ' ' GLU . 4.6 mp 65.05 141.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.866 -179.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . 132.62 141.86 4.74 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.487 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 545' ' ' ASN . . . . . . . . . . . . . 36.1 m-20 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.923 179.983 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.449 ' CE ' HG21 ' A' ' 46' ' ' ILE . 7.4 tpt . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.475 0.179 . . . . 0.0 111.2 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.431 ' O ' ' CE ' ' A' ' 1' ' ' MET . 39.4 tp60 60.76 137.83 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.047 0.451 . . . . 0.0 110.917 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.524 ' CG2' ' CE1' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -124.24 -165.95 1.43 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.609 -179.492 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.494 ' N ' HD12 ' A' ' 53' ' ' LEU . 0.2 OUTLIER -150.92 138.26 13.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.581 -179.593 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -95.0 101.35 13.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.748 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.402 ' SG ' ' CD2' ' A' ' 55' ' ' LEU . 20.2 m -80.25 110.1 15.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.287 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.7 t -151.16 106.74 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.766 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.418 HG22 ' N ' ' A' ' 9' ' ' VAL . 2.4 p -89.3 135.48 25.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.296 0.569 . . . . 0.0 111.583 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.471 HG23 ' CD2' ' A' ' 78' ' ' PHE . 2.8 m -133.41 129.44 56.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.197 178.41 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 141.69 -165.3 26.52 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.067 -1.064 . . . . 0.0 112.483 -179.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.7 21.87 5.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.764 0.316 . . . . 0.0 110.992 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.416 ' HA3' ' CB ' ' A' ' 81' ' ' CYS . . . -128.13 161.6 21.97 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.501 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.435 ' CB ' ' HB2' ' A' ' 18' ' ' CYS . . . -93.08 -20.1 20.87 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.402 ' HA ' HD11 ' A' ' 19' ' ' LEU . 4.0 m -42.41 92.67 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 CA-C-O 120.892 0.377 . . . . 0.0 111.643 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.458 ' N ' HD23 ' A' ' 19' ' ' LEU . . . -178.13 -77.97 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.76 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.432 ' HG2' ' CB ' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -98.08 -84.1 0.39 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.927 0.394 . . . . 0.0 111.825 -179.354 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.416 ' HA ' HG12 ' A' ' 21' ' ' ILE . 4.3 p -63.33 -50.39 70.19 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.435 ' HB2' ' CB ' ' A' ' 13' ' ' ALA . 51.9 t -32.46 -70.83 0.06 Allowed 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 113.634 0.975 . . . . 0.0 113.634 -178.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.507 ' HG ' ' CD1' ' A' ' 169' ' ' PHE . 0.0 OUTLIER -58.05 -71.23 0.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -178.19 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.43 HD11 ' N ' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -51.05 -65.88 0.48 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -178.283 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.416 HG12 ' HA ' ' A' ' 17' ' ' THR . 30.4 mm -45.6 -67.9 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.107 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.2 t -49.82 -26.12 3.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.961 0.41 . . . . 0.0 110.752 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -82.86 -25.34 32.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.72 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.403 ' N ' ' O ' ' A' ' 21' ' ' ILE . 66.7 p -100.52 -64.21 1.06 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.243 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 40.1 p -62.41 -58.28 8.2 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.993 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.439 ' N ' ' ND2' ' A' ' 26' ' ' ASN . 0.4 OUTLIER 74.9 42.67 0.26 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.181 179.584 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.47 ' O ' ' CE1' ' A' ' 32' ' ' TYR . 4.2 mtmm -119.66 91.58 3.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.968 0.413 . . . . 0.0 110.928 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.48 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 9.4 t80 -89.81 -45.38 0.41 Allowed Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.872 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 88.0 Cg_endo -84.16 79.02 2.73 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.424 2.083 . . . . 0.0 113.04 -179.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.9 m -174.02 -94.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.879 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.41 154.74 25.46 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 120.635 0.255 . . . . 0.0 110.449 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.47 ' CE1' ' O ' ' A' ' 27' ' ' LYS . 15.6 m-85 -133.82 93.98 3.2 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.905 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.564 ' N ' ' CD ' ' A' ' 34' ' ' PRO . 2.1 t -131.59 28.09 0.15 Allowed Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.564 ' CD ' ' N ' ' A' ' 33' ' ' VAL . 42.3 Cg_endo -86.09 -37.59 0.1 Allowed 'Trans proline' 0 C--N 1.359 1.109 0 C-N-CA 121.889 1.726 . . . . 0.0 112.496 179.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.438 ' CG2' HD23 ' B' ' 543' ' ' LEU . 1.4 m -48.46 99.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.881 -179.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.432 ' HA ' ' CB ' ' A' ' 59' ' ' ALA . 7.4 p 176.98 -34.95 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.825 179.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.411 ' N ' HG13 ' A' ' 36' ' ' VAL . 0.7 OUTLIER -109.39 35.88 3.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.582 179.814 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.432 ' CB ' ' HG2' ' A' ' 16' ' ' LYS . 18.3 m-20 -89.58 45.47 1.28 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.127 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -106.03 -16.28 14.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.077 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -60.59 174.97 0.51 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.79 0.329 . . . . 0.0 110.865 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.431 ' HB2' ' CD1' ' B' ' 519' ' ' ILE . . . -91.99 174.48 7.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.294 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.419 ' HA ' HG13 ' B' ' 519' ' ' ILE . 30.9 m -139.32 144.67 28.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.734 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.422 ' O ' ' CG2' ' A' ' 44' ' ' VAL . 2.1 p -85.05 106.33 16.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.499 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.448 ' HB ' ' CG2' ' A' ' 52' ' ' THR . 53.9 t -158.04 153.11 6.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.158 -179.195 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.463 ' HE2' ' N ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -117.73 96.31 5.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.17 179.313 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.47 ' O ' ' N ' ' A' ' 48' ' ' GLY . 5.5 mm -71.1 88.1 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.539 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.431 ' O ' ' CE ' ' A' ' 45' ' ' MET . . . 37.28 -87.85 0.01 OUTLIER Glycine 0 CA--C 1.521 0.409 0 CA-C-N 115.811 -0.631 . . . . 0.0 113.919 179.326 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . -38.88 -78.6 0.05 OUTLIER Glycine 0 C--N 1.334 0.439 0 C-N-CA 121.52 -0.371 . . . . 0.0 113.177 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.463 ' N ' ' HE2' ' A' ' 45' ' ' MET . 3.2 mt-10 -142.29 162.23 46.25 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-O 120.909 0.385 . . . . 0.0 111.373 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.42 92.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.79 2.327 . . . . 0.0 112.558 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.524 ' CE1' ' CG2' ' A' ' 3' ' ' THR . 0.0 OUTLIER -172.95 126.07 0.45 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.073 179.749 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.448 ' CG2' ' HB ' ' A' ' 44' ' ' VAL . 4.3 p -134.57 141.77 46.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.919 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.494 HD12 ' N ' ' A' ' 4' ' ' ILE . 5.3 mt -71.16 121.69 18.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.877 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -52.28 153.4 6.08 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.092 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.402 ' CD2' ' SG ' ' A' ' 6' ' ' CYS . 2.6 mp -109.79 95.04 5.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.839 0.352 . . . . 0.0 110.884 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -84.73 105.45 15.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.633 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.421 ' OD2' ' CG2' ' A' ' 35' ' ' THR . 1.5 t70 -94.44 163.77 13.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.822 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.431 HG22 ' CD2' ' A' ' 70' ' ' LEU . 6.7 p -89.44 146.38 24.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.32 -179.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.432 ' CB ' ' HA ' ' A' ' 36' ' ' VAL . . . -172.14 -162.78 0.22 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.677 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 166.41 66.75 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.467 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.444 HD23 ' CG1' ' A' ' 33' ' ' VAL . 5.8 mp -120.97 -87.01 0.65 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.727 0.299 . . . . 0.0 111.02 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.79 -31.56 11.81 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.902 0.382 . . . . 0.0 111.108 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -70.8 -63.25 1.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.37 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -118.33 160.25 21.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.805 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -85.92 -68.35 0.74 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.807 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -96.69 -52.2 4.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.117 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.5 tt 56.42 106.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.64 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.438 ' N ' ' HD3' ' A' ' 69' ' ' PRO . 1.7 ppt_? -142.47 53.33 2.87 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.321 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.438 ' HD3' ' N ' ' A' ' 68' ' ' ARG . 94.1 Cg_endo -83.95 -20.25 4.49 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.764 2.309 . . . . 0.0 112.26 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.445 ' CD1' ' HA ' ' B' ' 541' ' ' LEU . 0.7 OUTLIER -77.76 1.0 21.49 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.925 -179.79 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.21 -61.23 2.28 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 120.908 0.385 . . . . 0.0 110.92 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.492 ' CD1' ' N ' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -159.22 56.76 0.96 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.791 179.884 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -60.94 174.44 1.77 Allowed 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.661 2.241 . . . . 0.0 112.307 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -95.68 10.57 36.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.524 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 98.8 m -46.51 145.21 1.88 Allowed 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.804 0.335 . . . . 0.0 111.05 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.418 ' O ' ' CG ' ' A' ' 109' ' ' PRO . 16.8 p-10 -106.4 -20.96 13.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.147 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.415 ' CG1' ' O ' ' A' ' 77' ' ' VAL . 7.9 p -123.55 83.96 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.827 0.346 . . . . 0.0 111.387 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.471 ' CD2' HG23 ' A' ' 9' ' ' VAL . 0.3 OUTLIER -80.79 166.3 21.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.599 179.736 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.419 ' CD1' ' O ' ' A' ' 111' ' ' LEU . 4.9 tp -143.39 108.46 4.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.02 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.436 ' CG2' ' HB2' ' A' ' 110' ' ' PHE . 35.9 m -84.74 147.11 5.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.838 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.481 ' O ' ' CZ3' ' A' ' 97' ' ' TRP . 2.0 m -113.97 174.35 5.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.118 0.485 . . . . 0.0 111.216 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.482 ' CZ ' ' HB3' ' A' ' 142' ' ' ALA . 6.0 p90 179.99 -173.54 0.23 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.769 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.441 ' N ' ' CD2' ' A' ' 82' ' ' PHE . 0.3 OUTLIER -156.42 136.34 12.66 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.847 0.356 . . . . 0.0 111.349 179.958 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.436 HG12 ' N ' ' A' ' 137' ' ' ILE . 99.3 t -51.48 -40.41 24.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.827 179.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.418 HG11 ' NE2' ' A' ' 116' ' ' GLN . 32.0 m -73.02 111.64 7.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.518 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.434 ' N ' HD23 ' A' ' 129' ' ' LEU . 83.4 p -151.28 135.27 9.51 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.743 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.414 ' O ' ' CB ' ' A' ' 88' ' ' SER . 74.2 Cg_endo -91.42 51.88 0.78 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.218 2.612 . . . . 0.0 111.585 179.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.46 ' CB ' ' CG ' ' A' ' 133' ' ' LYS . 0.1 OUTLIER 79.15 26.85 0.42 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.665 -179.426 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.426 ' O ' ' CG2' ' A' ' 93' ' ' VAL . 52.4 p -96.5 -25.73 15.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.999 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.475 ' CZ ' HG21 ' A' ' 137' ' ' ILE . 3.3 t80 -48.96 -54.08 17.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.075 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -49.82 -53.41 25.62 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.932 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -64.29 -47.68 78.57 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.724 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.534 ' CG1' ' CZ3' ' A' ' 97' ' ' TRP . 65.9 t -51.1 -39.84 20.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.049 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.3 tttm -64.51 -50.39 67.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.847 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -82.97 7.39 15.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.695 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.2 mttp -109.82 -26.14 9.97 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.751 0.31 . . . . 0.0 110.872 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.534 ' CZ3' ' CG1' ' A' ' 93' ' ' VAL . 5.7 m0 -94.01 -45.73 7.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.196 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.473 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 58.5 t -49.94 -46.73 81.43 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.63 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.473 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 94.2 Cg_endo -80.74 -15.5 10.78 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.393 2.062 . . . . 0.0 112.612 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -90.11 -49.09 6.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.771 0.32 . . . . 0.0 110.901 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 9.9 tt -62.95 -22.86 31.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.197 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 61.2 p -91.51 -26.11 18.94 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.878 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 42.0 t60 -76.92 -57.79 3.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.895 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -65.66 -56.96 9.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.951 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.407 ' CB ' ' OG1' ' A' ' 108' ' ' THR . 60.4 m -86.65 142.94 35.16 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.976 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -69.23 60.27 1.4 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.558 2.172 . . . . 0.0 112.315 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.78 78.58 0.27 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.927 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.407 ' OG1' ' CB ' ' A' ' 105' ' ' CYS . 0.2 OUTLIER -108.52 141.12 22.59 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.813 179.847 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.418 ' CG ' ' O ' ' A' ' 76' ' ' ASP . 33.8 Cg_endo -65.53 177.91 2.46 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.507 2.138 . . . . 0.0 112.52 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.466 ' CD2' ' HB1' ' A' ' 151' ' ' ALA . 4.6 p90 -166.22 132.55 2.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.782 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.419 ' O ' ' CD1' ' A' ' 79' ' ' LEU . 5.5 tt -108.94 142.0 40.21 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.678 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.454 HD11 ' CD1' ' A' ' 82' ' ' PHE . 4.2 mm? -89.59 155.03 19.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.586 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.463 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 2.4 t -142.12 134.17 26.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.946 0.403 . . . . 0.0 111.792 -179.448 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.419 ' O ' ' CD1' ' A' ' 117' ' ' ILE . . . -106.03 86.09 0.47 Allowed Glycine 0 C--N 1.332 0.338 0 C-N-CA 121.004 -0.617 . . . . 0.0 111.857 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.443 ' CG2' HG12 ' A' ' 113' ' ' VAL . 1.0 OUTLIER -110.34 1.68 18.61 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -178.805 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.422 ' HB3' ' CG2' ' A' ' 84' ' ' VAL . 4.4 tp60 -96.87 -22.74 16.71 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.442 HD11 ' N ' ' A' ' 118' ' ' ASP . 0.2 OUTLIER -46.04 -25.75 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.096 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.839 178.931 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.442 ' N ' HD11 ' A' ' 117' ' ' ILE . 4.8 t0 -53.72 -47.52 70.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.372 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.476 ' CD1' ' N ' ' A' ' 119' ' ' LEU . 0.0 OUTLIER -122.98 14.31 9.88 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -178.976 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.4 ' HG2' ' HA ' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -48.82 -28.61 3.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.897 0.379 . . . . 0.0 110.87 179.815 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.3 p30 -72.22 -22.39 61.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.094 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.402 ' OD1' ' O ' ' A' ' 119' ' ' LEU . 20.1 p-10 -48.24 104.32 0.41 Allowed Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 120.983 0.421 . . . . 0.0 110.974 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -66.49 -6.57 15.48 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.381 2.054 . . . . 0.0 113.172 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.417 ' OG ' ' N ' ' A' ' 125' ' ' THR . 54.3 p -79.78 -66.52 0.86 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.417 ' N ' ' OG ' ' A' ' 124' ' ' SER . 34.5 m -55.76 -38.06 69.34 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.446 HG13 HD11 ' A' ' 129' ' ' LEU . 0.1 OUTLIER -56.37 -41.68 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 115.01 -0.996 . . . . 0.0 109.803 179.229 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.401 ' HB3' ' O ' ' A' ' 124' ' ' SER . 1.0 OUTLIER -60.59 -37.51 81.58 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.436 179.256 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 125' ' ' THR . 0.0 OUTLIER -60.88 -31.3 70.77 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.595 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.446 HD11 HG13 ' A' ' 126' ' ' ILE . 5.1 mt -75.36 -41.68 55.9 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 177.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.41 ' HA ' ' HB3' ' A' ' 134' ' ' GLN . . . -44.26 -33.9 1.73 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.99 -1.004 . . . . 0.0 111.105 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 18.0 mmtm -49.79 -33.05 15.42 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.416 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -123.29 -31.36 3.57 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.341 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.523 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 0.8 OUTLIER -144.6 -99.17 0.1 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 119.191 -0.433 . . . . 0.0 111.571 179.793 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.523 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 2.7 pt20 129.57 -23.86 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.528 1.131 . . . . 0.0 110.313 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.2 mmtt -68.73 110.26 5.64 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.778 -179.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' A' ' 134' ' ' GLN . 96.1 Cg_endo -79.55 127.36 7.23 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.485 2.123 . . . . 0.0 111.239 179.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.484 ' CD1' ' N ' ' A' ' 137' ' ' ILE . 1.1 mm -56.76 95.9 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.962 0.411 . . . . 0.0 110.738 -179.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 47.0 p -67.65 155.65 90.81 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.087 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.421 ' HA ' ' CE2' ' A' ' 154' ' ' TYR . 75.3 Cg_exo -47.54 -27.85 8.1 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.461 2.107 . . . . 0.0 112.184 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -77.1 -30.53 55.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.626 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.434 ' CG2' HG22 ' A' ' 137' ' ' ILE . 5.8 m -69.58 -62.49 1.36 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.727 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.482 ' HB3' ' CZ ' ' A' ' 82' ' ' PHE . . . -52.14 -36.05 50.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.637 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -65.83 -41.53 91.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.505 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 19.4 tptp -55.11 -62.77 1.45 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.634 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.401 ' CD1' HD22 ' A' ' 149' ' ' LEU . 17.2 tp -58.31 -43.81 88.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.543 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -55.06 -35.3 64.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.924 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 12.3 mtt-85 -91.47 -30.87 16.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.618 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -65.12 -44.28 89.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.707 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.401 HD22 ' CD1' ' A' ' 145' ' ' LEU . 3.0 mm? -89.8 14.05 12.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.123 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 47.41 45.8 17.11 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.835 0.35 . . . . 0.0 111.002 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.466 ' HB1' ' CD2' ' A' ' 110' ' ' PHE . . . -65.09 -82.22 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.198 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.437 ' CG2' ' O ' ' A' ' 151' ' ' ALA . 70.7 t -161.09 -75.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.826 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.57 108.41 0.06 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.792 -178.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.468 ' CD1' ' HB1' ' A' ' 142' ' ' ALA . 19.5 t80 -80.98 114.56 19.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.425 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 3.7 t -108.87 155.12 9.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.826 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -94.37 118.58 31.83 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.223 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.418 ' SG ' ' CG1' ' A' ' 168' ' ' VAL . 20.3 p 178.95 137.46 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.615 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.416 ' OG ' ' CD1' ' A' ' 117' ' ' ILE . 27.4 m -112.72 149.31 33.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.981 0.419 . . . . 0.0 111.221 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -83.21 -42.54 17.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.82 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.42 HD13 ' CD1' ' A' ' 119' ' ' LEU . 0.1 OUTLIER -49.53 -36.5 23.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.703 179.779 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 15.3 t -111.37 -22.48 11.3 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.685 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.413 ' N ' ' O ' ' A' ' 158' ' ' SER . 0.9 OUTLIER 73.11 62.25 0.1 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.781 -179.89 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.403 ' HB3' ' HA ' ' A' ' 157' ' ' CYS . 0.0 OUTLIER -93.08 22.59 4.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.061 -179.943 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.413 ' N ' ' HB2' ' A' ' 157' ' ' CYS . . . 133.34 35.39 0.29 Allowed Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.484 -0.865 . . . . 0.0 113.412 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.451 ' CD2' HD12 ' A' ' 19' ' ' LEU . 10.5 mt -48.88 -42.3 36.27 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.913 0.357 . . . . 0.0 110.844 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.411 ' O ' ' N ' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -70.18 -34.18 72.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.992 179.747 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.4 ' O ' ' HB2' ' A' ' 170' ' ' ASP . 0.1 OUTLIER -58.03 -72.18 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.241 -179.811 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.442 ' CG1' HG13 ' A' ' 113' ' ' VAL . 7.1 p -50.08 -46.91 24.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.981 0.42 . . . . 0.0 110.988 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.507 ' CD1' ' HG ' ' A' ' 19' ' ' LEU . 1.1 t80 -64.6 -33.38 75.78 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.672 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.42 ' O ' ' CB ' ' A' ' 174' ' ' LEU . 0.5 OUTLIER -56.3 -32.84 64.99 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.967 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -75.0 -36.21 61.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.887 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -67.31 -43.41 81.72 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.623 179.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 1.7 pp -78.23 -33.14 17.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.661 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.427 HD11 ' CD1' ' B' ' 505' ' ' LEU . 22.0 tp -59.13 -43.62 92.01 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.634 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -54.34 -22.03 11.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.112 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.454 ' CB ' HG23 ' A' ' 4' ' ' ILE . . . -87.53 -37.03 17.25 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.395 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 94.9 mt -68.83 -27.98 66.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.962 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.11 136.73 1.93 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.981 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -57.32 112.02 1.0 Allowed 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.563 2.175 . . . . 0.0 112.302 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.53 162.1 33.55 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.625 2.217 . . . . 0.0 112.276 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -131.37 143.85 50.98 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.959 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -76.53 -165.12 0.29 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.721 2.281 . . . . 0.0 112.329 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 1.8 mmmt -71.26 83.54 0.75 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.87 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 7.7 mttt . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.979 179.992 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 502' ' ' GLY . . . . . 0.416 ' CA ' ' O ' ' B' ' 509' ' ' ASP . . . . . . . . 0 N--CA 1.489 2.195 0 N-CA-C 112.524 -0.23 . . . . 0.0 112.524 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 503' ' ' SER . . . . . . . . . . . . . 37.4 t -107.06 -74.62 0.65 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.781 0.324 . . . . 0.0 110.944 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 504' ' ' GLY . . . . . . . . . . . . . . . 116.58 103.86 2.35 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.36 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 505' ' ' LEU . . . . . 0.427 ' CD1' HD11 ' A' ' 174' ' ' LEU . 0.1 OUTLIER -174.55 38.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.698 0.285 . . . . 0.0 111.141 -179.871 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 506' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 68.95 34.26 3.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.127 0.489 . . . . 0.0 110.566 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 507' ' ' ALA . . . . . . . . . . . . . . . -137.47 35.97 2.48 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.548 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 508' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 74.73 3.38 4.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.441 -178.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 509' ' ' ASP . . . . . 0.416 ' O ' ' CA ' ' B' ' 502' ' ' GLY . 16.0 t70 71.7 44.83 0.47 Allowed 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.158 0.504 . . . . 0.0 110.816 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 510' ' ' ILE . . . . . 0.427 ' CG2' HG22 ' A' ' 46' ' ' ILE . 44.5 mt -93.17 138.29 20.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.846 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 511' ' ' SER . . . . . 0.421 ' N ' HG21 ' B' ' 510' ' ' ILE . 22.1 t -108.04 157.16 18.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.359 -179.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 512' ' ' GLN . . . . . 0.478 ' CB ' ' CD ' ' B' ' 513' ' ' PRO . 27.9 tp60 -110.21 -71.2 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.513 179.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 513' ' ' PRO . . . . . 0.478 ' CD ' ' CB ' ' B' ' 512' ' ' GLN . 73.3 Cg_endo -74.6 58.96 4.75 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.021 1.814 . . . . 0.0 111.632 179.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 514' ' ' LEU . . . . . 0.441 ' CD1' ' O ' ' A' ' 45' ' ' MET . 2.6 mp -65.81 -86.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.65 -179.272 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 515' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -69.3 -96.1 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.218 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -127.32 -12.26 5.67 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 517' ' ' SER . . . . . 0.404 ' HA ' HG23 ' A' ' 44' ' ' VAL . 1.5 m 48.62 31.78 3.14 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.705 0.288 . . . . 0.0 111.135 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 518' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -163.3 91.96 0.72 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.143 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 519' ' ' ILE . . . . . 0.431 ' CD1' ' HB2' ' A' ' 41' ' ' ALA . 41.5 mt -64.23 -64.68 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.84 0.353 . . . . 0.0 110.755 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -126.6 -168.95 1.94 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.891 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 521' ' ' THR . . . . . . . . . . . . . 6.6 m -119.76 113.99 21.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.002 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 522' ' ' GLY . . . . . . . . . . . . . . . -107.16 120.6 6.23 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.522 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 523' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -114.58 -84.44 0.61 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.716 0.294 . . . . 0.0 110.96 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 524' ' ' GLY . . . . . . . . . . . . . . . 101.21 -44.14 1.6 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.412 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 525' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -152.01 32.95 0.54 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.862 0.363 . . . . 0.0 110.907 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 526' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.1 97.56 6.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.887 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 527' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -145.88 161.68 39.02 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.914 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.42 96.59 0.65 Allowed 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.598 2.199 . . . . 0.0 112.242 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 529' ' ' ARG . . . . . . . . . . . . . 1.9 mtp85 -96.08 -23.1 16.94 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.202 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 530' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -178.76 -82.77 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.938 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 50.1 t 178.29 -68.67 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.886 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 532' ' ' TRP . . . . . 0.521 ' CZ2' ' NH2' ' B' ' 537' ' ' ARG . 0.6 OUTLIER -126.32 -49.8 1.54 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.967 -179.908 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 533' ' ' GLY . . . . . 0.472 ' O ' ' CG ' ' B' ' 534' ' ' PHE . . . 106.4 -56.28 0.51 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.483 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 534' ' ' PHE . . . . . 0.472 ' CG ' ' O ' ' B' ' 533' ' ' GLY . 98.0 m-85 -160.67 160.72 25.5 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.76 0.314 . . . . 0.0 110.88 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -48.05 123.36 8.61 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.559 2.173 . . . . 0.0 112.274 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 2.9 t0 68.25 145.18 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.747 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 537' ' ' ARG . . . . . 0.521 ' NH2' ' CZ2' ' B' ' 532' ' ' TRP . 0.1 OUTLIER -51.94 139.19 22.93 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.036 0.446 . . . . 0.0 111.09 -179.867 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 538' ' ' ILE . . . . . 0.434 ' CG2' ' HA ' ' B' ' 543' ' ' LEU . 5.8 tp -59.38 144.94 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.959 179.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 539' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -43.84 136.95 3.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.815 0.341 . . . . 0.0 111.275 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 540' ' ' GLU . . . . . 0.431 ' HA ' ' CD1' ' B' ' 543' ' ' LEU . 33.1 mm-40 -52.72 -21.66 4.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.163 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 541' ' ' LEU . . . . . 0.445 ' HA ' ' CD1' ' A' ' 70' ' ' LEU . 1.1 mp -37.03 -63.59 0.42 Allowed 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 542' ' ' TYR . . . . . 0.412 ' O ' ' CB ' ' B' ' 543' ' ' LEU . 0.1 OUTLIER -105.16 -58.68 1.86 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.304 -179.574 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 543' ' ' LEU . . . . . 0.438 HD23 ' CG2' ' A' ' 35' ' ' THR . 0.1 OUTLIER 81.27 -167.97 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.369 -179.225 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 544' ' ' GLY . . . . . 0.42 ' O ' ' ND2' ' B' ' 545' ' ' ASN . . . 93.44 -176.3 36.77 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.497 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 545' ' ' ASN . . . . . 0.42 ' ND2' ' O ' ' B' ' 544' ' ' GLY . 9.3 m-80 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.279 -0.867 . . . . 0.0 110.987 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.9 tpt . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.769 0.319 . . . . 0.0 111.3 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 62.25 134.04 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.448 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.503 HG23 ' CE1' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -107.39 -166.5 1.16 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.908 -179.158 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.437 ' CD1' HD11 ' A' ' 53' ' ' LEU . 4.9 pt -156.44 162.36 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.588 -179.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.12 99.41 4.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.437 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.3 m -78.25 103.25 8.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.518 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.1 t -135.15 112.57 14.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.327 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.434 ' CG1' ' HG3' ' A' ' 16' ' ' LYS . 0.2 OUTLIER -103.42 138.62 27.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.299 0.571 . . . . 0.0 111.203 -179.592 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.458 HG13 ' CE1' ' A' ' 78' ' ' PHE . 30.5 m -130.25 129.62 65.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.346 178.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 142.19 -172.42 24.2 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 119.867 -1.159 . . . . 0.0 112.7 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -96.5 27.48 3.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.779 0.323 . . . . 0.0 110.8 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.445 ' HA2' ' CD ' ' B' ' 537' ' ' ARG . . . -149.35 150.69 22.84 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.745 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.476 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -58.16 -54.56 45.55 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.551 0.215 . . . . 0.0 110.849 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.441 ' CG2' ' HB3' ' A' ' 81' ' ' CYS . 0.0 OUTLIER 44.62 -87.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.472 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 13' ' ' ALA . . . -102.32 23.13 35.31 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.242 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.577 ' HD2' ' H2 ' ' A' ' 187' ' ' HOH . 0.0 OUTLIER -84.34 -163.52 0.81 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.947 0.403 . . . . 0.0 110.945 -179.823 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.443 ' HB ' ' CG1' ' A' ' 21' ' ' ILE . 6.1 p -74.84 -28.6 60.75 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.029 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.404 ' HB2' ' O2B' ' A' ' 185' ' ' GNP . 53.3 t -41.47 -30.06 0.18 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.643 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.499 HD23 ' CE2' ' A' ' 169' ' ' PHE . 0.0 OUTLIER -62.83 -71.05 0.17 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.889 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.4 mt -70.07 -36.12 74.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.97 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.443 ' CG1' ' HB ' ' A' ' 17' ' ' THR . 4.5 mm -58.31 -71.2 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.418 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 25' ' ' THR . 24.5 m -55.22 -34.83 64.3 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 121.098 -0.241 . . . . 0.0 110.666 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.421 ' HB2' ' CD1' ' A' ' 165' ' ' LEU . 49.9 t80 -52.65 -35.12 54.36 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.97 -46.24 5.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.71 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.49 ' O ' ' CB ' ' A' ' 26' ' ' ASN . 6.7 t -177.83 -162.84 0.07 Allowed 'General case' 0 C--O 1.227 -0.082 0 CA-C-N 116.342 -0.39 . . . . 0.0 112.003 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.49 ' CB ' ' O ' ' A' ' 25' ' ' THR . 2.5 t30 97.6 -20.87 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.659 0.784 . . . . 0.0 110.616 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.6 mttp 60.06 146.67 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.963 0.411 . . . . 0.0 111.395 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.479 ' CE1' " O3'" ' A' ' 185' ' ' GNP . 19.7 t80 -89.2 -47.69 0.41 Allowed Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.871 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 67.7 Cg_endo -88.29 58.14 2.71 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.793 2.328 . . . . 0.0 112.797 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.2 m -133.85 -85.53 0.43 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.823 0.344 . . . . 0.0 110.759 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -158.59 162.83 37.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.754 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.516 ' CD2' ' O1G' ' A' ' 185' ' ' GNP . 67.4 m-85 -135.22 103.56 5.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.971 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.44 ' HB ' ' CB ' ' B' ' 526' ' ' SER . 0.0 OUTLIER -165.31 -61.35 0.01 OUTLIER Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.341 -179.935 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.482 ' O ' ' CD1' ' A' ' 37' ' ' PHE . 86.7 Cg_exo -42.84 -28.49 1.18 Allowed 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.371 2.048 . . . . 0.0 112.528 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.453 HG23 ' H1 ' ' A' ' 187' ' ' HOH . 4.2 t -57.44 -20.81 32.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.192 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.426 ' CG2' ' HB2' ' A' ' 61' ' ' LEU . 12.6 p -52.0 -21.18 2.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.521 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.482 ' CD1' ' O ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -83.02 46.9 1.15 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.66 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.439 ' CB ' ' HB2' ' A' ' 57' ' ' ASP . 5.0 p-10 -63.66 -158.29 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.645 0.259 . . . . 0.0 110.837 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 73.73 22.48 2.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.804 0.335 . . . . 0.0 111.006 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.487 ' CE2' ' HA ' ' B' ' 520' ' ' HIS . 1.8 m-30 -60.18 129.31 41.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.77 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.411 ' O ' HG12 ' B' ' 519' ' ' ILE . . . -95.51 119.61 34.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.582 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.416 ' CG1' ' O ' ' B' ' 517' ' ' SER . 17.5 m -117.74 159.82 17.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.986 0.422 . . . . 0.0 111.72 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.34 104.79 6.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.384 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.478 ' CG2' ' CG2' ' A' ' 52' ' ' THR . 10.4 m -149.04 -177.46 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.366 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.464 ' HE1' ' N ' ' A' ' 46' ' ' ILE . 4.7 tpt -99.07 96.62 7.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.342 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.464 ' N ' ' HE1' ' A' ' 45' ' ' MET . 1.3 mm -80.44 86.66 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-O 121.33 0.586 . . . . 0.0 109.695 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 42.74 -92.42 0.01 OUTLIER Glycine 0 CA--C 1.524 0.601 0 CA-C-N 115.537 -0.756 . . . . 0.0 113.71 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . -38.55 -91.59 0.01 OUTLIER Glycine 0 CA--C 1.52 0.39 0 N-CA-C 113.988 0.355 . . . . 0.0 113.988 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.431 ' C ' ' CE ' ' A' ' 45' ' ' MET . 1.3 pt-20 -125.88 152.47 72.73 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-O 120.693 0.282 . . . . 0.0 110.932 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.401 ' N ' ' SD ' ' A' ' 45' ' ' MET . 83.0 Cg_exo -43.28 105.55 0.06 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.51 2.14 . . . . 0.0 112.266 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.503 ' CE1' HG23 ' A' ' 3' ' ' THR . 8.8 t80 -172.02 159.21 4.93 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.303 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.478 ' CG2' ' CG2' ' A' ' 44' ' ' VAL . 6.5 p -136.09 153.2 51.39 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.146 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.437 HD11 ' CD1' ' A' ' 4' ' ' ILE . 0.0 OUTLIER -87.27 -179.19 6.37 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.919 179.807 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -128.54 103.51 0.62 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.627 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.66 97.38 10.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.807 0.336 . . . . 0.0 110.254 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -84.23 105.61 15.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.694 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.439 ' HB2' ' CB ' ' A' ' 38' ' ' ASP . 0.6 OUTLIER -90.75 137.05 32.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.061 -179.775 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.469 ' CB ' HD11 ' A' ' 67' ' ' LEU . 0.1 OUTLIER -99.03 143.38 29.37 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.278 179.807 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.425 ' CB ' HG22 ' A' ' 36' ' ' VAL . . . -153.14 177.4 10.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.923 0.392 . . . . 0.0 111.384 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' A' ' 65' ' ' ASP . . . -129.96 51.81 0.85 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.94 -0.647 . . . . 0.0 112.09 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.426 ' HB2' ' CG2' ' A' ' 36' ' ' VAL . 0.4 OUTLIER -120.82 -175.24 2.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.934 0.397 . . . . 0.0 111.199 -179.56 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -46.73 -40.24 13.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.347 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.417 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . 59.4 m-20 -47.25 -56.95 5.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.184 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.495 ' CD1' ' N ' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -166.8 93.34 0.47 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.837 -179.855 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.402 ' HA ' ' HA2' ' A' ' 60' ' ' GLY . 0.2 OUTLIER -86.33 -7.43 58.49 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.558 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.37 -20.63 20.87 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.473 HD22 ' CG ' ' A' ' 64' ' ' TYR . 4.5 pp -51.36 160.98 0.5 Allowed 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.783 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 20.6 ttp85 -178.18 62.82 0.16 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.012 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -84.79 -23.38 2.62 Favored 'Trans proline' 0 N--CA 1.461 -0.383 0 C-N-CA 122.859 2.373 . . . . 0.0 112.581 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.471 ' CD2' ' N ' ' B' ' 541' ' ' LEU . 0.1 OUTLIER -71.75 -6.16 39.32 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.448 -179.672 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -48.36 -71.25 0.07 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.86 0.362 . . . . 0.0 111.097 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -140.33 62.52 20.03 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.879 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -52.36 130.58 36.55 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.685 2.257 . . . . 0.0 112.284 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -86.15 10.27 14.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.499 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 15.3 t -50.82 174.6 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.806 0.336 . . . . 0.0 110.817 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -112.3 -25.73 9.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.882 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.436 ' CB ' ' HB2' ' A' ' 175' ' ' ALA . 8.2 p -126.57 99.14 5.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.172 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.458 ' CE1' HG13 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -80.89 176.58 9.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.61 179.826 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.465 ' HG ' ' N ' ' A' ' 15' ' ' GLY . 0.0 OUTLIER -127.83 108.74 10.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.077 -179.808 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.483 HG23 ' CD1' ' A' ' 110' ' ' PHE . 34.4 m -97.97 127.88 49.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.65 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.441 ' HB3' ' CG2' ' A' ' 14' ' ' VAL . 21.1 p -99.63 174.02 6.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.14 0.495 . . . . 0.0 111.632 -179.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.484 ' CZ ' ' HB1' ' A' ' 142' ' ' ALA . 8.3 p90 -179.63 -174.3 0.29 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.17 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.427 ' N ' ' CD2' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -156.08 149.89 25.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.752 0.31 . . . . 0.0 110.856 179.885 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.448 ' HB ' ' CB ' ' A' ' 120' ' ' ARG . 43.8 t -61.71 -41.84 92.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.345 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.439 ' CA ' HD23 ' A' ' 129' ' ' LEU . 17.6 m -59.64 114.8 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.365 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.412 ' N ' ' CD2' ' A' ' 129' ' ' LEU . 0.6 OUTLIER -152.02 117.47 3.08 Favored Pre-proline 0 C--N 1.329 -0.294 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.801 -179.57 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.425 ' O ' ' CB ' ' A' ' 132' ' ' ASN . 89.7 Cg_endo -94.01 53.28 0.33 Allowed 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.114 2.543 . . . . 0.0 111.288 179.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.425 ' HA ' ' HG3' ' A' ' 133' ' ' LYS . 0.2 OUTLIER 81.12 30.07 0.16 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.661 -179.253 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 73.9 m -97.2 -16.84 20.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.133 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.479 ' CZ ' HG21 ' A' ' 137' ' ' ILE . 0.1 OUTLIER -43.26 -42.11 4.22 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.869 0.366 . . . . 0.0 111.403 -179.919 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -63.41 -33.6 75.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.973 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.406 ' O ' ' N ' ' A' ' 96' ' ' LYS . 7.4 m120 -75.23 -52.98 9.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.095 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.417 ' CG2' ' HA ' ' A' ' 90' ' ' PHE . 7.4 m -49.71 -44.59 20.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.233 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.44 -49.78 67.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.899 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -82.57 7.34 14.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.671 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.406 ' N ' ' O ' ' A' ' 92' ' ' ASN . 4.8 tttt -115.3 -27.34 7.27 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.721 0.296 . . . . 0.0 111.036 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 1.7 m95 -94.31 -50.18 5.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.388 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.48 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 61.9 t -50.89 -46.01 87.42 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.962 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 95.3 Cg_endo -81.03 -11.21 12.38 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.377 2.051 . . . . 0.0 113.016 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -90.34 -57.0 2.99 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 120.906 0.384 . . . . 0.0 110.187 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 20.8 tt -57.34 -27.88 29.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.084 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 23.2 p -86.33 -29.66 22.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.75 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -58.62 -54.84 42.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.851 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 52.9 m170 -65.54 -42.04 92.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.79 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -125.87 124.02 24.71 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.669 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -50.98 89.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.414 2.076 . . . . 0.0 112.261 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 63.29 94.54 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.911 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -119.66 126.76 26.77 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.875 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -60.64 176.84 0.75 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.435 2.09 . . . . 0.0 112.236 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.484 ' CD1' ' HB3' ' A' ' 151' ' ' ALA . 32.7 p90 -165.93 176.39 7.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.852 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.426 ' CD1' HG13 ' A' ' 152' ' ' VAL . 1.1 tt -139.56 134.37 32.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.886 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.407 HD21 ' CG2' ' A' ' 80' ' ' VAL . 4.1 mm? -89.78 138.48 31.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.205 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.428 ' CG1' HG12 ' A' ' 168' ' ' VAL . 11.0 t -130.45 147.57 33.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.11 0.481 . . . . 0.0 112.064 -179.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -113.31 142.18 17.3 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.648 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.579 ' OG1' " H2'" ' A' ' 185' ' ' GNP . 0.8 OUTLIER -153.83 -61.53 0.14 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.853 0.359 . . . . 0.0 111.03 -179.622 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.489 ' HG2' HO2' ' A' ' 185' ' ' GNP . 10.5 mm100 -60.12 -20.4 58.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.026 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.467 HD12 ' N ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -40.69 -29.13 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.867 -179.796 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -65.93 -42.19 90.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.812 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.432 HD22 ' CD2' ' A' ' 160' ' ' LEU . 0.1 OUTLIER -93.02 -48.16 6.64 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -179.327 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.448 ' CB ' ' HB ' ' A' ' 84' ' ' VAL . 1.4 mmt180 -48.15 -26.78 2.03 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.814 0.34 . . . . 0.0 111.024 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.06 -21.07 43.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.871 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.62 153.56 87.04 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.867 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -81.35 -2.68 11.73 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.997 2.465 . . . . 0.0 112.957 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 40.7 t -81.49 -69.98 0.57 Allowed 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 120.879 0.371 . . . . 0.0 110.49 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.416 ' CG2' HG12 ' A' ' 85' ' ' VAL . 8.4 m -51.46 -33.77 32.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.411 0.624 . . . . 0.0 109.6 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.461 ' HA ' ' CD1' ' A' ' 129' ' ' LEU . 0.1 OUTLIER -58.63 -42.85 86.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.449 179.021 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -57.3 -35.41 69.78 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.568 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.406 ' HB2' ' O ' ' A' ' 125' ' ' THR . 3.9 mptt -65.66 -33.15 75.22 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.461 ' CD1' ' HA ' ' A' ' 126' ' ' ILE . 9.0 mt -73.64 -36.61 65.44 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.404 ' HA ' ' HB3' ' A' ' 134' ' ' GLN . . . -49.15 -34.1 13.58 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.97 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 10.9 mmmm -47.58 -32.77 5.77 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.666 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.425 ' CB ' ' O ' ' A' ' 87' ' ' PRO . 43.4 m-80 -123.12 -31.22 3.63 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.281 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.512 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 9.3 mmtm -146.2 -95.05 0.09 Allowed 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 119.273 -0.394 . . . . 0.0 111.367 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.512 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 7.4 pt20 128.94 -21.17 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.482 1.113 . . . . 0.0 110.574 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.6 mttm -68.4 110.88 6.52 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.648 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.438 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 93.1 Cg_endo -82.86 130.15 5.69 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.67 2.246 . . . . 0.0 111.576 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.479 HG21 ' CZ ' ' A' ' 90' ' ' PHE . 1.1 mm -62.47 96.78 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.941 0.401 . . . . 0.0 110.748 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.7 p -67.69 156.11 89.8 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.888 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.494 ' HA ' ' CE1' ' A' ' 154' ' ' TYR . 10.3 Cg_endo -51.71 -23.23 14.99 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.657 2.238 . . . . 0.0 112.023 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -86.11 -26.41 25.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.587 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.8 m -63.35 -56.84 13.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.661 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.484 ' HB1' ' CZ ' ' A' ' 82' ' ' PHE . . . -52.5 -36.96 56.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.828 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.14 -36.04 82.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.709 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.15 -56.86 13.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.815 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 50.5 tp -65.17 -36.77 85.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.764 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -57.46 -51.09 70.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.943 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 -71.64 -24.51 61.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.857 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -50.24 -41.74 50.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.832 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.42 ' O ' ' CD ' ' A' ' 150' ' ' LYS . 1.3 mp -104.42 25.18 10.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.847 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.42 ' CD ' ' O ' ' A' ' 149' ' ' LEU . 0.0 OUTLIER 44.95 39.25 3.5 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.305 -179.971 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.484 ' HB3' ' CD1' ' A' ' 110' ' ' PHE . . . -62.26 -81.02 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.028 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.426 HG13 ' CD1' ' A' ' 111' ' ' LEU . 78.4 t -159.59 -75.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.023 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.428 ' HG3' ' N ' ' A' ' 154' ' ' TYR . 0.5 OUTLIER 170.13 146.06 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.746 -178.971 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.494 ' CE1' ' HA ' ' A' ' 139' ' ' PRO . 10.2 t80 -100.77 113.58 26.61 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.442 ' CG2' ' HA ' ' A' ' 168' ' ' VAL . 1.7 t -101.6 175.73 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.629 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -88.8 145.19 25.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.021 0.439 . . . . 0.0 111.073 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.431 ' CB ' HG12 ' A' ' 168' ' ' VAL . 2.8 t -169.93 151.22 4.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.257 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 2.4 t -160.23 123.47 3.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.072 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -92.74 20.56 6.35 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.953 179.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.432 ' CD2' HD22 ' A' ' 119' ' ' LEU . 0.3 OUTLIER -131.57 -44.06 1.0 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.575 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 15.3 t -107.06 -19.51 13.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.889 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 78.05 77.78 0.07 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.098 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 25.6 tptt -96.17 30.23 2.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.815 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 119.01 -58.09 0.54 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.516 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.44 ' CD2' ' HA ' ' A' ' 19' ' ' LEU . 0.7 OUTLIER 66.74 -73.58 0.07 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.787 0.327 . . . . 0.0 111.123 179.909 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.427 ' O ' ' N ' ' A' ' 170' ' ' ASP . 1.9 mtpt -56.9 -31.9 65.36 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.01 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -52.31 -71.71 0.06 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.291 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.442 ' HA ' ' CG2' ' A' ' 155' ' ' VAL . 13.6 p -57.06 -47.43 83.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.478 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.499 ' CE2' HD23 ' A' ' 19' ' ' LEU . 1.8 t80 -62.38 -25.79 68.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.59 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' A' ' 166' ' ' LYS . 28.4 t0 -71.58 -29.84 65.16 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.67 -29.84 62.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.845 179.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.422 ' HB1' ' CD2' ' A' ' 79' ' ' LEU . . . -67.44 -49.67 62.66 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.835 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 1.6 pp -72.49 -32.59 42.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.11 0.481 . . . . 0.0 110.414 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.429 ' CD2' ' HB2' ' B' ' 505' ' ' LEU . 10.1 tp -46.13 -44.47 15.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.175 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.436 ' HB2' ' CB ' ' A' ' 77' ' ' VAL . . . -57.0 -24.24 52.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.818 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.411 ' HB2' ' HB ' ' A' ' 4' ' ' ILE . . . -94.87 -31.72 13.57 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.104 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.46 ' CD2' ' HB ' ' B' ' 510' ' ' ILE . 2.5 tp -68.27 -26.13 65.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.676 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.439 ' CB ' ' CB ' ' B' ' 507' ' ' ALA . 1.0 OUTLIER 171.24 149.3 0.17 Allowed Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.687 179.808 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . 0.433 ' HD2' ' CG ' ' A' ' 178' ' ' GLU . 16.1 Cg_endo -57.48 107.71 0.32 Allowed 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.691 2.261 . . . . 0.0 112.272 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -80.53 171.88 14.14 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.664 2.242 . . . . 0.0 112.419 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -113.62 139.56 23.52 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.872 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -76.46 -165.28 0.3 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.68 2.253 . . . . 0.0 112.342 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 10.7 mttt -134.62 80.28 1.84 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.865 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.88 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.193 0 N-CA-C 112.525 -0.23 . . . . 0.0 112.525 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 503' ' ' SER . . . . . 0.43 ' HB3' ' CD1' ' B' ' 505' ' ' LEU . 37.5 m -64.14 -78.77 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.856 0.36 . . . . 0.0 110.844 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 504' ' ' GLY . . . . . 0.403 ' C ' ' CD1' ' B' ' 505' ' ' LEU . . . 87.82 109.69 0.99 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.414 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 505' ' ' LEU . . . . . 0.487 ' N ' ' CD2' ' B' ' 505' ' ' LEU . 0.0 OUTLIER -167.17 55.12 0.08 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.701 0.286 . . . . 0.0 111.137 -179.274 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 506' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 48.48 66.44 1.07 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.917 0.389 . . . . 0.0 110.613 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 507' ' ' ALA . . . . . 0.449 ' O ' ' HB3' ' B' ' 508' ' ' GLN . . . -175.5 53.42 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.79 -179.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 508' ' ' GLN . . . . . 0.449 ' HB3' ' O ' ' B' ' 507' ' ' ALA . 1.7 tt0 68.86 5.35 4.94 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.664 -178.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 509' ' ' ASP . . . . . . . . . . . . . 2.7 p30 51.54 47.1 25.45 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.449 0.643 . . . . 0.0 110.799 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 510' ' ' ILE . . . . . 0.46 ' HB ' ' CD2' ' A' ' 177' ' ' LEU . 80.3 mt -87.49 138.3 19.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.401 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 511' ' ' SER . . . . . . . . . . . . . 1.2 m -78.33 122.24 25.49 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.335 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 512' ' ' GLN . . . . . 0.474 ' HB2' ' HD2' ' B' ' 513' ' ' PRO . 0.0 OUTLIER -50.6 179.58 0.04 OUTLIER Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.893 179.265 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 513' ' ' PRO . . . . . 0.474 ' HD2' ' HB2' ' B' ' 512' ' ' GLN . 85.0 Cg_exo -46.12 92.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 121.78 1.653 . . . . 0.0 111.46 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 514' ' ' LEU . . . . . 0.448 ' N ' ' O ' ' B' ' 512' ' ' GLN . 0.0 OUTLIER -62.84 -168.33 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.27 -179.021 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 515' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -89.02 178.59 6.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.874 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 66.56 11.22 7.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.192 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 517' ' ' SER . . . . . 0.416 ' O ' ' CG1' ' A' ' 42' ' ' VAL . 3.4 p -100.9 65.48 1.12 Allowed 'General case' 0 N--CA 1.456 -0.139 0 CA-C-O 120.898 0.38 . . . . 0.0 110.759 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 518' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -158.06 91.86 1.14 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.644 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 519' ' ' ILE . . . . . 0.411 HG12 ' O ' ' A' ' 41' ' ' ALA . 3.5 mm -100.49 -19.02 6.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.581 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 520' ' ' HIS . . . . . 0.487 ' HA ' ' CE2' ' A' ' 40' ' ' TYR . 0.7 OUTLIER 72.91 103.12 0.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.866 0.365 . . . . 0.0 110.906 -179.737 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 521' ' ' THR . . . . . . . . . . . . . 3.2 m -143.86 57.6 1.35 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.825 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 522' ' ' GLY . . . . . . . . . . . . . . . -149.52 159.94 28.27 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.218 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 523' ' ' HIS . . . . . 0.436 ' CD2' ' C ' ' B' ' 523' ' ' HIS . 9.6 t-160 -98.68 -91.26 0.28 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.675 0.238 . . . . 0.0 110.959 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 524' ' ' GLY . . . . . 0.424 ' O ' ' CB ' ' B' ' 525' ' ' ASP . . . 45.52 -131.98 9.24 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.777 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 525' ' ' ASP . . . . . 0.424 ' CB ' ' O ' ' B' ' 524' ' ' GLY . 4.2 m-20 82.07 79.22 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.038 0.446 . . . . 0.0 111.02 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 526' ' ' SER . . . . . 0.44 ' CB ' ' HB ' ' A' ' 33' ' ' VAL . 0.4 OUTLIER -113.75 99.44 7.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.459 179.594 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 527' ' ' ASP . . . . . 0.409 ' HB2' ' HD2' ' B' ' 528' ' ' PRO . 0.4 OUTLIER -40.15 163.61 0.08 OUTLIER Pre-proline 0 N--CA 1.465 0.309 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.724 -179.703 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 528' ' ' PRO . . . . . 0.409 ' HD2' ' HB2' ' B' ' 527' ' ' ASP . 10.6 Cg_endo -51.08 112.05 0.7 Allowed 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 123.053 2.502 . . . . 0.0 111.988 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 529' ' ' ARG . . . . . . . . . . . . . 30.3 mtp180 -100.71 -54.1 2.91 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.258 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 530' ' ' HIS . . . . . . . . . . . . . 25.4 m-70 -137.68 10.29 2.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.587 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 3.9 m 44.99 -160.96 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.84 0.352 . . . . 0.0 111.286 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 532' ' ' TRP . . . . . 0.477 ' HB2' ' CD1' ' A' ' 32' ' ' TYR . 12.1 t-105 -132.34 92.29 3.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.867 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . -92.82 -48.87 2.82 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.526 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 534' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -106.87 140.21 21.15 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.658 0.266 . . . . 0.0 110.916 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -56.17 -158.16 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.518 2.146 . . . . 0.0 112.303 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 69.24 61.36 0.31 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.886 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 537' ' ' ARG . . . . . 0.509 ' HG2' ' PA ' ' A' ' 185' ' ' GNP . 0.0 OUTLIER -48.75 159.56 0.23 Allowed 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.0 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 538' ' ' ILE . . . . . 0.437 ' CG1' ' HB2' ' B' ' 542' ' ' TYR . 10.3 tp -81.72 141.33 15.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.482 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 539' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -45.5 161.16 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.883 0.373 . . . . 0.0 111.221 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 540' ' ' GLU . . . . . 0.433 ' O ' ' CG2' ' A' ' 58' ' ' THR . 0.4 OUTLIER -61.61 -14.89 34.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.555 -179.854 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 541' ' ' LEU . . . . . 0.471 ' N ' ' CD2' ' A' ' 70' ' ' LEU . 0.2 OUTLIER -66.22 -32.77 74.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.365 0.603 . . . . 0.0 110.062 179.708 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 542' ' ' TYR . . . . . 0.437 ' HB2' ' CG1' ' B' ' 538' ' ' ILE . 40.7 m-85 -104.9 -50.76 3.19 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.17 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 543' ' ' LEU . . . . . 0.428 ' CD1' ' O ' ' A' ' 58' ' ' THR . 0.5 OUTLIER 72.42 -68.02 0.24 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.931 -179.678 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . -117.44 164.02 12.61 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.493 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 545' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.888 179.988 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' GNP . . . . . 0.579 " H2'" ' OG1' ' A' ' 115' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' HOH . . . . . 0.577 ' H2 ' ' HD2' ' A' ' 16' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' HOH . . . . . 0.439 ' H1 ' ' PG ' ' A' ' 185' ' ' GNP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.518 ' CE ' ' CD1' ' A' ' 51' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.418 0 N-CA-C 111.529 0.196 . . . . 0.0 111.529 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.403 ' O ' ' HE3' ' A' ' 1' ' ' MET . 32.7 tp60 56.42 154.93 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.104 0.478 . . . . 0.0 111.556 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.444 ' HB ' ' CD2' ' A' ' 53' ' ' LEU . 0.3 OUTLIER -146.02 -168.97 3.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.034 179.991 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.447 ' CG2' ' HG ' ' A' ' 177' ' ' LEU . 0.1 OUTLIER -145.1 156.08 13.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.561 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 28.9 mttm -118.19 105.74 12.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.515 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.422 ' O ' ' N ' ' A' ' 56' ' ' PHE . 36.2 t -77.3 105.07 8.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.09 0.471 . . . . 0.0 111.934 -178.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 t -132.94 118.86 34.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.836 178.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.416 HG13 ' HG3' ' B' ' 540' ' ' GLU . 0.4 OUTLIER -96.69 143.41 12.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.315 0.579 . . . . 0.0 111.08 -179.235 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.41 HG22 ' CD2' ' A' ' 78' ' ' PHE . 12.6 m -140.88 129.75 24.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.482 178.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.43 -143.06 9.61 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.024 -1.084 . . . . 0.0 112.734 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -123.24 22.71 9.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.668 0.27 . . . . 0.0 110.953 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.434 ' CA ' ' O ' ' B' ' 536' ' ' ASP . . . -153.42 -172.45 21.62 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.406 -0.902 . . . . 0.0 113.364 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.69 -48.74 75.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.777 0.322 . . . . 0.0 111.462 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.433 ' CG1' ' HG ' ' A' ' 79' ' ' LEU . 61.5 t 68.37 -72.14 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.117 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.448 ' CA ' ' CD2' ' A' ' 19' ' ' LEU . . . -172.36 66.32 0.13 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.631 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.469 ' CD ' ' CD2' ' B' ' 543' ' ' LEU . 27.0 mttt -97.14 -97.56 0.2 Allowed 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 121.457 -0.097 . . . . 0.0 110.803 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.419 ' CG2' HG23 ' A' ' 35' ' ' THR . 58.3 p -98.22 -57.35 2.23 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-O 120.832 0.349 . . . . 0.0 111.177 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.446 ' CB ' ' O2A' ' A' ' 185' ' ' GNP . 14.8 p -36.17 -43.84 0.37 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.456 -179.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.509 ' CD2' ' CD2' ' A' ' 169' ' ' PHE . 1.8 mp -46.41 -70.96 0.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.793 0.33 . . . . 0.0 111.284 -179.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.454 HD23 ' CD2' ' A' ' 169' ' ' PHE . 14.7 mt -61.96 -25.57 67.69 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.84 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.418 ' CG2' ' OG1' ' A' ' 25' ' ' THR . 15.2 mm -67.2 -70.36 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.666 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.412 ' HB2' ' CD1' ' A' ' 165' ' ' LEU . 3.4 m -47.79 -28.93 2.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.082 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -66.84 -68.18 0.39 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.833 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.02 -48.11 39.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.72 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.418 ' OG1' ' CG2' ' A' ' 21' ' ' ILE . 13.4 p -83.2 -152.29 0.12 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.424 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -160.11 33.46 0.17 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.821 0.343 . . . . 0.0 111.033 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 13.8 mmtt -121.32 101.71 7.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.408 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.493 ' CE1' " O3'" ' A' ' 185' ' ' GNP . 7.9 t80 -104.87 -60.11 0.06 OUTLIER Pre-proline 0 CA--C 1.537 0.444 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.124 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.463 ' HD3' ' HB3' ' A' ' 28' ' ' PHE . 95.1 Cg_endo -84.21 48.7 2.56 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.151 1.9 . . . . 0.0 112.608 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.84 -80.79 0.43 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.029 0.442 . . . . 0.0 110.656 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.432 ' HB2' ' NE ' ' B' ' 529' ' ' ARG . 12.9 pt-20 -158.34 140.98 14.51 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.63 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.525 ' CD1' ' N3B' ' A' ' 185' ' ' GNP . 91.7 m-85 -130.21 100.91 5.57 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.514 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.441 ' CG2' ' HD3' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -165.28 -63.55 0.01 OUTLIER Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.157 -179.541 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.441 ' HD3' ' CG2' ' A' ' 33' ' ' VAL . 74.9 Cg_exo -38.75 -29.77 0.17 Allowed 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.745 2.296 . . . . 0.0 112.905 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.45 HG22 ' CD2' ' B' ' 543' ' ' LEU . 60.9 m -56.53 85.54 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.993 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.434 ' CG1' ' HB3' ' A' ' 59' ' ' ALA . 2.6 t -140.5 -40.42 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.282 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.457 ' CE2' ' OD1' ' A' ' 63' ' ' ASP . 0.3 OUTLIER -91.19 25.13 2.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.966 179.698 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.435 ' HB2' ' CB ' ' A' ' 57' ' ' ASP . 0.7 OUTLIER -57.78 -159.85 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.873 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 68.26 29.46 6.01 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.943 0.401 . . . . 0.0 110.46 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.414 ' CE1' ' O ' ' B' ' 521' ' ' THR . 0.7 OUTLIER -60.72 -160.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.852 -179.808 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.415 ' O ' ' CG1' ' B' ' 519' ' ' ILE . . . -122.97 123.27 40.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.466 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.3 t -106.76 121.7 59.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.64 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.423 ' O ' ' CG1' ' A' ' 44' ' ' VAL . 6.5 p -108.79 106.84 17.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.197 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.469 ' CG2' ' CG2' ' A' ' 52' ' ' THR . 27.3 m -159.46 -178.91 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.916 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.428 ' HG2' ' N ' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -98.37 103.39 15.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.844 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.486 ' CG2' ' O ' ' A' ' 46' ' ' ILE . 1.2 tt -95.2 106.29 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-O 121.529 0.681 . . . . 0.0 111.021 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.466 ' CA ' ' HA ' ' B' ' 510' ' ' ILE . . . 43.61 -93.19 0.01 OUTLIER Glycine 0 CA--C 1.517 0.178 0 C-N-CA 121.001 -0.619 . . . . 0.0 113.526 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.439 ' HA3' ' CB ' ' A' ' 1' ' ' MET . . . -39.2 -86.16 0.01 OUTLIER Glycine 0 C--N 1.334 0.458 0 C-N-CA 121.393 -0.432 . . . . 0.0 113.371 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.429 ' HB3' ' CD ' ' A' ' 50' ' ' PRO . 4.0 mt-10 -144.06 177.58 1.76 Allowed Pre-proline 0 C--N 1.331 -0.205 0 CA-C-O 120.671 0.272 . . . . 0.0 111.04 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.429 ' CD ' ' HB3' ' A' ' 49' ' ' GLU . 76.8 Cg_exo -51.23 92.98 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.551 2.167 . . . . 0.0 112.614 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.518 ' CD1' ' CE ' ' A' ' 1' ' ' MET . 2.8 t80 -173.29 125.96 0.42 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.386 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.469 ' CG2' ' CG2' ' A' ' 44' ' ' VAL . 0.1 OUTLIER -134.3 144.29 48.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.798 0.332 . . . . 0.0 111.161 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.444 ' CD2' ' HB ' ' A' ' 3' ' ' THR . 0.9 OUTLIER -87.69 -177.33 5.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.89 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -123.92 116.47 2.86 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.438 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.402 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 2.2 mp -50.77 139.13 17.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.874 0.369 . . . . 0.0 110.844 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.422 ' N ' ' O ' ' A' ' 6' ' ' CYS . 7.8 t80 -85.76 135.0 33.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.311 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.435 ' CB ' ' HB2' ' A' ' 38' ' ' ASP . 0.1 OUTLIER -150.54 131.88 14.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.372 179.558 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.433 ' O ' ' CD1' ' B' ' 543' ' ' LEU . 2.5 p -130.25 125.0 33.75 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.164 -179.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.434 ' HB3' ' CG1' ' A' ' 36' ' ' VAL . . . -144.19 99.68 3.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.7 179.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.09 75.79 0.25 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.684 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.431 ' CD1' ' HB2' ' A' ' 59' ' ' ALA . 4.6 mp -121.49 -95.89 0.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 121.312 -0.155 . . . . 0.0 111.207 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -99.36 -30.3 12.29 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 120.766 0.317 . . . . 0.0 111.487 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.457 ' OD1' ' CE2' ' A' ' 37' ' ' PHE . 29.7 t0 -80.57 -63.73 1.34 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.619 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.524 ' CD2' ' CD1' ' A' ' 67' ' ' LEU . 19.0 m-85 -88.27 144.53 26.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.917 0.389 . . . . 0.0 110.874 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -86.26 -62.04 1.61 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.831 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.29 -52.98 3.49 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -178.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.524 ' CD1' ' CD2' ' A' ' 64' ' ' TYR . 0.4 OUTLIER 64.78 -151.25 0.28 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 120.596 -0.442 . . . . 0.0 109.832 -179.566 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.499 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.1 OUTLIER 78.28 41.94 0.06 OUTLIER Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 179.5 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.499 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 88.3 Cg_endo -82.89 -21.95 4.55 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.302 2.002 . . . . 0.0 112.09 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.45 ' CD2' ' HA ' ' B' ' 541' ' ' LEU . 0.1 OUTLIER -60.52 -15.17 24.68 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.621 -179.677 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.33 -60.55 3.68 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.752 0.311 . . . . 0.0 110.968 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.01 65.07 74.47 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.923 0.392 . . . . 0.0 111.146 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.403 ' HD3' ' O ' ' A' ' 70' ' ' LEU . 83.6 Cg_endo -82.56 145.88 13.31 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.801 2.334 . . . . 0.0 112.189 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -96.64 10.25 39.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.48 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 11.5 t -53.05 -176.32 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.752 0.31 . . . . 0.0 110.878 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -136.5 7.35 3.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.553 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.421 ' CG2' ' HB2' ' A' ' 176' ' ' ALA . 4.8 t -139.03 86.76 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.725 0.298 . . . . 0.0 111.458 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.411 ' N ' ' O ' ' A' ' 109' ' ' PRO . 0.5 OUTLIER -80.85 172.01 14.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.084 179.351 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.433 ' HG ' ' CG1' ' A' ' 14' ' ' VAL . 9.8 tp -157.0 120.98 4.28 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.084 0.469 . . . . 0.0 111.812 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.476 ' HB ' ' CH2' ' A' ' 97' ' ' TRP . 0.7 OUTLIER -114.11 135.83 52.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.981 179.041 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.432 ' HB2' ' N7 ' ' A' ' 185' ' ' GNP . 4.6 p -125.83 164.33 20.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.245 0.545 . . . . 0.0 112.283 -178.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.482 ' O ' ' CD1' ' A' ' 82' ' ' PHE . 11.3 p90 -169.36 135.61 1.64 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.131 179.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.433 ' HA ' ' C2 ' ' A' ' 185' ' ' GNP . 50.2 p -88.41 144.66 26.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.816 0.341 . . . . 0.0 110.943 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.437 HG13 ' CB ' ' A' ' 120' ' ' ARG . 45.1 t -46.17 -63.14 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.56 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.3 m -45.47 110.02 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.698 0.285 . . . . 0.0 110.829 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.401 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 0.2 OUTLIER -151.6 131.46 6.94 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.827 -179.347 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.42 ' O ' ' CB ' ' A' ' 88' ' ' SER . 67.8 Cg_endo -92.58 53.33 0.55 Allowed 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 123.289 2.659 . . . . 0.0 111.837 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.43 ' CA ' ' HG3' ' A' ' 133' ' ' LYS . 1.0 OUTLIER 80.31 30.17 0.22 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.069 -179.745 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.22 -23.03 17.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.857 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.486 ' CZ ' HG23 ' A' ' 137' ' ' ILE . 0.8 OUTLIER -52.49 -58.41 6.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.93 179.924 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -58.22 -40.7 82.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.936 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -64.64 -59.21 4.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.886 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.479 HG12 ' CD1' ' A' ' 97' ' ' TRP . 47.1 t -51.22 -52.74 17.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.181 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.438 ' HG3' ' CD1' ' A' ' 145' ' ' LEU . 10.8 tmtt? -50.49 -50.43 52.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.901 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -54.25 -42.12 69.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.183 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.72 12.23 34.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.543 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.479 ' CD1' HG12 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -94.47 -53.16 4.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.744 0.307 . . . . 0.0 111.087 179.918 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.493 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 3.5 t -60.36 -44.94 97.31 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.896 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.493 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 16.4 Cg_exo -68.31 -33.72 23.14 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.539 2.159 . . . . 0.0 112.923 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -85.73 -35.7 20.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.649 -0.25 . . . . 0.0 111.437 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.454 HD13 ' CG ' ' A' ' 110' ' ' PHE . 12.7 tt -68.75 -25.98 31.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.755 0.312 . . . . 0.0 111.056 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 68.0 p -97.18 -26.85 14.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.046 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.47 ' CG ' ' O ' ' A' ' 99' ' ' PRO . 5.1 m170 -66.68 -41.84 87.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.047 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -76.68 -24.33 53.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.103 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.414 ' O ' ' N ' ' A' ' 107' ' ' LYS . 8.0 m -137.4 123.06 12.91 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.854 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.17 79.76 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.571 2.181 . . . . 0.0 112.234 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.414 ' N ' ' O ' ' A' ' 105' ' ' CYS . 2.6 mmmp? 61.39 91.41 0.06 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.917 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.413 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 0.1 OUTLIER -122.57 138.08 28.79 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.921 179.929 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 108' ' ' THR . 31.5 Cg_exo -60.28 138.02 78.49 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.618 2.212 . . . . 0.0 112.468 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.485 ' N ' ' CD1' ' A' ' 110' ' ' PHE . 1.0 OUTLIER -142.25 147.18 36.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.715 179.656 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.475 ' CD1' ' CG1' ' A' ' 152' ' ' VAL . 0.9 OUTLIER -130.02 158.0 40.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.314 -179.678 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.477 ' CD2' ' CB ' ' A' ' 151' ' ' ALA . 3.0 mm? -97.19 161.35 13.85 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.667 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.44 ' HA ' ' CG2' ' A' ' 168' ' ' VAL . 18.2 t -135.03 138.69 48.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.049 0.452 . . . . 0.0 111.889 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.414 ' HA3' ' CZ ' ' A' ' 154' ' ' TYR . . . -123.26 107.31 1.08 Allowed Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.59 179.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.819 ' OG1' " H2'" ' A' ' 185' ' ' GNP . 0.0 OUTLIER -130.81 -53.18 1.06 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.852 0.358 . . . . 0.0 110.704 -179.187 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.494 ' HB2' HO2' ' A' ' 185' ' ' GNP . 1.6 tt0 -79.89 53.8 1.74 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.274 179.008 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.427 ' O ' ' CG ' ' A' ' 120' ' ' ARG . 0.1 OUTLIER -99.12 -5.8 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.006 179.834 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -77.73 -27.43 50.51 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.936 0.398 . . . . 0.0 110.536 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.432 ' CD1' ' HG2' ' A' ' 116' ' ' GLN . 5.0 mp -76.69 -24.36 53.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.591 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.437 ' CB ' HG13 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -46.71 -29.38 1.86 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.811 179.783 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -83.79 -34.92 24.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.405 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.63 104.49 0.44 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.575 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.415 ' HA ' ' CG2' ' A' ' 126' ' ' ILE . 14.7 Cg_exo -69.06 -3.73 12.14 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.703 2.269 . . . . 0.0 113.106 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.03 -66.4 0.87 Allowed 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 121.109 0.48 . . . . 0.0 109.758 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.406 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 18.2 m -57.92 -37.92 74.94 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.465 ' HA ' ' CD1' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -54.85 -42.95 65.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.781 179.337 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -60.08 -35.1 74.45 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.86 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.406 ' HB2' ' O ' ' A' ' 125' ' ' THR . 0.0 OUTLIER -65.38 -30.91 71.79 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.071 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.465 ' CD1' ' HA ' ' A' ' 126' ' ' ILE . 7.4 mt -73.94 -35.59 64.59 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -46.25 -34.63 4.56 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.894 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 5.7 mmmt -47.51 -33.06 5.89 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.478 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.404 ' CB ' ' O ' ' A' ' 87' ' ' PRO . 55.7 m-80 -123.43 -31.4 3.53 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.451 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.523 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 16.7 mmtp -146.85 -97.49 0.09 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 119.208 -0.425 . . . . 0.0 111.662 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.523 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 9.2 pt20 128.99 -25.74 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.473 1.109 . . . . 0.0 110.331 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -69.36 110.63 6.64 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.761 -179.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.436 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 95.3 Cg_endo -79.53 136.97 12.71 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.514 2.143 . . . . 0.0 111.371 179.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.496 ' N ' ' CD1' ' A' ' 137' ' ' ILE . 0.8 OUTLIER -69.25 96.59 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.91 0.386 . . . . 0.0 110.953 -179.463 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.6 p -70.48 160.2 82.21 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.182 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.471 ' HA ' ' CE1' ' A' ' 154' ' ' TYR . 72.0 Cg_exo -48.14 -42.88 32.34 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.572 2.181 . . . . 0.0 112.213 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -67.44 -34.74 77.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.776 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 97.5 m -58.29 -55.32 36.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.904 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.511 ' CB ' ' CD2' ' A' ' 154' ' ' TYR . . . -50.9 -36.53 38.75 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.899 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -64.72 -42.59 95.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.833 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.55 -56.76 15.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.698 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.438 ' CD1' ' HG3' ' A' ' 94' ' ' LYS . 2.9 tt -67.92 -31.97 72.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.707 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.431 ' CB ' HD21 ' A' ' 112' ' ' LEU . . . -55.66 -66.02 0.49 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.931 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 16.1 mtp85 -63.52 -24.12 67.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.977 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -54.11 -40.95 67.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.2 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.408 HD13 ' CD2' ' A' ' 145' ' ' LEU . 0.5 OUTLIER -117.32 24.5 11.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.076 -179.862 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.79 59.06 2.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.786 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.477 ' CB ' ' CD2' ' A' ' 112' ' ' LEU . . . -94.22 27.92 2.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.118 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.475 ' CG1' ' CD1' ' A' ' 111' ' ' LEU . 92.8 t 68.94 -74.8 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.975 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.423 ' O ' ' CD2' ' A' ' 111' ' ' LEU . 0.2 OUTLIER 173.13 139.21 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.109 0.481 . . . . 0.0 111.394 -179.234 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.511 ' CD2' ' CB ' ' A' ' 142' ' ' ALA . 3.2 t80 -94.66 116.69 29.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.248 178.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 5.2 t -101.12 158.7 4.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.31 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -89.67 143.58 26.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.522 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.414 ' O ' HD13 ' A' ' 117' ' ' ILE . 25.3 p 178.9 179.25 0.41 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.012 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.426 ' OG ' ' N ' ' A' ' 163' ' ' LYS . 28.4 p -159.89 160.24 33.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.953 0.406 . . . . 0.0 111.308 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.422 ' CB ' HD13 ' A' ' 165' ' ' LEU . . . -113.8 -27.14 7.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.915 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.68 -37.39 41.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.782 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 7.7 t -116.59 -13.69 10.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.189 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.412 ' N ' ' OG ' ' A' ' 158' ' ' SER . 0.5 OUTLIER 71.56 82.02 0.15 Allowed 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.698 0.285 . . . . 0.0 111.254 179.827 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.426 ' N ' ' OG ' ' A' ' 158' ' ' SER . 5.5 mttm -101.92 22.15 13.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.053 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 105.2 44.23 1.51 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.442 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.422 HD13 ' CB ' ' A' ' 159' ' ' ALA . 2.3 mt -46.09 -31.7 2.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.783 0.325 . . . . 0.0 111.155 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.427 ' HG3' ' N ' ' A' ' 167' ' ' ASN . 0.1 OUTLIER -66.57 -28.62 68.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.902 179.825 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.427 ' N ' ' HG3' ' A' ' 166' ' ' LYS . 0.1 OUTLIER -57.48 -70.87 0.11 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.698 179.874 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.44 ' CG2' ' HA ' ' A' ' 113' ' ' VAL . 11.4 p -50.77 -44.27 25.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.914 0.388 . . . . 0.0 110.565 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.509 ' CD2' ' CD2' ' A' ' 19' ' ' LEU . 0.3 OUTLIER -63.85 -30.59 71.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.097 179.436 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.414 ' O ' HG13 ' A' ' 173' ' ' ILE . 20.4 t0 -70.65 -22.52 62.49 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.565 179.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -84.61 -35.1 22.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.248 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -67.28 -32.62 73.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.74 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.441 ' CG2' HG13 ' A' ' 4' ' ' ILE . 2.0 pp -82.52 -35.11 12.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.771 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.45 ' CD1' ' HB3' ' B' ' 505' ' ' LEU . 9.7 tp -52.83 -43.56 66.08 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.977 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -50.65 -23.48 2.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.642 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.44 ' CB ' HG21 ' A' ' 4' ' ' ILE . . . -96.72 -34.71 11.25 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.699 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.447 ' HG ' ' CG2' ' A' ' 4' ' ' ILE . 96.7 mt -68.76 -24.01 64.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.797 0.332 . . . . 0.0 110.729 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -179.92 154.33 0.68 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.926 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -68.1 108.8 1.81 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.603 2.202 . . . . 0.0 112.256 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.55 174.08 9.84 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.531 2.154 . . . . 0.0 112.449 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -145.64 144.47 22.64 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.781 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.3 -165.14 0.27 Allowed 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.598 2.198 . . . . 0.0 112.26 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 7.6 mttm -126.71 171.67 10.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.918 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 3.4 mtpt . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.192 -0.909 . . . . 0.0 110.867 -179.961 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 502' ' ' GLY . . . . . 0.425 ' CA ' ' O ' ' B' ' 509' ' ' ASP . . . . . . . . 0 N--CA 1.488 2.116 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 503' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.49 -75.29 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.797 0.332 . . . . 0.0 110.968 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 504' ' ' GLY . . . . . 0.471 ' CA ' ' HA ' ' B' ' 509' ' ' ASP . . . 147.22 -101.33 0.23 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.0 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 505' ' ' LEU . . . . . 0.45 ' HB3' ' CD1' ' A' ' 174' ' ' LEU . 0.5 OUTLIER 69.39 -61.77 0.43 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 179.244 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 506' ' ' SER . . . . . 0.424 ' CB ' ' O ' ' B' ' 505' ' ' LEU . 1.1 p 165.0 -45.71 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.722 0.296 . . . . 0.0 111.108 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 507' ' ' ALA . . . . . . . . . . . . . . . -36.92 -66.51 0.23 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.947 0.88 . . . . 0.0 111.43 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 508' ' ' GLN . . . . . 0.484 ' O ' ' CB ' ' B' ' 509' ' ' ASP . 7.3 mt-30 -160.48 -45.42 0.05 OUTLIER 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.02 -1.445 . . . . 0.0 107.841 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 509' ' ' ASP . . . . . 0.484 ' CB ' ' O ' ' B' ' 508' ' ' GLN . 3.3 p30 146.88 43.57 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 113.994 -1.457 . . . . 0.0 110.259 178.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 510' ' ' ILE . . . . . 0.466 ' HA ' ' CA ' ' A' ' 47' ' ' GLY . 2.3 mt -65.15 133.09 30.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.163 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 511' ' ' SER . . . . . 0.423 ' CB ' ' HG ' ' B' ' 514' ' ' LEU . 2.6 m -109.35 158.72 17.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.257 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 512' ' ' GLN . . . . . 0.484 ' CB ' ' HD3' ' B' ' 513' ' ' PRO . 0.7 OUTLIER -100.37 -65.43 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.724 179.562 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 513' ' ' PRO . . . . . 0.484 ' HD3' ' CB ' ' B' ' 512' ' ' GLN . 69.9 Cg_endo -83.81 53.49 4.11 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.549 2.166 . . . . 0.0 112.06 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 514' ' ' LEU . . . . . 0.423 ' HG ' ' CB ' ' B' ' 511' ' ' SER . 0.7 OUTLIER -61.75 -84.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.374 -179.468 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 515' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -78.91 -86.8 0.07 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.207 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -118.41 -32.32 4.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.779 0.323 . . . . 0.0 111.243 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 517' ' ' SER . . . . . 0.476 ' O ' ' CD1' ' B' ' 518' ' ' PHE . 0.4 OUTLIER 73.06 7.85 5.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.649 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 518' ' ' PHE . . . . . 0.476 ' CD1' ' O ' ' B' ' 517' ' ' SER . 6.5 m-85 -163.43 125.03 2.43 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.723 0.297 . . . . 0.0 110.901 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 519' ' ' ILE . . . . . 0.415 ' CG1' ' O ' ' A' ' 41' ' ' ALA . 40.1 mm -79.94 -34.37 15.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.214 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 520' ' ' HIS . . . . . 0.415 ' O ' ' CG2' ' B' ' 521' ' ' THR . 41.5 t-80 -163.25 -87.04 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.069 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 521' ' ' THR . . . . . 0.415 ' CG2' ' O ' ' B' ' 520' ' ' HIS . 0.1 OUTLIER 170.23 -172.43 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 120.848 0.356 . . . . 0.0 110.886 179.911 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 522' ' ' GLY . . . . . . . . . . . . . . . -93.23 -125.91 4.08 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.37 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 523' ' ' HIS . . . . . 0.434 ' CD2' ' C ' ' B' ' 523' ' ' HIS . 8.7 t-160 -157.47 -91.64 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.501 0.191 . . . . 0.0 110.767 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 524' ' ' GLY . . . . . . . . . . . . . . . 48.4 -178.23 0.01 OUTLIER Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.854 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 525' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 168.77 60.46 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.824 0.345 . . . . 0.0 110.809 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 526' ' ' SER . . . . . 0.42 ' OG ' ' CG1' ' A' ' 33' ' ' VAL . 12.2 t -92.34 97.01 10.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.012 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 527' ' ' ASP . . . . . 0.478 ' CB ' ' CD ' ' B' ' 528' ' ' PRO . 0.2 OUTLIER -52.72 -64.31 1.68 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.98 179.944 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 528' ' ' PRO . . . . . 0.478 ' CD ' ' CB ' ' B' ' 527' ' ' ASP . 12.8 Cg_endo -53.45 103.43 0.09 OUTLIER 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.97 2.447 . . . . 0.0 112.17 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 529' ' ' ARG . . . . . 0.432 ' NE ' ' HB2' ' A' ' 31' ' ' GLU . 13.7 mtt85 -100.59 -32.06 10.95 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.968 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 530' ' ' HIS . . . . . 0.503 ' O ' ' CG ' ' B' ' 530' ' ' HIS . 0.1 OUTLIER 70.5 6.47 5.82 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.116 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER 59.55 177.51 0.08 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.89 0.376 . . . . 0.0 111.034 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 532' ' ' TRP . . . . . 0.411 ' CD2' ' O ' ' B' ' 532' ' ' TRP . 72.4 t90 -75.28 73.03 2.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.844 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . -96.21 -19.0 29.52 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.491 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 534' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -88.67 156.02 50.38 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.78 0.324 . . . . 0.0 111.003 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -73.89 95.08 0.88 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.565 2.176 . . . . 0.0 112.362 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 536' ' ' ASP . . . . . 0.434 ' O ' ' CA ' ' A' ' 12' ' ' GLY . 35.4 m-20 62.97 46.91 4.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.019 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 537' ' ' ARG . . . . . 0.438 ' NH2' " H4'" ' A' ' 185' ' ' GNP . 20.9 mmt-85 73.86 -173.89 0.14 Allowed 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.373 0.606 . . . . 0.0 111.518 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 538' ' ' ILE . . . . . 0.494 ' CD1' ' CB ' ' B' ' 542' ' ' TYR . 4.8 pt -106.66 -153.68 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.031 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 539' ' ' ASP . . . . . 0.402 ' N ' HG13 ' B' ' 538' ' ' ILE . 51.8 p30 -104.04 161.42 14.01 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.944 0.402 . . . . 0.0 111.35 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 540' ' ' GLU . . . . . 0.416 ' HG3' HG13 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -57.12 -23.79 49.6 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.801 179.634 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 541' ' ' LEU . . . . . 0.45 ' HA ' ' CD2' ' A' ' 70' ' ' LEU . 0.4 OUTLIER -60.09 -34.79 73.94 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.339 0.59 . . . . 0.0 109.884 179.794 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 542' ' ' TYR . . . . . 0.494 ' CB ' ' CD1' ' B' ' 538' ' ' ILE . 2.9 m-85 -102.66 -57.34 2.07 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.999 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 543' ' ' LEU . . . . . 0.469 ' CD2' ' CD ' ' A' ' 16' ' ' LYS . 0.2 OUTLIER 64.74 -71.41 0.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.915 179.865 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 544' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' B' ' 542' ' ' TYR . . . -62.87 165.66 24.92 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.349 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 545' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.276 -0.869 . . . . 0.0 111.018 -179.907 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' GNP . . . . . 0.819 " H2'" ' OG1' ' A' ' 115' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.466 ' HE2' ' CD1' ' A' ' 51' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.323 0.106 . . . . 0.0 111.117 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.407 ' N ' ' SD ' ' A' ' 1' ' ' MET . 13.1 tp60 56.97 151.94 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.126 0.489 . . . . 0.0 111.58 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.486 ' OG1' ' CE1' ' A' ' 51' ' ' TYR . 0.3 OUTLIER -154.65 -158.69 0.87 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.247 179.919 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.455 ' CD1' ' N ' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -144.82 155.57 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 CA-C-O 121.189 0.519 . . . . 0.0 111.973 -179.514 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 36.3 mttt -134.45 116.61 15.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.704 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 45.7 t -138.38 154.22 48.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.364 0.602 . . . . 0.0 112.52 -178.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.426 ' CG1' ' OE2' ' B' ' 540' ' ' GLU . 11.9 t -128.37 150.35 34.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.208 178.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.466 ' CG2' ' HA ' ' A' ' 14' ' ' VAL . 2.8 p -83.8 121.65 36.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.307 0.575 . . . . 0.0 111.707 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 19.2 m -129.87 129.9 66.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.928 178.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.468 ' HA2' ' CZ2' ' A' ' 97' ' ' TRP . . . 137.49 -142.8 13.79 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.194 -1.003 . . . . 0.0 112.652 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.427 ' CB ' ' O ' ' B' ' 537' ' ' ARG . 0.4 OUTLIER -122.52 26.68 8.22 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.879 0.371 . . . . 0.0 110.633 179.915 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.425 ' O ' ' CB ' ' B' ' 537' ' ' ARG . . . -86.04 -176.2 49.96 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.765 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.428 ' CB ' ' HD3' ' B' ' 537' ' ' ARG . . . -89.39 4.82 47.76 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.466 ' HA ' ' CG2' ' A' ' 8' ' ' VAL . 8.7 t 81.24 107.18 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.066 0.46 . . . . 0.0 110.651 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.486 ' HA3' ' CE1' ' A' ' 169' ' ' PHE . . . -65.32 -9.29 41.96 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.723 -0.671 . . . . 0.0 113.423 -179.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.428 ' CD ' ' HB3' ' A' ' 55' ' ' LEU . 3.1 mmtt -77.07 -51.25 11.38 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 122.395 -0.473 . . . . 0.0 111.031 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.41 ' HB ' HG13 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -98.14 -44.36 6.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.596 -179.583 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.421 ' CB ' ' O ' ' A' ' 14' ' ' VAL . 44.0 t -36.12 -73.83 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.54 ' CD1' ' CE1' ' A' ' 169' ' ' PHE . 1.8 mp -56.53 -68.66 0.2 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.951 0.405 . . . . 0.0 111.583 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.9 mt -46.38 -61.45 1.79 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.201 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.41 HG13 ' HB ' ' A' ' 17' ' ' THR . 47.6 mm -49.35 -72.15 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.781 0.324 . . . . 0.0 111.191 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 27.7 t -51.2 -23.0 2.98 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.606 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -75.41 -68.07 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.731 0.3 . . . . 0.0 111.382 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.4 m -75.91 -34.69 59.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.31 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.402 ' OG1' ' O ' ' A' ' 21' ' ' ILE . 1.5 p -87.9 -156.12 0.34 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.882 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -151.41 21.13 0.73 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.089 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -108.59 123.51 49.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.869 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.492 ' CD1' ' O1A' ' A' ' 185' ' ' GNP . 0.4 OUTLIER -153.78 -68.25 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.411 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.632 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.473 ' CD ' ' CB ' ' A' ' 28' ' ' PHE . 74.0 Cg_endo -75.45 54.26 3.79 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.479 2.119 . . . . 0.0 112.939 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 33.9 t -145.96 -80.02 0.16 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.916 0.389 . . . . 0.0 110.976 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -158.34 159.02 35.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.45 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.522 ' CD2' ' PG ' ' A' ' 185' ' ' GNP . 10.6 m-85 -128.44 93.36 3.62 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.065 0.46 . . . . 0.0 110.918 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.474 ' CG1' ' CB ' ' B' ' 526' ' ' SER . 1.9 t -108.45 -50.01 0.08 OUTLIER Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.545 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.419 ' HD3' ' HB ' ' A' ' 33' ' ' VAL . 77.6 Cg_exo -52.01 -22.14 13.88 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.009 1.806 . . . . 0.0 112.203 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.417 HG23 ' CD2' ' B' ' 543' ' ' LEU . 27.9 m -52.3 -24.33 7.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.545 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.425 ' CG1' ' HA2' ' B' ' 524' ' ' GLY . 5.6 p -57.98 -25.35 25.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.164 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.477 ' CD1' ' HA3' ' B' ' 522' ' ' GLY . 0.2 OUTLIER -125.79 53.36 1.59 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.963 0.411 . . . . 0.0 110.645 179.724 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.409 ' OD2' ' CB ' ' A' ' 16' ' ' LYS . 24.4 t70 -88.95 14.18 11.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.554 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -92.82 19.87 7.15 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.769 0.318 . . . . 0.0 110.905 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -61.95 -175.11 0.06 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.699 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -116.43 169.77 9.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.438 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.442 ' HA ' ' CG1' ' B' ' 519' ' ' ILE . 35.1 m -146.94 129.33 7.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.911 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.425 ' O ' ' CG1' ' A' ' 44' ' ' VAL . 16.4 p -87.5 105.61 17.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.554 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.499 ' CG2' ' CG2' ' A' ' 52' ' ' THR . 19.3 m -158.93 -177.09 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.53 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.479 ' HE1' ' N ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -124.85 107.54 11.01 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.795 0.295 . . . . 0.0 111.795 -179.639 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.456 ' CG2' HG21 ' B' ' 510' ' ' ILE . 5.1 mm -79.96 86.13 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 26.21 90.29 0.01 OUTLIER Glycine 0 CA--C 1.526 0.731 0 O-C-N 123.64 0.587 . . . . 0.0 114.449 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 140.39 -95.51 0.2 Allowed Glycine 0 N--CA 1.454 -0.156 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.448 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.479 ' N ' ' HE1' ' A' ' 45' ' ' MET . 0.0 OUTLIER -130.31 144.99 55.46 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.791 0.329 . . . . 0.0 110.638 179.347 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.41 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 68.8 Cg_exo -34.39 102.4 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.46 2.773 . . . . 0.0 113.446 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.486 ' CE1' ' OG1' ' A' ' 3' ' ' THR . 3.1 t80 -173.4 138.22 0.69 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.159 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.499 ' CG2' ' CG2' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -134.12 153.16 51.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.112 0.482 . . . . 0.0 111.402 179.495 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.435 HD11 ' CG1' ' A' ' 4' ' ' ILE . 0.4 OUTLIER -80.25 109.9 15.17 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.169 -179.616 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -62.95 107.61 1.75 Allowed Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.0 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.428 ' HB3' ' CD ' ' A' ' 16' ' ' LYS . 1.4 mp -63.59 116.88 6.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.836 0.35 . . . . 0.0 110.413 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -84.58 125.33 32.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.352 0.596 . . . . 0.0 111.751 -178.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -175.17 137.34 0.4 Allowed 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.457 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.455 ' OG1' ' CD2' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -155.07 160.02 40.69 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.483 -178.645 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.445 ' HB1' ' CD2' ' A' ' 61' ' ' LEU . . . -132.34 155.48 48.32 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.816 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -106.65 79.46 0.26 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.533 -0.841 . . . . 0.0 113.328 -179.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.445 ' CD2' ' HB1' ' A' ' 59' ' ' ALA . 0.1 OUTLIER -121.47 -87.76 0.63 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.72 0.295 . . . . 0.0 110.643 179.24 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -98.73 -26.52 14.32 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.99 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -89.4 -63.42 1.29 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.4 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.468 ' CB ' ' CD2' ' A' ' 67' ' ' LEU . 12.8 m-85 -96.85 146.54 24.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.958 0.409 . . . . 0.0 111.086 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -87.43 -58.5 2.56 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.402 ' O ' ' CB ' ' A' ' 67' ' ' LEU . 0.6 OUTLIER -98.35 -51.17 4.06 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -178.209 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.468 ' CD2' ' CB ' ' A' ' 64' ' ' TYR . 0.2 OUTLIER 76.4 87.74 0.08 Allowed 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -178.636 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.475 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 34.5 ptt180 -126.59 48.19 2.94 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.563 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.475 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 97.4 Cg_endo -79.0 -39.56 0.34 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.67 2.246 . . . . 0.0 111.875 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.47 ' CD2' ' CB ' ' B' ' 541' ' ' LEU . 0.1 OUTLIER -82.04 -8.45 59.67 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.038 179.959 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.4 ' O ' ' CD2' ' A' ' 104' ' ' HIS . 0.2 OUTLIER -51.8 -35.11 42.87 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.692 0.282 . . . . 0.0 111.14 -179.955 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.444 ' CZ ' ' O ' ' A' ' 104' ' ' HIS . 1.5 t80 -169.08 67.63 0.65 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.196 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.48 ' HG2' ' CE2' ' A' ' 78' ' ' PHE . 73.0 Cg_endo -75.75 142.66 25.9 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.641 2.227 . . . . 0.0 112.216 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 25.6 tp60 -101.42 10.8 40.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.608 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.2 t -47.46 167.78 0.02 OUTLIER 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.931 0.396 . . . . 0.0 111.211 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -91.49 -22.59 20.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.609 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 19.1 m -137.95 143.98 32.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.982 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.503 ' CE1' ' CG2' ' A' ' 108' ' ' THR . 3.7 m-85 -116.35 121.01 40.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.432 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.415 HD23 ' CE1' ' A' ' 169' ' ' PHE . 5.9 tp -82.38 108.18 15.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.887 0.375 . . . . 0.0 111.031 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 19.4 m -107.87 95.6 3.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.199 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.449 ' HB3' ' N7 ' ' A' ' 185' ' ' GNP . 14.3 m -95.14 155.25 16.81 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.575 -179.184 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -153.36 128.28 9.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.462 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.469 ' HA ' ' C2 ' ' A' ' 185' ' ' GNP . 6.1 p -83.62 136.44 34.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.0 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.422 ' N ' ' OE1' ' A' ' 116' ' ' GLN . 58.7 t -45.32 -54.59 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.443 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.413 HG12 ' CG2' ' A' ' 125' ' ' THR . 28.8 m -49.52 112.97 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.682 0.277 . . . . 0.0 110.577 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.407 ' N ' HD21 ' A' ' 129' ' ' LEU . 18.4 m -151.37 122.36 3.76 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.665 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.412 ' O ' ' CB ' ' A' ' 88' ' ' SER . 87.1 Cg_endo -93.81 56.2 0.36 Allowed 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.228 2.619 . . . . 0.0 111.599 179.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.412 ' CB ' ' O ' ' A' ' 87' ' ' PRO . 0.9 OUTLIER 81.11 20.38 0.41 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.07 -179.449 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.418 ' O ' ' CG2' ' A' ' 93' ' ' VAL . 2.8 m -97.29 -27.29 14.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.827 0.346 . . . . 0.0 110.79 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -50.67 -53.86 27.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.016 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -50.18 -45.39 53.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.974 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.413 ' O ' ' N ' ' A' ' 96' ' ' LYS . 24.1 m120 -72.55 -44.58 61.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.872 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.418 ' CG2' ' O ' ' A' ' 89' ' ' SER . 62.0 t -51.34 -37.5 18.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.245 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.433 ' HG3' ' CD1' ' A' ' 145' ' ' LEU . 3.9 tttt -73.34 -49.96 24.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.886 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -82.87 6.98 16.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.562 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.413 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.1 OUTLIER -113.86 -28.47 7.39 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.713 0.292 . . . . 0.0 110.991 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.468 ' CZ2' ' HA2' ' A' ' 10' ' ' GLY . 3.1 m95 -94.32 -49.24 5.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.179 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.471 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 61.8 t -48.62 -47.48 70.72 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.662 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 71.9 Cg_endo -77.9 -16.75 14.24 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.242 1.961 . . . . 0.0 112.517 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.38 -47.0 8.31 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.729 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.414 HG13 ' N ' ' A' ' 102' ' ' THR . 2.0 pt -60.21 -26.71 37.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.026 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.414 ' N ' HG13 ' A' ' 101' ' ' ILE . 27.0 p -82.56 -39.66 21.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.867 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -54.16 -48.73 70.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.799 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.444 ' O ' ' CZ ' ' A' ' 72' ' ' TYR . 0.4 OUTLIER -70.06 -26.83 64.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.715 179.852 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -143.62 99.01 5.28 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.813 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_exo -43.03 99.02 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.6 2.2 . . . . 0.0 112.484 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.5 mmtm 57.61 102.62 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.869 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.503 ' CG2' ' CE1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -133.13 136.76 28.01 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.862 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.96 154.79 48.24 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.555 2.17 . . . . 0.0 112.292 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.42 ' CB ' ' O ' ' A' ' 78' ' ' PHE . 3.7 p90 -165.55 140.39 4.9 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.241 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.424 ' CD2' ' O ' ' A' ' 112' ' ' LEU . 1.8 tt -116.1 153.23 32.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.892 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.432 HD23 ' CB ' ' A' ' 146' ' ' ALA . 0.8 OUTLIER -98.01 161.53 13.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.833 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.431 ' CG1' HG11 ' A' ' 168' ' ' VAL . 10.6 t -140.53 143.59 28.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 121.08 0.467 . . . . 0.0 112.025 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -120.43 108.9 1.49 Allowed Glycine 0 C--N 1.332 0.34 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.625 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.88 5.28 3.08 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.879 0.325 . . . . 0.0 111.879 -178.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.535 ' CB ' HN22 ' A' ' 185' ' ' GNP . 39.7 tt0 -118.32 -4.03 10.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.753 0.311 . . . . 0.0 110.459 179.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.452 ' CD1' ' O ' ' A' ' 157' ' ' CYS . 0.1 OUTLIER -44.88 -26.47 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.141 179.263 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -73.88 -31.5 63.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.292 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.408 ' N ' ' O ' ' A' ' 116' ' ' GLN . 3.9 mp -85.82 -23.7 27.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.359 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.435 ' CG ' ' O ' ' A' ' 117' ' ' ILE . 1.0 OUTLIER -49.63 -26.18 3.43 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.961 0.41 . . . . 0.0 110.684 179.818 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -85.46 -31.66 22.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.591 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.2 107.18 0.79 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.648 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.421 ' O ' ' CG ' ' A' ' 127' ' ' GLU . 43.1 Cg_endo -68.87 -5.91 16.76 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.493 2.129 . . . . 0.0 113.131 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.1 t -75.75 -67.22 0.69 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.413 ' CG2' HG12 ' A' ' 85' ' ' VAL . 3.1 m -57.81 -38.17 75.06 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.566 178.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.459 ' HA ' ' CD1' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -55.39 -46.36 78.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.81 179.407 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.421 ' CG ' ' O ' ' A' ' 123' ' ' PRO . 4.8 mm-40 -56.34 -35.43 67.6 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.924 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.406 ' HA ' ' CD ' ' A' ' 131' ' ' LYS . 6.0 mptt -65.36 -31.49 72.63 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.459 ' CD1' ' HA ' ' A' ' 126' ' ' ILE . 7.1 mt -73.87 -37.82 64.63 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -44.81 -37.97 4.19 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.224 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.406 ' CD ' ' HA ' ' A' ' 128' ' ' LYS . 0.1 OUTLIER -47.29 -32.6 4.82 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.933 179.816 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -123.12 -31.36 3.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.476 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.523 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 9.3 mmmt -146.98 -100.21 0.09 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 118.993 -0.527 . . . . 0.0 111.132 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.523 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 1.4 pt20 133.29 -21.16 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.281 1.032 . . . . 0.0 110.55 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 16.1 mmtp -68.44 110.95 6.67 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.705 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -85.48 122.27 2.37 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.832 2.355 . . . . 0.0 111.534 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.47 ' N ' ' CD1' ' A' ' 137' ' ' ILE . 1.2 mm -53.72 96.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.009 0.433 . . . . 0.0 110.664 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 33.8 p -68.66 155.82 92.19 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.908 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -50.59 -26.24 16.42 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.699 2.266 . . . . 0.0 111.875 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -81.46 -33.4 32.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.59 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.411 ' CG2' HG21 ' A' ' 137' ' ' ILE . 89.9 m -57.62 -49.17 77.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.636 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.485 ' HB1' ' CD1' ' A' ' 154' ' ' TYR . . . -55.17 -32.79 62.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.789 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -68.14 -40.68 82.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.621 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.59 -49.93 74.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.676 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.433 ' CD1' ' HG3' ' A' ' 94' ' ' LYS . 1.6 tt -70.08 -36.23 74.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.655 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.432 ' CB ' HD23 ' A' ' 112' ' ' LEU . . . -59.55 -58.1 10.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.965 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 38.1 mtt180 -67.86 -24.28 65.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.965 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -50.2 -36.11 29.29 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.785 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.64 23.6 7.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.86 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 37.0 mttt 45.57 59.75 3.45 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.126 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.438 ' O ' ' CG2' ' A' ' 152' ' ' VAL . . . -65.46 -82.39 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.212 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.438 ' CG2' ' O ' ' A' ' 151' ' ' ALA . 45.1 t -161.86 -72.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.653 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 12.4 tppt? -179.8 118.9 0.06 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.883 -178.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.485 ' CD1' ' HB1' ' A' ' 142' ' ' ALA . 63.1 t80 -89.86 110.85 21.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.372 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.438 ' CG2' ' HA ' ' A' ' 168' ' ' VAL . 2.6 t -101.61 167.46 2.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.739 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -106.58 119.06 38.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.123 0.487 . . . . 0.0 111.653 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.452 ' O ' ' CD1' ' A' ' 117' ' ' ILE . 14.8 p -140.19 -172.01 3.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.635 179.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -159.1 127.95 5.31 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.459 -0.497 . . . . 0.0 111.884 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -94.67 20.33 8.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.512 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.472 ' CD1' ' N ' ' A' ' 160' ' ' LEU . 0.0 OUTLIER -129.99 -44.19 1.18 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.327 179.925 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 8.3 t -113.25 -17.84 12.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.984 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 77.45 85.75 0.08 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.2 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 3.7 ttpp -107.82 22.71 15.56 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.051 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 115.44 40.73 0.84 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.793 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.438 HD23 ' CD2' ' A' ' 19' ' ' LEU . 9.2 mt -49.79 -42.79 47.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.77 0.319 . . . . 0.0 110.8 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.56 -32.02 72.5 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.423 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.22 -65.76 0.63 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.738 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.438 ' HA ' ' CG2' ' A' ' 155' ' ' VAL . 8.9 p -48.67 -43.64 13.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 121.081 0.467 . . . . 0.0 110.581 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.54 ' CE1' ' CD1' ' A' ' 19' ' ' LEU . 0.1 OUTLIER -69.3 -27.03 65.04 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.079 179.221 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.57 -29.98 70.37 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -77.9 -39.7 42.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.04 179.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -55.33 -48.22 74.5 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.579 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.429 HD13 ' CD1' ' A' ' 177' ' ' LEU . 1.4 pp -74.4 -33.69 34.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.843 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.434 ' CD1' ' HG ' ' B' ' 505' ' ' LEU . 21.7 tp -50.52 -68.73 0.15 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.928 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -54.44 -22.01 11.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.05 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.402 ' CB ' HG23 ' A' ' 4' ' ' ILE . . . -81.85 -45.84 14.97 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.281 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.446 ' CD2' HG21 ' B' ' 510' ' ' ILE . 2.1 mt -68.57 -25.01 64.68 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.864 0.364 . . . . 0.0 110.734 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.401 ' HB2' ' HA ' ' B' ' 507' ' ' ALA . 0.0 OUTLIER -159.57 151.63 17.17 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.727 179.928 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -53.03 139.07 62.07 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.534 2.156 . . . . 0.0 112.329 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.21 -168.71 0.59 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.546 2.164 . . . . 0.0 112.385 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -143.24 96.97 5.73 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.977 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.03 -165.0 0.26 Allowed 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.613 2.208 . . . . 0.0 112.207 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -116.33 121.03 40.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.945 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 16.4 mttp . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.884 179.979 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 502' ' ' GLY . . . . . 0.402 ' CA ' ' HB2' ' B' ' 511' ' ' SER . . . . . . . . 0 N--CA 1.49 2.272 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 503' ' ' SER . . . . . 0.402 ' N ' ' HB2' ' B' ' 511' ' ' SER . 18.5 m -77.77 -74.92 0.23 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.688 0.28 . . . . 0.0 110.908 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 504' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' B' ' 509' ' ' ASP . . . 105.43 110.08 3.47 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.388 -0.911 . . . . 0.0 112.316 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 505' ' ' LEU . . . . . 0.474 ' N ' ' CD2' ' B' ' 505' ' ' LEU . 1.4 pt? -179.93 44.89 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.755 0.312 . . . . 0.0 110.936 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 506' ' ' SER . . . . . . . . . . . . . 4.8 p 65.78 39.85 4.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.074 0.464 . . . . 0.0 110.48 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 507' ' ' ALA . . . . . 0.425 ' O ' ' HB2' ' B' ' 508' ' ' GLN . . . -144.25 37.56 1.26 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.657 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 508' ' ' GLN . . . . . 0.433 ' HB3' ' CD1' ' B' ' 510' ' ' ILE . 3.3 mt-30 70.04 4.29 4.75 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.09 -178.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 509' ' ' ASP . . . . . 0.404 ' HA ' ' HA2' ' B' ' 504' ' ' GLY . 52.1 t0 67.84 45.49 1.4 Allowed 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 121.012 0.434 . . . . 0.0 111.416 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 510' ' ' ILE . . . . . 0.456 HG21 ' CG2' ' A' ' 46' ' ' ILE . 1.7 mp -84.62 133.11 30.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.945 179.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 511' ' ' SER . . . . . 0.433 ' HB3' ' CG ' ' B' ' 514' ' ' LEU . 40.9 t -109.28 152.78 24.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.805 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 512' ' ' GLN . . . . . 0.488 ' CB ' ' HD3' ' B' ' 513' ' ' PRO . 0.0 OUTLIER -101.3 -57.91 0.11 Allowed Pre-proline 0 CA--C 1.529 0.155 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.426 179.271 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 513' ' ' PRO . . . . . 0.488 ' HD3' ' CB ' ' B' ' 512' ' ' GLN . 49.0 Cg_endo -93.89 63.12 0.39 Allowed 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.096 2.531 . . . . 0.0 112.169 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 514' ' ' LEU . . . . . 0.442 ' CD2' ' O ' ' A' ' 45' ' ' MET . 1.3 mp -70.54 -87.49 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.599 -179.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 515' ' ' GLN . . . . . . . . . . . . . 18.8 mm100 -78.82 -86.73 0.07 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.635 0.255 . . . . 0.0 111.233 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -118.08 -36.73 3.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.856 0.36 . . . . 0.0 110.835 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 517' ' ' SER . . . . . . . . . . . . . 7.3 m 60.73 27.68 17.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.816 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 518' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -163.58 113.09 1.28 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.401 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 519' ' ' ILE . . . . . 0.442 ' CG1' ' HA ' ' A' ' 42' ' ' VAL . 0.5 OUTLIER -137.36 111.34 8.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.124 179.483 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 80.3 m-70 60.64 174.47 0.1 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.012 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 521' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.1 136.8 28.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.812 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 522' ' ' GLY . . . . . 0.477 ' HA3' ' CD1' ' A' ' 37' ' ' PHE . . . -52.81 -174.96 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.474 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 523' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -64.0 -86.57 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.701 0.286 . . . . 0.0 110.871 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 524' ' ' GLY . . . . . 0.425 ' HA2' ' CG1' ' A' ' 36' ' ' VAL . . . 45.96 46.12 14.44 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.72 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 525' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -89.43 46.95 1.42 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.787 0.327 . . . . 0.0 110.958 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 526' ' ' SER . . . . . 0.474 ' CB ' ' CG1' ' A' ' 33' ' ' VAL . 0.5 OUTLIER -87.91 100.58 13.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.67 179.784 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 527' ' ' ASP . . . . . 0.462 ' CB ' ' HD2' ' B' ' 528' ' ' PRO . 0.4 OUTLIER -43.05 167.9 0.07 OUTLIER Pre-proline 0 N--CA 1.464 0.273 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.403 -179.848 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 528' ' ' PRO . . . . . 0.462 ' HD2' ' CB ' ' B' ' 527' ' ' ASP . 9.8 Cg_endo -48.91 102.37 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.925 2.416 . . . . 0.0 111.884 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 529' ' ' ARG . . . . . 0.422 ' CG ' ' O ' ' B' ' 527' ' ' ASP . 11.1 mtp85 -100.84 -55.04 2.67 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.602 -179.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 530' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -148.87 94.02 2.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.405 -179.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 1.8 m -54.24 -173.75 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.606 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 532' ' ' TRP . . . . . 0.494 ' CZ2' ' HG3' ' B' ' 537' ' ' ARG . 13.2 t-105 -107.99 163.17 13.37 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.945 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . 169.86 -30.98 0.15 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.473 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 534' ' ' PHE . . . . . 0.479 ' O ' ' CZ2' ' B' ' 532' ' ' TRP . 4.2 t80 -82.35 115.54 58.47 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.507 0.194 . . . . 0.0 110.745 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -45.25 151.74 0.83 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.48 2.12 . . . . 0.0 112.5 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 65.85 135.13 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.854 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 537' ' ' ARG . . . . . 0.494 ' HG3' ' CZ2' ' B' ' 532' ' ' TRP . 0.0 OUTLIER -99.34 176.25 5.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.107 0.479 . . . . 0.0 111.159 -179.962 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 538' ' ' ILE . . . . . 0.487 ' CD1' ' CB ' ' B' ' 542' ' ' TYR . 0.1 OUTLIER -118.71 139.37 46.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.556 179.649 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 539' ' ' ASP . . . . . 0.419 ' HB2' ' CD2' ' A' ' 70' ' ' LEU . 30.6 p30 -38.84 161.23 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.086 -178.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 540' ' ' GLU . . . . . 0.442 ' HG2' ' N ' ' B' ' 541' ' ' LEU . 0.9 OUTLIER -64.99 -33.44 76.05 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.056 -179.907 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 541' ' ' LEU . . . . . 0.47 ' CB ' ' CD2' ' A' ' 70' ' ' LEU . 4.4 tt -47.59 -29.69 3.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.105 0.479 . . . . 0.0 110.551 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 542' ' ' TYR . . . . . 0.487 ' CB ' ' CD1' ' B' ' 538' ' ' ILE . 6.2 m-85 -105.44 -17.08 14.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.626 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 543' ' ' LEU . . . . . 0.44 ' CD1' ' HA ' ' B' ' 540' ' ' GLU . 1.9 mp -40.11 136.54 1.15 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.89 0.376 . . . . 0.0 111.291 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 544' ' ' GLY . . . . . 0.435 ' HA2' ' CD2' ' A' ' 61' ' ' LEU . . . 157.8 101.68 0.18 Allowed Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.595 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 545' ' ' ASN . . . . . . . . . . . . . 16.3 p30 . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.265 -0.874 . . . . 0.0 111.008 -179.975 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' GNP . . . . . 0.713 ' N3 ' " H2'" ' A' ' 185' ' ' GNP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.439 ' HE2' ' N ' ' A' ' 2' ' ' GLN . 7.8 tpt . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.828 0.347 . . . . 0.0 111.2 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.439 ' N ' ' HE2' ' A' ' 1' ' ' MET . 2.1 pt20 -155.44 111.25 3.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.898 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.532 ' CG2' ' CE1' ' A' ' 51' ' ' TYR . 1.3 t -96.37 178.42 5.37 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.536 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.5 ' CG2' ' O ' ' A' ' 3' ' ' THR . 0.3 OUTLIER -165.23 159.94 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.096 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 179.874 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.3 mtpt -111.65 137.47 49.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.329 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 39.8 t -121.55 142.91 49.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.041 0.448 . . . . 0.0 111.503 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.8 t -135.13 120.6 30.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.486 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.4 p -84.71 149.56 4.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.209 0.528 . . . . 0.0 111.051 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.3 m -143.43 130.2 17.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.902 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.67 -140.08 8.71 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.139 -1.029 . . . . 0.0 112.584 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -123.19 27.03 7.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.857 0.361 . . . . 0.0 110.647 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.427 ' CA ' ' HB2' ' B' ' 537' ' ' ARG . . . -120.13 171.42 14.54 Favored Glycine 0 C--N 1.331 0.25 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.651 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.412 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -93.84 -25.3 17.41 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.721 0.296 . . . . 0.0 111.403 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.469 ' CG2' ' CD2' ' A' ' 19' ' ' LEU . 4.1 p -41.52 94.6 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.355 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.432 ' O ' ' CD1' ' A' ' 19' ' ' LEU . . . -151.21 -103.16 0.25 Allowed Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.612 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.457 ' CD ' ' HA ' ' A' ' 38' ' ' ASP . 0.2 OUTLIER -97.93 -43.8 6.94 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 -179.547 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.456 ' O ' ' N ' ' A' ' 21' ' ' ILE . 2.6 p -94.93 -53.12 3.95 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.446 ' CB ' ' O2A' ' A' ' 185' ' ' GNP . 37.2 t -32.04 -69.62 0.08 Allowed 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -178.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.487 HD11 ' CZ ' ' A' ' 169' ' ' PHE . 0.5 OUTLIER -58.68 -68.09 0.3 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.393 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.423 ' O ' ' N ' ' A' ' 23' ' ' TYR . 2.9 mm? -61.05 -67.44 0.4 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -178.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.492 ' CG2' ' N ' ' A' ' 22' ' ' SER . 1.3 tp -37.08 -54.54 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -179.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.492 ' N ' ' CG2' ' A' ' 21' ' ' ILE . 0.4 OUTLIER -67.92 -30.21 69.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.791 0.329 . . . . 0.0 110.858 -179.557 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.423 ' N ' ' O ' ' A' ' 20' ' ' LEU . 27.3 t80 -53.79 -37.95 64.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.132 0.492 . . . . 0.0 109.987 179.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.49 -31.68 11.16 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.667 179.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.432 ' CG2' ' O ' ' A' ' 21' ' ' ILE . 3.3 t -136.82 79.79 1.78 Allowed 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.984 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.411 ' ND2' ' OG ' ' A' ' 22' ' ' SER . 1.4 m120 -66.6 79.28 0.11 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.298 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.4 mmtm -100.29 101.04 11.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.746 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.57 ' CE1' ' CZ2' ' B' ' 532' ' ' TRP . 0.1 OUTLIER -99.28 -53.61 0.19 Allowed Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.648 -179.67 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.404 ' HD3' ' HB3' ' A' ' 28' ' ' PHE . 84.7 Cg_endo -88.54 69.95 2.69 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.76 2.307 . . . . 0.0 112.981 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -144.8 -92.68 0.1 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.667 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -159.62 158.64 31.96 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.745 0.307 . . . . 0.0 110.818 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -133.07 99.98 4.73 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.406 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.451 ' HB ' ' CD ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -162.49 -63.46 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.866 -179.398 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.46 ' O ' ' N ' ' A' ' 36' ' ' VAL . 2.9 Cg_exo -36.07 -29.73 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.381 2.721 . . . . 0.0 113.012 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.429 HG22 ' CG2' ' A' ' 17' ' ' THR . 21.2 m -63.85 71.1 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.754 0.312 . . . . 0.0 110.886 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.482 HG11 ' CD1' ' A' ' 37' ' ' PHE . 10.2 p -130.55 -3.82 2.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.482 ' CD1' HG11 ' A' ' 36' ' ' VAL . 0.7 OUTLIER -84.22 50.05 1.78 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.742 0.306 . . . . 0.0 111.242 -179.793 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.457 ' HA ' ' CD ' ' A' ' 16' ' ' LYS . 5.5 m-20 -58.97 -21.43 58.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.158 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -86.98 -6.21 58.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.629 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.466 ' CD1' ' O ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -60.77 157.18 15.41 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.848 0.356 . . . . 0.0 110.913 179.935 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.4 ' HB1' HD13 ' B' ' 519' ' ' ILE . . . -108.07 175.72 5.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.35 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.455 ' CA ' HD11 ' B' ' 519' ' ' ILE . 12.8 m -140.57 121.71 14.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.167 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.421 ' O ' ' CG1' ' A' ' 44' ' ' VAL . 1.1 t -86.25 104.71 16.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.042 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.465 ' CG2' ' CG2' ' A' ' 52' ' ' THR . 24.9 m -158.19 -177.28 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.918 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.485 ' HE3' ' N ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -121.01 99.61 6.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.485 -179.523 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.454 HG23 ' CG2' ' B' ' 510' ' ' ILE . 0.7 OUTLIER -75.93 86.02 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 178.723 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.438 ' N ' ' HE2' ' A' ' 45' ' ' MET . . . 27.91 96.26 0.01 OUTLIER Glycine 0 C--N 1.337 0.616 0 CA-C-N 115.667 -0.697 . . . . 0.0 114.275 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.434 ' N ' ' HE3' ' A' ' 45' ' ' MET . . . 137.64 -92.32 0.21 Allowed Glycine 0 CA--C 1.518 0.262 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.024 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.485 ' N ' ' HE3' ' A' ' 45' ' ' MET . 0.7 OUTLIER -137.44 138.49 24.89 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-O 120.757 0.313 . . . . 0.0 111.222 -179.828 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.42 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 62.0 Cg_exo -35.77 95.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.315 2.677 . . . . 0.0 113.079 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.532 ' CE1' ' CG2' ' A' ' 3' ' ' THR . 2.5 t80 -173.0 105.2 0.14 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.307 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.465 ' CG2' ' CG2' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -124.06 153.64 41.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.473 -178.933 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.45 HD22 ' CA ' ' A' ' 4' ' ' ILE . 6.7 tp -102.73 146.7 27.83 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.75 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.89 -162.81 23.44 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.241 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.472 ' N ' ' CD2' ' A' ' 55' ' ' LEU . 1.2 mm? -121.88 114.17 20.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.813 0.34 . . . . 0.0 110.44 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -84.26 105.71 15.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.6 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -138.65 -176.33 4.44 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.088 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.441 ' HB ' ' CG ' ' A' ' 69' ' ' PRO . 0.1 OUTLIER -125.63 143.33 51.07 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.943 -179.647 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.456 ' CB ' ' HA ' ' A' ' 36' ' ' VAL . . . -147.78 100.7 3.24 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.936 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' B' ' 542' ' ' TYR . . . -75.66 80.9 1.01 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.63 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.424 ' CD1' HG11 ' A' ' 33' ' ' VAL . 3.1 mm? -121.3 -119.74 0.3 Allowed 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 110.577 -0.157 . . . . 0.0 110.577 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -98.53 -30.49 12.49 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-N 118.151 0.432 . . . . 0.0 111.075 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.34 -63.2 1.25 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.148 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.449 ' HB2' ' CD1' ' A' ' 67' ' ' LEU . 75.6 m-85 -87.67 146.34 25.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.037 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -86.5 -68.72 0.72 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.174 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.433 ' HD2' ' N ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -98.89 -50.33 4.24 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.924 -179.638 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.449 ' CD1' ' HB2' ' A' ' 64' ' ' TYR . 0.6 OUTLIER 65.35 114.95 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.629 0.252 . . . . 0.0 110.846 -179.753 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.492 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.5 OUTLIER -149.14 44.0 0.31 Allowed Pre-proline 0 C--N 1.329 -0.297 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 179.616 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.492 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 90.6 Cg_endo -83.08 -42.98 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.344 2.029 . . . . 0.0 112.269 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.455 ' CD2' ' HB2' ' B' ' 541' ' ' LEU . 0.2 OUTLIER -63.08 -16.34 59.62 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.322 -179.842 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 93.9 p -46.37 -56.3 6.07 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.854 0.359 . . . . 0.0 111.274 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -156.89 65.28 3.65 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.944 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.481 ' HB2' ' CZ ' ' A' ' 78' ' ' PHE . 35.0 Cg_exo -59.59 154.62 47.26 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.542 2.161 . . . . 0.0 112.233 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 7.4 mm-40 -98.5 10.33 41.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.309 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.1 m -56.7 161.36 2.84 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.818 0.342 . . . . 0.0 110.924 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.76 7.27 30.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.487 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.5 p -156.95 91.7 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.334 -0.084 0 CA-C-O 120.859 0.361 . . . . 0.0 111.219 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.481 ' CZ ' ' HB2' ' A' ' 73' ' ' PRO . 3.1 m-85 -80.88 -177.04 6.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.622 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.421 HD23 ' CG2' ' A' ' 113' ' ' VAL . 1.1 tt -149.83 114.19 5.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.972 0.415 . . . . 0.0 111.5 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.416 ' N ' HD21 ' A' ' 79' ' ' LEU . 2.1 t -98.6 156.4 3.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.285 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.437 ' CB ' HG13 ' A' ' 14' ' ' VAL . 1.8 p -152.04 153.08 33.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.086 0.47 . . . . 0.0 111.751 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.514 ' CE1' ' CE1' ' A' ' 90' ' ' PHE . 9.1 p90 -166.32 134.24 2.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.261 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.431 ' HA ' ' C2 ' ' A' ' 185' ' ' GNP . 0.3 OUTLIER -85.34 141.72 29.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.942 -179.802 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.441 HG13 ' N ' ' A' ' 137' ' ' ILE . 57.8 t -44.47 -55.14 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.359 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.445 ' CA ' HD23 ' A' ' 129' ' ' LEU . 34.9 m -47.81 115.71 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.732 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.417 ' N ' HD23 ' A' ' 129' ' ' LEU . 5.1 p -150.94 129.78 6.26 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.584 -179.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.425 ' O ' ' CB ' ' A' ' 132' ' ' ASN . 87.4 Cg_endo -90.83 50.37 0.85 Allowed 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.043 2.495 . . . . 0.0 111.963 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.45 ' N ' ' HB3' ' A' ' 133' ' ' LYS . 0.3 OUTLIER 76.35 14.37 2.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.522 -179.785 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 8.4 t -97.39 -27.06 14.64 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.994 0.426 . . . . 0.0 110.583 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.514 ' CE1' ' CE1' ' A' ' 82' ' ' PHE . 59.3 t80 -51.14 -33.35 26.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.034 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.2 -48.51 28.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.191 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -69.1 -44.81 71.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.183 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.481 HG23 ' CZ3' ' A' ' 97' ' ' TRP . 11.6 p -58.84 -45.31 91.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.366 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.459 ' HE2' ' CE2' ' A' ' 82' ' ' PHE . 9.2 mmtt -59.62 -57.32 13.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.792 0.33 . . . . 0.0 110.997 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.423 ' O ' ' CG ' ' A' ' 99' ' ' PRO . 70.0 mm-40 -62.22 -18.5 61.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.259 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.8 tmtt? -101.49 -12.42 18.55 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.489 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.481 ' CZ3' HG23 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -84.27 -56.7 3.51 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.787 0.327 . . . . 0.0 111.124 -179.823 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.482 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 5.1 t -49.48 -46.6 78.41 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.643 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.482 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 82.1 Cg_exo -44.63 -41.23 14.47 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.458 2.105 . . . . 0.0 112.85 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.429 ' CG ' ' O ' ' A' ' 97' ' ' TRP . 2.1 pt-20 -79.51 -31.72 42.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.058 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.425 ' N ' ' HG3' ' A' ' 100' ' ' GLU . 23.0 mt -53.74 -41.71 48.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.018 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 23.1 p -93.81 -21.05 19.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.981 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -60.24 -31.46 70.22 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.936 0.398 . . . . 0.0 110.69 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 -88.64 -25.77 22.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.886 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -144.58 136.19 12.81 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.792 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -59.48 -15.28 29.52 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.598 2.199 . . . . 0.0 112.607 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -169.6 84.05 0.13 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.825 0.345 . . . . 0.0 110.906 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -108.79 101.82 45.52 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.813 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -60.4 155.17 48.31 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.493 2.128 . . . . 0.0 112.122 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.42 ' O ' ' CG2' ' A' ' 152' ' ' VAL . 32.1 p90 -155.99 169.4 24.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.188 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.474 ' CD1' ' CG1' ' A' ' 152' ' ' VAL . 0.7 OUTLIER -132.85 150.18 52.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.863 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.479 HD12 ' CE2' ' A' ' 82' ' ' PHE . 0.3 OUTLIER -98.93 161.57 13.56 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.113 -179.745 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.421 ' CG2' HD23 ' A' ' 79' ' ' LEU . 2.5 t -136.81 144.04 33.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.036 0.446 . . . . 0.0 111.805 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.479 ' HA3' ' CZ ' ' A' ' 154' ' ' TYR . . . -133.15 103.83 0.52 Allowed Glycine 0 C--N 1.33 0.233 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.697 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.887 ' OG1' " H2'" ' A' ' 185' ' ' GNP . 0.4 OUTLIER -125.01 -1.41 7.79 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -178.647 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.549 ' CB ' HN22 ' A' ' 185' ' ' GNP . 0.0 OUTLIER -99.2 -8.39 25.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.974 0.416 . . . . 0.0 110.011 178.78 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -49.25 -24.02 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.563 178.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -86.13 -20.51 28.54 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.562 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.44 ' CD1' ' NE2' ' A' ' 116' ' ' GLN . 4.2 pp -110.89 -12.84 14.21 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 9.1 ptt85 -50.88 -25.33 4.43 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.911 0.386 . . . . 0.0 110.72 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -72.24 -24.86 61.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.912 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -47.0 101.27 0.26 Allowed Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.838 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.418 ' O ' ' CG ' ' A' ' 127' ' ' GLU . 17.1 Cg_exo -67.4 -6.07 15.53 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.77 2.314 . . . . 0.0 113.021 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.7 t -84.67 -67.06 0.83 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.026 0.441 . . . . 0.0 110.001 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.9 m -52.47 -33.84 46.42 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.381 0.61 . . . . 0.0 109.358 178.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.477 ' HA ' ' CD1' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -60.03 -40.83 84.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.455 179.017 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.418 ' CG ' ' O ' ' A' ' 123' ' ' PRO . 3.7 mm-40 -56.13 -35.85 67.58 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.262 178.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -66.86 -32.71 74.16 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.477 ' CD1' ' HA ' ' A' ' 126' ' ' ILE . 7.3 mt -73.36 -41.55 63.28 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 177.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.458 ' HA ' ' HB3' ' A' ' 134' ' ' GLN . . . -48.88 -26.01 2.22 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.202 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 16.2 mmtp -65.6 -33.91 77.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.773 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.425 ' CB ' ' O ' ' A' ' 87' ' ' PRO . 39.1 m-80 -123.8 -30.6 3.54 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -179.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.492 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 0.0 OUTLIER -133.62 -72.53 0.5 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 120.991 -0.284 . . . . 0.0 111.424 -178.85 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.492 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 2.7 pt20 99.58 -37.4 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.959 0.903 . . . . 0.0 110.658 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.18 107.48 2.17 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.897 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.439 ' HG3' ' CD1' ' A' ' 126' ' ' ILE . 3.0 Cg_exo -80.65 134.96 10.06 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.823 2.349 . . . . 0.0 111.221 179.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.497 HG23 ' CZ ' ' A' ' 90' ' ' PHE . 0.8 OUTLIER -67.13 96.48 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.882 0.372 . . . . 0.0 110.817 -179.608 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 6.2 p -67.74 159.23 79.96 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.079 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -50.62 -28.99 23.76 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.636 2.224 . . . . 0.0 112.274 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -82.65 -26.72 31.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.701 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 8.7 m -66.66 -51.16 59.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.782 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.474 ' HB2' ' CD1' ' A' ' 154' ' ' TYR . . . -55.49 -37.98 68.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.924 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -66.54 -45.39 79.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.908 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp -54.22 -64.07 0.95 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.993 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.431 ' CD1' ' HG3' ' A' ' 94' ' ' LYS . 5.3 tt -60.6 -42.75 97.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.9 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.416 ' CB ' ' O ' ' A' ' 142' ' ' ALA . . . -48.99 -61.99 1.77 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.05 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.2 mtp85 -63.51 -23.14 67.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.861 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -50.16 -50.95 47.42 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.827 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -93.65 -72.14 0.62 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.673 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 170.26 60.44 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.516 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.454 ' O ' ' N ' ' A' ' 153' ' ' LYS . . . -94.81 27.46 3.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.535 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.474 ' CG1' ' CD1' ' A' ' 111' ' ' LEU . 75.8 t 61.11 -74.75 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.454 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.454 ' N ' ' O ' ' A' ' 151' ' ' ALA . 1.6 ttpt -176.41 121.74 0.16 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.829 -179.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.479 ' CZ ' ' HA3' ' A' ' 114' ' ' GLY . 13.2 t80 -84.97 112.38 20.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.688 179.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 3.2 t -101.28 156.11 4.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.181 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -94.19 127.58 40.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.584 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.415 ' HA ' ' HB3' ' A' ' 163' ' ' LYS . 1.1 p 178.62 125.12 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.305 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.406 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 37.1 m -104.53 155.76 18.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.959 0.409 . . . . 0.0 111.657 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.428 ' HB2' ' CD1' ' A' ' 165' ' ' LEU . . . -92.2 -52.65 4.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.592 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -48.3 -29.78 4.2 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.738 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.9 -21.97 10.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.914 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 69.19 62.46 0.3 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.804 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.415 ' HB3' ' HA ' ' A' ' 157' ' ' CYS . 0.1 OUTLIER -93.41 35.99 1.08 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.255 -179.75 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 95.21 46.56 2.79 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.21 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.445 ' CD1' ' HA ' ' A' ' 19' ' ' LEU . 0.4 OUTLIER -53.49 -29.88 38.31 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.988 0.423 . . . . 0.0 110.588 179.688 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 28.8 pttt -68.52 -24.54 64.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.763 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 30.7 t30 -58.25 -68.95 0.2 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.565 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 14.4 p -54.28 -45.81 68.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.565 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.487 ' CZ ' HD11 ' A' ' 19' ' ' LEU . 1.2 t80 -60.38 -41.02 92.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.501 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -54.91 -34.96 63.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.875 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -75.89 -26.47 57.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.174 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.85 -42.96 97.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.213 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.417 HD11 ' N ' ' A' ' 174' ' ' LEU . 0.0 OUTLIER -89.94 -23.45 6.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.633 -179.866 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.418 ' CD1' ' HB3' ' B' ' 505' ' ' LEU . 2.8 tp -49.05 -43.83 41.19 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.989 0.423 . . . . 0.0 110.41 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -62.14 -27.36 68.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.995 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.466 ' CB ' HG22 ' A' ' 4' ' ' ILE . . . -87.71 -39.41 14.99 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.636 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.475 ' CD1' HG13 ' A' ' 4' ' ' ILE . 0.6 OUTLIER -68.61 -26.39 65.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.518 179.628 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.436 ' CB ' ' HD2' ' A' ' 179' ' ' PRO . 0.5 OUTLIER -166.82 167.72 7.64 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.651 179.861 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . 0.436 ' HD2' ' CB ' ' A' ' 178' ' ' GLU . 18.9 Cg_endo -60.27 118.77 5.69 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.541 2.161 . . . . 0.0 112.229 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.87 153.96 63.59 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.527 2.151 . . . . 0.0 112.423 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -149.63 119.92 3.96 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.822 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.01 -164.89 0.25 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.429 2.086 . . . . 0.0 112.219 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 11.9 mmtt -105.0 83.41 1.98 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.958 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.16 -0.924 . . . . 0.0 110.819 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.221 0 N-CA-C 112.525 -0.23 . . . . 0.0 112.525 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 503' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.74 -49.32 3.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.751 0.31 . . . . 0.0 111.011 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 504' ' ' GLY . . . . . 0.437 ' O ' ' CD2' ' B' ' 505' ' ' LEU . . . 124.78 -93.52 0.45 Allowed Glycine 0 CA--C 1.508 -0.405 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.862 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 505' ' ' LEU . . . . . 0.487 ' CD1' ' N ' ' B' ' 505' ' ' LEU . 0.1 OUTLIER 74.17 0.28 3.56 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 179.45 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 506' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 52.93 23.79 3.04 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.022 0.439 . . . . 0.0 111.047 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 507' ' ' ALA . . . . . . . . . . . . . . . -107.86 -74.25 0.66 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.774 0.797 . . . . 0.0 109.506 179.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 508' ' ' GLN . . . . . 0.412 ' O ' ' HB3' ' B' ' 509' ' ' ASP . 0.0 OUTLIER -137.82 4.95 2.58 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.28 -1.327 . . . . 0.0 110.213 179.061 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 509' ' ' ASP . . . . . 0.412 ' HB3' ' O ' ' B' ' 508' ' ' GLN . 48.6 t0 72.47 38.85 0.78 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.587 0.708 . . . . 0.0 109.765 -178.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 510' ' ' ILE . . . . . 0.454 ' CG2' HG23 ' A' ' 46' ' ' ILE . 1.3 mt -66.34 143.72 15.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.847 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 511' ' ' SER . . . . . . . . . . . . . 47.2 t -109.44 148.0 31.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.498 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 512' ' ' GLN . . . . . 0.487 ' CB ' ' CD ' ' B' ' 513' ' ' PRO . 0.0 OUTLIER -98.62 -67.7 0.05 OUTLIER Pre-proline 0 CA--C 1.53 0.176 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.752 179.547 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 513' ' ' PRO . . . . . 0.487 ' CD ' ' CB ' ' B' ' 512' ' ' GLN . 88.1 Cg_endo -79.16 56.95 6.24 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.456 2.104 . . . . 0.0 111.917 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 514' ' ' LEU . . . . . 0.428 ' CD1' ' O ' ' A' ' 45' ' ' MET . 0.9 OUTLIER -64.1 -87.01 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.39 -179.568 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 515' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -93.07 -158.71 0.63 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.74 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 15.1 m-80 -50.37 -29.0 9.03 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.934 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 517' ' ' SER . . . . . 0.458 ' O ' ' CD1' ' B' ' 518' ' ' PHE . 0.9 OUTLIER 39.85 53.92 2.59 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.821 179.927 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 518' ' ' PHE . . . . . 0.458 ' CD1' ' O ' ' B' ' 517' ' ' SER . 6.1 m-85 -163.29 119.46 1.77 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.915 0.388 . . . . 0.0 111.438 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 519' ' ' ILE . . . . . 0.455 HD11 ' CA ' ' A' ' 42' ' ' VAL . 8.9 mt -126.83 82.49 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.058 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 41.8 p-80 -54.21 101.24 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.767 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 521' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.82 31.79 1.81 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.097 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 522' ' ' GLY . . . . . 0.471 ' HA3' ' CD1' ' A' ' 37' ' ' PHE . . . -111.12 -177.83 20.42 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.409 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 523' ' ' HIS . . . . . 0.455 ' CD2' ' N ' ' B' ' 524' ' ' GLY . 34.4 t60 -117.9 -85.64 0.64 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.744 0.306 . . . . 0.0 110.956 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 524' ' ' GLY . . . . . 0.455 ' N ' ' CD2' ' B' ' 523' ' ' HIS . . . 52.71 -144.4 21.87 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.604 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 525' ' ' ASP . . . . . . . . . . . . . 19.8 p30 -149.82 85.3 1.42 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.833 0.349 . . . . 0.0 110.933 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 526' ' ' SER . . . . . 0.405 ' CB ' ' HB3' ' A' ' 34' ' ' PRO . 2.4 m -74.92 95.64 3.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.662 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 527' ' ' ASP . . . . . . . . . . . . . 43.1 p-10 -153.97 150.58 22.99 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.919 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.36 100.98 0.94 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.72 2.28 . . . . 0.0 112.348 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 529' ' ' ARG . . . . . . . . . . . . . 39.7 mtp180 -100.41 -55.24 2.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.296 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 530' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -168.51 95.79 0.38 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.107 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 531' ' ' CYS . . . . . 0.412 ' O ' ' N ' ' B' ' 533' ' ' GLY . 18.3 t -49.79 130.64 21.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.014 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 532' ' ' TRP . . . . . 0.57 ' CZ2' ' CE1' ' A' ' 28' ' ' PHE . 0.0 OUTLIER 60.42 -81.84 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.933 179.893 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 533' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' B' ' 531' ' ' CYS . . . 92.3 -35.38 4.05 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.613 -0.804 . . . . 0.0 112.592 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 534' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -155.17 156.94 31.65 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.634 0.254 . . . . 0.0 110.846 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -53.21 -59.1 1.12 Allowed 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.749 2.299 . . . . 0.0 112.088 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -86.87 141.41 28.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.636 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 537' ' ' ARG . . . . . 0.427 ' HB2' ' CA ' ' A' ' 12' ' ' GLY . 25.4 mmt-85 -65.89 136.24 55.86 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.133 0.492 . . . . 0.0 111.214 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 538' ' ' ILE . . . . . 0.41 HG13 ' HB2' ' B' ' 542' ' ' TYR . 6.3 tp -59.57 143.22 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.208 179.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 539' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -44.13 143.41 1.18 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.874 0.369 . . . . 0.0 111.035 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 540' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -50.4 -24.39 3.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.014 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 541' ' ' LEU . . . . . 0.455 ' HB2' ' CD2' ' A' ' 70' ' ' LEU . 0.1 OUTLIER -55.3 -27.04 44.21 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 121.4 0.619 . . . . 0.0 109.77 179.07 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 542' ' ' TYR . . . . . 0.418 ' O ' ' N ' ' A' ' 60' ' ' GLY . 14.2 m-85 -104.23 -63.05 1.24 Allowed 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.903 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 543' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 49.73 103.86 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.318 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . 118.28 -100.99 0.87 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.529 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 545' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.919 -179.884 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' GNP . . . . . 0.887 " H2'" ' OG1' ' A' ' 115' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.434 ' CE ' HG22 ' A' ' 46' ' ' ILE . 3.0 ptm . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.796 0.332 . . . . 0.0 111.21 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.427 ' N ' ' HG3' ' A' ' 1' ' ' MET . 0.0 OUTLIER 57.65 161.88 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.706 -179.891 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.505 HG23 ' CZ ' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -129.93 -177.41 4.28 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.333 -179.786 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.479 ' CG2' ' CD2' ' A' ' 177' ' ' LEU . 6.0 pt -153.89 148.22 13.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.758 -179.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.1 mttt -134.0 95.7 3.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.095 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -112.31 155.29 24.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.406 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -137.2 159.58 36.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.309 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.469 ' CG2' ' CB ' ' A' ' 16' ' ' LYS . 60.1 t -90.0 113.68 26.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.997 0.427 . . . . 0.0 111.299 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.452 ' CA ' ' HG2' ' B' ' 540' ' ' GLU . 93.5 t -130.65 129.48 64.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.673 179.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 138.73 -113.19 0.92 Allowed Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.014 -1.089 . . . . 0.0 113.013 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -110.61 -53.65 2.67 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.448 ' O ' ' CG1' ' A' ' 8' ' ' VAL . . . -140.06 -148.48 5.18 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.176 -1.011 . . . . 0.0 113.494 -179.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.427 ' O ' ' CG2' ' A' ' 14' ' ' VAL . . . -41.4 -31.97 0.28 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.433 HG21 HG11 ' A' ' 8' ' ' VAL . 6.3 m 48.08 25.52 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.966 0.412 . . . . 0.0 110.721 -178.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.462 ' HA2' ' CD1' ' A' ' 19' ' ' LEU . . . 83.36 26.53 43.16 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.951 -0.643 . . . . 0.0 112.723 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.484 ' HA ' ' CZ ' ' A' ' 169' ' ' PHE . 5.6 tptm -98.19 -72.91 0.63 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.776 0.322 . . . . 0.0 111.699 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.1 p -96.06 -58.32 2.12 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.456 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.49 ' SG ' ' PA ' ' A' ' 185' ' ' GNP . 12.0 t -42.34 -46.62 4.67 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.693 0.282 . . . . 0.0 111.64 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.462 ' CD1' ' HA2' ' A' ' 15' ' ' GLY . 0.7 OUTLIER -47.15 -49.74 21.79 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.886 0.374 . . . . 0.0 110.724 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.7 mt -64.75 -24.18 67.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.399 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.446 ' O ' ' N ' ' A' ' 25' ' ' THR . 14.2 mm -73.99 -70.52 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.19 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 59.8 p -48.26 -27.53 2.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.742 0.306 . . . . 0.0 111.048 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -70.44 -67.36 0.5 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.742 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 89.6 m -72.23 -48.58 41.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.647 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.446 ' N ' ' O ' ' A' ' 21' ' ' ILE . 20.6 p -85.58 -151.12 0.14 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.382 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -160.28 29.39 0.17 Allowed 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.859 0.361 . . . . 0.0 111.077 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.58 104.83 9.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.281 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.493 ' CD2' ' HD3' ' A' ' 29' ' ' PRO . 0.1 OUTLIER -110.34 -61.71 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.106 -179.977 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.493 ' HD3' ' CD2' ' A' ' 28' ' ' PHE . 91.5 Cg_endo -86.61 89.35 0.67 Allowed 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.369 2.046 . . . . 0.0 113.052 -179.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.3 p -163.94 -94.74 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.395 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.491 ' CG ' ' HA ' ' B' ' 530' ' ' HIS . 0.2 OUTLIER -160.25 121.87 3.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.716 0.293 . . . . 0.0 110.818 179.684 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.463 ' CD2' ' N3B' ' A' ' 185' ' ' GNP . 3.4 m-30 -101.96 94.23 5.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.934 0.397 . . . . 0.0 110.809 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.409 ' CB ' ' HD3' ' A' ' 34' ' ' PRO . 0.6 OUTLIER -98.73 -51.97 0.2 Allowed Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.367 -179.757 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.409 ' HD3' ' CB ' ' A' ' 33' ' ' VAL . 7.0 Cg_exo -73.9 55.94 3.47 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.812 2.341 . . . . 0.0 112.44 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.7 t -116.77 -33.68 4.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.665 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.441 ' HB ' ' CD1' ' A' ' 61' ' ' LEU . 7.6 p -52.6 -27.1 11.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.802 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -93.97 40.08 1.08 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.535 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.61 36.17 1.1 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.978 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -123.77 18.15 9.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.142 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.411 ' CD2' ' HB ' ' B' ' 521' ' ' THR . 0.2 OUTLIER -75.74 -165.39 0.44 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.789 0.328 . . . . 0.0 110.71 179.973 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -96.18 161.76 13.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.164 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.407 ' CG1' ' O ' ' B' ' 517' ' ' SER . 7.6 m -149.47 129.44 3.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.147 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.0 t -87.9 106.13 17.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.632 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.46 ' HB ' ' CG2' ' A' ' 52' ' ' THR . 1.8 t -161.1 157.86 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.726 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.468 ' HE1' ' N ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -101.74 97.61 7.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.711 -179.481 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.451 HG21 ' CG2' ' B' ' 510' ' ' ILE . 3.0 mm -77.0 86.38 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.446 ' N ' ' HE3' ' A' ' 45' ' ' MET . . . 25.63 98.63 0.01 OUTLIER Glycine 0 C--N 1.339 0.73 0 CA-C-N 115.505 -0.77 . . . . 0.0 114.435 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.427 ' N ' ' HE1' ' A' ' 45' ' ' MET . . . 128.46 -89.89 0.32 Allowed Glycine 0 CA--C 1.519 0.281 0 C-N-CA 120.596 -0.811 . . . . 0.0 113.007 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.468 ' N ' ' HE1' ' A' ' 45' ' ' MET . 1.4 pt-20 -124.73 139.85 34.26 Favored Pre-proline 0 CA--C 1.53 0.202 0 CA-C-O 120.799 0.333 . . . . 0.0 111.233 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.453 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 78.9 Cg_exo -38.12 101.26 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 123.074 2.516 . . . . 0.0 112.822 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.505 ' CZ ' HG23 ' A' ' 3' ' ' THR . 2.2 t80 -172.98 154.69 2.89 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.436 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.46 ' CG2' ' HB ' ' A' ' 44' ' ' VAL . 0.1 OUTLIER -136.72 152.99 50.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.746 179.046 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.431 HD13 ' CD1' ' A' ' 4' ' ' ILE . 0.0 OUTLIER -74.94 161.53 29.42 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.002 -179.899 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -88.8 87.51 1.49 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.626 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.405 ' HG ' HD22 ' A' ' 53' ' ' LEU . 1.1 mp -58.37 99.9 0.05 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.844 0.354 . . . . 0.0 110.664 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -84.76 105.76 15.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.997 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -104.14 129.16 51.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.84 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.43 ' HA ' ' CD2' ' A' ' 67' ' ' LEU . 26.4 p -98.21 126.14 43.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.979 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.47 ' CB ' ' CD1' ' A' ' 61' ' ' LEU . . . -157.63 118.43 3.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.317 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.402 ' HA2' ' O ' ' A' ' 64' ' ' TYR . . . -69.36 73.85 0.42 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.286 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.47 ' CD1' ' CB ' ' A' ' 59' ' ' ALA . 6.7 mp -120.7 -117.26 0.31 Allowed 'General case' 0 CA--C 1.539 0.536 0 O-C-N 122.944 -0.151 . . . . 0.0 111.052 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -99.08 -31.3 11.85 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 118.069 0.395 . . . . 0.0 111.426 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.425 ' CB ' HG23 ' A' ' 36' ' ' VAL . 6.2 t0 -74.33 -63.26 1.27 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.311 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.454 ' CB ' ' CD2' ' A' ' 67' ' ' LEU . 0.2 OUTLIER -115.95 133.69 55.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.718 -179.759 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.95 -69.12 0.7 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.838 0.352 . . . . 0.0 111.146 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.404 ' O ' ' HB2' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -99.44 -34.99 10.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.33 -179.885 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.454 ' CD2' ' CB ' ' A' ' 64' ' ' TYR . 1.0 OUTLIER 70.15 123.88 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.978 -179.652 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.458 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 2.5 mpt_? -82.91 -49.26 0.77 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.147 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.458 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 83.0 Cg_exo -44.83 -58.37 1.59 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.588 2.192 . . . . 0.0 112.538 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.432 ' CD2' ' HA ' ' B' ' 541' ' ' LEU . 0.2 OUTLIER -51.08 -38.31 50.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.69 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.1 t -76.74 -53.78 7.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.906 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -114.32 61.57 1.12 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.638 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.428 ' N ' ' O ' ' A' ' 69' ' ' PRO . 52.1 Cg_endo -68.65 112.44 2.87 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.575 2.184 . . . . 0.0 112.466 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 15.2 tp60 -101.96 10.16 39.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.375 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.34 166.64 0.81 Allowed 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 120.802 0.334 . . . . 0.0 110.809 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -72.74 -26.02 61.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.707 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.3 p -164.4 116.31 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.132 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.52 ' CZ ' ' CG2' ' A' ' 108' ' ' THR . 0.0 OUTLIER -92.89 134.51 35.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.166 179.349 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.424 ' CD2' ' O ' ' A' ' 14' ' ' VAL . 7.5 tp -70.6 108.01 4.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.095 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.441 ' CG2' ' HB2' ' A' ' 110' ' ' PHE . 23.3 m -103.54 121.09 54.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.013 179.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.43 ' HB2' ' CB ' ' A' ' 14' ' ' VAL . 41.1 m -129.13 171.42 12.42 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.359 0.599 . . . . 0.0 112.493 -178.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.474 ' CE2' HG22 ' A' ' 137' ' ' ILE . 41.3 p90 -140.86 -174.04 3.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.88 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.3 p -134.66 122.74 22.68 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.808 0.337 . . . . 0.0 111.071 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.436 ' HA ' HG12 ' A' ' 137' ' ' ILE . 2.9 t -57.15 170.52 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.184 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.437 ' CG2' HD11 ' A' ' 119' ' ' LEU . 0.0 OUTLIER 61.09 105.57 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -179.287 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.448 ' N ' HD23 ' A' ' 129' ' ' LEU . 13.9 p -152.5 143.16 15.5 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-O 120.956 0.408 . . . . 0.0 112.039 -179.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.433 ' O ' ' CB ' ' A' ' 88' ' ' SER . 83.1 Cg_endo -90.84 53.36 1.01 Allowed 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.29 2.66 . . . . 0.0 111.585 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 87' ' ' PRO . 0.3 OUTLIER 84.29 25.62 0.1 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.663 -179.533 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.413 ' O ' ' CG2' ' A' ' 93' ' ' VAL . 2.8 p -97.23 -25.1 15.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.992 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.469 ' CE2' HG22 ' A' ' 141' ' ' THR . 19.4 t80 -53.86 -43.79 69.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.016 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -53.96 -61.71 2.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.929 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.419 ' O ' ' N ' ' A' ' 96' ' ' LYS . 30.0 m-80 -53.88 -42.31 68.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.941 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.413 ' CG2' ' O ' ' A' ' 89' ' ' SER . 60.1 t -47.47 -63.74 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.303 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.423 ' HG3' ' CG ' ' A' ' 145' ' ' LEU . 0.0 OUTLIER -51.04 -45.75 61.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.869 179.91 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -85.31 10.79 11.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.723 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.2 OUTLIER -111.04 -36.18 5.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.934 0.397 . . . . 0.0 110.976 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 33.4 m95 -94.36 -42.95 8.63 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.543 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.454 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 82.3 t -53.26 -47.3 96.53 Favored Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 77.9 Cg_endo -78.95 -18.52 11.44 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.237 1.958 . . . . 0.0 112.629 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -81.61 -40.18 23.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.923 0.392 . . . . 0.0 110.492 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.498 ' CD1' ' CD2' ' A' ' 110' ' ' PHE . 32.8 pt -69.49 -29.79 43.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.904 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.414 ' N ' HG13 ' A' ' 101' ' ' ILE . 70.5 p -78.2 -32.91 50.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.697 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 -63.21 -54.76 32.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.652 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 16.2 m80 -71.65 -24.28 61.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.79 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 1.6 t -143.85 95.96 5.64 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.866 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -47.63 112.07 0.5 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.654 2.236 . . . . 0.0 112.509 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.8 mttt 49.8 99.26 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.157 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.52 ' CG2' ' CZ ' ' A' ' 78' ' ' PHE . 8.7 m -139.24 144.34 40.04 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.03 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -60.67 159.29 28.93 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.762 2.308 . . . . 0.0 112.829 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.498 ' CD2' ' CD1' ' A' ' 101' ' ' ILE . 2.4 p90 -165.37 148.24 7.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.556 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.434 HD13 ' CG ' ' A' ' 171' ' ' GLU . 1.1 tt -120.05 154.79 34.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.168 -179.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.426 HD13 ' CA ' ' A' ' 146' ' ' ALA . 13.1 mt -111.73 146.43 37.57 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.799 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.467 ' CG1' ' CG2' ' A' ' 168' ' ' VAL . 21.9 t -130.87 149.69 33.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.15 0.5 . . . . 0.0 111.884 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -124.97 112.43 1.73 Allowed Glycine 0 N--CA 1.452 -0.247 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.407 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.833 ' OG1' " H2'" ' A' ' 185' ' ' GNP . 0.2 OUTLIER -127.84 -54.82 1.31 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.839 0.352 . . . . 0.0 111.329 -179.009 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.443 ' HG3' HO2' ' A' ' 185' ' ' GNP . 2.0 tt0 -58.56 -17.65 23.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.26 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.416 ' N ' HG21 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -44.81 -27.31 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 120.841 0.353 . . . . 0.0 111.592 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.41 ' N ' HG12 ' A' ' 117' ' ' ILE . 21.4 t0 -66.76 -35.37 79.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.688 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.437 HD11 ' CG2' ' A' ' 85' ' ' VAL . 3.8 pp -99.49 -3.89 32.54 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.434 ' CB ' HG11 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -52.37 -35.67 51.87 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.977 0.418 . . . . 0.0 110.481 179.583 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -62.48 -24.17 67.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.759 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -42.36 100.6 0.23 Allowed Pre-proline 0 N--CA 1.463 0.208 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.025 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.44 ' O ' ' CG ' ' A' ' 127' ' ' GLU . 37.7 Cg_endo -66.67 -8.99 22.83 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.434 2.089 . . . . 0.0 112.897 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.7 t -74.14 -67.52 0.61 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.08 0.467 . . . . 0.0 110.008 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.438 ' O ' ' N ' ' A' ' 128' ' ' LYS . 73.6 m -56.36 -47.15 79.44 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.462 ' O ' ' HB2' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -46.91 -40.46 4.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.959 179.413 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.44 ' CG ' ' O ' ' A' ' 123' ' ' PRO . 4.8 mm-40 -60.07 -39.11 84.93 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.438 ' N ' ' O ' ' A' ' 125' ' ' THR . 0.0 OUTLIER -68.67 -34.02 74.97 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.155 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.479 ' N ' HD13 ' A' ' 129' ' ' LEU . 9.8 mp -64.84 -37.75 88.66 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 177.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.445 ' HA ' ' HB2' ' A' ' 134' ' ' GLN . . . -43.58 -39.16 3.34 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 114.453 -1.249 . . . . 0.0 111.567 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 6.3 mmtm -58.65 -24.8 61.91 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.579 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.426 ' CB ' ' O ' ' A' ' 87' ' ' PRO . 11.1 m-80 -124.38 -31.52 3.27 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -179.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.431 ' HG2' ' CB ' ' A' ' 88' ' ' SER . 2.2 mmtt -156.41 -63.38 0.1 Allowed 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -178.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.445 ' HB2' ' HA ' ' A' ' 130' ' ' ALA . 2.0 tt0 80.9 14.18 0.69 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.208 -178.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 35.2 mmtt -97.87 96.54 3.45 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.634 0.254 . . . . 0.0 111.175 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -64.74 131.1 28.15 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.389 2.059 . . . . 0.0 111.738 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.474 HG22 ' CE2' ' A' ' 82' ' ' PHE . 1.6 mm -67.55 96.38 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.0 0.429 . . . . 0.0 110.749 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.4 ' O ' ' N ' ' A' ' 141' ' ' THR . 2.3 p -77.0 147.28 76.84 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.868 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.466 ' HA ' ' CE1' ' A' ' 154' ' ' TYR . 96.4 Cg_exo -43.0 -28.22 1.17 Allowed 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.584 2.189 . . . . 0.0 112.286 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -72.88 -36.55 67.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.865 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.469 HG22 ' CE2' ' A' ' 90' ' ' PHE . 16.6 m -54.57 -61.93 1.99 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.898 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.443 ' HB2' ' CE1' ' A' ' 82' ' ' PHE . . . -52.04 -40.81 61.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.066 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -51.18 -45.29 61.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.821 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.4 ttpp -64.06 -49.08 73.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.812 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.423 ' CG ' ' HG3' ' A' ' 94' ' ' LYS . 0.9 OUTLIER -61.43 -46.77 88.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.674 179.819 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.426 ' CA ' HD13 ' A' ' 112' ' ' LEU . . . -50.93 -45.52 60.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.98 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.57 -26.6 32.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.772 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -53.18 -38.4 62.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.766 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.4 ' HG ' HG13 ' A' ' 98' ' ' VAL . 2.9 mm? -114.48 21.25 14.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.926 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 48.16 51.3 14.99 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.037 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.442 ' O ' ' CG2' ' A' ' 152' ' ' VAL . . . -66.66 -82.86 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.978 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.442 ' CG2' ' O ' ' A' ' 151' ' ' ALA . 36.5 t -164.32 -69.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.244 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 176.65 135.76 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.134 -179.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.466 ' CE1' ' HA ' ' A' ' 139' ' ' PRO . 27.7 t80 -106.54 108.01 19.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.64 178.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -101.32 -171.89 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.89 0.376 . . . . 0.0 111.319 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -89.73 156.51 18.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.159 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.442 ' CB ' HG11 ' A' ' 168' ' ' VAL . 13.0 t 178.82 160.02 0.62 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.199 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 8.4 t -159.69 123.56 3.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.866 0.365 . . . . 0.0 111.19 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.463 ' HB1' HO3' ' A' ' 185' ' ' GNP . . . -92.3 20.25 6.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.073 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.428 ' CD1' ' N ' ' A' ' 160' ' ' LEU . 0.0 OUTLIER -133.11 -44.71 0.85 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.527 179.927 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 9.7 t -111.06 -16.08 13.57 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.993 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 75.9 85.41 0.09 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.84 0.352 . . . . 0.0 111.355 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 22.1 mmmt -111.12 45.77 1.14 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.52 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.436 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . 128.95 -63.22 0.63 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.106 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.439 HD13 ' CA ' ' A' ' 19' ' ' LEU . 0.2 OUTLIER 62.23 -74.46 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.711 0.291 . . . . 0.0 111.257 179.597 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.436 ' N ' ' O ' ' A' ' 164' ' ' GLY . 0.0 OUTLIER -69.76 -23.42 63.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.99 -179.961 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -56.02 -56.07 25.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.006 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.467 ' CG2' ' CG1' ' A' ' 113' ' ' VAL . 16.2 m -71.27 -36.74 63.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.582 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.484 ' CZ ' ' HA ' ' A' ' 16' ' ' LYS . 0.5 OUTLIER -75.03 -19.52 60.0 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.853 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.432 ' CB ' ' O ' ' A' ' 166' ' ' LYS . 28.7 t70 -83.06 -34.81 26.11 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.011 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.434 ' CG ' HD13 ' A' ' 111' ' ' LEU . 2.1 pt-20 -75.15 -31.66 61.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.912 0.387 . . . . 0.0 110.34 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.417 ' N ' HD13 ' A' ' 111' ' ' LEU . . . -73.09 -47.81 41.23 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.586 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 170' ' ' ASP . 1.7 pp -64.34 -38.63 83.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.756 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.44 ' HG ' ' CB ' ' B' ' 505' ' ' LEU . 3.3 tm? -52.3 -35.4 50.43 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.921 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -51.76 -24.31 5.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.984 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.434 ' CB ' ' HB ' ' A' ' 4' ' ' ILE . . . -95.05 -36.94 11.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.106 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.479 ' CD2' ' CG2' ' A' ' 4' ' ' ILE . 9.6 mt -68.82 -24.34 64.37 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.844 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -172.94 128.8 0.54 Allowed Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.908 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -57.19 115.75 2.72 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.559 2.172 . . . . 0.0 112.304 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -77.47 -166.44 0.39 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.451 2.101 . . . . 0.0 112.312 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -149.08 131.55 7.84 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.891 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -80.71 -165.47 0.34 Allowed 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.667 2.245 . . . . 0.0 112.326 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 29.3 mttt -133.98 170.85 15.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.894 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 2.3 mttm . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.184 -0.913 . . . . 0.0 110.905 -179.946 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.202 0 N-CA-C 112.428 -0.269 . . . . 0.0 112.428 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 503' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.5 -162.37 0.51 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.819 0.343 . . . . 0.0 110.849 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 504' ' ' GLY . . . . . 0.44 ' CA ' ' HA ' ' B' ' 509' ' ' ASP . . . 131.17 -101.89 0.5 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.321 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 505' ' ' LEU . . . . . 0.44 ' CB ' ' HG ' ' A' ' 174' ' ' LEU . 0.0 OUTLIER 58.96 18.08 5.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.563 0.22 . . . . 0.0 111.3 179.773 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 506' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 65.26 100.19 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.925 0.393 . . . . 0.0 110.649 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 507' ' ' ALA . . . . . 0.44 ' O ' ' CB ' ' B' ' 508' ' ' GLN . . . 169.15 -36.29 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.389 0.614 . . . . 0.0 110.44 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 508' ' ' GLN . . . . . 0.476 ' O ' ' CB ' ' B' ' 509' ' ' ASP . 0.5 OUTLIER 156.62 -26.36 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.394 -179.364 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 509' ' ' ASP . . . . . 0.476 ' CB ' ' O ' ' B' ' 508' ' ' GLN . 0.3 OUTLIER 98.07 32.4 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.975 0.91 . . . . 0.0 110.872 179.739 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 510' ' ' ILE . . . . . 0.451 ' CG2' HG21 ' A' ' 46' ' ' ILE . 3.3 mp -54.05 130.9 16.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.443 179.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 511' ' ' SER . . . . . 0.441 ' CB ' ' HG ' ' B' ' 514' ' ' LEU . 0.4 OUTLIER -109.09 154.48 22.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.261 -179.459 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 512' ' ' GLN . . . . . 0.452 ' CB ' ' HD3' ' B' ' 513' ' ' PRO . 0.0 OUTLIER -97.9 -57.69 0.17 Allowed Pre-proline 0 C--N 1.333 -0.149 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.799 179.575 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 513' ' ' PRO . . . . . 0.452 ' HD3' ' CB ' ' B' ' 512' ' ' GLN . 59.9 Cg_endo -90.85 42.4 0.43 Allowed 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.905 2.404 . . . . 0.0 112.043 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 514' ' ' LEU . . . . . 0.447 ' CD2' ' O ' ' A' ' 45' ' ' MET . 0.3 OUTLIER -46.49 -85.62 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.624 -179.388 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 515' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.09 -86.52 0.23 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.124 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -125.12 -37.15 2.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.218 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 517' ' ' SER . . . . . 0.407 ' O ' ' CG1' ' A' ' 42' ' ' VAL . 0.7 OUTLIER 63.79 29.57 14.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.962 -179.884 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 518' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -163.22 123.98 2.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.06 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 519' ' ' ILE . . . . . . . . . . . . . 12.1 mm -94.42 31.87 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.162 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 52.26 38.26 24.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.858 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 521' ' ' THR . . . . . 0.411 ' HB ' ' CD2' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -113.51 -172.11 2.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.845 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 522' ' ' GLY . . . . . . . . . . . . . . . 101.08 125.46 5.6 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.356 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 523' ' ' HIS . . . . . . . . . . . . . 26.4 t60 -117.86 -81.28 0.62 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.747 0.308 . . . . 0.0 110.98 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 524' ' ' GLY . . . . . . . . . . . . . . . 58.09 -106.05 0.74 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.648 -0.786 . . . . 0.0 112.619 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 525' ' ' ASP . . . . . . . . . . . . . 4.7 t0 57.77 73.77 0.45 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.754 0.311 . . . . 0.0 110.891 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 526' ' ' SER . . . . . 0.437 ' CB ' ' HB3' ' A' ' 61' ' ' LEU . 32.0 t -108.83 96.77 6.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.987 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 527' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 70.7 95.79 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.053 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -74.95 58.83 4.98 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.736 2.291 . . . . 0.0 112.472 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 529' ' ' ARG . . . . . 0.403 ' HB2' ' OD1' ' B' ' 545' ' ' ASN . 0.1 OUTLIER -53.31 -43.09 67.32 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.192 0.52 . . . . 0.0 110.122 179.519 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 530' ' ' HIS . . . . . 0.491 ' HA ' ' CG ' ' A' ' 31' ' ' GLU . 41.2 m170 64.74 51.05 1.93 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.931 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -155.99 132.1 9.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.16 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 532' ' ' TRP . . . . . 0.407 ' NE1' ' O ' ' B' ' 536' ' ' ASP . 6.6 t-105 -92.22 -22.22 19.92 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.887 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . 92.44 -136.59 13.29 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.447 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 534' ' ' PHE . . . . . 0.426 ' O ' ' N ' ' B' ' 536' ' ' ASP . 39.2 m-85 -81.42 165.5 43.95 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.655 0.264 . . . . 0.0 110.629 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -56.18 81.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.587 2.191 . . . . 0.0 112.377 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 536' ' ' ASP . . . . . 0.439 ' HA ' ' NH1' ' B' ' 537' ' ' ARG . 0.2 OUTLIER 171.45 -164.22 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.92 -180.0 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 537' ' ' ARG . . . . . 0.449 ' HD2' " C1'" ' A' ' 185' ' ' GNP . 0.0 OUTLIER -125.47 155.88 39.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.148 0.499 . . . . 0.0 110.532 179.77 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 538' ' ' ILE . . . . . 0.428 ' CG2' ' HA ' ' B' ' 543' ' ' LEU . 6.7 tp -83.34 123.96 39.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.483 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 539' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -33.68 130.19 0.28 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.156 0.503 . . . . 0.0 112.115 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 540' ' ' GLU . . . . . 0.452 ' HG2' ' CA ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -41.79 -28.35 0.15 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.254 -179.29 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 541' ' ' LEU . . . . . 0.432 ' HA ' ' CD2' ' A' ' 70' ' ' LEU . 0.8 OUTLIER -40.91 -50.26 3.24 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.864 0.364 . . . . 0.0 111.319 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 542' ' ' TYR . . . . . 0.406 ' CD1' ' N ' ' B' ' 542' ' ' TYR . 0.1 OUTLIER -105.35 -63.37 1.24 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.234 179.949 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 543' ' ' LEU . . . . . 0.488 HD22 ' H2 ' ' A' ' 188' ' ' HOH . 0.3 OUTLIER 72.83 166.68 0.3 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.474 -179.345 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . 116.47 156.97 10.86 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.655 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 545' ' ' ASN . . . . . 0.431 ' HB2' ' CB ' ' A' ' 31' ' ' GLU . 5.9 p30 . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.199 -0.905 . . . . 0.0 111.098 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' GNP . . . . . 0.833 " H2'" ' OG1' ' A' ' 115' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' HOH . . . . . 0.488 ' H2 ' HD22 ' B' ' 543' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.2 tpt . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.807 0.337 . . . . 0.0 111.252 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.23 144.61 57.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.49 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.51 HG22 ' CZ ' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -110.79 -173.82 2.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.535 -179.545 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.441 HD12 ' CG1' ' A' ' 173' ' ' ILE . 5.7 pt -154.92 127.29 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.16 -179.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.44 ' CB ' ' HB ' ' A' ' 75' ' ' THR . 5.6 mmtp -100.6 100.58 11.32 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.425 ' CB ' ' HB3' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -77.63 132.56 38.31 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.201 0.524 . . . . 0.0 112.061 -178.71 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.3 t -144.52 159.66 14.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.918 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.424 HG22 ' HG3' ' A' ' 16' ' ' LYS . 48.7 t -133.72 128.57 54.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.301 0.572 . . . . 0.0 112.143 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.436 ' HA ' ' CG ' ' B' ' 540' ' ' GLU . 3.3 m -134.06 129.38 54.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.267 -0.878 . . . . 0.0 109.694 178.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 134.98 -160.3 24.26 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.247 -0.978 . . . . 0.0 112.6 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.418 ' O ' ' N ' ' B' ' 537' ' ' ARG . 6.6 p30 -122.87 27.27 7.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.642 0.258 . . . . 0.0 111.047 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -104.59 174.59 21.96 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.823 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.441 ' CB ' ' H8 ' ' A' ' 185' ' ' GNP . . . -95.16 -56.38 2.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.863 0.363 . . . . 0.0 111.1 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.445 HG23 ' CG1' ' A' ' 113' ' ' VAL . 14.7 p -53.61 105.93 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.047 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.444 ' HA2' ' CD1' ' A' ' 19' ' ' LEU . . . 153.01 -44.51 0.61 Allowed Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.069 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.424 ' HG3' HG22 ' A' ' 8' ' ' VAL . 9.8 mtmt -90.18 -95.24 0.11 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 120.368 0.127 . . . . 0.0 111.077 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 61.3 p -98.44 -49.6 4.6 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 120.939 0.4 . . . . 0.0 111.482 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.436 ' O ' ' CB ' ' A' ' 22' ' ' SER . 10.2 t -36.9 -41.32 0.33 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.447 -179.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.486 HD11 ' CD1' ' A' ' 169' ' ' PHE . 6.5 mt -49.84 -73.79 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.864 0.364 . . . . 0.0 111.557 -179.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.2 mt -74.74 -30.9 61.66 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.017 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.426 ' CG2' ' OG1' ' A' ' 25' ' ' THR . 16.2 mm -66.44 -69.44 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 178.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.439 ' O ' ' ND2' ' A' ' 26' ' ' ASN . 7.4 t -49.74 -25.8 3.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.594 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -65.37 -46.59 79.52 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.447 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.58 -55.01 3.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.478 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.426 ' OG1' ' CG2' ' A' ' 21' ' ' ILE . 30.1 p -88.38 76.4 8.31 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.439 ' ND2' ' O ' ' A' ' 22' ' ' SER . 0.6 OUTLIER -69.52 62.28 0.16 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.436 -178.742 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.2 mtmt -121.87 90.85 3.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.599 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.495 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 2.2 t80 -90.03 -44.95 0.41 Allowed Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.749 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 86.6 Cg_endo -85.78 13.56 2.71 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.5 2.133 . . . . 0.0 113.082 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.2 m -93.68 -93.7 0.17 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.631 -0.258 . . . . 0.0 110.845 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -158.99 145.52 16.95 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.789 0.328 . . . . 0.0 110.786 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.526 ' CD2' ' N3B' ' A' ' 185' ' ' GNP . 11.9 m-85 -126.23 133.61 51.44 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.669 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.445 ' CB ' ' HD3' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -162.53 -56.55 0.01 OUTLIER Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.612 -179.537 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.445 ' HD3' ' CB ' ' A' ' 33' ' ' VAL . 51.5 Cg_exo -56.49 78.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.527 2.151 . . . . 0.0 112.686 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.463 ' CG2' ' CD2' ' B' ' 543' ' ' LEU . 29.2 m -121.57 -5.35 9.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.253 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.478 ' HA ' ' CB ' ' A' ' 59' ' ' ALA . 0.1 OUTLIER -89.69 -3.34 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -179.863 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -81.0 9.24 6.82 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -52.39 -174.12 0.0 OUTLIER 'General case' 0 C--O 1.231 0.101 0 CA-C-O 120.778 0.323 . . . . 0.0 111.052 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.418 ' ND2' ' OH ' ' A' ' 64' ' ' TYR . 9.8 p30 48.82 25.45 1.03 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.895 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.418 ' CB ' ' HB ' ' B' ' 521' ' ' THR . 8.8 p90 -65.16 -174.29 0.16 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.733 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.431 ' O ' ' CG1' ' B' ' 519' ' ' ILE . . . -122.93 152.01 41.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.272 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.432 ' CG2' ' HB ' ' A' ' 52' ' ' THR . 34.2 m -145.89 156.12 12.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.916 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.406 ' O ' ' CG1' ' A' ' 44' ' ' VAL . 0.1 OUTLIER -123.52 106.39 10.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.957 0.408 . . . . 0.0 111.239 -179.736 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.494 ' CG2' ' CG2' ' A' ' 52' ' ' THR . 10.7 m -156.5 -177.24 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.917 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.455 ' O ' ' CD1' ' B' ' 514' ' ' LEU . 4.8 tpt -107.01 96.1 6.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.303 -179.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.445 ' N ' ' HE1' ' A' ' 45' ' ' MET . 3.9 mm -76.79 86.85 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 121.036 0.446 . . . . 0.0 110.629 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.423 ' HA3' ' CG2' ' B' ' 510' ' ' ILE . . . 39.6 -92.73 0.01 OUTLIER Glycine 0 CA--C 1.521 0.454 0 CA-C-N 115.778 -0.647 . . . . 0.0 113.851 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . -35.59 -87.07 0.01 OUTLIER Glycine 0 C--N 1.334 0.457 0 N-CA-C 114.019 0.368 . . . . 0.0 114.019 -179.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.436 ' N ' ' HE3' ' A' ' 45' ' ' MET . 0.5 OUTLIER -133.32 159.16 73.68 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 120.705 0.288 . . . . 0.0 110.775 -179.693 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.403 ' N ' ' SD ' ' A' ' 45' ' ' MET . 86.1 Cg_exo -45.2 100.21 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.326 2.017 . . . . 0.0 112.161 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.51 ' CZ ' HG22 ' A' ' 3' ' ' THR . 8.8 t80 -167.21 153.78 8.29 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.442 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.494 ' CG2' ' CG2' ' A' ' 44' ' ' VAL . 1.8 p -136.86 153.37 50.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.037 0.446 . . . . 0.0 111.467 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.44 HD11 ' CD1' ' A' ' 4' ' ' ILE . 0.0 OUTLIER -83.38 167.99 17.02 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.844 179.637 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -105.21 -25.72 6.59 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.801 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.425 ' HB3' ' CB ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER 52.12 92.54 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.785 0.326 . . . . 0.0 111.038 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -84.95 105.57 15.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.365 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -105.95 165.99 10.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.109 0.48 . . . . 0.0 111.272 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.451 ' CG2' ' HB3' ' A' ' 70' ' ' LEU . 1.5 p -89.32 152.98 21.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.033 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.478 ' CB ' ' HA ' ' A' ' 36' ' ' VAL . . . -172.12 100.36 0.16 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.667 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' B' ' 543' ' ' LEU . . . -98.66 70.67 0.6 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.814 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.433 ' CD2' ' CB ' ' B' ' 526' ' ' SER . 6.5 mp -120.19 -107.69 0.36 Allowed 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 110.601 -0.148 . . . . 0.0 110.601 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -99.8 -24.67 14.61 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 120.775 0.322 . . . . 0.0 111.334 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.424 ' CB ' ' CG1' ' A' ' 36' ' ' VAL . 16.0 t0 -70.71 -63.41 1.1 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.676 -179.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.431 ' CD1' ' N ' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -151.66 116.25 5.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.848 0.356 . . . . 0.0 111.028 -179.54 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.67 -13.77 47.55 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.392 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.32 -50.7 4.23 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.651 0.262 . . . . 0.0 111.656 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.431 HD13 ' CG2' ' A' ' 58' ' ' THR . 13.5 mt 69.82 -148.18 0.1 Allowed 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 -179.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.418 ' CB ' ' CD ' ' A' ' 69' ' ' PRO . 3.8 mtt-85 -172.55 -61.38 0.0 OUTLIER Pre-proline 0 CA--C 1.528 0.102 0 C-N-CA 120.776 -0.369 . . . . 0.0 111.883 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.418 ' CD ' ' CB ' ' A' ' 68' ' ' ARG . 50.0 Cg_exo -35.99 -60.26 0.35 Allowed 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 123.059 2.506 . . . . 0.0 113.236 -179.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.451 ' HB3' ' CG2' ' A' ' 58' ' ' THR . 0.3 OUTLIER -46.88 -26.74 1.04 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.351 -179.777 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.5 t -74.6 -70.45 0.4 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.289 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -95.49 150.17 37.14 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.213 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.49 120.78 5.72 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.706 2.271 . . . . 0.0 112.531 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.415 ' NE2' ' O ' ' A' ' 69' ' ' PRO . 1.3 mp0 -102.03 -60.3 1.56 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.848 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.44 ' HB ' ' CB ' ' A' ' 5' ' ' LYS . 7.9 t -82.15 -178.71 7.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.053 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.405 ' O ' ' CG ' ' A' ' 109' ' ' PRO . 0.1 OUTLIER -104.3 7.7 35.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.382 179.899 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.412 ' O ' ' CG1' ' A' ' 77' ' ' VAL . 11.3 p -156.47 106.92 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.711 0.291 . . . . 0.0 111.24 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.481 ' CD1' HG21 ' A' ' 108' ' ' THR . 4.9 m-85 -83.59 -177.9 6.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.607 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.19 117.71 29.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.95 0.405 . . . . 0.0 111.427 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.522 ' CG2' ' CD1' ' A' ' 110' ' ' PHE . 1.8 t -111.35 100.32 10.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.367 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.426 ' CB ' HG13 ' A' ' 14' ' ' VAL . 2.3 p -109.57 137.74 46.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.04 0.448 . . . . 0.0 111.538 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.483 ' CE1' ' CE1' ' A' ' 90' ' ' PHE . 28.7 p90 -147.18 145.22 29.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.224 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.6 m -83.29 130.58 35.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.901 0.381 . . . . 0.0 111.269 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.445 ' HA ' ' HB ' ' A' ' 137' ' ' ILE . 97.2 t -45.93 -73.72 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.481 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.424 HG13 ' CD1' ' A' ' 119' ' ' LEU . 5.6 m -43.64 117.75 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.332 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.418 ' N ' HD21 ' A' ' 129' ' ' LEU . 0.4 OUTLIER -151.57 136.89 10.71 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.336 -179.798 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.421 ' O ' ' CB ' ' A' ' 88' ' ' SER . 68.2 Cg_endo -92.42 52.75 0.58 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 123.212 2.608 . . . . 0.0 111.816 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.426 ' OG ' ' CG ' ' A' ' 133' ' ' LYS . 0.1 OUTLIER 80.84 26.25 0.26 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.908 -179.499 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 43.3 t -96.78 -26.17 15.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.911 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.483 ' CE1' ' CE1' ' A' ' 82' ' ' PHE . 3.9 t80 -54.65 -46.97 74.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.983 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -52.3 -58.26 7.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.994 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.416 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.4 OUTLIER -54.39 -43.17 71.19 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.027 -179.947 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.449 HG11 ' CE2' ' A' ' 97' ' ' TRP . 60.5 t -54.35 -45.54 68.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.254 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.9 tttt -59.6 -55.12 38.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.056 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.8 0.14 24.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.741 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.416 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 2.0 tttt -112.22 -22.53 10.89 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.656 0.265 . . . . 0.0 111.072 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.474 ' CZ3' HG13 ' A' ' 80' ' ' VAL . 25.2 m0 -93.06 -55.13 3.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.111 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.48 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 61.1 t -43.68 -56.13 7.69 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.869 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 30.6 Cg_endo -62.67 -18.8 65.85 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.169 1.912 . . . . 0.0 112.381 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.29 -45.32 9.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.006 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 19.7 mm -52.58 -56.92 5.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.159 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.1 p -65.25 -22.3 66.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.238 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 22.3 t-160 -64.93 -68.74 0.34 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.892 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -75.54 -27.22 58.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.004 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.434 ' HB3' ' CB ' ' A' ' 108' ' ' THR . 8.3 m -122.64 75.16 45.48 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.024 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -57.08 131.96 48.56 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.642 2.228 . . . . 0.0 112.166 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 9.7 mmtp 50.31 39.16 19.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.824 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.481 HG21 ' CD1' ' A' ' 78' ' ' PHE . 46.0 m -108.3 101.69 43.31 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.95 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.405 ' CG ' ' O ' ' A' ' 76' ' ' ASP . 36.3 Cg_exo -60.19 171.78 2.91 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.632 2.221 . . . . 0.0 112.425 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.522 ' CD1' ' CG2' ' A' ' 80' ' ' VAL . 6.6 p90 -158.52 -177.55 6.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.711 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.463 ' CD1' ' CG1' ' A' ' 152' ' ' VAL . 3.1 tt -142.2 152.88 43.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.828 0.347 . . . . 0.0 111.245 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -101.52 161.15 13.85 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.559 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.445 ' CG1' HG23 ' A' ' 14' ' ' VAL . 2.5 t -138.74 155.5 27.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.007 0.432 . . . . 0.0 111.743 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' A' ' 157' ' ' CYS . . . -140.14 114.23 0.96 Allowed Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.327 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.934 ' OG1' " H2'" ' A' ' 185' ' ' GNP . 0.1 OUTLIER -126.97 -49.14 1.47 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.919 0.39 . . . . 0.0 110.284 -179.676 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.427 ' HB2' ' N3 ' ' A' ' 185' ' ' GNP . 0.7 OUTLIER -61.69 -16.28 47.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.634 179.284 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.432 HG12 ' N ' ' A' ' 118' ' ' ASP . 0.2 OUTLIER -40.58 -28.57 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 179.906 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.442 ' CB ' ' HB ' ' A' ' 161' ' ' THR . 2.3 p30 -66.9 -29.56 69.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.852 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.425 ' O ' ' CD1' ' A' ' 119' ' ' LEU . 3.6 pp -106.01 13.71 28.87 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.44 ' O ' ' CD1' ' A' ' 126' ' ' ILE . 1.8 ppt_? -66.86 -20.64 65.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.727 0.299 . . . . 0.0 110.696 179.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -85.47 -25.97 26.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.484 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -49.95 104.98 0.46 Allowed Pre-proline 0 C--N 1.332 -0.171 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.696 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.43 ' HA ' ' CG2' ' A' ' 126' ' ' ILE . 37.4 Cg_endo -66.32 -7.9 18.92 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.582 2.188 . . . . 0.0 113.174 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.38 -67.28 0.64 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.402 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 12.4 m -58.24 -39.41 79.04 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 178.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.456 HG13 HD12 ' A' ' 129' ' ' LEU . 0.1 OUTLIER -54.39 -44.68 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.684 179.176 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -57.84 -36.87 72.89 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.896 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 125' ' ' THR . 0.0 OUTLIER -63.31 -30.72 71.81 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.902 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.456 HD12 HG13 ' A' ' 126' ' ' ILE . 6.8 mt -74.54 -38.04 62.86 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 177.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -45.47 -33.15 2.51 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 114.867 -1.06 . . . . 0.0 111.048 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.2 mmtp -48.95 -34.89 13.82 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.512 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.419 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 2.7 m-80 -123.2 -31.23 3.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.362 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.524 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 36.8 mmtt -143.59 -100.67 0.12 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 119.092 -0.48 . . . . 0.0 111.478 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.524 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 4.5 pt20 131.33 -22.34 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.456 1.102 . . . . 0.0 110.45 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 5.9 mmpp? -68.57 110.6 6.14 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.739 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.425 ' HB3' ' CD1' ' A' ' 126' ' ' ILE . 90.6 Cg_endo -80.86 134.4 9.55 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.527 2.152 . . . . 0.0 111.656 179.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.525 ' N ' ' CD1' ' A' ' 137' ' ' ILE . 0.4 OUTLIER -64.34 96.6 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.323 -179.694 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.417 ' O ' ' N ' ' A' ' 141' ' ' THR . 2.9 p -68.78 145.72 97.05 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.888 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.427 ' O ' ' CE1' ' A' ' 154' ' ' TYR . 89.1 Cg_exo -43.19 -28.21 1.34 Allowed 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.573 2.182 . . . . 0.0 112.248 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -78.75 -36.7 42.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.676 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.417 ' N ' ' O ' ' A' ' 138' ' ' THR . 6.1 m -54.88 -56.06 23.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.714 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.509 ' CB ' ' CD2' ' A' ' 154' ' ' TYR . . . -53.02 -36.56 60.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.777 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.64 -38.82 90.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.667 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 17.2 tptt -63.41 -50.59 69.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.703 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.23 -33.99 72.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.593 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -67.69 -44.7 77.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.894 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 60.2 mtt180 -75.14 -23.18 57.8 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.793 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -56.14 -46.88 79.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.745 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -95.54 19.7 10.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.058 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.1 mtmp? 44.82 40.39 4.25 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.428 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.487 ' HB1' ' CD1' ' A' ' 110' ' ' PHE . . . -59.58 -81.72 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.866 0.365 . . . . 0.0 110.818 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.463 ' CG1' ' CD1' ' A' ' 111' ' ' LEU . 83.5 t -159.65 -73.82 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.833 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 4.1 tppt? 177.42 135.6 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.954 -179.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.509 ' CD2' ' CB ' ' A' ' 142' ' ' ALA . 3.3 t80 -98.06 112.49 24.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.154 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.431 ' CG2' ' HA ' ' A' ' 168' ' ' VAL . 0.3 OUTLIER -115.04 -172.84 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.637 -179.924 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.422 ' CB ' ' HG2' ' A' ' 163' ' ' LYS . 2.1 mp0 -89.58 163.3 15.24 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.868 0.366 . . . . 0.0 111.145 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.438 ' HB3' ' CG2' ' A' ' 115' ' ' THR . 0.1 OUTLIER -133.56 -172.73 3.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.987 -179.786 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.442 ' CB ' ' HB2' ' A' ' 165' ' ' LEU . 1.1 p -128.38 147.85 50.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.984 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . 169.58 -57.96 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.805 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.2 mp -100.39 -60.07 1.59 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.62 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.442 ' HB ' ' CB ' ' A' ' 118' ' ' ASP . 13.4 t -86.04 -26.4 25.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.474 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.426 ' HA ' ' HB2' ' A' ' 158' ' ' SER . 2.8 tt0 73.39 77.11 0.13 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.16 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.422 ' HG2' ' CB ' ' A' ' 156' ' ' GLU . 0.0 OUTLIER -88.19 -21.37 24.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.131 179.979 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 142.07 -36.07 1.7 Allowed Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.491 -0.861 . . . . 0.0 112.887 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.447 HD22 ' CD2' ' A' ' 19' ' ' LEU . 0.4 OUTLIER 68.37 -63.7 0.33 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.791 0.329 . . . . 0.0 111.064 -179.796 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.407 ' O ' ' CB ' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -48.49 -30.92 5.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.264 -179.848 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.403 ' ND2' HG11 ' A' ' 155' ' ' VAL . 0.2 OUTLIER -56.46 -71.5 0.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.313 -179.707 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.431 ' HA ' ' CG2' ' A' ' 155' ' ' VAL . 8.5 p -58.48 -46.77 89.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.823 0.344 . . . . 0.0 111.061 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.486 ' CD1' HD11 ' A' ' 19' ' ' LEU . 4.2 t80 -57.71 -37.39 73.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.187 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.407 ' CB ' ' O ' ' A' ' 166' ' ' LYS . 17.0 m-20 -58.83 -37.47 76.5 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -66.34 -32.29 73.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.785 179.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.5 -30.63 71.0 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.68 179.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.441 ' CG1' HD12 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -90.55 -26.15 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.097 -0.502 . . . . 0.0 109.763 179.256 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.442 ' CD2' HD12 ' B' ' 505' ' ' LEU . 1.2 mt -49.48 -46.81 48.63 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.01 0.434 . . . . 0.0 110.612 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.71 -22.68 64.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.098 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -97.09 -38.22 9.83 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.219 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.441 ' CD2' ' HB ' ' B' ' 510' ' ' ILE . 2.6 tp -68.71 -21.88 64.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.868 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.434 ' HB2' ' CB ' ' B' ' 507' ' ' ALA . 0.0 OUTLIER -174.06 158.08 2.72 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.788 179.905 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.65 110.68 3.06 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.654 2.236 . . . . 0.0 112.262 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -83.2 164.77 14.96 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.69 2.26 . . . . 0.0 112.472 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . 0.425 ' O ' ' CG ' ' A' ' 181' ' ' GLU . 9.5 pt-20 -113.11 110.11 51.49 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.551 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.66 -164.91 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.411 2.074 . . . . 0.0 112.278 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.66 86.21 1.64 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.874 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.872 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.224 0 N-CA-C 112.56 -0.216 . . . . 0.0 112.56 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 503' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -76.64 -82.44 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.735 0.302 . . . . 0.0 110.909 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 504' ' ' GLY . . . . . 0.403 ' HA2' ' HA ' ' B' ' 509' ' ' ASP . . . 93.55 104.23 1.7 Allowed Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.397 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 505' ' ' LEU . . . . . 0.442 HD12 ' CD2' ' A' ' 174' ' ' LEU . 0.1 OUTLIER -170.32 39.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.747 0.308 . . . . 0.0 110.982 -179.767 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 506' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 68.14 33.04 4.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.031 0.443 . . . . 0.0 110.486 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 507' ' ' ALA . . . . . 0.434 ' CB ' ' HB2' ' A' ' 178' ' ' GLU . . . -134.93 36.58 3.06 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.698 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 508' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 74.39 3.41 4.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.551 -178.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 509' ' ' ASP . . . . . 0.403 ' HA ' ' HA2' ' B' ' 504' ' ' GLY . 22.2 t70 70.49 43.62 0.77 Allowed 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 121.024 0.44 . . . . 0.0 110.985 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 510' ' ' ILE . . . . . 0.441 ' HB ' ' CD2' ' A' ' 177' ' ' LEU . 66.4 mt -95.25 139.0 19.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.579 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 511' ' ' SER . . . . . 0.418 ' N ' HG23 ' B' ' 510' ' ' ILE . 34.6 t -108.28 148.12 30.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.989 0.424 . . . . 0.0 112.039 -178.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 512' ' ' GLN . . . . . 0.471 ' HB3' ' HD3' ' B' ' 513' ' ' PRO . 11.8 tp60 -100.06 -69.08 0.04 OUTLIER Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.998 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 513' ' ' PRO . . . . . 0.471 ' HD3' ' HB3' ' B' ' 512' ' ' GLN . 85.3 Cg_endo -78.49 73.6 5.79 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.219 1.946 . . . . 0.0 110.934 178.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 514' ' ' LEU . . . . . 0.455 ' CD1' ' O ' ' A' ' 45' ' ' MET . 1.3 mp -80.38 -93.76 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -178.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 515' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.33 -83.7 0.03 OUTLIER 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.839 0.352 . . . . 0.0 111.914 -178.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 516' ' ' ASN . . . . . 0.413 ' ND2' ' O ' ' B' ' 518' ' ' PHE . 48.9 t30 -120.91 -37.11 3.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.485 -178.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 517' ' ' SER . . . . . 0.401 ' HA ' ' HB ' ' A' ' 42' ' ' VAL . 0.7 OUTLIER 55.87 26.0 9.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.854 -179.806 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 518' ' ' PHE . . . . . 0.413 ' O ' ' ND2' ' B' ' 516' ' ' ASN . 0.0 OUTLIER -162.98 106.89 1.07 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.054 -179.78 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 519' ' ' ILE . . . . . 0.431 ' CG1' ' O ' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -107.6 -84.97 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.991 179.851 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 13.7 t-160 -175.17 102.55 0.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.889 0.376 . . . . 0.0 110.899 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 521' ' ' THR . . . . . 0.418 ' HB ' ' CB ' ' A' ' 40' ' ' TYR . 0.2 OUTLIER -150.68 178.37 9.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.769 -179.964 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 522' ' ' GLY . . . . . . . . . . . . . . . 58.93 161.47 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.375 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 523' ' ' HIS . . . . . 0.427 ' NE2' ' HB2' ' B' ' 525' ' ' ASP . 16.3 t-160 -137.61 -84.92 0.31 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.704 0.288 . . . . 0.0 111.126 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 524' ' ' GLY . . . . . . . . . . . . . . . 92.37 -97.54 2.29 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.379 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 525' ' ' ASP . . . . . 0.427 ' HB2' ' NE2' ' B' ' 523' ' ' HIS . 2.7 t0 75.32 78.44 0.1 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.926 0.393 . . . . 0.0 111.279 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 526' ' ' SER . . . . . 0.434 ' O ' ' CG1' ' A' ' 33' ' ' VAL . 0.5 OUTLIER -117.4 98.19 6.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.723 179.545 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 527' ' ' ASP . . . . . 0.447 ' CB ' ' HD3' ' B' ' 528' ' ' PRO . 0.1 OUTLIER -44.32 -50.9 21.06 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.301 -179.807 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 528' ' ' PRO . . . . . 0.447 ' HD3' ' CB ' ' B' ' 527' ' ' ASP . 23.6 Cg_exo -68.08 118.65 5.77 Favored 'Trans proline' 0 CA--C 1.518 -0.305 0 C-N-CA 123.058 2.505 . . . . 0.0 112.108 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 529' ' ' ARG . . . . . 0.403 ' HA ' ' HB3' ' B' ' 545' ' ' ASN . 0.0 OUTLIER -100.92 -37.47 8.64 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.879 -179.162 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 530' ' ' HIS . . . . . 0.48 ' O ' ' CG ' ' B' ' 530' ' ' HIS . 0.0 OUTLIER 67.71 9.62 7.21 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.012 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 531' ' ' CYS . . . . . 0.465 ' O ' ' CD2' ' B' ' 530' ' ' HIS . 1.2 m 49.1 -174.45 0.02 OUTLIER 'General case' 0 C--N 1.334 -0.093 0 CA-C-O 120.87 0.367 . . . . 0.0 111.072 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 532' ' ' TRP . . . . . . . . . . . . . 23.0 t90 -65.44 -63.16 1.16 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.864 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . 95.52 -119.11 6.09 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.377 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 534' ' ' PHE . . . . . 0.418 ' O ' ' N ' ' B' ' 536' ' ' ASP . 11.3 m-85 -119.39 151.2 50.99 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.729 0.3 . . . . 0.0 110.892 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.48 83.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.586 2.191 . . . . 0.0 112.262 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 536' ' ' ASP . . . . . 0.418 ' N ' ' O ' ' B' ' 534' ' ' PHE . 1.0 OUTLIER 172.23 80.85 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.7 179.979 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 537' ' ' ARG . . . . . 0.499 ' NH2' " C4'" ' A' ' 185' ' ' GNP . 32.3 mmt-85 -51.78 132.92 31.81 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.116 0.484 . . . . 0.0 111.062 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 538' ' ' ILE . . . . . . . . . . . . . 3.1 tp -50.9 133.53 11.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.446 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 539' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -40.39 117.76 0.84 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.317 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 540' ' ' GLU . . . . . 0.436 ' CG ' ' HA ' ' A' ' 9' ' ' VAL . 2.8 pp20? -47.45 -24.87 0.91 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.116 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 541' ' ' LEU . . . . . 0.437 ' HA ' ' CD2' ' A' ' 70' ' ' LEU . 0.4 OUTLIER -38.53 -42.66 0.78 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.164 0.507 . . . . 0.0 111.012 179.435 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 542' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -105.3 -59.48 1.75 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.427 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 543' ' ' LEU . . . . . 0.463 ' CD2' ' CG2' ' A' ' 35' ' ' THR . 0.1 OUTLIER 59.98 122.88 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.881 -179.911 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 544' ' ' GLY . . . . . 0.402 ' HA2' ' CD1' ' A' ' 61' ' ' LEU . . . 164.3 105.21 0.19 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.538 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 545' ' ' ASN . . . . . 0.412 ' ND2' ' O ' ' A' ' 32' ' ' TYR . 10.0 m120 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.951 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' GNP . . . . . 0.934 " H2'" ' OG1' ' A' ' 115' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.46 ' HE2' ' CD1' ' A' ' 51' ' ' TYR . 6.9 tpt . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.267 0.079 . . . . 0.0 111.082 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.43 ' N ' ' HG3' ' A' ' 1' ' ' MET . 5.7 tt0 42.22 100.08 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.294 0.568 . . . . 0.0 111.804 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.489 ' OG1' ' CE1' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -104.82 -159.48 0.71 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.652 -179.889 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.481 ' CG2' ' CB ' ' A' ' 176' ' ' ALA . 0.3 OUTLIER -156.37 163.18 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -178.653 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 16.2 mttp -134.45 102.36 5.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.876 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 32.3 m -103.07 156.2 17.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.225 0.536 . . . . 0.0 112.083 -178.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.7 t -139.11 159.87 29.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.248 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.433 ' CG1' HG22 ' A' ' 14' ' ' VAL . 65.4 t -106.89 141.5 21.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.239 0.542 . . . . 0.0 111.752 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.408 ' N ' HG11 ' A' ' 8' ' ' VAL . 98.0 t -156.51 129.96 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.855 179.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.55 -171.14 32.99 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 119.976 -1.107 . . . . 0.0 113.051 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -94.81 27.78 2.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.791 0.329 . . . . 0.0 110.852 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.43 ' HA2' ' CB ' ' B' ' 537' ' ' ARG . . . -170.04 -170.06 33.98 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.419 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -60.84 -30.17 69.95 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.953 0.406 . . . . 0.0 110.712 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.446 ' HA ' ' HB3' ' A' ' 81' ' ' CYS . 2.7 t 63.45 -71.21 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.584 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.467 ' O ' ' CE1' ' A' ' 169' ' ' PHE . . . 175.22 59.19 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.169 -1.015 . . . . 0.0 113.232 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.436 ' CD ' HD13 ' B' ' 543' ' ' LEU . 0.0 OUTLIER -97.85 -85.71 0.36 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.861 0.33 . . . . 0.0 110.217 178.75 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.438 ' HB ' ' CG1' ' A' ' 21' ' ' ILE . 45.9 p -99.5 -36.64 9.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.001 0.429 . . . . 0.0 111.116 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.442 ' CB ' ' O1A' ' A' ' 185' ' ' GNP . 30.0 p -40.28 -36.31 0.51 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.314 -179.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.483 HD21 ' CD1' ' A' ' 169' ' ' PHE . 0.0 OUTLIER -71.15 -69.3 0.38 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.926 0.393 . . . . 0.0 110.883 -179.68 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.415 HD22 ' N ' ' A' ' 20' ' ' LEU . 3.6 mt -55.98 -43.47 77.63 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.234 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.438 ' CG1' ' HB ' ' A' ' 17' ' ' THR . 42.4 mm -62.41 -66.9 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.864 0.364 . . . . 0.0 110.587 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.405 ' CB ' ' O ' ' A' ' 18' ' ' CYS . 52.3 p -46.18 -27.41 0.98 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.258 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -73.89 -68.14 0.54 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.954 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.91 -46.27 75.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.716 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.417 ' OG1' ' CG2' ' A' ' 21' ' ' ILE . 19.0 p -85.26 -149.1 0.12 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.308 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -161.18 30.11 0.14 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.746 0.307 . . . . 0.0 111.105 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.8 mttt -115.35 156.31 25.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.271 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.492 ' HA ' ' CE1' ' A' ' 32' ' ' TYR . 4.1 t80 -163.67 -62.15 0.01 OUTLIER Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.726 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.483 ' HD3' ' HB3' ' A' ' 28' ' ' PHE . 63.2 Cg_endo -85.07 -16.37 5.15 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.627 2.218 . . . . 0.0 112.989 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.2 m -50.61 -87.75 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.398 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -158.12 116.86 3.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.525 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.507 ' CD2' ' O1B' ' A' ' 185' ' ' GNP . 6.6 m-85 -111.56 94.14 4.82 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.108 0.48 . . . . 0.0 110.769 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.464 ' HB ' ' HD3' ' A' ' 34' ' ' PRO . 2.1 t -117.25 -52.22 0.04 OUTLIER Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.23 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.472 ' O ' ' CD1' ' A' ' 37' ' ' PHE . 5.1 Cg_exo -80.14 52.99 4.54 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.501 2.134 . . . . 0.0 112.245 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.9 t -98.88 -25.22 14.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.835 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.435 ' HB ' ' CD1' ' A' ' 61' ' ' LEU . 7.4 p -51.0 -27.63 5.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.326 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.472 ' CD1' ' O ' ' A' ' 34' ' ' PRO . 3.4 p90 -54.79 -21.15 10.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.965 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.436 ' HB3' ' CB ' ' A' ' 57' ' ' ASP . 59.2 t0 -44.71 -29.73 0.81 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.413 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -70.29 -30.75 67.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.167 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.515 ' CE1' ' CG2' ' B' ' 521' ' ' THR . 8.6 m-85 -60.68 -174.07 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.86 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -101.57 -179.63 4.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.087 0.47 . . . . 0.0 111.538 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.1 m -141.11 165.15 19.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.553 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.464 ' O ' ' CG1' ' A' ' 44' ' ' VAL . 0.7 OUTLIER -110.2 102.11 10.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.883 0.373 . . . . 0.0 111.649 -179.483 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.507 ' CG2' ' CG2' ' A' ' 52' ' ' THR . 30.1 m -164.81 -177.16 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.728 178.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.489 ' O ' ' HG3' ' A' ' 45' ' ' MET . 0.0 OUTLIER -128.53 101.12 6.03 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.54 0.686 . . . . 0.0 110.95 179.844 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.475 ' O ' ' N ' ' A' ' 48' ' ' GLY . 3.8 mm -55.49 101.6 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.478 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.454 ' O ' ' CE ' ' A' ' 45' ' ' MET . . . 29.48 -83.88 0.0 OUTLIER Glycine 0 C--N 1.337 0.626 0 N-CA-C 114.862 0.705 . . . . 0.0 114.862 178.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . -42.28 -77.32 0.08 OUTLIER Glycine 0 CA--C 1.519 0.311 0 C-N-CA 121.226 -0.511 . . . . 0.0 113.167 -179.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.409 ' HB3' ' HD2' ' A' ' 50' ' ' PRO . 2.0 mt-10 -143.57 164.28 31.52 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-O 120.807 0.337 . . . . 0.0 111.448 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.418 ' HA ' ' HB2' ' A' ' 45' ' ' MET . 4.2 Cg_endo -47.09 101.12 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.942 2.428 . . . . 0.0 112.309 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.489 ' CE1' ' OG1' ' A' ' 3' ' ' THR . 5.0 t80 -172.85 137.04 0.73 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.967 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.507 ' CG2' ' CG2' ' A' ' 44' ' ' VAL . 16.5 p -134.26 138.54 45.11 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.114 0.483 . . . . 0.0 111.369 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.421 ' CB ' ' O ' ' A' ' 4' ' ' ILE . 1.5 pp -74.04 178.07 5.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.752 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -111.89 86.91 0.44 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.071 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -47.62 116.81 1.58 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.854 0.359 . . . . 0.0 110.501 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -83.92 105.3 14.7 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.042 -179.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.436 ' CB ' ' HB3' ' A' ' 38' ' ' ASP . 0.1 OUTLIER -130.16 111.31 12.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.153 179.593 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.448 ' HB ' ' CD1' ' A' ' 67' ' ' LEU . 0.6 OUTLIER -86.28 129.78 34.73 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.748 -179.512 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.429 ' N ' HD11 ' A' ' 67' ' ' LEU . . . -135.99 114.75 12.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.909 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -67.48 63.8 0.27 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.775 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.436 ' CB ' ' HB2' ' B' ' 525' ' ' ASP . 9.7 mt -121.45 -171.72 2.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.834 0.349 . . . . 0.0 110.874 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.433 ' CB ' ' O ' ' B' ' 524' ' ' GLY . 0.1 OUTLIER -44.43 -45.53 9.08 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.51 -179.878 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.477 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . 5.3 m-20 -59.35 -62.99 1.47 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.163 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.477 ' CE1' ' HB3' ' A' ' 63' ' ' ASP . 0.1 OUTLIER -128.42 132.15 48.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.862 -179.68 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -86.68 -68.73 0.72 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.435 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.401 ' O ' ' HB2' ' A' ' 67' ' ' LEU . 11.1 mmt180 -98.41 -34.67 10.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.337 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.556 ' O ' ' CB ' ' A' ' 68' ' ' ARG . 1.2 mp 69.72 -80.07 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.058 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.556 ' CB ' ' O ' ' A' ' 67' ' ' LEU . 25.8 ttp180 113.83 -42.61 0.0 OUTLIER Pre-proline 0 N--CA 1.487 1.39 0 C-N-CA 123.89 0.876 . . . . 0.0 112.904 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 67.7 Cg_exo -41.61 -49.83 5.07 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.499 2.132 . . . . 0.0 113.182 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.524 ' CD2' ' CA ' ' B' ' 541' ' ' LEU . 0.1 OUTLIER -53.38 -26.23 18.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.78 0.324 . . . . 0.0 110.564 -179.924 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.412 ' CB ' ' O ' ' A' ' 68' ' ' ARG . 8.5 t -50.95 -67.68 0.23 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.081 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -147.14 73.57 12.03 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.012 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -56.47 164.78 5.13 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.58 2.187 . . . . 0.0 112.202 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 54.6 tp60 -95.02 -17.53 21.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.296 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.427 ' CG2' HG22 ' A' ' 77' ' ' VAL . 93.5 m -46.62 149.99 0.74 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.773 0.321 . . . . 0.0 111.201 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -90.43 -24.19 20.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.05 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.427 HG22 ' CG2' ' A' ' 75' ' ' THR . 1.2 m -103.83 91.6 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.135 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -80.98 122.09 26.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.17 109.65 12.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.013 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.408 HG21 ' HB2' ' A' ' 110' ' ' PHE . 1.8 m -106.75 121.4 59.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.379 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.446 ' HB3' ' HA ' ' A' ' 14' ' ' VAL . 9.0 p -95.37 161.43 14.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.319 0.581 . . . . 0.0 112.304 -178.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.523 ' CE1' ' CD2' ' A' ' 112' ' ' LEU . 14.3 p90 179.61 123.58 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.897 179.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.35 151.02 20.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.952 0.406 . . . . 0.0 111.341 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.435 ' CG2' ' HB3' ' A' ' 120' ' ' ARG . 1.5 m -52.52 -51.78 31.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.591 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.428 ' CG2' ' OE1' ' A' ' 116' ' ' GLN . 19.6 m -53.28 116.64 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.588 0.232 . . . . 0.0 110.615 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 6.4 m -151.14 129.2 5.89 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.455 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -91.17 51.39 0.81 Allowed 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.989 2.46 . . . . 0.0 111.684 179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.462 ' N ' ' CB ' ' A' ' 133' ' ' LYS . 0.1 OUTLIER 75.1 15.86 2.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.21 -179.626 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.4 ' O ' ' CG2' ' A' ' 93' ' ' VAL . 43.8 t -97.6 -22.4 16.52 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.121 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.487 ' CE2' ' CG2' ' A' ' 137' ' ' ILE . 12.0 t80 -47.07 -59.18 3.3 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.322 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -48.71 -47.18 41.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.967 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -69.89 -32.61 71.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.781 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.4 ' CG2' ' O ' ' A' ' 89' ' ' SER . 93.8 t -57.1 -68.51 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.964 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.437 ' CB ' HD11 ' A' ' 145' ' ' LEU . 6.9 mmtt -52.09 -52.86 48.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.745 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -57.44 -22.58 44.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.791 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -100.39 -12.38 19.46 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.355 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.421 ' O ' ' CG ' ' A' ' 100' ' ' GLU . 3.1 m0 -89.24 -56.27 3.34 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.628 0.252 . . . . 0.0 111.179 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.491 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 12.9 t -45.88 -45.44 37.57 Favored Pre-proline 0 C--N 1.329 -0.293 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.491 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 50.2 Cg_exo -54.14 -37.77 87.41 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.323 2.015 . . . . 0.0 112.523 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.438 ' HG3' ' N ' ' A' ' 101' ' ' ILE . 6.3 pt-20 -82.82 -32.53 27.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.078 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.438 ' N ' ' HG3' ' A' ' 100' ' ' GLU . 19.0 mm -53.86 -35.54 27.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.892 0.377 . . . . 0.0 110.648 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 43.9 p -95.93 -22.45 17.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.055 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 13.5 t-160 -66.02 -29.01 69.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.741 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 3.5 m170 -90.93 -25.22 19.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.799 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 1.1 m -145.33 142.2 17.98 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.886 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.51 90.48 0.22 Allowed 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.535 2.157 . . . . 0.0 112.207 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 58.9 90.83 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.743 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.93 116.07 30.29 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.969 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -60.14 156.32 40.49 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.575 2.184 . . . . 0.0 112.226 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.479 ' CE2' ' HB2' ' A' ' 151' ' ' ALA . 3.4 p90 -145.9 147.83 32.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.943 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.433 ' CD1' ' HB3' ' A' ' 171' ' ' GLU . 3.7 tt -108.45 141.38 40.4 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.011 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.523 ' CD2' ' CE1' ' A' ' 82' ' ' PHE . 25.1 mt -98.71 142.94 29.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.81 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.432 ' CG1' HG11 ' A' ' 168' ' ' VAL . 58.1 t -121.6 142.58 37.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.98 0.419 . . . . 0.0 111.775 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -117.43 121.74 5.21 Favored Glycine 0 N--CA 1.45 -0.375 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.812 ' OG1' " H2'" ' A' ' 185' ' ' GNP . 1.3 p -136.63 -56.23 0.74 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.736 0.303 . . . . 0.0 111.134 -179.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.433 ' HG2' ' CG2' ' A' ' 84' ' ' VAL . 2.6 tt0 -59.36 -16.81 24.95 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.821 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.449 HD13 ' CA ' ' A' ' 115' ' ' THR . 0.4 OUTLIER -55.15 -16.05 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 179.912 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.426 ' N ' HD12 ' A' ' 117' ' ' ILE . 1.3 t0 -82.13 -19.99 38.92 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 120.732 0.301 . . . . 0.0 111.151 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.1 pp -121.35 1.72 10.21 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.908 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.435 ' HB3' ' CG2' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -50.05 -30.9 11.77 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.986 0.422 . . . . 0.0 110.647 179.88 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -59.84 -21.65 61.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.978 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -44.79 99.84 0.22 Allowed Pre-proline 0 N--CA 1.462 0.136 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.869 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.416 ' O ' ' CG ' ' A' ' 127' ' ' GLU . 15.1 Cg_exo -68.94 -4.68 13.92 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.711 2.274 . . . . 0.0 112.968 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.3 t -83.36 -64.7 1.12 Allowed 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.4 ' HA ' ' HD3' ' A' ' 128' ' ' LYS . 32.5 m -55.84 -36.43 67.51 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.436 ' O ' ' N ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -58.69 -39.39 76.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.945 179.24 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.416 ' CG ' ' O ' ' A' ' 123' ' ' PRO . 8.8 mm-40 -63.71 -29.28 70.52 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.776 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.4 ' HD3' ' HA ' ' A' ' 125' ' ' THR . 1.8 mptt -74.16 -58.34 3.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.789 179.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.425 ' HG ' ' HA ' ' A' ' 126' ' ' ILE . 3.6 pp -63.22 -25.89 68.54 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.483 ' HA ' ' CA ' ' A' ' 134' ' ' GLN . . . -52.61 -41.69 63.9 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.564 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 18.0 mmtm -46.22 -24.08 0.42 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.637 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -123.04 -30.23 3.79 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.478 ' CG ' ' N ' ' A' ' 134' ' ' GLN . 0.0 OUTLIER -132.21 -72.45 0.53 Allowed 'General case' 0 CA--C 1.534 0.331 0 O-C-N 122.097 -0.377 . . . . 0.0 111.871 -178.783 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.483 ' CA ' ' HA ' ' A' ' 130' ' ' ALA . 9.5 mt-30 98.63 -46.54 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.841 0.856 . . . . 0.0 110.945 -179.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 4.2 mtpp -73.77 109.1 5.9 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.42 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.06 -170.8 0.44 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.087 1.858 . . . . 0.0 110.764 179.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.487 ' CG2' ' CE2' ' A' ' 90' ' ' PHE . 1.2 mm -112.08 95.89 4.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.163 0.506 . . . . 0.0 111.057 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.412 ' O ' ' N ' ' A' ' 141' ' ' THR . 0.1 OUTLIER -71.57 150.03 93.52 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.76 -179.981 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -44.01 -28.85 2.37 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.698 2.265 . . . . 0.0 112.383 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -71.26 -31.26 67.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.85 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.412 ' N ' ' O ' ' A' ' 138' ' ' THR . 55.4 m -72.64 -50.58 24.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.905 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.456 ' HB1' ' CG ' ' A' ' 154' ' ' TYR . . . -50.28 -61.19 2.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.853 0.359 . . . . 0.0 110.792 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.45 -40.12 68.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.751 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -50.78 -61.24 2.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.705 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.437 HD11 ' CB ' ' A' ' 94' ' ' LYS . 3.6 tt -67.22 -34.0 76.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.568 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.411 ' CB ' HD11 ' A' ' 112' ' ' LEU . . . -57.2 -45.01 84.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.852 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 5.1 mtm180 -79.49 -25.6 41.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.843 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -58.24 -46.09 86.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.797 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.8 mt -102.05 24.18 10.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.804 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 39.07 55.14 2.13 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.758 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.479 ' HB2' ' CE2' ' A' ' 110' ' ' PHE . . . -67.04 -81.62 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.056 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.429 HG11 ' CD1' ' A' ' 111' ' ' LEU . 50.9 t -160.54 -74.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.81 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.16 114.9 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.11 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.456 ' CG ' ' HB1' ' A' ' 142' ' ' ALA . 45.7 t80 -90.55 109.9 21.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.048 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 3.6 t -101.67 161.43 3.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.393 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -89.7 140.33 29.68 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.098 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.408 ' SG ' ' CG1' ' A' ' 168' ' ' VAL . 1.8 p 178.71 -175.14 0.19 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.314 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' A' ' 115' ' ' THR . 4.5 t -160.28 163.75 33.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.109 0.48 . . . . 0.0 111.677 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.441 ' CB ' HD11 ' A' ' 165' ' ' LEU . . . -114.82 -42.15 3.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.09 179.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.43 -29.08 61.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.189 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -111.87 -26.4 8.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.659 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 73.52 70.57 0.12 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.232 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 12.3 mtmt -95.2 23.56 5.68 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.109 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 101.71 42.78 2.24 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.914 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.478 ' CD2' ' CD2' ' A' ' 19' ' ' LEU . 0.3 OUTLIER -52.29 -25.0 8.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.691 0.282 . . . . 0.0 111.042 179.911 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -69.04 -23.31 64.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.691 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.16 -70.33 0.24 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.707 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.445 ' CG1' ' N ' ' A' ' 169' ' ' PHE . 7.5 p -52.64 -46.78 50.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.114 0.483 . . . . 0.0 110.431 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.483 ' CD1' HD21 ' A' ' 19' ' ' LEU . 2.6 t80 -57.25 -32.55 66.68 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.111 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -71.22 -25.85 62.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.047 178.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.433 ' HB3' ' CD1' ' A' ' 111' ' ' LEU . 0.8 OUTLIER -74.16 -28.12 61.16 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.126 179.308 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.432 ' N ' HD11 ' A' ' 111' ' ' LEU . . . -75.44 -40.74 57.21 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.709 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.417 ' CD1' HD11 ' A' ' 177' ' ' LEU . 1.6 pp -80.89 -33.71 13.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.916 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.455 ' CD2' ' HB3' ' B' ' 505' ' ' LEU . 1.0 OUTLIER -55.42 -58.59 7.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.417 179.647 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.436 ' CB ' ' HG3' ' A' ' 180' ' ' PRO . . . -49.5 -25.85 2.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.791 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.481 ' CB ' ' CG2' ' A' ' 4' ' ' ILE . . . -87.8 -41.19 13.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.118 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.456 ' CD2' HG21 ' A' ' 4' ' ' ILE . 41.8 mt -68.82 -23.68 64.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.892 0.377 . . . . 0.0 110.614 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.43 ' CG ' ' HD2' ' A' ' 179' ' ' PRO . 24.8 tt0 -168.19 142.78 2.85 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.841 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . 0.43 ' HD2' ' CG ' ' A' ' 178' ' ' GLU . 93.3 Cg_exo -44.07 115.44 0.73 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.587 2.191 . . . . 0.0 112.405 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . 0.436 ' HG3' ' CB ' ' A' ' 175' ' ' ALA . 67.6 Cg_endo -73.08 -171.76 0.86 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.452 2.101 . . . . 0.0 112.358 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -148.83 151.59 35.45 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.787 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -59.45 -152.72 0.01 OUTLIER 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.706 2.271 . . . . 0.0 112.469 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.4 148.77 46.62 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.961 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.268 -0.872 . . . . 0.0 110.843 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.165 0 N-CA-C 112.514 -0.234 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 503' ' ' SER . . . . . . . . . . . . . 98.7 p -62.82 -170.9 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.843 0.354 . . . . 0.0 110.894 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 504' ' ' GLY . . . . . 0.405 ' N ' ' OD1' ' B' ' 509' ' ' ASP . . . -157.31 -106.63 0.24 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.396 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 505' ' ' LEU . . . . . 0.455 ' HB3' ' CD2' ' A' ' 174' ' ' LEU . 1.1 pt? 44.15 -171.77 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.114 0.483 . . . . 0.0 111.867 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 506' ' ' SER . . . . . . . . . . . . . 4.9 m -117.66 -15.69 10.14 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.106 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 507' ' ' ALA . . . . . 0.418 ' CB ' ' HB2' ' A' ' 178' ' ' GLU . . . -67.89 59.62 0.07 Allowed 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.087 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 508' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 69.86 3.17 4.18 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.608 -178.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 509' ' ' ASP . . . . . 0.406 ' HA ' ' HG ' ' B' ' 505' ' ' LEU . 15.7 t0 46.7 53.47 10.08 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.378 0.609 . . . . 0.0 111.094 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 510' ' ' ILE . . . . . 0.443 ' CG1' HG22 ' A' ' 46' ' ' ILE . 0.9 OUTLIER -50.6 107.78 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.352 179.561 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 511' ' ' SER . . . . . . . . . . . . . 48.2 m -61.87 86.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.91 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 512' ' ' GLN . . . . . 0.472 ' CB ' ' CD ' ' B' ' 513' ' ' PRO . 23.6 tp60 -50.89 -67.69 0.45 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.464 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 513' ' ' PRO . . . . . 0.472 ' CD ' ' CB ' ' B' ' 512' ' ' GLN . 98.3 Cg_endo -77.06 66.09 7.76 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.506 2.137 . . . . 0.0 112.13 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 514' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -73.69 138.78 44.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.847 0.356 . . . . 0.0 111.082 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 515' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.49 143.52 15.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.927 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 72.02 23.51 3.46 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.988 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 517' ' ' SER . . . . . 0.467 ' O ' ' CD1' ' B' ' 518' ' ' PHE . 3.1 m -82.75 53.79 2.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.185 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 518' ' ' PHE . . . . . 0.467 ' CD1' ' O ' ' B' ' 517' ' ' SER . 10.4 m-85 -163.63 94.98 0.8 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.603 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 519' ' ' ILE . . . . . 0.408 ' O ' ' HB2' ' B' ' 520' ' ' HIS . 13.2 mt -55.87 -100.16 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.316 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 520' ' ' HIS . . . . . 0.408 ' HB2' ' O ' ' B' ' 519' ' ' ILE . 15.7 t-160 179.22 40.14 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.763 0.316 . . . . 0.0 110.943 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 521' ' ' THR . . . . . 0.515 ' CG2' ' CE1' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -112.87 -177.1 3.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.262 -179.792 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 522' ' ' GLY . . . . . . . . . . . . . . . 71.58 97.33 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.265 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 523' ' ' HIS . . . . . 0.413 ' CD2' ' N ' ' B' ' 524' ' ' GLY . 15.8 p-80 -144.82 -45.77 0.23 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.821 0.343 . . . . 0.0 111.334 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 524' ' ' GLY . . . . . 0.433 ' O ' ' CB ' ' A' ' 62' ' ' GLU . . . -67.81 68.63 0.3 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.256 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 525' ' ' ASP . . . . . 0.436 ' HB2' ' CB ' ' A' ' 61' ' ' LEU . 0.2 OUTLIER 176.3 37.47 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.822 0.344 . . . . 0.0 110.549 -179.732 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 526' ' ' SER . . . . . 0.43 ' HA ' ' CG1' ' A' ' 33' ' ' VAL . 3.1 t -113.55 96.17 5.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.901 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 527' ' ' ASP . . . . . 0.52 ' CB ' ' CD ' ' B' ' 528' ' ' PRO . 0.4 OUTLIER -134.05 -70.67 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.831 179.518 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 528' ' ' PRO . . . . . 0.52 ' CD ' ' CB ' ' B' ' 527' ' ' ASP . 13.4 Cg_endo -53.97 90.07 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.671 2.247 . . . . 0.0 112.396 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 529' ' ' ARG . . . . . 0.415 ' CG ' HG21 ' A' ' 33' ' ' VAL . 0.5 OUTLIER -96.19 5.11 51.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.003 179.491 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 530' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -49.33 -53.8 20.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.751 0.31 . . . . 0.0 111.537 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER 71.23 -154.52 0.1 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.531 -179.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 532' ' ' TRP . . . . . 0.459 ' CD1' ' NH2' ' B' ' 537' ' ' ARG . 0.0 OUTLIER -41.9 142.06 0.75 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.962 0.411 . . . . 0.0 111.55 -179.86 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . -163.56 -40.45 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.308 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 534' ' ' PHE . . . . . 0.476 ' CZ ' HG22 ' B' ' 538' ' ' ILE . 4.5 p90 -133.17 161.16 65.45 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 120.679 0.276 . . . . 0.0 110.553 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 535' ' ' PRO . . . . . 0.405 ' HD2' ' HB2' ' B' ' 534' ' ' PHE . 91.0 Cg_exo -42.93 103.37 0.04 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.58 2.187 . . . . 0.0 112.49 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 1.8 t0 70.53 159.36 0.2 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.987 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 537' ' ' ARG . . . . . 0.459 ' NH2' ' CD1' ' B' ' 532' ' ' TRP . 0.0 OUTLIER -62.96 -165.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.301 0.572 . . . . 0.0 110.908 179.864 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 538' ' ' ILE . . . . . 0.476 HG22 ' CZ ' ' B' ' 534' ' ' PHE . 0.0 OUTLIER -105.5 -160.74 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.269 -0.878 . . . . 0.0 108.981 178.524 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 539' ' ' ASP . . . . . 0.475 ' N ' HG12 ' B' ' 538' ' ' ILE . 38.5 p-10 -79.83 153.13 29.32 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.329 -0.548 . . . . 0.0 111.014 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 540' ' ' GLU . . . . . 0.423 ' CG ' ' HB ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -52.57 -22.27 4.77 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.754 -179.389 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 541' ' ' LEU . . . . . 0.524 ' CA ' ' CD2' ' A' ' 70' ' ' LEU . 5.4 tp -54.84 -22.31 14.13 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.175 0.512 . . . . 0.0 110.853 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 542' ' ' TYR . . . . . 0.472 ' HB2' ' CG1' ' B' ' 538' ' ' ILE . 3.1 m-85 -104.91 -63.86 1.18 Allowed 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.708 -178.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 543' ' ' LEU . . . . . 0.436 HD13 ' CD ' ' A' ' 16' ' ' LYS . 0.1 OUTLIER 62.85 46.23 5.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.879 -179.566 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . 175.67 -70.2 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.465 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 545' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.274 -0.87 . . . . 0.0 110.887 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' GNP . . . . . 0.812 " H2'" ' OG1' ' A' ' 115' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' HOH . . . . . 0.448 ' O ' ' CD2' ' A' ' 32' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.421 ' HG2' ' CG ' ' A' ' 49' ' ' GLU . 2.4 ppp? . . . . . 0 N--CA 1.488 1.448 0 CA-C-O 120.842 0.353 . . . . 0.0 111.128 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 62.1 tp60 -161.14 125.21 3.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.313 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.443 ' CG2' ' HB2' ' A' ' 53' ' ' LEU . 13.1 t -123.65 -173.79 2.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.227 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.444 HG22 ' CB ' ' A' ' 176' ' ' ALA . 0.1 OUTLIER -153.39 156.11 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -178.983 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 16.3 pttm -124.9 95.52 4.54 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.044 179.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 8.3 m -95.61 156.5 16.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.99 0.424 . . . . 0.0 111.458 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.429 ' CG1' ' HB3' ' A' ' 56' ' ' PHE . 0.2 OUTLIER -120.12 159.65 21.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.471 179.704 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.434 ' CG2' ' N ' ' A' ' 15' ' ' GLY . 6.1 p -110.36 114.37 46.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.248 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.522 ' CG2' ' CE2' ' A' ' 78' ' ' PHE . 81.7 t -134.6 129.75 52.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.099 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 149.53 -150.01 22.05 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.186 -1.007 . . . . 0.0 112.917 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -118.81 -13.56 9.53 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.624 0.231 . . . . 0.0 111.624 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.434 ' O ' ' NH1' ' B' ' 537' ' ' ARG . . . -50.51 -101.22 0.01 OUTLIER Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.363 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.456 ' CB ' ' H8 ' ' A' ' 185' ' ' GNP . . . -102.5 -19.08 15.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.79 0.329 . . . . 0.0 111.032 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.44 ' CG2' ' HB3' ' B' ' 537' ' ' ARG . 37.9 t 64.52 23.34 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.647 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.434 ' N ' ' CG2' ' A' ' 8' ' ' VAL . . . -153.9 134.53 4.38 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.632 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.487 ' HE2' ' CZ ' ' A' ' 169' ' ' PHE . 0.4 OUTLIER -86.54 7.55 25.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.75 0.309 . . . . 0.0 110.718 179.365 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.3 p -97.24 -45.03 6.67 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 120.938 0.399 . . . . 0.0 110.992 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.469 ' HB3' ' PB ' ' A' ' 185' ' ' GNP . 28.6 p -39.26 -45.96 1.46 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.307 -179.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.52 ' CD2' ' CD1' ' A' ' 169' ' ' PHE . 1.4 mp -51.12 -50.0 59.67 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.923 0.392 . . . . 0.0 110.737 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.419 ' N ' HD21 ' A' ' 20' ' ' LEU . 3.0 mm? -73.02 -19.42 61.2 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.028 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.432 ' O ' ' N ' ' A' ' 25' ' ' THR . 17.4 mm -66.7 -71.04 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 CA-C-O 120.719 0.295 . . . . 0.0 110.7 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.3 t -61.22 -27.0 68.12 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.81 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -58.9 -62.94 1.5 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.916 0.388 . . . . 0.0 110.354 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 54.7 m -82.66 -46.53 13.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.403 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.432 ' N ' ' O ' ' A' ' 21' ' ' ILE . 14.2 p -101.23 -158.07 0.65 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.416 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -153.3 27.86 0.51 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.81 0.338 . . . . 0.0 111.114 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -96.17 73.15 2.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.046 0.45 . . . . 0.0 110.502 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.496 ' CD1' ' O2A' ' A' ' 185' ' ' GNP . 0.3 OUTLIER -86.85 -53.1 0.41 Allowed Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.745 -179.745 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.432 ' HD3' ' HB3' ' A' ' 28' ' ' PHE . 84.0 Cg_endo -85.34 78.79 2.4 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.717 2.278 . . . . 0.0 112.757 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.417 ' O ' ' CB ' ' B' ' 531' ' ' CYS . 2.8 m -141.84 -96.18 0.13 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.815 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -159.39 133.56 7.61 Favored 'General case' 0 C--N 1.334 -0.083 0 CA-C-O 120.793 0.33 . . . . 0.0 110.977 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.527 ' CE1' ' N3B' ' A' ' 185' ' ' GNP . 3.0 m-30 -97.31 94.45 7.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.403 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.431 ' CG1' ' HG3' ' B' ' 529' ' ' ARG . 0.0 OUTLIER -134.2 -59.04 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.995 -179.521 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.429 ' HD3' ' CB ' ' A' ' 33' ' ' VAL . 77.7 Cg_exo -52.45 -21.53 14.17 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.107 1.871 . . . . 0.0 112.21 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 52.8 m -71.74 62.3 0.41 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.621 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.478 ' CG2' ' CB ' ' A' ' 59' ' ' ALA . 4.1 p -132.25 -39.86 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.559 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.475 ' CD2' ' HA ' ' A' ' 40' ' ' TYR . 5.6 t80 -41.13 -30.52 0.15 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.585 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.427 ' CB ' ' OH ' ' A' ' 64' ' ' TYR . 11.6 t0 66.55 -68.41 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.923 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.474 ' O ' ' CE2' ' A' ' 37' ' ' PHE . 0.7 OUTLIER -77.89 55.18 1.37 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.365 -179.928 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.475 ' HA ' ' CD2' ' A' ' 37' ' ' PHE . 6.7 m-85 -60.5 139.88 57.54 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.804 0.335 . . . . 0.0 110.464 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.437 ' O ' ' CG1' ' B' ' 519' ' ' ILE . . . -90.59 119.4 30.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.207 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.4 m -137.09 123.23 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.726 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.434 ' CG2' ' HB3' ' B' ' 516' ' ' ASN . 8.8 t -84.29 104.16 14.09 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.459 ' CG1' ' HB2' ' B' ' 514' ' ' LEU . 25.5 t -145.03 148.27 18.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.184 -178.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.464 ' HE1' ' N ' ' A' ' 49' ' ' GLU . 3.2 tpt -96.18 96.47 8.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.973 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.441 HG22 ' CG2' ' B' ' 510' ' ' ILE . 1.2 mm -83.25 85.76 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 120.718 0.294 . . . . 0.0 110.578 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.417 ' N ' ' HE3' ' A' ' 45' ' ' MET . . . 30.8 94.22 0.01 OUTLIER Glycine 0 CA--C 1.524 0.644 0 CA-C-N 115.694 -0.685 . . . . 0.0 114.035 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 135.27 -97.44 0.28 Allowed Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.83 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.464 ' N ' ' HE1' ' A' ' 45' ' ' MET . 0.2 OUTLIER -119.8 129.76 25.19 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.503 0.192 . . . . 0.0 110.551 179.701 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -37.14 96.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.914 2.41 . . . . 0.0 112.919 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.435 ' CD1' ' C ' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -172.86 142.91 1.16 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.753 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.45 ' CG2' ' HB ' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -135.0 153.82 51.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.267 -178.982 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.443 ' HB2' ' CG2' ' A' ' 3' ' ' THR . 5.8 tp -95.67 136.17 36.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.768 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -64.99 142.07 44.41 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.453 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -76.33 134.98 39.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.842 0.353 . . . . 0.0 110.505 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.429 ' HB3' ' CG1' ' A' ' 7' ' ' VAL . 0.9 OUTLIER -84.59 108.74 17.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.912 0.387 . . . . 0.0 110.886 -179.875 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -140.41 142.07 35.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.138 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.454 ' HB ' ' CD1' ' A' ' 67' ' ' LEU . 43.4 p -101.28 -176.66 3.22 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.105 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.478 ' CB ' ' CG2' ' A' ' 36' ' ' VAL . . . -172.44 -162.58 0.2 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.886 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -148.78 43.11 0.81 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.295 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.439 ' CD2' ' HB3' ' B' ' 525' ' ' ASP . 0.4 OUTLIER -121.26 -160.03 0.83 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.922 0.391 . . . . 0.0 111.364 -179.732 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -48.71 -44.84 38.49 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.387 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.479 ' HB3' ' CD1' ' A' ' 64' ' ' TYR . 0.5 OUTLIER -45.97 -61.14 1.87 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.431 -179.651 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.479 ' CD1' ' HB3' ' A' ' 63' ' ' ASP . 0.1 OUTLIER -164.31 139.44 5.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.908 0.385 . . . . 0.0 111.021 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -86.73 -68.16 0.76 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.531 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.55 -32.17 19.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.634 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.454 ' CD1' ' HB ' ' A' ' 58' ' ' THR . 1.3 mp 71.16 -149.05 0.08 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.535 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.475 ' CB ' ' CD ' ' A' ' 69' ' ' PRO . 1.0 OUTLIER -159.05 -65.36 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.177 0 N-CA-C 111.717 0.265 . . . . 0.0 111.717 -179.831 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.475 ' CD ' ' CB ' ' A' ' 68' ' ' ARG . 46.1 Cg_exo -35.52 -60.26 0.33 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.039 2.493 . . . . 0.0 113.377 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.437 ' CD2' ' HA ' ' B' ' 541' ' ' LEU . 0.3 OUTLIER -46.62 -26.66 0.95 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.658 0.266 . . . . 0.0 111.473 -179.73 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.6 t -95.39 -6.81 40.1 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.401 ' O ' ' O ' ' A' ' 69' ' ' PRO . 23.7 m-85 -134.39 151.67 76.64 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-O 120.867 0.365 . . . . 0.0 111.474 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -80.1 51.37 3.88 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.749 2.299 . . . . 0.0 112.434 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.425 ' NE2' ' HB ' ' A' ' 75' ' ' THR . 4.1 pp0? -73.65 -30.44 62.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.0 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.425 ' HB ' ' NE2' ' A' ' 74' ' ' GLN . 12.1 t -70.61 -176.65 1.32 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.968 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -113.42 -21.77 10.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.904 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.8 t -150.74 112.87 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.041 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.522 ' CE2' ' CG2' ' A' ' 9' ' ' VAL . 0.1 OUTLIER -80.74 176.87 9.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.707 179.912 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.63 108.71 5.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.218 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.479 HG12 ' CH2' ' A' ' 97' ' ' TRP . 20.0 m -93.57 96.06 5.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.833 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.444 ' HB3' ' N7 ' ' A' ' 185' ' ' GNP . 3.9 m -82.13 177.48 8.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.077 0.465 . . . . 0.0 111.458 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.459 ' CE1' ' O ' ' A' ' 113' ' ' VAL . 19.1 p90 -179.49 -173.47 0.26 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.011 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.82 134.66 18.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.783 0.325 . . . . 0.0 110.651 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.406 ' CG1' ' O ' ' A' ' 137' ' ' ILE . 2.2 m -45.36 -56.76 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.567 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 33.7 m -54.27 113.24 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.404 ' N ' HD21 ' A' ' 129' ' ' LEU . 4.1 m -151.24 125.49 4.49 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.684 0.278 . . . . 0.0 111.721 -179.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.433 ' O ' ' CB ' ' A' ' 88' ' ' SER . 87.5 Cg_endo -92.51 54.23 0.58 Allowed 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 123.177 2.585 . . . . 0.0 111.56 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 87' ' ' PRO . 0.1 OUTLIER 81.97 24.08 0.23 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.889 -179.413 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 6.1 t -97.21 -26.91 14.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.747 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.474 ' CE2' HG23 ' A' ' 137' ' ' ILE . 13.4 t80 -55.23 -41.34 71.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.89 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 19.2 mp0 -70.22 -38.84 75.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.028 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -67.6 -45.22 76.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.158 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.437 ' O ' ' N ' ' A' ' 97' ' ' TRP . 7.4 p -65.6 -48.98 80.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.488 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.432 ' N ' HG11 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -51.15 -63.18 1.21 Allowed 'General case' 0 C--O 1.235 0.31 0 CA-C-O 120.944 0.402 . . . . 0.0 110.766 179.851 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.425 ' O ' ' CD ' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -52.47 -39.73 61.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.583 179.864 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.404 ' O ' ' CG ' ' A' ' 96' ' ' LYS . 0.2 OUTLIER -88.6 9.17 24.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.274 179.753 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.479 ' CH2' HG12 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -93.06 -58.33 2.36 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.946 0.403 . . . . 0.0 110.877 -179.908 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.491 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 40.8 t -56.27 -44.07 99.56 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.383 -179.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.491 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 6.0 Cg_exo -74.3 -19.74 19.37 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.556 2.171 . . . . 0.0 112.921 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -90.46 -59.13 2.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.932 0.396 . . . . 0.0 111.174 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.446 ' CD1' ' HB3' ' A' ' 110' ' ' PHE . 11.5 tt -52.17 -26.22 8.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.709 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 73.7 p -94.54 -62.09 1.39 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.177 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.423 ' CB ' ' O ' ' A' ' 99' ' ' PRO . 7.9 t60 -48.33 -43.32 33.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.222 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 34.1 m-70 -85.1 -23.59 28.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.129 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 5.3 m -146.47 75.81 12.23 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.033 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -62.19 142.37 91.54 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.638 2.226 . . . . 0.0 112.259 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.8 mmtt 63.14 56.06 1.82 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.074 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -138.28 108.06 8.03 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.651 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.424 ' O ' ' N ' ' A' ' 78' ' ' PHE . 31.2 Cg_exo -60.26 164.07 13.44 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.488 2.125 . . . . 0.0 112.354 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.496 ' CD2' ' HB2' ' A' ' 151' ' ' ALA . 0.7 OUTLIER -154.42 139.59 17.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.024 179.955 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.419 HD13 ' CG1' ' A' ' 152' ' ' VAL . 5.8 tt -121.58 146.31 47.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.942 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -94.61 153.47 17.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.651 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.459 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 93.3 t -136.69 146.24 28.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.095 0.474 . . . . 0.0 111.614 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -126.01 104.01 0.72 Allowed Glycine 0 N--CA 1.452 -0.243 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.553 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.958 ' OG1' " H2'" ' A' ' 185' ' ' GNP . 0.2 OUTLIER -120.65 -50.94 2.18 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.978 0.418 . . . . 0.0 110.701 -179.037 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.445 ' CB ' HN22 ' A' ' 185' ' ' GNP . 4.8 tt0 -67.3 -8.86 35.41 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.445 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.512 HD11 ' CA ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -44.6 -26.84 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-O 120.681 0.277 . . . . 0.0 111.332 -179.865 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -64.17 -25.22 67.99 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.779 0.323 . . . . 0.0 111.048 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' A' ' 122' ' ' ASP . 4.9 mp -95.64 -19.86 19.4 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.418 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.426 ' CG ' ' O ' ' A' ' 117' ' ' ILE . 5.7 ppt_? -49.43 -26.46 3.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.946 0.403 . . . . 0.0 110.684 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.37 -27.13 29.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.519 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.417 ' N ' ' O ' ' A' ' 119' ' ' LEU . 38.0 t0 -55.1 108.02 1.04 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.599 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -68.75 -3.9 12.18 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.715 2.277 . . . . 0.0 113.034 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.78 -67.76 0.75 Allowed 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 7.2 m -56.35 -35.39 67.59 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.457 178.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.444 ' HA ' ' CD1' ' A' ' 129' ' ' LEU . 0.1 OUTLIER -56.37 -42.02 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.772 179.348 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -60.74 -35.33 76.1 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.778 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.52 -31.66 72.97 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.444 ' CD1' ' HA ' ' A' ' 126' ' ' ILE . 8.0 mt -73.1 -35.74 66.64 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -46.2 -34.56 4.43 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.007 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -48.11 -32.95 7.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.531 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.412 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 6.2 m-80 -123.24 -31.24 3.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.416 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.521 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 17.3 mmtt -147.19 -97.96 0.09 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 119.115 -0.469 . . . . 0.0 111.399 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.521 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 7.2 pt20 130.52 -25.1 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.412 1.085 . . . . 0.0 110.297 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 60.5 mmtt -69.28 110.64 6.61 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.766 -179.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -80.17 150.96 20.5 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.565 2.177 . . . . 0.0 111.431 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.491 ' CD1' ' N ' ' A' ' 137' ' ' ILE . 1.1 mm -81.93 96.29 3.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.106 0.479 . . . . 0.0 110.83 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.3 p -72.02 151.06 92.71 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.031 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.491 ' HA ' ' CE2' ' A' ' 154' ' ' TYR . 79.7 Cg_exo -44.09 -37.83 10.02 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.496 2.13 . . . . 0.0 112.244 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -68.6 -33.71 74.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.773 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 24.6 m -63.56 -60.58 3.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.717 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -53.15 -38.14 62.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.893 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -59.77 -46.84 87.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.812 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 22.7 tttp -61.36 -47.8 84.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.836 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.403 HD12 ' CG ' ' A' ' 94' ' ' LYS . 32.8 tp -67.23 -36.09 80.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.73 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -60.45 -54.33 46.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.057 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 11.2 mtp85 -73.05 -26.89 61.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.776 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.66 -46.47 63.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.014 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.443 ' CD1' ' CG2' ' A' ' 98' ' ' VAL . 1.0 OUTLIER -93.36 19.61 8.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.049 -179.956 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 78.3 tttt 48.19 43.94 19.09 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.789 0.328 . . . . 0.0 110.984 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.496 ' HB2' ' CD2' ' A' ' 110' ' ' PHE . . . -72.36 -81.72 0.05 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.311 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.433 ' CG2' ' O ' ' A' ' 151' ' ' ALA . 69.4 t -160.18 -74.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.773 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt 175.84 139.65 0.06 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.776 -179.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.491 ' CE2' ' HA ' ' A' ' 139' ' ' PRO . 18.0 t80 -99.96 112.28 24.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.693 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.419 ' CG2' ' HA ' ' A' ' 168' ' ' VAL . 3.0 t -101.24 166.03 2.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.201 -179.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -89.51 150.23 22.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.12 0.486 . . . . 0.0 111.402 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.437 ' O ' HD11 ' A' ' 117' ' ' ILE . 1.6 p 178.52 -179.24 0.31 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.089 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -160.14 152.49 20.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.875 0.369 . . . . 0.0 111.179 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -109.99 -28.66 8.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.923 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.2 mp -83.78 -45.22 13.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.651 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -98.8 -24.31 15.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.587 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 75.34 76.9 0.1 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.108 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 2.8 tttm -94.82 34.21 1.38 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.698 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . 116.34 -62.32 0.38 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.589 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.417 ' CD1' ' O ' ' A' ' 19' ' ' LEU . 1.9 mt 67.55 -63.03 0.31 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.745 0.307 . . . . 0.0 111.05 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.418 ' O ' ' N ' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -55.49 -27.97 51.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.075 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -52.12 -72.63 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.858 0.361 . . . . 0.0 110.687 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.444 HG11 ' CG1' ' A' ' 113' ' ' VAL . 7.4 p -52.69 -46.22 49.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.173 0.511 . . . . 0.0 110.29 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.52 ' CD1' ' CD2' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -56.97 -29.32 63.13 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.744 179.225 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.453 ' O ' ' CD1' ' A' ' 173' ' ' ILE . 22.5 t0 -69.08 -29.47 67.58 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.494 178.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.414 ' CG ' HG21 ' A' ' 155' ' ' VAL . 28.8 mm-40 -75.91 -24.28 55.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.972 178.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.01 -54.91 9.55 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.381 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.453 ' CD1' ' O ' ' A' ' 170' ' ' ASP . 0.2 OUTLIER -67.64 -31.97 54.82 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-O 120.896 0.379 . . . . 0.0 110.666 -179.793 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.433 HD21 ' CD1' ' B' ' 505' ' ' LEU . 2.5 tm? -48.6 -33.65 10.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.742 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -74.53 -25.15 59.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.053 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.444 ' CB ' HG22 ' A' ' 4' ' ' ILE . . . -97.29 -32.41 11.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.646 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.453 ' CD1' ' HB ' ' B' ' 510' ' ' ILE . 14.4 mt -68.66 -11.23 59.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.223 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.426 ' HB2' ' CB ' ' B' ' 507' ' ' ALA . 0.0 OUTLIER 173.01 148.79 0.21 Allowed Pre-proline 0 C--N 1.332 -0.193 0 CA-C-O 120.768 0.318 . . . . 0.0 110.94 179.761 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -47.26 105.52 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.618 2.212 . . . . 0.0 112.305 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.97 171.85 14.97 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.581 2.188 . . . . 0.0 112.346 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -142.11 130.73 11.93 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.805 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.74 -164.95 0.23 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.546 2.164 . . . . 0.0 112.248 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.77 78.86 4.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.902 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.187 -0.911 . . . . 0.0 110.918 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 502' ' ' GLY . . . . . 0.423 ' CA ' ' OG ' ' B' ' 511' ' ' SER . . . . . . . . 0 N--CA 1.489 2.199 0 N-CA-C 112.539 -0.224 . . . . 0.0 112.539 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 503' ' ' SER . . . . . . . . . . . . . 26.7 t -58.83 -73.29 0.08 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.795 0.331 . . . . 0.0 110.855 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 504' ' ' GLY . . . . . 0.436 ' HA2' ' CB ' ' B' ' 509' ' ' ASP . . . 94.05 103.61 1.74 Allowed Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.393 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 505' ' ' LEU . . . . . 0.473 ' CD1' ' N ' ' B' ' 505' ' ' LEU . 0.1 OUTLIER -174.26 57.36 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.809 0.338 . . . . 0.0 110.741 -179.62 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 506' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 46.83 58.07 5.05 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.936 0.398 . . . . 0.0 110.66 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 507' ' ' ALA . . . . . 0.426 ' CB ' ' HB2' ' A' ' 178' ' ' GLU . . . -169.56 42.06 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.894 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 508' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 73.65 4.53 4.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.786 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 509' ' ' ASP . . . . . 0.436 ' CB ' ' HA2' ' B' ' 504' ' ' GLY . 3.0 p30 51.9 48.69 22.28 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 121.496 0.665 . . . . 0.0 110.673 -179.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 510' ' ' ILE . . . . . 0.453 ' HB ' ' CD1' ' A' ' 177' ' ' LEU . 37.5 mt -72.68 130.03 35.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.054 -0.975 . . . . 0.0 111.087 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 511' ' ' SER . . . . . 0.424 ' O ' ' CD1' ' B' ' 514' ' ' LEU . 16.5 m -77.2 135.79 38.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.3 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 512' ' ' GLN . . . . . 0.423 ' HB3' ' HD3' ' B' ' 513' ' ' PRO . 0.0 OUTLIER -97.91 -53.8 0.2 Allowed Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.092 179.744 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 513' ' ' PRO . . . . . 0.423 ' HD3' ' HB3' ' B' ' 512' ' ' GLN . 97.2 Cg_endo -90.56 59.39 1.46 Allowed 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.835 2.357 . . . . 0.0 112.231 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 514' ' ' LEU . . . . . 0.459 ' HB2' ' CG1' ' A' ' 44' ' ' VAL . 1.2 mp -75.21 -174.61 2.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.946 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 515' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -72.27 158.28 36.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.932 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 516' ' ' ASN . . . . . 0.434 ' HB3' ' CG2' ' A' ' 43' ' ' THR . 9.7 m120 59.89 24.04 13.09 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.885 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 517' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -41.08 -29.48 0.12 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.854 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 518' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -150.92 135.49 17.14 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.839 0.352 . . . . 0.0 111.409 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 519' ' ' ILE . . . . . 0.437 ' CG1' ' O ' ' A' ' 41' ' ' ALA . 2.7 pt -121.21 -37.02 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.845 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -120.04 -166.84 1.35 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.672 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 521' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -151.47 54.55 0.85 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.063 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 522' ' ' GLY . . . . . 0.451 ' CA ' ' CB ' ' A' ' 37' ' ' PHE . . . 45.52 -148.0 1.89 Allowed Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.529 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 523' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -173.1 -101.36 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.641 0.221 . . . . 0.0 111.037 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 524' ' ' GLY . . . . . . . . . . . . . . . 69.13 -63.0 0.54 Allowed Glycine 0 C--N 1.337 0.619 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.4 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 525' ' ' ASP . . . . . 0.439 ' HB3' ' CD2' ' A' ' 61' ' ' LEU . 24.2 t70 177.29 82.59 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.874 0.369 . . . . 0.0 110.719 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 526' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.51 95.99 5.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.801 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 527' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -146.1 158.57 48.09 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.915 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -68.62 97.56 0.54 Allowed 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.626 2.217 . . . . 0.0 112.328 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 529' ' ' ARG . . . . . 0.431 ' HG3' ' CG1' ' A' ' 33' ' ' VAL . 0.2 OUTLIER -100.53 -53.6 3.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.971 -179.998 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 530' ' ' HIS . . . . . 0.416 ' O ' ' CD2' ' B' ' 530' ' ' HIS . 12.4 t60 -166.76 95.16 0.51 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.492 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 531' ' ' CYS . . . . . 0.417 ' CB ' ' O ' ' A' ' 30' ' ' SER . 96.5 m -55.46 160.43 2.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.943 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 532' ' ' TRP . . . . . 0.468 ' CD1' ' OH ' ' A' ' 32' ' ' TYR . 88.5 t90 -55.12 139.46 41.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.832 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . -134.53 -123.69 2.38 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.594 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 534' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.84 147.43 89.51 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.745 0.307 . . . . 0.0 110.948 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_exo -51.61 -176.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.697 2.265 . . . . 0.0 112.351 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 3.5 t70 53.64 99.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.996 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 537' ' ' ARG . . . . . 0.44 ' HB3' ' CG2' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -75.57 179.02 5.57 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.299 0.571 . . . . 0.0 110.893 179.898 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 538' ' ' ILE . . . . . 0.424 ' O ' ' CG2' ' A' ' 14' ' ' VAL . 1.8 pt -74.87 -154.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.984 179.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 539' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -107.58 148.19 29.61 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.726 0.298 . . . . 0.0 110.419 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 540' ' ' GLU . . . . . 0.42 ' HA ' ' CG1' ' A' ' 14' ' ' VAL . 12.9 pm0 -48.11 -25.58 1.51 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.036 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 541' ' ' LEU . . . . . 0.437 ' HA ' ' CD2' ' A' ' 70' ' ' LEU . 11.0 mt -37.5 -45.29 0.72 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.523 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 542' ' ' TYR . . . . . 0.456 ' CD1' ' N ' ' B' ' 542' ' ' TYR . 1.4 m-30 -104.73 -63.12 1.25 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.879 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 543' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER 76.9 125.06 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.844 -179.853 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . 55.77 -159.08 7.56 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.483 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 545' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.207 -0.901 . . . . 0.0 110.925 179.983 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' GNP . . . . . 0.958 " H2'" ' OG1' ' A' ' 115' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.435 ' CE ' HG22 ' A' ' 46' ' ' ILE . 5.4 tpt . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.889 0.376 . . . . 0.0 111.085 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.4 tm0? -81.78 144.1 31.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.635 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.514 HG22 ' CE1' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -93.82 -175.52 3.76 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.342 -179.639 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.471 ' CD1' ' CD2' ' A' ' 53' ' ' LEU . 5.2 pt -154.99 143.67 13.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.948 -179.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.2 ptpp? -134.33 95.57 3.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.131 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 80.5 m -118.87 153.34 34.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.059 0.457 . . . . 0.0 111.332 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.5 t -142.99 128.46 16.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.453 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.407 ' HB ' ' HA3' ' A' ' 15' ' ' GLY . 1.4 p -84.68 113.84 23.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.166 0.507 . . . . 0.0 111.192 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.3 m -114.74 129.75 70.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.443 178.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.477 ' HA2' ' CZ2' ' A' ' 97' ' ' TRP . . . 149.13 -170.11 29.48 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.098 -1.049 . . . . 0.0 112.808 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.435 ' O ' ' N ' ' B' ' 537' ' ' ARG . 0.4 OUTLIER -98.3 27.54 4.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.715 0.293 . . . . 0.0 110.691 179.91 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.425 ' CA ' ' HB2' ' B' ' 537' ' ' ARG . . . -126.34 170.62 18.15 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.684 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.444 ' CB ' H5'1 ' A' ' 185' ' ' GNP . . . -98.27 -38.26 9.34 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.715 0.293 . . . . 0.0 111.344 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.438 HG23 ' N7 ' ' A' ' 185' ' ' GNP . 2.1 m -43.94 91.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.481 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.483 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . . . -175.55 -71.43 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.934 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.423 ' CD ' ' HB3' ' A' ' 55' ' ' LEU . 8.8 mmtm -97.39 -80.67 0.44 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.007 0.432 . . . . 0.0 111.912 -179.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.471 ' CG2' ' CG2' ' A' ' 35' ' ' THR . 71.7 p -75.1 -69.57 0.47 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.547 -178.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.447 ' CA ' ' O2B' ' A' ' 185' ' ' GNP . 43.2 t -33.01 -43.35 0.1 Allowed 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -178.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.515 ' CD2' ' CG ' ' A' ' 169' ' ' PHE . 0.2 OUTLIER -60.71 -52.71 63.94 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.782 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -70.49 -24.42 62.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.842 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.416 ' O ' ' N ' ' A' ' 25' ' ' THR . 27.7 mm -57.81 -71.18 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.492 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.5 m -60.87 -23.37 65.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.128 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.458 ' CE2' ' HB2' ' B' ' 513' ' ' PRO . 41.5 t80 -65.19 -68.24 0.38 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.858 0.361 . . . . 0.0 110.284 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 96.9 m -75.87 -37.58 58.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.744 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.416 ' N ' ' O ' ' A' ' 21' ' ' ILE . 9.4 p -113.12 -166.8 1.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.684 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -142.0 19.08 2.12 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.12 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.8 mmtm -93.35 95.98 9.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.021 0.438 . . . . 0.0 110.566 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.496 ' CD1' ' O1A' ' A' ' 185' ' ' GNP . 2.6 t80 -87.01 -50.6 0.45 Allowed Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.301 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.45 ' HD3' ' HB3' ' A' ' 28' ' ' PHE . 64.9 Cg_endo -88.66 46.04 1.01 Allowed 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.842 2.361 . . . . 0.0 112.475 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.5 p -83.7 -94.36 0.07 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.127 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -158.87 124.74 4.44 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.797 0.332 . . . . 0.0 111.17 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.407 ' CE2' ' HA ' ' B' ' 532' ' ' TRP . 4.6 m-30 -88.58 94.7 9.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.598 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.445 ' CB ' ' CD ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -165.03 -64.07 0.01 OUTLIER Pre-proline 0 N--CA 1.466 0.328 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.633 -179.804 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.445 ' CD ' ' CB ' ' A' ' 33' ' ' VAL . 10.3 Cg_endo -53.09 -16.98 7.25 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.889 2.393 . . . . 0.0 112.67 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.471 ' CG2' ' CG2' ' A' ' 17' ' ' THR . 45.4 m -36.18 -31.83 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.441 ' CG1' ' CB ' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -44.31 -28.37 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 120.685 0.279 . . . . 0.0 111.436 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.467 ' O ' ' CG ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -78.39 57.7 1.98 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.088 179.857 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -135.05 -47.46 0.72 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.845 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -63.96 -16.88 62.55 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.265 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.66 -157.5 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.932 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -90.76 162.6 14.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.068 0.461 . . . . 0.0 111.951 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.8 t -134.86 166.58 28.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.078 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.446 ' O ' ' CG1' ' A' ' 44' ' ' VAL . 9.4 t -143.82 103.8 4.1 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.508 ' CG2' ' CG2' ' A' ' 52' ' ' THR . 30.9 m -161.84 -177.46 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.017 178.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.454 ' HE2' ' N ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -105.63 100.01 9.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.61 0.243 . . . . 0.0 111.642 -179.479 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.443 HG21 ' CG2' ' B' ' 510' ' ' ILE . 5.1 mm -75.01 86.59 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 178.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.433 ' HA3' ' HA ' ' B' ' 510' ' ' ILE . . . 45.76 -95.61 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.689 -0.687 . . . . 0.0 113.401 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -38.04 -90.41 0.01 OUTLIER Glycine 0 CA--C 1.52 0.355 0 N-CA-C 113.992 0.357 . . . . 0.0 113.992 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.454 ' N ' ' HE2' ' A' ' 45' ' ' MET . 0.1 OUTLIER -123.14 159.12 55.69 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.789 0.328 . . . . 0.0 111.161 -179.181 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.416 ' HD2' ' HB2' ' A' ' 49' ' ' GLU . 2.7 Cg_endo -46.15 105.06 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.792 2.328 . . . . 0.0 112.356 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.514 ' CE1' HG22 ' A' ' 3' ' ' THR . 1.7 t80 -172.27 158.72 4.53 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.328 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.508 ' CG2' ' CG2' ' A' ' 44' ' ' VAL . 3.3 p -136.41 153.07 51.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.154 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.471 ' CD2' ' CD1' ' A' ' 4' ' ' ILE . 0.5 OUTLIER -78.76 -174.64 4.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.629 179.61 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -114.16 76.14 0.24 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.399 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.423 ' HB3' ' CD ' ' A' ' 16' ' ' LYS . 0.6 OUTLIER -52.56 114.62 1.44 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.938 0.399 . . . . 0.0 110.356 179.845 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -84.4 109.42 17.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.069 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -108.2 -175.76 2.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.652 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.426 ' HA ' ' CD1' ' A' ' 67' ' ' LEU . 16.8 p -135.83 170.38 16.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.093 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.441 ' CB ' ' CG1' ' A' ' 36' ' ' VAL . . . -171.82 167.01 6.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.111 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' B' ' 543' ' ' LEU . . . -146.14 33.73 1.46 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.306 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.22 -173.68 2.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.765 0.317 . . . . 0.0 110.817 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -44.52 -27.76 0.5 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.697 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.465 ' OD2' ' CE1' ' A' ' 64' ' ' TYR . 45.2 t0 -47.67 -63.44 1.06 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.223 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.465 ' CE1' ' OD2' ' A' ' 63' ' ' ASP . 0.0 OUTLIER 170.88 73.65 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.175 179.905 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -58.76 -19.9 44.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.101 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.14 -14.24 61.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.596 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.456 HD23 ' CD1' ' A' ' 64' ' ' TYR . 3.6 pp -47.69 135.51 11.56 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.839 0.352 . . . . 0.0 111.087 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.479 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -139.55 48.52 1.64 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.084 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 71.0 Cg_endo -74.17 -9.58 22.03 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.451 2.101 . . . . 0.0 112.484 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.477 ' O ' ' CD2' ' A' ' 72' ' ' TYR . 0.1 OUTLIER -78.78 1.04 24.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.641 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -55.13 -20.47 10.16 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.625 0.25 . . . . 0.0 111.437 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.477 ' CD2' ' O ' ' A' ' 70' ' ' LEU . 34.2 m-85 73.59 64.84 0.31 Allowed Pre-proline 0 C--N 1.332 -0.17 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.819 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.1 -150.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.581 2.188 . . . . 0.0 111.955 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -60.39 -16.17 32.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.374 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 55.3 m -42.12 133.06 3.15 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.871 0.367 . . . . 0.0 111.298 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.419 ' HA ' ' CG2' ' A' ' 108' ' ' THR . 0.4 OUTLIER -115.1 7.47 15.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.562 -179.82 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.429 HG23 ' CB ' ' A' ' 175' ' ' ALA . 7.9 p -145.21 79.95 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.881 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.493 ' CE2' ' HB ' ' A' ' 108' ' ' THR . 1.1 p90 -92.8 124.82 37.07 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 178.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.424 HD11 ' CG2' ' A' ' 113' ' ' VAL . 12.7 tp -70.37 108.65 4.34 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.78 -178.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.489 HG23 ' CD1' ' A' ' 110' ' ' PHE . 2.1 t -80.19 156.13 4.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.696 178.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.433 ' HB3' ' N7 ' ' A' ' 185' ' ' GNP . 2.8 m -145.77 129.75 17.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.318 0.58 . . . . 0.0 112.363 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.47 ' O ' ' CD1' ' A' ' 82' ' ' PHE . 17.4 p90 -152.21 128.78 10.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.564 178.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.457 ' HA ' ' C2 ' ' A' ' 185' ' ' GNP . 0.7 OUTLIER -83.06 137.62 34.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.125 0.488 . . . . 0.0 111.76 -178.663 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.442 ' HA ' ' HB ' ' A' ' 137' ' ' ILE . 72.5 t -47.85 -78.73 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.246 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 29.6 m -42.8 113.95 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.086 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.429 ' N ' HD22 ' A' ' 129' ' ' LEU . 3.0 p -152.25 145.07 17.19 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.888 0.375 . . . . 0.0 111.909 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.424 ' O ' ' CB ' ' A' ' 88' ' ' SER . 76.9 Cg_endo -91.23 53.96 0.91 Allowed 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.226 2.618 . . . . 0.0 111.659 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.482 ' N ' ' CB ' ' A' ' 133' ' ' LYS . 0.7 OUTLIER 82.15 33.26 0.09 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.806 -179.455 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.412 ' O ' ' CG2' ' A' ' 93' ' ' VAL . 1.1 t -88.31 -24.75 23.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.023 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.499 ' CD1' HG13 ' A' ' 137' ' ' ILE . 2.1 t80 -51.07 -56.78 10.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.096 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -53.11 -41.9 65.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.131 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.422 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 1.8 t-20 -72.73 -53.16 12.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.975 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.412 ' CG2' ' O ' ' A' ' 89' ' ' SER . 46.5 t -49.81 -44.44 20.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.207 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.416 ' O ' ' CG2' ' A' ' 98' ' ' VAL . 30.4 tttt -62.23 -52.59 63.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.998 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 70.2 mt-10 -84.51 9.38 13.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.681 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.422 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 25.7 tttp -116.12 -37.75 3.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.729 0.3 . . . . 0.0 110.725 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.477 ' CZ2' ' HA2' ' A' ' 10' ' ' GLY . 0.8 OUTLIER -94.42 -46.85 6.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.34 -179.769 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.482 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 56.9 t -51.98 -46.07 92.89 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.654 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.482 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 92.0 Cg_endo -81.1 -12.37 11.82 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.342 2.028 . . . . 0.0 112.757 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -86.61 -49.17 7.72 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.861 0.362 . . . . 0.0 110.585 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 32.4 pt -66.55 -28.15 42.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.879 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 27.5 p -77.68 -33.25 53.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.579 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -64.12 -46.09 85.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.758 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 27.5 m170 -82.86 -24.15 33.37 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.758 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -142.94 95.8 6.13 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.665 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -68.81 133.13 26.51 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.594 2.196 . . . . 0.0 112.574 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 49.02 77.32 0.1 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.156 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.493 ' HB ' ' CE2' ' A' ' 78' ' ' PHE . 0.1 OUTLIER -139.29 115.09 8.35 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.878 179.857 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.404 ' HD2' ' O ' ' A' ' 76' ' ' ASP . 32.1 Cg_exo -59.42 162.78 13.91 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.639 2.226 . . . . 0.0 112.826 -179.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.49 ' HB3' ' CE1' ' A' ' 78' ' ' PHE . 37.0 p90 -161.69 165.05 28.73 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.549 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.426 ' CD1' HG13 ' A' ' 152' ' ' VAL . 0.9 OUTLIER -114.96 159.62 20.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.939 0.399 . . . . 0.0 111.635 -179.562 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.459 ' N ' ' CD2' ' A' ' 112' ' ' LEU . 2.4 mm? -119.48 161.14 21.07 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.575 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.425 HG12 ' CG2' ' A' ' 115' ' ' THR . 3.1 t -134.4 142.85 39.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.911 0.386 . . . . 0.0 111.694 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.456 ' HA3' ' CZ ' ' A' ' 154' ' ' TYR . . . -121.76 67.77 0.45 Allowed Glycine 0 C--N 1.331 0.28 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.989 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.636 ' OG1' " H2'" ' A' ' 185' ' ' GNP . 1.4 p -92.38 26.55 2.55 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -178.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.648 ' N ' HN22 ' A' ' 185' ' ' GNP . 2.9 mm-40 -131.88 23.85 4.62 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.199 0.523 . . . . 0.0 109.737 179.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.497 HD13 ' N ' ' A' ' 158' ' ' SER . 0.0 OUTLIER -67.68 -9.62 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.8 179.253 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -100.43 -40.59 7.39 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.144 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.423 ' CD1' ' HA ' ' A' ' 116' ' ' GLN . 3.5 mp -69.54 -33.79 73.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.313 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -47.25 -33.83 5.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.891 0.377 . . . . 0.0 110.984 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -80.13 -27.35 39.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.549 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' A' ' 119' ' ' LEU . 2.2 t70 -57.59 106.47 0.69 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.76 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -70.0 -3.83 12.95 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.643 2.229 . . . . 0.0 112.847 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.98 -67.27 0.77 Allowed 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.059 0.457 . . . . 0.0 110.0 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.408 ' O ' ' HB3' ' A' ' 128' ' ' LYS . 2.1 m -56.17 -43.58 78.51 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 178.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.455 ' HA ' ' CD1' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -48.28 -42.17 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.524 178.913 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -55.63 -49.44 72.84 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.006 178.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.408 ' HB3' ' O ' ' A' ' 125' ' ' THR . 0.1 OUTLIER -54.67 -32.89 59.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.2 179.017 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.455 ' CD1' ' HA ' ' A' ' 126' ' ' ILE . 7.5 mt -72.41 -42.0 65.62 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.459 ' HA ' ' CB ' ' A' ' 134' ' ' GLN . . . -42.51 -30.7 0.37 Allowed 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.106 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.9 mmmt -58.94 -39.56 81.97 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.247 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -125.16 -30.59 3.17 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.482 ' CB ' ' N ' ' A' ' 88' ' ' SER . 0.3 OUTLIER -130.51 -69.68 0.65 Allowed 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -177.719 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.467 ' N ' ' HG3' ' A' ' 133' ' ' LYS . 2.8 tt0 87.73 -37.23 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.428 ' CB ' ' HE3' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -69.03 111.23 7.82 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 120.733 0.301 . . . . 0.0 111.505 -179.137 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.431 ' HB3' ' CD1' ' A' ' 126' ' ' ILE . 74.2 Cg_endo -77.5 129.68 10.33 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.544 2.163 . . . . 0.0 112.019 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.51 ' N ' ' CD1' ' A' ' 137' ' ' ILE . 0.6 OUTLIER -59.42 96.9 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.94 179.904 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.42 ' O ' ' N ' ' A' ' 141' ' ' THR . 11.1 p -67.32 147.29 98.91 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.897 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_exo -40.88 -40.71 3.75 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.728 2.285 . . . . 0.0 112.318 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -69.24 -36.6 77.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.6 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.42 ' N ' ' O ' ' A' ' 138' ' ' THR . 90.6 m -55.31 -56.69 17.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.76 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.489 ' HB3' ' CD1' ' A' ' 154' ' ' TYR . . . -52.53 -39.57 61.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.81 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.98 -34.98 79.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.703 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.2 tptt -59.98 -58.63 7.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.783 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.407 ' HA ' ' HB2' ' A' ' 148' ' ' ASP . 24.1 tp -65.71 -35.98 82.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.761 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -58.11 -61.04 2.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.167 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 4.4 mtt85 -72.39 -25.44 61.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.012 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.407 ' HB2' ' HA ' ' A' ' 145' ' ' LEU . 1.8 m-20 -49.36 -41.87 40.31 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.036 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 5.9 mt -102.69 23.14 12.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.922 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 48.34 33.85 4.17 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.971 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.489 ' HB1' ' CD1' ' A' ' 110' ' ' PHE . . . -51.96 -81.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.187 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.431 ' CG2' ' O ' ' A' ' 151' ' ' ALA . 8.0 t -164.56 -69.21 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.894 0.378 . . . . 0.0 110.394 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 177.41 135.45 0.07 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.243 -179.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.489 ' CD1' ' HB3' ' A' ' 142' ' ' ALA . 24.7 t80 -106.75 114.7 28.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.728 178.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 2.8 t -101.24 151.99 5.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.733 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -99.12 118.58 36.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.4 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.436 ' CA ' HD13 ' A' ' 117' ' ' ILE . 0.9 OUTLIER 178.3 125.96 0.05 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.546 179.523 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.517 ' N ' ' HB2' ' A' ' 163' ' ' LYS . 40.2 t -118.61 151.57 37.66 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.076 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -72.06 -38.46 69.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.942 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.1 mp -52.6 -52.55 54.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.562 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 12.9 t -77.23 -42.62 36.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.562 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.404 ' O ' ' O ' ' A' ' 163' ' ' LYS . 3.1 tt0 176.71 -85.38 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.195 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.517 ' HB2' ' N ' ' A' ' 158' ' ' SER . 4.7 tttm 58.76 118.76 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.925 0.393 . . . . 0.0 110.726 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -71.12 -10.12 68.32 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.43 -0.89 . . . . 0.0 112.523 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.475 ' CD1' ' HA ' ' A' ' 19' ' ' LEU . 4.0 mm? 66.95 -63.73 0.26 Allowed 'General case' 0 CA--C 1.522 -0.097 0 CA-C-O 120.702 0.287 . . . . 0.0 110.474 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.436 ' O ' ' CB ' ' A' ' 170' ' ' ASP . 1.7 ptmt -57.04 -32.14 65.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.688 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.421 ' N ' ' HG2' ' A' ' 166' ' ' LYS . 0.1 OUTLIER -53.92 -72.17 0.06 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.764 0.316 . . . . 0.0 110.617 179.832 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 5.9 t -63.41 -43.06 98.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.244 0.545 . . . . 0.0 110.073 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.515 ' CG ' ' CD2' ' A' ' 19' ' ' LEU . 0.9 OUTLIER -58.57 -24.01 59.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.603 179.539 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.438 ' HA ' ' CG1' ' A' ' 173' ' ' ILE . 27.5 t0 -76.99 -41.53 42.5 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.879 0.371 . . . . 0.0 110.038 179.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -56.59 -33.76 66.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.185 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.42 ' N ' HD11 ' A' ' 111' ' ' LEU . . . -73.54 -58.22 3.46 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.129 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.438 ' CG1' ' HA ' ' A' ' 170' ' ' ASP . 1.3 pp -62.66 -39.93 86.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.23 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.444 HD22 ' CB ' ' B' ' 505' ' ' LEU . 5.0 tp -48.03 -43.18 29.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.194 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.429 ' CB ' HG23 ' A' ' 77' ' ' VAL . . . -52.59 -23.26 6.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.071 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.44 ' CB ' ' HB ' ' A' ' 4' ' ' ILE . . . -90.88 -36.5 14.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.394 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.449 ' CD2' ' CG2' ' A' ' 4' ' ' ILE . 80.7 mt -68.55 -23.02 64.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.816 0.341 . . . . 0.0 110.671 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.429 ' HG3' ' CA ' ' B' ' 507' ' ' ALA . 0.6 OUTLIER -169.96 167.22 5.08 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.799 179.878 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . 0.417 ' HD2' ' CB ' ' A' ' 178' ' ' GLU . 32.4 Cg_endo -64.17 124.58 13.67 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.576 2.184 . . . . 0.0 112.251 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -74.03 164.7 33.79 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.457 2.104 . . . . 0.0 112.455 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . 0.409 ' O ' ' CG ' ' A' ' 181' ' ' GLU . 0.7 OUTLIER -117.09 114.41 38.96 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.807 179.999 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.62 -165.04 0.25 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.567 2.178 . . . . 0.0 112.321 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.48 77.66 7.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.999 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.168 -0.92 . . . . 0.0 110.787 179.99 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.122 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 503' ' ' SER . . . . . . . . . . . . . 31.0 t -105.41 -71.93 0.73 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.78 0.324 . . . . 0.0 111.034 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 504' ' ' GLY . . . . . . . . . . . . . . . 111.93 122.49 4.14 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.126 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 505' ' ' LEU . . . . . 0.444 ' CB ' HD22 ' A' ' 174' ' ' LEU . 0.4 OUTLIER -173.92 -37.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.54 -179.572 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 506' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 171.46 -56.82 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.704 0.288 . . . . 0.0 110.913 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 507' ' ' ALA . . . . . 0.429 ' CA ' ' HG3' ' A' ' 178' ' ' GLU . . . -39.9 -43.74 1.55 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.688 0.756 . . . . 0.0 111.073 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 508' ' ' GLN . . . . . 0.48 ' O ' ' CB ' ' B' ' 509' ' ' ASP . 13.5 pt20 164.99 -39.22 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.362 -1.29 . . . . 0.0 108.226 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 509' ' ' ASP . . . . . 0.48 ' CB ' ' O ' ' B' ' 508' ' ' GLN . 7.6 p30 147.25 41.44 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 113.94 -1.482 . . . . 0.0 110.197 179.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 510' ' ' ILE . . . . . 0.443 ' CG2' HG21 ' A' ' 46' ' ' ILE . 13.7 mt -72.08 126.27 32.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.263 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 511' ' ' SER . . . . . . . . . . . . . 30.3 t -109.47 141.73 41.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.288 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 512' ' ' GLN . . . . . 0.46 ' CB ' ' CD ' ' B' ' 513' ' ' PRO . 4.3 tp60 -92.89 -67.68 0.1 OUTLIER Pre-proline 0 CA--C 1.532 0.27 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 513' ' ' PRO . . . . . 0.46 ' CD ' ' CB ' ' B' ' 512' ' ' GLN . 92.3 Cg_endo -80.3 74.31 5.6 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.451 2.101 . . . . 0.0 111.461 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 514' ' ' LEU . . . . . 0.444 ' CD2' ' O ' ' A' ' 45' ' ' MET . 2.3 mp -73.45 -86.7 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.488 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 515' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -79.25 -87.76 0.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.693 -0.231 . . . . 0.0 111.052 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -117.57 -29.67 5.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.803 0.335 . . . . 0.0 111.134 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 517' ' ' SER . . . . . 0.48 ' O ' ' CD1' ' B' ' 518' ' ' PHE . 2.6 m 72.01 22.27 3.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.964 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 518' ' ' PHE . . . . . 0.48 ' CD1' ' O ' ' B' ' 517' ' ' SER . 12.1 m-85 -150.13 130.44 13.73 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.027 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 519' ' ' ILE . . . . . . . . . . . . . 43.9 mm -63.62 -68.32 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.994 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -155.06 -67.41 0.13 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.061 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 521' ' ' THR . . . . . . . . . . . . . 11.2 m -163.88 157.63 18.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.101 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 522' ' ' GLY . . . . . . . . . . . . . . . -91.78 -92.08 1.39 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.333 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 523' ' ' HIS . . . . . 0.411 ' CD2' ' N ' ' B' ' 523' ' ' HIS . 0.1 OUTLIER 174.73 -98.81 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.475 0.137 . . . . 0.0 110.845 179.881 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 524' ' ' GLY . . . . . . . . . . . . . . . 42.35 -95.06 0.01 OUTLIER Glycine 0 C--N 1.338 0.658 0 C-N-CA 120.991 -0.623 . . . . 0.0 113.009 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 525' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' B' ' 523' ' ' HIS . 33.2 p-10 177.46 91.65 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.815 0.34 . . . . 0.0 111.088 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 526' ' ' SER . . . . . 0.43 ' CB ' ' HB3' ' A' ' 34' ' ' PRO . 9.2 t -80.04 95.71 6.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.724 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 527' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -144.6 147.91 37.93 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.816 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.55 99.92 0.65 Allowed 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.552 2.168 . . . . 0.0 112.323 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 529' ' ' ARG . . . . . . . . . . . . . 12.6 mtp180 -100.29 -54.88 2.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.004 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 530' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -158.72 96.85 1.4 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.836 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 27.8 p -68.76 112.13 5.29 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.955 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 532' ' ' TRP . . . . . 0.504 ' CD1' ' NH2' ' B' ' 537' ' ' ARG . 22.4 t90 66.74 -68.95 0.13 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.833 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . 61.39 -80.76 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.52 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 534' ' ' PHE . . . . . 0.416 ' O ' ' NH1' ' B' ' 537' ' ' ARG . 17.7 m-85 -105.54 149.86 38.35 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.685 0.279 . . . . 0.0 110.844 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.27 -12.72 30.26 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.502 2.135 . . . . 0.0 112.555 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -112.98 120.79 42.61 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.831 0.348 . . . . 0.0 111.003 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 537' ' ' ARG . . . . . 0.504 ' NH2' ' CD1' ' B' ' 532' ' ' TRP . 11.6 mmt-85 -71.57 138.51 48.86 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.156 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 538' ' ' ILE . . . . . . . . . . . . . 4.1 tp -56.46 139.03 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.941 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 539' ' ' ASP . . . . . . . . . . . . . 34.3 p-10 -42.64 126.03 3.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.862 0.363 . . . . 0.0 111.125 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 540' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -49.34 -22.58 1.15 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.077 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 541' ' ' LEU . . . . . 0.475 ' CD2' ' CD1' ' A' ' 70' ' ' LEU . 0.4 OUTLIER -35.26 -53.21 0.62 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.995 0.426 . . . . 0.0 111.62 179.81 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 542' ' ' TYR . . . . . 0.429 ' O ' ' N ' ' A' ' 59' ' ' ALA . 0.4 OUTLIER -104.8 -62.5 1.33 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.327 179.4 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 543' ' ' LEU . . . . . 0.425 ' O ' ' N ' ' A' ' 60' ' ' GLY . 3.4 tp 62.22 153.05 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.567 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . 103.26 82.73 1.65 Allowed Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.382 -0.913 . . . . 0.0 112.592 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 545' ' ' ASN . . . . . . . . . . . . . 1.1 m120 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.862 -179.932 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' GNP . . . . . 0.648 HN22 ' N ' ' A' ' 116' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' HOH . . . . . 0.402 ' H1 ' ' PG ' ' A' ' 185' ' ' GNP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.437 ' HG2' ' CG ' ' A' ' 49' ' ' GLU . 5.5 tpt . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 120.861 0.363 . . . . 0.0 111.233 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.431 ' O ' ' CD2' ' A' ' 177' ' ' LEU . 5.8 pt20 -167.17 138.81 3.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.753 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.495 HG21 ' CE1' ' A' ' 51' ' ' TYR . 13.7 t -109.94 -139.67 0.38 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.26 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.467 HG22 ' CB ' ' A' ' 176' ' ' ALA . 0.2 OUTLIER -150.55 152.54 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -178.865 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 13.1 pttt -134.0 95.61 3.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.602 178.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.405 ' O ' ' CE ' ' A' ' 16' ' ' LYS . 25.1 m -102.03 154.35 19.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.188 0.518 . . . . 0.0 111.876 -178.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.6 t -133.12 150.21 32.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.164 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.464 ' HB ' ' CG ' ' B' ' 540' ' ' GLU . 53.5 t -97.3 143.75 12.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.267 0.556 . . . . 0.0 111.056 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.439 ' N ' HG13 ' A' ' 8' ' ' VAL . 6.7 m -161.67 129.95 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.853 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 148.59 -178.68 26.0 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 119.882 -1.151 . . . . 0.0 112.909 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -102.46 -27.16 12.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.89 0.376 . . . . 0.0 110.593 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.9 -129.56 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.211 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.46 ' CB ' ' O2A' ' A' ' 185' ' ' GNP . . . -102.42 -56.95 2.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.824 0.345 . . . . 0.0 111.258 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.438 ' HB ' ' CG1' ' A' ' 8' ' ' VAL . 2.8 t 43.38 29.06 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.461 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.404 ' HA3' ' O1A' ' A' ' 185' ' ' GNP . . . -64.51 89.49 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.802 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.435 ' HB2' ' CG2' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -52.59 -33.45 46.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.933 0.397 . . . . 0.0 110.273 179.675 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 39.2 p -81.15 -53.15 6.64 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.677 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.404 ' HB2' ' O3A' ' A' ' 185' ' ' GNP . 1.6 t -42.72 -38.54 2.11 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.265 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.52 ' CD2' ' CE1' ' A' ' 169' ' ' PHE . 0.0 OUTLIER -49.32 -58.67 4.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.545 179.668 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.59 -27.62 64.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.923 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.449 ' O ' ' N ' ' A' ' 25' ' ' THR . 37.3 mm -64.23 -71.43 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.242 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 9.6 t -50.0 -31.02 11.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.809 0.338 . . . . 0.0 110.717 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -63.54 -66.61 0.52 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.659 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.27 -54.63 6.77 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.73 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.449 ' N ' ' O ' ' A' ' 21' ' ' ILE . 27.4 p -78.47 -154.08 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.345 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.419 ' N ' ' ND2' ' A' ' 26' ' ' ASN . 0.1 OUTLIER -157.46 35.52 0.27 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.735 0.302 . . . . 0.0 111.088 -179.888 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -123.02 101.47 7.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.932 0.396 . . . . 0.0 111.525 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.488 ' CD2' ' HD3' ' A' ' 29' ' ' PRO . 0.4 OUTLIER -101.4 -70.04 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.726 178.92 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.488 ' HD3' ' CD2' ' A' ' 28' ' ' PHE . 95.7 Cg_endo -79.1 54.45 5.18 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.23 1.953 . . . . 0.0 111.518 178.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.02 -85.73 0.5 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.356 -179.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -147.54 118.53 7.68 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.196 0.522 . . . . 0.0 112.085 -179.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.601 ' CE2' ' PB ' ' A' ' 185' ' ' GNP . 4.2 m-30 -99.78 94.37 6.29 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.577 178.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.45 ' CG1' ' CB ' ' B' ' 526' ' ' SER . 0.0 OUTLIER -163.82 -63.85 0.01 OUTLIER Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.857 -179.177 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.436 ' HD2' HG23 ' A' ' 33' ' ' VAL . 8.8 Cg_endo -50.81 -20.43 6.78 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.781 2.321 . . . . 0.0 112.328 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.413 ' HB ' ' H1 ' ' A' ' 188' ' ' HOH . 8.2 t -40.92 -29.66 0.11 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.501 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.476 ' CG1' ' CB ' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -43.63 -29.68 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-O 120.924 0.393 . . . . 0.0 111.016 179.648 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.493 ' O ' ' CG ' ' A' ' 40' ' ' TYR . 0.8 OUTLIER -55.36 -23.48 24.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.62 179.478 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.417 ' HA ' ' CE1' ' A' ' 40' ' ' TYR . 21.9 t70 -41.67 -28.29 0.14 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.121 -0.49 . . . . 0.0 112.122 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -72.79 -1.86 18.25 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.493 ' CG ' ' O ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -60.0 -176.48 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.767 0.318 . . . . 0.0 110.651 179.856 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.421 ' O ' ' CG1' ' B' ' 519' ' ' ILE . . . -112.84 144.54 42.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.455 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.434 ' CG1' ' O ' ' B' ' 517' ' ' SER . 0.8 OUTLIER -116.61 121.85 68.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.981 179.604 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.7 p -111.3 106.59 15.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.749 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.42 HG22 ' CD1' ' B' ' 514' ' ' LEU . 6.4 p -164.05 148.78 2.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.283 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.483 ' CE ' ' N ' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -74.56 104.38 5.23 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 178.773 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.489 ' HA ' ' CD1' ' B' ' 514' ' ' LEU . 7.8 tt -99.92 87.67 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.676 -179.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.411 ' N ' ' HE1' ' A' ' 45' ' ' MET . . . 75.77 -108.06 2.46 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.303 -0.862 . . . . 0.0 113.13 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -47.96 -88.88 0.01 OUTLIER Glycine 0 C--N 1.331 0.264 0 C-N-CA 121.184 -0.531 . . . . 0.0 113.342 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.473 ' N ' ' HE2' ' A' ' 45' ' ' MET . 5.0 pt-20 -126.16 170.89 8.71 Favored Pre-proline 0 CA--C 1.53 0.204 0 CA-C-O 120.627 0.251 . . . . 0.0 110.902 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.436 ' CD ' ' HB2' ' A' ' 49' ' ' GLU . 33.1 Cg_exo -60.28 107.48 0.42 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.684 2.256 . . . . 0.0 112.777 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.495 ' CE1' HG21 ' A' ' 3' ' ' THR . 6.2 t80 -172.87 104.72 0.14 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.402 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.6 128.92 51.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.844 0.354 . . . . 0.0 110.875 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.452 ' HG ' ' CG2' ' A' ' 3' ' ' THR . 11.3 mt -70.8 172.05 9.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.97 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -115.19 108.22 1.88 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.79 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.1 mp -48.73 114.55 1.0 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.842 0.353 . . . . 0.0 110.641 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -83.63 105.14 14.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.508 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.406 ' HB2' ' HB3' ' A' ' 38' ' ' ASP . 0.4 OUTLIER -99.53 -175.63 3.05 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.843 -179.87 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.438 ' CG2' HD11 ' A' ' 67' ' ' LEU . 1.2 p -136.05 167.84 20.47 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.784 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.476 ' CB ' ' CG1' ' A' ' 36' ' ' VAL . . . -171.2 179.99 2.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.184 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -151.48 31.24 0.94 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.293 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.45 -160.84 0.81 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.754 0.311 . . . . 0.0 110.815 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.6 mp0 -52.82 -27.11 16.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.184 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.404 ' C ' ' CG ' ' A' ' 64' ' ' TYR . 9.2 m-20 -50.49 -63.63 1.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.281 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.493 ' CD1' ' N ' ' A' ' 64' ' ' TYR . 0.0 OUTLIER 169.1 82.88 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.91 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -68.07 -22.32 64.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.086 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.92 -29.87 21.91 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.21 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.471 HD22 ' CD1' ' A' ' 64' ' ' TYR . 4.5 pp -48.39 140.28 7.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.957 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.465 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.1 OUTLIER -150.69 50.23 0.69 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 120.893 0.377 . . . . 0.0 110.893 -179.949 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 71.6 Cg_endo -76.79 -31.29 4.13 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.657 2.238 . . . . 0.0 112.647 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.458 ' CD2' ' HB2' ' B' ' 541' ' ' LEU . 0.1 OUTLIER -66.98 -25.19 66.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.842 0.354 . . . . 0.0 110.663 -179.914 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.449 ' OG ' ' CE2' ' A' ' 72' ' ' TYR . 13.9 t -59.89 -70.59 0.16 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.942 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.449 ' CE2' ' OG ' ' A' ' 71' ' ' SER . 3.5 m-85 -123.94 67.57 42.81 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.908 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.08 140.39 31.17 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.619 2.213 . . . . 0.0 112.282 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 9.8 tp60 -101.62 10.39 40.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.451 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 84.6 m -75.87 124.61 27.61 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.811 0.338 . . . . 0.0 110.982 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -79.3 -18.32 52.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.156 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.4 t -103.71 78.91 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.224 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -83.19 175.15 10.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.751 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 19.3 tp -147.63 108.9 4.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.99 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.408 ' CG2' ' O ' ' A' ' 80' ' ' VAL . 35.3 m -113.32 100.17 10.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.864 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.444 ' HB3' ' N7 ' ' A' ' 185' ' ' GNP . 68.7 m -94.51 173.56 7.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.419 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.43 ' O ' ' N1 ' ' A' ' 185' ' ' GNP . 8.6 p90 -175.19 142.14 0.6 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.26 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.472 ' HA ' ' N2 ' ' A' ' 185' ' ' GNP . 5.4 m -83.31 155.83 23.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.088 0.471 . . . . 0.0 111.543 -179.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.474 ' CG1' ' N ' ' A' ' 137' ' ' ILE . 15.9 t -55.01 -51.71 51.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.518 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.438 HG11 ' CG2' ' A' ' 125' ' ' THR . 1.9 m -47.58 117.01 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.059 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.444 ' N ' HD21 ' A' ' 129' ' ' LEU . 0.1 OUTLIER -151.43 117.86 3.23 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.438 -179.741 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.423 ' O ' ' CB ' ' A' ' 88' ' ' SER . 78.3 Cg_endo -90.38 49.68 0.95 Allowed 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.981 2.454 . . . . 0.0 111.969 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.437 ' CB ' ' HG2' ' A' ' 133' ' ' LYS . 0.1 OUTLIER 81.56 28.34 0.17 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.694 -179.525 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 95.2 p -90.04 -15.94 30.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.256 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.486 ' CZ ' HG23 ' A' ' 137' ' ' ILE . 0.1 OUTLIER -46.29 -51.31 14.81 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.799 0.333 . . . . 0.0 111.157 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -62.46 -36.41 82.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.822 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -72.63 -57.89 3.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.467 HG12 ' CE2' ' A' ' 97' ' ' TRP . 24.2 t -52.11 -45.48 42.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.059 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.72 -50.49 73.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.811 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -82.87 6.9 16.9 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.633 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -117.15 -30.66 5.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.804 0.335 . . . . 0.0 110.971 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.467 ' CE2' HG12 ' A' ' 93' ' ' VAL . 23.3 m0 -94.01 -51.94 4.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.176 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.453 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 85.5 t -50.5 -57.6 12.62 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.612 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 29.8 Cg_endo -62.89 -15.51 47.88 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.197 1.931 . . . . 0.0 112.422 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -89.97 -54.48 4.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.878 0.37 . . . . 0.0 110.728 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.9 tt -55.17 -30.33 24.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.9 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 11.2 p -85.91 -25.29 26.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.774 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -60.71 -51.04 71.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.667 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 28.4 m80 -60.99 -38.53 86.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.69 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -137.53 126.52 14.91 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.734 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -49.79 89.14 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.461 2.108 . . . . 0.0 112.248 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 12.3 mttp 61.9 106.38 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.769 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.406 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 0.2 OUTLIER -127.95 137.19 30.27 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.9 -179.944 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 108' ' ' THR . 36.2 Cg_exo -60.24 156.02 42.67 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.485 2.123 . . . . 0.0 112.478 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.485 ' CE2' ' HB1' ' A' ' 151' ' ' ALA . 1.9 p90 -158.72 148.77 19.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.75 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.443 ' HG ' ' CG1' ' A' ' 152' ' ' VAL . 0.5 OUTLIER -111.18 148.54 32.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.482 -179.434 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.433 ' CD1' ' HB1' ' A' ' 146' ' ' ALA . 11.6 mt -103.98 158.07 16.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.824 179.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.444 ' CG1' HG11 ' A' ' 168' ' ' VAL . 14.3 t -146.1 150.73 15.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.399 0.619 . . . . 0.0 112.445 -179.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -131.31 124.65 4.17 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.86 179.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.811 ' OG1' " H2'" ' A' ' 185' ' ' GNP . 0.9 OUTLIER -140.68 -58.51 0.52 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.908 0.354 . . . . 0.0 111.761 -178.694 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.45 ' HB3' ' CG ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -53.78 -21.84 8.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.853 0.358 . . . . 0.0 110.922 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.434 HG21 ' CG2' ' A' ' 84' ' ' VAL . 0.3 OUTLIER -41.81 -29.13 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.217 -179.859 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -63.81 -43.16 97.09 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -178.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.427 ' CD2' HD23 ' A' ' 160' ' ' LEU . 0.3 OUTLIER -118.47 14.71 13.73 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -178.537 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.45 ' CG ' ' HB3' ' A' ' 116' ' ' GLN . 0.8 OUTLIER -87.18 -20.32 27.15 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.096 179.585 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.01 -18.59 35.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.85 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -46.1 122.27 6.24 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.049 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.403 ' HA ' ' CG2' ' A' ' 126' ' ' ILE . 14.0 Cg_exo -68.74 -3.52 11.43 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.576 2.184 . . . . 0.0 113.028 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 29.8 t -76.85 -71.18 0.41 Allowed 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.027 0.441 . . . . 0.0 110.247 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.438 ' CG2' HG11 ' A' ' 85' ' ' VAL . 95.0 m -55.68 -35.15 65.71 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.536 ' HA ' ' CD1' ' A' ' 129' ' ' LEU . 0.1 OUTLIER -56.68 -39.18 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.722 179.087 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -64.04 -31.9 73.26 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.31 178.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.445 ' O ' ' HG3' ' A' ' 131' ' ' LYS . 0.0 OUTLIER -69.69 -24.79 63.64 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.843 178.92 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.536 ' CD1' ' HA ' ' A' ' 126' ' ' ILE . 3.2 mt -85.02 -28.86 25.43 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 177.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.463 ' HA ' ' HB3' ' A' ' 134' ' ' GLN . . . -48.0 -39.87 20.91 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.501 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.445 ' HG3' ' O ' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -44.85 -28.75 0.69 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.884 0.373 . . . . 0.0 110.724 179.882 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.441 ' N ' ' HD2' ' A' ' 131' ' ' LYS . 52.9 m-20 -123.55 -32.03 3.41 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.391 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.512 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 52.1 mmtt -151.25 -92.73 0.06 Allowed 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.512 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 6.5 pt20 120.09 -18.09 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.783 1.233 . . . . 0.0 110.821 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.99 111.15 7.55 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.215 -0.448 . . . . 0.0 112.204 -178.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.402 ' HB2' HG12 ' A' ' 84' ' ' VAL . 96.8 Cg_endo -79.61 129.89 8.55 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.645 2.23 . . . . 0.0 111.503 179.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.488 ' CD1' ' N ' ' A' ' 137' ' ' ILE . 0.8 OUTLIER -58.57 96.64 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.014 0.435 . . . . 0.0 111.616 -179.331 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 16.5 p -69.32 151.61 96.84 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.462 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.47 ' HA ' ' CE1' ' A' ' 154' ' ' TYR . 4.2 Cg_endo -47.06 -25.07 3.8 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 122.809 2.339 . . . . 0.0 112.33 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -81.38 -38.66 26.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.12 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.405 ' HB ' HG21 ' A' ' 137' ' ' ILE . 0.2 OUTLIER -57.38 -54.2 49.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.138 -179.812 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.474 ' HB2' ' CD2' ' A' ' 154' ' ' TYR . . . -47.85 -43.43 28.3 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.884 0.373 . . . . 0.0 110.99 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -59.44 -40.25 86.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.589 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -55.03 -55.81 26.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.59 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.73 -29.14 68.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.492 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.433 ' HB1' ' CD1' ' A' ' 112' ' ' LEU . . . -65.41 -41.24 93.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.793 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 9.0 mtp180 -85.63 -25.89 26.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.678 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -52.37 -32.62 39.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.739 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.401 ' CD1' HG22 ' A' ' 98' ' ' VAL . 3.5 mt -119.8 19.7 12.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.057 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 6.3 mttp 48.46 47.46 20.17 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.202 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.485 ' HB1' ' CE2' ' A' ' 110' ' ' PHE . . . -63.98 -81.51 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.879 0.371 . . . . 0.0 110.865 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.443 ' CG1' ' HG ' ' A' ' 111' ' ' LEU . 70.3 t -160.56 -75.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.778 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.43 ' HD3' ' N ' ' A' ' 154' ' ' TYR . 7.0 tppt? 173.65 116.91 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.278 -179.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.474 ' CD2' ' HB2' ' A' ' 142' ' ' ALA . 5.6 t80 -81.4 116.08 21.05 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 12.9 t -101.4 159.35 4.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.451 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -89.9 139.84 30.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.129 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.437 ' O ' ' HA ' ' A' ' 115' ' ' THR . 3.3 p 178.71 -174.54 0.18 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.416 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.459 ' HA ' ' HA ' ' A' ' 115' ' ' THR . 24.3 p -159.99 167.87 26.95 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.937 0.399 . . . . 0.0 111.164 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -116.6 -46.11 2.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.585 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.427 HD23 ' CD2' ' A' ' 119' ' ' LEU . 0.7 OUTLIER -63.81 -33.25 75.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.402 179.557 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 1.3 p -113.0 -22.83 10.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.807 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.415 ' N ' ' OG ' ' A' ' 158' ' ' SER . 1.3 tt0 74.58 71.81 0.1 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.022 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.43 ' N ' ' OG ' ' A' ' 158' ' ' SER . 0.2 OUTLIER -93.96 13.63 22.2 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.501 -179.816 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 121.08 34.48 0.89 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.345 -0.931 . . . . 0.0 113.2 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.422 ' CD2' HD13 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -49.58 -27.79 4.92 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.956 0.408 . . . . 0.0 110.515 179.697 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.412 ' O ' ' N ' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -73.67 -34.16 64.78 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.626 179.568 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.409 ' N ' ' HE2' ' A' ' 166' ' ' LYS . 0.6 OUTLIER -56.58 -67.61 0.29 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.421 179.601 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.444 HG11 ' CG1' ' A' ' 113' ' ' VAL . 14.2 p -50.63 -46.31 27.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.33 179.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.52 ' CE1' ' CD2' ' A' ' 19' ' ' LEU . 1.9 t80 -61.9 -31.26 71.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.732 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.412 ' N ' ' O ' ' A' ' 166' ' ' LYS . 4.6 t0 -57.42 -39.97 77.31 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.514 178.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -66.72 -35.35 79.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.612 178.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -59.83 -29.93 68.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.739 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.459 ' CD1' ' N ' ' A' ' 174' ' ' LEU . 0.0 OUTLIER -94.11 -43.88 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.438 179.633 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.459 ' N ' ' CD1' ' A' ' 173' ' ' ILE . 3.5 tm? -52.75 -27.79 19.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.953 0.406 . . . . 0.0 110.363 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -72.04 -29.78 64.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.744 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.467 ' CB ' HG22 ' A' ' 4' ' ' ILE . . . -80.84 -37.15 30.51 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.738 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.434 HD21 ' CG2' ' A' ' 4' ' ' ILE . 58.8 mt -70.76 -24.53 62.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.635 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 29.1 tp10 -165.2 137.05 3.33 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.526 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -49.8 141.65 27.58 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.376 2.05 . . . . 0.0 112.347 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.89 171.4 18.36 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.548 2.166 . . . . 0.0 112.222 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -154.24 151.31 24.0 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.055 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.48 -164.73 0.23 Allowed 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.669 2.246 . . . . 0.0 112.271 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 8.0 pttp -87.51 152.21 22.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.863 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.188 -0.911 . . . . 0.0 110.909 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.17 0 N-CA-C 112.449 -0.26 . . . . 0.0 112.449 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 503' ' ' SER . . . . . . . . . . . . . 75.3 m -96.18 -78.52 0.46 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.889 0.376 . . . . 0.0 110.857 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 504' ' ' GLY . . . . . . . . . . . . . . . 81.12 106.32 0.32 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.515 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 505' ' ' LEU . . . . . 0.478 ' CD1' ' N ' ' B' ' 505' ' ' LEU . 0.1 OUTLIER -166.58 99.27 0.58 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.93 0.395 . . . . 0.0 111.063 -179.947 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 506' ' ' SER . . . . . . . . . . . . . 13.3 p 59.76 -170.95 0.13 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.005 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 507' ' ' ALA . . . . . . . . . . . . . . . 59.31 -93.21 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.725 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 508' ' ' GLN . . . . . 0.426 ' O ' ' CB ' ' B' ' 509' ' ' ASP . 20.0 mt-30 -141.29 4.84 1.83 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.048 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 509' ' ' ASP . . . . . 0.426 ' CB ' ' O ' ' B' ' 508' ' ' GLN . 8.5 t70 81.83 35.39 0.08 Allowed 'General case' 0 C--N 1.341 0.238 0 CA-C-O 121.371 0.605 . . . . 0.0 109.704 -178.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 510' ' ' ILE . . . . . 0.451 ' CG2' HG12 ' A' ' 46' ' ' ILE . 87.4 mt -64.84 156.14 5.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.579 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 511' ' ' SER . . . . . 0.427 ' N ' HG21 ' B' ' 510' ' ' ILE . 8.7 t -109.54 167.39 10.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.098 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 512' ' ' GLN . . . . . 0.491 ' CB ' ' CD ' ' B' ' 513' ' ' PRO . 18.2 tt0 -114.2 -71.81 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.205 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 513' ' ' PRO . . . . . 0.491 ' CD ' ' CB ' ' B' ' 512' ' ' GLN . 93.5 Cg_endo -78.85 59.81 7.47 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.207 1.938 . . . . 0.0 111.29 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 514' ' ' LEU . . . . . 0.489 ' CD1' ' HA ' ' A' ' 46' ' ' ILE . 4.9 mt -53.31 -89.02 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.826 -178.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 515' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -92.99 -86.55 0.25 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.666 0.269 . . . . 0.0 111.255 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -127.57 -36.99 2.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.23 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 517' ' ' SER . . . . . 0.485 ' O ' ' CD1' ' B' ' 518' ' ' PHE . 6.4 m 72.01 22.8 3.64 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.047 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 518' ' ' PHE . . . . . 0.485 ' CD1' ' O ' ' B' ' 517' ' ' SER . 23.7 m-85 -140.99 91.79 2.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.79 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 519' ' ' ILE . . . . . 0.421 ' CG1' ' O ' ' A' ' 41' ' ' ALA . 7.3 mm -88.89 -11.06 10.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.667 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 72.56 104.75 0.07 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.84 0.353 . . . . 0.0 110.925 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 521' ' ' THR . . . . . . . . . . . . . 1.4 m -160.91 106.5 1.41 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.818 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 522' ' ' GLY . . . . . 0.473 ' O ' ' CZ ' ' A' ' 37' ' ' PHE . . . 143.2 178.67 19.24 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.349 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 523' ' ' HIS . . . . . . . . . . . . . 22.9 t60 -104.71 -83.42 0.5 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.745 0.307 . . . . 0.0 110.867 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 524' ' ' GLY . . . . . 0.444 ' CA ' HG23 ' A' ' 36' ' ' VAL . . . 49.68 -118.65 5.76 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.638 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 525' ' ' ASP . . . . . . . . . . . . . 1.2 p30 53.41 28.53 7.61 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 121.071 0.463 . . . . 0.0 110.498 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 526' ' ' SER . . . . . 0.45 ' CB ' ' CG1' ' A' ' 33' ' ' VAL . 3.9 m -57.15 100.1 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.207 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 527' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -37.44 162.08 0.05 OUTLIER Pre-proline 0 N--CA 1.467 0.381 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.227 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -53.75 104.79 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.195 2.597 . . . . 0.0 112.299 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 529' ' ' ARG . . . . . . . . . . . . . 2.3 mtt-85 -100.7 -42.42 6.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.073 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 530' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -153.32 -44.02 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.878 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 3.6 m 70.36 -160.53 0.15 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.876 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 532' ' ' TRP . . . . . . . . . . . . . 22.9 t90 -46.19 -65.0 0.62 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.159 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . 59.71 -87.13 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.622 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 534' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -116.56 152.67 48.52 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.698 0.285 . . . . 0.0 111.018 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -55.56 176.59 0.15 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.65 2.233 . . . . 0.0 112.456 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 59.92 92.86 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.082 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 537' ' ' ARG . . . . . 0.418 ' NH2' ' HB3' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -73.46 151.06 41.22 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.13 0.491 . . . . 0.0 110.844 179.829 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 538' ' ' ILE . . . . . 0.435 HG13 ' HB2' ' B' ' 542' ' ' TYR . 10.2 tp -61.18 157.22 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.262 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 539' ' ' ASP . . . . . 0.43 ' N ' HG13 ' B' ' 538' ' ' ILE . 2.3 m-20 -61.33 162.16 8.15 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.051 0.453 . . . . 0.0 111.126 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 540' ' ' GLU . . . . . 0.464 ' CG ' ' HB ' ' A' ' 8' ' ' VAL . 0.3 OUTLIER -48.22 -50.14 30.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.854 -179.633 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 541' ' ' LEU . . . . . 0.458 ' HB2' ' CD2' ' A' ' 70' ' ' LEU . 0.2 OUTLIER -39.99 -32.51 0.16 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.324 0.583 . . . . 0.0 111.063 -179.496 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 542' ' ' TYR . . . . . 0.435 ' HB2' HG13 ' B' ' 538' ' ' ILE . 35.3 m-85 -104.45 -59.21 1.77 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.896 -179.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 543' ' ' LEU . . . . . 0.489 ' HG ' ' PG ' ' A' ' 185' ' ' GNP . 2.0 tp 66.47 -67.68 0.15 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.061 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 544' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' B' ' 542' ' ' TYR . . . -89.02 139.41 15.25 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.485 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 545' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.945 179.979 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' GNP . . . . . 0.811 " H2'" ' OG1' ' A' ' 115' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' HOH . . . . . 0.413 ' H1 ' ' HB ' ' A' ' 35' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.484 ' CE ' ' CG2' ' A' ' 46' ' ' ILE . 1.3 tmt? . . . . . 0 N--CA 1.487 1.42 0 CA-C-O 120.84 0.352 . . . . 0.0 111.03 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 73.32 121.13 0.04 OUTLIER 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.994 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.445 HG22 ' CD1' ' A' ' 53' ' ' LEU . 0.3 OUTLIER -93.26 170.09 9.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.719 -179.345 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.462 ' HB ' ' CB ' ' A' ' 176' ' ' ALA . 0.1 OUTLIER -152.71 162.49 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -178.92 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.4 127.91 40.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.945 179.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 43.6 t -116.54 153.42 32.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.069 0.461 . . . . 0.0 111.906 -179.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.7 t -151.11 159.51 4.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.408 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.481 ' CG2' ' CG1' ' A' ' 14' ' ' VAL . 0.9 OUTLIER -110.91 155.77 12.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.323 0.582 . . . . 0.0 111.329 -179.848 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.425 HG12 ' CD1' ' A' ' 70' ' ' LEU . 66.9 t -159.17 129.91 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.042 179.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 138.44 -149.06 20.35 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.183 -1.008 . . . . 0.0 112.861 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' B' ' 537' ' ' ARG . 0.4 OUTLIER -110.8 27.15 9.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.938 0.399 . . . . 0.0 110.74 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -134.68 174.26 21.12 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.439 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.431 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -80.97 -57.63 3.45 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 123.063 -0.081 . . . . 0.0 111.195 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.481 ' CG1' ' CG2' ' A' ' 8' ' ' VAL . 13.8 p 23.96 44.61 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.443 ' CA ' HD12 ' A' ' 19' ' ' LEU . . . -125.39 -178.26 15.24 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.58 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.415 ' HB2' ' HG ' ' A' ' 55' ' ' LEU . 1.3 tmpt? -59.71 -17.68 36.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.585 0.231 . . . . 0.0 111.199 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.418 ' OG1' ' N ' ' A' ' 18' ' ' CYS . 34.1 p -79.58 -70.88 0.48 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.804 0.335 . . . . 0.0 111.463 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.418 ' N ' ' OG1' ' A' ' 17' ' ' THR . 16.5 t -62.49 -57.9 9.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.958 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.531 ' CD1' ' CE1' ' A' ' 169' ' ' PHE . 18.7 mt -47.87 -71.76 0.06 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -178.436 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.432 ' N ' ' CD2' ' A' ' 20' ' ' LEU . 2.5 mm? -56.74 -60.18 3.93 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -178.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.426 ' CG2' ' OG1' ' A' ' 25' ' ' THR . 50.0 mm -48.2 -70.52 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 120.936 -0.305 . . . . 0.0 111.189 -179.424 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.429 ' CB ' ' HB3' ' A' ' 159' ' ' ALA . 19.7 m -42.2 -29.3 0.24 Allowed 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 111.582 0.215 . . . . 0.0 111.582 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.482 ' CZ ' ' HG2' ' A' ' 166' ' ' LYS . 17.5 t80 -81.45 -68.72 0.67 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.856 0.36 . . . . 0.0 110.804 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.412 ' CG2' ' N ' ' A' ' 25' ' ' THR . 10.8 t -58.87 -46.75 87.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.128 0.489 . . . . 0.0 110.583 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.426 ' OG1' ' CG2' ' A' ' 21' ' ' ILE . 18.7 p -86.42 -153.46 0.2 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.431 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -150.03 55.5 0.94 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.658 0.266 . . . . 0.0 110.985 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.7 mttt -144.22 157.56 44.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.927 0.394 . . . . 0.0 111.252 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.492 ' CD2' ' HD3' ' A' ' 29' ' ' PRO . 0.5 OUTLIER -163.17 -64.64 0.01 OUTLIER Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.481 179.698 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.492 ' HD3' ' CD2' ' A' ' 28' ' ' PHE . 87.5 Cg_endo -81.77 57.87 6.51 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.62 2.213 . . . . 0.0 112.841 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.407 ' O ' ' N ' ' B' ' 532' ' ' TRP . 0.4 OUTLIER -131.45 -89.39 0.45 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.906 179.844 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.71 116.08 2.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.364 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.502 ' CD2' ' O2B' ' A' ' 185' ' ' GNP . 18.6 m-85 -111.17 92.39 4.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.078 0.466 . . . . 0.0 111.188 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.496 ' N ' ' CD ' ' A' ' 34' ' ' PRO . 2.8 t -105.69 -33.55 0.19 Allowed Pre-proline 0 CA--C 1.544 0.731 0 N-CA-C 114.174 1.175 . . . . 0.0 114.174 -179.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.496 ' CD ' ' N ' ' A' ' 33' ' ' VAL . 46.6 Cg_exo -40.44 -26.5 0.22 Allowed 'Trans proline' 0 C--N 1.357 1.022 0 C-N-CA 122.361 2.041 . . . . 0.0 113.965 -178.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.48 ' CG2' ' CD2' ' B' ' 543' ' ' LEU . 51.4 m -54.07 88.38 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.625 0.25 . . . . 0.0 111.041 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.476 ' CG1' ' CA ' ' B' ' 524' ' ' GLY . 7.6 p 171.2 -32.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.7 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -108.06 23.44 14.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.904 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -61.23 -16.69 47.87 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.271 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -45.54 -27.25 0.71 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.717 0.294 . . . . 0.0 111.516 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.482 ' OH ' ' CE1' ' B' ' 518' ' ' PHE . 2.7 p90 -60.27 142.53 54.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.93 0.395 . . . . 0.0 110.72 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.41 ' C ' ' CD1' ' B' ' 519' ' ' ILE . . . -91.17 -178.75 5.25 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.972 -179.205 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.46 ' HA ' HG13 ' B' ' 519' ' ' ILE . 18.3 m -131.31 121.28 48.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.441 178.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.442 ' O ' ' CG1' ' A' ' 44' ' ' VAL . 5.0 t -86.24 104.61 15.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.422 -179.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.442 ' CG1' ' O ' ' A' ' 43' ' ' THR . 29.5 m -161.23 144.3 4.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.177 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.518 ' HE2' ' N ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -77.55 96.4 4.76 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.428 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.484 ' CG2' ' CE ' ' A' ' 1' ' ' MET . 5.9 tt -97.29 96.11 5.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.285 -179.125 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.452 ' N ' ' HE1' ' A' ' 45' ' ' MET . . . 101.91 -108.53 3.39 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.378 -0.828 . . . . 0.0 112.937 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.464 ' N ' ' HE2' ' A' ' 45' ' ' MET . . . -118.11 -22.78 3.75 Favored Glycine 0 CA--C 1.521 0.419 0 C-N-CA 120.511 -0.852 . . . . 0.0 113.375 -179.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.518 ' N ' ' HE2' ' A' ' 45' ' ' MET . 2.0 mt-10 -117.4 132.54 23.5 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.995 0.398 . . . . 0.0 111.148 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.434 ' HA ' ' HA ' ' A' ' 45' ' ' MET . 42.9 Cg_endo -68.65 90.26 0.42 Allowed 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.853 2.369 . . . . 0.0 113.839 -179.225 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.528 ' O ' ' CD1' ' A' ' 51' ' ' TYR . 2.3 p90 -173.41 132.18 0.47 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.728 178.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.401 ' HB ' ' CG2' ' A' ' 42' ' ' VAL . 0.1 OUTLIER -129.91 141.51 50.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.027 0.441 . . . . 0.0 111.354 -179.046 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.455 HD23 ' N ' ' A' ' 4' ' ' ILE . 2.1 tp -89.18 148.58 23.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.838 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -87.3 178.97 47.98 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.213 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.465 ' N ' ' CD2' ' A' ' 55' ' ' LEU . 0.4 OUTLIER -112.3 136.62 51.52 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.73 0.3 . . . . 0.0 110.54 179.758 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -84.38 116.34 22.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.918 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.409 ' OD2' ' N ' ' A' ' 36' ' ' VAL . 16.0 p-10 -119.3 167.74 11.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.057 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.435 ' CB ' HD23 ' A' ' 67' ' ' LEU . 0.6 OUTLIER -154.22 139.92 18.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.984 -179.826 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.423 ' CB ' ' HB3' ' B' ' 543' ' ' LEU . . . -171.07 136.08 1.05 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.807 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.77 73.1 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.613 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.425 ' CD2' ' HB2' ' B' ' 525' ' ' ASP . 0.3 OUTLIER -121.17 -175.41 3.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.918 0.389 . . . . 0.0 111.022 179.957 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -49.76 -39.51 37.92 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.028 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.407 ' HB3' ' CG2' ' A' ' 36' ' ' VAL . 11.2 t0 -64.11 -62.7 1.46 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.102 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.48 ' CD2' HD21 ' A' ' 67' ' ' LEU . 0.5 OUTLIER -120.07 140.53 50.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.78 -179.802 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.85 -69.08 0.7 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -179.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.428 ' O ' ' HB2' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -98.65 -46.51 5.68 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 -178.939 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.48 HD21 ' CD2' ' A' ' 64' ' ' TYR . 1.2 mp 69.37 131.43 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.06 -179.214 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.546 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 6.9 mtp180 -130.38 36.59 0.35 Allowed Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.961 178.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.546 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 61.1 Cg_endo -84.23 -39.93 0.1 Allowed 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 122.122 1.881 . . . . 0.0 112.044 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.454 ' CD2' ' HB2' ' B' ' 541' ' ' LEU . 0.1 OUTLIER -83.98 -7.84 59.31 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.156 -179.802 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.9 t -49.07 -64.11 0.9 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.745 0.307 . . . . 0.0 111.026 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -159.0 55.83 0.85 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.086 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.0 160.86 46.48 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.532 2.155 . . . . 0.0 112.209 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.05 10.24 34.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.462 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 69.3 m -50.73 117.86 2.75 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.828 0.347 . . . . 0.0 110.907 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -76.12 -20.07 57.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.061 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.434 ' CG2' ' HB3' ' A' ' 176' ' ' ALA . 43.1 t -103.93 72.53 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.897 0.379 . . . . 0.0 111.18 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -80.82 172.54 13.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.559 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.422 HD22 ' CG2' ' A' ' 14' ' ' VAL . 1.2 tt -152.61 108.73 3.37 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.853 0.359 . . . . 0.0 111.147 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.8 m -93.1 133.1 35.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.701 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.403 ' SG ' ' CG1' ' A' ' 14' ' ' VAL . 1.2 p -119.17 138.16 53.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.092 0.472 . . . . 0.0 111.36 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.469 ' CZ ' ' HB1' ' A' ' 142' ' ' ALA . 39.5 p90 -135.26 -174.12 3.53 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.008 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.1 m -145.81 139.08 26.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.745 0.307 . . . . 0.0 110.797 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.1 t -53.67 -67.6 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.302 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.9 m -48.62 108.65 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.737 0.304 . . . . 0.0 110.725 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -151.55 128.9 5.62 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.687 -179.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.411 ' O ' ' CB ' ' A' ' 88' ' ' SER . 74.0 Cg_endo -92.56 53.36 0.56 Allowed 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 123.272 2.648 . . . . 0.0 111.723 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.416 ' OG ' ' CG ' ' A' ' 133' ' ' LYS . 0.1 OUTLIER 81.95 39.21 0.05 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.823 -179.415 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.415 ' O ' ' CG2' ' A' ' 93' ' ' VAL . 0.1 OUTLIER -97.25 -34.89 10.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.804 179.862 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.497 ' CZ ' HG21 ' A' ' 137' ' ' ILE . 0.0 OUTLIER -51.83 -37.95 53.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.827 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -50.81 -57.41 8.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.661 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.427 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 4.1 p-10 -74.93 -43.57 53.44 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.676 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.469 HG11 ' CD2' ' A' ' 97' ' ' TRP . 57.4 t -52.31 -31.61 15.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.991 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.09 -50.92 10.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.915 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -82.75 6.31 18.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.648 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.427 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.6 OUTLIER -115.13 -27.81 7.18 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.754 0.312 . . . . 0.0 111.063 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.469 ' CD2' HG11 ' A' ' 93' ' ' VAL . 38.1 m0 -91.59 -44.81 8.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.02 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.472 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 64.4 t -53.48 -46.03 98.29 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.792 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 97.4 Cg_endo -80.61 -15.22 11.08 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.334 2.023 . . . . 0.0 112.781 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -85.8 -36.14 20.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.948 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.8 pt -79.14 -25.53 12.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.104 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 47.8 p -89.42 -31.63 17.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.038 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 74.5 t60 -72.8 -54.97 7.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.065 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -71.07 -25.84 62.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.047 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 28.5 m -132.31 95.37 21.21 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.9 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -50.2 110.69 0.41 Allowed 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.573 2.182 . . . . 0.0 112.263 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 7.6 mmpt? 50.8 92.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.906 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.59 113.04 12.92 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.85 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.15 133.62 51.02 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.584 2.189 . . . . 0.0 112.446 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.499 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 0.8 OUTLIER -134.92 142.81 46.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.96 179.923 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.434 ' CD1' HG11 ' A' ' 152' ' ' VAL . 5.0 tt -110.92 141.45 44.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.197 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.425 ' O ' ' CD2' ' A' ' 111' ' ' LEU . 3.6 mm? -89.8 158.38 17.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.627 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.434 ' CG2' ' O6 ' ' A' ' 185' ' ' GNP . 0.0 OUTLIER -137.84 150.42 25.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.123 0.487 . . . . 0.0 111.804 -179.554 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -129.59 134.92 8.12 Favored Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.525 179.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.838 ' OG1' " H2'" ' A' ' 185' ' ' GNP . 0.0 OUTLIER -155.28 -41.49 0.08 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.859 0.33 . . . . 0.0 111.088 -179.279 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.443 ' HG2' ' CG ' ' A' ' 119' ' ' LEU . 10.5 tt0 -71.87 -9.09 57.82 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.322 178.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.449 HD12 ' N ' ' A' ' 117' ' ' ILE . 0.2 OUTLIER -54.39 -20.79 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.689 -179.848 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -75.55 -35.54 60.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.383 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.443 ' CG ' ' HG2' ' A' ' 116' ' ' GLN . 4.3 pp -97.02 14.21 26.38 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.626 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.403 ' O ' ' CD1' ' A' ' 126' ' ' ILE . 37.4 ptt85 -68.05 -27.29 66.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.951 0.405 . . . . 0.0 110.329 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -72.63 -25.68 61.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.827 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -47.58 101.63 0.27 Allowed Pre-proline 0 C--N 1.332 -0.169 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.703 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -67.83 -5.85 15.46 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.745 2.297 . . . . 0.0 113.049 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.46 -65.45 1.01 Allowed 'General case' 0 C--O 1.234 0.261 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.401 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 5.0 m -55.43 -38.94 69.65 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.449 ' HA ' ' CD1' ' A' ' 129' ' ' LEU . 0.1 OUTLIER -55.53 -47.41 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.713 179.179 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.413 ' N ' ' CG2' ' A' ' 126' ' ' ILE . 2.7 mm-40 -53.47 -35.77 60.91 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.02 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 125' ' ' THR . 1.7 mptp? -66.82 -32.09 73.14 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.449 ' CD1' ' HA ' ' A' ' 126' ' ' ILE . 6.2 mt -74.44 -36.8 63.39 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 177.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.464 ' HA ' ' HB2' ' A' ' 134' ' ' GLN . . . -43.98 -42.47 6.02 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.374 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.97 -26.38 10.41 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.365 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.408 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 29.5 m120 -124.61 -31.55 3.21 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -179.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.425 ' O ' ' HB2' ' A' ' 134' ' ' GLN . 6.4 mmpt? -152.06 -63.88 0.17 Allowed 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 -178.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.464 ' HB2' ' HA ' ' A' ' 130' ' ' ALA . 2.0 tt0 81.18 15.94 0.56 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.695 0.283 . . . . 0.0 110.97 -178.035 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 51.6 mttm -101.17 88.66 1.13 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.97 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -63.93 124.94 14.36 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.449 2.1 . . . . 0.0 111.859 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.497 HG21 ' CZ ' ' A' ' 90' ' ' PHE . 1.3 mm -60.14 97.25 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.106 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.9 p -74.34 153.83 88.05 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.807 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -47.14 -36.19 21.09 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.607 2.205 . . . . 0.0 112.324 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -67.9 -28.33 67.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.859 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 87.4 m -66.23 -53.55 35.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.841 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.469 ' HB1' ' CZ ' ' A' ' 82' ' ' PHE . . . -57.7 -36.66 72.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.898 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.98 -39.95 95.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.704 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 43.9 mttt -65.16 -51.61 60.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.862 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.16 -40.24 86.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.803 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -55.62 -44.81 77.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.037 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.25 -24.52 27.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.874 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -53.69 -31.57 48.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.855 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.428 ' CD1' HG21 ' A' ' 98' ' ' VAL . 2.1 mt -119.3 19.62 12.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.154 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 29.1 mmtm 48.06 42.42 16.85 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.784 0.326 . . . . 0.0 111.095 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.485 ' HB2' ' CE2' ' A' ' 110' ' ' PHE . . . -58.18 -81.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.913 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.434 HG11 ' CD1' ' A' ' 111' ' ' LEU . 47.6 t -160.73 -74.67 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.747 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 179.51 128.03 0.08 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.24 -179.057 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.462 ' CE2' ' HB3' ' A' ' 142' ' ' ALA . 38.3 t80 -100.19 112.49 24.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.755 178.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 2.8 t -101.52 154.58 4.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.416 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -90.55 120.13 31.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.94 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.404 ' O ' HD11 ' A' ' 117' ' ' ILE . 35.3 m -156.79 175.57 13.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.588 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.44 ' HA ' ' HA ' ' A' ' 115' ' ' THR . 4.6 t -158.07 145.16 17.96 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.089 0.471 . . . . 0.0 111.849 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.429 ' HB3' ' CB ' ' A' ' 22' ' ' SER . . . -104.72 -44.03 4.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.34 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.474 ' HB3' ' CE2' ' A' ' 28' ' ' PHE . 0.9 OUTLIER -62.94 -33.16 74.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.268 179.503 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -106.54 -21.74 12.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.565 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 77.9 60.48 0.03 OUTLIER 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.317 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.429 ' HB2' ' CB ' ' A' ' 158' ' ' SER . 0.5 OUTLIER -91.88 41.94 1.09 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.688 179.538 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.405 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . 104.09 -66.04 0.32 Allowed Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.719 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.451 ' CD2' ' HA ' ' A' ' 19' ' ' LEU . 0.5 OUTLIER 66.04 -66.77 0.16 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.724 0.297 . . . . 0.0 111.308 -179.914 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.482 ' HG2' ' CZ ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -50.09 -26.22 4.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.807 0.337 . . . . 0.0 110.872 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -62.22 -69.05 0.27 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.425 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.415 HG12 ' N ' ' A' ' 169' ' ' PHE . 14.0 p -54.41 -47.12 70.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.094 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.531 ' CE1' ' CD1' ' A' ' 19' ' ' LEU . 1.7 t80 -60.73 -31.86 71.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.338 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.442 ' O ' ' CD1' ' A' ' 173' ' ' ILE . 0.3 OUTLIER -62.48 -36.43 82.48 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.775 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -69.14 -28.77 66.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.633 178.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -61.04 -51.47 69.04 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.221 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.442 ' CD1' ' O ' ' A' ' 170' ' ' ASP . 0.1 OUTLIER -83.33 -23.65 8.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.031 -179.767 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.441 HD21 ' CD2' ' B' ' 505' ' ' LEU . 3.2 tm? -50.54 -48.53 57.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.048 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -51.02 -25.52 4.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.894 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.462 ' CB ' ' HB ' ' A' ' 4' ' ' ILE . . . -83.3 -42.77 16.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.11 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.434 ' CD1' HG23 ' B' ' 510' ' ' ILE . 8.3 mt -68.73 -17.54 64.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.991 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -171.79 145.11 1.62 Allowed Pre-proline 0 C--N 1.333 -0.109 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.746 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.9 127.99 28.62 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.619 2.212 . . . . 0.0 112.224 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.85 142.23 25.16 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.444 2.096 . . . . 0.0 112.242 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -113.99 141.48 26.33 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.92 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.3 -165.1 0.29 Allowed 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.639 2.226 . . . . 0.0 112.31 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 9.4 mttm -98.98 98.25 9.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.88 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.184 -0.913 . . . . 0.0 110.96 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.133 0 N-CA-C 112.509 -0.237 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 503' ' ' SER . . . . . 0.429 ' CB ' ' OD1' ' A' ' 170' ' ' ASP . 71.1 m -88.06 -81.55 0.25 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.79 0.329 . . . . 0.0 111.009 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 504' ' ' GLY . . . . . 0.419 ' N ' HD12 ' B' ' 505' ' ' LEU . . . 83.76 104.01 0.55 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.326 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 505' ' ' LEU . . . . . 0.5 ' N ' ' CD2' ' B' ' 505' ' ' LEU . 0.0 OUTLIER -148.38 90.44 1.8 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.911 0.386 . . . . 0.0 111.077 -179.137 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 506' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 55.57 -172.92 0.06 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.082 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 507' ' ' ALA . . . . . . . . . . . . . . . 63.86 -93.27 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.771 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 508' ' ' GLN . . . . . 0.423 ' O ' ' CB ' ' B' ' 509' ' ' ASP . 2.6 mt-30 -133.87 3.25 3.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.018 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 509' ' ' ASP . . . . . 0.423 ' CB ' ' O ' ' B' ' 508' ' ' GLN . 8.4 t70 80.61 36.67 0.1 Allowed 'General case' 0 CA--C 1.521 -0.165 0 CA-C-O 121.167 0.508 . . . . 0.0 109.915 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 510' ' ' ILE . . . . . 0.434 HG22 ' CG1' ' A' ' 46' ' ' ILE . 1.4 mp -53.75 128.59 13.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.162 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 511' ' ' SER . . . . . 0.438 ' HB2' ' CD2' ' B' ' 514' ' ' LEU . 11.5 m -109.33 158.57 17.76 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.16 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 512' ' ' GLN . . . . . 0.472 ' CB ' ' HD3' ' B' ' 513' ' ' PRO . 0.1 OUTLIER -103.24 -64.25 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.883 179.661 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 513' ' ' PRO . . . . . 0.472 ' HD3' ' CB ' ' B' ' 512' ' ' GLN . 67.7 Cg_endo -85.45 53.45 3.46 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.408 2.072 . . . . 0.0 112.202 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 514' ' ' LEU . . . . . 0.46 ' CD1' ' HA ' ' A' ' 46' ' ' ILE . 1.1 mp -62.62 -81.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.176 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 515' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -85.91 -85.0 0.16 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.897 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -120.66 -37.55 2.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.711 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 517' ' ' SER . . . . . 0.499 ' O ' ' CD1' ' B' ' 518' ' ' PHE . 0.9 OUTLIER 69.66 27.07 4.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.403 179.657 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 518' ' ' PHE . . . . . 0.499 ' CD1' ' O ' ' B' ' 517' ' ' SER . 24.9 m-85 -162.35 112.79 1.53 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.142 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 519' ' ' ILE . . . . . 0.46 HG13 ' HA ' ' A' ' 42' ' ' VAL . 31.3 mt -78.56 -30.09 15.04 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 CA-C-O 120.806 0.336 . . . . 0.0 110.703 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 63.39 94.45 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.885 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 521' ' ' THR . . . . . . . . . . . . . 2.2 t -167.93 47.65 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.844 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 522' ' ' GLY . . . . . . . . . . . . . . . -155.51 165.77 32.55 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.491 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 523' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -106.32 -84.83 0.51 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.737 0.303 . . . . 0.0 110.898 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 524' ' ' GLY . . . . . 0.476 ' CA ' ' CG1' ' A' ' 36' ' ' VAL . . . 75.97 21.34 76.47 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.619 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 525' ' ' ASP . . . . . 0.429 ' O ' ' CG1' ' A' ' 33' ' ' VAL . 26.2 m-20 50.93 56.74 7.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.842 0.353 . . . . 0.0 110.887 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 526' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.13 96.82 7.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.935 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 527' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -164.55 163.42 14.61 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.247 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -69.44 87.27 0.52 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 123.054 2.503 . . . . 0.0 111.734 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 529' ' ' ARG . . . . . . . . . . . . . 4.0 mtp180 -100.8 -45.67 5.39 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.527 -179.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 530' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -123.06 -42.76 2.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.057 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 3.7 m 72.72 138.81 0.05 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.924 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 532' ' ' TRP . . . . . 0.482 ' CZ2' ' HG3' ' B' ' 537' ' ' ARG . 11.2 t-105 -89.78 115.15 26.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.935 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . -110.46 -53.31 0.57 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.508 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 534' ' ' PHE . . . . . 0.475 ' O ' ' CZ2' ' B' ' 532' ' ' TRP . 32.2 m-85 -107.09 147.84 35.9 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.661 0.267 . . . . 0.0 110.881 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -67.61 -167.01 0.14 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.528 2.152 . . . . 0.0 112.298 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 70.14 102.51 0.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.945 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 537' ' ' ARG . . . . . 0.482 ' HG3' ' CZ2' ' B' ' 532' ' ' TRP . 0.0 OUTLIER -108.13 -177.11 3.24 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.391 0.615 . . . . 0.0 111.146 -179.991 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 538' ' ' ILE . . . . . 0.459 HG13 ' N ' ' B' ' 539' ' ' ASP . 11.4 pt -114.47 -156.05 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-N 114.999 -1.001 . . . . 0.0 109.749 179.295 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 539' ' ' ASP . . . . . 0.459 ' N ' HG13 ' B' ' 538' ' ' ILE . 0.3 OUTLIER -93.98 135.12 35.66 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.328 179.198 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 540' ' ' GLU . . . . . 0.437 ' HG3' ' CG1' ' A' ' 8' ' ' VAL . 1.4 mm-40 -41.33 -33.82 0.44 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.762 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 541' ' ' LEU . . . . . 0.485 HD23 ' CD1' ' B' ' 542' ' ' TYR . 2.4 tt -54.46 -34.36 61.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.117 0.484 . . . . 0.0 110.434 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 542' ' ' TYR . . . . . 0.485 ' CD1' HD23 ' B' ' 541' ' ' LEU . 89.4 m-85 -99.26 -6.55 27.85 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.923 -179.378 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 543' ' ' LEU . . . . . 0.48 ' CD2' ' CG2' ' A' ' 35' ' ' THR . 0.9 OUTLIER -50.17 167.03 0.06 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.789 0.328 . . . . 0.0 110.781 -179.786 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . 146.26 71.11 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.432 -0.89 . . . . 0.0 112.621 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 545' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.922 179.978 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' GNP . . . . . 0.838 " H2'" ' OG1' ' A' ' 115' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' HOH . . . . . 0.461 ' H2 ' ' HB3' ' A' ' 32' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.531 ' CE ' ' CD1' ' A' ' 51' ' ' TYR . 6.1 tpt . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.746 0.308 . . . . 0.0 111.263 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -100.04 150.88 22.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.022 0.439 . . . . 0.0 110.864 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.463 ' CG2' ' HB3' ' A' ' 53' ' ' LEU . 0.2 OUTLIER -93.46 -178.71 4.81 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.273 -179.538 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.479 ' CG2' ' CD2' ' A' ' 177' ' ' LEU . 3.8 pt -148.48 112.21 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.96 -179.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 44.8 mttt -94.85 95.83 8.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.191 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.523 ' CB ' ' CE2' ' A' ' 56' ' ' PHE . 4.0 m -121.35 136.99 54.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.666 -179.177 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.4 t -137.26 146.22 28.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.421 179.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.514 HG21 ' CD2' ' A' ' 56' ' ' PHE . 19.7 t -84.65 140.0 16.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.232 0.539 . . . . 0.0 111.668 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.41 ' N ' HG12 ' A' ' 8' ' ' VAL . 96.2 t -150.66 129.81 3.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.534 179.061 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 135.03 -148.8 19.71 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.089 -1.053 . . . . 0.0 112.63 -179.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -122.47 23.64 9.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.825 0.345 . . . . 0.0 110.721 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.401 ' HA2' ' HB2' ' B' ' 537' ' ' ARG . . . -142.28 148.9 20.71 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.451 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.439 ' CB ' ' O3A' ' A' ' 185' ' ' GNP . . . -98.79 4.76 47.7 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.466 ' CG1' ' N7 ' ' A' ' 185' ' ' GNP . 6.8 p -43.69 -31.26 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 CA-C-O 120.692 0.282 . . . . 0.0 111.463 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.428 ' CA ' HD11 ' A' ' 19' ' ' LEU . . . -113.27 18.94 20.55 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.415 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.432 ' NZ ' HD21 ' B' ' 543' ' ' LEU . 2.3 tttm -97.52 -126.49 0.15 Allowed 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 119.949 -0.072 . . . . 0.0 110.851 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.434 ' HB ' ' CG1' ' A' ' 21' ' ' ILE . 3.3 p -97.34 -31.08 12.58 Favored 'General case' 0 C--N 1.34 0.172 0 O-C-N 122.041 -0.412 . . . . 0.0 111.435 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.441 ' O ' ' CB ' ' A' ' 22' ' ' SER . 15.6 p -42.08 -36.38 1.13 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.903 -179.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.494 HD22 ' CG ' ' A' ' 169' ' ' PHE . 2.8 mp -48.4 -72.79 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.322 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.6 mt -78.12 -40.71 37.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.875 0.369 . . . . 0.0 110.612 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.478 ' CD1' ' CZ ' ' B' ' 518' ' ' PHE . 24.3 mm -62.56 -69.35 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.209 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.441 ' CB ' ' O ' ' A' ' 18' ' ' CYS . 1.5 t -52.86 -46.33 67.8 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.558 -179.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.425 ' CB ' ' O ' ' A' ' 19' ' ' LEU . 28.6 t80 -48.99 -42.66 38.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.686 0.279 . . . . 0.0 111.414 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.1 m -100.51 -64.59 1.03 Allowed 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.423 ' N ' ' O ' ' A' ' 21' ' ' ILE . 97.8 m -100.55 164.64 11.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.933 0.396 . . . . 0.0 111.379 -179.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.416 ' ND2' ' O ' ' A' ' 31' ' ' GLU . 7.1 t-20 73.89 -60.67 0.52 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.079 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 74.4 174.13 0.27 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.821 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.488 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 8.1 t80 -86.71 -46.22 0.54 Allowed Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.645 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.488 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 87.1 Cg_endo -82.99 50.8 3.47 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.501 2.134 . . . . 0.0 112.792 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.3 m -143.18 -100.46 0.12 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.79 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.416 ' O ' ' ND2' ' A' ' 26' ' ' ASN . 1.2 pt-20 -159.69 163.2 34.99 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.902 0.382 . . . . 0.0 111.073 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.482 ' CE2' ' O2A' ' A' ' 185' ' ' GNP . 36.9 m-85 -135.21 117.09 15.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.266 179.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.436 ' CG1' ' HG3' ' B' ' 529' ' ' ARG . 0.0 OUTLIER -163.39 -62.87 0.01 OUTLIER Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.686 -179.471 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.439 ' HB3' ' CB ' ' B' ' 526' ' ' SER . 29.0 Cg_endo -62.9 57.33 0.15 Allowed 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.816 2.344 . . . . 0.0 113.592 -179.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.438 HG22 ' PG ' ' A' ' 185' ' ' GNP . 4.0 t -122.74 22.45 9.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.846 0.355 . . . . 0.0 110.172 178.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.446 ' HA ' ' CB ' ' A' ' 59' ' ' ALA . 2.3 t -73.13 -45.64 53.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.751 -179.059 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.48 ' O ' ' CD2' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -85.5 48.77 1.64 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.786 0.327 . . . . 0.0 111.303 -179.731 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -69.75 -16.87 63.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.111 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -86.02 11.28 11.95 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.593 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.48 ' CD2' ' O ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -60.25 173.81 0.61 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.821 0.343 . . . . 0.0 110.725 179.874 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -92.16 147.43 22.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.174 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.408 HG13 ' HA ' ' B' ' 518' ' ' PHE . 6.7 m -134.91 147.05 29.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.887 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.423 ' N ' HD11 ' B' ' 519' ' ' ILE . 2.8 t -85.81 102.63 13.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.984 0.421 . . . . 0.0 109.911 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.455 HG22 ' N ' ' A' ' 45' ' ' MET . 1.1 p -165.77 145.61 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.872 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.455 ' N ' HG22 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -115.75 140.33 49.31 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.424 179.521 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.453 HG22 ' CG2' ' B' ' 510' ' ' ILE . 7.8 mm -95.38 115.46 34.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-O 120.947 0.403 . . . . 0.0 111.561 -179.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.423 ' O ' ' CE ' ' A' ' 45' ' ' MET . . . 33.18 -90.35 0.01 OUTLIER Glycine 0 C--N 1.336 0.552 0 CA-C-N 115.595 -0.73 . . . . 0.0 114.223 178.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . -41.14 -87.7 0.01 OUTLIER Glycine 0 C--N 1.332 0.315 0 C-N-CA 121.205 -0.522 . . . . 0.0 113.07 -179.435 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.413 ' HB3' ' HD2' ' A' ' 50' ' ' PRO . 1.1 mt-10 -143.51 165.36 25.53 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.406 0.103 . . . . 0.0 111.214 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.42 ' HA ' ' CB ' ' A' ' 45' ' ' MET . 39.2 Cg_exo -31.24 103.02 0.03 OUTLIER 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.619 2.879 . . . . 0.0 113.012 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.531 ' CD1' ' CE ' ' A' ' 1' ' ' MET . 8.7 t80 -172.53 120.67 0.41 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.772 -179.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.434 HG22 ' CG1' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -135.43 155.73 50.08 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.088 -178.741 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.463 ' HB3' ' CG2' ' A' ' 3' ' ' THR . 0.0 OUTLIER -115.55 156.3 26.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.186 179.973 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -62.26 109.85 2.87 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.6 -0.81 . . . . 0.0 111.875 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.22 -153.15 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.656 0.265 . . . . 0.0 110.895 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.523 ' CE2' ' CB ' ' A' ' 6' ' ' CYS . 9.0 m-85 -84.41 105.76 15.49 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 120.921 0.391 . . . . 0.0 111.127 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -120.74 113.06 19.64 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.939 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -154.21 125.77 7.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.87 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.446 ' CB ' ' HA ' ' A' ' 36' ' ' VAL . . . -172.52 119.86 0.39 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.992 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -95.18 75.45 0.89 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.445 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.43 ' CD1' ' CB ' ' A' ' 59' ' ' ALA . 3.5 mp -117.46 -115.09 0.33 Allowed 'General case' 0 CA--C 1.538 0.513 0 O-C-N 122.912 -0.17 . . . . 0.0 110.872 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -98.6 -29.55 12.99 Favored 'General case' 0 N--CA 1.455 -0.182 0 O-C-N 122.073 -0.392 . . . . 0.0 111.254 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.457 ' HB3' ' CD1' ' A' ' 64' ' ' TYR . 14.8 t0 -67.38 -63.25 1.1 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.066 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.457 ' CD1' ' HB3' ' A' ' 63' ' ' ASP . 0.2 OUTLIER -124.13 137.22 54.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.674 179.966 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -87.25 -62.5 1.49 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.897 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.476 ' N ' ' CD ' ' A' ' 66' ' ' ARG . 0.3 OUTLIER -98.68 -21.09 16.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.181 -179.777 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.425 ' CD2' ' HB2' ' A' ' 64' ' ' TYR . 1.7 mt 67.03 -135.38 0.13 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.297 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.467 ' CB ' ' CD ' ' A' ' 69' ' ' PRO . 1.2 mtt180 -166.06 -64.07 0.01 OUTLIER Pre-proline 0 CA--C 1.529 0.151 0 CA-C-N 118.28 0.491 . . . . 0.0 111.814 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.467 ' CD ' ' CB ' ' A' ' 68' ' ' ARG . 63.7 Cg_exo -36.96 -60.27 0.4 Allowed 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.965 2.443 . . . . 0.0 113.103 -179.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.406 ' CD1' ' C ' ' A' ' 70' ' ' LEU . 0.4 OUTLIER -50.08 -29.64 9.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.384 -179.752 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 68' ' ' ARG . 35.5 p -47.46 -64.76 0.7 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.759 0.314 . . . . 0.0 111.194 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.422 ' N ' ' OG ' ' A' ' 71' ' ' SER . 6.1 p90 -179.55 92.38 0.2 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.07 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.93 136.03 26.67 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.523 2.149 . . . . 0.0 112.313 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -87.4 10.91 15.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.512 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 11.7 t -70.13 -173.16 0.64 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.784 0.326 . . . . 0.0 110.933 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -124.31 7.69 8.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.431 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.404 ' O ' ' CG1' ' A' ' 77' ' ' VAL . 9.0 p -129.14 78.59 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.755 0.312 . . . . 0.0 111.388 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.526 ' CZ ' ' CG2' ' A' ' 108' ' ' THR . 7.6 m-30 -80.7 172.43 13.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.224 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.417 ' CD2' ' HA3' ' A' ' 15' ' ' GLY . 8.1 tp -143.83 108.55 4.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.876 0.37 . . . . 0.0 111.374 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.402 HG21 ' HB2' ' A' ' 110' ' ' PHE . 4.4 m -94.52 155.12 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.18 179.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.449 ' HB3' ' N7 ' ' A' ' 185' ' ' GNP . 2.3 m -134.85 146.21 49.03 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.194 0.521 . . . . 0.0 111.92 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -166.22 124.63 1.5 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.158 179.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.47 ' HA ' ' C2 ' ' A' ' 185' ' ' GNP . 0.1 OUTLIER -90.24 139.26 30.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.014 0.435 . . . . 0.0 111.562 -179.244 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.451 HG21 ' CB ' ' A' ' 116' ' ' GLN . 10.2 m -63.26 -170.1 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.408 179.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.425 ' CG1' HD12 ' A' ' 129' ' ' LEU . 0.1 OUTLIER 56.19 102.11 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -179.282 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.431 ' CA ' HD23 ' A' ' 129' ' ' LEU . 0.2 OUTLIER -151.26 145.9 18.49 Favored Pre-proline 0 C--N 1.325 -0.465 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.923 -179.183 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.425 ' N ' HD22 ' A' ' 129' ' ' LEU . 83.6 Cg_endo -85.73 50.04 2.51 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 123.121 2.548 . . . . 0.0 111.654 179.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.463 ' N ' ' HB3' ' A' ' 133' ' ' LYS . 2.6 t 82.9 27.8 0.11 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.877 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 44.5 t -97.3 -24.16 15.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.848 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -49.56 -62.1 1.74 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.066 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -50.36 -31.16 13.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.873 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.424 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 1.4 t-20 -72.59 -63.22 1.2 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.859 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.43 HG12 ' N ' ' A' ' 94' ' ' LYS . 12.9 p -52.43 -41.74 36.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.039 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.436 ' HG3' ' CD1' ' A' ' 145' ' ' LEU . 0.8 OUTLIER -55.87 -62.27 1.81 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.699 179.93 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -78.32 2.81 17.34 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.782 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.481 ' HD3' ' CZ3' ' A' ' 97' ' ' TRP . 55.9 tttt -105.24 -38.43 6.53 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.869 0.366 . . . . 0.0 110.56 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.481 ' CZ3' ' HD3' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -74.8 -49.45 20.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.15 179.967 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.464 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 67.8 t -47.01 -52.3 34.57 Favored Pre-proline 0 CA--C 1.532 0.28 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.919 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 60.7 Cg_endo -72.22 -20.57 24.53 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.112 1.875 . . . . 0.0 112.385 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -84.89 -46.26 11.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.015 0.436 . . . . 0.0 110.622 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 5.9 tt -66.07 -26.11 37.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.906 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 60.3 p -91.55 -26.53 18.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.739 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.454 ' CG ' ' O ' ' A' ' 99' ' ' PRO . 1.9 m170 -67.52 -69.25 0.33 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.828 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -64.32 -42.93 96.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.634 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 4.5 m -112.59 149.21 40.79 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.603 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -49.21 162.31 0.5 Allowed 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.509 2.139 . . . . 0.0 112.269 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.43 56.21 2.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.801 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.526 ' CG2' ' CZ ' ' A' ' 78' ' ' PHE . 1.3 p -81.58 165.33 44.63 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.227 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -60.62 162.68 17.45 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.856 2.37 . . . . 0.0 112.323 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.427 ' O ' ' CB ' ' A' ' 151' ' ' ALA . 8.8 p90 -156.07 153.83 30.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.757 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.433 ' CD1' HG12 ' A' ' 152' ' ' VAL . 4.7 tt -113.81 142.95 45.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.408 -179.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.421 ' O ' ' CD2' ' A' ' 111' ' ' LEU . 3.8 mm? -99.14 158.68 15.51 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.387 179.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.477 ' CG1' ' CG1' ' A' ' 168' ' ' VAL . 2.6 t -141.94 146.95 22.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.166 0.507 . . . . 0.0 112.193 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.482 ' HA3' ' CZ ' ' A' ' 154' ' ' TYR . . . -122.49 92.02 0.47 Allowed Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.968 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.663 ' OG1' " H2'" ' A' ' 185' ' ' GNP . 0.7 OUTLIER -114.34 6.76 16.18 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.281 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.605 ' CB ' HN22 ' A' ' 185' ' ' GNP . 2.3 mt-30 -110.22 25.86 11.31 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.301 0.572 . . . . 0.0 109.56 179.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.422 ' CD1' ' O ' ' A' ' 114' ' ' GLY . 0.0 OUTLIER -65.53 -10.45 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.501 179.008 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -96.9 -20.5 18.09 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.245 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.403 HD11 ' HA ' ' A' ' 116' ' ' GLN . 5.2 mp -89.02 -37.66 15.0 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.256 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -48.09 -31.56 5.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.828 0.347 . . . . 0.0 110.894 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -78.58 -37.06 43.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.485 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -47.97 104.24 0.4 Allowed Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.909 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.424 ' O ' ' CG ' ' A' ' 127' ' ' GLU . 55.4 Cg_endo -70.99 -6.17 18.61 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.444 2.096 . . . . 0.0 112.898 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.93 -66.58 0.77 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.401 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 17.2 m -57.51 -40.86 79.62 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.449 ' HA ' ' CD1' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -52.84 -46.56 52.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.805 179.231 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.424 ' CG ' ' O ' ' A' ' 123' ' ' PRO . 20.5 mm-40 -58.14 -33.69 69.46 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.9 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.432 ' HA ' ' CE ' ' A' ' 131' ' ' LYS . 9.9 mptt -68.99 -24.77 64.27 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 178.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.449 ' CD1' ' HA ' ' A' ' 126' ' ' ILE . 4.4 mt -79.43 -35.58 40.3 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 177.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.431 ' HA ' ' HB3' ' A' ' 134' ' ' GLN . . . -39.55 -39.1 0.67 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.033 -0.985 . . . . 0.0 112.391 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.432 ' CE ' ' HA ' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -69.88 -21.63 63.31 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.793 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.422 ' CB ' ' O ' ' A' ' 87' ' ' PRO . 17.5 m120 -124.01 -31.72 3.34 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -179.243 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.488 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 0.0 OUTLIER -139.63 -74.68 0.36 Allowed 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 -179.303 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.488 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 1.2 pt20 99.46 -41.21 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.075 0.95 . . . . 0.0 110.806 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.408 ' N ' ' HG2' ' A' ' 134' ' ' GLN . 0.8 OUTLIER -74.33 109.03 6.02 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.438 -179.648 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -68.28 -169.35 0.25 Allowed 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.253 1.968 . . . . 0.0 111.141 179.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.473 ' CD1' ' N ' ' A' ' 137' ' ' ILE . 1.0 OUTLIER -115.37 96.42 4.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.028 0.442 . . . . 0.0 110.585 179.877 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.415 ' O ' ' N ' ' A' ' 141' ' ' THR . 26.3 p -69.85 144.24 93.08 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.929 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.466 ' O ' ' CE1' ' A' ' 154' ' ' TYR . 1.8 Cg_endo -42.61 -46.07 8.22 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 122.893 2.395 . . . . 0.0 112.012 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -59.96 -32.66 71.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.417 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.415 ' N ' ' O ' ' A' ' 138' ' ' THR . 29.5 m -61.55 -53.17 59.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.686 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.526 ' CB ' ' CD2' ' A' ' 154' ' ' TYR . . . -51.91 -36.84 50.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.689 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -62.84 -40.88 98.8 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.492 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 37.4 tttp -59.38 -56.13 25.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.415 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.436 ' CD1' ' HG3' ' A' ' 94' ' ' LYS . 0.9 OUTLIER -62.15 -41.06 97.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.341 179.512 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -58.86 -53.19 61.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.739 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.06 -27.06 61.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.666 179.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -50.45 -45.08 55.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.709 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.11 20.73 18.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.926 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 18.9 mttt 48.67 63.55 2.05 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.091 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.433 ' O ' ' CG2' ' A' ' 152' ' ' VAL . . . -80.19 -82.29 0.11 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.959 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.433 ' CG2' ' O ' ' A' ' 151' ' ' ALA . 54.9 t -162.05 -75.6 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.794 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.17 120.14 0.12 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.855 -178.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.526 ' CD2' ' CB ' ' A' ' 142' ' ' ALA . 12.5 t80 -89.83 114.56 26.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.296 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 2.8 t -111.7 154.67 13.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.032 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -93.49 119.84 33.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.021 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 1.3 m -172.49 135.71 0.73 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.808 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.9 p -150.1 170.69 18.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.922 0.392 . . . . 0.0 111.153 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.39 -30.84 21.82 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.99 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.1 mt -51.38 -72.39 0.05 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.664 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 14.6 t -74.21 -16.81 60.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.086 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 71.07 50.84 0.3 Allowed 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.069 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -68.78 -21.02 64.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.969 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 139.05 -42.45 1.25 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.388 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.429 HD22 ' CD2' ' A' ' 19' ' ' LEU . 0.3 OUTLIER 68.15 -62.18 0.37 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.796 0.332 . . . . 0.0 111.079 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.426 ' O ' ' N ' ' A' ' 170' ' ' ASP . 0.1 OUTLIER -48.12 -25.52 1.49 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.388 -179.733 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -52.34 -71.64 0.06 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.798 0.332 . . . . 0.0 110.47 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.477 ' CG1' ' CG1' ' A' ' 113' ' ' VAL . 14.7 p -59.24 -29.92 42.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.266 0.555 . . . . 0.0 110.184 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.494 ' CG ' HD22 ' A' ' 19' ' ' LEU . 0.6 OUTLIER -67.53 -29.8 69.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.325 179.714 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 166' ' ' LYS . 68.9 m-20 -77.28 -27.72 53.17 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.191 179.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -75.5 -28.5 59.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.316 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.425 ' N ' HD13 ' A' ' 111' ' ' LEU . . . -75.02 -48.06 25.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.961 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 1.3 pp -65.72 -34.71 72.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.72 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.446 HD12 ' CD1' ' B' ' 505' ' ' LEU . 1.6 tp -48.86 -58.04 5.45 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.912 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -47.87 -26.46 1.69 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.136 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -77.29 -47.85 18.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.209 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.479 ' CD2' ' CG2' ' A' ' 4' ' ' ILE . 3.0 mt -68.53 -23.82 64.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.881 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.28 155.82 22.02 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.963 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.0 122.43 8.1 Favored 'Trans proline' 0 CA--C 1.529 0.253 0 C-N-CA 122.631 2.221 . . . . 0.0 112.18 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.53 175.82 5.64 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.434 2.09 . . . . 0.0 112.376 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 25.8 mp0 -144.63 96.72 5.12 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.887 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.23 -165.08 0.27 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.573 2.182 . . . . 0.0 112.235 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 5.8 mmtp -80.09 141.72 35.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.815 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.903 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.154 0 N-CA-C 112.521 -0.232 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 503' ' ' SER . . . . . . . . . . . . . 54.5 p -99.47 -160.49 0.81 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.745 0.307 . . . . 0.0 110.813 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 504' ' ' GLY . . . . . . . . . . . . . . . 149.23 95.81 0.15 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.331 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 505' ' ' LEU . . . . . 0.446 ' CD1' HD12 ' A' ' 174' ' ' LEU . 0.2 OUTLIER -157.43 146.51 19.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.057 0.456 . . . . 0.0 111.477 -179.698 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 506' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.05 81.83 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.728 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 507' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' B' ' 505' ' ' LEU . . . 170.82 43.71 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.486 -179.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 508' ' ' GLN . . . . . 0.444 ' HB2' ' CD1' ' B' ' 510' ' ' ILE . 0.0 OUTLIER 75.33 3.79 4.05 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.692 -177.385 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 509' ' ' ASP . . . . . . . . . . . . . 3.7 p30 45.9 53.16 9.23 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.164 0.507 . . . . 0.0 111.393 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 510' ' ' ILE . . . . . 0.453 ' CG2' HG22 ' A' ' 46' ' ' ILE . 1.2 mp -52.97 143.72 4.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.104 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 511' ' ' SER . . . . . 0.421 ' O ' ' CD1' ' B' ' 514' ' ' LEU . 22.8 t -108.67 153.74 23.0 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.889 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 512' ' ' GLN . . . . . 0.487 ' OE1' ' CD2' ' A' ' 169' ' ' PHE . 9.6 tt0 -102.46 -70.59 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.181 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 513' ' ' PRO . . . . . 0.487 ' CD ' ' CB ' ' B' ' 512' ' ' GLN . 87.5 Cg_endo -77.54 56.59 5.63 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.279 1.986 . . . . 0.0 111.617 179.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 514' ' ' LEU . . . . . 0.432 HD11 ' CG2' ' A' ' 44' ' ' VAL . 2.1 mp -60.72 -89.99 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.623 -179.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 515' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -84.15 -159.61 0.4 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.63 0.252 . . . . 0.0 110.792 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -48.12 -27.32 2.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.834 0.35 . . . . 0.0 110.733 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 517' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 39.57 33.75 0.13 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.724 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 518' ' ' PHE . . . . . 0.478 ' CZ ' ' CD1' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -163.51 106.72 1.0 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.371 -179.9 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 519' ' ' ILE . . . . . 0.423 HD11 ' N ' ' A' ' 43' ' ' THR . 3.6 mm -87.13 -37.31 10.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.906 0.384 . . . . 0.0 110.842 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -167.52 -170.75 1.5 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.668 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 521' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.27 157.54 19.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.849 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 522' ' ' GLY . . . . . 0.446 ' CA ' ' CB ' ' A' ' 37' ' ' PHE . . . -61.67 -126.52 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.32 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 523' ' ' HIS . . . . . 0.482 ' CD2' ' N ' ' B' ' 524' ' ' GLY . 41.1 t60 -165.05 -88.07 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.625 0.25 . . . . 0.0 111.065 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 524' ' ' GLY . . . . . 0.482 ' N ' ' CD2' ' B' ' 523' ' ' HIS . . . 42.49 -153.39 0.19 Allowed Glycine 0 C--N 1.334 0.418 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.841 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 525' ' ' ASP . . . . . 0.42 ' OD1' ' CD2' ' A' ' 61' ' ' LEU . 41.0 p-10 -83.29 65.81 8.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.902 0.382 . . . . 0.0 110.655 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 526' ' ' SER . . . . . 0.439 ' CB ' ' HB3' ' A' ' 34' ' ' PRO . 53.6 p -73.19 96.12 2.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.796 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 527' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -168.24 153.36 6.47 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.003 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.62 100.81 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.684 2.256 . . . . 0.0 112.069 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 529' ' ' ARG . . . . . 0.436 ' HG3' ' CG1' ' A' ' 33' ' ' VAL . 7.6 mtp85 -100.71 -55.34 2.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.286 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 530' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -162.94 98.33 0.95 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.123 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 19.2 t -46.81 95.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.887 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 532' ' ' TRP . . . . . 0.445 ' CE3' ' O ' ' B' ' 533' ' ' GLY . 21.0 t90 68.48 -67.36 0.2 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.948 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 533' ' ' GLY . . . . . 0.445 ' O ' ' CE3' ' B' ' 532' ' ' TRP . . . 87.34 -122.69 6.29 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.592 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 534' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -95.08 155.38 39.05 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 120.738 0.304 . . . . 0.0 110.87 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -64.54 166.38 17.77 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.619 2.213 . . . . 0.0 112.302 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 64.81 97.06 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.828 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 537' ' ' ARG . . . . . 0.401 ' HB2' ' HA2' ' A' ' 12' ' ' GLY . 0.2 OUTLIER -50.59 143.14 9.79 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.047 0.451 . . . . 0.0 111.054 -179.919 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 538' ' ' ILE . . . . . 0.439 ' CG2' ' HA ' ' B' ' 543' ' ' LEU . 6.1 tp -56.17 141.84 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.912 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 539' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -43.06 143.06 0.83 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.943 0.401 . . . . 0.0 111.387 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 540' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -54.15 -20.45 6.76 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.383 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 541' ' ' LEU . . . . . 0.406 ' HA ' HD13 ' A' ' 70' ' ' LEU . 3.9 mt -41.54 -57.9 2.09 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.878 0.37 . . . . 0.0 111.348 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 542' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -104.38 -63.54 1.2 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.804 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 543' ' ' LEU . . . . . 0.572 HD22 ' H2 ' ' A' ' 188' ' ' HOH . 0.3 OUTLIER 67.21 152.93 0.08 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.754 -179.834 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . 120.25 -123.98 5.77 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.536 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 545' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.911 179.903 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' GNP . . . . . 0.663 " H2'" ' OG1' ' A' ' 115' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' HOH . . . . . 0.572 ' H2 ' HD22 ' B' ' 543' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.439 ' CE ' HG23 ' A' ' 46' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.788 0.328 . . . . 0.0 111.204 . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.4 ' O ' ' CE ' ' A' ' 1' ' ' MET . 6.5 tt0 54.12 170.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.715 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.503 HG23 ' CE1' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -132.28 -172.46 2.9 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.317 -179.744 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.467 ' CG2' ' HG ' ' A' ' 177' ' ' LEU . 4.5 pt -153.14 132.06 3.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.526 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -91.45 95.78 10.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.575 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.43 ' CB ' HD11 ' A' ' 55' ' ' LEU . 1.1 m -80.37 98.64 7.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.273 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.1 t -126.25 159.43 35.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.478 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.4 t -128.97 117.62 44.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.039 0.447 . . . . 0.0 111.65 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 96.7 t -123.82 129.98 74.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.917 179.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 134.17 -164.91 24.48 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.205 -0.997 . . . . 0.0 112.612 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' B' ' 539' ' ' ASP . 1.2 m-20 -98.82 25.93 6.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.837 0.351 . . . . 0.0 110.572 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.422 ' HA3' ' N7 ' ' A' ' 185' ' ' GNP . . . -138.27 150.01 20.78 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.645 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.508 ' HB3' ' PA ' ' A' ' 185' ' ' GNP . . . -89.83 -14.93 33.36 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -179.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.452 HG21 ' C8 ' ' A' ' 185' ' ' GNP . 92.2 t -43.51 102.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-O 120.903 0.382 . . . . 0.0 111.29 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 142.12 -13.02 2.58 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.624 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.45 ' NZ ' ' CD2' ' B' ' 543' ' ' LEU . 77.0 mttt -97.61 -105.73 0.18 Allowed 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.645 0.222 . . . . 0.0 111.377 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.438 ' HB ' ' CG1' ' A' ' 21' ' ' ILE . 69.2 p -98.49 -39.32 8.81 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 -179.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.426 ' O ' ' CB ' ' A' ' 22' ' ' SER . 23.8 t -35.9 -34.19 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -179.021 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.486 HD13 ' CE2' ' A' ' 169' ' ' PHE . 0.0 OUTLIER -80.71 -70.31 0.54 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.761 0.315 . . . . 0.0 111.036 -179.746 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.406 ' CD2' ' O ' ' A' ' 16' ' ' LYS . 0.5 OUTLIER -50.84 -43.59 59.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.653 -179.908 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.464 ' CD1' ' CE2' ' B' ' 518' ' ' PHE . 32.5 mm -63.73 -64.05 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.171 179.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.426 ' CB ' ' O ' ' A' ' 18' ' ' CYS . 45.4 t -45.93 -30.17 1.67 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.958 0.408 . . . . 0.0 110.707 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -65.44 -45.24 84.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.412 179.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -87.39 -50.73 6.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.557 179.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.2 p -102.18 -158.55 0.68 Allowed 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.221 179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -159.33 38.45 0.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.005 0.431 . . . . 0.0 110.821 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.6 98.9 8.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.92 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.447 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . 9.4 t80 -97.56 -52.04 0.21 Allowed Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.024 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.447 ' HD3' ' HB3' ' A' ' 28' ' ' PHE . 65.3 Cg_endo -90.37 26.53 0.49 Allowed 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.782 2.321 . . . . 0.0 112.62 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.57 -87.32 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.129 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -158.13 115.86 2.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.844 0.354 . . . . 0.0 110.737 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.469 ' CE2' ' PB ' ' A' ' 185' ' ' GNP . 12.0 m-30 -105.83 119.5 39.32 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.759 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.475 ' CB ' ' HD3' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -161.86 -56.14 0.01 OUTLIER Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.145 179.863 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.48 ' O ' ' CD1' ' A' ' 37' ' ' PHE . 19.1 Cg_exo -66.22 -15.52 48.61 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.469 2.112 . . . . 0.0 112.558 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.0 t -41.94 -30.67 0.28 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.907 0.384 . . . . 0.0 111.387 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.445 ' CB ' HD12 ' A' ' 61' ' ' LEU . 12.3 p -51.29 -22.47 2.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.329 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.48 ' CD1' ' O ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -81.88 48.15 1.18 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.311 179.896 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.406 ' OD2' ' N ' ' A' ' 57' ' ' ASP . 14.6 p-10 -74.13 -2.6 25.29 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.498 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -83.94 11.11 8.26 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 111.603 0.223 . . . . 0.0 111.603 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 48.7 p90 -60.27 160.96 7.7 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.74 0.305 . . . . 0.0 110.616 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.423 ' O ' ' CG1' ' B' ' 519' ' ' ILE . . . -109.89 135.99 49.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.476 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.427 HG21 ' CG2' ' A' ' 52' ' ' THR . 13.5 m -114.57 121.68 67.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.824 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.43 ' O ' ' CG1' ' A' ' 44' ' ' VAL . 1.6 p -91.51 103.84 16.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.524 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.493 ' CG2' ' CG2' ' A' ' 52' ' ' THR . 29.2 m -159.26 -177.12 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.305 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.461 ' HE3' ' N ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -112.76 97.59 6.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.511 -179.58 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.442 ' O ' ' N ' ' A' ' 48' ' ' GLY . 1.6 mm -69.54 87.67 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.053 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 39.79 -90.59 0.01 OUTLIER Glycine 0 CA--C 1.521 0.466 0 CA-C-N 116.066 -0.516 . . . . 0.0 113.53 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . -38.38 -82.76 0.01 OUTLIER Glycine 0 C--N 1.334 0.467 0 C-N-CA 121.542 -0.361 . . . . 0.0 113.502 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.461 ' N ' ' HE3' ' A' ' 45' ' ' MET . 1.9 mt-10 -135.35 165.96 32.41 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-O 120.898 0.38 . . . . 0.0 111.581 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.415 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 51.4 Cg_exo -54.28 99.74 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.769 2.313 . . . . 0.0 113.032 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.503 ' CE1' HG23 ' A' ' 3' ' ' THR . 6.2 t80 -173.24 153.06 2.37 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.667 179.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.496 ' N ' ' CD1' ' A' ' 51' ' ' TYR . 0.8 OUTLIER -136.79 153.21 50.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.623 179.201 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.461 ' CD2' ' CD1' ' A' ' 4' ' ' ILE . 0.6 OUTLIER -80.93 -172.92 3.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.165 -179.879 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.408 ' O ' ' CE2' ' A' ' 56' ' ' PHE . . . -124.65 98.09 0.55 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.037 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.43 HD11 ' CB ' ' A' ' 6' ' ' CYS . 3.5 mm? -51.54 123.68 10.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.812 0.339 . . . . 0.0 111.053 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.408 ' CE2' ' O ' ' A' ' 54' ' ' GLY . 45.0 m-85 -113.6 118.75 35.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.786 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.41 ' HB2' ' CD ' ' A' ' 16' ' ' LYS . 35.6 p-10 -121.66 -176.57 3.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.119 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 75.7 p -124.52 130.83 53.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.923 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.43 ' CB ' HG22 ' A' ' 36' ' ' VAL . . . -140.93 -167.47 2.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.004 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.16 44.51 0.58 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.656 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.445 HD12 ' CB ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -121.33 -158.11 0.75 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.702 0.287 . . . . 0.0 110.898 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -62.84 -34.96 78.42 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.341 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.453 ' HB3' ' CD1' ' A' ' 64' ' ' TYR . 0.5 OUTLIER -47.37 -58.0 4.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.079 -179.848 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.453 ' CD1' ' HB3' ' A' ' 63' ' ' ASP . 0.1 OUTLIER -175.2 100.58 0.08 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.721 179.778 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.24 -21.91 39.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.158 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.42 ' HG2' ' N ' ' A' ' 67' ' ' LEU . 0.1 OUTLIER -88.29 -29.1 20.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.129 -179.852 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.42 ' N ' ' HG2' ' A' ' 66' ' ' ARG . 20.8 mt 51.86 -153.23 0.21 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.486 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.423 ' O ' ' N ' ' A' ' 71' ' ' SER . 0.3 OUTLIER 179.56 -56.87 0.0 OUTLIER Pre-proline 0 C--N 1.333 -0.152 0 CA-C-O 120.731 0.3 . . . . 0.0 111.427 -179.992 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -42.23 -27.99 0.81 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.673 2.249 . . . . 0.0 112.799 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.89 -31.18 22.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.903 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.423 ' N ' ' O ' ' A' ' 68' ' ' ARG . 35.0 t -47.45 -71.19 0.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.158 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.455 ' CD1' ' N ' ' A' ' 72' ' ' TYR . 0.0 OUTLIER 176.67 64.72 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.047 -179.855 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.98 172.9 11.99 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.51 2.14 . . . . 0.0 112.149 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 16.3 tp60 -87.98 10.2 19.71 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.495 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 12.3 t -52.35 161.13 0.7 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.783 0.325 . . . . 0.0 110.819 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -122.82 5.16 9.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.468 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.0 t -140.48 97.81 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.782 0.325 . . . . 0.0 111.117 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -95.59 -177.97 4.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.71 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.7 tp -147.35 108.8 4.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.255 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.0 m -95.09 131.02 43.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.359 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.435 ' HB3' ' N7 ' ' A' ' 185' ' ' GNP . 2.6 m -127.08 134.67 50.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.922 0.391 . . . . 0.0 111.42 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.421 ' N ' ' O6 ' ' A' ' 185' ' ' GNP . 10.6 p90 -148.06 132.47 17.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.546 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.462 ' HA ' ' C2 ' ' A' ' 185' ' ' GNP . 0.5 OUTLIER -83.84 133.14 34.76 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.251 -179.675 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.446 HG12 ' N ' ' A' ' 137' ' ' ILE . 59.5 t -42.45 -67.75 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.566 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.435 ' CA ' HD22 ' A' ' 129' ' ' LEU . 28.5 m -37.03 111.17 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-O 120.75 0.31 . . . . 0.0 111.379 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.42 ' N ' HD22 ' A' ' 129' ' ' LEU . 0.1 OUTLIER -151.5 139.24 12.62 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.828 -179.064 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.426 ' O ' ' CB ' ' A' ' 132' ' ' ASN . 91.6 Cg_endo -91.02 53.19 0.93 Allowed 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 123.189 2.592 . . . . 0.0 111.681 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.451 ' CA ' ' HB2' ' A' ' 133' ' ' LYS . 0.1 OUTLIER 70.68 19.45 6.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.077 -179.521 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.4 m -97.23 -23.37 16.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.964 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -47.1 -48.48 22.87 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.183 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -51.94 -40.4 60.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.991 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -76.62 -36.55 57.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.933 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.473 ' O ' ' CG ' ' A' ' 97' ' ' TRP . 62.9 t -51.09 -57.25 3.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.291 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.432 ' HG2' ' CD1' ' A' ' 145' ' ' LEU . 3.8 mptp? -73.6 -32.35 64.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.118 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -64.72 -23.99 67.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.093 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 13.5 ptmt -108.35 -17.67 13.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.4 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.473 ' CG ' ' O ' ' A' ' 93' ' ' VAL . 34.0 m0 -76.83 -54.4 6.65 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.765 0.317 . . . . 0.0 111.078 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.492 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 42.6 t -47.18 -50.15 48.55 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.841 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.492 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 62.2 Cg_endo -72.98 -16.19 25.81 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.145 1.897 . . . . 0.0 112.549 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -85.5 -39.63 17.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.906 0.384 . . . . 0.0 110.933 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 40.8 pt -71.58 -32.93 47.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.05 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 11.0 p -80.26 -32.69 38.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.908 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -64.73 -50.09 68.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.685 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -76.03 -33.08 59.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.855 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 41.6 m -125.92 101.18 29.68 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.832 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -44.33 93.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.55 2.167 . . . . 0.0 112.49 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.2 mmmm 53.95 103.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.85 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.55 129.21 15.22 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.753 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -60.2 162.82 15.91 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.448 2.099 . . . . 0.0 112.25 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.479 ' CE2' ' HB2' ' A' ' 151' ' ' ALA . 7.6 p90 -162.9 150.57 13.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.947 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.429 ' CD1' HG11 ' A' ' 152' ' ' VAL . 9.7 tt -120.51 150.67 40.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.063 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.435 HD11 ' CB ' ' A' ' 146' ' ' ALA . 20.0 mt -108.03 156.19 19.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.813 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.431 ' CG1' HG13 ' A' ' 168' ' ' VAL . 3.8 t -130.92 148.82 33.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.913 0.387 . . . . 0.0 111.44 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.427 ' HA3' ' CZ ' ' A' ' 154' ' ' TYR . . . -123.54 84.85 0.37 Allowed Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.266 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.692 ' OG1' " H2'" ' A' ' 185' ' ' GNP . 0.7 OUTLIER -106.52 7.32 30.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.657 0.265 . . . . 0.0 111.667 -179.558 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.557 ' N ' HN22 ' A' ' 185' ' ' GNP . 0.7 OUTLIER -98.07 -17.05 19.33 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.628 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.445 HD12 ' N ' ' A' ' 118' ' ' ASP . 0.2 OUTLIER -48.75 -24.11 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.831 179.238 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.445 ' N ' HD12 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -75.14 -22.14 58.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.163 -179.749 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.41 ' O ' ' N ' ' A' ' 122' ' ' ASP . 4.5 pp -122.45 -10.04 8.46 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.4 ' O ' ' CD1' ' A' ' 126' ' ' ILE . 0.7 OUTLIER -50.44 -27.18 5.99 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.942 0.401 . . . . 0.0 110.719 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -77.32 -26.62 52.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.529 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 119' ' ' LEU . 9.0 m-20 -50.81 103.92 0.4 Allowed Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.639 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -68.61 -3.99 12.24 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.8 2.334 . . . . 0.0 113.047 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 26.7 t -80.88 -67.42 0.78 Allowed 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.42 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 9.0 m -56.32 -32.74 64.92 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.408 0.623 . . . . 0.0 109.355 178.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.467 ' HA ' ' CD1' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -61.6 -43.33 96.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.466 179.196 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -56.2 -34.51 66.32 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.45 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 125' ' ' THR . 2.2 mptt -65.95 -32.95 74.74 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.467 ' CD1' ' HA ' ' A' ' 126' ' ' ILE . 6.8 mt -71.85 -39.3 69.79 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.449 ' HA ' ' HB3' ' A' ' 134' ' ' GLN . . . -48.01 -26.71 1.89 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.094 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.7 mmtp -64.69 -32.32 73.94 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.579 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.426 ' CB ' ' O ' ' A' ' 87' ' ' PRO . 47.8 m-80 -124.2 -30.99 3.38 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -179.186 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.492 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 0.0 OUTLIER -133.63 -73.16 0.49 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.345 -178.836 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.492 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 2.3 pt20 99.28 -33.42 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.866 0.866 . . . . 0.0 111.089 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -68.61 110.46 5.93 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.774 -178.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.436 ' HB3' ' CD1' ' A' ' 126' ' ' ILE . 72.4 Cg_endo -76.07 123.08 7.05 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.32 2.014 . . . . 0.0 111.355 179.049 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.446 ' N ' HG12 ' A' ' 84' ' ' VAL . 0.8 OUTLIER -57.38 96.36 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.549 -179.696 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.424 ' O ' ' N ' ' A' ' 141' ' ' THR . 0.5 OUTLIER -72.56 150.22 91.2 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.737 -179.808 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.442 ' HG3' ' CG2' ' A' ' 117' ' ' ILE . 97.8 Cg_exo -41.35 -38.34 3.61 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.682 2.255 . . . . 0.0 112.586 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -65.63 -33.36 75.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.004 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.427 ' CG2' HG21 ' A' ' 137' ' ' ILE . 58.5 m -60.15 -63.77 1.18 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.952 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.527 ' CB ' ' CD2' ' A' ' 154' ' ' TYR . . . -48.73 -48.16 40.78 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.807 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -58.98 -37.24 76.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.449 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -60.51 -58.38 8.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.48 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.432 ' CD1' ' HG2' ' A' ' 94' ' ' LYS . 0.5 OUTLIER -63.78 -33.32 75.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.393 179.574 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.435 ' CB ' HD11 ' A' ' 112' ' ' LEU . . . -65.05 -34.39 78.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.697 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -90.5 -25.31 20.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.655 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -57.01 -33.09 66.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.827 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.07 19.49 17.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.14 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt 47.91 40.31 12.58 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.196 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.479 ' HB2' ' CE2' ' A' ' 110' ' ' PHE . . . -58.4 -80.97 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.069 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.429 HG11 ' CD1' ' A' ' 111' ' ' LEU . 55.6 t -160.52 -75.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.744 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 176.07 126.82 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.773 -179.148 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.527 ' CD2' ' CB ' ' A' ' 142' ' ' ALA . 6.0 t80 -96.78 111.02 23.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.08 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 2.6 t -101.76 152.43 5.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.867 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -91.78 127.05 37.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.24 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.429 ' HA ' ' HB3' ' A' ' 163' ' ' LYS . 1.1 p 179.31 126.92 0.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.988 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.42 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 87.7 p -100.38 153.9 18.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.399 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.429 ' CB ' HD21 ' A' ' 165' ' ' LEU . . . -94.09 -35.58 12.49 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.828 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.2 mp -47.5 -41.74 21.54 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.641 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.0 t -112.97 -16.94 12.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.738 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.405 ' O ' ' NE2' ' A' ' 162' ' ' GLN . 0.8 OUTLIER 72.86 70.88 0.13 Allowed 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.837 179.983 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.429 ' HB3' ' HA ' ' A' ' 157' ' ' CYS . 2.1 tttm -87.84 -20.02 26.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.21 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 168.19 37.32 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.74 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.453 ' CD1' ' HA ' ' A' ' 19' ' ' LEU . 0.5 OUTLIER -47.82 -39.62 18.86 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.762 0.315 . . . . 0.0 110.914 179.966 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 13.8 pttp -72.61 -32.92 66.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.793 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -54.56 -70.3 0.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.597 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.431 HG13 ' CG1' ' A' ' 113' ' ' VAL . 7.7 p -53.7 -46.52 62.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.08 0.467 . . . . 0.0 110.358 179.525 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.486 ' CE2' HD13 ' A' ' 19' ' ' LEU . 0.8 OUTLIER -55.37 -34.09 64.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.239 179.324 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.423 ' HA ' ' CG1' ' A' ' 173' ' ' ILE . 52.5 t0 -62.13 -43.65 98.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.277 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -62.48 -28.99 70.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.367 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -78.73 -49.21 13.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.134 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.423 ' CG1' ' HA ' ' A' ' 170' ' ' ASP . 1.5 pp -72.05 -36.84 58.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.344 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -63.08 -32.67 74.1 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.969 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.69 -22.47 62.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.026 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -87.76 -31.41 19.65 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.102 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.481 ' CD1' ' CG2' ' B' ' 510' ' ' ILE . 0.3 OUTLIER -92.7 15.27 14.86 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.278 -179.87 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 176.92 98.11 0.11 Allowed Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.692 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -46.8 102.93 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.654 2.236 . . . . 0.0 112.547 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.26 170.88 19.37 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.59 2.193 . . . . 0.0 112.37 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -146.01 139.28 14.47 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.782 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -77.96 -165.27 0.32 Allowed 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.553 2.168 . . . . 0.0 112.332 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.9 153.95 32.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.879 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 2.3 mtpt . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.892 179.88 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.165 0 N-CA-C 112.458 -0.257 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 503' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.8 -86.62 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.714 0.292 . . . . 0.0 110.726 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 504' ' ' GLY . . . . . 0.464 ' HA2' ' N ' ' B' ' 510' ' ' ILE . . . 63.46 119.75 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.259 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 505' ' ' LEU . . . . . 0.483 ' N ' ' CD2' ' B' ' 505' ' ' LEU . 0.8 OUTLIER -173.66 115.59 0.23 Allowed 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 120.811 0.339 . . . . 0.0 111.818 -178.374 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 506' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 79.0 -74.11 0.06 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.615 179.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 507' ' ' ALA . . . . . 0.422 ' O ' ' CG ' ' B' ' 508' ' ' GLN . . . -35.26 -38.14 0.09 Allowed 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.436 0.636 . . . . 0.0 111.651 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 508' ' ' GLN . . . . . 0.519 ' O ' ' CB ' ' B' ' 509' ' ' ASP . 0.9 OUTLIER 159.47 -33.86 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.768 -1.105 . . . . 0.0 108.747 -179.677 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 509' ' ' ASP . . . . . 0.519 ' CB ' ' O ' ' B' ' 508' ' ' GLN . 27.0 t70 138.13 43.35 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 O-C-N 124.957 1.411 . . . . 0.0 109.704 179.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 510' ' ' ILE . . . . . 0.481 ' CG2' ' CD1' ' A' ' 177' ' ' LEU . 21.9 mm -60.4 107.63 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.701 179.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 511' ' ' SER . . . . . 0.431 ' CB ' ' HG ' ' B' ' 514' ' ' LEU . 3.9 m -101.89 130.07 48.28 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.949 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 512' ' ' GLN . . . . . 0.49 ' CB ' ' HD3' ' B' ' 513' ' ' PRO . 1.2 mm-40 -79.75 -66.87 0.25 Allowed Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.539 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 513' ' ' PRO . . . . . 0.49 ' HD3' ' CB ' ' B' ' 512' ' ' GLN . 79.0 Cg_endo -82.25 56.29 5.72 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.573 2.182 . . . . 0.0 111.84 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 514' ' ' LEU . . . . . 0.467 ' HB2' ' HB ' ' A' ' 44' ' ' VAL . 0.7 OUTLIER -55.53 -84.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.047 -179.583 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 515' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.62 -84.81 0.23 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.828 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -110.68 -36.8 5.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.538 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 517' ' ' SER . . . . . 0.417 ' HA ' ' HB ' ' A' ' 42' ' ' VAL . 15.4 m 52.58 27.23 4.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.205 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 518' ' ' PHE . . . . . 0.464 ' CE2' ' CD1' ' A' ' 21' ' ' ILE . 0.3 OUTLIER -163.54 91.59 0.68 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.365 -179.879 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 519' ' ' ILE . . . . . 0.423 ' CG1' ' O ' ' A' ' 41' ' ' ALA . 4.7 mm -101.35 131.82 48.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.858 0.361 . . . . 0.0 110.901 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -54.16 108.43 0.37 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.993 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 521' ' ' THR . . . . . . . . . . . . . 3.5 m -166.25 143.53 5.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.941 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 522' ' ' GLY . . . . . . . . . . . . . . . 128.47 179.06 15.67 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.552 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 523' ' ' HIS . . . . . . . . . . . . . 74.8 t60 -148.52 -84.12 0.1 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.808 0.337 . . . . 0.0 110.962 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 524' ' ' GLY . . . . . . . . . . . . . . . 57.81 -169.81 4.25 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.595 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 525' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -110.58 88.02 2.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.902 0.382 . . . . 0.0 110.86 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 526' ' ' SER . . . . . . . . . . . . . 35.6 p -77.44 95.59 4.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.786 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 527' ' ' ASP . . . . . 0.484 ' CB ' ' CD ' ' B' ' 528' ' ' PRO . 0.1 OUTLIER -174.32 -64.71 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.956 179.632 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 528' ' ' PRO . . . . . 0.484 ' CD ' ' CB ' ' B' ' 527' ' ' ASP . 20.3 Cg_endo -58.01 78.83 0.04 OUTLIER 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.971 2.447 . . . . 0.0 112.368 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 529' ' ' ARG . . . . . 0.448 ' HD3' ' CG2' ' A' ' 33' ' ' VAL . 7.0 mtt85 -82.8 -31.96 27.94 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.698 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 530' ' ' HIS . . . . . . . . . . . . . 9.4 m170 51.92 24.01 2.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.82 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 16.5 p 41.78 -163.8 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.377 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 532' ' ' TRP . . . . . 0.484 ' CZ2' ' HA ' ' B' ' 537' ' ' ARG . 34.9 t-105 -169.48 127.82 0.96 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.982 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . -159.62 35.4 0.47 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.234 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 534' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -109.66 161.62 23.45 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 120.708 0.289 . . . . 0.0 111.065 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -57.38 -57.44 1.26 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.622 2.215 . . . . 0.0 112.203 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -123.38 157.82 32.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.011 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 537' ' ' ARG . . . . . 0.484 ' HA ' ' CZ2' ' B' ' 532' ' ' TRP . 24.6 mmt180 -66.94 145.48 55.39 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.153 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 538' ' ' ILE . . . . . 0.445 ' CG2' HD12 ' B' ' 543' ' ' LEU . 5.8 tp -59.93 143.71 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.633 179.088 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 539' ' ' ASP . . . . . 0.453 ' O ' ' CD1' ' B' ' 543' ' ' LEU . 1.1 m-20 -42.7 128.33 4.08 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.812 0.339 . . . . 0.0 111.786 -179.05 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 540' ' ' GLU . . . . . 0.463 ' HA ' ' CD1' ' B' ' 543' ' ' LEU . 41.0 mm-40 -40.95 -24.47 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.27 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 541' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -31.12 -69.6 0.07 Allowed 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -179.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 542' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -104.45 -64.74 1.08 Allowed 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -178.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 543' ' ' LEU . . . . . 0.463 ' CD1' ' HA ' ' B' ' 540' ' ' GLU . 10.2 mp 58.37 179.5 0.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.739 0.304 . . . . 0.0 110.388 -178.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . -172.91 -54.84 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.503 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 545' ' ' ASN . . . . . . . . . . . . . 42.6 p30 . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.81 179.877 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' GNP . . . . . 0.692 " H2'" ' OG1' ' A' ' 115' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.422 ' CE ' ' HB ' ' A' ' 46' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.873 0.368 . . . . 0.0 111.107 . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.432 ' O ' ' CD2' ' A' ' 177' ' ' LEU . 5.4 tt0 -174.71 130.66 0.33 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.695 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.464 ' OG1' ' CD1' ' A' ' 51' ' ' TYR . 0.6 OUTLIER -116.86 -173.7 2.44 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.246 -179.591 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.512 ' CD1' ' N ' ' A' ' 4' ' ' ILE . 0.1 OUTLIER -151.38 163.27 2.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.769 -178.541 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.65 156.23 17.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.766 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.454 ' SG ' ' CZ ' ' A' ' 169' ' ' PHE . 0.0 OUTLIER -118.57 141.51 48.52 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.278 -179.755 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.1 t -148.34 159.77 7.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.669 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.432 HG13 ' N ' ' A' ' 9' ' ' VAL . 16.3 t -119.38 151.76 21.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.238 0.542 . . . . 0.0 111.753 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.432 ' N ' HG13 ' A' ' 8' ' ' VAL . 86.2 t -156.19 130.05 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.044 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.89 -140.52 14.74 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.197 -1.002 . . . . 0.0 112.836 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -123.23 27.85 7.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.657 0.265 . . . . 0.0 110.934 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -118.23 177.54 16.53 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.961 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.449 ' CB ' ' O2A' ' A' ' 185' ' ' GNP . . . -103.51 -26.85 12.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.775 0.322 . . . . 0.0 111.515 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.44 ' CG1' HG21 ' A' ' 113' ' ' VAL . 54.1 t -43.12 94.58 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 121.006 0.431 . . . . 0.0 111.418 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.447 ' HA2' ' CE1' ' A' ' 169' ' ' PHE . . . 132.89 -23.47 3.94 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.026 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.515 ' HD3' ' H2 ' ' A' ' 188' ' ' HOH . 14.7 mttt -90.3 -159.13 0.58 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.767 0.318 . . . . 0.0 110.709 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.439 ' HB ' ' CG1' ' A' ' 21' ' ' ILE . 31.5 p -66.46 -44.91 81.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.392 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.516 ' HB2' ' PB ' ' A' ' 185' ' ' GNP . 43.3 t -33.26 -58.54 0.39 Allowed 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.526 ' CD1' ' CD1' ' A' ' 169' ' ' PHE . 13.8 mt -42.2 -67.93 0.23 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.718 -179.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.468 ' N ' ' CD2' ' A' ' 20' ' ' LEU . 1.5 mm? -72.43 -25.73 61.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.444 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.439 ' CG1' ' HB ' ' A' ' 17' ' ' THR . 20.7 mm -70.83 -68.2 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.765 0.317 . . . . 0.0 110.565 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 27.1 t -57.77 -25.74 60.92 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.983 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.429 ' HB2' ' CD1' ' A' ' 165' ' ' LEU . 4.4 t80 -80.1 -68.52 0.67 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.005 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 97.8 m -70.26 -48.64 55.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.031 0.444 . . . . 0.0 110.658 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.433 ' N ' ' O ' ' A' ' 21' ' ' ILE . 0.2 OUTLIER -77.48 -156.04 0.08 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.646 179.876 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -149.7 40.13 0.81 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.719 0.295 . . . . 0.0 110.805 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.4 mtmt -133.51 126.88 32.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.969 0.414 . . . . 0.0 111.369 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.488 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . 3.6 t80 -163.66 -53.44 0.01 OUTLIER Pre-proline 0 CA--C 1.536 0.437 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.947 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.488 ' HD3' ' HB3' ' A' ' 28' ' ' PHE . 5.7 Cg_exo -79.55 56.44 6.05 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.774 2.316 . . . . 0.0 112.418 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.7 m -143.54 -80.03 0.2 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.755 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -157.69 162.43 38.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.593 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.528 ' CD2' ' N3B' ' A' ' 185' ' ' GNP . 9.3 m-85 -131.55 94.6 3.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.967 0.413 . . . . 0.0 111.108 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.446 ' CG1' ' HG3' ' B' ' 529' ' ' ARG . 0.2 OUTLIER -133.05 -56.2 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.666 179.703 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.464 ' O ' ' CZ ' ' A' ' 37' ' ' PHE . 7.8 Cg_exo -72.17 59.08 2.99 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.346 2.031 . . . . 0.0 111.983 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.8 t -120.53 21.89 11.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.88 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.429 ' HA ' ' CB ' ' A' ' 59' ' ' ALA . 2.4 t -83.84 -4.75 8.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.648 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.464 ' CZ ' ' O ' ' A' ' 34' ' ' PRO . 4.2 m-85 -46.03 -27.7 1.0 Allowed 'General case' 0 N--CA 1.461 0.099 0 CA-C-O 120.813 0.34 . . . . 0.0 111.108 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.8 t0 69.26 33.07 3.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.642 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.422 ' CB ' ' O ' ' A' ' 55' ' ' LEU . 8.3 m120 52.01 87.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.609 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.475 ' OH ' ' CZ ' ' B' ' 518' ' ' PHE . 3.2 p90 -59.98 -175.73 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.707 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -90.77 160.5 15.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.055 0.455 . . . . 0.0 111.823 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.4 ' HA ' HG12 ' B' ' 519' ' ' ILE . 3.5 m -127.25 128.19 69.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.621 179.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.432 ' CG2' HD13 ' B' ' 519' ' ' ILE . 59.1 p -85.59 104.76 15.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.943 0.401 . . . . 0.0 111.17 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.468 ' CG2' ' CG2' ' A' ' 52' ' ' THR . 20.7 m -157.79 -177.7 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.859 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.477 ' HE3' ' CA ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -128.03 116.93 20.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.349 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.445 ' O ' ' N ' ' A' ' 48' ' ' GLY . 0.8 OUTLIER -81.98 87.65 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.676 0.274 . . . . 0.0 111.668 -179.865 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 56.87 -78.08 0.01 OUTLIER Glycine 0 C--N 1.333 0.374 0 CA-C-N 116.105 -0.498 . . . . 0.0 113.776 178.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . -54.0 -99.78 0.01 OUTLIER Glycine 0 C--N 1.331 0.285 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.979 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.477 ' CA ' ' HE3' ' A' ' 45' ' ' MET . 0.6 OUTLIER -119.72 164.26 22.99 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 120.878 0.37 . . . . 0.0 111.396 -179.617 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.76 100.93 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.699 2.266 . . . . 0.0 112.596 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.464 ' CD1' ' OG1' ' A' ' 3' ' ' THR . 12.3 t80 -172.84 106.61 0.16 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.361 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.468 ' CG2' ' CG2' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -124.43 153.78 41.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.939 0.399 . . . . 0.0 111.038 -179.92 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.446 HD13 ' CA ' ' A' ' 4' ' ' ILE . 82.7 mt -113.44 100.0 8.19 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.863 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -46.17 164.13 0.11 Allowed Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.396 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.422 ' O ' ' CB ' ' A' ' 39' ' ' ASN . 2.4 mp -79.66 152.87 29.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.71 0.29 . . . . 0.0 110.847 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.422 ' CB ' ' O ' ' A' ' 6' ' ' CYS . 0.3 OUTLIER -103.32 122.05 44.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.524 -179.52 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.65 167.0 17.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.36 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.446 ' HB ' ' CD2' ' A' ' 67' ' ' LEU . 0.2 OUTLIER -149.41 128.72 12.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.905 0.383 . . . . 0.0 111.122 -179.444 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.429 ' CB ' ' HA ' ' A' ' 36' ' ' VAL . . . -144.86 100.73 3.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.664 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.65 83.05 0.38 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.717 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.428 HD13 ' CG2' ' A' ' 36' ' ' VAL . 3.9 mp -121.5 -108.36 0.35 Allowed 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.564 0.182 . . . . 0.0 111.027 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -99.03 -30.02 12.57 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 120.827 0.346 . . . . 0.0 111.167 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.9 -63.32 1.19 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.442 -179.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.41 ' HB2' ' HB3' ' A' ' 67' ' ' LEU . 0.4 OUTLIER -107.62 120.6 42.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.94 -179.624 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -87.16 -53.39 4.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 112.029 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.21 8.8 44.28 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -178.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.446 ' CD2' ' HB ' ' A' ' 58' ' ' THR . 0.0 OUTLIER -47.46 110.68 0.33 Allowed 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 120.728 0.299 . . . . 0.0 110.667 179.625 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.404 ' HG2' HD21 ' B' ' 541' ' ' LEU . 0.0 OUTLIER -149.97 70.92 9.45 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.235 -179.788 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.412 ' CG ' HG23 ' A' ' 58' ' ' THR . 88.9 Cg_endo -81.02 -37.07 0.33 Allowed 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.591 2.194 . . . . 0.0 112.455 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.443 ' CD2' ' HB2' ' B' ' 541' ' ' LEU . 0.1 OUTLIER -58.83 -18.2 30.36 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.002 -179.939 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.472 ' HB3' ' CD2' ' A' ' 72' ' ' TYR . 0.3 OUTLIER -43.34 -50.44 6.7 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.389 -179.962 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.472 ' CD2' ' HB3' ' A' ' 71' ' ' SER . 5.6 p90 -165.2 70.9 1.39 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.289 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -70.01 153.36 67.85 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.881 2.387 . . . . 0.0 112.063 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 -102.42 10.28 39.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.568 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 14.1 t -57.49 178.63 0.07 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.844 0.354 . . . . 0.0 110.986 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -115.85 -18.74 10.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.282 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.5 m -118.94 91.1 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.755 0.312 . . . . 0.0 111.284 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -81.14 121.64 26.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.486 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.434 ' CD1' HG11 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -83.48 108.52 16.67 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.953 0.406 . . . . 0.0 111.236 -179.675 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.401 HG21 ' HB2' ' A' ' 110' ' ' PHE . 3.3 m -110.25 100.7 11.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.887 179.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.437 ' HB2' ' N7 ' ' A' ' 185' ' ' GNP . 0.5 OUTLIER -113.37 146.94 38.65 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.536 -179.187 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.466 ' O ' ' N1 ' ' A' ' 185' ' ' GNP . 6.3 p90 -155.48 143.05 19.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.216 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.41 ' HA ' ' C2 ' ' A' ' 185' ' ' GNP . 0.1 OUTLIER -81.96 133.4 35.3 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.112 0.482 . . . . 0.0 111.188 -179.472 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.49 ' CG1' ' N ' ' A' ' 137' ' ' ILE . 89.2 t -48.5 -69.6 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.551 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.406 ' HB ' HG23 ' A' ' 125' ' ' THR . 16.0 m -40.84 110.45 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 120.742 0.306 . . . . 0.0 111.332 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.485 ' N ' ' CD2' ' A' ' 129' ' ' LEU . 52.4 p -154.36 134.03 7.69 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.772 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.408 ' O ' ' HB2' ' A' ' 133' ' ' LYS . 20.0 Cg_endo -61.21 -81.76 0.01 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 121.909 1.739 . . . . 0.0 111.408 179.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.9 t -144.87 24.55 1.49 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.832 0.349 . . . . 0.0 110.966 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.7 t -93.44 -21.88 19.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.176 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.439 ' CZ ' HG22 ' A' ' 137' ' ' ILE . 24.9 t80 -48.41 -49.01 36.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.178 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -57.84 -40.6 80.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.996 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 17.5 m-20 -67.42 -50.03 61.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.903 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.474 HG11 ' CE2' ' A' ' 97' ' ' TRP . 47.2 t -51.47 -52.37 20.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.193 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.3 tttp -52.31 -54.68 28.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.022 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -78.66 3.11 17.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.829 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.5 ttmm -115.2 -19.07 10.96 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.721 0.296 . . . . 0.0 111.184 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.474 ' CE2' HG11 ' A' ' 93' ' ' VAL . 27.9 m0 -93.74 -51.4 4.93 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.199 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.501 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 16.8 t -49.68 -44.98 78.71 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.706 -179.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.501 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 3.6 Cg_exo -74.88 -16.49 20.51 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.641 2.228 . . . . 0.0 112.612 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -90.19 -53.64 4.37 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.841 0.353 . . . . 0.0 110.976 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.514 ' CD1' ' CE2' ' A' ' 110' ' ' PHE . 1.0 OUTLIER -56.61 -24.2 18.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.151 179.997 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.7 p -88.8 -45.66 9.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.861 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -50.13 -32.68 16.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.959 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -79.52 -26.97 41.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.021 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -151.59 104.88 2.89 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.977 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -49.67 108.8 0.22 Allowed 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.397 2.065 . . . . 0.0 112.09 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 67.7 93.07 0.08 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.747 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.05 119.4 10.5 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.034 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -60.67 154.4 55.1 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.534 2.156 . . . . 0.0 112.438 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.514 ' CE2' ' CD1' ' A' ' 101' ' ' ILE . 1.2 p90 -151.53 147.85 27.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.864 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.424 HD12 ' N ' ' A' ' 172' ' ' ALA . 0.8 OUTLIER -110.38 160.67 16.37 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.417 -179.595 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -123.48 161.19 25.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.586 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.44 HG21 ' CG1' ' A' ' 14' ' ' VAL . 21.6 t -139.6 143.57 30.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.974 0.416 . . . . 0.0 111.912 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.442 ' O ' ' CD1' ' A' ' 117' ' ' ILE . . . -119.54 92.03 0.52 Allowed Glycine 0 C--N 1.331 0.297 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.005 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.666 ' OG1' " H2'" ' A' ' 185' ' ' GNP . 0.6 OUTLIER -117.25 9.51 13.48 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -178.836 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.632 ' CB ' HN22 ' A' ' 185' ' ' GNP . 1.9 mm-40 -114.74 11.97 16.94 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.879 0.371 . . . . 0.0 110.323 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.442 ' CD1' ' O ' ' A' ' 114' ' ' GLY . 0.1 OUTLIER -57.97 -17.37 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.718 179.043 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -100.13 -17.3 17.48 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.544 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.435 ' CD1' ' HA ' ' A' ' 116' ' ' GLN . 5.5 mp -91.79 -32.58 15.31 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.775 0.321 . . . . 0.0 110.992 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.415 ' CB ' ' HB2' ' A' ' 136' ' ' PRO . 1.0 OUTLIER -42.44 -52.42 4.66 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.361 -179.916 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.49 -42.59 98.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.58 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -45.37 102.79 0.31 Allowed Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.886 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.445 ' HA ' ' CG2' ' A' ' 126' ' ' ILE . 42.8 Cg_endo -68.6 -6.88 18.86 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.409 2.073 . . . . 0.0 112.947 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.34 -66.15 0.58 Allowed 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.045 0.45 . . . . 0.0 109.853 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.455 ' O ' ' N ' ' A' ' 128' ' ' LYS . 49.2 m -60.62 -49.37 77.79 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.445 ' CG2' ' HA ' ' A' ' 123' ' ' PRO . 0.0 OUTLIER -47.3 -36.98 4.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.001 179.566 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.59 -40.85 98.23 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.455 ' N ' ' O ' ' A' ' 125' ' ' THR . 0.2 OUTLIER -65.06 -33.73 76.74 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 177.992 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.488 HD11 ' N ' ' A' ' 129' ' ' LEU . 7.3 mp -68.83 -40.65 79.33 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 177.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -44.9 -31.37 1.23 Allowed 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.587 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -51.41 -27.27 9.63 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.986 179.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.468 ' O ' ' CG ' ' A' ' 133' ' ' LYS . 1.2 m-80 -123.3 -34.67 3.08 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.211 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.484 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 46.7 mttt -169.65 -86.21 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 O-C-N 123.107 0.255 . . . . 0.0 111.641 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.484 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 0.1 OUTLIER 102.49 106.7 0.01 OUTLIER 'General case' 0 C--N 1.351 0.638 0 C-N-CA 124.37 1.068 . . . . 0.0 110.38 -179.284 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.5 mmtm -159.38 92.44 1.84 Allowed Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.329 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.415 ' HB2' ' CB ' ' A' ' 120' ' ' ARG . 21.1 Cg_endo -62.12 103.22 0.29 Allowed 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 122.252 1.968 . . . . 0.0 112.306 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.49 ' N ' ' CG1' ' A' ' 84' ' ' VAL . 1.5 mm -45.31 106.56 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.443 179.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.421 ' O ' ' N ' ' A' ' 141' ' ' THR . 1.6 p -67.19 141.25 96.07 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.342 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -40.42 -29.77 0.42 Allowed 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.901 2.4 . . . . 0.0 112.015 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.35 -41.12 94.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.556 179.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.427 ' HB ' ' CG2' ' A' ' 137' ' ' ILE . 47.0 m -57.39 -66.61 0.43 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.009 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -47.7 -49.31 28.27 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.887 0.375 . . . . 0.0 110.919 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -64.16 -33.92 76.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.432 179.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 15.6 tttt -73.71 -46.63 44.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.631 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 14.5 tp -68.24 -39.91 82.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.208 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -62.11 -35.82 79.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.666 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.7 mtp180 -90.32 -29.86 17.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.666 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -50.79 -29.52 11.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.733 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.5 mt -123.02 21.09 9.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.91 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 45.5 mttt 48.08 52.24 13.45 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.943 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.471 ' O ' ' CG2' ' A' ' 152' ' ' VAL . . . -59.17 -83.37 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.032 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.471 ' CG2' ' O ' ' A' ' 151' ' ' ALA . 19.1 t -166.33 -68.38 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.285 179.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.04 144.04 2.06 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.144 0.497 . . . . 0.0 111.824 -179.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -135.96 102.57 5.08 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.434 ' HB ' ' CG2' ' A' ' 168' ' ' VAL . 2.3 t -105.93 167.87 3.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.328 -178.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -89.58 118.6 29.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.126 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.431 ' O ' ' CD1' ' A' ' 117' ' ' ILE . 17.9 p -144.92 -175.79 4.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.174 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.423 ' CB ' HG23 ' A' ' 161' ' ' THR . 3.1 m -159.61 158.29 31.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.965 0.412 . . . . 0.0 111.576 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -115.44 -33.41 5.27 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.464 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.19 -34.85 32.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.65 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.423 HG23 ' CB ' ' A' ' 158' ' ' SER . 5.0 t -113.0 -24.65 9.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.925 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 72.6 93.92 0.08 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.045 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -124.93 33.11 5.27 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.133 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 120.87 47.79 0.31 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.762 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.429 ' CD1' ' HB2' ' A' ' 23' ' ' TYR . 0.8 OUTLIER -56.52 -56.24 23.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.822 0.344 . . . . 0.0 110.745 179.838 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.403 ' O ' ' CB ' ' A' ' 170' ' ' ASP . 4.8 pttt -63.44 -29.14 70.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.805 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -51.54 -72.31 0.05 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.9 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.434 ' CG2' ' HB ' ' A' ' 155' ' ' VAL . 61.8 t -56.59 -53.36 42.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.994 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.526 ' CD1' ' CD1' ' A' ' 19' ' ' LEU . 3.2 t80 -53.24 -35.82 60.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.871 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.403 ' CB ' ' O ' ' A' ' 166' ' ' LYS . 5.3 m-20 -61.4 -40.34 94.02 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.915 0.388 . . . . 0.0 109.995 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -60.6 -34.89 74.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.163 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.424 ' N ' HD12 ' A' ' 111' ' ' LEU . . . -62.01 -65.0 0.76 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.68 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 1.4 pp -59.76 -41.53 85.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.985 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.436 HD23 ' N ' ' B' ' 505' ' ' LEU . 5.2 tp -60.37 -43.77 96.25 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.006 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -54.61 -22.33 13.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.943 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -86.49 -37.78 17.92 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.122 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.482 ' CD1' ' CG2' ' B' ' 510' ' ' ILE . 1.9 mt -72.94 -35.88 67.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.897 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -141.79 139.46 18.42 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.949 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.83 111.61 2.87 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.545 2.163 . . . . 0.0 112.286 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -64.35 167.05 15.55 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.355 2.036 . . . . 0.0 112.211 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -102.79 96.38 7.61 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.142 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -76.64 -164.93 0.28 Allowed 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.702 2.268 . . . . 0.0 112.208 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.53 83.16 4.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.901 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 14.6 mttm . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.892 179.967 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.174 0 N-CA-C 112.435 -0.266 . . . . 0.0 112.435 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 503' ' ' SER . . . . . . . . . . . . . 1.4 m -61.39 -177.23 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.812 0.339 . . . . 0.0 110.799 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 504' ' ' GLY . . . . . . . . . . . . . . . -99.78 65.27 0.62 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.387 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 505' ' ' LEU . . . . . 0.449 ' HA ' ' HB ' ' B' ' 510' ' ' ILE . 0.3 OUTLIER -108.92 159.89 16.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.05 0.453 . . . . 0.0 111.197 -179.971 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 506' ' ' SER . . . . . 0.401 ' HB3' HD12 ' A' ' 174' ' ' LEU . 11.3 t 165.8 -44.63 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.539 -179.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 507' ' ' ALA . . . . . . . . . . . . . . . -47.98 -28.31 2.68 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.159 178.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 508' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 167.17 -31.82 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.373 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 509' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 172.2 37.58 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.927 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 510' ' ' ILE . . . . . 0.482 ' CG2' ' CD1' ' A' ' 177' ' ' LEU . 46.9 mm -67.53 103.24 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.913 0.387 . . . . 0.0 111.286 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 511' ' ' SER . . . . . . . . . . . . . 2.1 m -101.43 131.79 47.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.921 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 512' ' ' GLN . . . . . 0.468 ' CB ' ' HD3' ' B' ' 513' ' ' PRO . 0.4 OUTLIER -93.41 -64.28 0.14 Allowed Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.144 -179.919 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 513' ' ' PRO . . . . . 0.468 ' HD3' ' CB ' ' B' ' 512' ' ' GLN . 89.4 Cg_endo -81.36 67.88 8.35 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.516 2.144 . . . . 0.0 112.521 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 514' ' ' LEU . . . . . 0.44 ' CD1' ' O ' ' A' ' 45' ' ' MET . 0.4 OUTLIER -81.16 -85.21 0.1 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.914 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 515' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -93.22 -158.9 0.64 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.671 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -46.97 -27.85 1.42 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.026 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 517' ' ' SER . . . . . . . . . . . . . 3.0 m 40.65 42.72 1.45 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.719 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 518' ' ' PHE . . . . . 0.475 ' CZ ' ' OH ' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -163.76 91.88 0.67 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.927 -179.951 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 519' ' ' ILE . . . . . 0.432 HD13 ' CG2' ' A' ' 43' ' ' THR . 6.2 mm -87.89 -33.74 6.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.748 0.309 . . . . 0.0 111.18 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 520' ' ' HIS . . . . . 0.457 ' HA ' ' CE2' ' A' ' 40' ' ' TYR . 0.7 OUTLIER 69.72 119.37 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.898 179.994 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 521' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -165.98 51.83 0.09 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.981 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 522' ' ' GLY . . . . . . . . . . . . . . . -138.26 157.62 24.51 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.445 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 523' ' ' HIS . . . . . . . . . . . . . 69.4 t60 -132.61 -84.74 0.47 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.662 0.268 . . . . 0.0 111.028 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 524' ' ' GLY . . . . . . . . . . . . . . . 66.22 176.67 7.14 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.465 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 525' ' ' ASP . . . . . 0.422 ' CB ' HD21 ' A' ' 61' ' ' LEU . 2.0 t0 -75.05 87.42 2.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.89 0.376 . . . . 0.0 110.837 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 526' ' ' SER . . . . . 0.419 ' CB ' ' HB3' ' A' ' 34' ' ' PRO . 1.1 m -89.62 95.98 10.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.884 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 527' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -159.13 145.71 12.58 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.939 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -68.83 105.59 1.35 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.705 2.27 . . . . 0.0 112.348 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 529' ' ' ARG . . . . . 0.446 ' HG3' ' CG1' ' A' ' 33' ' ' VAL . 0.1 OUTLIER -100.31 -55.13 2.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.051 -179.885 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 530' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -165.89 97.63 0.64 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.846 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 95.5 m -46.27 171.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.121 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 532' ' ' TRP . . . . . 0.483 ' CZ2' ' HG3' ' B' ' 537' ' ' ARG . 0.0 OUTLIER -49.65 158.03 0.5 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.0 -179.886 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . -155.71 -56.82 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.534 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 534' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -94.35 142.73 25.25 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.742 0.306 . . . . 0.0 111.052 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.29 74.09 1.56 Allowed 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.63 2.22 . . . . 0.0 112.308 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 2.8 p30 172.73 143.56 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.671 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 537' ' ' ARG . . . . . 0.483 ' HG3' ' CZ2' ' B' ' 532' ' ' TRP . 2.0 mpt_? -92.85 179.93 5.32 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.203 0.525 . . . . 0.0 111.172 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 538' ' ' ILE . . . . . 0.438 HG13 ' HB2' ' B' ' 542' ' ' TYR . 5.0 tp -118.06 134.87 60.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.196 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 539' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -50.86 145.19 7.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.61 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 540' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -45.69 -44.72 13.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.454 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 541' ' ' LEU . . . . . 0.492 HD23 ' CE1' ' B' ' 542' ' ' TYR . 1.7 tt -48.43 -40.28 25.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.432 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 542' ' ' TYR . . . . . 0.492 ' CE1' HD23 ' B' ' 541' ' ' LEU . 63.2 m-85 -102.49 9.25 39.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.931 -179.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 543' ' ' LEU . . . . . . . . . . . . . 3.1 tp -58.64 95.74 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.781 0.324 . . . . 0.0 110.71 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . 176.23 89.09 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.506 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 545' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.854 179.935 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' GNP . . . . . 0.666 " H2'" ' OG1' ' A' ' 115' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' HOH . . . . . 0.515 ' H2 ' ' HD3' ' A' ' 16' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.45 ' CE ' HG22 ' A' ' 46' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.375 0 CA-C-O 120.761 0.315 . . . . 0.0 111.222 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -111.19 127.03 55.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.219 0.533 . . . . 0.0 110.948 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.483 HG23 ' N ' ' A' ' 4' ' ' ILE . 36.8 m -104.19 158.2 16.61 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.739 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.485 ' CD1' ' N ' ' A' ' 4' ' ' ILE . 0.1 OUTLIER -155.25 160.34 2.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.852 -179.587 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.04 140.43 46.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.631 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.4 p -138.11 124.53 20.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.908 0.385 . . . . 0.0 111.573 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.1 t -114.04 136.57 50.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.45 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.8 p -84.84 113.52 23.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.952 0.406 . . . . 0.0 111.125 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.0 p -117.69 129.57 73.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.893 178.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.485 ' HA2' ' CE2' ' A' ' 97' ' ' TRP . . . 133.57 -160.35 23.97 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.267 -0.968 . . . . 0.0 112.455 -179.289 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -92.9 21.99 5.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.726 0.298 . . . . 0.0 111.047 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.14 160.2 51.05 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.538 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.452 ' O ' ' HB ' ' A' ' 14' ' ' VAL . . . -53.27 -57.3 11.0 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.489 0.185 . . . . 0.0 111.296 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.452 ' HB ' ' O ' ' A' ' 13' ' ' ALA . 2.6 p 154.88 94.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 O-C-N 123.75 0.656 . . . . 0.0 109.908 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.435 ' HA2' ' CD1' ' A' ' 19' ' ' LEU . . . -47.82 -22.79 2.11 Favored Glycine 0 CA--C 1.519 0.305 0 CA-C-N 115.844 -0.616 . . . . 0.0 113.502 -179.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.406 ' HG2' ' HB2' ' A' ' 55' ' ' LEU . 1.6 tmtm? -70.68 -59.74 2.65 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 122.544 -0.386 . . . . 0.0 111.676 -179.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.428 ' CG2' HG23 ' A' ' 35' ' ' THR . 1.2 p -97.34 -39.43 9.22 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -178.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.454 ' HA ' ' PA ' ' A' ' 185' ' ' GNP . 44.6 t -33.74 -73.49 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.182 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.494 HD11 ' CE1' ' A' ' 169' ' ' PHE . 0.3 OUTLIER -65.34 -68.22 0.38 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.827 -179.377 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.409 ' O ' ' N ' ' A' ' 23' ' ' TYR . 3.5 mt -49.0 -70.22 0.1 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.802 -179.043 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.426 ' HB ' ' O ' ' A' ' 17' ' ' THR . 1.1 tp -43.09 -48.49 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-O 120.817 0.341 . . . . 0.0 111.619 -179.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.422 ' OG ' ' ND2' ' A' ' 26' ' ' ASN . 35.2 t -62.48 -29.19 70.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.916 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.409 ' N ' ' O ' ' A' ' 20' ' ' LEU . 20.1 t80 -75.34 -37.43 60.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.949 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 10.1 t -87.23 -49.8 7.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.06 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 77.6 p -94.06 -61.77 1.47 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.88 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.422 ' ND2' ' OG ' ' A' ' 22' ' ' SER . 2.4 t-20 72.38 41.46 0.6 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.005 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -100.71 69.75 1.39 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.706 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.485 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 35.3 t80 -86.77 -45.59 0.54 Allowed Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.647 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.485 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 92.7 Cg_endo -82.22 73.41 5.66 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.354 2.036 . . . . 0.0 112.481 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.3 m -172.06 -85.34 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.982 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -158.29 164.57 36.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.016 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.513 ' CE2' ' N3B' ' A' ' 185' ' ' GNP . 10.2 m-85 -130.86 124.17 30.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.471 ' HB ' ' HD3' ' A' ' 34' ' ' PRO . 1.5 t -157.1 -53.61 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.772 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.471 ' HD3' ' HB ' ' A' ' 33' ' ' VAL . 5.4 Cg_exo -74.84 56.4 4.15 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.458 2.105 . . . . 0.0 112.292 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.428 HG23 ' CG2' ' A' ' 17' ' ' THR . 18.7 m -106.95 -20.64 13.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.844 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.489 ' CG1' ' CB ' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -42.38 -65.13 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.767 -0.197 . . . . 0.0 110.863 179.8 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.437 ' O ' ' N ' ' A' ' 39' ' ' ASN . 10.8 m-85 33.92 -88.4 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.684 0.615 . . . . 0.0 112.171 179.091 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.473 ' N ' ' O ' ' A' ' 36' ' ' VAL . 96.9 m-20 65.29 -65.46 0.16 Allowed 'General case' 0 CA--C 1.527 0.087 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.584 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.437 ' N ' ' O ' ' A' ' 37' ' ' PHE . 1.1 p-10 -71.7 -4.49 27.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.772 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.486 ' CZ ' HG22 ' B' ' 521' ' ' THR . 0.4 OUTLIER -59.78 95.36 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.925 0.393 . . . . 0.0 110.302 179.793 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.404 ' O ' HD12 ' B' ' 519' ' ' ILE . . . -90.36 -179.37 5.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.11 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.446 ' HA ' HD12 ' B' ' 519' ' ' ILE . 34.5 m -144.12 161.04 15.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.083 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.8 p -125.48 105.87 9.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.173 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.472 ' CG2' ' CG2' ' A' ' 52' ' ' THR . 19.2 m -156.32 -177.55 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.086 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.48 ' HE1' ' N ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -100.79 97.44 8.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.532 -179.486 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.45 HG22 ' CE ' ' A' ' 1' ' ' MET . 1.5 mm -70.91 91.08 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-O 120.824 0.345 . . . . 0.0 110.242 179.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 38.62 -91.81 0.01 OUTLIER Glycine 0 CA--C 1.519 0.337 0 CA-C-N 116.002 -0.545 . . . . 0.0 113.654 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . -39.85 -82.93 0.01 OUTLIER Glycine 0 C--N 1.333 0.374 0 C-N-CA 121.457 -0.402 . . . . 0.0 113.406 -179.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.48 ' N ' ' HE1' ' A' ' 45' ' ' MET . 2.7 mt-10 -133.99 165.7 34.75 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.786 0.327 . . . . 0.0 111.402 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.415 ' HD2' ' HB3' ' A' ' 49' ' ' GLU . 82.7 Cg_exo -48.36 104.69 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.6 2.2 . . . . 0.0 112.955 -179.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.509 ' CD1' ' N ' ' A' ' 52' ' ' THR . 14.1 t80 -172.46 155.59 3.48 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.275 179.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.509 ' N ' ' CD1' ' A' ' 51' ' ' TYR . 1.8 p -138.31 153.34 49.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.18 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.474 ' CD1' ' CD1' ' A' ' 4' ' ' ILE . 0.3 OUTLIER -110.47 99.36 8.37 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.835 179.716 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -50.97 -179.17 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.366 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.406 ' HB2' ' HG2' ' A' ' 16' ' ' LYS . 1.8 mp -139.72 97.65 3.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.853 0.359 . . . . 0.0 110.565 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -84.28 114.88 22.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.628 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -113.97 -175.56 2.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.376 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.413 ' CB ' ' O ' ' B' ' 540' ' ' GLU . 18.4 p -89.67 -175.73 4.76 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.617 -179.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.489 ' CB ' ' CG1' ' A' ' 36' ' ' VAL . . . -172.26 168.15 5.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.553 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -149.15 21.25 1.23 Allowed Glycine 0 C--N 1.329 0.189 0 C-N-CA 120.384 -0.912 . . . . 0.0 112.759 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.455 ' CG ' HG12 ' A' ' 36' ' ' VAL . 0.2 OUTLIER -121.34 -171.59 2.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.568 0.223 . . . . 0.0 110.777 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -38.24 -31.2 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.877 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.433 ' HB3' ' CD1' ' A' ' 64' ' ' TYR . 0.2 OUTLIER -45.28 -63.18 1.0 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.143 179.875 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.518 ' CD1' ' N ' ' A' ' 64' ' ' TYR . 0.0 OUTLIER 166.82 77.48 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.981 179.777 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -62.48 -22.22 66.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.059 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.45 -21.74 10.7 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.311 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.481 ' CD2' ' N ' ' A' ' 59' ' ' ALA . 3.4 pp -48.02 141.29 6.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.794 0.33 . . . . 0.0 111.058 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.467 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 1.1 ptm180 -158.84 49.58 0.33 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.035 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.467 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 61.4 Cg_endo -74.4 -48.49 0.2 Allowed 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.451 2.1 . . . . 0.0 112.386 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.51 ' CD2' ' N ' ' B' ' 541' ' ' LEU . 0.6 OUTLIER -51.27 -24.43 4.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.966 179.882 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 69.3 m -51.1 -30.13 15.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.854 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.433 ' N ' ' HD3' ' A' ' 73' ' ' PRO . 5.4 t80 177.3 65.04 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.821 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.433 ' HD3' ' N ' ' A' ' 72' ' ' TYR . 13.5 Cg_exo -69.3 154.62 69.3 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.706 2.271 . . . . 0.0 112.302 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.62 10.46 40.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.169 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.4 m -49.5 172.82 0.02 OUTLIER 'General case' 0 C--N 1.334 -0.108 0 CA-C-O 120.849 0.357 . . . . 0.0 110.897 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -113.89 -23.91 9.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.032 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.404 ' O ' ' CG1' ' A' ' 77' ' ' VAL . 7.2 p -130.22 92.38 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.283 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.512 ' CE1' ' CG2' ' A' ' 108' ' ' THR . 15.2 m-85 -80.78 167.32 20.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.623 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 38.8 tp -141.88 109.06 5.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.976 0.417 . . . . 0.0 111.297 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 29.1 m -96.93 126.51 49.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.583 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 1.6 m -116.77 158.95 23.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.161 0.505 . . . . 0.0 111.711 -179.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.437 ' O ' ' C6 ' ' A' ' 185' ' ' GNP . 41.7 p90 -147.15 -173.79 4.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.89 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.0 p -138.59 131.58 29.7 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.795 0.331 . . . . 0.0 111.116 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.408 ' O ' HG12 ' A' ' 137' ' ' ILE . 60.9 t -47.57 -72.06 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.186 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.43 HG21 ' NE2' ' A' ' 116' ' ' GLN . 32.6 m -46.58 106.85 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.81 0.338 . . . . 0.0 110.527 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -149.99 137.35 11.49 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.551 -179.175 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.416 ' O ' ' CB ' ' A' ' 88' ' ' SER . 85.1 Cg_endo -91.76 53.29 0.75 Allowed 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.214 2.61 . . . . 0.0 111.778 179.49 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.442 ' CB ' ' HG3' ' A' ' 133' ' ' LYS . 0.1 OUTLIER 81.09 30.65 0.15 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.79 -179.534 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -96.85 -25.94 15.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.063 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.483 ' CE2' HG22 ' A' ' 137' ' ' ILE . 6.4 t80 -50.74 -59.85 3.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.061 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -50.19 -57.88 6.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.9 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -51.35 -62.73 1.44 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.867 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 60.3 t -44.55 -47.12 2.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.414 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.418 ' O ' ' CG2' ' A' ' 98' ' ' VAL . 1.3 tmtt? -53.69 -51.01 64.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.705 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -84.0 6.59 21.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.486 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -110.52 -31.61 7.19 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.69 0.281 . . . . 0.0 111.021 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.485 ' CE2' ' HA2' ' A' ' 10' ' ' GLY . 0.5 OUTLIER -94.11 -44.93 7.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.372 -179.722 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.476 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 79.2 t -50.24 -46.41 83.21 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.575 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 97.5 Cg_endo -81.08 -15.13 10.53 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.288 1.992 . . . . 0.0 112.633 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -89.32 -44.96 9.85 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.872 0.368 . . . . 0.0 110.832 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 7.5 tt -66.48 -30.65 50.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.145 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 38.9 p -83.19 -26.52 30.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.931 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.09 -51.5 53.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.904 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.407 ' O ' ' CE1' ' A' ' 72' ' ' TYR . 27.7 m170 -69.5 -44.31 71.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.979 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.409 ' O ' ' N ' ' A' ' 107' ' ' LYS . 0.6 OUTLIER -111.95 126.65 28.1 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.834 -179.961 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -57.63 81.23 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.475 2.117 . . . . 0.0 112.269 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.409 ' N ' ' O ' ' A' ' 105' ' ' CYS . 0.1 OUTLIER 53.44 97.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.895 -179.993 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.512 ' CG2' ' CE1' ' A' ' 78' ' ' PHE . 0.1 OUTLIER -117.85 141.26 28.86 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.804 179.998 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.02 142.63 98.83 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.553 2.169 . . . . 0.0 112.412 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.476 ' CD2' ' HB3' ' A' ' 151' ' ' ALA . 1.9 p90 -147.78 136.27 21.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.816 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.426 HD13 ' CG1' ' A' ' 152' ' ' VAL . 4.8 tt -110.31 155.16 22.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.127 -179.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.414 ' O ' ' CD2' ' A' ' 111' ' ' LEU . 3.6 mm? -108.98 147.39 32.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.493 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.403 ' HA ' HG13 ' A' ' 168' ' ' VAL . 2.7 t -131.62 147.72 32.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.935 0.397 . . . . 0.0 111.855 -179.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.408 ' O ' ' CD1' ' A' ' 117' ' ' ILE . . . -125.55 100.64 0.6 Allowed Glycine 0 N--CA 1.453 -0.222 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.924 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.78 ' OG1' " H2'" ' A' ' 185' ' ' GNP . 0.1 OUTLIER -116.18 -45.05 2.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.994 0.426 . . . . 0.0 110.894 -179.205 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.488 ' CB ' HN21 ' A' ' 185' ' ' GNP . 9.3 tt0 -64.96 -10.27 27.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.054 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.432 HG12 ' N ' ' A' ' 118' ' ' ASP . 0.2 OUTLIER -42.93 -27.74 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-O 120.717 0.294 . . . . 0.0 111.626 179.709 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.432 ' N ' HG12 ' A' ' 117' ' ' ILE . 1.7 m-20 -71.29 -30.16 65.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.36 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.8 mp -79.91 -23.18 41.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.129 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.417 ' CG ' ' O ' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -44.85 -29.22 0.76 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.934 0.397 . . . . 0.0 110.941 179.975 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.4 -38.69 34.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.549 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -46.47 103.37 0.35 Allowed Pre-proline 0 C--N 1.332 -0.192 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.918 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -69.7 -7.19 20.42 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.506 2.138 . . . . 0.0 112.934 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.3 t -77.92 -66.45 0.84 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.025 0.441 . . . . 0.0 109.945 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.407 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 5.0 m -56.73 -39.01 73.16 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.048 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.451 ' HA ' ' CD1' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -53.43 -45.45 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.854 179.309 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -57.44 -37.18 72.4 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.008 179.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.407 ' HB2' ' O ' ' A' ' 125' ' ' THR . 2.3 mptp? -63.67 -30.09 71.24 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.451 ' CD1' ' HA ' ' A' ' 126' ' ' ILE . 6.7 mt -74.89 -38.08 61.97 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.07 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -44.87 -33.64 2.03 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.948 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 9.1 mmtt -49.44 -34.42 16.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.506 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.408 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 0.6 OUTLIER -123.32 -30.92 3.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.514 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.526 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 6.7 mmtt -145.46 -101.21 0.1 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 119.109 -0.472 . . . . 0.0 111.317 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.526 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 0.9 OUTLIER 133.65 -26.2 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.331 1.052 . . . . 0.0 110.249 -179.858 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 8.9 mtpp -69.0 110.7 6.55 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.715 -179.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -80.34 133.72 9.81 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.682 2.254 . . . . 0.0 111.484 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.505 ' CD1' ' N ' ' A' ' 137' ' ' ILE . 0.8 OUTLIER -67.26 96.62 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.901 0.381 . . . . 0.0 110.871 -179.513 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.2 p -82.97 163.68 49.94 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.816 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.483 ' HA ' ' CE1' ' A' ' 154' ' ' TYR . 86.9 Cg_exo -46.15 -40.55 21.4 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.549 2.166 . . . . 0.0 112.275 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -57.56 -52.28 66.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.752 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 7.4 m -57.21 -52.09 66.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.76 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -54.01 -52.66 60.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.901 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -51.08 -32.52 22.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.682 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 7.4 ttpt -66.04 -61.3 2.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.76 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.407 ' O ' ' CD2' ' A' ' 145' ' ' LEU . 0.7 OUTLIER -60.75 -36.45 78.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.661 179.843 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -61.84 -41.54 97.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.973 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -87.59 -25.74 23.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.746 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -67.64 -42.21 82.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.961 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.05 16.37 12.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.258 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.7 mttm 46.88 35.02 2.94 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.768 0.318 . . . . 0.0 111.196 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.476 ' HB3' ' CD2' ' A' ' 110' ' ' PHE . . . -55.64 -82.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.09 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.438 ' CG2' ' O ' ' A' ' 151' ' ' ALA . 56.0 t -162.28 -75.67 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.711 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.417 ' HE3' ' N ' ' A' ' 154' ' ' TYR . 0.0 OUTLIER -176.56 113.54 0.1 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.801 -178.843 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.483 ' CE1' ' HA ' ' A' ' 139' ' ' PRO . 16.5 t80 -87.84 106.75 18.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.467 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.438 ' CB ' HG23 ' A' ' 168' ' ' VAL . 0.1 OUTLIER -101.74 177.07 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.448 179.745 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -99.48 118.76 36.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.8 0.333 . . . . 0.0 111.194 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.4 ' HB2' ' HA ' ' A' ' 165' ' ' LEU . 7.2 p -160.16 126.37 4.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.776 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.09 157.11 22.01 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.249 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -107.8 -33.39 7.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.698 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.64 -37.19 79.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.697 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 14.0 t -110.74 -18.78 13.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.012 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 75.76 66.54 0.06 Allowed 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 120.856 0.36 . . . . 0.0 110.975 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.26 38.1 1.0 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.244 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 89.48 48.89 3.59 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.97 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.457 ' CD1' ' HA ' ' A' ' 19' ' ' LEU . 4.3 mt -47.53 -31.6 4.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.77 0.319 . . . . 0.0 111.308 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.426 ' O ' ' N ' ' A' ' 170' ' ' ASP . 36.1 pttt -70.57 -29.67 66.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.3 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -52.09 -72.36 0.05 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.852 0.358 . . . . 0.0 110.94 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.438 HG23 ' CB ' ' A' ' 155' ' ' VAL . 57.4 t -57.69 -50.42 77.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.919 0.39 . . . . 0.0 110.584 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.494 ' CE1' HD11 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -54.32 -29.49 47.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.463 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 166' ' ' LYS . 6.1 m-20 -72.54 -29.28 63.43 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 178.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -73.94 -31.42 63.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.237 179.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -67.78 -48.13 67.23 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.796 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.424 HD12 ' CD2' ' B' ' 505' ' ' LEU . 1.1 pp -73.8 -31.82 32.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.625 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.402 HD12 ' HB3' ' B' ' 505' ' ' LEU . 4.6 tp -50.57 -53.98 26.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.789 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -50.91 -25.28 4.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.824 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.45 ' CB ' ' HB ' ' A' ' 4' ' ' ILE . . . -83.13 -48.68 10.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.166 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.472 ' CD2' ' CG2' ' B' ' 510' ' ' ILE . 1.0 OUTLIER -68.72 -23.62 64.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.867 179.955 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.418 ' CG ' ' HD2' ' A' ' 179' ' ' PRO . 2.4 tm-20 -152.14 142.63 15.2 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.807 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . 0.418 ' HD2' ' CG ' ' A' ' 178' ' ' GLU . 9.3 Cg_endo -52.76 117.84 4.12 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.724 2.283 . . . . 0.0 112.003 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -66.91 155.02 72.63 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.517 2.145 . . . . 0.0 112.487 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -148.01 98.13 3.83 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.804 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.21 -165.1 0.27 Allowed 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.713 2.275 . . . . 0.0 112.269 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -134.82 157.45 46.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.756 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.249 -0.882 . . . . 0.0 110.897 -179.999 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.311 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 503' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -104.65 -161.42 0.82 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.846 0.355 . . . . 0.0 110.886 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 504' ' ' GLY . . . . . . . . . . . . . . . -156.92 69.58 0.27 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.727 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 505' ' ' LEU . . . . . 0.463 ' O ' ' CB ' ' B' ' 506' ' ' SER . 1.3 mt -133.19 -56.91 0.91 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.642 0.258 . . . . 0.0 111.254 -179.13 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 506' ' ' SER . . . . . 0.463 ' CB ' ' O ' ' B' ' 505' ' ' LEU . 5.2 t 88.95 -20.57 0.16 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.404 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 507' ' ' ALA . . . . . . . . . . . . . . . -51.46 -79.99 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.331 0.586 . . . . 0.0 110.494 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 508' ' ' GLN . . . . . 0.443 ' HB2' ' CD1' ' B' ' 510' ' ' ILE . 5.8 mt-30 -130.91 3.55 4.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.418 179.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 509' ' ' ASP . . . . . 0.441 ' CB ' ' O ' ' B' ' 508' ' ' GLN . 25.5 t0 84.41 39.03 0.03 OUTLIER 'General case' 0 C--N 1.344 0.341 0 CA-C-O 120.98 0.419 . . . . 0.0 110.946 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 510' ' ' ILE . . . . . 0.472 ' CG2' ' CD2' ' A' ' 177' ' ' LEU . 1.8 mp -68.96 73.21 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.476 179.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 511' ' ' SER . . . . . 0.415 ' O ' ' CD1' ' B' ' 514' ' ' LEU . 14.9 t -60.12 140.78 56.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.904 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 512' ' ' GLN . . . . . 0.476 ' CB ' ' HD3' ' B' ' 513' ' ' PRO . 0.7 OUTLIER -89.84 -64.03 0.19 Allowed Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.735 179.803 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 513' ' ' PRO . . . . . 0.476 ' HD3' ' CB ' ' B' ' 512' ' ' GLN . 88.6 Cg_endo -82.37 49.94 3.27 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.638 2.225 . . . . 0.0 112.463 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 514' ' ' LEU . . . . . 0.44 ' CD1' ' O ' ' A' ' 45' ' ' MET . 0.4 OUTLIER -52.88 -89.3 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.784 -179.79 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 515' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -93.2 -157.67 0.55 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -48.7 -29.44 4.44 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.139 0.495 . . . . 0.0 110.316 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 517' ' ' SER . . . . . 0.435 ' O ' ' CG1' ' A' ' 42' ' ' VAL . 14.2 p 38.15 59.48 1.39 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.101 179.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 518' ' ' PHE . . . . . 0.485 ' CZ ' ' CE2' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -165.06 108.41 0.86 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.734 0.302 . . . . 0.0 111.393 179.485 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 519' ' ' ILE . . . . . 0.446 HD12 ' HA ' ' A' ' 42' ' ' VAL . 0.1 OUTLIER -151.1 152.16 11.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.171 179.246 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 70.33 76.0 0.2 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.825 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 521' ' ' THR . . . . . 0.486 HG22 ' CZ ' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -75.7 120.77 21.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.014 -179.951 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 522' ' ' GLY . . . . . . . . . . . . . . . -61.65 -158.26 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.389 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 523' ' ' HIS . . . . . 0.42 ' ND1' ' N ' ' B' ' 523' ' ' HIS . 0.4 OUTLIER -118.66 -83.97 0.65 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.788 0.327 . . . . 0.0 110.808 179.943 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 524' ' ' GLY . . . . . . . . . . . . . . . 67.71 122.13 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.714 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 525' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -142.0 57.91 1.48 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.777 0.323 . . . . 0.0 111.067 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 526' ' ' SER . . . . . 0.45 ' HB3' ' CG1' ' A' ' 33' ' ' VAL . 2.9 t -78.79 96.81 5.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.754 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 527' ' ' ASP . . . . . 0.466 ' CB ' ' HD3' ' B' ' 528' ' ' PRO . 1.7 t0 -43.93 -52.52 15.05 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.679 0.276 . . . . 0.0 111.019 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 528' ' ' PRO . . . . . 0.466 ' HD3' ' CB ' ' B' ' 527' ' ' ASP . 17.7 Cg_exo -70.82 134.06 24.96 Favored 'Trans proline' 0 CA--C 1.518 -0.306 0 C-N-CA 123.125 2.55 . . . . 0.0 111.726 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 529' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -101.06 -30.02 11.84 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.986 -179.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 530' ' ' HIS . . . . . 0.502 ' CG ' ' O ' ' B' ' 530' ' ' HIS . 0.1 OUTLIER 70.35 5.02 5.16 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.399 179.712 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 1.2 m 52.76 -88.08 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.637 0.256 . . . . 0.0 111.011 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 532' ' ' TRP . . . . . 0.434 ' N ' ' O ' ' B' ' 530' ' ' HIS . 15.6 t90 -154.27 -45.33 0.09 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.855 0.36 . . . . 0.0 110.685 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . 67.89 -143.08 41.08 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.572 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 534' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -65.86 150.83 96.02 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.791 0.329 . . . . 0.0 110.896 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -49.35 -49.74 14.76 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.614 2.21 . . . . 0.0 112.247 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.49 109.19 11.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.78 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 537' ' ' ARG . . . . . 0.44 ' NH2' ' CE2' ' A' ' 32' ' ' TYR . 0.2 OUTLIER -50.38 143.11 9.31 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 120.989 0.423 . . . . 0.0 111.006 179.998 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 538' ' ' ILE . . . . . 0.441 HG13 ' HB2' ' B' ' 542' ' ' TYR . 7.4 tp -58.69 146.78 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.148 179.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 539' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -46.37 140.52 4.1 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.914 0.388 . . . . 0.0 111.165 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 540' ' ' GLU . . . . . 0.413 ' O ' ' CB ' ' A' ' 58' ' ' THR . 14.0 mp0 -44.94 -27.68 0.57 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.357 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 541' ' ' LEU . . . . . 0.51 ' N ' ' CD2' ' A' ' 70' ' ' LEU . 0.9 OUTLIER -55.68 -32.06 62.94 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.351 0.596 . . . . 0.0 110.147 179.615 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 542' ' ' TYR . . . . . 0.441 ' HB2' HG13 ' B' ' 538' ' ' ILE . 11.1 m-85 -105.45 0.88 27.19 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.031 -0.986 . . . . 0.0 112.171 -178.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 543' ' ' LEU . . . . . . . . . . . . . 1.6 tp -49.23 117.64 2.26 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.814 0.34 . . . . 0.0 110.679 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . 135.09 -46.83 1.02 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.505 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 545' ' ' ASN . . . . . 0.408 ' ND2' ' HB3' ' B' ' 530' ' ' HIS . 72.9 m-20 . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.253 -0.879 . . . . 0.0 111.027 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' GNP . . . . . 0.78 " H2'" ' OG1' ' A' ' 115' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.409 ' HE2' ' CD1' ' A' ' 51' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.375 0 CA-C-O 120.749 0.309 . . . . 0.0 111.216 . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 57.66 160.54 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.715 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.513 HG21 ' CE1' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -119.52 -174.53 2.76 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.407 -179.632 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.475 ' CG2' ' CD2' ' A' ' 177' ' ' LEU . 25.7 pt -155.05 149.49 12.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.101 0.477 . . . . 0.0 111.991 -179.273 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 33.9 mttt -134.38 95.87 3.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.274 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -100.31 138.66 37.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.024 0.44 . . . . 0.0 111.491 -179.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.6 160.09 41.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.087 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.421 ' O ' ' CG1' ' A' ' 9' ' ' VAL . 47.3 t -111.69 137.64 43.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.289 0.566 . . . . 0.0 112.184 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.421 ' CG1' ' O ' ' A' ' 8' ' ' VAL . 19.3 m -161.44 130.04 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.862 179.232 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 149.37 -144.01 11.56 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.238 -0.982 . . . . 0.0 112.62 -179.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.5 p30 -122.15 25.3 9.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.938 0.399 . . . . 0.0 110.825 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.406 ' HA2' ' HB2' ' B' ' 537' ' ' ARG . . . -157.36 -160.24 10.03 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.324 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.41 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -79.11 -48.18 14.79 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.556 0.217 . . . . 0.0 110.836 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.521 ' CG2' ' N ' ' A' ' 15' ' ' GLY . 0.6 OUTLIER 65.59 -60.04 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.403 179.55 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.521 ' N ' ' CG2' ' A' ' 14' ' ' VAL . . . -165.83 30.31 0.21 Allowed Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.445 ' HA ' ' CB ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -91.01 -165.32 1.33 Allowed 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 121.232 0.539 . . . . 0.0 111.359 -179.313 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.424 HG22 ' CG2' ' A' ' 35' ' ' THR . 43.6 p -38.95 -65.85 0.33 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.478 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.431 ' O ' ' CB ' ' A' ' 22' ' ' SER . 23.6 t -32.42 -43.6 0.09 Allowed 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -178.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.45 ' CD2' ' HA2' ' A' ' 15' ' ' GLY . 2.5 mp -56.88 -71.74 0.09 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.73 0.3 . . . . 0.0 111.269 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.55 -50.3 14.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.192 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.479 HD11 ' CE1' ' B' ' 518' ' ' PHE . 10.9 mm -48.31 -55.79 2.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.403 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.467 ' HA ' ' CB ' ' A' ' 26' ' ' ASN . 3.1 t -64.03 -43.59 95.11 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 121.092 -0.243 . . . . 0.0 111.585 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.483 ' CE2' ' HB3' ' A' ' 165' ' ' LEU . 0.2 OUTLIER -45.79 -35.07 4.09 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.187 0.517 . . . . 0.0 110.16 179.6 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -101.67 -33.52 9.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.279 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.434 ' N ' ' O ' ' A' ' 21' ' ' ILE . 1.0 OUTLIER 173.46 127.14 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.722 0.296 . . . . 0.0 111.039 -178.98 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.467 ' CB ' ' HA ' ' A' ' 22' ' ' SER . 61.2 t30 178.56 -43.87 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.666 178.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.6 mtmm 65.1 142.17 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.734 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.483 ' CE2' " O3'" ' A' ' 185' ' ' GNP . 0.2 OUTLIER -86.68 -49.5 0.48 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.782 179.995 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.46 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 5.8 Cg_exo -79.35 52.15 4.16 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.933 2.422 . . . . 0.0 112.248 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 77.9 p -133.87 -108.74 0.23 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.679 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -159.57 118.75 2.89 Favored 'General case' 0 N--CA 1.457 -0.098 0 O-C-N 122.169 -0.332 . . . . 0.0 111.016 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.453 ' CD2' ' O ' ' A' ' 188' ' ' HOH . 5.3 m-85 -90.55 121.51 32.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.391 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.454 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 0.2 OUTLIER -160.99 -61.98 0.02 OUTLIER Pre-proline 0 N--CA 1.468 0.434 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.363 -179.415 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.473 ' HB3' ' CE2' ' A' ' 37' ' ' PHE . 3.0 Cg_exo -34.98 -28.57 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.649 2.899 . . . . 0.0 113.653 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.434 ' N ' ' O ' ' A' ' 33' ' ' VAL . 28.4 m -29.73 -38.46 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.468 ' CG2' ' CB ' ' A' ' 63' ' ' ASP . 11.5 p -50.4 -24.3 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.765 0.317 . . . . 0.0 111.373 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.473 ' CE2' ' HB3' ' A' ' 34' ' ' PRO . 7.1 m-30 -66.07 -10.02 36.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.576 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -46.26 172.62 0.01 OUTLIER 'General case' 0 C--O 1.231 0.102 0 CA-C-O 120.864 0.364 . . . . 0.0 111.159 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 75.37 5.43 4.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.303 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -60.38 -174.85 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.719 0.295 . . . . 0.0 110.607 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -110.11 124.18 51.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.586 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.423 ' HA ' HG12 ' B' ' 519' ' ' ILE . 24.0 m -118.44 124.88 73.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.014 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.72 104.82 16.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.934 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.478 ' CG2' ' CG2' ' A' ' 52' ' ' THR . 12.6 m -153.23 -177.24 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.931 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.457 ' HE1' ' N ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -111.96 103.71 11.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.651 -179.537 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.438 ' CG1' ' O ' ' A' ' 51' ' ' TYR . 2.7 mm -74.02 86.09 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.1 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.458 ' HA3' ' HA ' ' B' ' 510' ' ' ILE . . . 43.9 -94.13 0.01 OUTLIER Glycine 0 CA--C 1.519 0.313 0 CA-C-N 115.498 -0.774 . . . . 0.0 113.636 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -38.62 -87.44 0.01 OUTLIER Glycine 0 C--N 1.332 0.356 0 C-N-CA 121.607 -0.33 . . . . 0.0 113.626 -179.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.457 ' N ' ' HE1' ' A' ' 45' ' ' MET . 1.8 pt-20 -125.23 164.75 30.03 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 120.708 0.289 . . . . 0.0 111.024 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.432 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 52.0 Cg_exo -54.22 106.82 0.18 Allowed 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.653 2.235 . . . . 0.0 112.289 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.513 ' CE1' HG21 ' A' ' 3' ' ' THR . 4.4 t80 -172.53 147.92 1.92 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.498 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.478 ' CG2' ' CG2' ' A' ' 44' ' ' VAL . 0.3 OUTLIER -137.61 154.06 49.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.624 179.706 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.471 ' CD1' ' N ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -131.15 177.99 7.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.877 0.37 . . . . 0.0 111.305 -179.734 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -74.09 114.8 4.67 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.161 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.478 ' HB2' ' CD2' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -81.15 -62.97 1.5 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.019 0.437 . . . . 0.0 110.942 -179.785 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.478 ' CD2' ' HB2' ' A' ' 55' ' ' LEU . 1.9 p90 -142.94 128.89 19.55 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.185 -179.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -142.26 109.6 5.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.032 0.444 . . . . 0.0 110.847 179.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.432 ' OG1' ' CE ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -155.8 131.48 9.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.316 179.524 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.434 ' CB ' ' HA ' ' A' ' 36' ' ' VAL . . . -170.93 158.44 5.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.027 0.441 . . . . 0.0 111.613 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -131.01 19.63 4.9 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.149 179.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -86.22 -175.51 5.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.814 0.34 . . . . 0.0 110.779 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -46.58 -31.48 2.84 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.312 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.468 ' CB ' ' CG2' ' A' ' 36' ' ' VAL . 7.2 t0 -50.52 -62.09 1.8 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.06 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.504 ' CD1' ' N ' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -168.41 137.37 2.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.975 0.417 . . . . 0.0 111.154 -179.898 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.13 -66.23 0.92 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.786 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 17.1 mmt85 -73.22 -24.9 60.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.991 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.406 ' O ' ' CB ' ' A' ' 68' ' ' ARG . 1.1 mt 68.52 -94.73 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.114 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.424 ' CB ' ' HD3' ' A' ' 69' ' ' PRO . 0.0 OUTLIER 166.34 -53.9 0.0 OUTLIER Pre-proline 0 N--CA 1.465 0.287 0 CA-C-O 120.722 0.296 . . . . 0.0 111.128 179.822 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.424 ' HD3' ' CB ' ' A' ' 68' ' ' ARG . 52.8 Cg_exo -52.91 -60.41 0.73 Allowed 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.662 2.242 . . . . 0.0 112.727 -179.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.435 ' CD2' ' HA ' ' B' ' 541' ' ' LEU . 0.3 OUTLIER -58.7 -31.89 68.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.031 -179.847 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.8 t -54.6 -35.63 63.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.223 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 65.3 t80 175.39 81.57 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.669 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.492 ' HG2' ' CZ ' ' A' ' 78' ' ' PHE . 94.4 Cg_endo -81.17 136.42 10.17 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.604 2.203 . . . . 0.0 112.307 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? -90.79 10.25 26.82 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.349 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.4 t -57.74 178.45 0.08 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.808 0.337 . . . . 0.0 110.737 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -123.34 7.33 9.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.535 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.402 ' O ' ' CG1' ' A' ' 77' ' ' VAL . 8.9 p -152.76 101.05 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 CA-C-O 120.758 0.313 . . . . 0.0 111.321 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.492 ' CZ ' ' HG2' ' A' ' 73' ' ' PRO . 3.2 m-85 -80.61 177.65 8.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.393 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.447 ' CD2' HG23 ' A' ' 14' ' ' VAL . 5.9 tp -138.93 108.25 6.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.047 0.451 . . . . 0.0 111.042 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 19.7 m -111.04 127.01 68.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.243 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.441 ' HB3' ' CG1' ' A' ' 14' ' ' VAL . 13.6 p -108.21 177.19 4.88 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.604 0.716 . . . . 0.0 112.51 -178.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.49 ' CE1' HG23 ' A' ' 137' ' ' ILE . 2.1 p90 -176.54 124.45 0.17 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.607 -1.178 . . . . 0.0 109.467 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.428 ' HA ' ' C2 ' ' A' ' 185' ' ' GNP . 60.4 m -87.89 143.65 27.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.831 0.348 . . . . 0.0 111.291 -179.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.43 ' CG1' ' N ' ' A' ' 137' ' ' ILE . 51.0 t -54.72 -53.08 35.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.748 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.406 ' CA ' HD23 ' A' ' 129' ' ' LEU . 34.3 m -52.09 110.1 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.225 179.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -151.46 128.38 5.44 Favored Pre-proline 0 C--N 1.33 -0.274 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.77 -179.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.401 ' HB2' ' HB2' ' A' ' 132' ' ' ASN . 82.5 Cg_endo -92.4 53.45 0.6 Allowed 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.299 2.666 . . . . 0.0 111.498 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.446 ' CA ' ' HG3' ' A' ' 133' ' ' LYS . 1.1 p 77.87 17.81 1.29 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.141 -179.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.0 p -97.28 -23.98 15.89 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.811 0.338 . . . . 0.0 111.066 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.491 ' CZ ' HG23 ' A' ' 137' ' ' ILE . 9.7 t80 -46.96 -46.77 21.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.186 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -50.77 -52.19 43.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.183 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.93 -40.38 83.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.168 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 62.1 t -48.36 -45.42 13.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.491 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.8 ptpp? -80.32 -36.81 33.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.107 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -74.61 -11.23 60.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.589 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.17 -20.49 12.33 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.58 0.228 . . . . 0.0 111.326 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.442 ' HA ' ' CE3' ' A' ' 97' ' ' TRP . 3.3 m95 -87.0 -51.61 5.92 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.712 0.291 . . . . 0.0 111.186 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.483 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 57.3 t -48.51 -47.79 69.02 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.598 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 73.4 Cg_endo -76.46 -13.65 18.39 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.169 1.913 . . . . 0.0 112.492 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -89.83 -49.17 6.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.885 0.374 . . . . 0.0 110.727 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 5.8 pt -56.84 -28.16 27.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.013 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 69.5 p -93.05 -25.89 17.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.93 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -63.5 -68.59 0.33 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.758 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 10.2 m80 -64.86 -51.1 63.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.795 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 2.9 m -101.57 141.15 22.01 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.811 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -51.24 155.21 6.89 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.591 2.194 . . . . 0.0 112.209 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 16.3 mttt -53.46 90.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.872 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.485 ' HB ' ' CD1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -115.65 152.43 47.26 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.918 -179.954 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -60.86 167.83 8.08 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.686 2.257 . . . . 0.0 112.415 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.472 ' CD2' ' HB1' ' A' ' 151' ' ' ALA . 1.8 p90 -155.8 159.39 39.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.738 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.44 ' CD1' ' CG1' ' A' ' 152' ' ' VAL . 4.2 tt -121.03 150.03 41.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.255 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -94.05 141.71 28.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.178 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.425 ' CG1' HG23 ' A' ' 168' ' ' VAL . 3.1 t -122.03 145.29 28.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.183 0.516 . . . . 0.0 112.07 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -130.51 125.78 4.71 Favored Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.093 179.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.734 ' OG1' " H2'" ' A' ' 185' ' ' GNP . 0.6 OUTLIER -144.27 -44.89 0.25 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.964 0.412 . . . . 0.0 110.752 -178.854 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.724 ' OE1' " H1'" ' A' ' 185' ' ' GNP . 0.1 OUTLIER -71.33 -2.68 17.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.23 179.26 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.424 ' O ' ' CG ' ' A' ' 120' ' ' ARG . 0.1 OUTLIER -42.29 -28.44 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 179.935 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.18 -34.7 61.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.771 0.319 . . . . 0.0 111.131 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.466 ' CD2' ' N ' ' A' ' 119' ' ' LEU . 2.2 mm? -69.44 -31.78 70.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.083 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.424 ' CG ' ' O ' ' A' ' 117' ' ' ILE . 0.3 OUTLIER -46.11 -29.87 1.69 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.949 -179.884 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -83.84 -31.96 25.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.505 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 119' ' ' LEU . 3.5 t0 -56.54 106.86 0.74 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.618 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.415 ' O ' ' CG ' ' A' ' 127' ' ' GLU . 14.2 Cg_exo -69.19 -3.62 12.0 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.686 2.257 . . . . 0.0 112.975 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.83 -65.24 1.04 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 121.058 0.456 . . . . 0.0 109.865 179.543 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.404 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 4.1 m -56.65 -38.95 72.86 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.457 ' HA ' ' CD1' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -54.34 -43.1 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.753 179.203 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.415 ' CG ' ' O ' ' A' ' 123' ' ' PRO . 1.7 mm-40 -58.31 -37.7 75.61 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.833 179.25 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 125' ' ' THR . 2.7 mptt -63.11 -30.71 71.81 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.457 ' CD1' ' HA ' ' A' ' 126' ' ' ILE . 8.0 mt -74.88 -39.22 61.63 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -46.57 -31.49 2.84 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.85 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.0 mmtt -50.14 -34.31 21.79 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.391 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.401 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 5.0 m-80 -123.3 -31.36 3.56 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.359 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.512 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 7.6 mmtt -144.79 -98.96 0.1 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 119.15 -0.452 . . . . 0.0 111.326 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.512 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 0.0 OUTLIER 132.22 -22.79 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.401 1.08 . . . . 0.0 110.503 -179.809 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 4.5 mmtt -68.75 110.82 6.62 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.726 -179.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -81.6 123.4 4.27 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.534 2.156 . . . . 0.0 111.394 179.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.491 HG23 ' CZ ' ' A' ' 90' ' ' PHE . 1.1 mm -55.05 96.61 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.958 0.409 . . . . 0.0 110.893 -179.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 74.2 p -69.09 156.59 91.25 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.028 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.445 ' HA ' ' CE2' ' A' ' 154' ' ' TYR . 9.4 Cg_endo -50.75 -41.35 54.81 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.709 2.272 . . . . 0.0 112.085 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -58.85 -34.8 72.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.583 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 84.3 m -63.62 -46.49 85.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.677 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.488 ' HB1' ' CG ' ' A' ' 154' ' ' TYR . . . -55.6 -48.74 74.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.905 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -53.48 -43.95 68.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.73 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 6.8 mttt -54.1 -61.8 2.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.704 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.425 ' O ' ' CD2' ' A' ' 145' ' ' LEU . 0.8 OUTLIER -61.57 -37.98 85.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.649 179.748 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.45 -49.22 78.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.861 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 16.2 mtp180 -79.68 -25.14 41.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.826 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -56.93 -40.71 76.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.447 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.1 mt -109.95 26.11 11.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.667 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.469 ' N ' ' CD ' ' A' ' 150' ' ' LYS . 0.0 OUTLIER 37.84 57.0 1.54 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.671 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.472 ' HB1' ' CD2' ' A' ' 110' ' ' PHE . . . -73.76 -82.16 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.025 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.449 ' CG2' ' O ' ' A' ' 151' ' ' ALA . 55.5 t -161.96 -76.12 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.752 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.435 ' HG3' ' N ' ' A' ' 154' ' ' TYR . 1.9 ttpt -177.01 145.91 0.5 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.343 -178.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.488 ' CG ' ' HB1' ' A' ' 142' ' ' ALA . 61.3 t80 -105.66 114.48 28.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.551 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.409 ' CG2' ' OE2' ' A' ' 171' ' ' GLU . 11.4 t -112.91 157.94 13.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.803 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -97.79 118.29 34.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.065 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.442 ' HA ' ' CB ' ' A' ' 163' ' ' LYS . 22.9 m -160.63 126.42 3.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.673 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.424 ' OG ' ' CD1' ' A' ' 160' ' ' LEU . 0.4 OUTLIER -147.41 153.62 39.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.916 0.389 . . . . 0.0 111.745 -179.591 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -78.47 -22.07 48.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.664 179.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.424 ' CD1' ' OG ' ' A' ' 158' ' ' SER . 0.3 OUTLIER -67.39 -59.46 3.38 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.073 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 3.5 t -91.92 -22.49 20.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.222 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 72.13 69.86 0.15 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.865 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.442 ' CB ' ' HA ' ' A' ' 157' ' ' CYS . 10.3 mptt -90.81 19.37 5.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.32 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 119.13 -42.21 1.83 Allowed Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.634 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.483 ' HB3' ' CE2' ' A' ' 23' ' ' TYR . 1.0 OUTLIER 66.35 -66.24 0.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.783 0.325 . . . . 0.0 111.359 179.904 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.423 ' O ' ' N ' ' A' ' 170' ' ' ASP . 6.2 ptpp? -58.04 -26.08 62.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.752 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.401 ' CB ' ' SG ' ' A' ' 157' ' ' CYS . 0.2 OUTLIER -54.51 -69.46 0.13 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.814 0.34 . . . . 0.0 111.06 -179.717 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.437 ' O ' ' CG ' ' A' ' 171' ' ' GLU . 13.6 p -56.15 -44.77 79.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.142 0.496 . . . . 0.0 110.69 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.429 ' HB2' ' CD2' ' A' ' 19' ' ' LEU . 5.6 t80 -66.85 -17.23 64.79 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.979 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' A' ' 166' ' ' LYS . 2.8 m-20 -80.95 -38.66 27.36 Favored 'General case' 0 C--N 1.334 -0.068 0 CA-C-O 120.809 0.338 . . . . 0.0 110.699 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.437 ' CG ' ' O ' ' A' ' 168' ' ' VAL . 9.4 pt-20 -69.45 -27.81 65.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.936 0.398 . . . . 0.0 110.033 179.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.423 ' N ' HD13 ' A' ' 111' ' ' LEU . . . -75.69 -42.23 51.58 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.911 179.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 1.7 pp -81.58 -34.44 13.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.044 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -56.36 -44.62 80.3 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.859 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -51.22 -24.78 4.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.904 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.443 ' CB ' ' HB ' ' A' ' 4' ' ' ILE . . . -84.84 -39.27 18.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.163 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.475 ' CD2' ' CG2' ' A' ' 4' ' ' ILE . 31.4 mt -68.56 -24.06 64.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.869 0.366 . . . . 0.0 110.405 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.415 ' CG ' ' HD2' ' A' ' 179' ' ' PRO . 21.7 tt0 -165.52 139.27 3.76 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.543 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . 0.415 ' HD2' ' CG ' ' A' ' 178' ' ' GLU . 43.9 Cg_endo -68.36 108.58 1.83 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.564 2.176 . . . . 0.0 112.507 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -70.83 -159.51 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.734 2.29 . . . . 0.0 112.185 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -145.57 146.73 30.62 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.886 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.23 -165.32 0.3 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.686 2.258 . . . . 0.0 112.287 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.5 154.6 35.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.888 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 8.2 mttt . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.297 -0.858 . . . . 0.0 110.877 -179.967 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 112.45 -0.26 . . . . 0.0 112.45 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 503' ' ' SER . . . . . . . . . . . . . 5.7 m -74.03 -69.49 0.44 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.833 0.349 . . . . 0.0 110.782 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 504' ' ' GLY . . . . . . . . . . . . . . . 64.09 114.67 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.684 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 505' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.53 -52.41 0.18 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.845 0.355 . . . . 0.0 110.709 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 506' ' ' SER . . . . . 0.41 ' CB ' ' OE1' ' A' ' 178' ' ' GLU . 1.4 m -155.19 -161.11 1.13 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.778 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 507' ' ' ALA . . . . . . . . . . . . . . . 55.01 -90.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.001 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 508' ' ' GLN . . . . . 0.414 ' O ' ' CB ' ' B' ' 509' ' ' ASP . 9.9 mt-30 -132.1 3.9 4.05 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.875 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 509' ' ' ASP . . . . . 0.414 ' CB ' ' O ' ' B' ' 508' ' ' GLN . 7.8 t70 80.71 42.44 0.05 OUTLIER 'General case' 0 C--N 1.34 0.19 0 CA-C-O 121.221 0.534 . . . . 0.0 110.012 -179.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 510' ' ' ILE . . . . . 0.458 ' HA ' ' HA3' ' A' ' 47' ' ' GLY . 11.2 mt -65.3 145.28 14.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.554 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 511' ' ' SER . . . . . . . . . . . . . 27.9 t -109.37 149.2 29.86 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.205 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 512' ' ' GLN . . . . . 0.448 ' CB ' ' HD3' ' B' ' 513' ' ' PRO . 0.0 OUTLIER -93.69 -53.53 0.25 Allowed Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.406 179.387 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 513' ' ' PRO . . . . . 0.448 ' HD3' ' CB ' ' B' ' 512' ' ' GLN . 55.8 Cg_endo -97.73 74.79 0.08 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 123.33 2.687 . . . . 0.0 111.813 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 514' ' ' LEU . . . . . 0.44 ' CD1' ' O ' ' A' ' 45' ' ' MET . 0.7 OUTLIER -73.33 -88.28 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.6 -179.257 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 515' ' ' GLN . . . . . 0.405 ' HB2' HG12 ' A' ' 44' ' ' VAL . 0.3 OUTLIER -87.45 -159.88 0.56 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.777 0.322 . . . . 0.0 111.006 -179.669 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -54.48 -21.24 9.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.235 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 517' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 47.24 29.14 1.14 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.821 0.343 . . . . 0.0 111.129 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 518' ' ' PHE . . . . . 0.479 ' CE1' HD11 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -150.18 91.62 1.79 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.83 -179.749 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 519' ' ' ILE . . . . . 0.423 HG12 ' HA ' ' A' ' 42' ' ' VAL . 5.3 mm -97.79 -68.89 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.442 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -117.65 -170.0 1.78 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.946 0.403 . . . . 0.0 111.005 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 521' ' ' THR . . . . . 0.421 ' OG1' ' CG ' ' A' ' 37' ' ' PHE . 15.3 t -119.32 -159.86 0.79 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.909 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 522' ' ' GLY . . . . . . . . . . . . . . . -110.57 -92.37 2.15 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.364 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 523' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -115.41 -88.29 0.58 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.643 0.259 . . . . 0.0 111.02 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 524' ' ' GLY . . . . . 0.401 ' HA2' ' CE1' ' A' ' 37' ' ' PHE . . . 164.47 123.9 0.68 Allowed Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.491 -0.862 . . . . 0.0 112.643 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 525' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 177.28 46.17 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.99 0.424 . . . . 0.0 110.592 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 526' ' ' SER . . . . . 0.429 ' CB ' ' HD3' ' A' ' 34' ' ' PRO . 71.8 m -104.3 100.11 9.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.068 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 527' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -156.17 164.79 20.25 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.835 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -61.09 95.69 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.588 2.192 . . . . 0.0 112.133 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 529' ' ' ARG . . . . . . . . . . . . . 2.8 mtp85 -97.67 -49.77 4.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.105 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 530' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -168.8 -41.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.158 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 2.7 m 72.71 177.02 0.26 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.772 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 532' ' ' TRP . . . . . . . . . . . . . 37.1 t90 -53.01 92.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.796 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . -114.86 -61.39 0.38 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.548 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 534' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -78.11 139.16 60.71 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.644 0.259 . . . . 0.0 110.875 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.79 123.86 14.45 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.557 2.172 . . . . 0.0 112.438 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 70.31 126.8 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.027 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 537' ' ' ARG . . . . . 0.437 ' CZ ' ' O3G' ' A' ' 185' ' ' GNP . 21.3 mmt180 -54.67 122.73 11.29 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.233 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 538' ' ' ILE . . . . . 0.404 ' CD1' ' C ' ' B' ' 538' ' ' ILE . 0.0 OUTLIER -48.17 151.05 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.152 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 539' ' ' ASP . . . . . 0.469 ' OD2' ' CD2' ' B' ' 542' ' ' TYR . 0.7 OUTLIER -38.52 104.62 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.218 0.532 . . . . 0.0 112.224 -178.58 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 540' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -45.25 -26.54 0.51 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.529 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 541' ' ' LEU . . . . . 0.435 ' HA ' ' CD2' ' A' ' 70' ' ' LEU . 42.1 mt -41.21 -35.18 0.57 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.953 0.406 . . . . 0.0 111.116 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 542' ' ' TYR . . . . . 0.469 ' CD2' ' OD2' ' B' ' 539' ' ' ASP . 4.1 m-30 -104.33 -57.25 2.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.525 179.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 543' ' ' LEU . . . . . 0.431 ' CD2' HG22 ' A' ' 35' ' ' THR . 0.2 OUTLIER 62.31 176.44 0.13 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.437 -179.884 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . 103.22 79.67 1.38 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.259 -0.972 . . . . 0.0 112.574 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 545' ' ' ASN . . . . . . . . . . . . . 2.5 m120 . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.955 179.921 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' GNP . . . . . 0.734 " H2'" ' OG1' ' A' ' 115' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' HOH . . . . . 0.453 ' O ' ' CD2' ' A' ' 32' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.431 ' HE1' ' HB2' ' A' ' 1' ' ' MET . 3.3 ppp? . . . . . 0 N--CA 1.488 1.472 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.421 ' N ' ' SD ' ' A' ' 1' ' ' MET . 50.4 tt0 61.93 132.84 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.893 0.377 . . . . 0.0 110.724 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.434 ' OG1' ' CE1' ' A' ' 51' ' ' TYR . 0.3 OUTLIER -133.36 -161.38 1.13 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.429 -179.679 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.512 ' CG2' ' CB ' ' A' ' 176' ' ' ALA . 0.3 OUTLIER -154.91 163.37 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -179.069 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 8.2 mtmt -111.29 136.59 50.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.041 179.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -108.32 138.73 44.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.063 0.459 . . . . 0.0 111.66 -179.356 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -151.11 160.41 3.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.098 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.3 m -143.24 139.95 26.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.845 0.355 . . . . 0.0 111.726 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.8 m -143.27 131.04 18.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.083 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.25 -110.11 3.92 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.623 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.73 -23.85 24.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.716 0.293 . . . . 0.0 110.92 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -49.43 150.56 4.32 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.617 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.446 ' O ' ' CG1' ' A' ' 14' ' ' VAL . . . -91.53 -56.35 3.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.549 0.214 . . . . 0.0 111.158 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.446 ' CG1' ' O ' ' A' ' 13' ' ' ALA . 0.0 OUTLIER 170.75 -56.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.788 179.584 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.47 ' HA3' ' CZ ' ' A' ' 169' ' ' PHE . . . 110.25 -16.29 29.85 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.419 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.438 ' HD3' ' CD2' ' A' ' 55' ' ' LEU . 15.4 tptm -93.44 -50.04 5.63 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.782 0.325 . . . . 0.0 111.076 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.447 ' O ' ' N ' ' A' ' 21' ' ' ILE . 0.6 OUTLIER -97.81 -71.2 0.69 Allowed 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.525 -179.516 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.417 ' SG ' ' CB ' ' A' ' 13' ' ' ALA . 0.1 OUTLIER -34.61 -74.18 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -178.823 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.486 ' CD2' ' CD1' ' A' ' 169' ' ' PHE . 7.8 mp -47.43 -39.21 15.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.058 -179.031 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.42 ' CD2' ' O ' ' A' ' 16' ' ' LYS . 3.1 mm? -76.9 -20.88 55.69 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.982 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.447 ' N ' ' O ' ' A' ' 17' ' ' THR . 9.1 mm -61.09 -69.64 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 74.8 m -56.55 -32.95 65.66 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.514 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.404 ' HB2' HD13 ' A' ' 165' ' ' LEU . 42.2 t80 -56.99 -68.38 0.23 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.026 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.3 m -76.65 -45.99 27.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.666 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.442 ' N ' ' O ' ' A' ' 21' ' ' ILE . 1.6 p -92.41 -155.91 0.44 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.435 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.414 ' N ' ' ND2' ' A' ' 26' ' ' ASN . 0.1 OUTLIER -155.75 23.8 0.39 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.776 0.322 . . . . 0.0 111.098 -179.908 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.33 100.22 9.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.947 0.403 . . . . 0.0 111.39 -179.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.488 ' CD2' ' HD3' ' A' ' 29' ' ' PRO . 0.1 OUTLIER -87.86 -64.95 0.2 Allowed Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.095 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.488 ' HD3' ' CD2' ' A' ' 28' ' ' PHE . 93.0 Cg_endo -81.72 54.16 4.96 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.597 2.198 . . . . 0.0 111.983 179.341 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.401 ' O ' ' HG3' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -97.17 -84.96 0.36 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.864 -179.64 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' B' ' 531' ' ' CYS . 27.0 mt-10 -149.52 126.49 11.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.041 0.448 . . . . 0.0 111.873 -179.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.504 ' HA ' ' PG ' ' A' ' 185' ' ' GNP . 3.1 m-85 -105.15 93.34 4.64 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.591 178.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.443 ' CB ' ' CD ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -165.81 -64.56 0.01 OUTLIER Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.253 -179.177 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.443 ' CD ' ' CB ' ' A' ' 33' ' ' VAL . 55.2 Cg_endo -70.78 56.7 1.86 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.599 2.199 . . . . 0.0 112.891 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.3 t -121.75 26.35 8.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.993 0.425 . . . . 0.0 110.52 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.435 HG22 ' CB ' ' A' ' 61' ' ' LEU . 1.8 t -80.46 -5.66 8.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.888 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.437 ' HB3' ' N ' ' B' ' 522' ' ' GLY . 29.5 p90 -93.98 26.54 3.17 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.785 0.326 . . . . 0.0 111.142 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.1 p30 -70.3 -19.25 63.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.12 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -100.11 11.12 40.11 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.514 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.457 ' CE1' ' HA2' ' B' ' 522' ' ' GLY . 1.0 OUTLIER -60.66 -159.42 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 120.685 0.278 . . . . 0.0 110.664 179.894 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -117.82 156.26 28.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.543 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -140.56 126.13 20.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.883 179.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.42 ' O ' ' CG2' ' A' ' 44' ' ' VAL . 9.9 t -85.51 104.49 15.34 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.929 0.395 . . . . 0.0 110.592 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.459 ' CG1' ' CD1' ' B' ' 514' ' ' LEU . 2.8 t -164.63 158.1 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.818 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.456 ' HG3' HD23 ' B' ' 514' ' ' LEU . 0.0 OUTLIER -112.75 118.83 36.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.599 178.758 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.466 ' O ' ' N ' ' A' ' 48' ' ' GLY . 1.4 mm -79.65 86.81 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.441 -179.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 54.68 -76.16 0.01 OUTLIER Glycine 0 CA--C 1.521 0.464 0 CA-C-N 115.678 -0.692 . . . . 0.0 114.353 178.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . -57.55 -95.91 0.01 OUTLIER Glycine 0 CA--C 1.518 0.272 0 C-N-CA 121.099 -0.572 . . . . 0.0 113.559 -179.042 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.412 ' HB2' ' HD2' ' A' ' 50' ' ' PRO . 0.3 OUTLIER -115.93 163.83 19.84 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-O 120.736 0.303 . . . . 0.0 111.311 -179.154 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.412 ' HD2' ' HB2' ' A' ' 49' ' ' GLU . 57.8 Cg_exo -51.6 100.38 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.483 2.122 . . . . 0.0 112.39 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.434 ' CE1' ' OG1' ' A' ' 3' ' ' THR . 3.5 t80 -172.2 118.61 0.39 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.227 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.459 ' CG2' ' HB ' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -113.95 138.64 50.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.49 179.807 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.438 ' CB ' ' O ' ' A' ' 4' ' ' ILE . 0.3 OUTLIER -70.7 109.07 4.71 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.375 -179.463 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -61.22 94.73 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.613 179.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.438 ' CD2' ' HD3' ' A' ' 16' ' ' LYS . 0.9 OUTLIER -41.56 110.95 0.19 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.853 0.359 . . . . 0.0 111.179 -179.398 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -83.74 104.97 14.28 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.884 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.423 ' CB ' ' OE1' ' B' ' 540' ' ' GLU . 17.1 m-20 -131.56 174.89 9.64 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.001 -179.322 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.442 ' HB ' ' CG ' ' A' ' 67' ' ' LEU . 0.1 OUTLIER -144.77 143.92 30.91 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.935 -179.395 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.43 ' CB ' HD23 ' A' ' 61' ' ' LEU . . . -140.66 125.46 18.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.046 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -75.66 66.19 2.41 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.728 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.435 ' CB ' HG22 ' A' ' 36' ' ' VAL . 3.0 mm? -121.23 -176.98 3.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.905 0.383 . . . . 0.0 110.978 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -52.79 -45.93 67.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.012 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.402 ' HB3' ' CE2' ' A' ' 64' ' ' TYR . 0.2 OUTLIER -50.68 -38.01 44.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.951 -179.959 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.438 ' CB ' ' HB3' ' A' ' 67' ' ' LEU . 1.4 m-85 -145.02 97.13 2.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.788 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -86.02 -37.54 18.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.211 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -97.51 4.27 50.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.781 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.442 ' CG ' ' HB ' ' A' ' 58' ' ' THR . 0.0 OUTLIER -62.15 133.66 55.53 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.764 0.316 . . . . 0.0 110.266 179.672 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -174.84 60.05 0.22 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.249 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.43 ' HG2' ' CG2' ' A' ' 58' ' ' THR . 62.4 Cg_endo -73.18 -23.23 18.24 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.567 2.178 . . . . 0.0 112.03 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.24 -20.19 52.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.096 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.9 p -50.77 -42.89 58.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.169 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -160.68 69.91 2.76 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.031 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.19 149.58 36.14 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.653 2.235 . . . . 0.0 112.32 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.49 10.48 40.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.42 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.3 t -48.96 176.01 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.864 0.364 . . . . 0.0 110.897 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -109.39 -24.16 11.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.985 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.0 p -134.26 143.34 38.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.278 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.84 174.48 8.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.627 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 46.4 tp -146.51 109.28 4.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.892 0.377 . . . . 0.0 111.238 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.427 ' CG2' ' HB2' ' A' ' 110' ' ' PHE . 31.1 m -98.79 115.36 39.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.633 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 3.6 m -108.29 168.07 9.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.094 0.473 . . . . 0.0 111.655 -179.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.446 ' CE1' HG23 ' A' ' 137' ' ' ILE . 10.8 p90 -169.75 135.9 1.53 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.353 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.424 ' HA ' ' C2 ' ' A' ' 185' ' ' GNP . 4.9 p -83.17 141.17 32.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.035 0.445 . . . . 0.0 111.562 -179.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.441 ' CG1' ' O ' ' A' ' 137' ' ' ILE . 16.4 m -57.05 -31.47 37.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.243 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.434 HG22 ' CB ' ' B' ' 535' ' ' PRO . 9.5 m -78.02 117.23 22.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.235 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.435 ' N ' HD22 ' A' ' 129' ' ' LEU . 0.4 OUTLIER -151.71 142.83 15.49 Favored Pre-proline 0 C--N 1.333 -0.151 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -179.141 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -92.45 53.93 0.59 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 123.406 2.737 . . . . 0.0 111.614 179.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.421 ' CB ' ' HB2' ' A' ' 133' ' ' LYS . 0.3 OUTLIER 71.0 19.77 5.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.99 -179.297 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 58.8 m -97.2 -21.59 17.21 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.741 0.305 . . . . 0.0 111.115 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.495 ' CZ ' HG23 ' A' ' 137' ' ' ILE . 17.4 t80 -47.48 -58.87 3.7 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.169 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.7 -39.29 36.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.868 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.419 ' O ' ' CD ' ' A' ' 96' ' ' LYS . 1.0 OUTLIER -72.52 -43.22 63.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.759 179.795 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 77.0 t -50.21 -63.47 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.051 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.433 ' CB ' HD11 ' A' ' 145' ' ' LEU . 0.0 OUTLIER -58.3 -39.32 79.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.913 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -65.81 -25.33 67.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.977 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.419 ' CD ' ' O ' ' A' ' 92' ' ' ASN . 1.4 mtpm? -100.06 -24.27 14.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.0 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.436 ' HA ' ' CE3' ' A' ' 97' ' ' TRP . 0.0 OUTLIER -67.18 -58.73 4.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.05 -179.853 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.47 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 95.4 t -45.57 -53.5 19.01 Favored Pre-proline 0 CA--C 1.532 0.26 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.814 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 51.9 Cg_endo -68.66 -14.43 39.35 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.173 1.915 . . . . 0.0 112.628 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -86.66 -35.66 19.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.87 0.367 . . . . 0.0 111.054 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.421 ' CD1' HG13 ' A' ' 80' ' ' VAL . 30.3 mt -78.31 -33.01 17.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.284 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 22.9 p -84.76 -21.69 29.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.215 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 19.9 t-80 -87.63 -51.62 5.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.815 0.34 . . . . 0.0 110.96 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -80.54 -29.76 37.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.093 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -117.11 147.27 39.92 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.924 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.48 60.58 2.07 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.514 2.143 . . . . 0.0 112.288 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 59.12 67.56 0.9 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.966 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -90.84 146.79 34.6 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.744 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -60.7 169.17 5.89 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.505 2.137 . . . . 0.0 112.314 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.489 ' CD2' ' HB1' ' A' ' 151' ' ' ALA . 2.9 p90 -162.2 134.63 5.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.877 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.434 HD21 ' N ' ' A' ' 112' ' ' LEU . 8.5 tt -119.93 154.53 34.3 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.997 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.434 ' N ' HD21 ' A' ' 111' ' ' LEU . 2.9 mm? -100.69 137.3 39.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.685 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.426 ' CG1' HG21 ' A' ' 168' ' ' VAL . 49.9 t -120.76 148.02 24.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.989 0.423 . . . . 0.0 111.373 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 157' ' ' CYS . . . -130.09 107.74 0.8 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.765 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.864 ' OG1' " H2'" ' A' ' 185' ' ' GNP . 0.0 OUTLIER -125.01 -41.14 2.11 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.909 0.385 . . . . 0.0 110.595 -179.106 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.421 ' OE1' ' CB ' ' A' ' 83' ' ' SER . 2.1 tt0 -78.28 1.96 19.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.127 179.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.435 HD12 ' CA ' ' A' ' 115' ' ' THR . 0.0 OUTLIER -46.55 -26.23 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.094 0 CA-C-O 120.775 0.322 . . . . 0.0 111.562 179.929 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -75.52 -25.88 57.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.492 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.414 ' CD1' HD22 ' A' ' 160' ' ' LEU . 3.9 mp -83.95 -25.61 29.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.124 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.432 ' O ' ' CD1' ' A' ' 126' ' ' ILE . 5.8 ppt_? -50.36 -25.52 3.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.978 0.418 . . . . 0.0 110.629 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -87.79 -25.82 23.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.574 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -61.33 112.19 5.5 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.767 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.401 ' O ' HG22 ' A' ' 126' ' ' ILE . 40.0 Cg_endo -67.92 -6.27 16.59 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.513 2.142 . . . . 0.0 113.114 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -77.39 -68.49 0.61 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.024 0.44 . . . . 0.0 109.929 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.417 ' CG2' HG11 ' A' ' 85' ' ' VAL . 4.8 m -56.71 -35.41 68.49 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.31 0.576 . . . . 0.0 109.556 179.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.491 ' HA ' ' CD1' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -57.53 -44.04 84.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.55 179.231 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -55.69 -36.85 67.61 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.469 179.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 125' ' ' THR . 0.0 OUTLIER -64.04 -31.3 72.44 Favored 'General case' 0 CA--C 1.518 -0.25 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.554 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.491 ' CD1' ' HA ' ' A' ' 126' ' ' ILE . 7.6 mt -74.0 -42.06 60.95 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.474 ' HA ' ' HB3' ' A' ' 134' ' ' GLN . . . -47.21 -28.97 2.09 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.956 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 31.4 mmtt -56.54 -34.12 66.75 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.753 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -124.36 -31.33 3.3 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.508 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 0.0 OUTLIER -137.42 -75.6 0.41 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 121.037 -0.265 . . . . 0.0 111.306 -179.009 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.508 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 3.0 pt20 111.53 -45.21 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.607 1.163 . . . . 0.0 111.016 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.5 mttp -69.81 111.06 7.8 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.91 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -72.43 -169.89 0.52 Allowed 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.353 2.036 . . . . 0.0 111.218 178.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.495 HG23 ' CZ ' ' A' ' 90' ' ' PHE . 1.1 mm -114.03 97.03 5.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.904 0.383 . . . . 0.0 110.99 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 3.0 p -67.3 155.63 90.27 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.943 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.468 ' HA ' ' CE2' ' A' ' 154' ' ' TYR . 10.2 Cg_endo -51.66 -38.68 66.34 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.747 2.298 . . . . 0.0 112.098 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.426 ' HG3' ' N ' ' A' ' 141' ' ' THR . 0.0 OUTLIER -64.73 -25.96 68.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.664 179.69 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.426 ' N ' ' HG3' ' A' ' 140' ' ' GLU . 45.5 m -71.82 -47.4 53.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.787 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.406 ' HB2' ' CG ' ' A' ' 154' ' ' TYR . . . -55.21 -39.2 69.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.877 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -68.04 -41.96 81.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.818 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -53.25 -60.6 3.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.867 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.433 HD11 ' CB ' ' A' ' 94' ' ' LYS . 1.6 tt -66.91 -39.8 87.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.64 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -48.94 -50.37 35.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.927 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 19.2 mtp180 -78.76 -24.14 44.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.704 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -49.62 -34.78 19.03 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.88 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.6 mt -121.5 21.78 10.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.893 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.1 mttp 47.84 57.5 5.95 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.059 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.489 ' HB1' ' CD2' ' A' ' 110' ' ' PHE . . . -70.58 -82.69 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.214 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.443 ' CG2' ' O ' ' A' ' 151' ' ' ALA . 72.9 t -161.81 -73.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.842 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 179.5 146.35 0.2 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.61 -178.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.468 ' CE2' ' HA ' ' A' ' 139' ' ' PRO . 65.0 t80 -112.79 103.69 11.7 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.305 179.396 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -102.99 -179.96 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.744 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.442 ' CB ' ' HE3' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -89.6 151.3 21.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.921 0.391 . . . . 0.0 111.099 -179.797 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.457 ' N ' ' O ' ' A' ' 114' ' ' GLY . 1.9 t -128.97 169.22 14.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.883 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.426 ' CB ' ' HA ' ' A' ' 162' ' ' GLN . 2.2 t -106.99 151.46 25.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.203 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.405 ' O ' ' CD1' ' A' ' 160' ' ' LEU . . . 172.68 -33.96 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.77 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.433 ' N ' HD23 ' A' ' 160' ' ' LEU . 0.2 OUTLIER -131.09 -44.35 1.04 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.7 179.753 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 9.7 t -100.08 -21.69 15.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.091 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.426 ' HA ' ' CB ' ' A' ' 158' ' ' SER . 1.9 tt0 72.89 77.7 0.14 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.955 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.442 ' HE3' ' CB ' ' A' ' 156' ' ' GLU . 0.0 OUTLIER -97.35 10.44 39.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.569 -179.948 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.406 ' O ' ' CB ' ' A' ' 165' ' ' LEU . . . 116.25 -50.85 0.76 Allowed Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.428 -0.892 . . . . 0.0 113.336 179.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.428 ' CD2' ' HB3' ' A' ' 19' ' ' LEU . 0.2 OUTLIER 79.54 -56.6 0.4 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.8 0.333 . . . . 0.0 110.8 -179.433 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -56.8 -21.32 27.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.791 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -55.32 -72.18 0.07 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.014 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.426 HG21 ' CG1' ' A' ' 113' ' ' VAL . 29.0 m -57.9 -40.79 77.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.036 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.486 ' CD1' ' CD2' ' A' ' 19' ' ' LEU . 1.4 t80 -63.58 -34.67 78.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.734 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.403 ' HA ' ' CG1' ' A' ' 173' ' ' ILE . 13.2 m-20 -74.64 -24.89 58.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.659 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -79.41 -33.41 42.69 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.59 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -73.23 -35.25 66.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.685 179.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.403 ' CG1' ' HA ' ' A' ' 170' ' ' ASP . 1.4 pp -82.78 -32.51 9.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.891 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.487 ' CD1' ' CB ' ' B' ' 505' ' ' LEU . 13.6 tp -54.68 -47.34 73.75 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.211 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -47.5 -26.89 1.54 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.113 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.512 ' CB ' ' CG2' ' A' ' 4' ' ' ILE . . . -93.9 -37.12 11.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.173 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.48 ' CD2' HG21 ' A' ' 4' ' ' ILE . 43.3 mt -68.71 -24.2 64.46 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.663 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -160.52 128.74 2.89 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.684 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.69 106.9 0.19 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.44 2.093 . . . . 0.0 112.333 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.19 176.48 9.89 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.557 2.171 . . . . 0.0 112.248 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -139.79 141.89 29.26 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.966 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.35 -165.04 0.29 Allowed 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.718 2.279 . . . . 0.0 112.227 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.08 173.87 1.01 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.018 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.289 -0.862 . . . . 0.0 110.882 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.153 0 N-CA-C 112.421 -0.272 . . . . 0.0 112.421 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 503' ' ' SER . . . . . 0.403 ' HB2' ' HA ' ' B' ' 511' ' ' SER . 0.5 OUTLIER -87.4 -80.66 0.25 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.809 0.338 . . . . 0.0 110.908 179.943 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 504' ' ' GLY . . . . . 0.41 ' HA2' ' HA ' ' B' ' 509' ' ' ASP . . . 102.6 113.09 3.72 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.541 -0.838 . . . . 0.0 111.941 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 505' ' ' LEU . . . . . 0.487 ' CB ' ' CD1' ' A' ' 174' ' ' LEU . 0.1 OUTLIER -139.03 -42.28 0.47 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 121.053 -0.259 . . . . 0.0 111.681 -179.195 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 506' ' ' SER . . . . . 0.435 ' CB ' ' O ' ' B' ' 505' ' ' LEU . 0.4 OUTLIER 162.74 -44.98 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.668 0.27 . . . . 0.0 110.741 -179.678 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 507' ' ' ALA . . . . . . . . . . . . . . . -37.58 -35.23 0.12 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.627 0.727 . . . . 0.0 111.109 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 508' ' ' GLN . . . . . 0.472 ' O ' ' CB ' ' B' ' 509' ' ' ASP . 7.3 pt20 165.79 -37.94 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.555 -1.202 . . . . 0.0 108.634 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 509' ' ' ASP . . . . . 0.472 ' CB ' ' O ' ' B' ' 508' ' ' GLN . 13.7 t0 148.21 44.92 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 114.201 -1.363 . . . . 0.0 109.394 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 510' ' ' ILE . . . . . 0.444 ' CB ' HD12 ' A' ' 177' ' ' LEU . 19.9 mm -55.18 133.65 18.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.406 -179.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 511' ' ' SER . . . . . 0.403 ' HA ' ' HB2' ' B' ' 503' ' ' SER . 30.2 t -109.59 134.82 51.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.836 179.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 512' ' ' GLN . . . . . 0.428 ' CB ' ' HD3' ' B' ' 513' ' ' PRO . 0.0 OUTLIER -99.47 -53.65 0.18 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.134 179.735 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 513' ' ' PRO . . . . . 0.428 ' HD3' ' CB ' ' B' ' 512' ' ' GLN . 91.0 Cg_endo -94.91 78.19 0.15 Allowed 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 123.152 2.568 . . . . 0.0 112.525 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 514' ' ' LEU . . . . . 0.459 ' CD1' ' CG1' ' A' ' 44' ' ' VAL . 4.7 mp -89.23 -89.88 0.14 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.227 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 515' ' ' GLN . . . . . 0.524 ' O ' ' HB3' ' B' ' 516' ' ' ASN . 6.4 mt-30 -93.4 47.31 1.24 Allowed 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 116.744 -0.207 . . . . 0.0 111.13 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 516' ' ' ASN . . . . . 0.524 ' HB3' ' O ' ' B' ' 515' ' ' GLN . 29.2 t30 77.7 -38.23 0.26 Allowed 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 517' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 61.24 54.33 3.27 Favored 'General case' 0 C--O 1.232 0.15 0 O-C-N 122.24 -0.287 . . . . 0.0 111.452 179.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 518' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -163.54 92.73 0.72 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.894 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 519' ' ' ILE . . . . . . . . . . . . . 22.4 mm -71.16 -69.13 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.089 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -160.47 -170.44 2.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.94 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 521' ' ' THR . . . . . 0.454 ' O ' ' CZ ' ' A' ' 40' ' ' TYR . 13.8 t -77.32 -168.37 1.12 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.058 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 522' ' ' GLY . . . . . 0.457 ' HA2' ' CE1' ' A' ' 40' ' ' TYR . . . -121.41 -75.12 0.37 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.38 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 523' ' ' HIS . . . . . 0.439 ' CD2' ' C ' ' B' ' 523' ' ' HIS . 9.4 t-160 178.98 -88.21 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.555 0.217 . . . . 0.0 110.902 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 524' ' ' GLY . . . . . 0.415 ' HA3' ' CG2' ' A' ' 36' ' ' VAL . . . 46.77 -139.5 7.53 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.778 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 525' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -137.99 82.85 1.94 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.837 0.351 . . . . 0.0 110.784 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 526' ' ' SER . . . . . 0.442 ' CB ' ' HB3' ' A' ' 34' ' ' PRO . 6.5 m -72.17 95.75 1.7 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.757 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 527' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -145.96 142.42 17.78 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.016 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.21 105.29 2.0 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.671 2.248 . . . . 0.0 112.113 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 529' ' ' ARG . . . . . . . . . . . . . 2.3 mtt-85 -100.27 -55.38 2.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.307 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 530' ' ' HIS . . . . . 0.418 ' O ' ' CB ' ' B' ' 531' ' ' CYS . 0.0 OUTLIER -130.57 -38.12 1.34 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.486 -179.592 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 531' ' ' CYS . . . . . 0.418 ' CB ' ' O ' ' B' ' 530' ' ' HIS . 4.0 m 79.49 28.74 0.34 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.988 0.423 . . . . 0.0 110.604 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 532' ' ' TRP . . . . . 0.421 ' CH2' ' HG3' ' B' ' 537' ' ' ARG . 1.7 t-105 59.28 103.28 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.035 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . -114.55 -24.31 4.42 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.278 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 534' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -133.47 130.97 21.2 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.489 0.185 . . . . 0.0 110.597 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 535' ' ' PRO . . . . . 0.434 ' CB ' HG22 ' A' ' 85' ' ' VAL . 51.4 Cg_exo -54.49 -170.03 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.458 2.106 . . . . 0.0 112.504 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 68.22 120.86 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.004 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 537' ' ' ARG . . . . . 0.421 ' HG3' ' CH2' ' B' ' 532' ' ' TRP . 0.0 OUTLIER -106.23 -179.32 3.91 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 121.599 0.714 . . . . 0.0 111.259 179.916 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 538' ' ' ILE . . . . . 0.418 HG12 ' HB2' ' B' ' 542' ' ' TYR . 1.2 tt -116.02 174.47 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 CA-C-N 114.594 -1.184 . . . . 0.0 109.891 179.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 539' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.8 162.3 28.14 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.482 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 540' ' ' GLU . . . . . 0.427 ' CB ' ' OG1' ' A' ' 58' ' ' THR . 2.4 mt-10 -40.38 -49.08 2.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.841 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 541' ' ' LEU . . . . . . . . . . . . . 1.1 tt -42.28 -67.91 0.23 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.797 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 542' ' ' TYR . . . . . 0.418 ' HB2' HG12 ' B' ' 538' ' ' ILE . 59.2 m-85 -84.57 9.62 13.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.981 -179.17 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 543' ' ' LEU . . . . . 0.427 ' CD2' HG13 ' A' ' 14' ' ' VAL . 16.5 tp -44.92 -28.47 0.67 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.834 0.35 . . . . 0.0 111.283 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . -72.52 77.91 0.74 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.548 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 545' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.975 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' GNP . . . . . 0.864 " H2'" ' OG1' ' A' ' 115' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' HOH . . . . . 0.403 ' O ' ' CG2' ' A' ' 14' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.411 ' HB3' ' N ' ' A' ' 49' ' ' GLU . 2.6 ppp? . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.828 0.347 . . . . 0.0 111.264 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.4 ' CG ' ' CD1' ' B' ' 510' ' ' ILE . 0.2 OUTLIER -129.44 141.17 51.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.52 179.464 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.524 HG22 ' CZ ' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -94.06 168.78 10.72 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.983 -179.815 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.47 ' CG2' ' CD2' ' A' ' 177' ' ' LEU . 2.3 pt -151.03 154.39 8.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.659 -179.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -121.03 110.38 16.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.397 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 40.1 m -91.61 107.4 19.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.004 0.43 . . . . 0.0 111.589 -179.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.407 ' CG2' ' CZ ' ' A' ' 56' ' ' PHE . 2.9 t -138.0 113.65 10.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.254 179.334 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.49 ' CG2' ' CG2' ' A' ' 14' ' ' VAL . 2.4 p -87.24 150.14 3.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.308 0.575 . . . . 0.0 111.436 -179.445 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.53 ' CG2' ' CE1' ' A' ' 78' ' ' PHE . 72.5 t -155.06 130.23 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.637 179.132 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.72 148.13 4.75 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.131 -1.033 . . . . 0.0 112.711 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -58.17 -42.18 85.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.893 0.378 . . . . 0.0 110.394 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.26 -149.94 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.701 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.446 ' HA ' ' HB2' ' B' ' 537' ' ' ARG . . . -103.1 -55.86 2.33 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.274 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.49 ' CG2' ' CG2' ' A' ' 8' ' ' VAL . 3.5 t 84.13 -51.52 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.264 -0.425 . . . . 0.0 109.949 -178.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.428 ' O ' ' CB ' ' A' ' 19' ' ' LEU . . . 90.49 25.48 25.67 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.857 -0.687 . . . . 0.0 113.045 179.041 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.434 ' HB2' ' CG1' ' A' ' 8' ' ' VAL . 0.7 OUTLIER -38.58 -43.2 0.85 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.11 0.481 . . . . 0.0 111.017 179.749 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.406 ' O ' HG12 ' A' ' 21' ' ' ILE . 81.9 p -98.47 -60.98 1.44 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.278 178.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.446 ' HA ' ' HB ' ' A' ' 21' ' ' ILE . 29.7 t -46.51 -32.65 3.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.014 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.532 ' CD1' ' CE2' ' A' ' 169' ' ' PHE . 3.3 mt -45.68 -71.99 0.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -178.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.409 ' CD2' ' CE2' ' A' ' 169' ' ' PHE . 3.0 mm? -64.64 -23.67 67.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.951 -179.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.446 ' HB ' ' HA ' ' A' ' 18' ' ' CYS . 14.6 mm -61.05 -70.95 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.945 0.403 . . . . 0.0 110.486 179.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.498 ' HA ' ' HA ' ' A' ' 26' ' ' ASN . 2.4 t -51.76 -34.42 39.38 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.162 -179.075 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.485 ' CZ ' ' HD3' ' A' ' 166' ' ' LYS . 27.5 t80 -55.93 -45.11 78.84 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.968 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.62 -64.42 1.05 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.543 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 79.9 p -66.27 -37.47 85.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.582 -179.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.498 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 1.5 t-20 67.08 56.91 0.63 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.941 -179.15 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.0 mmtt -132.91 83.25 2.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.134 0.492 . . . . 0.0 110.961 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.468 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 40.5 t80 -92.35 -45.56 0.34 Allowed Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.082 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.468 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 62.6 Cg_endo -94.86 90.22 0.11 Allowed 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.955 2.436 . . . . 0.0 112.939 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.429 ' O ' ' CB ' ' B' ' 531' ' ' CYS . 0.4 OUTLIER -150.47 -89.2 0.07 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.627 0.251 . . . . 0.0 110.855 179.616 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -159.12 126.26 4.76 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.627 -0.261 . . . . 0.0 110.427 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.512 ' CG ' ' NH2' ' B' ' 537' ' ' ARG . 3.8 m-85 -111.55 121.87 46.31 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.194 0.521 . . . . 0.0 111.283 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.436 ' CB ' ' CD ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -165.42 -64.55 0.01 OUTLIER Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.433 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.436 ' CD ' ' CB ' ' A' ' 33' ' ' VAL . 50.5 Cg_endo -69.9 58.37 1.62 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.385 2.057 . . . . 0.0 112.428 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.2 t -87.64 10.47 17.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.737 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.412 HG11 ' CB ' ' A' ' 59' ' ' ALA . 3.3 m -76.0 -30.03 20.33 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-O 120.865 0.364 . . . . 0.0 110.84 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.409 ' O ' ' CG ' ' A' ' 40' ' ' TYR . 0.2 OUTLIER -50.87 -25.01 4.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.017 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -50.34 -28.29 7.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.971 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -88.99 14.52 10.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.165 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.473 ' CE1' HG13 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -71.59 -169.99 0.49 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.787 0.327 . . . . 0.0 110.911 179.809 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -112.16 119.92 40.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.316 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.473 HG13 ' CE1' ' A' ' 40' ' ' TYR . 2.5 m -122.71 121.71 64.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.023 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.4 t -104.69 128.79 52.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.9 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.483 ' CG1' ' CG2' ' A' ' 52' ' ' THR . 1.0 OUTLIER -164.54 -177.45 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.871 179.895 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.482 ' HE1' ' N ' ' A' ' 49' ' ' GLU . 5.9 tpt -101.4 96.13 6.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.012 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.462 ' O ' ' N ' ' A' ' 48' ' ' GLY . 1.6 mm -74.86 86.9 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 120.841 0.353 . . . . 0.0 110.219 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.436 ' HA3' ' HA ' ' B' ' 510' ' ' ILE . . . 33.71 -87.72 0.01 OUTLIER Glycine 0 CA--C 1.523 0.549 0 CA-C-N 115.676 -0.693 . . . . 0.0 114.327 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . -37.72 -79.17 0.04 OUTLIER Glycine 0 C--N 1.333 0.392 0 N-CA-C 113.899 0.319 . . . . 0.0 113.899 -179.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.482 ' N ' ' HE1' ' A' ' 45' ' ' MET . 2.7 mt-10 -140.52 156.34 69.42 Favored Pre-proline 0 C--N 1.332 -0.162 0 CA-C-O 120.808 0.337 . . . . 0.0 111.621 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' A' ' 49' ' ' GLU . 1.7 Cg_endo -43.2 101.01 0.04 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 123.137 2.558 . . . . 0.0 112.838 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.524 ' CZ ' HG22 ' A' ' 3' ' ' THR . 17.8 t80 -172.68 153.62 2.81 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.368 179.221 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.483 ' CG2' ' CG1' ' A' ' 44' ' ' VAL . 0.8 OUTLIER -136.88 154.11 50.57 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.961 179.53 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.46 ' HG ' ' CG1' ' A' ' 4' ' ' ILE . 0.0 OUTLIER -99.56 166.57 11.08 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.984 179.772 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 56' ' ' PHE . . . -115.17 87.56 0.44 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.42 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.34 82.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.781 0.324 . . . . 0.0 110.538 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.464 ' CG ' ' O ' ' A' ' 56' ' ' PHE . 37.4 p90 -84.36 105.5 15.24 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.571 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 56.6 p30 -98.19 -177.88 3.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.761 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.421 HG21 ' CD2' ' A' ' 70' ' ' LEU . 73.6 p -94.39 161.54 14.19 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.816 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.418 ' CA ' ' O ' ' B' ' 542' ' ' TYR . . . -170.84 179.84 3.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.172 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -150.97 34.66 0.93 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.463 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -95.71 -173.18 2.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.863 0.363 . . . . 0.0 110.917 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -51.02 -25.54 4.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.734 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.95 -54.79 34.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.798 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -132.53 152.07 51.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.774 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -85.88 -68.27 0.75 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.205 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.8 -52.27 4.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.224 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.406 HD22 ' CD ' ' A' ' 69' ' ' PRO . 7.2 tt 55.42 98.61 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.484 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.0 mmm180 -132.88 58.93 39.26 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.128 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.406 ' CD ' HD22 ' A' ' 67' ' ' LEU . 83.5 Cg_endo -83.68 -21.72 4.04 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.827 2.351 . . . . 0.0 112.172 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.466 ' CD1' ' HA ' ' B' ' 541' ' ' LEU . 1.1 pt? -85.69 1.32 49.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.721 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 46.3 t -70.59 -71.16 0.26 Allowed 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.728 0.299 . . . . 0.0 111.065 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -121.85 72.55 32.76 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.861 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -78.71 140.87 16.85 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.713 2.275 . . . . 0.0 112.457 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.8 tp60 -102.11 10.39 39.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.349 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 13.6 t -59.55 -173.75 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.866 0.365 . . . . 0.0 111.055 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -136.22 7.83 3.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.503 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.434 ' CG1' ' HB2' ' A' ' 175' ' ' ALA . 64.0 t -151.14 101.15 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 CA-C-O 120.788 0.328 . . . . 0.0 111.249 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.53 ' CE1' ' CG2' ' A' ' 9' ' ' VAL . 0.1 OUTLIER -102.08 -177.85 3.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.645 179.785 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 21.7 tp -154.13 114.59 3.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.831 0.348 . . . . 0.0 111.633 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.9 m -94.61 156.22 3.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.486 179.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.434 ' HB3' ' CG2' ' A' ' 14' ' ' VAL . 22.3 p -128.98 168.93 15.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.237 0.541 . . . . 0.0 112.178 -179.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.48 ' O ' ' CD1' ' A' ' 82' ' ' PHE . 46.9 p90 179.27 123.51 0.06 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.926 179.273 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.431 ' HA ' ' C2 ' ' A' ' 185' ' ' GNP . 98.8 p -93.61 146.27 23.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.881 0.372 . . . . 0.0 111.44 -179.497 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.436 ' CG1' ' HG2' ' A' ' 120' ' ' ARG . 58.1 t -51.3 -73.95 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.366 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.1 m -43.27 105.76 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 120.756 0.313 . . . . 0.0 110.968 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.424 ' N ' HD22 ' A' ' 129' ' ' LEU . 87.6 p -151.33 138.65 12.19 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.62 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.407 ' O ' ' CB ' ' A' ' 88' ' ' SER . 80.3 Cg_endo -91.65 53.93 0.8 Allowed 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.305 2.67 . . . . 0.0 112.026 179.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.447 ' CB ' ' CG ' ' A' ' 133' ' ' LYS . 0.1 OUTLIER 81.42 30.33 0.14 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.84 -179.611 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 11.1 t -88.18 -24.42 23.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.697 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.464 ' CZ ' ' CG2' ' A' ' 137' ' ' ILE . 0.4 OUTLIER -50.89 -64.41 0.82 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.871 179.901 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -51.83 -37.58 52.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.936 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.413 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 3.3 m120 -67.96 -64.2 0.91 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.917 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 50.7 t -49.26 -46.7 18.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.368 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.436 ' HB2' ' CD1' ' A' ' 145' ' ' LEU . 4.5 ttpt -54.19 -59.08 5.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.276 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -83.46 9.9 10.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.869 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.413 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 13.7 tttt -116.86 -33.09 4.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.724 0.297 . . . . 0.0 111.067 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -94.35 -45.31 7.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.459 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.493 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 43.8 t -53.09 -44.44 97.13 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 -179.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.493 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 2.7 Cg_exo -76.01 -24.48 11.24 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.609 2.206 . . . . 0.0 112.641 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -88.73 -49.69 6.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.016 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.9 tt -51.16 -24.55 3.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.157 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 59.3 p -97.22 -28.72 13.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.006 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 54.1 t60 -72.82 -69.29 0.42 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.926 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -62.88 -42.15 99.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.733 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 17.0 m -111.03 148.41 38.58 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.739 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -49.29 167.7 0.15 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.502 2.135 . . . . 0.0 112.21 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.6 tmtt? -83.01 54.98 2.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.799 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.4 p -76.88 156.81 82.33 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.031 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -60.45 166.52 9.43 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.653 2.235 . . . . 0.0 112.238 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.482 ' CE2' ' HB1' ' A' ' 151' ' ' ALA . 9.1 p90 -163.11 142.44 8.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.925 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.434 ' CD1' HG13 ' A' ' 152' ' ' VAL . 0.9 OUTLIER -108.56 159.7 16.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.983 -179.721 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.43 ' CD2' ' HB3' ' A' ' 146' ' ' ALA . 3.1 mm? -106.15 128.03 53.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.659 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.423 ' HB ' ' O6 ' ' A' ' 185' ' ' GNP . 43.8 t -89.96 128.45 41.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.134 0.492 . . . . 0.0 111.555 -179.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.494 ' HA2' ' CE2' ' A' ' 154' ' ' TYR . . . -112.36 103.62 1.49 Allowed Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.253 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.525 ' C ' ' N2 ' ' A' ' 185' ' ' GNP . 0.4 OUTLIER -144.1 -153.65 0.48 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.826 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.537 ' CB ' HN22 ' A' ' 185' ' ' GNP . 0.4 OUTLIER 39.39 29.95 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.065 0.459 . . . . 0.0 111.329 179.333 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.432 ' CD1' ' HA ' ' A' ' 115' ' ' THR . 0.0 OUTLIER -74.37 -4.3 5.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.711 179.376 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -100.28 -22.01 15.26 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.11 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.476 ' CD2' ' N ' ' A' ' 119' ' ' LEU . 2.1 mm? -72.85 -29.65 63.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.097 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.436 ' HG2' ' CG1' ' A' ' 84' ' ' VAL . 25.7 mtp180 -47.32 -35.5 8.12 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.917 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -76.32 -42.55 44.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.794 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -46.93 100.52 0.24 Allowed Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.89 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.425 ' O ' ' CG ' ' A' ' 127' ' ' GLU . 10.5 Cg_exo -71.57 -3.76 13.7 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.737 2.291 . . . . 0.0 112.675 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.3 t -79.45 -64.11 1.26 Allowed 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.404 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 11.0 m -58.92 -40.14 83.68 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 178.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.441 ' HA ' ' CD1' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -53.78 -45.73 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.777 179.217 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.425 ' CG ' ' O ' ' A' ' 123' ' ' PRO . 3.2 mm-40 -57.54 -36.08 71.15 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.068 179.385 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 125' ' ' THR . 1.4 mptt -64.75 -30.66 71.67 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.144 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.441 ' CD1' ' HA ' ' A' ' 126' ' ' ILE . 5.3 mt -74.16 -40.8 62.34 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.09 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.424 ' HA ' ' HB3' ' A' ' 134' ' ' GLN . . . -42.91 -36.97 1.69 Allowed 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.438 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.3 mmtp -50.6 -29.06 9.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.974 0.416 . . . . 0.0 110.364 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -123.88 -31.09 3.45 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.732 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.516 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 4.0 mmpt? -148.86 -90.81 0.08 Allowed 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.516 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 1.2 pt20 122.24 -25.18 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.713 1.205 . . . . 0.0 110.314 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 4.5 ptmm? -69.21 110.71 6.7 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.716 -179.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.411 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 88.2 Cg_endo -82.01 127.69 5.5 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.574 2.182 . . . . 0.0 111.302 179.084 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.482 ' CD1' ' N ' ' A' ' 137' ' ' ILE . 0.9 OUTLIER -58.65 96.75 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.916 0.389 . . . . 0.0 110.792 -179.423 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.407 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 7.2 p -70.24 155.96 92.62 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.042 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.436 ' CD ' ' CZ ' ' A' ' 120' ' ' ARG . 10.3 Cg_endo -51.23 -24.37 15.16 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.653 2.235 . . . . 0.0 112.175 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -79.79 -46.36 17.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.551 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 6.8 m -56.2 -45.3 79.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.669 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.497 ' HB2' ' CD2' ' A' ' 154' ' ' TYR . . . -51.76 -51.49 55.82 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.847 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -53.97 -39.42 65.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.744 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.26 -55.81 24.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.701 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.436 ' CD1' ' HB2' ' A' ' 94' ' ' LYS . 1.6 tt -69.43 -36.96 77.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.572 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.43 ' HB3' ' CD2' ' A' ' 112' ' ' LEU . . . -54.42 -71.9 0.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.051 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.421 ' CZ ' ' HE3' ' A' ' 183' ' ' LYS . 10.0 mtt180 -61.35 -23.16 65.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.098 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -49.98 -37.16 31.18 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.855 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.77 20.59 16.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.087 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.3 mttt 47.89 49.09 17.3 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.144 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.482 ' HB1' ' CE2' ' A' ' 110' ' ' PHE . . . -65.25 -81.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.956 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.434 HG13 ' CD1' ' A' ' 111' ' ' LEU . 49.1 t -161.56 -75.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.732 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.75 131.18 0.26 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.923 -178.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.497 ' CD2' ' HB2' ' A' ' 142' ' ' ALA . 11.1 t80 -104.47 103.71 13.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.15 179.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.433 ' HB ' ' CG2' ' A' ' 168' ' ' VAL . 1.4 t -102.16 164.64 3.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.141 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -89.86 135.78 33.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.82 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.418 ' N ' ' O ' ' A' ' 114' ' ' GLY . 20.4 p -178.59 129.51 0.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.922 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.417 ' O ' ' CA ' ' A' ' 162' ' ' GLN . 0.1 OUTLIER -125.74 140.4 52.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.172 -179.906 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.409 ' N ' HD12 ' A' ' 165' ' ' LEU . . . -84.19 -44.32 14.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.072 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -47.77 -34.97 9.21 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.763 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.6 t -116.02 -15.87 11.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.118 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.417 ' CA ' ' O ' ' A' ' 158' ' ' SER . 1.5 tt0 70.33 66.8 0.21 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.812 0.339 . . . . 0.0 110.68 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -93.81 22.79 5.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.254 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 102.36 41.98 2.28 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.48 -0.867 . . . . 0.0 113.111 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.459 ' CD2' ' HA ' ' A' ' 19' ' ' LEU . 1.7 tp -50.4 -25.07 3.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.864 0.364 . . . . 0.0 110.691 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.485 ' HD3' ' CZ ' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -68.54 -26.08 65.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.842 179.514 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -58.33 -72.29 0.1 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.827 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.433 ' CG2' ' HB ' ' A' ' 155' ' ' VAL . 91.3 t -52.44 -43.63 41.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.967 0.413 . . . . 0.0 110.461 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.532 ' CE2' ' CD1' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -62.77 -33.66 75.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.277 179.681 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 166' ' ' LYS . 27.1 t0 -69.82 -25.61 63.84 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.599 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -78.75 -29.15 44.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.132 179.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.426 ' N ' HD12 ' A' ' 111' ' ' LEU . . . -75.1 -43.51 52.53 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.888 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 1.6 pp -68.75 -36.11 72.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.838 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.422 ' CD2' ' HB3' ' B' ' 505' ' ' LEU . 26.0 tp -55.13 -42.95 73.68 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.776 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.434 ' HB2' ' CG1' ' A' ' 77' ' ' VAL . . . -48.17 -27.01 2.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.775 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.432 ' CB ' ' HB ' ' A' ' 4' ' ' ILE . . . -86.7 -43.75 12.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.845 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.47 ' CD2' ' CG2' ' A' ' 4' ' ' ILE . 56.3 mt -68.73 -26.94 65.51 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.957 0.408 . . . . 0.0 110.255 179.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.428 ' HG3' ' N ' ' B' ' 507' ' ' ALA . 0.1 OUTLIER -174.14 92.6 0.33 Allowed Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.721 179.788 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -47.74 106.04 0.1 OUTLIER 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.645 2.23 . . . . 0.0 112.428 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.22 171.99 10.69 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.47 2.114 . . . . 0.0 112.205 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -110.19 137.79 20.67 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.979 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -79.42 -165.17 0.32 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.576 2.184 . . . . 0.0 112.272 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.421 ' HE3' ' CZ ' ' A' ' 147' ' ' ARG . 0.0 OUTLIER -135.97 97.33 3.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.925 179.992 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.166 -0.921 . . . . 0.0 110.921 -179.985 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 503' ' ' SER . . . . . . . . . . . . . 3.3 m -90.41 -75.97 0.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.744 0.307 . . . . 0.0 110.918 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 504' ' ' GLY . . . . . 0.422 ' O ' ' CD1' ' B' ' 505' ' ' LEU . . . 144.16 -116.84 0.99 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.368 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 505' ' ' LEU . . . . . 0.422 ' CD1' ' O ' ' B' ' 504' ' ' GLY . 0.1 OUTLIER 64.99 -70.6 0.09 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.786 0.327 . . . . 0.0 111.204 179.823 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 506' ' ' SER . . . . . 0.42 ' N ' ' O ' ' B' ' 504' ' ' GLY . 0.1 OUTLIER -171.92 -159.77 0.15 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.546 -179.973 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 507' ' ' ALA . . . . . 0.428 ' N ' ' HG3' ' A' ' 178' ' ' GLU . . . 62.97 -95.71 0.05 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.469 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 508' ' ' GLN . . . . . 0.462 ' O ' ' CB ' ' B' ' 509' ' ' ASP . 28.6 mt-30 -137.28 4.04 2.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.875 179.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 509' ' ' ASP . . . . . 0.462 ' CB ' ' O ' ' B' ' 508' ' ' GLN . 0.1 OUTLIER 92.36 29.7 0.01 OUTLIER 'General case' 0 C--N 1.345 0.406 0 CA-C-O 121.461 0.648 . . . . 0.0 109.864 -179.127 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 510' ' ' ILE . . . . . 0.44 ' CG2' HG23 ' A' ' 46' ' ' ILE . 43.0 mt -61.58 149.48 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.393 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 511' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.23 146.62 33.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.291 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 512' ' ' GLN . . . . . 0.494 ' CB ' ' CD ' ' B' ' 513' ' ' PRO . 1.5 pm0 -57.79 -176.2 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.35 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 513' ' ' PRO . . . . . 0.494 ' CD ' ' CB ' ' B' ' 512' ' ' GLN . 50.9 Cg_exo -55.52 82.37 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.492 2.128 . . . . 0.0 111.694 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 514' ' ' LEU . . . . . 0.455 ' CD1' HG13 ' A' ' 44' ' ' VAL . 1.8 mp -46.38 171.96 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.003 -179.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 515' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -94.26 -168.65 1.89 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.766 179.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 66.22 10.49 7.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.589 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 517' ' ' SER . . . . . 0.45 ' CB ' ' HB ' ' A' ' 44' ' ' VAL . 72.5 p -133.47 80.77 1.89 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.912 0.387 . . . . 0.0 111.02 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 518' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -140.45 91.69 2.46 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.897 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 519' ' ' ILE . . . . . . . . . . . . . 3.0 mm -84.97 138.12 19.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.046 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -41.89 -88.86 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.409 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 521' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 47.86 -161.59 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.873 0.368 . . . . 0.0 111.009 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 522' ' ' GLY . . . . . . . . . . . . . . . 55.24 170.33 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.47 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 523' ' ' HIS . . . . . . . . . . . . . 22.7 t60 -156.6 -77.45 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.787 0.327 . . . . 0.0 110.876 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 524' ' ' GLY . . . . . . . . . . . . . . . 46.68 -144.62 4.33 Favored Glycine 0 N--CA 1.454 -0.164 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.722 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 525' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -119.24 81.47 1.72 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.826 0.346 . . . . 0.0 110.842 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 526' ' ' SER . . . . . 0.433 ' CA ' ' HB3' ' A' ' 34' ' ' PRO . 0.7 OUTLIER -88.43 96.25 10.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.785 179.968 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 527' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -162.08 141.28 7.28 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.795 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -57.52 97.61 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.677 2.251 . . . . 0.0 112.072 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 529' ' ' ARG . . . . . 0.429 ' CD ' HG11 ' A' ' 33' ' ' VAL . 10.4 mtp180 -100.23 -54.74 2.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.099 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 530' ' ' HIS . . . . . 0.487 ' CE1' ' HB3' ' B' ' 545' ' ' ASN . 6.2 p80 -165.47 97.45 0.68 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.831 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 531' ' ' CYS . . . . . 0.429 ' CB ' ' O ' ' A' ' 30' ' ' SER . 18.8 p -53.49 -171.65 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.068 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 532' ' ' TRP . . . . . . . . . . . . . 87.4 t90 -49.06 103.78 0.05 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.013 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . -116.39 -57.47 0.32 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.496 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 534' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -68.38 155.97 91.38 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 120.705 0.288 . . . . 0.0 110.872 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -63.34 -19.52 68.39 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.633 2.222 . . . . 0.0 112.485 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -151.66 139.01 19.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.929 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 537' ' ' ARG . . . . . 0.512 ' NH2' ' CG ' ' A' ' 32' ' ' TYR . 0.1 OUTLIER -48.07 152.23 0.85 Allowed 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.114 179.921 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 538' ' ' ILE . . . . . 0.41 ' CG2' ' HA ' ' B' ' 543' ' ' LEU . 5.6 tp -63.42 140.77 19.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.139 179.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 539' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -44.61 147.39 0.61 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.733 0.301 . . . . 0.0 111.162 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 540' ' ' GLU . . . . . 0.404 ' O ' HG21 ' A' ' 58' ' ' THR . 49.8 mm-40 -60.14 -15.86 27.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.613 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 541' ' ' LEU . . . . . 0.466 ' HA ' ' CD1' ' A' ' 70' ' ' LEU . 2.9 mm? -41.31 -59.59 1.5 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.99 0.424 . . . . 0.0 110.897 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 542' ' ' TYR . . . . . 0.44 ' CD1' ' HB3' ' B' ' 541' ' ' LEU . 0.1 OUTLIER -105.84 -53.63 2.61 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.578 179.41 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 543' ' ' LEU . . . . . 0.41 ' HA ' ' CG2' ' B' ' 538' ' ' ILE . 6.8 tp 57.01 31.94 20.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.936 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . -119.13 83.6 0.35 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.468 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 545' ' ' ASN . . . . . 0.487 ' HB3' ' CE1' ' B' ' 530' ' ' HIS . 3.6 m120 . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.211 -0.9 . . . . 0.0 110.851 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' GNP . . . . . 0.537 HN22 ' CB ' ' A' ' 116' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.405 ' N ' ' OE1' ' B' ' 508' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.796 0.331 . . . . 0.0 111.255 . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.81 144.4 47.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.388 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.497 HG22 ' CE1' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -93.86 176.34 6.38 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.925 -179.948 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.449 HG13 ' CD1' ' A' ' 53' ' ' LEU . 4.0 pt -152.27 146.36 15.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.009 0.433 . . . . 0.0 112.115 -178.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.427 ' O ' ' CB ' ' A' ' 75' ' ' THR . 13.1 tptp -134.44 95.73 3.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.399 179.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -110.08 119.74 40.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.979 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.426 ' HA ' ' HB3' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -104.79 145.55 13.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.14 0.495 . . . . 0.0 111.301 179.772 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.49 HG11 ' CG ' ' A' ' 56' ' ' PHE . 2.6 p -91.63 113.55 27.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.268 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 30.1 m -134.9 150.33 29.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.081 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 127.93 -144.46 15.22 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.508 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -103.25 -21.34 13.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.72 0.295 . . . . 0.0 110.956 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -105.02 156.33 16.87 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.611 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.427 ' O ' HG21 ' A' ' 14' ' ' VAL . . . -82.47 4.78 22.93 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.427 HG21 ' O ' ' A' ' 13' ' ' ALA . 1.9 m 40.99 31.07 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 120.985 0.422 . . . . 0.0 111.37 -179.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.435 ' O ' ' CG ' ' A' ' 19' ' ' LEU . . . 56.96 24.93 52.22 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.407 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.54 ' CB ' ' CE1' ' A' ' 56' ' ' PHE . 9.6 ptmt -38.31 -45.43 0.99 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.809 0.338 . . . . 0.0 111.628 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.427 ' CG2' HG13 ' A' ' 21' ' ' ILE . 0.2 OUTLIER -97.46 -57.43 2.25 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.49 179.341 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.447 ' O ' ' CB ' ' A' ' 22' ' ' SER . 46.8 m -47.65 -32.06 5.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.245 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.522 ' CD1' ' CD1' ' A' ' 169' ' ' PHE . 9.6 mt -47.35 -71.32 0.07 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.026 0.441 . . . . 0.0 111.079 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.08 -27.47 23.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.947 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.458 ' CG2' ' CG ' ' A' ' 27' ' ' LYS . 46.8 mm -68.44 -52.96 31.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 179.051 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.447 ' CB ' ' O ' ' A' ' 18' ' ' CYS . 2.3 t -69.73 -37.61 76.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.519 179.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -51.87 -45.9 64.26 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.575 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.1 m -94.03 -48.58 6.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.566 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.441 ' N ' ' O ' ' A' ' 21' ' ' ILE . 1.3 p -96.4 -146.19 0.29 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.228 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.44 ' N ' ' ND2' ' A' ' 26' ' ' ASN . 0.1 OUTLIER -163.2 34.64 0.09 Allowed 'General case' 0 C--O 1.232 0.139 0 O-C-N 122.341 -0.225 . . . . 0.0 111.365 -179.746 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.458 ' CG ' ' CG2' ' A' ' 21' ' ' ILE . 0.1 OUTLIER -86.42 127.41 34.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.926 0.393 . . . . 0.0 111.067 -179.896 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.511 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . 89.0 t80 -164.04 -50.71 0.01 OUTLIER Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.035 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.511 ' HD3' ' HB3' ' A' ' 28' ' ' PHE . 88.1 Cg_endo -93.03 33.06 0.24 Allowed 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.171 1.914 . . . . 0.0 112.65 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.43 -84.8 0.58 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.772 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -159.04 147.59 18.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.697 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.462 ' HB3' ' PG ' ' A' ' 185' ' ' GNP . 9.7 m-85 -126.02 124.04 39.8 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.675 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.443 ' CG2' ' HD3' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -165.17 -61.76 0.01 OUTLIER Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.112 -179.763 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.479 ' O ' ' CD1' ' A' ' 37' ' ' PHE . 79.5 Cg_exo -46.36 -25.78 3.5 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.382 2.054 . . . . 0.0 112.329 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.454 ' CG2' ' O2G' ' A' ' 185' ' ' GNP . 6.5 t -40.54 -29.51 0.09 Allowed 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.893 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.43 ' CG1' HD11 ' A' ' 61' ' ' LEU . 12.0 p -51.95 -22.25 2.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.607 -0.269 . . . . 0.0 111.394 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.479 ' CD1' ' O ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -88.68 18.34 4.76 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.494 179.899 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.403 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 25.6 t0 -58.74 -18.02 27.94 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.223 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -86.57 13.56 8.31 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.546 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.466 ' CD1' ' N ' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -60.8 179.09 0.19 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.819 0.342 . . . . 0.0 110.946 179.91 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -98.05 124.94 42.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.143 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.414 ' CG1' ' O ' ' B' ' 517' ' ' SER . 2.8 t -119.1 146.63 23.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.737 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.4 p -129.13 112.02 13.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.867 0.365 . . . . 0.0 111.566 -179.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.501 ' CG2' ' CG2' ' A' ' 52' ' ' THR . 4.1 m -153.1 -176.97 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.652 179.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.479 ' HE2' ' N ' ' A' ' 46' ' ' ILE . 4.4 tpt -100.65 95.94 7.01 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.658 -179.099 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.479 ' N ' ' HE2' ' A' ' 45' ' ' MET . 1.2 mm -82.23 87.32 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-O 121.382 0.61 . . . . 0.0 109.913 178.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 46.23 -90.69 0.01 OUTLIER Glycine 0 CA--C 1.522 0.494 0 CA-C-N 115.488 -0.778 . . . . 0.0 113.647 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . -36.5 -96.39 0.01 OUTLIER Glycine 0 C--N 1.335 0.477 0 N-CA-C 113.997 0.359 . . . . 0.0 113.997 -179.076 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.448 ' N ' ' HE1' ' A' ' 45' ' ' MET . 1.6 pt-20 -125.66 158.85 63.54 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 120.539 0.209 . . . . 0.0 110.555 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -40.2 101.07 0.03 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.595 2.196 . . . . 0.0 112.542 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.498 ' CG ' ' N ' ' A' ' 52' ' ' THR . 5.6 t80 -172.24 162.43 5.59 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.422 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.501 ' CG2' ' CG2' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -136.62 145.82 45.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.07 179.377 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.449 ' CD1' HG13 ' A' ' 4' ' ' ILE . 0.8 OUTLIER -83.54 179.57 7.6 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.848 179.847 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -103.14 109.93 3.59 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.236 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.38 -159.26 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.801 0.334 . . . . 0.0 110.76 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.54 ' CE1' ' CB ' ' A' ' 16' ' ' LYS . 0.1 OUTLIER -104.3 166.27 10.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.053 0.454 . . . . 0.0 111.091 -179.909 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.403 ' OD1' ' N ' ' A' ' 38' ' ' ASP . 31.0 t70 -167.63 111.2 0.66 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.444 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.434 ' HB ' ' CD2' ' A' ' 67' ' ' LEU . 22.5 p -144.96 126.43 14.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.044 -179.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -171.16 126.2 0.66 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.094 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -74.92 65.35 2.23 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.478 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.43 HD11 ' CG1' ' A' ' 36' ' ' VAL . 55.9 mt -115.88 172.97 6.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.802 0.334 . . . . 0.0 110.911 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -52.27 -37.04 54.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.815 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.449 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 1.0 OUTLIER -58.19 -62.42 1.84 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.798 179.866 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.449 ' CD2' ' HB3' ' A' ' 63' ' ' ASP . 0.3 OUTLIER -136.16 77.31 1.65 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.594 179.969 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -86.05 -16.04 39.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.491 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -83.45 -53.22 5.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.581 0.229 . . . . 0.0 111.478 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.434 ' CD2' ' HB ' ' A' ' 58' ' ' THR . 1.6 mp 49.6 -179.73 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.487 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 168.25 -57.33 0.0 OUTLIER Pre-proline 0 N--CA 1.465 0.3 0 CA-C-O 120.688 0.28 . . . . 0.0 111.354 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.412 ' O ' ' NE2' ' A' ' 74' ' ' GLN . 68.0 Cg_exo -38.12 -47.77 2.26 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.981 2.454 . . . . 0.0 113.039 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.422 ' CD2' ' O ' ' B' ' 541' ' ' LEU . 0.3 OUTLIER -48.06 -26.9 2.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.164 -179.757 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.64 -31.75 12.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.812 0.339 . . . . 0.0 111.448 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -82.66 143.29 46.88 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.116 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.37 100.41 0.89 Allowed 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.646 2.231 . . . . 0.0 111.977 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.412 ' NE2' ' O ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -102.19 -67.55 0.87 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.514 -179.461 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.427 ' CB ' ' O ' ' A' ' 5' ' ' LYS . 12.4 t -84.26 -164.67 0.98 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.706 -179.281 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.413 ' O ' ' HD2' ' A' ' 109' ' ' PRO . 4.2 p30 -124.74 8.33 8.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.238 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 39.3 t -141.55 91.18 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 CA-C-O 120.758 0.313 . . . . 0.0 111.157 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.48 ' CD1' HG21 ' A' ' 108' ' ' THR . 2.9 m-30 -80.79 -177.7 6.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.6 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.417 ' CD2' HG23 ' A' ' 14' ' ' VAL . 8.1 tp -143.34 108.46 4.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.262 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.48 HG22 ' CD2' ' A' ' 110' ' ' PHE . 21.5 m -105.61 135.09 45.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.02 179.088 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.403 ' HB2' HG12 ' A' ' 14' ' ' VAL . 9.6 m -137.38 170.7 15.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.212 0.529 . . . . 0.0 111.968 -179.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.526 ' CZ ' ' CE1' ' A' ' 90' ' ' PHE . 15.0 p90 -167.77 137.29 2.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.439 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.454 ' HA ' ' C2 ' ' A' ' 185' ' ' GNP . 57.4 p -83.68 139.4 32.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.725 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.443 ' HA ' HG12 ' A' ' 137' ' ' ILE . 65.6 t -48.48 -63.78 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.22 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.422 HG13 ' CD1' ' A' ' 119' ' ' LEU . 30.4 m -45.35 111.85 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-O 120.61 0.243 . . . . 0.0 110.518 179.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.409 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 3.4 p -149.0 140.76 14.56 Favored Pre-proline 0 C--N 1.33 -0.24 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -178.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.436 ' CA ' ' HB2' ' A' ' 132' ' ' ASN . 72.3 Cg_endo -93.07 54.3 0.44 Allowed 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 123.381 2.721 . . . . 0.0 111.797 179.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.433 ' CB ' ' HB2' ' A' ' 133' ' ' LYS . 0.5 OUTLIER 72.93 21.73 3.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.043 -179.554 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 43.3 p -97.48 -17.8 19.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.264 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.526 ' CE1' ' CZ ' ' A' ' 82' ' ' PHE . 8.5 t80 -45.68 -72.86 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.743 0.306 . . . . 0.0 111.302 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -53.64 -31.2 46.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.812 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.41 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 8.3 t-20 -66.8 -58.18 5.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.953 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.432 HG11 ' N ' ' A' ' 94' ' ' LYS . 12.3 p -62.42 -41.3 91.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.256 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.432 ' N ' HG11 ' A' ' 93' ' ' VAL . 0.8 OUTLIER -55.65 -75.33 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.832 179.951 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.423 ' O ' ' CG ' ' A' ' 99' ' ' PRO . 24.3 mm-40 -52.24 -24.01 6.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.913 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.41 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 57.4 tttt -83.62 -22.51 32.2 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.114 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.457 ' HA ' ' CE3' ' A' ' 97' ' ' TRP . 0.0 OUTLIER -82.09 -55.49 4.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.58 -179.79 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.472 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 5.0 t -41.49 -46.63 8.55 Favored Pre-proline 0 N--CA 1.466 0.358 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -179.001 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 13.7 Cg_exo -69.96 -35.02 12.81 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.72 2.28 . . . . 0.0 112.354 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.415 ' OE1' ' N ' ' A' ' 100' ' ' GLU . 1.3 mp0 -76.73 -37.63 55.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.78 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 54.8 mt -65.93 -25.36 35.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.001 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 25.1 p -93.52 -26.93 16.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.858 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -66.09 -68.04 0.4 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.816 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -59.56 -34.76 73.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.696 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 89.3 m -127.4 103.58 22.48 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.756 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.68 106.72 0.64 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.439 2.093 . . . . 0.0 112.193 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.71 82.85 0.15 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.949 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.48 HG21 ' CD1' ' A' ' 78' ' ' PHE . 0.1 OUTLIER -131.59 100.12 16.63 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.853 179.98 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.413 ' HD2' ' O ' ' A' ' 76' ' ' ASP . 31.3 Cg_exo -59.69 158.54 27.87 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.677 2.251 . . . . 0.0 112.251 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.481 ' CD2' ' HB2' ' A' ' 151' ' ' ALA . 24.8 p90 -150.62 -176.62 5.57 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.092 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.446 ' CD1' ' CG1' ' A' ' 152' ' ' VAL . 4.4 tt -146.27 147.63 31.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.863 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.42 ' O ' ' CD2' ' A' ' 111' ' ' LEU . 4.2 mm? -93.43 156.8 16.56 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.626 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.439 ' CG1' HG23 ' A' ' 168' ' ' VAL . 11.0 t -143.21 150.68 17.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.091 0.472 . . . . 0.0 112.227 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.419 ' O ' ' CD1' ' A' ' 117' ' ' ILE . . . -124.46 100.15 0.62 Allowed Glycine 0 C--N 1.331 0.272 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.509 179.387 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.96 ' OG1' " H2'" ' A' ' 185' ' ' GNP . 1.3 p -122.97 -2.47 8.7 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -178.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.59 ' CB ' HN22 ' A' ' 185' ' ' GNP . 1.6 tp-100 -111.66 10.23 21.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.115 0.483 . . . . 0.0 109.86 178.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.419 ' CD1' ' O ' ' A' ' 114' ' ' GLY . 0.1 OUTLIER -64.36 -11.63 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.948 179.018 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -80.34 -43.22 21.54 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.852 -179.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.43 ' CD1' ' HG3' ' A' ' 116' ' ' GLN . 4.0 pp -99.43 0.52 42.8 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -179.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.422 ' O ' ' CD1' ' A' ' 126' ' ' ILE . 0.3 OUTLIER -54.71 -27.63 41.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.002 0.429 . . . . 0.0 110.017 179.245 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -80.85 -23.91 38.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.306 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -51.27 104.65 0.44 Allowed Pre-proline 0 C--N 1.332 -0.162 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.501 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.432 ' HA ' ' CG2' ' A' ' 126' ' ' ILE . 14.3 Cg_exo -69.31 -3.52 11.88 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 122.739 2.293 . . . . 0.0 112.978 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 10.3 t -72.56 -69.36 0.41 Allowed 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 120.914 0.388 . . . . 0.0 109.969 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.436 HG21 ' CD1' ' A' ' 129' ' ' LEU . 17.2 m -58.31 -44.27 88.51 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.432 ' CG2' ' HA ' ' A' ' 123' ' ' PRO . 0.0 OUTLIER -50.09 -33.93 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.093 179.694 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.426 ' CG ' ' O ' ' A' ' 123' ' ' PRO . 3.9 mm-40 -70.88 -35.19 72.25 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.433 ' N ' ' O ' ' A' ' 125' ' ' THR . 0.1 OUTLIER -68.44 -34.85 76.71 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 177.934 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.476 HD12 ' N ' ' A' ' 129' ' ' LEU . 9.2 mp -60.76 -42.54 97.65 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.473 ' HA ' ' HB3' ' A' ' 134' ' ' GLN . . . -42.52 -36.33 1.32 Allowed 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 114.602 -1.181 . . . . 0.0 111.503 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm -55.1 -29.44 57.62 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.859 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.436 ' HB2' ' CA ' ' A' ' 87' ' ' PRO . 29.8 m-80 -124.44 -32.49 3.14 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -179.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.512 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 1.3 ttpt -142.69 -83.13 0.18 Allowed 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 122.332 -0.23 . . . . 0.0 111.083 -179.047 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.512 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 9.9 pt20 114.94 -42.1 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.682 1.193 . . . . 0.0 111.077 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.2 mptt -68.61 110.1 5.3 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.112 -0.494 . . . . 0.0 112.235 -178.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.25 148.11 33.92 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.494 2.129 . . . . 0.0 111.209 178.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.518 ' CD1' ' N ' ' A' ' 137' ' ' ILE . 0.7 OUTLIER -76.87 96.8 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.898 0.38 . . . . 0.0 111.053 -179.31 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 3.3 p -68.79 148.78 98.01 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.736 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.431 ' HA ' ' CE2' ' A' ' 154' ' ' TYR . 83.3 Cg_exo -45.56 -26.92 3.15 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.607 2.205 . . . . 0.0 112.382 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -77.48 -32.39 54.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.816 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.2 m -64.25 -57.55 9.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.89 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -51.11 -44.15 61.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.063 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -56.14 -44.12 78.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.949 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.6 mttt -56.92 -62.91 1.41 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.786 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.422 ' CD1' ' HG3' ' A' ' 94' ' ' LYS . 1.0 OUTLIER -60.2 -35.9 76.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.775 179.833 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -51.55 -60.86 2.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.863 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 22.2 mtt180 -67.29 -22.32 65.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.885 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -50.25 -48.81 54.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.695 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -92.89 17.43 10.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.084 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 9.9 mttt 47.6 51.44 13.86 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.787 0.327 . . . . 0.0 111.021 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.481 ' HB2' ' CD2' ' A' ' 110' ' ' PHE . . . -75.73 -82.2 0.07 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.176 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.446 ' CG1' ' CD1' ' A' ' 111' ' ' LEU . 69.8 t -160.42 -74.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.928 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.403 ' HG3' ' N ' ' A' ' 154' ' ' TYR . 0.2 OUTLIER -177.52 144.43 0.39 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.65 -179.042 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.431 ' CE2' ' HA ' ' A' ' 139' ' ' PRO . 18.3 t80 -105.75 109.59 21.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.186 179.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 3.1 t -101.64 158.81 4.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.998 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -100.49 126.18 46.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.016 0.436 . . . . 0.0 111.666 -179.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.402 ' HA ' ' HB3' ' A' ' 163' ' ' LYS . 1.4 p 178.51 126.07 0.05 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.548 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.413 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 15.4 m -112.5 167.99 10.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.943 0.402 . . . . 0.0 111.427 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.44 ' CB ' ' HB3' ' A' ' 18' ' ' CYS . . . -98.77 -33.53 10.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.843 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -51.14 -38.69 53.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.448 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.0 t -117.33 -12.91 10.42 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.163 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 64.65 72.48 0.44 Allowed 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.818 0.342 . . . . 0.0 110.892 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.408 ' CG ' ' O ' ' A' ' 163' ' ' LYS . 68.1 tttt -97.17 22.82 8.07 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.19 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 107.82 41.0 1.63 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.161 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.443 ' CD1' ' HA ' ' A' ' 19' ' ' LEU . 0.4 OUTLIER -49.26 -30.82 7.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.089 0.471 . . . . 0.0 110.632 179.596 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 22.9 pttm -68.79 -31.66 70.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.657 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -52.59 -69.28 0.12 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.546 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.439 HG23 ' CG1' ' A' ' 113' ' ' VAL . 12.3 p -50.29 -44.19 23.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.059 0.457 . . . . 0.0 110.441 179.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.522 ' CD1' ' CD1' ' A' ' 19' ' ' LEU . 2.2 t80 -59.85 -34.32 72.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.12 179.306 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.423 ' HA ' ' CG1' ' A' ' 173' ' ' ILE . 0.6 OUTLIER -60.7 -34.87 75.01 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.837 179.236 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.12 -30.46 63.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.2 179.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.424 ' N ' HD12 ' A' ' 111' ' ' LEU . . . -76.39 -42.39 44.63 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.648 179.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.423 ' CG1' ' HA ' ' A' ' 170' ' ' ASP . 1.5 pp -76.97 -32.62 19.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.423 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.423 ' CD2' HD23 ' B' ' 505' ' ' LEU . 22.8 tp -53.37 -49.34 67.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.551 179.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.84 -22.29 62.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.783 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.433 ' CB ' ' HB ' ' A' ' 4' ' ' ILE . . . -85.4 -41.82 15.08 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.058 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.448 ' CD1' ' HB ' ' B' ' 510' ' ' ILE . 32.6 mt -68.78 -23.18 64.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.819 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.4 ' HB2' ' CB ' ' B' ' 507' ' ' ALA . 0.0 OUTLIER -168.3 153.56 6.5 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.784 179.934 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -52.72 124.01 14.32 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.621 2.214 . . . . 0.0 112.313 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.53 -178.43 3.37 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.538 2.159 . . . . 0.0 112.404 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -144.42 99.53 4.89 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.858 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -88.47 35.43 0.4 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 123.197 2.598 . . . . 0.0 113.038 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 17.4 pttt -56.36 157.35 5.04 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.878 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 7.2 mttm . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.898 -179.978 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.204 0 N-CA-C 112.506 -0.238 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 503' ' ' SER . . . . . . . . . . . . . 22.3 m -67.35 -78.93 0.05 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.805 0.336 . . . . 0.0 110.814 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 504' ' ' GLY . . . . . 0.418 ' CA ' ' OD2' ' B' ' 509' ' ' ASP . . . 92.71 103.53 1.54 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.278 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 505' ' ' LEU . . . . . 0.423 HD23 ' CD2' ' A' ' 174' ' ' LEU . 0.2 OUTLIER -164.36 47.56 0.11 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.792 0.329 . . . . 0.0 111.31 -179.614 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 506' ' ' SER . . . . . . . . . . . . . 4.9 m 59.31 87.86 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.975 0.417 . . . . 0.0 110.022 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 507' ' ' ALA . . . . . 0.446 ' O ' ' CB ' ' B' ' 508' ' ' GLN . . . 173.75 -37.68 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.242 -179.083 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 508' ' ' GLN . . . . . 0.487 ' CB ' ' CD1' ' B' ' 510' ' ' ILE . 1.3 mt-30 155.48 -20.85 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.7 -1.136 . . . . 0.0 109.994 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 509' ' ' ASP . . . . . 0.455 ' CB ' ' O ' ' B' ' 508' ' ' GLN . 8.4 t70 90.03 38.67 0.01 OUTLIER 'General case' 0 C--N 1.343 0.323 0 CA-C-O 121.309 0.576 . . . . 0.0 110.6 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 510' ' ' ILE . . . . . 0.487 ' CD1' ' CB ' ' B' ' 508' ' ' GLN . 1.9 mp -68.99 136.39 26.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.346 179.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 511' ' ' SER . . . . . 0.437 ' HB2' ' CD2' ' B' ' 514' ' ' LEU . 4.1 m -109.23 153.98 23.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.061 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 512' ' ' GLN . . . . . 0.49 ' CB ' ' CD ' ' B' ' 513' ' ' PRO . 1.8 mm-40 -98.53 -68.37 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.82 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 513' ' ' PRO . . . . . 0.49 ' CD ' ' CB ' ' B' ' 512' ' ' GLN . 90.4 Cg_endo -78.64 59.55 7.27 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.4 2.067 . . . . 0.0 111.781 179.384 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 514' ' ' LEU . . . . . 0.451 ' CD1' ' O ' ' A' ' 45' ' ' MET . 1.1 mt -73.34 -86.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.751 -179.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 515' ' ' GLN . . . . . 0.406 ' CB ' HG12 ' A' ' 44' ' ' VAL . 0.5 OUTLIER -88.1 -10.31 50.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.649 -179.529 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 53.59 24.52 4.23 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.936 0.398 . . . . 0.0 110.379 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 517' ' ' SER . . . . . 0.414 ' O ' ' CG1' ' A' ' 42' ' ' VAL . 75.4 m -68.28 58.8 0.08 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.618 -179.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 518' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -78.28 91.48 4.42 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.42 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 519' ' ' ILE . . . . . . . . . . . . . 3.5 mm -76.28 157.47 5.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.251 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -101.57 119.59 39.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.903 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 521' ' ' THR . . . . . . . . . . . . . 18.7 p -133.93 -61.99 0.78 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.829 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 522' ' ' GLY . . . . . . . . . . . . . . . -55.74 119.56 14.62 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.564 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 523' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -59.05 -83.76 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.772 0.32 . . . . 0.0 110.882 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 524' ' ' GLY . . . . . 0.426 ' HA3' ' CG1' ' A' ' 36' ' ' VAL . . . 67.88 167.86 4.04 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.492 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 525' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.28 83.19 8.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.83 0.348 . . . . 0.0 110.94 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 526' ' ' SER . . . . . 0.436 ' CB ' ' HG3' ' A' ' 34' ' ' PRO . 6.4 t -83.58 95.79 8.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.694 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 527' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -177.52 147.36 0.66 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.995 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.74 101.56 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.685 2.257 . . . . 0.0 112.109 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 529' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.16 -55.3 2.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.352 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 530' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -142.3 -47.21 0.34 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.025 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 3.0 m 72.94 -172.1 0.14 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.806 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 532' ' ' TRP . . . . . . . . . . . . . 24.1 t90 -62.06 102.74 0.31 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.962 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . -122.02 -38.46 0.6 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.481 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 534' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -105.61 154.86 38.9 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 120.731 0.301 . . . . 0.0 110.932 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -67.18 125.51 13.65 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.641 2.228 . . . . 0.0 112.085 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 1.3 t0 70.84 141.35 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.768 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 537' ' ' ARG . . . . . 0.433 ' NE ' ' O3A' ' A' ' 185' ' ' GNP . 30.3 mmt180 -70.8 144.6 50.76 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.25 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 538' ' ' ILE . . . . . 0.45 ' CG2' HD12 ' B' ' 543' ' ' LEU . 6.2 tp -58.16 145.17 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 539' ' ' ASP . . . . . 0.449 ' O ' ' CD1' ' B' ' 543' ' ' LEU . 20.5 t0 -41.38 132.85 2.6 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.969 0.414 . . . . 0.0 112.028 -178.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 540' ' ' GLU . . . . . 0.473 ' HA ' ' CD1' ' B' ' 543' ' ' LEU . 0.8 OUTLIER -40.55 -27.27 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.047 179.702 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 541' ' ' LEU . . . . . 0.444 ' HB3' ' CD1' ' B' ' 542' ' ' TYR . 5.3 mt -31.93 -69.24 0.08 Allowed 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 542' ' ' TYR . . . . . 0.444 ' CD1' ' HB3' ' B' ' 541' ' ' LEU . 0.1 OUTLIER -103.36 -63.78 1.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.317 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 543' ' ' LEU . . . . . 0.473 ' CD1' ' HA ' ' B' ' 540' ' ' GLU . 4.6 mp 65.05 141.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.866 -179.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . 132.62 141.86 4.74 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.487 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 545' ' ' ASN . . . . . . . . . . . . . 36.1 m-20 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.923 179.983 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' GNP . . . . . 0.96 " H2'" ' OG1' ' A' ' 115' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' HOH . . . . . 0.491 ' H2 ' ' HD3' ' A' ' 16' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' HOH . . . . . 0.417 ' O ' ' CD2' ' A' ' 32' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.449 ' CE ' HG21 ' A' ' 46' ' ' ILE . 7.4 tpt . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.475 0.179 . . . . 0.0 111.2 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.431 ' O ' ' CE ' ' A' ' 1' ' ' MET . 39.4 tp60 60.76 137.83 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.047 0.451 . . . . 0.0 110.917 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.524 ' CG2' ' CE1' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -124.24 -165.95 1.43 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.609 -179.492 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.494 ' N ' HD12 ' A' ' 53' ' ' LEU . 0.2 OUTLIER -150.92 138.26 13.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.581 -179.593 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -95.0 101.35 13.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.748 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.402 ' SG ' ' CD2' ' A' ' 55' ' ' LEU . 20.2 m -80.25 110.1 15.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.287 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.7 t -151.16 106.74 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.766 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.418 HG22 ' N ' ' A' ' 9' ' ' VAL . 2.4 p -89.3 135.48 25.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.296 0.569 . . . . 0.0 111.583 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.471 HG23 ' CD2' ' A' ' 78' ' ' PHE . 2.8 m -133.41 129.44 56.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.197 178.41 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 141.69 -165.3 26.52 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.067 -1.064 . . . . 0.0 112.483 -179.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.7 21.87 5.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.764 0.316 . . . . 0.0 110.992 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.416 ' HA3' ' CB ' ' A' ' 81' ' ' CYS . . . -128.13 161.6 21.97 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.501 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.435 ' CB ' ' HB2' ' A' ' 18' ' ' CYS . . . -93.08 -20.1 20.87 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.425 HG13 ' N7 ' ' A' ' 185' ' ' GNP . 4.0 m -42.41 92.67 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 CA-C-O 120.892 0.377 . . . . 0.0 111.643 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.458 ' N ' HD23 ' A' ' 19' ' ' LEU . . . -178.13 -77.97 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.76 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.432 ' HG2' ' CB ' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -98.08 -84.1 0.39 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.927 0.394 . . . . 0.0 111.825 -179.354 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.416 ' HA ' HG12 ' A' ' 21' ' ' ILE . 4.3 p -63.33 -50.39 70.19 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.435 ' HB2' ' CB ' ' A' ' 13' ' ' ALA . 51.9 t -32.46 -70.83 0.06 Allowed 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 113.634 0.975 . . . . 0.0 113.634 -178.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.507 ' HG ' ' CD1' ' A' ' 169' ' ' PHE . 0.0 OUTLIER -58.05 -71.23 0.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -178.19 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.43 HD11 ' N ' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -51.05 -65.88 0.48 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -178.283 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.416 HG12 ' HA ' ' A' ' 17' ' ' THR . 30.4 mm -45.6 -67.9 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.107 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.2 t -49.82 -26.12 3.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.961 0.41 . . . . 0.0 110.752 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -82.86 -25.34 32.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.72 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.403 ' N ' ' O ' ' A' ' 21' ' ' ILE . 66.7 p -100.52 -64.21 1.06 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.243 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 40.1 p -62.41 -58.28 8.2 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.993 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.439 ' N ' ' ND2' ' A' ' 26' ' ' ASN . 0.4 OUTLIER 74.9 42.67 0.26 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.181 179.584 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.47 ' O ' ' CE1' ' A' ' 32' ' ' TYR . 4.2 mtmm -119.66 91.58 3.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.968 0.413 . . . . 0.0 110.928 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.48 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 9.4 t80 -89.81 -45.38 0.41 Allowed Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.872 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 88.0 Cg_endo -84.16 79.02 2.73 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.424 2.083 . . . . 0.0 113.04 -179.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.9 m -174.02 -94.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.879 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.41 154.74 25.46 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 120.635 0.255 . . . . 0.0 110.449 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.5 ' CE2' ' O3A' ' A' ' 185' ' ' GNP . 15.6 m-85 -133.82 93.98 3.2 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.905 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.564 ' N ' ' CD ' ' A' ' 34' ' ' PRO . 2.1 t -131.59 28.09 0.15 Allowed Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.564 ' CD ' ' N ' ' A' ' 33' ' ' VAL . 42.3 Cg_endo -86.09 -37.59 0.1 Allowed 'Trans proline' 0 C--N 1.359 1.109 0 C-N-CA 121.889 1.726 . . . . 0.0 112.496 179.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.438 ' CG2' HD23 ' B' ' 543' ' ' LEU . 1.4 m -48.46 99.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.881 -179.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.432 ' HA ' ' CB ' ' A' ' 59' ' ' ALA . 7.4 p 176.98 -34.95 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.825 179.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.411 ' N ' HG13 ' A' ' 36' ' ' VAL . 0.7 OUTLIER -109.39 35.88 3.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.582 179.814 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.432 ' CB ' ' HG2' ' A' ' 16' ' ' LYS . 18.3 m-20 -89.58 45.47 1.28 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.127 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -106.03 -16.28 14.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.077 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -60.59 174.97 0.51 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.79 0.329 . . . . 0.0 110.865 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.431 ' HB2' ' CD1' ' B' ' 519' ' ' ILE . . . -91.99 174.48 7.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.294 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.419 ' HA ' HG13 ' B' ' 519' ' ' ILE . 30.9 m -139.32 144.67 28.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.734 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.422 ' O ' ' CG2' ' A' ' 44' ' ' VAL . 2.1 p -85.05 106.33 16.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.499 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.448 ' HB ' ' CG2' ' A' ' 52' ' ' THR . 53.9 t -158.04 153.11 6.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.158 -179.195 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.463 ' HE2' ' N ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -117.73 96.31 5.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.17 179.313 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.47 ' O ' ' N ' ' A' ' 48' ' ' GLY . 5.5 mm -71.1 88.1 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.539 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.431 ' O ' ' CE ' ' A' ' 45' ' ' MET . . . 37.28 -87.85 0.01 OUTLIER Glycine 0 CA--C 1.521 0.409 0 CA-C-N 115.811 -0.631 . . . . 0.0 113.919 179.326 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . -38.88 -78.6 0.05 OUTLIER Glycine 0 C--N 1.334 0.439 0 C-N-CA 121.52 -0.371 . . . . 0.0 113.177 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.463 ' N ' ' HE2' ' A' ' 45' ' ' MET . 3.2 mt-10 -142.29 162.23 46.25 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-O 120.909 0.385 . . . . 0.0 111.373 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.42 92.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.79 2.327 . . . . 0.0 112.558 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.524 ' CE1' ' CG2' ' A' ' 3' ' ' THR . 0.0 OUTLIER -172.95 126.07 0.45 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.073 179.749 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.448 ' CG2' ' HB ' ' A' ' 44' ' ' VAL . 4.3 p -134.57 141.77 46.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.919 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.494 HD12 ' N ' ' A' ' 4' ' ' ILE . 5.3 mt -71.16 121.69 18.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.877 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -52.28 153.4 6.08 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.092 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.402 ' CD2' ' SG ' ' A' ' 6' ' ' CYS . 2.6 mp -109.79 95.04 5.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.839 0.352 . . . . 0.0 110.884 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -84.73 105.45 15.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.633 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.421 ' OD2' ' CG2' ' A' ' 35' ' ' THR . 1.5 t70 -94.44 163.77 13.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.822 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.431 HG22 ' CD2' ' A' ' 70' ' ' LEU . 6.7 p -89.44 146.38 24.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.32 -179.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.432 ' CB ' ' HA ' ' A' ' 36' ' ' VAL . . . -172.14 -162.78 0.22 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.677 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 166.41 66.75 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.467 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.444 HD23 ' CG1' ' A' ' 33' ' ' VAL . 5.8 mp -120.97 -87.01 0.65 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.727 0.299 . . . . 0.0 111.02 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.79 -31.56 11.81 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.902 0.382 . . . . 0.0 111.108 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -70.8 -63.25 1.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.37 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -118.33 160.25 21.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.805 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -85.92 -68.35 0.74 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.807 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -96.69 -52.2 4.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.117 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.5 tt 56.42 106.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.64 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.438 ' N ' ' HD3' ' A' ' 69' ' ' PRO . 1.7 ppt_? -142.47 53.33 2.87 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.321 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.438 ' HD3' ' N ' ' A' ' 68' ' ' ARG . 94.1 Cg_endo -83.95 -20.25 4.49 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.764 2.309 . . . . 0.0 112.26 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.445 ' CD1' ' HA ' ' B' ' 541' ' ' LEU . 0.7 OUTLIER -77.76 1.0 21.49 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.925 -179.79 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.21 -61.23 2.28 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 120.908 0.385 . . . . 0.0 110.92 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.492 ' CD1' ' N ' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -159.22 56.76 0.96 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.791 179.884 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -60.94 174.44 1.77 Allowed 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.661 2.241 . . . . 0.0 112.307 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -95.68 10.57 36.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.524 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 98.8 m -46.51 145.21 1.88 Allowed 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.804 0.335 . . . . 0.0 111.05 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.418 ' O ' ' CG ' ' A' ' 109' ' ' PRO . 16.8 p-10 -106.4 -20.96 13.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.147 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.415 ' CG1' ' O ' ' A' ' 77' ' ' VAL . 7.9 p -123.55 83.96 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.827 0.346 . . . . 0.0 111.387 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.471 ' CD2' HG23 ' A' ' 9' ' ' VAL . 0.3 OUTLIER -80.79 166.3 21.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.599 179.736 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.419 ' CD1' ' O ' ' A' ' 111' ' ' LEU . 4.9 tp -143.39 108.46 4.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.02 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.436 ' CG2' ' HB2' ' A' ' 110' ' ' PHE . 35.9 m -84.74 147.11 5.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.838 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.481 ' O ' ' CZ3' ' A' ' 97' ' ' TRP . 2.0 m -113.97 174.35 5.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.118 0.485 . . . . 0.0 111.216 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.482 ' CZ ' ' HB3' ' A' ' 142' ' ' ALA . 6.0 p90 179.99 -173.54 0.23 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.769 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.441 ' N ' ' CD2' ' A' ' 82' ' ' PHE . 0.3 OUTLIER -156.42 136.34 12.66 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.847 0.356 . . . . 0.0 111.349 179.958 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.436 HG12 ' N ' ' A' ' 137' ' ' ILE . 99.3 t -51.48 -40.41 24.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.827 179.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.418 HG11 ' NE2' ' A' ' 116' ' ' GLN . 32.0 m -73.02 111.64 7.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.518 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.434 ' N ' HD23 ' A' ' 129' ' ' LEU . 83.4 p -151.28 135.27 9.51 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.743 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.414 ' O ' ' CB ' ' A' ' 88' ' ' SER . 74.2 Cg_endo -91.42 51.88 0.78 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.218 2.612 . . . . 0.0 111.585 179.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.46 ' CB ' ' CG ' ' A' ' 133' ' ' LYS . 0.1 OUTLIER 79.15 26.85 0.42 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.665 -179.426 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.426 ' O ' ' CG2' ' A' ' 93' ' ' VAL . 52.4 p -96.5 -25.73 15.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.999 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.475 ' CZ ' HG21 ' A' ' 137' ' ' ILE . 3.3 t80 -48.96 -54.08 17.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.075 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -49.82 -53.41 25.62 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.932 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -64.29 -47.68 78.57 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.724 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.534 ' CG1' ' CZ3' ' A' ' 97' ' ' TRP . 65.9 t -51.1 -39.84 20.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.049 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.3 tttm -64.51 -50.39 67.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.847 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -82.97 7.39 15.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.695 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.2 mttp -109.82 -26.14 9.97 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.751 0.31 . . . . 0.0 110.872 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.534 ' CZ3' ' CG1' ' A' ' 93' ' ' VAL . 5.7 m0 -94.01 -45.73 7.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.196 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.473 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 58.5 t -49.94 -46.73 81.43 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.63 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.473 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 94.2 Cg_endo -80.74 -15.5 10.78 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.393 2.062 . . . . 0.0 112.612 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -90.11 -49.09 6.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.771 0.32 . . . . 0.0 110.901 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 9.9 tt -62.95 -22.86 31.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.197 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 61.2 p -91.51 -26.11 18.94 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.878 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 42.0 t60 -76.92 -57.79 3.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.895 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -65.66 -56.96 9.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.951 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.407 ' CB ' ' OG1' ' A' ' 108' ' ' THR . 60.4 m -86.65 142.94 35.16 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.976 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -69.23 60.27 1.4 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.558 2.172 . . . . 0.0 112.315 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.78 78.58 0.27 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.927 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.407 ' OG1' ' CB ' ' A' ' 105' ' ' CYS . 0.2 OUTLIER -108.52 141.12 22.59 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.813 179.847 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.418 ' CG ' ' O ' ' A' ' 76' ' ' ASP . 33.8 Cg_endo -65.53 177.91 2.46 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.507 2.138 . . . . 0.0 112.52 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.466 ' CD2' ' HB1' ' A' ' 151' ' ' ALA . 4.6 p90 -166.22 132.55 2.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.782 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.419 ' O ' ' CD1' ' A' ' 79' ' ' LEU . 5.5 tt -108.94 142.0 40.21 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.678 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.454 HD11 ' CD1' ' A' ' 82' ' ' PHE . 4.2 mm? -89.59 155.03 19.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.586 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.463 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 2.4 t -142.12 134.17 26.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.946 0.403 . . . . 0.0 111.792 -179.448 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.419 ' O ' ' CD1' ' A' ' 117' ' ' ILE . . . -106.03 86.09 0.47 Allowed Glycine 0 C--N 1.332 0.338 0 C-N-CA 121.004 -0.617 . . . . 0.0 111.857 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.827 ' OG1' " H2'" ' A' ' 185' ' ' GNP . 1.0 OUTLIER -110.34 1.68 18.61 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -178.805 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.54 ' HB2' HN22 ' A' ' 185' ' ' GNP . 4.4 tp60 -96.87 -22.74 16.71 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.442 HD11 ' N ' ' A' ' 118' ' ' ASP . 0.2 OUTLIER -46.04 -25.75 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.096 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.839 178.931 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.442 ' N ' HD11 ' A' ' 117' ' ' ILE . 4.8 t0 -53.72 -47.52 70.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.372 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.476 ' CD1' ' N ' ' A' ' 119' ' ' LEU . 0.0 OUTLIER -122.98 14.31 9.88 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -178.976 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.4 ' HG2' ' HA ' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -48.82 -28.61 3.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.897 0.379 . . . . 0.0 110.87 179.815 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.3 p30 -72.22 -22.39 61.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.094 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.402 ' OD1' ' O ' ' A' ' 119' ' ' LEU . 20.1 p-10 -48.24 104.32 0.41 Allowed Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 120.983 0.421 . . . . 0.0 110.974 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -66.49 -6.57 15.48 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.381 2.054 . . . . 0.0 113.172 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.417 ' OG ' ' N ' ' A' ' 125' ' ' THR . 54.3 p -79.78 -66.52 0.86 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.417 ' N ' ' OG ' ' A' ' 124' ' ' SER . 34.5 m -55.76 -38.06 69.34 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.446 HG13 HD11 ' A' ' 129' ' ' LEU . 0.1 OUTLIER -56.37 -41.68 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 115.01 -0.996 . . . . 0.0 109.803 179.229 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.401 ' HB3' ' O ' ' A' ' 124' ' ' SER . 1.0 OUTLIER -60.59 -37.51 81.58 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.436 179.256 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 125' ' ' THR . 0.0 OUTLIER -60.88 -31.3 70.77 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.595 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.446 HD11 HG13 ' A' ' 126' ' ' ILE . 5.1 mt -75.36 -41.68 55.9 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 177.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.41 ' HA ' ' HB3' ' A' ' 134' ' ' GLN . . . -44.26 -33.9 1.73 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.99 -1.004 . . . . 0.0 111.105 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 18.0 mmtm -49.79 -33.05 15.42 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.416 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -123.29 -31.36 3.57 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.341 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.523 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 0.8 OUTLIER -144.6 -99.17 0.1 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 119.191 -0.433 . . . . 0.0 111.571 179.793 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.523 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 2.7 pt20 129.57 -23.86 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.528 1.131 . . . . 0.0 110.313 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.2 mmtt -68.73 110.26 5.64 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.778 -179.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' A' ' 134' ' ' GLN . 96.1 Cg_endo -79.55 127.36 7.23 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.485 2.123 . . . . 0.0 111.239 179.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.484 ' CD1' ' N ' ' A' ' 137' ' ' ILE . 1.1 mm -56.76 95.9 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.962 0.411 . . . . 0.0 110.738 -179.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 47.0 p -67.65 155.65 90.81 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.087 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.421 ' HA ' ' CE2' ' A' ' 154' ' ' TYR . 75.3 Cg_exo -47.54 -27.85 8.1 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.461 2.107 . . . . 0.0 112.184 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -77.1 -30.53 55.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.626 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.434 ' CG2' HG22 ' A' ' 137' ' ' ILE . 5.8 m -69.58 -62.49 1.36 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.727 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.482 ' HB3' ' CZ ' ' A' ' 82' ' ' PHE . . . -52.14 -36.05 50.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.637 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -65.83 -41.53 91.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.505 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 19.4 tptp -55.11 -62.77 1.45 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.634 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.401 ' CD1' HD22 ' A' ' 149' ' ' LEU . 17.2 tp -58.31 -43.81 88.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.543 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -55.06 -35.3 64.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.924 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 12.3 mtt-85 -91.47 -30.87 16.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.618 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -65.12 -44.28 89.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.707 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.401 HD22 ' CD1' ' A' ' 145' ' ' LEU . 3.0 mm? -89.8 14.05 12.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.123 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 47.41 45.8 17.11 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.835 0.35 . . . . 0.0 111.002 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.466 ' HB1' ' CD2' ' A' ' 110' ' ' PHE . . . -65.09 -82.22 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.198 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.437 ' CG2' ' O ' ' A' ' 151' ' ' ALA . 70.7 t -161.09 -75.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.826 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.57 108.41 0.06 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.792 -178.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.468 ' CD1' ' HB1' ' A' ' 142' ' ' ALA . 19.5 t80 -80.98 114.56 19.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.425 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 3.7 t -108.87 155.12 9.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.826 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -94.37 118.58 31.83 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.223 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.418 ' SG ' ' CG1' ' A' ' 168' ' ' VAL . 20.3 p 178.95 137.46 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.615 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.416 ' OG ' ' CD1' ' A' ' 117' ' ' ILE . 27.4 m -112.72 149.31 33.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.981 0.419 . . . . 0.0 111.221 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -83.21 -42.54 17.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.82 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.42 HD13 ' CD1' ' A' ' 119' ' ' LEU . 0.1 OUTLIER -49.53 -36.5 23.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.703 179.779 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 15.3 t -111.37 -22.48 11.3 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.685 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.413 ' N ' ' O ' ' A' ' 158' ' ' SER . 0.9 OUTLIER 73.11 62.25 0.1 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.781 -179.89 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.403 ' HB3' ' HA ' ' A' ' 157' ' ' CYS . 0.0 OUTLIER -93.08 22.59 4.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.061 -179.943 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.413 ' N ' ' HB2' ' A' ' 157' ' ' CYS . . . 133.34 35.39 0.29 Allowed Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.484 -0.865 . . . . 0.0 113.412 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.451 ' CD2' HD12 ' A' ' 19' ' ' LEU . 10.5 mt -48.88 -42.3 36.27 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.913 0.357 . . . . 0.0 110.844 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.411 ' O ' ' N ' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -70.18 -34.18 72.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.992 179.747 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.4 ' O ' ' HB2' ' A' ' 170' ' ' ASP . 0.1 OUTLIER -58.03 -72.18 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.241 -179.811 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.442 ' CG1' HG13 ' A' ' 113' ' ' VAL . 7.1 p -50.08 -46.91 24.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.981 0.42 . . . . 0.0 110.988 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.507 ' CD1' ' HG ' ' A' ' 19' ' ' LEU . 1.1 t80 -64.6 -33.38 75.78 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.672 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.42 ' O ' ' CB ' ' A' ' 174' ' ' LEU . 0.5 OUTLIER -56.3 -32.84 64.99 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.967 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -75.0 -36.21 61.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.887 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -67.31 -43.41 81.72 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.623 179.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 1.7 pp -78.23 -33.14 17.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.661 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.427 HD11 ' CD1' ' B' ' 505' ' ' LEU . 22.0 tp -59.13 -43.62 92.01 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.634 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -54.34 -22.03 11.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.112 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.454 ' CB ' HG23 ' A' ' 4' ' ' ILE . . . -87.53 -37.03 17.25 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.395 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 94.9 mt -68.83 -27.98 66.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.962 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.11 136.73 1.93 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.981 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -57.32 112.02 1.0 Allowed 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.563 2.175 . . . . 0.0 112.302 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.53 162.1 33.55 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.625 2.217 . . . . 0.0 112.276 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -131.37 143.85 50.98 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.959 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -76.53 -165.12 0.29 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.721 2.281 . . . . 0.0 112.329 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 1.8 mmmt -71.26 83.54 0.75 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.87 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 7.7 mttt . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.979 179.992 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 502' ' ' GLY . . . . . 0.416 ' CA ' ' O ' ' B' ' 509' ' ' ASP . . . . . . . . 0 N--CA 1.489 2.195 0 N-CA-C 112.524 -0.23 . . . . 0.0 112.524 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 503' ' ' SER . . . . . . . . . . . . . 37.4 t -107.06 -74.62 0.65 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.781 0.324 . . . . 0.0 110.944 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 504' ' ' GLY . . . . . . . . . . . . . . . 116.58 103.86 2.35 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.36 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 505' ' ' LEU . . . . . 0.427 ' CD1' HD11 ' A' ' 174' ' ' LEU . 0.1 OUTLIER -174.55 38.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.698 0.285 . . . . 0.0 111.141 -179.871 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 506' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 68.95 34.26 3.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.127 0.489 . . . . 0.0 110.566 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 507' ' ' ALA . . . . . . . . . . . . . . . -137.47 35.97 2.48 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.548 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 508' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 74.73 3.38 4.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.441 -178.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 509' ' ' ASP . . . . . 0.416 ' O ' ' CA ' ' B' ' 502' ' ' GLY . 16.0 t70 71.7 44.83 0.47 Allowed 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.158 0.504 . . . . 0.0 110.816 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 510' ' ' ILE . . . . . 0.427 ' CG2' HG22 ' A' ' 46' ' ' ILE . 44.5 mt -93.17 138.29 20.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.846 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 511' ' ' SER . . . . . 0.421 ' N ' HG21 ' B' ' 510' ' ' ILE . 22.1 t -108.04 157.16 18.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.359 -179.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 512' ' ' GLN . . . . . 0.478 ' CB ' ' CD ' ' B' ' 513' ' ' PRO . 27.9 tp60 -110.21 -71.2 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.513 179.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 513' ' ' PRO . . . . . 0.478 ' CD ' ' CB ' ' B' ' 512' ' ' GLN . 73.3 Cg_endo -74.6 58.96 4.75 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.021 1.814 . . . . 0.0 111.632 179.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 514' ' ' LEU . . . . . 0.441 ' CD1' ' O ' ' A' ' 45' ' ' MET . 2.6 mp -65.81 -86.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.65 -179.272 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 515' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -69.3 -96.1 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.218 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -127.32 -12.26 5.67 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 517' ' ' SER . . . . . 0.404 ' HA ' HG23 ' A' ' 44' ' ' VAL . 1.5 m 48.62 31.78 3.14 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.705 0.288 . . . . 0.0 111.135 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 518' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -163.3 91.96 0.72 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.143 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 519' ' ' ILE . . . . . 0.431 ' CD1' ' HB2' ' A' ' 41' ' ' ALA . 41.5 mt -64.23 -64.68 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.84 0.353 . . . . 0.0 110.755 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -126.6 -168.95 1.94 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.891 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 521' ' ' THR . . . . . . . . . . . . . 6.6 m -119.76 113.99 21.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.002 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 522' ' ' GLY . . . . . . . . . . . . . . . -107.16 120.6 6.23 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.522 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 523' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -114.58 -84.44 0.61 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.716 0.294 . . . . 0.0 110.96 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 524' ' ' GLY . . . . . . . . . . . . . . . 101.21 -44.14 1.6 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.412 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 525' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -152.01 32.95 0.54 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.862 0.363 . . . . 0.0 110.907 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 526' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.1 97.56 6.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.887 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 527' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -145.88 161.68 39.02 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.914 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.42 96.59 0.65 Allowed 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.598 2.199 . . . . 0.0 112.242 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 529' ' ' ARG . . . . . . . . . . . . . 1.9 mtp85 -96.08 -23.1 16.94 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.202 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 530' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -178.76 -82.77 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.938 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 50.1 t 178.29 -68.67 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.886 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 532' ' ' TRP . . . . . 0.521 ' CZ2' ' NH2' ' B' ' 537' ' ' ARG . 0.6 OUTLIER -126.32 -49.8 1.54 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.967 -179.908 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 533' ' ' GLY . . . . . 0.472 ' O ' ' CG ' ' B' ' 534' ' ' PHE . . . 106.4 -56.28 0.51 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.483 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 534' ' ' PHE . . . . . 0.472 ' CG ' ' O ' ' B' ' 533' ' ' GLY . 98.0 m-85 -160.67 160.72 25.5 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.76 0.314 . . . . 0.0 110.88 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -48.05 123.36 8.61 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.559 2.173 . . . . 0.0 112.274 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 2.9 t0 68.25 145.18 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.747 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 537' ' ' ARG . . . . . 0.521 ' NH2' ' CZ2' ' B' ' 532' ' ' TRP . 0.1 OUTLIER -51.94 139.19 22.93 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.036 0.446 . . . . 0.0 111.09 -179.867 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 538' ' ' ILE . . . . . 0.434 ' CG2' ' HA ' ' B' ' 543' ' ' LEU . 5.8 tp -59.38 144.94 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.959 179.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 539' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -43.84 136.95 3.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.815 0.341 . . . . 0.0 111.275 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 540' ' ' GLU . . . . . 0.431 ' HA ' ' CD1' ' B' ' 543' ' ' LEU . 33.1 mm-40 -52.72 -21.66 4.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.163 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 541' ' ' LEU . . . . . 0.445 ' HA ' ' CD1' ' A' ' 70' ' ' LEU . 1.1 mp -37.03 -63.59 0.42 Allowed 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 542' ' ' TYR . . . . . 0.412 ' O ' ' CB ' ' B' ' 543' ' ' LEU . 0.1 OUTLIER -105.16 -58.68 1.86 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.304 -179.574 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 543' ' ' LEU . . . . . 0.438 HD23 ' CG2' ' A' ' 35' ' ' THR . 0.1 OUTLIER 81.27 -167.97 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.369 -179.225 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 544' ' ' GLY . . . . . 0.42 ' O ' ' ND2' ' B' ' 545' ' ' ASN . . . 93.44 -176.3 36.77 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.497 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 545' ' ' ASN . . . . . 0.42 ' ND2' ' O ' ' B' ' 544' ' ' GLY . 9.3 m-80 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.279 -0.867 . . . . 0.0 110.987 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' GNP . . . . . 0.827 " H2'" ' OG1' ' A' ' 115' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' HOH . . . . . 0.402 ' H2 ' ' HD2' ' A' ' 34' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.461 ' HE2' ' O ' ' A' ' 2' ' ' GLN . 7.9 tpt . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.769 0.319 . . . . 0.0 111.3 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.461 ' O ' ' HE2' ' A' ' 1' ' ' MET . 2.7 tt0 62.25 134.04 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.448 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.708 HG23 ' CE1' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -107.39 -166.5 1.16 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.908 -179.158 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.756 HD11 ' CD1' ' A' ' 53' ' ' LEU . 4.9 pt -156.44 162.36 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.588 -179.293 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.12 99.41 4.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.437 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.426 ' SG ' HD23 ' A' ' 55' ' ' LEU . 1.3 m -78.25 103.25 8.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.518 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.1 t -135.15 112.57 14.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.327 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.482 HG11 ' HG3' ' A' ' 16' ' ' LYS . 0.2 OUTLIER -103.42 138.62 27.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.299 0.571 . . . . 0.0 111.203 -179.592 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.406 ' O ' HG23 ' A' ' 9' ' ' VAL . 30.5 m -130.25 129.62 65.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.346 178.623 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 142.19 -172.42 24.2 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 119.867 -1.159 . . . . 0.0 112.7 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -96.5 27.48 3.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.779 0.323 . . . . 0.0 110.8 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.457 ' HA2' ' CD ' ' B' ' 537' ' ' ARG . . . -149.35 150.69 22.84 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.745 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.476 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -58.16 -54.56 45.55 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.551 0.215 . . . . 0.0 110.849 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.9 ' O ' HD21 ' A' ' 19' ' ' LEU . 0.0 OUTLIER 44.62 -87.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.472 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.528 ' HA2' HD21 ' A' ' 19' ' ' LEU . . . -102.32 23.13 35.31 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.242 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.712 ' O ' HD22 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -84.34 -163.52 0.81 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.947 0.403 . . . . 0.0 110.945 -179.823 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.452 ' HB ' ' CG1' ' A' ' 21' ' ' ILE . 6.1 p -74.84 -28.6 60.75 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.029 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.405 ' HB3' ' HB1' ' A' ' 13' ' ' ALA . 53.3 t -41.47 -30.06 0.18 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.643 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.9 HD21 ' O ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -62.83 -71.05 0.17 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.889 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.4 mt -70.07 -36.12 74.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.97 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.492 HG23 ' HB2' ' A' ' 26' ' ' ASN . 4.5 mm -58.31 -71.2 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.418 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 25' ' ' THR . 24.5 m -55.22 -34.83 64.3 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 121.098 -0.241 . . . . 0.0 110.666 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.8 ' HB2' HD13 ' A' ' 165' ' ' LEU . 49.9 t80 -52.65 -35.12 54.36 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.435 ' O ' ' HB ' ' A' ' 25' ' ' THR . 0.2 OUTLIER -100.97 -46.24 5.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.71 179.258 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.49 ' O ' ' CB ' ' A' ' 26' ' ' ASN . 6.7 t -177.83 -162.84 0.07 Allowed 'General case' 0 C--O 1.227 -0.082 0 CA-C-N 116.342 -0.39 . . . . 0.0 112.003 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.492 ' HB2' HG23 ' A' ' 21' ' ' ILE . 2.5 t30 97.6 -20.87 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.659 0.784 . . . . 0.0 110.616 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.6 mttp 60.06 146.67 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.963 0.411 . . . . 0.0 111.395 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.473 ' CD1' ' OH ' ' A' ' 32' ' ' TYR . 19.7 t80 -89.2 -47.69 0.41 Allowed Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.871 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 67.7 Cg_endo -88.29 58.14 2.71 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.793 2.328 . . . . 0.0 112.797 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.2 m -133.85 -85.53 0.43 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.823 0.344 . . . . 0.0 110.759 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -158.59 162.83 37.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.754 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.487 ' CD1' ' HB2' ' B' ' 532' ' ' TRP . 67.4 m-85 -135.22 103.56 5.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.971 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.567 HG12 HD21 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -165.31 -61.35 0.01 OUTLIER Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.341 -179.935 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.506 ' HD3' HG23 ' A' ' 33' ' ' VAL . 86.7 Cg_exo -42.84 -28.49 1.18 Allowed 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.371 2.048 . . . . 0.0 112.528 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.82 HG23 HD23 ' B' ' 543' ' ' LEU . 4.2 t -57.44 -20.81 32.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.192 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.964 HG21 ' HB2' ' A' ' 61' ' ' LEU . 12.6 p -52.0 -21.18 2.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.521 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.482 ' CD1' ' O ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -83.02 46.9 1.15 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.66 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.466 ' CB ' ' HB2' ' A' ' 57' ' ' ASP . 5.0 p-10 -63.66 -158.29 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.645 0.259 . . . . 0.0 110.837 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 73.73 22.48 2.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.804 0.335 . . . . 0.0 111.006 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.497 ' CE2' ' HA ' ' B' ' 520' ' ' HIS . 1.8 m-30 -60.18 129.31 41.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.77 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.443 ' O ' HG12 ' B' ' 519' ' ' ILE . . . -95.51 119.61 34.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.582 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.809 HG23 HG21 ' A' ' 52' ' ' THR . 17.5 m -117.74 159.82 17.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.986 0.422 . . . . 0.0 111.72 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.34 104.79 6.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.384 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.692 HG22 ' CG2' ' A' ' 52' ' ' THR . 10.4 m -149.04 -177.46 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.366 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.624 ' O ' HD11 ' B' ' 514' ' ' LEU . 4.7 tpt -99.07 96.62 7.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.342 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.669 HG22 ' O ' ' A' ' 46' ' ' ILE . 1.3 mm -80.44 86.66 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-O 121.33 0.586 . . . . 0.0 109.695 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.718 ' HA3' HG23 ' B' ' 510' ' ' ILE . . . 42.74 -92.42 0.01 OUTLIER Glycine 0 CA--C 1.524 0.601 0 CA-C-N 115.537 -0.756 . . . . 0.0 113.71 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . -38.55 -91.59 0.01 OUTLIER Glycine 0 CA--C 1.52 0.39 0 N-CA-C 113.988 0.355 . . . . 0.0 113.988 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.463 ' N ' ' HE1' ' A' ' 45' ' ' MET . 1.3 pt-20 -125.88 152.47 72.73 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-O 120.693 0.282 . . . . 0.0 110.932 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.401 ' N ' ' SD ' ' A' ' 45' ' ' MET . 83.0 Cg_exo -43.28 105.55 0.06 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.51 2.14 . . . . 0.0 112.266 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.708 ' CE1' HG23 ' A' ' 3' ' ' THR . 8.8 t80 -172.02 159.21 4.93 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.303 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.809 HG21 HG23 ' A' ' 42' ' ' VAL . 6.5 p -136.09 153.2 51.39 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.146 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.756 ' CD1' HD11 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -87.27 -179.19 6.37 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.919 179.807 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -128.54 103.51 0.62 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.627 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.426 HD23 ' SG ' ' A' ' 6' ' ' CYS . 0.1 OUTLIER -85.66 97.38 10.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.807 0.336 . . . . 0.0 110.254 179.702 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -84.23 105.61 15.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.694 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.807 ' OD2' HD21 ' B' ' 543' ' ' LEU . 0.6 OUTLIER -90.75 137.05 32.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.061 -179.775 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.879 ' O ' HD13 ' B' ' 543' ' ' LEU . 0.1 OUTLIER -99.03 143.38 29.37 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.278 179.807 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.901 ' HB3' HG23 ' A' ' 36' ' ' VAL . . . -153.14 177.4 10.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.923 0.392 . . . . 0.0 111.384 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.417 ' HA2' ' HA ' ' A' ' 65' ' ' ASP . . . -129.96 51.81 0.85 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.94 -0.647 . . . . 0.0 112.09 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.964 ' HB2' HG21 ' A' ' 36' ' ' VAL . 0.4 OUTLIER -120.82 -175.24 2.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.934 0.397 . . . . 0.0 111.199 -179.56 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -46.73 -40.24 13.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.347 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.439 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . 59.4 m-20 -47.25 -56.95 5.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.184 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.61 ' HB2' HD23 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -166.8 93.34 0.47 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.837 -179.855 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.417 ' HA ' ' HA2' ' A' ' 60' ' ' GLY . 0.2 OUTLIER -86.33 -7.43 58.49 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.558 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.37 -20.63 20.87 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.61 HD23 ' HB2' ' A' ' 64' ' ' TYR . 4.5 pp -51.36 160.98 0.5 Allowed 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.783 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 20.6 ttp85 -178.18 62.82 0.16 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.012 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -84.79 -23.38 2.62 Favored 'Trans proline' 0 N--CA 1.461 -0.383 0 C-N-CA 122.859 2.373 . . . . 0.0 112.581 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.71 ' O ' HD12 ' A' ' 70' ' ' LEU . 0.1 OUTLIER -71.75 -6.16 39.32 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.448 -179.672 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -48.36 -71.25 0.07 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.86 0.362 . . . . 0.0 111.097 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.405 ' N ' ' HD3' ' A' ' 73' ' ' PRO . 10.4 m-85 -140.33 62.52 20.03 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.879 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.409 ' HB2' ' CZ ' ' A' ' 78' ' ' PHE . 54.4 Cg_exo -52.36 130.58 36.55 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.685 2.257 . . . . 0.0 112.284 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -86.15 10.27 14.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.499 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 15.3 t -50.82 174.6 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.806 0.336 . . . . 0.0 110.817 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -112.3 -25.73 9.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.882 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.657 ' O ' HG13 ' A' ' 77' ' ' VAL . 8.2 p -126.57 99.14 5.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.172 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.414 ' HB2' ' O ' ' A' ' 109' ' ' PRO . 0.2 OUTLIER -80.89 176.58 9.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.61 179.826 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.559 ' CD2' ' HB1' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -127.83 108.74 10.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.077 -179.808 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.712 HG13 ' HB2' ' A' ' 110' ' ' PHE . 34.4 m -97.97 127.88 49.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.65 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.457 ' HB3' ' CG2' ' A' ' 14' ' ' VAL . 21.1 p -99.63 174.02 6.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.14 0.495 . . . . 0.0 111.632 -179.386 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.571 ' CZ ' ' HB2' ' A' ' 142' ' ' ALA . 8.3 p90 -179.63 -174.3 0.29 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.17 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.427 ' N ' ' CD2' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -156.08 149.89 25.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.752 0.31 . . . . 0.0 110.856 179.885 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.771 ' CG2' HG22 ' A' ' 117' ' ' ILE . 43.8 t -61.71 -41.84 92.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.345 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.689 HG13 ' CD ' ' A' ' 120' ' ' ARG . 17.6 m -59.64 114.8 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.365 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.785 ' N ' HD22 ' A' ' 129' ' ' LEU . 0.6 OUTLIER -152.02 117.47 3.08 Favored Pre-proline 0 C--N 1.329 -0.294 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.801 -179.57 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.425 ' O ' ' CB ' ' A' ' 132' ' ' ASN . 89.7 Cg_endo -94.01 53.28 0.33 Allowed 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.114 2.543 . . . . 0.0 111.288 179.154 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.46 ' HA ' ' HG3' ' A' ' 133' ' ' LYS . 0.2 OUTLIER 81.12 30.07 0.16 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.661 -179.253 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 73.9 m -97.2 -16.84 20.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.133 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.821 ' CE2' HD12 ' A' ' 137' ' ' ILE . 0.1 OUTLIER -43.26 -42.11 4.22 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.869 0.366 . . . . 0.0 111.403 -179.919 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -63.41 -33.6 75.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.973 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.406 ' O ' ' N ' ' A' ' 96' ' ' LYS . 7.4 m120 -75.23 -52.98 9.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.095 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.434 ' CG2' ' HA ' ' A' ' 90' ' ' PHE . 7.4 m -49.71 -44.59 20.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.233 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.454 ' O ' HG23 ' A' ' 98' ' ' VAL . 0.1 OUTLIER -65.44 -49.78 67.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.899 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -82.57 7.34 14.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.671 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.406 ' N ' ' O ' ' A' ' 92' ' ' ASN . 4.8 tttt -115.3 -27.34 7.27 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.721 0.296 . . . . 0.0 111.036 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.413 ' O ' HG22 ' A' ' 101' ' ' ILE . 1.7 m95 -94.31 -50.18 5.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.388 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.674 HG13 HD21 ' A' ' 149' ' ' LEU . 61.9 t -50.89 -46.01 87.42 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.962 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 95.3 Cg_endo -81.03 -11.21 12.38 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.377 2.051 . . . . 0.0 113.016 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.405 ' HB3' ' O ' ' A' ' 96' ' ' LYS . 1.2 tt0 -90.34 -57.0 2.99 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 120.906 0.384 . . . . 0.0 110.187 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.413 HG22 ' O ' ' A' ' 97' ' ' TRP . 20.8 tt -57.34 -27.88 29.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.084 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.76 HG22 ' HA ' ' A' ' 107' ' ' LYS . 23.2 p -86.33 -29.66 22.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.75 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -58.62 -54.84 42.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.851 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 52.9 m170 -65.54 -42.04 92.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.79 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -125.87 124.02 24.71 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.669 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -50.98 89.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.414 2.076 . . . . 0.0 112.261 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.76 ' HA ' HG22 ' A' ' 102' ' ' THR . 0.1 OUTLIER 63.29 94.54 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.911 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.428 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 0.1 OUTLIER -119.66 126.76 26.77 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.875 -179.974 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 108' ' ' THR . 37.5 Cg_exo -60.64 176.84 0.75 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.435 2.09 . . . . 0.0 112.236 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.712 ' HB2' HG13 ' A' ' 80' ' ' VAL . 32.7 p90 -165.93 176.39 7.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.852 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.632 HD12 HG11 ' A' ' 152' ' ' VAL . 1.1 tt -139.56 134.37 32.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.886 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.538 HD23 ' CB ' ' A' ' 146' ' ' ALA . 4.1 mm? -89.78 138.48 31.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.205 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 1.02 HG13 HG21 ' A' ' 168' ' ' VAL . 11.0 t -130.45 147.57 33.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.11 0.481 . . . . 0.0 112.064 -179.202 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -113.31 142.18 17.3 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.648 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.677 ' C ' HD13 ' A' ' 117' ' ' ILE . 0.8 OUTLIER -153.83 -61.53 0.14 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.853 0.359 . . . . 0.0 111.03 -179.622 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.445 ' N ' ' OG1' ' A' ' 115' ' ' THR . 10.5 mm100 -60.12 -20.4 58.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.026 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.771 HG22 ' CG2' ' A' ' 84' ' ' VAL . 0.2 OUTLIER -40.69 -29.13 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.867 -179.796 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -65.93 -42.19 90.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.812 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.71 HD22 HD22 ' A' ' 160' ' ' LEU . 0.1 OUTLIER -93.02 -48.16 6.64 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -179.327 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.689 ' CD ' HG13 ' A' ' 85' ' ' VAL . 1.4 mmt180 -48.15 -26.78 2.03 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.814 0.34 . . . . 0.0 111.024 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.06 -21.07 43.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.871 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.418 ' OD1' ' HD3' ' A' ' 123' ' ' PRO . 0.2 OUTLIER -64.62 153.56 87.04 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.867 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.451 ' O ' HG22 ' A' ' 126' ' ' ILE . 2.3 Cg_endo -81.35 -2.68 11.73 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.997 2.465 . . . . 0.0 112.957 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 40.7 t -81.49 -69.98 0.57 Allowed 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 120.879 0.371 . . . . 0.0 110.49 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.657 HG21 HG11 ' A' ' 85' ' ' VAL . 8.4 m -51.46 -33.77 32.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.411 0.624 . . . . 0.0 109.6 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.691 HD11 ' HB3' ' A' ' 136' ' ' PRO . 0.1 OUTLIER -58.63 -42.85 86.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.449 179.021 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.456 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 1.4 mm-40 -57.3 -35.41 69.78 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.568 179.147 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 125' ' ' THR . 3.9 mptt -65.66 -33.15 75.22 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.785 HD22 ' N ' ' A' ' 86' ' ' SER . 9.0 mt -73.64 -36.61 65.44 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.1 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 127' ' ' GLU . . . -49.15 -34.1 13.58 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.97 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 10.9 mmmm -47.58 -32.77 5.77 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.666 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.425 ' CB ' ' O ' ' A' ' 87' ' ' PRO . 43.4 m-80 -123.12 -31.22 3.63 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.281 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.512 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 9.3 mmtm -146.2 -95.05 0.09 Allowed 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 119.273 -0.394 . . . . 0.0 111.367 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.512 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 7.4 pt20 128.94 -21.17 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.482 1.113 . . . . 0.0 110.574 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.6 mttm -68.4 110.88 6.52 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.648 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.691 ' HB3' HD11 ' A' ' 126' ' ' ILE . 93.1 Cg_endo -82.86 130.15 5.69 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.67 2.246 . . . . 0.0 111.576 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.821 HD12 ' CE2' ' A' ' 90' ' ' PHE . 1.1 mm -62.47 96.78 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.941 0.401 . . . . 0.0 110.748 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.445 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.7 p -67.69 156.11 89.8 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.888 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.497 ' HA ' ' CE1' ' A' ' 154' ' ' TYR . 10.3 Cg_endo -51.71 -23.23 14.99 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.657 2.238 . . . . 0.0 112.023 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -86.11 -26.41 25.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.587 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.537 ' HB ' HG22 ' A' ' 137' ' ' ILE . 1.8 m -63.35 -56.84 13.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.661 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.571 ' HB2' ' CZ ' ' A' ' 82' ' ' PHE . . . -52.5 -36.96 56.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.828 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.14 -36.04 82.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.709 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.15 -56.86 13.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.815 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 50.5 tp -65.17 -36.77 85.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.764 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.538 ' CB ' HD23 ' A' ' 112' ' ' LEU . . . -57.46 -51.09 70.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.943 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 -71.64 -24.51 61.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.857 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -50.24 -41.74 50.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.832 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.674 HD21 HG13 ' A' ' 98' ' ' VAL . 1.3 mp -104.42 25.18 10.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.847 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.42 ' CD ' ' O ' ' A' ' 149' ' ' LEU . 0.0 OUTLIER 44.95 39.25 3.5 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.305 -179.971 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.679 ' HB1' ' O ' ' A' ' 110' ' ' PHE . . . -62.26 -81.02 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.028 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.632 HG11 HD12 ' A' ' 111' ' ' LEU . 78.4 t -159.59 -75.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.023 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.439 ' HG3' ' N ' ' A' ' 154' ' ' TYR . 0.5 OUTLIER 170.13 146.06 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.746 -178.971 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.497 ' CE1' ' HA ' ' A' ' 139' ' ' PRO . 10.2 t80 -100.77 113.58 26.61 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.478 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.628 HG12 ' H ' ' A' ' 156' ' ' GLU . 1.7 t -101.6 175.73 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.629 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.628 ' H ' HG12 ' A' ' 155' ' ' VAL . 0.5 OUTLIER -88.8 145.19 25.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.021 0.439 . . . . 0.0 111.073 -179.444 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.453 ' O ' HD11 ' A' ' 117' ' ' ILE . 2.8 t -169.93 151.22 4.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.257 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.562 ' OG ' HG22 ' A' ' 161' ' ' THR . 2.4 t -160.23 123.47 3.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.072 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -92.74 20.56 6.35 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.953 179.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.71 HD22 HD22 ' A' ' 119' ' ' LEU . 0.3 OUTLIER -131.57 -44.06 1.0 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.575 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.562 HG22 ' OG ' ' A' ' 158' ' ' SER . 15.3 t -107.06 -19.51 13.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.889 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 78.05 77.78 0.07 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.098 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.424 ' HB2' ' HB2' ' A' ' 158' ' ' SER . 25.6 tptt -96.17 30.23 2.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.815 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 119.01 -58.09 0.54 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.516 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.8 HD13 ' HB2' ' A' ' 23' ' ' TYR . 0.7 OUTLIER 66.74 -73.58 0.07 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.787 0.327 . . . . 0.0 111.123 179.909 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.427 ' O ' ' N ' ' A' ' 170' ' ' ASP . 1.9 mtpt -56.9 -31.9 65.36 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.01 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.575 ' OD1' HG11 ' A' ' 155' ' ' VAL . 1.2 t-20 -52.31 -71.71 0.06 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.291 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 1.02 HG21 HG13 ' A' ' 113' ' ' VAL . 13.6 p -57.06 -47.43 83.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.478 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.796 ' CD2' HD23 ' A' ' 19' ' ' LEU . 1.8 t80 -62.38 -25.79 68.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.59 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' A' ' 166' ' ' LYS . 28.4 t0 -71.58 -29.84 65.16 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.481 ' HB3' HD11 ' A' ' 111' ' ' LEU . 0.7 OUTLIER -73.67 -29.84 62.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.845 179.123 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.559 ' HB1' ' CD2' ' A' ' 79' ' ' LEU . . . -67.44 -49.67 62.66 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.835 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 1.6 pp -72.49 -32.59 42.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.11 0.481 . . . . 0.0 110.414 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.615 HD13 HD23 ' B' ' 505' ' ' LEU . 10.1 tp -46.13 -44.47 15.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.175 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.637 ' HB3' HG21 ' A' ' 77' ' ' VAL . . . -57.0 -24.24 52.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.818 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.507 ' HB1' ' HA ' ' A' ' 4' ' ' ILE . . . -94.87 -31.72 13.57 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.104 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.492 HD13 HG21 ' A' ' 4' ' ' ILE . 2.5 tp -68.27 -26.13 65.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.676 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.775 ' HB2' ' HB1' ' B' ' 507' ' ' ALA . 1.0 OUTLIER 171.24 149.3 0.17 Allowed Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.687 179.808 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 179' ' ' PRO . . . . . 0.437 ' HD2' ' CG ' ' A' ' 178' ' ' GLU . 16.1 Cg_endo -57.48 107.71 0.32 Allowed 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.691 2.261 . . . . 0.0 112.272 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -80.53 171.88 14.14 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.664 2.242 . . . . 0.0 112.419 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -113.62 139.56 23.52 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.872 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -76.46 -165.28 0.3 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.68 2.253 . . . . 0.0 112.342 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 10.7 mttt -134.62 80.28 1.84 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.865 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.88 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.193 0 N-CA-C 112.525 -0.23 . . . . 0.0 112.525 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 503' ' ' SER . . . . . 0.452 ' HB3' ' CD1' ' B' ' 505' ' ' LEU . 37.5 m -64.14 -78.77 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.856 0.36 . . . . 0.0 110.844 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 504' ' ' GLY . . . . . 0.847 ' C ' HD13 ' B' ' 505' ' ' LEU . . . 87.82 109.69 0.99 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.414 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 505' ' ' LEU . . . . . 0.847 HD13 ' C ' ' B' ' 504' ' ' GLY . 0.0 OUTLIER -167.17 55.12 0.08 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.701 0.286 . . . . 0.0 111.137 -179.274 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 506' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 48.48 66.44 1.07 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.917 0.389 . . . . 0.0 110.613 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 507' ' ' ALA . . . . . 0.775 ' HB1' ' HB2' ' A' ' 178' ' ' GLU . . . -175.5 53.42 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.79 -179.282 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 508' ' ' GLN . . . . . 0.465 ' HB3' ' O ' ' B' ' 507' ' ' ALA . 1.7 tt0 68.86 5.35 4.94 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.664 -178.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 509' ' ' ASP . . . . . 0.418 ' HA ' ' HA2' ' B' ' 504' ' ' GLY . 2.7 p30 51.54 47.1 25.45 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.449 0.643 . . . . 0.0 110.799 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 510' ' ' ILE . . . . . 0.718 HG23 ' HA3' ' A' ' 47' ' ' GLY . 80.3 mt -87.49 138.3 19.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.401 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 511' ' ' SER . . . . . . . . . . . . . 1.2 m -78.33 122.24 25.49 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.335 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 512' ' ' GLN . . . . . 0.517 ' HB2' ' HD2' ' B' ' 513' ' ' PRO . 0.0 OUTLIER -50.6 179.58 0.04 OUTLIER Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.893 179.265 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 513' ' ' PRO . . . . . 0.517 ' HD2' ' HB2' ' B' ' 512' ' ' GLN . 85.0 Cg_exo -46.12 92.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 121.78 1.653 . . . . 0.0 111.46 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 514' ' ' LEU . . . . . 0.624 HD11 ' O ' ' A' ' 45' ' ' MET . 0.0 OUTLIER -62.84 -168.33 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.27 -179.021 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 515' ' ' GLN . . . . . 0.518 ' O ' HG11 ' A' ' 44' ' ' VAL . 7.9 mt-30 -89.02 178.59 6.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.874 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 66.56 11.22 7.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.192 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 517' ' ' SER . . . . . 0.56 ' O ' HG11 ' A' ' 42' ' ' VAL . 3.4 p -100.9 65.48 1.12 Allowed 'General case' 0 N--CA 1.456 -0.139 0 CA-C-O 120.898 0.38 . . . . 0.0 110.759 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 518' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -158.06 91.86 1.14 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.644 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 519' ' ' ILE . . . . . 0.443 HG12 ' O ' ' A' ' 41' ' ' ALA . 3.5 mm -100.49 -19.02 6.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.581 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 520' ' ' HIS . . . . . 0.497 ' HA ' ' CE2' ' A' ' 40' ' ' TYR . 0.7 OUTLIER 72.91 103.12 0.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.866 0.365 . . . . 0.0 110.906 -179.737 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 521' ' ' THR . . . . . . . . . . . . . 3.2 m -143.86 57.6 1.35 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.825 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 522' ' ' GLY . . . . . . . . . . . . . . . -149.52 159.94 28.27 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.218 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 523' ' ' HIS . . . . . 0.454 ' N ' ' HB2' ' A' ' 37' ' ' PHE . 0.3 OUTLIER -98.68 -91.26 0.28 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.675 0.238 . . . . 0.0 110.959 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 524' ' ' GLY . . . . . 0.424 ' O ' ' CB ' ' B' ' 525' ' ' ASP . . . 45.52 -131.98 9.24 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.777 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 525' ' ' ASP . . . . . 0.424 ' CB ' ' O ' ' B' ' 524' ' ' GLY . 4.2 m-20 82.07 79.22 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.038 0.446 . . . . 0.0 111.02 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 526' ' ' SER . . . . . 0.482 ' HB3' HG11 ' A' ' 33' ' ' VAL . 0.4 OUTLIER -113.75 99.44 7.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.459 179.594 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 527' ' ' ASP . . . . . 0.411 ' HB2' ' HD2' ' B' ' 528' ' ' PRO . 0.4 OUTLIER -40.15 163.61 0.08 OUTLIER Pre-proline 0 N--CA 1.465 0.309 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.724 -179.703 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 528' ' ' PRO . . . . . 0.411 ' HD2' ' HB2' ' B' ' 527' ' ' ASP . 10.6 Cg_endo -51.08 112.05 0.7 Allowed 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 123.053 2.502 . . . . 0.0 111.988 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 529' ' ' ARG . . . . . 0.45 ' HD2' HG11 ' A' ' 33' ' ' VAL . 30.3 mtp180 -100.71 -54.1 2.91 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.258 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 530' ' ' HIS . . . . . . . . . . . . . 25.4 m-70 -137.68 10.29 2.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.587 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 3.9 m 44.99 -160.96 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.84 0.352 . . . . 0.0 111.286 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 532' ' ' TRP . . . . . 0.487 ' HB2' ' CD1' ' A' ' 32' ' ' TYR . 12.1 t-105 -132.34 92.29 3.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.867 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . -92.82 -48.87 2.82 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.526 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 534' ' ' PHE . . . . . 0.402 ' HA ' ' HD3' ' B' ' 535' ' ' PRO . 32.5 m-85 -106.87 140.21 21.15 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.658 0.266 . . . . 0.0 110.916 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 535' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' B' ' 534' ' ' PHE . 42.9 Cg_exo -56.17 -158.16 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.518 2.146 . . . . 0.0 112.303 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 69.24 61.36 0.31 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.886 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 537' ' ' ARG . . . . . 0.457 ' CD ' ' HA2' ' A' ' 12' ' ' GLY . 0.0 OUTLIER -48.75 159.56 0.23 Allowed 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.0 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 538' ' ' ILE . . . . . 0.453 ' CG1' ' HB2' ' B' ' 542' ' ' TYR . 10.3 tp -81.72 141.33 15.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.482 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 539' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -45.5 161.16 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.883 0.373 . . . . 0.0 111.221 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 540' ' ' GLU . . . . . 0.684 ' O ' HG23 ' A' ' 58' ' ' THR . 0.4 OUTLIER -61.61 -14.89 34.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.555 -179.854 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 541' ' ' LEU . . . . . 0.532 ' CB ' HD23 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -66.22 -32.77 74.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.365 0.603 . . . . 0.0 110.062 179.708 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 542' ' ' TYR . . . . . 0.453 ' HB2' ' CG1' ' B' ' 538' ' ' ILE . 40.7 m-85 -104.9 -50.76 3.19 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.17 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 543' ' ' LEU . . . . . 0.879 HD13 ' O ' ' A' ' 58' ' ' THR . 0.5 OUTLIER 72.42 -68.02 0.24 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.931 -179.678 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . -117.44 164.02 12.61 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.493 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 545' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.888 179.988 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.597 ' HE1' ' HD1' ' A' ' 51' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.418 0 N-CA-C 111.529 0.196 . . . . 0.0 111.529 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.402 ' O ' ' O ' ' A' ' 1' ' ' MET . 32.7 tp60 56.42 154.93 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.104 0.478 . . . . 0.0 111.556 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.891 ' HB ' HD22 ' A' ' 53' ' ' LEU . 0.3 OUTLIER -146.02 -168.97 3.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.034 179.991 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.755 ' O ' HD23 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -145.1 156.08 13.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.561 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 28.9 mttm -118.19 105.74 12.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.515 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.422 ' O ' ' N ' ' A' ' 56' ' ' PHE . 36.2 t -77.3 105.07 8.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.09 0.471 . . . . 0.0 111.934 -178.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.534 HG22 ' CB ' ' A' ' 56' ' ' PHE . 2.6 t -132.94 118.86 34.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.836 178.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.611 HG11 ' HG3' ' A' ' 16' ' ' LYS . 0.4 OUTLIER -96.69 143.41 12.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.315 0.579 . . . . 0.0 111.08 -179.235 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.83 HG21 ' CD2' ' A' ' 78' ' ' PHE . 12.6 m -140.88 129.75 24.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.482 178.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.407 ' O ' ' HB3' ' B' ' 539' ' ' ASP . . . 154.43 -143.06 9.61 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.024 -1.084 . . . . 0.0 112.734 -179.252 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -123.24 22.71 9.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.668 0.27 . . . . 0.0 110.953 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.434 ' CA ' ' O ' ' B' ' 536' ' ' ASP . . . -153.42 -172.45 21.62 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.406 -0.902 . . . . 0.0 113.364 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.666 ' HB2' ' HG3' ' B' ' 537' ' ' ARG . . . -63.69 -48.74 75.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.777 0.322 . . . . 0.0 111.462 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.665 HG22 ' SG ' ' A' ' 81' ' ' CYS . 61.5 t 68.37 -72.14 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.117 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.882 ' CA ' HD22 ' A' ' 19' ' ' LEU . . . -172.36 66.32 0.13 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.631 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.667 ' CD ' HD21 ' B' ' 543' ' ' LEU . 27.0 mttt -97.14 -97.56 0.2 Allowed 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 121.457 -0.097 . . . . 0.0 110.803 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.425 ' O ' HG12 ' A' ' 21' ' ' ILE . 58.3 p -98.22 -57.35 2.23 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-O 120.832 0.349 . . . . 0.0 111.177 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.402 ' HA ' ' HB ' ' A' ' 21' ' ' ILE . 14.8 p -36.17 -43.84 0.37 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.456 -179.403 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.967 HD23 ' CD2' ' A' ' 169' ' ' PHE . 1.8 mp -46.41 -70.96 0.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.793 0.33 . . . . 0.0 111.284 -179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.466 HD12 ' CZ ' ' B' ' 518' ' ' PHE . 14.7 mt -61.96 -25.57 67.69 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.84 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.442 HG22 ' OG1' ' A' ' 25' ' ' THR . 15.2 mm -67.2 -70.36 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.666 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.435 ' HB2' ' CD1' ' A' ' 165' ' ' LEU . 3.4 m -47.79 -28.93 2.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.082 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -66.84 -68.18 0.39 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.833 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.02 -48.11 39.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.72 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.442 ' OG1' HG22 ' A' ' 21' ' ' ILE . 13.4 p -83.2 -152.29 0.12 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.424 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -160.11 33.46 0.17 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.821 0.343 . . . . 0.0 111.033 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 13.8 mmtt -121.32 101.71 7.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.408 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.493 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . 7.9 t80 -104.87 -60.11 0.06 OUTLIER Pre-proline 0 CA--C 1.537 0.444 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.124 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.493 ' HD3' ' HB3' ' A' ' 28' ' ' PHE . 95.1 Cg_endo -84.21 48.7 2.56 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.151 1.9 . . . . 0.0 112.608 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.84 -80.79 0.43 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.029 0.442 . . . . 0.0 110.656 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.448 ' HB2' ' NE ' ' B' ' 529' ' ' ARG . 12.9 pt-20 -158.34 140.98 14.51 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.63 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.463 ' C ' HG22 ' A' ' 33' ' ' VAL . 91.7 m-85 -130.21 100.91 5.57 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.514 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.556 HG23 ' HD3' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -165.28 -63.55 0.01 OUTLIER Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.157 -179.541 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.556 ' HD3' HG23 ' A' ' 33' ' ' VAL . 74.9 Cg_exo -38.75 -29.77 0.17 Allowed 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.745 2.296 . . . . 0.0 112.905 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.947 HG23 ' OD2' ' A' ' 38' ' ' ASP . 60.9 m -56.53 85.54 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.993 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.592 HG11 ' HB2' ' A' ' 61' ' ' LEU . 2.6 t -140.5 -40.42 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.282 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.457 ' CE2' ' OD1' ' A' ' 63' ' ' ASP . 0.3 OUTLIER -91.19 25.13 2.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.966 179.698 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.947 ' OD2' HG23 ' A' ' 35' ' ' THR . 0.7 OUTLIER -57.78 -159.85 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.873 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 68.26 29.46 6.01 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.943 0.401 . . . . 0.0 110.46 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.414 ' CE1' ' O ' ' B' ' 521' ' ' THR . 0.7 OUTLIER -60.72 -160.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.852 -179.808 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.419 ' O ' HG12 ' B' ' 519' ' ' ILE . . . -122.97 123.27 40.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.466 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.481 HG13 ' C ' ' B' ' 517' ' ' SER . 3.3 t -106.76 121.7 59.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.64 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.593 ' OG1' HD11 ' B' ' 519' ' ' ILE . 6.5 p -108.79 106.84 17.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.197 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.655 ' CG2' HG21 ' A' ' 52' ' ' THR . 27.3 m -159.46 -178.91 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.916 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.651 ' O ' HD22 ' B' ' 514' ' ' LEU . 0.0 OUTLIER -98.37 103.39 15.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.844 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.571 HG22 ' O ' ' A' ' 51' ' ' TYR . 1.2 tt -95.2 106.29 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-O 121.529 0.681 . . . . 0.0 111.021 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.51 ' N ' HG23 ' B' ' 510' ' ' ILE . . . 43.61 -93.19 0.01 OUTLIER Glycine 0 CA--C 1.517 0.178 0 C-N-CA 121.001 -0.619 . . . . 0.0 113.526 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.444 ' HA3' ' CB ' ' A' ' 1' ' ' MET . . . -39.2 -86.16 0.01 OUTLIER Glycine 0 C--N 1.334 0.458 0 C-N-CA 121.393 -0.432 . . . . 0.0 113.371 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.481 ' HB3' ' HD2' ' A' ' 50' ' ' PRO . 4.0 mt-10 -144.06 177.58 1.76 Allowed Pre-proline 0 C--N 1.331 -0.205 0 CA-C-O 120.671 0.272 . . . . 0.0 111.04 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 49' ' ' GLU . 76.8 Cg_exo -51.23 92.98 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.551 2.167 . . . . 0.0 112.614 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.597 ' HD1' ' HE1' ' A' ' 1' ' ' MET . 2.8 t80 -173.29 125.96 0.42 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.386 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.655 HG21 ' CG2' ' A' ' 44' ' ' VAL . 0.1 OUTLIER -134.3 144.29 48.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.798 0.332 . . . . 0.0 111.161 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.891 HD22 ' HB ' ' A' ' 3' ' ' THR . 0.9 OUTLIER -87.69 -177.33 5.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.89 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -123.92 116.47 2.86 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.438 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.45 ' H ' HD12 ' A' ' 55' ' ' LEU . 2.2 mp -50.77 139.13 17.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.874 0.369 . . . . 0.0 110.844 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.534 ' CB ' HG22 ' A' ' 7' ' ' VAL . 7.8 t80 -85.76 135.0 33.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.311 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.452 ' CB ' ' HB2' ' A' ' 38' ' ' ASP . 0.1 OUTLIER -150.54 131.88 14.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.372 179.558 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.743 ' OG1' HD21 ' A' ' 67' ' ' LEU . 2.5 p -130.25 125.0 33.75 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.164 -179.185 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.72 ' HB1' ' CD1' ' A' ' 61' ' ' LEU . . . -144.19 99.68 3.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.7 179.141 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.09 75.79 0.25 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.684 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.72 ' CD1' ' HB1' ' A' ' 59' ' ' ALA . 4.6 mp -121.49 -95.89 0.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 121.312 -0.155 . . . . 0.0 111.207 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -99.36 -30.3 12.29 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 120.766 0.317 . . . . 0.0 111.487 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.457 ' OD1' ' CE2' ' A' ' 37' ' ' PHE . 29.7 t0 -80.57 -63.73 1.34 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.619 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.524 ' CD2' ' CD1' ' A' ' 67' ' ' LEU . 19.0 m-85 -88.27 144.53 26.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.917 0.389 . . . . 0.0 110.874 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -86.26 -62.04 1.61 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.831 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.29 -52.98 3.49 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -178.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.743 HD21 ' OG1' ' A' ' 58' ' ' THR . 0.4 OUTLIER 64.78 -151.25 0.28 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 120.596 -0.442 . . . . 0.0 109.832 -179.566 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.576 ' CB ' HD21 ' B' ' 541' ' ' LEU . 0.1 OUTLIER 78.28 41.94 0.06 OUTLIER Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 179.5 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.574 ' CG ' HG21 ' A' ' 58' ' ' THR . 88.3 Cg_endo -82.89 -21.95 4.55 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.302 2.002 . . . . 0.0 112.09 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.974 HD21 ' HA ' ' B' ' 541' ' ' LEU . 0.1 OUTLIER -60.52 -15.17 24.68 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.621 -179.677 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.33 -60.55 3.68 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.752 0.311 . . . . 0.0 110.968 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.01 65.07 74.47 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.923 0.392 . . . . 0.0 111.146 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 70' ' ' LEU . 83.6 Cg_endo -82.56 145.88 13.31 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.801 2.334 . . . . 0.0 112.189 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -96.64 10.25 39.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.48 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 11.5 t -53.05 -176.32 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.752 0.31 . . . . 0.0 110.878 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -136.5 7.35 3.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.553 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.907 HG21 ' HB2' ' A' ' 176' ' ' ALA . 4.8 t -139.03 86.76 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.725 0.298 . . . . 0.0 111.458 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.83 ' CD2' HG21 ' A' ' 9' ' ' VAL . 0.5 OUTLIER -80.85 172.01 14.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.084 179.351 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.518 HD23 HG12 ' A' ' 14' ' ' VAL . 9.8 tp -157.0 120.98 4.28 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.084 0.469 . . . . 0.0 111.812 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.485 ' HB ' ' CH2' ' A' ' 97' ' ' TRP . 0.7 OUTLIER -114.11 135.83 52.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.981 179.041 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.665 ' SG ' HG22 ' A' ' 14' ' ' VAL . 4.6 p -125.83 164.33 20.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.245 0.545 . . . . 0.0 112.283 -178.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.487 ' CE2' HD12 ' A' ' 112' ' ' LEU . 11.3 p90 -169.36 135.61 1.64 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.131 179.483 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 50.2 p -88.41 144.66 26.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.816 0.341 . . . . 0.0 110.943 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.743 HG13 ' N ' ' A' ' 137' ' ' ILE . 45.1 t -46.17 -63.14 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.56 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.604 ' O ' HG23 ' A' ' 85' ' ' VAL . 35.3 m -45.47 110.02 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.698 0.285 . . . . 0.0 110.829 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.623 ' N ' HD22 ' A' ' 129' ' ' LEU . 0.2 OUTLIER -151.6 131.46 6.94 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.827 -179.347 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 86' ' ' SER . 67.8 Cg_endo -92.58 53.33 0.55 Allowed 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 123.289 2.659 . . . . 0.0 111.837 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.451 ' CA ' ' HG3' ' A' ' 133' ' ' LYS . 1.0 OUTLIER 80.31 30.17 0.22 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.069 -179.745 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.729 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -95.22 -23.03 17.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.857 179.658 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.654 ' CZ ' HG21 ' A' ' 137' ' ' ILE . 0.8 OUTLIER -52.49 -58.41 6.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.93 179.924 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -58.22 -40.7 82.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.936 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -64.64 -59.21 4.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.886 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.729 HG23 ' O ' ' A' ' 89' ' ' SER . 47.1 t -51.22 -52.74 17.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.181 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.766 ' HG3' HD11 ' A' ' 145' ' ' LEU . 10.8 tmtt? -50.49 -50.43 52.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.901 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.406 ' O ' ' HG2' ' A' ' 99' ' ' PRO . 3.1 mt-10 -54.25 -42.12 69.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.183 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.72 12.23 34.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.543 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.507 ' O ' HG22 ' A' ' 101' ' ' ILE . 0.0 OUTLIER -94.47 -53.16 4.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.744 0.307 . . . . 0.0 111.087 179.918 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 1.016 HG22 HD13 ' A' ' 149' ' ' LEU . 3.5 t -60.36 -44.94 97.31 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.896 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.493 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 16.4 Cg_exo -68.31 -33.72 23.14 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.539 2.159 . . . . 0.0 112.923 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -85.73 -35.7 20.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.649 -0.25 . . . . 0.0 111.437 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.622 HD11 ' HB3' ' A' ' 110' ' ' PHE . 12.7 tt -68.75 -25.98 31.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.755 0.312 . . . . 0.0 111.056 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 68.0 p -97.18 -26.85 14.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.046 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.47 ' CG ' ' O ' ' A' ' 99' ' ' PRO . 5.1 m170 -66.68 -41.84 87.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.047 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -76.68 -24.33 53.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.103 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.414 ' O ' ' N ' ' A' ' 107' ' ' LYS . 8.0 m -137.4 123.06 12.91 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.854 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 105' ' ' CYS . 32.3 Cg_exo -58.17 79.76 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.571 2.181 . . . . 0.0 112.234 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.414 ' N ' ' O ' ' A' ' 105' ' ' CYS . 2.6 mmmp? 61.39 91.41 0.06 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.917 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.442 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 0.1 OUTLIER -122.57 138.08 28.79 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.921 179.929 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 108' ' ' THR . 31.5 Cg_exo -60.28 138.02 78.49 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.618 2.212 . . . . 0.0 112.468 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.622 ' HB3' HD11 ' A' ' 101' ' ' ILE . 1.0 OUTLIER -142.25 147.18 36.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.715 179.656 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.757 HD23 ' O ' ' A' ' 112' ' ' LEU . 0.9 OUTLIER -130.02 158.0 40.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.314 -179.678 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.757 ' O ' HD23 ' A' ' 111' ' ' LEU . 3.0 mm? -97.19 161.35 13.85 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.667 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.752 ' HA ' HG21 ' A' ' 168' ' ' VAL . 18.2 t -135.03 138.69 48.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.049 0.452 . . . . 0.0 111.889 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.432 ' HA3' ' CZ ' ' A' ' 154' ' ' TYR . . . -123.26 107.31 1.08 Allowed Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.59 179.334 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.746 ' C ' HD13 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -130.81 -53.18 1.06 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.852 0.358 . . . . 0.0 110.704 -179.187 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.832 ' HG2' HD13 ' A' ' 119' ' ' LEU . 1.6 tt0 -79.89 53.8 1.74 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.274 179.008 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.786 HD11 ' O ' ' A' ' 157' ' ' CYS . 0.1 OUTLIER -99.12 -5.8 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.006 179.834 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -77.73 -27.43 50.51 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.936 0.398 . . . . 0.0 110.536 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.832 HD13 ' HG2' ' A' ' 116' ' ' GLN . 5.0 mp -76.69 -24.36 53.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.591 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.462 ' O ' HD13 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -46.71 -29.38 1.86 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.811 179.783 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -83.79 -34.92 24.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.405 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.63 104.49 0.44 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.575 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.457 ' HA ' ' CG2' ' A' ' 126' ' ' ILE . 14.7 Cg_exo -69.06 -3.73 12.14 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.703 2.269 . . . . 0.0 113.106 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.03 -66.4 0.87 Allowed 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 121.109 0.48 . . . . 0.0 109.758 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.416 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 18.2 m -57.92 -37.92 74.94 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.482 ' HA ' HD12 ' A' ' 129' ' ' LEU . 0.0 OUTLIER -54.85 -42.95 65.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.781 179.337 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.537 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 35.6 mt-10 -60.08 -35.1 74.45 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.86 179.222 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 125' ' ' THR . 0.0 OUTLIER -65.38 -30.91 71.79 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.071 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.623 HD22 ' N ' ' A' ' 86' ' ' SER . 7.4 mt -73.94 -35.59 64.59 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.036 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 127' ' ' GLU . . . -46.25 -34.63 4.56 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.894 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 5.7 mmmt -47.51 -33.06 5.89 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.478 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.418 ' HB2' ' O ' ' A' ' 87' ' ' PRO . 55.7 m-80 -123.43 -31.4 3.53 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.451 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.523 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 16.7 mmtp -146.85 -97.49 0.09 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 119.208 -0.425 . . . . 0.0 111.662 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.523 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 4.6 pt20 128.99 -25.74 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.473 1.109 . . . . 0.0 110.331 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -69.36 110.63 6.64 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.761 -179.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.432 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 95.3 Cg_endo -79.53 136.97 12.71 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.514 2.143 . . . . 0.0 111.371 179.105 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.743 ' N ' HG13 ' A' ' 84' ' ' VAL . 0.8 OUTLIER -69.25 96.59 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.91 0.386 . . . . 0.0 110.953 -179.463 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.402 ' O ' ' HB ' ' A' ' 141' ' ' THR . 2.6 p -70.48 160.2 82.21 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.182 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.496 ' HA ' ' CE1' ' A' ' 154' ' ' TYR . 72.0 Cg_exo -48.14 -42.88 32.34 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.572 2.181 . . . . 0.0 112.213 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -67.44 -34.74 77.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.776 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.517 HG21 HG23 ' A' ' 137' ' ' ILE . 97.5 m -58.29 -55.32 36.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.904 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.511 ' CB ' ' CD2' ' A' ' 154' ' ' TYR . . . -50.9 -36.53 38.75 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.899 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -64.72 -42.59 95.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.833 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.55 -56.76 15.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.698 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.766 HD11 ' HG3' ' A' ' 94' ' ' LYS . 2.9 tt -67.92 -31.97 72.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.707 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.412 ' CA ' ' HB3' ' A' ' 151' ' ' ALA . . . -55.66 -66.02 0.49 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.931 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 16.1 mtp85 -63.52 -24.12 67.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.977 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -54.11 -40.95 67.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.2 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 1.016 HD13 HG22 ' A' ' 98' ' ' VAL . 0.5 OUTLIER -117.32 24.5 11.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.076 -179.862 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.79 59.06 2.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.786 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.514 ' HB1' ' CD2' ' A' ' 112' ' ' LEU . . . -94.22 27.92 2.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.118 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.621 ' CB ' HD12 ' A' ' 111' ' ' LEU . 92.8 t 68.94 -74.8 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.975 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.695 ' O ' HD21 ' A' ' 111' ' ' LEU . 0.2 OUTLIER 173.13 139.21 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.109 0.481 . . . . 0.0 111.394 -179.234 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.511 ' CD2' ' CB ' ' A' ' 142' ' ' ALA . 3.2 t80 -94.66 116.69 29.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.248 178.441 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.402 HG12 ' N ' ' A' ' 156' ' ' GLU . 5.2 t -101.12 158.7 4.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.31 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.402 ' N ' HG12 ' A' ' 155' ' ' VAL . 3.3 tt0 -89.67 143.58 26.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.522 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.786 ' O ' HD11 ' A' ' 117' ' ' ILE . 25.3 p 178.9 179.25 0.41 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.012 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.441 ' HA ' ' HA ' ' A' ' 115' ' ' THR . 28.4 p -159.89 160.24 33.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.953 0.406 . . . . 0.0 111.308 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.475 ' HB2' HD11 ' A' ' 165' ' ' LEU . . . -113.8 -27.14 7.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.915 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.68 -37.39 41.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.782 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.405 ' O ' ' HB3' ' A' ' 162' ' ' GLN . 7.7 t -116.59 -13.69 10.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.189 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.412 ' N ' ' OG ' ' A' ' 158' ' ' SER . 10.8 tt0 71.56 82.02 0.15 Allowed 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.698 0.285 . . . . 0.0 111.254 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.426 ' N ' ' OG ' ' A' ' 158' ' ' SER . 5.5 mttm -101.92 22.15 13.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.053 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 105.2 44.23 1.51 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.442 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.743 HD22 ' HG ' ' A' ' 19' ' ' LEU . 2.3 mt -46.09 -31.7 2.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.783 0.325 . . . . 0.0 111.155 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.421 ' HG3' ' N ' ' A' ' 167' ' ' ASN . 0.1 OUTLIER -66.57 -28.62 68.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.902 179.825 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.421 ' N ' ' HG3' ' A' ' 166' ' ' LYS . 2.6 t-20 -57.48 -70.87 0.11 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.698 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.752 HG21 ' HA ' ' A' ' 113' ' ' VAL . 11.4 p -50.77 -44.27 25.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.914 0.388 . . . . 0.0 110.565 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.967 ' CD2' HD23 ' A' ' 19' ' ' LEU . 0.3 OUTLIER -63.85 -30.59 71.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.097 179.436 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.421 ' O ' HG13 ' A' ' 173' ' ' ILE . 20.4 t0 -70.65 -22.52 62.49 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.565 179.367 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -84.61 -35.1 22.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.248 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -67.28 -32.62 73.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.74 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.601 ' O ' HG21 ' A' ' 4' ' ' ILE . 2.0 pp -82.52 -35.11 12.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.771 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.645 ' HB2' HD22 ' B' ' 505' ' ' LEU . 9.7 tp -52.83 -43.56 66.08 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.977 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -50.65 -23.48 2.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.642 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.907 ' HB2' HG21 ' A' ' 77' ' ' VAL . . . -96.72 -34.71 11.25 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.699 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.825 HD13 ' HB ' ' B' ' 510' ' ' ILE . 96.7 mt -68.76 -24.01 64.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.797 0.332 . . . . 0.0 110.729 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -179.92 154.33 0.68 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.926 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' PRO . . . . . 0.425 ' HA ' ' HD2' ' A' ' 180' ' ' PRO . 43.8 Cg_endo -68.1 108.8 1.81 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.603 2.202 . . . . 0.0 112.256 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 179' ' ' PRO . 54.6 Cg_endo -69.55 174.08 9.84 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.531 2.154 . . . . 0.0 112.449 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -145.64 144.47 22.64 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.781 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.3 -165.14 0.27 Allowed 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.598 2.198 . . . . 0.0 112.26 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 7.6 mttm -126.71 171.67 10.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.918 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 3.4 mtpt . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.192 -0.909 . . . . 0.0 110.867 -179.961 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 502' ' ' GLY . . . . . 0.425 ' CA ' ' O ' ' B' ' 509' ' ' ASP . . . . . . . . 0 N--CA 1.488 2.116 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 503' ' ' SER . . . . . 0.401 ' HB2' ' O ' ' B' ' 510' ' ' ILE . 0.1 OUTLIER -66.49 -75.29 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.797 0.332 . . . . 0.0 110.968 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 504' ' ' GLY . . . . . 0.492 ' CA ' ' HA ' ' B' ' 509' ' ' ASP . . . 147.22 -101.33 0.23 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.0 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 505' ' ' LEU . . . . . 0.645 HD22 ' HB2' ' A' ' 174' ' ' LEU . 0.5 OUTLIER 69.39 -61.77 0.43 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 179.244 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 506' ' ' SER . . . . . 0.424 ' CB ' ' O ' ' B' ' 505' ' ' LEU . 1.1 p 165.0 -45.71 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.722 0.296 . . . . 0.0 111.108 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 507' ' ' ALA . . . . . . . . . . . . . . . -36.92 -66.51 0.23 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.947 0.88 . . . . 0.0 111.43 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 508' ' ' GLN . . . . . 0.484 ' O ' ' CB ' ' B' ' 509' ' ' ASP . 7.3 mt-30 -160.48 -45.42 0.05 OUTLIER 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.02 -1.445 . . . . 0.0 107.841 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 509' ' ' ASP . . . . . 0.492 ' HA ' ' CA ' ' B' ' 504' ' ' GLY . 3.3 p30 146.88 43.57 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 113.994 -1.457 . . . . 0.0 110.259 178.678 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 510' ' ' ILE . . . . . 0.825 ' HB ' HD13 ' A' ' 177' ' ' LEU . 2.3 mt -65.15 133.09 30.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.163 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 511' ' ' SER . . . . . 0.42 ' CB ' ' HG ' ' B' ' 514' ' ' LEU . 2.6 m -109.35 158.72 17.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.257 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 512' ' ' GLN . . . . . 0.505 ' CB ' ' HD3' ' B' ' 513' ' ' PRO . 0.7 OUTLIER -100.37 -65.43 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.724 179.562 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 513' ' ' PRO . . . . . 0.505 ' HD3' ' CB ' ' B' ' 512' ' ' GLN . 69.9 Cg_endo -83.81 53.49 4.11 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.549 2.166 . . . . 0.0 112.06 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 514' ' ' LEU . . . . . 0.651 HD22 ' O ' ' A' ' 45' ' ' MET . 0.7 OUTLIER -61.75 -84.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.374 -179.468 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 515' ' ' GLN . . . . . 0.433 ' HB2' HG12 ' A' ' 44' ' ' VAL . 1.6 mt-30 -78.91 -86.8 0.07 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.207 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -118.41 -32.32 4.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.779 0.323 . . . . 0.0 111.243 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 517' ' ' SER . . . . . 0.481 ' C ' HG13 ' A' ' 42' ' ' VAL . 0.4 OUTLIER 73.06 7.85 5.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.649 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 518' ' ' PHE . . . . . 0.476 ' CD1' ' O ' ' B' ' 517' ' ' SER . 6.5 m-85 -163.43 125.03 2.43 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.723 0.297 . . . . 0.0 110.901 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 519' ' ' ILE . . . . . 0.593 HD11 ' OG1' ' A' ' 43' ' ' THR . 40.1 mm -79.94 -34.37 15.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.214 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 520' ' ' HIS . . . . . 0.704 ' O ' HG23 ' B' ' 521' ' ' THR . 41.5 t-80 -163.25 -87.04 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.069 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 521' ' ' THR . . . . . 0.704 HG23 ' O ' ' B' ' 520' ' ' HIS . 0.1 OUTLIER 170.23 -172.43 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 120.848 0.356 . . . . 0.0 110.886 179.911 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 522' ' ' GLY . . . . . . . . . . . . . . . -93.23 -125.91 4.08 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.37 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 523' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -157.47 -91.64 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.501 0.191 . . . . 0.0 110.767 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 524' ' ' GLY . . . . . . . . . . . . . . . 48.4 -178.23 0.01 OUTLIER Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.854 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 525' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 168.77 60.46 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.824 0.345 . . . . 0.0 110.809 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 526' ' ' SER . . . . . 0.42 ' OG ' ' CG1' ' A' ' 33' ' ' VAL . 12.2 t -92.34 97.01 10.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.012 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 527' ' ' ASP . . . . . 0.478 ' CB ' ' CD ' ' B' ' 528' ' ' PRO . 0.2 OUTLIER -52.72 -64.31 1.68 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.98 179.944 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 528' ' ' PRO . . . . . 0.478 ' CD ' ' CB ' ' B' ' 527' ' ' ASP . 12.8 Cg_endo -53.45 103.43 0.09 OUTLIER 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.97 2.447 . . . . 0.0 112.17 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 529' ' ' ARG . . . . . 0.522 ' HG2' HG21 ' A' ' 33' ' ' VAL . 13.7 mtt85 -100.59 -32.06 10.95 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.968 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 530' ' ' HIS . . . . . 0.503 ' CG ' ' O ' ' B' ' 530' ' ' HIS . 0.1 OUTLIER 70.5 6.47 5.82 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.116 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER 59.55 177.51 0.08 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.89 0.376 . . . . 0.0 111.034 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 532' ' ' TRP . . . . . 0.411 ' CD2' ' O ' ' B' ' 532' ' ' TRP . 72.4 t90 -75.28 73.03 2.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.844 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . -96.21 -19.0 29.52 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.491 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 534' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -88.67 156.02 50.38 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.78 0.324 . . . . 0.0 111.003 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -73.89 95.08 0.88 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.565 2.176 . . . . 0.0 112.362 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 536' ' ' ASP . . . . . 0.434 ' O ' ' CA ' ' A' ' 12' ' ' GLY . 35.4 m-20 62.97 46.91 4.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.019 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 537' ' ' ARG . . . . . 0.666 ' HG3' ' HB2' ' A' ' 13' ' ' ALA . 20.9 mmt-85 73.86 -173.89 0.14 Allowed 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.373 0.606 . . . . 0.0 111.518 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 538' ' ' ILE . . . . . 0.732 HD12 ' CB ' ' B' ' 542' ' ' TYR . 4.8 pt -106.66 -153.68 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.031 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 539' ' ' ASP . . . . . 0.418 ' N ' HG13 ' B' ' 538' ' ' ILE . 51.8 p30 -104.04 161.42 14.01 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.944 0.402 . . . . 0.0 111.35 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 540' ' ' GLU . . . . . 0.5 ' HG3' HG13 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -57.12 -23.79 49.6 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.801 179.634 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 541' ' ' LEU . . . . . 0.974 ' HA ' HD21 ' A' ' 70' ' ' LEU . 0.4 OUTLIER -60.09 -34.79 73.94 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.339 0.59 . . . . 0.0 109.884 179.794 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 542' ' ' TYR . . . . . 0.732 ' CB ' HD12 ' B' ' 538' ' ' ILE . 2.9 m-85 -102.66 -57.34 2.07 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.999 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 543' ' ' LEU . . . . . 0.667 HD21 ' CD ' ' A' ' 16' ' ' LYS . 0.2 OUTLIER 64.74 -71.41 0.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.915 179.865 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 544' ' ' GLY . . . . . 0.652 ' HA3' HD11 ' A' ' 61' ' ' LEU . . . -62.87 165.66 24.92 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.349 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 545' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.276 -0.869 . . . . 0.0 111.018 -179.907 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.505 ' HE1' ' CD1' ' A' ' 51' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.323 0.106 . . . . 0.0 111.117 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.407 ' N ' ' SD ' ' A' ' 1' ' ' MET . 13.1 tp60 56.97 151.94 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.126 0.489 . . . . 0.0 111.58 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' THR . . . . . 1.085 HG23 HG21 ' A' ' 46' ' ' ILE . 0.3 OUTLIER -154.65 -158.69 0.87 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.247 179.919 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.979 HD11 HD22 ' A' ' 53' ' ' LEU . 0.2 OUTLIER -144.82 155.57 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 CA-C-O 121.189 0.519 . . . . 0.0 111.973 -179.514 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 36.3 mttt -134.45 116.61 15.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.704 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.641 ' SG ' HG23 ' A' ' 77' ' ' VAL . 45.7 t -138.38 154.22 48.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.364 0.602 . . . . 0.0 112.52 -178.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.822 HG22 ' CB ' ' A' ' 56' ' ' PHE . 11.9 t -128.37 150.35 34.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.208 178.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.948 HG11 HG13 ' A' ' 14' ' ' VAL . 2.8 p -83.8 121.65 36.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.307 0.575 . . . . 0.0 111.707 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.705 HG12 ' HB2' ' A' ' 70' ' ' LEU . 19.2 m -129.87 129.9 66.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.928 178.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.471 ' HA2' ' CZ2' ' A' ' 97' ' ' TRP . . . 137.49 -142.8 13.79 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.194 -1.003 . . . . 0.0 112.652 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.427 ' CB ' ' O ' ' B' ' 537' ' ' ARG . 0.4 OUTLIER -122.52 26.68 8.22 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.879 0.371 . . . . 0.0 110.633 179.915 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.425 ' O ' ' CB ' ' B' ' 537' ' ' ARG . . . -86.04 -176.2 49.96 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.765 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.579 ' HB2' ' CD ' ' B' ' 537' ' ' ARG . . . -89.39 4.82 47.76 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.958 HG21 HD21 ' B' ' 543' ' ' LEU . 8.7 t 81.24 107.18 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.066 0.46 . . . . 0.0 110.651 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.504 ' HA3' ' CE1' ' A' ' 169' ' ' PHE . . . -65.32 -9.29 41.96 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.723 -0.671 . . . . 0.0 113.423 -179.352 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.439 ' CD ' ' HB3' ' A' ' 55' ' ' LEU . 3.1 mmtt -77.07 -51.25 11.38 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 122.395 -0.473 . . . . 0.0 111.031 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.841 HG22 ' OD1' ' A' ' 38' ' ' ASP . 0.1 OUTLIER -98.14 -44.36 6.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.596 -179.583 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.421 ' CB ' ' O ' ' A' ' 14' ' ' VAL . 44.0 t -36.12 -73.83 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.725 ' HA ' HD13 ' A' ' 165' ' ' LEU . 1.8 mp -56.53 -68.66 0.2 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.951 0.405 . . . . 0.0 111.583 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.593 HD23 ' N ' ' A' ' 20' ' ' LEU . 2.9 mt -46.38 -61.45 1.79 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.201 -178.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.442 ' HA ' HG23 ' A' ' 25' ' ' THR . 47.6 mm -49.35 -72.15 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.781 0.324 . . . . 0.0 111.191 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 27.7 t -51.2 -23.0 2.98 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.606 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.416 ' HB2' ' O ' ' A' ' 19' ' ' LEU . 85.1 t80 -75.41 -68.07 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.731 0.3 . . . . 0.0 111.382 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.4 m -75.91 -34.69 59.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.31 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.442 HG23 ' HA ' ' A' ' 21' ' ' ILE . 1.5 p -87.9 -156.12 0.34 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.882 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -151.41 21.13 0.73 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.089 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -108.59 123.51 49.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.869 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.473 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 0.4 OUTLIER -153.78 -68.25 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.411 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.632 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.473 ' CD ' ' CB ' ' A' ' 28' ' ' PHE . 74.0 Cg_endo -75.45 54.26 3.79 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.479 2.119 . . . . 0.0 112.939 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 33.9 t -145.96 -80.02 0.16 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.916 0.389 . . . . 0.0 110.976 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -158.34 159.02 35.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.45 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.413 ' CE1' ' O ' ' A' ' 28' ' ' PHE . 10.6 m-85 -128.44 93.36 3.62 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.065 0.46 . . . . 0.0 110.918 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.981 HG11 ' O ' ' B' ' 526' ' ' SER . 1.9 t -108.45 -50.01 0.08 OUTLIER Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.545 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.433 ' HD3' ' HB ' ' A' ' 33' ' ' VAL . 77.6 Cg_exo -52.01 -22.14 13.88 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.009 1.806 . . . . 0.0 112.203 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.632 ' CG2' HD23 ' B' ' 543' ' ' LEU . 27.9 m -52.3 -24.33 7.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.545 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.756 ' HB ' HD21 ' A' ' 61' ' ' LEU . 5.6 p -57.98 -25.35 25.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.164 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.494 ' CD1' ' HA3' ' B' ' 522' ' ' GLY . 0.2 OUTLIER -125.79 53.36 1.59 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.963 0.411 . . . . 0.0 110.645 179.724 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.841 ' OD1' HG22 ' A' ' 17' ' ' THR . 24.4 t70 -88.95 14.18 11.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.554 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -92.82 19.87 7.15 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.769 0.318 . . . . 0.0 110.905 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -61.95 -175.11 0.06 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.699 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -116.43 169.77 9.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.438 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.455 ' HA ' ' CG1' ' B' ' 519' ' ' ILE . 35.1 m -146.94 129.33 7.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.911 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.455 HG23 HG12 ' B' ' 519' ' ' ILE . 16.4 p -87.5 105.61 17.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.554 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.499 ' CG2' ' CG2' ' A' ' 52' ' ' THR . 19.3 m -158.93 -177.09 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.53 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.516 ' HE2' ' C ' ' A' ' 45' ' ' MET . 0.0 OUTLIER -124.85 107.54 11.01 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.795 0.295 . . . . 0.0 111.795 -179.639 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 1.085 HG21 HG23 ' A' ' 3' ' ' THR . 5.1 mm -79.96 86.13 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 26.21 90.29 0.01 OUTLIER Glycine 0 CA--C 1.526 0.731 0 O-C-N 123.64 0.587 . . . . 0.0 114.449 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 140.39 -95.51 0.2 Allowed Glycine 0 N--CA 1.454 -0.156 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.448 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.466 ' N ' ' HE1' ' A' ' 45' ' ' MET . 0.0 OUTLIER -130.31 144.99 55.46 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.791 0.329 . . . . 0.0 110.638 179.347 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_exo -34.39 102.4 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.46 2.773 . . . . 0.0 113.446 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.505 ' CD1' ' HE1' ' A' ' 1' ' ' MET . 3.1 t80 -173.4 138.22 0.69 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.159 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.499 ' CG2' ' CG2' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -134.12 153.16 51.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.112 0.482 . . . . 0.0 111.402 179.495 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.979 HD22 HD11 ' A' ' 4' ' ' ILE . 0.4 OUTLIER -80.25 109.9 15.17 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.169 -179.616 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -62.95 107.61 1.75 Allowed Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.0 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.439 ' HB3' ' CD ' ' A' ' 16' ' ' LYS . 1.4 mp -63.59 116.88 6.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.836 0.35 . . . . 0.0 110.413 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.822 ' CB ' HG22 ' A' ' 7' ' ' VAL . 0.7 OUTLIER -84.58 125.33 32.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.352 0.596 . . . . 0.0 111.751 -178.916 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.938 ' OD2' HG11 ' A' ' 14' ' ' VAL . 38.5 t0 -175.17 137.34 0.4 Allowed 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.457 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.912 ' OG1' HD21 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -155.07 160.02 40.69 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.483 -178.645 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.709 ' HB3' HD21 ' A' ' 61' ' ' LEU . . . -132.34 155.48 48.32 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.816 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.419 ' HA2' ' HB2' ' A' ' 64' ' ' TYR . . . -106.65 79.46 0.26 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.533 -0.841 . . . . 0.0 113.328 -179.282 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.837 HD22 ' HA2' ' B' ' 544' ' ' GLY . 0.1 OUTLIER -121.47 -87.76 0.63 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.72 0.295 . . . . 0.0 110.643 179.24 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -98.73 -26.52 14.32 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.99 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -89.4 -63.42 1.29 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.4 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.765 ' HB2' HD23 ' A' ' 67' ' ' LEU . 12.8 m-85 -96.85 146.54 24.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.958 0.409 . . . . 0.0 111.086 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -87.43 -58.5 2.56 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.402 ' O ' ' CB ' ' A' ' 67' ' ' LEU . 0.6 OUTLIER -98.35 -51.17 4.06 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -178.209 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.912 HD21 ' OG1' ' A' ' 58' ' ' THR . 0.2 OUTLIER 76.4 87.74 0.08 Allowed 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -178.636 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.475 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 34.5 ptt180 -126.59 48.19 2.94 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.563 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.525 ' HG3' HG23 ' A' ' 58' ' ' THR . 97.4 Cg_endo -79.0 -39.56 0.34 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.67 2.246 . . . . 0.0 111.875 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.945 HD23 ' CB ' ' B' ' 541' ' ' LEU . 0.1 OUTLIER -82.04 -8.45 59.67 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.038 179.959 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -51.8 -35.11 42.87 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.692 0.282 . . . . 0.0 111.14 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.444 ' CZ ' ' O ' ' A' ' 104' ' ' HIS . 1.5 t80 -169.08 67.63 0.65 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.196 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.504 ' HG2' ' CE2' ' A' ' 78' ' ' PHE . 73.0 Cg_endo -75.75 142.66 25.9 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.641 2.227 . . . . 0.0 112.216 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 25.6 tp60 -101.42 10.8 40.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.608 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.679 HG23 ' CE1' ' A' ' 78' ' ' PHE . 1.2 t -47.46 167.78 0.02 OUTLIER 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.931 0.396 . . . . 0.0 111.211 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -91.49 -22.59 20.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.609 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.641 HG23 ' SG ' ' A' ' 6' ' ' CYS . 19.1 m -137.95 143.98 32.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.982 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.775 ' CE1' HG21 ' A' ' 108' ' ' THR . 3.7 m-85 -116.35 121.01 40.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.432 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.522 HD21 ' HE1' ' A' ' 169' ' ' PHE . 5.9 tp -82.38 108.18 15.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.887 0.375 . . . . 0.0 111.031 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.599 ' O ' HG23 ' A' ' 80' ' ' VAL . 19.4 m -107.87 95.6 3.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.199 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 14.3 m -95.14 155.25 16.81 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.575 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.671 ' HE1' HD12 ' A' ' 112' ' ' LEU . 23.4 p90 -153.36 128.28 9.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.462 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.1 p -83.62 136.44 34.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.0 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.796 HG13 ' N ' ' A' ' 137' ' ' ILE . 58.7 t -45.32 -54.59 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.443 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.78 HG11 HG21 ' A' ' 125' ' ' THR . 28.8 m -49.52 112.97 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.682 0.277 . . . . 0.0 110.577 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.717 ' N ' HD22 ' A' ' 129' ' ' LEU . 18.4 m -151.37 122.36 3.76 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.665 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 86' ' ' SER . 87.1 Cg_endo -93.81 56.2 0.36 Allowed 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.228 2.619 . . . . 0.0 111.599 179.311 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.445 ' HB3' ' HG2' ' A' ' 133' ' ' LYS . 0.9 OUTLIER 81.11 20.38 0.41 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.07 -179.449 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.95 ' O ' HG23 ' A' ' 93' ' ' VAL . 2.8 m -97.29 -27.29 14.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.827 0.346 . . . . 0.0 110.79 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -50.67 -53.86 27.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.016 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -50.18 -45.39 53.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.974 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.413 ' O ' ' N ' ' A' ' 96' ' ' LYS . 24.1 m120 -72.55 -44.58 61.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.872 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.95 HG23 ' O ' ' A' ' 89' ' ' SER . 62.0 t -51.34 -37.5 18.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.245 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.635 ' HB2' HD11 ' A' ' 145' ' ' LEU . 3.9 tttt -73.34 -49.96 24.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.886 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -82.87 6.98 16.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.562 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.413 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.1 OUTLIER -113.86 -28.47 7.39 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.713 0.292 . . . . 0.0 110.991 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.471 ' CZ2' ' HA2' ' A' ' 10' ' ' GLY . 3.1 m95 -94.32 -49.24 5.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.179 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 94' ' ' LYS . 61.8 t -48.62 -47.48 70.72 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.662 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 71.9 Cg_endo -77.9 -16.75 14.24 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.242 1.961 . . . . 0.0 112.517 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.38 -47.0 8.31 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.729 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.415 HG13 ' N ' ' A' ' 102' ' ' THR . 2.0 pt -60.21 -26.71 37.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.026 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.415 ' N ' HG13 ' A' ' 101' ' ' ILE . 27.0 p -82.56 -39.66 21.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.867 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -54.16 -48.73 70.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.799 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.444 ' O ' ' CZ ' ' A' ' 72' ' ' TYR . 15.4 m170 -70.06 -26.83 64.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.715 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -143.62 99.01 5.28 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.813 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_exo -43.03 99.02 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.6 2.2 . . . . 0.0 112.484 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.5 mmtm 57.61 102.62 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.869 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.775 HG21 ' CE1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -133.13 136.76 28.01 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.862 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 108' ' ' THR . 31.3 Cg_exo -59.96 154.79 48.24 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.555 2.17 . . . . 0.0 112.292 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.564 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 3.7 p90 -165.55 140.39 4.9 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.241 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.657 HD12 ' CG1' ' A' ' 152' ' ' VAL . 1.8 tt -116.1 153.23 32.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.892 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.671 HD12 ' HE1' ' A' ' 82' ' ' PHE . 0.8 OUTLIER -98.01 161.53 13.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.833 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.916 HG13 HG21 ' A' ' 168' ' ' VAL . 10.6 t -140.53 143.59 28.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 121.08 0.467 . . . . 0.0 112.025 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -120.43 108.9 1.49 Allowed Glycine 0 C--N 1.332 0.34 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.625 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.686 HG22 ' SG ' ' A' ' 157' ' ' CYS . 0.1 OUTLIER -135.88 5.28 3.08 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.879 0.325 . . . . 0.0 111.879 -178.796 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.857 ' HG3' HD13 ' A' ' 119' ' ' LEU . 39.7 tt0 -118.32 -4.03 10.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.753 0.311 . . . . 0.0 110.459 179.205 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.971 HD11 ' O ' ' A' ' 157' ' ' CYS . 0.1 OUTLIER -44.88 -26.47 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.141 179.263 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -73.88 -31.5 63.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.292 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.857 HD13 ' HG3' ' A' ' 116' ' ' GLN . 3.9 mp -85.82 -23.7 27.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.359 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.609 ' CB ' HG11 ' A' ' 84' ' ' VAL . 1.0 OUTLIER -49.63 -26.18 3.43 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.961 0.41 . . . . 0.0 110.684 179.818 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -85.46 -31.66 22.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.591 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.2 107.18 0.79 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.648 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.451 ' HA ' ' CG2' ' A' ' 126' ' ' ILE . 43.1 Cg_endo -68.87 -5.91 16.76 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.493 2.129 . . . . 0.0 113.131 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.1 t -75.75 -67.22 0.69 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.78 HG21 HG11 ' A' ' 85' ' ' VAL . 3.1 m -57.81 -38.17 75.06 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.566 178.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.723 HD11 ' HB3' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -55.39 -46.36 78.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.81 179.407 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.509 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 4.8 mm-40 -56.34 -35.43 67.6 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.924 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.4 ' HA ' ' CD ' ' A' ' 131' ' ' LYS . 6.0 mptt -65.36 -31.49 72.63 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.717 HD22 ' N ' ' A' ' 86' ' ' SER . 7.1 mt -73.87 -37.82 64.63 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.095 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.509 ' HB3' ' O ' ' A' ' 127' ' ' GLU . . . -44.81 -37.97 4.19 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.224 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.4 ' CD ' ' HA ' ' A' ' 128' ' ' LYS . 0.1 OUTLIER -47.29 -32.6 4.82 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.933 179.816 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 87' ' ' PRO . 13.7 m120 -123.12 -31.36 3.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.476 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.523 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 9.3 mmmt -146.98 -100.21 0.09 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 118.993 -0.527 . . . . 0.0 111.132 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.523 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 1.4 pt20 133.29 -21.16 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.281 1.032 . . . . 0.0 110.55 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 16.1 mmtp -68.44 110.95 6.67 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.705 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.723 ' HB3' HD11 ' A' ' 126' ' ' ILE . 65.3 Cg_endo -85.48 122.27 2.37 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.832 2.355 . . . . 0.0 111.534 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.796 ' N ' HG13 ' A' ' 84' ' ' VAL . 1.2 mm -53.72 96.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.009 0.433 . . . . 0.0 110.664 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.44 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 33.8 p -68.66 155.82 92.19 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.908 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.44 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 8.6 Cg_endo -50.59 -26.24 16.42 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.699 2.266 . . . . 0.0 111.875 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -81.46 -33.4 32.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.59 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.445 ' CG2' HG23 ' A' ' 137' ' ' ILE . 89.9 m -57.62 -49.17 77.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.636 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.456 ' HB3' ' CD2' ' A' ' 154' ' ' TYR . . . -55.17 -32.79 62.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.789 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -68.14 -40.68 82.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.621 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.59 -49.93 74.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.676 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.684 HD23 ' O ' ' A' ' 145' ' ' LEU . 1.6 tt -70.08 -36.23 74.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.655 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.433 ' CB ' HD23 ' A' ' 112' ' ' LEU . . . -59.55 -58.1 10.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.965 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 38.1 mtt180 -67.86 -24.28 65.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.965 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -50.2 -36.11 29.29 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.785 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.64 23.6 7.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.86 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 37.0 mttt 45.57 59.75 3.45 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.126 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.584 ' O ' HG23 ' A' ' 152' ' ' VAL . . . -65.46 -82.39 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.212 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.657 ' CG1' HD12 ' A' ' 111' ' ' LEU . 45.1 t -161.86 -72.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.653 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 12.4 tppt? -179.8 118.9 0.06 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.883 -178.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.456 ' CD2' ' HB3' ' A' ' 142' ' ' ALA . 63.1 t80 -89.86 110.85 21.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.372 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.521 HG12 ' H ' ' A' ' 156' ' ' GLU . 2.6 t -101.61 167.46 2.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.739 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.521 ' H ' HG12 ' A' ' 155' ' ' VAL . 1.1 pm0 -106.58 119.06 38.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.123 0.487 . . . . 0.0 111.653 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.971 ' O ' HD11 ' A' ' 117' ' ' ILE . 14.8 p -140.19 -172.01 3.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.635 179.328 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.409 ' HB2' ' HB2' ' A' ' 163' ' ' LYS . 0.5 OUTLIER -159.1 127.95 5.31 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.459 -0.497 . . . . 0.0 111.884 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.565 ' HA ' HD11 ' A' ' 165' ' ' LEU . . . -94.67 20.33 8.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.512 178.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.702 ' N ' HD12 ' A' ' 160' ' ' LEU . 0.0 OUTLIER -129.99 -44.19 1.18 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.327 179.925 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 8.3 t -113.25 -17.84 12.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.984 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 77.45 85.75 0.08 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.2 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.409 ' HB2' ' HB2' ' A' ' 158' ' ' SER . 3.7 ttpp -107.82 22.71 15.56 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.051 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 115.44 40.73 0.84 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.793 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.725 HD13 ' HA ' ' A' ' 19' ' ' LEU . 9.2 mt -49.79 -42.79 47.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.77 0.319 . . . . 0.0 110.8 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.404 ' O ' ' HB2' ' A' ' 170' ' ' ASP . 0.5 OUTLIER -67.56 -32.02 72.5 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.423 179.418 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.22 -65.76 0.63 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.738 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.916 HG21 HG13 ' A' ' 113' ' ' VAL . 8.9 p -48.67 -43.64 13.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 121.081 0.467 . . . . 0.0 110.581 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.592 ' CE1' HD11 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -69.3 -27.03 65.04 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.079 179.221 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.404 ' HB2' ' O ' ' A' ' 166' ' ' LYS . 0.7 OUTLIER -61.57 -29.98 70.37 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.484 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.518 ' HB2' HD11 ' A' ' 111' ' ' LEU . 39.9 mm-40 -77.9 -39.7 42.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.04 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.578 ' N ' HD13 ' A' ' 111' ' ' LEU . . . -55.33 -48.22 74.5 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.579 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.558 HD12 ' CD1' ' A' ' 177' ' ' LEU . 1.4 pp -74.4 -33.69 34.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.843 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.837 HD13 ' HG ' ' B' ' 505' ' ' LEU . 21.7 tp -50.52 -68.73 0.15 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.928 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -54.44 -22.01 11.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.05 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.535 ' CB ' HG21 ' A' ' 4' ' ' ILE . . . -81.85 -45.84 14.97 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.281 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.869 ' CD2' HG21 ' B' ' 510' ' ' ILE . 2.1 mt -68.57 -25.01 64.68 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.864 0.364 . . . . 0.0 110.734 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.415 ' HB2' ' HA ' ' B' ' 507' ' ' ALA . 0.0 OUTLIER -159.57 151.63 17.17 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.727 179.928 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -53.03 139.07 62.07 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.534 2.156 . . . . 0.0 112.329 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.21 -168.71 0.59 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.546 2.164 . . . . 0.0 112.385 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -143.24 96.97 5.73 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.977 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.03 -165.0 0.26 Allowed 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.613 2.208 . . . . 0.0 112.207 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -116.33 121.03 40.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.945 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 16.4 mttp . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.884 179.979 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 502' ' ' GLY . . . . . 0.425 ' CA ' ' HB2' ' B' ' 511' ' ' SER . . . . . . . . 0 N--CA 1.49 2.272 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 503' ' ' SER . . . . . 0.403 ' N ' ' HB2' ' B' ' 511' ' ' SER . 18.5 m -77.77 -74.92 0.23 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.688 0.28 . . . . 0.0 110.908 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 504' ' ' GLY . . . . . 0.41 ' HA2' ' HA ' ' B' ' 509' ' ' ASP . . . 105.43 110.08 3.47 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.388 -0.911 . . . . 0.0 112.316 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 505' ' ' LEU . . . . . 0.837 ' HG ' HD13 ' A' ' 174' ' ' LEU . 1.4 pt? -179.93 44.89 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.755 0.312 . . . . 0.0 110.936 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 506' ' ' SER . . . . . . . . . . . . . 4.8 p 65.78 39.85 4.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.074 0.464 . . . . 0.0 110.48 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 507' ' ' ALA . . . . . 0.57 ' O ' HD13 ' B' ' 510' ' ' ILE . . . -144.25 37.56 1.26 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.657 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 508' ' ' GLN . . . . . 0.459 ' HB3' ' CD1' ' B' ' 510' ' ' ILE . 12.5 mt-30 70.04 4.29 4.75 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.09 -178.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 509' ' ' ASP . . . . . 0.41 ' HA ' ' HA2' ' B' ' 504' ' ' GLY . 52.1 t0 67.84 45.49 1.4 Allowed 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 121.012 0.434 . . . . 0.0 111.416 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 510' ' ' ILE . . . . . 0.975 HG23 HG23 ' A' ' 46' ' ' ILE . 1.7 mp -84.62 133.11 30.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.945 179.111 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 511' ' ' SER . . . . . 0.788 ' O ' HD13 ' A' ' 46' ' ' ILE . 40.9 t -109.28 152.78 24.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.805 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 512' ' ' GLN . . . . . 0.504 ' CB ' ' HD3' ' B' ' 513' ' ' PRO . 0.0 OUTLIER -101.3 -57.91 0.11 Allowed Pre-proline 0 CA--C 1.529 0.155 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.426 179.271 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 513' ' ' PRO . . . . . 0.504 ' HD3' ' CB ' ' B' ' 512' ' ' GLN . 49.0 Cg_endo -93.89 63.12 0.39 Allowed 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.096 2.531 . . . . 0.0 112.169 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 514' ' ' LEU . . . . . 0.442 ' CD2' ' O ' ' A' ' 45' ' ' MET . 1.3 mp -70.54 -87.49 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.599 -179.225 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 515' ' ' GLN . . . . . . . . . . . . . 18.8 mm100 -78.82 -86.73 0.07 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.635 0.255 . . . . 0.0 111.233 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 22.6 m-20 -118.08 -36.73 3.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.856 0.36 . . . . 0.0 110.835 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 517' ' ' SER . . . . . 0.413 ' HA ' ' HB ' ' A' ' 42' ' ' VAL . 7.3 m 60.73 27.68 17.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.816 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 518' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -163.58 113.09 1.28 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.401 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 519' ' ' ILE . . . . . 0.455 HG12 HG23 ' A' ' 43' ' ' THR . 0.5 OUTLIER -137.36 111.34 8.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.124 179.483 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 80.3 m-70 60.64 174.47 0.1 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.012 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 521' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.1 136.8 28.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.812 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 522' ' ' GLY . . . . . 0.494 ' HA3' ' CD1' ' A' ' 37' ' ' PHE . . . -52.81 -174.96 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.474 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 523' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -64.0 -86.57 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.701 0.286 . . . . 0.0 110.871 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 524' ' ' GLY . . . . . 0.467 ' HA2' HG11 ' A' ' 36' ' ' VAL . . . 45.96 46.12 14.44 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.72 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 525' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -89.43 46.95 1.42 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.787 0.327 . . . . 0.0 110.958 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 526' ' ' SER . . . . . 0.981 ' O ' HG11 ' A' ' 33' ' ' VAL . 0.5 OUTLIER -87.91 100.58 13.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.67 179.784 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 527' ' ' ASP . . . . . 0.466 ' CB ' ' HD2' ' B' ' 528' ' ' PRO . 0.4 OUTLIER -43.05 167.9 0.07 OUTLIER Pre-proline 0 N--CA 1.464 0.273 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.403 -179.848 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 528' ' ' PRO . . . . . 0.466 ' HD2' ' CB ' ' B' ' 527' ' ' ASP . 9.8 Cg_endo -48.91 102.37 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.925 2.416 . . . . 0.0 111.884 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 529' ' ' ARG . . . . . 0.422 ' CG ' ' O ' ' B' ' 527' ' ' ASP . 11.1 mtp85 -100.84 -55.04 2.67 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.602 -179.235 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 530' ' ' HIS . . . . . 0.433 ' HB2' ' HB2' ' B' ' 545' ' ' ASN . 3.2 m-70 -148.87 94.02 2.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.405 -179.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 1.8 m -54.24 -173.75 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.606 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 532' ' ' TRP . . . . . 0.508 ' CZ2' ' HG3' ' B' ' 537' ' ' ARG . 13.2 t-105 -107.99 163.17 13.37 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.945 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . 169.86 -30.98 0.15 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.473 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 534' ' ' PHE . . . . . 0.479 ' O ' ' CZ2' ' B' ' 532' ' ' TRP . 4.2 t80 -82.35 115.54 58.47 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.507 0.194 . . . . 0.0 110.745 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -45.25 151.74 0.83 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.48 2.12 . . . . 0.0 112.5 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 65.85 135.13 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.854 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 537' ' ' ARG . . . . . 0.579 ' CD ' ' HB2' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -99.34 176.25 5.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.107 0.479 . . . . 0.0 111.159 -179.962 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 538' ' ' ILE . . . . . 0.813 HD11 ' CB ' ' B' ' 542' ' ' TYR . 0.1 OUTLIER -118.71 139.37 46.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.556 179.649 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 539' ' ' ASP . . . . . 0.701 ' HB2' HD22 ' A' ' 70' ' ' LEU . 30.6 p30 -38.84 161.23 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.086 -178.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 540' ' ' GLU . . . . . 0.729 ' HA ' HD13 ' B' ' 543' ' ' LEU . 0.9 OUTLIER -64.99 -33.44 76.05 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.056 -179.907 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 541' ' ' LEU . . . . . 0.945 ' CB ' HD23 ' A' ' 70' ' ' LEU . 4.4 tt -47.59 -29.69 3.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.105 0.479 . . . . 0.0 110.551 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 542' ' ' TYR . . . . . 0.813 ' CB ' HD11 ' B' ' 538' ' ' ILE . 6.2 m-85 -105.44 -17.08 14.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.626 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 543' ' ' LEU . . . . . 0.958 HD21 HG21 ' A' ' 14' ' ' VAL . 1.9 mp -40.11 136.54 1.15 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.89 0.376 . . . . 0.0 111.291 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 544' ' ' GLY . . . . . 0.837 ' HA2' HD22 ' A' ' 61' ' ' LEU . . . 157.8 101.68 0.18 Allowed Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.595 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 545' ' ' ASN . . . . . 0.444 ' O ' HG22 ' A' ' 33' ' ' VAL . 16.3 p30 . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.265 -0.874 . . . . 0.0 111.008 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.706 ' HE1' ' HB ' ' A' ' 46' ' ' ILE . 7.8 tpt . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.828 0.347 . . . . 0.0 111.2 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.522 ' O ' HD11 ' A' ' 177' ' ' LEU . 4.6 pt20 -155.44 111.25 3.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.898 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.82 ' O ' HG23 ' A' ' 4' ' ' ILE . 1.3 t -96.37 178.42 5.37 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.536 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.82 HG23 ' O ' ' A' ' 3' ' ' THR . 0.3 OUTLIER -165.23 159.94 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.096 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 179.874 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.659 ' N ' HD23 ' A' ' 53' ' ' LEU . 2.3 mtpt -111.65 137.47 49.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.329 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 39.8 t -121.55 142.91 49.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.041 0.448 . . . . 0.0 111.503 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.74 HG13 ' O ' ' A' ' 56' ' ' PHE . 2.8 t -135.13 120.6 30.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.486 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.869 HG13 ' HG2' ' B' ' 540' ' ' GLU . 2.4 p -84.71 149.56 4.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.209 0.528 . . . . 0.0 111.051 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.3 m -143.43 130.2 17.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.902 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.67 -140.08 8.71 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.139 -1.029 . . . . 0.0 112.584 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -123.19 27.03 7.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.857 0.361 . . . . 0.0 110.647 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.427 ' CA ' ' HB2' ' B' ' 537' ' ' ARG . . . -120.13 171.42 14.54 Favored Glycine 0 C--N 1.331 0.25 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.651 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.412 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -93.84 -25.3 17.41 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.721 0.296 . . . . 0.0 111.403 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 1.084 HG23 HD21 ' A' ' 19' ' ' LEU . 4.1 p -41.52 94.6 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.355 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.432 ' O ' ' CD1' ' A' ' 19' ' ' LEU . . . -151.21 -103.16 0.25 Allowed Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.612 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.474 ' HG3' ' CG2' ' A' ' 17' ' ' THR . 0.2 OUTLIER -97.93 -43.8 6.94 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 -179.547 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.665 HG21 HG23 ' A' ' 35' ' ' THR . 2.6 p -94.93 -53.12 3.95 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 37.2 t -32.04 -69.62 0.08 Allowed 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -178.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 1.084 HD21 HG23 ' A' ' 14' ' ' VAL . 0.5 OUTLIER -58.68 -68.09 0.3 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.393 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.503 ' H ' HD22 ' A' ' 20' ' ' LEU . 2.9 mm? -61.05 -67.44 0.4 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -178.511 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.527 ' O ' HG22 ' A' ' 25' ' ' THR . 1.3 tp -37.08 -54.54 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -179.122 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.492 ' N ' ' CG2' ' A' ' 21' ' ' ILE . 0.4 OUTLIER -67.92 -30.21 69.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.791 0.329 . . . . 0.0 110.858 -179.557 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.423 ' N ' ' O ' ' A' ' 20' ' ' LEU . 27.3 t80 -53.79 -37.95 64.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.132 0.492 . . . . 0.0 109.987 179.163 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.49 -31.68 11.16 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.667 179.401 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.527 HG22 ' O ' ' A' ' 21' ' ' ILE . 3.3 t -136.82 79.79 1.78 Allowed 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.984 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.464 ' ND2' ' O ' ' A' ' 159' ' ' ALA . 9.1 m-20 -66.6 79.28 0.11 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.298 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.4 mmtm -100.29 101.04 11.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.746 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.57 ' CE1' ' CZ2' ' B' ' 532' ' ' TRP . 0.1 OUTLIER -99.28 -53.61 0.19 Allowed Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.648 -179.67 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.425 ' HD3' ' HB3' ' A' ' 28' ' ' PHE . 84.7 Cg_endo -88.54 69.95 2.69 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.76 2.307 . . . . 0.0 112.981 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -144.8 -92.68 0.1 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.667 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -159.62 158.64 31.96 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.745 0.307 . . . . 0.0 110.818 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.455 ' O ' HG22 ' A' ' 33' ' ' VAL . 53.1 m-85 -133.07 99.98 4.73 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.406 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.542 HG12 HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -162.49 -63.46 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.866 -179.398 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.477 ' CD ' ' HB ' ' A' ' 33' ' ' VAL . 2.9 Cg_exo -36.07 -29.73 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.381 2.721 . . . . 0.0 113.012 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.665 HG23 HG21 ' A' ' 17' ' ' THR . 21.2 m -63.85 71.1 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.754 0.312 . . . . 0.0 110.886 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.819 HG11 ' HA3' ' B' ' 524' ' ' GLY . 10.2 p -130.55 -3.82 2.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.471 ' CD1' ' HA3' ' B' ' 522' ' ' GLY . 0.7 OUTLIER -84.22 50.05 1.78 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.742 0.306 . . . . 0.0 111.242 -179.793 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.466 ' HA ' ' CD ' ' A' ' 16' ' ' LYS . 5.5 m-20 -58.97 -21.43 58.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.158 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -86.98 -6.21 58.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.629 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.466 ' CD1' ' O ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -60.77 157.18 15.41 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.848 0.356 . . . . 0.0 110.913 179.935 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.575 ' C ' HD12 ' B' ' 519' ' ' ILE . . . -108.07 175.72 5.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.35 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.422 ' HA ' HG13 ' B' ' 519' ' ' ILE . 12.8 m -140.57 121.71 14.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.167 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.422 ' C ' HG13 ' A' ' 44' ' ' VAL . 1.1 t -86.25 104.71 16.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.042 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.745 ' CG2' HG21 ' A' ' 52' ' ' THR . 24.9 m -158.19 -177.28 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.918 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.477 ' HE1' ' N ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -121.01 99.61 6.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.485 -179.523 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.925 ' CG1' HG23 ' A' ' 52' ' ' THR . 0.7 OUTLIER -75.93 86.02 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 178.723 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.44 ' N ' ' HE2' ' A' ' 45' ' ' MET . . . 27.91 96.26 0.01 OUTLIER Glycine 0 C--N 1.337 0.616 0 CA-C-N 115.667 -0.697 . . . . 0.0 114.275 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.468 ' N ' ' HE1' ' A' ' 45' ' ' MET . . . 137.64 -92.32 0.21 Allowed Glycine 0 CA--C 1.518 0.262 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.024 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.477 ' N ' ' HE1' ' A' ' 45' ' ' MET . 0.7 OUTLIER -137.44 138.49 24.89 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-O 120.757 0.313 . . . . 0.0 111.222 -179.828 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_exo -35.77 95.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.315 2.677 . . . . 0.0 113.079 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.532 ' CE1' ' CG2' ' A' ' 3' ' ' THR . 2.5 t80 -173.0 105.2 0.14 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.307 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.925 HG23 ' CG1' ' A' ' 46' ' ' ILE . 0.2 OUTLIER -124.06 153.64 41.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.473 -178.933 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.814 HD23 ' C ' ' A' ' 4' ' ' ILE . 6.7 tp -102.73 146.7 27.83 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.75 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.577 ' C ' HD22 ' A' ' 55' ' ' LEU . . . -78.89 -162.81 23.44 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.241 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.721 HD22 ' N ' ' A' ' 55' ' ' LEU . 1.2 mm? -121.88 114.17 20.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.813 0.34 . . . . 0.0 110.44 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.74 ' O ' HG13 ' A' ' 7' ' ' VAL . 0.9 OUTLIER -84.26 105.71 15.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.6 -179.756 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -138.65 -176.33 4.44 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.088 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.806 ' CB ' HD22 ' A' ' 67' ' ' LEU . 0.1 OUTLIER -125.63 143.33 51.07 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.943 -179.647 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.682 ' HB3' HG23 ' A' ' 36' ' ' VAL . . . -147.78 100.7 3.24 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.936 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.556 ' C ' HD22 ' A' ' 61' ' ' LEU . . . -75.66 80.9 1.01 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.63 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.646 HD23 ' HB1' ' A' ' 59' ' ' ALA . 3.1 mm? -121.3 -119.74 0.3 Allowed 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 110.577 -0.157 . . . . 0.0 110.577 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -98.53 -30.49 12.49 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-N 118.151 0.432 . . . . 0.0 111.075 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.34 -63.2 1.25 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.148 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.638 ' HB2' HD12 ' A' ' 67' ' ' LEU . 75.6 m-85 -87.67 146.34 25.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.037 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -86.5 -68.72 0.72 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.174 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.431 ' HD2' ' N ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -98.89 -50.33 4.24 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.924 -179.638 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.806 HD22 ' CB ' ' A' ' 58' ' ' THR . 0.6 OUTLIER 65.35 114.95 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.629 0.252 . . . . 0.0 110.846 -179.753 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.518 ' N ' ' HD3' ' A' ' 69' ' ' PRO . 0.5 OUTLIER -149.14 44.0 0.31 Allowed Pre-proline 0 C--N 1.329 -0.297 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 179.616 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.518 ' HD3' ' N ' ' A' ' 68' ' ' ARG . 90.6 Cg_endo -83.08 -42.98 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.344 2.029 . . . . 0.0 112.269 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.785 ' HG ' HD12 ' B' ' 541' ' ' LEU . 0.2 OUTLIER -63.08 -16.34 59.62 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.322 -179.842 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 93.9 p -46.37 -56.3 6.07 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.854 0.359 . . . . 0.0 111.274 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -156.89 65.28 3.65 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.944 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.474 ' HB2' ' CZ ' ' A' ' 78' ' ' PHE . 35.0 Cg_exo -59.59 154.62 47.26 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.542 2.161 . . . . 0.0 112.233 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 7.4 mm-40 -98.5 10.33 41.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.309 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.1 m -56.7 161.36 2.84 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.818 0.342 . . . . 0.0 110.924 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.76 7.27 30.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.487 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.779 HG11 ' HB2' ' A' ' 176' ' ' ALA . 7.5 p -156.95 91.7 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.334 -0.084 0 CA-C-O 120.859 0.361 . . . . 0.0 111.219 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.474 ' CZ ' ' HB2' ' A' ' 73' ' ' PRO . 3.1 m-85 -80.88 -177.04 6.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.622 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.51 HD21 ' CG2' ' A' ' 113' ' ' VAL . 1.1 tt -149.83 114.19 5.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.972 0.415 . . . . 0.0 111.5 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.1 t -98.6 156.4 3.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.285 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.745 ' HB3' HG11 ' A' ' 14' ' ' VAL . 1.8 p -152.04 153.08 33.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.086 0.47 . . . . 0.0 111.751 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.514 ' CE1' ' CE1' ' A' ' 90' ' ' PHE . 9.1 p90 -166.32 134.24 2.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.261 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.43 ' CB ' ' HG3' ' A' ' 116' ' ' GLN . 0.3 OUTLIER -85.34 141.72 29.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.942 -179.802 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.784 HG13 ' N ' ' A' ' 137' ' ' ILE . 57.8 t -44.47 -55.14 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.359 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.655 HG11 HG21 ' A' ' 125' ' ' THR . 34.9 m -47.81 115.71 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.732 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.801 ' N ' HD22 ' A' ' 129' ' ' LEU . 5.1 p -150.94 129.78 6.26 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.584 -179.213 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.425 ' O ' ' CB ' ' A' ' 132' ' ' ASN . 87.4 Cg_endo -90.83 50.37 0.85 Allowed 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.043 2.495 . . . . 0.0 111.963 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.469 ' N ' ' HB3' ' A' ' 133' ' ' LYS . 0.3 OUTLIER 76.35 14.37 2.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.522 -179.785 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.491 ' O ' HG12 ' A' ' 93' ' ' VAL . 8.4 t -97.39 -27.06 14.64 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.994 0.426 . . . . 0.0 110.583 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.514 ' CE1' ' CE1' ' A' ' 82' ' ' PHE . 59.3 t80 -51.14 -33.35 26.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.034 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.2 -48.51 28.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.191 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -69.1 -44.81 71.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.183 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.733 HG22 ' CE3' ' A' ' 97' ' ' TRP . 11.6 p -58.84 -45.31 91.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.366 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.602 ' HG3' HD13 ' A' ' 145' ' ' LEU . 9.2 mmtt -59.62 -57.32 13.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.792 0.33 . . . . 0.0 110.997 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.423 ' O ' ' CG ' ' A' ' 99' ' ' PRO . 70.0 mm-40 -62.22 -18.5 61.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.259 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.8 tmtt? -101.49 -12.42 18.55 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.489 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.733 ' CE3' HG22 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -84.27 -56.7 3.51 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.787 0.327 . . . . 0.0 111.124 -179.823 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.562 HG11 ' HG ' ' A' ' 149' ' ' LEU . 5.1 t -49.48 -46.6 78.41 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.643 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.482 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 82.1 Cg_exo -44.63 -41.23 14.47 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.458 2.105 . . . . 0.0 112.85 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.434 ' HG3' ' N ' ' A' ' 101' ' ' ILE . 2.1 pt-20 -79.51 -31.72 42.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.058 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.434 ' N ' ' HG3' ' A' ' 100' ' ' GLU . 23.0 mt -53.74 -41.71 48.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.018 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 23.1 p -93.81 -21.05 19.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.981 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.414 ' HB3' ' HA ' ' A' ' 100' ' ' GLU . 83.9 t60 -60.24 -31.46 70.22 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.936 0.398 . . . . 0.0 110.69 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 -88.64 -25.77 22.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.886 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -144.58 136.19 12.81 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.792 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -59.48 -15.28 29.52 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.598 2.199 . . . . 0.0 112.607 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -169.6 84.05 0.13 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.825 0.345 . . . . 0.0 110.906 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -108.79 101.82 45.52 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.813 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -60.4 155.17 48.31 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.493 2.128 . . . . 0.0 112.122 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.862 ' O ' HG23 ' A' ' 152' ' ' VAL . 32.1 p90 -155.99 169.4 24.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.188 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.89 HD12 ' HB ' ' A' ' 152' ' ' VAL . 0.7 OUTLIER -132.85 150.18 52.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.863 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.795 HD23 ' CB ' ' A' ' 151' ' ' ALA . 0.3 OUTLIER -98.93 161.57 13.56 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.113 -179.745 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.777 ' HA ' HG21 ' A' ' 168' ' ' VAL . 2.5 t -136.81 144.04 33.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.036 0.446 . . . . 0.0 111.805 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.5 ' HA3' ' CZ ' ' A' ' 154' ' ' TYR . . . -133.15 103.83 0.52 Allowed Glycine 0 C--N 1.33 0.233 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.697 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.491 ' HB ' ' HA ' ' A' ' 158' ' ' SER . 0.4 OUTLIER -125.01 -1.41 7.79 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -178.647 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.948 ' NE2' HD21 ' A' ' 119' ' ' LEU . 2.2 mm-40 -99.2 -8.39 25.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.974 0.416 . . . . 0.0 110.011 178.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.498 ' H ' HD13 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -49.25 -24.02 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.563 178.799 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -86.13 -20.51 28.54 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.562 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.948 HD21 ' NE2' ' A' ' 116' ' ' GLN . 4.2 pp -110.89 -12.84 14.21 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.498 ' HB2' HG11 ' A' ' 84' ' ' VAL . 9.1 ptt85 -50.88 -25.33 4.43 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.911 0.386 . . . . 0.0 110.72 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -72.24 -24.86 61.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.912 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.402 ' O ' ' HB ' ' A' ' 126' ' ' ILE . 4.9 m-20 -47.0 101.27 0.26 Allowed Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.838 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.418 ' O ' ' CG ' ' A' ' 127' ' ' GLU . 17.1 Cg_exo -67.4 -6.07 15.53 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.77 2.314 . . . . 0.0 113.021 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.7 t -84.67 -67.06 0.83 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.026 0.441 . . . . 0.0 110.001 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.655 HG21 HG11 ' A' ' 85' ' ' VAL . 4.9 m -52.47 -33.84 46.42 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.381 0.61 . . . . 0.0 109.358 178.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.78 HD11 ' HG3' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -60.03 -40.83 84.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.455 179.017 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.418 ' CG ' ' O ' ' A' ' 123' ' ' PRO . 3.7 mm-40 -56.13 -35.85 67.58 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.262 178.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.403 ' HB2' ' O ' ' A' ' 125' ' ' THR . 1.9 mptp? -66.86 -32.71 74.16 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.801 HD22 ' N ' ' A' ' 86' ' ' SER . 7.3 mt -73.36 -41.55 63.28 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 177.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.49 ' HA ' ' HB3' ' A' ' 134' ' ' GLN . . . -48.88 -26.01 2.22 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.202 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 16.2 mmtp -65.6 -33.91 77.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.773 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.425 ' CB ' ' O ' ' A' ' 87' ' ' PRO . 39.1 m-80 -123.8 -30.6 3.54 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -179.021 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.492 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 0.0 OUTLIER -133.62 -72.53 0.5 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 120.991 -0.284 . . . . 0.0 111.424 -178.85 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.492 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 2.7 pt20 99.58 -37.4 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.959 0.903 . . . . 0.0 110.658 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.443 ' HA ' ' HD3' ' A' ' 136' ' ' PRO . 0.6 OUTLIER -69.18 107.48 2.17 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.897 -179.065 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.78 ' HG3' HD11 ' A' ' 126' ' ' ILE . 3.0 Cg_exo -80.65 134.96 10.06 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.823 2.349 . . . . 0.0 111.221 179.134 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.784 ' N ' HG13 ' A' ' 84' ' ' VAL . 0.8 OUTLIER -67.13 96.48 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.882 0.372 . . . . 0.0 110.817 -179.608 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 6.2 p -67.74 159.23 79.96 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.079 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -50.62 -28.99 23.76 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.636 2.224 . . . . 0.0 112.274 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -82.65 -26.72 31.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.701 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.497 ' HB ' HG22 ' A' ' 137' ' ' ILE . 8.7 m -66.66 -51.16 59.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.782 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.55 ' HB1' ' CD2' ' A' ' 154' ' ' TYR . . . -55.49 -37.98 68.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.924 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -66.54 -45.39 79.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.908 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp -54.22 -64.07 0.95 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.993 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.602 HD13 ' HG3' ' A' ' 94' ' ' LYS . 5.3 tt -60.6 -42.75 97.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.9 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.734 ' HB1' ' HB3' ' A' ' 151' ' ' ALA . . . -48.99 -61.99 1.77 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.05 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.2 mtp85 -63.51 -23.14 67.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.861 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.575 ' HB3' HD22 ' A' ' 149' ' ' LEU . 6.2 t0 -50.16 -50.95 47.42 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.827 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.575 HD22 ' HB3' ' A' ' 148' ' ' ASP . 2.0 mm? -93.65 -72.14 0.62 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.673 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 170.26 60.44 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.516 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.795 ' CB ' HD23 ' A' ' 112' ' ' LEU . . . -94.81 27.46 3.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.535 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.89 ' HB ' HD12 ' A' ' 111' ' ' LEU . 75.8 t 61.11 -74.75 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.454 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.469 ' N ' ' O ' ' A' ' 151' ' ' ALA . 1.6 ttpt -176.41 121.74 0.16 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.829 -179.082 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.55 ' CD2' ' HB1' ' A' ' 142' ' ' ALA . 13.2 t80 -84.97 112.38 20.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.688 179.224 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.409 ' CG2' ' HA ' ' A' ' 168' ' ' VAL . 3.2 t -101.28 156.11 4.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.181 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -94.19 127.58 40.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.584 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.479 ' SG ' HG12 ' A' ' 168' ' ' VAL . 1.1 p 178.62 125.12 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.305 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.491 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 37.1 m -104.53 155.76 18.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.959 0.409 . . . . 0.0 111.657 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.6 ' HB2' HD11 ' A' ' 165' ' ' LEU . . . -92.2 -52.65 4.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.592 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -48.3 -29.78 4.2 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.738 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.9 -21.97 10.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.914 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 69.19 62.46 0.3 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.804 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.443 ' HB3' ' HA ' ' A' ' 157' ' ' CYS . 0.1 OUTLIER -93.41 35.99 1.08 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.255 -179.75 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 95.21 46.56 2.79 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.21 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.858 ' CD2' HD23 ' A' ' 19' ' ' LEU . 0.4 OUTLIER -53.49 -29.88 38.31 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.988 0.423 . . . . 0.0 110.588 179.688 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 28.8 pttt -68.52 -24.54 64.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.763 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 30.7 t30 -58.25 -68.95 0.2 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.565 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.777 HG21 ' HA ' ' A' ' 113' ' ' VAL . 14.4 p -54.28 -45.81 68.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.565 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.674 ' CZ ' HD13 ' A' ' 19' ' ' LEU . 1.2 t80 -60.38 -41.02 92.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.501 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -54.91 -34.96 63.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.875 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -75.89 -26.47 57.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.174 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.688 ' HB2' HD22 ' A' ' 111' ' ' LEU . . . -63.85 -42.96 97.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.213 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.91 HD13 ' N ' ' A' ' 174' ' ' LEU . 0.0 OUTLIER -89.94 -23.45 6.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.633 -179.866 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.91 ' N ' HD13 ' A' ' 173' ' ' ILE . 2.8 tp -49.05 -43.83 41.19 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.989 0.423 . . . . 0.0 110.41 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -62.14 -27.36 68.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.995 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.779 ' HB2' HG11 ' A' ' 77' ' ' VAL . . . -87.71 -39.41 14.99 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.636 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.747 HD12 HG13 ' A' ' 4' ' ' ILE . 0.6 OUTLIER -68.61 -26.39 65.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.518 179.628 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.439 ' CB ' ' HD2' ' A' ' 179' ' ' PRO . 0.5 OUTLIER -166.82 167.72 7.64 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.651 179.861 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 179' ' ' PRO . . . . . 0.439 ' HD2' ' CB ' ' A' ' 178' ' ' GLU . 18.9 Cg_endo -60.27 118.77 5.69 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.541 2.161 . . . . 0.0 112.229 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.87 153.96 63.59 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.527 2.151 . . . . 0.0 112.423 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -149.63 119.92 3.96 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.822 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.01 -164.89 0.25 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.429 2.086 . . . . 0.0 112.219 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 11.9 mmtt -105.0 83.41 1.98 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.958 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.16 -0.924 . . . . 0.0 110.819 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.221 0 N-CA-C 112.525 -0.23 . . . . 0.0 112.525 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 503' ' ' SER . . . . . 0.401 ' OG ' ' HA ' ' B' ' 511' ' ' SER . 0.0 OUTLIER -111.74 -49.32 3.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.751 0.31 . . . . 0.0 111.011 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 504' ' ' GLY . . . . . 0.738 ' C ' HD22 ' B' ' 505' ' ' LEU . . . 124.78 -93.52 0.45 Allowed Glycine 0 CA--C 1.508 -0.405 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.862 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 505' ' ' LEU . . . . . 0.816 ' HB3' HD13 ' A' ' 174' ' ' LEU . 0.1 OUTLIER 74.17 0.28 3.56 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 179.45 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 506' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 52.93 23.79 3.04 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.022 0.439 . . . . 0.0 111.047 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 507' ' ' ALA . . . . . . . . . . . . . . . -107.86 -74.25 0.66 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.774 0.797 . . . . 0.0 109.506 179.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 508' ' ' GLN . . . . . 0.422 ' O ' ' HB3' ' B' ' 509' ' ' ASP . 0.0 OUTLIER -137.82 4.95 2.58 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.28 -1.327 . . . . 0.0 110.213 179.061 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 509' ' ' ASP . . . . . 0.422 ' HB3' ' O ' ' B' ' 508' ' ' GLN . 48.6 t0 72.47 38.85 0.78 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.587 0.708 . . . . 0.0 109.765 -178.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 510' ' ' ILE . . . . . 0.746 HG21 HD21 ' A' ' 177' ' ' LEU . 1.3 mt -66.34 143.72 15.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.847 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 511' ' ' SER . . . . . 0.452 ' O ' HD11 ' B' ' 514' ' ' LEU . 47.2 t -109.44 148.0 31.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.498 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 512' ' ' GLN . . . . . 0.498 ' OE1' HG21 ' A' ' 173' ' ' ILE . 0.0 OUTLIER -98.62 -67.7 0.05 OUTLIER Pre-proline 0 CA--C 1.53 0.176 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.752 179.547 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 513' ' ' PRO . . . . . 0.497 ' HD3' ' CB ' ' B' ' 512' ' ' GLN . 88.1 Cg_endo -79.16 56.95 6.24 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.456 2.104 . . . . 0.0 111.917 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 514' ' ' LEU . . . . . 0.452 HD11 ' O ' ' B' ' 511' ' ' SER . 0.9 OUTLIER -64.1 -87.01 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.39 -179.568 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 515' ' ' GLN . . . . . 0.404 ' HB2' HG12 ' A' ' 44' ' ' VAL . 4.4 mt-30 -93.07 -158.71 0.63 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.74 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 15.1 m-80 -50.37 -29.0 9.03 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.934 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 517' ' ' SER . . . . . 0.458 ' O ' ' CD1' ' B' ' 518' ' ' PHE . 0.9 OUTLIER 39.85 53.92 2.59 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.821 179.927 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 518' ' ' PHE . . . . . 0.489 ' CE2' HD12 ' A' ' 21' ' ' ILE . 6.1 m-85 -163.29 119.46 1.77 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.915 0.388 . . . . 0.0 111.438 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 519' ' ' ILE . . . . . 0.575 HD12 ' C ' ' A' ' 41' ' ' ALA . 8.9 mt -126.83 82.49 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.058 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 41.8 p-80 -54.21 101.24 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.767 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 521' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.82 31.79 1.81 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.097 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 522' ' ' GLY . . . . . 0.471 ' HA3' ' CD1' ' A' ' 37' ' ' PHE . . . -111.12 -177.83 20.42 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.409 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 523' ' ' HIS . . . . . . . . . . . . . 28.6 t-80 -117.9 -85.64 0.64 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.744 0.306 . . . . 0.0 110.956 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 524' ' ' GLY . . . . . 0.819 ' HA3' HG11 ' A' ' 36' ' ' VAL . . . 52.71 -144.4 21.87 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.604 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 525' ' ' ASP . . . . . . . . . . . . . 19.8 p30 -149.82 85.3 1.42 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.833 0.349 . . . . 0.0 110.933 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 526' ' ' SER . . . . . 0.405 ' CB ' ' HB3' ' A' ' 34' ' ' PRO . 2.4 m -74.92 95.64 3.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.662 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 527' ' ' ASP . . . . . . . . . . . . . 43.1 p-10 -153.97 150.58 22.99 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.919 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.36 100.98 0.94 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.72 2.28 . . . . 0.0 112.348 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 529' ' ' ARG . . . . . 0.509 ' HG3' HG21 ' A' ' 33' ' ' VAL . 39.7 mtp180 -100.41 -55.24 2.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.296 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 530' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -168.51 95.79 0.38 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.107 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 531' ' ' CYS . . . . . 0.412 ' O ' ' N ' ' B' ' 533' ' ' GLY . 18.3 t -49.79 130.64 21.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.014 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 532' ' ' TRP . . . . . 0.57 ' CZ2' ' CE1' ' A' ' 28' ' ' PHE . 0.0 OUTLIER 60.42 -81.84 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.933 179.893 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 533' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' B' ' 531' ' ' CYS . . . 92.3 -35.38 4.05 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.613 -0.804 . . . . 0.0 112.592 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 534' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -155.17 156.94 31.65 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.634 0.254 . . . . 0.0 110.846 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -53.21 -59.1 1.12 Allowed 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.749 2.299 . . . . 0.0 112.088 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -86.87 141.41 28.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.636 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 537' ' ' ARG . . . . . 0.427 ' HB2' ' CA ' ' A' ' 12' ' ' GLY . 25.4 mmt-85 -65.89 136.24 55.86 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.133 0.492 . . . . 0.0 111.214 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 538' ' ' ILE . . . . . 0.443 HG13 ' HB2' ' B' ' 542' ' ' TYR . 6.3 tp -59.57 143.22 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.208 179.335 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 539' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -44.13 143.41 1.18 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.874 0.369 . . . . 0.0 111.035 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 540' ' ' GLU . . . . . 0.869 ' HG2' HG13 ' A' ' 8' ' ' VAL . 0.3 OUTLIER -50.4 -24.39 3.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.014 -179.719 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 541' ' ' LEU . . . . . 0.785 HD12 ' HG ' ' A' ' 70' ' ' LEU . 0.1 OUTLIER -55.3 -27.04 44.21 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 121.4 0.619 . . . . 0.0 109.77 179.07 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 542' ' ' TYR . . . . . 0.443 ' HB2' HG13 ' B' ' 538' ' ' ILE . 14.2 m-85 -104.23 -63.05 1.24 Allowed 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.903 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 543' ' ' LEU . . . . . 0.403 ' HB2' ' O ' ' A' ' 58' ' ' THR . 0.3 OUTLIER 49.73 103.86 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.318 179.648 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . 118.28 -100.99 0.87 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.529 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 545' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.919 -179.884 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.426 ' HG3' ' N ' ' A' ' 2' ' ' GLN . 3.0 ptm . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.796 0.332 . . . . 0.0 111.21 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.426 ' N ' ' HG3' ' A' ' 1' ' ' MET . 0.0 OUTLIER 57.65 161.88 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.706 -179.891 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.732 HG23 ' CE1' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -129.93 -177.41 4.28 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.333 -179.786 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.515 HD11 ' CD1' ' A' ' 53' ' ' LEU . 6.0 pt -153.89 148.22 13.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.758 -179.474 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.1 mttt -134.0 95.7 3.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.095 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -112.31 155.29 24.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.406 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.422 HG23 HG21 ' A' ' 75' ' ' THR . 0.2 OUTLIER -137.2 159.58 36.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.309 179.667 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.824 HG12 ' CG ' ' B' ' 540' ' ' GLU . 60.1 t -90.0 113.68 26.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.997 0.427 . . . . 0.0 111.299 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.463 ' CA ' ' HG2' ' B' ' 540' ' ' GLU . 93.5 t -130.65 129.48 64.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.673 179.133 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 138.73 -113.19 0.92 Allowed Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.014 -1.089 . . . . 0.0 113.013 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.403 ' O ' ' HB2' ' B' ' 537' ' ' ARG . 6.9 m-20 -110.61 -53.65 2.67 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.975 ' O ' HG13 ' A' ' 14' ' ' VAL . . . -140.06 -148.48 5.18 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.176 -1.011 . . . . 0.0 113.494 -179.317 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.624 ' O ' HG22 ' A' ' 14' ' ' VAL . . . -41.4 -31.97 0.28 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.975 HG13 ' O ' ' A' ' 12' ' ' GLY . 6.3 m 48.08 25.52 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.966 0.412 . . . . 0.0 110.721 -178.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.936 ' CA ' HD22 ' A' ' 19' ' ' LEU . . . 83.36 26.53 43.16 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.951 -0.643 . . . . 0.0 112.723 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.68 ' CB ' HG22 ' A' ' 8' ' ' VAL . 5.6 tptm -98.19 -72.91 0.63 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.776 0.322 . . . . 0.0 111.699 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.1 p -96.06 -58.32 2.12 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.456 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.501 ' HB2' ' HB2' ' A' ' 13' ' ' ALA . 12.0 t -42.34 -46.62 4.67 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.693 0.282 . . . . 0.0 111.64 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.936 HD22 ' CA ' ' A' ' 15' ' ' GLY . 0.7 OUTLIER -47.15 -49.74 21.79 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.886 0.374 . . . . 0.0 110.724 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.568 HD21 ' CE2' ' A' ' 169' ' ' PHE . 3.7 mt -64.75 -24.18 67.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.399 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.727 HG22 ' OG1' ' A' ' 25' ' ' THR . 14.2 mm -73.99 -70.52 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.19 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 59.8 p -48.26 -27.53 2.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.742 0.306 . . . . 0.0 111.048 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -70.44 -67.36 0.5 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.742 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 89.6 m -72.23 -48.58 41.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.647 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.727 ' OG1' HG22 ' A' ' 21' ' ' ILE . 20.6 p -85.58 -151.12 0.14 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.382 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -160.28 29.39 0.17 Allowed 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.859 0.361 . . . . 0.0 111.077 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.58 104.83 9.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.281 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.486 ' CD2' ' HD3' ' A' ' 29' ' ' PRO . 0.1 OUTLIER -110.34 -61.71 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.106 -179.977 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.486 ' HD3' ' CD2' ' A' ' 28' ' ' PHE . 91.5 Cg_endo -86.61 89.35 0.67 Allowed 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.369 2.046 . . . . 0.0 113.052 -179.091 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.3 p -163.94 -94.74 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.395 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.51 ' CG ' ' HA ' ' B' ' 530' ' ' HIS . 0.2 OUTLIER -160.25 121.87 3.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.716 0.293 . . . . 0.0 110.818 179.684 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -101.96 94.23 5.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.934 0.397 . . . . 0.0 110.809 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.812 HG13 ' ND2' ' B' ' 545' ' ' ASN . 0.6 OUTLIER -98.73 -51.97 0.2 Allowed Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.367 -179.757 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.419 ' HD3' ' HB ' ' A' ' 33' ' ' VAL . 7.0 Cg_exo -73.9 55.94 3.47 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.812 2.341 . . . . 0.0 112.44 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.7 t -116.77 -33.68 4.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.665 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.861 ' HB ' HD13 ' A' ' 61' ' ' LEU . 7.6 p -52.6 -27.1 11.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.802 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -93.97 40.08 1.08 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.535 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.419 ' HB2' ' HB3' ' A' ' 57' ' ' ASP . 0.4 OUTLIER -93.61 36.17 1.1 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.978 -179.946 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -123.77 18.15 9.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.142 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.411 ' CD2' ' HB ' ' B' ' 521' ' ' THR . 0.2 OUTLIER -75.74 -165.39 0.44 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.789 0.328 . . . . 0.0 110.71 179.973 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.41 ' O ' HG12 ' B' ' 519' ' ' ILE . . . -96.18 161.76 13.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.164 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.503 HG23 ' OG1' ' A' ' 52' ' ' THR . 7.6 m -149.47 129.44 3.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.147 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.612 ' O ' HG23 ' A' ' 44' ' ' VAL . 5.0 t -87.9 106.13 17.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.632 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.643 HG13 ' HB2' ' B' ' 514' ' ' LEU . 1.8 t -161.1 157.86 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.726 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.48 ' HE1' ' N ' ' A' ' 48' ' ' GLY . 0.0 OUTLIER -101.74 97.61 7.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.711 -179.481 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.699 HG23 ' CG2' ' B' ' 510' ' ' ILE . 3.0 mm -77.0 86.38 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.386 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.44 ' N ' ' HE2' ' A' ' 45' ' ' MET . . . 25.63 98.63 0.01 OUTLIER Glycine 0 C--N 1.339 0.73 0 CA-C-N 115.505 -0.77 . . . . 0.0 114.435 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.48 ' N ' ' HE1' ' A' ' 45' ' ' MET . . . 128.46 -89.89 0.32 Allowed Glycine 0 CA--C 1.519 0.281 0 C-N-CA 120.596 -0.811 . . . . 0.0 113.007 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.449 ' N ' ' HE1' ' A' ' 45' ' ' MET . 1.4 pt-20 -124.73 139.85 34.26 Favored Pre-proline 0 CA--C 1.53 0.202 0 CA-C-O 120.799 0.333 . . . . 0.0 111.233 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.425 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 78.9 Cg_exo -38.12 101.26 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 123.074 2.516 . . . . 0.0 112.822 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.732 ' CE1' HG23 ' A' ' 3' ' ' THR . 2.2 t80 -172.98 154.69 2.89 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.436 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.509 HG21 ' HB ' ' A' ' 44' ' ' VAL . 0.1 OUTLIER -136.72 152.99 50.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.746 179.046 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.646 ' H ' HD13 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -74.94 161.53 29.42 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.002 -179.899 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -88.8 87.51 1.49 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.626 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.553 ' H ' HD12 ' A' ' 55' ' ' LEU . 1.1 mp -58.37 99.9 0.05 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.844 0.354 . . . . 0.0 110.664 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -84.76 105.76 15.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.997 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.419 ' HB3' ' HB2' ' A' ' 38' ' ' ASP . 30.1 t0 -104.14 129.16 51.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.84 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.884 ' O ' HD22 ' B' ' 543' ' ' LEU . 26.4 p -98.21 126.14 43.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.979 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.824 ' HB1' ' CD1' ' A' ' 61' ' ' LEU . . . -157.63 118.43 3.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.317 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.403 ' HA2' ' O ' ' A' ' 64' ' ' TYR . . . -69.36 73.85 0.42 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.286 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.861 HD13 ' HB ' ' A' ' 36' ' ' VAL . 6.7 mp -120.7 -117.26 0.31 Allowed 'General case' 0 CA--C 1.539 0.536 0 O-C-N 122.944 -0.151 . . . . 0.0 111.052 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -99.08 -31.3 11.85 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 118.069 0.395 . . . . 0.0 111.426 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.435 ' CB ' HG22 ' A' ' 36' ' ' VAL . 6.2 t0 -74.33 -63.26 1.27 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.311 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.545 ' CD2' HD21 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -115.95 133.69 55.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.718 -179.759 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.95 -69.12 0.7 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.838 0.352 . . . . 0.0 111.146 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.4 ' O ' ' HB2' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -99.44 -34.99 10.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.33 -179.885 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.597 HD13 ' HB ' ' A' ' 58' ' ' THR . 1.0 OUTLIER 70.15 123.88 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.978 -179.652 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.458 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 2.5 mpt_? -82.91 -49.26 0.77 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.147 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.458 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 83.0 Cg_exo -44.83 -58.37 1.59 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.588 2.192 . . . . 0.0 112.538 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.56 ' C ' HD12 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -51.08 -38.31 50.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.69 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.1 t -76.74 -53.78 7.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.906 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -114.32 61.57 1.12 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.638 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.428 ' N ' ' O ' ' A' ' 69' ' ' PRO . 52.1 Cg_endo -68.65 112.44 2.87 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.575 2.184 . . . . 0.0 112.466 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 15.2 tp60 -101.96 10.16 39.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.375 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.422 HG21 HG23 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -56.34 166.64 0.81 Allowed 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 120.802 0.334 . . . . 0.0 110.809 179.979 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -72.74 -26.02 61.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.707 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.632 HG11 ' HB3' ' A' ' 175' ' ' ALA . 10.3 p -164.4 116.31 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.132 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.683 ' CZ ' HG21 ' A' ' 108' ' ' THR . 0.0 OUTLIER -92.89 134.51 35.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.166 179.349 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.619 HD13 ' HB1' ' A' ' 172' ' ' ALA . 7.5 tp -70.6 108.01 4.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.095 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.516 ' O ' HG23 ' A' ' 80' ' ' VAL . 23.3 m -103.54 121.09 54.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.013 179.237 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.564 ' HB2' HG12 ' A' ' 14' ' ' VAL . 41.1 m -129.13 171.42 12.42 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.359 0.599 . . . . 0.0 112.493 -178.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.555 ' CZ ' ' HB2' ' A' ' 142' ' ' ALA . 41.3 p90 -140.86 -174.04 3.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.88 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.3 p -134.66 122.74 22.68 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.808 0.337 . . . . 0.0 111.071 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.66 HG11 ' HB3' ' A' ' 120' ' ' ARG . 2.9 t -57.15 170.52 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.184 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.756 HG22 ' HA ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER 61.09 105.57 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -179.287 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.531 ' N ' HD21 ' A' ' 129' ' ' LEU . 13.9 p -152.5 143.16 15.5 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-O 120.956 0.408 . . . . 0.0 112.039 -179.14 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.433 ' O ' ' CB ' ' A' ' 88' ' ' SER . 83.1 Cg_endo -90.84 53.36 1.01 Allowed 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.29 2.66 . . . . 0.0 111.585 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.46 ' CB ' ' HG2' ' A' ' 133' ' ' LYS . 0.3 OUTLIER 84.29 25.62 0.1 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.663 -179.533 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.964 ' O ' HG23 ' A' ' 93' ' ' VAL . 2.8 p -97.23 -25.1 15.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.992 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -53.86 -43.79 69.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.016 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -53.96 -61.71 2.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.929 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.419 ' O ' ' N ' ' A' ' 96' ' ' LYS . 30.0 m-80 -53.88 -42.31 68.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.941 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.964 HG23 ' O ' ' A' ' 89' ' ' SER . 60.1 t -47.47 -63.74 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.303 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.7 ' CG ' HD11 ' A' ' 145' ' ' LEU . 0.0 OUTLIER -51.04 -45.75 61.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.869 179.91 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.412 ' O ' ' HG3' ' A' ' 99' ' ' PRO . 0.8 OUTLIER -85.31 10.79 11.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.723 -179.952 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.2 OUTLIER -111.04 -36.18 5.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.934 0.397 . . . . 0.0 110.976 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.401 ' O ' HG23 ' A' ' 101' ' ' ILE . 33.4 m95 -94.36 -42.95 8.63 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.543 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 94' ' ' LYS . 82.3 t -53.26 -47.3 96.53 Favored Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 77.9 Cg_endo -78.95 -18.52 11.44 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.237 1.958 . . . . 0.0 112.629 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -81.61 -40.18 23.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.923 0.392 . . . . 0.0 110.492 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.498 ' CD1' ' CD2' ' A' ' 110' ' ' PHE . 32.8 pt -69.49 -29.79 43.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.904 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.543 HG23 ' O ' ' A' ' 98' ' ' VAL . 70.5 p -78.2 -32.91 50.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.697 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 -63.21 -54.76 32.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.652 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 16.2 m80 -71.65 -24.28 61.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.79 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 1.6 t -143.85 95.96 5.64 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.866 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -47.63 112.07 0.5 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.654 2.236 . . . . 0.0 112.509 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.8 mttt 49.8 99.26 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.157 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.683 HG21 ' CZ ' ' A' ' 78' ' ' PHE . 8.7 m -139.24 144.34 40.04 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.03 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.427 ' C ' HG23 ' A' ' 77' ' ' VAL . 34.2 Cg_exo -60.67 159.29 28.93 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.762 2.308 . . . . 0.0 112.829 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.498 ' CD2' ' CD1' ' A' ' 101' ' ' ILE . 2.4 p90 -165.37 148.24 7.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.556 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 1.006 HD22 ' HB2' ' A' ' 172' ' ' ALA . 1.1 tt -120.05 154.79 34.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.168 -179.343 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.913 HD12 ' HB2' ' A' ' 146' ' ' ALA . 13.1 mt -111.73 146.43 37.57 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.799 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.831 ' CG1' HG21 ' A' ' 168' ' ' VAL . 21.9 t -130.87 149.69 33.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.15 0.5 . . . . 0.0 111.884 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.517 ' C ' HD12 ' A' ' 117' ' ' ILE . . . -124.97 112.43 1.73 Allowed Glycine 0 N--CA 1.452 -0.247 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.407 179.064 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.716 ' C ' HD13 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -127.84 -54.82 1.31 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.839 0.352 . . . . 0.0 111.329 -179.009 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.474 ' HG2' HD21 ' A' ' 119' ' ' LEU . 2.0 tt0 -58.56 -17.65 23.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.26 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.871 HD11 ' O ' ' A' ' 157' ' ' CYS . 0.2 OUTLIER -44.81 -27.31 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 120.841 0.353 . . . . 0.0 111.592 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.413 ' N ' HG12 ' A' ' 117' ' ' ILE . 21.4 t0 -66.76 -35.37 79.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.688 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.633 ' C ' HD12 ' A' ' 119' ' ' LEU . 3.8 pp -99.49 -3.89 32.54 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.466 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.756 ' HA ' HG22 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -52.37 -35.67 51.87 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.977 0.418 . . . . 0.0 110.481 179.583 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -62.48 -24.17 67.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.759 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.412 ' O ' ' HB ' ' A' ' 126' ' ' ILE . 8.9 t0 -42.36 100.6 0.23 Allowed Pre-proline 0 N--CA 1.463 0.208 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.025 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.44 ' O ' ' CG ' ' A' ' 127' ' ' GLU . 37.7 Cg_endo -66.67 -8.99 22.83 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.434 2.089 . . . . 0.0 112.897 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.7 t -74.14 -67.52 0.61 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.08 0.467 . . . . 0.0 110.008 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.894 HG22 ' CD1' ' A' ' 129' ' ' LEU . 73.6 m -56.36 -47.15 79.44 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.523 HD11 ' HB3' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -46.91 -40.46 4.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.959 179.413 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.646 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 4.8 mm-40 -60.07 -39.11 84.93 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.438 ' N ' ' O ' ' A' ' 125' ' ' THR . 0.0 OUTLIER -68.67 -34.02 74.97 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.155 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.894 ' CD1' HG22 ' A' ' 125' ' ' THR . 9.8 mp -64.84 -37.75 88.66 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 177.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.646 ' HB3' ' O ' ' A' ' 127' ' ' GLU . . . -43.58 -39.16 3.34 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 114.453 -1.249 . . . . 0.0 111.567 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 6.3 mmtm -58.65 -24.8 61.91 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.579 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.426 ' CB ' ' O ' ' A' ' 87' ' ' PRO . 11.1 m-80 -124.38 -31.52 3.27 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -179.124 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.46 ' HG2' ' CB ' ' A' ' 88' ' ' SER . 2.2 mmtt -156.41 -63.38 0.1 Allowed 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -178.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.578 ' CD ' ' HB2' ' A' ' 130' ' ' ALA . 2.0 tt0 80.9 14.18 0.69 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.208 -178.511 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.402 ' HA ' ' HD2' ' A' ' 136' ' ' PRO . 35.2 mmtt -97.87 96.54 3.45 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.634 0.254 . . . . 0.0 111.175 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.523 ' HB3' HD11 ' A' ' 126' ' ' ILE . 30.9 Cg_endo -64.74 131.1 28.15 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.389 2.059 . . . . 0.0 111.738 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.659 ' O ' HG13 ' A' ' 84' ' ' VAL . 1.6 mm -67.55 96.38 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.0 0.429 . . . . 0.0 110.749 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.3 p -77.0 147.28 76.84 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.868 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.487 ' HA ' ' CE1' ' A' ' 154' ' ' TYR . 96.4 Cg_exo -43.0 -28.22 1.17 Allowed 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.584 2.189 . . . . 0.0 112.286 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -72.88 -36.55 67.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.865 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 16.6 m -54.57 -61.93 1.99 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.898 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.555 ' HB2' ' CZ ' ' A' ' 82' ' ' PHE . . . -52.04 -40.81 61.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.066 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -51.18 -45.29 61.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.821 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.4 ttpp -64.06 -49.08 73.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.812 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.7 HD11 ' CG ' ' A' ' 94' ' ' LYS . 0.9 OUTLIER -61.43 -46.77 88.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.674 179.819 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.913 ' HB2' HD12 ' A' ' 112' ' ' LEU . . . -50.93 -45.52 60.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.98 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.57 -26.6 32.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.772 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.483 ' HB3' HD22 ' A' ' 149' ' ' LEU . 25.0 t0 -53.18 -38.4 62.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.766 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.483 HD22 ' HB3' ' A' ' 148' ' ' ASP . 2.9 mm? -114.48 21.25 14.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.926 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 48.16 51.3 14.99 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.037 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.649 ' O ' HG23 ' A' ' 152' ' ' VAL . . . -66.66 -82.86 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.978 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.881 HG11 HD12 ' A' ' 111' ' ' LEU . 36.5 t -164.32 -69.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.244 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 176.65 135.76 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.134 -179.298 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.487 ' CE1' ' HA ' ' A' ' 139' ' ' PRO . 27.7 t80 -106.54 108.01 19.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.64 178.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.552 HG23 ' OE2' ' A' ' 171' ' ' GLU . 0.2 OUTLIER -101.32 -171.89 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.89 0.376 . . . . 0.0 111.319 -179.175 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.504 ' H ' HG12 ' A' ' 155' ' ' VAL . 8.9 mt-10 -89.73 156.51 18.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.159 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.871 ' O ' HD11 ' A' ' 117' ' ' ILE . 13.0 t 178.82 160.02 0.62 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.199 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.631 ' OG ' HG22 ' A' ' 161' ' ' THR . 8.4 t -159.69 123.56 3.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.866 0.365 . . . . 0.0 111.19 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -92.3 20.25 6.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.073 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.652 ' N ' HD12 ' A' ' 160' ' ' LEU . 0.0 OUTLIER -133.11 -44.71 0.85 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.527 179.927 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.631 HG22 ' OG ' ' A' ' 158' ' ' SER . 9.7 t -111.06 -16.08 13.57 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.993 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 75.9 85.41 0.09 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.84 0.352 . . . . 0.0 111.355 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.502 ' HG2' HG23 ' A' ' 161' ' ' THR . 22.1 mmmt -111.12 45.77 1.14 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.52 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.436 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . 128.95 -63.22 0.63 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.106 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.832 HD11 ' O ' ' A' ' 19' ' ' LEU . 0.2 OUTLIER 62.23 -74.46 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.711 0.291 . . . . 0.0 111.257 179.597 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.442 ' HB3' ' HG3' ' B' ' 513' ' ' PRO . 0.0 OUTLIER -69.76 -23.42 63.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.99 -179.961 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -56.02 -56.07 25.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.006 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.831 HG21 ' CG1' ' A' ' 113' ' ' VAL . 16.2 m -71.27 -36.74 63.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.582 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.689 ' HB2' HD23 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -75.03 -19.52 60.0 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.853 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.72 ' OD2' HD21 ' B' ' 505' ' ' LEU . 28.7 t70 -83.06 -34.81 26.11 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.011 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.836 ' CD ' HD11 ' A' ' 111' ' ' LEU . 2.1 pt-20 -75.15 -31.66 61.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.912 0.387 . . . . 0.0 110.34 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 1.006 ' HB2' HD22 ' A' ' 111' ' ' LEU . . . -73.09 -47.81 41.23 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.586 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.424 HG12 ' O ' ' A' ' 169' ' ' PHE . 1.7 pp -64.34 -38.63 83.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.756 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.854 HD23 HD13 ' B' ' 505' ' ' LEU . 3.3 tm? -52.3 -35.4 50.43 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.921 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.632 ' HB3' HG11 ' A' ' 77' ' ' VAL . . . -51.76 -24.31 5.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.984 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.48 ' HB3' ' HB ' ' A' ' 4' ' ' ILE . . . -95.05 -36.94 11.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.106 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.921 HD13 ' HB ' ' B' ' 510' ' ' ILE . 9.6 mt -68.82 -24.34 64.37 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.844 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -172.94 128.8 0.54 Allowed Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.908 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -57.19 115.75 2.72 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.559 2.172 . . . . 0.0 112.304 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -77.47 -166.44 0.39 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.451 2.101 . . . . 0.0 112.312 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -149.08 131.55 7.84 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.891 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -80.71 -165.47 0.34 Allowed 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.667 2.245 . . . . 0.0 112.326 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 29.3 mttt -133.98 170.85 15.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.894 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 2.3 mttm . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.184 -0.913 . . . . 0.0 110.905 -179.946 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.202 0 N-CA-C 112.428 -0.269 . . . . 0.0 112.428 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 503' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.5 -162.37 0.51 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.819 0.343 . . . . 0.0 110.849 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 504' ' ' GLY . . . . . 0.844 ' O ' HD12 ' B' ' 505' ' ' LEU . . . 131.17 -101.89 0.5 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.321 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 505' ' ' LEU . . . . . 0.854 HD13 HD23 ' A' ' 174' ' ' LEU . 0.0 OUTLIER 58.96 18.08 5.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.563 0.22 . . . . 0.0 111.3 179.773 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 506' ' ' SER . . . . . 0.54 ' O ' ' HB2' ' B' ' 507' ' ' ALA . 0.7 OUTLIER 65.26 100.19 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.925 0.393 . . . . 0.0 110.649 -179.922 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 507' ' ' ALA . . . . . 0.54 ' HB2' ' O ' ' B' ' 506' ' ' SER . . . 169.15 -36.29 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.389 0.614 . . . . 0.0 110.44 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 508' ' ' GLN . . . . . 0.476 ' O ' ' CB ' ' B' ' 509' ' ' ASP . 0.5 OUTLIER 156.62 -26.36 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.394 -179.364 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 509' ' ' ASP . . . . . 0.476 ' CB ' ' O ' ' B' ' 508' ' ' GLN . 0.3 OUTLIER 98.07 32.4 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.975 0.91 . . . . 0.0 110.872 179.739 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 510' ' ' ILE . . . . . 0.921 ' HB ' HD13 ' A' ' 177' ' ' LEU . 3.3 mp -54.05 130.9 16.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.443 179.213 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 511' ' ' SER . . . . . 0.487 ' O ' HD12 ' B' ' 514' ' ' LEU . 0.4 OUTLIER -109.09 154.48 22.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.261 -179.459 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 512' ' ' GLN . . . . . 0.465 ' CB ' ' HD3' ' B' ' 513' ' ' PRO . 0.0 OUTLIER -97.9 -57.69 0.17 Allowed Pre-proline 0 C--N 1.333 -0.149 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.799 179.575 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 513' ' ' PRO . . . . . 0.465 ' HD3' ' CB ' ' B' ' 512' ' ' GLN . 59.9 Cg_endo -90.85 42.4 0.43 Allowed 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.905 2.404 . . . . 0.0 112.043 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 514' ' ' LEU . . . . . 0.643 ' HB2' HG13 ' A' ' 44' ' ' VAL . 0.3 OUTLIER -46.49 -85.62 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.624 -179.388 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 515' ' ' GLN . . . . . 0.617 ' H ' HG22 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -92.09 -86.52 0.23 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.124 -179.741 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -125.12 -37.15 2.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.218 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 517' ' ' SER . . . . . 0.407 ' O ' ' CG1' ' A' ' 42' ' ' VAL . 0.7 OUTLIER 63.79 29.57 14.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.962 -179.884 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 518' ' ' PHE . . . . . 0.405 ' HA ' HG12 ' A' ' 42' ' ' VAL . 1.2 m-85 -163.22 123.98 2.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.06 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 519' ' ' ILE . . . . . 0.556 HD11 ' H ' ' A' ' 43' ' ' THR . 12.1 mm -94.42 31.87 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.162 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 52.26 38.26 24.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.858 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 521' ' ' THR . . . . . 0.411 ' HB ' ' CD2' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -113.51 -172.11 2.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.845 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 522' ' ' GLY . . . . . . . . . . . . . . . 101.08 125.46 5.6 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.356 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 523' ' ' HIS . . . . . . . . . . . . . 32.3 t-80 -117.86 -81.28 0.62 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.747 0.308 . . . . 0.0 110.98 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 524' ' ' GLY . . . . . . . . . . . . . . . 58.09 -106.05 0.74 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.648 -0.786 . . . . 0.0 112.619 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 525' ' ' ASP . . . . . . . . . . . . . 4.7 t0 57.77 73.77 0.45 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.754 0.311 . . . . 0.0 110.891 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 526' ' ' SER . . . . . 0.431 ' CB ' ' HB3' ' A' ' 61' ' ' LEU . 32.0 t -108.83 96.77 6.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.987 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 527' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 70.7 95.79 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.053 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -74.95 58.83 4.98 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.736 2.291 . . . . 0.0 112.472 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 529' ' ' ARG . . . . . 0.401 ' HD2' ' OD1' ' B' ' 545' ' ' ASN . 0.1 OUTLIER -53.31 -43.09 67.32 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.192 0.52 . . . . 0.0 110.122 179.519 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 530' ' ' HIS . . . . . 0.51 ' HA ' ' CG ' ' A' ' 31' ' ' GLU . 41.2 m170 64.74 51.05 1.93 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.931 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -155.99 132.1 9.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.16 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 532' ' ' TRP . . . . . 0.407 ' NE1' ' O ' ' B' ' 536' ' ' ASP . 6.6 t-105 -92.22 -22.22 19.92 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.887 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . 92.44 -136.59 13.29 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.447 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 534' ' ' PHE . . . . . 0.433 ' HB3' ' HD2' ' B' ' 535' ' ' PRO . 39.2 m-85 -81.42 165.5 43.95 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.655 0.264 . . . . 0.0 110.629 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 535' ' ' PRO . . . . . 0.433 ' HD2' ' HB3' ' B' ' 534' ' ' PHE . 48.6 Cg_exo -56.18 81.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.587 2.191 . . . . 0.0 112.377 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 536' ' ' ASP . . . . . 0.45 ' HA ' ' NH1' ' B' ' 537' ' ' ARG . 0.2 OUTLIER 171.45 -164.22 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.92 -180.0 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 537' ' ' ARG . . . . . 0.45 ' NH1' ' HA ' ' B' ' 536' ' ' ASP . 0.0 OUTLIER -125.47 155.88 39.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.148 0.499 . . . . 0.0 110.532 179.77 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 538' ' ' ILE . . . . . 0.512 HG23 ' HA ' ' B' ' 543' ' ' LEU . 6.7 tp -83.34 123.96 39.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.483 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 539' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -33.68 130.19 0.28 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.156 0.503 . . . . 0.0 112.115 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 540' ' ' GLU . . . . . 0.824 ' CG ' HG12 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -41.79 -28.35 0.15 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.254 -179.29 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 541' ' ' LEU . . . . . 0.537 ' HA ' HD21 ' A' ' 70' ' ' LEU . 0.8 OUTLIER -40.91 -50.26 3.24 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.864 0.364 . . . . 0.0 111.319 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 542' ' ' TYR . . . . . 0.406 ' CD1' ' N ' ' B' ' 542' ' ' TYR . 0.1 OUTLIER -105.35 -63.37 1.24 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.234 179.949 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 543' ' ' LEU . . . . . 0.884 HD22 ' O ' ' A' ' 58' ' ' THR . 0.3 OUTLIER 72.83 166.68 0.3 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.474 -179.345 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . 116.47 156.97 10.86 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.655 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 545' ' ' ASN . . . . . 0.812 ' ND2' HG13 ' A' ' 33' ' ' VAL . 5.9 p30 . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.199 -0.905 . . . . 0.0 111.098 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.4 ' HE3' ' O ' ' A' ' 2' ' ' GLN . 5.2 tpt . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.807 0.337 . . . . 0.0 111.252 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.4 ' O ' ' HE3' ' A' ' 1' ' ' MET . 0.0 OUTLIER -64.23 144.61 57.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.49 179.822 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.761 HG23 ' CE1' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -110.79 -173.82 2.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.535 -179.545 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.658 HD11 ' CD1' ' A' ' 53' ' ' LEU . 5.7 pt -154.92 127.29 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.16 -179.113 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.458 ' CB ' ' HB ' ' A' ' 75' ' ' THR . 5.6 mmtp -100.6 100.58 11.32 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.429 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -77.63 132.56 38.31 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.201 0.524 . . . . 0.0 112.061 -178.71 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.3 t -144.52 159.66 14.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.918 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.589 HG21 ' C ' ' A' ' 15' ' ' GLY . 48.7 t -133.72 128.57 54.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.301 0.572 . . . . 0.0 112.143 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.44 ' HA ' ' CG ' ' B' ' 540' ' ' GLU . 3.3 m -134.06 129.38 54.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.267 -0.878 . . . . 0.0 109.694 178.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 134.98 -160.3 24.26 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.247 -0.978 . . . . 0.0 112.6 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.418 ' O ' ' N ' ' B' ' 537' ' ' ARG . 6.6 p30 -122.87 27.27 7.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.642 0.258 . . . . 0.0 111.047 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -104.59 174.59 21.96 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.823 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.434 ' CA ' ' HG3' ' B' ' 537' ' ' ARG . . . -95.16 -56.38 2.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.863 0.363 . . . . 0.0 111.1 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.773 HG21 HG11 ' A' ' 113' ' ' VAL . 14.7 p -53.61 105.93 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.047 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.589 ' C ' HG21 ' A' ' 8' ' ' VAL . . . 153.01 -44.51 0.61 Allowed Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.069 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.675 ' CD ' HD11 ' B' ' 543' ' ' LEU . 9.8 mtmt -90.18 -95.24 0.11 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 120.368 0.127 . . . . 0.0 111.077 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.8 HG21 ' HA ' ' A' ' 35' ' ' THR . 61.3 p -98.44 -49.6 4.6 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 120.939 0.4 . . . . 0.0 111.482 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.436 ' O ' ' CB ' ' A' ' 22' ' ' SER . 10.2 t -36.9 -41.32 0.33 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.447 -179.222 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.621 ' CD2' HG23 ' A' ' 14' ' ' VAL . 6.5 mt -49.84 -73.79 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.864 0.364 . . . . 0.0 111.557 -179.268 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.2 mt -74.74 -30.9 61.66 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.017 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.712 HD11 ' HZ ' ' A' ' 37' ' ' PHE . 16.2 mm -66.44 -69.44 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 178.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.439 ' O ' ' ND2' ' A' ' 26' ' ' ASN . 7.4 t -49.74 -25.8 3.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.594 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -65.37 -46.59 79.52 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.447 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.58 -55.01 3.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.478 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.431 ' OG1' HG23 ' A' ' 21' ' ' ILE . 30.1 p -88.38 76.4 8.31 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.046 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.439 ' ND2' ' O ' ' A' ' 22' ' ' SER . 0.6 OUTLIER -69.52 62.28 0.16 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.436 -178.742 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.2 mtmt -121.87 90.85 3.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.599 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.495 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 2.2 t80 -90.03 -44.95 0.41 Allowed Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.749 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 86.6 Cg_endo -85.78 13.56 2.71 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.5 2.133 . . . . 0.0 113.082 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.2 m -93.68 -93.7 0.17 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.631 -0.258 . . . . 0.0 110.845 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.407 ' HB2' ' HD2' ' B' ' 529' ' ' ARG . 3.6 pt-20 -158.99 145.52 16.95 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.789 0.328 . . . . 0.0 110.786 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.417 ' O ' HG22 ' A' ' 33' ' ' VAL . 11.9 m-85 -126.23 133.61 51.44 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.669 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.74 HG11 ' O ' ' B' ' 526' ' ' SER . 0.0 OUTLIER -162.53 -56.55 0.01 OUTLIER Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.612 -179.537 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.535 ' HD3' HG23 ' A' ' 33' ' ' VAL . 51.5 Cg_exo -56.49 78.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.527 2.151 . . . . 0.0 112.686 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.8 ' HA ' HG21 ' A' ' 17' ' ' THR . 29.2 m -121.57 -5.35 9.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.253 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.651 HG22 HD13 ' A' ' 61' ' ' LEU . 0.1 OUTLIER -89.69 -3.34 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -179.863 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.712 ' HZ ' HD11 ' A' ' 21' ' ' ILE . 17.4 p90 -81.0 9.24 6.82 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.419 ' HB2' ' HB2' ' A' ' 57' ' ' ASP . 4.5 p-10 -52.39 -174.12 0.0 OUTLIER 'General case' 0 C--O 1.231 0.101 0 CA-C-O 120.778 0.323 . . . . 0.0 111.052 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 48.82 25.45 1.03 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.895 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -65.16 -174.29 0.16 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.733 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.431 ' O ' ' CG1' ' B' ' 519' ' ' ILE . . . -122.93 152.01 41.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.272 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.698 HG23 HG21 ' A' ' 52' ' ' THR . 34.2 m -145.89 156.12 12.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.916 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.41 ' C ' HG13 ' A' ' 44' ' ' VAL . 0.1 OUTLIER -123.52 106.39 10.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.957 0.408 . . . . 0.0 111.239 -179.736 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.985 HG22 ' CG2' ' A' ' 52' ' ' THR . 10.7 m -156.5 -177.24 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.917 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.484 ' HE3' ' N ' ' A' ' 46' ' ' ILE . 4.8 tpt -107.01 96.1 6.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.303 -179.299 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.62 HD13 ' O ' ' B' ' 511' ' ' SER . 3.9 mm -76.79 86.85 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 121.036 0.446 . . . . 0.0 110.629 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.722 ' HA3' HG23 ' B' ' 510' ' ' ILE . . . 39.6 -92.73 0.01 OUTLIER Glycine 0 CA--C 1.521 0.454 0 CA-C-N 115.778 -0.647 . . . . 0.0 113.851 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . -35.59 -87.07 0.01 OUTLIER Glycine 0 C--N 1.334 0.457 0 N-CA-C 114.019 0.368 . . . . 0.0 114.019 -179.123 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.47 ' N ' ' HE1' ' A' ' 45' ' ' MET . 0.5 OUTLIER -133.32 159.16 73.68 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 120.705 0.288 . . . . 0.0 110.775 -179.693 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.403 ' N ' ' SD ' ' A' ' 45' ' ' MET . 86.1 Cg_exo -45.2 100.21 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.326 2.017 . . . . 0.0 112.161 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.761 ' CE1' HG23 ' A' ' 3' ' ' THR . 8.8 t80 -167.21 153.78 8.29 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.442 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.985 ' CG2' HG22 ' A' ' 44' ' ' VAL . 1.8 p -136.86 153.37 50.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.037 0.446 . . . . 0.0 111.467 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.812 HD11 ' OE1' ' B' ' 512' ' ' GLN . 0.0 OUTLIER -83.38 167.99 17.02 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.844 179.637 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.78 ' C ' HD12 ' A' ' 55' ' ' LEU . . . -105.21 -25.72 6.59 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.801 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.78 HD12 ' C ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER 52.12 92.54 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.785 0.326 . . . . 0.0 111.038 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -84.95 105.57 15.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.365 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.503 ' OD1' HG23 ' A' ' 8' ' ' VAL . 6.3 m-20 -105.95 165.99 10.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.109 0.48 . . . . 0.0 111.272 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.811 HG22 HD13 ' A' ' 67' ' ' LEU . 1.5 p -89.32 152.98 21.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.033 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.568 ' HB1' HG13 ' A' ' 36' ' ' VAL . . . -172.12 100.36 0.16 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.667 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.415 ' HA2' ' HA ' ' A' ' 65' ' ' ASP . . . -98.66 70.67 0.6 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.814 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.922 HD23 ' CB ' ' B' ' 526' ' ' SER . 6.5 mp -120.19 -107.69 0.36 Allowed 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 110.601 -0.148 . . . . 0.0 110.601 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -99.8 -24.67 14.61 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 120.775 0.322 . . . . 0.0 111.334 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.424 ' CB ' ' CG1' ' A' ' 36' ' ' VAL . 16.0 t0 -70.71 -63.41 1.1 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.676 -179.409 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.431 ' CD1' ' N ' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -151.66 116.25 5.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.848 0.356 . . . . 0.0 111.028 -179.54 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.415 ' HA ' ' HA2' ' A' ' 60' ' ' GLY . 0.2 OUTLIER -85.67 -13.77 47.55 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.392 179.961 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.32 -50.7 4.23 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.651 0.262 . . . . 0.0 111.656 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.811 HD13 HG22 ' A' ' 58' ' ' THR . 13.5 mt 69.82 -148.18 0.1 Allowed 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 -179.236 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.418 ' CB ' ' CD ' ' A' ' 69' ' ' PRO . 3.8 mtt-85 -172.55 -61.38 0.0 OUTLIER Pre-proline 0 CA--C 1.528 0.102 0 C-N-CA 120.776 -0.369 . . . . 0.0 111.883 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.418 ' CD ' ' CB ' ' A' ' 68' ' ' ARG . 50.0 Cg_exo -35.99 -60.26 0.35 Allowed 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 123.059 2.506 . . . . 0.0 113.236 -179.53 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.697 HD22 ' HA ' ' B' ' 541' ' ' LEU . 0.3 OUTLIER -46.88 -26.74 1.04 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.351 -179.777 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.5 t -74.6 -70.45 0.4 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.289 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -95.49 150.17 37.14 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.213 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.49 120.78 5.72 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.706 2.271 . . . . 0.0 112.531 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.415 ' NE2' ' O ' ' A' ' 69' ' ' PRO . 1.3 mp0 -102.03 -60.3 1.56 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.848 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.458 ' HB ' ' CB ' ' A' ' 5' ' ' LYS . 7.9 t -82.15 -178.71 7.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.053 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.405 ' O ' ' CG ' ' A' ' 109' ' ' PRO . 0.1 OUTLIER -104.3 7.7 35.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.382 179.899 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.655 ' O ' HG13 ' A' ' 77' ' ' VAL . 11.3 p -156.47 106.92 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.711 0.291 . . . . 0.0 111.24 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.552 ' CE1' HG21 ' A' ' 108' ' ' THR . 4.9 m-85 -83.59 -177.9 6.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.607 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.531 HD13 ' N ' ' A' ' 80' ' ' VAL . 0.2 OUTLIER -119.19 117.71 29.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.95 0.405 . . . . 0.0 111.427 -179.602 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.67 HG21 ' CD1' ' A' ' 110' ' ' PHE . 1.8 t -111.35 100.32 10.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.367 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.536 ' HB3' HG13 ' A' ' 14' ' ' VAL . 2.3 p -109.57 137.74 46.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.04 0.448 . . . . 0.0 111.538 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.756 ' CE1' HG21 ' A' ' 137' ' ' ILE . 28.7 p90 -147.18 145.22 29.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.224 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.6 m -83.29 130.58 35.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.901 0.381 . . . . 0.0 111.269 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.463 HG13 ' HB ' ' A' ' 137' ' ' ILE . 97.2 t -45.93 -73.72 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.481 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.636 ' HB ' HD21 ' A' ' 129' ' ' LEU . 5.6 m -43.64 117.75 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.332 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.469 ' N ' HD22 ' A' ' 129' ' ' LEU . 0.4 OUTLIER -151.57 136.89 10.71 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.336 -179.798 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.421 ' O ' ' CB ' ' A' ' 88' ' ' SER . 68.2 Cg_endo -92.42 52.75 0.58 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 123.212 2.608 . . . . 0.0 111.816 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.448 ' CB ' ' HG2' ' A' ' 133' ' ' LYS . 0.1 OUTLIER 80.84 26.25 0.26 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.908 -179.499 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.817 ' O ' HG23 ' A' ' 93' ' ' VAL . 43.3 t -96.78 -26.17 15.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.911 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.483 ' CE1' ' CE1' ' A' ' 82' ' ' PHE . 3.9 t80 -54.65 -46.97 74.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.983 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -52.3 -58.26 7.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.994 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.416 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.4 OUTLIER -54.39 -43.17 71.19 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.027 -179.947 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.817 HG23 ' O ' ' A' ' 89' ' ' SER . 60.5 t -54.35 -45.54 68.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.254 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.521 ' O ' HG23 ' A' ' 98' ' ' VAL . 14.9 tttt -59.6 -55.12 38.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.056 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.8 0.14 24.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.741 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.416 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 2.0 tttt -112.22 -22.53 10.89 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.656 0.265 . . . . 0.0 111.072 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.662 ' HZ3' HG12 ' A' ' 80' ' ' VAL . 25.2 m0 -93.06 -55.13 3.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.111 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 94' ' ' LYS . 61.1 t -43.68 -56.13 7.69 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.869 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 30.6 Cg_endo -62.67 -18.8 65.85 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.169 1.912 . . . . 0.0 112.381 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.29 -45.32 9.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.006 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.403 HG12 ' O ' ' A' ' 97' ' ' TRP . 19.7 mm -52.58 -56.92 5.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.159 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.1 p -65.25 -22.3 66.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.238 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 22.3 t-160 -64.93 -68.74 0.34 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.892 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -75.54 -27.22 58.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.004 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.459 ' HB3' ' CB ' ' A' ' 108' ' ' THR . 8.3 m -122.64 75.16 45.48 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.024 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -57.08 131.96 48.56 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.642 2.228 . . . . 0.0 112.166 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 9.7 mmtp 50.31 39.16 19.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.824 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.552 HG21 ' CE1' ' A' ' 78' ' ' PHE . 46.0 m -108.3 101.69 43.31 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.95 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.405 ' CG ' ' O ' ' A' ' 76' ' ' ASP . 36.3 Cg_exo -60.19 171.78 2.91 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.632 2.221 . . . . 0.0 112.425 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.754 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 6.6 p90 -158.52 -177.55 6.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.711 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.88 HD12 ' HB ' ' A' ' 152' ' ' VAL . 3.1 tt -142.2 152.88 43.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.828 0.347 . . . . 0.0 111.245 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.528 HD12 ' HE2' ' A' ' 82' ' ' PHE . 4.3 mm? -101.52 161.15 13.85 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.559 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.78 HG13 HG21 ' A' ' 168' ' ' VAL . 2.5 t -138.74 155.5 27.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.007 0.432 . . . . 0.0 111.743 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.474 ' C ' HD12 ' A' ' 117' ' ' ILE . . . -140.14 114.23 0.96 Allowed Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.327 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.763 ' C ' HD13 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -126.97 -49.14 1.47 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.919 0.39 . . . . 0.0 110.284 -179.676 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.584 ' CG ' HD21 ' A' ' 119' ' ' LEU . 0.7 OUTLIER -61.69 -16.28 47.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.634 179.284 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.763 HD13 ' C ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -40.58 -28.57 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 179.906 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.441 ' N ' HG12 ' A' ' 117' ' ' ILE . 2.3 p30 -66.9 -29.56 69.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.852 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.713 ' O ' HD12 ' A' ' 119' ' ' LEU . 3.6 pp -106.01 13.71 28.87 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.44 ' O ' ' CD1' ' A' ' 126' ' ' ILE . 1.8 ppt_? -66.86 -20.64 65.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.727 0.299 . . . . 0.0 110.696 179.264 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -85.47 -25.97 26.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.484 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -49.95 104.98 0.46 Allowed Pre-proline 0 C--N 1.332 -0.171 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.696 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.476 ' HA ' ' CG2' ' A' ' 126' ' ' ILE . 37.4 Cg_endo -66.32 -7.9 18.92 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.582 2.188 . . . . 0.0 113.174 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.38 -67.28 0.64 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.443 ' CG2' HG11 ' A' ' 85' ' ' VAL . 12.4 m -58.24 -39.41 79.04 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 178.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.828 HD11 ' HB3' ' A' ' 136' ' ' PRO . 0.1 OUTLIER -54.39 -44.68 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.684 179.176 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.538 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 11.4 mm-40 -57.84 -36.87 72.89 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.896 179.314 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 125' ' ' THR . 0.0 OUTLIER -63.31 -30.72 71.81 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.902 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.636 HD21 ' HB ' ' A' ' 85' ' ' VAL . 6.8 mt -74.54 -38.04 62.86 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 177.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.538 ' HB3' ' O ' ' A' ' 127' ' ' GLU . . . -45.47 -33.15 2.51 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 114.867 -1.06 . . . . 0.0 111.048 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.2 mmtp -48.95 -34.89 13.82 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.512 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.412 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 5.0 m120 -123.2 -31.23 3.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.362 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.524 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 36.8 mmtt -143.59 -100.67 0.12 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 119.092 -0.48 . . . . 0.0 111.478 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.524 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 4.5 pt20 131.33 -22.34 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.456 1.102 . . . . 0.0 110.45 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 5.9 mmpp? -68.57 110.6 6.14 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.739 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.828 ' HB3' HD11 ' A' ' 126' ' ' ILE . 90.6 Cg_endo -80.86 134.4 9.55 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.527 2.152 . . . . 0.0 111.656 179.294 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.756 HG21 ' CE1' ' A' ' 82' ' ' PHE . 0.4 OUTLIER -64.34 96.6 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.323 -179.694 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.417 ' O ' ' N ' ' A' ' 141' ' ' THR . 2.9 p -68.78 145.72 97.05 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.888 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.453 ' HA ' ' CE1' ' A' ' 154' ' ' TYR . 89.1 Cg_exo -43.19 -28.21 1.34 Allowed 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.573 2.182 . . . . 0.0 112.248 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -78.75 -36.7 42.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.676 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.417 ' N ' ' O ' ' A' ' 138' ' ' THR . 6.1 m -54.88 -56.06 23.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.714 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.509 ' CB ' ' CD2' ' A' ' 154' ' ' TYR . . . -53.02 -36.56 60.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.777 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.64 -38.82 90.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.667 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 17.2 tptt -63.41 -50.59 69.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.703 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.482 HD23 ' O ' ' A' ' 145' ' ' LEU . 0.6 OUTLIER -70.23 -33.99 72.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.593 179.798 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -67.69 -44.7 77.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.894 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 60.2 mtt180 -75.14 -23.18 57.8 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.793 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -56.14 -46.88 79.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.745 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -95.54 19.7 10.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.058 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.1 mtmp? 44.82 40.39 4.25 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.428 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.754 ' HB1' ' O ' ' A' ' 110' ' ' PHE . . . -59.58 -81.72 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.866 0.365 . . . . 0.0 110.818 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.88 ' HB ' HD12 ' A' ' 111' ' ' LEU . 83.5 t -159.65 -73.82 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.833 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.413 ' HG3' HG22 ' A' ' 155' ' ' VAL . 4.1 tppt? 177.42 135.6 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.954 -179.188 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.517 ' OH ' HG21 ' A' ' 117' ' ' ILE . 3.3 t80 -98.06 112.49 24.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.154 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.646 HG11 ' OD1' ' A' ' 167' ' ' ASN . 0.3 OUTLIER -115.04 -172.84 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.637 -179.924 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.586 ' H ' HG12 ' A' ' 155' ' ' VAL . 2.1 mp0 -89.58 163.3 15.24 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.868 0.366 . . . . 0.0 111.145 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.751 ' CB ' HG22 ' A' ' 115' ' ' THR . 0.1 OUTLIER -133.56 -172.73 3.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.987 -179.786 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.551 ' O ' ' HB2' ' A' ' 159' ' ' ALA . 1.1 p -128.38 147.85 50.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.984 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.551 ' HB2' ' O ' ' A' ' 158' ' ' SER . . . 169.58 -57.96 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.805 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.488 HD22 HD23 ' A' ' 119' ' ' LEU . 1.2 mp -100.39 -60.07 1.59 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.62 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.438 ' CG2' ' HB3' ' A' ' 118' ' ' ASP . 13.4 t -86.04 -26.4 25.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.474 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.447 ' HA ' ' HB2' ' A' ' 158' ' ' SER . 2.8 tt0 73.39 77.11 0.13 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.16 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.422 ' CB ' ' O ' ' A' ' 157' ' ' CYS . 0.0 OUTLIER -88.19 -21.37 24.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.131 179.979 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . 142.07 -36.07 1.7 Allowed Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.491 -0.861 . . . . 0.0 112.887 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.476 HD11 ' HA ' ' A' ' 19' ' ' LEU . 0.4 OUTLIER 68.37 -63.7 0.33 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.791 0.329 . . . . 0.0 111.064 -179.796 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.407 ' O ' ' CB ' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -48.49 -30.92 5.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.264 -179.848 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.646 ' OD1' HG11 ' A' ' 155' ' ' VAL . 5.2 t-20 -56.46 -71.5 0.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.313 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.78 HG21 HG13 ' A' ' 113' ' ' VAL . 8.5 p -58.48 -46.77 89.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.823 0.344 . . . . 0.0 111.061 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.503 ' N ' HG13 ' A' ' 168' ' ' VAL . 4.2 t80 -57.71 -37.39 73.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.187 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.407 ' CB ' ' O ' ' A' ' 166' ' ' LYS . 17.0 m-20 -58.83 -37.47 76.5 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.022 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.814 ' OE2' HD12 ' A' ' 174' ' ' LEU . 21.9 mm-40 -66.34 -32.29 73.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.785 179.112 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.528 ' HB2' HD22 ' A' ' 111' ' ' LEU . . . -66.5 -30.63 71.0 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.68 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.928 HD11 HD22 ' A' ' 177' ' ' LEU . 0.0 OUTLIER -90.55 -26.15 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.097 -0.502 . . . . 0.0 109.763 179.256 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 1.076 HD21 HD13 ' B' ' 505' ' ' LEU . 1.2 mt -49.48 -46.81 48.63 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.01 0.434 . . . . 0.0 110.612 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.573 ' HB3' HG11 ' A' ' 77' ' ' VAL . . . -60.71 -22.68 64.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.098 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -97.09 -38.22 9.83 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.219 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.928 HD22 HD11 ' A' ' 173' ' ' ILE . 2.6 tp -68.71 -21.88 64.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.868 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.448 ' HB2' ' CB ' ' B' ' 507' ' ' ALA . 0.0 OUTLIER -174.06 158.08 2.72 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.788 179.905 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.65 110.68 3.06 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.654 2.236 . . . . 0.0 112.262 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -83.2 164.77 14.96 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.69 2.26 . . . . 0.0 112.472 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' GLU . . . . . 0.425 ' O ' ' CG ' ' A' ' 181' ' ' GLU . 9.5 pt-20 -113.11 110.11 51.49 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.551 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.66 -164.91 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.411 2.074 . . . . 0.0 112.278 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.66 86.21 1.64 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.874 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.872 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.224 0 N-CA-C 112.56 -0.216 . . . . 0.0 112.56 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 503' ' ' SER . . . . . 0.4 ' HB2' ' O ' ' B' ' 510' ' ' ILE . 0.5 OUTLIER -76.64 -82.44 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.735 0.302 . . . . 0.0 110.909 179.993 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 504' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' B' ' 509' ' ' ASP . . . 93.55 104.23 1.7 Allowed Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.397 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 505' ' ' LEU . . . . . 1.076 HD13 HD21 ' A' ' 174' ' ' LEU . 0.1 OUTLIER -170.32 39.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.747 0.308 . . . . 0.0 110.982 -179.767 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 506' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 68.14 33.04 4.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.031 0.443 . . . . 0.0 110.486 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 507' ' ' ALA . . . . . 0.448 ' HB3' ' CD1' ' B' ' 505' ' ' LEU . . . -134.93 36.58 3.06 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.698 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 508' ' ' GLN . . . . . 0.407 ' O ' ' HB3' ' B' ' 509' ' ' ASP . 30.7 mt-30 74.39 3.41 4.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.551 -178.57 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 509' ' ' ASP . . . . . 0.408 ' HA ' ' HA2' ' B' ' 504' ' ' GLY . 22.2 t70 70.49 43.62 0.77 Allowed 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 121.024 0.44 . . . . 0.0 110.985 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 510' ' ' ILE . . . . . 0.722 HG23 ' HA3' ' A' ' 47' ' ' GLY . 66.4 mt -95.25 139.0 19.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.579 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 511' ' ' SER . . . . . 0.62 ' O ' HD13 ' A' ' 46' ' ' ILE . 34.6 t -108.28 148.12 30.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.989 0.424 . . . . 0.0 112.039 -178.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 512' ' ' GLN . . . . . 0.812 ' OE1' HD11 ' A' ' 53' ' ' LEU . 11.8 tp60 -100.06 -69.08 0.04 OUTLIER Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.998 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 513' ' ' PRO . . . . . 0.511 ' HD3' ' HB3' ' B' ' 512' ' ' GLN . 85.3 Cg_endo -78.49 73.6 5.79 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.219 1.946 . . . . 0.0 110.934 178.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 514' ' ' LEU . . . . . 0.552 HD21 ' HB3' ' B' ' 511' ' ' SER . 1.3 mp -80.38 -93.76 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -178.413 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 515' ' ' GLN . . . . . 0.45 ' HB2' HG12 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -69.33 -83.7 0.03 OUTLIER 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.839 0.352 . . . . 0.0 111.914 -178.707 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 516' ' ' ASN . . . . . 0.413 ' ND2' ' O ' ' B' ' 518' ' ' PHE . 48.9 t30 -120.91 -37.11 3.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.485 -178.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 517' ' ' SER . . . . . 0.474 ' O ' HG11 ' A' ' 42' ' ' VAL . 0.7 OUTLIER 55.87 26.0 9.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.854 -179.806 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 518' ' ' PHE . . . . . 0.413 ' O ' ' ND2' ' B' ' 516' ' ' ASN . 0.0 OUTLIER -162.98 106.89 1.07 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.054 -179.78 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 519' ' ' ILE . . . . . 0.431 ' CG1' ' O ' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -107.6 -84.97 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.991 179.851 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 13.7 t-160 -175.17 102.55 0.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.889 0.376 . . . . 0.0 110.899 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 521' ' ' THR . . . . . 0.414 HG22 ' H ' ' B' ' 522' ' ' GLY . 0.2 OUTLIER -150.68 178.37 9.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.769 -179.964 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 522' ' ' GLY . . . . . 0.414 ' H ' HG22 ' B' ' 521' ' ' THR . . . 58.93 161.47 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.375 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 523' ' ' HIS . . . . . 0.422 ' NE2' ' HB2' ' B' ' 525' ' ' ASP . 16.3 t-160 -137.61 -84.92 0.31 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.704 0.288 . . . . 0.0 111.126 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 524' ' ' GLY . . . . . . . . . . . . . . . 92.37 -97.54 2.29 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.379 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 525' ' ' ASP . . . . . 0.422 ' HB2' ' NE2' ' B' ' 523' ' ' HIS . 2.7 t0 75.32 78.44 0.1 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.926 0.393 . . . . 0.0 111.279 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 526' ' ' SER . . . . . 0.922 ' CB ' HD23 ' A' ' 61' ' ' LEU . 0.5 OUTLIER -117.4 98.19 6.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.723 179.545 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 527' ' ' ASP . . . . . 0.445 ' CB ' ' HD3' ' B' ' 528' ' ' PRO . 0.1 OUTLIER -44.32 -50.9 21.06 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.301 -179.807 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 528' ' ' PRO . . . . . 0.445 ' HD3' ' CB ' ' B' ' 527' ' ' ASP . 23.6 Cg_exo -68.08 118.65 5.77 Favored 'Trans proline' 0 CA--C 1.518 -0.305 0 C-N-CA 123.058 2.505 . . . . 0.0 112.108 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 529' ' ' ARG . . . . . 0.559 ' HD3' HG21 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -100.92 -37.47 8.64 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.879 -179.162 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 530' ' ' HIS . . . . . 0.48 ' CG ' ' O ' ' B' ' 530' ' ' HIS . 0.0 OUTLIER 67.71 9.62 7.21 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.012 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 1.2 m 49.1 -174.45 0.02 OUTLIER 'General case' 0 C--N 1.334 -0.093 0 CA-C-O 120.87 0.367 . . . . 0.0 111.072 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 532' ' ' TRP . . . . . . . . . . . . . 23.0 t90 -65.44 -63.16 1.16 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.864 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . 95.52 -119.11 6.09 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.377 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 534' ' ' PHE . . . . . 0.418 ' O ' ' N ' ' B' ' 536' ' ' ASP . 11.3 m-85 -119.39 151.2 50.99 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.729 0.3 . . . . 0.0 110.892 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.48 83.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.586 2.191 . . . . 0.0 112.262 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 536' ' ' ASP . . . . . 0.418 ' N ' ' O ' ' B' ' 534' ' ' PHE . 1.0 OUTLIER 172.23 80.85 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.7 179.979 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 537' ' ' ARG . . . . . 0.434 ' HG3' ' CA ' ' A' ' 13' ' ' ALA . 32.3 mmt-85 -51.78 132.92 31.81 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.116 0.484 . . . . 0.0 111.062 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 538' ' ' ILE . . . . . 0.408 HD12 ' H ' ' B' ' 539' ' ' ASP . 3.1 tp -50.9 133.53 11.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.446 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 539' ' ' ASP . . . . . 0.408 ' H ' HD12 ' B' ' 538' ' ' ILE . 62.5 m-20 -40.39 117.76 0.84 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.317 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 540' ' ' GLU . . . . . 0.783 ' HA ' HD12 ' B' ' 543' ' ' LEU . 2.8 pp20? -47.45 -24.87 0.91 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.116 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 541' ' ' LEU . . . . . 0.697 ' HA ' HD22 ' A' ' 70' ' ' LEU . 0.4 OUTLIER -38.53 -42.66 0.78 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.164 0.507 . . . . 0.0 111.012 179.435 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 542' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -105.3 -59.48 1.75 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.427 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 543' ' ' LEU . . . . . 0.783 HD12 ' HA ' ' B' ' 540' ' ' GLU . 0.1 OUTLIER 59.98 122.88 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.881 -179.911 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 544' ' ' GLY . . . . . 0.449 ' HA2' HD11 ' A' ' 61' ' ' LEU . . . 164.3 105.21 0.19 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.538 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 545' ' ' ASN . . . . . 0.439 ' HB3' ' HA ' ' B' ' 529' ' ' ARG . 10.0 m120 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.951 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.466 ' HE1' ' CD1' ' A' ' 51' ' ' TYR . 6.9 tpt . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.267 0.079 . . . . 0.0 111.082 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.43 ' N ' ' HG3' ' A' ' 1' ' ' MET . 5.7 tt0 42.22 100.08 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.294 0.568 . . . . 0.0 111.804 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.556 HG23 HG21 ' A' ' 46' ' ' ILE . 0.2 OUTLIER -104.82 -159.48 0.71 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.652 -179.889 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.701 ' O ' HD22 ' A' ' 53' ' ' LEU . 0.3 OUTLIER -156.37 163.18 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -178.653 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.519 ' HA ' HD13 ' A' ' 53' ' ' LEU . 16.2 mttp -134.45 102.36 5.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.876 179.037 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 32.3 m -103.07 156.2 17.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.225 0.536 . . . . 0.0 112.083 -178.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.445 HG13 ' O ' ' A' ' 56' ' ' PHE . 2.7 t -139.11 159.87 29.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.248 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.708 HG13 ' HB ' ' A' ' 14' ' ' VAL . 65.4 t -106.89 141.5 21.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.239 0.542 . . . . 0.0 111.752 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 98.0 t -156.51 129.96 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.855 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.55 -171.14 32.99 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 119.976 -1.107 . . . . 0.0 113.051 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -94.81 27.78 2.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.791 0.329 . . . . 0.0 110.852 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.635 ' O ' HG23 ' A' ' 14' ' ' VAL . . . -170.04 -170.06 33.98 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.419 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.444 ' N ' ' HB2' ' B' ' 537' ' ' ARG . . . -60.84 -30.17 69.95 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.953 0.406 . . . . 0.0 110.712 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.708 ' HB ' HG13 ' A' ' 8' ' ' VAL . 2.7 t 63.45 -71.21 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.584 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.934 ' C ' HD11 ' A' ' 19' ' ' LEU . . . 175.22 59.19 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.169 -1.015 . . . . 0.0 113.232 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.688 ' CE ' HG11 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -97.85 -85.71 0.36 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.861 0.33 . . . . 0.0 110.217 178.75 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.46 ' HB ' ' CG1' ' A' ' 21' ' ' ILE . 45.9 p -99.5 -36.64 9.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.001 0.429 . . . . 0.0 111.116 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.405 ' O ' ' CB ' ' A' ' 22' ' ' SER . 30.0 p -40.28 -36.31 0.51 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.314 -179.183 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.94 HD23 ' CD2' ' A' ' 165' ' ' LEU . 0.0 OUTLIER -71.15 -69.3 0.38 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.926 0.393 . . . . 0.0 110.883 -179.68 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.535 HD21 ' CD2' ' A' ' 169' ' ' PHE . 3.6 mt -55.98 -43.47 77.63 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.234 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.608 HG22 ' OG1' ' A' ' 25' ' ' THR . 42.4 mm -62.41 -66.9 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.864 0.364 . . . . 0.0 110.587 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.405 ' CB ' ' O ' ' A' ' 18' ' ' CYS . 52.3 p -46.18 -27.41 0.98 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.258 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -73.89 -68.14 0.54 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.954 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.91 -46.27 75.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.716 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.608 ' OG1' HG22 ' A' ' 21' ' ' ILE . 19.0 p -85.26 -149.1 0.12 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.308 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.7 p-10 -161.18 30.11 0.14 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.746 0.307 . . . . 0.0 111.105 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.8 mttt -115.35 156.31 25.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.271 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.518 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . 4.1 t80 -163.67 -62.15 0.01 OUTLIER Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.726 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.518 ' HD3' ' HB3' ' A' ' 28' ' ' PHE . 63.2 Cg_endo -85.07 -16.37 5.15 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.627 2.218 . . . . 0.0 112.989 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.2 m -50.61 -87.75 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.398 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -158.12 116.86 3.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.525 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.482 ' CE1' ' HA ' ' A' ' 28' ' ' PHE . 6.6 m-85 -111.56 94.14 4.82 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.108 0.48 . . . . 0.0 110.769 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.822 HG21 ' HD3' ' B' ' 529' ' ' ARG . 2.1 t -117.25 -52.22 0.04 OUTLIER Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.23 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.472 ' O ' ' CD1' ' A' ' 37' ' ' PHE . 5.1 Cg_exo -80.14 52.99 4.54 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.501 2.134 . . . . 0.0 112.245 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.9 t -98.88 -25.22 14.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.835 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.799 HG11 ' CG ' ' B' ' 525' ' ' ASP . 7.4 p -51.0 -27.63 5.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.326 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.472 ' CD1' ' O ' ' A' ' 34' ' ' PRO . 3.4 p90 -54.79 -21.15 10.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.965 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.431 ' HB3' ' CB ' ' A' ' 57' ' ' ASP . 59.2 t0 -44.71 -29.73 0.81 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.413 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -70.29 -30.75 67.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.167 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.663 ' CE1' HG21 ' B' ' 521' ' ' THR . 8.6 m-85 -60.68 -174.07 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.86 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.681 ' O ' HD12 ' B' ' 519' ' ' ILE . . . -101.57 -179.63 4.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.087 0.47 . . . . 0.0 111.538 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.1 m -141.11 165.15 19.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.553 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.547 ' O ' HG13 ' A' ' 44' ' ' VAL . 0.7 OUTLIER -110.2 102.11 10.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.883 0.373 . . . . 0.0 111.649 -179.483 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.658 HG11 ' OG ' ' B' ' 517' ' ' SER . 30.1 m -164.81 -177.16 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.728 178.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.491 ' O ' ' HG3' ' A' ' 45' ' ' MET . 0.0 OUTLIER -128.53 101.12 6.03 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.54 0.686 . . . . 0.0 110.95 179.844 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.736 HG23 HG23 ' B' ' 510' ' ' ILE . 3.8 mm -55.49 101.6 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.478 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.454 ' O ' ' CE ' ' A' ' 45' ' ' MET . . . 29.48 -83.88 0.0 OUTLIER Glycine 0 C--N 1.337 0.626 0 N-CA-C 114.862 0.705 . . . . 0.0 114.862 178.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . -42.28 -77.32 0.08 OUTLIER Glycine 0 CA--C 1.519 0.311 0 C-N-CA 121.226 -0.511 . . . . 0.0 113.167 -179.372 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -143.57 164.28 31.52 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-O 120.807 0.337 . . . . 0.0 111.448 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.433 ' HA ' ' HA ' ' A' ' 45' ' ' MET . 4.2 Cg_endo -47.09 101.12 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.942 2.428 . . . . 0.0 112.309 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.494 ' HE1' HG21 ' A' ' 3' ' ' THR . 5.0 t80 -172.85 137.04 0.73 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.967 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.627 HG21 HG22 ' A' ' 44' ' ' VAL . 16.5 p -134.26 138.54 45.11 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.114 0.483 . . . . 0.0 111.369 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.701 HD22 ' O ' ' A' ' 4' ' ' ILE . 1.5 pp -74.04 178.07 5.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.752 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -111.89 86.91 0.44 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.071 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -47.62 116.81 1.58 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.854 0.359 . . . . 0.0 110.501 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.445 ' O ' HG13 ' A' ' 7' ' ' VAL . 0.8 OUTLIER -83.92 105.3 14.7 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.042 -179.374 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.805 ' OD2' HD21 ' B' ' 543' ' ' LEU . 0.1 OUTLIER -130.16 111.31 12.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.153 179.593 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.826 ' O ' HD13 ' B' ' 543' ' ' LEU . 0.6 OUTLIER -86.28 129.78 34.73 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.748 -179.512 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.643 ' HB3' HG23 ' A' ' 36' ' ' VAL . . . -135.99 114.75 12.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.909 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -67.48 63.8 0.27 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.775 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.784 HD12 ' HB ' ' A' ' 36' ' ' VAL . 9.7 mt -121.45 -171.72 2.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.834 0.349 . . . . 0.0 110.874 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.433 ' CB ' ' O ' ' B' ' 524' ' ' GLY . 0.1 OUTLIER -44.43 -45.53 9.08 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.51 -179.878 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.496 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . 5.3 m-20 -59.35 -62.99 1.47 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.163 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.496 ' CE1' ' HB3' ' A' ' 63' ' ' ASP . 0.1 OUTLIER -128.42 132.15 48.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.862 -179.68 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -86.68 -68.73 0.72 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.435 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.401 ' O ' ' HB2' ' A' ' 67' ' ' LEU . 11.1 mmt180 -98.41 -34.67 10.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.337 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.779 HD13 ' HB ' ' A' ' 58' ' ' THR . 1.2 mp 69.72 -80.07 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.058 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.556 ' CB ' ' O ' ' A' ' 67' ' ' LEU . 25.8 ttp180 113.83 -42.61 0.0 OUTLIER Pre-proline 0 N--CA 1.487 1.39 0 C-N-CA 123.89 0.876 . . . . 0.0 112.904 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 67.7 Cg_exo -41.61 -49.83 5.07 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.499 2.132 . . . . 0.0 113.182 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.783 HD22 ' N ' ' B' ' 541' ' ' LEU . 0.1 OUTLIER -53.38 -26.23 18.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.78 0.324 . . . . 0.0 110.564 -179.924 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.412 ' CB ' ' O ' ' A' ' 68' ' ' ARG . 8.5 t -50.95 -67.68 0.23 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.081 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -147.14 73.57 12.03 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.012 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -56.47 164.78 5.13 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.58 2.187 . . . . 0.0 112.202 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 54.6 tp60 -95.02 -17.53 21.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.296 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.664 HG22 ' H ' ' A' ' 77' ' ' VAL . 93.5 m -46.62 149.99 0.74 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.773 0.321 . . . . 0.0 111.201 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -90.43 -24.19 20.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.05 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.664 ' H ' HG22 ' A' ' 75' ' ' THR . 1.2 m -103.83 91.6 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.135 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -80.98 122.09 26.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.606 HD12 HG12 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -78.17 109.65 12.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.013 -179.883 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.466 HG23 HD23 ' A' ' 112' ' ' LEU . 1.8 m -106.75 121.4 59.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.379 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.67 ' HB3' HG22 ' A' ' 14' ' ' VAL . 9.0 p -95.37 161.43 14.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.319 0.581 . . . . 0.0 112.304 -178.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 1.008 ' CE1' HD22 ' A' ' 112' ' ' LEU . 14.3 p90 179.61 123.58 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.897 179.457 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.35 151.02 20.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.952 0.406 . . . . 0.0 111.341 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.956 HG22 ' HB3' ' A' ' 116' ' ' GLN . 1.5 m -52.52 -51.78 31.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.591 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.578 HG22 ' OE1' ' A' ' 116' ' ' GLN . 19.6 m -53.28 116.64 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.588 0.232 . . . . 0.0 110.615 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.678 ' H ' HD22 ' A' ' 129' ' ' LEU . 6.4 m -151.14 129.2 5.89 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.455 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -91.17 51.39 0.81 Allowed 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.989 2.46 . . . . 0.0 111.684 179.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.472 ' CA ' ' HB2' ' A' ' 133' ' ' LYS . 0.1 OUTLIER 75.1 15.86 2.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.21 -179.626 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.931 ' O ' HG23 ' A' ' 93' ' ' VAL . 43.8 t -97.6 -22.4 16.52 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.121 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.585 ' CZ ' HG21 ' A' ' 137' ' ' ILE . 12.0 t80 -47.07 -59.18 3.3 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.322 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -48.71 -47.18 41.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.967 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -69.89 -32.61 71.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.781 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.931 HG23 ' O ' ' A' ' 89' ' ' SER . 93.8 t -57.1 -68.51 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.964 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.838 ' HG3' HD13 ' A' ' 145' ' ' LEU . 6.9 mmtt -52.09 -52.86 48.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.745 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -57.44 -22.58 44.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.791 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -100.39 -12.38 19.46 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.355 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.421 ' O ' ' CG ' ' A' ' 100' ' ' GLU . 3.1 m0 -89.24 -56.27 3.34 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.628 0.252 . . . . 0.0 111.179 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.671 HG11 HD22 ' A' ' 149' ' ' LEU . 12.9 t -45.88 -45.44 37.57 Favored Pre-proline 0 C--N 1.329 -0.293 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.491 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 50.2 Cg_exo -54.14 -37.77 87.41 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.323 2.015 . . . . 0.0 112.523 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.445 ' HG3' ' N ' ' A' ' 101' ' ' ILE . 6.3 pt-20 -82.82 -32.53 27.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.078 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.776 HG21 ' CD1' ' A' ' 110' ' ' PHE . 19.0 mm -53.86 -35.54 27.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.892 0.377 . . . . 0.0 110.648 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 43.9 p -95.93 -22.45 17.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.055 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -66.02 -29.01 69.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.741 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 3.5 m170 -90.93 -25.22 19.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.799 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 1.1 m -145.33 142.2 17.98 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.886 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.51 90.48 0.22 Allowed 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.535 2.157 . . . . 0.0 112.207 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 58.9 90.83 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.743 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.93 116.07 30.29 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.969 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -60.14 156.32 40.49 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.575 2.184 . . . . 0.0 112.226 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.776 ' CD1' HG21 ' A' ' 101' ' ' ILE . 3.4 p90 -145.9 147.83 32.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.943 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 1.028 HD12 HG11 ' A' ' 152' ' ' VAL . 3.7 tt -108.45 141.38 40.4 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.011 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 1.008 HD22 ' CE1' ' A' ' 82' ' ' PHE . 25.1 mt -98.71 142.94 29.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.81 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.955 HG13 HG11 ' A' ' 168' ' ' VAL . 58.1 t -121.6 142.58 37.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.98 0.419 . . . . 0.0 111.775 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -117.43 121.74 5.21 Favored Glycine 0 N--CA 1.45 -0.375 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.637 ' O ' HD12 ' A' ' 117' ' ' ILE . 1.3 p -136.63 -56.23 0.74 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.736 0.303 . . . . 0.0 111.134 -179.159 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.956 ' HB3' HG22 ' A' ' 84' ' ' VAL . 2.6 tt0 -59.36 -16.81 24.95 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.821 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.637 HD12 ' O ' ' A' ' 115' ' ' THR . 0.4 OUTLIER -55.15 -16.05 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 179.912 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.451 ' OD2' HG21 ' A' ' 161' ' ' THR . 1.3 t0 -82.13 -19.99 38.92 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 120.732 0.301 . . . . 0.0 111.151 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.57 ' C ' HD12 ' A' ' 119' ' ' LEU . 4.1 pp -121.35 1.72 10.21 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.908 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.806 ' HB3' HG21 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -50.05 -30.9 11.77 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.986 0.422 . . . . 0.0 110.647 179.88 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -59.84 -21.65 61.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.978 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.405 ' O ' ' HB ' ' A' ' 126' ' ' ILE . 31.8 t0 -44.79 99.84 0.22 Allowed Pre-proline 0 N--CA 1.462 0.136 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.869 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.416 ' O ' ' CG ' ' A' ' 127' ' ' GLU . 15.1 Cg_exo -68.94 -4.68 13.92 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.711 2.274 . . . . 0.0 112.968 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.3 t -83.36 -64.7 1.12 Allowed 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.541 HG21 HG11 ' A' ' 85' ' ' VAL . 32.5 m -55.84 -36.43 67.51 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.693 HG13 HD11 ' A' ' 129' ' ' LEU . 0.0 OUTLIER -58.69 -39.39 76.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.945 179.24 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.416 ' CG ' ' O ' ' A' ' 123' ' ' PRO . 8.8 mm-40 -63.71 -29.28 70.52 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.776 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.423 ' HD3' ' HA ' ' A' ' 125' ' ' THR . 1.8 mptt -74.16 -58.34 3.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.789 179.122 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.693 HD11 HG13 ' A' ' 126' ' ' ILE . 3.6 pp -63.22 -25.89 68.54 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.404 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.673 ' HB1' ' HG2' ' A' ' 134' ' ' GLN . . . -52.61 -41.69 63.9 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.564 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 18.0 mmtm -46.22 -24.08 0.42 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.637 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -123.04 -30.23 3.79 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.478 ' CG ' ' N ' ' A' ' 134' ' ' GLN . 0.0 OUTLIER -132.21 -72.45 0.53 Allowed 'General case' 0 CA--C 1.534 0.331 0 O-C-N 122.097 -0.377 . . . . 0.0 111.871 -178.783 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.673 ' HG2' ' HB1' ' A' ' 130' ' ' ALA . 9.5 mt-30 98.63 -46.54 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.841 0.856 . . . . 0.0 110.945 -179.038 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 4.2 mtpp -73.77 109.1 5.9 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.42 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.898 ' C ' HD13 ' A' ' 137' ' ' ILE . 55.8 Cg_endo -70.06 -170.8 0.44 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.087 1.858 . . . . 0.0 110.764 179.002 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.898 HD13 ' C ' ' A' ' 136' ' ' PRO . 1.2 mm -112.08 95.89 4.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.163 0.506 . . . . 0.0 111.057 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.415 HG22 ' H ' ' A' ' 138' ' ' THR . 0.1 OUTLIER -71.57 150.03 93.52 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.76 -179.981 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -44.01 -28.85 2.37 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.698 2.265 . . . . 0.0 112.383 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -71.26 -31.26 67.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.85 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.524 HG21 HG23 ' A' ' 137' ' ' ILE . 55.4 m -72.64 -50.58 24.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.905 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.55 ' HB3' ' CE2' ' A' ' 154' ' ' TYR . . . -50.28 -61.19 2.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.853 0.359 . . . . 0.0 110.792 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.45 -40.12 68.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.751 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -50.78 -61.24 2.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.705 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.838 HD13 ' HG3' ' A' ' 94' ' ' LYS . 3.6 tt -67.22 -34.0 76.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.568 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.964 ' HB2' HD12 ' A' ' 112' ' ' LEU . . . -57.2 -45.01 84.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.852 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 5.1 mtm180 -79.49 -25.6 41.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.843 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -58.24 -46.09 86.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.797 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.671 HD22 HG11 ' A' ' 98' ' ' VAL . 1.8 mt -102.05 24.18 10.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.804 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 39.07 55.14 2.13 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.758 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.611 ' HB1' ' O ' ' A' ' 110' ' ' PHE . . . -67.04 -81.62 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.056 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 1.028 HG11 HD12 ' A' ' 111' ' ' LEU . 50.9 t -160.54 -74.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.81 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.16 114.9 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.11 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.55 ' CE2' ' HB3' ' A' ' 142' ' ' ALA . 45.7 t80 -90.55 109.9 21.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.048 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.44 HG12 ' N ' ' A' ' 156' ' ' GLU . 3.6 t -101.67 161.43 3.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.393 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.44 ' N ' HG12 ' A' ' 155' ' ' VAL . 8.9 tt0 -89.7 140.33 29.68 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.098 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.589 ' O ' HD11 ' A' ' 117' ' ' ILE . 1.8 p 178.71 -175.14 0.19 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.314 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.516 ' O ' HD12 ' A' ' 165' ' ' LEU . 4.5 t -160.28 163.75 33.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.109 0.48 . . . . 0.0 111.677 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.762 ' HB2' HD11 ' A' ' 165' ' ' LEU . . . -114.82 -42.15 3.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.09 179.186 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.408 ' CD1' HD23 ' A' ' 119' ' ' LEU . 0.5 OUTLIER -74.43 -29.08 61.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.189 179.36 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.451 HG21 ' OD2' ' A' ' 118' ' ' ASP . 0.9 OUTLIER -111.87 -26.4 8.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.659 179.872 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.401 ' HA ' ' O ' ' A' ' 158' ' ' SER . 0.0 OUTLIER 73.52 70.57 0.12 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.232 179.844 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.409 ' HB3' ' HA ' ' A' ' 157' ' ' CYS . 12.3 mtmt -95.2 23.56 5.68 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.109 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 101.71 42.78 2.24 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.914 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.94 ' CD2' HD23 ' A' ' 19' ' ' LEU . 0.3 OUTLIER -52.29 -25.0 8.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.691 0.282 . . . . 0.0 111.042 179.911 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.405 ' HD2' ' CA ' ' B' ' 502' ' ' GLY . 22.4 pttp -69.04 -23.31 64.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.691 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -65.16 -70.33 0.24 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.707 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.955 HG11 HG13 ' A' ' 113' ' ' VAL . 7.5 p -52.64 -46.78 50.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.114 0.483 . . . . 0.0 110.431 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.624 ' CG ' HD22 ' A' ' 19' ' ' LEU . 2.6 t80 -57.25 -32.55 66.68 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.111 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 166' ' ' LYS . 30.9 t70 -71.22 -25.85 62.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.047 178.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.885 ' HB3' HD11 ' A' ' 111' ' ' LEU . 0.8 OUTLIER -74.16 -28.12 61.16 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.126 179.308 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.554 ' CA ' HD13 ' A' ' 111' ' ' LEU . . . -75.44 -40.74 57.21 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.709 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.636 HD12 HD12 ' A' ' 177' ' ' LEU . 1.6 pp -80.89 -33.71 13.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.916 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.807 HD13 ' CB ' ' B' ' 505' ' ' LEU . 1.0 OUTLIER -55.42 -58.59 7.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.417 179.647 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.579 ' HB1' ' HG3' ' A' ' 180' ' ' PRO . . . -49.5 -25.85 2.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.791 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.529 ' HB3' HG21 ' A' ' 4' ' ' ILE . . . -87.8 -41.19 13.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.118 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.636 HD12 HD12 ' A' ' 173' ' ' ILE . 41.8 mt -68.82 -23.68 64.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.892 0.377 . . . . 0.0 110.614 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.637 ' CB ' ' HB2' ' B' ' 507' ' ' ALA . 24.8 tt0 -168.19 142.78 2.85 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.841 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' PRO . . . . . 0.436 ' HD2' ' CG ' ' A' ' 178' ' ' GLU . 93.3 Cg_exo -44.07 115.44 0.73 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.587 2.191 . . . . 0.0 112.405 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' PRO . . . . . 0.579 ' HG3' ' HB1' ' A' ' 175' ' ' ALA . 67.6 Cg_endo -73.08 -171.76 0.86 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.452 2.101 . . . . 0.0 112.358 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' GLU . . . . . 0.4 ' HA ' ' HD3' ' A' ' 182' ' ' PRO . 41.4 mt-10 -148.83 151.59 35.45 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.787 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 181' ' ' GLU . 36.6 Cg_exo -59.45 -152.72 0.01 OUTLIER 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.706 2.271 . . . . 0.0 112.469 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.4 148.77 46.62 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.961 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.268 -0.872 . . . . 0.0 110.843 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 502' ' ' GLY . . . . . 0.405 ' CA ' ' HD2' ' A' ' 166' ' ' LYS . . . . . . . . 0 N--CA 1.488 2.165 0 N-CA-C 112.514 -0.234 . . . . 0.0 112.514 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 503' ' ' SER . . . . . . . . . . . . . 98.7 p -62.82 -170.9 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.843 0.354 . . . . 0.0 110.894 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 504' ' ' GLY . . . . . 0.702 ' C ' HD23 ' B' ' 505' ' ' LEU . . . -157.31 -106.63 0.24 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.396 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 505' ' ' LEU . . . . . 0.82 HD12 ' HB3' ' B' ' 507' ' ' ALA . 1.1 pt? 44.15 -171.77 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.114 0.483 . . . . 0.0 111.867 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 506' ' ' SER . . . . . . . . . . . . . 4.9 m -117.66 -15.69 10.14 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.106 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 507' ' ' ALA . . . . . 0.82 ' HB3' HD12 ' B' ' 505' ' ' LEU . . . -67.89 59.62 0.07 Allowed 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.087 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 508' ' ' GLN . . . . . 0.561 ' HB2' HD12 ' B' ' 510' ' ' ILE . 9.7 mt-30 69.86 3.17 4.18 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.608 -178.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 509' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' B' ' 504' ' ' GLY . 15.7 t0 46.7 53.47 10.08 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.378 0.609 . . . . 0.0 111.094 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 510' ' ' ILE . . . . . 0.736 HG23 HG23 ' A' ' 46' ' ' ILE . 0.9 OUTLIER -50.6 107.78 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.352 179.561 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 511' ' ' SER . . . . . 0.439 ' O ' HD12 ' B' ' 514' ' ' LEU . 48.2 m -61.87 86.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.91 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 512' ' ' GLN . . . . . 0.472 ' CB ' ' CD ' ' B' ' 513' ' ' PRO . 23.6 tp60 -50.89 -67.69 0.45 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.464 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 513' ' ' PRO . . . . . 0.472 ' CD ' ' CB ' ' B' ' 512' ' ' GLN . 98.3 Cg_endo -77.06 66.09 7.76 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.506 2.137 . . . . 0.0 112.13 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 514' ' ' LEU . . . . . 0.439 HD12 ' O ' ' B' ' 511' ' ' SER . 0.7 OUTLIER -73.69 138.78 44.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.847 0.356 . . . . 0.0 111.082 -179.756 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 515' ' ' GLN . . . . . 0.544 ' O ' HG12 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -52.49 143.52 15.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.927 -179.892 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 72.02 23.51 3.46 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.988 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 517' ' ' SER . . . . . 0.658 ' OG ' HG11 ' A' ' 44' ' ' VAL . 3.1 m -82.75 53.79 2.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.185 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 518' ' ' PHE . . . . . 0.467 ' CD1' ' O ' ' B' ' 517' ' ' SER . 10.4 m-85 -163.63 94.98 0.8 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.603 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 519' ' ' ILE . . . . . 0.681 HD12 ' O ' ' A' ' 41' ' ' ALA . 13.2 mt -55.87 -100.16 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.316 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 520' ' ' HIS . . . . . 0.553 ' N ' HG22 ' B' ' 519' ' ' ILE . 15.7 t-160 179.22 40.14 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.763 0.316 . . . . 0.0 110.943 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 521' ' ' THR . . . . . 0.663 HG21 ' CE1' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -112.87 -177.1 3.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.262 -179.792 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 522' ' ' GLY . . . . . . . . . . . . . . . 71.58 97.33 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.265 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 523' ' ' HIS . . . . . 0.413 ' O ' ' N ' ' B' ' 525' ' ' ASP . 26.1 p80 -144.82 -45.77 0.23 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.821 0.343 . . . . 0.0 111.334 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 524' ' ' GLY . . . . . 0.433 ' O ' ' CB ' ' A' ' 62' ' ' GLU . . . -67.81 68.63 0.3 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.256 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 525' ' ' ASP . . . . . 0.799 ' CG ' HG11 ' A' ' 36' ' ' VAL . 0.2 OUTLIER 176.3 37.47 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.822 0.344 . . . . 0.0 110.549 -179.732 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 526' ' ' SER . . . . . 0.772 ' HA ' HG12 ' A' ' 33' ' ' VAL . 3.1 t -113.55 96.17 5.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.901 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 527' ' ' ASP . . . . . 0.52 ' CB ' ' CD ' ' B' ' 528' ' ' PRO . 0.4 OUTLIER -134.05 -70.67 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.831 179.518 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 528' ' ' PRO . . . . . 0.52 ' CD ' ' CB ' ' B' ' 527' ' ' ASP . 13.4 Cg_endo -53.97 90.07 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.671 2.247 . . . . 0.0 112.396 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 529' ' ' ARG . . . . . 0.822 ' HD3' HG21 ' A' ' 33' ' ' VAL . 0.5 OUTLIER -96.19 5.11 51.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.003 179.491 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 530' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -49.33 -53.8 20.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.751 0.31 . . . . 0.0 111.537 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER 71.23 -154.52 0.1 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.531 -179.477 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 532' ' ' TRP . . . . . 0.459 ' CD1' ' NH2' ' B' ' 537' ' ' ARG . 0.0 OUTLIER -41.9 142.06 0.75 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.962 0.411 . . . . 0.0 111.55 -179.86 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . -163.56 -40.45 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.308 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 534' ' ' PHE . . . . . 0.627 ' CZ ' HG22 ' B' ' 538' ' ' ILE . 4.5 p90 -133.17 161.16 65.45 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 120.679 0.276 . . . . 0.0 110.553 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 535' ' ' PRO . . . . . 0.426 ' HD2' ' HB2' ' B' ' 534' ' ' PHE . 91.0 Cg_exo -42.93 103.37 0.04 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.58 2.187 . . . . 0.0 112.49 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 1.8 t0 70.53 159.36 0.2 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.987 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 537' ' ' ARG . . . . . 0.459 ' NH2' ' CD1' ' B' ' 532' ' ' TRP . 0.0 OUTLIER -62.96 -165.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.301 0.572 . . . . 0.0 110.908 179.864 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 538' ' ' ILE . . . . . 0.627 HG22 ' CZ ' ' B' ' 534' ' ' PHE . 0.0 OUTLIER -105.5 -160.74 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.269 -0.878 . . . . 0.0 108.981 178.524 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 539' ' ' ASP . . . . . 0.476 ' N ' HG12 ' B' ' 538' ' ' ILE . 38.5 p-10 -79.83 153.13 29.32 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.329 -0.548 . . . . 0.0 111.014 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 540' ' ' GLU . . . . . 0.464 ' HG2' HD12 ' B' ' 543' ' ' LEU . 0.0 OUTLIER -52.57 -22.27 4.77 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.754 -179.389 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 541' ' ' LEU . . . . . 0.783 ' N ' HD22 ' A' ' 70' ' ' LEU . 5.4 tp -54.84 -22.31 14.13 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.175 0.512 . . . . 0.0 110.853 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 542' ' ' TYR . . . . . 0.575 ' HE1' HD23 ' B' ' 541' ' ' LEU . 3.1 m-85 -104.91 -63.86 1.18 Allowed 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.708 -178.551 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 543' ' ' LEU . . . . . 0.826 HD13 ' O ' ' A' ' 58' ' ' THR . 0.1 OUTLIER 62.85 46.23 5.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.879 -179.566 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . 175.67 -70.2 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.465 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 545' ' ' ASN . . . . . 0.401 ' HB2' ' HB2' ' B' ' 528' ' ' PRO . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.274 -0.87 . . . . 0.0 110.887 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.436 ' HG2' ' CG ' ' A' ' 49' ' ' GLU . 2.4 ppp? . . . . . 0 N--CA 1.488 1.448 0 CA-C-O 120.842 0.353 . . . . 0.0 111.128 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.41 ' O ' HD13 ' B' ' 510' ' ' ILE . 62.1 tp60 -161.14 125.21 3.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.313 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.972 HG23 HD22 ' A' ' 53' ' ' LEU . 13.1 t -123.65 -173.79 2.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.227 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.934 ' C ' HD23 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -153.39 156.11 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -178.983 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.539 ' N ' HD23 ' A' ' 53' ' ' LEU . 16.3 pttm -124.9 95.52 4.54 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.044 179.155 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.422 ' HB2' ' HE3' ' A' ' 16' ' ' LYS . 8.3 m -95.61 156.5 16.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.99 0.424 . . . . 0.0 111.458 -179.257 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.921 HG13 ' HB3' ' A' ' 56' ' ' PHE . 0.2 OUTLIER -120.12 159.65 21.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.471 179.704 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.898 HG11 ' HA2' ' A' ' 15' ' ' GLY . 6.1 p -110.36 114.37 46.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.248 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.911 HG13 ' CD ' ' B' ' 540' ' ' GLU . 81.7 t -134.6 129.75 52.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.099 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 149.53 -150.01 22.05 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.186 -1.007 . . . . 0.0 112.917 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -118.81 -13.56 9.53 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.624 0.231 . . . . 0.0 111.624 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.434 ' O ' ' NH1' ' B' ' 537' ' ' ARG . . . -50.51 -101.22 0.01 OUTLIER Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.363 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -102.5 -19.08 15.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.79 0.329 . . . . 0.0 111.032 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.678 HG12 ' O ' ' A' ' 14' ' ' VAL . 37.9 t 64.52 23.34 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.647 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.898 ' HA2' HG11 ' A' ' 8' ' ' VAL . . . -153.9 134.53 4.38 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.632 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.573 ' NZ ' HD12 ' A' ' 55' ' ' LEU . 0.4 OUTLIER -86.54 7.55 25.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.75 0.309 . . . . 0.0 110.718 179.365 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.704 HG21 HG23 ' A' ' 35' ' ' THR . 1.3 p -97.24 -45.03 6.67 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 120.938 0.399 . . . . 0.0 110.992 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 28.6 p -39.26 -45.96 1.46 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.307 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.961 HD22 ' CD1' ' A' ' 169' ' ' PHE . 1.4 mp -51.12 -50.0 59.67 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.923 0.392 . . . . 0.0 110.737 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.462 HD22 ' N ' ' A' ' 20' ' ' LEU . 3.0 mm? -73.02 -19.42 61.2 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.028 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.402 ' O ' ' N ' ' A' ' 25' ' ' THR . 17.4 mm -66.7 -71.04 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 CA-C-O 120.719 0.295 . . . . 0.0 110.7 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.3 t -61.22 -27.0 68.12 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.81 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -58.9 -62.94 1.5 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.916 0.388 . . . . 0.0 110.354 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 54.7 m -82.66 -46.53 13.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.403 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.402 ' N ' ' O ' ' A' ' 21' ' ' ILE . 14.2 p -101.23 -158.07 0.65 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.416 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -153.3 27.86 0.51 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.81 0.338 . . . . 0.0 111.114 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -96.17 73.15 2.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.046 0.45 . . . . 0.0 110.502 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.454 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . 0.3 OUTLIER -86.85 -53.1 0.41 Allowed Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.745 -179.745 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.454 ' HD3' ' HB3' ' A' ' 28' ' ' PHE . 84.0 Cg_endo -85.34 78.79 2.4 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.717 2.278 . . . . 0.0 112.757 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.417 ' O ' ' CB ' ' B' ' 531' ' ' CYS . 2.8 m -141.84 -96.18 0.13 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.815 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -159.39 133.56 7.61 Favored 'General case' 0 C--N 1.334 -0.083 0 CA-C-O 120.793 0.33 . . . . 0.0 110.977 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.445 ' OH ' ' CD1' ' B' ' 532' ' ' TRP . 3.0 m-30 -97.31 94.45 7.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.403 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.561 HG13 ' HG3' ' B' ' 529' ' ' ARG . 0.0 OUTLIER -134.2 -59.04 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.995 -179.521 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.445 ' HD2' ' H ' ' A' ' 33' ' ' VAL . 77.7 Cg_exo -52.45 -21.53 14.17 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.107 1.871 . . . . 0.0 112.21 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.704 HG23 HG21 ' A' ' 17' ' ' THR . 52.8 m -71.74 62.3 0.41 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.621 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.057 HG23 ' HB3' ' A' ' 59' ' ' ALA . 4.1 p -132.25 -39.86 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.559 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.481 ' CD2' ' HA ' ' A' ' 40' ' ' TYR . 5.6 t80 -41.13 -30.52 0.15 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.585 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.427 ' CB ' ' OH ' ' A' ' 64' ' ' TYR . 11.6 t0 66.55 -68.41 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.923 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.474 ' O ' ' CE2' ' A' ' 37' ' ' PHE . 0.7 OUTLIER -77.89 55.18 1.37 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.365 -179.928 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.481 ' HA ' ' CD2' ' A' ' 37' ' ' PHE . 6.7 m-85 -60.5 139.88 57.54 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.804 0.335 . . . . 0.0 110.464 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.437 ' O ' ' CG1' ' B' ' 519' ' ' ILE . . . -90.59 119.4 30.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.207 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.7 HG12 ' HA ' ' B' ' 518' ' ' PHE . 15.4 m -137.09 123.23 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.726 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.62 HG23 ' HB3' ' B' ' 516' ' ' ASN . 8.8 t -84.29 104.16 14.09 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.855 HG13 ' HB2' ' B' ' 514' ' ' LEU . 25.5 t -145.03 148.27 18.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.184 -178.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.496 ' HE1' ' N ' ' A' ' 49' ' ' GLU . 3.2 tpt -96.18 96.47 8.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.973 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.64 HG22 ' O ' ' A' ' 46' ' ' ILE . 1.2 mm -83.25 85.76 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 120.718 0.294 . . . . 0.0 110.578 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.443 ' N ' ' HE2' ' A' ' 45' ' ' MET . . . 30.8 94.22 0.01 OUTLIER Glycine 0 CA--C 1.524 0.644 0 CA-C-N 115.694 -0.685 . . . . 0.0 114.035 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 135.27 -97.44 0.28 Allowed Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.83 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.496 ' N ' ' HE1' ' A' ' 45' ' ' MET . 0.2 OUTLIER -119.8 129.76 25.19 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.503 0.192 . . . . 0.0 110.551 179.701 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' A' ' 45' ' ' MET . 74.8 Cg_exo -37.14 96.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.914 2.41 . . . . 0.0 112.919 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.435 ' C ' ' CD1' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -172.86 142.91 1.16 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.753 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.478 HG21 ' HB ' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -135.0 153.82 51.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.267 -178.982 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.972 HD22 HG23 ' A' ' 3' ' ' THR . 5.8 tp -95.67 136.17 36.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.768 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -64.99 142.07 44.41 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.453 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.594 ' H ' HD22 ' A' ' 55' ' ' LEU . 1.6 mm? -76.33 134.98 39.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.842 0.353 . . . . 0.0 110.505 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.921 ' HB3' HG13 ' A' ' 7' ' ' VAL . 0.9 OUTLIER -84.59 108.74 17.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.912 0.387 . . . . 0.0 110.886 -179.875 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.492 ' OD1' HD21 ' B' ' 543' ' ' LEU . 0.7 OUTLIER -140.41 142.07 35.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.138 -179.886 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.793 ' OG1' HD13 ' B' ' 543' ' ' LEU . 43.4 p -101.28 -176.66 3.22 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.105 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 1.057 ' HB3' HG23 ' A' ' 36' ' ' VAL . . . -172.44 -162.58 0.2 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.886 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -148.78 43.11 0.81 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.295 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.885 HD22 ' HB3' ' B' ' 525' ' ' ASP . 0.4 OUTLIER -121.26 -160.03 0.83 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.922 0.391 . . . . 0.0 111.364 -179.732 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -48.71 -44.84 38.49 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.387 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.485 ' HB3' ' CD1' ' A' ' 64' ' ' TYR . 0.5 OUTLIER -45.97 -61.14 1.87 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.431 -179.651 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.485 ' CD1' ' HB3' ' A' ' 63' ' ' ASP . 0.1 OUTLIER -164.31 139.44 5.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.908 0.385 . . . . 0.0 111.021 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -86.73 -68.16 0.76 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.531 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.458 ' C ' HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -87.55 -32.17 19.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.634 -179.344 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.54 HD13 ' HB ' ' A' ' 58' ' ' THR . 1.3 mp 71.16 -149.05 0.08 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.535 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.475 ' CB ' ' CD ' ' A' ' 69' ' ' PRO . 1.0 OUTLIER -159.05 -65.36 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.177 0 N-CA-C 111.717 0.265 . . . . 0.0 111.717 -179.831 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.475 ' CD ' ' CB ' ' A' ' 68' ' ' ARG . 46.1 Cg_exo -35.52 -60.26 0.33 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.039 2.493 . . . . 0.0 113.377 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.891 HD13 ' HG2' ' B' ' 540' ' ' GLU . 0.3 OUTLIER -46.62 -26.66 0.95 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.658 0.266 . . . . 0.0 111.473 -179.73 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.6 t -95.39 -6.81 40.1 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.401 ' O ' ' O ' ' A' ' 69' ' ' PRO . 23.7 m-85 -134.39 151.67 76.64 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-O 120.867 0.365 . . . . 0.0 111.474 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -80.1 51.37 3.88 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.749 2.299 . . . . 0.0 112.434 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.496 ' NE2' ' CE2' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -73.65 -30.44 62.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.0 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.617 HG21 ' HD1' ' A' ' 78' ' ' PHE . 12.1 t -70.61 -176.65 1.32 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.968 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -113.42 -21.77 10.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.904 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.628 HG13 ' HB2' ' A' ' 109' ' ' PRO . 47.8 t -150.74 112.87 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.041 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.906 ' CE2' HG21 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -80.74 176.87 9.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.707 179.912 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.405 HD22 ' HA ' ' A' ' 79' ' ' LEU . 0.2 OUTLIER -142.63 108.71 5.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.218 -179.715 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.95 HG12 ' CH2' ' A' ' 97' ' ' TRP . 20.0 m -93.57 96.06 5.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.833 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 3.9 m -82.13 177.48 8.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.077 0.465 . . . . 0.0 111.458 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.459 ' CE1' ' O ' ' A' ' 113' ' ' VAL . 19.1 p90 -179.49 -173.47 0.26 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.011 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.82 134.66 18.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.783 0.325 . . . . 0.0 110.651 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.871 HG12 ' O ' ' A' ' 137' ' ' ILE . 2.2 m -45.36 -56.76 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.567 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.632 HG22 ' OE1' ' A' ' 116' ' ' GLN . 33.7 m -54.27 113.24 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.66 ' N ' HD22 ' A' ' 129' ' ' LEU . 4.1 m -151.24 125.49 4.49 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.684 0.278 . . . . 0.0 111.721 -179.197 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.433 ' O ' ' CB ' ' A' ' 88' ' ' SER . 87.5 Cg_endo -92.51 54.23 0.58 Allowed 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 123.177 2.585 . . . . 0.0 111.56 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.451 ' CB ' ' HG2' ' A' ' 133' ' ' LYS . 0.1 OUTLIER 81.97 24.08 0.23 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.889 -179.413 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.425 ' O ' HG12 ' A' ' 93' ' ' VAL . 6.1 t -97.21 -26.91 14.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.747 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.716 ' CZ ' HG21 ' A' ' 137' ' ' ILE . 13.4 t80 -55.23 -41.34 71.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.89 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 19.2 mp0 -70.22 -38.84 75.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.028 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -67.6 -45.22 76.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.158 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.747 HG22 ' CD1' ' A' ' 97' ' ' TRP . 7.4 p -65.6 -48.98 80.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.488 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.526 ' N ' HG13 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -51.15 -63.18 1.21 Allowed 'General case' 0 C--O 1.235 0.31 0 CA-C-O 120.944 0.402 . . . . 0.0 110.766 179.851 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.425 ' O ' ' CD ' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -52.47 -39.73 61.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.583 179.864 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.404 ' O ' ' CG ' ' A' ' 96' ' ' LYS . 0.2 OUTLIER -88.6 9.17 24.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.274 179.753 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.95 ' CH2' HG12 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -93.06 -58.33 2.36 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.946 0.403 . . . . 0.0 110.877 -179.908 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 1.024 HG22 HD13 ' A' ' 149' ' ' LEU . 40.8 t -56.27 -44.07 99.56 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.383 -179.361 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.491 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 6.0 Cg_exo -74.3 -19.74 19.37 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.556 2.171 . . . . 0.0 112.921 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -90.46 -59.13 2.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.932 0.396 . . . . 0.0 111.174 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.764 HG22 ' O ' ' A' ' 97' ' ' TRP . 11.5 tt -52.17 -26.22 8.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.709 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 73.7 p -94.54 -62.09 1.39 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.177 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.423 ' CB ' ' O ' ' A' ' 99' ' ' PRO . 7.9 t60 -48.33 -43.32 33.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.222 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 34.1 m-70 -85.1 -23.59 28.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.129 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 5.3 m -146.47 75.81 12.23 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.033 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -62.19 142.37 91.54 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.638 2.226 . . . . 0.0 112.259 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.8 mmtt 63.14 56.06 1.82 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.074 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -138.28 108.06 8.03 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.651 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.628 ' HB2' HG13 ' A' ' 77' ' ' VAL . 31.2 Cg_exo -60.26 164.07 13.44 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.488 2.125 . . . . 0.0 112.354 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.947 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 0.7 OUTLIER -154.42 139.59 17.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.024 179.955 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.929 HD12 HG11 ' A' ' 152' ' ' VAL . 5.8 tt -121.58 146.31 47.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.942 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.602 ' O ' HD23 ' A' ' 111' ' ' LEU . 3.3 mm? -94.61 153.47 17.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.651 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.896 HG13 HG11 ' A' ' 168' ' ' VAL . 93.3 t -136.69 146.24 28.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.095 0.474 . . . . 0.0 111.614 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.401 ' HA3' ' OH ' ' A' ' 154' ' ' TYR . . . -126.01 104.01 0.72 Allowed Glycine 0 N--CA 1.452 -0.243 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.553 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.685 ' O ' HD12 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -120.65 -50.94 2.18 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.978 0.418 . . . . 0.0 110.701 -179.037 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.687 ' HB3' HG22 ' A' ' 84' ' ' VAL . 4.8 tt0 -67.3 -8.86 35.41 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.445 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.735 HD11 ' O ' ' A' ' 157' ' ' CYS . 0.2 OUTLIER -44.6 -26.84 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-O 120.681 0.277 . . . . 0.0 111.332 -179.865 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -64.17 -25.22 67.99 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.779 0.323 . . . . 0.0 111.048 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.543 HD12 ' N ' ' A' ' 119' ' ' LEU . 4.9 mp -95.64 -19.86 19.4 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.418 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.48 ' HB3' HG11 ' A' ' 84' ' ' VAL . 5.7 ppt_? -49.43 -26.46 3.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.946 0.403 . . . . 0.0 110.684 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.37 -27.13 29.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.519 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.417 ' N ' ' O ' ' A' ' 119' ' ' LEU . 38.0 t0 -55.1 108.02 1.04 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.599 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.4 ' O ' HG22 ' A' ' 126' ' ' ILE . 15.6 Cg_exo -68.75 -3.9 12.18 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.715 2.277 . . . . 0.0 113.034 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.78 -67.76 0.75 Allowed 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.591 HG21 HG11 ' A' ' 85' ' ' VAL . 7.2 m -56.35 -35.39 67.59 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.457 178.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.599 HD11 ' HB3' ' A' ' 136' ' ' PRO . 0.1 OUTLIER -56.37 -42.02 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.772 179.348 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.553 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 66.6 mt-10 -60.74 -35.33 76.1 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.778 179.131 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 125' ' ' THR . 0.2 OUTLIER -64.52 -31.66 72.97 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.094 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.66 HD22 ' N ' ' A' ' 86' ' ' SER . 8.0 mt -73.1 -35.74 66.64 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.214 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.553 ' HB3' ' O ' ' A' ' 127' ' ' GLU . . . -46.2 -34.56 4.43 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.007 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -48.11 -32.95 7.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.531 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.408 ' HB2' ' O ' ' A' ' 87' ' ' PRO . 6.2 m-80 -123.24 -31.24 3.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.416 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.521 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 17.3 mmtt -147.19 -97.96 0.09 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 119.115 -0.469 . . . . 0.0 111.399 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.521 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 7.2 pt20 130.52 -25.1 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.412 1.085 . . . . 0.0 110.297 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 60.5 mmtt -69.28 110.64 6.61 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.766 -179.209 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.599 ' HB3' HD11 ' A' ' 126' ' ' ILE . 83.9 Cg_endo -80.17 150.96 20.5 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.565 2.177 . . . . 0.0 111.431 179.171 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.871 ' O ' HG12 ' A' ' 84' ' ' VAL . 1.1 mm -81.93 96.29 3.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.106 0.479 . . . . 0.0 110.83 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.3 p -72.02 151.06 92.71 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.031 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.5 ' HA ' ' CE2' ' A' ' 154' ' ' TYR . 79.7 Cg_exo -44.09 -37.83 10.02 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.496 2.13 . . . . 0.0 112.244 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -68.6 -33.71 74.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.773 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 24.6 m -63.56 -60.58 3.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.717 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -53.15 -38.14 62.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.893 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -59.77 -46.84 87.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.812 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 22.7 tttp -61.36 -47.8 84.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.836 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.403 ' HA ' ' HB2' ' A' ' 148' ' ' ASP . 32.8 tp -67.23 -36.09 80.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.73 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.418 ' CB ' HD23 ' A' ' 112' ' ' LEU . . . -60.45 -54.33 46.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.057 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 11.2 mtp85 -73.05 -26.89 61.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.776 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.403 ' HB2' ' HA ' ' A' ' 145' ' ' LEU . 0.3 OUTLIER -51.66 -46.47 63.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.014 179.928 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 1.024 HD13 HG22 ' A' ' 98' ' ' VAL . 1.0 OUTLIER -93.36 19.61 8.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.049 -179.956 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 78.3 tttt 48.19 43.94 19.09 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.789 0.328 . . . . 0.0 110.984 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.947 ' HB1' ' O ' ' A' ' 110' ' ' PHE . . . -72.36 -81.72 0.05 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.311 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.929 HG11 HD12 ' A' ' 111' ' ' LEU . 69.4 t -160.18 -74.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.773 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt 175.84 139.65 0.06 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.776 -179.076 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.5 ' CE2' ' HA ' ' A' ' 139' ' ' PRO . 18.0 t80 -99.96 112.28 24.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.693 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.483 HG12 ' H ' ' A' ' 156' ' ' GLU . 3.0 t -101.24 166.03 2.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.201 -179.275 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.483 ' H ' HG12 ' A' ' 155' ' ' VAL . 1.3 mm-40 -89.51 150.23 22.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.12 0.486 . . . . 0.0 111.402 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.735 ' O ' HD11 ' A' ' 117' ' ' ILE . 1.6 p 178.52 -179.24 0.31 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.089 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.429 ' HB2' ' HB2' ' A' ' 163' ' ' LYS . 0.7 OUTLIER -160.14 152.49 20.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.875 0.369 . . . . 0.0 111.179 179.698 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -109.99 -28.66 8.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.923 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.619 ' H ' HD12 ' A' ' 160' ' ' LEU . 3.2 mp -83.78 -45.22 13.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.651 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -98.8 -24.31 15.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.587 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 75.34 76.9 0.1 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.108 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.429 ' HB2' ' HB2' ' A' ' 158' ' ' SER . 2.8 tttm -94.82 34.21 1.38 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.698 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . 116.34 -62.32 0.38 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.589 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.942 HD13 ' O ' ' A' ' 19' ' ' LEU . 1.9 mt 67.55 -63.03 0.31 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.745 0.307 . . . . 0.0 111.05 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.417 ' O ' ' N ' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -55.49 -27.97 51.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.075 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -52.12 -72.63 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.858 0.361 . . . . 0.0 110.687 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.896 HG11 HG13 ' A' ' 113' ' ' VAL . 7.4 p -52.69 -46.22 49.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.173 0.511 . . . . 0.0 110.29 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.961 ' CD1' HD22 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -56.97 -29.32 63.13 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.744 179.225 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.716 ' O ' HD13 ' A' ' 173' ' ' ILE . 22.5 t0 -69.08 -29.47 67.58 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.494 178.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.667 ' HB3' HD11 ' A' ' 111' ' ' LEU . 28.8 mm-40 -75.91 -24.28 55.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.972 178.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.481 ' HA ' HD13 ' A' ' 111' ' ' LEU . . . -71.01 -54.91 9.55 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.381 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.716 HD13 ' O ' ' A' ' 170' ' ' ASP . 0.2 OUTLIER -67.64 -31.97 54.82 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-O 120.896 0.379 . . . . 0.0 110.666 -179.793 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.721 HD23 HD13 ' B' ' 505' ' ' LEU . 2.5 tm? -48.6 -33.65 10.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.742 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -74.53 -25.15 59.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.053 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.673 ' HB3' HG21 ' A' ' 4' ' ' ILE . . . -97.29 -32.41 11.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.646 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.862 HD13 ' HB ' ' B' ' 510' ' ' ILE . 14.4 mt -68.66 -11.23 59.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.223 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.456 ' HB2' ' HB1' ' B' ' 507' ' ' ALA . 0.0 OUTLIER 173.01 148.79 0.21 Allowed Pre-proline 0 C--N 1.332 -0.193 0 CA-C-O 120.768 0.318 . . . . 0.0 110.94 179.761 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 179' ' ' PRO . . . . . 0.402 ' HA ' ' HD2' ' A' ' 180' ' ' PRO . 84.5 Cg_exo -47.26 105.52 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.618 2.212 . . . . 0.0 112.305 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 179' ' ' PRO . 57.5 Cg_endo -70.97 171.85 14.97 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.581 2.188 . . . . 0.0 112.346 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -142.11 130.73 11.93 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.805 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.74 -164.95 0.23 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.546 2.164 . . . . 0.0 112.248 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.77 78.86 4.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.902 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.187 -0.911 . . . . 0.0 110.918 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 502' ' ' GLY . . . . . 0.423 ' CA ' ' OG ' ' B' ' 511' ' ' SER . . . . . . . . 0 N--CA 1.489 2.199 0 N-CA-C 112.539 -0.224 . . . . 0.0 112.539 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 503' ' ' SER . . . . . 0.403 ' HB3' ' O ' ' B' ' 510' ' ' ILE . 26.7 t -58.83 -73.29 0.08 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.795 0.331 . . . . 0.0 110.855 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 504' ' ' GLY . . . . . 0.445 ' HA2' ' CB ' ' B' ' 509' ' ' ASP . . . 94.05 103.61 1.74 Allowed Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.393 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 505' ' ' LEU . . . . . 0.721 HD13 HD23 ' A' ' 174' ' ' LEU . 0.1 OUTLIER -174.26 57.36 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.809 0.338 . . . . 0.0 110.741 -179.62 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 506' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 46.83 58.07 5.05 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.936 0.398 . . . . 0.0 110.66 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 507' ' ' ALA . . . . . 0.456 ' HB1' ' HB2' ' A' ' 178' ' ' GLU . . . -169.56 42.06 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.894 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 508' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 73.65 4.53 4.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.786 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 509' ' ' ASP . . . . . 0.445 ' CB ' ' HA2' ' B' ' 504' ' ' GLY . 3.0 p30 51.9 48.69 22.28 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 121.496 0.665 . . . . 0.0 110.673 -179.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 510' ' ' ILE . . . . . 0.862 ' HB ' HD13 ' A' ' 177' ' ' LEU . 37.5 mt -72.68 130.03 35.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.054 -0.975 . . . . 0.0 111.087 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 511' ' ' SER . . . . . 0.593 ' O ' HD11 ' B' ' 514' ' ' LEU . 16.5 m -77.2 135.79 38.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.3 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 512' ' ' GLN . . . . . 0.444 ' HB3' ' HD3' ' B' ' 513' ' ' PRO . 0.0 OUTLIER -97.91 -53.8 0.2 Allowed Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.092 179.744 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 513' ' ' PRO . . . . . 0.444 ' HD3' ' HB3' ' B' ' 512' ' ' GLN . 97.2 Cg_endo -90.56 59.39 1.46 Allowed 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.835 2.357 . . . . 0.0 112.231 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 514' ' ' LEU . . . . . 0.855 ' HB2' HG13 ' A' ' 44' ' ' VAL . 1.2 mp -75.21 -174.61 2.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.946 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 515' ' ' GLN . . . . . 0.596 ' O ' HG22 ' A' ' 44' ' ' VAL . 1.9 mt-30 -72.27 158.28 36.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.932 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 516' ' ' ASN . . . . . 0.62 ' HB3' HG23 ' A' ' 43' ' ' THR . 9.7 m120 59.89 24.04 13.09 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.885 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 517' ' ' SER . . . . . 0.54 ' HA ' HG21 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -41.08 -29.48 0.12 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.854 -179.737 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 518' ' ' PHE . . . . . 0.7 ' HA ' HG12 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -150.92 135.49 17.14 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.839 0.352 . . . . 0.0 111.409 -179.778 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 519' ' ' ILE . . . . . 0.437 ' CG1' ' O ' ' A' ' 41' ' ' ALA . 2.7 pt -121.21 -37.02 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.845 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -120.04 -166.84 1.35 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.672 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 521' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -151.47 54.55 0.85 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.063 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 522' ' ' GLY . . . . . 0.457 ' HA2' ' CD2' ' A' ' 37' ' ' PHE . . . 45.52 -148.0 1.89 Allowed Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.529 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 523' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -173.1 -101.36 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.641 0.221 . . . . 0.0 111.037 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 524' ' ' GLY . . . . . . . . . . . . . . . 69.13 -63.0 0.54 Allowed Glycine 0 C--N 1.337 0.619 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.4 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 525' ' ' ASP . . . . . 0.885 ' HB3' HD22 ' A' ' 61' ' ' LEU . 24.2 t70 177.29 82.59 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.874 0.369 . . . . 0.0 110.719 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 526' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.51 95.99 5.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.801 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 527' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -146.1 158.57 48.09 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.915 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -68.62 97.56 0.54 Allowed 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.626 2.217 . . . . 0.0 112.328 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 529' ' ' ARG . . . . . 0.561 ' HG3' HG13 ' A' ' 33' ' ' VAL . 0.2 OUTLIER -100.53 -53.6 3.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.971 -179.998 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 530' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -166.76 95.16 0.51 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.492 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 531' ' ' CYS . . . . . 0.417 ' CB ' ' O ' ' A' ' 30' ' ' SER . 96.5 m -55.46 160.43 2.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.943 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 532' ' ' TRP . . . . . 0.445 ' CD1' ' OH ' ' A' ' 32' ' ' TYR . 88.5 t90 -55.12 139.46 41.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.832 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . -134.53 -123.69 2.38 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.594 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 534' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.84 147.43 89.51 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.745 0.307 . . . . 0.0 110.948 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_exo -51.61 -176.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.697 2.265 . . . . 0.0 112.351 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 3.5 t70 53.64 99.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.996 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 537' ' ' ARG . . . . . 0.464 ' HB3' ' CG2' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -75.57 179.02 5.57 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.299 0.571 . . . . 0.0 110.893 179.898 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 538' ' ' ILE . . . . . 0.43 ' O ' HG21 ' A' ' 14' ' ' VAL . 1.8 pt -74.87 -154.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.984 179.405 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 539' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -107.58 148.19 29.61 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.726 0.298 . . . . 0.0 110.419 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 540' ' ' GLU . . . . . 0.911 ' CD ' HG13 ' A' ' 9' ' ' VAL . 12.9 pm0 -48.11 -25.58 1.51 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.036 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 541' ' ' LEU . . . . . 0.517 ' HA ' HD21 ' A' ' 70' ' ' LEU . 11.0 mt -37.5 -45.29 0.72 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.523 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 542' ' ' TYR . . . . . 0.456 ' CD1' ' N ' ' B' ' 542' ' ' TYR . 1.4 m-30 -104.73 -63.12 1.25 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.879 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 543' ' ' LEU . . . . . 0.886 HD12 ' HA ' ' B' ' 540' ' ' GLU . 0.0 OUTLIER 76.9 125.06 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.844 -179.853 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 544' ' ' GLY . . . . . 0.424 ' HA2' ' HB2' ' A' ' 32' ' ' TYR . . . 55.77 -159.08 7.56 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.483 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 545' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.207 -0.901 . . . . 0.0 110.925 179.983 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.4 tpt . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.889 0.376 . . . . 0.0 111.085 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.4 tm0? -81.78 144.1 31.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.635 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.704 HG23 ' CE1' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -93.82 -175.52 3.76 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.342 -179.639 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.977 HG13 HD13 ' A' ' 53' ' ' LEU . 5.2 pt -154.99 143.67 13.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.948 -179.151 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.416 ' O ' HG23 ' A' ' 75' ' ' THR . 3.2 ptpp? -134.33 95.57 3.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.131 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.499 ' SG ' HG13 ' A' ' 77' ' ' VAL . 80.5 m -118.87 153.34 34.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.059 0.457 . . . . 0.0 111.332 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.656 HG22 ' HB2' ' A' ' 56' ' ' PHE . 2.5 t -142.99 128.46 16.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.453 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.724 HG23 ' SG ' ' A' ' 81' ' ' CYS . 1.4 p -84.68 113.84 23.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.166 0.507 . . . . 0.0 111.192 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.868 HG11 ' CE1' ' A' ' 72' ' ' TYR . 1.3 m -114.74 129.75 70.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.443 178.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.482 ' HA2' ' CZ2' ' A' ' 97' ' ' TRP . . . 149.13 -170.11 29.48 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.098 -1.049 . . . . 0.0 112.808 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.435 ' O ' ' N ' ' B' ' 537' ' ' ARG . 0.4 OUTLIER -98.3 27.54 4.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.715 0.293 . . . . 0.0 110.691 179.91 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.428 ' CA ' ' HB2' ' B' ' 537' ' ' ARG . . . -126.34 170.62 18.15 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.684 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.71 ' HB1' ' HB2' ' A' ' 18' ' ' CYS . . . -98.27 -38.26 9.34 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.715 0.293 . . . . 0.0 111.344 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.816 HG11 HG21 ' A' ' 115' ' ' THR . 2.1 m -43.94 91.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.481 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.66 ' CA ' HD22 ' A' ' 19' ' ' LEU . . . -175.55 -71.43 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.934 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.441 ' CD ' ' HB3' ' A' ' 55' ' ' LEU . 8.8 mmtm -97.39 -80.67 0.44 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.007 0.432 . . . . 0.0 111.912 -179.293 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . 1.026 HG21 HG23 ' A' ' 35' ' ' THR . 71.7 p -75.1 -69.57 0.47 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.547 -178.576 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.71 ' HB2' ' HB1' ' A' ' 13' ' ' ALA . 43.2 t -33.01 -43.35 0.1 Allowed 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -178.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.8 HD13 ' HA ' ' A' ' 14' ' ' VAL . 0.2 OUTLIER -60.71 -52.71 63.94 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.782 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -70.49 -24.42 62.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.842 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 27.7 mm -57.81 -71.18 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.492 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.5 m -60.87 -23.37 65.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.128 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.471 ' CE2' ' HB2' ' B' ' 513' ' ' PRO . 41.5 t80 -65.19 -68.24 0.38 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.858 0.361 . . . . 0.0 110.284 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 96.9 m -75.87 -37.58 58.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.744 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.4 p -113.12 -166.8 1.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.684 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -142.0 19.08 2.12 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.12 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.8 mmtm -93.35 95.98 9.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.021 0.438 . . . . 0.0 110.566 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.473 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . 2.6 t80 -87.01 -50.6 0.45 Allowed Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.301 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.473 ' HD3' ' HB3' ' A' ' 28' ' ' PHE . 64.9 Cg_endo -88.66 46.04 1.01 Allowed 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.842 2.361 . . . . 0.0 112.475 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.5 p -83.7 -94.36 0.07 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.127 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -158.87 124.74 4.44 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.797 0.332 . . . . 0.0 111.17 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.475 ' O ' HG22 ' A' ' 33' ' ' VAL . 4.6 m-30 -88.58 94.7 9.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.598 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.652 HG13 ' OXT' ' B' ' 545' ' ' ASN . 0.0 OUTLIER -165.03 -64.07 0.01 OUTLIER Pre-proline 0 N--CA 1.466 0.328 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.633 -179.804 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.452 ' CD ' ' HB ' ' A' ' 33' ' ' VAL . 10.3 Cg_endo -53.09 -16.98 7.25 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.889 2.393 . . . . 0.0 112.67 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' THR . . . . . 1.026 HG23 HG21 ' A' ' 17' ' ' THR . 45.4 m -36.18 -31.83 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.533 HG21 ' HA3' ' B' ' 524' ' ' GLY . 0.0 OUTLIER -44.31 -28.37 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 120.685 0.279 . . . . 0.0 111.436 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.467 ' O ' ' CG ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -78.39 57.7 1.98 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.088 179.857 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -135.05 -47.46 0.72 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.845 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -63.96 -16.88 62.55 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.265 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.66 -157.5 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.932 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.409 ' O ' HG12 ' B' ' 519' ' ' ILE . . . -90.76 162.6 14.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.068 0.461 . . . . 0.0 111.951 -179.26 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.588 HG13 ' C ' ' B' ' 517' ' ' SER . 4.8 t -134.86 166.58 28.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.078 179.537 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.69 HG22 HD13 ' B' ' 519' ' ' ILE . 9.4 t -143.82 103.8 4.1 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.904 HG22 ' CG2' ' A' ' 52' ' ' THR . 30.9 m -161.84 -177.46 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.017 178.489 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.499 ' O ' HD21 ' B' ' 514' ' ' LEU . 0.0 OUTLIER -105.63 100.01 9.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.61 0.243 . . . . 0.0 111.642 -179.479 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.608 HG22 ' O ' ' A' ' 46' ' ' ILE . 5.1 mm -75.01 86.59 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 178.334 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.458 ' HA3' ' HA ' ' B' ' 510' ' ' ILE . . . 45.76 -95.61 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.689 -0.687 . . . . 0.0 113.401 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -38.04 -90.41 0.01 OUTLIER Glycine 0 CA--C 1.52 0.355 0 N-CA-C 113.992 0.357 . . . . 0.0 113.992 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.439 ' N ' ' HE1' ' A' ' 45' ' ' MET . 0.1 OUTLIER -123.14 159.12 55.69 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.789 0.328 . . . . 0.0 111.161 -179.181 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.416 ' HD2' ' HB2' ' A' ' 49' ' ' GLU . 2.7 Cg_endo -46.15 105.06 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.792 2.328 . . . . 0.0 112.356 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.704 ' CE1' HG23 ' A' ' 3' ' ' THR . 1.7 t80 -172.27 158.72 4.53 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.328 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.904 ' CG2' HG22 ' A' ' 44' ' ' VAL . 3.3 p -136.41 153.07 51.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.154 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.977 HD13 HG13 ' A' ' 4' ' ' ILE . 0.5 OUTLIER -78.76 -174.64 4.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.629 179.61 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -114.16 76.14 0.24 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.399 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.64 HD21 ' NE2' ' B' ' 512' ' ' GLN . 0.6 OUTLIER -52.56 114.62 1.44 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.938 0.399 . . . . 0.0 110.356 179.845 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.656 ' HB2' HG22 ' A' ' 7' ' ' VAL . 77.3 m-85 -84.4 109.42 17.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.069 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.417 ' HA ' ' HG3' ' A' ' 16' ' ' LYS . 3.5 t0 -108.2 -175.76 2.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.652 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.607 HG21 ' O ' ' B' ' 540' ' ' GLU . 16.8 p -135.83 170.38 16.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.093 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.821 ' N ' HD21 ' A' ' 67' ' ' LEU . . . -171.82 167.01 6.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.111 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' B' ' 543' ' ' LEU . . . -146.14 33.73 1.46 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.306 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.694 HD13 ' OD1' ' B' ' 525' ' ' ASP . 0.0 OUTLIER -121.22 -173.68 2.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.765 0.317 . . . . 0.0 110.817 179.957 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -44.52 -27.76 0.5 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.697 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.465 ' OD2' ' CE1' ' A' ' 64' ' ' TYR . 45.2 t0 -47.67 -63.44 1.06 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.223 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.523 ' O ' HD23 ' A' ' 67' ' ' LEU . 0.0 OUTLIER 170.88 73.65 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.175 179.905 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -58.76 -19.9 44.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.101 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.14 -14.24 61.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.596 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.821 HD21 ' N ' ' A' ' 59' ' ' ALA . 3.6 pp -47.69 135.51 11.56 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.839 0.352 . . . . 0.0 111.087 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.479 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -139.55 48.52 1.64 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.084 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 71.0 Cg_endo -74.17 -9.58 22.03 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.451 2.101 . . . . 0.0 112.484 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.769 HD11 HD23 ' B' ' 541' ' ' LEU . 0.1 OUTLIER -78.78 1.04 24.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.641 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -55.13 -20.47 10.16 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.625 0.25 . . . . 0.0 111.437 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.868 ' CE1' HG11 ' A' ' 9' ' ' VAL . 34.2 m-85 73.59 64.84 0.31 Allowed Pre-proline 0 C--N 1.332 -0.17 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.819 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.1 -150.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.581 2.188 . . . . 0.0 111.955 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -60.39 -16.17 32.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.374 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 5' ' ' LYS . 55.3 m -42.12 133.06 3.15 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.871 0.367 . . . . 0.0 111.298 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.846 ' HA ' HG22 ' A' ' 108' ' ' THR . 0.4 OUTLIER -115.1 7.47 15.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.562 -179.82 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.758 HG21 ' HB3' ' A' ' 175' ' ' ALA . 7.9 p -145.21 79.95 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.881 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.586 ' HE1' HD12 ' A' ' 101' ' ' ILE . 1.1 p90 -92.8 124.82 37.07 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 178.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.482 HD11 ' CG2' ' A' ' 113' ' ' VAL . 12.7 tp -70.37 108.65 4.34 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.78 -178.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.659 HG21 ' CD1' ' A' ' 110' ' ' PHE . 2.1 t -80.19 156.13 4.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.696 178.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.724 ' SG ' HG23 ' A' ' 8' ' ' VAL . 2.8 m -145.77 129.75 17.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.318 0.58 . . . . 0.0 112.363 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.699 ' HE2' HD12 ' A' ' 112' ' ' LEU . 17.4 p90 -152.21 128.78 10.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.564 178.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -83.06 137.62 34.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.125 0.488 . . . . 0.0 111.76 -178.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.727 HG11 ' HB3' ' A' ' 120' ' ' ARG . 72.5 t -47.85 -78.73 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.246 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.73 HG22 ' OE1' ' A' ' 116' ' ' GLN . 29.6 m -42.8 113.95 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.086 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.537 ' C ' HD22 ' A' ' 129' ' ' LEU . 3.0 p -152.25 145.07 17.19 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.888 0.375 . . . . 0.0 111.909 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.427 ' HA ' ' HB3' ' A' ' 133' ' ' LYS . 76.9 Cg_endo -91.23 53.96 0.91 Allowed 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.226 2.618 . . . . 0.0 111.659 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.482 ' N ' ' CB ' ' A' ' 133' ' ' LYS . 0.7 OUTLIER 82.15 33.26 0.09 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.806 -179.455 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.898 ' O ' HG23 ' A' ' 93' ' ' VAL . 1.1 t -88.31 -24.75 23.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.023 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.512 ' CD1' HG13 ' A' ' 137' ' ' ILE . 2.1 t80 -51.07 -56.78 10.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.096 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -53.11 -41.9 65.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.131 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.422 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 1.8 t-20 -72.73 -53.16 12.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.975 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.898 HG23 ' O ' ' A' ' 89' ' ' SER . 46.5 t -49.81 -44.44 20.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.207 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.469 ' O ' HG23 ' A' ' 98' ' ' VAL . 30.4 tttt -62.23 -52.59 63.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.998 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.414 ' O ' ' HG3' ' A' ' 99' ' ' PRO . 70.2 mt-10 -84.51 9.38 13.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.681 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.422 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 25.7 tttp -116.12 -37.75 3.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.729 0.3 . . . . 0.0 110.725 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.482 ' CZ2' ' HA2' ' A' ' 10' ' ' GLY . 0.8 OUTLIER -94.42 -46.85 6.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.34 -179.769 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.482 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 56.9 t -51.98 -46.07 92.89 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.654 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.482 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 92.0 Cg_endo -81.1 -12.37 11.82 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.342 2.028 . . . . 0.0 112.757 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -86.61 -49.17 7.72 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.861 0.362 . . . . 0.0 110.585 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.586 HD12 ' HE1' ' A' ' 78' ' ' PHE . 32.4 pt -66.55 -28.15 42.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.879 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.425 HG23 ' O ' ' A' ' 98' ' ' VAL . 27.5 p -77.68 -33.25 53.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.579 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -64.12 -46.09 85.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.758 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 27.5 m170 -82.86 -24.15 33.37 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.758 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -142.94 95.8 6.13 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.665 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -68.81 133.13 26.51 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.594 2.196 . . . . 0.0 112.574 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 49.02 77.32 0.1 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.156 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.846 HG22 ' HA ' ' A' ' 76' ' ' ASP . 0.1 OUTLIER -139.29 115.09 8.35 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.878 179.857 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.42 162.78 13.91 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.639 2.226 . . . . 0.0 112.826 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.659 ' CD1' HG21 ' A' ' 80' ' ' VAL . 37.0 p90 -161.69 165.05 28.73 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.549 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.975 HD12 HG11 ' A' ' 152' ' ' VAL . 0.9 OUTLIER -114.96 159.62 20.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.939 0.399 . . . . 0.0 111.635 -179.562 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.737 HD22 ' C ' ' A' ' 111' ' ' LEU . 2.4 mm? -119.48 161.14 21.07 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.575 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.492 HG12 ' CG2' ' A' ' 115' ' ' THR . 3.1 t -134.4 142.85 39.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.911 0.386 . . . . 0.0 111.694 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.628 ' O ' HD13 ' A' ' 117' ' ' ILE . . . -121.76 67.77 0.45 Allowed Glycine 0 C--N 1.331 0.28 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.989 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.816 HG21 HG11 ' A' ' 14' ' ' VAL . 1.4 p -92.38 26.55 2.55 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -178.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.73 ' OE1' HG22 ' A' ' 85' ' ' VAL . 2.9 mm-40 -131.88 23.85 4.62 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.199 0.523 . . . . 0.0 109.737 179.12 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.725 HD11 ' N ' ' A' ' 158' ' ' SER . 0.0 OUTLIER -67.68 -9.62 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.8 179.253 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -100.43 -40.59 7.39 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.144 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.625 HD13 ' CD ' ' A' ' 116' ' ' GLN . 3.5 mp -69.54 -33.79 73.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.313 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.727 ' HB3' HG11 ' A' ' 84' ' ' VAL . 0.1 OUTLIER -47.25 -33.83 5.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.891 0.377 . . . . 0.0 110.984 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -80.13 -27.35 39.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.549 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' A' ' 119' ' ' LEU . 2.2 t70 -57.59 106.47 0.69 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.76 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -70.0 -3.83 12.95 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.643 2.229 . . . . 0.0 112.847 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.98 -67.27 0.77 Allowed 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.059 0.457 . . . . 0.0 110.0 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.416 ' O ' ' HB3' ' A' ' 128' ' ' LYS . 2.1 m -56.17 -43.58 78.51 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 178.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.88 HD11 ' HB3' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -48.28 -42.17 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.524 178.913 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.573 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 0.4 OUTLIER -55.63 -49.44 72.84 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.006 178.679 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.682 ' HD2' HD23 ' A' ' 129' ' ' LEU . 0.1 OUTLIER -54.67 -32.89 59.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.2 179.017 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.682 HD23 ' HD2' ' A' ' 128' ' ' LYS . 7.5 mt -72.41 -42.0 65.62 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.578 ' HB2' ' HG3' ' A' ' 134' ' ' GLN . . . -42.51 -30.7 0.37 Allowed 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.106 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.404 ' HG2' ' O ' ' A' ' 128' ' ' LYS . 2.9 mmmt -58.94 -39.56 81.97 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.247 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -125.16 -30.59 3.17 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.482 ' CB ' ' N ' ' A' ' 88' ' ' SER . 0.3 OUTLIER -130.51 -69.68 0.65 Allowed 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -177.719 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.578 ' HG3' ' HB2' ' A' ' 130' ' ' ALA . 2.8 tt0 87.73 -37.23 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.341 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.44 ' CB ' ' HE3' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -69.03 111.23 7.82 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 120.733 0.301 . . . . 0.0 111.505 -179.137 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.88 ' HB3' HD11 ' A' ' 126' ' ' ILE . 74.2 Cg_endo -77.5 129.68 10.33 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.544 2.163 . . . . 0.0 112.019 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.531 ' HB ' HG13 ' A' ' 84' ' ' VAL . 0.6 OUTLIER -59.42 96.9 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.94 179.904 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.42 ' O ' ' N ' ' A' ' 141' ' ' THR . 11.1 p -67.32 147.29 98.91 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.897 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_exo -40.88 -40.71 3.75 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.728 2.285 . . . . 0.0 112.318 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -69.24 -36.6 77.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.6 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.42 ' N ' ' O ' ' A' ' 138' ' ' THR . 90.6 m -55.31 -56.69 17.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.76 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.572 ' HB3' ' CE2' ' A' ' 154' ' ' TYR . . . -52.53 -39.57 61.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.81 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.98 -34.98 79.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.703 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.2 tptt -59.98 -58.63 7.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.783 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.425 ' HA ' ' HB2' ' A' ' 148' ' ' ASP . 24.1 tp -65.71 -35.98 82.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.761 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -58.11 -61.04 2.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.167 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 4.4 mtt85 -72.39 -25.44 61.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.012 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.425 ' HB2' ' HA ' ' A' ' 145' ' ' LEU . 1.8 m-20 -49.36 -41.87 40.31 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.036 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 5.9 mt -102.69 23.14 12.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.922 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 48.34 33.85 4.17 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.971 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.707 ' O ' HG23 ' A' ' 152' ' ' VAL . . . -51.96 -81.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.187 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.975 HG11 HD12 ' A' ' 111' ' ' LEU . 8.0 t -164.56 -69.21 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.894 0.378 . . . . 0.0 110.394 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 177.41 135.45 0.07 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.243 -179.104 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.572 ' CE2' ' HB3' ' A' ' 142' ' ' ALA . 24.7 t80 -106.75 114.7 28.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.728 178.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.622 ' HB ' HG22 ' A' ' 168' ' ' VAL . 2.8 t -101.24 151.99 5.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.733 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -99.12 118.58 36.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.4 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.512 ' N ' HD12 ' A' ' 117' ' ' ILE . 0.9 OUTLIER 178.3 125.96 0.05 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.546 179.523 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.725 ' N ' HD11 ' A' ' 117' ' ' ILE . 40.2 t -118.61 151.57 37.66 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.076 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -72.06 -38.46 69.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.942 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.514 ' H ' HD12 ' A' ' 160' ' ' LEU . 4.1 mp -52.6 -52.55 54.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.562 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 12.9 t -77.23 -42.62 36.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.562 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.404 ' O ' ' O ' ' A' ' 163' ' ' LYS . 3.1 tt0 176.71 -85.38 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.195 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.938 ' HG2' HD22 ' A' ' 165' ' ' LEU . 4.7 tttm 58.76 118.76 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.925 0.393 . . . . 0.0 110.726 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . -71.12 -10.12 68.32 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.43 -0.89 . . . . 0.0 112.523 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.938 HD22 ' HG2' ' A' ' 163' ' ' LYS . 4.0 mm? 66.95 -63.73 0.26 Allowed 'General case' 0 CA--C 1.522 -0.097 0 CA-C-O 120.702 0.287 . . . . 0.0 110.474 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.436 ' O ' ' CB ' ' A' ' 170' ' ' ASP . 1.7 ptmt -57.04 -32.14 65.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.688 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.433 ' N ' ' HG2' ' A' ' 166' ' ' LYS . 2.6 t-20 -53.92 -72.17 0.06 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.764 0.316 . . . . 0.0 110.617 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.622 HG22 ' HB ' ' A' ' 155' ' ' VAL . 5.9 t -63.41 -43.06 98.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.244 0.545 . . . . 0.0 110.073 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.763 ' CG ' HD23 ' A' ' 19' ' ' LEU . 0.9 OUTLIER -58.57 -24.01 59.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.603 179.539 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.443 ' HA ' ' CG1' ' A' ' 173' ' ' ILE . 27.5 t0 -76.99 -41.53 42.5 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.879 0.371 . . . . 0.0 110.038 179.26 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.509 ' HB3' HD11 ' A' ' 111' ' ' LEU . 13.4 mm-40 -56.59 -33.76 66.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.185 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.606 ' N ' HD13 ' A' ' 111' ' ' LEU . . . -73.54 -58.22 3.46 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.129 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.488 ' HB ' HD12 ' A' ' 4' ' ' ILE . 1.3 pp -62.66 -39.93 86.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.23 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.883 HD13 HD22 ' B' ' 505' ' ' LEU . 5.0 tp -48.03 -43.18 29.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.194 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.758 ' HB3' HG21 ' A' ' 77' ' ' VAL . . . -52.59 -23.26 6.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.071 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.49 ' HB3' ' HB ' ' A' ' 4' ' ' ILE . . . -90.88 -36.5 14.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.394 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.847 HD13 ' HB ' ' B' ' 510' ' ' ILE . 80.7 mt -68.55 -23.02 64.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.816 0.341 . . . . 0.0 110.671 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.481 ' HG3' ' HB2' ' B' ' 507' ' ' ALA . 0.6 OUTLIER -169.96 167.22 5.08 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.799 179.878 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 179' ' ' PRO . . . . . 0.422 ' HD2' ' CB ' ' A' ' 178' ' ' GLU . 32.4 Cg_endo -64.17 124.58 13.67 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.576 2.184 . . . . 0.0 112.251 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -74.03 164.7 33.79 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.457 2.104 . . . . 0.0 112.455 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' GLU . . . . . 0.409 ' O ' ' CG ' ' A' ' 181' ' ' GLU . 0.7 OUTLIER -117.09 114.41 38.96 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.807 179.999 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.62 -165.04 0.25 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.567 2.178 . . . . 0.0 112.321 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.48 77.66 7.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.999 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.168 -0.92 . . . . 0.0 110.787 179.99 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.122 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 503' ' ' SER . . . . . . . . . . . . . 31.0 t -105.41 -71.93 0.73 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.78 0.324 . . . . 0.0 111.034 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 504' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' B' ' 509' ' ' ASP . . . 111.93 122.49 4.14 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.126 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 505' ' ' LEU . . . . . 0.883 HD22 HD13 ' A' ' 174' ' ' LEU . 0.4 OUTLIER -173.92 -37.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.54 -179.572 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 506' ' ' SER . . . . . 0.599 ' N ' HD12 ' B' ' 505' ' ' LEU . 0.3 OUTLIER 171.46 -56.82 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.704 0.288 . . . . 0.0 110.913 -179.821 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 507' ' ' ALA . . . . . 0.481 ' HB2' ' HG3' ' A' ' 178' ' ' GLU . . . -39.9 -43.74 1.55 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.688 0.756 . . . . 0.0 111.073 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 508' ' ' GLN . . . . . 0.48 ' O ' ' CB ' ' B' ' 509' ' ' ASP . 1.9 pt20 164.99 -39.22 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.362 -1.29 . . . . 0.0 108.226 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 509' ' ' ASP . . . . . 0.48 ' CB ' ' O ' ' B' ' 508' ' ' GLN . 7.6 p30 147.25 41.44 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 113.94 -1.482 . . . . 0.0 110.197 179.007 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 510' ' ' ILE . . . . . 0.847 ' HB ' HD13 ' A' ' 177' ' ' LEU . 13.7 mt -72.08 126.27 32.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.263 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 511' ' ' SER . . . . . . . . . . . . . 30.3 t -109.47 141.73 41.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.288 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 512' ' ' GLN . . . . . 0.64 ' NE2' HD21 ' A' ' 55' ' ' LEU . 4.3 tp60 -92.89 -67.68 0.1 OUTLIER Pre-proline 0 CA--C 1.532 0.27 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.151 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 513' ' ' PRO . . . . . 0.492 ' HD3' ' HB3' ' B' ' 512' ' ' GLN . 92.3 Cg_endo -80.3 74.31 5.6 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.451 2.101 . . . . 0.0 111.461 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 514' ' ' LEU . . . . . 0.499 HD21 ' O ' ' A' ' 45' ' ' MET . 2.3 mp -73.45 -86.7 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.488 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 515' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -79.25 -87.76 0.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.693 -0.231 . . . . 0.0 111.052 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -117.57 -29.67 5.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.803 0.335 . . . . 0.0 111.134 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 517' ' ' SER . . . . . 0.588 ' C ' HG13 ' A' ' 42' ' ' VAL . 2.6 m 72.01 22.27 3.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.964 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 518' ' ' PHE . . . . . 0.48 ' CD1' ' O ' ' B' ' 517' ' ' SER . 12.1 m-85 -150.13 130.44 13.73 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.027 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 519' ' ' ILE . . . . . 0.69 HD13 HG22 ' A' ' 43' ' ' THR . 43.9 mm -63.62 -68.32 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.994 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -155.06 -67.41 0.13 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.061 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 521' ' ' THR . . . . . . . . . . . . . 11.2 m -163.88 157.63 18.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.101 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 522' ' ' GLY . . . . . . . . . . . . . . . -91.78 -92.08 1.39 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.333 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 523' ' ' HIS . . . . . 0.411 ' CD2' ' N ' ' B' ' 523' ' ' HIS . 0.1 OUTLIER 174.73 -98.81 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.475 0.137 . . . . 0.0 110.845 179.881 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 524' ' ' GLY . . . . . 0.533 ' HA3' HG21 ' A' ' 36' ' ' VAL . . . 42.35 -95.06 0.01 OUTLIER Glycine 0 C--N 1.338 0.658 0 C-N-CA 120.991 -0.623 . . . . 0.0 113.009 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 525' ' ' ASP . . . . . 0.694 ' OD1' HD13 ' A' ' 61' ' ' LEU . 33.2 p-10 177.46 91.65 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.815 0.34 . . . . 0.0 111.088 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 526' ' ' SER . . . . . 0.443 ' CB ' ' HB3' ' A' ' 34' ' ' PRO . 9.2 t -80.04 95.71 6.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.724 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 527' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -144.6 147.91 37.93 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.816 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.55 99.92 0.65 Allowed 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.552 2.168 . . . . 0.0 112.323 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 529' ' ' ARG . . . . . 0.614 ' HG3' HG21 ' A' ' 33' ' ' VAL . 12.6 mtp180 -100.29 -54.88 2.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.004 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 530' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -158.72 96.85 1.4 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.836 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 27.8 p -68.76 112.13 5.29 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.955 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 532' ' ' TRP . . . . . 0.504 ' CD1' ' NH2' ' B' ' 537' ' ' ARG . 22.4 t90 66.74 -68.95 0.13 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.833 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . 61.39 -80.76 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.52 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 534' ' ' PHE . . . . . 0.416 ' O ' ' NH1' ' B' ' 537' ' ' ARG . 17.7 m-85 -105.54 149.86 38.35 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.685 0.279 . . . . 0.0 110.844 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.27 -12.72 30.26 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.502 2.135 . . . . 0.0 112.555 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -112.98 120.79 42.61 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.831 0.348 . . . . 0.0 111.003 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 537' ' ' ARG . . . . . 0.504 ' NH2' ' CD1' ' B' ' 532' ' ' TRP . 11.6 mmt-85 -71.57 138.51 48.86 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.156 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 538' ' ' ILE . . . . . 0.4 HD12 ' HA ' ' B' ' 538' ' ' ILE . 4.1 tp -56.46 139.03 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.941 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 539' ' ' ASP . . . . . . . . . . . . . 34.3 p-10 -42.64 126.03 3.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.862 0.363 . . . . 0.0 111.125 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 540' ' ' GLU . . . . . 0.607 ' O ' HG21 ' A' ' 58' ' ' THR . 19.8 mm-40 -49.34 -22.58 1.15 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.077 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 541' ' ' LEU . . . . . 0.769 HD23 HD11 ' A' ' 70' ' ' LEU . 0.4 OUTLIER -35.26 -53.21 0.62 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.995 0.426 . . . . 0.0 111.62 179.81 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 542' ' ' TYR . . . . . 0.429 ' O ' ' N ' ' A' ' 59' ' ' ALA . 0.4 OUTLIER -104.8 -62.5 1.33 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.327 179.4 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 543' ' ' LEU . . . . . 0.496 HD13 ' HA ' ' B' ' 540' ' ' GLU . 3.4 tp 62.22 153.05 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.567 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . 103.26 82.73 1.65 Allowed Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.382 -0.913 . . . . 0.0 112.592 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 545' ' ' ASN . . . . . 0.652 ' OXT' HG13 ' A' ' 33' ' ' VAL . 1.1 m120 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.862 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.656 ' CE ' HG23 ' A' ' 46' ' ' ILE . 5.5 tpt . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 120.861 0.363 . . . . 0.0 111.233 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.678 ' O ' HD22 ' A' ' 177' ' ' LEU . 15.3 pt20 -167.17 138.81 3.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.753 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.941 HG23 HD12 ' A' ' 53' ' ' LEU . 13.7 t -109.94 -139.67 0.38 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.26 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.849 HG22 ' HB3' ' A' ' 176' ' ' ALA . 0.2 OUTLIER -150.55 152.54 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -178.865 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 13.1 pttt -134.0 95.61 3.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.602 178.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.409 ' O ' ' HE2' ' A' ' 16' ' ' LYS . 25.1 m -102.03 154.35 19.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.188 0.518 . . . . 0.0 111.876 -178.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.6 t -133.12 150.21 32.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.164 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.71 HG13 ' HB ' ' A' ' 14' ' ' VAL . 53.5 t -97.3 143.75 12.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.267 0.556 . . . . 0.0 111.056 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.596 HG13 ' O ' ' A' ' 8' ' ' VAL . 6.7 m -161.67 129.95 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.853 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 148.59 -178.68 26.0 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 119.882 -1.151 . . . . 0.0 112.909 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -102.46 -27.16 12.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.89 0.376 . . . . 0.0 110.593 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' B' ' 537' ' ' ARG . . . -66.9 -129.56 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.211 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -102.42 -56.95 2.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.824 0.345 . . . . 0.0 111.258 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.71 ' HB ' HG13 ' A' ' 8' ' ' VAL . 2.8 t 43.38 29.06 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.461 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.429 ' O ' HD22 ' A' ' 19' ' ' LEU . . . -64.51 89.49 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.802 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.573 ' HA ' HD22 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -52.59 -33.45 46.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.933 0.397 . . . . 0.0 110.273 179.675 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.428 HG21 ' HB2' ' A' ' 38' ' ' ASP . 39.2 p -81.15 -53.15 6.64 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.677 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.6 t -42.72 -38.54 2.11 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.265 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.984 HD23 ' CE1' ' A' ' 169' ' ' PHE . 0.0 OUTLIER -49.32 -58.67 4.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.545 179.668 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.662 ' H ' HD22 ' A' ' 20' ' ' LEU . 0.6 OUTLIER -70.59 -27.62 64.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.923 179.944 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.449 ' O ' ' N ' ' A' ' 25' ' ' THR . 37.3 mm -64.23 -71.43 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.242 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 9.6 t -50.0 -31.02 11.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.809 0.338 . . . . 0.0 110.717 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.406 ' CE1' ' HG2' ' A' ' 166' ' ' LYS . 46.5 t80 -63.54 -66.61 0.52 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.659 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.27 -54.63 6.77 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.73 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.449 ' N ' ' O ' ' A' ' 21' ' ' ILE . 27.4 p -78.47 -154.08 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.345 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -157.46 35.52 0.27 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.735 0.302 . . . . 0.0 111.088 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -123.02 101.47 7.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.932 0.396 . . . . 0.0 111.525 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.486 ' CD2' ' HD3' ' A' ' 29' ' ' PRO . 0.4 OUTLIER -101.4 -70.04 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.726 178.92 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.486 ' HD3' ' CD2' ' A' ' 28' ' ' PHE . 95.7 Cg_endo -79.1 54.45 5.18 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.23 1.953 . . . . 0.0 111.518 178.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.02 -85.73 0.5 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.356 -179.194 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -147.54 118.53 7.68 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.196 0.522 . . . . 0.0 112.085 -179.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.427 ' C ' HG22 ' A' ' 33' ' ' VAL . 4.2 m-30 -99.78 94.37 6.29 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.577 178.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.474 HG11 ' HB3' ' B' ' 526' ' ' SER . 0.0 OUTLIER -163.82 -63.85 0.01 OUTLIER Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.857 -179.177 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.469 ' HD2' HG23 ' A' ' 33' ' ' VAL . 8.8 Cg_endo -50.81 -20.43 6.78 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.781 2.321 . . . . 0.0 112.328 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.661 HG23 HD23 ' B' ' 543' ' ' LEU . 8.2 t -40.92 -29.66 0.11 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.501 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.671 HG12 ' HB2' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -43.63 -29.68 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-O 120.924 0.393 . . . . 0.0 111.016 179.648 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.493 ' O ' ' CG ' ' A' ' 40' ' ' TYR . 0.8 OUTLIER -55.36 -23.48 24.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.62 179.478 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.441 ' HA ' ' CE1' ' A' ' 40' ' ' TYR . 21.9 t70 -41.67 -28.29 0.14 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.121 -0.49 . . . . 0.0 112.122 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -72.79 -1.86 18.25 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.493 ' CG ' ' O ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -60.0 -176.48 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.767 0.318 . . . . 0.0 110.651 179.856 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.421 ' O ' ' CG1' ' B' ' 519' ' ' ILE . . . -112.84 144.54 42.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.455 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.744 HG23 ' HB ' ' A' ' 52' ' ' THR . 0.8 OUTLIER -116.61 121.85 68.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.981 179.604 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.539 ' H ' HD11 ' B' ' 519' ' ' ILE . 1.7 p -111.3 106.59 15.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.749 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.727 HG21 ' HB2' ' B' ' 514' ' ' LEU . 6.4 p -164.05 148.78 2.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.283 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.702 ' O ' HD22 ' B' ' 514' ' ' LEU . 0.0 OUTLIER -74.56 104.38 5.23 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 178.773 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.73 ' HA ' HD11 ' B' ' 514' ' ' LEU . 7.8 tt -99.92 87.67 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.676 -179.066 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.77 -108.06 2.46 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.303 -0.862 . . . . 0.0 113.13 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -47.96 -88.88 0.01 OUTLIER Glycine 0 C--N 1.331 0.264 0 C-N-CA 121.184 -0.531 . . . . 0.0 113.342 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.458 ' N ' ' HE1' ' A' ' 45' ' ' MET . 5.0 pt-20 -126.16 170.89 8.71 Favored Pre-proline 0 CA--C 1.53 0.204 0 CA-C-O 120.627 0.251 . . . . 0.0 110.902 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.443 ' HD2' ' HB2' ' A' ' 49' ' ' GLU . 33.1 Cg_exo -60.28 107.48 0.42 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.684 2.256 . . . . 0.0 112.777 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.822 ' CE1' HG22 ' A' ' 3' ' ' THR . 6.2 t80 -172.87 104.72 0.14 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.402 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.744 ' HB ' HG23 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -122.6 128.92 51.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.844 0.354 . . . . 0.0 110.875 179.873 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.941 HD12 HG23 ' A' ' 3' ' ' THR . 11.3 mt -70.8 172.05 9.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.97 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -115.19 108.22 1.88 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.79 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.1 mp -48.73 114.55 1.0 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.842 0.353 . . . . 0.0 110.641 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -83.63 105.14 14.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.508 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.408 ' HB2' ' HB3' ' A' ' 38' ' ' ASP . 0.4 OUTLIER -99.53 -175.63 3.05 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.843 -179.87 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . 1.005 HG22 HD13 ' A' ' 67' ' ' LEU . 1.2 p -136.05 167.84 20.47 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.784 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.671 ' HB2' HG12 ' A' ' 36' ' ' VAL . . . -171.2 179.99 2.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.184 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.403 ' HA2' ' CB ' ' A' ' 65' ' ' ASP . . . -151.48 31.24 0.94 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.293 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.544 HD22 ' OG ' ' B' ' 526' ' ' SER . 0.0 OUTLIER -118.45 -160.84 0.81 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.754 0.311 . . . . 0.0 110.815 -179.847 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.6 mp0 -52.82 -27.11 16.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.184 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.452 ' OD2' HD13 ' A' ' 61' ' ' LEU . 9.2 m-20 -50.49 -63.63 1.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.281 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.562 ' O ' HD23 ' A' ' 67' ' ' LEU . 0.0 OUTLIER 169.1 82.88 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.91 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.403 ' CB ' ' HA2' ' A' ' 60' ' ' GLY . 9.8 t70 -68.07 -22.32 64.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.086 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.92 -29.87 21.91 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.21 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 1.005 HD13 HG22 ' A' ' 58' ' ' THR . 4.5 pp -48.39 140.28 7.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.957 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.465 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.1 OUTLIER -150.69 50.23 0.69 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 120.893 0.377 . . . . 0.0 110.893 -179.949 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 71.6 Cg_endo -76.79 -31.29 4.13 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.657 2.238 . . . . 0.0 112.647 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.711 HD23 HD23 ' B' ' 541' ' ' LEU . 0.1 OUTLIER -66.98 -25.19 66.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.842 0.354 . . . . 0.0 110.663 -179.914 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.416 ' OG ' ' CE2' ' A' ' 72' ' ' TYR . 13.9 t -59.89 -70.59 0.16 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.942 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.416 ' CE2' ' OG ' ' A' ' 71' ' ' SER . 3.5 m-85 -123.94 67.57 42.81 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.908 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.08 140.39 31.17 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.619 2.213 . . . . 0.0 112.282 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 9.8 tp60 -101.62 10.39 40.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.451 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 84.6 m -75.87 124.61 27.61 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.811 0.338 . . . . 0.0 110.982 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -79.3 -18.32 52.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.156 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.4 t -103.71 78.91 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.224 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.669 ' CE2' HG21 ' A' ' 108' ' ' THR . 15.4 m-85 -83.19 175.15 10.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.751 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.4 HD12 ' O ' ' A' ' 111' ' ' LEU . 19.3 tp -147.63 108.9 4.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.99 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.658 ' O ' HG23 ' A' ' 80' ' ' VAL . 35.3 m -113.32 100.17 10.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.864 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.544 ' HB2' HG22 ' A' ' 14' ' ' VAL . 68.7 m -94.51 173.56 7.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.419 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.701 ' CE1' HG21 ' A' ' 137' ' ' ILE . 8.6 p90 -175.19 142.14 0.6 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.26 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.4 m -83.31 155.83 23.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.088 0.471 . . . . 0.0 111.543 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.784 HG21 ' HA ' ' A' ' 117' ' ' ILE . 15.9 t -55.01 -51.71 51.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.518 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.869 HG13 ' HD3' ' A' ' 120' ' ' ARG . 1.9 m -47.58 117.01 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.059 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -151.43 117.86 3.23 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.438 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.423 ' O ' ' CB ' ' A' ' 88' ' ' SER . 78.3 Cg_endo -90.38 49.68 0.95 Allowed 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.981 2.454 . . . . 0.0 111.969 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.466 ' CB ' ' HG2' ' A' ' 133' ' ' LYS . 0.1 OUTLIER 81.56 28.34 0.17 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.694 -179.525 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.517 ' O ' HG23 ' A' ' 93' ' ' VAL . 95.2 p -90.04 -15.94 30.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.256 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.649 ' CE1' HD12 ' A' ' 145' ' ' LEU . 0.1 OUTLIER -46.29 -51.31 14.81 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.799 0.333 . . . . 0.0 111.157 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -62.46 -36.41 82.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.822 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -72.63 -57.89 3.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.693 HG13 ' CE2' ' A' ' 97' ' ' TRP . 24.2 t -52.11 -45.48 42.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.059 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.722 ' HG3' HD11 ' A' ' 145' ' ' LEU . 0.3 OUTLIER -59.72 -50.49 73.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.811 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.408 ' O ' ' HG3' ' A' ' 99' ' ' PRO . 4.2 mt-10 -82.87 6.9 16.9 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.633 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -117.15 -30.66 5.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.804 0.335 . . . . 0.0 110.971 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.693 ' CE2' HG13 ' A' ' 93' ' ' VAL . 23.3 m0 -94.01 -51.94 4.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.176 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.474 ' HB ' ' HD3' ' A' ' 99' ' ' PRO . 85.5 t -50.5 -57.6 12.62 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.612 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.474 ' HD3' ' HB ' ' A' ' 98' ' ' VAL . 29.8 Cg_endo -62.89 -15.51 47.88 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.197 1.931 . . . . 0.0 112.422 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -89.97 -54.48 4.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.878 0.37 . . . . 0.0 110.728 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.9 tt -55.17 -30.33 24.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.9 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.747 HG22 ' HA ' ' A' ' 107' ' ' LYS . 11.2 p -85.91 -25.29 26.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.774 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -60.71 -51.04 71.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.667 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 28.4 m80 -60.99 -38.53 86.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.69 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -137.53 126.52 14.91 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.734 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -49.79 89.14 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.461 2.108 . . . . 0.0 112.248 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.747 ' HA ' HG22 ' A' ' 102' ' ' THR . 12.3 mttp 61.9 106.38 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.769 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.669 HG21 ' CE2' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -127.95 137.19 30.27 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.9 -179.944 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 108' ' ' THR . 36.2 Cg_exo -60.24 156.02 42.67 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.485 2.123 . . . . 0.0 112.478 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.766 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 1.9 p90 -158.72 148.77 19.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.75 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.803 HD11 ' HB3' ' A' ' 171' ' ' GLU . 0.5 OUTLIER -111.18 148.54 32.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.482 -179.434 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 1.018 HD12 ' HB2' ' A' ' 146' ' ' ALA . 11.6 mt -103.98 158.07 16.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.824 179.124 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.756 HG13 HG11 ' A' ' 168' ' ' VAL . 14.3 t -146.1 150.73 15.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.399 0.619 . . . . 0.0 112.445 -179.294 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -131.31 124.65 4.17 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.86 179.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.756 ' O ' HD13 ' A' ' 117' ' ' ILE . 0.9 OUTLIER -140.68 -58.51 0.52 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.908 0.354 . . . . 0.0 111.761 -178.694 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.445 ' HB3' ' CG ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -53.78 -21.84 8.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.853 0.358 . . . . 0.0 110.922 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.784 ' HA ' HG21 ' A' ' 84' ' ' VAL . 0.3 OUTLIER -41.81 -29.13 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.217 -179.859 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.641 ' CG ' HG21 ' A' ' 161' ' ' THR . 12.2 t70 -63.81 -43.16 97.09 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -178.667 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 1.002 HD21 HD22 ' A' ' 160' ' ' LEU . 0.3 OUTLIER -118.47 14.71 13.73 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -178.537 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.869 ' HD3' HG13 ' A' ' 85' ' ' VAL . 0.8 OUTLIER -87.18 -20.32 27.15 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.096 179.585 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.01 -18.59 35.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.85 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -46.1 122.27 6.24 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.049 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.441 ' HA ' ' CG2' ' A' ' 126' ' ' ILE . 14.0 Cg_exo -68.74 -3.52 11.43 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.576 2.184 . . . . 0.0 113.028 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 29.8 t -76.85 -71.18 0.41 Allowed 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.027 0.441 . . . . 0.0 110.247 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.697 HG21 HG11 ' A' ' 85' ' ' VAL . 95.0 m -55.68 -35.15 65.71 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.838 ' HA ' HD12 ' A' ' 129' ' ' LEU . 0.1 OUTLIER -56.68 -39.18 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.722 179.087 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.472 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 19.5 mt-10 -64.04 -31.9 73.26 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.31 178.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.479 ' O ' ' HG3' ' A' ' 131' ' ' LYS . 0.0 OUTLIER -69.69 -24.79 63.64 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.843 178.92 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.838 HD12 ' HA ' ' A' ' 126' ' ' ILE . 3.2 mt -85.02 -28.86 25.43 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 177.7 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' A' ' 127' ' ' GLU . . . -48.0 -39.87 20.91 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.501 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.479 ' HG3' ' O ' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -44.85 -28.75 0.69 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.884 0.373 . . . . 0.0 110.724 179.882 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.462 ' N ' ' HD2' ' A' ' 131' ' ' LYS . 52.9 m-20 -123.55 -32.03 3.41 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.391 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.512 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 52.1 mmtt -151.25 -92.73 0.06 Allowed 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.512 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 6.5 pt20 120.09 -18.09 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.783 1.233 . . . . 0.0 110.821 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.99 111.15 7.55 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.215 -0.448 . . . . 0.0 112.204 -178.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.686 ' HB3' HD11 ' A' ' 126' ' ' ILE . 96.8 Cg_endo -79.61 129.89 8.55 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.645 2.23 . . . . 0.0 111.503 179.091 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.722 ' N ' HD13 ' A' ' 137' ' ' ILE . 0.8 OUTLIER -58.57 96.64 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.014 0.435 . . . . 0.0 111.616 -179.331 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 16.5 p -69.32 151.61 96.84 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.462 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.496 ' HA ' ' CE1' ' A' ' 154' ' ' TYR . 4.2 Cg_endo -47.06 -25.07 3.8 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 122.809 2.339 . . . . 0.0 112.33 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -81.38 -38.66 26.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.12 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.38 -54.2 49.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.138 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.416 ' CB ' ' CD2' ' A' ' 154' ' ' TYR . . . -47.85 -43.43 28.3 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.884 0.373 . . . . 0.0 110.99 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -59.44 -40.25 86.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.589 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -55.03 -55.81 26.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.59 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.722 HD11 ' HG3' ' A' ' 94' ' ' LYS . 0.4 OUTLIER -67.73 -29.14 68.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.492 179.701 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 1.018 ' HB2' HD12 ' A' ' 112' ' ' LEU . . . -65.41 -41.24 93.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.793 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 9.0 mtp180 -85.63 -25.89 26.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.678 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -52.37 -32.62 39.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.739 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 3.5 mt -119.8 19.7 12.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.057 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 6.3 mttp 48.46 47.46 20.17 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.202 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.766 ' HB1' ' O ' ' A' ' 110' ' ' PHE . . . -63.98 -81.51 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.879 0.371 . . . . 0.0 110.865 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 151' ' ' ALA . 70.3 t -160.56 -75.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.778 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.596 ' O ' HD21 ' A' ' 111' ' ' LEU . 7.0 tppt? 173.65 116.91 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.278 -179.238 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.496 ' CE1' ' HA ' ' A' ' 139' ' ' PRO . 5.6 t80 -81.4 116.08 21.05 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.467 HG12 ' N ' ' A' ' 156' ' ' GLU . 12.9 t -101.4 159.35 4.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.451 -179.371 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.467 ' N ' HG12 ' A' ' 155' ' ' VAL . 3.6 mp0 -89.9 139.84 30.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.129 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.752 ' O ' HD11 ' A' ' 117' ' ' ILE . 3.3 p 178.71 -174.54 0.18 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.416 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.475 ' HA ' ' HA ' ' A' ' 115' ' ' THR . 24.3 p -159.99 167.87 26.95 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.937 0.399 . . . . 0.0 111.164 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -116.6 -46.11 2.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.585 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 1.002 HD22 HD21 ' A' ' 119' ' ' LEU . 0.7 OUTLIER -63.81 -33.25 75.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.402 179.557 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.641 HG21 ' CG ' ' A' ' 118' ' ' ASP . 1.3 p -113.0 -22.83 10.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.807 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.415 ' N ' ' OG ' ' A' ' 158' ' ' SER . 1.3 tt0 74.58 71.81 0.1 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.022 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.43 ' N ' ' OG ' ' A' ' 158' ' ' SER . 0.2 OUTLIER -93.96 13.63 22.2 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.501 -179.816 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 121.08 34.48 0.89 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.345 -0.931 . . . . 0.0 113.2 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.745 HD13 ' HA ' ' A' ' 19' ' ' LEU . 0.5 OUTLIER -49.58 -27.79 4.92 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.956 0.408 . . . . 0.0 110.515 179.697 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.421 ' HE2' ' N ' ' A' ' 167' ' ' ASN . 0.0 OUTLIER -73.67 -34.16 64.78 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.626 179.568 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.421 ' N ' ' HE2' ' A' ' 166' ' ' LYS . 0.6 OUTLIER -56.58 -67.61 0.29 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.421 179.601 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.756 HG11 HG13 ' A' ' 113' ' ' VAL . 14.2 p -50.63 -46.31 27.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.33 179.36 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.984 ' CE1' HD23 ' A' ' 19' ' ' LEU . 1.9 t80 -61.9 -31.26 71.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.732 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.412 ' N ' ' O ' ' A' ' 166' ' ' LYS . 4.6 t0 -57.42 -39.97 77.31 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.514 178.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.803 ' HB3' HD11 ' A' ' 111' ' ' LEU . 5.0 mm-40 -66.72 -35.35 79.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.612 178.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.466 ' HA ' HD12 ' A' ' 111' ' ' LEU . . . -59.83 -29.93 68.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.739 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.919 HD13 ' N ' ' A' ' 174' ' ' LEU . 0.0 OUTLIER -94.11 -43.88 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.438 179.633 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 1.027 HD23 HD13 ' B' ' 505' ' ' LEU . 3.5 tm? -52.75 -27.79 19.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.953 0.406 . . . . 0.0 110.363 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -72.04 -29.78 64.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.744 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.849 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -80.84 -37.15 30.51 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.738 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.721 HD13 ' HB ' ' B' ' 510' ' ' ILE . 58.8 mt -70.76 -24.53 62.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.635 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 29.1 tp10 -165.2 137.05 3.33 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.526 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -49.8 141.65 27.58 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.376 2.05 . . . . 0.0 112.347 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.89 171.4 18.36 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.548 2.166 . . . . 0.0 112.222 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -154.24 151.31 24.0 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.055 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.48 -164.73 0.23 Allowed 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.669 2.246 . . . . 0.0 112.271 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 8.0 pttp -87.51 152.21 22.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.863 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.188 -0.911 . . . . 0.0 110.909 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.17 0 N-CA-C 112.449 -0.26 . . . . 0.0 112.449 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 503' ' ' SER . . . . . . . . . . . . . 75.3 m -96.18 -78.52 0.46 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.889 0.376 . . . . 0.0 110.857 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 504' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' B' ' 509' ' ' ASP . . . 81.12 106.32 0.32 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.515 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 505' ' ' LEU . . . . . 1.027 HD13 HD23 ' A' ' 174' ' ' LEU . 0.1 OUTLIER -166.58 99.27 0.58 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.93 0.395 . . . . 0.0 111.063 -179.947 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 506' ' ' SER . . . . . . . . . . . . . 13.3 p 59.76 -170.95 0.13 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.005 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 507' ' ' ALA . . . . . . . . . . . . . . . 59.31 -93.21 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.725 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 508' ' ' GLN . . . . . 0.426 ' O ' ' CB ' ' B' ' 509' ' ' ASP . 56.9 mt-30 -141.29 4.84 1.83 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.048 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 509' ' ' ASP . . . . . 0.426 ' CB ' ' O ' ' B' ' 508' ' ' GLN . 8.5 t70 81.83 35.39 0.08 Allowed 'General case' 0 C--N 1.341 0.238 0 CA-C-O 121.371 0.605 . . . . 0.0 109.704 -178.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 510' ' ' ILE . . . . . 0.721 ' HB ' HD13 ' A' ' 177' ' ' LEU . 87.4 mt -64.84 156.14 5.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.579 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 511' ' ' SER . . . . . 0.472 ' HB3' HD21 ' B' ' 514' ' ' LEU . 8.7 t -109.54 167.39 10.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.098 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 512' ' ' GLN . . . . . 0.491 ' CB ' ' CD ' ' B' ' 513' ' ' PRO . 18.2 tt0 -114.2 -71.81 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.205 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 513' ' ' PRO . . . . . 0.491 ' CD ' ' CB ' ' B' ' 512' ' ' GLN . 93.5 Cg_endo -78.85 59.81 7.47 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.207 1.938 . . . . 0.0 111.29 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 514' ' ' LEU . . . . . 0.73 HD11 ' HA ' ' A' ' 46' ' ' ILE . 4.9 mt -53.31 -89.02 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.826 -178.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 515' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -92.99 -86.55 0.25 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.666 0.269 . . . . 0.0 111.255 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -127.57 -36.99 2.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.23 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 517' ' ' SER . . . . . 0.589 ' C ' HG12 ' A' ' 42' ' ' VAL . 6.4 m 72.01 22.8 3.64 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.047 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 518' ' ' PHE . . . . . 0.485 ' CD1' ' O ' ' B' ' 517' ' ' SER . 23.7 m-85 -140.99 91.79 2.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.79 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 519' ' ' ILE . . . . . 0.539 HD11 ' H ' ' A' ' 43' ' ' THR . 7.3 mm -88.89 -11.06 10.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.667 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 72.56 104.75 0.07 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.84 0.353 . . . . 0.0 110.925 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 521' ' ' THR . . . . . . . . . . . . . 1.4 m -160.91 106.5 1.41 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.818 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 522' ' ' GLY . . . . . 0.473 ' O ' ' CZ ' ' A' ' 37' ' ' PHE . . . 143.2 178.67 19.24 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.349 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 523' ' ' HIS . . . . . . . . . . . . . 30.8 t-80 -104.71 -83.42 0.5 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.745 0.307 . . . . 0.0 110.867 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 524' ' ' GLY . . . . . 0.482 ' HA3' HG23 ' A' ' 36' ' ' VAL . . . 49.68 -118.65 5.76 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.638 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 525' ' ' ASP . . . . . . . . . . . . . 1.2 p30 53.41 28.53 7.61 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 121.071 0.463 . . . . 0.0 110.498 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 526' ' ' SER . . . . . 0.544 ' OG ' HD22 ' A' ' 61' ' ' LEU . 3.9 m -57.15 100.1 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.207 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 527' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -37.44 162.08 0.05 OUTLIER Pre-proline 0 N--CA 1.467 0.381 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.227 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -53.75 104.79 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.195 2.597 . . . . 0.0 112.299 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 529' ' ' ARG . . . . . . . . . . . . . 2.3 mtt-85 -100.7 -42.42 6.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.073 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 530' ' ' HIS . . . . . 0.408 ' HB2' ' CB ' ' B' ' 545' ' ' ASN . 1.4 m-70 -153.32 -44.02 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.878 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 3.6 m 70.36 -160.53 0.15 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.876 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 532' ' ' TRP . . . . . . . . . . . . . 22.9 t90 -46.19 -65.0 0.62 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.159 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . 59.71 -87.13 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.622 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 534' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -116.56 152.67 48.52 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.698 0.285 . . . . 0.0 111.018 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -55.56 176.59 0.15 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.65 2.233 . . . . 0.0 112.456 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 59.92 92.86 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.082 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 537' ' ' ARG . . . . . 0.402 ' HB2' ' O ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER -73.46 151.06 41.22 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.13 0.491 . . . . 0.0 110.844 179.829 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 538' ' ' ILE . . . . . 0.482 HG13 ' HB2' ' B' ' 542' ' ' TYR . 10.2 tp -61.18 157.22 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.262 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 539' ' ' ASP . . . . . 0.412 ' N ' HG13 ' B' ' 538' ' ' ILE . 2.3 m-20 -61.33 162.16 8.15 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.051 0.453 . . . . 0.0 111.126 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 540' ' ' GLU . . . . . 0.487 ' CG ' ' HB ' ' A' ' 8' ' ' VAL . 0.3 OUTLIER -48.22 -50.14 30.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.854 -179.633 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 541' ' ' LEU . . . . . 0.711 HD23 HD23 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -39.99 -32.51 0.16 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.324 0.583 . . . . 0.0 111.063 -179.496 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 542' ' ' TYR . . . . . 0.482 ' HB2' HG13 ' B' ' 538' ' ' ILE . 35.3 m-85 -104.45 -59.21 1.77 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.896 -179.401 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 543' ' ' LEU . . . . . 0.661 HD23 HG23 ' A' ' 35' ' ' THR . 2.0 tp 66.47 -67.68 0.15 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.061 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 544' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' B' ' 542' ' ' TYR . . . -89.02 139.41 15.25 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.485 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 545' ' ' ASN . . . . . 0.408 ' CB ' ' HB2' ' B' ' 530' ' ' HIS . 1.2 m-80 . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.945 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.819 ' CE ' HG23 ' A' ' 46' ' ' ILE . 1.3 tmt? . . . . . 0 N--CA 1.487 1.42 0 CA-C-O 120.84 0.352 . . . . 0.0 111.03 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 73.32 121.13 0.04 OUTLIER 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.994 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.797 HG22 ' HB2' ' A' ' 53' ' ' LEU . 0.3 OUTLIER -93.26 170.09 9.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.719 -179.345 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.779 ' O ' HD23 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -152.71 162.49 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -178.92 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.4 127.91 40.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.945 179.219 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 43.6 t -116.54 153.42 32.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.069 0.461 . . . . 0.0 111.906 -179.158 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.632 HG13 ' O ' ' A' ' 56' ' ' PHE . 1.7 t -151.11 159.51 4.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.408 179.448 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.873 HG13 ' HG3' ' B' ' 540' ' ' GLU . 0.9 OUTLIER -110.91 155.77 12.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.323 0.582 . . . . 0.0 111.329 -179.848 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.764 HG13 HD13 ' A' ' 70' ' ' LEU . 66.9 t -159.17 129.91 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.042 179.332 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 138.44 -149.06 20.35 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.183 -1.008 . . . . 0.0 112.861 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' B' ' 537' ' ' ARG . 0.4 OUTLIER -110.8 27.15 9.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.938 0.399 . . . . 0.0 110.74 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -134.68 174.26 21.12 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.439 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.431 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -80.97 -57.63 3.45 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 123.063 -0.081 . . . . 0.0 111.195 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.874 HG21 HD22 ' A' ' 79' ' ' LEU . 13.8 p 23.96 44.61 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 13' ' ' ALA . . . -125.39 -178.26 15.24 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.58 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.481 ' HG3' HD23 ' A' ' 55' ' ' LEU . 1.3 tmpt? -59.71 -17.68 36.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.585 0.231 . . . . 0.0 111.199 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.822 HG21 ' OG1' ' A' ' 35' ' ' THR . 34.1 p -79.58 -70.88 0.48 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.804 0.335 . . . . 0.0 111.463 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.418 ' N ' ' OG1' ' A' ' 17' ' ' THR . 16.5 t -62.49 -57.9 9.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.958 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.84 ' O ' HD13 ' A' ' 165' ' ' LEU . 18.7 mt -47.87 -71.76 0.06 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -178.436 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.432 ' N ' ' CD2' ' A' ' 20' ' ' LEU . 2.5 mm? -56.74 -60.18 3.93 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -178.318 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.524 HG22 ' OG1' ' A' ' 25' ' ' THR . 50.0 mm -48.2 -70.52 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 120.936 -0.305 . . . . 0.0 111.189 -179.424 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.43 ' CB ' ' HB1' ' A' ' 159' ' ' ALA . 19.7 m -42.2 -29.3 0.24 Allowed 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 111.582 0.215 . . . . 0.0 111.582 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.497 ' CZ ' ' HG2' ' A' ' 166' ' ' LYS . 17.5 t80 -81.45 -68.72 0.67 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.856 0.36 . . . . 0.0 110.804 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.649 HG23 HG23 ' A' ' 25' ' ' THR . 10.8 t -58.87 -46.75 87.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.128 0.489 . . . . 0.0 110.583 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.649 HG23 HG23 ' A' ' 24' ' ' THR . 18.7 p -86.42 -153.46 0.2 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.431 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -150.03 55.5 0.94 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.658 0.266 . . . . 0.0 110.985 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.7 mttt -144.22 157.56 44.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.927 0.394 . . . . 0.0 111.252 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.497 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . 0.5 OUTLIER -163.17 -64.64 0.01 OUTLIER Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.481 179.698 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.497 ' HD3' ' HB3' ' A' ' 28' ' ' PHE . 87.5 Cg_endo -81.77 57.87 6.51 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.62 2.213 . . . . 0.0 112.841 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.407 ' O ' ' N ' ' B' ' 532' ' ' TRP . 0.4 OUTLIER -131.45 -89.39 0.45 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.906 179.844 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.71 116.08 2.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.364 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -111.17 92.39 4.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.078 0.466 . . . . 0.0 111.188 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.787 HG21 ' O ' ' B' ' 527' ' ' ASP . 2.8 t -105.69 -33.55 0.19 Allowed Pre-proline 0 CA--C 1.544 0.731 0 N-CA-C 114.174 1.175 . . . . 0.0 114.174 -179.073 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.496 ' CD ' ' N ' ' A' ' 33' ' ' VAL . 46.6 Cg_exo -40.44 -26.5 0.22 Allowed 'Trans proline' 0 C--N 1.357 1.022 0 C-N-CA 122.361 2.041 . . . . 0.0 113.965 -178.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.955 HG21 ' CD2' ' B' ' 543' ' ' LEU . 51.4 m -54.07 88.38 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.625 0.25 . . . . 0.0 111.041 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.726 ' HB ' HD13 ' A' ' 61' ' ' LEU . 7.6 p 171.2 -32.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.7 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.409 ' CD2' ' HA3' ' B' ' 522' ' ' GLY . 0.2 OUTLIER -108.06 23.44 14.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.904 179.921 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -61.23 -16.69 47.87 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.271 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -45.54 -27.25 0.71 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.717 0.294 . . . . 0.0 111.516 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.44 ' OH ' ' CE1' ' B' ' 518' ' ' PHE . 2.7 p90 -60.27 142.53 54.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.93 0.395 . . . . 0.0 110.72 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.749 ' O ' HD12 ' B' ' 519' ' ' ILE . . . -91.17 -178.75 5.25 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.972 -179.205 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 42' ' ' VAL . 18.3 m -131.31 121.28 48.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.441 178.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.461 HG23 ' O ' ' A' ' 43' ' ' THR . 5.0 t -86.24 104.61 15.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.422 -179.242 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.472 HG12 ' HB2' ' B' ' 515' ' ' GLN . 29.5 m -161.23 144.3 4.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.177 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.91 ' O ' HD22 ' B' ' 514' ' ' LEU . 0.0 OUTLIER -77.55 96.4 4.76 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.428 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.852 ' CG1' HG23 ' B' ' 510' ' ' ILE . 5.9 tt -97.29 96.11 5.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.285 -179.125 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.481 ' N ' ' HE2' ' A' ' 45' ' ' MET . . . 101.91 -108.53 3.39 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.378 -0.828 . . . . 0.0 112.937 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.445 ' N ' ' HE1' ' A' ' 45' ' ' MET . . . -118.11 -22.78 3.75 Favored Glycine 0 CA--C 1.521 0.419 0 C-N-CA 120.511 -0.852 . . . . 0.0 113.375 -179.637 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.554 ' N ' ' HE1' ' A' ' 45' ' ' MET . 2.0 mt-10 -117.4 132.54 23.5 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.995 0.398 . . . . 0.0 111.148 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.479 ' HA ' ' HA ' ' A' ' 45' ' ' MET . 42.9 Cg_endo -68.65 90.26 0.42 Allowed 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.853 2.369 . . . . 0.0 113.839 -179.225 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.528 ' CD1' ' O ' ' A' ' 51' ' ' TYR . 2.3 p90 -173.41 132.18 0.47 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.728 178.245 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.603 HG23 ' CG2' ' A' ' 46' ' ' ILE . 0.1 OUTLIER -129.91 141.51 50.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.027 0.441 . . . . 0.0 111.354 -179.046 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.797 ' HB2' HG22 ' A' ' 3' ' ' THR . 2.1 tp -89.18 148.58 23.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.838 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -87.3 178.97 47.98 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.213 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.718 HD22 ' N ' ' A' ' 55' ' ' LEU . 0.4 OUTLIER -112.3 136.62 51.52 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.73 0.3 . . . . 0.0 110.54 179.758 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.632 ' O ' HG13 ' A' ' 7' ' ' VAL . 0.3 OUTLIER -84.38 116.34 22.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.918 -179.654 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.409 ' OD2' ' N ' ' A' ' 36' ' ' VAL . 16.0 p-10 -119.3 167.74 11.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.057 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.747 ' CB ' HD22 ' A' ' 67' ' ' LEU . 0.6 OUTLIER -154.22 139.92 18.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.984 -179.826 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -171.07 136.08 1.05 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.807 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.77 73.1 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.613 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.726 HD13 ' HB ' ' A' ' 36' ' ' VAL . 0.3 OUTLIER -121.17 -175.41 3.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.918 0.389 . . . . 0.0 111.022 179.957 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -49.76 -39.51 37.92 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.028 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.43 ' HB3' ' CG2' ' A' ' 36' ' ' VAL . 11.2 t0 -64.11 -62.7 1.46 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.102 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.937 ' CD2' HD21 ' A' ' 67' ' ' LEU . 0.5 OUTLIER -120.07 140.53 50.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.78 -179.802 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.85 -69.08 0.7 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -179.464 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.431 ' O ' ' HB2' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -98.65 -46.51 5.68 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 -178.939 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.937 HD21 ' CD2' ' A' ' 64' ' ' TYR . 1.2 mp 69.37 131.43 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.06 -179.214 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.546 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 6.9 mtp180 -130.38 36.59 0.35 Allowed Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.961 178.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.546 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 61.1 Cg_endo -84.23 -39.93 0.1 Allowed 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 122.122 1.881 . . . . 0.0 112.044 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.877 HD23 ' HB2' ' B' ' 541' ' ' LEU . 0.1 OUTLIER -83.98 -7.84 59.31 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.156 -179.802 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.9 t -49.07 -64.11 0.9 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.745 0.307 . . . . 0.0 111.026 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -159.0 55.83 0.85 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.086 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.0 160.86 46.48 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.532 2.155 . . . . 0.0 112.209 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.05 10.24 34.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.462 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.47 ' O ' HG22 ' A' ' 108' ' ' THR . 69.3 m -50.73 117.86 2.75 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.828 0.347 . . . . 0.0 110.907 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -76.12 -20.07 57.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.061 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.835 HG21 ' HB2' ' A' ' 176' ' ' ALA . 43.1 t -103.93 72.53 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.897 0.379 . . . . 0.0 111.18 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.402 ' CE2' HG21 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -80.82 172.54 13.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.559 179.822 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.874 HD22 HG21 ' A' ' 14' ' ' VAL . 1.2 tt -152.61 108.73 3.37 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.853 0.359 . . . . 0.0 111.147 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.572 ' CG2' HD22 ' A' ' 112' ' ' LEU . 2.8 m -93.1 133.1 35.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.701 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.501 ' SG ' HG12 ' A' ' 14' ' ' VAL . 1.2 p -119.17 138.16 53.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.092 0.472 . . . . 0.0 111.36 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.412 ' CZ ' ' HB2' ' A' ' 142' ' ' ALA . 39.5 p90 -135.26 -174.12 3.53 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.008 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.1 m -145.81 139.08 26.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.745 0.307 . . . . 0.0 110.797 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.804 HG21 ' HA ' ' A' ' 117' ' ' ILE . 60.1 t -53.67 -67.6 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.302 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.853 HG22 ' OE1' ' A' ' 116' ' ' GLN . 34.9 m -48.62 108.65 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.737 0.304 . . . . 0.0 110.725 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.589 ' N ' HD22 ' A' ' 129' ' ' LEU . 0.3 OUTLIER -151.55 128.9 5.62 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.687 -179.41 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 86' ' ' SER . 74.0 Cg_endo -92.56 53.36 0.56 Allowed 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 123.272 2.648 . . . . 0.0 111.723 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.43 ' CA ' ' HG3' ' A' ' 133' ' ' LYS . 0.1 OUTLIER 81.95 39.21 0.05 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.823 -179.415 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.873 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -97.25 -34.89 10.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.804 179.862 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -51.83 -37.95 53.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.827 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -50.81 -57.41 8.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.661 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.427 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 4.1 p-10 -74.93 -43.57 53.44 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.676 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.873 HG23 ' O ' ' A' ' 89' ' ' SER . 57.4 t -52.31 -31.61 15.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.991 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.622 ' O ' HG23 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -79.09 -50.92 10.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.915 -179.967 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.405 ' O ' ' HG3' ' A' ' 99' ' ' PRO . 25.2 mt-10 -82.75 6.31 18.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.648 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.427 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.6 OUTLIER -115.13 -27.81 7.18 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.754 0.312 . . . . 0.0 111.063 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.809 ' CE2' HG13 ' A' ' 93' ' ' VAL . 38.1 m0 -91.59 -44.81 8.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.02 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.622 HG23 ' O ' ' A' ' 94' ' ' LYS . 64.4 t -53.48 -46.03 98.29 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.792 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 97.4 Cg_endo -80.61 -15.22 11.08 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.334 2.023 . . . . 0.0 112.781 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -85.8 -36.14 20.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.948 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.41 HG13 ' N ' ' A' ' 102' ' ' THR . 13.8 pt -79.14 -25.53 12.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.104 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.41 ' N ' HG13 ' A' ' 101' ' ' ILE . 47.8 p -89.42 -31.63 17.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.038 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.403 ' HB2' ' O ' ' A' ' 99' ' ' PRO . 74.5 t60 -72.8 -54.97 7.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.065 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -71.07 -25.84 62.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.047 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.416 ' HB2' ' OG1' ' A' ' 108' ' ' THR . 28.5 m -132.31 95.37 21.21 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.9 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -50.2 110.69 0.41 Allowed 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.573 2.182 . . . . 0.0 112.263 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 7.6 mmpt? 50.8 92.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.906 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.47 HG22 ' O ' ' A' ' 75' ' ' THR . 0.2 OUTLIER -133.59 113.04 12.92 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.85 179.95 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.401 ' O ' ' HB2' ' A' ' 78' ' ' PHE . 31.3 Cg_exo -60.15 133.62 51.02 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.584 2.189 . . . . 0.0 112.446 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.517 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 0.8 OUTLIER -134.92 142.81 46.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.96 179.923 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.98 HD12 HG11 ' A' ' 152' ' ' VAL . 5.0 tt -110.92 141.45 44.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.197 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.795 ' O ' HD23 ' A' ' 111' ' ' LEU . 3.6 mm? -89.8 158.38 17.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.627 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.42 HG21 HG21 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -137.84 150.42 25.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.123 0.487 . . . . 0.0 111.804 -179.554 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -129.59 134.92 8.12 Favored Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.525 179.288 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 158' ' ' SER . 0.0 OUTLIER -155.28 -41.49 0.08 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.859 0.33 . . . . 0.0 111.088 -179.279 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.853 ' OE1' HG22 ' A' ' 85' ' ' VAL . 10.5 tt0 -71.87 -9.09 57.82 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.322 178.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.804 ' HA ' HG21 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -54.39 -20.79 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.689 -179.848 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -75.55 -35.54 60.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.383 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.617 HD21 ' HG3' ' A' ' 116' ' ' GLN . 4.3 pp -97.02 14.21 26.38 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.626 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.676 ' CB ' HG11 ' A' ' 84' ' ' VAL . 37.4 ptt85 -68.05 -27.29 66.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.951 0.405 . . . . 0.0 110.329 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -72.63 -25.68 61.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.827 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.408 ' O ' ' HB ' ' A' ' 126' ' ' ILE . 9.2 t70 -47.58 101.63 0.27 Allowed Pre-proline 0 C--N 1.332 -0.169 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.703 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -67.83 -5.85 15.46 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.745 2.297 . . . . 0.0 113.049 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.46 -65.45 1.01 Allowed 'General case' 0 C--O 1.234 0.261 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.536 HG21 HG11 ' A' ' 85' ' ' VAL . 5.0 m -55.43 -38.94 69.65 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.662 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.46 HG13 HD12 ' A' ' 129' ' ' LEU . 0.1 OUTLIER -55.53 -47.41 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.713 179.179 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.538 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 2.7 mm-40 -53.47 -35.77 60.91 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.02 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.407 ' HB2' ' O ' ' A' ' 125' ' ' THR . 1.7 mptp? -66.82 -32.09 73.14 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.589 HD22 ' N ' ' A' ' 86' ' ' SER . 6.2 mt -74.44 -36.8 63.39 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 177.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.538 ' HB3' ' O ' ' A' ' 127' ' ' GLU . . . -43.98 -42.47 6.02 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.374 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.97 -26.38 10.41 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.365 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.401 ' OD1' ' HB2' ' A' ' 87' ' ' PRO . 29.5 m120 -124.61 -31.55 3.21 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -179.309 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.442 ' O ' ' HB2' ' A' ' 134' ' ' GLN . 6.4 mmpt? -152.06 -63.88 0.17 Allowed 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 -178.653 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.532 ' HG3' ' HB2' ' A' ' 130' ' ' ALA . 2.0 tt0 81.18 15.94 0.56 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.695 0.283 . . . . 0.0 110.97 -178.035 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 51.6 mttm -101.17 88.66 1.13 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.97 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' ' 134' ' ' GLN . 32.8 Cg_endo -63.93 124.94 14.36 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.449 2.1 . . . . 0.0 111.859 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.688 ' N ' HD13 ' A' ' 137' ' ' ILE . 1.3 mm -60.14 97.25 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.106 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.9 p -74.34 153.83 88.05 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.807 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -47.14 -36.19 21.09 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.607 2.205 . . . . 0.0 112.324 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -67.9 -28.33 67.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.859 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.401 HG21 HG23 ' A' ' 137' ' ' ILE . 87.4 m -66.23 -53.55 35.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.841 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.557 ' HB3' ' CE2' ' A' ' 154' ' ' TYR . . . -57.7 -36.66 72.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.898 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.98 -39.95 95.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.704 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 43.9 mttt -65.16 -51.61 60.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.862 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.508 HD23 ' O ' ' A' ' 145' ' ' LEU . 0.9 OUTLIER -67.16 -40.24 86.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.803 -179.995 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -55.62 -44.81 77.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.037 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.25 -24.52 27.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.874 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -53.69 -31.57 48.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.855 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.1 mt -119.3 19.62 12.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.154 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 29.1 mmtm 48.06 42.42 16.85 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.784 0.326 . . . . 0.0 111.095 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.555 ' O ' HG23 ' A' ' 152' ' ' VAL . . . -58.18 -81.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.913 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.98 HG11 HD12 ' A' ' 111' ' ' LEU . 47.6 t -160.73 -74.67 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.747 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 179.51 128.03 0.08 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.24 -179.057 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.557 ' CE2' ' HB3' ' A' ' 142' ' ' ALA . 38.3 t80 -100.19 112.49 24.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.755 178.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 2.8 t -101.52 154.58 4.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.416 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -90.55 120.13 31.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.94 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.41 ' HA ' ' HB3' ' A' ' 163' ' ' LYS . 35.3 m -156.79 175.57 13.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.588 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.461 ' HA ' ' HA ' ' A' ' 115' ' ' THR . 4.6 t -158.07 145.16 17.96 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.089 0.471 . . . . 0.0 111.849 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.43 ' HB1' ' CB ' ' A' ' 22' ' ' SER . . . -104.72 -44.03 4.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.34 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.492 ' HB3' ' CE2' ' A' ' 28' ' ' PHE . 0.9 OUTLIER -62.94 -33.16 74.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.268 179.503 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -106.54 -21.74 12.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.565 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 77.9 60.48 0.03 OUTLIER 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.317 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.451 ' HB2' ' CB ' ' A' ' 158' ' ' SER . 0.5 OUTLIER -91.88 41.94 1.09 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.688 179.538 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.415 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . 104.09 -66.04 0.32 Allowed Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.719 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.84 HD13 ' O ' ' A' ' 19' ' ' LEU . 0.5 OUTLIER 66.04 -66.77 0.16 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.724 0.297 . . . . 0.0 111.308 -179.914 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.497 ' HG2' ' CZ ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -50.09 -26.22 4.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.807 0.337 . . . . 0.0 110.872 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.414 ' O ' ' HB2' ' A' ' 170' ' ' ASP . 0.4 OUTLIER -62.22 -69.05 0.27 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.425 -179.733 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.545 HG13 ' N ' ' A' ' 169' ' ' PHE . 14.0 p -54.41 -47.12 70.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.094 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.788 ' CD1' HD13 ' A' ' 19' ' ' LEU . 1.7 t80 -60.73 -31.86 71.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.338 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.766 ' O ' HD13 ' A' ' 173' ' ' ILE . 0.3 OUTLIER -62.48 -36.43 82.48 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.775 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -69.14 -28.77 66.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.633 178.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.61 ' HA ' HD13 ' A' ' 111' ' ' LEU . . . -61.04 -51.47 69.04 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.221 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.766 HD13 ' O ' ' A' ' 170' ' ' ASP . 0.1 OUTLIER -83.33 -23.65 8.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.031 -179.767 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.784 HD23 HD23 ' B' ' 505' ' ' LEU . 3.2 tm? -50.54 -48.53 57.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.048 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -51.02 -25.52 4.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.894 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.835 ' HB2' HG21 ' A' ' 77' ' ' VAL . . . -83.3 -42.77 16.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.11 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.594 HD22 HG12 ' B' ' 510' ' ' ILE . 8.3 mt -68.73 -17.54 64.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.991 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.474 ' OE2' HD11 ' A' ' 174' ' ' LEU . 0.7 OUTLIER -171.79 145.11 1.62 Allowed Pre-proline 0 C--N 1.333 -0.109 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.746 179.835 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.9 127.99 28.62 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.619 2.212 . . . . 0.0 112.224 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.85 142.23 25.16 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.444 2.096 . . . . 0.0 112.242 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -113.99 141.48 26.33 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.92 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.3 -165.1 0.29 Allowed 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.639 2.226 . . . . 0.0 112.31 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 9.4 mttm -98.98 98.25 9.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.88 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.184 -0.913 . . . . 0.0 110.96 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.133 0 N-CA-C 112.509 -0.237 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 503' ' ' SER . . . . . 0.557 ' HB3' HD11 ' B' ' 505' ' ' LEU . 71.1 m -88.06 -81.55 0.25 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.79 0.329 . . . . 0.0 111.009 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 504' ' ' GLY . . . . . 0.881 ' C ' HD13 ' B' ' 505' ' ' LEU . . . 83.76 104.01 0.55 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.326 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 505' ' ' LEU . . . . . 0.881 HD13 ' C ' ' B' ' 504' ' ' GLY . 0.0 OUTLIER -148.38 90.44 1.8 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.911 0.386 . . . . 0.0 111.077 -179.137 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 506' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 55.57 -172.92 0.06 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.082 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 507' ' ' ALA . . . . . 0.434 ' HB2' ' HB3' ' A' ' 178' ' ' GLU . . . 63.86 -93.27 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.771 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 508' ' ' GLN . . . . . 0.423 ' O ' ' CB ' ' B' ' 509' ' ' ASP . 4.1 mt-30 -133.87 3.25 3.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.018 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 509' ' ' ASP . . . . . 0.423 ' CB ' ' O ' ' B' ' 508' ' ' GLN . 8.4 t70 80.61 36.67 0.1 Allowed 'General case' 0 CA--C 1.521 -0.165 0 CA-C-O 121.167 0.508 . . . . 0.0 109.915 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 510' ' ' ILE . . . . . 0.852 HG23 ' CG1' ' A' ' 46' ' ' ILE . 1.4 mp -53.75 128.59 13.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.162 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 511' ' ' SER . . . . . 0.588 ' HB2' HD21 ' B' ' 514' ' ' LEU . 11.5 m -109.33 158.57 17.76 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.16 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 512' ' ' GLN . . . . . 0.49 ' CB ' ' HD3' ' B' ' 513' ' ' PRO . 0.1 OUTLIER -103.24 -64.25 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.883 179.661 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 513' ' ' PRO . . . . . 0.49 ' HD3' ' CB ' ' B' ' 512' ' ' GLN . 67.7 Cg_endo -85.45 53.45 3.46 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.408 2.072 . . . . 0.0 112.202 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 514' ' ' LEU . . . . . 0.91 HD22 ' O ' ' A' ' 45' ' ' MET . 1.1 mp -62.62 -81.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.176 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 515' ' ' GLN . . . . . 0.472 ' HB2' HG12 ' A' ' 44' ' ' VAL . 0.2 OUTLIER -85.91 -85.0 0.16 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.897 -179.921 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -120.66 -37.55 2.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.711 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 517' ' ' SER . . . . . 0.499 ' O ' ' CD1' ' B' ' 518' ' ' PHE . 0.9 OUTLIER 69.66 27.07 4.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.403 179.657 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 518' ' ' PHE . . . . . 0.499 ' CD1' ' O ' ' B' ' 517' ' ' SER . 24.9 m-85 -162.35 112.79 1.53 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.142 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 519' ' ' ILE . . . . . 0.749 HD12 ' O ' ' A' ' 41' ' ' ALA . 31.3 mt -78.56 -30.09 15.04 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 CA-C-O 120.806 0.336 . . . . 0.0 110.703 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 63.39 94.45 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.885 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 521' ' ' THR . . . . . . . . . . . . . 2.2 t -167.93 47.65 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.844 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 522' ' ' GLY . . . . . 0.409 ' HA3' ' CD2' ' A' ' 37' ' ' PHE . . . -155.51 165.77 32.55 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.491 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 523' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -106.32 -84.83 0.51 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.737 0.303 . . . . 0.0 110.898 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 524' ' ' GLY . . . . . 0.476 ' CA ' ' CG1' ' A' ' 36' ' ' VAL . . . 75.97 21.34 76.47 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.619 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 525' ' ' ASP . . . . . 0.543 ' O ' HG11 ' A' ' 33' ' ' VAL . 26.2 m-20 50.93 56.74 7.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.842 0.353 . . . . 0.0 110.887 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 526' ' ' SER . . . . . 0.419 ' HA ' ' HB ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -81.13 96.82 7.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.935 -179.967 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 527' ' ' ASP . . . . . 0.787 ' O ' HG21 ' A' ' 33' ' ' VAL . 1.2 m-20 -164.55 163.42 14.61 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.247 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -69.44 87.27 0.52 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 123.054 2.503 . . . . 0.0 111.734 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 529' ' ' ARG . . . . . . . . . . . . . 4.0 mtp180 -100.8 -45.67 5.39 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.527 -179.184 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 530' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -123.06 -42.76 2.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.057 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 3.7 m 72.72 138.81 0.05 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.924 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 532' ' ' TRP . . . . . 0.497 ' CZ2' ' HG3' ' B' ' 537' ' ' ARG . 11.2 t-105 -89.78 115.15 26.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.935 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . -110.46 -53.31 0.57 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.508 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 534' ' ' PHE . . . . . 0.475 ' O ' ' CZ2' ' B' ' 532' ' ' TRP . 32.2 m-85 -107.09 147.84 35.9 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.661 0.267 . . . . 0.0 110.881 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -67.61 -167.01 0.14 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.528 2.152 . . . . 0.0 112.298 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 70.14 102.51 0.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.945 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 537' ' ' ARG . . . . . 0.497 ' HG3' ' CZ2' ' B' ' 532' ' ' TRP . 0.0 OUTLIER -108.13 -177.11 3.24 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.391 0.615 . . . . 0.0 111.146 -179.991 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 538' ' ' ILE . . . . . 0.621 HD12 ' HB2' ' B' ' 542' ' ' TYR . 11.4 pt -114.47 -156.05 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-N 114.999 -1.001 . . . . 0.0 109.749 179.295 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 539' ' ' ASP . . . . . 0.68 ' HB3' HD21 ' A' ' 70' ' ' LEU . 0.3 OUTLIER -93.98 135.12 35.66 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.328 179.198 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 540' ' ' GLU . . . . . 0.873 ' HG3' HG13 ' A' ' 8' ' ' VAL . 1.4 mm-40 -41.33 -33.82 0.44 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.762 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 541' ' ' LEU . . . . . 0.877 ' HB2' HD23 ' A' ' 70' ' ' LEU . 2.4 tt -54.46 -34.36 61.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.117 0.484 . . . . 0.0 110.434 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 542' ' ' TYR . . . . . 0.621 ' HB2' HD12 ' B' ' 538' ' ' ILE . 89.4 m-85 -99.26 -6.55 27.85 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.923 -179.378 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 543' ' ' LEU . . . . . 0.955 ' CD2' HG21 ' A' ' 35' ' ' THR . 0.9 OUTLIER -50.17 167.03 0.06 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.789 0.328 . . . . 0.0 110.781 -179.786 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . 146.26 71.11 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.432 -0.89 . . . . 0.0 112.621 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 545' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.922 179.978 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.563 ' HE1' ' CD1' ' A' ' 51' ' ' TYR . 6.1 tpt . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.746 0.308 . . . . 0.0 111.263 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.432 ' O ' ' HE3' ' A' ' 1' ' ' MET . 41.3 tt0 -100.04 150.88 22.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.022 0.439 . . . . 0.0 110.864 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.679 HG23 ' HE1' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -93.46 -178.71 4.81 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.273 -179.538 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.575 ' H ' HG22 ' A' ' 3' ' ' THR . 3.8 pt -148.48 112.21 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.96 -179.38 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 44.8 mttt -94.85 95.83 8.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.191 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.523 ' CB ' ' CE2' ' A' ' 56' ' ' PHE . 4.0 m -121.35 136.99 54.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.666 -179.177 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.4 t -137.26 146.22 28.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.421 179.382 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.869 HG23 ' HB3' ' A' ' 56' ' ' PHE . 19.7 t -84.65 140.0 16.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.232 0.539 . . . . 0.0 111.668 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 96.2 t -150.66 129.81 3.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.534 179.061 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 135.03 -148.8 19.71 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.089 -1.053 . . . . 0.0 112.63 -179.324 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -122.47 23.64 9.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.825 0.345 . . . . 0.0 110.721 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.412 ' HA2' ' HB2' ' B' ' 537' ' ' ARG . . . -142.28 148.9 20.71 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.451 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -98.79 4.76 47.7 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.721 HG23 HG21 ' A' ' 115' ' ' THR . 6.8 p -43.69 -31.26 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 CA-C-O 120.692 0.282 . . . . 0.0 111.463 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.543 ' CA ' HD11 ' A' ' 19' ' ' LEU . . . -113.27 18.94 20.55 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.415 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.519 ' HA ' HG21 ' A' ' 8' ' ' VAL . 2.3 tttm -97.52 -126.49 0.15 Allowed 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 119.949 -0.072 . . . . 0.0 110.851 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.537 HG21 ' CG ' ' A' ' 38' ' ' ASP . 3.3 p -97.34 -31.08 12.58 Favored 'General case' 0 C--N 1.34 0.172 0 O-C-N 122.041 -0.412 . . . . 0.0 111.435 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.441 ' O ' ' CB ' ' A' ' 22' ' ' SER . 15.6 p -42.08 -36.38 1.13 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.903 -179.259 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.941 HD22 ' CG ' ' A' ' 169' ' ' PHE . 2.8 mp -48.4 -72.79 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.322 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.6 mt -78.12 -40.71 37.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.875 0.369 . . . . 0.0 110.612 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.588 HD12 ' CZ ' ' B' ' 518' ' ' PHE . 24.3 mm -62.56 -69.35 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.209 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.441 ' CB ' ' O ' ' A' ' 18' ' ' CYS . 1.5 t -52.86 -46.33 67.8 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.558 -179.535 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.425 ' CB ' ' O ' ' A' ' 19' ' ' LEU . 28.6 t80 -48.99 -42.66 38.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.686 0.279 . . . . 0.0 111.414 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.1 m -100.51 -64.59 1.03 Allowed 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.499 HG22 ' N ' ' A' ' 26' ' ' ASN . 97.8 m -100.55 164.64 11.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.933 0.396 . . . . 0.0 111.379 -179.322 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.499 ' N ' HG22 ' A' ' 25' ' ' THR . 7.1 t-20 73.89 -60.67 0.52 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.079 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 74.4 174.13 0.27 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.821 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.488 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 8.1 t80 -86.71 -46.22 0.54 Allowed Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.645 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.488 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 87.1 Cg_endo -82.99 50.8 3.47 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.501 2.134 . . . . 0.0 112.792 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.3 m -143.18 -100.46 0.12 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.79 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.416 ' O ' ' ND2' ' A' ' 26' ' ' ASN . 1.2 pt-20 -159.69 163.2 34.99 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.902 0.382 . . . . 0.0 111.073 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.474 ' O ' HG22 ' A' ' 33' ' ' VAL . 36.9 m-85 -135.21 117.09 15.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.266 179.475 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.659 HG11 ' HG3' ' B' ' 529' ' ' ARG . 0.0 OUTLIER -163.39 -62.87 0.01 OUTLIER Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.686 -179.471 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.449 ' HB3' ' CB ' ' B' ' 526' ' ' SER . 29.0 Cg_endo -62.9 57.33 0.15 Allowed 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.816 2.344 . . . . 0.0 113.592 -179.147 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.431 ' N ' ' O ' ' A' ' 33' ' ' VAL . 4.0 t -122.74 22.45 9.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.846 0.355 . . . . 0.0 110.172 178.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.71 ' CG2' HD22 ' A' ' 61' ' ' LEU . 2.3 t -73.13 -45.64 53.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.751 -179.059 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.48 ' O ' ' CD2' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -85.5 48.77 1.64 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.786 0.327 . . . . 0.0 111.303 -179.731 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.537 ' CG ' HG21 ' A' ' 17' ' ' THR . 99.4 m-20 -69.75 -16.87 63.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.111 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -86.02 11.28 11.95 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.593 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.534 ' HH ' ' HZ ' ' B' ' 518' ' ' PHE . 0.0 OUTLIER -60.25 173.81 0.61 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.821 0.343 . . . . 0.0 110.725 179.874 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.413 ' O ' HG12 ' B' ' 519' ' ' ILE . . . -92.16 147.43 22.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.174 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.529 HG12 ' HA ' ' B' ' 518' ' ' PHE . 6.7 m -134.91 147.05 29.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.887 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.705 ' N ' HD11 ' B' ' 519' ' ' ILE . 2.8 t -85.81 102.63 13.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.984 0.421 . . . . 0.0 109.911 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 1.019 HG13 HG21 ' A' ' 52' ' ' THR . 1.1 p -165.77 145.61 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.872 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.616 ' HG3' HD22 ' B' ' 514' ' ' LEU . 0.0 OUTLIER -115.75 140.33 49.31 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.424 179.521 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.604 HG23 ' CG2' ' B' ' 510' ' ' ILE . 7.8 mm -95.38 115.46 34.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-O 120.947 0.403 . . . . 0.0 111.561 -179.414 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.549 ' O ' ' HE1' ' A' ' 45' ' ' MET . . . 33.18 -90.35 0.01 OUTLIER Glycine 0 C--N 1.336 0.552 0 CA-C-N 115.595 -0.73 . . . . 0.0 114.223 178.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.408 ' C ' ' HE1' ' A' ' 45' ' ' MET . . . -41.14 -87.7 0.01 OUTLIER Glycine 0 C--N 1.332 0.315 0 C-N-CA 121.205 -0.522 . . . . 0.0 113.07 -179.435 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.407 ' CB ' ' HD2' ' A' ' 50' ' ' PRO . 1.1 mt-10 -143.51 165.36 25.53 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.406 0.103 . . . . 0.0 111.214 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.416 ' HA ' ' CB ' ' A' ' 45' ' ' MET . 39.2 Cg_exo -31.24 103.02 0.03 OUTLIER 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.619 2.879 . . . . 0.0 113.012 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.679 ' HE1' HG23 ' A' ' 3' ' ' THR . 8.7 t80 -172.53 120.67 0.41 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.772 -179.475 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' THR . . . . . 1.019 HG21 HG13 ' A' ' 44' ' ' VAL . 0.2 OUTLIER -135.43 155.73 50.08 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.088 -178.741 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.675 ' N ' HD13 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -115.55 156.3 26.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.186 179.973 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -62.26 109.85 2.87 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.6 -0.81 . . . . 0.0 111.875 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.22 -153.15 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.656 0.265 . . . . 0.0 110.895 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.869 ' HB3' HG23 ' A' ' 8' ' ' VAL . 9.0 m-85 -84.41 105.76 15.49 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 120.921 0.391 . . . . 0.0 111.127 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.402 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 4.3 p30 -120.74 113.06 19.64 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.939 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.593 HG22 HD13 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -154.21 125.77 7.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.87 179.86 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.884 ' HB1' ' CD1' ' A' ' 61' ' ' LEU . . . -172.52 119.86 0.39 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.992 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.4 ' HA2' ' O ' ' A' ' 64' ' ' TYR . . . -95.18 75.45 0.89 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.445 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.884 ' CD1' ' HB1' ' A' ' 59' ' ' ALA . 3.5 mp -117.46 -115.09 0.33 Allowed 'General case' 0 CA--C 1.538 0.513 0 O-C-N 122.912 -0.17 . . . . 0.0 110.872 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -98.6 -29.55 12.99 Favored 'General case' 0 N--CA 1.455 -0.182 0 O-C-N 122.073 -0.392 . . . . 0.0 111.254 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.45 ' HB3' ' CD1' ' A' ' 64' ' ' TYR . 14.8 t0 -67.38 -63.25 1.1 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.066 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.45 ' CD1' ' HB3' ' A' ' 63' ' ' ASP . 0.2 OUTLIER -124.13 137.22 54.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.674 179.966 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -87.25 -62.5 1.49 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.897 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.476 ' N ' ' CD ' ' A' ' 66' ' ' ARG . 0.3 OUTLIER -98.68 -21.09 16.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.181 -179.777 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.593 HD13 HG22 ' A' ' 58' ' ' THR . 1.7 mt 67.03 -135.38 0.13 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.297 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.467 ' CB ' ' CD ' ' A' ' 69' ' ' PRO . 1.2 mtt180 -166.06 -64.07 0.01 OUTLIER Pre-proline 0 CA--C 1.529 0.151 0 CA-C-N 118.28 0.491 . . . . 0.0 111.814 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.467 ' CD ' ' CB ' ' A' ' 68' ' ' ARG . 63.7 Cg_exo -36.96 -60.27 0.4 Allowed 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.965 2.443 . . . . 0.0 113.103 -179.536 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.649 ' C ' HD12 ' A' ' 70' ' ' LEU . 0.4 OUTLIER -50.08 -29.64 9.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.384 -179.752 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 68' ' ' ARG . 35.5 p -47.46 -64.76 0.7 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.759 0.314 . . . . 0.0 111.194 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.422 ' N ' ' OG ' ' A' ' 71' ' ' SER . 6.1 p90 -179.55 92.38 0.2 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.07 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.93 136.03 26.67 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.523 2.149 . . . . 0.0 112.313 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -87.4 10.91 15.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.512 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 11.7 t -70.13 -173.16 0.64 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.784 0.326 . . . . 0.0 110.933 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -124.31 7.69 8.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.431 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.986 HG11 ' HB2' ' A' ' 176' ' ' ALA . 9.0 p -129.14 78.59 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.755 0.312 . . . . 0.0 111.388 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.598 ' CZ ' HG21 ' A' ' 108' ' ' THR . 7.6 m-30 -80.7 172.43 13.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.224 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.435 ' CD2' ' HA3' ' A' ' 15' ' ' GLY . 8.1 tp -143.83 108.55 4.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.876 0.37 . . . . 0.0 111.374 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.593 ' CG1' HD12 ' A' ' 101' ' ' ILE . 4.4 m -94.52 155.12 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.18 179.167 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.591 ' HB3' HG12 ' A' ' 14' ' ' VAL . 2.3 m -134.85 146.21 49.03 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.194 0.521 . . . . 0.0 111.92 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.822 ' CE1' HD12 ' A' ' 112' ' ' LEU . 6.2 p90 -166.22 124.63 1.5 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.158 179.36 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.429 ' CB ' ' HG3' ' A' ' 116' ' ' GLN . 0.1 OUTLIER -90.24 139.26 30.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.014 0.435 . . . . 0.0 111.562 -179.244 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.956 HG22 ' CB ' ' A' ' 116' ' ' GLN . 10.2 m -63.26 -170.1 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.408 179.475 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.807 ' CG2' HG23 ' A' ' 84' ' ' VAL . 0.1 OUTLIER 56.19 102.11 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -179.282 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.898 ' C ' HD22 ' A' ' 129' ' ' LEU . 0.2 OUTLIER -151.26 145.9 18.49 Favored Pre-proline 0 C--N 1.325 -0.465 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.923 -179.183 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.584 ' N ' HD22 ' A' ' 129' ' ' LEU . 83.6 Cg_endo -85.73 50.04 2.51 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 123.121 2.548 . . . . 0.0 111.654 179.185 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.484 ' N ' ' HB3' ' A' ' 133' ' ' LYS . 2.6 t 82.9 27.8 0.11 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.877 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 44.5 t -97.3 -24.16 15.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.848 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.407 ' CZ ' HD12 ' A' ' 145' ' ' LEU . 11.2 t80 -49.56 -62.1 1.74 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.066 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -50.36 -31.16 13.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.873 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.424 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 1.4 t-20 -72.59 -63.22 1.2 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.859 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.437 HG13 ' N ' ' A' ' 94' ' ' LYS . 12.9 p -52.43 -41.74 36.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.039 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.831 ' CG ' HD11 ' A' ' 145' ' ' LEU . 0.8 OUTLIER -55.87 -62.27 1.81 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.699 179.93 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.409 ' O ' ' HG3' ' A' ' 99' ' ' PRO . 1.1 mm-40 -78.32 2.81 17.34 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.782 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.468 ' HD3' ' CZ3' ' A' ' 97' ' ' TRP . 55.9 tttt -105.24 -38.43 6.53 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.869 0.366 . . . . 0.0 110.56 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.468 ' CZ3' ' HD3' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -74.8 -49.45 20.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.15 179.967 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 94' ' ' LYS . 67.8 t -47.01 -52.3 34.57 Favored Pre-proline 0 CA--C 1.532 0.28 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.919 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 60.7 Cg_endo -72.22 -20.57 24.53 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.112 1.875 . . . . 0.0 112.385 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -84.89 -46.26 11.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.015 0.436 . . . . 0.0 110.622 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.593 HD12 ' CG1' ' A' ' 80' ' ' VAL . 5.9 tt -66.07 -26.11 37.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.906 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.46 HG22 ' HA ' ' A' ' 107' ' ' LYS . 60.3 p -91.55 -26.53 18.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.739 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.454 ' CG ' ' O ' ' A' ' 99' ' ' PRO . 1.9 m170 -67.52 -69.25 0.33 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.828 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -64.32 -42.93 96.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.634 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 4.5 m -112.59 149.21 40.79 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.603 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -49.21 162.31 0.5 Allowed 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.509 2.139 . . . . 0.0 112.269 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.46 ' HA ' HG22 ' A' ' 102' ' ' THR . 0.2 OUTLIER -81.43 56.21 2.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.801 179.921 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.598 HG21 ' CZ ' ' A' ' 78' ' ' PHE . 1.3 p -81.58 165.33 44.63 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.227 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -60.62 162.68 17.45 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.856 2.37 . . . . 0.0 112.323 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.832 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 8.8 p90 -156.07 153.83 30.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.757 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 1.023 HD12 HG11 ' A' ' 152' ' ' VAL . 4.7 tt -113.81 142.95 45.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.408 -179.511 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.822 HD12 ' CE1' ' A' ' 82' ' ' PHE . 3.8 mm? -99.14 158.68 15.51 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.387 179.389 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.957 ' CG1' HG11 ' A' ' 168' ' ' VAL . 2.6 t -141.94 146.95 22.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.166 0.507 . . . . 0.0 112.193 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.499 ' HA3' ' CZ ' ' A' ' 154' ' ' TYR . . . -122.49 92.02 0.47 Allowed Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.968 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.721 HG21 HG23 ' A' ' 14' ' ' VAL . 0.7 OUTLIER -114.34 6.76 16.18 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.281 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.956 ' CB ' HG22 ' A' ' 84' ' ' VAL . 2.3 mt-30 -110.22 25.86 11.31 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.301 0.572 . . . . 0.0 109.56 179.126 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.422 ' CD1' ' O ' ' A' ' 114' ' ' GLY . 0.0 OUTLIER -65.53 -10.45 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.501 179.008 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -96.9 -20.5 18.09 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.245 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.468 ' CB ' HG21 ' A' ' 85' ' ' VAL . 5.2 mp -89.02 -37.66 15.0 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.256 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.453 ' O ' HD13 ' A' ' 126' ' ' ILE . 8.2 ptm180 -48.09 -31.56 5.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.828 0.347 . . . . 0.0 110.894 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -78.58 -37.06 43.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.485 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -47.97 104.24 0.4 Allowed Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.909 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.424 ' O ' ' CG ' ' A' ' 127' ' ' GLU . 55.4 Cg_endo -70.99 -6.17 18.61 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.444 2.096 . . . . 0.0 112.898 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.93 -66.58 0.77 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.625 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.411 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 17.2 m -57.51 -40.86 79.62 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.576 HD11 ' HB3' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -52.84 -46.56 52.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.805 179.231 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.52 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 20.5 mm-40 -58.14 -33.69 69.46 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.9 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.441 ' HA ' ' CE ' ' A' ' 131' ' ' LYS . 9.9 mptt -68.99 -24.77 64.27 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 178.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.898 HD22 ' C ' ' A' ' 86' ' ' SER . 4.4 mt -79.43 -35.58 40.3 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 177.591 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 127' ' ' GLU . . . -39.55 -39.1 0.67 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.033 -0.985 . . . . 0.0 112.391 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.441 ' CE ' ' HA ' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -69.88 -21.63 63.31 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.793 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.422 ' CB ' ' O ' ' A' ' 87' ' ' PRO . 17.5 m120 -124.01 -31.72 3.34 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -179.243 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.488 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 0.0 OUTLIER -139.63 -74.68 0.36 Allowed 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 -179.303 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.488 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 1.2 pt20 99.46 -41.21 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.075 0.95 . . . . 0.0 110.806 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.421 ' N ' ' HG2' ' A' ' 134' ' ' GLN . 0.8 OUTLIER -74.33 109.03 6.02 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.438 -179.648 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.91 ' C ' HD13 ' A' ' 137' ' ' ILE . 54.4 Cg_endo -68.28 -169.35 0.25 Allowed 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.253 1.968 . . . . 0.0 111.141 179.095 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.91 HD13 ' C ' ' A' ' 136' ' ' PRO . 1.0 OUTLIER -115.37 96.42 4.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.028 0.442 . . . . 0.0 110.585 179.877 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.415 ' O ' ' N ' ' A' ' 141' ' ' THR . 26.3 p -69.85 144.24 93.08 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.929 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.466 ' O ' ' CE1' ' A' ' 154' ' ' TYR . 1.8 Cg_endo -42.61 -46.07 8.22 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 122.893 2.395 . . . . 0.0 112.012 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.402 ' HG2' ' OG1' ' A' ' 138' ' ' THR . 9.6 pt-20 -59.96 -32.66 71.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.417 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.415 ' N ' ' O ' ' A' ' 138' ' ' THR . 29.5 m -61.55 -53.17 59.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.686 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.526 ' CB ' ' CD2' ' A' ' 154' ' ' TYR . . . -51.91 -36.84 50.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.689 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -62.84 -40.88 98.8 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.492 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 37.4 tttp -59.38 -56.13 25.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.415 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.831 HD11 ' CG ' ' A' ' 94' ' ' LYS . 0.9 OUTLIER -62.15 -41.06 97.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.341 179.512 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.449 ' CB ' HD23 ' A' ' 112' ' ' LEU . . . -58.86 -53.19 61.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.739 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.06 -27.06 61.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.666 179.625 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -50.45 -45.08 55.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.709 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.11 20.73 18.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.926 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 18.9 mttt 48.67 63.55 2.05 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.091 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.832 ' HB1' ' O ' ' A' ' 110' ' ' PHE . . . -80.19 -82.29 0.11 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.959 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 1.023 HG11 HD12 ' A' ' 111' ' ' LEU . 54.9 t -162.05 -75.6 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.794 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.409 ' HE2' ' N ' ' A' ' 154' ' ' TYR . 0.0 OUTLIER -177.17 120.14 0.12 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.855 -178.831 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.526 ' CD2' ' CB ' ' A' ' 142' ' ' ALA . 12.5 t80 -89.83 114.56 26.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.296 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.48 HG21 ' HG3' ' A' ' 171' ' ' GLU . 2.8 t -111.7 154.67 13.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.032 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -93.49 119.84 33.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.021 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.571 ' O ' HG22 ' A' ' 115' ' ' THR . 1.3 m -172.49 135.71 0.73 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.808 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.434 ' CB ' ' HB ' ' A' ' 115' ' ' THR . 1.9 p -150.1 170.69 18.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.922 0.392 . . . . 0.0 111.153 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.39 -30.84 21.82 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.99 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.1 mt -51.38 -72.39 0.05 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.664 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 14.6 t -74.21 -16.81 60.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.086 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 71.07 50.84 0.3 Allowed 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.069 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.418 ' HB3' ' HA ' ' A' ' 157' ' ' CYS . 0.6 OUTLIER -68.78 -21.02 64.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.969 179.67 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 139.05 -42.45 1.25 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.388 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.702 HD22 ' HA ' ' A' ' 19' ' ' LEU . 0.3 OUTLIER 68.15 -62.18 0.37 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.796 0.332 . . . . 0.0 111.079 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.426 ' O ' ' N ' ' A' ' 170' ' ' ASP . 0.1 OUTLIER -48.12 -25.52 1.49 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.388 -179.733 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -52.34 -71.64 0.06 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.798 0.332 . . . . 0.0 110.47 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.957 HG11 ' CG1' ' A' ' 113' ' ' VAL . 14.7 p -59.24 -29.92 42.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.266 0.555 . . . . 0.0 110.184 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.941 ' CG ' HD22 ' A' ' 19' ' ' LEU . 0.6 OUTLIER -67.53 -29.8 69.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.325 179.714 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 166' ' ' LYS . 68.9 m-20 -77.28 -27.72 53.17 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.191 179.31 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.48 ' HG3' HG21 ' A' ' 155' ' ' VAL . 8.1 mm-40 -75.5 -28.5 59.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.316 179.489 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.583 ' CA ' HD13 ' A' ' 111' ' ' LEU . . . -75.02 -48.06 25.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.961 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.506 ' O ' ' HB3' ' A' ' 176' ' ' ALA . 1.3 pp -65.72 -34.71 72.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.72 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.731 HD13 ' CB ' ' B' ' 505' ' ' LEU . 1.6 tp -48.86 -58.04 5.45 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.912 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.447 ' HB3' HG23 ' A' ' 77' ' ' VAL . . . -47.87 -26.46 1.69 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.136 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.986 ' HB2' HG11 ' A' ' 77' ' ' VAL . . . -77.29 -47.85 18.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.209 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.696 ' CD2' HG21 ' B' ' 510' ' ' ILE . 3.0 mt -68.53 -23.82 64.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.881 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.431 ' HB3' ' HB2' ' B' ' 507' ' ' ALA . 0.0 OUTLIER -160.28 155.82 22.02 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.963 179.753 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.0 122.43 8.1 Favored 'Trans proline' 0 CA--C 1.529 0.253 0 C-N-CA 122.631 2.221 . . . . 0.0 112.18 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.53 175.82 5.64 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.434 2.09 . . . . 0.0 112.376 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 25.8 mp0 -144.63 96.72 5.12 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.887 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.23 -165.08 0.27 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.573 2.182 . . . . 0.0 112.235 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 5.8 mmtp -80.09 141.72 35.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.815 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.903 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.154 0 N-CA-C 112.521 -0.232 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 503' ' ' SER . . . . . . . . . . . . . 54.5 p -99.47 -160.49 0.81 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.745 0.307 . . . . 0.0 110.813 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 504' ' ' GLY . . . . . 0.407 ' HA2' ' HB2' ' B' ' 509' ' ' ASP . . . 149.23 95.81 0.15 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.331 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 505' ' ' LEU . . . . . 0.731 ' CB ' HD13 ' A' ' 174' ' ' LEU . 0.2 OUTLIER -157.43 146.51 19.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.057 0.456 . . . . 0.0 111.477 -179.698 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 506' ' ' SER . . . . . 0.482 ' O ' ' HB2' ' B' ' 507' ' ' ALA . 0.6 OUTLIER -60.05 81.83 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.728 179.579 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 507' ' ' ALA . . . . . 0.482 ' HB2' ' O ' ' B' ' 506' ' ' SER . . . 170.82 43.71 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.486 -179.311 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 508' ' ' GLN . . . . . 0.595 ' HB2' HD12 ' B' ' 510' ' ' ILE . 0.0 OUTLIER 75.33 3.79 4.05 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.692 -177.385 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 509' ' ' ASP . . . . . 0.407 ' HB2' ' HA2' ' B' ' 504' ' ' GLY . 3.7 p30 45.9 53.16 9.23 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.164 0.507 . . . . 0.0 111.393 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 510' ' ' ILE . . . . . 0.696 HG21 ' CD2' ' A' ' 177' ' ' LEU . 1.2 mp -52.97 143.72 4.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.104 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 511' ' ' SER . . . . . 0.532 ' O ' HD11 ' B' ' 514' ' ' LEU . 22.8 t -108.67 153.74 23.0 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.889 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 512' ' ' GLN . . . . . 0.487 ' OE1' ' CD2' ' A' ' 169' ' ' PHE . 9.6 tt0 -102.46 -70.59 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.181 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 513' ' ' PRO . . . . . 0.487 ' CD ' ' CB ' ' B' ' 512' ' ' GLN . 87.5 Cg_endo -77.54 56.59 5.63 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.279 1.986 . . . . 0.0 111.617 179.07 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 514' ' ' LEU . . . . . 0.898 ' HB2' HG23 ' A' ' 44' ' ' VAL . 2.1 mp -60.72 -89.99 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.623 -179.147 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 515' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -84.15 -159.61 0.4 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.63 0.252 . . . . 0.0 110.792 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -48.12 -27.32 2.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.834 0.35 . . . . 0.0 110.733 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 517' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 39.57 33.75 0.13 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.724 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 518' ' ' PHE . . . . . 0.588 ' CZ ' HD12 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -163.51 106.72 1.0 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.371 -179.9 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 519' ' ' ILE . . . . . 0.705 HD11 ' N ' ' A' ' 43' ' ' THR . 3.6 mm -87.13 -37.31 10.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.906 0.384 . . . . 0.0 110.842 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -167.52 -170.75 1.5 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.668 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 521' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.27 157.54 19.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.849 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 522' ' ' GLY . . . . . 0.452 ' CA ' ' HB3' ' A' ' 37' ' ' PHE . . . -61.67 -126.52 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.32 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 523' ' ' HIS . . . . . . . . . . . . . 30.6 t-80 -165.05 -88.07 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.625 0.25 . . . . 0.0 111.065 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 524' ' ' GLY . . . . . 0.481 ' HA3' HG21 ' A' ' 36' ' ' VAL . . . 42.49 -153.39 0.19 Allowed Glycine 0 C--N 1.334 0.418 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.841 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 525' ' ' ASP . . . . . 0.518 ' OD1' HD23 ' A' ' 61' ' ' LEU . 41.0 p-10 -83.29 65.81 8.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.902 0.382 . . . . 0.0 110.655 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 526' ' ' SER . . . . . 0.449 ' CB ' ' HB3' ' A' ' 34' ' ' PRO . 53.6 p -73.19 96.12 2.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.796 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 527' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -168.24 153.36 6.47 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.003 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.62 100.81 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.684 2.256 . . . . 0.0 112.069 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 529' ' ' ARG . . . . . 0.659 ' HG3' HG11 ' A' ' 33' ' ' VAL . 7.6 mtp85 -100.71 -55.34 2.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.286 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 530' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -162.94 98.33 0.95 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.123 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 19.2 t -46.81 95.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.887 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 532' ' ' TRP . . . . . 0.445 ' CE3' ' O ' ' B' ' 533' ' ' GLY . 21.0 t90 68.48 -67.36 0.2 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.948 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 533' ' ' GLY . . . . . 0.445 ' O ' ' CE3' ' B' ' 532' ' ' TRP . . . 87.34 -122.69 6.29 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.592 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 534' ' ' PHE . . . . . 0.4 ' HB3' ' HD2' ' B' ' 535' ' ' PRO . 49.4 m-85 -95.08 155.38 39.05 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 120.738 0.304 . . . . 0.0 110.87 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 535' ' ' PRO . . . . . 0.4 ' HD2' ' HB3' ' B' ' 534' ' ' PHE . 33.9 Cg_endo -64.54 166.38 17.77 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.619 2.213 . . . . 0.0 112.302 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 64.81 97.06 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.828 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 537' ' ' ARG . . . . . 0.412 ' HB2' ' HA2' ' A' ' 12' ' ' GLY . 0.2 OUTLIER -50.59 143.14 9.79 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.047 0.451 . . . . 0.0 111.054 -179.919 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 538' ' ' ILE . . . . . 0.448 ' CG2' ' HA ' ' B' ' 543' ' ' LEU . 6.1 tp -56.17 141.84 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.912 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 539' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -43.06 143.06 0.83 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.943 0.401 . . . . 0.0 111.387 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 540' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -54.15 -20.45 6.76 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.383 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 541' ' ' LEU . . . . . 0.494 ' HA ' HD22 ' A' ' 70' ' ' LEU . 3.9 mt -41.54 -57.9 2.09 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.878 0.37 . . . . 0.0 111.348 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 542' ' ' TYR . . . . . 0.404 ' O ' ' HA ' ' A' ' 59' ' ' ALA . 1.6 m-85 -104.38 -63.54 1.2 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.804 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 543' ' ' LEU . . . . . 0.454 HD22 ' O ' ' A' ' 58' ' ' THR . 0.3 OUTLIER 67.21 152.93 0.08 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.754 -179.834 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . 120.25 -123.98 5.77 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.536 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 545' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.911 179.903 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.4 ' CE ' ' O ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.788 0.328 . . . . 0.0 111.204 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.4 ' O ' ' CE ' ' A' ' 1' ' ' MET . 6.5 tt0 54.12 170.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.715 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.771 HG23 ' CE1' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -132.28 -172.46 2.9 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.317 -179.744 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.945 HG13 HD13 ' A' ' 53' ' ' LEU . 4.5 pt -153.14 132.06 3.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.526 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -91.45 95.78 10.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.575 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.616 ' CB ' HD13 ' A' ' 55' ' ' LEU . 1.1 m -80.37 98.64 7.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.273 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.1 t -126.25 159.43 35.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.478 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.805 HG21 ' HG3' ' A' ' 16' ' ' LYS . 22.4 t -128.97 117.62 44.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.039 0.447 . . . . 0.0 111.65 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 96.7 t -123.82 129.98 74.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.917 179.123 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 134.17 -164.91 24.48 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.205 -0.997 . . . . 0.0 112.612 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' B' ' 539' ' ' ASP . 1.2 m-20 -98.82 25.93 6.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.837 0.351 . . . . 0.0 110.572 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -138.27 150.01 20.78 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.645 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -89.83 -14.93 33.36 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.877 HG11 HG11 ' A' ' 113' ' ' VAL . 92.2 t -43.51 102.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-O 120.903 0.382 . . . . 0.0 111.29 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.623 ' CA ' HD11 ' A' ' 19' ' ' LEU . . . 142.12 -13.02 2.58 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.624 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.805 ' HG3' HG21 ' A' ' 8' ' ' VAL . 77.0 mttt -97.61 -105.73 0.18 Allowed 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.645 0.222 . . . . 0.0 111.377 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.46 ' HB ' ' CG1' ' A' ' 21' ' ' ILE . 69.2 p -98.49 -39.32 8.81 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 -179.408 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.426 ' O ' ' CB ' ' A' ' 22' ' ' SER . 23.8 t -35.9 -34.19 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -179.021 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.837 HD22 ' CD2' ' A' ' 169' ' ' PHE . 0.0 OUTLIER -80.71 -70.31 0.54 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.761 0.315 . . . . 0.0 111.036 -179.746 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.676 ' H ' HD22 ' A' ' 20' ' ' LEU . 0.5 OUTLIER -50.84 -43.59 59.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.653 -179.908 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.781 HD11 ' CE2' ' B' ' 518' ' ' PHE . 32.5 mm -63.73 -64.05 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.171 179.267 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.426 ' CB ' ' O ' ' A' ' 18' ' ' CYS . 45.4 t -45.93 -30.17 1.67 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.958 0.408 . . . . 0.0 110.707 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -65.44 -45.24 84.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.412 179.381 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -87.39 -50.73 6.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.557 179.576 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.2 p -102.18 -158.55 0.68 Allowed 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.221 179.541 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -159.33 38.45 0.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.005 0.431 . . . . 0.0 110.821 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.6 98.9 8.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.92 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.469 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . 9.4 t80 -97.56 -52.04 0.21 Allowed Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.024 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.469 ' HD3' ' HB3' ' A' ' 28' ' ' PHE . 65.3 Cg_endo -90.37 26.53 0.49 Allowed 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.782 2.321 . . . . 0.0 112.62 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.57 -87.32 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.129 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.429 ' HB2' ' HD3' ' B' ' 529' ' ' ARG . 4.7 pt-20 -158.13 115.86 2.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.844 0.354 . . . . 0.0 110.737 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.439 ' O ' HG22 ' A' ' 33' ' ' VAL . 12.0 m-30 -105.83 119.5 39.32 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.759 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.508 HG23 ' HD3' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -161.86 -56.14 0.01 OUTLIER Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.145 179.863 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.508 ' HD3' HG23 ' A' ' 33' ' ' VAL . 19.1 Cg_exo -66.22 -15.52 48.61 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.469 2.112 . . . . 0.0 112.558 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.0 t -41.94 -30.67 0.28 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.907 0.384 . . . . 0.0 111.387 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.506 HG23 ' HB3' ' A' ' 59' ' ' ALA . 12.3 p -51.29 -22.47 2.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.329 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.48 ' CD1' ' O ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -81.88 48.15 1.18 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.311 179.896 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.406 ' OD2' ' N ' ' A' ' 57' ' ' ASP . 14.6 p-10 -74.13 -2.6 25.29 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.498 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -83.94 11.11 8.26 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 111.603 0.223 . . . . 0.0 111.603 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 48.7 p90 -60.27 160.96 7.7 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.74 0.305 . . . . 0.0 110.616 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.423 ' O ' ' CG1' ' B' ' 519' ' ' ILE . . . -109.89 135.99 49.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.476 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.881 HG23 HG21 ' A' ' 52' ' ' THR . 13.5 m -114.57 121.68 67.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.824 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.43 ' O ' ' CG1' ' A' ' 44' ' ' VAL . 1.6 p -91.51 103.84 16.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.524 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.67 HG22 ' CG2' ' A' ' 52' ' ' THR . 29.2 m -159.26 -177.12 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.305 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.467 ' HE1' ' N ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -112.76 97.59 6.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.511 -179.58 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 1.032 HG23 HG23 ' B' ' 510' ' ' ILE . 1.6 mm -69.54 87.67 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.053 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.504 ' HA3' HD13 ' B' ' 510' ' ' ILE . . . 39.79 -90.59 0.01 OUTLIER Glycine 0 CA--C 1.521 0.466 0 CA-C-N 116.066 -0.516 . . . . 0.0 113.53 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . -38.38 -82.76 0.01 OUTLIER Glycine 0 C--N 1.334 0.467 0 C-N-CA 121.542 -0.361 . . . . 0.0 113.502 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.467 ' N ' ' HE1' ' A' ' 45' ' ' MET . 1.9 mt-10 -135.35 165.96 32.41 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-O 120.898 0.38 . . . . 0.0 111.581 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.418 ' HD2' ' HB3' ' A' ' 49' ' ' GLU . 51.4 Cg_exo -54.28 99.74 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.769 2.313 . . . . 0.0 113.032 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.771 ' CE1' HG23 ' A' ' 3' ' ' THR . 6.2 t80 -173.24 153.06 2.37 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.667 179.319 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.881 HG21 HG23 ' A' ' 42' ' ' VAL . 0.8 OUTLIER -136.79 153.21 50.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.623 179.201 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.945 HD13 HG13 ' A' ' 4' ' ' ILE . 0.6 OUTLIER -80.93 -172.92 3.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.165 -179.879 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.408 ' O ' ' CE2' ' A' ' 56' ' ' PHE . . . -124.65 98.09 0.55 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.037 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.616 HD13 ' CB ' ' A' ' 6' ' ' CYS . 3.5 mm? -51.54 123.68 10.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.812 0.339 . . . . 0.0 111.053 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.408 ' CE2' ' O ' ' A' ' 54' ' ' GLY . 45.0 m-85 -113.6 118.75 35.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.786 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.433 ' HB2' ' CD ' ' A' ' 16' ' ' LYS . 35.6 p-10 -121.66 -176.57 3.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.119 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.643 ' OG1' HD22 ' B' ' 543' ' ' LEU . 75.7 p -124.52 130.83 53.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.923 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.506 ' HB3' HG23 ' A' ' 36' ' ' VAL . . . -140.93 -167.47 2.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.004 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.16 44.51 0.58 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.656 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.447 ' CD1' ' HB1' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -121.33 -158.11 0.75 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.702 0.287 . . . . 0.0 110.898 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -62.84 -34.96 78.42 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.341 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.458 ' HB3' ' CD1' ' A' ' 64' ' ' TYR . 0.5 OUTLIER -47.37 -58.0 4.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.079 -179.848 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.458 ' CD1' ' HB3' ' A' ' 63' ' ' ASP . 0.1 OUTLIER -175.2 100.58 0.08 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.721 179.778 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.24 -21.91 39.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.158 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.422 ' HG2' ' N ' ' A' ' 67' ' ' LEU . 0.1 OUTLIER -88.29 -29.1 20.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.129 -179.852 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.479 HD21 ' H ' ' A' ' 59' ' ' ALA . 20.8 mt 51.86 -153.23 0.21 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.486 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.423 ' O ' ' N ' ' A' ' 71' ' ' SER . 0.3 OUTLIER 179.56 -56.87 0.0 OUTLIER Pre-proline 0 C--N 1.333 -0.152 0 CA-C-O 120.731 0.3 . . . . 0.0 111.427 -179.992 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.406 ' HD3' ' HB3' ' A' ' 68' ' ' ARG . 85.8 Cg_exo -42.23 -27.99 0.81 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.673 2.249 . . . . 0.0 112.799 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.723 ' O ' HD12 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -85.89 -31.18 22.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.903 -179.783 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.423 ' N ' ' O ' ' A' ' 68' ' ' ARG . 35.0 t -47.45 -71.19 0.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.158 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.455 ' N ' ' CD1' ' A' ' 72' ' ' TYR . 0.0 OUTLIER 176.67 64.72 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.047 -179.855 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.98 172.9 11.99 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.51 2.14 . . . . 0.0 112.149 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 16.3 tp60 -87.98 10.2 19.71 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.495 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 12.3 t -52.35 161.13 0.7 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.783 0.325 . . . . 0.0 110.819 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -122.82 5.16 9.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.468 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.466 HG21 ' CA ' ' A' ' 176' ' ' ALA . 60.0 t -140.48 97.81 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.782 0.325 . . . . 0.0 111.117 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -95.59 -177.97 4.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.71 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.513 HD12 ' O ' ' A' ' 111' ' ' LEU . 10.7 tp -147.35 108.8 4.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.255 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.0 m -95.09 131.02 43.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.359 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 2.6 m -127.08 134.67 50.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.922 0.391 . . . . 0.0 111.42 -179.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.848 ' CE2' HD22 ' A' ' 112' ' ' LEU . 10.6 p90 -148.06 132.47 17.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.546 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.43 ' CA ' ' HG3' ' A' ' 116' ' ' GLN . 0.5 OUTLIER -83.84 133.14 34.76 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.251 -179.675 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.88 HG23 ' HB2' ' A' ' 116' ' ' GLN . 59.5 t -42.45 -67.75 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.566 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.785 HG13 ' OE1' ' A' ' 116' ' ' GLN . 28.5 m -37.03 111.17 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-O 120.75 0.31 . . . . 0.0 111.379 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.798 ' N ' HD22 ' A' ' 129' ' ' LEU . 0.1 OUTLIER -151.5 139.24 12.62 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.828 -179.064 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.426 ' O ' ' CB ' ' A' ' 132' ' ' ASN . 91.6 Cg_endo -91.02 53.19 0.93 Allowed 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 123.189 2.592 . . . . 0.0 111.681 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.474 ' CA ' ' HB2' ' A' ' 133' ' ' LYS . 0.1 OUTLIER 70.68 19.45 6.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.077 -179.521 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.568 ' O ' HG23 ' A' ' 93' ' ' VAL . 1.4 m -97.23 -23.37 16.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.964 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -47.1 -48.48 22.87 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.183 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -51.94 -40.4 60.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.991 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.412 ' HA ' ' HB2' ' A' ' 95' ' ' GLU . 0.7 OUTLIER -76.62 -36.55 57.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.933 -179.873 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 89' ' ' SER . 62.9 t -51.09 -57.25 3.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.291 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.771 ' HG2' HD13 ' A' ' 145' ' ' LEU . 3.8 mptp? -73.6 -32.35 64.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.118 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.412 ' HB2' ' HA ' ' A' ' 92' ' ' ASN . 6.3 mm-40 -64.72 -23.99 67.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.093 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 93' ' ' VAL . 13.5 ptmt -108.35 -17.67 13.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.4 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.527 ' CE2' HG13 ' A' ' 93' ' ' VAL . 34.0 m0 -76.83 -54.4 6.65 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.765 0.317 . . . . 0.0 111.078 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.531 HG11 HD22 ' A' ' 149' ' ' LEU . 42.6 t -47.18 -50.15 48.55 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.841 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 62.2 Cg_endo -72.98 -16.19 25.81 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.145 1.897 . . . . 0.0 112.549 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -85.5 -39.63 17.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.906 0.384 . . . . 0.0 110.933 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 40.8 pt -71.58 -32.93 47.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.05 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 11.0 p -80.26 -32.69 38.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.908 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -64.73 -50.09 68.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.685 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -76.03 -33.08 59.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.855 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 41.6 m -125.92 101.18 29.68 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.832 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -44.33 93.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.55 2.167 . . . . 0.0 112.49 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.2 mmmm 53.95 103.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.85 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.424 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -138.55 129.21 15.22 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.753 179.915 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 108' ' ' THR . 31.6 Cg_exo -60.2 162.82 15.91 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.448 2.099 . . . . 0.0 112.25 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.837 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 7.6 p90 -162.9 150.57 13.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.947 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.92 HD12 HG11 ' A' ' 152' ' ' VAL . 9.7 tt -120.51 150.67 40.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.063 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.98 HD12 ' HB2' ' A' ' 146' ' ' ALA . 20.0 mt -108.03 156.19 19.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.813 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.897 HG13 HG11 ' A' ' 168' ' ' VAL . 3.8 t -130.92 148.82 33.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.913 0.387 . . . . 0.0 111.44 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.53 ' O ' HD11 ' A' ' 117' ' ' ILE . . . -123.54 84.85 0.37 Allowed Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.266 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.499 ' HB ' ' HA ' ' A' ' 158' ' ' SER . 0.7 OUTLIER -106.52 7.32 30.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.657 0.265 . . . . 0.0 111.667 -179.558 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.88 ' HB2' HG23 ' A' ' 84' ' ' VAL . 0.7 OUTLIER -98.07 -17.05 19.33 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.628 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.65 HD12 ' N ' ' A' ' 117' ' ' ILE . 0.2 OUTLIER -48.75 -24.11 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.831 179.238 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.14 -22.14 58.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.163 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.651 HD11 ' CD ' ' A' ' 116' ' ' GLN . 4.5 pp -122.45 -10.04 8.46 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.623 ' HD3' HG22 ' A' ' 117' ' ' ILE . 0.7 OUTLIER -50.44 -27.18 5.99 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.942 0.401 . . . . 0.0 110.719 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -77.32 -26.62 52.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.529 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 119' ' ' LEU . 9.0 m-20 -50.81 103.92 0.4 Allowed Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.639 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.401 ' HA ' ' CG2' ' A' ' 126' ' ' ILE . 15.1 Cg_exo -68.61 -3.99 12.24 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.8 2.334 . . . . 0.0 113.047 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 26.7 t -80.88 -67.42 0.78 Allowed 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.56 HG21 HG11 ' A' ' 85' ' ' VAL . 9.0 m -56.32 -32.74 64.92 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.408 0.623 . . . . 0.0 109.355 178.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.977 HD11 ' HB3' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -61.6 -43.33 96.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.466 179.196 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.479 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 7.0 mm-40 -56.2 -34.51 66.32 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.45 178.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.429 ' HB2' ' O ' ' A' ' 125' ' ' THR . 2.2 mptt -65.95 -32.95 74.74 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.63 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.798 HD22 ' N ' ' A' ' 86' ' ' SER . 6.8 mt -71.85 -39.3 69.79 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.794 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.488 ' HA ' ' HB3' ' A' ' 134' ' ' GLN . . . -48.01 -26.71 1.89 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.094 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.7 mmtp -64.69 -32.32 73.94 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.579 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.426 ' CB ' ' O ' ' A' ' 87' ' ' PRO . 47.8 m-80 -124.2 -30.99 3.38 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -179.186 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.492 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 0.0 OUTLIER -133.63 -73.16 0.49 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.345 -178.836 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.492 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 2.3 pt20 99.28 -33.42 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.866 0.866 . . . . 0.0 111.089 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -68.61 110.46 5.93 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.774 -178.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.977 ' HB3' HD11 ' A' ' 126' ' ' ILE . 72.4 Cg_endo -76.07 123.08 7.05 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.32 2.014 . . . . 0.0 111.355 179.049 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.68 ' N ' HD13 ' A' ' 137' ' ' ILE . 0.8 OUTLIER -57.38 96.36 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.549 -179.696 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.423 HG22 ' H ' ' A' ' 138' ' ' THR . 0.5 OUTLIER -72.56 150.22 91.2 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.737 -179.808 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.488 ' HG3' HG21 ' A' ' 117' ' ' ILE . 97.8 Cg_exo -41.35 -38.34 3.61 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.682 2.255 . . . . 0.0 112.586 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -65.63 -33.36 75.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.004 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.565 HG21 HG23 ' A' ' 137' ' ' ILE . 58.5 m -60.15 -63.77 1.18 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.952 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.57 ' HB1' ' CD2' ' A' ' 154' ' ' TYR . . . -48.73 -48.16 40.78 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.807 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -58.98 -37.24 76.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.449 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -60.51 -58.38 8.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.48 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.771 HD13 ' HG2' ' A' ' 94' ' ' LYS . 0.5 OUTLIER -63.78 -33.32 75.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.393 179.574 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.98 ' HB2' HD12 ' A' ' 112' ' ' LEU . . . -65.05 -34.39 78.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.697 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -90.5 -25.31 20.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.655 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -57.01 -33.09 66.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.827 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.531 HD22 HG11 ' A' ' 98' ' ' VAL . 0.3 OUTLIER -113.07 19.49 17.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.14 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt 47.91 40.31 12.58 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.196 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.837 ' HB1' ' O ' ' A' ' 110' ' ' PHE . . . -58.4 -80.97 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.069 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.92 HG11 HD12 ' A' ' 111' ' ' LEU . 55.6 t -160.52 -75.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.744 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 176.07 126.82 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.773 -179.148 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.57 ' CD2' ' HB1' ' A' ' 142' ' ' ALA . 6.0 t80 -96.78 111.02 23.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.08 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 2.6 t -101.76 152.43 5.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.867 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -91.78 127.05 37.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.24 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.457 ' HA ' ' HB3' ' A' ' 163' ' ' LYS . 1.1 p 179.31 126.92 0.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.988 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.499 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 87.7 p -100.38 153.9 18.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.399 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.588 ' HB2' HD21 ' A' ' 165' ' ' LEU . . . -94.09 -35.58 12.49 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.828 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.454 ' H ' HD12 ' A' ' 160' ' ' LEU . 1.2 mp -47.5 -41.74 21.54 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.641 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.4 HG22 ' OG ' ' A' ' 158' ' ' SER . 5.0 t -112.97 -16.94 12.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.738 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.405 ' O ' ' NE2' ' A' ' 162' ' ' GLN . 0.8 OUTLIER 72.86 70.88 0.13 Allowed 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.837 179.983 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.457 ' HB3' ' HA ' ' A' ' 157' ' ' CYS . 2.1 tttm -87.84 -20.02 26.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.21 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 168.19 37.32 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.74 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.831 HD12 ' CB ' ' A' ' 19' ' ' LEU . 0.5 OUTLIER -47.82 -39.62 18.86 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.762 0.315 . . . . 0.0 110.914 179.966 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 13.8 pttp -72.61 -32.92 66.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.793 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -54.56 -70.3 0.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.597 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.897 HG11 HG13 ' A' ' 113' ' ' VAL . 7.7 p -53.7 -46.52 62.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.08 0.467 . . . . 0.0 110.358 179.525 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.837 ' CD2' HD22 ' A' ' 19' ' ' LEU . 0.8 OUTLIER -55.37 -34.09 64.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.239 179.324 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.429 ' HA ' ' CG1' ' A' ' 173' ' ' ILE . 52.5 t0 -62.13 -43.65 98.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.277 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.547 ' CB ' HD11 ' A' ' 111' ' ' LEU . 62.8 mm-40 -62.48 -28.99 70.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.367 179.454 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.619 ' N ' HD13 ' A' ' 111' ' ' LEU . . . -78.73 -49.21 13.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.134 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.446 ' HB ' HD12 ' A' ' 4' ' ' ILE . 1.5 pp -72.05 -36.84 58.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.344 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.833 HD13 ' O ' ' A' ' 174' ' ' LEU . 3.1 tm? -63.08 -32.67 74.1 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.969 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.69 -22.47 62.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.026 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.466 ' CA ' HG21 ' A' ' 77' ' ' VAL . . . -87.76 -31.41 19.65 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.102 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.861 HD13 HG21 ' B' ' 510' ' ' ILE . 0.3 OUTLIER -92.7 15.27 14.86 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.278 -179.87 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 176.92 98.11 0.11 Allowed Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.692 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -46.8 102.93 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.654 2.236 . . . . 0.0 112.547 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.26 170.88 19.37 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.59 2.193 . . . . 0.0 112.37 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -146.01 139.28 14.47 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.782 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -77.96 -165.27 0.32 Allowed 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.553 2.168 . . . . 0.0 112.332 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.9 153.95 32.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.879 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 2.3 mtpt . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.892 179.88 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 502' ' ' GLY . . . . . 0.837 ' N ' ' HG ' ' B' ' 511' ' ' SER . . . . . . . . 0 N--CA 1.488 2.165 0 N-CA-C 112.458 -0.257 . . . . 0.0 112.458 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 503' ' ' SER . . . . . 0.401 ' HB3' ' OD2' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -75.8 -86.62 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.714 0.292 . . . . 0.0 110.726 179.91 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 504' ' ' GLY . . . . . 0.61 ' C ' HD23 ' B' ' 505' ' ' LEU . . . 63.46 119.75 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.259 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 505' ' ' LEU . . . . . 0.726 ' N ' HD23 ' B' ' 505' ' ' LEU . 0.8 OUTLIER -173.66 115.59 0.23 Allowed 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 120.811 0.339 . . . . 0.0 111.818 -178.374 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 506' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 79.0 -74.11 0.06 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.615 179.036 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 507' ' ' ALA . . . . . 0.436 ' HB3' HG12 ' B' ' 510' ' ' ILE . . . -35.26 -38.14 0.09 Allowed 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.436 0.636 . . . . 0.0 111.651 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 508' ' ' GLN . . . . . 0.519 ' O ' ' CB ' ' B' ' 509' ' ' ASP . 0.9 OUTLIER 159.47 -33.86 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.768 -1.105 . . . . 0.0 108.747 -179.677 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 509' ' ' ASP . . . . . 0.519 ' CB ' ' O ' ' B' ' 508' ' ' GLN . 27.0 t70 138.13 43.35 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 O-C-N 124.957 1.411 . . . . 0.0 109.704 179.306 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 510' ' ' ILE . . . . . 1.032 HG23 HG23 ' A' ' 46' ' ' ILE . 21.9 mm -60.4 107.63 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.701 179.309 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 511' ' ' SER . . . . . 0.837 ' HG ' ' N ' ' B' ' 502' ' ' GLY . 3.9 m -101.89 130.07 48.28 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.949 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 512' ' ' GLN . . . . . 0.513 ' CB ' ' HD3' ' B' ' 513' ' ' PRO . 1.2 mm-40 -79.75 -66.87 0.25 Allowed Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.539 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 513' ' ' PRO . . . . . 0.513 ' HD3' ' CB ' ' B' ' 512' ' ' GLN . 79.0 Cg_endo -82.25 56.29 5.72 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.573 2.182 . . . . 0.0 111.84 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 514' ' ' LEU . . . . . 0.502 ' HB2' ' HB ' ' A' ' 44' ' ' VAL . 0.7 OUTLIER -55.53 -84.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.047 -179.583 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 515' ' ' GLN . . . . . 0.501 ' HB2' HG12 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -90.62 -84.81 0.23 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.828 -179.982 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -110.68 -36.8 5.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.538 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 517' ' ' SER . . . . . 0.483 ' C ' HG12 ' A' ' 42' ' ' VAL . 15.4 m 52.58 27.23 4.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.205 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 518' ' ' PHE . . . . . 0.781 ' CE2' HD11 ' A' ' 21' ' ' ILE . 0.3 OUTLIER -163.54 91.59 0.68 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.365 -179.879 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 519' ' ' ILE . . . . . 0.461 HG12 ' HA ' ' A' ' 42' ' ' VAL . 4.7 mm -101.35 131.82 48.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.858 0.361 . . . . 0.0 110.901 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -54.16 108.43 0.37 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.993 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 521' ' ' THR . . . . . . . . . . . . . 3.5 m -166.25 143.53 5.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.941 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 522' ' ' GLY . . . . . . . . . . . . . . . 128.47 179.06 15.67 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.552 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 523' ' ' HIS . . . . . . . . . . . . . 39.7 t-80 -148.52 -84.12 0.1 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.808 0.337 . . . . 0.0 110.962 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 524' ' ' GLY . . . . . . . . . . . . . . . 57.81 -169.81 4.25 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.595 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 525' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -110.58 88.02 2.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.902 0.382 . . . . 0.0 110.86 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 526' ' ' SER . . . . . . . . . . . . . 35.6 p -77.44 95.59 4.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.786 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 527' ' ' ASP . . . . . 0.485 ' H ' HG11 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -174.32 -64.71 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.956 179.632 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 528' ' ' PRO . . . . . 0.484 ' CD ' ' CB ' ' B' ' 527' ' ' ASP . 20.3 Cg_endo -58.01 78.83 0.04 OUTLIER 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.971 2.447 . . . . 0.0 112.368 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 529' ' ' ARG . . . . . 0.437 ' HD3' ' CG2' ' A' ' 33' ' ' VAL . 7.0 mtt85 -82.8 -31.96 27.94 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.698 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 530' ' ' HIS . . . . . . . . . . . . . 9.4 m170 51.92 24.01 2.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.82 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 16.5 p 41.78 -163.8 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.377 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 532' ' ' TRP . . . . . 0.502 ' CZ2' ' HA ' ' B' ' 537' ' ' ARG . 34.9 t-105 -169.48 127.82 0.96 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.982 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . -159.62 35.4 0.47 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.234 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 534' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -109.66 161.62 23.45 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 120.708 0.289 . . . . 0.0 111.065 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -57.38 -57.44 1.26 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.622 2.215 . . . . 0.0 112.203 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -123.38 157.82 32.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.011 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 537' ' ' ARG . . . . . 0.502 ' HA ' ' CZ2' ' B' ' 532' ' ' TRP . 24.6 mmt180 -66.94 145.48 55.39 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.153 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 538' ' ' ILE . . . . . 0.697 HG23 HD12 ' B' ' 543' ' ' LEU . 5.8 tp -59.93 143.71 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.633 179.088 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 539' ' ' ASP . . . . . 0.611 ' HB3' HD12 ' B' ' 541' ' ' LEU . 1.1 m-20 -42.7 128.33 4.08 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.812 0.339 . . . . 0.0 111.786 -179.05 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 540' ' ' GLU . . . . . 0.492 ' HA ' ' CD1' ' B' ' 543' ' ' LEU . 41.0 mm-40 -40.95 -24.47 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.27 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 541' ' ' LEU . . . . . 0.611 HD12 ' HB3' ' B' ' 539' ' ' ASP . 0.8 OUTLIER -31.12 -69.6 0.07 Allowed 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -179.251 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 542' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -104.45 -64.74 1.08 Allowed 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -178.288 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 543' ' ' LEU . . . . . 0.697 HD12 HG23 ' B' ' 538' ' ' ILE . 10.2 mp 58.37 179.5 0.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.739 0.304 . . . . 0.0 110.388 -178.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . -172.91 -54.84 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.503 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 545' ' ' ASN . . . . . . . . . . . . . 42.6 p30 . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.81 179.877 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.439 ' CE ' ' HB ' ' A' ' 46' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.873 0.368 . . . . 0.0 111.107 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.432 ' O ' ' CD2' ' A' ' 177' ' ' LEU . 5.4 tt0 -174.71 130.66 0.33 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.695 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.925 HG23 HD12 ' A' ' 46' ' ' ILE . 0.6 OUTLIER -116.86 -173.7 2.44 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.246 -179.591 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.704 ' H ' HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -151.38 163.27 2.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.769 -178.541 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.65 156.23 17.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.766 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.433 ' SG ' ' CZ ' ' A' ' 169' ' ' PHE . 0.0 OUTLIER -118.57 141.51 48.52 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.278 -179.755 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.1 t -148.34 159.77 7.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.669 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.83 HG22 ' HA3' ' A' ' 15' ' ' GLY . 16.3 t -119.38 151.76 21.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.238 0.542 . . . . 0.0 111.753 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 86.2 t -156.19 130.05 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.044 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.89 -140.52 14.74 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.197 -1.002 . . . . 0.0 112.836 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' B' ' 537' ' ' ARG . 3.4 m-20 -123.23 27.85 7.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.657 0.265 . . . . 0.0 110.934 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -118.23 177.54 16.53 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.961 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.585 ' HB1' ' HB3' ' A' ' 18' ' ' CYS . . . -103.51 -26.85 12.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.775 0.322 . . . . 0.0 111.515 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.967 HG11 HG21 ' A' ' 113' ' ' VAL . 54.1 t -43.12 94.58 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 121.006 0.431 . . . . 0.0 111.418 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.83 ' HA3' HG22 ' A' ' 8' ' ' VAL . . . 132.89 -23.47 3.94 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.026 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.758 ' CG ' HG21 ' A' ' 8' ' ' VAL . 14.7 mttt -90.3 -159.13 0.58 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.767 0.318 . . . . 0.0 110.709 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.45 ' HB ' ' CG1' ' A' ' 21' ' ' ILE . 31.5 p -66.46 -44.91 81.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.392 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.585 ' HB3' ' HB1' ' A' ' 13' ' ' ALA . 43.3 t -33.26 -58.54 0.39 Allowed 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.562 HD13 ' CG ' ' A' ' 169' ' ' PHE . 13.8 mt -42.2 -67.93 0.23 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.718 -179.406 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.468 ' N ' ' CD2' ' A' ' 20' ' ' LEU . 1.5 mm? -72.43 -25.73 61.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.444 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.45 ' CG1' ' HB ' ' A' ' 17' ' ' THR . 20.7 mm -70.83 -68.2 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.765 0.317 . . . . 0.0 110.565 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 27.1 t -57.77 -25.74 60.92 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.983 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.811 ' HB2' HD13 ' A' ' 165' ' ' LEU . 4.4 t80 -80.1 -68.52 0.67 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.005 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 97.8 m -70.26 -48.64 55.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.031 0.444 . . . . 0.0 110.658 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.446 HG22 ' H ' ' A' ' 26' ' ' ASN . 0.2 OUTLIER -77.48 -156.04 0.08 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.646 179.876 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.446 ' H ' HG22 ' A' ' 25' ' ' THR . 0.9 OUTLIER -149.7 40.13 0.81 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.719 0.295 . . . . 0.0 110.805 -179.935 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.4 mtmt -133.51 126.88 32.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.969 0.414 . . . . 0.0 111.369 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.501 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . 3.6 t80 -163.66 -53.44 0.01 OUTLIER Pre-proline 0 CA--C 1.536 0.437 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.947 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.501 ' HD3' ' HB3' ' A' ' 28' ' ' PHE . 5.7 Cg_exo -79.55 56.44 6.05 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.774 2.316 . . . . 0.0 112.418 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.7 m -143.54 -80.03 0.2 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.755 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -157.69 162.43 38.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.593 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.464 ' OH ' ' CD1' ' A' ' 28' ' ' PHE . 9.3 m-85 -131.55 94.6 3.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.967 0.413 . . . . 0.0 111.108 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.534 HG11 ' HG3' ' B' ' 529' ' ' ARG . 0.2 OUTLIER -133.05 -56.2 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.666 179.703 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.464 ' O ' ' CZ ' ' A' ' 37' ' ' PHE . 7.8 Cg_exo -72.17 59.08 2.99 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.346 2.031 . . . . 0.0 111.983 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.588 HG23 HD23 ' B' ' 543' ' ' LEU . 5.8 t -120.53 21.89 11.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.88 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.024 HG22 HD13 ' A' ' 61' ' ' LEU . 2.4 t -83.84 -4.75 8.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.648 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.464 ' CZ ' ' O ' ' A' ' 34' ' ' PRO . 4.2 m-85 -46.03 -27.7 1.0 Allowed 'General case' 0 N--CA 1.461 0.099 0 CA-C-O 120.813 0.34 . . . . 0.0 111.108 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.419 ' HA ' ' HB3' ' A' ' 57' ' ' ASP . 6.8 t0 69.26 33.07 3.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.642 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.422 ' CB ' ' O ' ' A' ' 55' ' ' LEU . 8.3 m120 52.01 87.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.609 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.473 ' OH ' ' CZ ' ' B' ' 518' ' ' PHE . 3.2 p90 -59.98 -175.73 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.707 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.408 ' O ' HG12 ' B' ' 519' ' ' ILE . . . -90.77 160.5 15.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.055 0.455 . . . . 0.0 111.823 -179.354 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.494 HG12 ' C ' ' B' ' 517' ' ' SER . 3.5 m -127.25 128.19 69.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.621 179.565 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.701 ' H ' HD11 ' B' ' 519' ' ' ILE . 59.1 p -85.59 104.76 15.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.943 0.401 . . . . 0.0 111.17 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.767 ' CG2' HG21 ' A' ' 52' ' ' THR . 20.7 m -157.79 -177.7 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.859 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.512 ' HG3' HD22 ' B' ' 514' ' ' LEU . 0.0 OUTLIER -128.03 116.93 20.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.349 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.925 HD12 HG23 ' A' ' 3' ' ' THR . 0.8 OUTLIER -81.98 87.65 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.676 0.274 . . . . 0.0 111.668 -179.865 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 56.87 -78.08 0.01 OUTLIER Glycine 0 C--N 1.333 0.374 0 CA-C-N 116.105 -0.498 . . . . 0.0 113.776 178.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . -54.0 -99.78 0.01 OUTLIER Glycine 0 C--N 1.331 0.285 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.979 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.478 ' CA ' ' HE3' ' A' ' 45' ' ' MET . 0.6 OUTLIER -119.72 164.26 22.99 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 120.878 0.37 . . . . 0.0 111.396 -179.617 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.76 100.93 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.699 2.266 . . . . 0.0 112.596 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.464 ' CD1' ' OG1' ' A' ' 3' ' ' THR . 12.3 t80 -172.84 106.61 0.16 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.361 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.767 HG21 ' CG2' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -124.43 153.78 41.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.939 0.399 . . . . 0.0 111.038 -179.92 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.653 HD12 ' N ' ' A' ' 4' ' ' ILE . 82.7 mt -113.44 100.0 8.19 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.863 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -46.17 164.13 0.11 Allowed Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.396 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.551 ' H ' HD12 ' A' ' 55' ' ' LEU . 2.4 mp -79.66 152.87 29.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.71 0.29 . . . . 0.0 110.847 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.422 ' CB ' ' O ' ' A' ' 6' ' ' CYS . 0.3 OUTLIER -103.32 122.05 44.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.524 -179.52 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.419 ' HB3' ' HA ' ' A' ' 38' ' ' ASP . 0.2 OUTLIER -127.65 167.0 17.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.36 179.367 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.701 ' HB ' HD11 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -149.41 128.72 12.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.905 0.383 . . . . 0.0 111.122 -179.444 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.691 ' HB3' ' HA ' ' A' ' 36' ' ' VAL . . . -144.86 100.73 3.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.664 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.406 ' HA2' ' O ' ' A' ' 64' ' ' TYR . . . -70.65 83.05 0.38 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.717 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 1.024 HD13 HG22 ' A' ' 36' ' ' VAL . 3.9 mp -121.5 -108.36 0.35 Allowed 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.564 0.182 . . . . 0.0 111.027 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -99.03 -30.02 12.57 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 120.827 0.346 . . . . 0.0 111.167 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.9 -63.32 1.19 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.442 -179.438 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.462 ' HE1' HG12 ' A' ' 36' ' ' VAL . 0.4 OUTLIER -107.62 120.6 42.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.94 -179.624 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -87.16 -53.39 4.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 112.029 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.21 8.8 44.28 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -178.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.813 HD23 ' O ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -47.46 110.68 0.33 Allowed 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 120.728 0.299 . . . . 0.0 110.667 179.625 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.671 ' HG2' HD11 ' B' ' 541' ' ' LEU . 0.0 OUTLIER -149.97 70.92 9.45 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.235 -179.788 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.668 ' CG ' HG21 ' A' ' 58' ' ' THR . 88.9 Cg_endo -81.02 -37.07 0.33 Allowed 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.591 2.194 . . . . 0.0 112.455 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.917 ' O ' HD12 ' A' ' 70' ' ' LEU . 0.1 OUTLIER -58.83 -18.2 30.36 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.002 -179.939 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.463 ' HB3' ' CD2' ' A' ' 72' ' ' TYR . 0.3 OUTLIER -43.34 -50.44 6.7 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.389 -179.962 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.463 ' CD2' ' HB3' ' A' ' 71' ' ' SER . 5.6 p90 -165.2 70.9 1.39 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.289 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -70.01 153.36 67.85 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.881 2.387 . . . . 0.0 112.063 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 -102.42 10.28 39.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.568 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 14.1 t -57.49 178.63 0.07 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.844 0.354 . . . . 0.0 110.986 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -115.85 -18.74 10.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.282 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.5 m -118.94 91.1 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.755 0.312 . . . . 0.0 111.284 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -81.14 121.64 26.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.486 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.594 HD11 ' CG1' ' A' ' 14' ' ' VAL . 0.1 OUTLIER -83.48 108.52 16.67 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.953 0.406 . . . . 0.0 111.236 -179.675 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.719 ' O ' HD13 ' A' ' 112' ' ' LEU . 3.3 m -110.25 100.7 11.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.887 179.063 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -113.37 146.94 38.65 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.536 -179.187 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.439 ' C ' ' CD1' ' A' ' 82' ' ' PHE . 6.3 p90 -155.48 143.05 19.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.216 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.96 133.4 35.3 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.112 0.482 . . . . 0.0 111.188 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.664 HG23 ' HB2' ' A' ' 116' ' ' GLN . 89.2 t -48.5 -69.6 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.551 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.72 HG22 ' OE1' ' A' ' 116' ' ' GLN . 16.0 m -40.84 110.45 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 120.742 0.306 . . . . 0.0 111.332 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.629 ' N ' HD21 ' A' ' 129' ' ' LEU . 52.4 p -154.36 134.03 7.69 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.772 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.435 ' O ' ' HB2' ' A' ' 133' ' ' LYS . 20.0 Cg_endo -61.21 -81.76 0.01 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 121.909 1.739 . . . . 0.0 111.408 179.371 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.9 t -144.87 24.55 1.49 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.832 0.349 . . . . 0.0 110.966 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.518 ' O ' HG23 ' A' ' 93' ' ' VAL . 1.7 t -93.44 -21.88 19.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.176 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -48.41 -49.01 36.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.178 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -57.84 -40.6 80.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.996 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 17.5 m-20 -67.42 -50.03 61.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.903 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.606 HG13 ' CE2' ' A' ' 97' ' ' TRP . 47.2 t -51.47 -52.37 20.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.193 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.662 ' O ' HG23 ' A' ' 98' ' ' VAL . 2.3 tttp -52.31 -54.68 28.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.022 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.405 ' O ' ' HG2' ' A' ' 99' ' ' PRO . 50.7 mt-10 -78.66 3.11 17.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.829 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.5 ttmm -115.2 -19.07 10.96 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.721 0.296 . . . . 0.0 111.184 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.606 ' CE2' HG13 ' A' ' 93' ' ' VAL . 27.9 m0 -93.74 -51.4 4.93 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.199 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 94' ' ' LYS . 16.8 t -49.68 -44.98 78.71 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.706 -179.704 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.501 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 3.6 Cg_exo -74.88 -16.49 20.51 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.641 2.228 . . . . 0.0 112.612 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -90.19 -53.64 4.37 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.841 0.353 . . . . 0.0 110.976 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.514 ' CD1' ' CE2' ' A' ' 110' ' ' PHE . 1.0 OUTLIER -56.61 -24.2 18.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.151 179.997 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.7 p -88.8 -45.66 9.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.861 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -50.13 -32.68 16.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.959 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -79.52 -26.97 41.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.021 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -151.59 104.88 2.89 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.977 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -49.67 108.8 0.22 Allowed 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.397 2.065 . . . . 0.0 112.09 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 67.7 93.07 0.08 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.747 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.05 119.4 10.5 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.034 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -60.67 154.4 55.1 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.534 2.156 . . . . 0.0 112.438 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.514 ' CE2' ' CD1' ' A' ' 101' ' ' ILE . 1.2 p90 -151.53 147.85 27.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.864 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.807 HD12 HG11 ' A' ' 152' ' ' VAL . 0.8 OUTLIER -110.38 160.67 16.37 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.417 -179.595 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.719 HD13 ' O ' ' A' ' 80' ' ' VAL . 2.5 mm? -123.48 161.19 25.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.586 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.967 HG21 HG11 ' A' ' 14' ' ' VAL . 21.6 t -139.6 143.57 30.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.974 0.416 . . . . 0.0 111.912 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.442 ' O ' ' CD1' ' A' ' 117' ' ' ILE . . . -119.54 92.03 0.52 Allowed Glycine 0 C--N 1.331 0.297 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.005 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.604 HG22 ' SG ' ' A' ' 157' ' ' CYS . 0.6 OUTLIER -117.25 9.51 13.48 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -178.836 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.72 ' OE1' HG22 ' A' ' 85' ' ' VAL . 1.9 mm-40 -114.74 11.97 16.94 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.879 0.371 . . . . 0.0 110.323 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.763 HD11 ' O ' ' A' ' 157' ' ' CYS . 0.1 OUTLIER -57.97 -17.37 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.718 179.043 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -100.13 -17.3 17.48 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.544 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.57 HD13 ' HA ' ' A' ' 116' ' ' GLN . 5.5 mp -91.79 -32.58 15.31 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.775 0.321 . . . . 0.0 110.992 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.541 ' O ' HD13 ' A' ' 126' ' ' ILE . 1.0 OUTLIER -42.44 -52.42 4.66 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.361 -179.916 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.49 -42.59 98.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.58 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -45.37 102.79 0.31 Allowed Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.886 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.469 ' HA ' ' CG2' ' A' ' 126' ' ' ILE . 42.8 Cg_endo -68.6 -6.88 18.86 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.409 2.073 . . . . 0.0 112.947 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.34 -66.15 0.58 Allowed 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.045 0.45 . . . . 0.0 109.853 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.706 HG22 ' CD1' ' A' ' 129' ' ' LEU . 49.2 m -60.62 -49.37 77.79 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.776 HD11 ' HD3' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -47.3 -36.98 4.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.001 179.566 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.603 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 0.2 OUTLIER -62.59 -40.85 98.23 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.694 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.455 ' N ' ' O ' ' A' ' 125' ' ' THR . 0.2 OUTLIER -65.06 -33.73 76.74 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 177.992 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.706 ' CD1' HG22 ' A' ' 125' ' ' THR . 7.3 mp -68.83 -40.65 79.33 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 177.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.603 ' HB3' ' O ' ' A' ' 127' ' ' GLU . . . -44.9 -31.37 1.23 Allowed 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.587 179.477 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -51.41 -27.27 9.63 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.986 179.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.468 ' O ' ' CG ' ' A' ' 133' ' ' LYS . 1.2 m-80 -123.3 -34.67 3.08 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.211 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.484 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 46.7 mttt -169.65 -86.21 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 O-C-N 123.107 0.255 . . . . 0.0 111.641 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.484 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 0.1 OUTLIER 102.49 106.7 0.01 OUTLIER 'General case' 0 C--N 1.351 0.638 0 C-N-CA 124.37 1.068 . . . . 0.0 110.38 -179.284 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.5 mmtm -159.38 92.44 1.84 Allowed Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.329 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.776 ' HD3' HD11 ' A' ' 126' ' ' ILE . 21.1 Cg_endo -62.12 103.22 0.29 Allowed 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 122.252 1.968 . . . . 0.0 112.306 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.831 HG22 ' HB ' ' A' ' 141' ' ' THR . 1.5 mm -45.31 106.56 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.443 179.336 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.421 ' O ' ' N ' ' A' ' 141' ' ' THR . 1.6 p -67.19 141.25 96.07 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.342 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -40.42 -29.77 0.42 Allowed 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.901 2.4 . . . . 0.0 112.015 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.35 -41.12 94.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.556 179.402 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.831 ' HB ' HG22 ' A' ' 137' ' ' ILE . 47.0 m -57.39 -66.61 0.43 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.009 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.523 ' HB3' ' CE2' ' A' ' 154' ' ' TYR . . . -47.7 -49.31 28.27 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.887 0.375 . . . . 0.0 110.919 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -64.16 -33.92 76.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.432 179.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 15.6 tttt -73.71 -46.63 44.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.631 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 14.5 tp -68.24 -39.91 82.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.208 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -62.11 -35.82 79.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.666 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.7 mtp180 -90.32 -29.86 17.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.666 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -50.79 -29.52 11.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.733 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.5 mt -123.02 21.09 9.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.91 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 45.5 mttt 48.08 52.24 13.45 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.943 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.714 ' O ' HG23 ' A' ' 152' ' ' VAL . . . -59.17 -83.37 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.032 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.807 HG11 HD12 ' A' ' 111' ' ' LEU . 19.1 t -166.33 -68.38 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.285 179.355 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.04 144.04 2.06 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.144 0.497 . . . . 0.0 111.824 -179.331 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.523 ' CE2' ' HB3' ' A' ' 142' ' ' ALA . 37.1 t80 -135.96 102.57 5.08 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.138 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.733 ' HB ' HG22 ' A' ' 168' ' ' VAL . 2.3 t -105.93 167.87 3.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.328 -178.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.526 ' H ' HG12 ' A' ' 155' ' ' VAL . 5.5 tt0 -89.58 118.6 29.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.126 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.763 ' O ' HD11 ' A' ' 117' ' ' ILE . 17.9 p -144.92 -175.79 4.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.174 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 3.1 m -159.61 158.29 31.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.965 0.412 . . . . 0.0 111.576 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -115.44 -33.41 5.27 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.464 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.46 HD23 ' H ' ' A' ' 160' ' ' LEU . 0.2 OUTLIER -81.19 -34.85 32.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.65 179.699 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.0 t -113.0 -24.65 9.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.925 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 72.6 93.92 0.08 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.045 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -124.93 33.11 5.27 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.133 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 120.87 47.79 0.31 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.762 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.811 HD13 ' HB2' ' A' ' 23' ' ' TYR . 0.8 OUTLIER -56.52 -56.24 23.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.822 0.344 . . . . 0.0 110.745 179.838 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.403 ' O ' ' CB ' ' A' ' 170' ' ' ASP . 4.8 pttt -63.44 -29.14 70.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.805 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -51.54 -72.31 0.05 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.9 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.854 HG11 HG22 ' A' ' 113' ' ' VAL . 61.8 t -56.59 -53.36 42.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.994 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.562 ' CG ' HD13 ' A' ' 19' ' ' LEU . 3.2 t80 -53.24 -35.82 60.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.871 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.403 ' CB ' ' O ' ' A' ' 166' ' ' LYS . 5.3 m-20 -61.4 -40.34 94.02 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.915 0.388 . . . . 0.0 109.995 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.622 ' CB ' HD11 ' A' ' 111' ' ' LEU . 7.6 mm-40 -60.6 -34.89 74.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.163 179.297 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.513 ' CB ' HD21 ' A' ' 79' ' ' LEU . . . -62.01 -65.0 0.76 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.68 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.56 HD13 ' HG2' ' B' ' 512' ' ' GLN . 1.4 pp -59.76 -41.53 85.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.985 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.761 HD11 ' HB3' ' B' ' 506' ' ' SER . 5.2 tp -60.37 -43.77 96.25 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.006 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -54.61 -22.33 13.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.943 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -86.49 -37.78 17.92 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.122 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 1.058 HD13 HG21 ' B' ' 510' ' ' ILE . 1.9 mt -72.94 -35.88 67.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.897 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -141.79 139.46 18.42 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.949 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' PRO . . . . . 0.45 ' HA ' ' HD2' ' A' ' 180' ' ' PRO . 53.6 Cg_endo -69.83 111.61 2.87 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.545 2.163 . . . . 0.0 112.286 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 180' ' ' PRO . . . . . 0.45 ' HD2' ' HA ' ' A' ' 179' ' ' PRO . 33.4 Cg_endo -64.35 167.05 15.55 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.355 2.036 . . . . 0.0 112.211 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -102.79 96.38 7.61 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.142 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 180' ' ' PRO . 81.0 Cg_endo -76.64 -164.93 0.28 Allowed 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.702 2.268 . . . . 0.0 112.208 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.53 83.16 4.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.901 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 14.6 mttm . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.892 179.967 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.174 0 N-CA-C 112.435 -0.266 . . . . 0.0 112.435 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 503' ' ' SER . . . . . . . . . . . . . 1.4 m -61.39 -177.23 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.812 0.339 . . . . 0.0 110.799 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 504' ' ' GLY . . . . . 0.592 ' HA2' HD22 ' A' ' 174' ' ' LEU . . . -99.78 65.27 0.62 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.387 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 505' ' ' LEU . . . . . 0.504 ' O ' HD21 ' A' ' 174' ' ' LEU . 0.3 OUTLIER -108.92 159.89 16.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.05 0.453 . . . . 0.0 111.197 -179.971 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 506' ' ' SER . . . . . 0.761 ' HB3' HD11 ' A' ' 174' ' ' LEU . 11.3 t 165.8 -44.63 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.539 -179.515 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 507' ' ' ALA . . . . . 0.599 ' HB3' HG12 ' B' ' 510' ' ' ILE . . . -47.98 -28.31 2.68 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.159 178.642 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 508' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 167.17 -31.82 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.373 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 509' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 172.2 37.58 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.927 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 510' ' ' ILE . . . . . 1.058 HG21 HD13 ' A' ' 177' ' ' LEU . 46.9 mm -67.53 103.24 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.913 0.387 . . . . 0.0 111.286 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 511' ' ' SER . . . . . . . . . . . . . 2.1 m -101.43 131.79 47.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.921 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 512' ' ' GLN . . . . . 0.56 ' HG2' HD13 ' A' ' 173' ' ' ILE . 0.4 OUTLIER -93.41 -64.28 0.14 Allowed Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.144 -179.919 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 513' ' ' PRO . . . . . 0.49 ' HD3' ' CB ' ' B' ' 512' ' ' GLN . 89.4 Cg_endo -81.36 67.88 8.35 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.516 2.144 . . . . 0.0 112.521 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 514' ' ' LEU . . . . . 0.512 HD22 ' HG3' ' A' ' 45' ' ' MET . 0.4 OUTLIER -81.16 -85.21 0.1 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.914 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 515' ' ' GLN . . . . . 0.411 ' HB2' HG12 ' A' ' 44' ' ' VAL . 2.3 mt-30 -93.22 -158.9 0.64 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.671 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -46.97 -27.85 1.42 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.026 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 517' ' ' SER . . . . . 0.494 ' C ' HG12 ' A' ' 42' ' ' VAL . 3.0 m 40.65 42.72 1.45 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.719 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 518' ' ' PHE . . . . . 0.473 ' CZ ' ' OH ' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -163.76 91.88 0.67 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.927 -179.951 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 519' ' ' ILE . . . . . 0.701 HD11 ' H ' ' A' ' 43' ' ' THR . 6.2 mm -87.89 -33.74 6.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.748 0.309 . . . . 0.0 111.18 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 520' ' ' HIS . . . . . 0.467 ' HA ' ' CE2' ' A' ' 40' ' ' TYR . 0.7 OUTLIER 69.72 119.37 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.898 179.994 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 521' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -165.98 51.83 0.09 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.981 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 522' ' ' GLY . . . . . . . . . . . . . . . -138.26 157.62 24.51 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.445 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 523' ' ' HIS . . . . . . . . . . . . . 37.8 t-80 -132.61 -84.74 0.47 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.662 0.268 . . . . 0.0 111.028 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 524' ' ' GLY . . . . . 0.408 ' HA3' ' HB ' ' A' ' 36' ' ' VAL . . . 66.22 176.67 7.14 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.465 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 525' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -75.05 87.42 2.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.89 0.376 . . . . 0.0 110.837 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 526' ' ' SER . . . . . 0.423 ' CB ' ' HB3' ' A' ' 34' ' ' PRO . 1.1 m -89.62 95.98 10.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.884 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 527' ' ' ASP . . . . . 0.496 ' O ' HG21 ' A' ' 33' ' ' VAL . 0.2 OUTLIER -159.13 145.71 12.58 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.939 179.864 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -68.83 105.59 1.35 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.705 2.27 . . . . 0.0 112.348 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 529' ' ' ARG . . . . . 0.534 ' HG3' HG11 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -100.31 -55.13 2.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.051 -179.885 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 530' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -165.89 97.63 0.64 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.846 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 95.5 m -46.27 171.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.121 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 532' ' ' TRP . . . . . 0.475 ' CZ2' ' HG3' ' B' ' 537' ' ' ARG . 0.0 OUTLIER -49.65 158.03 0.5 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.0 -179.886 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . -155.71 -56.82 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.534 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 534' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -94.35 142.73 25.25 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.742 0.306 . . . . 0.0 111.052 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.29 74.09 1.56 Allowed 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.63 2.22 . . . . 0.0 112.308 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 2.8 p30 172.73 143.56 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.671 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 537' ' ' ARG . . . . . 0.475 ' HG3' ' CZ2' ' B' ' 532' ' ' TRP . 2.0 mpt_? -92.85 179.93 5.32 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.203 0.525 . . . . 0.0 111.172 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 538' ' ' ILE . . . . . 0.648 HG23 HD12 ' B' ' 543' ' ' LEU . 5.0 tp -118.06 134.87 60.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.196 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 539' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -50.86 145.19 7.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.61 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 540' ' ' GLU . . . . . 0.415 ' HB3' ' OG1' ' A' ' 58' ' ' THR . 61.2 mt-10 -45.69 -44.72 13.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.454 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 541' ' ' LEU . . . . . 0.75 ' HB2' HD23 ' A' ' 70' ' ' LEU . 1.7 tt -48.43 -40.28 25.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.432 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 542' ' ' TYR . . . . . 0.476 ' HB2' HG13 ' B' ' 538' ' ' ILE . 63.2 m-85 -102.49 9.25 39.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.931 -179.209 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 543' ' ' LEU . . . . . 0.648 HD12 HG23 ' B' ' 538' ' ' ILE . 3.1 tp -58.64 95.74 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.781 0.324 . . . . 0.0 110.71 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . 176.23 89.09 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.506 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 545' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.854 179.935 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.401 ' HB2' ' HG3' ' A' ' 49' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.375 0 CA-C-O 120.761 0.315 . . . . 0.0 111.222 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -111.19 127.03 55.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.219 0.533 . . . . 0.0 110.948 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.548 HG21 ' OH ' ' A' ' 51' ' ' TYR . 36.8 m -104.19 158.2 16.61 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.739 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.836 ' CD1' HD13 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -155.25 160.34 2.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.852 -179.587 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.04 140.43 46.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.631 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.4 p -138.11 124.53 20.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.908 0.385 . . . . 0.0 111.573 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.1 t -114.04 136.57 50.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.45 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.59 HG13 ' HG2' ' B' ' 540' ' ' GLU . 2.8 p -84.84 113.52 23.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.952 0.406 . . . . 0.0 111.125 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.0 p -117.69 129.57 73.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.893 178.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.498 ' HA2' ' CE2' ' A' ' 97' ' ' TRP . . . 133.57 -160.35 23.97 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.267 -0.968 . . . . 0.0 112.455 -179.289 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -92.9 21.99 5.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.726 0.298 . . . . 0.0 111.047 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.407 ' HA3' ' HB2' ' A' ' 81' ' ' CYS . . . -76.14 160.2 51.05 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.538 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.458 ' O ' ' HB ' ' A' ' 14' ' ' VAL . . . -53.27 -57.3 11.0 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.489 0.185 . . . . 0.0 111.296 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.726 HG13 ' H ' ' A' ' 18' ' ' CYS . 2.6 p 154.88 94.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 O-C-N 123.75 0.656 . . . . 0.0 109.908 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.599 ' HA2' HD11 ' A' ' 19' ' ' LEU . . . -47.82 -22.79 2.11 Favored Glycine 0 CA--C 1.519 0.305 0 CA-C-N 115.844 -0.616 . . . . 0.0 113.502 -179.514 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.449 ' HG2' ' HB2' ' A' ' 55' ' ' LEU . 1.6 tmtm? -70.68 -59.74 2.65 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 122.544 -0.386 . . . . 0.0 111.676 -179.401 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.591 ' CG2' HG23 ' A' ' 35' ' ' THR . 1.2 p -97.34 -39.43 9.22 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -178.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.726 ' H ' HG13 ' A' ' 14' ' ' VAL . 44.6 t -33.74 -73.49 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.182 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.71 ' CB ' HD22 ' A' ' 165' ' ' LEU . 0.3 OUTLIER -65.34 -68.22 0.38 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.827 -179.377 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.54 HD23 ' N ' ' A' ' 20' ' ' LEU . 3.5 mt -49.0 -70.22 0.1 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.802 -179.043 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.474 HG22 ' O ' ' A' ' 17' ' ' THR . 1.1 tp -43.09 -48.49 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-O 120.817 0.341 . . . . 0.0 111.619 -179.495 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.407 ' HB3' ' O ' ' A' ' 18' ' ' CYS . 35.2 t -62.48 -29.19 70.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.916 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.409 ' N ' ' O ' ' A' ' 20' ' ' LEU . 20.1 t80 -75.34 -37.43 60.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.949 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.616 HG23 HG23 ' A' ' 25' ' ' THR . 10.1 t -87.23 -49.8 7.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.06 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.616 HG23 HG23 ' A' ' 24' ' ' THR . 77.6 p -94.06 -61.77 1.47 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.88 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.404 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 15.4 t30 72.38 41.46 0.6 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.005 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -100.71 69.75 1.39 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.706 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.485 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 35.3 t80 -86.77 -45.59 0.54 Allowed Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.647 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.485 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 92.7 Cg_endo -82.22 73.41 5.66 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.354 2.036 . . . . 0.0 112.481 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.3 m -172.06 -85.34 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.982 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -158.29 164.57 36.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.016 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.469 ' OH ' ' CG ' ' A' ' 28' ' ' PHE . 10.2 m-85 -130.86 124.17 30.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.488 ' HB ' ' HD3' ' A' ' 34' ' ' PRO . 1.5 t -157.1 -53.61 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.772 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.488 ' HD3' ' HB ' ' A' ' 33' ' ' VAL . 5.4 Cg_exo -74.84 56.4 4.15 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.458 2.105 . . . . 0.0 112.292 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.591 HG23 ' CG2' ' A' ' 17' ' ' THR . 18.7 m -106.95 -20.64 13.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.844 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.953 HG12 ' CB ' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -42.38 -65.13 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.767 -0.197 . . . . 0.0 110.863 179.8 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.447 ' H ' HG23 ' A' ' 36' ' ' VAL . 10.8 m-85 33.92 -88.4 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.684 0.615 . . . . 0.0 112.171 179.091 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.473 ' N ' ' O ' ' A' ' 36' ' ' VAL . 96.9 m-20 65.29 -65.46 0.16 Allowed 'General case' 0 CA--C 1.527 0.087 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.584 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.437 ' N ' ' O ' ' A' ' 37' ' ' PHE . 15.1 p30 -71.7 -4.49 27.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.772 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.485 ' CE2' ' CZ ' ' B' ' 518' ' ' PHE . 0.4 OUTLIER -59.78 95.36 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.925 0.393 . . . . 0.0 110.302 179.793 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.687 ' O ' HD13 ' B' ' 519' ' ' ILE . . . -90.36 -179.37 5.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.11 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.639 HG23 HG21 ' A' ' 52' ' ' THR . 34.5 m -144.12 161.04 15.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.083 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.8 p -125.48 105.87 9.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.173 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.911 HG22 ' CG2' ' A' ' 52' ' ' THR . 19.2 m -156.32 -177.55 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.086 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.461 ' HE1' ' N ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -100.79 97.44 8.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.532 -179.486 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 1.008 HG23 HG23 ' B' ' 510' ' ' ILE . 1.5 mm -70.91 91.08 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-O 120.824 0.345 . . . . 0.0 110.242 179.26 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 38.62 -91.81 0.01 OUTLIER Glycine 0 CA--C 1.519 0.337 0 CA-C-N 116.002 -0.545 . . . . 0.0 113.654 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . -39.85 -82.93 0.01 OUTLIER Glycine 0 C--N 1.333 0.374 0 C-N-CA 121.457 -0.402 . . . . 0.0 113.406 -179.569 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.461 ' N ' ' HE1' ' A' ' 45' ' ' MET . 2.7 mt-10 -133.99 165.7 34.75 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.786 0.327 . . . . 0.0 111.402 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.461 ' HD2' ' HB3' ' A' ' 49' ' ' GLU . 82.7 Cg_exo -48.36 104.69 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.6 2.2 . . . . 0.0 112.955 -179.531 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.548 ' OH ' HG21 ' A' ' 3' ' ' THR . 14.1 t80 -172.46 155.59 3.48 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.275 179.29 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.911 ' CG2' HG22 ' A' ' 44' ' ' VAL . 1.8 p -138.31 153.34 49.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.18 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.836 HD13 ' CD1' ' A' ' 4' ' ' ILE . 0.3 OUTLIER -110.47 99.36 8.37 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.835 179.716 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -50.97 -179.17 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.366 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.449 ' HB2' ' HG2' ' A' ' 16' ' ' LYS . 1.8 mp -139.72 97.65 3.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.853 0.359 . . . . 0.0 110.565 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -84.28 114.88 22.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.628 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.479 ' OD1' HG12 ' A' ' 8' ' ' VAL . 0.6 OUTLIER -113.97 -175.56 2.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.376 -179.883 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.483 HG22 HD13 ' A' ' 67' ' ' LEU . 18.4 p -89.67 -175.73 4.76 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.617 -179.291 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.953 ' CB ' HG12 ' A' ' 36' ' ' VAL . . . -172.26 168.15 5.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.553 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.411 ' H ' HD23 ' A' ' 61' ' ' LEU . . . -149.15 21.25 1.23 Allowed Glycine 0 C--N 1.329 0.189 0 C-N-CA 120.384 -0.912 . . . . 0.0 112.759 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.705 HD13 ' HB2' ' B' ' 526' ' ' SER . 0.2 OUTLIER -121.34 -171.59 2.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.568 0.223 . . . . 0.0 110.777 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -38.24 -31.2 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.877 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.686 ' HB2' HG11 ' A' ' 36' ' ' VAL . 0.2 OUTLIER -45.28 -63.18 1.0 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.143 179.875 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.68 ' O ' HD23 ' A' ' 67' ' ' LEU . 0.0 OUTLIER 166.82 77.48 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.981 179.777 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -62.48 -22.22 66.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.059 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.45 -21.74 10.7 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.311 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.69 HD21 ' N ' ' A' ' 59' ' ' ALA . 3.4 pp -48.02 141.29 6.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.794 0.33 . . . . 0.0 111.058 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.467 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 1.1 ptm180 -158.84 49.58 0.33 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.035 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.467 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 61.4 Cg_endo -74.4 -48.49 0.2 Allowed 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.451 2.1 . . . . 0.0 112.386 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.676 HD21 ' CB ' ' B' ' 541' ' ' LEU . 0.6 OUTLIER -51.27 -24.43 4.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.966 179.882 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 69.3 m -51.1 -30.13 15.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.854 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.432 ' N ' ' HD3' ' A' ' 73' ' ' PRO . 5.4 t80 177.3 65.04 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.821 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.432 ' HD3' ' N ' ' A' ' 72' ' ' TYR . 13.5 Cg_exo -69.3 154.62 69.3 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.706 2.271 . . . . 0.0 112.302 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.62 10.46 40.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.169 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.51 HG22 ' H ' ' A' ' 76' ' ' ASP . 1.4 m -49.5 172.82 0.02 OUTLIER 'General case' 0 C--N 1.334 -0.108 0 CA-C-O 120.849 0.357 . . . . 0.0 110.897 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.51 ' H ' HG22 ' A' ' 75' ' ' THR . 19.9 p-10 -113.89 -23.91 9.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.032 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.703 HG11 ' HB2' ' A' ' 176' ' ' ALA . 7.2 p -130.22 92.38 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.283 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.777 ' CE1' HG21 ' A' ' 108' ' ' THR . 15.2 m-85 -80.78 167.32 20.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.623 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 38.8 tp -141.88 109.06 5.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.976 0.417 . . . . 0.0 111.297 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.446 ' O ' HG23 ' A' ' 80' ' ' VAL . 29.1 m -96.93 126.51 49.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.583 179.489 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.407 ' HB2' ' HA3' ' A' ' 12' ' ' GLY . 1.6 m -116.77 158.95 23.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.161 0.505 . . . . 0.0 111.711 -179.438 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.565 ' CE2' HD12 ' A' ' 112' ' ' LEU . 41.7 p90 -147.15 -173.79 4.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.89 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.0 p -138.59 131.58 29.7 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.795 0.331 . . . . 0.0 111.116 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.715 HG21 ' HA ' ' A' ' 117' ' ' ILE . 60.9 t -47.57 -72.06 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.186 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.701 HG22 ' OE1' ' A' ' 116' ' ' GLN . 32.6 m -46.58 106.85 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.81 0.338 . . . . 0.0 110.527 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.536 ' N ' HD22 ' A' ' 129' ' ' LEU . 0.2 OUTLIER -149.99 137.35 11.49 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.551 -179.175 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.437 ' HB2' ' HB2' ' A' ' 132' ' ' ASN . 85.1 Cg_endo -91.76 53.29 0.75 Allowed 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.214 2.61 . . . . 0.0 111.778 179.49 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.467 ' CB ' ' HG3' ' A' ' 133' ' ' LYS . 0.1 OUTLIER 81.09 30.65 0.15 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.79 -179.534 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.72 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.9 OUTLIER -96.85 -25.94 15.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.063 179.972 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.767 ' CZ ' HG21 ' A' ' 137' ' ' ILE . 6.4 t80 -50.74 -59.85 3.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.061 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -50.19 -57.88 6.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.9 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -51.35 -62.73 1.44 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.867 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.72 HG23 ' O ' ' A' ' 89' ' ' SER . 60.3 t -44.55 -47.12 2.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.414 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.751 ' CG ' HD11 ' A' ' 145' ' ' LEU . 1.3 tmtt? -53.69 -51.01 64.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.705 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -84.0 6.59 21.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.486 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -110.52 -31.61 7.19 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.69 0.281 . . . . 0.0 111.021 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.589 ' O ' HG22 ' A' ' 101' ' ' ILE . 0.5 OUTLIER -94.11 -44.93 7.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.372 -179.722 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 94' ' ' LYS . 79.2 t -50.24 -46.41 83.21 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.575 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 97.5 Cg_endo -81.08 -15.13 10.53 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.288 1.992 . . . . 0.0 112.633 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -89.32 -44.96 9.85 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.872 0.368 . . . . 0.0 110.832 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.589 HG22 ' O ' ' A' ' 97' ' ' TRP . 7.5 tt -66.48 -30.65 50.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.145 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 38.9 p -83.19 -26.52 30.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.931 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.09 -51.5 53.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.904 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.407 ' O ' ' CE1' ' A' ' 72' ' ' TYR . 27.7 m170 -69.5 -44.31 71.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.979 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.409 ' O ' ' N ' ' A' ' 107' ' ' LYS . 0.6 OUTLIER -111.95 126.65 28.1 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.834 -179.961 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -57.63 81.23 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.475 2.117 . . . . 0.0 112.269 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.409 ' N ' ' O ' ' A' ' 105' ' ' CYS . 0.1 OUTLIER 53.44 97.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.895 -179.993 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.777 HG21 ' CE1' ' A' ' 78' ' ' PHE . 0.1 OUTLIER -117.85 141.26 28.86 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.804 179.998 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 108' ' ' THR . 31.8 Cg_exo -60.02 142.63 98.83 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.553 2.169 . . . . 0.0 112.412 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.794 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 1.9 p90 -147.78 136.27 21.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.816 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.989 HD12 HG11 ' A' ' 152' ' ' VAL . 4.8 tt -110.31 155.16 22.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.127 -179.638 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.656 ' O ' HD23 ' A' ' 111' ' ' LEU . 3.6 mm? -108.98 147.39 32.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.493 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.784 HG13 HG11 ' A' ' 168' ' ' VAL . 2.7 t -131.62 147.72 32.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.935 0.397 . . . . 0.0 111.855 -179.59 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.677 ' O ' HD12 ' A' ' 117' ' ' ILE . . . -125.55 100.64 0.6 Allowed Glycine 0 N--CA 1.453 -0.222 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.924 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.703 ' C ' HD13 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -116.18 -45.05 2.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.994 0.426 . . . . 0.0 110.894 -179.205 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.701 ' OE1' HG22 ' A' ' 85' ' ' VAL . 9.3 tt0 -64.96 -10.27 27.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.054 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.715 ' HA ' HG21 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -42.93 -27.74 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-O 120.717 0.294 . . . . 0.0 111.626 179.709 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.438 ' N ' HG12 ' A' ' 117' ' ' ILE . 1.7 m-20 -71.29 -30.16 65.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.36 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.594 HD12 ' N ' ' A' ' 119' ' ' LEU . 4.8 mp -79.91 -23.18 41.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.129 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.612 ' HB3' HG11 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -44.85 -29.22 0.76 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.934 0.397 . . . . 0.0 110.941 179.975 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.4 -38.69 34.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.549 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -46.47 103.37 0.35 Allowed Pre-proline 0 C--N 1.332 -0.192 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.918 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.43 ' O ' HG22 ' A' ' 126' ' ' ILE . 47.2 Cg_endo -69.7 -7.19 20.42 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.506 2.138 . . . . 0.0 112.934 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.3 t -77.92 -66.45 0.84 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.025 0.441 . . . . 0.0 109.945 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.416 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 5.0 m -56.73 -39.01 73.16 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.048 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.463 ' HA ' ' CD1' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -53.43 -45.45 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.854 179.309 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.514 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 3.7 mt-10 -57.44 -37.18 72.4 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.008 179.37 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 125' ' ' THR . 2.3 mptp? -63.67 -30.09 71.24 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.536 HD22 ' N ' ' A' ' 86' ' ' SER . 6.7 mt -74.89 -38.08 61.97 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.07 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 127' ' ' GLU . . . -44.87 -33.64 2.03 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.948 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 9.1 mmtt -49.44 -34.42 16.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.506 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.437 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 0.6 OUTLIER -123.32 -30.92 3.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.514 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.526 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 6.7 mmtt -145.46 -101.21 0.1 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 119.109 -0.472 . . . . 0.0 111.317 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.526 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 0.9 OUTLIER 133.65 -26.2 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.331 1.052 . . . . 0.0 110.249 -179.858 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 8.9 mtpp -69.0 110.7 6.55 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.715 -179.145 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.413 ' HB2' ' HB2' ' A' ' 120' ' ' ARG . 83.2 Cg_endo -80.34 133.72 9.81 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.682 2.254 . . . . 0.0 111.484 179.223 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.767 HG21 ' CZ ' ' A' ' 90' ' ' PHE . 0.8 OUTLIER -67.26 96.62 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.901 0.381 . . . . 0.0 110.871 -179.513 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.419 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.2 p -82.97 163.68 49.94 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.816 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.494 ' HA ' ' CE1' ' A' ' 154' ' ' TYR . 86.9 Cg_exo -46.15 -40.55 21.4 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.549 2.166 . . . . 0.0 112.275 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -57.56 -52.28 66.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.752 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 7.4 m -57.21 -52.09 66.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.76 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.471 ' HB1' ' CD2' ' A' ' 154' ' ' TYR . . . -54.01 -52.66 60.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.901 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -51.08 -32.52 22.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.682 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 7.4 ttpt -66.04 -61.3 2.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.76 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.751 HD11 ' CG ' ' A' ' 94' ' ' LYS . 0.7 OUTLIER -60.75 -36.45 78.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.661 179.843 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -61.84 -41.54 97.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.973 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -87.59 -25.74 23.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.746 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -67.64 -42.21 82.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.961 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.453 HD21 HG11 ' A' ' 98' ' ' VAL . 0.1 OUTLIER -93.05 16.37 12.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.258 179.912 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.7 mttm 46.88 35.02 2.94 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.768 0.318 . . . . 0.0 111.196 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.794 ' HB1' ' O ' ' A' ' 110' ' ' PHE . . . -55.64 -82.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.09 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.989 HG11 HD12 ' A' ' 111' ' ' LEU . 56.0 t -162.28 -75.67 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.711 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.425 ' HE3' ' N ' ' A' ' 154' ' ' TYR . 0.0 OUTLIER -176.56 113.54 0.1 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.801 -178.843 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.494 ' CE1' ' HA ' ' A' ' 139' ' ' PRO . 16.5 t80 -87.84 106.75 18.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.467 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.636 ' HB ' HG22 ' A' ' 168' ' ' VAL . 0.1 OUTLIER -101.74 177.07 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.448 179.745 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -99.48 118.76 36.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.8 0.333 . . . . 0.0 111.194 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.433 ' HB3' HG23 ' A' ' 168' ' ' VAL . 7.2 p -160.16 126.37 4.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.776 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.552 ' HB3' HG22 ' A' ' 161' ' ' THR . 0.3 OUTLIER -113.09 157.11 22.01 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.249 -179.728 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.505 ' CB ' HD11 ' A' ' 165' ' ' LEU . . . -107.8 -33.39 7.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.698 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.536 ' H ' HD12 ' A' ' 160' ' ' LEU . 0.4 OUTLIER -68.64 -37.19 79.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.697 179.755 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.552 HG22 ' HB3' ' A' ' 158' ' ' SER . 14.0 t -110.74 -18.78 13.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.012 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 75.76 66.54 0.06 Allowed 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 120.856 0.36 . . . . 0.0 110.975 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.417 ' HB2' ' HB2' ' A' ' 158' ' ' SER . 0.1 OUTLIER -92.26 38.1 1.0 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.244 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.414 ' O ' ' HB2' ' A' ' 167' ' ' ASN . . . 89.48 48.89 3.59 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.97 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.71 HD22 ' CB ' ' A' ' 19' ' ' LEU . 4.3 mt -47.53 -31.6 4.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.77 0.319 . . . . 0.0 111.308 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.426 ' O ' ' N ' ' A' ' 170' ' ' ASP . 36.1 pttt -70.57 -29.67 66.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.3 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.414 ' HB2' ' O ' ' A' ' 164' ' ' GLY . 2.1 t30 -52.09 -72.36 0.05 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.852 0.358 . . . . 0.0 110.94 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.784 HG11 HG13 ' A' ' 113' ' ' VAL . 57.4 t -57.69 -50.42 77.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.919 0.39 . . . . 0.0 110.584 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.676 ' CZ ' HD13 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -54.32 -29.49 47.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.463 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 166' ' ' LYS . 6.1 m-20 -72.54 -29.28 63.43 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 178.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.523 ' CB ' HD11 ' A' ' 111' ' ' LEU . 45.1 mm-40 -73.94 -31.42 63.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.237 179.32 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.692 ' O ' HG21 ' A' ' 77' ' ' VAL . . . -67.78 -48.13 67.23 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.796 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.656 HD12 ' CD1' ' A' ' 177' ' ' LEU . 1.1 pp -73.8 -31.82 32.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.625 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.692 HD13 ' HB3' ' B' ' 505' ' ' LEU . 4.6 tp -50.57 -53.98 26.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.789 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -50.91 -25.28 4.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.824 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.703 ' HB2' HG11 ' A' ' 77' ' ' VAL . . . -83.13 -48.68 10.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.166 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.994 HD22 HG21 ' B' ' 510' ' ' ILE . 1.0 OUTLIER -68.72 -23.62 64.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.867 179.955 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.414 ' CG ' ' HD2' ' A' ' 179' ' ' PRO . 2.4 tm-20 -152.14 142.63 15.2 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.807 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' PRO . . . . . 0.414 ' HD2' ' CG ' ' A' ' 178' ' ' GLU . 9.3 Cg_endo -52.76 117.84 4.12 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.724 2.283 . . . . 0.0 112.003 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -66.91 155.02 72.63 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.517 2.145 . . . . 0.0 112.487 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -148.01 98.13 3.83 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.804 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.21 -165.1 0.27 Allowed 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.713 2.275 . . . . 0.0 112.269 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -134.82 157.45 46.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.756 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.249 -0.882 . . . . 0.0 110.897 -179.999 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.311 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 503' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -104.65 -161.42 0.82 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.846 0.355 . . . . 0.0 110.886 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 504' ' ' GLY . . . . . 0.574 ' O ' HD22 ' A' ' 174' ' ' LEU . . . -156.92 69.58 0.27 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.727 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 505' ' ' LEU . . . . . 0.816 HD13 HD13 ' A' ' 177' ' ' LEU . 1.3 mt -133.19 -56.91 0.91 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.642 0.258 . . . . 0.0 111.254 -179.13 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 506' ' ' SER . . . . . 0.463 ' CB ' ' O ' ' B' ' 505' ' ' LEU . 5.2 t 88.95 -20.57 0.16 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.404 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 507' ' ' ALA . . . . . . . . . . . . . . . -51.46 -79.99 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.331 0.586 . . . . 0.0 110.494 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 508' ' ' GLN . . . . . 0.457 ' HB2' HD11 ' B' ' 510' ' ' ILE . 5.8 mt-30 -130.91 3.55 4.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.418 179.302 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 509' ' ' ASP . . . . . 0.441 ' CB ' ' O ' ' B' ' 508' ' ' GLN . 25.5 t0 84.41 39.03 0.03 OUTLIER 'General case' 0 C--N 1.344 0.341 0 CA-C-O 120.98 0.419 . . . . 0.0 110.946 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 510' ' ' ILE . . . . . 1.008 HG23 HG23 ' A' ' 46' ' ' ILE . 1.8 mp -68.96 73.21 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.476 179.472 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 511' ' ' SER . . . . . 0.415 ' O ' ' CD1' ' B' ' 514' ' ' LEU . 14.9 t -60.12 140.78 56.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.904 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 512' ' ' GLN . . . . . 0.495 ' CB ' ' HD3' ' B' ' 513' ' ' PRO . 0.7 OUTLIER -89.84 -64.03 0.19 Allowed Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.735 179.803 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 513' ' ' PRO . . . . . 0.495 ' HD3' ' CB ' ' B' ' 512' ' ' GLN . 88.6 Cg_endo -82.37 49.94 3.27 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.638 2.225 . . . . 0.0 112.463 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 514' ' ' LEU . . . . . 0.443 ' HB2' ' HB ' ' A' ' 44' ' ' VAL . 0.4 OUTLIER -52.88 -89.3 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.784 -179.79 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 515' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -93.2 -157.67 0.55 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -48.7 -29.44 4.44 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.139 0.495 . . . . 0.0 110.316 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 517' ' ' SER . . . . . 0.435 ' O ' ' CG1' ' A' ' 42' ' ' VAL . 14.2 p 38.15 59.48 1.39 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.101 179.43 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 518' ' ' PHE . . . . . 0.485 ' CZ ' ' CE2' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -165.06 108.41 0.86 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.734 0.302 . . . . 0.0 111.393 179.485 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 519' ' ' ILE . . . . . 0.687 HD13 ' O ' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -151.1 152.16 11.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.171 179.246 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 70.33 76.0 0.2 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.825 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 521' ' ' THR . . . . . 0.425 HG23 ' OH ' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -75.7 120.77 21.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.014 -179.951 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 522' ' ' GLY . . . . . . . . . . . . . . . -61.65 -158.26 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.389 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 523' ' ' HIS . . . . . 0.42 ' ND1' ' N ' ' B' ' 523' ' ' HIS . 0.4 OUTLIER -118.66 -83.97 0.65 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.788 0.327 . . . . 0.0 110.808 179.943 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 524' ' ' GLY . . . . . 0.444 ' CA ' HG21 ' A' ' 36' ' ' VAL . . . 67.71 122.13 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.714 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 525' ' ' ASP . . . . . 0.407 ' H ' HD12 ' A' ' 61' ' ' LEU . 18.3 m-20 -142.0 57.91 1.48 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.777 0.323 . . . . 0.0 111.067 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 526' ' ' SER . . . . . 0.705 ' HB2' HD13 ' A' ' 61' ' ' LEU . 2.9 t -78.79 96.81 5.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.754 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 527' ' ' ASP . . . . . 0.466 ' CB ' ' HD3' ' B' ' 528' ' ' PRO . 1.7 t0 -43.93 -52.52 15.05 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.679 0.276 . . . . 0.0 111.019 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 528' ' ' PRO . . . . . 0.466 ' HD3' ' CB ' ' B' ' 527' ' ' ASP . 17.7 Cg_exo -70.82 134.06 24.96 Favored 'Trans proline' 0 CA--C 1.518 -0.306 0 C-N-CA 123.125 2.55 . . . . 0.0 111.726 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 529' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -101.06 -30.02 11.84 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.986 -179.211 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 530' ' ' HIS . . . . . 0.502 ' CG ' ' O ' ' B' ' 530' ' ' HIS . 0.1 OUTLIER 70.35 5.02 5.16 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.399 179.712 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 1.2 m 52.76 -88.08 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.637 0.256 . . . . 0.0 111.011 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 532' ' ' TRP . . . . . 0.434 ' N ' ' O ' ' B' ' 530' ' ' HIS . 15.6 t90 -154.27 -45.33 0.09 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.855 0.36 . . . . 0.0 110.685 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . 67.89 -143.08 41.08 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.572 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 534' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -65.86 150.83 96.02 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.791 0.329 . . . . 0.0 110.896 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 535' ' ' PRO . . . . . 0.539 ' HB3' HG23 ' A' ' 85' ' ' VAL . 73.7 Cg_exo -49.35 -49.74 14.76 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.614 2.21 . . . . 0.0 112.247 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.49 109.19 11.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.78 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 537' ' ' ARG . . . . . 0.44 ' NH2' ' CE2' ' A' ' 32' ' ' TYR . 0.2 OUTLIER -50.38 143.11 9.31 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 120.989 0.423 . . . . 0.0 111.006 179.998 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 538' ' ' ILE . . . . . 0.488 HG13 ' HB2' ' B' ' 542' ' ' TYR . 7.4 tp -58.69 146.78 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.148 179.355 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 539' ' ' ASP . . . . . 0.41 ' HA ' ' O ' ' A' ' 10' ' ' GLY . 3.7 m-20 -46.37 140.52 4.1 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.914 0.388 . . . . 0.0 111.165 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 540' ' ' GLU . . . . . 0.59 ' HG2' HG13 ' A' ' 8' ' ' VAL . 14.0 mp0 -44.94 -27.68 0.57 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.357 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 541' ' ' LEU . . . . . 0.676 ' CB ' HD21 ' A' ' 70' ' ' LEU . 0.9 OUTLIER -55.68 -32.06 62.94 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.351 0.596 . . . . 0.0 110.147 179.615 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 542' ' ' TYR . . . . . 0.488 ' HB2' HG13 ' B' ' 538' ' ' ILE . 11.1 m-85 -105.45 0.88 27.19 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.031 -0.986 . . . . 0.0 112.171 -178.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 543' ' ' LEU . . . . . 0.71 HD21 ' HB ' ' A' ' 14' ' ' VAL . 1.6 tp -49.23 117.64 2.26 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.814 0.34 . . . . 0.0 110.679 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . 135.09 -46.83 1.02 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.505 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 545' ' ' ASN . . . . . . . . . . . . . 22.3 m120 . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.253 -0.879 . . . . 0.0 111.027 -179.933 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.375 0 CA-C-O 120.749 0.309 . . . . 0.0 111.216 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 57.66 160.54 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.715 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.717 HG23 ' CE1' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -119.52 -174.53 2.76 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.407 -179.632 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.609 HG23 HD23 ' A' ' 177' ' ' LEU . 25.7 pt -155.05 149.49 12.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.101 0.477 . . . . 0.0 111.991 -179.273 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 33.9 mttt -134.38 95.87 3.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.274 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -100.31 138.66 37.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.024 0.44 . . . . 0.0 111.491 -179.437 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.6 160.09 41.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.087 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.849 HG21 ' CG ' ' A' ' 16' ' ' LYS . 47.3 t -111.69 137.64 43.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.289 0.566 . . . . 0.0 112.184 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.547 HG13 ' O ' ' A' ' 8' ' ' VAL . 19.3 m -161.44 130.04 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.862 179.232 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 149.37 -144.01 11.56 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.238 -0.982 . . . . 0.0 112.62 -179.444 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.5 p30 -122.15 25.3 9.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.938 0.399 . . . . 0.0 110.825 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.401 ' HA2' ' HB2' ' B' ' 537' ' ' ARG . . . -157.36 -160.24 10.03 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.324 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.492 ' C ' HG13 ' A' ' 14' ' ' VAL . . . -79.11 -48.18 14.79 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.556 0.217 . . . . 0.0 110.836 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.722 HG12 ' HB3' ' A' ' 81' ' ' CYS . 0.6 OUTLIER 65.59 -60.04 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.403 179.55 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.655 ' HA2' HD22 ' A' ' 19' ' ' LEU . . . -165.83 30.31 0.21 Allowed Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.849 ' CG ' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -91.01 -165.32 1.33 Allowed 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 121.232 0.539 . . . . 0.0 111.359 -179.313 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.588 ' CG2' HG23 ' A' ' 35' ' ' THR . 43.6 p -38.95 -65.85 0.33 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.478 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.431 ' O ' ' CB ' ' A' ' 22' ' ' SER . 23.6 t -32.42 -43.6 0.09 Allowed 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -178.646 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.655 HD22 ' HA2' ' A' ' 15' ' ' GLY . 2.5 mp -56.88 -71.74 0.09 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.73 0.3 . . . . 0.0 111.269 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 20' ' ' LEU . 0.3 OUTLIER -76.55 -50.3 14.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.192 -179.741 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.732 HG22 ' HB2' ' A' ' 26' ' ' ASN . 10.9 mm -48.31 -55.79 2.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.403 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.474 ' HA ' ' CB ' ' A' ' 26' ' ' ASN . 3.1 t -64.03 -43.59 95.11 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 121.092 -0.243 . . . . 0.0 111.585 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.571 ' CG ' HD13 ' A' ' 165' ' ' LEU . 0.2 OUTLIER -45.79 -35.07 4.09 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.187 0.517 . . . . 0.0 110.16 179.6 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -101.67 -33.52 9.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.279 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 173.46 127.14 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.722 0.296 . . . . 0.0 111.039 -178.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.732 ' HB2' HG22 ' A' ' 21' ' ' ILE . 61.2 t30 178.56 -43.87 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.666 178.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.6 mtmm 65.1 142.17 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.734 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.46 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -86.68 -49.5 0.48 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.782 179.995 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.46 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 5.8 Cg_exo -79.35 52.15 4.16 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.933 2.422 . . . . 0.0 112.248 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 77.9 p -133.87 -108.74 0.23 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.679 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -159.57 118.75 2.89 Favored 'General case' 0 N--CA 1.457 -0.098 0 O-C-N 122.169 -0.332 . . . . 0.0 111.016 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.475 ' O ' HG22 ' A' ' 33' ' ' VAL . 5.3 m-85 -90.55 121.51 32.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.391 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.499 HG11 ' HD2' ' B' ' 529' ' ' ARG . 0.2 OUTLIER -160.99 -61.98 0.02 OUTLIER Pre-proline 0 N--CA 1.468 0.434 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.363 -179.415 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.476 ' CD ' ' HB ' ' A' ' 33' ' ' VAL . 3.0 Cg_exo -34.98 -28.57 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.649 2.899 . . . . 0.0 113.653 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.588 HG23 ' CG2' ' A' ' 17' ' ' THR . 28.4 m -29.73 -38.46 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.638 ' HA ' ' HB2' ' A' ' 59' ' ' ALA . 11.5 p -50.4 -24.3 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.765 0.317 . . . . 0.0 111.373 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.471 ' CE2' ' HB3' ' A' ' 34' ' ' PRO . 7.1 m-30 -66.07 -10.02 36.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.576 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -46.26 172.62 0.01 OUTLIER 'General case' 0 C--O 1.231 0.102 0 CA-C-O 120.864 0.364 . . . . 0.0 111.159 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 75.37 5.43 4.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.303 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -60.38 -174.85 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.719 0.295 . . . . 0.0 110.607 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -110.11 124.18 51.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.586 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.722 HG23 HG21 ' A' ' 52' ' ' THR . 24.0 m -118.44 124.88 73.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.014 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.72 104.82 16.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.934 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.79 HG22 ' CG2' ' A' ' 52' ' ' THR . 12.6 m -153.23 -177.24 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.931 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.447 ' HE1' ' N ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -111.96 103.71 11.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.651 -179.537 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.645 HG22 ' O ' ' A' ' 46' ' ' ILE . 2.7 mm -74.02 86.09 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.1 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.476 ' HA3' ' HA ' ' B' ' 510' ' ' ILE . . . 43.9 -94.13 0.01 OUTLIER Glycine 0 CA--C 1.519 0.313 0 CA-C-N 115.498 -0.774 . . . . 0.0 113.636 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -38.62 -87.44 0.01 OUTLIER Glycine 0 C--N 1.332 0.356 0 C-N-CA 121.607 -0.33 . . . . 0.0 113.626 -179.132 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.447 ' N ' ' HE1' ' A' ' 45' ' ' MET . 1.8 pt-20 -125.23 164.75 30.03 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 120.708 0.289 . . . . 0.0 111.024 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.41 ' HD2' ' HB2' ' A' ' 49' ' ' GLU . 52.0 Cg_exo -54.22 106.82 0.18 Allowed 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.653 2.235 . . . . 0.0 112.289 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.717 ' CE1' HG23 ' A' ' 3' ' ' THR . 4.4 t80 -172.53 147.92 1.92 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.498 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.79 ' CG2' HG22 ' A' ' 44' ' ' VAL . 0.3 OUTLIER -137.61 154.06 49.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.624 179.706 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.718 ' N ' HD13 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -131.15 177.99 7.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.877 0.37 . . . . 0.0 111.305 -179.734 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -74.09 114.8 4.67 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.161 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.519 ' H ' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -81.15 -62.97 1.5 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.019 0.437 . . . . 0.0 110.942 -179.785 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.491 ' CD2' ' HB2' ' A' ' 55' ' ' LEU . 1.9 p90 -142.94 128.89 19.55 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.185 -179.214 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -142.26 109.6 5.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.032 0.444 . . . . 0.0 110.847 179.545 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.536 ' O ' HD22 ' B' ' 543' ' ' LEU . 0.0 OUTLIER -155.8 131.48 9.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.316 179.524 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.638 ' HB2' ' HA ' ' A' ' 36' ' ' VAL . . . -170.93 158.44 5.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.027 0.441 . . . . 0.0 111.613 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -131.01 19.63 4.9 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.149 179.491 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.535 HD23 ' HB ' ' A' ' 36' ' ' VAL . 2.5 mm? -86.22 -175.51 5.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.814 0.34 . . . . 0.0 110.779 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -46.58 -31.48 2.84 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.312 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.468 ' CB ' ' CG2' ' A' ' 36' ' ' VAL . 7.2 t0 -50.52 -62.09 1.8 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.06 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.504 ' CD1' ' N ' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -168.41 137.37 2.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.975 0.417 . . . . 0.0 111.154 -179.898 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.13 -66.23 0.92 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.786 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 17.1 mmt85 -73.22 -24.9 60.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.991 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.577 HD11 ' H ' ' A' ' 59' ' ' ALA . 1.1 mt 68.52 -94.73 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.114 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.432 ' CB ' ' HD3' ' A' ' 69' ' ' PRO . 0.0 OUTLIER 166.34 -53.9 0.0 OUTLIER Pre-proline 0 N--CA 1.465 0.287 0 CA-C-O 120.722 0.296 . . . . 0.0 111.128 179.822 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.432 ' HD3' ' CB ' ' A' ' 68' ' ' ARG . 52.8 Cg_exo -52.91 -60.41 0.73 Allowed 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.662 2.242 . . . . 0.0 112.727 -179.534 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.922 HD22 ' HA ' ' B' ' 541' ' ' LEU . 0.3 OUTLIER -58.7 -31.89 68.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.031 -179.847 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.8 t -54.6 -35.63 63.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.223 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 65.3 t80 175.39 81.57 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.669 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.515 ' HG2' ' CZ ' ' A' ' 78' ' ' PHE . 94.4 Cg_endo -81.17 136.42 10.17 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.604 2.203 . . . . 0.0 112.307 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? -90.79 10.25 26.82 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.349 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.504 HG22 ' HB2' ' A' ' 73' ' ' PRO . 4.4 t -57.74 178.45 0.08 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.808 0.337 . . . . 0.0 110.737 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -123.34 7.33 9.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.535 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.655 ' O ' HG13 ' A' ' 77' ' ' VAL . 8.9 p -152.76 101.05 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 CA-C-O 120.758 0.313 . . . . 0.0 111.321 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.515 ' CZ ' ' HG2' ' A' ' 73' ' ' PRO . 3.2 m-85 -80.61 177.65 8.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.393 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.662 HD23 HG23 ' A' ' 14' ' ' VAL . 5.9 tp -138.93 108.25 6.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.047 0.451 . . . . 0.0 111.042 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.416 HG22 ' HB2' ' A' ' 110' ' ' PHE . 19.7 m -111.04 127.01 68.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.243 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.722 ' HB3' HG12 ' A' ' 14' ' ' VAL . 13.6 p -108.21 177.19 4.88 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.604 0.716 . . . . 0.0 112.51 -178.829 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.655 ' HZ ' ' HB2' ' A' ' 142' ' ' ALA . 2.1 p90 -176.54 124.45 0.17 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.607 -1.178 . . . . 0.0 109.467 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.4 m -87.89 143.65 27.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.831 0.348 . . . . 0.0 111.291 -179.28 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.782 HG13 ' N ' ' A' ' 137' ' ' ILE . 51.0 t -54.72 -53.08 35.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.748 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.762 HG11 HG21 ' A' ' 125' ' ' THR . 34.3 m -52.09 110.1 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.225 179.318 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.75 ' N ' HD22 ' A' ' 129' ' ' LEU . 0.3 OUTLIER -151.46 128.38 5.44 Favored Pre-proline 0 C--N 1.33 -0.274 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.77 -179.36 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 86' ' ' SER . 82.5 Cg_endo -92.4 53.45 0.6 Allowed 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.299 2.666 . . . . 0.0 111.498 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.468 ' CA ' ' HG3' ' A' ' 133' ' ' LYS . 1.1 p 77.87 17.81 1.29 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.141 -179.485 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.769 ' O ' HG23 ' A' ' 93' ' ' VAL . 5.0 p -97.28 -23.98 15.89 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.811 0.338 . . . . 0.0 111.066 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.453 ' CZ ' HG21 ' A' ' 137' ' ' ILE . 9.7 t80 -46.96 -46.77 21.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.186 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -50.77 -52.19 43.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.183 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.93 -40.38 83.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.168 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.769 HG23 ' O ' ' A' ' 89' ' ' SER . 62.1 t -48.36 -45.42 13.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.491 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.551 ' O ' HG23 ' A' ' 98' ' ' VAL . 3.8 ptpp? -80.32 -36.81 33.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.107 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -74.61 -11.23 60.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.589 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.17 -20.49 12.33 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.58 0.228 . . . . 0.0 111.326 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.446 ' CE3' ' HA ' ' A' ' 97' ' ' TRP . 3.3 m95 -87.0 -51.61 5.92 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.712 0.291 . . . . 0.0 111.186 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 94' ' ' LYS . 57.3 t -48.51 -47.79 69.02 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.598 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 73.4 Cg_endo -76.46 -13.65 18.39 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.169 1.913 . . . . 0.0 112.492 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -89.83 -49.17 6.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.885 0.374 . . . . 0.0 110.727 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.424 HG13 HG23 ' A' ' 102' ' ' THR . 5.8 pt -56.84 -28.16 27.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.013 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.424 HG23 HG13 ' A' ' 101' ' ' ILE . 69.5 p -93.05 -25.89 17.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.93 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -63.5 -68.59 0.33 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.758 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 10.2 m80 -64.86 -51.1 63.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.795 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 2.9 m -101.57 141.15 22.01 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.811 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -51.24 155.21 6.89 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.591 2.194 . . . . 0.0 112.209 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 16.3 mttt -53.46 90.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.872 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.44 ' HB ' ' CD1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -115.65 152.43 47.26 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.918 -179.954 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -60.86 167.83 8.08 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.686 2.257 . . . . 0.0 112.415 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.738 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 1.8 p90 -155.8 159.39 39.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.738 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 1.021 HD12 HG11 ' A' ' 152' ' ' VAL . 4.2 tt -121.03 150.03 41.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.255 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.7 ' O ' HD23 ' A' ' 111' ' ' LEU . 3.8 mm? -94.05 141.71 28.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.178 179.468 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.996 HG13 HG21 ' A' ' 168' ' ' VAL . 3.1 t -122.03 145.29 28.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.183 0.516 . . . . 0.0 112.07 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -130.51 125.78 4.71 Favored Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.093 179.287 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.653 ' C ' HD13 ' A' ' 117' ' ' ILE . 0.6 OUTLIER -144.27 -44.89 0.25 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.964 0.412 . . . . 0.0 110.752 -178.854 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.463 ' HA ' HD23 ' A' ' 119' ' ' LEU . 0.1 OUTLIER -71.33 -2.68 17.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.23 179.26 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.653 HD13 ' C ' ' A' ' 115' ' ' THR . 0.1 OUTLIER -42.29 -28.44 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 179.935 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.18 -34.7 61.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.771 0.319 . . . . 0.0 111.131 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.557 ' N ' HD22 ' A' ' 119' ' ' LEU . 2.2 mm? -69.44 -31.78 70.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.083 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.456 ' CB ' HG11 ' A' ' 84' ' ' VAL . 0.3 OUTLIER -46.11 -29.87 1.69 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.949 -179.884 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -83.84 -31.96 25.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.505 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 119' ' ' LEU . 3.5 t0 -56.54 106.86 0.74 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.618 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.415 ' O ' ' CG ' ' A' ' 127' ' ' GLU . 14.2 Cg_exo -69.19 -3.62 12.0 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.686 2.257 . . . . 0.0 112.975 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.83 -65.24 1.04 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 121.058 0.456 . . . . 0.0 109.865 179.543 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.762 HG21 HG11 ' A' ' 85' ' ' VAL . 4.1 m -56.65 -38.95 72.86 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.854 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.532 HD11 ' HB3' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -54.34 -43.1 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.753 179.203 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.459 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 1.7 mm-40 -58.31 -37.7 75.61 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.833 179.25 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 125' ' ' THR . 2.7 mptt -63.11 -30.71 71.81 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.75 HD22 ' N ' ' A' ' 86' ' ' SER . 8.0 mt -74.88 -39.22 61.63 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.102 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 127' ' ' GLU . . . -46.57 -31.49 2.84 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.85 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.0 mmtt -50.14 -34.31 21.79 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.391 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.404 ' HB2' ' O ' ' A' ' 87' ' ' PRO . 5.0 m-80 -123.3 -31.36 3.56 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.359 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.512 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 7.6 mmtt -144.79 -98.96 0.1 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 119.15 -0.452 . . . . 0.0 111.326 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.512 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 0.0 OUTLIER 132.22 -22.79 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.401 1.08 . . . . 0.0 110.503 -179.809 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 4.5 mmtt -68.75 110.82 6.62 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.726 -179.055 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.532 ' HB3' HD11 ' A' ' 126' ' ' ILE . 85.2 Cg_endo -81.6 123.4 4.27 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.534 2.156 . . . . 0.0 111.394 179.303 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.782 ' N ' HG13 ' A' ' 84' ' ' VAL . 1.1 mm -55.05 96.61 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.958 0.409 . . . . 0.0 110.893 -179.466 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.44 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 74.2 p -69.09 156.59 91.25 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.028 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.44 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 9.4 Cg_endo -50.75 -41.35 54.81 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.709 2.272 . . . . 0.0 112.085 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -58.85 -34.8 72.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.583 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.409 HG21 HG23 ' A' ' 137' ' ' ILE . 84.3 m -63.62 -46.49 85.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.677 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.655 ' HB2' ' HZ ' ' A' ' 82' ' ' PHE . . . -55.6 -48.74 74.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.905 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -53.48 -43.95 68.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.73 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 6.8 mttt -54.1 -61.8 2.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.704 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.663 HD21 HD11 ' A' ' 149' ' ' LEU . 0.8 OUTLIER -61.57 -37.98 85.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.649 179.748 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.478 ' HB2' ' HG ' ' A' ' 112' ' ' LEU . . . -59.45 -49.22 78.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.861 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 16.2 mtp180 -79.68 -25.14 41.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.826 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -56.93 -40.71 76.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.447 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.663 HD11 HD21 ' A' ' 145' ' ' LEU . 1.1 mt -109.95 26.11 11.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.667 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.469 ' N ' ' CD ' ' A' ' 150' ' ' LYS . 0.0 OUTLIER 37.84 57.0 1.54 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.671 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.738 ' HB1' ' O ' ' A' ' 110' ' ' PHE . . . -73.76 -82.16 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.025 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 1.021 HG11 HD12 ' A' ' 111' ' ' LEU . 55.5 t -161.96 -76.12 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.752 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.443 ' HG3' ' N ' ' A' ' 154' ' ' TYR . 1.9 ttpt -177.01 145.91 0.5 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.343 -178.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.443 ' N ' ' HG3' ' A' ' 153' ' ' LYS . 61.3 t80 -105.66 114.48 28.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.551 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.718 HG23 ' OE2' ' A' ' 171' ' ' GLU . 11.4 t -112.91 157.94 13.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.803 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.425 ' N ' HG12 ' A' ' 155' ' ' VAL . 2.6 pt-20 -97.79 118.29 34.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.065 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.452 ' HA ' ' CB ' ' A' ' 163' ' ' LYS . 22.9 m -160.63 126.42 3.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.673 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.789 ' OG ' HD12 ' A' ' 160' ' ' LEU . 0.4 OUTLIER -147.41 153.62 39.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.916 0.389 . . . . 0.0 111.745 -179.591 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -78.47 -22.07 48.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.664 179.3 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.789 HD12 ' OG ' ' A' ' 158' ' ' SER . 0.3 OUTLIER -67.39 -59.46 3.38 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.073 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.52 HG23 ' HD3' ' A' ' 163' ' ' LYS . 3.5 t -91.92 -22.49 20.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.222 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 72.13 69.86 0.15 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.865 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.52 ' HD3' HG23 ' A' ' 161' ' ' THR . 10.3 mptt -90.81 19.37 5.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.32 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 119.13 -42.21 1.83 Allowed Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.634 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.645 HD21 ' CA ' ' A' ' 19' ' ' LEU . 1.0 OUTLIER 66.35 -66.24 0.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.783 0.325 . . . . 0.0 111.359 179.904 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.423 ' O ' ' N ' ' A' ' 170' ' ' ASP . 6.2 ptpp? -58.04 -26.08 62.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.752 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.409 ' O ' ' HB2' ' A' ' 170' ' ' ASP . 0.2 OUTLIER -54.51 -69.46 0.13 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.814 0.34 . . . . 0.0 111.06 -179.717 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.996 HG21 HG13 ' A' ' 113' ' ' VAL . 13.6 p -56.15 -44.77 79.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.142 0.496 . . . . 0.0 110.69 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.559 ' HB2' HD23 ' A' ' 19' ' ' LEU . 5.6 t80 -66.85 -17.23 64.79 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.979 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' A' ' 166' ' ' LYS . 2.8 m-20 -80.95 -38.66 27.36 Favored 'General case' 0 C--N 1.334 -0.068 0 CA-C-O 120.809 0.338 . . . . 0.0 110.699 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.744 ' CD ' HD21 ' A' ' 111' ' ' LEU . 9.4 pt-20 -69.45 -27.81 65.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.936 0.398 . . . . 0.0 110.033 179.37 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.472 ' HA ' HD13 ' A' ' 111' ' ' LEU . . . -75.69 -42.23 51.58 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.911 179.459 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.546 HD13 ' HG2' ' B' ' 512' ' ' GLN . 1.7 pp -81.58 -34.44 13.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.044 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.839 HD23 HD13 ' B' ' 505' ' ' LEU . 1.2 tm? -56.36 -44.62 80.3 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.859 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.422 ' N ' HD13 ' A' ' 174' ' ' LEU . . . -51.22 -24.78 4.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.904 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.494 ' CB ' HG22 ' A' ' 4' ' ' ILE . . . -84.84 -39.27 18.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.163 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.855 HD13 ' HB ' ' B' ' 510' ' ' ILE . 31.4 mt -68.56 -24.06 64.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.869 0.366 . . . . 0.0 110.405 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.435 ' HB2' ' HB2' ' B' ' 507' ' ' ALA . 21.7 tt0 -165.52 139.27 3.76 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.543 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 179' ' ' PRO . . . . . 0.419 ' HA ' ' HD3' ' A' ' 180' ' ' PRO . 43.9 Cg_endo -68.36 108.58 1.83 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.564 2.176 . . . . 0.0 112.507 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 180' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 179' ' ' PRO . 11.8 Cg_exo -70.83 -159.51 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.734 2.29 . . . . 0.0 112.185 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -145.57 146.73 30.62 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.886 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.23 -165.32 0.3 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.686 2.258 . . . . 0.0 112.287 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.5 154.6 35.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.888 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 8.2 mttt . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.297 -0.858 . . . . 0.0 110.877 -179.967 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 112.45 -0.26 . . . . 0.0 112.45 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 503' ' ' SER . . . . . . . . . . . . . 5.7 m -74.03 -69.49 0.44 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.833 0.349 . . . . 0.0 110.782 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 504' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' B' ' 509' ' ' ASP . . . 64.09 114.67 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.684 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 505' ' ' LEU . . . . . 0.839 HD13 HD23 ' A' ' 174' ' ' LEU . 0.0 OUTLIER -148.53 -52.41 0.18 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.845 0.355 . . . . 0.0 110.709 -179.922 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 506' ' ' SER . . . . . 0.41 ' CB ' ' OE1' ' A' ' 178' ' ' GLU . 1.4 m -155.19 -161.11 1.13 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.778 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 507' ' ' ALA . . . . . 0.435 ' HB2' ' HB2' ' A' ' 178' ' ' GLU . . . 55.01 -90.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.001 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 508' ' ' GLN . . . . . 0.414 ' O ' ' CB ' ' B' ' 509' ' ' ASP . 13.1 mt-30 -132.1 3.9 4.05 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.875 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 509' ' ' ASP . . . . . 0.423 ' HA ' ' HA2' ' B' ' 504' ' ' GLY . 7.8 t70 80.71 42.44 0.05 OUTLIER 'General case' 0 C--N 1.34 0.19 0 CA-C-O 121.221 0.534 . . . . 0.0 110.012 -179.347 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 510' ' ' ILE . . . . . 0.855 ' HB ' HD13 ' A' ' 177' ' ' LEU . 11.2 mt -65.3 145.28 14.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.554 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 511' ' ' SER . . . . . . . . . . . . . 27.9 t -109.37 149.2 29.86 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.205 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 512' ' ' GLN . . . . . 0.546 ' HG2' HD13 ' A' ' 173' ' ' ILE . 0.0 OUTLIER -93.69 -53.53 0.25 Allowed Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.406 179.387 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 513' ' ' PRO . . . . . 0.458 ' HD3' ' CB ' ' B' ' 512' ' ' GLN . 55.8 Cg_endo -97.73 74.79 0.08 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 123.33 2.687 . . . . 0.0 111.813 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 514' ' ' LEU . . . . . 0.44 ' CD1' ' O ' ' A' ' 45' ' ' MET . 0.7 OUTLIER -73.33 -88.28 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.6 -179.257 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 515' ' ' GLN . . . . . 0.565 ' HB2' HG12 ' A' ' 44' ' ' VAL . 0.3 OUTLIER -87.45 -159.88 0.56 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.777 0.322 . . . . 0.0 111.006 -179.669 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -54.48 -21.24 9.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.235 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 517' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 47.24 29.14 1.14 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.821 0.343 . . . . 0.0 111.129 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 518' ' ' PHE . . . . . 0.517 ' CZ ' HD12 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -150.18 91.62 1.79 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.83 -179.749 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 519' ' ' ILE . . . . . 0.459 HG12 ' HA ' ' A' ' 42' ' ' VAL . 5.3 mm -97.79 -68.89 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.442 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -117.65 -170.0 1.78 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.946 0.403 . . . . 0.0 111.005 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 521' ' ' THR . . . . . 0.421 ' OG1' ' CG ' ' A' ' 37' ' ' PHE . 15.3 t -119.32 -159.86 0.79 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.909 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 522' ' ' GLY . . . . . . . . . . . . . . . -110.57 -92.37 2.15 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.364 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 523' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -115.41 -88.29 0.58 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.643 0.259 . . . . 0.0 111.02 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 524' ' ' GLY . . . . . . . . . . . . . . . 164.47 123.9 0.68 Allowed Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.491 -0.862 . . . . 0.0 112.643 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 525' ' ' ASP . . . . . 0.406 ' HB3' ' HG ' ' A' ' 61' ' ' LEU . 0.9 OUTLIER 177.28 46.17 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.99 0.424 . . . . 0.0 110.592 179.827 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 526' ' ' SER . . . . . 0.42 ' CB ' ' HD3' ' A' ' 34' ' ' PRO . 71.8 m -104.3 100.11 9.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.068 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 527' ' ' ASP . . . . . 0.431 ' O ' HG21 ' A' ' 33' ' ' VAL . 7.2 m-20 -156.17 164.79 20.25 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.835 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -61.09 95.69 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.588 2.192 . . . . 0.0 112.133 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 529' ' ' ARG . . . . . 0.499 ' HD2' HG11 ' A' ' 33' ' ' VAL . 2.8 mtp85 -97.67 -49.77 4.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.105 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 530' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -168.8 -41.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.158 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 2.7 m 72.71 177.02 0.26 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.772 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 532' ' ' TRP . . . . . . . . . . . . . 37.1 t90 -53.01 92.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.796 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . -114.86 -61.39 0.38 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.548 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 534' ' ' PHE . . . . . 0.4 ' HA ' ' HD3' ' B' ' 535' ' ' PRO . 44.0 m-85 -78.11 139.16 60.71 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.644 0.259 . . . . 0.0 110.875 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 535' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' B' ' 534' ' ' PHE . 50.5 Cg_exo -53.79 123.86 14.45 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.557 2.172 . . . . 0.0 112.438 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 70.31 126.8 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.027 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 537' ' ' ARG . . . . . 0.401 ' HB2' ' HA2' ' A' ' 12' ' ' GLY . 21.3 mmt180 -54.67 122.73 11.29 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.233 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 538' ' ' ILE . . . . . 0.624 ' C ' HD13 ' B' ' 538' ' ' ILE . 0.0 OUTLIER -48.17 151.05 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.152 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 539' ' ' ASP . . . . . 0.469 ' OD2' ' CD2' ' B' ' 542' ' ' TYR . 0.7 OUTLIER -38.52 104.62 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.218 0.532 . . . . 0.0 112.224 -178.58 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 540' ' ' GLU . . . . . 0.773 ' OE2' HG11 ' A' ' 8' ' ' VAL . 1.1 mm-40 -45.25 -26.54 0.51 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.529 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 541' ' ' LEU . . . . . 0.922 ' HA ' HD22 ' A' ' 70' ' ' LEU . 42.1 mt -41.21 -35.18 0.57 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.953 0.406 . . . . 0.0 111.116 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 542' ' ' TYR . . . . . 0.469 ' CD2' ' OD2' ' B' ' 539' ' ' ASP . 4.1 m-30 -104.33 -57.25 2.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.525 179.378 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 543' ' ' LEU . . . . . 0.752 HD12 ' HA ' ' B' ' 540' ' ' GLU . 0.2 OUTLIER 62.31 176.44 0.13 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.437 -179.884 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . 103.22 79.67 1.38 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.259 -0.972 . . . . 0.0 112.574 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 545' ' ' ASN . . . . . 0.43 ' HB3' ' HB2' ' B' ' 529' ' ' ARG . 2.5 m120 . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.955 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.427 ' HE2' ' HB2' ' A' ' 1' ' ' MET . 3.3 ppp? . . . . . 0 N--CA 1.488 1.472 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.421 ' N ' ' SD ' ' A' ' 1' ' ' MET . 50.4 tt0 61.93 132.84 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.893 0.377 . . . . 0.0 110.724 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.704 HG22 ' CD2' ' A' ' 53' ' ' LEU . 0.3 OUTLIER -133.36 -161.38 1.13 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.429 -179.679 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.883 HD13 HD22 ' A' ' 53' ' ' LEU . 0.3 OUTLIER -154.91 163.37 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -179.069 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 8.2 mtmt -111.29 136.59 50.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.041 179.224 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.424 ' HB2' HD12 ' A' ' 55' ' ' LEU . 1.0 OUTLIER -108.32 138.73 44.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.063 0.459 . . . . 0.0 111.66 -179.356 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -151.11 160.41 3.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.098 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.498 HG11 ' CA ' ' A' ' 14' ' ' VAL . 3.3 m -143.24 139.95 26.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.845 0.355 . . . . 0.0 111.726 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.447 HG12 HD13 ' A' ' 70' ' ' LEU . 14.8 m -143.27 131.04 18.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.083 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.25 -110.11 3.92 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.623 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.73 -23.85 24.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.716 0.293 . . . . 0.0 110.92 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -49.43 150.56 4.32 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.617 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.773 ' O ' HG13 ' A' ' 14' ' ' VAL . . . -91.53 -56.35 3.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.549 0.214 . . . . 0.0 111.158 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.773 HG13 ' O ' ' A' ' 13' ' ' ALA . 0.0 OUTLIER 170.75 -56.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.788 179.584 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.659 ' HA2' HD13 ' A' ' 19' ' ' LEU . . . 110.25 -16.29 29.85 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.419 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.846 ' O ' HD23 ' A' ' 20' ' ' LEU . 15.4 tptm -93.44 -50.04 5.63 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.782 0.325 . . . . 0.0 111.076 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.632 HG21 ' OG1' ' A' ' 35' ' ' THR . 0.6 OUTLIER -97.81 -71.2 0.69 Allowed 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.525 -179.516 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.438 ' HA ' HG12 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -34.61 -74.18 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -178.823 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.737 HD22 ' CD1' ' A' ' 169' ' ' PHE . 7.8 mp -47.43 -39.21 15.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.058 -179.031 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.846 HD23 ' O ' ' A' ' 16' ' ' LYS . 3.1 mm? -76.9 -20.88 55.69 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.982 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.443 ' N ' ' O ' ' A' ' 17' ' ' THR . 9.1 mm -61.09 -69.64 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.439 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 74.8 m -56.55 -32.95 65.66 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.514 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.488 ' HB2' HD13 ' A' ' 165' ' ' LEU . 42.2 t80 -56.99 -68.38 0.23 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.026 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.3 m -76.65 -45.99 27.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.666 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.442 ' N ' ' O ' ' A' ' 21' ' ' ILE . 1.6 p -92.41 -155.91 0.44 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.435 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -155.75 23.8 0.39 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.776 0.322 . . . . 0.0 111.098 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.33 100.22 9.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.947 0.403 . . . . 0.0 111.39 -179.679 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.491 ' HE2' HD21 ' A' ' 119' ' ' LEU . 0.1 OUTLIER -87.86 -64.95 0.2 Allowed Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.095 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.487 ' HD3' ' CD2' ' A' ' 28' ' ' PHE . 93.0 Cg_endo -81.72 54.16 4.96 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.597 2.198 . . . . 0.0 111.983 179.341 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.414 ' O ' ' HG3' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -97.17 -84.96 0.36 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.864 -179.64 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.417 ' HA ' ' HA ' ' B' ' 531' ' ' CYS . 27.0 mt-10 -149.52 126.49 11.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.041 0.448 . . . . 0.0 111.873 -179.75 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.469 ' C ' HG22 ' A' ' 33' ' ' VAL . 3.1 m-85 -105.15 93.34 4.64 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.591 178.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.569 HG23 ' CD ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -165.81 -64.56 0.01 OUTLIER Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.253 -179.177 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.569 ' CD ' HG23 ' A' ' 33' ' ' VAL . 55.2 Cg_endo -70.78 56.7 1.86 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.599 2.199 . . . . 0.0 112.891 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.632 ' OG1' HG21 ' A' ' 17' ' ' THR . 7.3 t -121.75 26.35 8.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.993 0.425 . . . . 0.0 110.52 179.523 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.768 HG22 HD23 ' A' ' 61' ' ' LEU . 1.8 t -80.46 -5.66 8.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.888 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.454 ' HB3' ' N ' ' B' ' 522' ' ' GLY . 29.5 p90 -93.98 26.54 3.17 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.785 0.326 . . . . 0.0 111.142 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.1 p30 -70.3 -19.25 63.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.12 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -100.11 11.12 40.11 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.514 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.468 ' CE1' ' HA2' ' B' ' 522' ' ' GLY . 1.0 OUTLIER -60.66 -159.42 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 120.685 0.278 . . . . 0.0 110.664 179.894 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.41 ' O ' HG12 ' B' ' 519' ' ' ILE . . . -117.82 156.26 28.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.543 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.421 HG12 ' C ' ' B' ' 517' ' ' SER . 0.5 OUTLIER -140.56 126.13 20.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.883 179.725 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.737 ' O ' HG23 ' A' ' 44' ' ' VAL . 9.9 t -85.51 104.49 15.34 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.929 0.395 . . . . 0.0 110.592 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.939 ' CG1' HD13 ' B' ' 514' ' ' LEU . 2.8 t -164.63 158.1 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.818 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.487 ' HG3' HD22 ' B' ' 514' ' ' LEU . 0.0 OUTLIER -112.75 118.83 36.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.599 178.758 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.87 HG23 HG23 ' B' ' 510' ' ' ILE . 1.4 mm -79.65 86.81 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.441 -179.185 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 54.68 -76.16 0.01 OUTLIER Glycine 0 CA--C 1.521 0.464 0 CA-C-N 115.678 -0.692 . . . . 0.0 114.353 178.652 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . -57.55 -95.91 0.01 OUTLIER Glycine 0 CA--C 1.518 0.272 0 C-N-CA 121.099 -0.572 . . . . 0.0 113.559 -179.042 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.438 ' HB2' ' HD2' ' A' ' 50' ' ' PRO . 0.3 OUTLIER -115.93 163.83 19.84 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-O 120.736 0.303 . . . . 0.0 111.311 -179.154 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.438 ' HD2' ' HB2' ' A' ' 49' ' ' GLU . 57.8 Cg_exo -51.6 100.38 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.483 2.122 . . . . 0.0 112.39 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.437 ' HE1' HG21 ' A' ' 3' ' ' THR . 3.5 t80 -172.2 118.61 0.39 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.227 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.774 HG21 ' HB ' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -113.95 138.64 50.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.49 179.807 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.883 HD22 HD13 ' A' ' 4' ' ' ILE . 0.3 OUTLIER -70.7 109.07 4.71 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.375 -179.463 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -61.22 94.73 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.613 179.316 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.833 HD23 ' HD3' ' A' ' 16' ' ' LYS . 0.9 OUTLIER -41.56 110.95 0.19 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.853 0.359 . . . . 0.0 111.179 -179.398 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -83.74 104.97 14.28 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.884 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.692 ' CG ' HG12 ' A' ' 14' ' ' VAL . 17.1 m-20 -131.56 174.89 9.64 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.001 -179.322 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.657 ' HA ' HD11 ' A' ' 67' ' ' LEU . 0.1 OUTLIER -144.77 143.92 30.91 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.935 -179.395 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.725 ' HB1' HD23 ' A' ' 61' ' ' LEU . . . -140.66 125.46 18.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.046 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.4 ' C ' HD22 ' A' ' 61' ' ' LEU . . . -75.66 66.19 2.41 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.728 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.768 HD23 HG22 ' A' ' 36' ' ' VAL . 3.0 mm? -121.23 -176.98 3.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.905 0.383 . . . . 0.0 110.978 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -52.79 -45.93 67.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.012 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.414 ' HB3' ' CE2' ' A' ' 64' ' ' TYR . 0.2 OUTLIER -50.68 -38.01 44.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.951 -179.959 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.726 ' HE2' HG12 ' A' ' 36' ' ' VAL . 1.4 m-85 -145.02 97.13 2.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.788 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -86.02 -37.54 18.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.211 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -97.51 4.27 50.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.781 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.731 HD23 ' O ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -62.15 133.66 55.53 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.764 0.316 . . . . 0.0 110.266 179.672 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -174.84 60.05 0.22 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.249 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.562 ' HD2' HG21 ' A' ' 58' ' ' THR . 62.4 Cg_endo -73.18 -23.23 18.24 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.567 2.178 . . . . 0.0 112.03 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.71 ' O ' HD12 ' A' ' 70' ' ' LEU . 0.3 OUTLIER -59.24 -20.19 52.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.096 -179.964 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.9 p -50.77 -42.89 58.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.169 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -160.68 69.91 2.76 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.031 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.421 ' HD3' ' O ' ' A' ' 70' ' ' LEU . 73.7 Cg_endo -75.19 149.58 36.14 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.653 2.235 . . . . 0.0 112.32 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.49 10.48 40.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.42 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.3 t -48.96 176.01 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.864 0.364 . . . . 0.0 110.897 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -109.39 -24.16 11.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.985 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.0 p -134.26 143.34 38.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.278 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.408 ' HB2' ' O ' ' A' ' 109' ' ' PRO . 0.1 OUTLIER -125.84 174.48 8.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.627 179.732 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.516 HD11 HG23 ' A' ' 113' ' ' VAL . 46.4 tp -146.51 109.28 4.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.892 0.377 . . . . 0.0 111.238 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.657 HG11 HD11 ' A' ' 101' ' ' ILE . 31.1 m -98.79 115.36 39.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.633 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 3.6 m -108.29 168.07 9.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.094 0.473 . . . . 0.0 111.655 -179.343 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.41 ' CE1' HG21 ' A' ' 137' ' ' ILE . 10.8 p90 -169.75 135.9 1.53 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.353 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.421 ' CB ' ' OE1' ' A' ' 116' ' ' GLN . 4.9 p -83.17 141.17 32.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.035 0.445 . . . . 0.0 111.562 -179.19 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.782 HG12 ' O ' ' A' ' 137' ' ' ILE . 16.4 m -57.05 -31.47 37.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.243 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.74 HG11 HG21 ' A' ' 125' ' ' THR . 9.5 m -78.02 117.23 22.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.235 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.757 ' N ' HD22 ' A' ' 129' ' ' LEU . 0.4 OUTLIER -151.71 142.83 15.49 Favored Pre-proline 0 C--N 1.333 -0.151 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -179.141 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 86' ' ' SER . 69.4 Cg_endo -92.45 53.93 0.59 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 123.406 2.737 . . . . 0.0 111.614 179.117 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.445 ' CB ' ' HB2' ' A' ' 133' ' ' LYS . 0.3 OUTLIER 71.0 19.77 5.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.99 -179.297 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.711 ' O ' HG23 ' A' ' 93' ' ' VAL . 58.8 m -97.2 -21.59 17.21 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.741 0.305 . . . . 0.0 111.115 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.542 ' CZ ' HG21 ' A' ' 137' ' ' ILE . 17.4 t80 -47.48 -58.87 3.7 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.169 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.7 -39.29 36.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.868 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.419 ' O ' ' CD ' ' A' ' 96' ' ' LYS . 1.0 OUTLIER -72.52 -43.22 63.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.759 179.795 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.711 HG23 ' O ' ' A' ' 89' ' ' SER . 77.0 t -50.21 -63.47 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.051 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.81 ' HG2' HD13 ' A' ' 145' ' ' LEU . 0.0 OUTLIER -58.3 -39.32 79.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.913 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -65.81 -25.33 67.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.977 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.419 ' CD ' ' O ' ' A' ' 92' ' ' ASN . 1.4 mtpm? -100.06 -24.27 14.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.0 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.434 ' CE3' ' HA ' ' A' ' 97' ' ' TRP . 0.0 OUTLIER -67.18 -58.73 4.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.05 -179.853 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.544 HG21 HD13 ' A' ' 149' ' ' LEU . 95.4 t -45.57 -53.5 19.01 Favored Pre-proline 0 CA--C 1.532 0.26 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.814 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 51.9 Cg_endo -68.66 -14.43 39.35 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.173 1.915 . . . . 0.0 112.628 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -86.66 -35.66 19.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.87 0.367 . . . . 0.0 111.054 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.657 HD11 HG11 ' A' ' 80' ' ' VAL . 30.3 mt -78.31 -33.01 17.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.284 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.515 HG23 ' O ' ' A' ' 98' ' ' VAL . 22.9 p -84.76 -21.69 29.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.215 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 19.9 t-80 -87.63 -51.62 5.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.815 0.34 . . . . 0.0 110.96 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -80.54 -29.76 37.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.093 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -117.11 147.27 39.92 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.924 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.48 60.58 2.07 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.514 2.143 . . . . 0.0 112.288 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 59.12 67.56 0.9 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.966 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -90.84 146.79 34.6 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.744 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.408 ' O ' ' HB2' ' A' ' 78' ' ' PHE . 36.0 Cg_exo -60.7 169.17 5.89 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.505 2.137 . . . . 0.0 112.314 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.565 ' HB2' HG22 ' A' ' 80' ' ' VAL . 2.9 p90 -162.2 134.63 5.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.877 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.955 HD12 HG11 ' A' ' 152' ' ' VAL . 8.5 tt -119.93 154.53 34.3 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.997 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.596 ' N ' HD23 ' A' ' 111' ' ' LEU . 2.9 mm? -100.69 137.3 39.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.685 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 1.019 HG13 HG21 ' A' ' 168' ' ' VAL . 49.9 t -120.76 148.02 24.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.989 0.423 . . . . 0.0 111.373 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 157' ' ' CYS . . . -130.09 107.74 0.8 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.765 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.491 HG22 ' CB ' ' A' ' 157' ' ' CYS . 0.0 OUTLIER -125.01 -41.14 2.11 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.909 0.385 . . . . 0.0 110.595 -179.106 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.736 ' HB3' HG22 ' A' ' 84' ' ' VAL . 2.1 tt0 -78.28 1.96 19.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.127 179.332 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.407 ' O ' ' CG ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -46.55 -26.23 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.094 0 CA-C-O 120.775 0.322 . . . . 0.0 111.562 179.929 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -75.52 -25.88 57.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.492 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.665 HD22 HE21 ' A' ' 116' ' ' GLN . 3.9 mp -83.95 -25.61 29.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.124 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.474 ' HB3' HG21 ' A' ' 84' ' ' VAL . 5.8 ppt_? -50.36 -25.52 3.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.978 0.418 . . . . 0.0 110.629 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -87.79 -25.82 23.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.574 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -61.33 112.19 5.5 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.767 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.418 ' O ' HG22 ' A' ' 126' ' ' ILE . 40.0 Cg_endo -67.92 -6.27 16.59 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.513 2.142 . . . . 0.0 113.114 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -77.39 -68.49 0.61 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.024 0.44 . . . . 0.0 109.929 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.74 HG21 HG11 ' A' ' 85' ' ' VAL . 4.8 m -56.71 -35.41 68.49 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.31 0.576 . . . . 0.0 109.556 179.117 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.721 HD11 ' HG3' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -57.53 -44.04 84.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.55 179.231 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' A' ' 123' ' ' PRO . 4.2 mm-40 -55.69 -36.85 67.61 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.469 179.099 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.426 ' HB2' ' O ' ' A' ' 125' ' ' THR . 0.0 OUTLIER -64.04 -31.3 72.44 Favored 'General case' 0 CA--C 1.518 -0.25 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.554 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.757 HD22 ' N ' ' A' ' 86' ' ' SER . 7.6 mt -74.0 -42.06 60.95 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.499 ' HA ' ' HB3' ' A' ' 134' ' ' GLN . . . -47.21 -28.97 2.09 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.956 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 31.4 mmtt -56.54 -34.12 66.75 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.753 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.412 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 1.7 m-80 -124.36 -31.33 3.3 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.582 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.508 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 0.0 OUTLIER -137.42 -75.6 0.41 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 121.037 -0.265 . . . . 0.0 111.306 -179.009 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.508 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 3.0 pt20 111.53 -45.21 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.607 1.163 . . . . 0.0 111.016 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.5 mttp -69.81 111.06 7.8 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.91 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.91 ' C ' HD13 ' A' ' 137' ' ' ILE . 69.9 Cg_endo -72.43 -169.89 0.52 Allowed 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.353 2.036 . . . . 0.0 111.218 178.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.91 HD13 ' C ' ' A' ' 136' ' ' PRO . 1.1 mm -114.03 97.03 5.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.904 0.383 . . . . 0.0 110.99 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.428 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 3.0 p -67.3 155.63 90.27 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.943 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.463 ' HA ' ' CE2' ' A' ' 154' ' ' TYR . 10.2 Cg_endo -51.66 -38.68 66.34 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.747 2.298 . . . . 0.0 112.098 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.422 ' HG3' ' N ' ' A' ' 141' ' ' THR . 0.0 OUTLIER -64.73 -25.96 68.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.664 179.69 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.422 ' N ' ' HG3' ' A' ' 140' ' ' GLU . 45.5 m -71.82 -47.4 53.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.787 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.492 ' O ' ' HB2' ' A' ' 146' ' ' ALA . . . -55.21 -39.2 69.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.877 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -68.04 -41.96 81.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.818 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -53.25 -60.6 3.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.867 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.81 HD13 ' HG2' ' A' ' 94' ' ' LYS . 1.6 tt -66.91 -39.8 87.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.64 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.492 ' HB2' ' O ' ' A' ' 142' ' ' ALA . . . -48.94 -50.37 35.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.927 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 19.2 mtp180 -78.76 -24.14 44.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.704 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -49.62 -34.78 19.03 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.88 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.544 HD13 HG21 ' A' ' 98' ' ' VAL . 1.6 mt -121.5 21.78 10.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.893 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.1 mttp 47.84 57.5 5.95 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.059 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.534 ' HB1' ' O ' ' A' ' 110' ' ' PHE . . . -70.58 -82.69 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.214 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.955 HG11 HD12 ' A' ' 111' ' ' LEU . 72.9 t -161.81 -73.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.842 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 179.5 146.35 0.2 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.61 -178.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.463 ' CE2' ' HA ' ' A' ' 139' ' ' PRO . 65.0 t80 -112.79 103.69 11.7 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.305 179.396 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.601 HG12 ' H ' ' A' ' 156' ' ' GLU . 0.6 OUTLIER -102.99 -179.96 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.744 -179.788 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.601 ' H ' HG12 ' A' ' 155' ' ' VAL . 0.0 OUTLIER -89.6 151.3 21.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.921 0.391 . . . . 0.0 111.099 -179.797 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.491 ' CB ' HG22 ' A' ' 115' ' ' THR . 1.9 t -128.97 169.22 14.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.883 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.497 ' O ' ' HB2' ' A' ' 159' ' ' ALA . 2.2 t -106.99 151.46 25.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.203 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.938 ' O ' HD13 ' A' ' 160' ' ' LEU . . . 172.68 -33.96 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.77 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.938 HD13 ' O ' ' A' ' 159' ' ' ALA . 0.2 OUTLIER -131.09 -44.35 1.04 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.7 179.753 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 9.7 t -100.08 -21.69 15.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.091 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.437 ' HA ' ' CB ' ' A' ' 158' ' ' SER . 1.9 tt0 72.89 77.7 0.14 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.955 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.458 ' HE3' ' CB ' ' A' ' 156' ' ' GLU . 0.0 OUTLIER -97.35 10.44 39.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.569 -179.948 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.406 ' O ' ' CB ' ' A' ' 165' ' ' LEU . . . 116.25 -50.85 0.76 Allowed Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.428 -0.892 . . . . 0.0 113.336 179.465 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.566 HD21 ' HA ' ' A' ' 19' ' ' LEU . 0.2 OUTLIER 79.54 -56.6 0.4 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.8 0.333 . . . . 0.0 110.8 -179.433 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -56.8 -21.32 27.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.791 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.409 ' OD1' HG11 ' A' ' 155' ' ' VAL . 0.6 OUTLIER -55.32 -72.18 0.07 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.014 179.889 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 1.019 HG21 HG13 ' A' ' 113' ' ' VAL . 29.0 m -57.9 -40.79 77.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.036 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.737 ' CD1' HD22 ' A' ' 19' ' ' LEU . 1.4 t80 -63.58 -34.67 78.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.734 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.41 ' HA ' ' CG1' ' A' ' 173' ' ' ILE . 13.2 m-20 -74.64 -24.89 58.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.659 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.517 ' CG ' HD11 ' A' ' 111' ' ' LEU . 5.1 tp10 -79.41 -33.41 42.69 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.59 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.582 ' N ' HD13 ' A' ' 111' ' ' LEU . . . -73.23 -35.25 66.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.685 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.537 HD12 HD12 ' A' ' 177' ' ' LEU . 1.4 pp -82.78 -32.51 9.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.891 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.807 HD13 ' CB ' ' B' ' 505' ' ' LEU . 13.6 tp -54.68 -47.34 73.75 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.211 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -47.5 -26.89 1.54 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.113 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.659 ' HB3' ' CG2' ' A' ' 4' ' ' ILE . . . -93.9 -37.12 11.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.173 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.796 ' CD1' HG21 ' B' ' 510' ' ' ILE . 43.3 mt -68.71 -24.2 64.46 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.663 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.416 ' HG3' ' N ' ' B' ' 507' ' ' ALA . 1.6 tm-20 -160.52 128.74 2.89 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.684 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.69 106.9 0.19 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.44 2.093 . . . . 0.0 112.333 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.19 176.48 9.89 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.557 2.171 . . . . 0.0 112.248 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -139.79 141.89 29.26 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.966 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.35 -165.04 0.29 Allowed 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.718 2.279 . . . . 0.0 112.227 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.08 173.87 1.01 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.018 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.289 -0.862 . . . . 0.0 110.882 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.153 0 N-CA-C 112.421 -0.272 . . . . 0.0 112.421 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 503' ' ' SER . . . . . 0.415 ' HB2' ' HA ' ' B' ' 511' ' ' SER . 0.5 OUTLIER -87.4 -80.66 0.25 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.809 0.338 . . . . 0.0 110.908 179.943 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 504' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' B' ' 509' ' ' ASP . . . 102.6 113.09 3.72 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.541 -0.838 . . . . 0.0 111.941 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 505' ' ' LEU . . . . . 0.807 ' CB ' HD13 ' A' ' 174' ' ' LEU . 0.1 OUTLIER -139.03 -42.28 0.47 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 121.053 -0.259 . . . . 0.0 111.681 -179.195 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 506' ' ' SER . . . . . 0.435 ' CB ' ' O ' ' B' ' 505' ' ' LEU . 0.4 OUTLIER 162.74 -44.98 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.668 0.27 . . . . 0.0 110.741 -179.678 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 507' ' ' ALA . . . . . 0.506 ' HB3' HG12 ' B' ' 510' ' ' ILE . . . -37.58 -35.23 0.12 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.627 0.727 . . . . 0.0 111.109 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 508' ' ' GLN . . . . . 0.493 ' O ' ' HB2' ' B' ' 509' ' ' ASP . 7.3 pt20 165.79 -37.94 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.555 -1.202 . . . . 0.0 108.634 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 509' ' ' ASP . . . . . 0.493 ' HB2' ' O ' ' B' ' 508' ' ' GLN . 13.7 t0 148.21 44.92 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 114.201 -1.363 . . . . 0.0 109.394 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 510' ' ' ILE . . . . . 0.87 HG23 HG23 ' A' ' 46' ' ' ILE . 19.9 mm -55.18 133.65 18.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.406 -179.624 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 511' ' ' SER . . . . . 0.48 ' HB3' HD11 ' B' ' 514' ' ' LEU . 30.2 t -109.59 134.82 51.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.836 179.559 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 512' ' ' GLN . . . . . 0.438 ' CB ' ' HD3' ' B' ' 513' ' ' PRO . 0.0 OUTLIER -99.47 -53.65 0.18 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.134 179.735 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 513' ' ' PRO . . . . . 0.438 ' HD3' ' CB ' ' B' ' 512' ' ' GLN . 91.0 Cg_endo -94.91 78.19 0.15 Allowed 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 123.152 2.568 . . . . 0.0 112.525 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 514' ' ' LEU . . . . . 0.939 HD13 ' CG1' ' A' ' 44' ' ' VAL . 4.7 mp -89.23 -89.88 0.14 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.227 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 515' ' ' GLN . . . . . 0.651 ' H ' HG22 ' A' ' 44' ' ' VAL . 6.4 mt-30 -93.4 47.31 1.24 Allowed 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 116.744 -0.207 . . . . 0.0 111.13 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 516' ' ' ASN . . . . . 0.546 ' HB3' ' O ' ' B' ' 515' ' ' GLN . 22.0 t-20 77.7 -38.23 0.26 Allowed 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 517' ' ' SER . . . . . 0.421 ' C ' HG12 ' A' ' 42' ' ' VAL . 0.5 OUTLIER 61.24 54.33 3.27 Favored 'General case' 0 C--O 1.232 0.15 0 O-C-N 122.24 -0.287 . . . . 0.0 111.452 179.554 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 518' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -163.54 92.73 0.72 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.894 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 519' ' ' ILE . . . . . 0.689 HD11 ' H ' ' A' ' 43' ' ' THR . 22.4 mm -71.16 -69.13 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.089 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -160.47 -170.44 2.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.94 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 521' ' ' THR . . . . . 0.454 ' O ' ' CZ ' ' A' ' 40' ' ' TYR . 13.8 t -77.32 -168.37 1.12 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.058 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 522' ' ' GLY . . . . . 0.468 ' HA2' ' CE1' ' A' ' 40' ' ' TYR . . . -121.41 -75.12 0.37 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.38 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 523' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 178.98 -88.21 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.555 0.217 . . . . 0.0 110.902 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 524' ' ' GLY . . . . . 0.506 ' HA3' HG21 ' A' ' 36' ' ' VAL . . . 46.77 -139.5 7.53 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.778 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 525' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -137.99 82.85 1.94 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.837 0.351 . . . . 0.0 110.784 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 526' ' ' SER . . . . . 0.465 ' CB ' ' HB3' ' A' ' 34' ' ' PRO . 6.5 m -72.17 95.75 1.7 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.757 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 527' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -145.96 142.42 17.78 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.016 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.21 105.29 2.0 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.671 2.248 . . . . 0.0 112.113 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 529' ' ' ARG . . . . . 0.471 ' HG3' HG11 ' A' ' 33' ' ' VAL . 2.3 mtt-85 -100.27 -55.38 2.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.307 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 530' ' ' HIS . . . . . 0.418 ' O ' ' CB ' ' B' ' 531' ' ' CYS . 0.0 OUTLIER -130.57 -38.12 1.34 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.486 -179.592 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 531' ' ' CYS . . . . . 0.418 ' CB ' ' O ' ' B' ' 530' ' ' HIS . 4.0 m 79.49 28.74 0.34 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.988 0.423 . . . . 0.0 110.604 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 532' ' ' TRP . . . . . 0.439 ' CH2' ' HG3' ' B' ' 537' ' ' ARG . 1.7 t-105 59.28 103.28 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.035 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . -114.55 -24.31 4.42 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.278 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 534' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -133.47 130.97 21.2 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.489 0.185 . . . . 0.0 110.597 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.49 -170.03 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.458 2.106 . . . . 0.0 112.504 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 68.22 120.86 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.004 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 537' ' ' ARG . . . . . 0.439 ' HG3' ' CH2' ' B' ' 532' ' ' TRP . 0.0 OUTLIER -106.23 -179.32 3.91 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 121.599 0.714 . . . . 0.0 111.259 179.916 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 538' ' ' ILE . . . . . 0.433 HG12 ' HB2' ' B' ' 542' ' ' TYR . 1.2 tt -116.02 174.47 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 CA-C-N 114.594 -1.184 . . . . 0.0 109.891 179.578 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 539' ' ' ASP . . . . . 0.469 ' HB3' HD22 ' A' ' 70' ' ' LEU . 0.3 OUTLIER -69.8 162.3 28.14 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.482 179.851 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 540' ' ' GLU . . . . . 0.427 ' CB ' ' OG1' ' A' ' 58' ' ' THR . 2.4 mt-10 -40.38 -49.08 2.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.841 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 541' ' ' LEU . . . . . . . . . . . . . 1.1 tt -42.28 -67.91 0.23 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.797 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 542' ' ' TYR . . . . . 0.433 ' HB2' HG12 ' B' ' 538' ' ' ILE . 59.2 m-85 -84.57 9.62 13.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.981 -179.17 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 543' ' ' LEU . . . . . 0.421 ' HB2' ' HA ' ' B' ' 540' ' ' GLU . 16.5 tp -44.92 -28.47 0.67 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.834 0.35 . . . . 0.0 111.283 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . -72.52 77.91 0.74 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.548 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 545' ' ' ASN . . . . . 0.461 ' HB2' HG13 ' A' ' 33' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.975 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.431 ' HB3' ' N ' ' A' ' 49' ' ' GLU . 2.6 ppp? . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.828 0.347 . . . . 0.0 111.264 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.423 ' CG ' HD11 ' B' ' 510' ' ' ILE . 0.2 OUTLIER -129.44 141.17 51.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.52 179.464 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.807 HG23 ' CE1' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -94.06 168.78 10.72 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.983 -179.815 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.551 ' HA ' ' HB1' ' A' ' 176' ' ' ALA . 2.3 pt -151.03 154.39 8.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.659 -179.118 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -121.03 110.38 16.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.397 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.463 ' SG ' HD23 ' A' ' 55' ' ' LEU . 40.1 m -91.61 107.4 19.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.004 0.43 . . . . 0.0 111.589 -179.388 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.452 HG22 ' CZ ' ' A' ' 56' ' ' PHE . 2.9 t -138.0 113.65 10.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.254 179.334 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.78 ' CG2' HG21 ' A' ' 14' ' ' VAL . 2.4 p -87.24 150.14 3.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.308 0.575 . . . . 0.0 111.436 -179.445 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.53 ' CG2' ' CE1' ' A' ' 78' ' ' PHE . 72.5 t -155.06 130.23 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.637 179.132 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.72 148.13 4.75 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.131 -1.033 . . . . 0.0 112.711 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -58.17 -42.18 85.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.893 0.378 . . . . 0.0 110.394 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.26 -149.94 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.701 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.614 ' C ' HG23 ' A' ' 14' ' ' VAL . . . -103.1 -55.86 2.33 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.274 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.958 HG22 ' HB3' ' A' ' 81' ' ' CYS . 3.5 t 84.13 -51.52 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.264 -0.425 . . . . 0.0 109.949 -178.481 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.676 ' C ' HD12 ' A' ' 19' ' ' LEU . . . 90.49 25.48 25.67 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.857 -0.687 . . . . 0.0 113.045 179.041 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.447 ' HE2' ' N ' ' A' ' 8' ' ' VAL . 0.7 OUTLIER -38.58 -43.2 0.85 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.11 0.481 . . . . 0.0 111.017 179.749 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.534 HG22 ' CG ' ' A' ' 38' ' ' ASP . 81.9 p -98.47 -60.98 1.44 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.278 178.791 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.48 ' HA ' ' HB ' ' A' ' 21' ' ' ILE . 29.7 t -46.51 -32.65 3.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.014 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.865 HD13 ' CE2' ' A' ' 169' ' ' PHE . 3.3 mt -45.68 -71.99 0.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -178.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.443 HD13 ' HA ' ' A' ' 20' ' ' LEU . 3.0 mm? -64.64 -23.67 67.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.951 -179.73 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.48 ' HB ' ' HA ' ' A' ' 18' ' ' CYS . 14.6 mm -61.05 -70.95 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.945 0.403 . . . . 0.0 110.486 179.4 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.528 ' HA ' ' HA ' ' A' ' 26' ' ' ASN . 2.4 t -51.76 -34.42 39.38 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.162 -179.075 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.509 ' CE2' ' HD3' ' A' ' 166' ' ' LYS . 27.5 t80 -55.93 -45.11 78.84 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.968 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.62 -64.42 1.05 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.543 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.431 ' OG1' HG23 ' A' ' 21' ' ' ILE . 79.9 p -66.27 -37.47 85.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.582 -179.416 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.528 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 35.2 t30 67.08 56.91 0.63 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.941 -179.15 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.0 mmtt -132.91 83.25 2.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.134 0.492 . . . . 0.0 110.961 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.468 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 40.5 t80 -92.35 -45.56 0.34 Allowed Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.082 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.468 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 62.6 Cg_endo -94.86 90.22 0.11 Allowed 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.955 2.436 . . . . 0.0 112.939 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.429 ' O ' ' CB ' ' B' ' 531' ' ' CYS . 0.4 OUTLIER -150.47 -89.2 0.07 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.627 0.251 . . . . 0.0 110.855 179.616 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -159.12 126.26 4.76 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.627 -0.261 . . . . 0.0 110.427 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.512 ' CG ' ' NH2' ' B' ' 537' ' ' ARG . 3.8 m-85 -111.55 121.87 46.31 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.194 0.521 . . . . 0.0 111.283 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.686 HG11 ' HG3' ' B' ' 529' ' ' ARG . 0.0 OUTLIER -165.42 -64.55 0.01 OUTLIER Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.433 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.478 ' CD ' HG23 ' A' ' 33' ' ' VAL . 50.5 Cg_endo -69.9 58.37 1.62 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.385 2.057 . . . . 0.0 112.428 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.2 t -87.64 10.47 17.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.737 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.698 HG13 HD23 ' A' ' 61' ' ' LEU . 3.3 m -76.0 -30.03 20.33 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-O 120.865 0.364 . . . . 0.0 110.84 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.409 ' O ' ' CG ' ' A' ' 40' ' ' TYR . 0.2 OUTLIER -50.87 -25.01 4.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.017 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.534 ' CG ' HG22 ' A' ' 17' ' ' THR . 20.8 t0 -50.34 -28.29 7.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.971 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -88.99 14.52 10.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.165 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.473 ' CZ ' ' CG1' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -71.59 -169.99 0.49 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.787 0.327 . . . . 0.0 110.911 179.809 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.402 ' O ' HG12 ' B' ' 519' ' ' ILE . . . -112.16 119.92 40.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.316 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.473 ' CG1' ' CZ ' ' A' ' 40' ' ' TYR . 2.5 m -122.71 121.71 64.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.023 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.4 t -104.69 128.79 52.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.9 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.986 HG12 ' CG2' ' A' ' 52' ' ' THR . 1.0 OUTLIER -164.54 -177.45 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.871 179.895 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.611 ' H ' HG22 ' A' ' 44' ' ' VAL . 5.9 tpt -101.4 96.13 6.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.012 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.675 HG22 ' O ' ' A' ' 46' ' ' ILE . 1.6 mm -74.86 86.9 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 120.841 0.353 . . . . 0.0 110.219 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.45 ' HA3' ' HA ' ' B' ' 510' ' ' ILE . . . 33.71 -87.72 0.01 OUTLIER Glycine 0 CA--C 1.523 0.549 0 CA-C-N 115.676 -0.693 . . . . 0.0 114.327 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . -37.72 -79.17 0.04 OUTLIER Glycine 0 C--N 1.333 0.392 0 N-CA-C 113.899 0.319 . . . . 0.0 113.899 -179.292 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.482 ' N ' ' HE1' ' A' ' 45' ' ' MET . 2.7 mt-10 -140.52 156.34 69.42 Favored Pre-proline 0 C--N 1.332 -0.162 0 CA-C-O 120.808 0.337 . . . . 0.0 111.621 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -43.2 101.01 0.04 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 123.137 2.558 . . . . 0.0 112.838 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.807 ' CE1' HG23 ' A' ' 3' ' ' THR . 17.8 t80 -172.68 153.62 2.81 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.368 179.221 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.986 ' CG2' HG12 ' A' ' 44' ' ' VAL . 0.8 OUTLIER -136.88 154.11 50.57 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.961 179.53 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.643 ' N ' HD13 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -99.56 166.57 11.08 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.984 179.772 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 56' ' ' PHE . . . -115.17 87.56 0.44 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.42 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.542 ' H ' HD12 ' A' ' 55' ' ' LEU . 0.5 OUTLIER -60.34 82.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.781 0.324 . . . . 0.0 110.538 179.888 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.464 ' CG ' ' O ' ' A' ' 56' ' ' PHE . 37.4 p90 -84.36 105.5 15.24 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.571 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 56.6 p30 -98.19 -177.88 3.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.761 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.96 HG21 HD22 ' A' ' 70' ' ' LEU . 73.6 p -94.39 161.54 14.19 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.816 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.418 ' CA ' ' O ' ' B' ' 542' ' ' TYR . . . -170.84 179.84 3.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.172 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.565 ' H ' HD22 ' A' ' 61' ' ' LEU . . . -150.97 34.66 0.93 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.463 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.698 HD23 HG13 ' A' ' 36' ' ' VAL . 2.0 mm? -95.71 -173.18 2.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.863 0.363 . . . . 0.0 110.917 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -51.02 -25.54 4.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.734 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.497 ' HB2' HG11 ' A' ' 36' ' ' VAL . 0.2 OUTLIER -53.95 -54.79 34.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.798 179.866 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.411 ' CD2' ' HB3' ' A' ' 63' ' ' ASP . 4.4 m-85 -132.53 152.07 51.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.774 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -85.88 -68.27 0.75 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.205 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.8 -52.27 4.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.224 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.761 HD23 ' O ' ' A' ' 67' ' ' LEU . 7.2 tt 55.42 98.61 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.484 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.0 mmm180 -132.88 58.93 39.26 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.128 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.494 ' HD2' HD23 ' A' ' 70' ' ' LEU . 83.5 Cg_endo -83.68 -21.72 4.04 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.827 2.351 . . . . 0.0 112.172 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.96 HD22 HG21 ' A' ' 58' ' ' THR . 1.1 pt? -85.69 1.32 49.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.721 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 46.3 t -70.59 -71.16 0.26 Allowed 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.728 0.299 . . . . 0.0 111.065 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -121.85 72.55 32.76 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.861 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.411 ' HG3' ' CZ ' ' A' ' 78' ' ' PHE . 98.4 Cg_endo -78.71 140.87 16.85 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.713 2.275 . . . . 0.0 112.457 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.8 tp60 -102.11 10.39 39.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.349 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 13.6 t -59.55 -173.75 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.866 0.365 . . . . 0.0 111.055 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -136.22 7.83 3.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.503 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.501 ' CG1' ' HB3' ' A' ' 175' ' ' ALA . 64.0 t -151.14 101.15 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 CA-C-O 120.788 0.328 . . . . 0.0 111.249 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.53 ' CE1' ' CG2' ' A' ' 9' ' ' VAL . 0.1 OUTLIER -102.08 -177.85 3.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.645 179.785 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.636 HD13 ' HB3' ' A' ' 111' ' ' LEU . 21.7 tp -154.13 114.59 3.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.831 0.348 . . . . 0.0 111.633 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.609 HG23 HD13 ' A' ' 112' ' ' LEU . 2.9 m -94.61 156.22 3.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.486 179.263 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.958 ' HB3' HG22 ' A' ' 14' ' ' VAL . 22.3 p -128.98 168.93 15.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.237 0.541 . . . . 0.0 112.178 -179.203 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.649 ' HZ ' ' HB1' ' A' ' 142' ' ' ALA . 46.9 p90 179.27 123.51 0.06 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.926 179.273 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 98.8 p -93.61 146.27 23.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.881 0.372 . . . . 0.0 111.44 -179.497 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.925 HG11 ' HG2' ' A' ' 120' ' ' ARG . 58.1 t -51.3 -73.95 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.366 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.445 ' O ' HG23 ' A' ' 85' ' ' VAL . 8.1 m -43.27 105.76 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 120.756 0.313 . . . . 0.0 110.968 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.443 ' N ' HD22 ' A' ' 129' ' ' LEU . 87.6 p -151.33 138.65 12.19 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.62 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.407 ' O ' ' CB ' ' A' ' 88' ' ' SER . 80.3 Cg_endo -91.65 53.93 0.8 Allowed 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.305 2.67 . . . . 0.0 112.026 179.475 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.461 ' CA ' ' HG3' ' A' ' 133' ' ' LYS . 0.1 OUTLIER 81.42 30.33 0.14 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.84 -179.611 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.533 ' O ' HG23 ' A' ' 93' ' ' VAL . 11.1 t -88.18 -24.42 23.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.697 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.631 ' CZ ' HG21 ' A' ' 137' ' ' ILE . 0.4 OUTLIER -50.89 -64.41 0.82 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.871 179.901 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -51.83 -37.58 52.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.936 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.413 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 3.3 m120 -67.96 -64.2 0.91 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.917 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 89' ' ' SER . 50.7 t -49.26 -46.7 18.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.368 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.791 ' HB2' HD11 ' A' ' 145' ' ' LEU . 4.5 ttpt -54.19 -59.08 5.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.276 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.415 ' O ' ' HG2' ' A' ' 99' ' ' PRO . 7.1 mt-10 -83.46 9.9 10.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.869 -179.563 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.413 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 13.7 tttt -116.86 -33.09 4.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.724 0.297 . . . . 0.0 111.067 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.558 ' O ' HG22 ' A' ' 101' ' ' ILE . 0.0 OUTLIER -94.35 -45.31 7.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.459 -179.658 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 94' ' ' LYS . 43.8 t -53.09 -44.44 97.13 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 -179.627 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.493 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 2.7 Cg_exo -76.01 -24.48 11.24 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.609 2.206 . . . . 0.0 112.641 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -88.73 -49.69 6.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.016 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.558 HG22 ' O ' ' A' ' 97' ' ' TRP . 8.9 tt -51.16 -24.55 3.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.157 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.416 HG23 HG23 ' A' ' 101' ' ' ILE . 59.3 p -97.22 -28.72 13.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.006 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 54.1 t60 -72.82 -69.29 0.42 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.926 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -62.88 -42.15 99.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.733 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 17.0 m -111.03 148.41 38.58 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.739 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -49.29 167.7 0.15 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.502 2.135 . . . . 0.0 112.21 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.6 tmtt? -83.01 54.98 2.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.799 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.4 p -76.88 156.81 82.33 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.031 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -60.45 166.52 9.43 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.653 2.235 . . . . 0.0 112.238 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.568 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 9.1 p90 -163.11 142.44 8.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.925 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.938 HD12 HG11 ' A' ' 152' ' ' VAL . 0.9 OUTLIER -108.56 159.7 16.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.983 -179.721 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.609 HD13 HG23 ' A' ' 80' ' ' VAL . 3.1 mm? -106.15 128.03 53.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.659 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.862 ' HA ' HG11 ' A' ' 168' ' ' VAL . 43.8 t -89.96 128.45 41.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.134 0.492 . . . . 0.0 111.555 -179.668 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.516 ' HA2' ' CE2' ' A' ' 154' ' ' TYR . . . -112.36 103.62 1.49 Allowed Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.253 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.666 HG23 HG12 ' A' ' 113' ' ' VAL . 0.4 OUTLIER -144.1 -153.65 0.48 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.826 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.509 ' HA ' HD23 ' A' ' 119' ' ' LEU . 0.4 OUTLIER 39.39 29.95 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.065 0.459 . . . . 0.0 111.329 179.333 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.534 HD13 ' C ' ' A' ' 115' ' ' THR . 0.0 OUTLIER -74.37 -4.3 5.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.711 179.376 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -100.28 -22.01 15.26 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.11 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.594 ' N ' HD22 ' A' ' 119' ' ' LEU . 2.1 mm? -72.85 -29.65 63.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.097 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.925 ' HG2' HG11 ' A' ' 84' ' ' VAL . 25.7 mtp180 -47.32 -35.5 8.12 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.917 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -76.32 -42.55 44.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.794 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -46.93 100.52 0.24 Allowed Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.89 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.442 ' HA ' ' CG2' ' A' ' 126' ' ' ILE . 10.5 Cg_exo -71.57 -3.76 13.7 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.737 2.291 . . . . 0.0 112.675 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.3 t -79.45 -64.11 1.26 Allowed 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.414 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 11.0 m -58.92 -40.14 83.68 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 178.761 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.48 HD13 ' O ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -53.78 -45.73 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.777 179.217 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.474 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 3.2 mm-40 -57.54 -36.08 71.15 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.068 179.385 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 125' ' ' THR . 1.4 mptt -64.75 -30.66 71.67 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.144 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.452 ' CD1' ' HA ' ' A' ' 126' ' ' ILE . 5.3 mt -74.16 -40.8 62.34 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.09 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 127' ' ' GLU . . . -42.91 -36.97 1.69 Allowed 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.438 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.3 mmtp -50.6 -29.06 9.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.974 0.416 . . . . 0.0 110.364 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.407 ' OD1' ' HB2' ' A' ' 87' ' ' PRO . 2.3 m120 -123.88 -31.09 3.45 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.732 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.516 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 4.0 mmpt? -148.86 -90.81 0.08 Allowed 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.516 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 1.2 pt20 122.24 -25.18 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.713 1.205 . . . . 0.0 110.314 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 4.5 ptmm? -69.21 110.71 6.7 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.716 -179.224 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.405 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 88.2 Cg_endo -82.01 127.69 5.5 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.574 2.182 . . . . 0.0 111.302 179.084 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.742 ' N ' HD13 ' A' ' 137' ' ' ILE . 0.9 OUTLIER -58.65 96.75 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.916 0.389 . . . . 0.0 110.792 -179.423 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.461 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 7.2 p -70.24 155.96 92.62 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.042 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.461 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 10.3 Cg_endo -51.23 -24.37 15.16 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.653 2.235 . . . . 0.0 112.175 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -79.79 -46.36 17.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.551 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 6.8 m -56.2 -45.3 79.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.669 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.649 ' HB1' ' HZ ' ' A' ' 82' ' ' PHE . . . -51.76 -51.49 55.82 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.847 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -53.97 -39.42 65.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.744 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.26 -55.81 24.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.701 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.791 HD11 ' HB2' ' A' ' 94' ' ' LYS . 1.6 tt -69.43 -36.96 77.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.572 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -54.42 -71.9 0.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.051 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.443 ' CZ ' ' HE3' ' A' ' 183' ' ' LYS . 10.0 mtt180 -61.35 -23.16 65.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.098 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -49.98 -37.16 31.18 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.855 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.484 ' CD1' HG11 ' A' ' 98' ' ' VAL . 0.6 OUTLIER -112.77 20.59 16.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.087 179.828 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.3 mttt 47.89 49.09 17.3 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.144 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.572 ' O ' HG23 ' A' ' 152' ' ' VAL . . . -65.25 -81.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.956 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.938 HG11 HD12 ' A' ' 111' ' ' LEU . 49.1 t -161.56 -75.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.732 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.449 ' O ' HD21 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -175.75 131.18 0.26 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.923 -178.822 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.516 ' CE2' ' HA2' ' A' ' 114' ' ' GLY . 11.1 t80 -104.47 103.71 13.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.15 179.429 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.56 ' HB ' HG22 ' A' ' 168' ' ' VAL . 1.4 t -102.16 164.64 3.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.141 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.4 ' H ' HG12 ' A' ' 155' ' ' VAL . 76.9 tt0 -89.86 135.78 33.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.82 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.424 ' HA ' ' HB3' ' A' ' 163' ' ' LYS . 20.4 p -178.59 129.51 0.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.922 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.651 ' HB3' HG22 ' A' ' 161' ' ' THR . 0.1 OUTLIER -125.74 140.4 52.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.172 -179.906 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.52 ' HB2' HD22 ' A' ' 165' ' ' LEU . . . -84.19 -44.32 14.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.072 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -47.77 -34.97 9.21 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.763 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.651 HG22 ' HB3' ' A' ' 158' ' ' SER . 10.6 t -116.02 -15.87 11.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.118 179.733 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.417 ' CA ' ' O ' ' A' ' 158' ' ' SER . 1.5 tt0 70.33 66.8 0.21 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.812 0.339 . . . . 0.0 110.68 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.424 ' HB3' ' HA ' ' A' ' 157' ' ' CYS . 1.0 OUTLIER -93.81 22.79 5.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.254 -179.686 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 102.36 41.98 2.28 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.48 -0.867 . . . . 0.0 113.111 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.849 HD23 ' HA ' ' A' ' 19' ' ' LEU . 1.7 tp -50.4 -25.07 3.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.864 0.364 . . . . 0.0 110.691 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.509 ' HD3' ' CE2' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -68.54 -26.08 65.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.842 179.514 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -58.33 -72.29 0.1 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.827 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.862 HG11 ' HA ' ' A' ' 113' ' ' VAL . 91.3 t -52.44 -43.63 41.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.967 0.413 . . . . 0.0 110.461 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.865 ' CE2' HD13 ' A' ' 19' ' ' LEU . 0.2 OUTLIER -62.77 -33.66 75.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.277 179.681 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.532 ' OD1' HD11 ' A' ' 173' ' ' ILE . 27.1 t0 -69.82 -25.61 63.84 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.599 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.607 ' CB ' HD11 ' A' ' 111' ' ' LEU . 4.4 mm-40 -78.75 -29.15 44.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.132 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.568 ' N ' HD13 ' A' ' 111' ' ' LEU . . . -75.1 -43.51 52.53 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.888 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.532 HD11 ' OD1' ' A' ' 170' ' ' ASP . 1.6 pp -68.75 -36.11 72.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.838 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.625 HD22 ' HB3' ' B' ' 505' ' ' LEU . 26.0 tp -55.13 -42.95 73.68 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.776 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.501 ' HB3' ' CG1' ' A' ' 77' ' ' VAL . . . -48.17 -27.01 2.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.775 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.551 ' HB1' ' HA ' ' A' ' 4' ' ' ILE . . . -86.7 -43.75 12.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.845 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.769 HD13 ' HB ' ' B' ' 510' ' ' ILE . 56.3 mt -68.73 -26.94 65.51 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.957 0.408 . . . . 0.0 110.255 179.462 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.488 ' HB2' ' HB2' ' B' ' 507' ' ' ALA . 0.1 OUTLIER -174.14 92.6 0.33 Allowed Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.721 179.788 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 179' ' ' PRO . . . . . 0.439 ' HA ' ' HD2' ' A' ' 180' ' ' PRO . 86.4 Cg_exo -47.74 106.04 0.1 OUTLIER 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.645 2.23 . . . . 0.0 112.428 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 180' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 179' ' ' PRO . 41.7 Cg_endo -67.22 171.99 10.69 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.47 2.114 . . . . 0.0 112.205 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -110.19 137.79 20.67 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.979 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -79.42 -165.17 0.32 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.576 2.184 . . . . 0.0 112.272 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.443 ' HE3' ' CZ ' ' A' ' 147' ' ' ARG . 0.0 OUTLIER -135.97 97.33 3.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.925 179.992 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.166 -0.921 . . . . 0.0 110.921 -179.985 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 503' ' ' SER . . . . . . . . . . . . . 3.3 m -90.41 -75.97 0.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.744 0.307 . . . . 0.0 110.918 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 504' ' ' GLY . . . . . 0.836 ' O ' HD12 ' B' ' 505' ' ' LEU . . . 144.16 -116.84 0.99 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.368 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 505' ' ' LEU . . . . . 0.836 HD12 ' O ' ' B' ' 504' ' ' GLY . 0.1 OUTLIER 64.99 -70.6 0.09 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.786 0.327 . . . . 0.0 111.204 179.823 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 506' ' ' SER . . . . . 0.42 ' N ' ' O ' ' B' ' 504' ' ' GLY . 0.1 OUTLIER -171.92 -159.77 0.15 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.546 -179.973 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 507' ' ' ALA . . . . . 0.488 ' HB2' ' HB2' ' A' ' 178' ' ' GLU . . . 62.97 -95.71 0.05 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.469 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 508' ' ' GLN . . . . . 0.462 ' O ' ' CB ' ' B' ' 509' ' ' ASP . 28.6 mt-30 -137.28 4.04 2.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.875 179.548 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 509' ' ' ASP . . . . . 0.462 ' CB ' ' O ' ' B' ' 508' ' ' GLN . 0.1 OUTLIER 92.36 29.7 0.01 OUTLIER 'General case' 0 C--N 1.345 0.406 0 CA-C-O 121.461 0.648 . . . . 0.0 109.864 -179.127 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 510' ' ' ILE . . . . . 0.769 ' HB ' HD13 ' A' ' 177' ' ' LEU . 43.0 mt -61.58 149.48 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.393 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 511' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.23 146.62 33.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.291 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 512' ' ' GLN . . . . . 0.529 ' HA ' HD13 ' A' ' 173' ' ' ILE . 1.5 pm0 -57.79 -176.2 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.35 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 513' ' ' PRO . . . . . 0.576 ' HG3' HD21 ' A' ' 53' ' ' LEU . 50.9 Cg_exo -55.52 82.37 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.492 2.128 . . . . 0.0 111.694 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 514' ' ' LEU . . . . . 0.451 ' N ' ' O ' ' B' ' 512' ' ' GLN . 1.8 mp -46.38 171.96 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.003 -179.164 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 515' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -94.26 -168.65 1.89 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.766 179.376 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 66.22 10.49 7.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.589 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 517' ' ' SER . . . . . 0.445 ' CB ' ' HB ' ' A' ' 44' ' ' VAL . 72.5 p -133.47 80.77 1.89 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.912 0.387 . . . . 0.0 111.02 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 518' ' ' PHE . . . . . 0.429 ' HA ' HG12 ' A' ' 42' ' ' VAL . 22.6 m-85 -140.45 91.69 2.46 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.897 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 519' ' ' ILE . . . . . 0.47 ' N ' HD13 ' B' ' 519' ' ' ILE . 3.0 mm -84.97 138.12 19.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.046 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -41.89 -88.86 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.409 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 521' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 47.86 -161.59 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.873 0.368 . . . . 0.0 111.009 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 522' ' ' GLY . . . . . . . . . . . . . . . 55.24 170.33 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.47 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 523' ' ' HIS . . . . . . . . . . . . . 38.1 t-80 -156.6 -77.45 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.787 0.327 . . . . 0.0 110.876 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 524' ' ' GLY . . . . . 0.627 ' HA3' HG21 ' A' ' 36' ' ' VAL . . . 46.68 -144.62 4.33 Favored Glycine 0 N--CA 1.454 -0.164 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.722 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 525' ' ' ASP . . . . . 0.693 ' HB2' HD12 ' A' ' 61' ' ' LEU . 30.4 m-20 -119.24 81.47 1.72 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.826 0.346 . . . . 0.0 110.842 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 526' ' ' SER . . . . . 0.448 ' CA ' ' HB3' ' A' ' 34' ' ' PRO . 0.7 OUTLIER -88.43 96.25 10.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.785 179.968 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 527' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -162.08 141.28 7.28 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.795 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -57.52 97.61 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.677 2.251 . . . . 0.0 112.072 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 529' ' ' ARG . . . . . 0.686 ' HG3' HG11 ' A' ' 33' ' ' VAL . 10.4 mtp180 -100.23 -54.74 2.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.099 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 530' ' ' HIS . . . . . 0.485 ' CE1' ' HB3' ' B' ' 545' ' ' ASN . 6.2 p80 -165.47 97.45 0.68 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.831 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 531' ' ' CYS . . . . . 0.429 ' CB ' ' O ' ' A' ' 30' ' ' SER . 18.8 p -53.49 -171.65 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.068 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 532' ' ' TRP . . . . . . . . . . . . . 87.4 t90 -49.06 103.78 0.05 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.013 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . -116.39 -57.47 0.32 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.496 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 534' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -68.38 155.97 91.38 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 120.705 0.288 . . . . 0.0 110.872 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -63.34 -19.52 68.39 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.633 2.222 . . . . 0.0 112.485 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -151.66 139.01 19.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.929 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 537' ' ' ARG . . . . . 0.516 ' HD3' ' HB2' ' A' ' 13' ' ' ALA . 0.1 OUTLIER -48.07 152.23 0.85 Allowed 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.114 179.921 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 538' ' ' ILE . . . . . 0.418 ' CG2' ' HA ' ' B' ' 543' ' ' LEU . 5.6 tp -63.42 140.77 19.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.139 179.612 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 539' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -44.61 147.39 0.61 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.733 0.301 . . . . 0.0 111.162 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 540' ' ' GLU . . . . . 0.533 ' OE1' HD13 ' B' ' 543' ' ' LEU . 49.8 mm-40 -60.14 -15.86 27.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.613 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 541' ' ' LEU . . . . . 0.813 ' HA ' HD11 ' A' ' 70' ' ' LEU . 2.9 mm? -41.31 -59.59 1.5 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.99 0.424 . . . . 0.0 110.897 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 542' ' ' TYR . . . . . 0.453 ' CD1' ' HB3' ' B' ' 541' ' ' LEU . 0.1 OUTLIER -105.84 -53.63 2.61 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.578 179.41 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 543' ' ' LEU . . . . . 0.786 HD23 ' O ' ' A' ' 58' ' ' THR . 6.8 tp 57.01 31.94 20.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.936 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . -119.13 83.6 0.35 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.468 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 545' ' ' ASN . . . . . 0.486 ' HB2' HG13 ' A' ' 33' ' ' VAL . 3.6 m120 . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.211 -0.9 . . . . 0.0 110.851 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.796 0.331 . . . . 0.0 111.255 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.81 144.4 47.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.388 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.645 HG23 ' CE1' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -93.86 176.34 6.38 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.925 -179.948 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 1.012 HG13 HD13 ' A' ' 53' ' ' LEU . 4.0 pt -152.27 146.36 15.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.009 0.433 . . . . 0.0 112.115 -178.723 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.608 ' O ' HG21 ' A' ' 75' ' ' THR . 13.1 tptp -134.44 95.73 3.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.399 179.429 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -110.08 119.74 40.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.979 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.417 ' HA ' ' HB3' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -104.79 145.55 13.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.14 0.495 . . . . 0.0 111.301 179.772 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.851 HG11 ' HE3' ' A' ' 16' ' ' LYS . 2.6 p -91.63 113.55 27.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.268 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.52 HG21 ' CD2' ' A' ' 78' ' ' PHE . 30.1 m -134.9 150.33 29.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.081 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 127.93 -144.46 15.22 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.508 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -103.25 -21.34 13.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.72 0.295 . . . . 0.0 110.956 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -105.02 156.33 16.87 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.611 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.47 4.78 22.93 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.811 HG21 HD23 ' A' ' 79' ' ' LEU . 1.9 m 40.99 31.07 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 120.985 0.422 . . . . 0.0 111.37 -179.305 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.435 ' O ' ' CG ' ' A' ' 19' ' ' LEU . . . 56.96 24.93 52.22 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.407 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.851 ' HE3' HG11 ' A' ' 8' ' ' VAL . 9.6 ptmt -38.31 -45.43 0.99 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.809 0.338 . . . . 0.0 111.628 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.929 HG22 HG13 ' A' ' 21' ' ' ILE . 0.2 OUTLIER -97.46 -57.43 2.25 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.49 179.341 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.522 ' HB3' ' HB1' ' A' ' 159' ' ' ALA . 46.8 m -47.65 -32.06 5.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.245 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.89 ' CD2' HD22 ' A' ' 165' ' ' LEU . 9.6 mt -47.35 -71.32 0.07 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.026 0.441 . . . . 0.0 111.079 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.629 ' H ' HD22 ' A' ' 20' ' ' LEU . 0.6 OUTLIER -87.08 -27.47 23.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.947 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.929 HG13 HG22 ' A' ' 17' ' ' THR . 46.8 mm -68.44 -52.96 31.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 179.051 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.447 ' CB ' ' O ' ' A' ' 18' ' ' CYS . 2.3 t -69.73 -37.61 76.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.519 179.665 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -51.87 -45.9 64.26 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.575 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.1 m -94.03 -48.58 6.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.566 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.441 ' N ' ' O ' ' A' ' 21' ' ' ILE . 1.3 p -96.4 -146.19 0.29 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.228 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.405 ' N ' ' OG1' ' A' ' 25' ' ' THR . 1.0 OUTLIER -163.2 34.64 0.09 Allowed 'General case' 0 C--O 1.232 0.139 0 O-C-N 122.341 -0.225 . . . . 0.0 111.365 -179.746 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.485 ' CG ' HG21 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -86.42 127.41 34.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.926 0.393 . . . . 0.0 111.067 -179.896 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.539 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . 89.0 t80 -164.04 -50.71 0.01 OUTLIER Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.035 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.539 ' HD3' ' HB3' ' A' ' 28' ' ' PHE . 88.1 Cg_endo -93.03 33.06 0.24 Allowed 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.171 1.914 . . . . 0.0 112.65 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.43 -84.8 0.58 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.772 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -159.04 147.59 18.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.697 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.454 ' C ' HG22 ' A' ' 33' ' ' VAL . 9.7 m-85 -126.02 124.04 39.8 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.675 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.558 HG23 ' HD3' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -165.17 -61.76 0.01 OUTLIER Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.112 -179.763 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.558 ' HD3' HG23 ' A' ' 33' ' ' VAL . 79.5 Cg_exo -46.36 -25.78 3.5 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.382 2.054 . . . . 0.0 112.329 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.5 t -40.54 -29.51 0.09 Allowed 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.893 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.893 HG23 ' HB3' ' A' ' 59' ' ' ALA . 12.0 p -51.95 -22.25 2.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.607 -0.269 . . . . 0.0 111.394 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.479 ' CD1' ' O ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -88.68 18.34 4.76 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.494 179.899 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.403 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 25.6 t0 -58.74 -18.02 27.94 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.223 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -86.57 13.56 8.31 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.546 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.466 ' CD1' ' N ' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -60.8 179.09 0.19 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.819 0.342 . . . . 0.0 110.946 179.91 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.423 ' O ' HG12 ' B' ' 519' ' ' ILE . . . -98.05 124.94 42.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.143 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.856 HG13 ' O ' ' B' ' 517' ' ' SER . 2.8 t -119.1 146.63 23.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.737 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.4 p -129.13 112.02 13.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.867 0.365 . . . . 0.0 111.566 -179.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 1.086 HG22 HG23 ' A' ' 52' ' ' THR . 4.1 m -153.1 -176.97 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.652 179.17 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.525 ' O ' HD13 ' B' ' 514' ' ' LEU . 4.4 tpt -100.65 95.94 7.01 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.658 -179.099 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.679 HG22 ' O ' ' A' ' 46' ' ' ILE . 1.2 mm -82.23 87.32 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-O 121.382 0.61 . . . . 0.0 109.913 178.598 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.403 ' HA3' ' HA ' ' B' ' 510' ' ' ILE . . . 46.23 -90.69 0.01 OUTLIER Glycine 0 CA--C 1.522 0.494 0 CA-C-N 115.488 -0.778 . . . . 0.0 113.647 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . -36.5 -96.39 0.01 OUTLIER Glycine 0 C--N 1.335 0.477 0 N-CA-C 113.997 0.359 . . . . 0.0 113.997 -179.076 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.47 ' N ' ' HE1' ' A' ' 45' ' ' MET . 1.6 pt-20 -125.66 158.85 63.54 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 120.539 0.209 . . . . 0.0 110.555 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.402 ' HD2' ' HB2' ' A' ' 49' ' ' GLU . 88.2 Cg_exo -40.2 101.07 0.03 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.595 2.196 . . . . 0.0 112.542 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.645 ' CE1' HG23 ' A' ' 3' ' ' THR . 5.6 t80 -172.24 162.43 5.59 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.422 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' THR . . . . . 1.086 HG23 HG22 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -136.62 145.82 45.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.07 179.377 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 1.012 HD13 HG13 ' A' ' 4' ' ' ILE . 0.8 OUTLIER -83.54 179.57 7.6 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.848 179.847 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -103.14 109.93 3.59 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.236 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.38 -159.26 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.801 0.334 . . . . 0.0 110.76 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.54 ' CE1' ' CB ' ' A' ' 16' ' ' LYS . 0.1 OUTLIER -104.3 166.27 10.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.053 0.454 . . . . 0.0 111.091 -179.909 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.403 ' OD1' ' N ' ' A' ' 38' ' ' ASP . 31.0 t70 -167.63 111.2 0.66 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.444 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.736 ' HA ' HD21 ' A' ' 67' ' ' LEU . 22.5 p -144.96 126.43 14.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.044 -179.638 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.893 ' HB3' HG23 ' A' ' 36' ' ' VAL . . . -171.16 126.2 0.66 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.094 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -74.92 65.35 2.23 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.478 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.773 HD12 ' HB ' ' A' ' 36' ' ' VAL . 55.9 mt -115.88 172.97 6.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.802 0.334 . . . . 0.0 110.911 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -52.27 -37.04 54.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.815 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.464 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 1.0 OUTLIER -58.19 -62.42 1.84 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.798 179.866 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.464 ' CD2' ' HB3' ' A' ' 63' ' ' ASP . 0.3 OUTLIER -136.16 77.31 1.65 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.594 179.969 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -86.05 -16.04 39.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.491 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -83.45 -53.22 5.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.581 0.229 . . . . 0.0 111.478 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.78 HD23 HD23 ' A' ' 70' ' ' LEU . 1.6 mp 49.6 -179.73 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.487 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.409 ' N ' ' HD2' ' A' ' 69' ' ' PRO . 0.0 OUTLIER 168.25 -57.33 0.0 OUTLIER Pre-proline 0 N--CA 1.465 0.3 0 CA-C-O 120.688 0.28 . . . . 0.0 111.354 -179.992 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.412 ' O ' ' NE2' ' A' ' 74' ' ' GLN . 68.0 Cg_exo -38.12 -47.77 2.26 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.981 2.454 . . . . 0.0 113.039 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.78 HD23 HD23 ' A' ' 67' ' ' LEU . 0.3 OUTLIER -48.06 -26.9 2.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.164 -179.757 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.64 -31.75 12.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.812 0.339 . . . . 0.0 111.448 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -82.66 143.29 46.88 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.116 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.37 100.41 0.89 Allowed 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.646 2.231 . . . . 0.0 111.977 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.412 ' NE2' ' O ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -102.19 -67.55 0.87 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.514 -179.461 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.608 HG21 ' O ' ' A' ' 5' ' ' LYS . 12.4 t -84.26 -164.67 0.98 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.706 -179.281 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.411 ' O ' ' HD2' ' A' ' 109' ' ' PRO . 4.2 p30 -124.74 8.33 8.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.238 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.4 ' H ' HG23 ' A' ' 75' ' ' THR . 39.3 t -141.55 91.18 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 CA-C-O 120.758 0.313 . . . . 0.0 111.157 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.52 ' CD2' HG21 ' A' ' 9' ' ' VAL . 2.9 m-30 -80.79 -177.7 6.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.6 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.811 HD23 HG21 ' A' ' 14' ' ' VAL . 8.1 tp -143.34 108.46 4.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.262 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.71 HG11 HD13 ' A' ' 101' ' ' ILE . 21.5 m -105.61 135.09 45.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.02 179.088 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.763 ' SG ' HG12 ' A' ' 14' ' ' VAL . 9.6 m -137.38 170.7 15.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.212 0.529 . . . . 0.0 111.968 -179.134 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.564 ' HE2' HD12 ' A' ' 112' ' ' LEU . 15.0 p90 -167.77 137.29 2.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.439 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 57.4 p -83.68 139.4 32.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.725 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.596 HG13 ' N ' ' A' ' 137' ' ' ILE . 65.6 t -48.48 -63.78 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.22 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.585 ' HA ' HD21 ' A' ' 129' ' ' LEU . 30.4 m -45.35 111.85 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-O 120.61 0.243 . . . . 0.0 110.518 179.527 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.445 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 3.4 p -149.0 140.76 14.56 Favored Pre-proline 0 C--N 1.33 -0.24 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -178.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.453 ' CA ' ' HB2' ' A' ' 132' ' ' ASN . 72.3 Cg_endo -93.07 54.3 0.44 Allowed 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 123.381 2.721 . . . . 0.0 111.797 179.322 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.452 ' CB ' ' HB2' ' A' ' 133' ' ' LYS . 0.5 OUTLIER 72.93 21.73 3.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.043 -179.554 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 43.3 p -97.48 -17.8 19.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.264 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.53 ' CE2' HG23 ' A' ' 137' ' ' ILE . 8.5 t80 -45.68 -72.86 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.743 0.306 . . . . 0.0 111.302 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -53.64 -31.2 46.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.812 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.41 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 8.3 t-20 -66.8 -58.18 5.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.953 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.428 HG13 ' N ' ' A' ' 94' ' ' LYS . 12.3 p -62.42 -41.3 91.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.256 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.784 ' HG3' HD13 ' A' ' 145' ' ' LEU . 0.8 OUTLIER -55.65 -75.33 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.832 179.951 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.423 ' O ' ' CG ' ' A' ' 99' ' ' PRO . 24.3 mm-40 -52.24 -24.01 6.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.913 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.41 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 57.4 tttt -83.62 -22.51 32.2 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.114 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.448 ' CE3' ' HA ' ' A' ' 97' ' ' TRP . 0.0 OUTLIER -82.09 -55.49 4.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.58 -179.79 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.472 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 5.0 t -41.49 -46.63 8.55 Favored Pre-proline 0 N--CA 1.466 0.358 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -179.001 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 13.7 Cg_exo -69.96 -35.02 12.81 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.72 2.28 . . . . 0.0 112.354 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.415 ' N ' ' OE1' ' A' ' 100' ' ' GLU . 1.3 mp0 -76.73 -37.63 55.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.78 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.71 HD13 HG11 ' A' ' 80' ' ' VAL . 54.8 mt -65.93 -25.36 35.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.001 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 25.1 p -93.52 -26.93 16.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.858 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -66.09 -68.04 0.4 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.816 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -59.56 -34.76 73.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.696 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.401 ' HA ' ' HD2' ' A' ' 106' ' ' PRO . 89.3 m -127.4 103.58 22.48 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.756 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 105' ' ' CYS . 29.7 Cg_endo -63.68 106.72 0.64 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.439 2.093 . . . . 0.0 112.193 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.71 82.85 0.15 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.949 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.59 100.12 16.63 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.853 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.411 ' HD2' ' O ' ' A' ' 76' ' ' ASP . 31.3 Cg_exo -59.69 158.54 27.87 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.677 2.251 . . . . 0.0 112.251 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.482 ' CE2' ' HB2' ' A' ' 151' ' ' ALA . 24.8 p90 -150.62 -176.62 5.57 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.092 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.779 HD23 ' O ' ' A' ' 112' ' ' LEU . 4.4 tt -146.27 147.63 31.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.863 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.779 ' O ' HD23 ' A' ' 111' ' ' LEU . 4.2 mm? -93.43 156.8 16.56 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.626 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.824 HG13 HG11 ' A' ' 168' ' ' VAL . 11.0 t -143.21 150.68 17.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.091 0.472 . . . . 0.0 112.227 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.419 ' O ' ' CD1' ' A' ' 117' ' ' ILE . . . -124.46 100.15 0.62 Allowed Glycine 0 C--N 1.331 0.272 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.509 179.387 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.494 ' HB ' ' HA ' ' A' ' 158' ' ' SER . 1.3 p -122.97 -2.47 8.7 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -178.56 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.475 ' CD ' HD21 ' A' ' 119' ' ' LEU . 1.6 tp-100 -111.66 10.23 21.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.115 0.483 . . . . 0.0 109.86 178.798 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.48 ' H ' HD13 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -64.36 -11.63 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.948 179.018 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -80.34 -43.22 21.54 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.852 -179.401 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.605 ' C ' HD12 ' A' ' 119' ' ' LEU . 4.0 pp -99.43 0.52 42.8 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -179.331 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.432 ' O ' HD13 ' A' ' 126' ' ' ILE . 0.3 OUTLIER -54.71 -27.63 41.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.002 0.429 . . . . 0.0 110.017 179.245 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -80.85 -23.91 38.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.306 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -51.27 104.65 0.44 Allowed Pre-proline 0 C--N 1.332 -0.162 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.501 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.467 ' HA ' ' CG2' ' A' ' 126' ' ' ILE . 14.3 Cg_exo -69.31 -3.52 11.88 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 122.739 2.293 . . . . 0.0 112.978 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 10.3 t -72.56 -69.36 0.41 Allowed 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 120.914 0.388 . . . . 0.0 109.969 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.766 HG22 ' CD1' ' A' ' 129' ' ' LEU . 17.2 m -58.31 -44.27 88.51 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.799 HD11 ' HB3' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -50.09 -33.93 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.093 179.694 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.56 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 3.9 mm-40 -70.88 -35.19 72.25 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.456 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.433 ' N ' ' O ' ' A' ' 125' ' ' THR . 0.1 OUTLIER -68.44 -34.85 76.71 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 177.934 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.766 ' CD1' HG22 ' A' ' 125' ' ' THR . 9.2 mp -60.76 -42.54 97.65 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.049 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' A' ' 127' ' ' GLU . . . -42.52 -36.33 1.32 Allowed 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 114.602 -1.181 . . . . 0.0 111.503 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm -55.1 -29.44 57.62 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.859 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.453 ' HB2' ' CA ' ' A' ' 87' ' ' PRO . 15.6 m120 -124.44 -32.49 3.14 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -179.489 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.512 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 1.3 ttpt -142.69 -83.13 0.18 Allowed 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 122.332 -0.23 . . . . 0.0 111.083 -179.047 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.512 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 9.9 pt20 114.94 -42.1 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.682 1.193 . . . . 0.0 111.077 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.418 ' HD2' ' HG3' ' A' ' 134' ' ' GLN . 3.2 mptt -68.61 110.1 5.3 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.112 -0.494 . . . . 0.0 112.235 -178.801 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.799 ' HB3' HD11 ' A' ' 126' ' ' ILE . 72.4 Cg_endo -75.25 148.11 33.92 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.494 2.129 . . . . 0.0 111.209 178.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.75 ' N ' HD13 ' A' ' 137' ' ' ILE . 0.7 OUTLIER -76.87 96.8 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.898 0.38 . . . . 0.0 111.053 -179.31 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 3.3 p -68.79 148.78 98.01 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.736 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.46 ' HA ' ' CE2' ' A' ' 154' ' ' TYR . 83.3 Cg_exo -45.56 -26.92 3.15 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.607 2.205 . . . . 0.0 112.382 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -77.48 -32.39 54.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.816 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.459 ' HB ' HG22 ' A' ' 137' ' ' ILE . 2.2 m -64.25 -57.55 9.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.89 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.41 ' HB2' ' HZ ' ' A' ' 82' ' ' PHE . . . -51.11 -44.15 61.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.063 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -56.14 -44.12 78.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.949 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.6 mttt -56.92 -62.91 1.41 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.786 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.784 HD13 ' HG3' ' A' ' 94' ' ' LYS . 1.0 OUTLIER -60.2 -35.9 76.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.775 179.833 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.477 ' HB2' ' HG ' ' A' ' 112' ' ' LEU . . . -51.55 -60.86 2.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.863 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 22.2 mtt180 -67.29 -22.32 65.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.885 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.617 ' HB3' HD22 ' A' ' 149' ' ' LEU . 24.2 t0 -50.25 -48.81 54.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.695 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.617 HD22 ' HB3' ' A' ' 148' ' ' ASP . 2.4 mm? -92.89 17.43 10.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.084 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 9.9 mttt 47.6 51.44 13.86 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.787 0.327 . . . . 0.0 111.021 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.482 ' HB2' ' CE2' ' A' ' 110' ' ' PHE . . . -75.73 -82.2 0.07 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.176 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.767 HG11 HD12 ' A' ' 111' ' ' LEU . 69.8 t -160.42 -74.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.928 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.41 ' HG3' ' N ' ' A' ' 154' ' ' TYR . 0.2 OUTLIER -177.52 144.43 0.39 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.65 -179.042 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.46 ' CE2' ' HA ' ' A' ' 139' ' ' PRO . 18.3 t80 -105.75 109.59 21.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.186 179.419 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.407 ' HB ' ' HB ' ' A' ' 168' ' ' VAL . 3.1 t -101.64 158.81 4.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.998 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -100.49 126.18 46.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.016 0.436 . . . . 0.0 111.666 -179.314 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.447 ' SG ' HG12 ' A' ' 168' ' ' VAL . 1.4 p 178.51 126.07 0.05 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.548 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.579 ' HB3' HD12 ' A' ' 160' ' ' LEU . 15.4 m -112.5 167.99 10.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.943 0.402 . . . . 0.0 111.427 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.522 ' HB1' ' HB3' ' A' ' 18' ' ' CYS . . . -98.77 -33.53 10.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.843 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.579 HD12 ' HB3' ' A' ' 158' ' ' SER . 0.9 OUTLIER -51.14 -38.69 53.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.448 179.788 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.0 t -117.33 -12.91 10.42 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.163 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 64.65 72.48 0.44 Allowed 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.818 0.342 . . . . 0.0 110.892 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.413 ' HB3' ' HA ' ' A' ' 157' ' ' CYS . 68.1 tttt -97.17 22.82 8.07 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.19 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 107.82 41.0 1.63 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.161 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.89 HD22 ' CD2' ' A' ' 19' ' ' LEU . 0.4 OUTLIER -49.26 -30.82 7.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.089 0.471 . . . . 0.0 110.632 179.596 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 22.9 pttm -68.79 -31.66 70.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.657 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -52.59 -69.28 0.12 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.546 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.824 HG11 HG13 ' A' ' 113' ' ' VAL . 12.3 p -50.29 -44.19 23.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.059 0.457 . . . . 0.0 110.441 179.435 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.522 ' CD1' ' CD1' ' A' ' 19' ' ' LEU . 2.2 t80 -59.85 -34.32 72.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.12 179.306 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.522 ' OD1' HD21 ' B' ' 505' ' ' LEU . 0.6 OUTLIER -60.7 -34.87 75.01 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.837 179.236 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.663 ' HB3' HD11 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -73.12 -30.46 63.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.2 179.229 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.451 ' CA ' HD13 ' A' ' 111' ' ' LEU . . . -76.39 -42.39 44.63 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.648 179.665 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.424 ' CG1' ' HA ' ' A' ' 170' ' ' ASP . 1.5 pp -76.97 -32.62 19.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.423 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 1.025 HD13 HD13 ' B' ' 505' ' ' LEU . 22.8 tp -53.37 -49.34 67.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.551 179.608 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.84 -22.29 62.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.783 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.588 ' HB1' ' HB ' ' A' ' 4' ' ' ILE . . . -85.4 -41.82 15.08 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.058 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.906 HD13 ' HB ' ' B' ' 510' ' ' ILE . 32.6 mt -68.78 -23.18 64.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.819 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.412 ' HB2' ' CB ' ' B' ' 507' ' ' ALA . 0.0 OUTLIER -168.3 153.56 6.5 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.784 179.934 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -52.72 124.01 14.32 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.621 2.214 . . . . 0.0 112.313 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.53 -178.43 3.37 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.538 2.159 . . . . 0.0 112.404 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -144.42 99.53 4.89 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.858 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -88.47 35.43 0.4 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 123.197 2.598 . . . . 0.0 113.038 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 17.4 pttt -56.36 157.35 5.04 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.878 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 7.2 mttm . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.898 -179.978 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.204 0 N-CA-C 112.506 -0.238 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 503' ' ' SER . . . . . . . . . . . . . 22.3 m -67.35 -78.93 0.05 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.805 0.336 . . . . 0.0 110.814 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 504' ' ' GLY . . . . . 0.418 ' CA ' ' OD2' ' B' ' 509' ' ' ASP . . . 92.71 103.53 1.54 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.278 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 505' ' ' LEU . . . . . 1.025 HD13 HD13 ' A' ' 174' ' ' LEU . 0.2 OUTLIER -164.36 47.56 0.11 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.792 0.329 . . . . 0.0 111.31 -179.614 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 506' ' ' SER . . . . . 0.481 ' O ' ' HB2' ' B' ' 507' ' ' ALA . 4.9 m 59.31 87.86 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.975 0.417 . . . . 0.0 110.022 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 507' ' ' ALA . . . . . 0.481 ' HB2' ' O ' ' B' ' 506' ' ' SER . . . 173.75 -37.68 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.242 -179.083 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 508' ' ' GLN . . . . . 0.487 ' CB ' ' CD1' ' B' ' 510' ' ' ILE . 1.3 mt-30 155.48 -20.85 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.7 -1.136 . . . . 0.0 109.994 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 509' ' ' ASP . . . . . 0.455 ' CB ' ' O ' ' B' ' 508' ' ' GLN . 8.4 t70 90.03 38.67 0.01 OUTLIER 'General case' 0 C--N 1.343 0.323 0 CA-C-O 121.309 0.576 . . . . 0.0 110.6 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 510' ' ' ILE . . . . . 0.906 ' HB ' HD13 ' A' ' 177' ' ' LEU . 1.9 mp -68.99 136.39 26.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.346 179.245 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 511' ' ' SER . . . . . 0.683 ' HB2' HD21 ' B' ' 514' ' ' LEU . 4.1 m -109.23 153.98 23.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.061 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 512' ' ' GLN . . . . . 0.492 ' CB ' ' HD3' ' B' ' 513' ' ' PRO . 0.3 OUTLIER -98.53 -68.37 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.82 179.847 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 513' ' ' PRO . . . . . 0.492 ' HD3' ' CB ' ' B' ' 512' ' ' GLN . 90.4 Cg_endo -78.64 59.55 7.27 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.4 2.067 . . . . 0.0 111.781 179.384 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 514' ' ' LEU . . . . . 0.683 HD21 ' HB2' ' B' ' 511' ' ' SER . 1.1 mt -73.34 -86.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.751 -179.235 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 515' ' ' GLN . . . . . 0.503 ' CB ' HG12 ' A' ' 44' ' ' VAL . 0.5 OUTLIER -88.1 -10.31 50.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.649 -179.529 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 53.59 24.52 4.23 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.936 0.398 . . . . 0.0 110.379 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 517' ' ' SER . . . . . 0.856 ' O ' HG13 ' A' ' 42' ' ' VAL . 75.4 m -68.28 58.8 0.08 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.618 -179.495 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 518' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -78.28 91.48 4.42 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.42 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 519' ' ' ILE . . . . . 0.423 HG12 ' O ' ' A' ' 41' ' ' ALA . 3.5 mm -76.28 157.47 5.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.251 -179.612 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -101.57 119.59 39.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.903 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 521' ' ' THR . . . . . . . . . . . . . 18.7 p -133.93 -61.99 0.78 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.829 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 522' ' ' GLY . . . . . . . . . . . . . . . -55.74 119.56 14.62 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.564 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 523' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -59.05 -83.76 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.772 0.32 . . . . 0.0 110.882 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 524' ' ' GLY . . . . . 0.5 ' HA3' HG11 ' A' ' 36' ' ' VAL . . . 67.88 167.86 4.04 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.492 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 525' ' ' ASP . . . . . 0.48 ' CG ' HD22 ' A' ' 61' ' ' LEU . 0.6 OUTLIER -85.28 83.19 8.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.83 0.348 . . . . 0.0 110.94 -179.967 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 526' ' ' SER . . . . . 0.44 ' CB ' ' HG3' ' A' ' 34' ' ' PRO . 6.4 t -83.58 95.79 8.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.694 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 527' ' ' ASP . . . . . 0.553 ' O ' HG21 ' A' ' 33' ' ' VAL . 3.2 p30 -177.52 147.36 0.66 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.995 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.74 101.56 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.685 2.257 . . . . 0.0 112.109 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 529' ' ' ARG . . . . . 0.423 ' HB2' ' HB3' ' B' ' 545' ' ' ASN . 0.1 OUTLIER -100.16 -55.3 2.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.352 -179.514 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 530' ' ' HIS . . . . . . . . . . . . . 14.2 m80 -142.3 -47.21 0.34 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.025 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 3.0 m 72.94 -172.1 0.14 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.806 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 532' ' ' TRP . . . . . . . . . . . . . 24.1 t90 -62.06 102.74 0.31 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.962 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . -122.02 -38.46 0.6 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.481 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 534' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -105.61 154.86 38.9 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 120.731 0.301 . . . . 0.0 110.932 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -67.18 125.51 13.65 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.641 2.228 . . . . 0.0 112.085 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 1.3 t0 70.84 141.35 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.768 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 537' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -70.8 144.6 50.76 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.25 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 538' ' ' ILE . . . . . 0.756 HG23 HD12 ' B' ' 543' ' ' LEU . 6.2 tp -58.16 145.17 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.055 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 539' ' ' ASP . . . . . 0.449 ' O ' ' CD1' ' B' ' 543' ' ' LEU . 20.5 t0 -41.38 132.85 2.6 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.969 0.414 . . . . 0.0 112.028 -178.662 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 540' ' ' GLU . . . . . 0.643 ' CG ' HG22 ' A' ' 8' ' ' VAL . 0.8 OUTLIER -40.55 -27.27 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.047 179.702 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 541' ' ' LEU . . . . . 0.669 ' O ' HD21 ' A' ' 70' ' ' LEU . 5.3 mt -31.93 -69.24 0.08 Allowed 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 542' ' ' TYR . . . . . 0.458 ' CD1' ' HB3' ' B' ' 541' ' ' LEU . 0.1 OUTLIER -103.36 -63.78 1.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.317 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 543' ' ' LEU . . . . . 0.756 HD12 HG23 ' B' ' 538' ' ' ILE . 4.6 mp 65.05 141.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.866 -179.377 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . 132.62 141.86 4.74 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.487 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 545' ' ' ASN . . . . . 0.423 ' HB3' ' HB2' ' B' ' 529' ' ' ARG . 36.1 m-20 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.923 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.516 ' HE3' ' CG2' ' A' ' 46' ' ' ILE . 7.4 tpt . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.475 0.179 . . . . 0.0 111.2 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.431 ' O ' ' CE ' ' A' ' 1' ' ' MET . 39.4 tp60 60.76 137.83 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.047 0.451 . . . . 0.0 110.917 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.598 HG21 ' HG ' ' A' ' 53' ' ' LEU . 0.2 OUTLIER -124.24 -165.95 1.43 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.609 -179.492 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.683 ' CG2' ' HB3' ' A' ' 176' ' ' ALA . 0.2 OUTLIER -150.92 138.26 13.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.581 -179.593 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.477 ' O ' HG13 ' A' ' 77' ' ' VAL . 3.6 ttmt -95.0 101.35 13.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.748 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.562 ' CB ' HD23 ' A' ' 55' ' ' LEU . 20.2 m -80.25 110.1 15.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.287 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.7 t -151.16 106.74 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.766 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.627 HG13 ' OE1' ' B' ' 540' ' ' GLU . 2.4 p -89.3 135.48 25.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.296 0.569 . . . . 0.0 111.583 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.747 HG21 ' CE2' ' A' ' 78' ' ' PHE . 2.8 m -133.41 129.44 56.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.197 178.41 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.409 ' O ' ' N ' ' B' ' 540' ' ' GLU . . . 141.69 -165.3 26.52 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.067 -1.064 . . . . 0.0 112.483 -179.106 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.7 21.87 5.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.764 0.316 . . . . 0.0 110.992 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.414 ' HA3' ' CB ' ' A' ' 81' ' ' CYS . . . -128.13 161.6 21.97 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.501 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.438 ' CB ' ' HB2' ' A' ' 18' ' ' CYS . . . -93.08 -20.1 20.87 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.4 ' CG2' ' SG ' ' A' ' 81' ' ' CYS . 4.0 m -42.41 92.67 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 CA-C-O 120.892 0.377 . . . . 0.0 111.643 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.439 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . . . -178.13 -77.97 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.76 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.508 ' O ' HD22 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -98.08 -84.1 0.39 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.927 0.394 . . . . 0.0 111.825 -179.354 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.436 ' HA ' HG12 ' A' ' 21' ' ' ILE . 4.3 p -63.33 -50.39 70.19 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.67 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.438 ' HB2' ' CB ' ' A' ' 13' ' ' ALA . 51.9 t -32.46 -70.83 0.06 Allowed 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 113.634 0.975 . . . . 0.0 113.634 -178.391 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.836 HD21 ' CE1' ' A' ' 169' ' ' PHE . 0.0 OUTLIER -58.05 -71.23 0.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -178.19 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.508 HD22 ' O ' ' A' ' 16' ' ' LYS . 0.2 OUTLIER -51.05 -65.88 0.48 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -178.283 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.512 HD11 ' CZ ' ' B' ' 518' ' ' PHE . 30.4 mm -45.6 -67.9 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.107 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.434 ' CB ' ' HB1' ' A' ' 159' ' ' ALA . 1.2 t -49.82 -26.12 3.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.961 0.41 . . . . 0.0 110.752 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -82.86 -25.34 32.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.72 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.42 HG23 ' O ' ' A' ' 20' ' ' LEU . 66.7 p -100.52 -64.21 1.06 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.243 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 40.1 p -62.41 -58.28 8.2 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.993 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 74.9 42.67 0.26 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.181 179.584 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.47 ' O ' ' CE1' ' A' ' 32' ' ' TYR . 4.2 mtmm -119.66 91.58 3.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.968 0.413 . . . . 0.0 110.928 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.48 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 9.4 t80 -89.81 -45.38 0.41 Allowed Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.872 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 88.0 Cg_endo -84.16 79.02 2.73 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.424 2.083 . . . . 0.0 113.04 -179.426 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.9 m -174.02 -94.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.879 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.41 154.74 25.46 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 120.635 0.255 . . . . 0.0 110.449 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.47 ' CE1' ' O ' ' A' ' 27' ' ' LYS . 15.6 m-85 -133.82 93.98 3.2 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.905 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.564 ' N ' ' CD ' ' A' ' 34' ' ' PRO . 2.1 t -131.59 28.09 0.15 Allowed Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.564 ' CD ' ' N ' ' A' ' 33' ' ' VAL . 42.3 Cg_endo -86.09 -37.59 0.1 Allowed 'Trans proline' 0 C--N 1.359 1.109 0 C-N-CA 121.889 1.726 . . . . 0.0 112.496 179.605 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.472 HG21 HD21 ' B' ' 543' ' ' LEU . 1.4 m -48.46 99.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.881 -179.26 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.466 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 7.4 p 176.98 -34.95 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.825 179.17 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -109.39 35.88 3.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.582 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.449 ' CB ' ' HG2' ' A' ' 16' ' ' LYS . 18.3 m-20 -89.58 45.47 1.28 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.127 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -106.03 -16.28 14.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.077 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -60.59 174.97 0.51 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.79 0.329 . . . . 0.0 110.865 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.759 ' C ' HD12 ' B' ' 519' ' ' ILE . . . -91.99 174.48 7.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.294 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.421 ' HA ' HG13 ' B' ' 519' ' ' ILE . 30.9 m -139.32 144.67 28.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.734 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.498 ' O ' HG23 ' A' ' 44' ' ' VAL . 2.1 p -85.05 106.33 16.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.499 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.912 ' HB ' HG21 ' A' ' 52' ' ' THR . 53.9 t -158.04 153.11 6.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.158 -179.195 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.53 ' HB3' HD22 ' B' ' 514' ' ' LEU . 0.0 OUTLIER -117.73 96.31 5.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.17 179.313 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.951 HG12 HG22 ' A' ' 52' ' ' THR . 5.5 mm -71.1 88.1 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.539 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.508 ' N ' HG23 ' B' ' 510' ' ' ILE . . . 37.28 -87.85 0.01 OUTLIER Glycine 0 CA--C 1.521 0.409 0 CA-C-N 115.811 -0.631 . . . . 0.0 113.919 179.326 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . -38.88 -78.6 0.05 OUTLIER Glycine 0 C--N 1.334 0.439 0 C-N-CA 121.52 -0.371 . . . . 0.0 113.177 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.451 ' N ' ' HE1' ' A' ' 45' ' ' MET . 3.2 mt-10 -142.29 162.23 46.25 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-O 120.909 0.385 . . . . 0.0 111.373 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.42 92.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.79 2.327 . . . . 0.0 112.558 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.549 ' CE1' HG23 ' A' ' 3' ' ' THR . 0.0 OUTLIER -172.95 126.07 0.45 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.073 179.749 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.951 HG22 HG12 ' A' ' 46' ' ' ILE . 4.3 p -134.57 141.77 46.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.919 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.598 ' HG ' HG21 ' A' ' 3' ' ' THR . 5.3 mt -71.16 121.69 18.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.877 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -52.28 153.4 6.08 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.092 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.562 HD23 ' CB ' ' A' ' 6' ' ' CYS . 2.6 mp -109.79 95.04 5.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.839 0.352 . . . . 0.0 110.884 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -84.73 105.45 15.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.633 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.421 ' OD2' ' CG2' ' A' ' 35' ' ' THR . 1.5 t70 -94.44 163.77 13.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.822 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' THR . . . . . 1.087 HG21 HD22 ' A' ' 70' ' ' LEU . 6.7 p -89.44 146.38 24.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.32 -179.551 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.466 ' HB3' ' HA ' ' A' ' 36' ' ' VAL . . . -172.14 -162.78 0.22 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.677 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.455 ' H ' HD12 ' A' ' 61' ' ' LEU . . . 166.41 66.75 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.467 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.455 HD12 ' H ' ' A' ' 60' ' ' GLY . 5.8 mp -120.97 -87.01 0.65 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.727 0.299 . . . . 0.0 111.02 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.79 -31.56 11.81 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.902 0.382 . . . . 0.0 111.108 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.425 ' HB3' HG22 ' A' ' 36' ' ' VAL . 50.7 t0 -70.8 -63.25 1.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.37 -179.577 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.489 ' CD1' HD12 ' A' ' 67' ' ' LEU . 0.1 OUTLIER -118.33 160.25 21.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.805 -179.757 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -85.92 -68.35 0.74 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.807 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -96.69 -52.2 4.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.117 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.715 HD23 ' O ' ' A' ' 67' ' ' LEU . 6.5 tt 56.42 106.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.64 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.452 ' N ' ' HD3' ' A' ' 69' ' ' PRO . 1.7 ppt_? -142.47 53.33 2.87 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.321 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.452 ' HD3' ' N ' ' A' ' 68' ' ' ARG . 94.1 Cg_endo -83.95 -20.25 4.49 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.764 2.309 . . . . 0.0 112.26 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 1.087 HD22 HG21 ' A' ' 58' ' ' THR . 0.7 OUTLIER -77.76 1.0 21.49 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.925 -179.79 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.21 -61.23 2.28 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 120.908 0.385 . . . . 0.0 110.92 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.492 ' N ' ' CD1' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -159.22 56.76 0.96 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.791 179.884 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -60.94 174.44 1.77 Allowed 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.661 2.241 . . . . 0.0 112.307 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -95.68 10.57 36.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.524 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.402 HG23 ' HB3' ' A' ' 5' ' ' LYS . 98.8 m -46.51 145.21 1.88 Allowed 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.804 0.335 . . . . 0.0 111.05 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.418 ' O ' ' CG ' ' A' ' 109' ' ' PRO . 16.8 p-10 -106.4 -20.96 13.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.147 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.666 ' O ' HG13 ' A' ' 77' ' ' VAL . 7.9 p -123.55 83.96 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.827 0.346 . . . . 0.0 111.387 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.747 ' CE2' HG21 ' A' ' 9' ' ' VAL . 0.3 OUTLIER -80.79 166.3 21.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.599 179.736 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.471 HD13 ' HB3' ' A' ' 111' ' ' LEU . 4.9 tp -143.39 108.46 4.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.02 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.706 HG13 ' CB ' ' A' ' 110' ' ' PHE . 35.9 m -84.74 147.11 5.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.838 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.481 ' O ' ' CZ3' ' A' ' 97' ' ' TRP . 2.0 m -113.97 174.35 5.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.118 0.485 . . . . 0.0 111.216 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.463 ' CE1' ' O ' ' A' ' 113' ' ' VAL . 6.0 p90 179.99 -173.54 0.23 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.769 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.441 ' N ' ' CD2' ' A' ' 82' ' ' PHE . 0.3 OUTLIER -156.42 136.34 12.66 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.847 0.356 . . . . 0.0 111.349 179.958 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.538 HG13 ' N ' ' A' ' 137' ' ' ILE . 99.3 t -51.48 -40.41 24.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.827 179.534 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.623 ' O ' HG23 ' A' ' 85' ' ' VAL . 32.0 m -73.02 111.64 7.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.518 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.455 ' H ' HD13 ' A' ' 129' ' ' LEU . 83.4 p -151.28 135.27 9.51 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.743 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.417 ' HB2' ' HB2' ' A' ' 132' ' ' ASN . 74.2 Cg_endo -91.42 51.88 0.78 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.218 2.612 . . . . 0.0 111.585 179.225 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.46 ' CB ' ' CG ' ' A' ' 133' ' ' LYS . 0.1 OUTLIER 79.15 26.85 0.42 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.665 -179.426 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.922 ' O ' HG23 ' A' ' 93' ' ' VAL . 52.4 p -96.5 -25.73 15.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.999 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.411 ' CZ ' HG21 ' A' ' 137' ' ' ILE . 3.3 t80 -48.96 -54.08 17.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.075 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -49.82 -53.41 25.62 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.932 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -64.29 -47.68 78.57 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.724 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.922 HG23 ' O ' ' A' ' 89' ' ' SER . 65.9 t -51.1 -39.84 20.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.049 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.645 ' HD2' HD13 ' A' ' 145' ' ' LEU . 12.3 tttm -64.51 -50.39 67.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.847 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.403 ' O ' ' HG3' ' A' ' 99' ' ' PRO . 4.7 mt-10 -82.97 7.39 15.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.695 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.2 mttp -109.82 -26.14 9.97 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.751 0.31 . . . . 0.0 110.872 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.73 ' O ' HG22 ' A' ' 101' ' ' ILE . 5.7 m0 -94.01 -45.73 7.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.196 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.64 HG23 ' O ' ' A' ' 94' ' ' LYS . 58.5 t -49.94 -46.73 81.43 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.63 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 94.2 Cg_endo -80.74 -15.5 10.78 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.393 2.062 . . . . 0.0 112.612 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -90.11 -49.09 6.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.771 0.32 . . . . 0.0 110.901 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.73 HG22 ' O ' ' A' ' 97' ' ' TRP . 9.9 tt -62.95 -22.86 31.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.197 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.515 HG23 ' O ' ' A' ' 98' ' ' VAL . 61.2 p -91.51 -26.11 18.94 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.878 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 42.0 t60 -76.92 -57.79 3.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.895 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -65.66 -56.96 9.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.951 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.407 ' CB ' ' OG1' ' A' ' 108' ' ' THR . 60.4 m -86.65 142.94 35.16 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.976 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -69.23 60.27 1.4 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.558 2.172 . . . . 0.0 112.315 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.78 78.58 0.27 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.927 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.407 ' OG1' ' CB ' ' A' ' 105' ' ' CYS . 0.2 OUTLIER -108.52 141.12 22.59 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.813 179.847 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.418 ' CG ' ' O ' ' A' ' 76' ' ' ASP . 33.8 Cg_endo -65.53 177.91 2.46 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.507 2.138 . . . . 0.0 112.52 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.845 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 4.6 p90 -166.22 132.55 2.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.782 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.849 HD12 ' CG1' ' A' ' 152' ' ' VAL . 5.5 tt -108.94 142.0 40.21 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.678 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.438 HD12 ' CD1' ' A' ' 82' ' ' PHE . 4.2 mm? -89.59 155.03 19.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.586 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 1.091 HG13 HG21 ' A' ' 168' ' ' VAL . 2.4 t -142.12 134.17 26.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.946 0.403 . . . . 0.0 111.792 -179.448 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.784 ' O ' HD11 ' A' ' 117' ' ' ILE . . . -106.03 86.09 0.47 Allowed Glycine 0 C--N 1.332 0.338 0 C-N-CA 121.004 -0.617 . . . . 0.0 111.857 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.481 ' HB ' ' HA ' ' A' ' 158' ' ' SER . 1.0 OUTLIER -110.34 1.68 18.61 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -178.805 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.531 ' HB3' HG23 ' A' ' 84' ' ' VAL . 4.4 tp60 -96.87 -22.74 16.71 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.442 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.784 HD11 ' O ' ' A' ' 114' ' ' GLY . 0.2 OUTLIER -46.04 -25.75 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.096 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.839 178.931 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.563 ' HB3' HD13 ' A' ' 119' ' ' LEU . 4.8 t0 -53.72 -47.52 70.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.372 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.722 HD13 ' N ' ' A' ' 119' ' ' LEU . 0.0 OUTLIER -122.98 14.31 9.88 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -178.976 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.82 -28.61 3.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.897 0.379 . . . . 0.0 110.87 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.3 p30 -72.22 -22.39 61.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.094 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.421 ' O ' ' HB ' ' A' ' 126' ' ' ILE . 20.1 p-10 -48.24 104.32 0.41 Allowed Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 120.983 0.421 . . . . 0.0 110.974 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.426 ' O ' HG22 ' A' ' 126' ' ' ILE . 36.7 Cg_endo -66.49 -6.57 15.48 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.381 2.054 . . . . 0.0 113.172 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.417 ' OG ' ' N ' ' A' ' 125' ' ' THR . 54.3 p -79.78 -66.52 0.86 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.417 ' N ' ' OG ' ' A' ' 124' ' ' SER . 34.5 m -55.76 -38.06 69.34 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.83 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.499 HD11 ' HB3' ' A' ' 136' ' ' PRO . 0.1 OUTLIER -56.37 -41.68 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 115.01 -0.996 . . . . 0.0 109.803 179.229 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.449 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 1.0 OUTLIER -60.59 -37.51 81.58 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.436 179.256 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 125' ' ' THR . 0.0 OUTLIER -60.88 -31.3 70.77 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.595 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.455 HD13 ' H ' ' A' ' 86' ' ' SER . 5.1 mt -75.36 -41.68 55.9 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 177.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 127' ' ' GLU . . . -44.26 -33.9 1.73 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.99 -1.004 . . . . 0.0 111.105 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 18.0 mmtm -49.79 -33.05 15.42 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.416 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.417 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 5.1 m-80 -123.29 -31.36 3.57 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.341 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.523 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 0.8 OUTLIER -144.6 -99.17 0.1 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 119.191 -0.433 . . . . 0.0 111.571 179.793 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.523 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 2.7 pt20 129.57 -23.86 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.528 1.131 . . . . 0.0 110.313 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.2 mmtt -68.73 110.26 5.64 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.778 -179.08 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.499 ' HB3' HD11 ' A' ' 126' ' ' ILE . 96.1 Cg_endo -79.55 127.36 7.23 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.485 2.123 . . . . 0.0 111.239 179.16 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.734 ' N ' HD13 ' A' ' 137' ' ' ILE . 1.1 mm -56.76 95.9 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.962 0.411 . . . . 0.0 110.738 -179.462 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 47.0 p -67.65 155.65 90.81 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.087 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.455 ' HG3' HG21 ' A' ' 117' ' ' ILE . 75.3 Cg_exo -47.54 -27.85 8.1 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.461 2.107 . . . . 0.0 112.184 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -77.1 -30.53 55.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.626 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.566 ' HB ' HG22 ' A' ' 137' ' ' ILE . 5.8 m -69.58 -62.49 1.36 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.727 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.403 ' HB3' ' CZ ' ' A' ' 154' ' ' TYR . . . -52.14 -36.05 50.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.637 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -65.83 -41.53 91.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.505 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 19.4 tptp -55.11 -62.77 1.45 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.634 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.755 ' CD1' HD23 ' A' ' 149' ' ' LEU . 17.2 tp -58.31 -43.81 88.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.543 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.403 ' HB2' ' HG ' ' A' ' 112' ' ' LEU . . . -55.06 -35.3 64.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.924 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 12.3 mtt-85 -91.47 -30.87 16.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.618 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -65.12 -44.28 89.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.707 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.755 HD23 ' CD1' ' A' ' 145' ' ' LEU . 3.0 mm? -89.8 14.05 12.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.123 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 47.41 45.8 17.11 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.835 0.35 . . . . 0.0 111.002 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.845 ' HB1' ' O ' ' A' ' 110' ' ' PHE . . . -65.09 -82.22 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.198 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.849 ' CG1' HD12 ' A' ' 111' ' ' LEU . 70.7 t -161.09 -75.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.826 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.57 108.41 0.06 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.792 -178.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.449 ' CE2' ' HA ' ' A' ' 139' ' ' PRO . 19.5 t80 -80.98 114.56 19.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.425 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 3.7 t -108.87 155.12 9.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.826 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.405 ' O ' ' HB3' ' A' ' 157' ' ' CYS . 1.2 pt-20 -94.37 118.58 31.83 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.223 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.435 ' HA ' ' HB3' ' A' ' 163' ' ' LYS . 20.3 p 178.95 137.46 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.615 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.481 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 27.4 m -112.72 149.31 33.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.981 0.419 . . . . 0.0 111.221 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.853 ' HB2' HD21 ' A' ' 165' ' ' LEU . . . -83.21 -42.54 17.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.82 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.491 HD23 ' H ' ' A' ' 160' ' ' LEU . 0.1 OUTLIER -49.53 -36.5 23.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.703 179.779 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.455 HG22 ' HB2' ' A' ' 158' ' ' SER . 15.3 t -111.37 -22.48 11.3 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.685 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.413 ' N ' ' O ' ' A' ' 158' ' ' SER . 0.9 OUTLIER 73.11 62.25 0.1 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.781 -179.89 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.435 ' HB3' ' HA ' ' A' ' 157' ' ' CYS . 0.0 OUTLIER -93.08 22.59 4.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.061 -179.943 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.435 ' N ' ' HB2' ' A' ' 157' ' ' CYS . . . 133.34 35.39 0.29 Allowed Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.484 -0.865 . . . . 0.0 113.412 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.853 HD21 ' HB2' ' A' ' 159' ' ' ALA . 10.5 mt -48.88 -42.3 36.27 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.913 0.357 . . . . 0.0 110.844 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.18 -34.18 72.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.992 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.418 ' O ' ' HB2' ' A' ' 170' ' ' ASP . 0.1 OUTLIER -58.03 -72.18 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.241 -179.811 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 1.091 HG21 HG13 ' A' ' 113' ' ' VAL . 7.1 p -50.08 -46.91 24.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.981 0.42 . . . . 0.0 110.988 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.836 ' CE1' HD21 ' A' ' 19' ' ' LEU . 1.1 t80 -64.6 -33.38 75.78 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.672 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.42 ' O ' ' CB ' ' A' ' 174' ' ' LEU . 0.5 OUTLIER -56.3 -32.84 64.99 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.967 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.699 ' HB2' HD11 ' A' ' 111' ' ' LEU . 58.7 mm-40 -75.0 -36.21 61.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.887 178.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.731 ' N ' HD13 ' A' ' 111' ' ' LEU . . . -67.31 -43.41 81.72 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.623 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.494 HD13 ' HB2' ' B' ' 512' ' ' GLN . 1.7 pp -78.23 -33.14 17.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.661 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.86 HD13 HD22 ' B' ' 505' ' ' LEU . 22.0 tp -59.13 -43.62 92.01 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.634 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -54.34 -22.03 11.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.112 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.683 ' HB3' ' CG2' ' A' ' 4' ' ' ILE . . . -87.53 -37.03 17.25 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.395 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.839 HD13 ' HB ' ' B' ' 510' ' ' ILE . 94.9 mt -68.83 -27.98 66.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.962 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.11 136.73 1.93 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.981 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -57.32 112.02 1.0 Allowed 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.563 2.175 . . . . 0.0 112.302 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.53 162.1 33.55 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.625 2.217 . . . . 0.0 112.276 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -131.37 143.85 50.98 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.959 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -76.53 -165.12 0.29 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.721 2.281 . . . . 0.0 112.329 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 1.8 mmmt -71.26 83.54 0.75 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.87 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 7.7 mttt . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.979 179.992 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 502' ' ' GLY . . . . . 0.416 ' CA ' ' O ' ' B' ' 509' ' ' ASP . . . . . . . . 0 N--CA 1.489 2.195 0 N-CA-C 112.524 -0.23 . . . . 0.0 112.524 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 503' ' ' SER . . . . . . . . . . . . . 37.4 t -107.06 -74.62 0.65 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.781 0.324 . . . . 0.0 110.944 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 504' ' ' GLY . . . . . . . . . . . . . . . 116.58 103.86 2.35 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.36 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 505' ' ' LEU . . . . . 0.86 HD22 HD13 ' A' ' 174' ' ' LEU . 0.1 OUTLIER -174.55 38.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.698 0.285 . . . . 0.0 111.141 -179.871 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 506' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 68.95 34.26 3.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.127 0.489 . . . . 0.0 110.566 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 507' ' ' ALA . . . . . 0.479 ' HB3' ' CD1' ' B' ' 505' ' ' LEU . . . -137.47 35.97 2.48 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.548 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 508' ' ' GLN . . . . . 0.4 ' O ' ' HB3' ' B' ' 509' ' ' ASP . 20.4 mt-30 74.73 3.38 4.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.441 -178.555 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 509' ' ' ASP . . . . . 0.416 ' O ' ' CA ' ' B' ' 502' ' ' GLY . 16.0 t70 71.7 44.83 0.47 Allowed 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.158 0.504 . . . . 0.0 110.816 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 510' ' ' ILE . . . . . 0.839 ' HB ' HD13 ' A' ' 177' ' ' LEU . 44.5 mt -93.17 138.29 20.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.846 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 511' ' ' SER . . . . . . . . . . . . . 22.1 t -108.04 157.16 18.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.359 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 512' ' ' GLN . . . . . 0.505 ' O ' HG11 ' A' ' 44' ' ' VAL . 27.9 tp60 -110.21 -71.2 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.513 179.59 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 513' ' ' PRO . . . . . 0.478 ' CD ' ' CB ' ' B' ' 512' ' ' GLN . 73.3 Cg_endo -74.6 58.96 4.75 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.021 1.814 . . . . 0.0 111.632 179.318 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 514' ' ' LEU . . . . . 0.53 HD22 ' HB3' ' A' ' 45' ' ' MET . 2.6 mp -65.81 -86.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.65 -179.272 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 515' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -69.3 -96.1 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.218 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -127.32 -12.26 5.67 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 517' ' ' SER . . . . . 0.418 ' HA ' ' HB ' ' A' ' 42' ' ' VAL . 1.5 m 48.62 31.78 3.14 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.705 0.288 . . . . 0.0 111.135 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 518' ' ' PHE . . . . . 0.512 ' CZ ' HD11 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -163.3 91.96 0.72 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.143 -179.795 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 519' ' ' ILE . . . . . 0.759 HD12 ' C ' ' A' ' 41' ' ' ALA . 41.5 mt -64.23 -64.68 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.84 0.353 . . . . 0.0 110.755 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -126.6 -168.95 1.94 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.891 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 521' ' ' THR . . . . . . . . . . . . . 6.6 m -119.76 113.99 21.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.002 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 522' ' ' GLY . . . . . . . . . . . . . . . -107.16 120.6 6.23 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.522 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 523' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -114.58 -84.44 0.61 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.716 0.294 . . . . 0.0 110.96 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 524' ' ' GLY . . . . . . . . . . . . . . . 101.21 -44.14 1.6 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.412 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 525' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -152.01 32.95 0.54 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.862 0.363 . . . . 0.0 110.907 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 526' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.1 97.56 6.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.887 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 527' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -145.88 161.68 39.02 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.914 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.42 96.59 0.65 Allowed 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.598 2.199 . . . . 0.0 112.242 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 529' ' ' ARG . . . . . . . . . . . . . 1.9 mtp85 -96.08 -23.1 16.94 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.202 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 530' ' ' HIS . . . . . 0.41 ' O ' ' HB2' ' B' ' 531' ' ' CYS . 0.0 OUTLIER -178.76 -82.77 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.938 -179.875 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 531' ' ' CYS . . . . . 0.41 ' HB2' ' O ' ' B' ' 530' ' ' HIS . 50.1 t 178.29 -68.67 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.886 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 532' ' ' TRP . . . . . 0.521 ' CZ2' ' NH2' ' B' ' 537' ' ' ARG . 0.6 OUTLIER -126.32 -49.8 1.54 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.967 -179.908 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 533' ' ' GLY . . . . . 0.472 ' O ' ' CG ' ' B' ' 534' ' ' PHE . . . 106.4 -56.28 0.51 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.483 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 534' ' ' PHE . . . . . 0.472 ' CG ' ' O ' ' B' ' 533' ' ' GLY . 98.0 m-85 -160.67 160.72 25.5 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.76 0.314 . . . . 0.0 110.88 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -48.05 123.36 8.61 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.559 2.173 . . . . 0.0 112.274 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 2.9 t0 68.25 145.18 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.747 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 537' ' ' ARG . . . . . 0.521 ' NH2' ' CZ2' ' B' ' 532' ' ' TRP . 0.1 OUTLIER -51.94 139.19 22.93 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.036 0.446 . . . . 0.0 111.09 -179.867 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 538' ' ' ILE . . . . . 0.434 ' CG2' ' HA ' ' B' ' 543' ' ' LEU . 5.8 tp -59.38 144.94 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.959 179.181 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 539' ' ' ASP . . . . . 0.408 ' HA ' ' O ' ' A' ' 10' ' ' GLY . 8.5 m-20 -43.84 136.95 3.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.815 0.341 . . . . 0.0 111.275 -179.432 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 540' ' ' GLU . . . . . 0.704 ' HA ' HD12 ' B' ' 543' ' ' LEU . 33.1 mm-40 -52.72 -21.66 4.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.163 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 541' ' ' LEU . . . . . 0.738 ' HA ' HD21 ' A' ' 70' ' ' LEU . 1.1 mp -37.03 -63.59 0.42 Allowed 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 542' ' ' TYR . . . . . 0.412 ' O ' ' CB ' ' B' ' 543' ' ' LEU . 0.1 OUTLIER -105.16 -58.68 1.86 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.304 -179.574 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 543' ' ' LEU . . . . . 0.704 HD12 ' HA ' ' B' ' 540' ' ' GLU . 0.1 OUTLIER 81.27 -167.97 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.369 -179.225 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . 93.44 -176.3 36.77 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.497 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 545' ' ' ASN . . . . . 0.552 ' HB2' HG22 ' A' ' 33' ' ' VAL . 6.1 m120 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.279 -0.867 . . . . 0.0 110.987 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.461 ' HE2' ' O ' ' A' ' 2' ' ' GLN . 7.9 tpt . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.769 0.319 . . . . 0.0 111.3 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.461 ' O ' ' HE2' ' A' ' 1' ' ' MET . 2.7 tt0 62.25 134.04 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.448 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.708 HG23 ' CE1' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -107.39 -166.5 1.16 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.908 -179.158 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.756 HD11 ' CD1' ' A' ' 53' ' ' LEU . 4.9 pt -156.44 162.36 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.588 -179.293 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.12 99.41 4.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.437 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.426 ' SG ' HD23 ' A' ' 55' ' ' LEU . 1.3 m -78.25 103.25 8.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.518 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.1 t -135.15 112.57 14.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.327 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.482 HG11 ' HG3' ' A' ' 16' ' ' LYS . 0.2 OUTLIER -103.42 138.62 27.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.299 0.571 . . . . 0.0 111.203 -179.592 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.406 ' O ' HG23 ' A' ' 9' ' ' VAL . 30.5 m -130.25 129.62 65.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.346 178.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 142.19 -172.42 24.2 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 119.867 -1.159 . . . . 0.0 112.7 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -96.5 27.48 3.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.779 0.323 . . . . 0.0 110.8 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.457 ' HA2' ' CD ' ' B' ' 537' ' ' ARG . . . -149.35 150.69 22.84 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.745 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.666 ' HB2' ' O2A' ' A' ' 185' ' ' GNP . . . -58.16 -54.56 45.55 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.551 0.215 . . . . 0.0 110.849 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.9 ' O ' HD21 ' A' ' 19' ' ' LEU . 0.0 OUTLIER 44.62 -87.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.472 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.528 ' HA2' HD21 ' A' ' 19' ' ' LEU . . . -102.32 23.13 35.31 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.242 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.712 ' O ' HD22 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -84.34 -163.52 0.81 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.947 0.403 . . . . 0.0 110.945 -179.823 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.452 ' HB ' ' CG1' ' A' ' 21' ' ' ILE . 6.1 p -74.84 -28.6 60.75 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.029 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.417 ' HB2' ' O2B' ' A' ' 185' ' ' GNP . 53.3 t -41.47 -30.06 0.18 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.643 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.9 HD21 ' O ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -62.83 -71.05 0.17 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.889 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.4 mt -70.07 -36.12 74.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.97 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.691 HG21 ' O ' ' A' ' 188' ' ' HOH . 4.5 mm -58.31 -71.2 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.418 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 25' ' ' THR . 24.5 m -55.22 -34.83 64.3 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 121.098 -0.241 . . . . 0.0 110.666 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.8 ' HB2' HD13 ' A' ' 165' ' ' LEU . 49.9 t80 -52.65 -35.12 54.36 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.435 ' O ' ' HB ' ' A' ' 25' ' ' THR . 0.2 OUTLIER -100.97 -46.24 5.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.71 179.258 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.49 ' O ' ' CB ' ' A' ' 26' ' ' ASN . 6.7 t -177.83 -162.84 0.07 Allowed 'General case' 0 C--O 1.227 -0.082 0 CA-C-N 116.342 -0.39 . . . . 0.0 112.003 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.492 ' HB2' HG23 ' A' ' 21' ' ' ILE . 14.1 t-20 97.6 -20.87 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.659 0.784 . . . . 0.0 110.616 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.6 mttp 60.06 146.67 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.963 0.411 . . . . 0.0 111.395 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.473 ' CD1' ' OH ' ' A' ' 32' ' ' TYR . 19.7 t80 -89.2 -47.69 0.41 Allowed Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.871 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 67.7 Cg_endo -88.29 58.14 2.71 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.793 2.328 . . . . 0.0 112.797 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.2 m -133.85 -85.53 0.43 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.823 0.344 . . . . 0.0 110.759 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -158.59 162.83 37.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.754 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.516 ' CD2' ' O1G' ' A' ' 185' ' ' GNP . 67.4 m-85 -135.22 103.56 5.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.971 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.567 HG12 HD21 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -165.31 -61.35 0.01 OUTLIER Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.341 -179.935 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.506 ' HD3' HG23 ' A' ' 33' ' ' VAL . 86.7 Cg_exo -42.84 -28.49 1.18 Allowed 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.371 2.048 . . . . 0.0 112.528 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.82 HG23 HD23 ' B' ' 543' ' ' LEU . 4.2 t -57.44 -20.81 32.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.192 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.964 HG21 ' HB2' ' A' ' 61' ' ' LEU . 12.6 p -52.0 -21.18 2.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.521 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.482 ' CD1' ' O ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -83.02 46.9 1.15 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.66 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.466 ' CB ' ' HB2' ' A' ' 57' ' ' ASP . 5.0 p-10 -63.66 -158.29 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.645 0.259 . . . . 0.0 110.837 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 73.73 22.48 2.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.804 0.335 . . . . 0.0 111.006 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.497 ' CE2' ' HA ' ' B' ' 520' ' ' HIS . 1.8 m-30 -60.18 129.31 41.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.77 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.443 ' O ' HG12 ' B' ' 519' ' ' ILE . . . -95.51 119.61 34.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.582 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.809 HG23 HG21 ' A' ' 52' ' ' THR . 17.5 m -117.74 159.82 17.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.986 0.422 . . . . 0.0 111.72 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.34 104.79 6.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.384 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.692 HG22 ' CG2' ' A' ' 52' ' ' THR . 10.4 m -149.04 -177.46 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.366 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.624 ' O ' HD11 ' B' ' 514' ' ' LEU . 4.7 tpt -99.07 96.62 7.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.342 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.669 HG22 ' O ' ' A' ' 46' ' ' ILE . 1.3 mm -80.44 86.66 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-O 121.33 0.586 . . . . 0.0 109.695 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.718 ' HA3' HG23 ' B' ' 510' ' ' ILE . . . 42.74 -92.42 0.01 OUTLIER Glycine 0 CA--C 1.524 0.601 0 CA-C-N 115.537 -0.756 . . . . 0.0 113.71 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . -38.55 -91.59 0.01 OUTLIER Glycine 0 CA--C 1.52 0.39 0 N-CA-C 113.988 0.355 . . . . 0.0 113.988 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.463 ' N ' ' HE1' ' A' ' 45' ' ' MET . 1.3 pt-20 -125.88 152.47 72.73 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-O 120.693 0.282 . . . . 0.0 110.932 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.401 ' N ' ' SD ' ' A' ' 45' ' ' MET . 83.0 Cg_exo -43.28 105.55 0.06 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.51 2.14 . . . . 0.0 112.266 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.708 ' CE1' HG23 ' A' ' 3' ' ' THR . 8.8 t80 -172.02 159.21 4.93 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.303 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.809 HG21 HG23 ' A' ' 42' ' ' VAL . 6.5 p -136.09 153.2 51.39 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.146 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.756 ' CD1' HD11 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -87.27 -179.19 6.37 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.919 179.807 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -128.54 103.51 0.62 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.627 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.426 HD23 ' SG ' ' A' ' 6' ' ' CYS . 0.1 OUTLIER -85.66 97.38 10.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.807 0.336 . . . . 0.0 110.254 179.702 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -84.23 105.61 15.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.694 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.807 ' OD2' HD21 ' B' ' 543' ' ' LEU . 0.6 OUTLIER -90.75 137.05 32.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.061 -179.775 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.879 ' O ' HD13 ' B' ' 543' ' ' LEU . 0.1 OUTLIER -99.03 143.38 29.37 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.278 179.807 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.901 ' HB3' HG23 ' A' ' 36' ' ' VAL . . . -153.14 177.4 10.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.923 0.392 . . . . 0.0 111.384 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.417 ' HA2' ' HA ' ' A' ' 65' ' ' ASP . . . -129.96 51.81 0.85 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.94 -0.647 . . . . 0.0 112.09 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.964 ' HB2' HG21 ' A' ' 36' ' ' VAL . 0.4 OUTLIER -120.82 -175.24 2.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.934 0.397 . . . . 0.0 111.199 -179.56 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -46.73 -40.24 13.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.347 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.439 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . 59.4 m-20 -47.25 -56.95 5.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.184 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.61 ' HB2' HD23 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -166.8 93.34 0.47 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.837 -179.855 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.417 ' HA ' ' HA2' ' A' ' 60' ' ' GLY . 0.2 OUTLIER -86.33 -7.43 58.49 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.558 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.37 -20.63 20.87 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.61 HD23 ' HB2' ' A' ' 64' ' ' TYR . 4.5 pp -51.36 160.98 0.5 Allowed 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.783 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 20.6 ttp85 -178.18 62.82 0.16 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.012 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -84.79 -23.38 2.62 Favored 'Trans proline' 0 N--CA 1.461 -0.383 0 C-N-CA 122.859 2.373 . . . . 0.0 112.581 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.71 ' O ' HD12 ' A' ' 70' ' ' LEU . 0.1 OUTLIER -71.75 -6.16 39.32 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.448 -179.672 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -48.36 -71.25 0.07 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.86 0.362 . . . . 0.0 111.097 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.405 ' N ' ' HD3' ' A' ' 73' ' ' PRO . 10.4 m-85 -140.33 62.52 20.03 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.879 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.409 ' HB2' ' CZ ' ' A' ' 78' ' ' PHE . 54.4 Cg_exo -52.36 130.58 36.55 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.685 2.257 . . . . 0.0 112.284 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -86.15 10.27 14.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.499 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 15.3 t -50.82 174.6 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.806 0.336 . . . . 0.0 110.817 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -112.3 -25.73 9.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.882 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.657 ' O ' HG13 ' A' ' 77' ' ' VAL . 8.2 p -126.57 99.14 5.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.172 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.414 ' HB2' ' O ' ' A' ' 109' ' ' PRO . 0.2 OUTLIER -80.89 176.58 9.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.61 179.826 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.559 ' CD2' ' HB1' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -127.83 108.74 10.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.077 -179.808 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.712 HG13 ' HB2' ' A' ' 110' ' ' PHE . 34.4 m -97.97 127.88 49.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.65 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.457 ' HB3' ' CG2' ' A' ' 14' ' ' VAL . 21.1 p -99.63 174.02 6.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.14 0.495 . . . . 0.0 111.632 -179.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.571 ' CZ ' ' HB2' ' A' ' 142' ' ' ALA . 8.3 p90 -179.63 -174.3 0.29 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.17 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.427 ' N ' ' CD2' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -156.08 149.89 25.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.752 0.31 . . . . 0.0 110.856 179.885 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.771 ' CG2' HG22 ' A' ' 117' ' ' ILE . 43.8 t -61.71 -41.84 92.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.345 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.689 HG13 ' CD ' ' A' ' 120' ' ' ARG . 17.6 m -59.64 114.8 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.365 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.785 ' N ' HD22 ' A' ' 129' ' ' LEU . 0.6 OUTLIER -152.02 117.47 3.08 Favored Pre-proline 0 C--N 1.329 -0.294 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.801 -179.57 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.425 ' O ' ' CB ' ' A' ' 132' ' ' ASN . 89.7 Cg_endo -94.01 53.28 0.33 Allowed 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.114 2.543 . . . . 0.0 111.288 179.154 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.46 ' HA ' ' HG3' ' A' ' 133' ' ' LYS . 0.2 OUTLIER 81.12 30.07 0.16 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.661 -179.253 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 73.9 m -97.2 -16.84 20.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.133 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.821 ' CE2' HD12 ' A' ' 137' ' ' ILE . 0.1 OUTLIER -43.26 -42.11 4.22 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.869 0.366 . . . . 0.0 111.403 -179.919 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -63.41 -33.6 75.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.973 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.406 ' O ' ' N ' ' A' ' 96' ' ' LYS . 7.4 m120 -75.23 -52.98 9.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.095 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.434 ' CG2' ' HA ' ' A' ' 90' ' ' PHE . 7.4 m -49.71 -44.59 20.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.233 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.454 ' O ' HG23 ' A' ' 98' ' ' VAL . 0.1 OUTLIER -65.44 -49.78 67.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.899 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -82.57 7.34 14.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.671 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.406 ' N ' ' O ' ' A' ' 92' ' ' ASN . 4.8 tttt -115.3 -27.34 7.27 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.721 0.296 . . . . 0.0 111.036 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.413 ' O ' HG22 ' A' ' 101' ' ' ILE . 1.7 m95 -94.31 -50.18 5.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.388 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.674 HG13 HD21 ' A' ' 149' ' ' LEU . 61.9 t -50.89 -46.01 87.42 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.962 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 95.3 Cg_endo -81.03 -11.21 12.38 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.377 2.051 . . . . 0.0 113.016 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.405 ' HB3' ' O ' ' A' ' 96' ' ' LYS . 1.2 tt0 -90.34 -57.0 2.99 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 120.906 0.384 . . . . 0.0 110.187 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.413 HG22 ' O ' ' A' ' 97' ' ' TRP . 20.8 tt -57.34 -27.88 29.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.084 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.76 HG22 ' HA ' ' A' ' 107' ' ' LYS . 23.2 p -86.33 -29.66 22.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.75 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -58.62 -54.84 42.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.851 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 52.9 m170 -65.54 -42.04 92.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.79 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -125.87 124.02 24.71 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.669 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -50.98 89.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.414 2.076 . . . . 0.0 112.261 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.76 ' HA ' HG22 ' A' ' 102' ' ' THR . 0.1 OUTLIER 63.29 94.54 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.911 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.428 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 0.1 OUTLIER -119.66 126.76 26.77 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.875 -179.974 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 108' ' ' THR . 37.5 Cg_exo -60.64 176.84 0.75 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.435 2.09 . . . . 0.0 112.236 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.712 ' HB2' HG13 ' A' ' 80' ' ' VAL . 32.7 p90 -165.93 176.39 7.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.852 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.632 HD12 HG11 ' A' ' 152' ' ' VAL . 1.1 tt -139.56 134.37 32.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.886 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.538 HD23 ' CB ' ' A' ' 146' ' ' ALA . 4.1 mm? -89.78 138.48 31.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.205 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 1.02 HG13 HG21 ' A' ' 168' ' ' VAL . 11.0 t -130.45 147.57 33.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.11 0.481 . . . . 0.0 112.064 -179.202 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -113.31 142.18 17.3 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.648 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.677 ' C ' HD13 ' A' ' 117' ' ' ILE . 0.8 OUTLIER -153.83 -61.53 0.14 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.853 0.359 . . . . 0.0 111.03 -179.622 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.452 ' H ' HN22 ' A' ' 185' ' ' GNP . 10.5 mm100 -60.12 -20.4 58.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.026 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.771 HG22 ' CG2' ' A' ' 84' ' ' VAL . 0.2 OUTLIER -40.69 -29.13 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.867 -179.796 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -65.93 -42.19 90.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.812 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.71 HD22 HD22 ' A' ' 160' ' ' LEU . 0.1 OUTLIER -93.02 -48.16 6.64 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -179.327 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.689 ' CD ' HG13 ' A' ' 85' ' ' VAL . 1.4 mmt180 -48.15 -26.78 2.03 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.814 0.34 . . . . 0.0 111.024 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.06 -21.07 43.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.871 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.418 ' OD1' ' HD3' ' A' ' 123' ' ' PRO . 0.2 OUTLIER -64.62 153.56 87.04 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.867 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.451 ' O ' HG22 ' A' ' 126' ' ' ILE . 2.3 Cg_endo -81.35 -2.68 11.73 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.997 2.465 . . . . 0.0 112.957 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 40.7 t -81.49 -69.98 0.57 Allowed 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 120.879 0.371 . . . . 0.0 110.49 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.657 HG21 HG11 ' A' ' 85' ' ' VAL . 8.4 m -51.46 -33.77 32.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.411 0.624 . . . . 0.0 109.6 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.691 HD11 ' HB3' ' A' ' 136' ' ' PRO . 0.1 OUTLIER -58.63 -42.85 86.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.449 179.021 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.456 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 1.4 mm-40 -57.3 -35.41 69.78 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.568 179.147 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 125' ' ' THR . 3.9 mptt -65.66 -33.15 75.22 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.785 HD22 ' N ' ' A' ' 86' ' ' SER . 9.0 mt -73.64 -36.61 65.44 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.1 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 127' ' ' GLU . . . -49.15 -34.1 13.58 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.97 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 10.9 mmmm -47.58 -32.77 5.77 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.666 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.425 ' CB ' ' O ' ' A' ' 87' ' ' PRO . 43.4 m-80 -123.12 -31.22 3.63 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.281 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.512 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 9.3 mmtm -146.2 -95.05 0.09 Allowed 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 119.273 -0.394 . . . . 0.0 111.367 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.512 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 7.4 pt20 128.94 -21.17 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.482 1.113 . . . . 0.0 110.574 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.6 mttm -68.4 110.88 6.52 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.648 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.691 ' HB3' HD11 ' A' ' 126' ' ' ILE . 93.1 Cg_endo -82.86 130.15 5.69 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.67 2.246 . . . . 0.0 111.576 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.821 HD12 ' CE2' ' A' ' 90' ' ' PHE . 1.1 mm -62.47 96.78 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.941 0.401 . . . . 0.0 110.748 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.445 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.7 p -67.69 156.11 89.8 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.888 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.497 ' HA ' ' CE1' ' A' ' 154' ' ' TYR . 10.3 Cg_endo -51.71 -23.23 14.99 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.657 2.238 . . . . 0.0 112.023 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -86.11 -26.41 25.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.587 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.537 ' HB ' HG22 ' A' ' 137' ' ' ILE . 1.8 m -63.35 -56.84 13.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.661 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.571 ' HB2' ' CZ ' ' A' ' 82' ' ' PHE . . . -52.5 -36.96 56.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.828 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.14 -36.04 82.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.709 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.15 -56.86 13.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.815 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 50.5 tp -65.17 -36.77 85.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.764 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.538 ' CB ' HD23 ' A' ' 112' ' ' LEU . . . -57.46 -51.09 70.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.943 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 -71.64 -24.51 61.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.857 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -50.24 -41.74 50.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.832 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.674 HD21 HG13 ' A' ' 98' ' ' VAL . 1.3 mp -104.42 25.18 10.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.847 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.42 ' CD ' ' O ' ' A' ' 149' ' ' LEU . 0.0 OUTLIER 44.95 39.25 3.5 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.305 -179.971 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.679 ' HB1' ' O ' ' A' ' 110' ' ' PHE . . . -62.26 -81.02 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.028 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.632 HG11 HD12 ' A' ' 111' ' ' LEU . 78.4 t -159.59 -75.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.023 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.439 ' HG3' ' N ' ' A' ' 154' ' ' TYR . 0.5 OUTLIER 170.13 146.06 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.746 -178.971 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.497 ' CE1' ' HA ' ' A' ' 139' ' ' PRO . 10.2 t80 -100.77 113.58 26.61 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.478 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.628 HG12 ' H ' ' A' ' 156' ' ' GLU . 1.7 t -101.6 175.73 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.629 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.628 ' H ' HG12 ' A' ' 155' ' ' VAL . 0.5 OUTLIER -88.8 145.19 25.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.021 0.439 . . . . 0.0 111.073 -179.444 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.453 ' O ' HD11 ' A' ' 117' ' ' ILE . 2.8 t -169.93 151.22 4.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.257 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.562 ' OG ' HG22 ' A' ' 161' ' ' THR . 2.4 t -160.23 123.47 3.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.072 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -92.74 20.56 6.35 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.953 179.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.71 HD22 HD22 ' A' ' 119' ' ' LEU . 0.3 OUTLIER -131.57 -44.06 1.0 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.575 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.562 HG22 ' OG ' ' A' ' 158' ' ' SER . 15.3 t -107.06 -19.51 13.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.889 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 78.05 77.78 0.07 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.098 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.424 ' HB2' ' HB2' ' A' ' 158' ' ' SER . 25.6 tptt -96.17 30.23 2.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.815 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 119.01 -58.09 0.54 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.516 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.8 HD13 ' HB2' ' A' ' 23' ' ' TYR . 0.7 OUTLIER 66.74 -73.58 0.07 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.787 0.327 . . . . 0.0 111.123 179.909 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.427 ' O ' ' N ' ' A' ' 170' ' ' ASP . 1.9 mtpt -56.9 -31.9 65.36 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.01 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.575 ' OD1' HG11 ' A' ' 155' ' ' VAL . 1.2 t-20 -52.31 -71.71 0.06 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.291 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 1.02 HG21 HG13 ' A' ' 113' ' ' VAL . 13.6 p -57.06 -47.43 83.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.478 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.796 ' CD2' HD23 ' A' ' 19' ' ' LEU . 1.8 t80 -62.38 -25.79 68.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.59 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' A' ' 166' ' ' LYS . 28.4 t0 -71.58 -29.84 65.16 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.481 ' HB3' HD11 ' A' ' 111' ' ' LEU . 0.7 OUTLIER -73.67 -29.84 62.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.845 179.123 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.559 ' HB1' ' CD2' ' A' ' 79' ' ' LEU . . . -67.44 -49.67 62.66 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.835 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 1.6 pp -72.49 -32.59 42.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.11 0.481 . . . . 0.0 110.414 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.615 HD13 HD23 ' B' ' 505' ' ' LEU . 10.1 tp -46.13 -44.47 15.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.175 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.637 ' HB3' HG21 ' A' ' 77' ' ' VAL . . . -57.0 -24.24 52.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.818 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.507 ' HB1' ' HA ' ' A' ' 4' ' ' ILE . . . -94.87 -31.72 13.57 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.104 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.492 HD13 HG21 ' A' ' 4' ' ' ILE . 2.5 tp -68.27 -26.13 65.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.676 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.775 ' HB2' ' HB1' ' B' ' 507' ' ' ALA . 1.0 OUTLIER 171.24 149.3 0.17 Allowed Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.687 179.808 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.437 ' HD2' ' CG ' ' A' ' 178' ' ' GLU . 16.1 Cg_endo -57.48 107.71 0.32 Allowed 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.691 2.261 . . . . 0.0 112.272 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -80.53 171.88 14.14 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.664 2.242 . . . . 0.0 112.419 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -113.62 139.56 23.52 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.872 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -76.46 -165.28 0.3 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.68 2.253 . . . . 0.0 112.342 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 10.7 mttt -134.62 80.28 1.84 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.865 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.88 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.193 0 N-CA-C 112.525 -0.23 . . . . 0.0 112.525 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 503' ' ' SER . . . . . 0.452 ' HB3' ' CD1' ' B' ' 505' ' ' LEU . 37.5 m -64.14 -78.77 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.856 0.36 . . . . 0.0 110.844 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 504' ' ' GLY . . . . . 0.847 ' C ' HD13 ' B' ' 505' ' ' LEU . . . 87.82 109.69 0.99 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.414 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 505' ' ' LEU . . . . . 0.847 HD13 ' C ' ' B' ' 504' ' ' GLY . 0.0 OUTLIER -167.17 55.12 0.08 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.701 0.286 . . . . 0.0 111.137 -179.274 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 506' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 48.48 66.44 1.07 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.917 0.389 . . . . 0.0 110.613 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 507' ' ' ALA . . . . . 0.775 ' HB1' ' HB2' ' A' ' 178' ' ' GLU . . . -175.5 53.42 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.79 -179.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 508' ' ' GLN . . . . . 0.465 ' HB3' ' O ' ' B' ' 507' ' ' ALA . 1.7 tt0 68.86 5.35 4.94 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.664 -178.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 509' ' ' ASP . . . . . 0.418 ' HA ' ' HA2' ' B' ' 504' ' ' GLY . 2.7 p30 51.54 47.1 25.45 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.449 0.643 . . . . 0.0 110.799 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 510' ' ' ILE . . . . . 0.718 HG23 ' HA3' ' A' ' 47' ' ' GLY . 80.3 mt -87.49 138.3 19.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.401 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 511' ' ' SER . . . . . . . . . . . . . 1.2 m -78.33 122.24 25.49 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.335 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 512' ' ' GLN . . . . . 0.517 ' HB2' ' HD2' ' B' ' 513' ' ' PRO . 0.0 OUTLIER -50.6 179.58 0.04 OUTLIER Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.893 179.265 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 513' ' ' PRO . . . . . 0.517 ' HD2' ' HB2' ' B' ' 512' ' ' GLN . 85.0 Cg_exo -46.12 92.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 121.78 1.653 . . . . 0.0 111.46 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 514' ' ' LEU . . . . . 0.624 HD11 ' O ' ' A' ' 45' ' ' MET . 0.0 OUTLIER -62.84 -168.33 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.27 -179.021 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 515' ' ' GLN . . . . . 0.518 ' O ' HG11 ' A' ' 44' ' ' VAL . 7.9 mt-30 -89.02 178.59 6.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.874 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 66.56 11.22 7.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.192 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 517' ' ' SER . . . . . 0.56 ' O ' HG11 ' A' ' 42' ' ' VAL . 3.4 p -100.9 65.48 1.12 Allowed 'General case' 0 N--CA 1.456 -0.139 0 CA-C-O 120.898 0.38 . . . . 0.0 110.759 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 518' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -158.06 91.86 1.14 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.644 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 519' ' ' ILE . . . . . 0.443 HG12 ' O ' ' A' ' 41' ' ' ALA . 3.5 mm -100.49 -19.02 6.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.581 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 520' ' ' HIS . . . . . 0.497 ' HA ' ' CE2' ' A' ' 40' ' ' TYR . 0.7 OUTLIER 72.91 103.12 0.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.866 0.365 . . . . 0.0 110.906 -179.737 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 521' ' ' THR . . . . . . . . . . . . . 3.2 m -143.86 57.6 1.35 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.825 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 522' ' ' GLY . . . . . . . . . . . . . . . -149.52 159.94 28.27 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.218 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 523' ' ' HIS . . . . . 0.454 ' N ' ' HB2' ' A' ' 37' ' ' PHE . 0.3 OUTLIER -98.68 -91.26 0.28 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.675 0.238 . . . . 0.0 110.959 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 524' ' ' GLY . . . . . 0.424 ' O ' ' CB ' ' B' ' 525' ' ' ASP . . . 45.52 -131.98 9.24 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.777 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 525' ' ' ASP . . . . . 0.424 ' CB ' ' O ' ' B' ' 524' ' ' GLY . 4.2 m-20 82.07 79.22 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.038 0.446 . . . . 0.0 111.02 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 526' ' ' SER . . . . . 0.482 ' HB3' HG11 ' A' ' 33' ' ' VAL . 0.4 OUTLIER -113.75 99.44 7.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.459 179.594 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 527' ' ' ASP . . . . . 0.411 ' HB2' ' HD2' ' B' ' 528' ' ' PRO . 0.4 OUTLIER -40.15 163.61 0.08 OUTLIER Pre-proline 0 N--CA 1.465 0.309 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.724 -179.703 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 528' ' ' PRO . . . . . 0.411 ' HD2' ' HB2' ' B' ' 527' ' ' ASP . 10.6 Cg_endo -51.08 112.05 0.7 Allowed 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 123.053 2.502 . . . . 0.0 111.988 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 529' ' ' ARG . . . . . 0.45 ' HD2' HG11 ' A' ' 33' ' ' VAL . 30.3 mtp180 -100.71 -54.1 2.91 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.258 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 530' ' ' HIS . . . . . . . . . . . . . 25.4 m-70 -137.68 10.29 2.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.587 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 3.9 m 44.99 -160.96 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.84 0.352 . . . . 0.0 111.286 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 532' ' ' TRP . . . . . 0.487 ' HB2' ' CD1' ' A' ' 32' ' ' TYR . 12.1 t-105 -132.34 92.29 3.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.867 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . -92.82 -48.87 2.82 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.526 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 534' ' ' PHE . . . . . 0.402 ' HA ' ' HD3' ' B' ' 535' ' ' PRO . 32.5 m-85 -106.87 140.21 21.15 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.658 0.266 . . . . 0.0 110.916 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 535' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' B' ' 534' ' ' PHE . 42.9 Cg_exo -56.17 -158.16 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.518 2.146 . . . . 0.0 112.303 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 69.24 61.36 0.31 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.886 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 537' ' ' ARG . . . . . 0.522 ' HG2' ' PA ' ' A' ' 185' ' ' GNP . 0.0 OUTLIER -48.75 159.56 0.23 Allowed 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.0 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 538' ' ' ILE . . . . . 0.453 ' CG1' ' HB2' ' B' ' 542' ' ' TYR . 10.3 tp -81.72 141.33 15.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.482 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 539' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -45.5 161.16 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.883 0.373 . . . . 0.0 111.221 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 540' ' ' GLU . . . . . 0.684 ' O ' HG23 ' A' ' 58' ' ' THR . 0.4 OUTLIER -61.61 -14.89 34.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.555 -179.854 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 541' ' ' LEU . . . . . 0.532 ' CB ' HD23 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -66.22 -32.77 74.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.365 0.603 . . . . 0.0 110.062 179.708 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 542' ' ' TYR . . . . . 0.453 ' HB2' ' CG1' ' B' ' 538' ' ' ILE . 40.7 m-85 -104.9 -50.76 3.19 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.17 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 543' ' ' LEU . . . . . 0.879 HD13 ' O ' ' A' ' 58' ' ' THR . 0.5 OUTLIER 72.42 -68.02 0.24 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.931 -179.678 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . -117.44 164.02 12.61 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.493 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 545' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.888 179.988 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 185' ' ' GNP . . . . . 0.666 ' O2A' ' HB2' ' A' ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 188' ' ' HOH . . . . . 0.691 ' O ' HG21 ' A' ' 21' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.597 ' HE1' ' HD1' ' A' ' 51' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.418 0 N-CA-C 111.529 0.196 . . . . 0.0 111.529 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.402 ' O ' ' O ' ' A' ' 1' ' ' MET . 32.7 tp60 56.42 154.93 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.104 0.478 . . . . 0.0 111.556 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.891 ' HB ' HD22 ' A' ' 53' ' ' LEU . 0.3 OUTLIER -146.02 -168.97 3.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.034 179.991 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.755 ' O ' HD23 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -145.1 156.08 13.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.561 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 28.9 mttm -118.19 105.74 12.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.515 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.422 ' O ' ' N ' ' A' ' 56' ' ' PHE . 36.2 t -77.3 105.07 8.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.09 0.471 . . . . 0.0 111.934 -178.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.534 HG22 ' CB ' ' A' ' 56' ' ' PHE . 2.6 t -132.94 118.86 34.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.836 178.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.611 HG11 ' HG3' ' A' ' 16' ' ' LYS . 0.4 OUTLIER -96.69 143.41 12.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.315 0.579 . . . . 0.0 111.08 -179.235 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.83 HG21 ' CD2' ' A' ' 78' ' ' PHE . 12.6 m -140.88 129.75 24.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.482 178.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.407 ' O ' ' HB3' ' B' ' 539' ' ' ASP . . . 154.43 -143.06 9.61 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.024 -1.084 . . . . 0.0 112.734 -179.252 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -123.24 22.71 9.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.668 0.27 . . . . 0.0 110.953 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.434 ' CA ' ' O ' ' B' ' 536' ' ' ASP . . . -153.42 -172.45 21.62 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.406 -0.902 . . . . 0.0 113.364 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.666 ' HB2' ' HG3' ' B' ' 537' ' ' ARG . . . -63.69 -48.74 75.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.777 0.322 . . . . 0.0 111.462 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.665 HG22 ' SG ' ' A' ' 81' ' ' CYS . 61.5 t 68.37 -72.14 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.117 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.882 ' CA ' HD22 ' A' ' 19' ' ' LEU . . . -172.36 66.32 0.13 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.631 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.667 ' CD ' HD21 ' B' ' 543' ' ' LEU . 27.0 mttt -97.14 -97.56 0.2 Allowed 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 121.457 -0.097 . . . . 0.0 110.803 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.425 ' O ' HG12 ' A' ' 21' ' ' ILE . 58.3 p -98.22 -57.35 2.23 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-O 120.832 0.349 . . . . 0.0 111.177 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.446 ' CB ' ' O2A' ' A' ' 185' ' ' GNP . 14.8 p -36.17 -43.84 0.37 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.456 -179.403 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.967 HD23 ' CD2' ' A' ' 169' ' ' PHE . 1.8 mp -46.41 -70.96 0.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.793 0.33 . . . . 0.0 111.284 -179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.466 HD12 ' CZ ' ' B' ' 518' ' ' PHE . 14.7 mt -61.96 -25.57 67.69 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.84 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.442 HG22 ' OG1' ' A' ' 25' ' ' THR . 15.2 mm -67.2 -70.36 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.666 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.435 ' HB2' ' CD1' ' A' ' 165' ' ' LEU . 3.4 m -47.79 -28.93 2.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.082 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -66.84 -68.18 0.39 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.833 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.02 -48.11 39.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.72 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.442 ' OG1' HG22 ' A' ' 21' ' ' ILE . 13.4 p -83.2 -152.29 0.12 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.424 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -160.11 33.46 0.17 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.821 0.343 . . . . 0.0 111.033 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 13.8 mmtt -121.32 101.71 7.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.408 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.493 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . 7.9 t80 -104.87 -60.11 0.06 OUTLIER Pre-proline 0 CA--C 1.537 0.444 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.124 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.493 ' HD3' ' HB3' ' A' ' 28' ' ' PHE . 95.1 Cg_endo -84.21 48.7 2.56 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.151 1.9 . . . . 0.0 112.608 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.84 -80.79 0.43 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.029 0.442 . . . . 0.0 110.656 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.448 ' HB2' ' NE ' ' B' ' 529' ' ' ARG . 12.9 pt-20 -158.34 140.98 14.51 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.63 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.525 ' CD1' ' N3B' ' A' ' 185' ' ' GNP . 91.7 m-85 -130.21 100.91 5.57 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.514 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.556 HG23 ' HD3' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -165.28 -63.55 0.01 OUTLIER Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.157 -179.541 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.556 ' HD3' HG23 ' A' ' 33' ' ' VAL . 74.9 Cg_exo -38.75 -29.77 0.17 Allowed 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.745 2.296 . . . . 0.0 112.905 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.947 HG23 ' OD2' ' A' ' 38' ' ' ASP . 60.9 m -56.53 85.54 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.993 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.592 HG11 ' HB2' ' A' ' 61' ' ' LEU . 2.6 t -140.5 -40.42 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.282 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.457 ' CE2' ' OD1' ' A' ' 63' ' ' ASP . 0.3 OUTLIER -91.19 25.13 2.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.966 179.698 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.947 ' OD2' HG23 ' A' ' 35' ' ' THR . 0.7 OUTLIER -57.78 -159.85 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.873 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 68.26 29.46 6.01 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.943 0.401 . . . . 0.0 110.46 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.414 ' CE1' ' O ' ' B' ' 521' ' ' THR . 0.7 OUTLIER -60.72 -160.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.852 -179.808 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.419 ' O ' HG12 ' B' ' 519' ' ' ILE . . . -122.97 123.27 40.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.466 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.481 HG13 ' C ' ' B' ' 517' ' ' SER . 3.3 t -106.76 121.7 59.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.64 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.593 ' OG1' HD11 ' B' ' 519' ' ' ILE . 6.5 p -108.79 106.84 17.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.197 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.655 ' CG2' HG21 ' A' ' 52' ' ' THR . 27.3 m -159.46 -178.91 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.916 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.651 ' O ' HD22 ' B' ' 514' ' ' LEU . 0.0 OUTLIER -98.37 103.39 15.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.844 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.571 HG22 ' O ' ' A' ' 51' ' ' TYR . 1.2 tt -95.2 106.29 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-O 121.529 0.681 . . . . 0.0 111.021 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.51 ' N ' HG23 ' B' ' 510' ' ' ILE . . . 43.61 -93.19 0.01 OUTLIER Glycine 0 CA--C 1.517 0.178 0 C-N-CA 121.001 -0.619 . . . . 0.0 113.526 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.444 ' HA3' ' CB ' ' A' ' 1' ' ' MET . . . -39.2 -86.16 0.01 OUTLIER Glycine 0 C--N 1.334 0.458 0 C-N-CA 121.393 -0.432 . . . . 0.0 113.371 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.481 ' HB3' ' HD2' ' A' ' 50' ' ' PRO . 4.0 mt-10 -144.06 177.58 1.76 Allowed Pre-proline 0 C--N 1.331 -0.205 0 CA-C-O 120.671 0.272 . . . . 0.0 111.04 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 49' ' ' GLU . 76.8 Cg_exo -51.23 92.98 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.551 2.167 . . . . 0.0 112.614 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.597 ' HD1' ' HE1' ' A' ' 1' ' ' MET . 2.8 t80 -173.29 125.96 0.42 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.386 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.655 HG21 ' CG2' ' A' ' 44' ' ' VAL . 0.1 OUTLIER -134.3 144.29 48.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.798 0.332 . . . . 0.0 111.161 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.891 HD22 ' HB ' ' A' ' 3' ' ' THR . 0.9 OUTLIER -87.69 -177.33 5.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.89 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -123.92 116.47 2.86 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.438 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.45 ' H ' HD12 ' A' ' 55' ' ' LEU . 2.2 mp -50.77 139.13 17.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.874 0.369 . . . . 0.0 110.844 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.534 ' CB ' HG22 ' A' ' 7' ' ' VAL . 7.8 t80 -85.76 135.0 33.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.311 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.452 ' CB ' ' HB2' ' A' ' 38' ' ' ASP . 0.1 OUTLIER -150.54 131.88 14.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.372 179.558 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.743 ' OG1' HD21 ' A' ' 67' ' ' LEU . 2.5 p -130.25 125.0 33.75 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.164 -179.185 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.72 ' HB1' ' CD1' ' A' ' 61' ' ' LEU . . . -144.19 99.68 3.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.7 179.141 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.09 75.79 0.25 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.684 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.72 ' CD1' ' HB1' ' A' ' 59' ' ' ALA . 4.6 mp -121.49 -95.89 0.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 121.312 -0.155 . . . . 0.0 111.207 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -99.36 -30.3 12.29 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 120.766 0.317 . . . . 0.0 111.487 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.457 ' OD1' ' CE2' ' A' ' 37' ' ' PHE . 29.7 t0 -80.57 -63.73 1.34 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.619 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.524 ' CD2' ' CD1' ' A' ' 67' ' ' LEU . 19.0 m-85 -88.27 144.53 26.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.917 0.389 . . . . 0.0 110.874 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -86.26 -62.04 1.61 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.831 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.29 -52.98 3.49 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -178.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.743 HD21 ' OG1' ' A' ' 58' ' ' THR . 0.4 OUTLIER 64.78 -151.25 0.28 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 120.596 -0.442 . . . . 0.0 109.832 -179.566 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.576 ' CB ' HD21 ' B' ' 541' ' ' LEU . 0.1 OUTLIER 78.28 41.94 0.06 OUTLIER Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 179.5 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.574 ' CG ' HG21 ' A' ' 58' ' ' THR . 88.3 Cg_endo -82.89 -21.95 4.55 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.302 2.002 . . . . 0.0 112.09 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.974 HD21 ' HA ' ' B' ' 541' ' ' LEU . 0.1 OUTLIER -60.52 -15.17 24.68 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.621 -179.677 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.33 -60.55 3.68 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.752 0.311 . . . . 0.0 110.968 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.01 65.07 74.47 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.923 0.392 . . . . 0.0 111.146 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 70' ' ' LEU . 83.6 Cg_endo -82.56 145.88 13.31 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.801 2.334 . . . . 0.0 112.189 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -96.64 10.25 39.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.48 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 11.5 t -53.05 -176.32 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.752 0.31 . . . . 0.0 110.878 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -136.5 7.35 3.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.553 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.907 HG21 ' HB2' ' A' ' 176' ' ' ALA . 4.8 t -139.03 86.76 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.725 0.298 . . . . 0.0 111.458 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.83 ' CD2' HG21 ' A' ' 9' ' ' VAL . 0.5 OUTLIER -80.85 172.01 14.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.084 179.351 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.518 HD23 HG12 ' A' ' 14' ' ' VAL . 9.8 tp -157.0 120.98 4.28 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.084 0.469 . . . . 0.0 111.812 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.485 ' HB ' ' CH2' ' A' ' 97' ' ' TRP . 0.7 OUTLIER -114.11 135.83 52.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.981 179.041 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.665 ' SG ' HG22 ' A' ' 14' ' ' VAL . 4.6 p -125.83 164.33 20.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.245 0.545 . . . . 0.0 112.283 -178.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.487 ' CE2' HD12 ' A' ' 112' ' ' LEU . 11.3 p90 -169.36 135.61 1.64 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.131 179.483 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.439 ' HA ' ' C2 ' ' A' ' 185' ' ' GNP . 50.2 p -88.41 144.66 26.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.816 0.341 . . . . 0.0 110.943 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.743 HG13 ' N ' ' A' ' 137' ' ' ILE . 45.1 t -46.17 -63.14 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.56 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.604 ' O ' HG23 ' A' ' 85' ' ' VAL . 35.3 m -45.47 110.02 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.698 0.285 . . . . 0.0 110.829 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.623 ' N ' HD22 ' A' ' 129' ' ' LEU . 0.2 OUTLIER -151.6 131.46 6.94 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.827 -179.347 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 86' ' ' SER . 67.8 Cg_endo -92.58 53.33 0.55 Allowed 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 123.289 2.659 . . . . 0.0 111.837 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.451 ' CA ' ' HG3' ' A' ' 133' ' ' LYS . 1.0 OUTLIER 80.31 30.17 0.22 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.069 -179.745 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.729 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -95.22 -23.03 17.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.857 179.658 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.654 ' CZ ' HG21 ' A' ' 137' ' ' ILE . 0.8 OUTLIER -52.49 -58.41 6.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.93 179.924 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -58.22 -40.7 82.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.936 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -64.64 -59.21 4.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.886 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.729 HG23 ' O ' ' A' ' 89' ' ' SER . 47.1 t -51.22 -52.74 17.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.181 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.766 ' HG3' HD11 ' A' ' 145' ' ' LEU . 10.8 tmtt? -50.49 -50.43 52.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.901 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.406 ' O ' ' HG2' ' A' ' 99' ' ' PRO . 3.1 mt-10 -54.25 -42.12 69.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.183 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.72 12.23 34.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.543 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.507 ' O ' HG22 ' A' ' 101' ' ' ILE . 0.0 OUTLIER -94.47 -53.16 4.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.744 0.307 . . . . 0.0 111.087 179.918 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 1.016 HG22 HD13 ' A' ' 149' ' ' LEU . 3.5 t -60.36 -44.94 97.31 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.896 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.493 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 16.4 Cg_exo -68.31 -33.72 23.14 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.539 2.159 . . . . 0.0 112.923 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -85.73 -35.7 20.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.649 -0.25 . . . . 0.0 111.437 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.622 HD11 ' HB3' ' A' ' 110' ' ' PHE . 12.7 tt -68.75 -25.98 31.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.755 0.312 . . . . 0.0 111.056 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 68.0 p -97.18 -26.85 14.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.046 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.47 ' CG ' ' O ' ' A' ' 99' ' ' PRO . 5.1 m170 -66.68 -41.84 87.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.047 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -76.68 -24.33 53.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.103 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.414 ' O ' ' N ' ' A' ' 107' ' ' LYS . 8.0 m -137.4 123.06 12.91 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.854 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 105' ' ' CYS . 32.3 Cg_exo -58.17 79.76 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.571 2.181 . . . . 0.0 112.234 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.414 ' N ' ' O ' ' A' ' 105' ' ' CYS . 2.6 mmmp? 61.39 91.41 0.06 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.917 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.442 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 0.1 OUTLIER -122.57 138.08 28.79 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.921 179.929 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 108' ' ' THR . 31.5 Cg_exo -60.28 138.02 78.49 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.618 2.212 . . . . 0.0 112.468 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.622 ' HB3' HD11 ' A' ' 101' ' ' ILE . 1.0 OUTLIER -142.25 147.18 36.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.715 179.656 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.757 HD23 ' O ' ' A' ' 112' ' ' LEU . 0.9 OUTLIER -130.02 158.0 40.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.314 -179.678 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.757 ' O ' HD23 ' A' ' 111' ' ' LEU . 3.0 mm? -97.19 161.35 13.85 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.667 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.752 ' HA ' HG21 ' A' ' 168' ' ' VAL . 18.2 t -135.03 138.69 48.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.049 0.452 . . . . 0.0 111.889 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.432 ' HA3' ' CZ ' ' A' ' 154' ' ' TYR . . . -123.26 107.31 1.08 Allowed Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.59 179.334 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.849 ' OG1' " H2'" ' A' ' 185' ' ' GNP . 0.0 OUTLIER -130.81 -53.18 1.06 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.852 0.358 . . . . 0.0 110.704 -179.187 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.832 ' HG2' HD13 ' A' ' 119' ' ' LEU . 1.6 tt0 -79.89 53.8 1.74 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.274 179.008 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.786 HD11 ' O ' ' A' ' 157' ' ' CYS . 0.1 OUTLIER -99.12 -5.8 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.006 179.834 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -77.73 -27.43 50.51 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.936 0.398 . . . . 0.0 110.536 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.832 HD13 ' HG2' ' A' ' 116' ' ' GLN . 5.0 mp -76.69 -24.36 53.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.591 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.462 ' O ' HD13 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -46.71 -29.38 1.86 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.811 179.783 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -83.79 -34.92 24.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.405 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.63 104.49 0.44 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.575 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.457 ' HA ' ' CG2' ' A' ' 126' ' ' ILE . 14.7 Cg_exo -69.06 -3.73 12.14 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.703 2.269 . . . . 0.0 113.106 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.03 -66.4 0.87 Allowed 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 121.109 0.48 . . . . 0.0 109.758 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.416 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 18.2 m -57.92 -37.92 74.94 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.482 ' HA ' HD12 ' A' ' 129' ' ' LEU . 0.0 OUTLIER -54.85 -42.95 65.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.781 179.337 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.537 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 35.6 mt-10 -60.08 -35.1 74.45 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.86 179.222 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 125' ' ' THR . 0.0 OUTLIER -65.38 -30.91 71.79 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.071 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.623 HD22 ' N ' ' A' ' 86' ' ' SER . 7.4 mt -73.94 -35.59 64.59 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.036 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 127' ' ' GLU . . . -46.25 -34.63 4.56 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.894 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 5.7 mmmt -47.51 -33.06 5.89 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.478 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.418 ' HB2' ' O ' ' A' ' 87' ' ' PRO . 55.7 m-80 -123.43 -31.4 3.53 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.451 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.523 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 16.7 mmtp -146.85 -97.49 0.09 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 119.208 -0.425 . . . . 0.0 111.662 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.523 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 4.6 pt20 128.99 -25.74 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.473 1.109 . . . . 0.0 110.331 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -69.36 110.63 6.64 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.761 -179.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.432 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 95.3 Cg_endo -79.53 136.97 12.71 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.514 2.143 . . . . 0.0 111.371 179.105 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.743 ' N ' HG13 ' A' ' 84' ' ' VAL . 0.8 OUTLIER -69.25 96.59 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.91 0.386 . . . . 0.0 110.953 -179.463 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.402 ' O ' ' HB ' ' A' ' 141' ' ' THR . 2.6 p -70.48 160.2 82.21 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.182 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.496 ' HA ' ' CE1' ' A' ' 154' ' ' TYR . 72.0 Cg_exo -48.14 -42.88 32.34 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.572 2.181 . . . . 0.0 112.213 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -67.44 -34.74 77.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.776 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.517 HG21 HG23 ' A' ' 137' ' ' ILE . 97.5 m -58.29 -55.32 36.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.904 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.511 ' CB ' ' CD2' ' A' ' 154' ' ' TYR . . . -50.9 -36.53 38.75 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.899 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -64.72 -42.59 95.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.833 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.55 -56.76 15.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.698 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.766 HD11 ' HG3' ' A' ' 94' ' ' LYS . 2.9 tt -67.92 -31.97 72.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.707 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.412 ' CA ' ' HB3' ' A' ' 151' ' ' ALA . . . -55.66 -66.02 0.49 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.931 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 16.1 mtp85 -63.52 -24.12 67.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.977 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -54.11 -40.95 67.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.2 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 1.016 HD13 HG22 ' A' ' 98' ' ' VAL . 0.5 OUTLIER -117.32 24.5 11.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.076 -179.862 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.79 59.06 2.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.786 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.514 ' HB1' ' CD2' ' A' ' 112' ' ' LEU . . . -94.22 27.92 2.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.118 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.621 ' CB ' HD12 ' A' ' 111' ' ' LEU . 92.8 t 68.94 -74.8 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.975 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.695 ' O ' HD21 ' A' ' 111' ' ' LEU . 0.2 OUTLIER 173.13 139.21 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.109 0.481 . . . . 0.0 111.394 -179.234 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.511 ' CD2' ' CB ' ' A' ' 142' ' ' ALA . 3.2 t80 -94.66 116.69 29.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.248 178.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.402 HG12 ' N ' ' A' ' 156' ' ' GLU . 5.2 t -101.12 158.7 4.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.31 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.402 ' N ' HG12 ' A' ' 155' ' ' VAL . 3.3 tt0 -89.67 143.58 26.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.522 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.786 ' O ' HD11 ' A' ' 117' ' ' ILE . 25.3 p 178.9 179.25 0.41 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.012 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.441 ' HA ' ' HA ' ' A' ' 115' ' ' THR . 28.4 p -159.89 160.24 33.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.953 0.406 . . . . 0.0 111.308 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.475 ' HB2' HD11 ' A' ' 165' ' ' LEU . . . -113.8 -27.14 7.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.915 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.68 -37.39 41.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.782 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.405 ' O ' ' HB3' ' A' ' 162' ' ' GLN . 7.7 t -116.59 -13.69 10.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.189 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.412 ' N ' ' OG ' ' A' ' 158' ' ' SER . 10.8 tt0 71.56 82.02 0.15 Allowed 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.698 0.285 . . . . 0.0 111.254 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.426 ' N ' ' OG ' ' A' ' 158' ' ' SER . 5.5 mttm -101.92 22.15 13.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.053 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 105.2 44.23 1.51 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.442 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.743 HD22 ' HG ' ' A' ' 19' ' ' LEU . 2.3 mt -46.09 -31.7 2.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.783 0.325 . . . . 0.0 111.155 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.421 ' HG3' ' N ' ' A' ' 167' ' ' ASN . 0.1 OUTLIER -66.57 -28.62 68.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.902 179.825 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.421 ' N ' ' HG3' ' A' ' 166' ' ' LYS . 2.6 t-20 -57.48 -70.87 0.11 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.698 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.752 HG21 ' HA ' ' A' ' 113' ' ' VAL . 11.4 p -50.77 -44.27 25.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.914 0.388 . . . . 0.0 110.565 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.967 ' CD2' HD23 ' A' ' 19' ' ' LEU . 0.3 OUTLIER -63.85 -30.59 71.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.097 179.436 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.421 ' O ' HG13 ' A' ' 173' ' ' ILE . 20.4 t0 -70.65 -22.52 62.49 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.565 179.367 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -84.61 -35.1 22.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.248 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -67.28 -32.62 73.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.74 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.601 ' O ' HG21 ' A' ' 4' ' ' ILE . 2.0 pp -82.52 -35.11 12.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.771 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.645 ' HB2' HD22 ' B' ' 505' ' ' LEU . 9.7 tp -52.83 -43.56 66.08 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.977 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -50.65 -23.48 2.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.642 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.907 ' HB2' HG21 ' A' ' 77' ' ' VAL . . . -96.72 -34.71 11.25 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.699 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.825 HD13 ' HB ' ' B' ' 510' ' ' ILE . 96.7 mt -68.76 -24.01 64.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.797 0.332 . . . . 0.0 110.729 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -179.92 154.33 0.68 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.926 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.425 ' HA ' ' HD2' ' A' ' 180' ' ' PRO . 43.8 Cg_endo -68.1 108.8 1.81 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.603 2.202 . . . . 0.0 112.256 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 179' ' ' PRO . 54.6 Cg_endo -69.55 174.08 9.84 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.531 2.154 . . . . 0.0 112.449 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -145.64 144.47 22.64 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.781 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.3 -165.14 0.27 Allowed 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.598 2.198 . . . . 0.0 112.26 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 7.6 mttm -126.71 171.67 10.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.918 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 3.4 mtpt . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.192 -0.909 . . . . 0.0 110.867 -179.961 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 502' ' ' GLY . . . . . 0.425 ' CA ' ' O ' ' B' ' 509' ' ' ASP . . . . . . . . 0 N--CA 1.488 2.116 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 503' ' ' SER . . . . . 0.401 ' HB2' ' O ' ' B' ' 510' ' ' ILE . 0.1 OUTLIER -66.49 -75.29 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.797 0.332 . . . . 0.0 110.968 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 504' ' ' GLY . . . . . 0.492 ' CA ' ' HA ' ' B' ' 509' ' ' ASP . . . 147.22 -101.33 0.23 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.0 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 505' ' ' LEU . . . . . 0.645 HD22 ' HB2' ' A' ' 174' ' ' LEU . 0.5 OUTLIER 69.39 -61.77 0.43 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 179.244 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 506' ' ' SER . . . . . 0.424 ' CB ' ' O ' ' B' ' 505' ' ' LEU . 1.1 p 165.0 -45.71 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.722 0.296 . . . . 0.0 111.108 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 507' ' ' ALA . . . . . . . . . . . . . . . -36.92 -66.51 0.23 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.947 0.88 . . . . 0.0 111.43 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 508' ' ' GLN . . . . . 0.484 ' O ' ' CB ' ' B' ' 509' ' ' ASP . 7.3 mt-30 -160.48 -45.42 0.05 OUTLIER 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.02 -1.445 . . . . 0.0 107.841 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 509' ' ' ASP . . . . . 0.492 ' HA ' ' CA ' ' B' ' 504' ' ' GLY . 3.3 p30 146.88 43.57 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 113.994 -1.457 . . . . 0.0 110.259 178.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 510' ' ' ILE . . . . . 0.825 ' HB ' HD13 ' A' ' 177' ' ' LEU . 2.3 mt -65.15 133.09 30.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.163 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 511' ' ' SER . . . . . 0.42 ' CB ' ' HG ' ' B' ' 514' ' ' LEU . 2.6 m -109.35 158.72 17.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.257 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 512' ' ' GLN . . . . . 0.505 ' CB ' ' HD3' ' B' ' 513' ' ' PRO . 0.7 OUTLIER -100.37 -65.43 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.724 179.562 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 513' ' ' PRO . . . . . 0.505 ' HD3' ' CB ' ' B' ' 512' ' ' GLN . 69.9 Cg_endo -83.81 53.49 4.11 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.549 2.166 . . . . 0.0 112.06 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 514' ' ' LEU . . . . . 0.651 HD22 ' O ' ' A' ' 45' ' ' MET . 0.7 OUTLIER -61.75 -84.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.374 -179.468 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 515' ' ' GLN . . . . . 0.433 ' HB2' HG12 ' A' ' 44' ' ' VAL . 1.6 mt-30 -78.91 -86.8 0.07 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.207 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -118.41 -32.32 4.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.779 0.323 . . . . 0.0 111.243 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 517' ' ' SER . . . . . 0.481 ' C ' HG13 ' A' ' 42' ' ' VAL . 0.4 OUTLIER 73.06 7.85 5.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.649 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 518' ' ' PHE . . . . . 0.476 ' CD1' ' O ' ' B' ' 517' ' ' SER . 6.5 m-85 -163.43 125.03 2.43 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.723 0.297 . . . . 0.0 110.901 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 519' ' ' ILE . . . . . 0.593 HD11 ' OG1' ' A' ' 43' ' ' THR . 40.1 mm -79.94 -34.37 15.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.214 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 520' ' ' HIS . . . . . 0.704 ' O ' HG23 ' B' ' 521' ' ' THR . 41.5 t-80 -163.25 -87.04 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.069 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 521' ' ' THR . . . . . 0.704 HG23 ' O ' ' B' ' 520' ' ' HIS . 0.1 OUTLIER 170.23 -172.43 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 120.848 0.356 . . . . 0.0 110.886 179.911 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 522' ' ' GLY . . . . . . . . . . . . . . . -93.23 -125.91 4.08 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.37 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 523' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -157.47 -91.64 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.501 0.191 . . . . 0.0 110.767 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 524' ' ' GLY . . . . . . . . . . . . . . . 48.4 -178.23 0.01 OUTLIER Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.854 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 525' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 168.77 60.46 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.824 0.345 . . . . 0.0 110.809 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 526' ' ' SER . . . . . 0.42 ' OG ' ' CG1' ' A' ' 33' ' ' VAL . 12.2 t -92.34 97.01 10.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.012 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 527' ' ' ASP . . . . . 0.478 ' CB ' ' CD ' ' B' ' 528' ' ' PRO . 0.2 OUTLIER -52.72 -64.31 1.68 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.98 179.944 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 528' ' ' PRO . . . . . 0.478 ' CD ' ' CB ' ' B' ' 527' ' ' ASP . 12.8 Cg_endo -53.45 103.43 0.09 OUTLIER 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.97 2.447 . . . . 0.0 112.17 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 529' ' ' ARG . . . . . 0.522 ' HG2' HG21 ' A' ' 33' ' ' VAL . 13.7 mtt85 -100.59 -32.06 10.95 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.968 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 530' ' ' HIS . . . . . 0.503 ' CG ' ' O ' ' B' ' 530' ' ' HIS . 0.1 OUTLIER 70.5 6.47 5.82 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.116 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER 59.55 177.51 0.08 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.89 0.376 . . . . 0.0 111.034 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 532' ' ' TRP . . . . . 0.411 ' CD2' ' O ' ' B' ' 532' ' ' TRP . 72.4 t90 -75.28 73.03 2.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.844 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . -96.21 -19.0 29.52 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.491 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 534' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -88.67 156.02 50.38 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.78 0.324 . . . . 0.0 111.003 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -73.89 95.08 0.88 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.565 2.176 . . . . 0.0 112.362 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 536' ' ' ASP . . . . . 0.434 ' O ' ' CA ' ' A' ' 12' ' ' GLY . 35.4 m-20 62.97 46.91 4.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.019 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 537' ' ' ARG . . . . . 0.666 ' HG3' ' HB2' ' A' ' 13' ' ' ALA . 20.9 mmt-85 73.86 -173.89 0.14 Allowed 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.373 0.606 . . . . 0.0 111.518 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 538' ' ' ILE . . . . . 0.732 HD12 ' CB ' ' B' ' 542' ' ' TYR . 4.8 pt -106.66 -153.68 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.031 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 539' ' ' ASP . . . . . 0.418 ' N ' HG13 ' B' ' 538' ' ' ILE . 51.8 p30 -104.04 161.42 14.01 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.944 0.402 . . . . 0.0 111.35 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 540' ' ' GLU . . . . . 0.5 ' HG3' HG13 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -57.12 -23.79 49.6 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.801 179.634 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 541' ' ' LEU . . . . . 0.974 ' HA ' HD21 ' A' ' 70' ' ' LEU . 0.4 OUTLIER -60.09 -34.79 73.94 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.339 0.59 . . . . 0.0 109.884 179.794 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 542' ' ' TYR . . . . . 0.732 ' CB ' HD12 ' B' ' 538' ' ' ILE . 2.9 m-85 -102.66 -57.34 2.07 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.999 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 543' ' ' LEU . . . . . 0.667 HD21 ' CD ' ' A' ' 16' ' ' LYS . 0.2 OUTLIER 64.74 -71.41 0.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.915 179.865 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 544' ' ' GLY . . . . . 0.652 ' HA3' HD11 ' A' ' 61' ' ' LEU . . . -62.87 165.66 24.92 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.349 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 545' ' ' ASN . . . . . . . . . . . . . 25.5 m120 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.276 -0.869 . . . . 0.0 111.018 -179.907 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 185' ' ' GNP . . . . . 0.849 " H2'" ' OG1' ' A' ' 115' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' HOH . . . . . 0.895 ' O ' HG21 ' A' ' 35' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.505 ' HE1' ' CD1' ' A' ' 51' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.323 0.106 . . . . 0.0 111.117 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.407 ' N ' ' SD ' ' A' ' 1' ' ' MET . 13.1 tp60 56.97 151.94 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.126 0.489 . . . . 0.0 111.58 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . 1.085 HG23 HG21 ' A' ' 46' ' ' ILE . 0.3 OUTLIER -154.65 -158.69 0.87 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.247 179.919 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.979 HD11 HD22 ' A' ' 53' ' ' LEU . 0.2 OUTLIER -144.82 155.57 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 CA-C-O 121.189 0.519 . . . . 0.0 111.973 -179.514 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 36.3 mttt -134.45 116.61 15.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.704 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.641 ' SG ' HG23 ' A' ' 77' ' ' VAL . 45.7 t -138.38 154.22 48.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.364 0.602 . . . . 0.0 112.52 -178.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.822 HG22 ' CB ' ' A' ' 56' ' ' PHE . 11.9 t -128.37 150.35 34.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.208 178.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.948 HG11 HG13 ' A' ' 14' ' ' VAL . 2.8 p -83.8 121.65 36.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.307 0.575 . . . . 0.0 111.707 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.705 HG12 ' HB2' ' A' ' 70' ' ' LEU . 19.2 m -129.87 129.9 66.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.928 178.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.471 ' HA2' ' CZ2' ' A' ' 97' ' ' TRP . . . 137.49 -142.8 13.79 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.194 -1.003 . . . . 0.0 112.652 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.427 ' CB ' ' O ' ' B' ' 537' ' ' ARG . 0.4 OUTLIER -122.52 26.68 8.22 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.879 0.371 . . . . 0.0 110.633 179.915 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.425 ' O ' ' CB ' ' B' ' 537' ' ' ARG . . . -86.04 -176.2 49.96 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.765 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.611 ' HB1' ' O3A' ' A' ' 185' ' ' GNP . . . -89.39 4.82 47.76 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.958 HG21 HD21 ' B' ' 543' ' ' LEU . 8.7 t 81.24 107.18 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.066 0.46 . . . . 0.0 110.651 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.504 ' HA3' ' CE1' ' A' ' 169' ' ' PHE . . . -65.32 -9.29 41.96 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.723 -0.671 . . . . 0.0 113.423 -179.352 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.439 ' CD ' ' HB3' ' A' ' 55' ' ' LEU . 3.1 mmtt -77.07 -51.25 11.38 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 122.395 -0.473 . . . . 0.0 111.031 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.841 HG22 ' OD1' ' A' ' 38' ' ' ASP . 0.1 OUTLIER -98.14 -44.36 6.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.596 -179.583 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.421 ' CB ' ' O ' ' A' ' 14' ' ' VAL . 44.0 t -36.12 -73.83 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.725 ' HA ' HD13 ' A' ' 165' ' ' LEU . 1.8 mp -56.53 -68.66 0.2 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.951 0.405 . . . . 0.0 111.583 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.593 HD23 ' N ' ' A' ' 20' ' ' LEU . 2.9 mt -46.38 -61.45 1.79 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.201 -178.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.442 ' HA ' HG23 ' A' ' 25' ' ' THR . 47.6 mm -49.35 -72.15 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.781 0.324 . . . . 0.0 111.191 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 27.7 t -51.2 -23.0 2.98 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.606 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.416 ' HB2' ' O ' ' A' ' 19' ' ' LEU . 85.1 t80 -75.41 -68.07 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.731 0.3 . . . . 0.0 111.382 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.4 m -75.91 -34.69 59.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.31 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.442 HG23 ' HA ' ' A' ' 21' ' ' ILE . 1.5 p -87.9 -156.12 0.34 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.882 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -151.41 21.13 0.73 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.089 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -108.59 123.51 49.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.869 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.492 ' CD1' ' O1A' ' A' ' 185' ' ' GNP . 0.4 OUTLIER -153.78 -68.25 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.411 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.632 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.473 ' CD ' ' CB ' ' A' ' 28' ' ' PHE . 74.0 Cg_endo -75.45 54.26 3.79 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.479 2.119 . . . . 0.0 112.939 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 33.9 t -145.96 -80.02 0.16 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.916 0.389 . . . . 0.0 110.976 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -158.34 159.02 35.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.45 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.522 ' CD2' ' PG ' ' A' ' 185' ' ' GNP . 10.6 m-85 -128.44 93.36 3.62 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.065 0.46 . . . . 0.0 110.918 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.981 HG11 ' O ' ' B' ' 526' ' ' SER . 1.9 t -108.45 -50.01 0.08 OUTLIER Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.545 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.433 ' HD3' ' HB ' ' A' ' 33' ' ' VAL . 77.6 Cg_exo -52.01 -22.14 13.88 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.009 1.806 . . . . 0.0 112.203 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.632 ' CG2' HD23 ' B' ' 543' ' ' LEU . 27.9 m -52.3 -24.33 7.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.545 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.756 ' HB ' HD21 ' A' ' 61' ' ' LEU . 5.6 p -57.98 -25.35 25.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.164 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.494 ' CD1' ' HA3' ' B' ' 522' ' ' GLY . 0.2 OUTLIER -125.79 53.36 1.59 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.963 0.411 . . . . 0.0 110.645 179.724 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.841 ' OD1' HG22 ' A' ' 17' ' ' THR . 24.4 t70 -88.95 14.18 11.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.554 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -92.82 19.87 7.15 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.769 0.318 . . . . 0.0 110.905 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -61.95 -175.11 0.06 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.699 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -116.43 169.77 9.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.438 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.455 ' HA ' ' CG1' ' B' ' 519' ' ' ILE . 35.1 m -146.94 129.33 7.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.911 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.455 HG23 HG12 ' B' ' 519' ' ' ILE . 16.4 p -87.5 105.61 17.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.554 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.499 ' CG2' ' CG2' ' A' ' 52' ' ' THR . 19.3 m -158.93 -177.09 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.53 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.516 ' HE2' ' C ' ' A' ' 45' ' ' MET . 0.0 OUTLIER -124.85 107.54 11.01 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.795 0.295 . . . . 0.0 111.795 -179.639 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 1.085 HG21 HG23 ' A' ' 3' ' ' THR . 5.1 mm -79.96 86.13 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 26.21 90.29 0.01 OUTLIER Glycine 0 CA--C 1.526 0.731 0 O-C-N 123.64 0.587 . . . . 0.0 114.449 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 140.39 -95.51 0.2 Allowed Glycine 0 N--CA 1.454 -0.156 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.448 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.466 ' N ' ' HE1' ' A' ' 45' ' ' MET . 0.0 OUTLIER -130.31 144.99 55.46 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.791 0.329 . . . . 0.0 110.638 179.347 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_exo -34.39 102.4 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.46 2.773 . . . . 0.0 113.446 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.505 ' CD1' ' HE1' ' A' ' 1' ' ' MET . 3.1 t80 -173.4 138.22 0.69 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.159 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.499 ' CG2' ' CG2' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -134.12 153.16 51.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.112 0.482 . . . . 0.0 111.402 179.495 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.979 HD22 HD11 ' A' ' 4' ' ' ILE . 0.4 OUTLIER -80.25 109.9 15.17 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.169 -179.616 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -62.95 107.61 1.75 Allowed Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.0 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.439 ' HB3' ' CD ' ' A' ' 16' ' ' LYS . 1.4 mp -63.59 116.88 6.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.836 0.35 . . . . 0.0 110.413 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.822 ' CB ' HG22 ' A' ' 7' ' ' VAL . 0.7 OUTLIER -84.58 125.33 32.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.352 0.596 . . . . 0.0 111.751 -178.916 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.938 ' OD2' HG11 ' A' ' 14' ' ' VAL . 38.5 t0 -175.17 137.34 0.4 Allowed 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.457 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.912 ' OG1' HD21 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -155.07 160.02 40.69 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.483 -178.645 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.709 ' HB3' HD21 ' A' ' 61' ' ' LEU . . . -132.34 155.48 48.32 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.816 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.419 ' HA2' ' HB2' ' A' ' 64' ' ' TYR . . . -106.65 79.46 0.26 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.533 -0.841 . . . . 0.0 113.328 -179.282 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.837 HD22 ' HA2' ' B' ' 544' ' ' GLY . 0.1 OUTLIER -121.47 -87.76 0.63 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.72 0.295 . . . . 0.0 110.643 179.24 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -98.73 -26.52 14.32 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.99 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -89.4 -63.42 1.29 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.4 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.765 ' HB2' HD23 ' A' ' 67' ' ' LEU . 12.8 m-85 -96.85 146.54 24.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.958 0.409 . . . . 0.0 111.086 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -87.43 -58.5 2.56 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.402 ' O ' ' CB ' ' A' ' 67' ' ' LEU . 0.6 OUTLIER -98.35 -51.17 4.06 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -178.209 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.912 HD21 ' OG1' ' A' ' 58' ' ' THR . 0.2 OUTLIER 76.4 87.74 0.08 Allowed 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -178.636 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.475 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 34.5 ptt180 -126.59 48.19 2.94 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.563 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.525 ' HG3' HG23 ' A' ' 58' ' ' THR . 97.4 Cg_endo -79.0 -39.56 0.34 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.67 2.246 . . . . 0.0 111.875 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.945 HD23 ' CB ' ' B' ' 541' ' ' LEU . 0.1 OUTLIER -82.04 -8.45 59.67 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.038 179.959 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -51.8 -35.11 42.87 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.692 0.282 . . . . 0.0 111.14 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.444 ' CZ ' ' O ' ' A' ' 104' ' ' HIS . 1.5 t80 -169.08 67.63 0.65 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.196 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.504 ' HG2' ' CE2' ' A' ' 78' ' ' PHE . 73.0 Cg_endo -75.75 142.66 25.9 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.641 2.227 . . . . 0.0 112.216 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 25.6 tp60 -101.42 10.8 40.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.608 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.679 HG23 ' CE1' ' A' ' 78' ' ' PHE . 1.2 t -47.46 167.78 0.02 OUTLIER 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.931 0.396 . . . . 0.0 111.211 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -91.49 -22.59 20.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.609 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.641 HG23 ' SG ' ' A' ' 6' ' ' CYS . 19.1 m -137.95 143.98 32.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.982 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.775 ' CE1' HG21 ' A' ' 108' ' ' THR . 3.7 m-85 -116.35 121.01 40.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.432 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.522 HD21 ' HE1' ' A' ' 169' ' ' PHE . 5.9 tp -82.38 108.18 15.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.887 0.375 . . . . 0.0 111.031 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.599 ' O ' HG23 ' A' ' 80' ' ' VAL . 19.4 m -107.87 95.6 3.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.199 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.457 ' HB3' ' N7 ' ' A' ' 185' ' ' GNP . 14.3 m -95.14 155.25 16.81 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.575 -179.184 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.671 ' HE1' HD12 ' A' ' 112' ' ' LEU . 23.4 p90 -153.36 128.28 9.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.462 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.472 ' HA ' ' C2 ' ' A' ' 185' ' ' GNP . 6.1 p -83.62 136.44 34.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.0 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.796 HG13 ' N ' ' A' ' 137' ' ' ILE . 58.7 t -45.32 -54.59 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.443 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.78 HG11 HG21 ' A' ' 125' ' ' THR . 28.8 m -49.52 112.97 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.682 0.277 . . . . 0.0 110.577 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.717 ' N ' HD22 ' A' ' 129' ' ' LEU . 18.4 m -151.37 122.36 3.76 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.665 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 86' ' ' SER . 87.1 Cg_endo -93.81 56.2 0.36 Allowed 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.228 2.619 . . . . 0.0 111.599 179.311 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.445 ' HB3' ' HG2' ' A' ' 133' ' ' LYS . 0.9 OUTLIER 81.11 20.38 0.41 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.07 -179.449 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.95 ' O ' HG23 ' A' ' 93' ' ' VAL . 2.8 m -97.29 -27.29 14.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.827 0.346 . . . . 0.0 110.79 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -50.67 -53.86 27.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.016 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -50.18 -45.39 53.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.974 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.413 ' O ' ' N ' ' A' ' 96' ' ' LYS . 24.1 m120 -72.55 -44.58 61.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.872 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.95 HG23 ' O ' ' A' ' 89' ' ' SER . 62.0 t -51.34 -37.5 18.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.245 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.635 ' HB2' HD11 ' A' ' 145' ' ' LEU . 3.9 tttt -73.34 -49.96 24.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.886 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -82.87 6.98 16.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.562 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.413 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.1 OUTLIER -113.86 -28.47 7.39 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.713 0.292 . . . . 0.0 110.991 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.471 ' CZ2' ' HA2' ' A' ' 10' ' ' GLY . 3.1 m95 -94.32 -49.24 5.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.179 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 94' ' ' LYS . 61.8 t -48.62 -47.48 70.72 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.662 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 71.9 Cg_endo -77.9 -16.75 14.24 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.242 1.961 . . . . 0.0 112.517 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.38 -47.0 8.31 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.729 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.415 HG13 ' N ' ' A' ' 102' ' ' THR . 2.0 pt -60.21 -26.71 37.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.026 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.415 ' N ' HG13 ' A' ' 101' ' ' ILE . 27.0 p -82.56 -39.66 21.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.867 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -54.16 -48.73 70.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.799 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.444 ' O ' ' CZ ' ' A' ' 72' ' ' TYR . 15.4 m170 -70.06 -26.83 64.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.715 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -143.62 99.01 5.28 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.813 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_exo -43.03 99.02 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.6 2.2 . . . . 0.0 112.484 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.5 mmtm 57.61 102.62 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.869 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.775 HG21 ' CE1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -133.13 136.76 28.01 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.862 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 108' ' ' THR . 31.3 Cg_exo -59.96 154.79 48.24 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.555 2.17 . . . . 0.0 112.292 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.564 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 3.7 p90 -165.55 140.39 4.9 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.241 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.657 HD12 ' CG1' ' A' ' 152' ' ' VAL . 1.8 tt -116.1 153.23 32.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.892 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.671 HD12 ' HE1' ' A' ' 82' ' ' PHE . 0.8 OUTLIER -98.01 161.53 13.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.833 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.916 HG13 HG21 ' A' ' 168' ' ' VAL . 10.6 t -140.53 143.59 28.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 121.08 0.467 . . . . 0.0 112.025 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -120.43 108.9 1.49 Allowed Glycine 0 C--N 1.332 0.34 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.625 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.686 HG22 ' SG ' ' A' ' 157' ' ' CYS . 0.1 OUTLIER -135.88 5.28 3.08 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.879 0.325 . . . . 0.0 111.879 -178.796 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.857 ' HG3' HD13 ' A' ' 119' ' ' LEU . 39.7 tt0 -118.32 -4.03 10.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.753 0.311 . . . . 0.0 110.459 179.205 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.971 HD11 ' O ' ' A' ' 157' ' ' CYS . 0.1 OUTLIER -44.88 -26.47 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.141 179.263 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -73.88 -31.5 63.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.292 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.857 HD13 ' HG3' ' A' ' 116' ' ' GLN . 3.9 mp -85.82 -23.7 27.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.359 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.609 ' CB ' HG11 ' A' ' 84' ' ' VAL . 1.0 OUTLIER -49.63 -26.18 3.43 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.961 0.41 . . . . 0.0 110.684 179.818 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -85.46 -31.66 22.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.591 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.2 107.18 0.79 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.648 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.451 ' HA ' ' CG2' ' A' ' 126' ' ' ILE . 43.1 Cg_endo -68.87 -5.91 16.76 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.493 2.129 . . . . 0.0 113.131 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.1 t -75.75 -67.22 0.69 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.78 HG21 HG11 ' A' ' 85' ' ' VAL . 3.1 m -57.81 -38.17 75.06 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.566 178.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.723 HD11 ' HB3' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -55.39 -46.36 78.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.81 179.407 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.509 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 4.8 mm-40 -56.34 -35.43 67.6 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.924 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.4 ' HA ' ' CD ' ' A' ' 131' ' ' LYS . 6.0 mptt -65.36 -31.49 72.63 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.717 HD22 ' N ' ' A' ' 86' ' ' SER . 7.1 mt -73.87 -37.82 64.63 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.095 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.509 ' HB3' ' O ' ' A' ' 127' ' ' GLU . . . -44.81 -37.97 4.19 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.224 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.4 ' CD ' ' HA ' ' A' ' 128' ' ' LYS . 0.1 OUTLIER -47.29 -32.6 4.82 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.933 179.816 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 87' ' ' PRO . 13.7 m120 -123.12 -31.36 3.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.476 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.523 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 9.3 mmmt -146.98 -100.21 0.09 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 118.993 -0.527 . . . . 0.0 111.132 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.523 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 1.4 pt20 133.29 -21.16 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.281 1.032 . . . . 0.0 110.55 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 16.1 mmtp -68.44 110.95 6.67 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.705 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.723 ' HB3' HD11 ' A' ' 126' ' ' ILE . 65.3 Cg_endo -85.48 122.27 2.37 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.832 2.355 . . . . 0.0 111.534 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.796 ' N ' HG13 ' A' ' 84' ' ' VAL . 1.2 mm -53.72 96.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.009 0.433 . . . . 0.0 110.664 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.44 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 33.8 p -68.66 155.82 92.19 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.908 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.44 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 8.6 Cg_endo -50.59 -26.24 16.42 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.699 2.266 . . . . 0.0 111.875 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -81.46 -33.4 32.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.59 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.445 ' CG2' HG23 ' A' ' 137' ' ' ILE . 89.9 m -57.62 -49.17 77.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.636 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.456 ' HB3' ' CD2' ' A' ' 154' ' ' TYR . . . -55.17 -32.79 62.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.789 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -68.14 -40.68 82.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.621 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.59 -49.93 74.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.676 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.684 HD23 ' O ' ' A' ' 145' ' ' LEU . 1.6 tt -70.08 -36.23 74.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.655 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.433 ' CB ' HD23 ' A' ' 112' ' ' LEU . . . -59.55 -58.1 10.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.965 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 38.1 mtt180 -67.86 -24.28 65.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.965 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -50.2 -36.11 29.29 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.785 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.64 23.6 7.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.86 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 37.0 mttt 45.57 59.75 3.45 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.126 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.584 ' O ' HG23 ' A' ' 152' ' ' VAL . . . -65.46 -82.39 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.212 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.657 ' CG1' HD12 ' A' ' 111' ' ' LEU . 45.1 t -161.86 -72.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.653 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 12.4 tppt? -179.8 118.9 0.06 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.883 -178.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.456 ' CD2' ' HB3' ' A' ' 142' ' ' ALA . 63.1 t80 -89.86 110.85 21.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.372 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.521 HG12 ' H ' ' A' ' 156' ' ' GLU . 2.6 t -101.61 167.46 2.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.739 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.521 ' H ' HG12 ' A' ' 155' ' ' VAL . 1.1 pm0 -106.58 119.06 38.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.123 0.487 . . . . 0.0 111.653 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.971 ' O ' HD11 ' A' ' 117' ' ' ILE . 14.8 p -140.19 -172.01 3.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.635 179.328 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.409 ' HB2' ' HB2' ' A' ' 163' ' ' LYS . 0.5 OUTLIER -159.1 127.95 5.31 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.459 -0.497 . . . . 0.0 111.884 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.565 ' HA ' HD11 ' A' ' 165' ' ' LEU . . . -94.67 20.33 8.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.512 178.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.702 ' N ' HD12 ' A' ' 160' ' ' LEU . 0.0 OUTLIER -129.99 -44.19 1.18 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.327 179.925 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 8.3 t -113.25 -17.84 12.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.984 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 77.45 85.75 0.08 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.2 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.409 ' HB2' ' HB2' ' A' ' 158' ' ' SER . 3.7 ttpp -107.82 22.71 15.56 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.051 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 115.44 40.73 0.84 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.793 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.725 HD13 ' HA ' ' A' ' 19' ' ' LEU . 9.2 mt -49.79 -42.79 47.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.77 0.319 . . . . 0.0 110.8 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.404 ' O ' ' HB2' ' A' ' 170' ' ' ASP . 0.5 OUTLIER -67.56 -32.02 72.5 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.423 179.418 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.22 -65.76 0.63 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.738 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.916 HG21 HG13 ' A' ' 113' ' ' VAL . 8.9 p -48.67 -43.64 13.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 121.081 0.467 . . . . 0.0 110.581 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.592 ' CE1' HD11 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -69.3 -27.03 65.04 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.079 179.221 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.404 ' HB2' ' O ' ' A' ' 166' ' ' LYS . 0.7 OUTLIER -61.57 -29.98 70.37 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.484 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.518 ' HB2' HD11 ' A' ' 111' ' ' LEU . 39.9 mm-40 -77.9 -39.7 42.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.04 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.578 ' N ' HD13 ' A' ' 111' ' ' LEU . . . -55.33 -48.22 74.5 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.579 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.558 HD12 ' CD1' ' A' ' 177' ' ' LEU . 1.4 pp -74.4 -33.69 34.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.843 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.837 HD13 ' HG ' ' B' ' 505' ' ' LEU . 21.7 tp -50.52 -68.73 0.15 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.928 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -54.44 -22.01 11.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.05 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.535 ' CB ' HG21 ' A' ' 4' ' ' ILE . . . -81.85 -45.84 14.97 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.281 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.869 ' CD2' HG21 ' B' ' 510' ' ' ILE . 2.1 mt -68.57 -25.01 64.68 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.864 0.364 . . . . 0.0 110.734 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.415 ' HB2' ' HA ' ' B' ' 507' ' ' ALA . 0.0 OUTLIER -159.57 151.63 17.17 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.727 179.928 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -53.03 139.07 62.07 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.534 2.156 . . . . 0.0 112.329 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.21 -168.71 0.59 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.546 2.164 . . . . 0.0 112.385 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -143.24 96.97 5.73 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.977 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.03 -165.0 0.26 Allowed 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.613 2.208 . . . . 0.0 112.207 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -116.33 121.03 40.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.945 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 16.4 mttp . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.884 179.979 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 502' ' ' GLY . . . . . 0.425 ' CA ' ' HB2' ' B' ' 511' ' ' SER . . . . . . . . 0 N--CA 1.49 2.272 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 503' ' ' SER . . . . . 0.403 ' N ' ' HB2' ' B' ' 511' ' ' SER . 18.5 m -77.77 -74.92 0.23 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.688 0.28 . . . . 0.0 110.908 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 504' ' ' GLY . . . . . 0.41 ' HA2' ' HA ' ' B' ' 509' ' ' ASP . . . 105.43 110.08 3.47 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.388 -0.911 . . . . 0.0 112.316 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 505' ' ' LEU . . . . . 0.837 ' HG ' HD13 ' A' ' 174' ' ' LEU . 1.4 pt? -179.93 44.89 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.755 0.312 . . . . 0.0 110.936 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 506' ' ' SER . . . . . . . . . . . . . 4.8 p 65.78 39.85 4.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.074 0.464 . . . . 0.0 110.48 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 507' ' ' ALA . . . . . 0.57 ' O ' HD13 ' B' ' 510' ' ' ILE . . . -144.25 37.56 1.26 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.657 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 508' ' ' GLN . . . . . 0.459 ' HB3' ' CD1' ' B' ' 510' ' ' ILE . 12.5 mt-30 70.04 4.29 4.75 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.09 -178.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 509' ' ' ASP . . . . . 0.41 ' HA ' ' HA2' ' B' ' 504' ' ' GLY . 52.1 t0 67.84 45.49 1.4 Allowed 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 121.012 0.434 . . . . 0.0 111.416 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 510' ' ' ILE . . . . . 0.975 HG23 HG23 ' A' ' 46' ' ' ILE . 1.7 mp -84.62 133.11 30.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.945 179.111 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 511' ' ' SER . . . . . 0.788 ' O ' HD13 ' A' ' 46' ' ' ILE . 40.9 t -109.28 152.78 24.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.805 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 512' ' ' GLN . . . . . 0.504 ' CB ' ' HD3' ' B' ' 513' ' ' PRO . 0.0 OUTLIER -101.3 -57.91 0.11 Allowed Pre-proline 0 CA--C 1.529 0.155 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.426 179.271 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 513' ' ' PRO . . . . . 0.504 ' HD3' ' CB ' ' B' ' 512' ' ' GLN . 49.0 Cg_endo -93.89 63.12 0.39 Allowed 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.096 2.531 . . . . 0.0 112.169 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 514' ' ' LEU . . . . . 0.442 ' CD2' ' O ' ' A' ' 45' ' ' MET . 1.3 mp -70.54 -87.49 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.599 -179.225 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 515' ' ' GLN . . . . . . . . . . . . . 18.8 mm100 -78.82 -86.73 0.07 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.635 0.255 . . . . 0.0 111.233 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 22.6 m-20 -118.08 -36.73 3.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.856 0.36 . . . . 0.0 110.835 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 517' ' ' SER . . . . . 0.413 ' HA ' ' HB ' ' A' ' 42' ' ' VAL . 7.3 m 60.73 27.68 17.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.816 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 518' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -163.58 113.09 1.28 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.401 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 519' ' ' ILE . . . . . 0.455 HG12 HG23 ' A' ' 43' ' ' THR . 0.5 OUTLIER -137.36 111.34 8.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.124 179.483 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 80.3 m-70 60.64 174.47 0.1 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.012 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 521' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.1 136.8 28.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.812 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 522' ' ' GLY . . . . . 0.494 ' HA3' ' CD1' ' A' ' 37' ' ' PHE . . . -52.81 -174.96 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.474 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 523' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -64.0 -86.57 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.701 0.286 . . . . 0.0 110.871 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 524' ' ' GLY . . . . . 0.467 ' HA2' HG11 ' A' ' 36' ' ' VAL . . . 45.96 46.12 14.44 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.72 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 525' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -89.43 46.95 1.42 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.787 0.327 . . . . 0.0 110.958 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 526' ' ' SER . . . . . 0.981 ' O ' HG11 ' A' ' 33' ' ' VAL . 0.5 OUTLIER -87.91 100.58 13.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.67 179.784 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 527' ' ' ASP . . . . . 0.466 ' CB ' ' HD2' ' B' ' 528' ' ' PRO . 0.4 OUTLIER -43.05 167.9 0.07 OUTLIER Pre-proline 0 N--CA 1.464 0.273 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.403 -179.848 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 528' ' ' PRO . . . . . 0.466 ' HD2' ' CB ' ' B' ' 527' ' ' ASP . 9.8 Cg_endo -48.91 102.37 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.925 2.416 . . . . 0.0 111.884 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 529' ' ' ARG . . . . . 0.422 ' CG ' ' O ' ' B' ' 527' ' ' ASP . 11.1 mtp85 -100.84 -55.04 2.67 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.602 -179.235 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 530' ' ' HIS . . . . . 0.433 ' HB2' ' HB2' ' B' ' 545' ' ' ASN . 3.2 m-70 -148.87 94.02 2.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.405 -179.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 1.8 m -54.24 -173.75 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.606 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 532' ' ' TRP . . . . . 0.508 ' CZ2' ' HG3' ' B' ' 537' ' ' ARG . 13.2 t-105 -107.99 163.17 13.37 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.945 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . 169.86 -30.98 0.15 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.473 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 534' ' ' PHE . . . . . 0.479 ' O ' ' CZ2' ' B' ' 532' ' ' TRP . 4.2 t80 -82.35 115.54 58.47 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.507 0.194 . . . . 0.0 110.745 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -45.25 151.74 0.83 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.48 2.12 . . . . 0.0 112.5 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 65.85 135.13 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.854 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 537' ' ' ARG . . . . . 0.579 ' CD ' ' HB2' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -99.34 176.25 5.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.107 0.479 . . . . 0.0 111.159 -179.962 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 538' ' ' ILE . . . . . 0.813 HD11 ' CB ' ' B' ' 542' ' ' TYR . 0.1 OUTLIER -118.71 139.37 46.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.556 179.649 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 539' ' ' ASP . . . . . 0.701 ' HB2' HD22 ' A' ' 70' ' ' LEU . 30.6 p30 -38.84 161.23 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.086 -178.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 540' ' ' GLU . . . . . 0.729 ' HA ' HD13 ' B' ' 543' ' ' LEU . 0.9 OUTLIER -64.99 -33.44 76.05 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.056 -179.907 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 541' ' ' LEU . . . . . 0.945 ' CB ' HD23 ' A' ' 70' ' ' LEU . 4.4 tt -47.59 -29.69 3.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.105 0.479 . . . . 0.0 110.551 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 542' ' ' TYR . . . . . 0.813 ' CB ' HD11 ' B' ' 538' ' ' ILE . 6.2 m-85 -105.44 -17.08 14.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.626 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 543' ' ' LEU . . . . . 0.958 HD21 HG21 ' A' ' 14' ' ' VAL . 1.9 mp -40.11 136.54 1.15 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.89 0.376 . . . . 0.0 111.291 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 544' ' ' GLY . . . . . 0.837 ' HA2' HD22 ' A' ' 61' ' ' LEU . . . 157.8 101.68 0.18 Allowed Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.595 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 545' ' ' ASN . . . . . 0.444 ' O ' HG22 ' A' ' 33' ' ' VAL . 16.3 p30 . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.265 -0.874 . . . . 0.0 111.008 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 185' ' ' GNP . . . . . 0.728 ' N3 ' " H2'" ' A' ' 185' ' ' GNP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' HOH . . . . . 0.408 ' O ' HG21 ' A' ' 14' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.706 ' HE1' ' HB ' ' A' ' 46' ' ' ILE . 7.8 tpt . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.828 0.347 . . . . 0.0 111.2 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.522 ' O ' HD11 ' A' ' 177' ' ' LEU . 4.6 pt20 -155.44 111.25 3.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.898 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.82 ' O ' HG23 ' A' ' 4' ' ' ILE . 1.3 t -96.37 178.42 5.37 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.536 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.82 HG23 ' O ' ' A' ' 3' ' ' THR . 0.3 OUTLIER -165.23 159.94 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.096 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 179.874 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.659 ' N ' HD23 ' A' ' 53' ' ' LEU . 2.3 mtpt -111.65 137.47 49.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.329 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 39.8 t -121.55 142.91 49.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.041 0.448 . . . . 0.0 111.503 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.74 HG13 ' O ' ' A' ' 56' ' ' PHE . 2.8 t -135.13 120.6 30.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.486 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.869 HG13 ' HG2' ' B' ' 540' ' ' GLU . 2.4 p -84.71 149.56 4.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.209 0.528 . . . . 0.0 111.051 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.3 m -143.43 130.2 17.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.902 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.67 -140.08 8.71 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.139 -1.029 . . . . 0.0 112.584 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -123.19 27.03 7.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.857 0.361 . . . . 0.0 110.647 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.427 ' CA ' ' HB2' ' B' ' 537' ' ' ARG . . . -120.13 171.42 14.54 Favored Glycine 0 C--N 1.331 0.25 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.651 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.412 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -93.84 -25.3 17.41 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.721 0.296 . . . . 0.0 111.403 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 1.084 HG23 HD21 ' A' ' 19' ' ' LEU . 4.1 p -41.52 94.6 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.355 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.432 ' O ' ' CD1' ' A' ' 19' ' ' LEU . . . -151.21 -103.16 0.25 Allowed Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.612 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.474 ' HG3' ' CG2' ' A' ' 17' ' ' THR . 0.2 OUTLIER -97.93 -43.8 6.94 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 -179.547 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.665 HG21 HG23 ' A' ' 35' ' ' THR . 2.6 p -94.93 -53.12 3.95 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.446 ' CB ' ' O2A' ' A' ' 185' ' ' GNP . 37.2 t -32.04 -69.62 0.08 Allowed 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -178.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 1.084 HD21 HG23 ' A' ' 14' ' ' VAL . 0.5 OUTLIER -58.68 -68.09 0.3 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.393 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.503 ' H ' HD22 ' A' ' 20' ' ' LEU . 2.9 mm? -61.05 -67.44 0.4 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -178.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.527 ' O ' HG22 ' A' ' 25' ' ' THR . 1.3 tp -37.08 -54.54 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -179.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.492 ' N ' ' CG2' ' A' ' 21' ' ' ILE . 0.4 OUTLIER -67.92 -30.21 69.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.791 0.329 . . . . 0.0 110.858 -179.557 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.423 ' N ' ' O ' ' A' ' 20' ' ' LEU . 27.3 t80 -53.79 -37.95 64.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.132 0.492 . . . . 0.0 109.987 179.163 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.49 -31.68 11.16 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.667 179.401 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.527 HG22 ' O ' ' A' ' 21' ' ' ILE . 3.3 t -136.82 79.79 1.78 Allowed 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.984 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.464 ' ND2' ' O ' ' A' ' 159' ' ' ALA . 9.1 m-20 -66.6 79.28 0.11 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.298 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.4 mmtm -100.29 101.04 11.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.746 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.57 ' CE1' ' CZ2' ' B' ' 532' ' ' TRP . 0.1 OUTLIER -99.28 -53.61 0.19 Allowed Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.648 -179.67 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.425 ' HD3' ' HB3' ' A' ' 28' ' ' PHE . 84.7 Cg_endo -88.54 69.95 2.69 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.76 2.307 . . . . 0.0 112.981 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -144.8 -92.68 0.1 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.667 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -159.62 158.64 31.96 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.745 0.307 . . . . 0.0 110.818 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.455 ' O ' HG22 ' A' ' 33' ' ' VAL . 53.1 m-85 -133.07 99.98 4.73 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.406 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.542 HG12 HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -162.49 -63.46 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.866 -179.398 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.477 ' CD ' ' HB ' ' A' ' 33' ' ' VAL . 2.9 Cg_exo -36.07 -29.73 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.381 2.721 . . . . 0.0 113.012 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.665 HG23 HG21 ' A' ' 17' ' ' THR . 21.2 m -63.85 71.1 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.754 0.312 . . . . 0.0 110.886 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.819 HG11 ' HA3' ' B' ' 524' ' ' GLY . 10.2 p -130.55 -3.82 2.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.471 ' CD1' ' HA3' ' B' ' 522' ' ' GLY . 0.7 OUTLIER -84.22 50.05 1.78 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.742 0.306 . . . . 0.0 111.242 -179.793 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.466 ' HA ' ' CD ' ' A' ' 16' ' ' LYS . 5.5 m-20 -58.97 -21.43 58.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.158 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -86.98 -6.21 58.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.629 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.466 ' CD1' ' O ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -60.77 157.18 15.41 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.848 0.356 . . . . 0.0 110.913 179.935 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.575 ' C ' HD12 ' B' ' 519' ' ' ILE . . . -108.07 175.72 5.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.35 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.422 ' HA ' HG13 ' B' ' 519' ' ' ILE . 12.8 m -140.57 121.71 14.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.167 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.422 ' C ' HG13 ' A' ' 44' ' ' VAL . 1.1 t -86.25 104.71 16.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.042 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.745 ' CG2' HG21 ' A' ' 52' ' ' THR . 24.9 m -158.19 -177.28 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.918 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.477 ' HE1' ' N ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -121.01 99.61 6.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.485 -179.523 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.925 ' CG1' HG23 ' A' ' 52' ' ' THR . 0.7 OUTLIER -75.93 86.02 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 178.723 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.44 ' N ' ' HE2' ' A' ' 45' ' ' MET . . . 27.91 96.26 0.01 OUTLIER Glycine 0 C--N 1.337 0.616 0 CA-C-N 115.667 -0.697 . . . . 0.0 114.275 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.468 ' N ' ' HE1' ' A' ' 45' ' ' MET . . . 137.64 -92.32 0.21 Allowed Glycine 0 CA--C 1.518 0.262 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.024 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.477 ' N ' ' HE1' ' A' ' 45' ' ' MET . 0.7 OUTLIER -137.44 138.49 24.89 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-O 120.757 0.313 . . . . 0.0 111.222 -179.828 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_exo -35.77 95.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.315 2.677 . . . . 0.0 113.079 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.532 ' CE1' ' CG2' ' A' ' 3' ' ' THR . 2.5 t80 -173.0 105.2 0.14 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.307 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.925 HG23 ' CG1' ' A' ' 46' ' ' ILE . 0.2 OUTLIER -124.06 153.64 41.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.473 -178.933 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.814 HD23 ' C ' ' A' ' 4' ' ' ILE . 6.7 tp -102.73 146.7 27.83 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.75 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.577 ' C ' HD22 ' A' ' 55' ' ' LEU . . . -78.89 -162.81 23.44 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.241 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.721 HD22 ' N ' ' A' ' 55' ' ' LEU . 1.2 mm? -121.88 114.17 20.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.813 0.34 . . . . 0.0 110.44 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.74 ' O ' HG13 ' A' ' 7' ' ' VAL . 0.9 OUTLIER -84.26 105.71 15.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.6 -179.756 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -138.65 -176.33 4.44 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.088 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.806 ' CB ' HD22 ' A' ' 67' ' ' LEU . 0.1 OUTLIER -125.63 143.33 51.07 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.943 -179.647 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.682 ' HB3' HG23 ' A' ' 36' ' ' VAL . . . -147.78 100.7 3.24 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.936 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.556 ' C ' HD22 ' A' ' 61' ' ' LEU . . . -75.66 80.9 1.01 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.63 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.646 HD23 ' HB1' ' A' ' 59' ' ' ALA . 3.1 mm? -121.3 -119.74 0.3 Allowed 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 110.577 -0.157 . . . . 0.0 110.577 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -98.53 -30.49 12.49 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-N 118.151 0.432 . . . . 0.0 111.075 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.34 -63.2 1.25 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.148 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.638 ' HB2' HD12 ' A' ' 67' ' ' LEU . 75.6 m-85 -87.67 146.34 25.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.037 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -86.5 -68.72 0.72 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.174 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.431 ' HD2' ' N ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -98.89 -50.33 4.24 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.924 -179.638 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.806 HD22 ' CB ' ' A' ' 58' ' ' THR . 0.6 OUTLIER 65.35 114.95 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.629 0.252 . . . . 0.0 110.846 -179.753 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.518 ' N ' ' HD3' ' A' ' 69' ' ' PRO . 0.5 OUTLIER -149.14 44.0 0.31 Allowed Pre-proline 0 C--N 1.329 -0.297 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 179.616 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.518 ' HD3' ' N ' ' A' ' 68' ' ' ARG . 90.6 Cg_endo -83.08 -42.98 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.344 2.029 . . . . 0.0 112.269 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.785 ' HG ' HD12 ' B' ' 541' ' ' LEU . 0.2 OUTLIER -63.08 -16.34 59.62 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.322 -179.842 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 93.9 p -46.37 -56.3 6.07 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.854 0.359 . . . . 0.0 111.274 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -156.89 65.28 3.65 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.944 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.474 ' HB2' ' CZ ' ' A' ' 78' ' ' PHE . 35.0 Cg_exo -59.59 154.62 47.26 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.542 2.161 . . . . 0.0 112.233 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 7.4 mm-40 -98.5 10.33 41.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.309 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.1 m -56.7 161.36 2.84 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.818 0.342 . . . . 0.0 110.924 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.76 7.27 30.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.487 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.779 HG11 ' HB2' ' A' ' 176' ' ' ALA . 7.5 p -156.95 91.7 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.334 -0.084 0 CA-C-O 120.859 0.361 . . . . 0.0 111.219 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.474 ' CZ ' ' HB2' ' A' ' 73' ' ' PRO . 3.1 m-85 -80.88 -177.04 6.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.622 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.51 HD21 ' CG2' ' A' ' 113' ' ' VAL . 1.1 tt -149.83 114.19 5.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.972 0.415 . . . . 0.0 111.5 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.1 t -98.6 156.4 3.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.285 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.745 ' HB3' HG11 ' A' ' 14' ' ' VAL . 1.8 p -152.04 153.08 33.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.086 0.47 . . . . 0.0 111.751 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.514 ' CE1' ' CE1' ' A' ' 90' ' ' PHE . 9.1 p90 -166.32 134.24 2.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.261 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.431 ' HA ' ' C2 ' ' A' ' 185' ' ' GNP . 0.3 OUTLIER -85.34 141.72 29.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.942 -179.802 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.784 HG13 ' N ' ' A' ' 137' ' ' ILE . 57.8 t -44.47 -55.14 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.359 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.655 HG11 HG21 ' A' ' 125' ' ' THR . 34.9 m -47.81 115.71 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.732 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.801 ' N ' HD22 ' A' ' 129' ' ' LEU . 5.1 p -150.94 129.78 6.26 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.584 -179.213 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.425 ' O ' ' CB ' ' A' ' 132' ' ' ASN . 87.4 Cg_endo -90.83 50.37 0.85 Allowed 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.043 2.495 . . . . 0.0 111.963 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.469 ' N ' ' HB3' ' A' ' 133' ' ' LYS . 0.3 OUTLIER 76.35 14.37 2.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.522 -179.785 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.491 ' O ' HG12 ' A' ' 93' ' ' VAL . 8.4 t -97.39 -27.06 14.64 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.994 0.426 . . . . 0.0 110.583 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.514 ' CE1' ' CE1' ' A' ' 82' ' ' PHE . 59.3 t80 -51.14 -33.35 26.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.034 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.2 -48.51 28.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.191 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -69.1 -44.81 71.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.183 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.733 HG22 ' CE3' ' A' ' 97' ' ' TRP . 11.6 p -58.84 -45.31 91.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.366 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.602 ' HG3' HD13 ' A' ' 145' ' ' LEU . 9.2 mmtt -59.62 -57.32 13.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.792 0.33 . . . . 0.0 110.997 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.423 ' O ' ' CG ' ' A' ' 99' ' ' PRO . 70.0 mm-40 -62.22 -18.5 61.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.259 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.8 tmtt? -101.49 -12.42 18.55 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.489 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.733 ' CE3' HG22 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -84.27 -56.7 3.51 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.787 0.327 . . . . 0.0 111.124 -179.823 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.562 HG11 ' HG ' ' A' ' 149' ' ' LEU . 5.1 t -49.48 -46.6 78.41 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.643 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.482 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 82.1 Cg_exo -44.63 -41.23 14.47 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.458 2.105 . . . . 0.0 112.85 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.434 ' HG3' ' N ' ' A' ' 101' ' ' ILE . 2.1 pt-20 -79.51 -31.72 42.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.058 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.434 ' N ' ' HG3' ' A' ' 100' ' ' GLU . 23.0 mt -53.74 -41.71 48.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.018 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 23.1 p -93.81 -21.05 19.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.981 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.414 ' HB3' ' HA ' ' A' ' 100' ' ' GLU . 83.9 t60 -60.24 -31.46 70.22 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.936 0.398 . . . . 0.0 110.69 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 -88.64 -25.77 22.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.886 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -144.58 136.19 12.81 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.792 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -59.48 -15.28 29.52 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.598 2.199 . . . . 0.0 112.607 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -169.6 84.05 0.13 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.825 0.345 . . . . 0.0 110.906 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -108.79 101.82 45.52 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.813 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -60.4 155.17 48.31 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.493 2.128 . . . . 0.0 112.122 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.862 ' O ' HG23 ' A' ' 152' ' ' VAL . 32.1 p90 -155.99 169.4 24.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.188 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.89 HD12 ' HB ' ' A' ' 152' ' ' VAL . 0.7 OUTLIER -132.85 150.18 52.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.863 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.795 HD23 ' CB ' ' A' ' 151' ' ' ALA . 0.3 OUTLIER -98.93 161.57 13.56 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.113 -179.745 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.777 ' HA ' HG21 ' A' ' 168' ' ' VAL . 2.5 t -136.81 144.04 33.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.036 0.446 . . . . 0.0 111.805 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.5 ' HA3' ' CZ ' ' A' ' 154' ' ' TYR . . . -133.15 103.83 0.52 Allowed Glycine 0 C--N 1.33 0.233 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.697 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.9 ' OG1' " H2'" ' A' ' 185' ' ' GNP . 0.4 OUTLIER -125.01 -1.41 7.79 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -178.647 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.948 ' NE2' HD21 ' A' ' 119' ' ' LEU . 2.2 mm-40 -99.2 -8.39 25.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.974 0.416 . . . . 0.0 110.011 178.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.498 ' H ' HD13 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -49.25 -24.02 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.563 178.799 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -86.13 -20.51 28.54 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.562 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.948 HD21 ' NE2' ' A' ' 116' ' ' GLN . 4.2 pp -110.89 -12.84 14.21 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.498 ' HB2' HG11 ' A' ' 84' ' ' VAL . 9.1 ptt85 -50.88 -25.33 4.43 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.911 0.386 . . . . 0.0 110.72 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -72.24 -24.86 61.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.912 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.402 ' O ' ' HB ' ' A' ' 126' ' ' ILE . 4.9 m-20 -47.0 101.27 0.26 Allowed Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.838 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.418 ' O ' ' CG ' ' A' ' 127' ' ' GLU . 17.1 Cg_exo -67.4 -6.07 15.53 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.77 2.314 . . . . 0.0 113.021 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.7 t -84.67 -67.06 0.83 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.026 0.441 . . . . 0.0 110.001 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.655 HG21 HG11 ' A' ' 85' ' ' VAL . 4.9 m -52.47 -33.84 46.42 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.381 0.61 . . . . 0.0 109.358 178.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.78 HD11 ' HG3' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -60.03 -40.83 84.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.455 179.017 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.418 ' CG ' ' O ' ' A' ' 123' ' ' PRO . 3.7 mm-40 -56.13 -35.85 67.58 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.262 178.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.403 ' HB2' ' O ' ' A' ' 125' ' ' THR . 1.9 mptp? -66.86 -32.71 74.16 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.801 HD22 ' N ' ' A' ' 86' ' ' SER . 7.3 mt -73.36 -41.55 63.28 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 177.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.49 ' HA ' ' HB3' ' A' ' 134' ' ' GLN . . . -48.88 -26.01 2.22 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.202 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 16.2 mmtp -65.6 -33.91 77.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.773 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.425 ' CB ' ' O ' ' A' ' 87' ' ' PRO . 39.1 m-80 -123.8 -30.6 3.54 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -179.021 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.492 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 0.0 OUTLIER -133.62 -72.53 0.5 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 120.991 -0.284 . . . . 0.0 111.424 -178.85 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.492 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 2.7 pt20 99.58 -37.4 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.959 0.903 . . . . 0.0 110.658 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.443 ' HA ' ' HD3' ' A' ' 136' ' ' PRO . 0.6 OUTLIER -69.18 107.48 2.17 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.897 -179.065 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.78 ' HG3' HD11 ' A' ' 126' ' ' ILE . 3.0 Cg_exo -80.65 134.96 10.06 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.823 2.349 . . . . 0.0 111.221 179.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.784 ' N ' HG13 ' A' ' 84' ' ' VAL . 0.8 OUTLIER -67.13 96.48 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.882 0.372 . . . . 0.0 110.817 -179.608 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 6.2 p -67.74 159.23 79.96 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.079 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -50.62 -28.99 23.76 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.636 2.224 . . . . 0.0 112.274 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -82.65 -26.72 31.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.701 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.497 ' HB ' HG22 ' A' ' 137' ' ' ILE . 8.7 m -66.66 -51.16 59.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.782 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.55 ' HB1' ' CD2' ' A' ' 154' ' ' TYR . . . -55.49 -37.98 68.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.924 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -66.54 -45.39 79.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.908 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp -54.22 -64.07 0.95 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.993 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.602 HD13 ' HG3' ' A' ' 94' ' ' LYS . 5.3 tt -60.6 -42.75 97.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.9 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.734 ' HB1' ' HB3' ' A' ' 151' ' ' ALA . . . -48.99 -61.99 1.77 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.05 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.2 mtp85 -63.51 -23.14 67.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.861 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.575 ' HB3' HD22 ' A' ' 149' ' ' LEU . 6.2 t0 -50.16 -50.95 47.42 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.827 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.575 HD22 ' HB3' ' A' ' 148' ' ' ASP . 2.0 mm? -93.65 -72.14 0.62 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.673 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 170.26 60.44 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.516 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.795 ' CB ' HD23 ' A' ' 112' ' ' LEU . . . -94.81 27.46 3.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.535 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.89 ' HB ' HD12 ' A' ' 111' ' ' LEU . 75.8 t 61.11 -74.75 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.454 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.469 ' N ' ' O ' ' A' ' 151' ' ' ALA . 1.6 ttpt -176.41 121.74 0.16 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.829 -179.082 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.55 ' CD2' ' HB1' ' A' ' 142' ' ' ALA . 13.2 t80 -84.97 112.38 20.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.688 179.224 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.409 ' CG2' ' HA ' ' A' ' 168' ' ' VAL . 3.2 t -101.28 156.11 4.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.181 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -94.19 127.58 40.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.584 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.479 ' SG ' HG12 ' A' ' 168' ' ' VAL . 1.1 p 178.62 125.12 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.305 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.491 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 37.1 m -104.53 155.76 18.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.959 0.409 . . . . 0.0 111.657 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.6 ' HB2' HD11 ' A' ' 165' ' ' LEU . . . -92.2 -52.65 4.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.592 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -48.3 -29.78 4.2 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.738 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.9 -21.97 10.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.914 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 69.19 62.46 0.3 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.804 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.443 ' HB3' ' HA ' ' A' ' 157' ' ' CYS . 0.1 OUTLIER -93.41 35.99 1.08 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.255 -179.75 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 95.21 46.56 2.79 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.21 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.858 ' CD2' HD23 ' A' ' 19' ' ' LEU . 0.4 OUTLIER -53.49 -29.88 38.31 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.988 0.423 . . . . 0.0 110.588 179.688 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 28.8 pttt -68.52 -24.54 64.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.763 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 30.7 t30 -58.25 -68.95 0.2 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.565 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.777 HG21 ' HA ' ' A' ' 113' ' ' VAL . 14.4 p -54.28 -45.81 68.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.565 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.674 ' CZ ' HD13 ' A' ' 19' ' ' LEU . 1.2 t80 -60.38 -41.02 92.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.501 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -54.91 -34.96 63.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.875 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -75.89 -26.47 57.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.174 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.688 ' HB2' HD22 ' A' ' 111' ' ' LEU . . . -63.85 -42.96 97.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.213 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.91 HD13 ' N ' ' A' ' 174' ' ' LEU . 0.0 OUTLIER -89.94 -23.45 6.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.633 -179.866 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.91 ' N ' HD13 ' A' ' 173' ' ' ILE . 2.8 tp -49.05 -43.83 41.19 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.989 0.423 . . . . 0.0 110.41 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -62.14 -27.36 68.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.995 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.779 ' HB2' HG11 ' A' ' 77' ' ' VAL . . . -87.71 -39.41 14.99 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.636 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.747 HD12 HG13 ' A' ' 4' ' ' ILE . 0.6 OUTLIER -68.61 -26.39 65.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.518 179.628 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.439 ' CB ' ' HD2' ' A' ' 179' ' ' PRO . 0.5 OUTLIER -166.82 167.72 7.64 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.651 179.861 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.439 ' HD2' ' CB ' ' A' ' 178' ' ' GLU . 18.9 Cg_endo -60.27 118.77 5.69 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.541 2.161 . . . . 0.0 112.229 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.87 153.96 63.59 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.527 2.151 . . . . 0.0 112.423 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -149.63 119.92 3.96 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.822 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.01 -164.89 0.25 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.429 2.086 . . . . 0.0 112.219 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 11.9 mmtt -105.0 83.41 1.98 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.958 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.16 -0.924 . . . . 0.0 110.819 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.221 0 N-CA-C 112.525 -0.23 . . . . 0.0 112.525 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 503' ' ' SER . . . . . 0.401 ' OG ' ' HA ' ' B' ' 511' ' ' SER . 0.0 OUTLIER -111.74 -49.32 3.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.751 0.31 . . . . 0.0 111.011 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 504' ' ' GLY . . . . . 0.738 ' C ' HD22 ' B' ' 505' ' ' LEU . . . 124.78 -93.52 0.45 Allowed Glycine 0 CA--C 1.508 -0.405 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.862 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 505' ' ' LEU . . . . . 0.816 ' HB3' HD13 ' A' ' 174' ' ' LEU . 0.1 OUTLIER 74.17 0.28 3.56 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 179.45 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 506' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 52.93 23.79 3.04 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.022 0.439 . . . . 0.0 111.047 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 507' ' ' ALA . . . . . . . . . . . . . . . -107.86 -74.25 0.66 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.774 0.797 . . . . 0.0 109.506 179.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 508' ' ' GLN . . . . . 0.422 ' O ' ' HB3' ' B' ' 509' ' ' ASP . 0.0 OUTLIER -137.82 4.95 2.58 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.28 -1.327 . . . . 0.0 110.213 179.061 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 509' ' ' ASP . . . . . 0.422 ' HB3' ' O ' ' B' ' 508' ' ' GLN . 48.6 t0 72.47 38.85 0.78 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.587 0.708 . . . . 0.0 109.765 -178.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 510' ' ' ILE . . . . . 0.746 HG21 HD21 ' A' ' 177' ' ' LEU . 1.3 mt -66.34 143.72 15.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.847 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 511' ' ' SER . . . . . 0.452 ' O ' HD11 ' B' ' 514' ' ' LEU . 47.2 t -109.44 148.0 31.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.498 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 512' ' ' GLN . . . . . 0.498 ' OE1' HG21 ' A' ' 173' ' ' ILE . 0.0 OUTLIER -98.62 -67.7 0.05 OUTLIER Pre-proline 0 CA--C 1.53 0.176 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.752 179.547 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 513' ' ' PRO . . . . . 0.497 ' HD3' ' CB ' ' B' ' 512' ' ' GLN . 88.1 Cg_endo -79.16 56.95 6.24 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.456 2.104 . . . . 0.0 111.917 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 514' ' ' LEU . . . . . 0.452 HD11 ' O ' ' B' ' 511' ' ' SER . 0.9 OUTLIER -64.1 -87.01 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.39 -179.568 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 515' ' ' GLN . . . . . 0.404 ' HB2' HG12 ' A' ' 44' ' ' VAL . 4.4 mt-30 -93.07 -158.71 0.63 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.74 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 15.1 m-80 -50.37 -29.0 9.03 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.934 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 517' ' ' SER . . . . . 0.458 ' O ' ' CD1' ' B' ' 518' ' ' PHE . 0.9 OUTLIER 39.85 53.92 2.59 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.821 179.927 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 518' ' ' PHE . . . . . 0.489 ' CE2' HD12 ' A' ' 21' ' ' ILE . 6.1 m-85 -163.29 119.46 1.77 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.915 0.388 . . . . 0.0 111.438 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 519' ' ' ILE . . . . . 0.575 HD12 ' C ' ' A' ' 41' ' ' ALA . 8.9 mt -126.83 82.49 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.058 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 41.8 p-80 -54.21 101.24 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.767 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 521' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.82 31.79 1.81 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.097 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 522' ' ' GLY . . . . . 0.471 ' HA3' ' CD1' ' A' ' 37' ' ' PHE . . . -111.12 -177.83 20.42 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.409 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 523' ' ' HIS . . . . . . . . . . . . . 28.6 t-80 -117.9 -85.64 0.64 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.744 0.306 . . . . 0.0 110.956 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 524' ' ' GLY . . . . . 0.819 ' HA3' HG11 ' A' ' 36' ' ' VAL . . . 52.71 -144.4 21.87 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.604 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 525' ' ' ASP . . . . . . . . . . . . . 19.8 p30 -149.82 85.3 1.42 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.833 0.349 . . . . 0.0 110.933 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 526' ' ' SER . . . . . 0.405 ' CB ' ' HB3' ' A' ' 34' ' ' PRO . 2.4 m -74.92 95.64 3.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.662 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 527' ' ' ASP . . . . . . . . . . . . . 43.1 p-10 -153.97 150.58 22.99 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.919 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.36 100.98 0.94 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.72 2.28 . . . . 0.0 112.348 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 529' ' ' ARG . . . . . 0.509 ' HG3' HG21 ' A' ' 33' ' ' VAL . 39.7 mtp180 -100.41 -55.24 2.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.296 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 530' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -168.51 95.79 0.38 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.107 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 531' ' ' CYS . . . . . 0.412 ' O ' ' N ' ' B' ' 533' ' ' GLY . 18.3 t -49.79 130.64 21.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.014 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 532' ' ' TRP . . . . . 0.57 ' CZ2' ' CE1' ' A' ' 28' ' ' PHE . 0.0 OUTLIER 60.42 -81.84 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.933 179.893 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 533' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' B' ' 531' ' ' CYS . . . 92.3 -35.38 4.05 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.613 -0.804 . . . . 0.0 112.592 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 534' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -155.17 156.94 31.65 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.634 0.254 . . . . 0.0 110.846 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -53.21 -59.1 1.12 Allowed 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.749 2.299 . . . . 0.0 112.088 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -86.87 141.41 28.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.636 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 537' ' ' ARG . . . . . 0.427 ' HB2' ' CA ' ' A' ' 12' ' ' GLY . 25.4 mmt-85 -65.89 136.24 55.86 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.133 0.492 . . . . 0.0 111.214 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 538' ' ' ILE . . . . . 0.443 HG13 ' HB2' ' B' ' 542' ' ' TYR . 6.3 tp -59.57 143.22 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.208 179.335 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 539' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -44.13 143.41 1.18 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.874 0.369 . . . . 0.0 111.035 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 540' ' ' GLU . . . . . 0.869 ' HG2' HG13 ' A' ' 8' ' ' VAL . 0.3 OUTLIER -50.4 -24.39 3.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.014 -179.719 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 541' ' ' LEU . . . . . 0.785 HD12 ' HG ' ' A' ' 70' ' ' LEU . 0.1 OUTLIER -55.3 -27.04 44.21 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 121.4 0.619 . . . . 0.0 109.77 179.07 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 542' ' ' TYR . . . . . 0.443 ' HB2' HG13 ' B' ' 538' ' ' ILE . 14.2 m-85 -104.23 -63.05 1.24 Allowed 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.903 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 543' ' ' LEU . . . . . 0.403 ' HB2' ' O ' ' A' ' 58' ' ' THR . 0.3 OUTLIER 49.73 103.86 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.318 179.648 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . 118.28 -100.99 0.87 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.529 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 545' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.919 -179.884 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 185' ' ' GNP . . . . . 0.9 " H2'" ' OG1' ' A' ' 115' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.426 ' HG3' ' N ' ' A' ' 2' ' ' GLN . 3.0 ptm . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.796 0.332 . . . . 0.0 111.21 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.426 ' N ' ' HG3' ' A' ' 1' ' ' MET . 0.0 OUTLIER 57.65 161.88 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.706 -179.891 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.732 HG23 ' CE1' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -129.93 -177.41 4.28 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.333 -179.786 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.515 HD11 ' CD1' ' A' ' 53' ' ' LEU . 6.0 pt -153.89 148.22 13.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.758 -179.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.1 mttt -134.0 95.7 3.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.095 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -112.31 155.29 24.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.406 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.422 HG23 HG21 ' A' ' 75' ' ' THR . 0.2 OUTLIER -137.2 159.58 36.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.309 179.667 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.824 HG12 ' CG ' ' B' ' 540' ' ' GLU . 60.1 t -90.0 113.68 26.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.997 0.427 . . . . 0.0 111.299 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.463 ' CA ' ' HG2' ' B' ' 540' ' ' GLU . 93.5 t -130.65 129.48 64.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.673 179.133 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 138.73 -113.19 0.92 Allowed Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.014 -1.089 . . . . 0.0 113.013 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.403 ' O ' ' HB2' ' B' ' 537' ' ' ARG . 6.9 m-20 -110.61 -53.65 2.67 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.975 ' O ' HG13 ' A' ' 14' ' ' VAL . . . -140.06 -148.48 5.18 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.176 -1.011 . . . . 0.0 113.494 -179.317 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.624 ' O ' HG22 ' A' ' 14' ' ' VAL . . . -41.4 -31.97 0.28 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.975 HG13 ' O ' ' A' ' 12' ' ' GLY . 6.3 m 48.08 25.52 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.966 0.412 . . . . 0.0 110.721 -178.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.936 ' CA ' HD22 ' A' ' 19' ' ' LEU . . . 83.36 26.53 43.16 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.951 -0.643 . . . . 0.0 112.723 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.68 ' CB ' HG22 ' A' ' 8' ' ' VAL . 5.6 tptm -98.19 -72.91 0.63 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.776 0.322 . . . . 0.0 111.699 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.1 p -96.06 -58.32 2.12 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.456 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.501 ' HB2' ' HB2' ' A' ' 13' ' ' ALA . 12.0 t -42.34 -46.62 4.67 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.693 0.282 . . . . 0.0 111.64 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.936 HD22 ' CA ' ' A' ' 15' ' ' GLY . 0.7 OUTLIER -47.15 -49.74 21.79 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.886 0.374 . . . . 0.0 110.724 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.568 HD21 ' CE2' ' A' ' 169' ' ' PHE . 3.7 mt -64.75 -24.18 67.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.399 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.727 HG22 ' OG1' ' A' ' 25' ' ' THR . 14.2 mm -73.99 -70.52 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.19 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 59.8 p -48.26 -27.53 2.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.742 0.306 . . . . 0.0 111.048 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -70.44 -67.36 0.5 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.742 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 89.6 m -72.23 -48.58 41.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.647 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.727 ' OG1' HG22 ' A' ' 21' ' ' ILE . 20.6 p -85.58 -151.12 0.14 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.382 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -160.28 29.39 0.17 Allowed 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.859 0.361 . . . . 0.0 111.077 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.58 104.83 9.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.281 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.486 ' CD2' ' HD3' ' A' ' 29' ' ' PRO . 0.1 OUTLIER -110.34 -61.71 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.106 -179.977 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.486 ' HD3' ' CD2' ' A' ' 28' ' ' PHE . 91.5 Cg_endo -86.61 89.35 0.67 Allowed 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.369 2.046 . . . . 0.0 113.052 -179.091 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.3 p -163.94 -94.74 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.395 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.51 ' CG ' ' HA ' ' B' ' 530' ' ' HIS . 0.2 OUTLIER -160.25 121.87 3.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.716 0.293 . . . . 0.0 110.818 179.684 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.463 ' CD2' ' N3B' ' A' ' 185' ' ' GNP . 3.4 m-30 -101.96 94.23 5.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.934 0.397 . . . . 0.0 110.809 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.812 HG13 ' ND2' ' B' ' 545' ' ' ASN . 0.6 OUTLIER -98.73 -51.97 0.2 Allowed Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.367 -179.757 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.419 ' HD3' ' HB ' ' A' ' 33' ' ' VAL . 7.0 Cg_exo -73.9 55.94 3.47 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.812 2.341 . . . . 0.0 112.44 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.426 HG21 ' O2G' ' A' ' 185' ' ' GNP . 5.7 t -116.77 -33.68 4.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.665 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.861 ' HB ' HD13 ' A' ' 61' ' ' LEU . 7.6 p -52.6 -27.1 11.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.802 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -93.97 40.08 1.08 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.535 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.419 ' HB2' ' HB3' ' A' ' 57' ' ' ASP . 0.4 OUTLIER -93.61 36.17 1.1 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.978 -179.946 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -123.77 18.15 9.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.142 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.411 ' CD2' ' HB ' ' B' ' 521' ' ' THR . 0.2 OUTLIER -75.74 -165.39 0.44 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.789 0.328 . . . . 0.0 110.71 179.973 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.41 ' O ' HG12 ' B' ' 519' ' ' ILE . . . -96.18 161.76 13.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.164 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.503 HG23 ' OG1' ' A' ' 52' ' ' THR . 7.6 m -149.47 129.44 3.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.147 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.612 ' O ' HG23 ' A' ' 44' ' ' VAL . 5.0 t -87.9 106.13 17.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.632 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.643 HG13 ' HB2' ' B' ' 514' ' ' LEU . 1.8 t -161.1 157.86 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.726 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.48 ' HE1' ' N ' ' A' ' 48' ' ' GLY . 0.0 OUTLIER -101.74 97.61 7.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.711 -179.481 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.699 HG23 ' CG2' ' B' ' 510' ' ' ILE . 3.0 mm -77.0 86.38 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.386 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.44 ' N ' ' HE2' ' A' ' 45' ' ' MET . . . 25.63 98.63 0.01 OUTLIER Glycine 0 C--N 1.339 0.73 0 CA-C-N 115.505 -0.77 . . . . 0.0 114.435 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.48 ' N ' ' HE1' ' A' ' 45' ' ' MET . . . 128.46 -89.89 0.32 Allowed Glycine 0 CA--C 1.519 0.281 0 C-N-CA 120.596 -0.811 . . . . 0.0 113.007 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.449 ' N ' ' HE1' ' A' ' 45' ' ' MET . 1.4 pt-20 -124.73 139.85 34.26 Favored Pre-proline 0 CA--C 1.53 0.202 0 CA-C-O 120.799 0.333 . . . . 0.0 111.233 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.425 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 78.9 Cg_exo -38.12 101.26 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 123.074 2.516 . . . . 0.0 112.822 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.732 ' CE1' HG23 ' A' ' 3' ' ' THR . 2.2 t80 -172.98 154.69 2.89 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.436 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.509 HG21 ' HB ' ' A' ' 44' ' ' VAL . 0.1 OUTLIER -136.72 152.99 50.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.746 179.046 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.646 ' H ' HD13 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -74.94 161.53 29.42 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.002 -179.899 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -88.8 87.51 1.49 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.626 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.553 ' H ' HD12 ' A' ' 55' ' ' LEU . 1.1 mp -58.37 99.9 0.05 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.844 0.354 . . . . 0.0 110.664 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -84.76 105.76 15.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.997 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.419 ' HB3' ' HB2' ' A' ' 38' ' ' ASP . 30.1 t0 -104.14 129.16 51.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.84 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.884 ' O ' HD22 ' B' ' 543' ' ' LEU . 26.4 p -98.21 126.14 43.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.979 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.824 ' HB1' ' CD1' ' A' ' 61' ' ' LEU . . . -157.63 118.43 3.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.317 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.403 ' HA2' ' O ' ' A' ' 64' ' ' TYR . . . -69.36 73.85 0.42 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.286 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.861 HD13 ' HB ' ' A' ' 36' ' ' VAL . 6.7 mp -120.7 -117.26 0.31 Allowed 'General case' 0 CA--C 1.539 0.536 0 O-C-N 122.944 -0.151 . . . . 0.0 111.052 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -99.08 -31.3 11.85 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 118.069 0.395 . . . . 0.0 111.426 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.435 ' CB ' HG22 ' A' ' 36' ' ' VAL . 6.2 t0 -74.33 -63.26 1.27 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.311 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.545 ' CD2' HD21 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -115.95 133.69 55.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.718 -179.759 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.95 -69.12 0.7 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.838 0.352 . . . . 0.0 111.146 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.4 ' O ' ' HB2' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -99.44 -34.99 10.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.33 -179.885 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.597 HD13 ' HB ' ' A' ' 58' ' ' THR . 1.0 OUTLIER 70.15 123.88 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.978 -179.652 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.458 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 2.5 mpt_? -82.91 -49.26 0.77 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.147 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.458 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 83.0 Cg_exo -44.83 -58.37 1.59 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.588 2.192 . . . . 0.0 112.538 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.56 ' C ' HD12 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -51.08 -38.31 50.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.69 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.1 t -76.74 -53.78 7.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.906 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -114.32 61.57 1.12 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.638 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.428 ' N ' ' O ' ' A' ' 69' ' ' PRO . 52.1 Cg_endo -68.65 112.44 2.87 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.575 2.184 . . . . 0.0 112.466 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 15.2 tp60 -101.96 10.16 39.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.375 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.422 HG21 HG23 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -56.34 166.64 0.81 Allowed 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 120.802 0.334 . . . . 0.0 110.809 179.979 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -72.74 -26.02 61.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.707 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.632 HG11 ' HB3' ' A' ' 175' ' ' ALA . 10.3 p -164.4 116.31 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.132 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.683 ' CZ ' HG21 ' A' ' 108' ' ' THR . 0.0 OUTLIER -92.89 134.51 35.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.166 179.349 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.619 HD13 ' HB1' ' A' ' 172' ' ' ALA . 7.5 tp -70.6 108.01 4.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.095 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.516 ' O ' HG23 ' A' ' 80' ' ' VAL . 23.3 m -103.54 121.09 54.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.013 179.237 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.564 ' HB2' HG12 ' A' ' 14' ' ' VAL . 41.1 m -129.13 171.42 12.42 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.359 0.599 . . . . 0.0 112.493 -178.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.555 ' CZ ' ' HB2' ' A' ' 142' ' ' ALA . 41.3 p90 -140.86 -174.04 3.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.88 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.3 p -134.66 122.74 22.68 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.808 0.337 . . . . 0.0 111.071 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.66 HG11 ' HB3' ' A' ' 120' ' ' ARG . 2.9 t -57.15 170.52 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.184 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.756 HG22 ' HA ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER 61.09 105.57 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -179.287 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.531 ' N ' HD21 ' A' ' 129' ' ' LEU . 13.9 p -152.5 143.16 15.5 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-O 120.956 0.408 . . . . 0.0 112.039 -179.14 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.433 ' O ' ' CB ' ' A' ' 88' ' ' SER . 83.1 Cg_endo -90.84 53.36 1.01 Allowed 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.29 2.66 . . . . 0.0 111.585 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.46 ' CB ' ' HG2' ' A' ' 133' ' ' LYS . 0.3 OUTLIER 84.29 25.62 0.1 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.663 -179.533 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.964 ' O ' HG23 ' A' ' 93' ' ' VAL . 2.8 p -97.23 -25.1 15.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.992 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -53.86 -43.79 69.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.016 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -53.96 -61.71 2.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.929 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.419 ' O ' ' N ' ' A' ' 96' ' ' LYS . 30.0 m-80 -53.88 -42.31 68.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.941 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.964 HG23 ' O ' ' A' ' 89' ' ' SER . 60.1 t -47.47 -63.74 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.303 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.7 ' CG ' HD11 ' A' ' 145' ' ' LEU . 0.0 OUTLIER -51.04 -45.75 61.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.869 179.91 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.412 ' O ' ' HG3' ' A' ' 99' ' ' PRO . 0.8 OUTLIER -85.31 10.79 11.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.723 -179.952 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.2 OUTLIER -111.04 -36.18 5.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.934 0.397 . . . . 0.0 110.976 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.401 ' O ' HG23 ' A' ' 101' ' ' ILE . 33.4 m95 -94.36 -42.95 8.63 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.543 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 94' ' ' LYS . 82.3 t -53.26 -47.3 96.53 Favored Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 77.9 Cg_endo -78.95 -18.52 11.44 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.237 1.958 . . . . 0.0 112.629 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -81.61 -40.18 23.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.923 0.392 . . . . 0.0 110.492 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.498 ' CD1' ' CD2' ' A' ' 110' ' ' PHE . 32.8 pt -69.49 -29.79 43.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.904 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.543 HG23 ' O ' ' A' ' 98' ' ' VAL . 70.5 p -78.2 -32.91 50.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.697 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 -63.21 -54.76 32.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.652 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 16.2 m80 -71.65 -24.28 61.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.79 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 1.6 t -143.85 95.96 5.64 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.866 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -47.63 112.07 0.5 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.654 2.236 . . . . 0.0 112.509 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.8 mttt 49.8 99.26 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.157 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.683 HG21 ' CZ ' ' A' ' 78' ' ' PHE . 8.7 m -139.24 144.34 40.04 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.03 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.427 ' C ' HG23 ' A' ' 77' ' ' VAL . 34.2 Cg_exo -60.67 159.29 28.93 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.762 2.308 . . . . 0.0 112.829 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.498 ' CD2' ' CD1' ' A' ' 101' ' ' ILE . 2.4 p90 -165.37 148.24 7.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.556 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 1.006 HD22 ' HB2' ' A' ' 172' ' ' ALA . 1.1 tt -120.05 154.79 34.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.168 -179.343 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.913 HD12 ' HB2' ' A' ' 146' ' ' ALA . 13.1 mt -111.73 146.43 37.57 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.799 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.831 ' CG1' HG21 ' A' ' 168' ' ' VAL . 21.9 t -130.87 149.69 33.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.15 0.5 . . . . 0.0 111.884 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.517 ' C ' HD12 ' A' ' 117' ' ' ILE . . . -124.97 112.43 1.73 Allowed Glycine 0 N--CA 1.452 -0.247 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.407 179.064 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.837 ' HG1' " H2'" ' A' ' 185' ' ' GNP . 0.2 OUTLIER -127.84 -54.82 1.31 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.839 0.352 . . . . 0.0 111.329 -179.009 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.474 ' HG2' HD21 ' A' ' 119' ' ' LEU . 2.0 tt0 -58.56 -17.65 23.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.26 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.871 HD11 ' O ' ' A' ' 157' ' ' CYS . 0.2 OUTLIER -44.81 -27.31 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 120.841 0.353 . . . . 0.0 111.592 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.413 ' N ' HG12 ' A' ' 117' ' ' ILE . 21.4 t0 -66.76 -35.37 79.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.688 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.633 ' C ' HD12 ' A' ' 119' ' ' LEU . 3.8 pp -99.49 -3.89 32.54 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.466 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.756 ' HA ' HG22 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -52.37 -35.67 51.87 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.977 0.418 . . . . 0.0 110.481 179.583 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -62.48 -24.17 67.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.759 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.412 ' O ' ' HB ' ' A' ' 126' ' ' ILE . 8.9 t0 -42.36 100.6 0.23 Allowed Pre-proline 0 N--CA 1.463 0.208 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.025 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.44 ' O ' ' CG ' ' A' ' 127' ' ' GLU . 37.7 Cg_endo -66.67 -8.99 22.83 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.434 2.089 . . . . 0.0 112.897 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.7 t -74.14 -67.52 0.61 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.08 0.467 . . . . 0.0 110.008 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.894 HG22 ' CD1' ' A' ' 129' ' ' LEU . 73.6 m -56.36 -47.15 79.44 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.523 HD11 ' HB3' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -46.91 -40.46 4.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.959 179.413 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.646 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 4.8 mm-40 -60.07 -39.11 84.93 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.438 ' N ' ' O ' ' A' ' 125' ' ' THR . 0.0 OUTLIER -68.67 -34.02 74.97 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.155 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.894 ' CD1' HG22 ' A' ' 125' ' ' THR . 9.8 mp -64.84 -37.75 88.66 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 177.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.646 ' HB3' ' O ' ' A' ' 127' ' ' GLU . . . -43.58 -39.16 3.34 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 114.453 -1.249 . . . . 0.0 111.567 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 6.3 mmtm -58.65 -24.8 61.91 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.579 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.426 ' CB ' ' O ' ' A' ' 87' ' ' PRO . 11.1 m-80 -124.38 -31.52 3.27 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -179.124 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.46 ' HG2' ' CB ' ' A' ' 88' ' ' SER . 2.2 mmtt -156.41 -63.38 0.1 Allowed 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -178.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.578 ' CD ' ' HB2' ' A' ' 130' ' ' ALA . 2.0 tt0 80.9 14.18 0.69 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.208 -178.511 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.402 ' HA ' ' HD2' ' A' ' 136' ' ' PRO . 35.2 mmtt -97.87 96.54 3.45 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.634 0.254 . . . . 0.0 111.175 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.523 ' HB3' HD11 ' A' ' 126' ' ' ILE . 30.9 Cg_endo -64.74 131.1 28.15 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.389 2.059 . . . . 0.0 111.738 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.659 ' O ' HG13 ' A' ' 84' ' ' VAL . 1.6 mm -67.55 96.38 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.0 0.429 . . . . 0.0 110.749 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.3 p -77.0 147.28 76.84 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.868 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.487 ' HA ' ' CE1' ' A' ' 154' ' ' TYR . 96.4 Cg_exo -43.0 -28.22 1.17 Allowed 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.584 2.189 . . . . 0.0 112.286 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -72.88 -36.55 67.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.865 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 16.6 m -54.57 -61.93 1.99 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.898 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.555 ' HB2' ' CZ ' ' A' ' 82' ' ' PHE . . . -52.04 -40.81 61.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.066 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -51.18 -45.29 61.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.821 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.4 ttpp -64.06 -49.08 73.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.812 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.7 HD11 ' CG ' ' A' ' 94' ' ' LYS . 0.9 OUTLIER -61.43 -46.77 88.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.674 179.819 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.913 ' HB2' HD12 ' A' ' 112' ' ' LEU . . . -50.93 -45.52 60.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.98 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.57 -26.6 32.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.772 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.483 ' HB3' HD22 ' A' ' 149' ' ' LEU . 25.0 t0 -53.18 -38.4 62.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.766 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.483 HD22 ' HB3' ' A' ' 148' ' ' ASP . 2.9 mm? -114.48 21.25 14.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.926 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 48.16 51.3 14.99 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.037 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.649 ' O ' HG23 ' A' ' 152' ' ' VAL . . . -66.66 -82.86 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.978 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.881 HG11 HD12 ' A' ' 111' ' ' LEU . 36.5 t -164.32 -69.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.244 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 176.65 135.76 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.134 -179.298 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.487 ' CE1' ' HA ' ' A' ' 139' ' ' PRO . 27.7 t80 -106.54 108.01 19.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.64 178.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.552 HG23 ' OE2' ' A' ' 171' ' ' GLU . 0.2 OUTLIER -101.32 -171.89 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.89 0.376 . . . . 0.0 111.319 -179.175 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.504 ' H ' HG12 ' A' ' 155' ' ' VAL . 8.9 mt-10 -89.73 156.51 18.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.159 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.871 ' O ' HD11 ' A' ' 117' ' ' ILE . 13.0 t 178.82 160.02 0.62 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.199 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.631 ' OG ' HG22 ' A' ' 161' ' ' THR . 8.4 t -159.69 123.56 3.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.866 0.365 . . . . 0.0 111.19 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -92.3 20.25 6.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.073 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.652 ' N ' HD12 ' A' ' 160' ' ' LEU . 0.0 OUTLIER -133.11 -44.71 0.85 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.527 179.927 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.631 HG22 ' OG ' ' A' ' 158' ' ' SER . 9.7 t -111.06 -16.08 13.57 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.993 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 75.9 85.41 0.09 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.84 0.352 . . . . 0.0 111.355 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.502 ' HG2' HG23 ' A' ' 161' ' ' THR . 22.1 mmmt -111.12 45.77 1.14 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.52 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.436 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . 128.95 -63.22 0.63 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.106 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.832 HD11 ' O ' ' A' ' 19' ' ' LEU . 0.2 OUTLIER 62.23 -74.46 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.711 0.291 . . . . 0.0 111.257 179.597 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.442 ' HB3' ' HG3' ' B' ' 513' ' ' PRO . 0.0 OUTLIER -69.76 -23.42 63.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.99 -179.961 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -56.02 -56.07 25.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.006 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.831 HG21 ' CG1' ' A' ' 113' ' ' VAL . 16.2 m -71.27 -36.74 63.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.582 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.689 ' HB2' HD23 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -75.03 -19.52 60.0 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.853 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.72 ' OD2' HD21 ' B' ' 505' ' ' LEU . 28.7 t70 -83.06 -34.81 26.11 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.011 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.836 ' CD ' HD11 ' A' ' 111' ' ' LEU . 2.1 pt-20 -75.15 -31.66 61.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.912 0.387 . . . . 0.0 110.34 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 1.006 ' HB2' HD22 ' A' ' 111' ' ' LEU . . . -73.09 -47.81 41.23 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.586 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.424 HG12 ' O ' ' A' ' 169' ' ' PHE . 1.7 pp -64.34 -38.63 83.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.756 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.854 HD23 HD13 ' B' ' 505' ' ' LEU . 3.3 tm? -52.3 -35.4 50.43 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.921 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.632 ' HB3' HG11 ' A' ' 77' ' ' VAL . . . -51.76 -24.31 5.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.984 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.48 ' HB3' ' HB ' ' A' ' 4' ' ' ILE . . . -95.05 -36.94 11.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.106 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.921 HD13 ' HB ' ' B' ' 510' ' ' ILE . 9.6 mt -68.82 -24.34 64.37 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.844 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -172.94 128.8 0.54 Allowed Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.908 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -57.19 115.75 2.72 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.559 2.172 . . . . 0.0 112.304 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -77.47 -166.44 0.39 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.451 2.101 . . . . 0.0 112.312 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -149.08 131.55 7.84 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.891 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -80.71 -165.47 0.34 Allowed 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.667 2.245 . . . . 0.0 112.326 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 29.3 mttt -133.98 170.85 15.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.894 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 2.3 mttm . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.184 -0.913 . . . . 0.0 110.905 -179.946 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.202 0 N-CA-C 112.428 -0.269 . . . . 0.0 112.428 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 503' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.5 -162.37 0.51 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.819 0.343 . . . . 0.0 110.849 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 504' ' ' GLY . . . . . 0.844 ' O ' HD12 ' B' ' 505' ' ' LEU . . . 131.17 -101.89 0.5 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.321 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 505' ' ' LEU . . . . . 0.854 HD13 HD23 ' A' ' 174' ' ' LEU . 0.0 OUTLIER 58.96 18.08 5.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.563 0.22 . . . . 0.0 111.3 179.773 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 506' ' ' SER . . . . . 0.54 ' O ' ' HB2' ' B' ' 507' ' ' ALA . 0.7 OUTLIER 65.26 100.19 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.925 0.393 . . . . 0.0 110.649 -179.922 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 507' ' ' ALA . . . . . 0.54 ' HB2' ' O ' ' B' ' 506' ' ' SER . . . 169.15 -36.29 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.389 0.614 . . . . 0.0 110.44 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 508' ' ' GLN . . . . . 0.476 ' O ' ' CB ' ' B' ' 509' ' ' ASP . 0.5 OUTLIER 156.62 -26.36 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.394 -179.364 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 509' ' ' ASP . . . . . 0.476 ' CB ' ' O ' ' B' ' 508' ' ' GLN . 0.3 OUTLIER 98.07 32.4 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.975 0.91 . . . . 0.0 110.872 179.739 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 510' ' ' ILE . . . . . 0.921 ' HB ' HD13 ' A' ' 177' ' ' LEU . 3.3 mp -54.05 130.9 16.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.443 179.213 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 511' ' ' SER . . . . . 0.487 ' O ' HD12 ' B' ' 514' ' ' LEU . 0.4 OUTLIER -109.09 154.48 22.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.261 -179.459 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 512' ' ' GLN . . . . . 0.465 ' CB ' ' HD3' ' B' ' 513' ' ' PRO . 0.0 OUTLIER -97.9 -57.69 0.17 Allowed Pre-proline 0 C--N 1.333 -0.149 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.799 179.575 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 513' ' ' PRO . . . . . 0.465 ' HD3' ' CB ' ' B' ' 512' ' ' GLN . 59.9 Cg_endo -90.85 42.4 0.43 Allowed 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.905 2.404 . . . . 0.0 112.043 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 514' ' ' LEU . . . . . 0.643 ' HB2' HG13 ' A' ' 44' ' ' VAL . 0.3 OUTLIER -46.49 -85.62 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.624 -179.388 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 515' ' ' GLN . . . . . 0.617 ' H ' HG22 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -92.09 -86.52 0.23 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.124 -179.741 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -125.12 -37.15 2.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.218 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 517' ' ' SER . . . . . 0.407 ' O ' ' CG1' ' A' ' 42' ' ' VAL . 0.7 OUTLIER 63.79 29.57 14.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.962 -179.884 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 518' ' ' PHE . . . . . 0.405 ' HA ' HG12 ' A' ' 42' ' ' VAL . 1.2 m-85 -163.22 123.98 2.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.06 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 519' ' ' ILE . . . . . 0.556 HD11 ' H ' ' A' ' 43' ' ' THR . 12.1 mm -94.42 31.87 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.162 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 52.26 38.26 24.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.858 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 521' ' ' THR . . . . . 0.411 ' HB ' ' CD2' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -113.51 -172.11 2.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.845 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 522' ' ' GLY . . . . . . . . . . . . . . . 101.08 125.46 5.6 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.356 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 523' ' ' HIS . . . . . . . . . . . . . 32.3 t-80 -117.86 -81.28 0.62 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.747 0.308 . . . . 0.0 110.98 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 524' ' ' GLY . . . . . . . . . . . . . . . 58.09 -106.05 0.74 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.648 -0.786 . . . . 0.0 112.619 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 525' ' ' ASP . . . . . . . . . . . . . 4.7 t0 57.77 73.77 0.45 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.754 0.311 . . . . 0.0 110.891 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 526' ' ' SER . . . . . 0.431 ' CB ' ' HB3' ' A' ' 61' ' ' LEU . 32.0 t -108.83 96.77 6.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.987 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 527' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 70.7 95.79 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.053 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -74.95 58.83 4.98 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.736 2.291 . . . . 0.0 112.472 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 529' ' ' ARG . . . . . 0.401 ' HD2' ' OD1' ' B' ' 545' ' ' ASN . 0.1 OUTLIER -53.31 -43.09 67.32 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.192 0.52 . . . . 0.0 110.122 179.519 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 530' ' ' HIS . . . . . 0.51 ' HA ' ' CG ' ' A' ' 31' ' ' GLU . 41.2 m170 64.74 51.05 1.93 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.931 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -155.99 132.1 9.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.16 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 532' ' ' TRP . . . . . 0.407 ' NE1' ' O ' ' B' ' 536' ' ' ASP . 6.6 t-105 -92.22 -22.22 19.92 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.887 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . 92.44 -136.59 13.29 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.447 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 534' ' ' PHE . . . . . 0.433 ' HB3' ' HD2' ' B' ' 535' ' ' PRO . 39.2 m-85 -81.42 165.5 43.95 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.655 0.264 . . . . 0.0 110.629 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 535' ' ' PRO . . . . . 0.433 ' HD2' ' HB3' ' B' ' 534' ' ' PHE . 48.6 Cg_exo -56.18 81.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.587 2.191 . . . . 0.0 112.377 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 536' ' ' ASP . . . . . 0.45 ' HA ' ' NH1' ' B' ' 537' ' ' ARG . 0.2 OUTLIER 171.45 -164.22 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.92 -180.0 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 537' ' ' ARG . . . . . 0.461 ' HD2' " C1'" ' A' ' 185' ' ' GNP . 0.0 OUTLIER -125.47 155.88 39.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.148 0.499 . . . . 0.0 110.532 179.77 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 538' ' ' ILE . . . . . 0.512 HG23 ' HA ' ' B' ' 543' ' ' LEU . 6.7 tp -83.34 123.96 39.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.483 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 539' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -33.68 130.19 0.28 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.156 0.503 . . . . 0.0 112.115 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 540' ' ' GLU . . . . . 0.824 ' CG ' HG12 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -41.79 -28.35 0.15 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.254 -179.29 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 541' ' ' LEU . . . . . 0.537 ' HA ' HD21 ' A' ' 70' ' ' LEU . 0.8 OUTLIER -40.91 -50.26 3.24 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.864 0.364 . . . . 0.0 111.319 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 542' ' ' TYR . . . . . 0.406 ' CD1' ' N ' ' B' ' 542' ' ' TYR . 0.1 OUTLIER -105.35 -63.37 1.24 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.234 179.949 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 543' ' ' LEU . . . . . 0.884 HD22 ' O ' ' A' ' 58' ' ' THR . 0.3 OUTLIER 72.83 166.68 0.3 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.474 -179.345 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . 116.47 156.97 10.86 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.655 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 545' ' ' ASN . . . . . 0.812 ' ND2' HG13 ' A' ' 33' ' ' VAL . 5.9 p30 . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.199 -0.905 . . . . 0.0 111.098 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 185' ' ' GNP . . . . . 0.837 " H2'" ' HG1' ' A' ' 115' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 188' ' ' HOH . . . . . 0.707 ' O ' HD21 ' B' ' 543' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.4 ' HE3' ' O ' ' A' ' 2' ' ' GLN . 5.2 tpt . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.807 0.337 . . . . 0.0 111.252 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.4 ' O ' ' HE3' ' A' ' 1' ' ' MET . 0.0 OUTLIER -64.23 144.61 57.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.49 179.822 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.761 HG23 ' CE1' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -110.79 -173.82 2.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.535 -179.545 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.658 HD11 ' CD1' ' A' ' 53' ' ' LEU . 5.7 pt -154.92 127.29 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.16 -179.113 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.458 ' CB ' ' HB ' ' A' ' 75' ' ' THR . 5.6 mmtp -100.6 100.58 11.32 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.429 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -77.63 132.56 38.31 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.201 0.524 . . . . 0.0 112.061 -178.71 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.3 t -144.52 159.66 14.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.918 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.589 HG21 ' C ' ' A' ' 15' ' ' GLY . 48.7 t -133.72 128.57 54.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.301 0.572 . . . . 0.0 112.143 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.44 ' HA ' ' CG ' ' B' ' 540' ' ' GLU . 3.3 m -134.06 129.38 54.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.267 -0.878 . . . . 0.0 109.694 178.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 134.98 -160.3 24.26 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.247 -0.978 . . . . 0.0 112.6 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.418 ' O ' ' N ' ' B' ' 537' ' ' ARG . 6.6 p30 -122.87 27.27 7.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.642 0.258 . . . . 0.0 111.047 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -104.59 174.59 21.96 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.823 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.787 ' HB3' ' H8 ' ' A' ' 185' ' ' GNP . . . -95.16 -56.38 2.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.863 0.363 . . . . 0.0 111.1 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.902 HG12 ' N7 ' ' A' ' 185' ' ' GNP . 14.7 p -53.61 105.93 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.047 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.589 ' C ' HG21 ' A' ' 8' ' ' VAL . . . 153.01 -44.51 0.61 Allowed Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.069 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.675 ' CD ' HD11 ' B' ' 543' ' ' LEU . 9.8 mtmt -90.18 -95.24 0.11 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 120.368 0.127 . . . . 0.0 111.077 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.8 HG21 ' HA ' ' A' ' 35' ' ' THR . 61.3 p -98.44 -49.6 4.6 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 120.939 0.4 . . . . 0.0 111.482 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.436 ' O ' ' CB ' ' A' ' 22' ' ' SER . 10.2 t -36.9 -41.32 0.33 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.447 -179.222 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.621 ' CD2' HG23 ' A' ' 14' ' ' VAL . 6.5 mt -49.84 -73.79 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.864 0.364 . . . . 0.0 111.557 -179.268 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.2 mt -74.74 -30.9 61.66 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.017 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.712 HD11 ' HZ ' ' A' ' 37' ' ' PHE . 16.2 mm -66.44 -69.44 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 178.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.439 ' O ' ' ND2' ' A' ' 26' ' ' ASN . 7.4 t -49.74 -25.8 3.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.594 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -65.37 -46.59 79.52 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.447 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.58 -55.01 3.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.478 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.431 ' OG1' HG23 ' A' ' 21' ' ' ILE . 30.1 p -88.38 76.4 8.31 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.046 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.439 ' ND2' ' O ' ' A' ' 22' ' ' SER . 0.6 OUTLIER -69.52 62.28 0.16 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.436 -178.742 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.2 mtmt -121.87 90.85 3.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.599 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.495 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 2.2 t80 -90.03 -44.95 0.41 Allowed Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.749 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 86.6 Cg_endo -85.78 13.56 2.71 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.5 2.133 . . . . 0.0 113.082 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.2 m -93.68 -93.7 0.17 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.631 -0.258 . . . . 0.0 110.845 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.407 ' HB2' ' HD2' ' B' ' 529' ' ' ARG . 3.6 pt-20 -158.99 145.52 16.95 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.789 0.328 . . . . 0.0 110.786 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.526 ' CD2' ' N3B' ' A' ' 185' ' ' GNP . 11.9 m-85 -126.23 133.61 51.44 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.669 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.74 HG11 ' O ' ' B' ' 526' ' ' SER . 0.0 OUTLIER -162.53 -56.55 0.01 OUTLIER Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.612 -179.537 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.535 ' HD3' HG23 ' A' ' 33' ' ' VAL . 51.5 Cg_exo -56.49 78.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.527 2.151 . . . . 0.0 112.686 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.8 ' HA ' HG21 ' A' ' 17' ' ' THR . 29.2 m -121.57 -5.35 9.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.253 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.651 HG22 HD13 ' A' ' 61' ' ' LEU . 0.1 OUTLIER -89.69 -3.34 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -179.863 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.712 ' HZ ' HD11 ' A' ' 21' ' ' ILE . 17.4 p90 -81.0 9.24 6.82 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.419 ' HB2' ' HB2' ' A' ' 57' ' ' ASP . 4.5 p-10 -52.39 -174.12 0.0 OUTLIER 'General case' 0 C--O 1.231 0.101 0 CA-C-O 120.778 0.323 . . . . 0.0 111.052 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 48.82 25.45 1.03 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.895 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -65.16 -174.29 0.16 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.733 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.431 ' O ' ' CG1' ' B' ' 519' ' ' ILE . . . -122.93 152.01 41.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.272 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.698 HG23 HG21 ' A' ' 52' ' ' THR . 34.2 m -145.89 156.12 12.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.916 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.41 ' C ' HG13 ' A' ' 44' ' ' VAL . 0.1 OUTLIER -123.52 106.39 10.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.957 0.408 . . . . 0.0 111.239 -179.736 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.985 HG22 ' CG2' ' A' ' 52' ' ' THR . 10.7 m -156.5 -177.24 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.917 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.484 ' HE3' ' N ' ' A' ' 46' ' ' ILE . 4.8 tpt -107.01 96.1 6.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.303 -179.299 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.62 HD13 ' O ' ' B' ' 511' ' ' SER . 3.9 mm -76.79 86.85 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 121.036 0.446 . . . . 0.0 110.629 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.722 ' HA3' HG23 ' B' ' 510' ' ' ILE . . . 39.6 -92.73 0.01 OUTLIER Glycine 0 CA--C 1.521 0.454 0 CA-C-N 115.778 -0.647 . . . . 0.0 113.851 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . -35.59 -87.07 0.01 OUTLIER Glycine 0 C--N 1.334 0.457 0 N-CA-C 114.019 0.368 . . . . 0.0 114.019 -179.123 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.47 ' N ' ' HE1' ' A' ' 45' ' ' MET . 0.5 OUTLIER -133.32 159.16 73.68 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 120.705 0.288 . . . . 0.0 110.775 -179.693 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.403 ' N ' ' SD ' ' A' ' 45' ' ' MET . 86.1 Cg_exo -45.2 100.21 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.326 2.017 . . . . 0.0 112.161 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.761 ' CE1' HG23 ' A' ' 3' ' ' THR . 8.8 t80 -167.21 153.78 8.29 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.442 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.985 ' CG2' HG22 ' A' ' 44' ' ' VAL . 1.8 p -136.86 153.37 50.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.037 0.446 . . . . 0.0 111.467 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.812 HD11 ' OE1' ' B' ' 512' ' ' GLN . 0.0 OUTLIER -83.38 167.99 17.02 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.844 179.637 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.78 ' C ' HD12 ' A' ' 55' ' ' LEU . . . -105.21 -25.72 6.59 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.801 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.78 HD12 ' C ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER 52.12 92.54 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.785 0.326 . . . . 0.0 111.038 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -84.95 105.57 15.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.365 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.503 ' OD1' HG23 ' A' ' 8' ' ' VAL . 6.3 m-20 -105.95 165.99 10.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.109 0.48 . . . . 0.0 111.272 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.811 HG22 HD13 ' A' ' 67' ' ' LEU . 1.5 p -89.32 152.98 21.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.033 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.568 ' HB1' HG13 ' A' ' 36' ' ' VAL . . . -172.12 100.36 0.16 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.667 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.415 ' HA2' ' HA ' ' A' ' 65' ' ' ASP . . . -98.66 70.67 0.6 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.814 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.922 HD23 ' CB ' ' B' ' 526' ' ' SER . 6.5 mp -120.19 -107.69 0.36 Allowed 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 110.601 -0.148 . . . . 0.0 110.601 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -99.8 -24.67 14.61 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 120.775 0.322 . . . . 0.0 111.334 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.424 ' CB ' ' CG1' ' A' ' 36' ' ' VAL . 16.0 t0 -70.71 -63.41 1.1 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.676 -179.409 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.431 ' CD1' ' N ' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -151.66 116.25 5.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.848 0.356 . . . . 0.0 111.028 -179.54 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.415 ' HA ' ' HA2' ' A' ' 60' ' ' GLY . 0.2 OUTLIER -85.67 -13.77 47.55 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.392 179.961 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.32 -50.7 4.23 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.651 0.262 . . . . 0.0 111.656 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.811 HD13 HG22 ' A' ' 58' ' ' THR . 13.5 mt 69.82 -148.18 0.1 Allowed 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 -179.236 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.418 ' CB ' ' CD ' ' A' ' 69' ' ' PRO . 3.8 mtt-85 -172.55 -61.38 0.0 OUTLIER Pre-proline 0 CA--C 1.528 0.102 0 C-N-CA 120.776 -0.369 . . . . 0.0 111.883 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.418 ' CD ' ' CB ' ' A' ' 68' ' ' ARG . 50.0 Cg_exo -35.99 -60.26 0.35 Allowed 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 123.059 2.506 . . . . 0.0 113.236 -179.53 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.697 HD22 ' HA ' ' B' ' 541' ' ' LEU . 0.3 OUTLIER -46.88 -26.74 1.04 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.351 -179.777 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.5 t -74.6 -70.45 0.4 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.289 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -95.49 150.17 37.14 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.213 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.49 120.78 5.72 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.706 2.271 . . . . 0.0 112.531 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.415 ' NE2' ' O ' ' A' ' 69' ' ' PRO . 1.3 mp0 -102.03 -60.3 1.56 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.848 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.458 ' HB ' ' CB ' ' A' ' 5' ' ' LYS . 7.9 t -82.15 -178.71 7.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.053 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.405 ' O ' ' CG ' ' A' ' 109' ' ' PRO . 0.1 OUTLIER -104.3 7.7 35.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.382 179.899 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.655 ' O ' HG13 ' A' ' 77' ' ' VAL . 11.3 p -156.47 106.92 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.711 0.291 . . . . 0.0 111.24 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.552 ' CE1' HG21 ' A' ' 108' ' ' THR . 4.9 m-85 -83.59 -177.9 6.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.607 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.531 HD13 ' N ' ' A' ' 80' ' ' VAL . 0.2 OUTLIER -119.19 117.71 29.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.95 0.405 . . . . 0.0 111.427 -179.602 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.67 HG21 ' CD1' ' A' ' 110' ' ' PHE . 1.8 t -111.35 100.32 10.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.367 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.536 ' HB3' HG13 ' A' ' 14' ' ' VAL . 2.3 p -109.57 137.74 46.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.04 0.448 . . . . 0.0 111.538 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.756 ' CE1' HG21 ' A' ' 137' ' ' ILE . 28.7 p90 -147.18 145.22 29.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.224 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.6 m -83.29 130.58 35.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.901 0.381 . . . . 0.0 111.269 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.676 HG23 ' N2 ' ' A' ' 185' ' ' GNP . 97.2 t -45.93 -73.72 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.481 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.636 ' HB ' HD21 ' A' ' 129' ' ' LEU . 5.6 m -43.64 117.75 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.332 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.469 ' N ' HD22 ' A' ' 129' ' ' LEU . 0.4 OUTLIER -151.57 136.89 10.71 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.336 -179.798 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.421 ' O ' ' CB ' ' A' ' 88' ' ' SER . 68.2 Cg_endo -92.42 52.75 0.58 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 123.212 2.608 . . . . 0.0 111.816 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.448 ' CB ' ' HG2' ' A' ' 133' ' ' LYS . 0.1 OUTLIER 80.84 26.25 0.26 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.908 -179.499 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.817 ' O ' HG23 ' A' ' 93' ' ' VAL . 43.3 t -96.78 -26.17 15.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.911 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.483 ' CE1' ' CE1' ' A' ' 82' ' ' PHE . 3.9 t80 -54.65 -46.97 74.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.983 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -52.3 -58.26 7.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.994 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.416 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.4 OUTLIER -54.39 -43.17 71.19 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.027 -179.947 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.817 HG23 ' O ' ' A' ' 89' ' ' SER . 60.5 t -54.35 -45.54 68.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.254 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.521 ' O ' HG23 ' A' ' 98' ' ' VAL . 14.9 tttt -59.6 -55.12 38.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.056 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.8 0.14 24.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.741 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.416 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 2.0 tttt -112.22 -22.53 10.89 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.656 0.265 . . . . 0.0 111.072 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.662 ' HZ3' HG12 ' A' ' 80' ' ' VAL . 25.2 m0 -93.06 -55.13 3.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.111 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 94' ' ' LYS . 61.1 t -43.68 -56.13 7.69 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.869 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 30.6 Cg_endo -62.67 -18.8 65.85 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.169 1.912 . . . . 0.0 112.381 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.29 -45.32 9.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.006 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.403 HG12 ' O ' ' A' ' 97' ' ' TRP . 19.7 mm -52.58 -56.92 5.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.159 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.1 p -65.25 -22.3 66.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.238 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 22.3 t-160 -64.93 -68.74 0.34 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.892 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -75.54 -27.22 58.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.004 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.459 ' HB3' ' CB ' ' A' ' 108' ' ' THR . 8.3 m -122.64 75.16 45.48 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.024 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -57.08 131.96 48.56 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.642 2.228 . . . . 0.0 112.166 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 9.7 mmtp 50.31 39.16 19.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.824 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.552 HG21 ' CE1' ' A' ' 78' ' ' PHE . 46.0 m -108.3 101.69 43.31 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.95 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.405 ' CG ' ' O ' ' A' ' 76' ' ' ASP . 36.3 Cg_exo -60.19 171.78 2.91 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.632 2.221 . . . . 0.0 112.425 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.754 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 6.6 p90 -158.52 -177.55 6.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.711 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.88 HD12 ' HB ' ' A' ' 152' ' ' VAL . 3.1 tt -142.2 152.88 43.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.828 0.347 . . . . 0.0 111.245 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.528 HD12 ' HE2' ' A' ' 82' ' ' PHE . 4.3 mm? -101.52 161.15 13.85 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.559 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.78 HG13 HG21 ' A' ' 168' ' ' VAL . 2.5 t -138.74 155.5 27.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.007 0.432 . . . . 0.0 111.743 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.474 ' C ' HD12 ' A' ' 117' ' ' ILE . . . -140.14 114.23 0.96 Allowed Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.327 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.956 ' OG1' " H2'" ' A' ' 185' ' ' GNP . 0.1 OUTLIER -126.97 -49.14 1.47 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.919 0.39 . . . . 0.0 110.284 -179.676 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.584 ' CG ' HD21 ' A' ' 119' ' ' LEU . 0.7 OUTLIER -61.69 -16.28 47.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.634 179.284 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.763 HD13 ' C ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -40.58 -28.57 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 179.906 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.441 ' N ' HG12 ' A' ' 117' ' ' ILE . 2.3 p30 -66.9 -29.56 69.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.852 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.713 ' O ' HD12 ' A' ' 119' ' ' LEU . 3.6 pp -106.01 13.71 28.87 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.44 ' O ' ' CD1' ' A' ' 126' ' ' ILE . 1.8 ppt_? -66.86 -20.64 65.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.727 0.299 . . . . 0.0 110.696 179.264 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -85.47 -25.97 26.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.484 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -49.95 104.98 0.46 Allowed Pre-proline 0 C--N 1.332 -0.171 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.696 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.476 ' HA ' ' CG2' ' A' ' 126' ' ' ILE . 37.4 Cg_endo -66.32 -7.9 18.92 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.582 2.188 . . . . 0.0 113.174 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.38 -67.28 0.64 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.443 ' CG2' HG11 ' A' ' 85' ' ' VAL . 12.4 m -58.24 -39.41 79.04 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 178.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.828 HD11 ' HB3' ' A' ' 136' ' ' PRO . 0.1 OUTLIER -54.39 -44.68 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.684 179.176 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.538 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 11.4 mm-40 -57.84 -36.87 72.89 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.896 179.314 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 125' ' ' THR . 0.0 OUTLIER -63.31 -30.72 71.81 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.902 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.636 HD21 ' HB ' ' A' ' 85' ' ' VAL . 6.8 mt -74.54 -38.04 62.86 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 177.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.538 ' HB3' ' O ' ' A' ' 127' ' ' GLU . . . -45.47 -33.15 2.51 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 114.867 -1.06 . . . . 0.0 111.048 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.2 mmtp -48.95 -34.89 13.82 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.512 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.412 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 5.0 m120 -123.2 -31.23 3.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.362 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.524 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 36.8 mmtt -143.59 -100.67 0.12 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 119.092 -0.48 . . . . 0.0 111.478 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.524 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 4.5 pt20 131.33 -22.34 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.456 1.102 . . . . 0.0 110.45 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 5.9 mmpp? -68.57 110.6 6.14 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.739 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.828 ' HB3' HD11 ' A' ' 126' ' ' ILE . 90.6 Cg_endo -80.86 134.4 9.55 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.527 2.152 . . . . 0.0 111.656 179.294 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.756 HG21 ' CE1' ' A' ' 82' ' ' PHE . 0.4 OUTLIER -64.34 96.6 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.323 -179.694 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.417 ' O ' ' N ' ' A' ' 141' ' ' THR . 2.9 p -68.78 145.72 97.05 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.888 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.453 ' HA ' ' CE1' ' A' ' 154' ' ' TYR . 89.1 Cg_exo -43.19 -28.21 1.34 Allowed 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.573 2.182 . . . . 0.0 112.248 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -78.75 -36.7 42.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.676 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.417 ' N ' ' O ' ' A' ' 138' ' ' THR . 6.1 m -54.88 -56.06 23.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.714 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.509 ' CB ' ' CD2' ' A' ' 154' ' ' TYR . . . -53.02 -36.56 60.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.777 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.64 -38.82 90.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.667 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 17.2 tptt -63.41 -50.59 69.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.703 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.482 HD23 ' O ' ' A' ' 145' ' ' LEU . 0.6 OUTLIER -70.23 -33.99 72.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.593 179.798 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -67.69 -44.7 77.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.894 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 60.2 mtt180 -75.14 -23.18 57.8 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.793 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -56.14 -46.88 79.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.745 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -95.54 19.7 10.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.058 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.1 mtmp? 44.82 40.39 4.25 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.428 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.754 ' HB1' ' O ' ' A' ' 110' ' ' PHE . . . -59.58 -81.72 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.866 0.365 . . . . 0.0 110.818 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.88 ' HB ' HD12 ' A' ' 111' ' ' LEU . 83.5 t -159.65 -73.82 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.833 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.413 ' HG3' HG22 ' A' ' 155' ' ' VAL . 4.1 tppt? 177.42 135.6 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.954 -179.188 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.517 ' OH ' HG21 ' A' ' 117' ' ' ILE . 3.3 t80 -98.06 112.49 24.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.154 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.646 HG11 ' OD1' ' A' ' 167' ' ' ASN . 0.3 OUTLIER -115.04 -172.84 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.637 -179.924 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.586 ' H ' HG12 ' A' ' 155' ' ' VAL . 2.1 mp0 -89.58 163.3 15.24 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.868 0.366 . . . . 0.0 111.145 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.751 ' CB ' HG22 ' A' ' 115' ' ' THR . 0.1 OUTLIER -133.56 -172.73 3.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.987 -179.786 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.551 ' O ' ' HB2' ' A' ' 159' ' ' ALA . 1.1 p -128.38 147.85 50.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.984 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.551 ' HB2' ' O ' ' A' ' 158' ' ' SER . . . 169.58 -57.96 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.805 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.488 HD22 HD23 ' A' ' 119' ' ' LEU . 1.2 mp -100.39 -60.07 1.59 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.62 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.438 ' CG2' ' HB3' ' A' ' 118' ' ' ASP . 13.4 t -86.04 -26.4 25.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.474 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.447 ' HA ' ' HB2' ' A' ' 158' ' ' SER . 2.8 tt0 73.39 77.11 0.13 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.16 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.422 ' CB ' ' O ' ' A' ' 157' ' ' CYS . 0.0 OUTLIER -88.19 -21.37 24.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.131 179.979 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . 142.07 -36.07 1.7 Allowed Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.491 -0.861 . . . . 0.0 112.887 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.476 HD11 ' HA ' ' A' ' 19' ' ' LEU . 0.4 OUTLIER 68.37 -63.7 0.33 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.791 0.329 . . . . 0.0 111.064 -179.796 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.407 ' O ' ' CB ' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -48.49 -30.92 5.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.264 -179.848 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.646 ' OD1' HG11 ' A' ' 155' ' ' VAL . 5.2 t-20 -56.46 -71.5 0.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.313 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.78 HG21 HG13 ' A' ' 113' ' ' VAL . 8.5 p -58.48 -46.77 89.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.823 0.344 . . . . 0.0 111.061 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.503 ' N ' HG13 ' A' ' 168' ' ' VAL . 4.2 t80 -57.71 -37.39 73.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.187 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.407 ' CB ' ' O ' ' A' ' 166' ' ' LYS . 17.0 m-20 -58.83 -37.47 76.5 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.022 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.814 ' OE2' HD12 ' A' ' 174' ' ' LEU . 21.9 mm-40 -66.34 -32.29 73.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.785 179.112 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.528 ' HB2' HD22 ' A' ' 111' ' ' LEU . . . -66.5 -30.63 71.0 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.68 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.928 HD11 HD22 ' A' ' 177' ' ' LEU . 0.0 OUTLIER -90.55 -26.15 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.097 -0.502 . . . . 0.0 109.763 179.256 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 1.076 HD21 HD13 ' B' ' 505' ' ' LEU . 1.2 mt -49.48 -46.81 48.63 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.01 0.434 . . . . 0.0 110.612 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.573 ' HB3' HG11 ' A' ' 77' ' ' VAL . . . -60.71 -22.68 64.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.098 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -97.09 -38.22 9.83 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.219 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.928 HD22 HD11 ' A' ' 173' ' ' ILE . 2.6 tp -68.71 -21.88 64.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.868 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.448 ' HB2' ' CB ' ' B' ' 507' ' ' ALA . 0.0 OUTLIER -174.06 158.08 2.72 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.788 179.905 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.65 110.68 3.06 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.654 2.236 . . . . 0.0 112.262 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -83.2 164.77 14.96 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.69 2.26 . . . . 0.0 112.472 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' GLU . . . . . 0.425 ' O ' ' CG ' ' A' ' 181' ' ' GLU . 9.5 pt-20 -113.11 110.11 51.49 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.551 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.66 -164.91 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.411 2.074 . . . . 0.0 112.278 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.66 86.21 1.64 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.874 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.872 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.224 0 N-CA-C 112.56 -0.216 . . . . 0.0 112.56 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 503' ' ' SER . . . . . 0.4 ' HB2' ' O ' ' B' ' 510' ' ' ILE . 0.5 OUTLIER -76.64 -82.44 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.735 0.302 . . . . 0.0 110.909 179.993 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 504' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' B' ' 509' ' ' ASP . . . 93.55 104.23 1.7 Allowed Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.397 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 505' ' ' LEU . . . . . 1.076 HD13 HD21 ' A' ' 174' ' ' LEU . 0.1 OUTLIER -170.32 39.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.747 0.308 . . . . 0.0 110.982 -179.767 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 506' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 68.14 33.04 4.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.031 0.443 . . . . 0.0 110.486 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 507' ' ' ALA . . . . . 0.448 ' HB3' ' CD1' ' B' ' 505' ' ' LEU . . . -134.93 36.58 3.06 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.698 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 508' ' ' GLN . . . . . 0.407 ' O ' ' HB3' ' B' ' 509' ' ' ASP . 30.7 mt-30 74.39 3.41 4.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.551 -178.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 509' ' ' ASP . . . . . 0.408 ' HA ' ' HA2' ' B' ' 504' ' ' GLY . 22.2 t70 70.49 43.62 0.77 Allowed 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 121.024 0.44 . . . . 0.0 110.985 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 510' ' ' ILE . . . . . 0.722 HG23 ' HA3' ' A' ' 47' ' ' GLY . 66.4 mt -95.25 139.0 19.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.579 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 511' ' ' SER . . . . . 0.62 ' O ' HD13 ' A' ' 46' ' ' ILE . 34.6 t -108.28 148.12 30.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.989 0.424 . . . . 0.0 112.039 -178.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 512' ' ' GLN . . . . . 0.812 ' OE1' HD11 ' A' ' 53' ' ' LEU . 11.8 tp60 -100.06 -69.08 0.04 OUTLIER Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.998 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 513' ' ' PRO . . . . . 0.511 ' HD3' ' HB3' ' B' ' 512' ' ' GLN . 85.3 Cg_endo -78.49 73.6 5.79 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.219 1.946 . . . . 0.0 110.934 178.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 514' ' ' LEU . . . . . 0.552 HD21 ' HB3' ' B' ' 511' ' ' SER . 1.3 mp -80.38 -93.76 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -178.413 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 515' ' ' GLN . . . . . 0.45 ' HB2' HG12 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -69.33 -83.7 0.03 OUTLIER 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.839 0.352 . . . . 0.0 111.914 -178.707 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 516' ' ' ASN . . . . . 0.413 ' ND2' ' O ' ' B' ' 518' ' ' PHE . 48.9 t30 -120.91 -37.11 3.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.485 -178.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 517' ' ' SER . . . . . 0.474 ' O ' HG11 ' A' ' 42' ' ' VAL . 0.7 OUTLIER 55.87 26.0 9.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.854 -179.806 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 518' ' ' PHE . . . . . 0.413 ' O ' ' ND2' ' B' ' 516' ' ' ASN . 0.0 OUTLIER -162.98 106.89 1.07 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.054 -179.78 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 519' ' ' ILE . . . . . 0.431 ' CG1' ' O ' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -107.6 -84.97 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.991 179.851 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 13.7 t-160 -175.17 102.55 0.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.889 0.376 . . . . 0.0 110.899 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 521' ' ' THR . . . . . 0.414 HG22 ' H ' ' B' ' 522' ' ' GLY . 0.2 OUTLIER -150.68 178.37 9.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.769 -179.964 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 522' ' ' GLY . . . . . 0.414 ' H ' HG22 ' B' ' 521' ' ' THR . . . 58.93 161.47 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.375 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 523' ' ' HIS . . . . . 0.422 ' NE2' ' HB2' ' B' ' 525' ' ' ASP . 16.3 t-160 -137.61 -84.92 0.31 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.704 0.288 . . . . 0.0 111.126 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 524' ' ' GLY . . . . . . . . . . . . . . . 92.37 -97.54 2.29 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.379 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 525' ' ' ASP . . . . . 0.422 ' HB2' ' NE2' ' B' ' 523' ' ' HIS . 2.7 t0 75.32 78.44 0.1 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.926 0.393 . . . . 0.0 111.279 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 526' ' ' SER . . . . . 0.922 ' CB ' HD23 ' A' ' 61' ' ' LEU . 0.5 OUTLIER -117.4 98.19 6.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.723 179.545 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 527' ' ' ASP . . . . . 0.445 ' CB ' ' HD3' ' B' ' 528' ' ' PRO . 0.1 OUTLIER -44.32 -50.9 21.06 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.301 -179.807 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 528' ' ' PRO . . . . . 0.445 ' HD3' ' CB ' ' B' ' 527' ' ' ASP . 23.6 Cg_exo -68.08 118.65 5.77 Favored 'Trans proline' 0 CA--C 1.518 -0.305 0 C-N-CA 123.058 2.505 . . . . 0.0 112.108 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 529' ' ' ARG . . . . . 0.559 ' HD3' HG21 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -100.92 -37.47 8.64 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.879 -179.162 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 530' ' ' HIS . . . . . 0.48 ' CG ' ' O ' ' B' ' 530' ' ' HIS . 0.0 OUTLIER 67.71 9.62 7.21 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.012 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 1.2 m 49.1 -174.45 0.02 OUTLIER 'General case' 0 C--N 1.334 -0.093 0 CA-C-O 120.87 0.367 . . . . 0.0 111.072 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 532' ' ' TRP . . . . . . . . . . . . . 23.0 t90 -65.44 -63.16 1.16 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.864 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . 95.52 -119.11 6.09 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.377 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 534' ' ' PHE . . . . . 0.418 ' O ' ' N ' ' B' ' 536' ' ' ASP . 11.3 m-85 -119.39 151.2 50.99 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.729 0.3 . . . . 0.0 110.892 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.48 83.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.586 2.191 . . . . 0.0 112.262 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 536' ' ' ASP . . . . . 0.418 ' N ' ' O ' ' B' ' 534' ' ' PHE . 1.0 OUTLIER 172.23 80.85 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.7 179.979 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 537' ' ' ARG . . . . . 0.499 ' NH2' " C4'" ' A' ' 185' ' ' GNP . 32.3 mmt-85 -51.78 132.92 31.81 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.116 0.484 . . . . 0.0 111.062 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 538' ' ' ILE . . . . . 0.408 HD12 ' H ' ' B' ' 539' ' ' ASP . 3.1 tp -50.9 133.53 11.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.446 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 539' ' ' ASP . . . . . 0.408 ' H ' HD12 ' B' ' 538' ' ' ILE . 62.5 m-20 -40.39 117.76 0.84 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.317 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 540' ' ' GLU . . . . . 0.783 ' HA ' HD12 ' B' ' 543' ' ' LEU . 2.8 pp20? -47.45 -24.87 0.91 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.116 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 541' ' ' LEU . . . . . 0.697 ' HA ' HD22 ' A' ' 70' ' ' LEU . 0.4 OUTLIER -38.53 -42.66 0.78 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.164 0.507 . . . . 0.0 111.012 179.435 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 542' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -105.3 -59.48 1.75 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.427 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 543' ' ' LEU . . . . . 0.783 HD12 ' HA ' ' B' ' 540' ' ' GLU . 0.1 OUTLIER 59.98 122.88 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.881 -179.911 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 544' ' ' GLY . . . . . 0.449 ' HA2' HD11 ' A' ' 61' ' ' LEU . . . 164.3 105.21 0.19 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.538 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 545' ' ' ASN . . . . . 0.439 ' HB3' ' HA ' ' B' ' 529' ' ' ARG . 10.0 m120 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.951 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 185' ' ' GNP . . . . . 0.956 " H2'" ' OG1' ' A' ' 115' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.466 ' HE1' ' CD1' ' A' ' 51' ' ' TYR . 6.9 tpt . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.267 0.079 . . . . 0.0 111.082 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.43 ' N ' ' HG3' ' A' ' 1' ' ' MET . 5.7 tt0 42.22 100.08 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.294 0.568 . . . . 0.0 111.804 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.556 HG23 HG21 ' A' ' 46' ' ' ILE . 0.2 OUTLIER -104.82 -159.48 0.71 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.652 -179.889 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.701 ' O ' HD22 ' A' ' 53' ' ' LEU . 0.3 OUTLIER -156.37 163.18 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -178.653 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.519 ' HA ' HD13 ' A' ' 53' ' ' LEU . 16.2 mttp -134.45 102.36 5.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.876 179.037 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 32.3 m -103.07 156.2 17.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.225 0.536 . . . . 0.0 112.083 -178.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.445 HG13 ' O ' ' A' ' 56' ' ' PHE . 2.7 t -139.11 159.87 29.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.248 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.708 HG13 ' HB ' ' A' ' 14' ' ' VAL . 65.4 t -106.89 141.5 21.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.239 0.542 . . . . 0.0 111.752 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 98.0 t -156.51 129.96 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.855 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.55 -171.14 32.99 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 119.976 -1.107 . . . . 0.0 113.051 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -94.81 27.78 2.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.791 0.329 . . . . 0.0 110.852 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.635 ' O ' HG23 ' A' ' 14' ' ' VAL . . . -170.04 -170.06 33.98 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.419 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.459 ' HB2' ' O3A' ' A' ' 185' ' ' GNP . . . -60.84 -30.17 69.95 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.953 0.406 . . . . 0.0 110.712 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.708 ' HB ' HG13 ' A' ' 8' ' ' VAL . 2.7 t 63.45 -71.21 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.584 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.934 ' C ' HD11 ' A' ' 19' ' ' LEU . . . 175.22 59.19 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.169 -1.015 . . . . 0.0 113.232 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.688 ' CE ' HG11 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -97.85 -85.71 0.36 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.861 0.33 . . . . 0.0 110.217 178.75 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.46 ' HB ' ' CG1' ' A' ' 21' ' ' ILE . 45.9 p -99.5 -36.64 9.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.001 0.429 . . . . 0.0 111.116 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.442 ' CB ' ' O1A' ' A' ' 185' ' ' GNP . 30.0 p -40.28 -36.31 0.51 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.314 -179.183 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.94 HD23 ' CD2' ' A' ' 165' ' ' LEU . 0.0 OUTLIER -71.15 -69.3 0.38 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.926 0.393 . . . . 0.0 110.883 -179.68 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.535 HD21 ' CD2' ' A' ' 169' ' ' PHE . 3.6 mt -55.98 -43.47 77.63 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.234 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.608 HG22 ' OG1' ' A' ' 25' ' ' THR . 42.4 mm -62.41 -66.9 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.864 0.364 . . . . 0.0 110.587 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.405 ' CB ' ' O ' ' A' ' 18' ' ' CYS . 52.3 p -46.18 -27.41 0.98 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.258 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -73.89 -68.14 0.54 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.954 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.91 -46.27 75.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.716 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.608 ' OG1' HG22 ' A' ' 21' ' ' ILE . 19.0 p -85.26 -149.1 0.12 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.308 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.7 p-10 -161.18 30.11 0.14 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.746 0.307 . . . . 0.0 111.105 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.8 mttt -115.35 156.31 25.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.271 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.518 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . 4.1 t80 -163.67 -62.15 0.01 OUTLIER Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.726 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.518 ' HD3' ' HB3' ' A' ' 28' ' ' PHE . 63.2 Cg_endo -85.07 -16.37 5.15 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.627 2.218 . . . . 0.0 112.989 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.2 m -50.61 -87.75 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.398 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -158.12 116.86 3.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.525 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.507 ' CD2' ' O1B' ' A' ' 185' ' ' GNP . 6.6 m-85 -111.56 94.14 4.82 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.108 0.48 . . . . 0.0 110.769 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.822 HG21 ' HD3' ' B' ' 529' ' ' ARG . 2.1 t -117.25 -52.22 0.04 OUTLIER Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.23 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.472 ' O ' ' CD1' ' A' ' 37' ' ' PHE . 5.1 Cg_exo -80.14 52.99 4.54 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.501 2.134 . . . . 0.0 112.245 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.622 HG21 ' O2G' ' A' ' 185' ' ' GNP . 3.9 t -98.88 -25.22 14.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.835 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.799 HG11 ' CG ' ' B' ' 525' ' ' ASP . 7.4 p -51.0 -27.63 5.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.326 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.472 ' CD1' ' O ' ' A' ' 34' ' ' PRO . 3.4 p90 -54.79 -21.15 10.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.965 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.431 ' HB3' ' CB ' ' A' ' 57' ' ' ASP . 59.2 t0 -44.71 -29.73 0.81 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.413 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -70.29 -30.75 67.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.167 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.663 ' CE1' HG21 ' B' ' 521' ' ' THR . 8.6 m-85 -60.68 -174.07 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.86 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.681 ' O ' HD12 ' B' ' 519' ' ' ILE . . . -101.57 -179.63 4.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.087 0.47 . . . . 0.0 111.538 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.1 m -141.11 165.15 19.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.553 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.547 ' O ' HG13 ' A' ' 44' ' ' VAL . 0.7 OUTLIER -110.2 102.11 10.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.883 0.373 . . . . 0.0 111.649 -179.483 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.658 HG11 ' OG ' ' B' ' 517' ' ' SER . 30.1 m -164.81 -177.16 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.728 178.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.491 ' O ' ' HG3' ' A' ' 45' ' ' MET . 0.0 OUTLIER -128.53 101.12 6.03 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.54 0.686 . . . . 0.0 110.95 179.844 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.736 HG23 HG23 ' B' ' 510' ' ' ILE . 3.8 mm -55.49 101.6 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.478 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.454 ' O ' ' CE ' ' A' ' 45' ' ' MET . . . 29.48 -83.88 0.0 OUTLIER Glycine 0 C--N 1.337 0.626 0 N-CA-C 114.862 0.705 . . . . 0.0 114.862 178.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . -42.28 -77.32 0.08 OUTLIER Glycine 0 CA--C 1.519 0.311 0 C-N-CA 121.226 -0.511 . . . . 0.0 113.167 -179.372 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -143.57 164.28 31.52 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-O 120.807 0.337 . . . . 0.0 111.448 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.433 ' HA ' ' HA ' ' A' ' 45' ' ' MET . 4.2 Cg_endo -47.09 101.12 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.942 2.428 . . . . 0.0 112.309 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.494 ' HE1' HG21 ' A' ' 3' ' ' THR . 5.0 t80 -172.85 137.04 0.73 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.967 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.627 HG21 HG22 ' A' ' 44' ' ' VAL . 16.5 p -134.26 138.54 45.11 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.114 0.483 . . . . 0.0 111.369 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.701 HD22 ' O ' ' A' ' 4' ' ' ILE . 1.5 pp -74.04 178.07 5.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.752 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -111.89 86.91 0.44 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.071 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -47.62 116.81 1.58 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.854 0.359 . . . . 0.0 110.501 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.445 ' O ' HG13 ' A' ' 7' ' ' VAL . 0.8 OUTLIER -83.92 105.3 14.7 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.042 -179.374 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.805 ' OD2' HD21 ' B' ' 543' ' ' LEU . 0.1 OUTLIER -130.16 111.31 12.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.153 179.593 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.826 ' O ' HD13 ' B' ' 543' ' ' LEU . 0.6 OUTLIER -86.28 129.78 34.73 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.748 -179.512 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.643 ' HB3' HG23 ' A' ' 36' ' ' VAL . . . -135.99 114.75 12.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.909 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -67.48 63.8 0.27 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.775 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.784 HD12 ' HB ' ' A' ' 36' ' ' VAL . 9.7 mt -121.45 -171.72 2.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.834 0.349 . . . . 0.0 110.874 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.433 ' CB ' ' O ' ' B' ' 524' ' ' GLY . 0.1 OUTLIER -44.43 -45.53 9.08 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.51 -179.878 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.496 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . 5.3 m-20 -59.35 -62.99 1.47 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.163 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.496 ' CE1' ' HB3' ' A' ' 63' ' ' ASP . 0.1 OUTLIER -128.42 132.15 48.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.862 -179.68 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -86.68 -68.73 0.72 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.435 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.401 ' O ' ' HB2' ' A' ' 67' ' ' LEU . 11.1 mmt180 -98.41 -34.67 10.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.337 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.779 HD13 ' HB ' ' A' ' 58' ' ' THR . 1.2 mp 69.72 -80.07 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.058 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.556 ' CB ' ' O ' ' A' ' 67' ' ' LEU . 25.8 ttp180 113.83 -42.61 0.0 OUTLIER Pre-proline 0 N--CA 1.487 1.39 0 C-N-CA 123.89 0.876 . . . . 0.0 112.904 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 67.7 Cg_exo -41.61 -49.83 5.07 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.499 2.132 . . . . 0.0 113.182 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.783 HD22 ' N ' ' B' ' 541' ' ' LEU . 0.1 OUTLIER -53.38 -26.23 18.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.78 0.324 . . . . 0.0 110.564 -179.924 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.412 ' CB ' ' O ' ' A' ' 68' ' ' ARG . 8.5 t -50.95 -67.68 0.23 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.081 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -147.14 73.57 12.03 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.012 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -56.47 164.78 5.13 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.58 2.187 . . . . 0.0 112.202 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 54.6 tp60 -95.02 -17.53 21.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.296 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.664 HG22 ' H ' ' A' ' 77' ' ' VAL . 93.5 m -46.62 149.99 0.74 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.773 0.321 . . . . 0.0 111.201 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -90.43 -24.19 20.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.05 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.664 ' H ' HG22 ' A' ' 75' ' ' THR . 1.2 m -103.83 91.6 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.135 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -80.98 122.09 26.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.606 HD12 HG12 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -78.17 109.65 12.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.013 -179.883 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.466 HG23 HD23 ' A' ' 112' ' ' LEU . 1.8 m -106.75 121.4 59.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.379 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.67 ' HB3' HG22 ' A' ' 14' ' ' VAL . 9.0 p -95.37 161.43 14.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.319 0.581 . . . . 0.0 112.304 -178.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 1.008 ' CE1' HD22 ' A' ' 112' ' ' LEU . 14.3 p90 179.61 123.58 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.897 179.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.35 151.02 20.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.952 0.406 . . . . 0.0 111.341 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.956 HG22 ' HB3' ' A' ' 116' ' ' GLN . 1.5 m -52.52 -51.78 31.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.591 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.578 HG22 ' OE1' ' A' ' 116' ' ' GLN . 19.6 m -53.28 116.64 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.588 0.232 . . . . 0.0 110.615 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.678 ' H ' HD22 ' A' ' 129' ' ' LEU . 6.4 m -151.14 129.2 5.89 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.455 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -91.17 51.39 0.81 Allowed 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.989 2.46 . . . . 0.0 111.684 179.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.472 ' CA ' ' HB2' ' A' ' 133' ' ' LYS . 0.1 OUTLIER 75.1 15.86 2.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.21 -179.626 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.931 ' O ' HG23 ' A' ' 93' ' ' VAL . 43.8 t -97.6 -22.4 16.52 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.121 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.585 ' CZ ' HG21 ' A' ' 137' ' ' ILE . 12.0 t80 -47.07 -59.18 3.3 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.322 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -48.71 -47.18 41.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.967 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -69.89 -32.61 71.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.781 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.931 HG23 ' O ' ' A' ' 89' ' ' SER . 93.8 t -57.1 -68.51 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.964 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.838 ' HG3' HD13 ' A' ' 145' ' ' LEU . 6.9 mmtt -52.09 -52.86 48.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.745 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -57.44 -22.58 44.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.791 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -100.39 -12.38 19.46 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.355 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.421 ' O ' ' CG ' ' A' ' 100' ' ' GLU . 3.1 m0 -89.24 -56.27 3.34 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.628 0.252 . . . . 0.0 111.179 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.671 HG11 HD22 ' A' ' 149' ' ' LEU . 12.9 t -45.88 -45.44 37.57 Favored Pre-proline 0 C--N 1.329 -0.293 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.491 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 50.2 Cg_exo -54.14 -37.77 87.41 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.323 2.015 . . . . 0.0 112.523 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.445 ' HG3' ' N ' ' A' ' 101' ' ' ILE . 6.3 pt-20 -82.82 -32.53 27.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.078 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.776 HG21 ' CD1' ' A' ' 110' ' ' PHE . 19.0 mm -53.86 -35.54 27.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.892 0.377 . . . . 0.0 110.648 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 43.9 p -95.93 -22.45 17.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.055 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -66.02 -29.01 69.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.741 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 3.5 m170 -90.93 -25.22 19.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.799 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 1.1 m -145.33 142.2 17.98 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.886 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.51 90.48 0.22 Allowed 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.535 2.157 . . . . 0.0 112.207 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 58.9 90.83 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.743 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.93 116.07 30.29 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.969 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -60.14 156.32 40.49 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.575 2.184 . . . . 0.0 112.226 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.776 ' CD1' HG21 ' A' ' 101' ' ' ILE . 3.4 p90 -145.9 147.83 32.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.943 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 1.028 HD12 HG11 ' A' ' 152' ' ' VAL . 3.7 tt -108.45 141.38 40.4 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.011 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 1.008 HD22 ' CE1' ' A' ' 82' ' ' PHE . 25.1 mt -98.71 142.94 29.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.81 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.955 HG13 HG11 ' A' ' 168' ' ' VAL . 58.1 t -121.6 142.58 37.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.98 0.419 . . . . 0.0 111.775 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -117.43 121.74 5.21 Favored Glycine 0 N--CA 1.45 -0.375 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.855 ' OG1' " H2'" ' A' ' 185' ' ' GNP . 1.3 p -136.63 -56.23 0.74 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.736 0.303 . . . . 0.0 111.134 -179.159 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.956 ' HB3' HG22 ' A' ' 84' ' ' VAL . 2.6 tt0 -59.36 -16.81 24.95 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.821 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.637 HD12 ' O ' ' A' ' 115' ' ' THR . 0.4 OUTLIER -55.15 -16.05 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 179.912 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.451 ' OD2' HG21 ' A' ' 161' ' ' THR . 1.3 t0 -82.13 -19.99 38.92 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 120.732 0.301 . . . . 0.0 111.151 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.57 ' C ' HD12 ' A' ' 119' ' ' LEU . 4.1 pp -121.35 1.72 10.21 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.908 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.806 ' HB3' HG21 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -50.05 -30.9 11.77 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.986 0.422 . . . . 0.0 110.647 179.88 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -59.84 -21.65 61.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.978 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.405 ' O ' ' HB ' ' A' ' 126' ' ' ILE . 31.8 t0 -44.79 99.84 0.22 Allowed Pre-proline 0 N--CA 1.462 0.136 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.869 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.416 ' O ' ' CG ' ' A' ' 127' ' ' GLU . 15.1 Cg_exo -68.94 -4.68 13.92 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.711 2.274 . . . . 0.0 112.968 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.3 t -83.36 -64.7 1.12 Allowed 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.541 HG21 HG11 ' A' ' 85' ' ' VAL . 32.5 m -55.84 -36.43 67.51 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.693 HG13 HD11 ' A' ' 129' ' ' LEU . 0.0 OUTLIER -58.69 -39.39 76.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.945 179.24 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.416 ' CG ' ' O ' ' A' ' 123' ' ' PRO . 8.8 mm-40 -63.71 -29.28 70.52 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.776 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.423 ' HD3' ' HA ' ' A' ' 125' ' ' THR . 1.8 mptt -74.16 -58.34 3.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.789 179.122 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.693 HD11 HG13 ' A' ' 126' ' ' ILE . 3.6 pp -63.22 -25.89 68.54 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.404 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.673 ' HB1' ' HG2' ' A' ' 134' ' ' GLN . . . -52.61 -41.69 63.9 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.564 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 18.0 mmtm -46.22 -24.08 0.42 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.637 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -123.04 -30.23 3.79 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.478 ' CG ' ' N ' ' A' ' 134' ' ' GLN . 0.0 OUTLIER -132.21 -72.45 0.53 Allowed 'General case' 0 CA--C 1.534 0.331 0 O-C-N 122.097 -0.377 . . . . 0.0 111.871 -178.783 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.673 ' HG2' ' HB1' ' A' ' 130' ' ' ALA . 9.5 mt-30 98.63 -46.54 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.841 0.856 . . . . 0.0 110.945 -179.038 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 4.2 mtpp -73.77 109.1 5.9 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.42 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.898 ' C ' HD13 ' A' ' 137' ' ' ILE . 55.8 Cg_endo -70.06 -170.8 0.44 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.087 1.858 . . . . 0.0 110.764 179.002 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.898 HD13 ' C ' ' A' ' 136' ' ' PRO . 1.2 mm -112.08 95.89 4.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.163 0.506 . . . . 0.0 111.057 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.415 HG22 ' H ' ' A' ' 138' ' ' THR . 0.1 OUTLIER -71.57 150.03 93.52 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.76 -179.981 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -44.01 -28.85 2.37 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.698 2.265 . . . . 0.0 112.383 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -71.26 -31.26 67.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.85 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.524 HG21 HG23 ' A' ' 137' ' ' ILE . 55.4 m -72.64 -50.58 24.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.905 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.55 ' HB3' ' CE2' ' A' ' 154' ' ' TYR . . . -50.28 -61.19 2.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.853 0.359 . . . . 0.0 110.792 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.45 -40.12 68.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.751 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -50.78 -61.24 2.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.705 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.838 HD13 ' HG3' ' A' ' 94' ' ' LYS . 3.6 tt -67.22 -34.0 76.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.568 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.964 ' HB2' HD12 ' A' ' 112' ' ' LEU . . . -57.2 -45.01 84.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.852 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 5.1 mtm180 -79.49 -25.6 41.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.843 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -58.24 -46.09 86.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.797 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.671 HD22 HG11 ' A' ' 98' ' ' VAL . 1.8 mt -102.05 24.18 10.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.804 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 39.07 55.14 2.13 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.758 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.611 ' HB1' ' O ' ' A' ' 110' ' ' PHE . . . -67.04 -81.62 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.056 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 1.028 HG11 HD12 ' A' ' 111' ' ' LEU . 50.9 t -160.54 -74.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.81 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.16 114.9 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.11 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.55 ' CE2' ' HB3' ' A' ' 142' ' ' ALA . 45.7 t80 -90.55 109.9 21.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.048 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.44 HG12 ' N ' ' A' ' 156' ' ' GLU . 3.6 t -101.67 161.43 3.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.393 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.44 ' N ' HG12 ' A' ' 155' ' ' VAL . 8.9 tt0 -89.7 140.33 29.68 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.098 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.589 ' O ' HD11 ' A' ' 117' ' ' ILE . 1.8 p 178.71 -175.14 0.19 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.314 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.516 ' O ' HD12 ' A' ' 165' ' ' LEU . 4.5 t -160.28 163.75 33.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.109 0.48 . . . . 0.0 111.677 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.762 ' HB2' HD11 ' A' ' 165' ' ' LEU . . . -114.82 -42.15 3.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.09 179.186 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.408 ' CD1' HD23 ' A' ' 119' ' ' LEU . 0.5 OUTLIER -74.43 -29.08 61.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.189 179.36 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.451 HG21 ' OD2' ' A' ' 118' ' ' ASP . 0.9 OUTLIER -111.87 -26.4 8.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.659 179.872 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.401 ' HA ' ' O ' ' A' ' 158' ' ' SER . 0.0 OUTLIER 73.52 70.57 0.12 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.232 179.844 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.409 ' HB3' ' HA ' ' A' ' 157' ' ' CYS . 12.3 mtmt -95.2 23.56 5.68 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.109 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 101.71 42.78 2.24 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.914 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.94 ' CD2' HD23 ' A' ' 19' ' ' LEU . 0.3 OUTLIER -52.29 -25.0 8.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.691 0.282 . . . . 0.0 111.042 179.911 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.405 ' HD2' ' CA ' ' B' ' 502' ' ' GLY . 22.4 pttp -69.04 -23.31 64.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.691 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -65.16 -70.33 0.24 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.707 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.955 HG11 HG13 ' A' ' 113' ' ' VAL . 7.5 p -52.64 -46.78 50.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.114 0.483 . . . . 0.0 110.431 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.624 ' CG ' HD22 ' A' ' 19' ' ' LEU . 2.6 t80 -57.25 -32.55 66.68 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.111 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 166' ' ' LYS . 30.9 t70 -71.22 -25.85 62.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.047 178.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.885 ' HB3' HD11 ' A' ' 111' ' ' LEU . 0.8 OUTLIER -74.16 -28.12 61.16 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.126 179.308 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.554 ' CA ' HD13 ' A' ' 111' ' ' LEU . . . -75.44 -40.74 57.21 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.709 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.636 HD12 HD12 ' A' ' 177' ' ' LEU . 1.6 pp -80.89 -33.71 13.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.916 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.807 HD13 ' CB ' ' B' ' 505' ' ' LEU . 1.0 OUTLIER -55.42 -58.59 7.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.417 179.647 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.579 ' HB1' ' HG3' ' A' ' 180' ' ' PRO . . . -49.5 -25.85 2.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.791 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.529 ' HB3' HG21 ' A' ' 4' ' ' ILE . . . -87.8 -41.19 13.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.118 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.636 HD12 HD12 ' A' ' 173' ' ' ILE . 41.8 mt -68.82 -23.68 64.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.892 0.377 . . . . 0.0 110.614 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.637 ' CB ' ' HB2' ' B' ' 507' ' ' ALA . 24.8 tt0 -168.19 142.78 2.85 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.841 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.436 ' HD2' ' CG ' ' A' ' 178' ' ' GLU . 93.3 Cg_exo -44.07 115.44 0.73 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.587 2.191 . . . . 0.0 112.405 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' PRO . . . . . 0.579 ' HG3' ' HB1' ' A' ' 175' ' ' ALA . 67.6 Cg_endo -73.08 -171.76 0.86 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.452 2.101 . . . . 0.0 112.358 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' GLU . . . . . 0.4 ' HA ' ' HD3' ' A' ' 182' ' ' PRO . 41.4 mt-10 -148.83 151.59 35.45 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.787 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 181' ' ' GLU . 36.6 Cg_exo -59.45 -152.72 0.01 OUTLIER 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.706 2.271 . . . . 0.0 112.469 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.4 148.77 46.62 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.961 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.268 -0.872 . . . . 0.0 110.843 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 502' ' ' GLY . . . . . 0.405 ' CA ' ' HD2' ' A' ' 166' ' ' LYS . . . . . . . . 0 N--CA 1.488 2.165 0 N-CA-C 112.514 -0.234 . . . . 0.0 112.514 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 503' ' ' SER . . . . . . . . . . . . . 98.7 p -62.82 -170.9 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.843 0.354 . . . . 0.0 110.894 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 504' ' ' GLY . . . . . 0.702 ' C ' HD23 ' B' ' 505' ' ' LEU . . . -157.31 -106.63 0.24 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.396 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 505' ' ' LEU . . . . . 0.82 HD12 ' HB3' ' B' ' 507' ' ' ALA . 1.1 pt? 44.15 -171.77 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.114 0.483 . . . . 0.0 111.867 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 506' ' ' SER . . . . . . . . . . . . . 4.9 m -117.66 -15.69 10.14 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.106 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 507' ' ' ALA . . . . . 0.82 ' HB3' HD12 ' B' ' 505' ' ' LEU . . . -67.89 59.62 0.07 Allowed 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.087 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 508' ' ' GLN . . . . . 0.561 ' HB2' HD12 ' B' ' 510' ' ' ILE . 9.7 mt-30 69.86 3.17 4.18 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.608 -178.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 509' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' B' ' 504' ' ' GLY . 15.7 t0 46.7 53.47 10.08 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.378 0.609 . . . . 0.0 111.094 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 510' ' ' ILE . . . . . 0.736 HG23 HG23 ' A' ' 46' ' ' ILE . 0.9 OUTLIER -50.6 107.78 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.352 179.561 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 511' ' ' SER . . . . . 0.439 ' O ' HD12 ' B' ' 514' ' ' LEU . 48.2 m -61.87 86.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.91 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 512' ' ' GLN . . . . . 0.472 ' CB ' ' CD ' ' B' ' 513' ' ' PRO . 23.6 tp60 -50.89 -67.69 0.45 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.464 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 513' ' ' PRO . . . . . 0.472 ' CD ' ' CB ' ' B' ' 512' ' ' GLN . 98.3 Cg_endo -77.06 66.09 7.76 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.506 2.137 . . . . 0.0 112.13 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 514' ' ' LEU . . . . . 0.439 HD12 ' O ' ' B' ' 511' ' ' SER . 0.7 OUTLIER -73.69 138.78 44.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.847 0.356 . . . . 0.0 111.082 -179.756 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 515' ' ' GLN . . . . . 0.544 ' O ' HG12 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -52.49 143.52 15.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.927 -179.892 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 72.02 23.51 3.46 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.988 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 517' ' ' SER . . . . . 0.658 ' OG ' HG11 ' A' ' 44' ' ' VAL . 3.1 m -82.75 53.79 2.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.185 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 518' ' ' PHE . . . . . 0.467 ' CD1' ' O ' ' B' ' 517' ' ' SER . 10.4 m-85 -163.63 94.98 0.8 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.603 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 519' ' ' ILE . . . . . 0.681 HD12 ' O ' ' A' ' 41' ' ' ALA . 13.2 mt -55.87 -100.16 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.316 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 520' ' ' HIS . . . . . 0.553 ' N ' HG22 ' B' ' 519' ' ' ILE . 15.7 t-160 179.22 40.14 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.763 0.316 . . . . 0.0 110.943 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 521' ' ' THR . . . . . 0.663 HG21 ' CE1' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -112.87 -177.1 3.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.262 -179.792 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 522' ' ' GLY . . . . . . . . . . . . . . . 71.58 97.33 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.265 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 523' ' ' HIS . . . . . 0.413 ' O ' ' N ' ' B' ' 525' ' ' ASP . 26.1 p80 -144.82 -45.77 0.23 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.821 0.343 . . . . 0.0 111.334 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 524' ' ' GLY . . . . . 0.433 ' O ' ' CB ' ' A' ' 62' ' ' GLU . . . -67.81 68.63 0.3 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.256 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 525' ' ' ASP . . . . . 0.799 ' CG ' HG11 ' A' ' 36' ' ' VAL . 0.2 OUTLIER 176.3 37.47 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.822 0.344 . . . . 0.0 110.549 -179.732 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 526' ' ' SER . . . . . 0.772 ' HA ' HG12 ' A' ' 33' ' ' VAL . 3.1 t -113.55 96.17 5.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.901 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 527' ' ' ASP . . . . . 0.52 ' CB ' ' CD ' ' B' ' 528' ' ' PRO . 0.4 OUTLIER -134.05 -70.67 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.831 179.518 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 528' ' ' PRO . . . . . 0.52 ' CD ' ' CB ' ' B' ' 527' ' ' ASP . 13.4 Cg_endo -53.97 90.07 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.671 2.247 . . . . 0.0 112.396 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 529' ' ' ARG . . . . . 0.822 ' HD3' HG21 ' A' ' 33' ' ' VAL . 0.5 OUTLIER -96.19 5.11 51.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.003 179.491 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 530' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -49.33 -53.8 20.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.751 0.31 . . . . 0.0 111.537 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER 71.23 -154.52 0.1 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.531 -179.477 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 532' ' ' TRP . . . . . 0.459 ' CD1' ' NH2' ' B' ' 537' ' ' ARG . 0.0 OUTLIER -41.9 142.06 0.75 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.962 0.411 . . . . 0.0 111.55 -179.86 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . -163.56 -40.45 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.308 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 534' ' ' PHE . . . . . 0.627 ' CZ ' HG22 ' B' ' 538' ' ' ILE . 4.5 p90 -133.17 161.16 65.45 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 120.679 0.276 . . . . 0.0 110.553 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 535' ' ' PRO . . . . . 0.426 ' HD2' ' HB2' ' B' ' 534' ' ' PHE . 91.0 Cg_exo -42.93 103.37 0.04 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.58 2.187 . . . . 0.0 112.49 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 1.8 t0 70.53 159.36 0.2 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.987 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 537' ' ' ARG . . . . . 0.459 ' NH2' ' CD1' ' B' ' 532' ' ' TRP . 0.0 OUTLIER -62.96 -165.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.301 0.572 . . . . 0.0 110.908 179.864 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 538' ' ' ILE . . . . . 0.627 HG22 ' CZ ' ' B' ' 534' ' ' PHE . 0.0 OUTLIER -105.5 -160.74 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.269 -0.878 . . . . 0.0 108.981 178.524 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 539' ' ' ASP . . . . . 0.476 ' N ' HG12 ' B' ' 538' ' ' ILE . 38.5 p-10 -79.83 153.13 29.32 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.329 -0.548 . . . . 0.0 111.014 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 540' ' ' GLU . . . . . 0.464 ' HG2' HD12 ' B' ' 543' ' ' LEU . 0.0 OUTLIER -52.57 -22.27 4.77 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.754 -179.389 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 541' ' ' LEU . . . . . 0.783 ' N ' HD22 ' A' ' 70' ' ' LEU . 5.4 tp -54.84 -22.31 14.13 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.175 0.512 . . . . 0.0 110.853 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 542' ' ' TYR . . . . . 0.575 ' HE1' HD23 ' B' ' 541' ' ' LEU . 3.1 m-85 -104.91 -63.86 1.18 Allowed 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.708 -178.551 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 543' ' ' LEU . . . . . 0.826 HD13 ' O ' ' A' ' 58' ' ' THR . 0.1 OUTLIER 62.85 46.23 5.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.879 -179.566 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . 175.67 -70.2 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.465 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 545' ' ' ASN . . . . . 0.401 ' HB2' ' HB2' ' B' ' 528' ' ' PRO . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.274 -0.87 . . . . 0.0 110.887 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 185' ' ' GNP . . . . . 0.855 " H2'" ' OG1' ' A' ' 115' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.436 ' HG2' ' CG ' ' A' ' 49' ' ' GLU . 2.4 ppp? . . . . . 0 N--CA 1.488 1.448 0 CA-C-O 120.842 0.353 . . . . 0.0 111.128 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.41 ' O ' HD13 ' B' ' 510' ' ' ILE . 62.1 tp60 -161.14 125.21 3.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.313 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.972 HG23 HD22 ' A' ' 53' ' ' LEU . 13.1 t -123.65 -173.79 2.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.227 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.934 ' C ' HD23 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -153.39 156.11 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -178.983 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.539 ' N ' HD23 ' A' ' 53' ' ' LEU . 16.3 pttm -124.9 95.52 4.54 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.044 179.155 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.422 ' HB2' ' HE3' ' A' ' 16' ' ' LYS . 8.3 m -95.61 156.5 16.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.99 0.424 . . . . 0.0 111.458 -179.257 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.921 HG13 ' HB3' ' A' ' 56' ' ' PHE . 0.2 OUTLIER -120.12 159.65 21.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.471 179.704 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.898 HG11 ' HA2' ' A' ' 15' ' ' GLY . 6.1 p -110.36 114.37 46.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.248 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.911 HG13 ' CD ' ' B' ' 540' ' ' GLU . 81.7 t -134.6 129.75 52.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.099 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 149.53 -150.01 22.05 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.186 -1.007 . . . . 0.0 112.917 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -118.81 -13.56 9.53 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.624 0.231 . . . . 0.0 111.624 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.434 ' O ' ' NH1' ' B' ' 537' ' ' ARG . . . -50.51 -101.22 0.01 OUTLIER Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.363 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.611 ' HB2' ' H8 ' ' A' ' 185' ' ' GNP . . . -102.5 -19.08 15.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.79 0.329 . . . . 0.0 111.032 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.678 HG12 ' O ' ' A' ' 14' ' ' VAL . 37.9 t 64.52 23.34 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.647 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.898 ' HA2' HG11 ' A' ' 8' ' ' VAL . . . -153.9 134.53 4.38 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.632 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.573 ' NZ ' HD12 ' A' ' 55' ' ' LEU . 0.4 OUTLIER -86.54 7.55 25.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.75 0.309 . . . . 0.0 110.718 179.365 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.704 HG21 HG23 ' A' ' 35' ' ' THR . 1.3 p -97.24 -45.03 6.67 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 120.938 0.399 . . . . 0.0 110.992 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.493 ' HB3' ' PB ' ' A' ' 185' ' ' GNP . 28.6 p -39.26 -45.96 1.46 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.307 -179.329 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.961 HD22 ' CD1' ' A' ' 169' ' ' PHE . 1.4 mp -51.12 -50.0 59.67 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.923 0.392 . . . . 0.0 110.737 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.462 HD22 ' N ' ' A' ' 20' ' ' LEU . 3.0 mm? -73.02 -19.42 61.2 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.028 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.424 HD11 ' O ' ' A' ' 188' ' ' HOH . 17.4 mm -66.7 -71.04 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 CA-C-O 120.719 0.295 . . . . 0.0 110.7 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.3 t -61.22 -27.0 68.12 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.81 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -58.9 -62.94 1.5 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.916 0.388 . . . . 0.0 110.354 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 54.7 m -82.66 -46.53 13.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.403 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.402 ' N ' ' O ' ' A' ' 21' ' ' ILE . 14.2 p -101.23 -158.07 0.65 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.416 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -153.3 27.86 0.51 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.81 0.338 . . . . 0.0 111.114 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -96.17 73.15 2.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.046 0.45 . . . . 0.0 110.502 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.496 ' CD1' ' O2A' ' A' ' 185' ' ' GNP . 0.3 OUTLIER -86.85 -53.1 0.41 Allowed Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.745 -179.745 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.454 ' HD3' ' HB3' ' A' ' 28' ' ' PHE . 84.0 Cg_endo -85.34 78.79 2.4 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.717 2.278 . . . . 0.0 112.757 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.417 ' O ' ' CB ' ' B' ' 531' ' ' CYS . 2.8 m -141.84 -96.18 0.13 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.815 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -159.39 133.56 7.61 Favored 'General case' 0 C--N 1.334 -0.083 0 CA-C-O 120.793 0.33 . . . . 0.0 110.977 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.527 ' CE1' ' N3B' ' A' ' 185' ' ' GNP . 3.0 m-30 -97.31 94.45 7.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.403 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.561 HG13 ' HG3' ' B' ' 529' ' ' ARG . 0.0 OUTLIER -134.2 -59.04 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.995 -179.521 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.445 ' HD2' ' H ' ' A' ' 33' ' ' VAL . 77.7 Cg_exo -52.45 -21.53 14.17 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.107 1.871 . . . . 0.0 112.21 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.704 HG23 HG21 ' A' ' 17' ' ' THR . 52.8 m -71.74 62.3 0.41 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.621 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.057 HG23 ' HB3' ' A' ' 59' ' ' ALA . 4.1 p -132.25 -39.86 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.559 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.481 ' CD2' ' HA ' ' A' ' 40' ' ' TYR . 5.6 t80 -41.13 -30.52 0.15 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.585 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.427 ' CB ' ' OH ' ' A' ' 64' ' ' TYR . 11.6 t0 66.55 -68.41 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.923 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.474 ' O ' ' CE2' ' A' ' 37' ' ' PHE . 0.7 OUTLIER -77.89 55.18 1.37 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.365 -179.928 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.481 ' HA ' ' CD2' ' A' ' 37' ' ' PHE . 6.7 m-85 -60.5 139.88 57.54 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.804 0.335 . . . . 0.0 110.464 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.437 ' O ' ' CG1' ' B' ' 519' ' ' ILE . . . -90.59 119.4 30.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.207 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.7 HG12 ' HA ' ' B' ' 518' ' ' PHE . 15.4 m -137.09 123.23 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.726 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.62 HG23 ' HB3' ' B' ' 516' ' ' ASN . 8.8 t -84.29 104.16 14.09 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.855 HG13 ' HB2' ' B' ' 514' ' ' LEU . 25.5 t -145.03 148.27 18.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.184 -178.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.496 ' HE1' ' N ' ' A' ' 49' ' ' GLU . 3.2 tpt -96.18 96.47 8.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.973 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.64 HG22 ' O ' ' A' ' 46' ' ' ILE . 1.2 mm -83.25 85.76 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 120.718 0.294 . . . . 0.0 110.578 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.443 ' N ' ' HE2' ' A' ' 45' ' ' MET . . . 30.8 94.22 0.01 OUTLIER Glycine 0 CA--C 1.524 0.644 0 CA-C-N 115.694 -0.685 . . . . 0.0 114.035 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 135.27 -97.44 0.28 Allowed Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.83 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.496 ' N ' ' HE1' ' A' ' 45' ' ' MET . 0.2 OUTLIER -119.8 129.76 25.19 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.503 0.192 . . . . 0.0 110.551 179.701 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' A' ' 45' ' ' MET . 74.8 Cg_exo -37.14 96.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.914 2.41 . . . . 0.0 112.919 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.435 ' C ' ' CD1' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -172.86 142.91 1.16 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.753 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.478 HG21 ' HB ' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -135.0 153.82 51.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.267 -178.982 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.972 HD22 HG23 ' A' ' 3' ' ' THR . 5.8 tp -95.67 136.17 36.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.768 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -64.99 142.07 44.41 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.453 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.594 ' H ' HD22 ' A' ' 55' ' ' LEU . 1.6 mm? -76.33 134.98 39.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.842 0.353 . . . . 0.0 110.505 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.921 ' HB3' HG13 ' A' ' 7' ' ' VAL . 0.9 OUTLIER -84.59 108.74 17.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.912 0.387 . . . . 0.0 110.886 -179.875 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.492 ' OD1' HD21 ' B' ' 543' ' ' LEU . 0.7 OUTLIER -140.41 142.07 35.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.138 -179.886 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.793 ' OG1' HD13 ' B' ' 543' ' ' LEU . 43.4 p -101.28 -176.66 3.22 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.105 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 1.057 ' HB3' HG23 ' A' ' 36' ' ' VAL . . . -172.44 -162.58 0.2 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.886 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -148.78 43.11 0.81 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.295 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.885 HD22 ' HB3' ' B' ' 525' ' ' ASP . 0.4 OUTLIER -121.26 -160.03 0.83 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.922 0.391 . . . . 0.0 111.364 -179.732 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -48.71 -44.84 38.49 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.387 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.485 ' HB3' ' CD1' ' A' ' 64' ' ' TYR . 0.5 OUTLIER -45.97 -61.14 1.87 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.431 -179.651 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.485 ' CD1' ' HB3' ' A' ' 63' ' ' ASP . 0.1 OUTLIER -164.31 139.44 5.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.908 0.385 . . . . 0.0 111.021 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -86.73 -68.16 0.76 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.531 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.458 ' C ' HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -87.55 -32.17 19.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.634 -179.344 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.54 HD13 ' HB ' ' A' ' 58' ' ' THR . 1.3 mp 71.16 -149.05 0.08 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.535 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.475 ' CB ' ' CD ' ' A' ' 69' ' ' PRO . 1.0 OUTLIER -159.05 -65.36 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.177 0 N-CA-C 111.717 0.265 . . . . 0.0 111.717 -179.831 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.475 ' CD ' ' CB ' ' A' ' 68' ' ' ARG . 46.1 Cg_exo -35.52 -60.26 0.33 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.039 2.493 . . . . 0.0 113.377 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.891 HD13 ' HG2' ' B' ' 540' ' ' GLU . 0.3 OUTLIER -46.62 -26.66 0.95 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.658 0.266 . . . . 0.0 111.473 -179.73 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.6 t -95.39 -6.81 40.1 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.401 ' O ' ' O ' ' A' ' 69' ' ' PRO . 23.7 m-85 -134.39 151.67 76.64 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-O 120.867 0.365 . . . . 0.0 111.474 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -80.1 51.37 3.88 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.749 2.299 . . . . 0.0 112.434 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.496 ' NE2' ' CE2' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -73.65 -30.44 62.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.0 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.617 HG21 ' HD1' ' A' ' 78' ' ' PHE . 12.1 t -70.61 -176.65 1.32 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.968 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -113.42 -21.77 10.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.904 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.628 HG13 ' HB2' ' A' ' 109' ' ' PRO . 47.8 t -150.74 112.87 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.041 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.906 ' CE2' HG21 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -80.74 176.87 9.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.707 179.912 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.405 HD22 ' HA ' ' A' ' 79' ' ' LEU . 0.2 OUTLIER -142.63 108.71 5.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.218 -179.715 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.95 HG12 ' CH2' ' A' ' 97' ' ' TRP . 20.0 m -93.57 96.06 5.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.833 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.451 ' HB3' ' N7 ' ' A' ' 185' ' ' GNP . 3.9 m -82.13 177.48 8.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.077 0.465 . . . . 0.0 111.458 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.459 ' CE1' ' O ' ' A' ' 113' ' ' VAL . 19.1 p90 -179.49 -173.47 0.26 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.011 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.82 134.66 18.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.783 0.325 . . . . 0.0 110.651 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.871 HG12 ' O ' ' A' ' 137' ' ' ILE . 2.2 m -45.36 -56.76 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.567 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.632 HG22 ' OE1' ' A' ' 116' ' ' GLN . 33.7 m -54.27 113.24 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.66 ' N ' HD22 ' A' ' 129' ' ' LEU . 4.1 m -151.24 125.49 4.49 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.684 0.278 . . . . 0.0 111.721 -179.197 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.433 ' O ' ' CB ' ' A' ' 88' ' ' SER . 87.5 Cg_endo -92.51 54.23 0.58 Allowed 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 123.177 2.585 . . . . 0.0 111.56 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.451 ' CB ' ' HG2' ' A' ' 133' ' ' LYS . 0.1 OUTLIER 81.97 24.08 0.23 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.889 -179.413 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.425 ' O ' HG12 ' A' ' 93' ' ' VAL . 6.1 t -97.21 -26.91 14.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.747 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.716 ' CZ ' HG21 ' A' ' 137' ' ' ILE . 13.4 t80 -55.23 -41.34 71.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.89 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 19.2 mp0 -70.22 -38.84 75.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.028 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -67.6 -45.22 76.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.158 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.747 HG22 ' CD1' ' A' ' 97' ' ' TRP . 7.4 p -65.6 -48.98 80.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.488 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.526 ' N ' HG13 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -51.15 -63.18 1.21 Allowed 'General case' 0 C--O 1.235 0.31 0 CA-C-O 120.944 0.402 . . . . 0.0 110.766 179.851 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.425 ' O ' ' CD ' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -52.47 -39.73 61.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.583 179.864 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.404 ' O ' ' CG ' ' A' ' 96' ' ' LYS . 0.2 OUTLIER -88.6 9.17 24.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.274 179.753 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.95 ' CH2' HG12 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -93.06 -58.33 2.36 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.946 0.403 . . . . 0.0 110.877 -179.908 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 1.024 HG22 HD13 ' A' ' 149' ' ' LEU . 40.8 t -56.27 -44.07 99.56 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.383 -179.361 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.491 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 6.0 Cg_exo -74.3 -19.74 19.37 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.556 2.171 . . . . 0.0 112.921 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -90.46 -59.13 2.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.932 0.396 . . . . 0.0 111.174 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.764 HG22 ' O ' ' A' ' 97' ' ' TRP . 11.5 tt -52.17 -26.22 8.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.709 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 73.7 p -94.54 -62.09 1.39 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.177 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.423 ' CB ' ' O ' ' A' ' 99' ' ' PRO . 7.9 t60 -48.33 -43.32 33.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.222 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 34.1 m-70 -85.1 -23.59 28.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.129 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 5.3 m -146.47 75.81 12.23 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.033 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -62.19 142.37 91.54 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.638 2.226 . . . . 0.0 112.259 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.8 mmtt 63.14 56.06 1.82 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.074 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -138.28 108.06 8.03 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.651 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.628 ' HB2' HG13 ' A' ' 77' ' ' VAL . 31.2 Cg_exo -60.26 164.07 13.44 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.488 2.125 . . . . 0.0 112.354 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.947 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 0.7 OUTLIER -154.42 139.59 17.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.024 179.955 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.929 HD12 HG11 ' A' ' 152' ' ' VAL . 5.8 tt -121.58 146.31 47.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.942 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.602 ' O ' HD23 ' A' ' 111' ' ' LEU . 3.3 mm? -94.61 153.47 17.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.651 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.896 HG13 HG11 ' A' ' 168' ' ' VAL . 93.3 t -136.69 146.24 28.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.095 0.474 . . . . 0.0 111.614 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.401 ' HA3' ' OH ' ' A' ' 154' ' ' TYR . . . -126.01 104.01 0.72 Allowed Glycine 0 N--CA 1.452 -0.243 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.553 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.964 ' OG1' " H2'" ' A' ' 185' ' ' GNP . 0.2 OUTLIER -120.65 -50.94 2.18 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.978 0.418 . . . . 0.0 110.701 -179.037 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.687 ' HB3' HG22 ' A' ' 84' ' ' VAL . 4.8 tt0 -67.3 -8.86 35.41 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.445 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.735 HD11 ' O ' ' A' ' 157' ' ' CYS . 0.2 OUTLIER -44.6 -26.84 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-O 120.681 0.277 . . . . 0.0 111.332 -179.865 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -64.17 -25.22 67.99 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.779 0.323 . . . . 0.0 111.048 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.543 HD12 ' N ' ' A' ' 119' ' ' LEU . 4.9 mp -95.64 -19.86 19.4 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.418 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.48 ' HB3' HG11 ' A' ' 84' ' ' VAL . 5.7 ppt_? -49.43 -26.46 3.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.946 0.403 . . . . 0.0 110.684 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.37 -27.13 29.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.519 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.417 ' N ' ' O ' ' A' ' 119' ' ' LEU . 38.0 t0 -55.1 108.02 1.04 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.599 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.4 ' O ' HG22 ' A' ' 126' ' ' ILE . 15.6 Cg_exo -68.75 -3.9 12.18 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.715 2.277 . . . . 0.0 113.034 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.78 -67.76 0.75 Allowed 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.591 HG21 HG11 ' A' ' 85' ' ' VAL . 7.2 m -56.35 -35.39 67.59 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.457 178.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.599 HD11 ' HB3' ' A' ' 136' ' ' PRO . 0.1 OUTLIER -56.37 -42.02 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.772 179.348 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.553 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 66.6 mt-10 -60.74 -35.33 76.1 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.778 179.131 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 125' ' ' THR . 0.2 OUTLIER -64.52 -31.66 72.97 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.094 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.66 HD22 ' N ' ' A' ' 86' ' ' SER . 8.0 mt -73.1 -35.74 66.64 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.214 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.553 ' HB3' ' O ' ' A' ' 127' ' ' GLU . . . -46.2 -34.56 4.43 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.007 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -48.11 -32.95 7.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.531 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.408 ' HB2' ' O ' ' A' ' 87' ' ' PRO . 6.2 m-80 -123.24 -31.24 3.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.416 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.521 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 17.3 mmtt -147.19 -97.96 0.09 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 119.115 -0.469 . . . . 0.0 111.399 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.521 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 7.2 pt20 130.52 -25.1 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.412 1.085 . . . . 0.0 110.297 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 60.5 mmtt -69.28 110.64 6.61 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.766 -179.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.599 ' HB3' HD11 ' A' ' 126' ' ' ILE . 83.9 Cg_endo -80.17 150.96 20.5 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.565 2.177 . . . . 0.0 111.431 179.171 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.871 ' O ' HG12 ' A' ' 84' ' ' VAL . 1.1 mm -81.93 96.29 3.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.106 0.479 . . . . 0.0 110.83 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.3 p -72.02 151.06 92.71 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.031 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.5 ' HA ' ' CE2' ' A' ' 154' ' ' TYR . 79.7 Cg_exo -44.09 -37.83 10.02 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.496 2.13 . . . . 0.0 112.244 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -68.6 -33.71 74.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.773 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 24.6 m -63.56 -60.58 3.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.717 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -53.15 -38.14 62.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.893 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -59.77 -46.84 87.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.812 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 22.7 tttp -61.36 -47.8 84.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.836 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.403 ' HA ' ' HB2' ' A' ' 148' ' ' ASP . 32.8 tp -67.23 -36.09 80.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.73 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.418 ' CB ' HD23 ' A' ' 112' ' ' LEU . . . -60.45 -54.33 46.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.057 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 11.2 mtp85 -73.05 -26.89 61.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.776 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.403 ' HB2' ' HA ' ' A' ' 145' ' ' LEU . 0.3 OUTLIER -51.66 -46.47 63.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.014 179.928 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 1.024 HD13 HG22 ' A' ' 98' ' ' VAL . 1.0 OUTLIER -93.36 19.61 8.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.049 -179.956 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 78.3 tttt 48.19 43.94 19.09 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.789 0.328 . . . . 0.0 110.984 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.947 ' HB1' ' O ' ' A' ' 110' ' ' PHE . . . -72.36 -81.72 0.05 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.311 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.929 HG11 HD12 ' A' ' 111' ' ' LEU . 69.4 t -160.18 -74.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.773 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt 175.84 139.65 0.06 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.776 -179.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.5 ' CE2' ' HA ' ' A' ' 139' ' ' PRO . 18.0 t80 -99.96 112.28 24.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.693 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.483 HG12 ' H ' ' A' ' 156' ' ' GLU . 3.0 t -101.24 166.03 2.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.201 -179.275 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.483 ' H ' HG12 ' A' ' 155' ' ' VAL . 1.3 mm-40 -89.51 150.23 22.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.12 0.486 . . . . 0.0 111.402 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.735 ' O ' HD11 ' A' ' 117' ' ' ILE . 1.6 p 178.52 -179.24 0.31 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.089 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.429 ' HB2' ' HB2' ' A' ' 163' ' ' LYS . 0.7 OUTLIER -160.14 152.49 20.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.875 0.369 . . . . 0.0 111.179 179.698 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.465 ' CB ' " H3'" ' A' ' 185' ' ' GNP . . . -109.99 -28.66 8.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.923 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.619 ' H ' HD12 ' A' ' 160' ' ' LEU . 3.2 mp -83.78 -45.22 13.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.651 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -98.8 -24.31 15.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.587 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 75.34 76.9 0.1 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.108 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.429 ' HB2' ' HB2' ' A' ' 158' ' ' SER . 2.8 tttm -94.82 34.21 1.38 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.698 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . 116.34 -62.32 0.38 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.589 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.942 HD13 ' O ' ' A' ' 19' ' ' LEU . 1.9 mt 67.55 -63.03 0.31 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.745 0.307 . . . . 0.0 111.05 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.417 ' O ' ' N ' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -55.49 -27.97 51.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.075 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -52.12 -72.63 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.858 0.361 . . . . 0.0 110.687 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.896 HG11 HG13 ' A' ' 113' ' ' VAL . 7.4 p -52.69 -46.22 49.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.173 0.511 . . . . 0.0 110.29 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.961 ' CD1' HD22 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -56.97 -29.32 63.13 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.744 179.225 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.716 ' O ' HD13 ' A' ' 173' ' ' ILE . 22.5 t0 -69.08 -29.47 67.58 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.494 178.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.667 ' HB3' HD11 ' A' ' 111' ' ' LEU . 28.8 mm-40 -75.91 -24.28 55.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.972 178.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.481 ' HA ' HD13 ' A' ' 111' ' ' LEU . . . -71.01 -54.91 9.55 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.381 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.716 HD13 ' O ' ' A' ' 170' ' ' ASP . 0.2 OUTLIER -67.64 -31.97 54.82 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-O 120.896 0.379 . . . . 0.0 110.666 -179.793 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.721 HD23 HD13 ' B' ' 505' ' ' LEU . 2.5 tm? -48.6 -33.65 10.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.742 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -74.53 -25.15 59.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.053 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.673 ' HB3' HG21 ' A' ' 4' ' ' ILE . . . -97.29 -32.41 11.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.646 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.862 HD13 ' HB ' ' B' ' 510' ' ' ILE . 14.4 mt -68.66 -11.23 59.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.223 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.456 ' HB2' ' HB1' ' B' ' 507' ' ' ALA . 0.0 OUTLIER 173.01 148.79 0.21 Allowed Pre-proline 0 C--N 1.332 -0.193 0 CA-C-O 120.768 0.318 . . . . 0.0 110.94 179.761 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.402 ' HA ' ' HD2' ' A' ' 180' ' ' PRO . 84.5 Cg_exo -47.26 105.52 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.618 2.212 . . . . 0.0 112.305 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 179' ' ' PRO . 57.5 Cg_endo -70.97 171.85 14.97 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.581 2.188 . . . . 0.0 112.346 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -142.11 130.73 11.93 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.805 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.74 -164.95 0.23 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.546 2.164 . . . . 0.0 112.248 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.77 78.86 4.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.902 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.187 -0.911 . . . . 0.0 110.918 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 502' ' ' GLY . . . . . 0.423 ' CA ' ' OG ' ' B' ' 511' ' ' SER . . . . . . . . 0 N--CA 1.489 2.199 0 N-CA-C 112.539 -0.224 . . . . 0.0 112.539 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 503' ' ' SER . . . . . 0.403 ' HB3' ' O ' ' B' ' 510' ' ' ILE . 26.7 t -58.83 -73.29 0.08 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.795 0.331 . . . . 0.0 110.855 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 504' ' ' GLY . . . . . 0.445 ' HA2' ' CB ' ' B' ' 509' ' ' ASP . . . 94.05 103.61 1.74 Allowed Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.393 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 505' ' ' LEU . . . . . 0.721 HD13 HD23 ' A' ' 174' ' ' LEU . 0.1 OUTLIER -174.26 57.36 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.809 0.338 . . . . 0.0 110.741 -179.62 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 506' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 46.83 58.07 5.05 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.936 0.398 . . . . 0.0 110.66 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 507' ' ' ALA . . . . . 0.456 ' HB1' ' HB2' ' A' ' 178' ' ' GLU . . . -169.56 42.06 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.894 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 508' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 73.65 4.53 4.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.786 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 509' ' ' ASP . . . . . 0.445 ' CB ' ' HA2' ' B' ' 504' ' ' GLY . 3.0 p30 51.9 48.69 22.28 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 121.496 0.665 . . . . 0.0 110.673 -179.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 510' ' ' ILE . . . . . 0.862 ' HB ' HD13 ' A' ' 177' ' ' LEU . 37.5 mt -72.68 130.03 35.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.054 -0.975 . . . . 0.0 111.087 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 511' ' ' SER . . . . . 0.593 ' O ' HD11 ' B' ' 514' ' ' LEU . 16.5 m -77.2 135.79 38.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.3 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 512' ' ' GLN . . . . . 0.444 ' HB3' ' HD3' ' B' ' 513' ' ' PRO . 0.0 OUTLIER -97.91 -53.8 0.2 Allowed Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.092 179.744 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 513' ' ' PRO . . . . . 0.444 ' HD3' ' HB3' ' B' ' 512' ' ' GLN . 97.2 Cg_endo -90.56 59.39 1.46 Allowed 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.835 2.357 . . . . 0.0 112.231 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 514' ' ' LEU . . . . . 0.855 ' HB2' HG13 ' A' ' 44' ' ' VAL . 1.2 mp -75.21 -174.61 2.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.946 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 515' ' ' GLN . . . . . 0.596 ' O ' HG22 ' A' ' 44' ' ' VAL . 1.9 mt-30 -72.27 158.28 36.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.932 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 516' ' ' ASN . . . . . 0.62 ' HB3' HG23 ' A' ' 43' ' ' THR . 9.7 m120 59.89 24.04 13.09 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.885 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 517' ' ' SER . . . . . 0.54 ' HA ' HG21 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -41.08 -29.48 0.12 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.854 -179.737 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 518' ' ' PHE . . . . . 0.7 ' HA ' HG12 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -150.92 135.49 17.14 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.839 0.352 . . . . 0.0 111.409 -179.778 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 519' ' ' ILE . . . . . 0.437 ' CG1' ' O ' ' A' ' 41' ' ' ALA . 2.7 pt -121.21 -37.02 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.845 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -120.04 -166.84 1.35 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.672 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 521' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -151.47 54.55 0.85 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.063 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 522' ' ' GLY . . . . . 0.457 ' HA2' ' CD2' ' A' ' 37' ' ' PHE . . . 45.52 -148.0 1.89 Allowed Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.529 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 523' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -173.1 -101.36 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.641 0.221 . . . . 0.0 111.037 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 524' ' ' GLY . . . . . . . . . . . . . . . 69.13 -63.0 0.54 Allowed Glycine 0 C--N 1.337 0.619 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.4 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 525' ' ' ASP . . . . . 0.885 ' HB3' HD22 ' A' ' 61' ' ' LEU . 24.2 t70 177.29 82.59 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.874 0.369 . . . . 0.0 110.719 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 526' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.51 95.99 5.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.801 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 527' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -146.1 158.57 48.09 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.915 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -68.62 97.56 0.54 Allowed 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.626 2.217 . . . . 0.0 112.328 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 529' ' ' ARG . . . . . 0.561 ' HG3' HG13 ' A' ' 33' ' ' VAL . 0.2 OUTLIER -100.53 -53.6 3.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.971 -179.998 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 530' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -166.76 95.16 0.51 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.492 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 531' ' ' CYS . . . . . 0.417 ' CB ' ' O ' ' A' ' 30' ' ' SER . 96.5 m -55.46 160.43 2.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.943 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 532' ' ' TRP . . . . . 0.445 ' CD1' ' OH ' ' A' ' 32' ' ' TYR . 88.5 t90 -55.12 139.46 41.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.832 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . -134.53 -123.69 2.38 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.594 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 534' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.84 147.43 89.51 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.745 0.307 . . . . 0.0 110.948 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_exo -51.61 -176.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.697 2.265 . . . . 0.0 112.351 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 3.5 t70 53.64 99.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.996 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 537' ' ' ARG . . . . . 0.464 ' HB3' ' CG2' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -75.57 179.02 5.57 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.299 0.571 . . . . 0.0 110.893 179.898 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 538' ' ' ILE . . . . . 0.43 ' O ' HG21 ' A' ' 14' ' ' VAL . 1.8 pt -74.87 -154.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.984 179.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 539' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -107.58 148.19 29.61 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.726 0.298 . . . . 0.0 110.419 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 540' ' ' GLU . . . . . 0.911 ' CD ' HG13 ' A' ' 9' ' ' VAL . 12.9 pm0 -48.11 -25.58 1.51 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.036 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 541' ' ' LEU . . . . . 0.517 ' HA ' HD21 ' A' ' 70' ' ' LEU . 11.0 mt -37.5 -45.29 0.72 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.523 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 542' ' ' TYR . . . . . 0.456 ' CD1' ' N ' ' B' ' 542' ' ' TYR . 1.4 m-30 -104.73 -63.12 1.25 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.879 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 543' ' ' LEU . . . . . 0.886 HD12 ' HA ' ' B' ' 540' ' ' GLU . 0.0 OUTLIER 76.9 125.06 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.844 -179.853 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 544' ' ' GLY . . . . . 0.424 ' HA2' ' HB2' ' A' ' 32' ' ' TYR . . . 55.77 -159.08 7.56 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.483 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 545' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.207 -0.901 . . . . 0.0 110.925 179.983 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 185' ' ' GNP . . . . . 0.964 " H2'" ' OG1' ' A' ' 115' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 188' ' ' HOH . . . . . 0.424 ' O ' HD11 ' A' ' 21' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.4 tpt . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.889 0.376 . . . . 0.0 111.085 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.4 tm0? -81.78 144.1 31.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.635 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.704 HG23 ' CE1' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -93.82 -175.52 3.76 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.342 -179.639 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.977 HG13 HD13 ' A' ' 53' ' ' LEU . 5.2 pt -154.99 143.67 13.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.948 -179.151 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.416 ' O ' HG23 ' A' ' 75' ' ' THR . 3.2 ptpp? -134.33 95.57 3.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.131 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.499 ' SG ' HG13 ' A' ' 77' ' ' VAL . 80.5 m -118.87 153.34 34.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.059 0.457 . . . . 0.0 111.332 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.656 HG22 ' HB2' ' A' ' 56' ' ' PHE . 2.5 t -142.99 128.46 16.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.453 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.724 HG23 ' SG ' ' A' ' 81' ' ' CYS . 1.4 p -84.68 113.84 23.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.166 0.507 . . . . 0.0 111.192 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.868 HG11 ' CE1' ' A' ' 72' ' ' TYR . 1.3 m -114.74 129.75 70.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.443 178.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.482 ' HA2' ' CZ2' ' A' ' 97' ' ' TRP . . . 149.13 -170.11 29.48 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.098 -1.049 . . . . 0.0 112.808 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.435 ' O ' ' N ' ' B' ' 537' ' ' ARG . 0.4 OUTLIER -98.3 27.54 4.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.715 0.293 . . . . 0.0 110.691 179.91 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.428 ' CA ' ' HB2' ' B' ' 537' ' ' ARG . . . -126.34 170.62 18.15 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.684 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.719 ' HB3' H5'1 ' A' ' 185' ' ' GNP . . . -98.27 -38.26 9.34 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.715 0.293 . . . . 0.0 111.344 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.816 HG11 HG21 ' A' ' 115' ' ' THR . 2.1 m -43.94 91.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.481 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.66 ' CA ' HD22 ' A' ' 19' ' ' LEU . . . -175.55 -71.43 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.934 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.441 ' CD ' ' HB3' ' A' ' 55' ' ' LEU . 8.8 mmtm -97.39 -80.67 0.44 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.007 0.432 . . . . 0.0 111.912 -179.293 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . 1.026 HG21 HG23 ' A' ' 35' ' ' THR . 71.7 p -75.1 -69.57 0.47 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.547 -178.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.71 ' HB2' ' HB1' ' A' ' 13' ' ' ALA . 43.2 t -33.01 -43.35 0.1 Allowed 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -178.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.8 HD13 ' HA ' ' A' ' 14' ' ' VAL . 0.2 OUTLIER -60.71 -52.71 63.94 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.782 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -70.49 -24.42 62.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.842 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 27.7 mm -57.81 -71.18 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.492 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.5 m -60.87 -23.37 65.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.128 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.471 ' CE2' ' HB2' ' B' ' 513' ' ' PRO . 41.5 t80 -65.19 -68.24 0.38 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.858 0.361 . . . . 0.0 110.284 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 96.9 m -75.87 -37.58 58.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.744 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.4 p -113.12 -166.8 1.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.684 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -142.0 19.08 2.12 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.12 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.8 mmtm -93.35 95.98 9.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.021 0.438 . . . . 0.0 110.566 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.496 ' CD1' ' O1A' ' A' ' 185' ' ' GNP . 2.6 t80 -87.01 -50.6 0.45 Allowed Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.301 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.473 ' HD3' ' HB3' ' A' ' 28' ' ' PHE . 64.9 Cg_endo -88.66 46.04 1.01 Allowed 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.842 2.361 . . . . 0.0 112.475 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.5 p -83.7 -94.36 0.07 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.127 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -158.87 124.74 4.44 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.797 0.332 . . . . 0.0 111.17 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.475 ' O ' HG22 ' A' ' 33' ' ' VAL . 4.6 m-30 -88.58 94.7 9.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.598 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.652 HG13 ' OXT' ' B' ' 545' ' ' ASN . 0.0 OUTLIER -165.03 -64.07 0.01 OUTLIER Pre-proline 0 N--CA 1.466 0.328 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.633 -179.804 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.452 ' CD ' ' HB ' ' A' ' 33' ' ' VAL . 10.3 Cg_endo -53.09 -16.98 7.25 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.889 2.393 . . . . 0.0 112.67 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . 1.026 HG23 HG21 ' A' ' 17' ' ' THR . 45.4 m -36.18 -31.83 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.533 HG21 ' HA3' ' B' ' 524' ' ' GLY . 0.0 OUTLIER -44.31 -28.37 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 120.685 0.279 . . . . 0.0 111.436 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.467 ' O ' ' CG ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -78.39 57.7 1.98 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.088 179.857 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -135.05 -47.46 0.72 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.845 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -63.96 -16.88 62.55 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.265 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.66 -157.5 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.932 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.409 ' O ' HG12 ' B' ' 519' ' ' ILE . . . -90.76 162.6 14.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.068 0.461 . . . . 0.0 111.951 -179.26 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.588 HG13 ' C ' ' B' ' 517' ' ' SER . 4.8 t -134.86 166.58 28.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.078 179.537 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.69 HG22 HD13 ' B' ' 519' ' ' ILE . 9.4 t -143.82 103.8 4.1 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.904 HG22 ' CG2' ' A' ' 52' ' ' THR . 30.9 m -161.84 -177.46 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.017 178.489 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.499 ' O ' HD21 ' B' ' 514' ' ' LEU . 0.0 OUTLIER -105.63 100.01 9.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.61 0.243 . . . . 0.0 111.642 -179.479 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.608 HG22 ' O ' ' A' ' 46' ' ' ILE . 5.1 mm -75.01 86.59 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 178.334 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.458 ' HA3' ' HA ' ' B' ' 510' ' ' ILE . . . 45.76 -95.61 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.689 -0.687 . . . . 0.0 113.401 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -38.04 -90.41 0.01 OUTLIER Glycine 0 CA--C 1.52 0.355 0 N-CA-C 113.992 0.357 . . . . 0.0 113.992 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.439 ' N ' ' HE1' ' A' ' 45' ' ' MET . 0.1 OUTLIER -123.14 159.12 55.69 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.789 0.328 . . . . 0.0 111.161 -179.181 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.416 ' HD2' ' HB2' ' A' ' 49' ' ' GLU . 2.7 Cg_endo -46.15 105.06 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.792 2.328 . . . . 0.0 112.356 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.704 ' CE1' HG23 ' A' ' 3' ' ' THR . 1.7 t80 -172.27 158.72 4.53 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.328 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.904 ' CG2' HG22 ' A' ' 44' ' ' VAL . 3.3 p -136.41 153.07 51.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.154 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.977 HD13 HG13 ' A' ' 4' ' ' ILE . 0.5 OUTLIER -78.76 -174.64 4.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.629 179.61 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -114.16 76.14 0.24 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.399 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.64 HD21 ' NE2' ' B' ' 512' ' ' GLN . 0.6 OUTLIER -52.56 114.62 1.44 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.938 0.399 . . . . 0.0 110.356 179.845 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.656 ' HB2' HG22 ' A' ' 7' ' ' VAL . 77.3 m-85 -84.4 109.42 17.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.069 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.417 ' HA ' ' HG3' ' A' ' 16' ' ' LYS . 3.5 t0 -108.2 -175.76 2.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.652 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.607 HG21 ' O ' ' B' ' 540' ' ' GLU . 16.8 p -135.83 170.38 16.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.093 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.821 ' N ' HD21 ' A' ' 67' ' ' LEU . . . -171.82 167.01 6.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.111 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' B' ' 543' ' ' LEU . . . -146.14 33.73 1.46 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.306 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.694 HD13 ' OD1' ' B' ' 525' ' ' ASP . 0.0 OUTLIER -121.22 -173.68 2.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.765 0.317 . . . . 0.0 110.817 179.957 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -44.52 -27.76 0.5 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.697 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.465 ' OD2' ' CE1' ' A' ' 64' ' ' TYR . 45.2 t0 -47.67 -63.44 1.06 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.223 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.523 ' O ' HD23 ' A' ' 67' ' ' LEU . 0.0 OUTLIER 170.88 73.65 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.175 179.905 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -58.76 -19.9 44.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.101 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.14 -14.24 61.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.596 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.821 HD21 ' N ' ' A' ' 59' ' ' ALA . 3.6 pp -47.69 135.51 11.56 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.839 0.352 . . . . 0.0 111.087 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.479 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -139.55 48.52 1.64 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.084 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 71.0 Cg_endo -74.17 -9.58 22.03 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.451 2.101 . . . . 0.0 112.484 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.769 HD11 HD23 ' B' ' 541' ' ' LEU . 0.1 OUTLIER -78.78 1.04 24.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.641 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -55.13 -20.47 10.16 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.625 0.25 . . . . 0.0 111.437 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.868 ' CE1' HG11 ' A' ' 9' ' ' VAL . 34.2 m-85 73.59 64.84 0.31 Allowed Pre-proline 0 C--N 1.332 -0.17 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.819 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.1 -150.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.581 2.188 . . . . 0.0 111.955 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -60.39 -16.17 32.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.374 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 5' ' ' LYS . 55.3 m -42.12 133.06 3.15 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.871 0.367 . . . . 0.0 111.298 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.846 ' HA ' HG22 ' A' ' 108' ' ' THR . 0.4 OUTLIER -115.1 7.47 15.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.562 -179.82 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.758 HG21 ' HB3' ' A' ' 175' ' ' ALA . 7.9 p -145.21 79.95 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.881 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.586 ' HE1' HD12 ' A' ' 101' ' ' ILE . 1.1 p90 -92.8 124.82 37.07 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 178.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.482 HD11 ' CG2' ' A' ' 113' ' ' VAL . 12.7 tp -70.37 108.65 4.34 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.78 -178.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.659 HG21 ' CD1' ' A' ' 110' ' ' PHE . 2.1 t -80.19 156.13 4.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.696 178.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.724 ' SG ' HG23 ' A' ' 8' ' ' VAL . 2.8 m -145.77 129.75 17.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.318 0.58 . . . . 0.0 112.363 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.699 ' HE2' HD12 ' A' ' 112' ' ' LEU . 17.4 p90 -152.21 128.78 10.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.564 178.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.46 ' HA ' ' C2 ' ' A' ' 185' ' ' GNP . 0.7 OUTLIER -83.06 137.62 34.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.125 0.488 . . . . 0.0 111.76 -178.663 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.727 HG11 ' HB3' ' A' ' 120' ' ' ARG . 72.5 t -47.85 -78.73 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.246 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.73 HG22 ' OE1' ' A' ' 116' ' ' GLN . 29.6 m -42.8 113.95 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.086 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.537 ' C ' HD22 ' A' ' 129' ' ' LEU . 3.0 p -152.25 145.07 17.19 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.888 0.375 . . . . 0.0 111.909 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.427 ' HA ' ' HB3' ' A' ' 133' ' ' LYS . 76.9 Cg_endo -91.23 53.96 0.91 Allowed 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.226 2.618 . . . . 0.0 111.659 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.482 ' N ' ' CB ' ' A' ' 133' ' ' LYS . 0.7 OUTLIER 82.15 33.26 0.09 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.806 -179.455 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.898 ' O ' HG23 ' A' ' 93' ' ' VAL . 1.1 t -88.31 -24.75 23.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.023 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.512 ' CD1' HG13 ' A' ' 137' ' ' ILE . 2.1 t80 -51.07 -56.78 10.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.096 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -53.11 -41.9 65.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.131 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.422 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 1.8 t-20 -72.73 -53.16 12.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.975 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.898 HG23 ' O ' ' A' ' 89' ' ' SER . 46.5 t -49.81 -44.44 20.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.207 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.469 ' O ' HG23 ' A' ' 98' ' ' VAL . 30.4 tttt -62.23 -52.59 63.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.998 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.414 ' O ' ' HG3' ' A' ' 99' ' ' PRO . 70.2 mt-10 -84.51 9.38 13.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.681 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.422 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 25.7 tttp -116.12 -37.75 3.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.729 0.3 . . . . 0.0 110.725 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.482 ' CZ2' ' HA2' ' A' ' 10' ' ' GLY . 0.8 OUTLIER -94.42 -46.85 6.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.34 -179.769 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.482 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 56.9 t -51.98 -46.07 92.89 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.654 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.482 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 92.0 Cg_endo -81.1 -12.37 11.82 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.342 2.028 . . . . 0.0 112.757 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -86.61 -49.17 7.72 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.861 0.362 . . . . 0.0 110.585 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.586 HD12 ' HE1' ' A' ' 78' ' ' PHE . 32.4 pt -66.55 -28.15 42.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.879 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.425 HG23 ' O ' ' A' ' 98' ' ' VAL . 27.5 p -77.68 -33.25 53.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.579 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -64.12 -46.09 85.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.758 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 27.5 m170 -82.86 -24.15 33.37 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.758 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -142.94 95.8 6.13 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.665 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -68.81 133.13 26.51 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.594 2.196 . . . . 0.0 112.574 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 49.02 77.32 0.1 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.156 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.846 HG22 ' HA ' ' A' ' 76' ' ' ASP . 0.1 OUTLIER -139.29 115.09 8.35 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.878 179.857 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.42 162.78 13.91 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.639 2.226 . . . . 0.0 112.826 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.659 ' CD1' HG21 ' A' ' 80' ' ' VAL . 37.0 p90 -161.69 165.05 28.73 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.549 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.975 HD12 HG11 ' A' ' 152' ' ' VAL . 0.9 OUTLIER -114.96 159.62 20.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.939 0.399 . . . . 0.0 111.635 -179.562 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.737 HD22 ' C ' ' A' ' 111' ' ' LEU . 2.4 mm? -119.48 161.14 21.07 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.575 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.492 HG12 ' CG2' ' A' ' 115' ' ' THR . 3.1 t -134.4 142.85 39.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.911 0.386 . . . . 0.0 111.694 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.628 ' O ' HD13 ' A' ' 117' ' ' ILE . . . -121.76 67.77 0.45 Allowed Glycine 0 C--N 1.331 0.28 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.989 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.816 HG21 HG11 ' A' ' 14' ' ' VAL . 1.4 p -92.38 26.55 2.55 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -178.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.73 ' OE1' HG22 ' A' ' 85' ' ' VAL . 2.9 mm-40 -131.88 23.85 4.62 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.199 0.523 . . . . 0.0 109.737 179.12 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.725 HD11 ' N ' ' A' ' 158' ' ' SER . 0.0 OUTLIER -67.68 -9.62 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.8 179.253 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -100.43 -40.59 7.39 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.144 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.625 HD13 ' CD ' ' A' ' 116' ' ' GLN . 3.5 mp -69.54 -33.79 73.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.313 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.727 ' HB3' HG11 ' A' ' 84' ' ' VAL . 0.1 OUTLIER -47.25 -33.83 5.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.891 0.377 . . . . 0.0 110.984 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -80.13 -27.35 39.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.549 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' A' ' 119' ' ' LEU . 2.2 t70 -57.59 106.47 0.69 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.76 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -70.0 -3.83 12.95 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.643 2.229 . . . . 0.0 112.847 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.98 -67.27 0.77 Allowed 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.059 0.457 . . . . 0.0 110.0 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.416 ' O ' ' HB3' ' A' ' 128' ' ' LYS . 2.1 m -56.17 -43.58 78.51 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 178.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.88 HD11 ' HB3' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -48.28 -42.17 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.524 178.913 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.573 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 0.4 OUTLIER -55.63 -49.44 72.84 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.006 178.679 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.682 ' HD2' HD23 ' A' ' 129' ' ' LEU . 0.1 OUTLIER -54.67 -32.89 59.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.2 179.017 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.682 HD23 ' HD2' ' A' ' 128' ' ' LYS . 7.5 mt -72.41 -42.0 65.62 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.578 ' HB2' ' HG3' ' A' ' 134' ' ' GLN . . . -42.51 -30.7 0.37 Allowed 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.106 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.404 ' HG2' ' O ' ' A' ' 128' ' ' LYS . 2.9 mmmt -58.94 -39.56 81.97 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.247 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -125.16 -30.59 3.17 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.482 ' CB ' ' N ' ' A' ' 88' ' ' SER . 0.3 OUTLIER -130.51 -69.68 0.65 Allowed 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -177.719 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.578 ' HG3' ' HB2' ' A' ' 130' ' ' ALA . 2.8 tt0 87.73 -37.23 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.341 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.44 ' CB ' ' HE3' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -69.03 111.23 7.82 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 120.733 0.301 . . . . 0.0 111.505 -179.137 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.88 ' HB3' HD11 ' A' ' 126' ' ' ILE . 74.2 Cg_endo -77.5 129.68 10.33 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.544 2.163 . . . . 0.0 112.019 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.531 ' HB ' HG13 ' A' ' 84' ' ' VAL . 0.6 OUTLIER -59.42 96.9 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.94 179.904 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.42 ' O ' ' N ' ' A' ' 141' ' ' THR . 11.1 p -67.32 147.29 98.91 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.897 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_exo -40.88 -40.71 3.75 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.728 2.285 . . . . 0.0 112.318 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -69.24 -36.6 77.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.6 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.42 ' N ' ' O ' ' A' ' 138' ' ' THR . 90.6 m -55.31 -56.69 17.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.76 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.572 ' HB3' ' CE2' ' A' ' 154' ' ' TYR . . . -52.53 -39.57 61.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.81 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.98 -34.98 79.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.703 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.2 tptt -59.98 -58.63 7.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.783 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.425 ' HA ' ' HB2' ' A' ' 148' ' ' ASP . 24.1 tp -65.71 -35.98 82.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.761 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -58.11 -61.04 2.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.167 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 4.4 mtt85 -72.39 -25.44 61.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.012 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.425 ' HB2' ' HA ' ' A' ' 145' ' ' LEU . 1.8 m-20 -49.36 -41.87 40.31 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.036 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 5.9 mt -102.69 23.14 12.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.922 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 48.34 33.85 4.17 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.971 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.707 ' O ' HG23 ' A' ' 152' ' ' VAL . . . -51.96 -81.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.187 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.975 HG11 HD12 ' A' ' 111' ' ' LEU . 8.0 t -164.56 -69.21 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.894 0.378 . . . . 0.0 110.394 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 177.41 135.45 0.07 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.243 -179.104 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.572 ' CE2' ' HB3' ' A' ' 142' ' ' ALA . 24.7 t80 -106.75 114.7 28.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.728 178.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.622 ' HB ' HG22 ' A' ' 168' ' ' VAL . 2.8 t -101.24 151.99 5.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.733 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -99.12 118.58 36.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.4 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.512 ' N ' HD12 ' A' ' 117' ' ' ILE . 0.9 OUTLIER 178.3 125.96 0.05 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.546 179.523 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.725 ' N ' HD11 ' A' ' 117' ' ' ILE . 40.2 t -118.61 151.57 37.66 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.076 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -72.06 -38.46 69.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.942 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.514 ' H ' HD12 ' A' ' 160' ' ' LEU . 4.1 mp -52.6 -52.55 54.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.562 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 12.9 t -77.23 -42.62 36.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.562 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.404 ' O ' ' O ' ' A' ' 163' ' ' LYS . 3.1 tt0 176.71 -85.38 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.195 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.938 ' HG2' HD22 ' A' ' 165' ' ' LEU . 4.7 tttm 58.76 118.76 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.925 0.393 . . . . 0.0 110.726 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . -71.12 -10.12 68.32 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.43 -0.89 . . . . 0.0 112.523 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.938 HD22 ' HG2' ' A' ' 163' ' ' LYS . 4.0 mm? 66.95 -63.73 0.26 Allowed 'General case' 0 CA--C 1.522 -0.097 0 CA-C-O 120.702 0.287 . . . . 0.0 110.474 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.436 ' O ' ' CB ' ' A' ' 170' ' ' ASP . 1.7 ptmt -57.04 -32.14 65.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.688 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.433 ' N ' ' HG2' ' A' ' 166' ' ' LYS . 2.6 t-20 -53.92 -72.17 0.06 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.764 0.316 . . . . 0.0 110.617 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.622 HG22 ' HB ' ' A' ' 155' ' ' VAL . 5.9 t -63.41 -43.06 98.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.244 0.545 . . . . 0.0 110.073 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.763 ' CG ' HD23 ' A' ' 19' ' ' LEU . 0.9 OUTLIER -58.57 -24.01 59.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.603 179.539 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.443 ' HA ' ' CG1' ' A' ' 173' ' ' ILE . 27.5 t0 -76.99 -41.53 42.5 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.879 0.371 . . . . 0.0 110.038 179.26 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.509 ' HB3' HD11 ' A' ' 111' ' ' LEU . 13.4 mm-40 -56.59 -33.76 66.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.185 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.606 ' N ' HD13 ' A' ' 111' ' ' LEU . . . -73.54 -58.22 3.46 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.129 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.488 ' HB ' HD12 ' A' ' 4' ' ' ILE . 1.3 pp -62.66 -39.93 86.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.23 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.883 HD13 HD22 ' B' ' 505' ' ' LEU . 5.0 tp -48.03 -43.18 29.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.194 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.758 ' HB3' HG21 ' A' ' 77' ' ' VAL . . . -52.59 -23.26 6.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.071 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.49 ' HB3' ' HB ' ' A' ' 4' ' ' ILE . . . -90.88 -36.5 14.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.394 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.847 HD13 ' HB ' ' B' ' 510' ' ' ILE . 80.7 mt -68.55 -23.02 64.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.816 0.341 . . . . 0.0 110.671 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.481 ' HG3' ' HB2' ' B' ' 507' ' ' ALA . 0.6 OUTLIER -169.96 167.22 5.08 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.799 179.878 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.422 ' HD2' ' CB ' ' A' ' 178' ' ' GLU . 32.4 Cg_endo -64.17 124.58 13.67 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.576 2.184 . . . . 0.0 112.251 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -74.03 164.7 33.79 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.457 2.104 . . . . 0.0 112.455 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' GLU . . . . . 0.409 ' O ' ' CG ' ' A' ' 181' ' ' GLU . 0.7 OUTLIER -117.09 114.41 38.96 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.807 179.999 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.62 -165.04 0.25 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.567 2.178 . . . . 0.0 112.321 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.48 77.66 7.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.999 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.168 -0.92 . . . . 0.0 110.787 179.99 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.122 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 503' ' ' SER . . . . . . . . . . . . . 31.0 t -105.41 -71.93 0.73 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.78 0.324 . . . . 0.0 111.034 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 504' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' B' ' 509' ' ' ASP . . . 111.93 122.49 4.14 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.126 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 505' ' ' LEU . . . . . 0.883 HD22 HD13 ' A' ' 174' ' ' LEU . 0.4 OUTLIER -173.92 -37.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.54 -179.572 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 506' ' ' SER . . . . . 0.599 ' N ' HD12 ' B' ' 505' ' ' LEU . 0.3 OUTLIER 171.46 -56.82 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.704 0.288 . . . . 0.0 110.913 -179.821 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 507' ' ' ALA . . . . . 0.481 ' HB2' ' HG3' ' A' ' 178' ' ' GLU . . . -39.9 -43.74 1.55 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.688 0.756 . . . . 0.0 111.073 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 508' ' ' GLN . . . . . 0.48 ' O ' ' CB ' ' B' ' 509' ' ' ASP . 1.9 pt20 164.99 -39.22 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.362 -1.29 . . . . 0.0 108.226 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 509' ' ' ASP . . . . . 0.48 ' CB ' ' O ' ' B' ' 508' ' ' GLN . 7.6 p30 147.25 41.44 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 113.94 -1.482 . . . . 0.0 110.197 179.007 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 510' ' ' ILE . . . . . 0.847 ' HB ' HD13 ' A' ' 177' ' ' LEU . 13.7 mt -72.08 126.27 32.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.263 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 511' ' ' SER . . . . . . . . . . . . . 30.3 t -109.47 141.73 41.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.288 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 512' ' ' GLN . . . . . 0.64 ' NE2' HD21 ' A' ' 55' ' ' LEU . 4.3 tp60 -92.89 -67.68 0.1 OUTLIER Pre-proline 0 CA--C 1.532 0.27 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.151 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 513' ' ' PRO . . . . . 0.492 ' HD3' ' HB3' ' B' ' 512' ' ' GLN . 92.3 Cg_endo -80.3 74.31 5.6 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.451 2.101 . . . . 0.0 111.461 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 514' ' ' LEU . . . . . 0.499 HD21 ' O ' ' A' ' 45' ' ' MET . 2.3 mp -73.45 -86.7 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.488 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 515' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -79.25 -87.76 0.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.693 -0.231 . . . . 0.0 111.052 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -117.57 -29.67 5.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.803 0.335 . . . . 0.0 111.134 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 517' ' ' SER . . . . . 0.588 ' C ' HG13 ' A' ' 42' ' ' VAL . 2.6 m 72.01 22.27 3.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.964 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 518' ' ' PHE . . . . . 0.48 ' CD1' ' O ' ' B' ' 517' ' ' SER . 12.1 m-85 -150.13 130.44 13.73 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.027 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 519' ' ' ILE . . . . . 0.69 HD13 HG22 ' A' ' 43' ' ' THR . 43.9 mm -63.62 -68.32 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.994 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -155.06 -67.41 0.13 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.061 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 521' ' ' THR . . . . . . . . . . . . . 11.2 m -163.88 157.63 18.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.101 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 522' ' ' GLY . . . . . . . . . . . . . . . -91.78 -92.08 1.39 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.333 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 523' ' ' HIS . . . . . 0.411 ' CD2' ' N ' ' B' ' 523' ' ' HIS . 0.1 OUTLIER 174.73 -98.81 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.475 0.137 . . . . 0.0 110.845 179.881 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 524' ' ' GLY . . . . . 0.533 ' HA3' HG21 ' A' ' 36' ' ' VAL . . . 42.35 -95.06 0.01 OUTLIER Glycine 0 C--N 1.338 0.658 0 C-N-CA 120.991 -0.623 . . . . 0.0 113.009 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 525' ' ' ASP . . . . . 0.694 ' OD1' HD13 ' A' ' 61' ' ' LEU . 33.2 p-10 177.46 91.65 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.815 0.34 . . . . 0.0 111.088 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 526' ' ' SER . . . . . 0.443 ' CB ' ' HB3' ' A' ' 34' ' ' PRO . 9.2 t -80.04 95.71 6.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.724 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 527' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -144.6 147.91 37.93 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.816 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.55 99.92 0.65 Allowed 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.552 2.168 . . . . 0.0 112.323 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 529' ' ' ARG . . . . . 0.614 ' HG3' HG21 ' A' ' 33' ' ' VAL . 12.6 mtp180 -100.29 -54.88 2.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.004 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 530' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -158.72 96.85 1.4 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.836 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 27.8 p -68.76 112.13 5.29 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.955 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 532' ' ' TRP . . . . . 0.504 ' CD1' ' NH2' ' B' ' 537' ' ' ARG . 22.4 t90 66.74 -68.95 0.13 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.833 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . 61.39 -80.76 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.52 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 534' ' ' PHE . . . . . 0.416 ' O ' ' NH1' ' B' ' 537' ' ' ARG . 17.7 m-85 -105.54 149.86 38.35 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.685 0.279 . . . . 0.0 110.844 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.27 -12.72 30.26 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.502 2.135 . . . . 0.0 112.555 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -112.98 120.79 42.61 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.831 0.348 . . . . 0.0 111.003 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 537' ' ' ARG . . . . . 0.504 ' NH2' ' CD1' ' B' ' 532' ' ' TRP . 11.6 mmt-85 -71.57 138.51 48.86 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.156 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 538' ' ' ILE . . . . . 0.4 HD12 ' HA ' ' B' ' 538' ' ' ILE . 4.1 tp -56.46 139.03 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.941 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 539' ' ' ASP . . . . . . . . . . . . . 34.3 p-10 -42.64 126.03 3.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.862 0.363 . . . . 0.0 111.125 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 540' ' ' GLU . . . . . 0.607 ' O ' HG21 ' A' ' 58' ' ' THR . 19.8 mm-40 -49.34 -22.58 1.15 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.077 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 541' ' ' LEU . . . . . 0.769 HD23 HD11 ' A' ' 70' ' ' LEU . 0.4 OUTLIER -35.26 -53.21 0.62 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.995 0.426 . . . . 0.0 111.62 179.81 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 542' ' ' TYR . . . . . 0.429 ' O ' ' N ' ' A' ' 59' ' ' ALA . 0.4 OUTLIER -104.8 -62.5 1.33 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.327 179.4 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 543' ' ' LEU . . . . . 0.496 HD13 ' HA ' ' B' ' 540' ' ' GLU . 3.4 tp 62.22 153.05 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.567 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . 103.26 82.73 1.65 Allowed Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.382 -0.913 . . . . 0.0 112.592 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 545' ' ' ASN . . . . . 0.652 ' OXT' HG13 ' A' ' 33' ' ' VAL . 1.1 m120 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.862 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 185' ' ' GNP . . . . . 0.719 H5'1 ' HB3' ' A' ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.656 ' CE ' HG23 ' A' ' 46' ' ' ILE . 5.5 tpt . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 120.861 0.363 . . . . 0.0 111.233 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.678 ' O ' HD22 ' A' ' 177' ' ' LEU . 15.3 pt20 -167.17 138.81 3.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.753 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.941 HG23 HD12 ' A' ' 53' ' ' LEU . 13.7 t -109.94 -139.67 0.38 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.26 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.849 HG22 ' HB3' ' A' ' 176' ' ' ALA . 0.2 OUTLIER -150.55 152.54 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -178.865 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 13.1 pttt -134.0 95.61 3.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.602 178.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.409 ' O ' ' HE2' ' A' ' 16' ' ' LYS . 25.1 m -102.03 154.35 19.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.188 0.518 . . . . 0.0 111.876 -178.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.6 t -133.12 150.21 32.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.164 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.71 HG13 ' HB ' ' A' ' 14' ' ' VAL . 53.5 t -97.3 143.75 12.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.267 0.556 . . . . 0.0 111.056 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.596 HG13 ' O ' ' A' ' 8' ' ' VAL . 6.7 m -161.67 129.95 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.853 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 148.59 -178.68 26.0 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 119.882 -1.151 . . . . 0.0 112.909 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -102.46 -27.16 12.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.89 0.376 . . . . 0.0 110.593 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' B' ' 537' ' ' ARG . . . -66.9 -129.56 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.211 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.891 ' HB1' ' PA ' ' A' ' 185' ' ' GNP . . . -102.42 -56.95 2.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.824 0.345 . . . . 0.0 111.258 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.71 ' HB ' HG13 ' A' ' 8' ' ' VAL . 2.8 t 43.38 29.06 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.461 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.429 ' O ' HD22 ' A' ' 19' ' ' LEU . . . -64.51 89.49 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.802 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.573 ' HA ' HD22 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -52.59 -33.45 46.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.933 0.397 . . . . 0.0 110.273 179.675 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.428 HG21 ' HB2' ' A' ' 38' ' ' ASP . 39.2 p -81.15 -53.15 6.64 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.677 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.404 ' HB2' ' O2B' ' A' ' 185' ' ' GNP . 1.6 t -42.72 -38.54 2.11 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.265 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.984 HD23 ' CE1' ' A' ' 169' ' ' PHE . 0.0 OUTLIER -49.32 -58.67 4.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.545 179.668 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.662 ' H ' HD22 ' A' ' 20' ' ' LEU . 0.6 OUTLIER -70.59 -27.62 64.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.923 179.944 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.449 ' O ' ' N ' ' A' ' 25' ' ' THR . 37.3 mm -64.23 -71.43 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.242 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 9.6 t -50.0 -31.02 11.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.809 0.338 . . . . 0.0 110.717 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.406 ' CE1' ' HG2' ' A' ' 166' ' ' LYS . 46.5 t80 -63.54 -66.61 0.52 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.659 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.27 -54.63 6.77 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.73 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.449 ' N ' ' O ' ' A' ' 21' ' ' ILE . 27.4 p -78.47 -154.08 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.345 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -157.46 35.52 0.27 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.735 0.302 . . . . 0.0 111.088 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -123.02 101.47 7.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.932 0.396 . . . . 0.0 111.525 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.486 ' CD2' ' HD3' ' A' ' 29' ' ' PRO . 0.4 OUTLIER -101.4 -70.04 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.726 178.92 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.486 ' HD3' ' CD2' ' A' ' 28' ' ' PHE . 95.7 Cg_endo -79.1 54.45 5.18 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.23 1.953 . . . . 0.0 111.518 178.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.02 -85.73 0.5 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.356 -179.194 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -147.54 118.53 7.68 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.196 0.522 . . . . 0.0 112.085 -179.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.601 ' CE2' ' PB ' ' A' ' 185' ' ' GNP . 4.2 m-30 -99.78 94.37 6.29 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.577 178.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.474 HG11 ' HB3' ' B' ' 526' ' ' SER . 0.0 OUTLIER -163.82 -63.85 0.01 OUTLIER Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.857 -179.177 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.469 ' HD2' HG23 ' A' ' 33' ' ' VAL . 8.8 Cg_endo -50.81 -20.43 6.78 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.781 2.321 . . . . 0.0 112.328 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.661 HG23 HD23 ' B' ' 543' ' ' LEU . 8.2 t -40.92 -29.66 0.11 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.501 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.671 HG12 ' HB2' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -43.63 -29.68 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-O 120.924 0.393 . . . . 0.0 111.016 179.648 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.493 ' O ' ' CG ' ' A' ' 40' ' ' TYR . 0.8 OUTLIER -55.36 -23.48 24.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.62 179.478 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.441 ' HA ' ' CE1' ' A' ' 40' ' ' TYR . 21.9 t70 -41.67 -28.29 0.14 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.121 -0.49 . . . . 0.0 112.122 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -72.79 -1.86 18.25 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.493 ' CG ' ' O ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -60.0 -176.48 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.767 0.318 . . . . 0.0 110.651 179.856 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.421 ' O ' ' CG1' ' B' ' 519' ' ' ILE . . . -112.84 144.54 42.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.455 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.744 HG23 ' HB ' ' A' ' 52' ' ' THR . 0.8 OUTLIER -116.61 121.85 68.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.981 179.604 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.539 ' H ' HD11 ' B' ' 519' ' ' ILE . 1.7 p -111.3 106.59 15.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.749 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.727 HG21 ' HB2' ' B' ' 514' ' ' LEU . 6.4 p -164.05 148.78 2.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.283 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.702 ' O ' HD22 ' B' ' 514' ' ' LEU . 0.0 OUTLIER -74.56 104.38 5.23 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 178.773 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.73 ' HA ' HD11 ' B' ' 514' ' ' LEU . 7.8 tt -99.92 87.67 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.676 -179.066 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.77 -108.06 2.46 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.303 -0.862 . . . . 0.0 113.13 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -47.96 -88.88 0.01 OUTLIER Glycine 0 C--N 1.331 0.264 0 C-N-CA 121.184 -0.531 . . . . 0.0 113.342 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.458 ' N ' ' HE1' ' A' ' 45' ' ' MET . 5.0 pt-20 -126.16 170.89 8.71 Favored Pre-proline 0 CA--C 1.53 0.204 0 CA-C-O 120.627 0.251 . . . . 0.0 110.902 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.443 ' HD2' ' HB2' ' A' ' 49' ' ' GLU . 33.1 Cg_exo -60.28 107.48 0.42 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.684 2.256 . . . . 0.0 112.777 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.822 ' CE1' HG22 ' A' ' 3' ' ' THR . 6.2 t80 -172.87 104.72 0.14 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.402 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.744 ' HB ' HG23 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -122.6 128.92 51.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.844 0.354 . . . . 0.0 110.875 179.873 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.941 HD12 HG23 ' A' ' 3' ' ' THR . 11.3 mt -70.8 172.05 9.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.97 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -115.19 108.22 1.88 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.79 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.1 mp -48.73 114.55 1.0 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.842 0.353 . . . . 0.0 110.641 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -83.63 105.14 14.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.508 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.408 ' HB2' ' HB3' ' A' ' 38' ' ' ASP . 0.4 OUTLIER -99.53 -175.63 3.05 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.843 -179.87 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . 1.005 HG22 HD13 ' A' ' 67' ' ' LEU . 1.2 p -136.05 167.84 20.47 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.784 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.671 ' HB2' HG12 ' A' ' 36' ' ' VAL . . . -171.2 179.99 2.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.184 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.403 ' HA2' ' CB ' ' A' ' 65' ' ' ASP . . . -151.48 31.24 0.94 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.293 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.544 HD22 ' OG ' ' B' ' 526' ' ' SER . 0.0 OUTLIER -118.45 -160.84 0.81 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.754 0.311 . . . . 0.0 110.815 -179.847 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.6 mp0 -52.82 -27.11 16.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.184 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.452 ' OD2' HD13 ' A' ' 61' ' ' LEU . 9.2 m-20 -50.49 -63.63 1.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.281 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.562 ' O ' HD23 ' A' ' 67' ' ' LEU . 0.0 OUTLIER 169.1 82.88 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.91 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.403 ' CB ' ' HA2' ' A' ' 60' ' ' GLY . 9.8 t70 -68.07 -22.32 64.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.086 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.92 -29.87 21.91 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.21 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 1.005 HD13 HG22 ' A' ' 58' ' ' THR . 4.5 pp -48.39 140.28 7.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.957 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.465 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.1 OUTLIER -150.69 50.23 0.69 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 120.893 0.377 . . . . 0.0 110.893 -179.949 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 71.6 Cg_endo -76.79 -31.29 4.13 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.657 2.238 . . . . 0.0 112.647 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.711 HD23 HD23 ' B' ' 541' ' ' LEU . 0.1 OUTLIER -66.98 -25.19 66.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.842 0.354 . . . . 0.0 110.663 -179.914 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.416 ' OG ' ' CE2' ' A' ' 72' ' ' TYR . 13.9 t -59.89 -70.59 0.16 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.942 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.416 ' CE2' ' OG ' ' A' ' 71' ' ' SER . 3.5 m-85 -123.94 67.57 42.81 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.908 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.08 140.39 31.17 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.619 2.213 . . . . 0.0 112.282 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 9.8 tp60 -101.62 10.39 40.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.451 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 84.6 m -75.87 124.61 27.61 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.811 0.338 . . . . 0.0 110.982 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -79.3 -18.32 52.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.156 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.4 t -103.71 78.91 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.224 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.669 ' CE2' HG21 ' A' ' 108' ' ' THR . 15.4 m-85 -83.19 175.15 10.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.751 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.4 HD12 ' O ' ' A' ' 111' ' ' LEU . 19.3 tp -147.63 108.9 4.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.99 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.658 ' O ' HG23 ' A' ' 80' ' ' VAL . 35.3 m -113.32 100.17 10.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.864 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.544 ' HB2' HG22 ' A' ' 14' ' ' VAL . 68.7 m -94.51 173.56 7.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.419 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.701 ' CE1' HG21 ' A' ' 137' ' ' ILE . 8.6 p90 -175.19 142.14 0.6 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.26 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.481 ' HA ' ' N2 ' ' A' ' 185' ' ' GNP . 5.4 m -83.31 155.83 23.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.088 0.471 . . . . 0.0 111.543 -179.341 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.784 HG21 ' HA ' ' A' ' 117' ' ' ILE . 15.9 t -55.01 -51.71 51.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.518 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.869 HG13 ' HD3' ' A' ' 120' ' ' ARG . 1.9 m -47.58 117.01 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.059 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -151.43 117.86 3.23 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.438 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.423 ' O ' ' CB ' ' A' ' 88' ' ' SER . 78.3 Cg_endo -90.38 49.68 0.95 Allowed 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.981 2.454 . . . . 0.0 111.969 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.466 ' CB ' ' HG2' ' A' ' 133' ' ' LYS . 0.1 OUTLIER 81.56 28.34 0.17 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.694 -179.525 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.517 ' O ' HG23 ' A' ' 93' ' ' VAL . 95.2 p -90.04 -15.94 30.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.256 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.649 ' CE1' HD12 ' A' ' 145' ' ' LEU . 0.1 OUTLIER -46.29 -51.31 14.81 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.799 0.333 . . . . 0.0 111.157 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -62.46 -36.41 82.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.822 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -72.63 -57.89 3.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.693 HG13 ' CE2' ' A' ' 97' ' ' TRP . 24.2 t -52.11 -45.48 42.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.059 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.722 ' HG3' HD11 ' A' ' 145' ' ' LEU . 0.3 OUTLIER -59.72 -50.49 73.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.811 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.408 ' O ' ' HG3' ' A' ' 99' ' ' PRO . 4.2 mt-10 -82.87 6.9 16.9 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.633 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -117.15 -30.66 5.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.804 0.335 . . . . 0.0 110.971 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.693 ' CE2' HG13 ' A' ' 93' ' ' VAL . 23.3 m0 -94.01 -51.94 4.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.176 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.474 ' HB ' ' HD3' ' A' ' 99' ' ' PRO . 85.5 t -50.5 -57.6 12.62 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.612 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.474 ' HD3' ' HB ' ' A' ' 98' ' ' VAL . 29.8 Cg_endo -62.89 -15.51 47.88 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.197 1.931 . . . . 0.0 112.422 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -89.97 -54.48 4.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.878 0.37 . . . . 0.0 110.728 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.9 tt -55.17 -30.33 24.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.9 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.747 HG22 ' HA ' ' A' ' 107' ' ' LYS . 11.2 p -85.91 -25.29 26.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.774 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -60.71 -51.04 71.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.667 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 28.4 m80 -60.99 -38.53 86.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.69 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -137.53 126.52 14.91 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.734 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -49.79 89.14 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.461 2.108 . . . . 0.0 112.248 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.747 ' HA ' HG22 ' A' ' 102' ' ' THR . 12.3 mttp 61.9 106.38 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.769 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.669 HG21 ' CE2' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -127.95 137.19 30.27 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.9 -179.944 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 108' ' ' THR . 36.2 Cg_exo -60.24 156.02 42.67 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.485 2.123 . . . . 0.0 112.478 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.766 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 1.9 p90 -158.72 148.77 19.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.75 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.803 HD11 ' HB3' ' A' ' 171' ' ' GLU . 0.5 OUTLIER -111.18 148.54 32.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.482 -179.434 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 1.018 HD12 ' HB2' ' A' ' 146' ' ' ALA . 11.6 mt -103.98 158.07 16.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.824 179.124 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.756 HG13 HG11 ' A' ' 168' ' ' VAL . 14.3 t -146.1 150.73 15.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.399 0.619 . . . . 0.0 112.445 -179.294 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -131.31 124.65 4.17 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.86 179.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.851 ' OG1' " H2'" ' A' ' 185' ' ' GNP . 0.9 OUTLIER -140.68 -58.51 0.52 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.908 0.354 . . . . 0.0 111.761 -178.694 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.445 ' HB3' ' CG ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -53.78 -21.84 8.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.853 0.358 . . . . 0.0 110.922 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.784 ' HA ' HG21 ' A' ' 84' ' ' VAL . 0.3 OUTLIER -41.81 -29.13 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.217 -179.859 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.641 ' CG ' HG21 ' A' ' 161' ' ' THR . 12.2 t70 -63.81 -43.16 97.09 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -178.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 1.002 HD21 HD22 ' A' ' 160' ' ' LEU . 0.3 OUTLIER -118.47 14.71 13.73 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -178.537 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.869 ' HD3' HG13 ' A' ' 85' ' ' VAL . 0.8 OUTLIER -87.18 -20.32 27.15 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.096 179.585 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.01 -18.59 35.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.85 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -46.1 122.27 6.24 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.049 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.441 ' HA ' ' CG2' ' A' ' 126' ' ' ILE . 14.0 Cg_exo -68.74 -3.52 11.43 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.576 2.184 . . . . 0.0 113.028 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 29.8 t -76.85 -71.18 0.41 Allowed 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.027 0.441 . . . . 0.0 110.247 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.697 HG21 HG11 ' A' ' 85' ' ' VAL . 95.0 m -55.68 -35.15 65.71 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.838 ' HA ' HD12 ' A' ' 129' ' ' LEU . 0.1 OUTLIER -56.68 -39.18 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.722 179.087 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.472 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 19.5 mt-10 -64.04 -31.9 73.26 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.31 178.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.479 ' O ' ' HG3' ' A' ' 131' ' ' LYS . 0.0 OUTLIER -69.69 -24.79 63.64 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.843 178.92 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.838 HD12 ' HA ' ' A' ' 126' ' ' ILE . 3.2 mt -85.02 -28.86 25.43 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 177.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' A' ' 127' ' ' GLU . . . -48.0 -39.87 20.91 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.501 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.479 ' HG3' ' O ' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -44.85 -28.75 0.69 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.884 0.373 . . . . 0.0 110.724 179.882 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.462 ' N ' ' HD2' ' A' ' 131' ' ' LYS . 52.9 m-20 -123.55 -32.03 3.41 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.391 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.512 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 52.1 mmtt -151.25 -92.73 0.06 Allowed 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.512 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 6.5 pt20 120.09 -18.09 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.783 1.233 . . . . 0.0 110.821 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.99 111.15 7.55 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.215 -0.448 . . . . 0.0 112.204 -178.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.686 ' HB3' HD11 ' A' ' 126' ' ' ILE . 96.8 Cg_endo -79.61 129.89 8.55 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.645 2.23 . . . . 0.0 111.503 179.091 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.722 ' N ' HD13 ' A' ' 137' ' ' ILE . 0.8 OUTLIER -58.57 96.64 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.014 0.435 . . . . 0.0 111.616 -179.331 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 16.5 p -69.32 151.61 96.84 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.462 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.496 ' HA ' ' CE1' ' A' ' 154' ' ' TYR . 4.2 Cg_endo -47.06 -25.07 3.8 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 122.809 2.339 . . . . 0.0 112.33 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -81.38 -38.66 26.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.12 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.38 -54.2 49.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.138 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.416 ' CB ' ' CD2' ' A' ' 154' ' ' TYR . . . -47.85 -43.43 28.3 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.884 0.373 . . . . 0.0 110.99 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -59.44 -40.25 86.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.589 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -55.03 -55.81 26.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.59 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.722 HD11 ' HG3' ' A' ' 94' ' ' LYS . 0.4 OUTLIER -67.73 -29.14 68.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.492 179.701 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 1.018 ' HB2' HD12 ' A' ' 112' ' ' LEU . . . -65.41 -41.24 93.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.793 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 9.0 mtp180 -85.63 -25.89 26.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.678 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -52.37 -32.62 39.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.739 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 3.5 mt -119.8 19.7 12.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.057 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 6.3 mttp 48.46 47.46 20.17 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.202 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.766 ' HB1' ' O ' ' A' ' 110' ' ' PHE . . . -63.98 -81.51 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.879 0.371 . . . . 0.0 110.865 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 151' ' ' ALA . 70.3 t -160.56 -75.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.778 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.596 ' O ' HD21 ' A' ' 111' ' ' LEU . 7.0 tppt? 173.65 116.91 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.278 -179.238 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.496 ' CE1' ' HA ' ' A' ' 139' ' ' PRO . 5.6 t80 -81.4 116.08 21.05 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.467 HG12 ' N ' ' A' ' 156' ' ' GLU . 12.9 t -101.4 159.35 4.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.451 -179.371 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.467 ' N ' HG12 ' A' ' 155' ' ' VAL . 3.6 mp0 -89.9 139.84 30.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.129 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.752 ' O ' HD11 ' A' ' 117' ' ' ILE . 3.3 p 178.71 -174.54 0.18 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.416 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.475 ' HA ' ' HA ' ' A' ' 115' ' ' THR . 24.3 p -159.99 167.87 26.95 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.937 0.399 . . . . 0.0 111.164 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -116.6 -46.11 2.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.585 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 1.002 HD22 HD21 ' A' ' 119' ' ' LEU . 0.7 OUTLIER -63.81 -33.25 75.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.402 179.557 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.641 HG21 ' CG ' ' A' ' 118' ' ' ASP . 1.3 p -113.0 -22.83 10.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.807 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.415 ' N ' ' OG ' ' A' ' 158' ' ' SER . 1.3 tt0 74.58 71.81 0.1 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.022 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.43 ' N ' ' OG ' ' A' ' 158' ' ' SER . 0.2 OUTLIER -93.96 13.63 22.2 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.501 -179.816 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 121.08 34.48 0.89 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.345 -0.931 . . . . 0.0 113.2 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.745 HD13 ' HA ' ' A' ' 19' ' ' LEU . 0.5 OUTLIER -49.58 -27.79 4.92 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.956 0.408 . . . . 0.0 110.515 179.697 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.421 ' HE2' ' N ' ' A' ' 167' ' ' ASN . 0.0 OUTLIER -73.67 -34.16 64.78 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.626 179.568 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.421 ' N ' ' HE2' ' A' ' 166' ' ' LYS . 0.6 OUTLIER -56.58 -67.61 0.29 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.421 179.601 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.756 HG11 HG13 ' A' ' 113' ' ' VAL . 14.2 p -50.63 -46.31 27.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.33 179.36 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.984 ' CE1' HD23 ' A' ' 19' ' ' LEU . 1.9 t80 -61.9 -31.26 71.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.732 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.412 ' N ' ' O ' ' A' ' 166' ' ' LYS . 4.6 t0 -57.42 -39.97 77.31 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.514 178.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.803 ' HB3' HD11 ' A' ' 111' ' ' LEU . 5.0 mm-40 -66.72 -35.35 79.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.612 178.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.466 ' HA ' HD12 ' A' ' 111' ' ' LEU . . . -59.83 -29.93 68.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.739 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.919 HD13 ' N ' ' A' ' 174' ' ' LEU . 0.0 OUTLIER -94.11 -43.88 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.438 179.633 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 1.027 HD23 HD13 ' B' ' 505' ' ' LEU . 3.5 tm? -52.75 -27.79 19.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.953 0.406 . . . . 0.0 110.363 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -72.04 -29.78 64.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.744 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.849 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -80.84 -37.15 30.51 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.738 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.721 HD13 ' HB ' ' B' ' 510' ' ' ILE . 58.8 mt -70.76 -24.53 62.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.635 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 29.1 tp10 -165.2 137.05 3.33 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.526 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -49.8 141.65 27.58 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.376 2.05 . . . . 0.0 112.347 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.89 171.4 18.36 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.548 2.166 . . . . 0.0 112.222 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -154.24 151.31 24.0 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.055 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.48 -164.73 0.23 Allowed 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.669 2.246 . . . . 0.0 112.271 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 8.0 pttp -87.51 152.21 22.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.863 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.188 -0.911 . . . . 0.0 110.909 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.17 0 N-CA-C 112.449 -0.26 . . . . 0.0 112.449 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 503' ' ' SER . . . . . . . . . . . . . 75.3 m -96.18 -78.52 0.46 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.889 0.376 . . . . 0.0 110.857 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 504' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' B' ' 509' ' ' ASP . . . 81.12 106.32 0.32 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.515 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 505' ' ' LEU . . . . . 1.027 HD13 HD23 ' A' ' 174' ' ' LEU . 0.1 OUTLIER -166.58 99.27 0.58 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.93 0.395 . . . . 0.0 111.063 -179.947 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 506' ' ' SER . . . . . . . . . . . . . 13.3 p 59.76 -170.95 0.13 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.005 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 507' ' ' ALA . . . . . . . . . . . . . . . 59.31 -93.21 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.725 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 508' ' ' GLN . . . . . 0.426 ' O ' ' CB ' ' B' ' 509' ' ' ASP . 56.9 mt-30 -141.29 4.84 1.83 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.048 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 509' ' ' ASP . . . . . 0.426 ' CB ' ' O ' ' B' ' 508' ' ' GLN . 8.5 t70 81.83 35.39 0.08 Allowed 'General case' 0 C--N 1.341 0.238 0 CA-C-O 121.371 0.605 . . . . 0.0 109.704 -178.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 510' ' ' ILE . . . . . 0.721 ' HB ' HD13 ' A' ' 177' ' ' LEU . 87.4 mt -64.84 156.14 5.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.579 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 511' ' ' SER . . . . . 0.472 ' HB3' HD21 ' B' ' 514' ' ' LEU . 8.7 t -109.54 167.39 10.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.098 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 512' ' ' GLN . . . . . 0.491 ' CB ' ' CD ' ' B' ' 513' ' ' PRO . 18.2 tt0 -114.2 -71.81 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.205 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 513' ' ' PRO . . . . . 0.491 ' CD ' ' CB ' ' B' ' 512' ' ' GLN . 93.5 Cg_endo -78.85 59.81 7.47 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.207 1.938 . . . . 0.0 111.29 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 514' ' ' LEU . . . . . 0.73 HD11 ' HA ' ' A' ' 46' ' ' ILE . 4.9 mt -53.31 -89.02 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.826 -178.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 515' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -92.99 -86.55 0.25 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.666 0.269 . . . . 0.0 111.255 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -127.57 -36.99 2.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.23 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 517' ' ' SER . . . . . 0.589 ' C ' HG12 ' A' ' 42' ' ' VAL . 6.4 m 72.01 22.8 3.64 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.047 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 518' ' ' PHE . . . . . 0.485 ' CD1' ' O ' ' B' ' 517' ' ' SER . 23.7 m-85 -140.99 91.79 2.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.79 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 519' ' ' ILE . . . . . 0.539 HD11 ' H ' ' A' ' 43' ' ' THR . 7.3 mm -88.89 -11.06 10.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.667 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 72.56 104.75 0.07 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.84 0.353 . . . . 0.0 110.925 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 521' ' ' THR . . . . . . . . . . . . . 1.4 m -160.91 106.5 1.41 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.818 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 522' ' ' GLY . . . . . 0.473 ' O ' ' CZ ' ' A' ' 37' ' ' PHE . . . 143.2 178.67 19.24 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.349 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 523' ' ' HIS . . . . . . . . . . . . . 30.8 t-80 -104.71 -83.42 0.5 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.745 0.307 . . . . 0.0 110.867 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 524' ' ' GLY . . . . . 0.482 ' HA3' HG23 ' A' ' 36' ' ' VAL . . . 49.68 -118.65 5.76 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.638 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 525' ' ' ASP . . . . . . . . . . . . . 1.2 p30 53.41 28.53 7.61 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 121.071 0.463 . . . . 0.0 110.498 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 526' ' ' SER . . . . . 0.544 ' OG ' HD22 ' A' ' 61' ' ' LEU . 3.9 m -57.15 100.1 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.207 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 527' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -37.44 162.08 0.05 OUTLIER Pre-proline 0 N--CA 1.467 0.381 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.227 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -53.75 104.79 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.195 2.597 . . . . 0.0 112.299 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 529' ' ' ARG . . . . . . . . . . . . . 2.3 mtt-85 -100.7 -42.42 6.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.073 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 530' ' ' HIS . . . . . 0.408 ' HB2' ' CB ' ' B' ' 545' ' ' ASN . 1.4 m-70 -153.32 -44.02 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.878 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 3.6 m 70.36 -160.53 0.15 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.876 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 532' ' ' TRP . . . . . . . . . . . . . 22.9 t90 -46.19 -65.0 0.62 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.159 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . 59.71 -87.13 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.622 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 534' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -116.56 152.67 48.52 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.698 0.285 . . . . 0.0 111.018 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -55.56 176.59 0.15 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.65 2.233 . . . . 0.0 112.456 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 59.92 92.86 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.082 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 537' ' ' ARG . . . . . 0.402 ' HB2' ' O ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER -73.46 151.06 41.22 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.13 0.491 . . . . 0.0 110.844 179.829 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 538' ' ' ILE . . . . . 0.482 HG13 ' HB2' ' B' ' 542' ' ' TYR . 10.2 tp -61.18 157.22 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.262 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 539' ' ' ASP . . . . . 0.412 ' N ' HG13 ' B' ' 538' ' ' ILE . 2.3 m-20 -61.33 162.16 8.15 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.051 0.453 . . . . 0.0 111.126 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 540' ' ' GLU . . . . . 0.487 ' CG ' ' HB ' ' A' ' 8' ' ' VAL . 0.3 OUTLIER -48.22 -50.14 30.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.854 -179.633 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 541' ' ' LEU . . . . . 0.711 HD23 HD23 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -39.99 -32.51 0.16 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.324 0.583 . . . . 0.0 111.063 -179.496 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 542' ' ' TYR . . . . . 0.482 ' HB2' HG13 ' B' ' 538' ' ' ILE . 35.3 m-85 -104.45 -59.21 1.77 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.896 -179.401 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 543' ' ' LEU . . . . . 0.661 HD23 HG23 ' A' ' 35' ' ' THR . 2.0 tp 66.47 -67.68 0.15 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.061 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 544' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' B' ' 542' ' ' TYR . . . -89.02 139.41 15.25 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.485 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 545' ' ' ASN . . . . . 0.408 ' CB ' ' HB2' ' B' ' 530' ' ' HIS . 1.2 m-80 . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.945 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 185' ' ' GNP . . . . . 0.891 ' PA ' ' HB1' ' A' ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.819 ' CE ' HG23 ' A' ' 46' ' ' ILE . 1.3 tmt? . . . . . 0 N--CA 1.487 1.42 0 CA-C-O 120.84 0.352 . . . . 0.0 111.03 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 73.32 121.13 0.04 OUTLIER 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.994 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.797 HG22 ' HB2' ' A' ' 53' ' ' LEU . 0.3 OUTLIER -93.26 170.09 9.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.719 -179.345 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.779 ' O ' HD23 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -152.71 162.49 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -178.92 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.4 127.91 40.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.945 179.219 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 43.6 t -116.54 153.42 32.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.069 0.461 . . . . 0.0 111.906 -179.158 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.632 HG13 ' O ' ' A' ' 56' ' ' PHE . 1.7 t -151.11 159.51 4.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.408 179.448 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.873 HG13 ' HG3' ' B' ' 540' ' ' GLU . 0.9 OUTLIER -110.91 155.77 12.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.323 0.582 . . . . 0.0 111.329 -179.848 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.764 HG13 HD13 ' A' ' 70' ' ' LEU . 66.9 t -159.17 129.91 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.042 179.332 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 138.44 -149.06 20.35 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.183 -1.008 . . . . 0.0 112.861 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' B' ' 537' ' ' ARG . 0.4 OUTLIER -110.8 27.15 9.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.938 0.399 . . . . 0.0 110.74 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -134.68 174.26 21.12 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.439 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.431 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -80.97 -57.63 3.45 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 123.063 -0.081 . . . . 0.0 111.195 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.874 HG21 HD22 ' A' ' 79' ' ' LEU . 13.8 p 23.96 44.61 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 13' ' ' ALA . . . -125.39 -178.26 15.24 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.58 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.481 ' HG3' HD23 ' A' ' 55' ' ' LEU . 1.3 tmpt? -59.71 -17.68 36.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.585 0.231 . . . . 0.0 111.199 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.822 HG21 ' OG1' ' A' ' 35' ' ' THR . 34.1 p -79.58 -70.88 0.48 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.804 0.335 . . . . 0.0 111.463 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.418 ' N ' ' OG1' ' A' ' 17' ' ' THR . 16.5 t -62.49 -57.9 9.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.958 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.84 ' O ' HD13 ' A' ' 165' ' ' LEU . 18.7 mt -47.87 -71.76 0.06 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -178.436 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.432 ' N ' ' CD2' ' A' ' 20' ' ' LEU . 2.5 mm? -56.74 -60.18 3.93 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -178.318 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.524 HG22 ' OG1' ' A' ' 25' ' ' THR . 50.0 mm -48.2 -70.52 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 120.936 -0.305 . . . . 0.0 111.189 -179.424 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.43 ' CB ' ' HB1' ' A' ' 159' ' ' ALA . 19.7 m -42.2 -29.3 0.24 Allowed 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 111.582 0.215 . . . . 0.0 111.582 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.497 ' CZ ' ' HG2' ' A' ' 166' ' ' LYS . 17.5 t80 -81.45 -68.72 0.67 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.856 0.36 . . . . 0.0 110.804 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.649 HG23 HG23 ' A' ' 25' ' ' THR . 10.8 t -58.87 -46.75 87.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.128 0.489 . . . . 0.0 110.583 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.649 HG23 HG23 ' A' ' 24' ' ' THR . 18.7 p -86.42 -153.46 0.2 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.431 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -150.03 55.5 0.94 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.658 0.266 . . . . 0.0 110.985 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.7 mttt -144.22 157.56 44.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.927 0.394 . . . . 0.0 111.252 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.497 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . 0.5 OUTLIER -163.17 -64.64 0.01 OUTLIER Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.481 179.698 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.497 ' HD3' ' HB3' ' A' ' 28' ' ' PHE . 87.5 Cg_endo -81.77 57.87 6.51 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.62 2.213 . . . . 0.0 112.841 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.407 ' O ' ' N ' ' B' ' 532' ' ' TRP . 0.4 OUTLIER -131.45 -89.39 0.45 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.906 179.844 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.71 116.08 2.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.364 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.502 ' CD2' ' O2B' ' A' ' 185' ' ' GNP . 18.6 m-85 -111.17 92.39 4.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.078 0.466 . . . . 0.0 111.188 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.787 HG21 ' O ' ' B' ' 527' ' ' ASP . 2.8 t -105.69 -33.55 0.19 Allowed Pre-proline 0 CA--C 1.544 0.731 0 N-CA-C 114.174 1.175 . . . . 0.0 114.174 -179.073 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.496 ' CD ' ' N ' ' A' ' 33' ' ' VAL . 46.6 Cg_exo -40.44 -26.5 0.22 Allowed 'Trans proline' 0 C--N 1.357 1.022 0 C-N-CA 122.361 2.041 . . . . 0.0 113.965 -178.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.955 HG21 ' CD2' ' B' ' 543' ' ' LEU . 51.4 m -54.07 88.38 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.625 0.25 . . . . 0.0 111.041 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.726 ' HB ' HD13 ' A' ' 61' ' ' LEU . 7.6 p 171.2 -32.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.7 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.409 ' CD2' ' HA3' ' B' ' 522' ' ' GLY . 0.2 OUTLIER -108.06 23.44 14.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.904 179.921 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -61.23 -16.69 47.87 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.271 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -45.54 -27.25 0.71 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.717 0.294 . . . . 0.0 111.516 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.44 ' OH ' ' CE1' ' B' ' 518' ' ' PHE . 2.7 p90 -60.27 142.53 54.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.93 0.395 . . . . 0.0 110.72 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.749 ' O ' HD12 ' B' ' 519' ' ' ILE . . . -91.17 -178.75 5.25 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.972 -179.205 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 42' ' ' VAL . 18.3 m -131.31 121.28 48.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.441 178.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.461 HG23 ' O ' ' A' ' 43' ' ' THR . 5.0 t -86.24 104.61 15.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.422 -179.242 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.472 HG12 ' HB2' ' B' ' 515' ' ' GLN . 29.5 m -161.23 144.3 4.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.177 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.91 ' O ' HD22 ' B' ' 514' ' ' LEU . 0.0 OUTLIER -77.55 96.4 4.76 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.428 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.852 ' CG1' HG23 ' B' ' 510' ' ' ILE . 5.9 tt -97.29 96.11 5.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.285 -179.125 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.481 ' N ' ' HE2' ' A' ' 45' ' ' MET . . . 101.91 -108.53 3.39 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.378 -0.828 . . . . 0.0 112.937 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.445 ' N ' ' HE1' ' A' ' 45' ' ' MET . . . -118.11 -22.78 3.75 Favored Glycine 0 CA--C 1.521 0.419 0 C-N-CA 120.511 -0.852 . . . . 0.0 113.375 -179.637 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.554 ' N ' ' HE1' ' A' ' 45' ' ' MET . 2.0 mt-10 -117.4 132.54 23.5 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.995 0.398 . . . . 0.0 111.148 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.479 ' HA ' ' HA ' ' A' ' 45' ' ' MET . 42.9 Cg_endo -68.65 90.26 0.42 Allowed 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.853 2.369 . . . . 0.0 113.839 -179.225 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.528 ' CD1' ' O ' ' A' ' 51' ' ' TYR . 2.3 p90 -173.41 132.18 0.47 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.728 178.245 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.603 HG23 ' CG2' ' A' ' 46' ' ' ILE . 0.1 OUTLIER -129.91 141.51 50.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.027 0.441 . . . . 0.0 111.354 -179.046 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.797 ' HB2' HG22 ' A' ' 3' ' ' THR . 2.1 tp -89.18 148.58 23.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.838 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -87.3 178.97 47.98 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.213 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.718 HD22 ' N ' ' A' ' 55' ' ' LEU . 0.4 OUTLIER -112.3 136.62 51.52 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.73 0.3 . . . . 0.0 110.54 179.758 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.632 ' O ' HG13 ' A' ' 7' ' ' VAL . 0.3 OUTLIER -84.38 116.34 22.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.918 -179.654 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.409 ' OD2' ' N ' ' A' ' 36' ' ' VAL . 16.0 p-10 -119.3 167.74 11.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.057 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.747 ' CB ' HD22 ' A' ' 67' ' ' LEU . 0.6 OUTLIER -154.22 139.92 18.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.984 -179.826 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -171.07 136.08 1.05 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.807 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.77 73.1 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.613 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.726 HD13 ' HB ' ' A' ' 36' ' ' VAL . 0.3 OUTLIER -121.17 -175.41 3.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.918 0.389 . . . . 0.0 111.022 179.957 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -49.76 -39.51 37.92 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.028 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.43 ' HB3' ' CG2' ' A' ' 36' ' ' VAL . 11.2 t0 -64.11 -62.7 1.46 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.102 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.937 ' CD2' HD21 ' A' ' 67' ' ' LEU . 0.5 OUTLIER -120.07 140.53 50.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.78 -179.802 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.85 -69.08 0.7 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -179.464 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.431 ' O ' ' HB2' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -98.65 -46.51 5.68 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 -178.939 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.937 HD21 ' CD2' ' A' ' 64' ' ' TYR . 1.2 mp 69.37 131.43 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.06 -179.214 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.546 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 6.9 mtp180 -130.38 36.59 0.35 Allowed Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.961 178.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.546 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 61.1 Cg_endo -84.23 -39.93 0.1 Allowed 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 122.122 1.881 . . . . 0.0 112.044 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.877 HD23 ' HB2' ' B' ' 541' ' ' LEU . 0.1 OUTLIER -83.98 -7.84 59.31 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.156 -179.802 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.9 t -49.07 -64.11 0.9 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.745 0.307 . . . . 0.0 111.026 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -159.0 55.83 0.85 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.086 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.0 160.86 46.48 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.532 2.155 . . . . 0.0 112.209 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.05 10.24 34.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.462 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.47 ' O ' HG22 ' A' ' 108' ' ' THR . 69.3 m -50.73 117.86 2.75 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.828 0.347 . . . . 0.0 110.907 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -76.12 -20.07 57.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.061 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.835 HG21 ' HB2' ' A' ' 176' ' ' ALA . 43.1 t -103.93 72.53 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.897 0.379 . . . . 0.0 111.18 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.402 ' CE2' HG21 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -80.82 172.54 13.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.559 179.822 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.874 HD22 HG21 ' A' ' 14' ' ' VAL . 1.2 tt -152.61 108.73 3.37 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.853 0.359 . . . . 0.0 111.147 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.572 ' CG2' HD22 ' A' ' 112' ' ' LEU . 2.8 m -93.1 133.1 35.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.701 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.501 ' SG ' HG12 ' A' ' 14' ' ' VAL . 1.2 p -119.17 138.16 53.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.092 0.472 . . . . 0.0 111.36 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.438 ' O ' ' C2 ' ' A' ' 185' ' ' GNP . 39.5 p90 -135.26 -174.12 3.53 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.008 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.1 m -145.81 139.08 26.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.745 0.307 . . . . 0.0 110.797 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.804 HG21 ' HA ' ' A' ' 117' ' ' ILE . 60.1 t -53.67 -67.6 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.302 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.853 HG22 ' OE1' ' A' ' 116' ' ' GLN . 34.9 m -48.62 108.65 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.737 0.304 . . . . 0.0 110.725 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.589 ' N ' HD22 ' A' ' 129' ' ' LEU . 0.3 OUTLIER -151.55 128.9 5.62 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.687 -179.41 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 86' ' ' SER . 74.0 Cg_endo -92.56 53.36 0.56 Allowed 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 123.272 2.648 . . . . 0.0 111.723 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.43 ' CA ' ' HG3' ' A' ' 133' ' ' LYS . 0.1 OUTLIER 81.95 39.21 0.05 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.823 -179.415 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.873 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -97.25 -34.89 10.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.804 179.862 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -51.83 -37.95 53.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.827 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -50.81 -57.41 8.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.661 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.427 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 4.1 p-10 -74.93 -43.57 53.44 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.676 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.873 HG23 ' O ' ' A' ' 89' ' ' SER . 57.4 t -52.31 -31.61 15.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.991 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.622 ' O ' HG23 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -79.09 -50.92 10.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.915 -179.967 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.405 ' O ' ' HG3' ' A' ' 99' ' ' PRO . 25.2 mt-10 -82.75 6.31 18.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.648 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.427 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.6 OUTLIER -115.13 -27.81 7.18 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.754 0.312 . . . . 0.0 111.063 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.809 ' CE2' HG13 ' A' ' 93' ' ' VAL . 38.1 m0 -91.59 -44.81 8.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.02 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.622 HG23 ' O ' ' A' ' 94' ' ' LYS . 64.4 t -53.48 -46.03 98.29 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.792 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 97.4 Cg_endo -80.61 -15.22 11.08 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.334 2.023 . . . . 0.0 112.781 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -85.8 -36.14 20.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.948 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.41 HG13 ' N ' ' A' ' 102' ' ' THR . 13.8 pt -79.14 -25.53 12.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.104 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.41 ' N ' HG13 ' A' ' 101' ' ' ILE . 47.8 p -89.42 -31.63 17.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.038 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.403 ' HB2' ' O ' ' A' ' 99' ' ' PRO . 74.5 t60 -72.8 -54.97 7.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.065 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -71.07 -25.84 62.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.047 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.416 ' HB2' ' OG1' ' A' ' 108' ' ' THR . 28.5 m -132.31 95.37 21.21 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.9 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -50.2 110.69 0.41 Allowed 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.573 2.182 . . . . 0.0 112.263 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 7.6 mmpt? 50.8 92.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.906 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.47 HG22 ' O ' ' A' ' 75' ' ' THR . 0.2 OUTLIER -133.59 113.04 12.92 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.85 179.95 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.401 ' O ' ' HB2' ' A' ' 78' ' ' PHE . 31.3 Cg_exo -60.15 133.62 51.02 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.584 2.189 . . . . 0.0 112.446 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.517 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 0.8 OUTLIER -134.92 142.81 46.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.96 179.923 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.98 HD12 HG11 ' A' ' 152' ' ' VAL . 5.0 tt -110.92 141.45 44.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.197 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.795 ' O ' HD23 ' A' ' 111' ' ' LEU . 3.6 mm? -89.8 158.38 17.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.627 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.74 HG23 ' O6 ' ' A' ' 185' ' ' GNP . 0.0 OUTLIER -137.84 150.42 25.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.123 0.487 . . . . 0.0 111.804 -179.554 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -129.59 134.92 8.12 Favored Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.525 179.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.818 ' OG1' " H2'" ' A' ' 185' ' ' GNP . 0.0 OUTLIER -155.28 -41.49 0.08 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.859 0.33 . . . . 0.0 111.088 -179.279 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.853 ' OE1' HG22 ' A' ' 85' ' ' VAL . 10.5 tt0 -71.87 -9.09 57.82 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.322 178.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.804 ' HA ' HG21 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -54.39 -20.79 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.689 -179.848 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -75.55 -35.54 60.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.383 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.617 HD21 ' HG3' ' A' ' 116' ' ' GLN . 4.3 pp -97.02 14.21 26.38 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.626 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.676 ' CB ' HG11 ' A' ' 84' ' ' VAL . 37.4 ptt85 -68.05 -27.29 66.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.951 0.405 . . . . 0.0 110.329 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -72.63 -25.68 61.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.827 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.408 ' O ' ' HB ' ' A' ' 126' ' ' ILE . 9.2 t70 -47.58 101.63 0.27 Allowed Pre-proline 0 C--N 1.332 -0.169 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.703 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -67.83 -5.85 15.46 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.745 2.297 . . . . 0.0 113.049 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.46 -65.45 1.01 Allowed 'General case' 0 C--O 1.234 0.261 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.536 HG21 HG11 ' A' ' 85' ' ' VAL . 5.0 m -55.43 -38.94 69.65 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.662 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.46 HG13 HD12 ' A' ' 129' ' ' LEU . 0.1 OUTLIER -55.53 -47.41 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.713 179.179 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.538 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 2.7 mm-40 -53.47 -35.77 60.91 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.02 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.407 ' HB2' ' O ' ' A' ' 125' ' ' THR . 1.7 mptp? -66.82 -32.09 73.14 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.589 HD22 ' N ' ' A' ' 86' ' ' SER . 6.2 mt -74.44 -36.8 63.39 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 177.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.538 ' HB3' ' O ' ' A' ' 127' ' ' GLU . . . -43.98 -42.47 6.02 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.374 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.97 -26.38 10.41 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.365 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.401 ' OD1' ' HB2' ' A' ' 87' ' ' PRO . 29.5 m120 -124.61 -31.55 3.21 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -179.309 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.442 ' O ' ' HB2' ' A' ' 134' ' ' GLN . 6.4 mmpt? -152.06 -63.88 0.17 Allowed 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 -178.653 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.532 ' HG3' ' HB2' ' A' ' 130' ' ' ALA . 2.0 tt0 81.18 15.94 0.56 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.695 0.283 . . . . 0.0 110.97 -178.035 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 51.6 mttm -101.17 88.66 1.13 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.97 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' ' 134' ' ' GLN . 32.8 Cg_endo -63.93 124.94 14.36 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.449 2.1 . . . . 0.0 111.859 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.688 ' N ' HD13 ' A' ' 137' ' ' ILE . 1.3 mm -60.14 97.25 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.106 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.9 p -74.34 153.83 88.05 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.807 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -47.14 -36.19 21.09 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.607 2.205 . . . . 0.0 112.324 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -67.9 -28.33 67.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.859 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.401 HG21 HG23 ' A' ' 137' ' ' ILE . 87.4 m -66.23 -53.55 35.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.841 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.557 ' HB3' ' CE2' ' A' ' 154' ' ' TYR . . . -57.7 -36.66 72.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.898 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.98 -39.95 95.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.704 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 43.9 mttt -65.16 -51.61 60.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.862 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.508 HD23 ' O ' ' A' ' 145' ' ' LEU . 0.9 OUTLIER -67.16 -40.24 86.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.803 -179.995 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -55.62 -44.81 77.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.037 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.25 -24.52 27.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.874 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -53.69 -31.57 48.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.855 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.1 mt -119.3 19.62 12.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.154 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 29.1 mmtm 48.06 42.42 16.85 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.784 0.326 . . . . 0.0 111.095 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.555 ' O ' HG23 ' A' ' 152' ' ' VAL . . . -58.18 -81.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.913 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.98 HG11 HD12 ' A' ' 111' ' ' LEU . 47.6 t -160.73 -74.67 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.747 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 179.51 128.03 0.08 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.24 -179.057 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.557 ' CE2' ' HB3' ' A' ' 142' ' ' ALA . 38.3 t80 -100.19 112.49 24.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.755 178.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 2.8 t -101.52 154.58 4.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.416 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -90.55 120.13 31.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.94 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.41 ' HA ' ' HB3' ' A' ' 163' ' ' LYS . 35.3 m -156.79 175.57 13.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.588 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.461 ' HA ' ' HA ' ' A' ' 115' ' ' THR . 4.6 t -158.07 145.16 17.96 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.089 0.471 . . . . 0.0 111.849 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.43 ' HB1' ' CB ' ' A' ' 22' ' ' SER . . . -104.72 -44.03 4.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.34 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.492 ' HB3' ' CE2' ' A' ' 28' ' ' PHE . 0.9 OUTLIER -62.94 -33.16 74.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.268 179.503 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -106.54 -21.74 12.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.565 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 77.9 60.48 0.03 OUTLIER 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.317 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.451 ' HB2' ' CB ' ' A' ' 158' ' ' SER . 0.5 OUTLIER -91.88 41.94 1.09 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.688 179.538 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.415 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . 104.09 -66.04 0.32 Allowed Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.719 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.84 HD13 ' O ' ' A' ' 19' ' ' LEU . 0.5 OUTLIER 66.04 -66.77 0.16 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.724 0.297 . . . . 0.0 111.308 -179.914 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.497 ' HG2' ' CZ ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -50.09 -26.22 4.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.807 0.337 . . . . 0.0 110.872 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.414 ' O ' ' HB2' ' A' ' 170' ' ' ASP . 0.4 OUTLIER -62.22 -69.05 0.27 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.425 -179.733 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.545 HG13 ' N ' ' A' ' 169' ' ' PHE . 14.0 p -54.41 -47.12 70.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.094 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.788 ' CD1' HD13 ' A' ' 19' ' ' LEU . 1.7 t80 -60.73 -31.86 71.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.338 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.766 ' O ' HD13 ' A' ' 173' ' ' ILE . 0.3 OUTLIER -62.48 -36.43 82.48 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.775 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -69.14 -28.77 66.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.633 178.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.61 ' HA ' HD13 ' A' ' 111' ' ' LEU . . . -61.04 -51.47 69.04 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.221 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.766 HD13 ' O ' ' A' ' 170' ' ' ASP . 0.1 OUTLIER -83.33 -23.65 8.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.031 -179.767 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.784 HD23 HD23 ' B' ' 505' ' ' LEU . 3.2 tm? -50.54 -48.53 57.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.048 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -51.02 -25.52 4.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.894 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.835 ' HB2' HG21 ' A' ' 77' ' ' VAL . . . -83.3 -42.77 16.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.11 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.594 HD22 HG12 ' B' ' 510' ' ' ILE . 8.3 mt -68.73 -17.54 64.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.991 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.474 ' OE2' HD11 ' A' ' 174' ' ' LEU . 0.7 OUTLIER -171.79 145.11 1.62 Allowed Pre-proline 0 C--N 1.333 -0.109 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.746 179.835 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.9 127.99 28.62 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.619 2.212 . . . . 0.0 112.224 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.85 142.23 25.16 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.444 2.096 . . . . 0.0 112.242 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -113.99 141.48 26.33 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.92 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.3 -165.1 0.29 Allowed 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.639 2.226 . . . . 0.0 112.31 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 9.4 mttm -98.98 98.25 9.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.88 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.184 -0.913 . . . . 0.0 110.96 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.133 0 N-CA-C 112.509 -0.237 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 503' ' ' SER . . . . . 0.557 ' HB3' HD11 ' B' ' 505' ' ' LEU . 71.1 m -88.06 -81.55 0.25 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.79 0.329 . . . . 0.0 111.009 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 504' ' ' GLY . . . . . 0.881 ' C ' HD13 ' B' ' 505' ' ' LEU . . . 83.76 104.01 0.55 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.326 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 505' ' ' LEU . . . . . 0.881 HD13 ' C ' ' B' ' 504' ' ' GLY . 0.0 OUTLIER -148.38 90.44 1.8 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.911 0.386 . . . . 0.0 111.077 -179.137 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 506' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 55.57 -172.92 0.06 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.082 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 507' ' ' ALA . . . . . 0.434 ' HB2' ' HB3' ' A' ' 178' ' ' GLU . . . 63.86 -93.27 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.771 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 508' ' ' GLN . . . . . 0.423 ' O ' ' CB ' ' B' ' 509' ' ' ASP . 4.1 mt-30 -133.87 3.25 3.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.018 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 509' ' ' ASP . . . . . 0.423 ' CB ' ' O ' ' B' ' 508' ' ' GLN . 8.4 t70 80.61 36.67 0.1 Allowed 'General case' 0 CA--C 1.521 -0.165 0 CA-C-O 121.167 0.508 . . . . 0.0 109.915 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 510' ' ' ILE . . . . . 0.852 HG23 ' CG1' ' A' ' 46' ' ' ILE . 1.4 mp -53.75 128.59 13.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.162 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 511' ' ' SER . . . . . 0.588 ' HB2' HD21 ' B' ' 514' ' ' LEU . 11.5 m -109.33 158.57 17.76 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.16 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 512' ' ' GLN . . . . . 0.49 ' CB ' ' HD3' ' B' ' 513' ' ' PRO . 0.1 OUTLIER -103.24 -64.25 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.883 179.661 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 513' ' ' PRO . . . . . 0.49 ' HD3' ' CB ' ' B' ' 512' ' ' GLN . 67.7 Cg_endo -85.45 53.45 3.46 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.408 2.072 . . . . 0.0 112.202 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 514' ' ' LEU . . . . . 0.91 HD22 ' O ' ' A' ' 45' ' ' MET . 1.1 mp -62.62 -81.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.176 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 515' ' ' GLN . . . . . 0.472 ' HB2' HG12 ' A' ' 44' ' ' VAL . 0.2 OUTLIER -85.91 -85.0 0.16 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.897 -179.921 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -120.66 -37.55 2.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.711 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 517' ' ' SER . . . . . 0.499 ' O ' ' CD1' ' B' ' 518' ' ' PHE . 0.9 OUTLIER 69.66 27.07 4.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.403 179.657 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 518' ' ' PHE . . . . . 0.499 ' CD1' ' O ' ' B' ' 517' ' ' SER . 24.9 m-85 -162.35 112.79 1.53 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.142 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 519' ' ' ILE . . . . . 0.749 HD12 ' O ' ' A' ' 41' ' ' ALA . 31.3 mt -78.56 -30.09 15.04 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 CA-C-O 120.806 0.336 . . . . 0.0 110.703 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 63.39 94.45 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.885 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 521' ' ' THR . . . . . . . . . . . . . 2.2 t -167.93 47.65 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.844 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 522' ' ' GLY . . . . . 0.409 ' HA3' ' CD2' ' A' ' 37' ' ' PHE . . . -155.51 165.77 32.55 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.491 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 523' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -106.32 -84.83 0.51 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.737 0.303 . . . . 0.0 110.898 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 524' ' ' GLY . . . . . 0.476 ' CA ' ' CG1' ' A' ' 36' ' ' VAL . . . 75.97 21.34 76.47 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.619 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 525' ' ' ASP . . . . . 0.543 ' O ' HG11 ' A' ' 33' ' ' VAL . 26.2 m-20 50.93 56.74 7.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.842 0.353 . . . . 0.0 110.887 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 526' ' ' SER . . . . . 0.419 ' HA ' ' HB ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -81.13 96.82 7.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.935 -179.967 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 527' ' ' ASP . . . . . 0.787 ' O ' HG21 ' A' ' 33' ' ' VAL . 1.2 m-20 -164.55 163.42 14.61 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.247 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -69.44 87.27 0.52 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 123.054 2.503 . . . . 0.0 111.734 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 529' ' ' ARG . . . . . . . . . . . . . 4.0 mtp180 -100.8 -45.67 5.39 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.527 -179.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 530' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -123.06 -42.76 2.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.057 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 3.7 m 72.72 138.81 0.05 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.924 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 532' ' ' TRP . . . . . 0.497 ' CZ2' ' HG3' ' B' ' 537' ' ' ARG . 11.2 t-105 -89.78 115.15 26.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.935 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . -110.46 -53.31 0.57 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.508 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 534' ' ' PHE . . . . . 0.475 ' O ' ' CZ2' ' B' ' 532' ' ' TRP . 32.2 m-85 -107.09 147.84 35.9 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.661 0.267 . . . . 0.0 110.881 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -67.61 -167.01 0.14 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.528 2.152 . . . . 0.0 112.298 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 70.14 102.51 0.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.945 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 537' ' ' ARG . . . . . 0.497 ' HG3' ' CZ2' ' B' ' 532' ' ' TRP . 0.0 OUTLIER -108.13 -177.11 3.24 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.391 0.615 . . . . 0.0 111.146 -179.991 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 538' ' ' ILE . . . . . 0.621 HD12 ' HB2' ' B' ' 542' ' ' TYR . 11.4 pt -114.47 -156.05 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-N 114.999 -1.001 . . . . 0.0 109.749 179.295 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 539' ' ' ASP . . . . . 0.68 ' HB3' HD21 ' A' ' 70' ' ' LEU . 0.3 OUTLIER -93.98 135.12 35.66 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.328 179.198 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 540' ' ' GLU . . . . . 0.873 ' HG3' HG13 ' A' ' 8' ' ' VAL . 1.4 mm-40 -41.33 -33.82 0.44 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.762 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 541' ' ' LEU . . . . . 0.877 ' HB2' HD23 ' A' ' 70' ' ' LEU . 2.4 tt -54.46 -34.36 61.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.117 0.484 . . . . 0.0 110.434 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 542' ' ' TYR . . . . . 0.621 ' HB2' HD12 ' B' ' 538' ' ' ILE . 89.4 m-85 -99.26 -6.55 27.85 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.923 -179.378 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 543' ' ' LEU . . . . . 0.955 ' CD2' HG21 ' A' ' 35' ' ' THR . 0.9 OUTLIER -50.17 167.03 0.06 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.789 0.328 . . . . 0.0 110.781 -179.786 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . 146.26 71.11 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.432 -0.89 . . . . 0.0 112.621 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 545' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.922 179.978 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 185' ' ' GNP . . . . . 0.818 " H2'" ' OG1' ' A' ' 115' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.563 ' HE1' ' CD1' ' A' ' 51' ' ' TYR . 6.1 tpt . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.746 0.308 . . . . 0.0 111.263 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.432 ' O ' ' HE3' ' A' ' 1' ' ' MET . 41.3 tt0 -100.04 150.88 22.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.022 0.439 . . . . 0.0 110.864 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.679 HG23 ' HE1' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -93.46 -178.71 4.81 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.273 -179.538 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.575 ' H ' HG22 ' A' ' 3' ' ' THR . 3.8 pt -148.48 112.21 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.96 -179.38 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 44.8 mttt -94.85 95.83 8.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.191 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.523 ' CB ' ' CE2' ' A' ' 56' ' ' PHE . 4.0 m -121.35 136.99 54.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.666 -179.177 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.4 t -137.26 146.22 28.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.421 179.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.869 HG23 ' HB3' ' A' ' 56' ' ' PHE . 19.7 t -84.65 140.0 16.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.232 0.539 . . . . 0.0 111.668 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 96.2 t -150.66 129.81 3.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.534 179.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 135.03 -148.8 19.71 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.089 -1.053 . . . . 0.0 112.63 -179.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -122.47 23.64 9.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.825 0.345 . . . . 0.0 110.721 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.412 ' HA2' ' HB2' ' B' ' 537' ' ' ARG . . . -142.28 148.9 20.71 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.451 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.462 ' HB3' ' O3A' ' A' ' 185' ' ' GNP . . . -98.79 4.76 47.7 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.721 HG23 HG21 ' A' ' 115' ' ' THR . 6.8 p -43.69 -31.26 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 CA-C-O 120.692 0.282 . . . . 0.0 111.463 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.543 ' CA ' HD11 ' A' ' 19' ' ' LEU . . . -113.27 18.94 20.55 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.415 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.519 ' HA ' HG21 ' A' ' 8' ' ' VAL . 2.3 tttm -97.52 -126.49 0.15 Allowed 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 119.949 -0.072 . . . . 0.0 110.851 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.537 HG21 ' CG ' ' A' ' 38' ' ' ASP . 3.3 p -97.34 -31.08 12.58 Favored 'General case' 0 C--N 1.34 0.172 0 O-C-N 122.041 -0.412 . . . . 0.0 111.435 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.441 ' O ' ' CB ' ' A' ' 22' ' ' SER . 15.6 p -42.08 -36.38 1.13 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.903 -179.259 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.941 HD22 ' CG ' ' A' ' 169' ' ' PHE . 2.8 mp -48.4 -72.79 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.322 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.6 mt -78.12 -40.71 37.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.875 0.369 . . . . 0.0 110.612 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.588 HD12 ' CZ ' ' B' ' 518' ' ' PHE . 24.3 mm -62.56 -69.35 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.209 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.441 ' CB ' ' O ' ' A' ' 18' ' ' CYS . 1.5 t -52.86 -46.33 67.8 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.558 -179.535 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.425 ' CB ' ' O ' ' A' ' 19' ' ' LEU . 28.6 t80 -48.99 -42.66 38.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.686 0.279 . . . . 0.0 111.414 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.1 m -100.51 -64.59 1.03 Allowed 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.499 HG22 ' N ' ' A' ' 26' ' ' ASN . 97.8 m -100.55 164.64 11.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.933 0.396 . . . . 0.0 111.379 -179.322 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.499 ' N ' HG22 ' A' ' 25' ' ' THR . 7.1 t-20 73.89 -60.67 0.52 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.079 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 74.4 174.13 0.27 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.821 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.488 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 8.1 t80 -86.71 -46.22 0.54 Allowed Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.645 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.488 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 87.1 Cg_endo -82.99 50.8 3.47 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.501 2.134 . . . . 0.0 112.792 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.3 m -143.18 -100.46 0.12 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.79 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.416 ' O ' ' ND2' ' A' ' 26' ' ' ASN . 1.2 pt-20 -159.69 163.2 34.99 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.902 0.382 . . . . 0.0 111.073 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.482 ' CE2' ' O2A' ' A' ' 185' ' ' GNP . 36.9 m-85 -135.21 117.09 15.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.266 179.475 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.659 HG11 ' HG3' ' B' ' 529' ' ' ARG . 0.0 OUTLIER -163.39 -62.87 0.01 OUTLIER Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.686 -179.471 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.449 ' HB3' ' CB ' ' B' ' 526' ' ' SER . 29.0 Cg_endo -62.9 57.33 0.15 Allowed 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.816 2.344 . . . . 0.0 113.592 -179.147 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.48 HG21 ' PG ' ' A' ' 185' ' ' GNP . 4.0 t -122.74 22.45 9.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.846 0.355 . . . . 0.0 110.172 178.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.71 ' CG2' HD22 ' A' ' 61' ' ' LEU . 2.3 t -73.13 -45.64 53.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.751 -179.059 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.48 ' O ' ' CD2' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -85.5 48.77 1.64 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.786 0.327 . . . . 0.0 111.303 -179.731 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.537 ' CG ' HG21 ' A' ' 17' ' ' THR . 99.4 m-20 -69.75 -16.87 63.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.111 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -86.02 11.28 11.95 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.593 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.534 ' HH ' ' HZ ' ' B' ' 518' ' ' PHE . 0.0 OUTLIER -60.25 173.81 0.61 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.821 0.343 . . . . 0.0 110.725 179.874 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.413 ' O ' HG12 ' B' ' 519' ' ' ILE . . . -92.16 147.43 22.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.174 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.529 HG12 ' HA ' ' B' ' 518' ' ' PHE . 6.7 m -134.91 147.05 29.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.887 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.705 ' N ' HD11 ' B' ' 519' ' ' ILE . 2.8 t -85.81 102.63 13.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.984 0.421 . . . . 0.0 109.911 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 1.019 HG13 HG21 ' A' ' 52' ' ' THR . 1.1 p -165.77 145.61 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.872 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.616 ' HG3' HD22 ' B' ' 514' ' ' LEU . 0.0 OUTLIER -115.75 140.33 49.31 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.424 179.521 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.604 HG23 ' CG2' ' B' ' 510' ' ' ILE . 7.8 mm -95.38 115.46 34.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-O 120.947 0.403 . . . . 0.0 111.561 -179.414 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.549 ' O ' ' HE1' ' A' ' 45' ' ' MET . . . 33.18 -90.35 0.01 OUTLIER Glycine 0 C--N 1.336 0.552 0 CA-C-N 115.595 -0.73 . . . . 0.0 114.223 178.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.408 ' C ' ' HE1' ' A' ' 45' ' ' MET . . . -41.14 -87.7 0.01 OUTLIER Glycine 0 C--N 1.332 0.315 0 C-N-CA 121.205 -0.522 . . . . 0.0 113.07 -179.435 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.407 ' CB ' ' HD2' ' A' ' 50' ' ' PRO . 1.1 mt-10 -143.51 165.36 25.53 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.406 0.103 . . . . 0.0 111.214 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.416 ' HA ' ' CB ' ' A' ' 45' ' ' MET . 39.2 Cg_exo -31.24 103.02 0.03 OUTLIER 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.619 2.879 . . . . 0.0 113.012 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.679 ' HE1' HG23 ' A' ' 3' ' ' THR . 8.7 t80 -172.53 120.67 0.41 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.772 -179.475 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . 1.019 HG21 HG13 ' A' ' 44' ' ' VAL . 0.2 OUTLIER -135.43 155.73 50.08 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.088 -178.741 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.675 ' N ' HD13 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -115.55 156.3 26.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.186 179.973 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -62.26 109.85 2.87 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.6 -0.81 . . . . 0.0 111.875 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.22 -153.15 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.656 0.265 . . . . 0.0 110.895 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.869 ' HB3' HG23 ' A' ' 8' ' ' VAL . 9.0 m-85 -84.41 105.76 15.49 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 120.921 0.391 . . . . 0.0 111.127 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.402 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 4.3 p30 -120.74 113.06 19.64 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.939 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.593 HG22 HD13 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -154.21 125.77 7.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.87 179.86 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.884 ' HB1' ' CD1' ' A' ' 61' ' ' LEU . . . -172.52 119.86 0.39 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.992 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.4 ' HA2' ' O ' ' A' ' 64' ' ' TYR . . . -95.18 75.45 0.89 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.445 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.884 ' CD1' ' HB1' ' A' ' 59' ' ' ALA . 3.5 mp -117.46 -115.09 0.33 Allowed 'General case' 0 CA--C 1.538 0.513 0 O-C-N 122.912 -0.17 . . . . 0.0 110.872 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -98.6 -29.55 12.99 Favored 'General case' 0 N--CA 1.455 -0.182 0 O-C-N 122.073 -0.392 . . . . 0.0 111.254 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.45 ' HB3' ' CD1' ' A' ' 64' ' ' TYR . 14.8 t0 -67.38 -63.25 1.1 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.066 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.45 ' CD1' ' HB3' ' A' ' 63' ' ' ASP . 0.2 OUTLIER -124.13 137.22 54.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.674 179.966 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -87.25 -62.5 1.49 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.897 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.476 ' N ' ' CD ' ' A' ' 66' ' ' ARG . 0.3 OUTLIER -98.68 -21.09 16.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.181 -179.777 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.593 HD13 HG22 ' A' ' 58' ' ' THR . 1.7 mt 67.03 -135.38 0.13 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.297 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.467 ' CB ' ' CD ' ' A' ' 69' ' ' PRO . 1.2 mtt180 -166.06 -64.07 0.01 OUTLIER Pre-proline 0 CA--C 1.529 0.151 0 CA-C-N 118.28 0.491 . . . . 0.0 111.814 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.467 ' CD ' ' CB ' ' A' ' 68' ' ' ARG . 63.7 Cg_exo -36.96 -60.27 0.4 Allowed 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.965 2.443 . . . . 0.0 113.103 -179.536 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.649 ' C ' HD12 ' A' ' 70' ' ' LEU . 0.4 OUTLIER -50.08 -29.64 9.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.384 -179.752 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 68' ' ' ARG . 35.5 p -47.46 -64.76 0.7 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.759 0.314 . . . . 0.0 111.194 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.422 ' N ' ' OG ' ' A' ' 71' ' ' SER . 6.1 p90 -179.55 92.38 0.2 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.07 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.93 136.03 26.67 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.523 2.149 . . . . 0.0 112.313 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -87.4 10.91 15.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.512 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 11.7 t -70.13 -173.16 0.64 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.784 0.326 . . . . 0.0 110.933 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -124.31 7.69 8.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.431 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.986 HG11 ' HB2' ' A' ' 176' ' ' ALA . 9.0 p -129.14 78.59 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.755 0.312 . . . . 0.0 111.388 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.598 ' CZ ' HG21 ' A' ' 108' ' ' THR . 7.6 m-30 -80.7 172.43 13.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.224 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.435 ' CD2' ' HA3' ' A' ' 15' ' ' GLY . 8.1 tp -143.83 108.55 4.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.876 0.37 . . . . 0.0 111.374 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.593 ' CG1' HD12 ' A' ' 101' ' ' ILE . 4.4 m -94.52 155.12 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.18 179.167 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.591 ' HB3' HG12 ' A' ' 14' ' ' VAL . 2.3 m -134.85 146.21 49.03 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.194 0.521 . . . . 0.0 111.92 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.822 ' CE1' HD12 ' A' ' 112' ' ' LEU . 6.2 p90 -166.22 124.63 1.5 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.158 179.36 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.474 ' HA ' ' C2 ' ' A' ' 185' ' ' GNP . 0.1 OUTLIER -90.24 139.26 30.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.014 0.435 . . . . 0.0 111.562 -179.244 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.956 HG22 ' CB ' ' A' ' 116' ' ' GLN . 10.2 m -63.26 -170.1 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.408 179.475 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.807 ' CG2' HG23 ' A' ' 84' ' ' VAL . 0.1 OUTLIER 56.19 102.11 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -179.282 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.898 ' C ' HD22 ' A' ' 129' ' ' LEU . 0.2 OUTLIER -151.26 145.9 18.49 Favored Pre-proline 0 C--N 1.325 -0.465 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.923 -179.183 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.584 ' N ' HD22 ' A' ' 129' ' ' LEU . 83.6 Cg_endo -85.73 50.04 2.51 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 123.121 2.548 . . . . 0.0 111.654 179.185 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.484 ' N ' ' HB3' ' A' ' 133' ' ' LYS . 2.6 t 82.9 27.8 0.11 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.877 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 44.5 t -97.3 -24.16 15.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.848 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.407 ' CZ ' HD12 ' A' ' 145' ' ' LEU . 11.2 t80 -49.56 -62.1 1.74 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.066 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -50.36 -31.16 13.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.873 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.424 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 1.4 t-20 -72.59 -63.22 1.2 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.859 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.437 HG13 ' N ' ' A' ' 94' ' ' LYS . 12.9 p -52.43 -41.74 36.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.039 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.831 ' CG ' HD11 ' A' ' 145' ' ' LEU . 0.8 OUTLIER -55.87 -62.27 1.81 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.699 179.93 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.409 ' O ' ' HG3' ' A' ' 99' ' ' PRO . 1.1 mm-40 -78.32 2.81 17.34 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.782 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.468 ' HD3' ' CZ3' ' A' ' 97' ' ' TRP . 55.9 tttt -105.24 -38.43 6.53 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.869 0.366 . . . . 0.0 110.56 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.468 ' CZ3' ' HD3' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -74.8 -49.45 20.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.15 179.967 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 94' ' ' LYS . 67.8 t -47.01 -52.3 34.57 Favored Pre-proline 0 CA--C 1.532 0.28 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.919 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 60.7 Cg_endo -72.22 -20.57 24.53 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.112 1.875 . . . . 0.0 112.385 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -84.89 -46.26 11.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.015 0.436 . . . . 0.0 110.622 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.593 HD12 ' CG1' ' A' ' 80' ' ' VAL . 5.9 tt -66.07 -26.11 37.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.906 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.46 HG22 ' HA ' ' A' ' 107' ' ' LYS . 60.3 p -91.55 -26.53 18.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.739 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.454 ' CG ' ' O ' ' A' ' 99' ' ' PRO . 1.9 m170 -67.52 -69.25 0.33 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.828 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -64.32 -42.93 96.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.634 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 4.5 m -112.59 149.21 40.79 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.603 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -49.21 162.31 0.5 Allowed 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.509 2.139 . . . . 0.0 112.269 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.46 ' HA ' HG22 ' A' ' 102' ' ' THR . 0.2 OUTLIER -81.43 56.21 2.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.801 179.921 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.598 HG21 ' CZ ' ' A' ' 78' ' ' PHE . 1.3 p -81.58 165.33 44.63 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.227 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -60.62 162.68 17.45 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.856 2.37 . . . . 0.0 112.323 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.832 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 8.8 p90 -156.07 153.83 30.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.757 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 1.023 HD12 HG11 ' A' ' 152' ' ' VAL . 4.7 tt -113.81 142.95 45.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.408 -179.511 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.822 HD12 ' CE1' ' A' ' 82' ' ' PHE . 3.8 mm? -99.14 158.68 15.51 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.387 179.389 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.957 ' CG1' HG11 ' A' ' 168' ' ' VAL . 2.6 t -141.94 146.95 22.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.166 0.507 . . . . 0.0 112.193 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.499 ' HA3' ' CZ ' ' A' ' 154' ' ' TYR . . . -122.49 92.02 0.47 Allowed Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.968 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.721 HG21 HG23 ' A' ' 14' ' ' VAL . 0.7 OUTLIER -114.34 6.76 16.18 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.281 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.956 ' CB ' HG22 ' A' ' 84' ' ' VAL . 2.3 mt-30 -110.22 25.86 11.31 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.301 0.572 . . . . 0.0 109.56 179.126 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.422 ' CD1' ' O ' ' A' ' 114' ' ' GLY . 0.0 OUTLIER -65.53 -10.45 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.501 179.008 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -96.9 -20.5 18.09 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.245 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.468 ' CB ' HG21 ' A' ' 85' ' ' VAL . 5.2 mp -89.02 -37.66 15.0 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.256 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.453 ' O ' HD13 ' A' ' 126' ' ' ILE . 8.2 ptm180 -48.09 -31.56 5.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.828 0.347 . . . . 0.0 110.894 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -78.58 -37.06 43.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.485 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -47.97 104.24 0.4 Allowed Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.909 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.424 ' O ' ' CG ' ' A' ' 127' ' ' GLU . 55.4 Cg_endo -70.99 -6.17 18.61 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.444 2.096 . . . . 0.0 112.898 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.93 -66.58 0.77 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.625 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.411 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 17.2 m -57.51 -40.86 79.62 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.576 HD11 ' HB3' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -52.84 -46.56 52.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.805 179.231 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.52 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 20.5 mm-40 -58.14 -33.69 69.46 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.9 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.441 ' HA ' ' CE ' ' A' ' 131' ' ' LYS . 9.9 mptt -68.99 -24.77 64.27 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 178.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.898 HD22 ' C ' ' A' ' 86' ' ' SER . 4.4 mt -79.43 -35.58 40.3 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 177.591 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 127' ' ' GLU . . . -39.55 -39.1 0.67 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.033 -0.985 . . . . 0.0 112.391 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.441 ' CE ' ' HA ' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -69.88 -21.63 63.31 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.793 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.422 ' CB ' ' O ' ' A' ' 87' ' ' PRO . 17.5 m120 -124.01 -31.72 3.34 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -179.243 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.488 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 0.0 OUTLIER -139.63 -74.68 0.36 Allowed 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 -179.303 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.488 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 1.2 pt20 99.46 -41.21 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.075 0.95 . . . . 0.0 110.806 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.421 ' N ' ' HG2' ' A' ' 134' ' ' GLN . 0.8 OUTLIER -74.33 109.03 6.02 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.438 -179.648 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.91 ' C ' HD13 ' A' ' 137' ' ' ILE . 54.4 Cg_endo -68.28 -169.35 0.25 Allowed 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.253 1.968 . . . . 0.0 111.141 179.095 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.91 HD13 ' C ' ' A' ' 136' ' ' PRO . 1.0 OUTLIER -115.37 96.42 4.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.028 0.442 . . . . 0.0 110.585 179.877 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.415 ' O ' ' N ' ' A' ' 141' ' ' THR . 26.3 p -69.85 144.24 93.08 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.929 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.466 ' O ' ' CE1' ' A' ' 154' ' ' TYR . 1.8 Cg_endo -42.61 -46.07 8.22 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 122.893 2.395 . . . . 0.0 112.012 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.402 ' HG2' ' OG1' ' A' ' 138' ' ' THR . 9.6 pt-20 -59.96 -32.66 71.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.417 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.415 ' N ' ' O ' ' A' ' 138' ' ' THR . 29.5 m -61.55 -53.17 59.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.686 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.526 ' CB ' ' CD2' ' A' ' 154' ' ' TYR . . . -51.91 -36.84 50.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.689 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -62.84 -40.88 98.8 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.492 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 37.4 tttp -59.38 -56.13 25.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.415 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.831 HD11 ' CG ' ' A' ' 94' ' ' LYS . 0.9 OUTLIER -62.15 -41.06 97.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.341 179.512 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.449 ' CB ' HD23 ' A' ' 112' ' ' LEU . . . -58.86 -53.19 61.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.739 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.06 -27.06 61.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.666 179.625 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -50.45 -45.08 55.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.709 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.11 20.73 18.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.926 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 18.9 mttt 48.67 63.55 2.05 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.091 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.832 ' HB1' ' O ' ' A' ' 110' ' ' PHE . . . -80.19 -82.29 0.11 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.959 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 1.023 HG11 HD12 ' A' ' 111' ' ' LEU . 54.9 t -162.05 -75.6 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.794 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.409 ' HE2' ' N ' ' A' ' 154' ' ' TYR . 0.0 OUTLIER -177.17 120.14 0.12 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.855 -178.831 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.526 ' CD2' ' CB ' ' A' ' 142' ' ' ALA . 12.5 t80 -89.83 114.56 26.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.296 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.48 HG21 ' HG3' ' A' ' 171' ' ' GLU . 2.8 t -111.7 154.67 13.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.032 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -93.49 119.84 33.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.021 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.571 ' O ' HG22 ' A' ' 115' ' ' THR . 1.3 m -172.49 135.71 0.73 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.808 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.434 ' CB ' ' HB ' ' A' ' 115' ' ' THR . 1.9 p -150.1 170.69 18.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.922 0.392 . . . . 0.0 111.153 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.39 -30.84 21.82 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.99 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.1 mt -51.38 -72.39 0.05 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.664 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 14.6 t -74.21 -16.81 60.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.086 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 71.07 50.84 0.3 Allowed 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.069 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.418 ' HB3' ' HA ' ' A' ' 157' ' ' CYS . 0.6 OUTLIER -68.78 -21.02 64.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.969 179.67 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 139.05 -42.45 1.25 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.388 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.702 HD22 ' HA ' ' A' ' 19' ' ' LEU . 0.3 OUTLIER 68.15 -62.18 0.37 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.796 0.332 . . . . 0.0 111.079 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.426 ' O ' ' N ' ' A' ' 170' ' ' ASP . 0.1 OUTLIER -48.12 -25.52 1.49 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.388 -179.733 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -52.34 -71.64 0.06 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.798 0.332 . . . . 0.0 110.47 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.957 HG11 ' CG1' ' A' ' 113' ' ' VAL . 14.7 p -59.24 -29.92 42.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.266 0.555 . . . . 0.0 110.184 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.941 ' CG ' HD22 ' A' ' 19' ' ' LEU . 0.6 OUTLIER -67.53 -29.8 69.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.325 179.714 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 166' ' ' LYS . 68.9 m-20 -77.28 -27.72 53.17 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.191 179.31 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.48 ' HG3' HG21 ' A' ' 155' ' ' VAL . 8.1 mm-40 -75.5 -28.5 59.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.316 179.489 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.583 ' CA ' HD13 ' A' ' 111' ' ' LEU . . . -75.02 -48.06 25.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.961 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.506 ' O ' ' HB3' ' A' ' 176' ' ' ALA . 1.3 pp -65.72 -34.71 72.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.72 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.731 HD13 ' CB ' ' B' ' 505' ' ' LEU . 1.6 tp -48.86 -58.04 5.45 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.912 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.447 ' HB3' HG23 ' A' ' 77' ' ' VAL . . . -47.87 -26.46 1.69 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.136 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.986 ' HB2' HG11 ' A' ' 77' ' ' VAL . . . -77.29 -47.85 18.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.209 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.696 ' CD2' HG21 ' B' ' 510' ' ' ILE . 3.0 mt -68.53 -23.82 64.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.881 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.431 ' HB3' ' HB2' ' B' ' 507' ' ' ALA . 0.0 OUTLIER -160.28 155.82 22.02 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.963 179.753 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.0 122.43 8.1 Favored 'Trans proline' 0 CA--C 1.529 0.253 0 C-N-CA 122.631 2.221 . . . . 0.0 112.18 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.53 175.82 5.64 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.434 2.09 . . . . 0.0 112.376 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 25.8 mp0 -144.63 96.72 5.12 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.887 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.23 -165.08 0.27 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.573 2.182 . . . . 0.0 112.235 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 5.8 mmtp -80.09 141.72 35.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.815 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.903 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.154 0 N-CA-C 112.521 -0.232 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 503' ' ' SER . . . . . . . . . . . . . 54.5 p -99.47 -160.49 0.81 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.745 0.307 . . . . 0.0 110.813 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 504' ' ' GLY . . . . . 0.407 ' HA2' ' HB2' ' B' ' 509' ' ' ASP . . . 149.23 95.81 0.15 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.331 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 505' ' ' LEU . . . . . 0.731 ' CB ' HD13 ' A' ' 174' ' ' LEU . 0.2 OUTLIER -157.43 146.51 19.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.057 0.456 . . . . 0.0 111.477 -179.698 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 506' ' ' SER . . . . . 0.482 ' O ' ' HB2' ' B' ' 507' ' ' ALA . 0.6 OUTLIER -60.05 81.83 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.728 179.579 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 507' ' ' ALA . . . . . 0.482 ' HB2' ' O ' ' B' ' 506' ' ' SER . . . 170.82 43.71 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.486 -179.311 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 508' ' ' GLN . . . . . 0.595 ' HB2' HD12 ' B' ' 510' ' ' ILE . 0.0 OUTLIER 75.33 3.79 4.05 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.692 -177.385 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 509' ' ' ASP . . . . . 0.407 ' HB2' ' HA2' ' B' ' 504' ' ' GLY . 3.7 p30 45.9 53.16 9.23 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.164 0.507 . . . . 0.0 111.393 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 510' ' ' ILE . . . . . 0.696 HG21 ' CD2' ' A' ' 177' ' ' LEU . 1.2 mp -52.97 143.72 4.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.104 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 511' ' ' SER . . . . . 0.532 ' O ' HD11 ' B' ' 514' ' ' LEU . 22.8 t -108.67 153.74 23.0 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.889 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 512' ' ' GLN . . . . . 0.487 ' OE1' ' CD2' ' A' ' 169' ' ' PHE . 9.6 tt0 -102.46 -70.59 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.181 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 513' ' ' PRO . . . . . 0.487 ' CD ' ' CB ' ' B' ' 512' ' ' GLN . 87.5 Cg_endo -77.54 56.59 5.63 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.279 1.986 . . . . 0.0 111.617 179.07 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 514' ' ' LEU . . . . . 0.898 ' HB2' HG23 ' A' ' 44' ' ' VAL . 2.1 mp -60.72 -89.99 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.623 -179.147 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 515' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -84.15 -159.61 0.4 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.63 0.252 . . . . 0.0 110.792 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -48.12 -27.32 2.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.834 0.35 . . . . 0.0 110.733 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 517' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 39.57 33.75 0.13 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.724 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 518' ' ' PHE . . . . . 0.588 ' CZ ' HD12 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -163.51 106.72 1.0 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.371 -179.9 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 519' ' ' ILE . . . . . 0.705 HD11 ' N ' ' A' ' 43' ' ' THR . 3.6 mm -87.13 -37.31 10.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.906 0.384 . . . . 0.0 110.842 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -167.52 -170.75 1.5 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.668 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 521' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.27 157.54 19.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.849 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 522' ' ' GLY . . . . . 0.452 ' CA ' ' HB3' ' A' ' 37' ' ' PHE . . . -61.67 -126.52 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.32 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 523' ' ' HIS . . . . . . . . . . . . . 30.6 t-80 -165.05 -88.07 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.625 0.25 . . . . 0.0 111.065 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 524' ' ' GLY . . . . . 0.481 ' HA3' HG21 ' A' ' 36' ' ' VAL . . . 42.49 -153.39 0.19 Allowed Glycine 0 C--N 1.334 0.418 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.841 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 525' ' ' ASP . . . . . 0.518 ' OD1' HD23 ' A' ' 61' ' ' LEU . 41.0 p-10 -83.29 65.81 8.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.902 0.382 . . . . 0.0 110.655 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 526' ' ' SER . . . . . 0.449 ' CB ' ' HB3' ' A' ' 34' ' ' PRO . 53.6 p -73.19 96.12 2.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.796 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 527' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -168.24 153.36 6.47 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.003 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.62 100.81 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.684 2.256 . . . . 0.0 112.069 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 529' ' ' ARG . . . . . 0.659 ' HG3' HG11 ' A' ' 33' ' ' VAL . 7.6 mtp85 -100.71 -55.34 2.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.286 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 530' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -162.94 98.33 0.95 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.123 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 19.2 t -46.81 95.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.887 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 532' ' ' TRP . . . . . 0.445 ' CE3' ' O ' ' B' ' 533' ' ' GLY . 21.0 t90 68.48 -67.36 0.2 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.948 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 533' ' ' GLY . . . . . 0.445 ' O ' ' CE3' ' B' ' 532' ' ' TRP . . . 87.34 -122.69 6.29 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.592 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 534' ' ' PHE . . . . . 0.4 ' HB3' ' HD2' ' B' ' 535' ' ' PRO . 49.4 m-85 -95.08 155.38 39.05 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 120.738 0.304 . . . . 0.0 110.87 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 535' ' ' PRO . . . . . 0.4 ' HD2' ' HB3' ' B' ' 534' ' ' PHE . 33.9 Cg_endo -64.54 166.38 17.77 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.619 2.213 . . . . 0.0 112.302 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 64.81 97.06 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.828 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 537' ' ' ARG . . . . . 0.412 ' HB2' ' HA2' ' A' ' 12' ' ' GLY . 0.2 OUTLIER -50.59 143.14 9.79 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.047 0.451 . . . . 0.0 111.054 -179.919 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 538' ' ' ILE . . . . . 0.448 ' CG2' ' HA ' ' B' ' 543' ' ' LEU . 6.1 tp -56.17 141.84 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.912 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 539' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -43.06 143.06 0.83 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.943 0.401 . . . . 0.0 111.387 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 540' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -54.15 -20.45 6.76 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.383 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 541' ' ' LEU . . . . . 0.494 ' HA ' HD22 ' A' ' 70' ' ' LEU . 3.9 mt -41.54 -57.9 2.09 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.878 0.37 . . . . 0.0 111.348 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 542' ' ' TYR . . . . . 0.404 ' O ' ' HA ' ' A' ' 59' ' ' ALA . 1.6 m-85 -104.38 -63.54 1.2 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.804 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 543' ' ' LEU . . . . . 0.454 HD22 ' O ' ' A' ' 58' ' ' THR . 0.3 OUTLIER 67.21 152.93 0.08 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.754 -179.834 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . 120.25 -123.98 5.77 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.536 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 545' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.911 179.903 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 185' ' ' GNP . . . . . 0.706 " H2'" ' OG1' ' A' ' 115' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.4 ' CE ' ' O ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.788 0.328 . . . . 0.0 111.204 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.4 ' O ' ' CE ' ' A' ' 1' ' ' MET . 6.5 tt0 54.12 170.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.715 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.771 HG23 ' CE1' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -132.28 -172.46 2.9 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.317 -179.744 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.945 HG13 HD13 ' A' ' 53' ' ' LEU . 4.5 pt -153.14 132.06 3.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.526 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -91.45 95.78 10.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.575 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.616 ' CB ' HD13 ' A' ' 55' ' ' LEU . 1.1 m -80.37 98.64 7.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.273 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.1 t -126.25 159.43 35.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.478 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.805 HG21 ' HG3' ' A' ' 16' ' ' LYS . 22.4 t -128.97 117.62 44.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.039 0.447 . . . . 0.0 111.65 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 96.7 t -123.82 129.98 74.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.917 179.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 134.17 -164.91 24.48 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.205 -0.997 . . . . 0.0 112.612 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' B' ' 539' ' ' ASP . 1.2 m-20 -98.82 25.93 6.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.837 0.351 . . . . 0.0 110.572 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.439 ' HA3' ' N7 ' ' A' ' 185' ' ' GNP . . . -138.27 150.01 20.78 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.645 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.668 ' HB1' ' O1B' ' A' ' 185' ' ' GNP . . . -89.83 -14.93 33.36 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -179.596 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.877 HG11 HG11 ' A' ' 113' ' ' VAL . 92.2 t -43.51 102.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-O 120.903 0.382 . . . . 0.0 111.29 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.623 ' CA ' HD11 ' A' ' 19' ' ' LEU . . . 142.12 -13.02 2.58 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.624 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.805 ' HG3' HG21 ' A' ' 8' ' ' VAL . 77.0 mttt -97.61 -105.73 0.18 Allowed 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.645 0.222 . . . . 0.0 111.377 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.46 ' HB ' ' CG1' ' A' ' 21' ' ' ILE . 69.2 p -98.49 -39.32 8.81 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 -179.408 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.426 ' O ' ' CB ' ' A' ' 22' ' ' SER . 23.8 t -35.9 -34.19 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -179.021 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.837 HD22 ' CD2' ' A' ' 169' ' ' PHE . 0.0 OUTLIER -80.71 -70.31 0.54 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.761 0.315 . . . . 0.0 111.036 -179.746 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.676 ' H ' HD22 ' A' ' 20' ' ' LEU . 0.5 OUTLIER -50.84 -43.59 59.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.653 -179.908 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.781 HD11 ' CE2' ' B' ' 518' ' ' PHE . 32.5 mm -63.73 -64.05 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.171 179.267 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.426 ' CB ' ' O ' ' A' ' 18' ' ' CYS . 45.4 t -45.93 -30.17 1.67 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.958 0.408 . . . . 0.0 110.707 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -65.44 -45.24 84.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.412 179.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -87.39 -50.73 6.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.557 179.576 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.2 p -102.18 -158.55 0.68 Allowed 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.221 179.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -159.33 38.45 0.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.005 0.431 . . . . 0.0 110.821 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.6 98.9 8.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.92 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.469 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . 9.4 t80 -97.56 -52.04 0.21 Allowed Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.024 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.469 ' HD3' ' HB3' ' A' ' 28' ' ' PHE . 65.3 Cg_endo -90.37 26.53 0.49 Allowed 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.782 2.321 . . . . 0.0 112.62 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.57 -87.32 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.129 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.429 ' HB2' ' HD3' ' B' ' 529' ' ' ARG . 4.7 pt-20 -158.13 115.86 2.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.844 0.354 . . . . 0.0 110.737 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.469 ' CE2' ' PB ' ' A' ' 185' ' ' GNP . 12.0 m-30 -105.83 119.5 39.32 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.759 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.508 HG23 ' HD3' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -161.86 -56.14 0.01 OUTLIER Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.145 179.863 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.508 ' HD3' HG23 ' A' ' 33' ' ' VAL . 19.1 Cg_exo -66.22 -15.52 48.61 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.469 2.112 . . . . 0.0 112.558 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.0 t -41.94 -30.67 0.28 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.907 0.384 . . . . 0.0 111.387 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.506 HG23 ' HB3' ' A' ' 59' ' ' ALA . 12.3 p -51.29 -22.47 2.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.329 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.48 ' CD1' ' O ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -81.88 48.15 1.18 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.311 179.896 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.406 ' OD2' ' N ' ' A' ' 57' ' ' ASP . 14.6 p-10 -74.13 -2.6 25.29 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.498 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -83.94 11.11 8.26 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 111.603 0.223 . . . . 0.0 111.603 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 48.7 p90 -60.27 160.96 7.7 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.74 0.305 . . . . 0.0 110.616 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.423 ' O ' ' CG1' ' B' ' 519' ' ' ILE . . . -109.89 135.99 49.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.476 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.881 HG23 HG21 ' A' ' 52' ' ' THR . 13.5 m -114.57 121.68 67.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.824 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.43 ' O ' ' CG1' ' A' ' 44' ' ' VAL . 1.6 p -91.51 103.84 16.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.524 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.67 HG22 ' CG2' ' A' ' 52' ' ' THR . 29.2 m -159.26 -177.12 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.305 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.467 ' HE1' ' N ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -112.76 97.59 6.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.511 -179.58 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 1.032 HG23 HG23 ' B' ' 510' ' ' ILE . 1.6 mm -69.54 87.67 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.053 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.504 ' HA3' HD13 ' B' ' 510' ' ' ILE . . . 39.79 -90.59 0.01 OUTLIER Glycine 0 CA--C 1.521 0.466 0 CA-C-N 116.066 -0.516 . . . . 0.0 113.53 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . -38.38 -82.76 0.01 OUTLIER Glycine 0 C--N 1.334 0.467 0 C-N-CA 121.542 -0.361 . . . . 0.0 113.502 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.467 ' N ' ' HE1' ' A' ' 45' ' ' MET . 1.9 mt-10 -135.35 165.96 32.41 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-O 120.898 0.38 . . . . 0.0 111.581 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.418 ' HD2' ' HB3' ' A' ' 49' ' ' GLU . 51.4 Cg_exo -54.28 99.74 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.769 2.313 . . . . 0.0 113.032 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.771 ' CE1' HG23 ' A' ' 3' ' ' THR . 6.2 t80 -173.24 153.06 2.37 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.667 179.319 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.881 HG21 HG23 ' A' ' 42' ' ' VAL . 0.8 OUTLIER -136.79 153.21 50.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.623 179.201 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.945 HD13 HG13 ' A' ' 4' ' ' ILE . 0.6 OUTLIER -80.93 -172.92 3.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.165 -179.879 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.408 ' O ' ' CE2' ' A' ' 56' ' ' PHE . . . -124.65 98.09 0.55 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.037 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.616 HD13 ' CB ' ' A' ' 6' ' ' CYS . 3.5 mm? -51.54 123.68 10.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.812 0.339 . . . . 0.0 111.053 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.408 ' CE2' ' O ' ' A' ' 54' ' ' GLY . 45.0 m-85 -113.6 118.75 35.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.786 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.433 ' HB2' ' CD ' ' A' ' 16' ' ' LYS . 35.6 p-10 -121.66 -176.57 3.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.119 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.643 ' OG1' HD22 ' B' ' 543' ' ' LEU . 75.7 p -124.52 130.83 53.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.923 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.506 ' HB3' HG23 ' A' ' 36' ' ' VAL . . . -140.93 -167.47 2.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.004 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.16 44.51 0.58 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.656 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.447 ' CD1' ' HB1' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -121.33 -158.11 0.75 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.702 0.287 . . . . 0.0 110.898 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -62.84 -34.96 78.42 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.341 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.458 ' HB3' ' CD1' ' A' ' 64' ' ' TYR . 0.5 OUTLIER -47.37 -58.0 4.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.079 -179.848 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.458 ' CD1' ' HB3' ' A' ' 63' ' ' ASP . 0.1 OUTLIER -175.2 100.58 0.08 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.721 179.778 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.24 -21.91 39.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.158 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.422 ' HG2' ' N ' ' A' ' 67' ' ' LEU . 0.1 OUTLIER -88.29 -29.1 20.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.129 -179.852 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.479 HD21 ' H ' ' A' ' 59' ' ' ALA . 20.8 mt 51.86 -153.23 0.21 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.486 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.423 ' O ' ' N ' ' A' ' 71' ' ' SER . 0.3 OUTLIER 179.56 -56.87 0.0 OUTLIER Pre-proline 0 C--N 1.333 -0.152 0 CA-C-O 120.731 0.3 . . . . 0.0 111.427 -179.992 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.406 ' HD3' ' HB3' ' A' ' 68' ' ' ARG . 85.8 Cg_exo -42.23 -27.99 0.81 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.673 2.249 . . . . 0.0 112.799 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.723 ' O ' HD12 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -85.89 -31.18 22.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.903 -179.783 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.423 ' N ' ' O ' ' A' ' 68' ' ' ARG . 35.0 t -47.45 -71.19 0.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.158 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.455 ' N ' ' CD1' ' A' ' 72' ' ' TYR . 0.0 OUTLIER 176.67 64.72 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.047 -179.855 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.98 172.9 11.99 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.51 2.14 . . . . 0.0 112.149 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 16.3 tp60 -87.98 10.2 19.71 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.495 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 12.3 t -52.35 161.13 0.7 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.783 0.325 . . . . 0.0 110.819 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -122.82 5.16 9.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.468 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.466 HG21 ' CA ' ' A' ' 176' ' ' ALA . 60.0 t -140.48 97.81 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.782 0.325 . . . . 0.0 111.117 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -95.59 -177.97 4.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.71 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.513 HD12 ' O ' ' A' ' 111' ' ' LEU . 10.7 tp -147.35 108.8 4.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.255 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.0 m -95.09 131.02 43.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.359 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.46 ' HB3' ' N7 ' ' A' ' 185' ' ' GNP . 2.6 m -127.08 134.67 50.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.922 0.391 . . . . 0.0 111.42 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.848 ' CE2' HD22 ' A' ' 112' ' ' LEU . 10.6 p90 -148.06 132.47 17.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.546 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.467 ' HA ' ' C2 ' ' A' ' 185' ' ' GNP . 0.5 OUTLIER -83.84 133.14 34.76 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.251 -179.675 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.88 HG23 ' HB2' ' A' ' 116' ' ' GLN . 59.5 t -42.45 -67.75 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.566 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.785 HG13 ' OE1' ' A' ' 116' ' ' GLN . 28.5 m -37.03 111.17 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-O 120.75 0.31 . . . . 0.0 111.379 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.798 ' N ' HD22 ' A' ' 129' ' ' LEU . 0.1 OUTLIER -151.5 139.24 12.62 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.828 -179.064 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.426 ' O ' ' CB ' ' A' ' 132' ' ' ASN . 91.6 Cg_endo -91.02 53.19 0.93 Allowed 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 123.189 2.592 . . . . 0.0 111.681 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.474 ' CA ' ' HB2' ' A' ' 133' ' ' LYS . 0.1 OUTLIER 70.68 19.45 6.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.077 -179.521 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.568 ' O ' HG23 ' A' ' 93' ' ' VAL . 1.4 m -97.23 -23.37 16.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.964 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -47.1 -48.48 22.87 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.183 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -51.94 -40.4 60.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.991 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.412 ' HA ' ' HB2' ' A' ' 95' ' ' GLU . 0.7 OUTLIER -76.62 -36.55 57.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.933 -179.873 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 89' ' ' SER . 62.9 t -51.09 -57.25 3.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.291 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.771 ' HG2' HD13 ' A' ' 145' ' ' LEU . 3.8 mptp? -73.6 -32.35 64.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.118 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.412 ' HB2' ' HA ' ' A' ' 92' ' ' ASN . 6.3 mm-40 -64.72 -23.99 67.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.093 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 93' ' ' VAL . 13.5 ptmt -108.35 -17.67 13.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.4 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.527 ' CE2' HG13 ' A' ' 93' ' ' VAL . 34.0 m0 -76.83 -54.4 6.65 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.765 0.317 . . . . 0.0 111.078 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.531 HG11 HD22 ' A' ' 149' ' ' LEU . 42.6 t -47.18 -50.15 48.55 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.841 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 62.2 Cg_endo -72.98 -16.19 25.81 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.145 1.897 . . . . 0.0 112.549 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -85.5 -39.63 17.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.906 0.384 . . . . 0.0 110.933 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 40.8 pt -71.58 -32.93 47.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.05 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 11.0 p -80.26 -32.69 38.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.908 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -64.73 -50.09 68.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.685 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -76.03 -33.08 59.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.855 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 41.6 m -125.92 101.18 29.68 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.832 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -44.33 93.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.55 2.167 . . . . 0.0 112.49 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.2 mmmm 53.95 103.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.85 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.424 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -138.55 129.21 15.22 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.753 179.915 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 108' ' ' THR . 31.6 Cg_exo -60.2 162.82 15.91 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.448 2.099 . . . . 0.0 112.25 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.837 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 7.6 p90 -162.9 150.57 13.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.947 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.92 HD12 HG11 ' A' ' 152' ' ' VAL . 9.7 tt -120.51 150.67 40.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.063 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.98 HD12 ' HB2' ' A' ' 146' ' ' ALA . 20.0 mt -108.03 156.19 19.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.813 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.897 HG13 HG11 ' A' ' 168' ' ' VAL . 3.8 t -130.92 148.82 33.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.913 0.387 . . . . 0.0 111.44 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.53 ' O ' HD11 ' A' ' 117' ' ' ILE . . . -123.54 84.85 0.37 Allowed Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.266 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.668 ' OG1' " H2'" ' A' ' 185' ' ' GNP . 0.7 OUTLIER -106.52 7.32 30.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.657 0.265 . . . . 0.0 111.667 -179.558 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.88 ' HB2' HG23 ' A' ' 84' ' ' VAL . 0.7 OUTLIER -98.07 -17.05 19.33 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.628 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.65 HD12 ' N ' ' A' ' 117' ' ' ILE . 0.2 OUTLIER -48.75 -24.11 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.831 179.238 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.14 -22.14 58.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.163 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.651 HD11 ' CD ' ' A' ' 116' ' ' GLN . 4.5 pp -122.45 -10.04 8.46 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.623 ' HD3' HG22 ' A' ' 117' ' ' ILE . 0.7 OUTLIER -50.44 -27.18 5.99 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.942 0.401 . . . . 0.0 110.719 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -77.32 -26.62 52.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.529 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 119' ' ' LEU . 9.0 m-20 -50.81 103.92 0.4 Allowed Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.639 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.401 ' HA ' ' CG2' ' A' ' 126' ' ' ILE . 15.1 Cg_exo -68.61 -3.99 12.24 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.8 2.334 . . . . 0.0 113.047 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 26.7 t -80.88 -67.42 0.78 Allowed 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.56 HG21 HG11 ' A' ' 85' ' ' VAL . 9.0 m -56.32 -32.74 64.92 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.408 0.623 . . . . 0.0 109.355 178.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.977 HD11 ' HB3' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -61.6 -43.33 96.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.466 179.196 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.479 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 7.0 mm-40 -56.2 -34.51 66.32 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.45 178.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.429 ' HB2' ' O ' ' A' ' 125' ' ' THR . 2.2 mptt -65.95 -32.95 74.74 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.798 HD22 ' N ' ' A' ' 86' ' ' SER . 6.8 mt -71.85 -39.3 69.79 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.488 ' HA ' ' HB3' ' A' ' 134' ' ' GLN . . . -48.01 -26.71 1.89 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.094 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.7 mmtp -64.69 -32.32 73.94 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.579 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.426 ' CB ' ' O ' ' A' ' 87' ' ' PRO . 47.8 m-80 -124.2 -30.99 3.38 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -179.186 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.492 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 0.0 OUTLIER -133.63 -73.16 0.49 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.345 -178.836 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.492 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 2.3 pt20 99.28 -33.42 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.866 0.866 . . . . 0.0 111.089 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -68.61 110.46 5.93 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.774 -178.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.977 ' HB3' HD11 ' A' ' 126' ' ' ILE . 72.4 Cg_endo -76.07 123.08 7.05 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.32 2.014 . . . . 0.0 111.355 179.049 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.68 ' N ' HD13 ' A' ' 137' ' ' ILE . 0.8 OUTLIER -57.38 96.36 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.549 -179.696 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.423 HG22 ' H ' ' A' ' 138' ' ' THR . 0.5 OUTLIER -72.56 150.22 91.2 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.737 -179.808 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.488 ' HG3' HG21 ' A' ' 117' ' ' ILE . 97.8 Cg_exo -41.35 -38.34 3.61 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.682 2.255 . . . . 0.0 112.586 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -65.63 -33.36 75.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.004 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.565 HG21 HG23 ' A' ' 137' ' ' ILE . 58.5 m -60.15 -63.77 1.18 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.952 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.57 ' HB1' ' CD2' ' A' ' 154' ' ' TYR . . . -48.73 -48.16 40.78 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.807 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -58.98 -37.24 76.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.449 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -60.51 -58.38 8.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.48 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.771 HD13 ' HG2' ' A' ' 94' ' ' LYS . 0.5 OUTLIER -63.78 -33.32 75.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.393 179.574 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.98 ' HB2' HD12 ' A' ' 112' ' ' LEU . . . -65.05 -34.39 78.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.697 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -90.5 -25.31 20.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.655 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -57.01 -33.09 66.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.827 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.531 HD22 HG11 ' A' ' 98' ' ' VAL . 0.3 OUTLIER -113.07 19.49 17.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.14 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt 47.91 40.31 12.58 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.196 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.837 ' HB1' ' O ' ' A' ' 110' ' ' PHE . . . -58.4 -80.97 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.069 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.92 HG11 HD12 ' A' ' 111' ' ' LEU . 55.6 t -160.52 -75.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.744 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 176.07 126.82 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.773 -179.148 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.57 ' CD2' ' HB1' ' A' ' 142' ' ' ALA . 6.0 t80 -96.78 111.02 23.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.08 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 2.6 t -101.76 152.43 5.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.867 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -91.78 127.05 37.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.24 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.457 ' HA ' ' HB3' ' A' ' 163' ' ' LYS . 1.1 p 179.31 126.92 0.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.988 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.499 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 87.7 p -100.38 153.9 18.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.399 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.588 ' HB2' HD21 ' A' ' 165' ' ' LEU . . . -94.09 -35.58 12.49 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.828 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.454 ' H ' HD12 ' A' ' 160' ' ' LEU . 1.2 mp -47.5 -41.74 21.54 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.641 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.4 HG22 ' OG ' ' A' ' 158' ' ' SER . 5.0 t -112.97 -16.94 12.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.738 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.405 ' O ' ' NE2' ' A' ' 162' ' ' GLN . 0.8 OUTLIER 72.86 70.88 0.13 Allowed 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.837 179.983 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.457 ' HB3' ' HA ' ' A' ' 157' ' ' CYS . 2.1 tttm -87.84 -20.02 26.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.21 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 168.19 37.32 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.74 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.831 HD12 ' CB ' ' A' ' 19' ' ' LEU . 0.5 OUTLIER -47.82 -39.62 18.86 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.762 0.315 . . . . 0.0 110.914 179.966 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 13.8 pttp -72.61 -32.92 66.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.793 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -54.56 -70.3 0.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.597 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.897 HG11 HG13 ' A' ' 113' ' ' VAL . 7.7 p -53.7 -46.52 62.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.08 0.467 . . . . 0.0 110.358 179.525 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.837 ' CD2' HD22 ' A' ' 19' ' ' LEU . 0.8 OUTLIER -55.37 -34.09 64.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.239 179.324 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.429 ' HA ' ' CG1' ' A' ' 173' ' ' ILE . 52.5 t0 -62.13 -43.65 98.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.277 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.547 ' CB ' HD11 ' A' ' 111' ' ' LEU . 62.8 mm-40 -62.48 -28.99 70.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.367 179.454 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.619 ' N ' HD13 ' A' ' 111' ' ' LEU . . . -78.73 -49.21 13.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.134 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.446 ' HB ' HD12 ' A' ' 4' ' ' ILE . 1.5 pp -72.05 -36.84 58.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.344 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.833 HD13 ' O ' ' A' ' 174' ' ' LEU . 3.1 tm? -63.08 -32.67 74.1 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.969 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.69 -22.47 62.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.026 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.466 ' CA ' HG21 ' A' ' 77' ' ' VAL . . . -87.76 -31.41 19.65 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.102 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.861 HD13 HG21 ' B' ' 510' ' ' ILE . 0.3 OUTLIER -92.7 15.27 14.86 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.278 -179.87 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 176.92 98.11 0.11 Allowed Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.692 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -46.8 102.93 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.654 2.236 . . . . 0.0 112.547 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.26 170.88 19.37 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.59 2.193 . . . . 0.0 112.37 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -146.01 139.28 14.47 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.782 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -77.96 -165.27 0.32 Allowed 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.553 2.168 . . . . 0.0 112.332 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.9 153.95 32.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.879 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 2.3 mtpt . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.892 179.88 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 502' ' ' GLY . . . . . 0.837 ' N ' ' HG ' ' B' ' 511' ' ' SER . . . . . . . . 0 N--CA 1.488 2.165 0 N-CA-C 112.458 -0.257 . . . . 0.0 112.458 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 503' ' ' SER . . . . . 0.401 ' HB3' ' OD2' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -75.8 -86.62 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.714 0.292 . . . . 0.0 110.726 179.91 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 504' ' ' GLY . . . . . 0.61 ' C ' HD23 ' B' ' 505' ' ' LEU . . . 63.46 119.75 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.259 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 505' ' ' LEU . . . . . 0.726 ' N ' HD23 ' B' ' 505' ' ' LEU . 0.8 OUTLIER -173.66 115.59 0.23 Allowed 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 120.811 0.339 . . . . 0.0 111.818 -178.374 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 506' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 79.0 -74.11 0.06 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.615 179.036 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 507' ' ' ALA . . . . . 0.436 ' HB3' HG12 ' B' ' 510' ' ' ILE . . . -35.26 -38.14 0.09 Allowed 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.436 0.636 . . . . 0.0 111.651 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 508' ' ' GLN . . . . . 0.519 ' O ' ' CB ' ' B' ' 509' ' ' ASP . 0.9 OUTLIER 159.47 -33.86 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.768 -1.105 . . . . 0.0 108.747 -179.677 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 509' ' ' ASP . . . . . 0.519 ' CB ' ' O ' ' B' ' 508' ' ' GLN . 27.0 t70 138.13 43.35 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 O-C-N 124.957 1.411 . . . . 0.0 109.704 179.306 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 510' ' ' ILE . . . . . 1.032 HG23 HG23 ' A' ' 46' ' ' ILE . 21.9 mm -60.4 107.63 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.701 179.309 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 511' ' ' SER . . . . . 0.837 ' HG ' ' N ' ' B' ' 502' ' ' GLY . 3.9 m -101.89 130.07 48.28 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.949 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 512' ' ' GLN . . . . . 0.513 ' CB ' ' HD3' ' B' ' 513' ' ' PRO . 1.2 mm-40 -79.75 -66.87 0.25 Allowed Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.539 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 513' ' ' PRO . . . . . 0.513 ' HD3' ' CB ' ' B' ' 512' ' ' GLN . 79.0 Cg_endo -82.25 56.29 5.72 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.573 2.182 . . . . 0.0 111.84 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 514' ' ' LEU . . . . . 0.502 ' HB2' ' HB ' ' A' ' 44' ' ' VAL . 0.7 OUTLIER -55.53 -84.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.047 -179.583 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 515' ' ' GLN . . . . . 0.501 ' HB2' HG12 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -90.62 -84.81 0.23 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.828 -179.982 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -110.68 -36.8 5.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.538 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 517' ' ' SER . . . . . 0.483 ' C ' HG12 ' A' ' 42' ' ' VAL . 15.4 m 52.58 27.23 4.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.205 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 518' ' ' PHE . . . . . 0.781 ' CE2' HD11 ' A' ' 21' ' ' ILE . 0.3 OUTLIER -163.54 91.59 0.68 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.365 -179.879 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 519' ' ' ILE . . . . . 0.461 HG12 ' HA ' ' A' ' 42' ' ' VAL . 4.7 mm -101.35 131.82 48.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.858 0.361 . . . . 0.0 110.901 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -54.16 108.43 0.37 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.993 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 521' ' ' THR . . . . . . . . . . . . . 3.5 m -166.25 143.53 5.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.941 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 522' ' ' GLY . . . . . . . . . . . . . . . 128.47 179.06 15.67 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.552 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 523' ' ' HIS . . . . . . . . . . . . . 39.7 t-80 -148.52 -84.12 0.1 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.808 0.337 . . . . 0.0 110.962 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 524' ' ' GLY . . . . . . . . . . . . . . . 57.81 -169.81 4.25 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.595 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 525' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -110.58 88.02 2.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.902 0.382 . . . . 0.0 110.86 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 526' ' ' SER . . . . . . . . . . . . . 35.6 p -77.44 95.59 4.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.786 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 527' ' ' ASP . . . . . 0.485 ' H ' HG11 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -174.32 -64.71 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.956 179.632 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 528' ' ' PRO . . . . . 0.484 ' CD ' ' CB ' ' B' ' 527' ' ' ASP . 20.3 Cg_endo -58.01 78.83 0.04 OUTLIER 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.971 2.447 . . . . 0.0 112.368 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 529' ' ' ARG . . . . . 0.437 ' HD3' ' CG2' ' A' ' 33' ' ' VAL . 7.0 mtt85 -82.8 -31.96 27.94 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.698 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 530' ' ' HIS . . . . . . . . . . . . . 9.4 m170 51.92 24.01 2.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.82 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 16.5 p 41.78 -163.8 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.377 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 532' ' ' TRP . . . . . 0.502 ' CZ2' ' HA ' ' B' ' 537' ' ' ARG . 34.9 t-105 -169.48 127.82 0.96 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.982 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . -159.62 35.4 0.47 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.234 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 534' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -109.66 161.62 23.45 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 120.708 0.289 . . . . 0.0 111.065 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -57.38 -57.44 1.26 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.622 2.215 . . . . 0.0 112.203 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -123.38 157.82 32.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.011 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 537' ' ' ARG . . . . . 0.502 ' HA ' ' CZ2' ' B' ' 532' ' ' TRP . 24.6 mmt180 -66.94 145.48 55.39 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.153 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 538' ' ' ILE . . . . . 0.697 HG23 HD12 ' B' ' 543' ' ' LEU . 5.8 tp -59.93 143.71 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.633 179.088 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 539' ' ' ASP . . . . . 0.611 ' HB3' HD12 ' B' ' 541' ' ' LEU . 1.1 m-20 -42.7 128.33 4.08 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.812 0.339 . . . . 0.0 111.786 -179.05 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 540' ' ' GLU . . . . . 0.492 ' HA ' ' CD1' ' B' ' 543' ' ' LEU . 41.0 mm-40 -40.95 -24.47 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.27 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 541' ' ' LEU . . . . . 0.611 HD12 ' HB3' ' B' ' 539' ' ' ASP . 0.8 OUTLIER -31.12 -69.6 0.07 Allowed 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -179.251 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 542' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -104.45 -64.74 1.08 Allowed 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -178.288 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 543' ' ' LEU . . . . . 0.697 HD12 HG23 ' B' ' 538' ' ' ILE . 10.2 mp 58.37 179.5 0.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.739 0.304 . . . . 0.0 110.388 -178.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . -172.91 -54.84 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.503 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 545' ' ' ASN . . . . . . . . . . . . . 42.6 p30 . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.81 179.877 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 185' ' ' GNP . . . . . 0.677 ' N3 ' " H2'" ' A' ' 185' ' ' GNP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.439 ' CE ' ' HB ' ' A' ' 46' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.873 0.368 . . . . 0.0 111.107 . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.432 ' O ' ' CD2' ' A' ' 177' ' ' LEU . 5.4 tt0 -174.71 130.66 0.33 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.695 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.925 HG23 HD12 ' A' ' 46' ' ' ILE . 0.6 OUTLIER -116.86 -173.7 2.44 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.246 -179.591 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.704 ' H ' HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -151.38 163.27 2.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.769 -178.541 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.65 156.23 17.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.766 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.433 ' SG ' ' CZ ' ' A' ' 169' ' ' PHE . 0.0 OUTLIER -118.57 141.51 48.52 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.278 -179.755 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.1 t -148.34 159.77 7.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.669 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.83 HG22 ' HA3' ' A' ' 15' ' ' GLY . 16.3 t -119.38 151.76 21.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.238 0.542 . . . . 0.0 111.753 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 86.2 t -156.19 130.05 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.044 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.89 -140.52 14.74 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.197 -1.002 . . . . 0.0 112.836 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' B' ' 537' ' ' ARG . 3.4 m-20 -123.23 27.85 7.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.657 0.265 . . . . 0.0 110.934 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -118.23 177.54 16.53 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.961 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.937 ' HB2' ' O2A' ' A' ' 185' ' ' GNP . . . -103.51 -26.85 12.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.775 0.322 . . . . 0.0 111.515 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.967 HG11 HG21 ' A' ' 113' ' ' VAL . 54.1 t -43.12 94.58 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 121.006 0.431 . . . . 0.0 111.418 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.83 ' HA3' HG22 ' A' ' 8' ' ' VAL . . . 132.89 -23.47 3.94 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.026 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.758 ' CG ' HG21 ' A' ' 8' ' ' VAL . 14.7 mttt -90.3 -159.13 0.58 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.767 0.318 . . . . 0.0 110.709 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.45 ' HB ' ' CG1' ' A' ' 21' ' ' ILE . 31.5 p -66.46 -44.91 81.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.392 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.585 ' HB3' ' HB1' ' A' ' 13' ' ' ALA . 43.3 t -33.26 -58.54 0.39 Allowed 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.562 HD13 ' CG ' ' A' ' 169' ' ' PHE . 13.8 mt -42.2 -67.93 0.23 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.718 -179.406 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.468 ' N ' ' CD2' ' A' ' 20' ' ' LEU . 1.5 mm? -72.43 -25.73 61.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.444 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.45 ' CG1' ' HB ' ' A' ' 17' ' ' THR . 20.7 mm -70.83 -68.2 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.765 0.317 . . . . 0.0 110.565 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 27.1 t -57.77 -25.74 60.92 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.983 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.811 ' HB2' HD13 ' A' ' 165' ' ' LEU . 4.4 t80 -80.1 -68.52 0.67 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.005 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 97.8 m -70.26 -48.64 55.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.031 0.444 . . . . 0.0 110.658 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.446 HG22 ' H ' ' A' ' 26' ' ' ASN . 0.2 OUTLIER -77.48 -156.04 0.08 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.646 179.876 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.446 ' H ' HG22 ' A' ' 25' ' ' THR . 0.9 OUTLIER -149.7 40.13 0.81 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.719 0.295 . . . . 0.0 110.805 -179.935 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.4 mtmt -133.51 126.88 32.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.969 0.414 . . . . 0.0 111.369 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.501 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . 3.6 t80 -163.66 -53.44 0.01 OUTLIER Pre-proline 0 CA--C 1.536 0.437 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.947 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.501 ' HD3' ' HB3' ' A' ' 28' ' ' PHE . 5.7 Cg_exo -79.55 56.44 6.05 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.774 2.316 . . . . 0.0 112.418 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.7 m -143.54 -80.03 0.2 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.755 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -157.69 162.43 38.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.593 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.528 ' CD2' ' N3B' ' A' ' 185' ' ' GNP . 9.3 m-85 -131.55 94.6 3.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.967 0.413 . . . . 0.0 111.108 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.534 HG11 ' HG3' ' B' ' 529' ' ' ARG . 0.2 OUTLIER -133.05 -56.2 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.666 179.703 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.464 ' O ' ' CZ ' ' A' ' 37' ' ' PHE . 7.8 Cg_exo -72.17 59.08 2.99 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.346 2.031 . . . . 0.0 111.983 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.588 HG23 HD23 ' B' ' 543' ' ' LEU . 5.8 t -120.53 21.89 11.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.88 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.024 HG22 HD13 ' A' ' 61' ' ' LEU . 2.4 t -83.84 -4.75 8.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.648 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.464 ' CZ ' ' O ' ' A' ' 34' ' ' PRO . 4.2 m-85 -46.03 -27.7 1.0 Allowed 'General case' 0 N--CA 1.461 0.099 0 CA-C-O 120.813 0.34 . . . . 0.0 111.108 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.419 ' HA ' ' HB3' ' A' ' 57' ' ' ASP . 6.8 t0 69.26 33.07 3.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.642 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.422 ' CB ' ' O ' ' A' ' 55' ' ' LEU . 8.3 m120 52.01 87.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.609 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.473 ' OH ' ' CZ ' ' B' ' 518' ' ' PHE . 3.2 p90 -59.98 -175.73 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.707 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.408 ' O ' HG12 ' B' ' 519' ' ' ILE . . . -90.77 160.5 15.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.055 0.455 . . . . 0.0 111.823 -179.354 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.494 HG12 ' C ' ' B' ' 517' ' ' SER . 3.5 m -127.25 128.19 69.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.621 179.565 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.701 ' H ' HD11 ' B' ' 519' ' ' ILE . 59.1 p -85.59 104.76 15.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.943 0.401 . . . . 0.0 111.17 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.767 ' CG2' HG21 ' A' ' 52' ' ' THR . 20.7 m -157.79 -177.7 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.859 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.512 ' HG3' HD22 ' B' ' 514' ' ' LEU . 0.0 OUTLIER -128.03 116.93 20.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.349 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.925 HD12 HG23 ' A' ' 3' ' ' THR . 0.8 OUTLIER -81.98 87.65 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.676 0.274 . . . . 0.0 111.668 -179.865 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 56.87 -78.08 0.01 OUTLIER Glycine 0 C--N 1.333 0.374 0 CA-C-N 116.105 -0.498 . . . . 0.0 113.776 178.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . -54.0 -99.78 0.01 OUTLIER Glycine 0 C--N 1.331 0.285 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.979 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.478 ' CA ' ' HE3' ' A' ' 45' ' ' MET . 0.6 OUTLIER -119.72 164.26 22.99 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 120.878 0.37 . . . . 0.0 111.396 -179.617 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.76 100.93 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.699 2.266 . . . . 0.0 112.596 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.464 ' CD1' ' OG1' ' A' ' 3' ' ' THR . 12.3 t80 -172.84 106.61 0.16 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.361 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.767 HG21 ' CG2' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -124.43 153.78 41.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.939 0.399 . . . . 0.0 111.038 -179.92 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.653 HD12 ' N ' ' A' ' 4' ' ' ILE . 82.7 mt -113.44 100.0 8.19 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.863 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -46.17 164.13 0.11 Allowed Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.396 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.551 ' H ' HD12 ' A' ' 55' ' ' LEU . 2.4 mp -79.66 152.87 29.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.71 0.29 . . . . 0.0 110.847 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.422 ' CB ' ' O ' ' A' ' 6' ' ' CYS . 0.3 OUTLIER -103.32 122.05 44.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.524 -179.52 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.419 ' HB3' ' HA ' ' A' ' 38' ' ' ASP . 0.2 OUTLIER -127.65 167.0 17.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.36 179.367 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.701 ' HB ' HD11 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -149.41 128.72 12.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.905 0.383 . . . . 0.0 111.122 -179.444 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.691 ' HB3' ' HA ' ' A' ' 36' ' ' VAL . . . -144.86 100.73 3.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.664 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.406 ' HA2' ' O ' ' A' ' 64' ' ' TYR . . . -70.65 83.05 0.38 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.717 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 1.024 HD13 HG22 ' A' ' 36' ' ' VAL . 3.9 mp -121.5 -108.36 0.35 Allowed 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.564 0.182 . . . . 0.0 111.027 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -99.03 -30.02 12.57 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 120.827 0.346 . . . . 0.0 111.167 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.9 -63.32 1.19 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.442 -179.438 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.462 ' HE1' HG12 ' A' ' 36' ' ' VAL . 0.4 OUTLIER -107.62 120.6 42.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.94 -179.624 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -87.16 -53.39 4.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 112.029 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.21 8.8 44.28 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -178.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.813 HD23 ' O ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -47.46 110.68 0.33 Allowed 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 120.728 0.299 . . . . 0.0 110.667 179.625 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.671 ' HG2' HD11 ' B' ' 541' ' ' LEU . 0.0 OUTLIER -149.97 70.92 9.45 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.235 -179.788 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.668 ' CG ' HG21 ' A' ' 58' ' ' THR . 88.9 Cg_endo -81.02 -37.07 0.33 Allowed 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.591 2.194 . . . . 0.0 112.455 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.917 ' O ' HD12 ' A' ' 70' ' ' LEU . 0.1 OUTLIER -58.83 -18.2 30.36 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.002 -179.939 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.463 ' HB3' ' CD2' ' A' ' 72' ' ' TYR . 0.3 OUTLIER -43.34 -50.44 6.7 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.389 -179.962 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.463 ' CD2' ' HB3' ' A' ' 71' ' ' SER . 5.6 p90 -165.2 70.9 1.39 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.289 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -70.01 153.36 67.85 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.881 2.387 . . . . 0.0 112.063 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 -102.42 10.28 39.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.568 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 14.1 t -57.49 178.63 0.07 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.844 0.354 . . . . 0.0 110.986 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -115.85 -18.74 10.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.282 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.5 m -118.94 91.1 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.755 0.312 . . . . 0.0 111.284 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -81.14 121.64 26.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.486 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.594 HD11 ' CG1' ' A' ' 14' ' ' VAL . 0.1 OUTLIER -83.48 108.52 16.67 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.953 0.406 . . . . 0.0 111.236 -179.675 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.719 ' O ' HD13 ' A' ' 112' ' ' LEU . 3.3 m -110.25 100.7 11.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.887 179.063 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.452 ' HB2' ' N7 ' ' A' ' 185' ' ' GNP . 0.5 OUTLIER -113.37 146.94 38.65 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.536 -179.187 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.466 ' O ' ' N1 ' ' A' ' 185' ' ' GNP . 6.3 p90 -155.48 143.05 19.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.216 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.416 ' HA ' ' C2 ' ' A' ' 185' ' ' GNP . 0.1 OUTLIER -81.96 133.4 35.3 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.112 0.482 . . . . 0.0 111.188 -179.472 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.664 HG23 ' HB2' ' A' ' 116' ' ' GLN . 89.2 t -48.5 -69.6 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.551 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.72 HG22 ' OE1' ' A' ' 116' ' ' GLN . 16.0 m -40.84 110.45 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 120.742 0.306 . . . . 0.0 111.332 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.629 ' N ' HD21 ' A' ' 129' ' ' LEU . 52.4 p -154.36 134.03 7.69 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.772 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.435 ' O ' ' HB2' ' A' ' 133' ' ' LYS . 20.0 Cg_endo -61.21 -81.76 0.01 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 121.909 1.739 . . . . 0.0 111.408 179.371 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.9 t -144.87 24.55 1.49 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.832 0.349 . . . . 0.0 110.966 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.518 ' O ' HG23 ' A' ' 93' ' ' VAL . 1.7 t -93.44 -21.88 19.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.176 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -48.41 -49.01 36.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.178 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -57.84 -40.6 80.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.996 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 17.5 m-20 -67.42 -50.03 61.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.903 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.606 HG13 ' CE2' ' A' ' 97' ' ' TRP . 47.2 t -51.47 -52.37 20.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.193 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.662 ' O ' HG23 ' A' ' 98' ' ' VAL . 2.3 tttp -52.31 -54.68 28.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.022 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.405 ' O ' ' HG2' ' A' ' 99' ' ' PRO . 50.7 mt-10 -78.66 3.11 17.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.829 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.5 ttmm -115.2 -19.07 10.96 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.721 0.296 . . . . 0.0 111.184 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.606 ' CE2' HG13 ' A' ' 93' ' ' VAL . 27.9 m0 -93.74 -51.4 4.93 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.199 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 94' ' ' LYS . 16.8 t -49.68 -44.98 78.71 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.706 -179.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.501 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 3.6 Cg_exo -74.88 -16.49 20.51 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.641 2.228 . . . . 0.0 112.612 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -90.19 -53.64 4.37 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.841 0.353 . . . . 0.0 110.976 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.514 ' CD1' ' CE2' ' A' ' 110' ' ' PHE . 1.0 OUTLIER -56.61 -24.2 18.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.151 179.997 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.7 p -88.8 -45.66 9.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.861 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -50.13 -32.68 16.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.959 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -79.52 -26.97 41.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.021 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -151.59 104.88 2.89 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.977 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -49.67 108.8 0.22 Allowed 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.397 2.065 . . . . 0.0 112.09 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 67.7 93.07 0.08 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.747 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.05 119.4 10.5 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.034 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -60.67 154.4 55.1 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.534 2.156 . . . . 0.0 112.438 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.514 ' CE2' ' CD1' ' A' ' 101' ' ' ILE . 1.2 p90 -151.53 147.85 27.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.864 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.807 HD12 HG11 ' A' ' 152' ' ' VAL . 0.8 OUTLIER -110.38 160.67 16.37 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.417 -179.595 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.719 HD13 ' O ' ' A' ' 80' ' ' VAL . 2.5 mm? -123.48 161.19 25.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.586 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.967 HG21 HG11 ' A' ' 14' ' ' VAL . 21.6 t -139.6 143.57 30.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.974 0.416 . . . . 0.0 111.912 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.442 ' O ' ' CD1' ' A' ' 117' ' ' ILE . . . -119.54 92.03 0.52 Allowed Glycine 0 C--N 1.331 0.297 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.005 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.687 ' OG1' " H2'" ' A' ' 185' ' ' GNP . 0.6 OUTLIER -117.25 9.51 13.48 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -178.836 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.72 ' OE1' HG22 ' A' ' 85' ' ' VAL . 1.9 mm-40 -114.74 11.97 16.94 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.879 0.371 . . . . 0.0 110.323 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.763 HD11 ' O ' ' A' ' 157' ' ' CYS . 0.1 OUTLIER -57.97 -17.37 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.718 179.043 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -100.13 -17.3 17.48 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.544 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.57 HD13 ' HA ' ' A' ' 116' ' ' GLN . 5.5 mp -91.79 -32.58 15.31 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.775 0.321 . . . . 0.0 110.992 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.541 ' O ' HD13 ' A' ' 126' ' ' ILE . 1.0 OUTLIER -42.44 -52.42 4.66 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.361 -179.916 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.49 -42.59 98.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.58 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -45.37 102.79 0.31 Allowed Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.886 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.469 ' HA ' ' CG2' ' A' ' 126' ' ' ILE . 42.8 Cg_endo -68.6 -6.88 18.86 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.409 2.073 . . . . 0.0 112.947 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.34 -66.15 0.58 Allowed 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.045 0.45 . . . . 0.0 109.853 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.706 HG22 ' CD1' ' A' ' 129' ' ' LEU . 49.2 m -60.62 -49.37 77.79 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.776 HD11 ' HD3' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -47.3 -36.98 4.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.001 179.566 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.603 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 0.2 OUTLIER -62.59 -40.85 98.23 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.694 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.455 ' N ' ' O ' ' A' ' 125' ' ' THR . 0.2 OUTLIER -65.06 -33.73 76.74 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 177.992 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.706 ' CD1' HG22 ' A' ' 125' ' ' THR . 7.3 mp -68.83 -40.65 79.33 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 177.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.603 ' HB3' ' O ' ' A' ' 127' ' ' GLU . . . -44.9 -31.37 1.23 Allowed 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.587 179.477 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -51.41 -27.27 9.63 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.986 179.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.468 ' O ' ' CG ' ' A' ' 133' ' ' LYS . 1.2 m-80 -123.3 -34.67 3.08 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.211 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.484 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 46.7 mttt -169.65 -86.21 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 O-C-N 123.107 0.255 . . . . 0.0 111.641 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.484 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 0.1 OUTLIER 102.49 106.7 0.01 OUTLIER 'General case' 0 C--N 1.351 0.638 0 C-N-CA 124.37 1.068 . . . . 0.0 110.38 -179.284 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.5 mmtm -159.38 92.44 1.84 Allowed Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.329 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.776 ' HD3' HD11 ' A' ' 126' ' ' ILE . 21.1 Cg_endo -62.12 103.22 0.29 Allowed 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 122.252 1.968 . . . . 0.0 112.306 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.831 HG22 ' HB ' ' A' ' 141' ' ' THR . 1.5 mm -45.31 106.56 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.443 179.336 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.421 ' O ' ' N ' ' A' ' 141' ' ' THR . 1.6 p -67.19 141.25 96.07 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.342 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -40.42 -29.77 0.42 Allowed 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.901 2.4 . . . . 0.0 112.015 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.35 -41.12 94.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.556 179.402 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.831 ' HB ' HG22 ' A' ' 137' ' ' ILE . 47.0 m -57.39 -66.61 0.43 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.009 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.523 ' HB3' ' CE2' ' A' ' 154' ' ' TYR . . . -47.7 -49.31 28.27 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.887 0.375 . . . . 0.0 110.919 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -64.16 -33.92 76.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.432 179.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 15.6 tttt -73.71 -46.63 44.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.631 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 14.5 tp -68.24 -39.91 82.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.208 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -62.11 -35.82 79.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.666 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.7 mtp180 -90.32 -29.86 17.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.666 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -50.79 -29.52 11.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.733 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.5 mt -123.02 21.09 9.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.91 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 45.5 mttt 48.08 52.24 13.45 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.943 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.714 ' O ' HG23 ' A' ' 152' ' ' VAL . . . -59.17 -83.37 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.032 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.807 HG11 HD12 ' A' ' 111' ' ' LEU . 19.1 t -166.33 -68.38 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.285 179.355 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.04 144.04 2.06 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.144 0.497 . . . . 0.0 111.824 -179.331 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.523 ' CE2' ' HB3' ' A' ' 142' ' ' ALA . 37.1 t80 -135.96 102.57 5.08 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.138 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.733 ' HB ' HG22 ' A' ' 168' ' ' VAL . 2.3 t -105.93 167.87 3.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.328 -178.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.526 ' H ' HG12 ' A' ' 155' ' ' VAL . 5.5 tt0 -89.58 118.6 29.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.126 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.763 ' O ' HD11 ' A' ' 117' ' ' ILE . 17.9 p -144.92 -175.79 4.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.174 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 3.1 m -159.61 158.29 31.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.965 0.412 . . . . 0.0 111.576 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -115.44 -33.41 5.27 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.464 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.46 HD23 ' H ' ' A' ' 160' ' ' LEU . 0.2 OUTLIER -81.19 -34.85 32.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.65 179.699 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.0 t -113.0 -24.65 9.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.925 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 72.6 93.92 0.08 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.045 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -124.93 33.11 5.27 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.133 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 120.87 47.79 0.31 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.762 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.811 HD13 ' HB2' ' A' ' 23' ' ' TYR . 0.8 OUTLIER -56.52 -56.24 23.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.822 0.344 . . . . 0.0 110.745 179.838 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.403 ' O ' ' CB ' ' A' ' 170' ' ' ASP . 4.8 pttt -63.44 -29.14 70.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.805 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -51.54 -72.31 0.05 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.9 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.854 HG11 HG22 ' A' ' 113' ' ' VAL . 61.8 t -56.59 -53.36 42.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.994 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.562 ' CG ' HD13 ' A' ' 19' ' ' LEU . 3.2 t80 -53.24 -35.82 60.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.871 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.403 ' CB ' ' O ' ' A' ' 166' ' ' LYS . 5.3 m-20 -61.4 -40.34 94.02 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.915 0.388 . . . . 0.0 109.995 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.622 ' CB ' HD11 ' A' ' 111' ' ' LEU . 7.6 mm-40 -60.6 -34.89 74.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.163 179.297 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.513 ' CB ' HD21 ' A' ' 79' ' ' LEU . . . -62.01 -65.0 0.76 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.68 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.56 HD13 ' HG2' ' B' ' 512' ' ' GLN . 1.4 pp -59.76 -41.53 85.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.985 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.761 HD11 ' HB3' ' B' ' 506' ' ' SER . 5.2 tp -60.37 -43.77 96.25 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.006 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -54.61 -22.33 13.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.943 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -86.49 -37.78 17.92 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.122 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 1.058 HD13 HG21 ' B' ' 510' ' ' ILE . 1.9 mt -72.94 -35.88 67.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.897 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -141.79 139.46 18.42 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.949 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.45 ' HA ' ' HD2' ' A' ' 180' ' ' PRO . 53.6 Cg_endo -69.83 111.61 2.87 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.545 2.163 . . . . 0.0 112.286 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 180' ' ' PRO . . . . . 0.45 ' HD2' ' HA ' ' A' ' 179' ' ' PRO . 33.4 Cg_endo -64.35 167.05 15.55 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.355 2.036 . . . . 0.0 112.211 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -102.79 96.38 7.61 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.142 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 180' ' ' PRO . 81.0 Cg_endo -76.64 -164.93 0.28 Allowed 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.702 2.268 . . . . 0.0 112.208 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.53 83.16 4.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.901 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 14.6 mttm . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.892 179.967 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.174 0 N-CA-C 112.435 -0.266 . . . . 0.0 112.435 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 503' ' ' SER . . . . . . . . . . . . . 1.4 m -61.39 -177.23 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.812 0.339 . . . . 0.0 110.799 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 504' ' ' GLY . . . . . 0.592 ' HA2' HD22 ' A' ' 174' ' ' LEU . . . -99.78 65.27 0.62 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.387 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 505' ' ' LEU . . . . . 0.504 ' O ' HD21 ' A' ' 174' ' ' LEU . 0.3 OUTLIER -108.92 159.89 16.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.05 0.453 . . . . 0.0 111.197 -179.971 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 506' ' ' SER . . . . . 0.761 ' HB3' HD11 ' A' ' 174' ' ' LEU . 11.3 t 165.8 -44.63 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.539 -179.515 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 507' ' ' ALA . . . . . 0.599 ' HB3' HG12 ' B' ' 510' ' ' ILE . . . -47.98 -28.31 2.68 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.159 178.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 508' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 167.17 -31.82 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.373 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 509' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 172.2 37.58 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.927 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 510' ' ' ILE . . . . . 1.058 HG21 HD13 ' A' ' 177' ' ' LEU . 46.9 mm -67.53 103.24 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.913 0.387 . . . . 0.0 111.286 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 511' ' ' SER . . . . . . . . . . . . . 2.1 m -101.43 131.79 47.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.921 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 512' ' ' GLN . . . . . 0.56 ' HG2' HD13 ' A' ' 173' ' ' ILE . 0.4 OUTLIER -93.41 -64.28 0.14 Allowed Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.144 -179.919 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 513' ' ' PRO . . . . . 0.49 ' HD3' ' CB ' ' B' ' 512' ' ' GLN . 89.4 Cg_endo -81.36 67.88 8.35 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.516 2.144 . . . . 0.0 112.521 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 514' ' ' LEU . . . . . 0.512 HD22 ' HG3' ' A' ' 45' ' ' MET . 0.4 OUTLIER -81.16 -85.21 0.1 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.914 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 515' ' ' GLN . . . . . 0.411 ' HB2' HG12 ' A' ' 44' ' ' VAL . 2.3 mt-30 -93.22 -158.9 0.64 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.671 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -46.97 -27.85 1.42 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.026 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 517' ' ' SER . . . . . 0.494 ' C ' HG12 ' A' ' 42' ' ' VAL . 3.0 m 40.65 42.72 1.45 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.719 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 518' ' ' PHE . . . . . 0.473 ' CZ ' ' OH ' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -163.76 91.88 0.67 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.927 -179.951 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 519' ' ' ILE . . . . . 0.701 HD11 ' H ' ' A' ' 43' ' ' THR . 6.2 mm -87.89 -33.74 6.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.748 0.309 . . . . 0.0 111.18 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 520' ' ' HIS . . . . . 0.467 ' HA ' ' CE2' ' A' ' 40' ' ' TYR . 0.7 OUTLIER 69.72 119.37 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.898 179.994 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 521' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -165.98 51.83 0.09 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.981 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 522' ' ' GLY . . . . . . . . . . . . . . . -138.26 157.62 24.51 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.445 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 523' ' ' HIS . . . . . . . . . . . . . 37.8 t-80 -132.61 -84.74 0.47 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.662 0.268 . . . . 0.0 111.028 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 524' ' ' GLY . . . . . 0.408 ' HA3' ' HB ' ' A' ' 36' ' ' VAL . . . 66.22 176.67 7.14 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.465 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 525' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -75.05 87.42 2.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.89 0.376 . . . . 0.0 110.837 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 526' ' ' SER . . . . . 0.423 ' CB ' ' HB3' ' A' ' 34' ' ' PRO . 1.1 m -89.62 95.98 10.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.884 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 527' ' ' ASP . . . . . 0.496 ' O ' HG21 ' A' ' 33' ' ' VAL . 0.2 OUTLIER -159.13 145.71 12.58 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.939 179.864 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -68.83 105.59 1.35 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.705 2.27 . . . . 0.0 112.348 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 529' ' ' ARG . . . . . 0.534 ' HG3' HG11 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -100.31 -55.13 2.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.051 -179.885 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 530' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -165.89 97.63 0.64 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.846 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 95.5 m -46.27 171.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.121 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 532' ' ' TRP . . . . . 0.475 ' CZ2' ' HG3' ' B' ' 537' ' ' ARG . 0.0 OUTLIER -49.65 158.03 0.5 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.0 -179.886 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . -155.71 -56.82 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.534 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 534' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -94.35 142.73 25.25 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.742 0.306 . . . . 0.0 111.052 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.29 74.09 1.56 Allowed 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.63 2.22 . . . . 0.0 112.308 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 2.8 p30 172.73 143.56 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.671 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 537' ' ' ARG . . . . . 0.475 ' HG3' ' CZ2' ' B' ' 532' ' ' TRP . 2.0 mpt_? -92.85 179.93 5.32 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.203 0.525 . . . . 0.0 111.172 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 538' ' ' ILE . . . . . 0.648 HG23 HD12 ' B' ' 543' ' ' LEU . 5.0 tp -118.06 134.87 60.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.196 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 539' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -50.86 145.19 7.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.61 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 540' ' ' GLU . . . . . 0.415 ' HB3' ' OG1' ' A' ' 58' ' ' THR . 61.2 mt-10 -45.69 -44.72 13.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.454 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 541' ' ' LEU . . . . . 0.75 ' HB2' HD23 ' A' ' 70' ' ' LEU . 1.7 tt -48.43 -40.28 25.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.432 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 542' ' ' TYR . . . . . 0.476 ' HB2' HG13 ' B' ' 538' ' ' ILE . 63.2 m-85 -102.49 9.25 39.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.931 -179.209 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 543' ' ' LEU . . . . . 0.883 HD11 ' O1G' ' A' ' 185' ' ' GNP . 3.1 tp -58.64 95.74 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.781 0.324 . . . . 0.0 110.71 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . 176.23 89.09 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.506 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 545' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.854 179.935 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 185' ' ' GNP . . . . . 0.937 ' O2A' ' HB2' ' A' ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.401 ' HB2' ' HG3' ' A' ' 49' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.375 0 CA-C-O 120.761 0.315 . . . . 0.0 111.222 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -111.19 127.03 55.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.219 0.533 . . . . 0.0 110.948 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.548 HG21 ' OH ' ' A' ' 51' ' ' TYR . 36.8 m -104.19 158.2 16.61 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.739 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.836 ' CD1' HD13 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -155.25 160.34 2.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.852 -179.587 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.04 140.43 46.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.631 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.4 p -138.11 124.53 20.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.908 0.385 . . . . 0.0 111.573 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.1 t -114.04 136.57 50.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.45 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.59 HG13 ' HG2' ' B' ' 540' ' ' GLU . 2.8 p -84.84 113.52 23.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.952 0.406 . . . . 0.0 111.125 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.0 p -117.69 129.57 73.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.893 178.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.498 ' HA2' ' CE2' ' A' ' 97' ' ' TRP . . . 133.57 -160.35 23.97 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.267 -0.968 . . . . 0.0 112.455 -179.289 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -92.9 21.99 5.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.726 0.298 . . . . 0.0 111.047 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.407 ' HA3' ' HB2' ' A' ' 81' ' ' CYS . . . -76.14 160.2 51.05 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.538 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.553 ' HB1' ' O2A' ' A' ' 185' ' ' GNP . . . -53.27 -57.3 11.0 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.489 0.185 . . . . 0.0 111.296 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.726 HG13 ' H ' ' A' ' 18' ' ' CYS . 2.6 p 154.88 94.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 O-C-N 123.75 0.656 . . . . 0.0 109.908 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.599 ' HA2' HD11 ' A' ' 19' ' ' LEU . . . -47.82 -22.79 2.11 Favored Glycine 0 CA--C 1.519 0.305 0 CA-C-N 115.844 -0.616 . . . . 0.0 113.502 -179.514 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.449 ' HG2' ' HB2' ' A' ' 55' ' ' LEU . 1.6 tmtm? -70.68 -59.74 2.65 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 122.544 -0.386 . . . . 0.0 111.676 -179.401 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.591 ' CG2' HG23 ' A' ' 35' ' ' THR . 1.2 p -97.34 -39.43 9.22 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -178.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.726 ' H ' HG13 ' A' ' 14' ' ' VAL . 44.6 t -33.74 -73.49 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.182 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.71 ' CB ' HD22 ' A' ' 165' ' ' LEU . 0.3 OUTLIER -65.34 -68.22 0.38 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.827 -179.377 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.54 HD23 ' N ' ' A' ' 20' ' ' LEU . 3.5 mt -49.0 -70.22 0.1 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.802 -179.043 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.474 HG22 ' O ' ' A' ' 17' ' ' THR . 1.1 tp -43.09 -48.49 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-O 120.817 0.341 . . . . 0.0 111.619 -179.495 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.407 ' HB3' ' O ' ' A' ' 18' ' ' CYS . 35.2 t -62.48 -29.19 70.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.916 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.409 ' N ' ' O ' ' A' ' 20' ' ' LEU . 20.1 t80 -75.34 -37.43 60.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.949 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.616 HG23 HG23 ' A' ' 25' ' ' THR . 10.1 t -87.23 -49.8 7.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.06 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.616 HG23 HG23 ' A' ' 24' ' ' THR . 77.6 p -94.06 -61.77 1.47 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.88 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.404 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 15.4 t30 72.38 41.46 0.6 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.005 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -100.71 69.75 1.39 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.706 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.508 ' CE1' " H4'" ' A' ' 185' ' ' GNP . 35.3 t80 -86.77 -45.59 0.54 Allowed Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.647 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.485 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 92.7 Cg_endo -82.22 73.41 5.66 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.354 2.036 . . . . 0.0 112.481 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.3 m -172.06 -85.34 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.982 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -158.29 164.57 36.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.016 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.513 ' CE2' ' N3B' ' A' ' 185' ' ' GNP . 10.2 m-85 -130.86 124.17 30.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.488 ' HB ' ' HD3' ' A' ' 34' ' ' PRO . 1.5 t -157.1 -53.61 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.772 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.488 ' HD3' ' HB ' ' A' ' 33' ' ' VAL . 5.4 Cg_exo -74.84 56.4 4.15 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.458 2.105 . . . . 0.0 112.292 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.591 HG23 ' CG2' ' A' ' 17' ' ' THR . 18.7 m -106.95 -20.64 13.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.844 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.953 HG12 ' CB ' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -42.38 -65.13 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.767 -0.197 . . . . 0.0 110.863 179.8 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.447 ' H ' HG23 ' A' ' 36' ' ' VAL . 10.8 m-85 33.92 -88.4 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.684 0.615 . . . . 0.0 112.171 179.091 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.473 ' N ' ' O ' ' A' ' 36' ' ' VAL . 96.9 m-20 65.29 -65.46 0.16 Allowed 'General case' 0 CA--C 1.527 0.087 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.584 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.437 ' N ' ' O ' ' A' ' 37' ' ' PHE . 15.1 p30 -71.7 -4.49 27.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.772 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.485 ' CE2' ' CZ ' ' B' ' 518' ' ' PHE . 0.4 OUTLIER -59.78 95.36 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.925 0.393 . . . . 0.0 110.302 179.793 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.687 ' O ' HD13 ' B' ' 519' ' ' ILE . . . -90.36 -179.37 5.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.11 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.639 HG23 HG21 ' A' ' 52' ' ' THR . 34.5 m -144.12 161.04 15.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.083 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.8 p -125.48 105.87 9.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.173 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.911 HG22 ' CG2' ' A' ' 52' ' ' THR . 19.2 m -156.32 -177.55 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.086 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.461 ' HE1' ' N ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -100.79 97.44 8.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.532 -179.486 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 1.008 HG23 HG23 ' B' ' 510' ' ' ILE . 1.5 mm -70.91 91.08 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-O 120.824 0.345 . . . . 0.0 110.242 179.26 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 38.62 -91.81 0.01 OUTLIER Glycine 0 CA--C 1.519 0.337 0 CA-C-N 116.002 -0.545 . . . . 0.0 113.654 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . -39.85 -82.93 0.01 OUTLIER Glycine 0 C--N 1.333 0.374 0 C-N-CA 121.457 -0.402 . . . . 0.0 113.406 -179.569 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.461 ' N ' ' HE1' ' A' ' 45' ' ' MET . 2.7 mt-10 -133.99 165.7 34.75 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.786 0.327 . . . . 0.0 111.402 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.461 ' HD2' ' HB3' ' A' ' 49' ' ' GLU . 82.7 Cg_exo -48.36 104.69 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.6 2.2 . . . . 0.0 112.955 -179.531 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.548 ' OH ' HG21 ' A' ' 3' ' ' THR . 14.1 t80 -172.46 155.59 3.48 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.275 179.29 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.911 ' CG2' HG22 ' A' ' 44' ' ' VAL . 1.8 p -138.31 153.34 49.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.18 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.836 HD13 ' CD1' ' A' ' 4' ' ' ILE . 0.3 OUTLIER -110.47 99.36 8.37 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.835 179.716 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -50.97 -179.17 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.366 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.449 ' HB2' ' HG2' ' A' ' 16' ' ' LYS . 1.8 mp -139.72 97.65 3.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.853 0.359 . . . . 0.0 110.565 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -84.28 114.88 22.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.628 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.479 ' OD1' HG12 ' A' ' 8' ' ' VAL . 0.6 OUTLIER -113.97 -175.56 2.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.376 -179.883 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.483 HG22 HD13 ' A' ' 67' ' ' LEU . 18.4 p -89.67 -175.73 4.76 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.617 -179.291 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.953 ' CB ' HG12 ' A' ' 36' ' ' VAL . . . -172.26 168.15 5.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.553 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.411 ' H ' HD23 ' A' ' 61' ' ' LEU . . . -149.15 21.25 1.23 Allowed Glycine 0 C--N 1.329 0.189 0 C-N-CA 120.384 -0.912 . . . . 0.0 112.759 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.705 HD13 ' HB2' ' B' ' 526' ' ' SER . 0.2 OUTLIER -121.34 -171.59 2.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.568 0.223 . . . . 0.0 110.777 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -38.24 -31.2 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.877 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.686 ' HB2' HG11 ' A' ' 36' ' ' VAL . 0.2 OUTLIER -45.28 -63.18 1.0 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.143 179.875 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.68 ' O ' HD23 ' A' ' 67' ' ' LEU . 0.0 OUTLIER 166.82 77.48 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.981 179.777 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -62.48 -22.22 66.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.059 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.45 -21.74 10.7 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.311 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.69 HD21 ' N ' ' A' ' 59' ' ' ALA . 3.4 pp -48.02 141.29 6.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.794 0.33 . . . . 0.0 111.058 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.467 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 1.1 ptm180 -158.84 49.58 0.33 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.035 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.467 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 61.4 Cg_endo -74.4 -48.49 0.2 Allowed 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.451 2.1 . . . . 0.0 112.386 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.676 HD21 ' CB ' ' B' ' 541' ' ' LEU . 0.6 OUTLIER -51.27 -24.43 4.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.966 179.882 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 69.3 m -51.1 -30.13 15.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.854 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.432 ' N ' ' HD3' ' A' ' 73' ' ' PRO . 5.4 t80 177.3 65.04 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.821 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.432 ' HD3' ' N ' ' A' ' 72' ' ' TYR . 13.5 Cg_exo -69.3 154.62 69.3 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.706 2.271 . . . . 0.0 112.302 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.62 10.46 40.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.169 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.51 HG22 ' H ' ' A' ' 76' ' ' ASP . 1.4 m -49.5 172.82 0.02 OUTLIER 'General case' 0 C--N 1.334 -0.108 0 CA-C-O 120.849 0.357 . . . . 0.0 110.897 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.51 ' H ' HG22 ' A' ' 75' ' ' THR . 19.9 p-10 -113.89 -23.91 9.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.032 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.703 HG11 ' HB2' ' A' ' 176' ' ' ALA . 7.2 p -130.22 92.38 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.283 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.777 ' CE1' HG21 ' A' ' 108' ' ' THR . 15.2 m-85 -80.78 167.32 20.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.623 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 38.8 tp -141.88 109.06 5.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.976 0.417 . . . . 0.0 111.297 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.446 ' O ' HG23 ' A' ' 80' ' ' VAL . 29.1 m -96.93 126.51 49.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.583 179.489 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.407 ' HB2' ' HA3' ' A' ' 12' ' ' GLY . 1.6 m -116.77 158.95 23.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.161 0.505 . . . . 0.0 111.711 -179.438 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.565 ' CE2' HD12 ' A' ' 112' ' ' LEU . 41.7 p90 -147.15 -173.79 4.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.89 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.0 p -138.59 131.58 29.7 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.795 0.331 . . . . 0.0 111.116 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.715 HG21 ' HA ' ' A' ' 117' ' ' ILE . 60.9 t -47.57 -72.06 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.186 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.701 HG22 ' OE1' ' A' ' 116' ' ' GLN . 32.6 m -46.58 106.85 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.81 0.338 . . . . 0.0 110.527 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.536 ' N ' HD22 ' A' ' 129' ' ' LEU . 0.2 OUTLIER -149.99 137.35 11.49 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.551 -179.175 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.437 ' HB2' ' HB2' ' A' ' 132' ' ' ASN . 85.1 Cg_endo -91.76 53.29 0.75 Allowed 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.214 2.61 . . . . 0.0 111.778 179.49 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.467 ' CB ' ' HG3' ' A' ' 133' ' ' LYS . 0.1 OUTLIER 81.09 30.65 0.15 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.79 -179.534 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.72 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.9 OUTLIER -96.85 -25.94 15.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.063 179.972 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.767 ' CZ ' HG21 ' A' ' 137' ' ' ILE . 6.4 t80 -50.74 -59.85 3.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.061 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -50.19 -57.88 6.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.9 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -51.35 -62.73 1.44 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.867 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.72 HG23 ' O ' ' A' ' 89' ' ' SER . 60.3 t -44.55 -47.12 2.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.414 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.751 ' CG ' HD11 ' A' ' 145' ' ' LEU . 1.3 tmtt? -53.69 -51.01 64.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.705 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -84.0 6.59 21.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.486 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -110.52 -31.61 7.19 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.69 0.281 . . . . 0.0 111.021 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.589 ' O ' HG22 ' A' ' 101' ' ' ILE . 0.5 OUTLIER -94.11 -44.93 7.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.372 -179.722 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 94' ' ' LYS . 79.2 t -50.24 -46.41 83.21 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.575 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 97.5 Cg_endo -81.08 -15.13 10.53 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.288 1.992 . . . . 0.0 112.633 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -89.32 -44.96 9.85 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.872 0.368 . . . . 0.0 110.832 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.589 HG22 ' O ' ' A' ' 97' ' ' TRP . 7.5 tt -66.48 -30.65 50.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.145 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 38.9 p -83.19 -26.52 30.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.931 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.09 -51.5 53.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.904 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.407 ' O ' ' CE1' ' A' ' 72' ' ' TYR . 27.7 m170 -69.5 -44.31 71.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.979 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.409 ' O ' ' N ' ' A' ' 107' ' ' LYS . 0.6 OUTLIER -111.95 126.65 28.1 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.834 -179.961 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -57.63 81.23 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.475 2.117 . . . . 0.0 112.269 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.409 ' N ' ' O ' ' A' ' 105' ' ' CYS . 0.1 OUTLIER 53.44 97.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.895 -179.993 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.777 HG21 ' CE1' ' A' ' 78' ' ' PHE . 0.1 OUTLIER -117.85 141.26 28.86 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.804 179.998 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 108' ' ' THR . 31.8 Cg_exo -60.02 142.63 98.83 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.553 2.169 . . . . 0.0 112.412 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.794 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 1.9 p90 -147.78 136.27 21.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.816 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.989 HD12 HG11 ' A' ' 152' ' ' VAL . 4.8 tt -110.31 155.16 22.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.127 -179.638 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.656 ' O ' HD23 ' A' ' 111' ' ' LEU . 3.6 mm? -108.98 147.39 32.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.493 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.784 HG13 HG11 ' A' ' 168' ' ' VAL . 2.7 t -131.62 147.72 32.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.935 0.397 . . . . 0.0 111.855 -179.59 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.677 ' O ' HD12 ' A' ' 117' ' ' ILE . . . -125.55 100.64 0.6 Allowed Glycine 0 N--CA 1.453 -0.222 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.924 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.75 ' OG1' " H2'" ' A' ' 185' ' ' GNP . 0.1 OUTLIER -116.18 -45.05 2.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.994 0.426 . . . . 0.0 110.894 -179.205 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.701 ' OE1' HG22 ' A' ' 85' ' ' VAL . 9.3 tt0 -64.96 -10.27 27.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.054 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.715 ' HA ' HG21 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -42.93 -27.74 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-O 120.717 0.294 . . . . 0.0 111.626 179.709 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.438 ' N ' HG12 ' A' ' 117' ' ' ILE . 1.7 m-20 -71.29 -30.16 65.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.36 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.594 HD12 ' N ' ' A' ' 119' ' ' LEU . 4.8 mp -79.91 -23.18 41.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.129 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.612 ' HB3' HG11 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -44.85 -29.22 0.76 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.934 0.397 . . . . 0.0 110.941 179.975 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.4 -38.69 34.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.549 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -46.47 103.37 0.35 Allowed Pre-proline 0 C--N 1.332 -0.192 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.918 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.43 ' O ' HG22 ' A' ' 126' ' ' ILE . 47.2 Cg_endo -69.7 -7.19 20.42 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.506 2.138 . . . . 0.0 112.934 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.3 t -77.92 -66.45 0.84 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.025 0.441 . . . . 0.0 109.945 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.416 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 5.0 m -56.73 -39.01 73.16 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.048 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.463 ' HA ' ' CD1' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -53.43 -45.45 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.854 179.309 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.514 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 3.7 mt-10 -57.44 -37.18 72.4 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.008 179.37 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 125' ' ' THR . 2.3 mptp? -63.67 -30.09 71.24 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.536 HD22 ' N ' ' A' ' 86' ' ' SER . 6.7 mt -74.89 -38.08 61.97 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.07 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 127' ' ' GLU . . . -44.87 -33.64 2.03 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.948 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 9.1 mmtt -49.44 -34.42 16.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.506 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.437 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 0.6 OUTLIER -123.32 -30.92 3.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.514 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.526 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 6.7 mmtt -145.46 -101.21 0.1 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 119.109 -0.472 . . . . 0.0 111.317 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.526 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 0.9 OUTLIER 133.65 -26.2 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.331 1.052 . . . . 0.0 110.249 -179.858 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 8.9 mtpp -69.0 110.7 6.55 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.715 -179.145 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.413 ' HB2' ' HB2' ' A' ' 120' ' ' ARG . 83.2 Cg_endo -80.34 133.72 9.81 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.682 2.254 . . . . 0.0 111.484 179.223 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.767 HG21 ' CZ ' ' A' ' 90' ' ' PHE . 0.8 OUTLIER -67.26 96.62 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.901 0.381 . . . . 0.0 110.871 -179.513 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.419 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.2 p -82.97 163.68 49.94 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.816 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.494 ' HA ' ' CE1' ' A' ' 154' ' ' TYR . 86.9 Cg_exo -46.15 -40.55 21.4 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.549 2.166 . . . . 0.0 112.275 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -57.56 -52.28 66.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.752 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 7.4 m -57.21 -52.09 66.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.76 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.471 ' HB1' ' CD2' ' A' ' 154' ' ' TYR . . . -54.01 -52.66 60.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.901 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -51.08 -32.52 22.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.682 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 7.4 ttpt -66.04 -61.3 2.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.76 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.751 HD11 ' CG ' ' A' ' 94' ' ' LYS . 0.7 OUTLIER -60.75 -36.45 78.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.661 179.843 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -61.84 -41.54 97.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.973 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -87.59 -25.74 23.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.746 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -67.64 -42.21 82.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.961 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.453 HD21 HG11 ' A' ' 98' ' ' VAL . 0.1 OUTLIER -93.05 16.37 12.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.258 179.912 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.7 mttm 46.88 35.02 2.94 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.768 0.318 . . . . 0.0 111.196 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.794 ' HB1' ' O ' ' A' ' 110' ' ' PHE . . . -55.64 -82.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.09 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.989 HG11 HD12 ' A' ' 111' ' ' LEU . 56.0 t -162.28 -75.67 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.711 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.425 ' HE3' ' N ' ' A' ' 154' ' ' TYR . 0.0 OUTLIER -176.56 113.54 0.1 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.801 -178.843 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.494 ' CE1' ' HA ' ' A' ' 139' ' ' PRO . 16.5 t80 -87.84 106.75 18.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.467 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.636 ' HB ' HG22 ' A' ' 168' ' ' VAL . 0.1 OUTLIER -101.74 177.07 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.448 179.745 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -99.48 118.76 36.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.8 0.333 . . . . 0.0 111.194 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.433 ' HB3' HG23 ' A' ' 168' ' ' VAL . 7.2 p -160.16 126.37 4.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.776 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.552 ' HB3' HG22 ' A' ' 161' ' ' THR . 0.3 OUTLIER -113.09 157.11 22.01 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.249 -179.728 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.505 ' CB ' HD11 ' A' ' 165' ' ' LEU . . . -107.8 -33.39 7.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.698 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.536 ' H ' HD12 ' A' ' 160' ' ' LEU . 0.4 OUTLIER -68.64 -37.19 79.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.697 179.755 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.552 HG22 ' HB3' ' A' ' 158' ' ' SER . 14.0 t -110.74 -18.78 13.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.012 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 75.76 66.54 0.06 Allowed 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 120.856 0.36 . . . . 0.0 110.975 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.417 ' HB2' ' HB2' ' A' ' 158' ' ' SER . 0.1 OUTLIER -92.26 38.1 1.0 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.244 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.414 ' O ' ' HB2' ' A' ' 167' ' ' ASN . . . 89.48 48.89 3.59 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.97 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.71 HD22 ' CB ' ' A' ' 19' ' ' LEU . 4.3 mt -47.53 -31.6 4.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.77 0.319 . . . . 0.0 111.308 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.426 ' O ' ' N ' ' A' ' 170' ' ' ASP . 36.1 pttt -70.57 -29.67 66.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.3 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.414 ' HB2' ' O ' ' A' ' 164' ' ' GLY . 2.1 t30 -52.09 -72.36 0.05 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.852 0.358 . . . . 0.0 110.94 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.784 HG11 HG13 ' A' ' 113' ' ' VAL . 57.4 t -57.69 -50.42 77.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.919 0.39 . . . . 0.0 110.584 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.676 ' CZ ' HD13 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -54.32 -29.49 47.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.463 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 166' ' ' LYS . 6.1 m-20 -72.54 -29.28 63.43 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 178.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.523 ' CB ' HD11 ' A' ' 111' ' ' LEU . 45.1 mm-40 -73.94 -31.42 63.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.237 179.32 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.692 ' O ' HG21 ' A' ' 77' ' ' VAL . . . -67.78 -48.13 67.23 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.796 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.656 HD12 ' CD1' ' A' ' 177' ' ' LEU . 1.1 pp -73.8 -31.82 32.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.625 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.692 HD13 ' HB3' ' B' ' 505' ' ' LEU . 4.6 tp -50.57 -53.98 26.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.789 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -50.91 -25.28 4.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.824 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.703 ' HB2' HG11 ' A' ' 77' ' ' VAL . . . -83.13 -48.68 10.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.166 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.994 HD22 HG21 ' B' ' 510' ' ' ILE . 1.0 OUTLIER -68.72 -23.62 64.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.867 179.955 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.414 ' CG ' ' HD2' ' A' ' 179' ' ' PRO . 2.4 tm-20 -152.14 142.63 15.2 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.807 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.414 ' HD2' ' CG ' ' A' ' 178' ' ' GLU . 9.3 Cg_endo -52.76 117.84 4.12 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.724 2.283 . . . . 0.0 112.003 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -66.91 155.02 72.63 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.517 2.145 . . . . 0.0 112.487 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -148.01 98.13 3.83 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.804 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.21 -165.1 0.27 Allowed 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.713 2.275 . . . . 0.0 112.269 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -134.82 157.45 46.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.756 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.249 -0.882 . . . . 0.0 110.897 -179.999 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.311 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 503' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -104.65 -161.42 0.82 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.846 0.355 . . . . 0.0 110.886 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 504' ' ' GLY . . . . . 0.574 ' O ' HD22 ' A' ' 174' ' ' LEU . . . -156.92 69.58 0.27 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.727 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 505' ' ' LEU . . . . . 0.816 HD13 HD13 ' A' ' 177' ' ' LEU . 1.3 mt -133.19 -56.91 0.91 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.642 0.258 . . . . 0.0 111.254 -179.13 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 506' ' ' SER . . . . . 0.463 ' CB ' ' O ' ' B' ' 505' ' ' LEU . 5.2 t 88.95 -20.57 0.16 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.404 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 507' ' ' ALA . . . . . . . . . . . . . . . -51.46 -79.99 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.331 0.586 . . . . 0.0 110.494 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 508' ' ' GLN . . . . . 0.457 ' HB2' HD11 ' B' ' 510' ' ' ILE . 5.8 mt-30 -130.91 3.55 4.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.418 179.302 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 509' ' ' ASP . . . . . 0.441 ' CB ' ' O ' ' B' ' 508' ' ' GLN . 25.5 t0 84.41 39.03 0.03 OUTLIER 'General case' 0 C--N 1.344 0.341 0 CA-C-O 120.98 0.419 . . . . 0.0 110.946 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 510' ' ' ILE . . . . . 1.008 HG23 HG23 ' A' ' 46' ' ' ILE . 1.8 mp -68.96 73.21 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.476 179.472 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 511' ' ' SER . . . . . 0.415 ' O ' ' CD1' ' B' ' 514' ' ' LEU . 14.9 t -60.12 140.78 56.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.904 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 512' ' ' GLN . . . . . 0.495 ' CB ' ' HD3' ' B' ' 513' ' ' PRO . 0.7 OUTLIER -89.84 -64.03 0.19 Allowed Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.735 179.803 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 513' ' ' PRO . . . . . 0.495 ' HD3' ' CB ' ' B' ' 512' ' ' GLN . 88.6 Cg_endo -82.37 49.94 3.27 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.638 2.225 . . . . 0.0 112.463 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 514' ' ' LEU . . . . . 0.443 ' HB2' ' HB ' ' A' ' 44' ' ' VAL . 0.4 OUTLIER -52.88 -89.3 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.784 -179.79 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 515' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -93.2 -157.67 0.55 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -48.7 -29.44 4.44 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.139 0.495 . . . . 0.0 110.316 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 517' ' ' SER . . . . . 0.435 ' O ' ' CG1' ' A' ' 42' ' ' VAL . 14.2 p 38.15 59.48 1.39 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.101 179.43 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 518' ' ' PHE . . . . . 0.485 ' CZ ' ' CE2' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -165.06 108.41 0.86 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.734 0.302 . . . . 0.0 111.393 179.485 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 519' ' ' ILE . . . . . 0.687 HD13 ' O ' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -151.1 152.16 11.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.171 179.246 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 70.33 76.0 0.2 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.825 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 521' ' ' THR . . . . . 0.425 HG23 ' OH ' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -75.7 120.77 21.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.014 -179.951 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 522' ' ' GLY . . . . . . . . . . . . . . . -61.65 -158.26 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.389 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 523' ' ' HIS . . . . . 0.42 ' ND1' ' N ' ' B' ' 523' ' ' HIS . 0.4 OUTLIER -118.66 -83.97 0.65 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.788 0.327 . . . . 0.0 110.808 179.943 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 524' ' ' GLY . . . . . 0.444 ' CA ' HG21 ' A' ' 36' ' ' VAL . . . 67.71 122.13 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.714 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 525' ' ' ASP . . . . . 0.407 ' H ' HD12 ' A' ' 61' ' ' LEU . 18.3 m-20 -142.0 57.91 1.48 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.777 0.323 . . . . 0.0 111.067 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 526' ' ' SER . . . . . 0.705 ' HB2' HD13 ' A' ' 61' ' ' LEU . 2.9 t -78.79 96.81 5.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.754 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 527' ' ' ASP . . . . . 0.466 ' CB ' ' HD3' ' B' ' 528' ' ' PRO . 1.7 t0 -43.93 -52.52 15.05 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.679 0.276 . . . . 0.0 111.019 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 528' ' ' PRO . . . . . 0.466 ' HD3' ' CB ' ' B' ' 527' ' ' ASP . 17.7 Cg_exo -70.82 134.06 24.96 Favored 'Trans proline' 0 CA--C 1.518 -0.306 0 C-N-CA 123.125 2.55 . . . . 0.0 111.726 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 529' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -101.06 -30.02 11.84 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.986 -179.211 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 530' ' ' HIS . . . . . 0.502 ' CG ' ' O ' ' B' ' 530' ' ' HIS . 0.1 OUTLIER 70.35 5.02 5.16 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.399 179.712 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 1.2 m 52.76 -88.08 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.637 0.256 . . . . 0.0 111.011 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 532' ' ' TRP . . . . . 0.434 ' N ' ' O ' ' B' ' 530' ' ' HIS . 15.6 t90 -154.27 -45.33 0.09 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.855 0.36 . . . . 0.0 110.685 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . 67.89 -143.08 41.08 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.572 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 534' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -65.86 150.83 96.02 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.791 0.329 . . . . 0.0 110.896 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 535' ' ' PRO . . . . . 0.539 ' HB3' HG23 ' A' ' 85' ' ' VAL . 73.7 Cg_exo -49.35 -49.74 14.76 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.614 2.21 . . . . 0.0 112.247 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.49 109.19 11.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.78 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 537' ' ' ARG . . . . . 0.44 ' NH2' ' CE2' ' A' ' 32' ' ' TYR . 0.2 OUTLIER -50.38 143.11 9.31 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 120.989 0.423 . . . . 0.0 111.006 179.998 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 538' ' ' ILE . . . . . 0.488 HG13 ' HB2' ' B' ' 542' ' ' TYR . 7.4 tp -58.69 146.78 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.148 179.355 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 539' ' ' ASP . . . . . 0.41 ' HA ' ' O ' ' A' ' 10' ' ' GLY . 3.7 m-20 -46.37 140.52 4.1 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.914 0.388 . . . . 0.0 111.165 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 540' ' ' GLU . . . . . 0.59 ' HG2' HG13 ' A' ' 8' ' ' VAL . 14.0 mp0 -44.94 -27.68 0.57 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.357 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 541' ' ' LEU . . . . . 0.676 ' CB ' HD21 ' A' ' 70' ' ' LEU . 0.9 OUTLIER -55.68 -32.06 62.94 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.351 0.596 . . . . 0.0 110.147 179.615 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 542' ' ' TYR . . . . . 0.488 ' HB2' HG13 ' B' ' 538' ' ' ILE . 11.1 m-85 -105.45 0.88 27.19 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.031 -0.986 . . . . 0.0 112.171 -178.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 543' ' ' LEU . . . . . 0.71 HD21 ' HB ' ' A' ' 14' ' ' VAL . 1.6 tp -49.23 117.64 2.26 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.814 0.34 . . . . 0.0 110.679 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . 135.09 -46.83 1.02 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.505 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 545' ' ' ASN . . . . . . . . . . . . . 22.3 m120 . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.253 -0.879 . . . . 0.0 111.027 -179.933 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 185' ' ' GNP . . . . . 0.75 " H2'" ' OG1' ' A' ' 115' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' HOH . . . . . 0.434 ' O ' HG21 ' A' ' 21' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.375 0 CA-C-O 120.749 0.309 . . . . 0.0 111.216 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 57.66 160.54 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.715 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.717 HG23 ' CE1' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -119.52 -174.53 2.76 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.407 -179.632 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.609 HG23 HD23 ' A' ' 177' ' ' LEU . 25.7 pt -155.05 149.49 12.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.101 0.477 . . . . 0.0 111.991 -179.273 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 33.9 mttt -134.38 95.87 3.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.274 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -100.31 138.66 37.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.024 0.44 . . . . 0.0 111.491 -179.437 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.6 160.09 41.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.087 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.849 HG21 ' CG ' ' A' ' 16' ' ' LYS . 47.3 t -111.69 137.64 43.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.289 0.566 . . . . 0.0 112.184 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.547 HG13 ' O ' ' A' ' 8' ' ' VAL . 19.3 m -161.44 130.04 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.862 179.232 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 149.37 -144.01 11.56 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.238 -0.982 . . . . 0.0 112.62 -179.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.5 p30 -122.15 25.3 9.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.938 0.399 . . . . 0.0 110.825 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.401 ' HA2' ' HB2' ' B' ' 537' ' ' ARG . . . -157.36 -160.24 10.03 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.324 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.687 ' HB2' ' O2A' ' A' ' 185' ' ' GNP . . . -79.11 -48.18 14.79 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.556 0.217 . . . . 0.0 110.836 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.722 HG12 ' HB3' ' A' ' 81' ' ' CYS . 0.6 OUTLIER 65.59 -60.04 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.403 179.55 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.655 ' HA2' HD22 ' A' ' 19' ' ' LEU . . . -165.83 30.31 0.21 Allowed Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.849 ' CG ' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -91.01 -165.32 1.33 Allowed 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 121.232 0.539 . . . . 0.0 111.359 -179.313 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.588 ' CG2' HG23 ' A' ' 35' ' ' THR . 43.6 p -38.95 -65.85 0.33 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.478 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.431 ' O ' ' CB ' ' A' ' 22' ' ' SER . 23.6 t -32.42 -43.6 0.09 Allowed 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -178.646 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.655 HD22 ' HA2' ' A' ' 15' ' ' GLY . 2.5 mp -56.88 -71.74 0.09 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.73 0.3 . . . . 0.0 111.269 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 20' ' ' LEU . 0.3 OUTLIER -76.55 -50.3 14.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.192 -179.741 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.732 HG22 ' HB2' ' A' ' 26' ' ' ASN . 10.9 mm -48.31 -55.79 2.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.403 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.474 ' HA ' ' CB ' ' A' ' 26' ' ' ASN . 3.1 t -64.03 -43.59 95.11 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 121.092 -0.243 . . . . 0.0 111.585 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.571 ' CG ' HD13 ' A' ' 165' ' ' LEU . 0.2 OUTLIER -45.79 -35.07 4.09 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.187 0.517 . . . . 0.0 110.16 179.6 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -101.67 -33.52 9.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.279 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 173.46 127.14 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.722 0.296 . . . . 0.0 111.039 -178.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.732 ' HB2' HG22 ' A' ' 21' ' ' ILE . 61.2 t30 178.56 -43.87 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.666 178.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.6 mtmm 65.1 142.17 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.734 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.483 ' CE2' " O3'" ' A' ' 185' ' ' GNP . 0.2 OUTLIER -86.68 -49.5 0.48 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.782 179.995 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.46 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 5.8 Cg_exo -79.35 52.15 4.16 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.933 2.422 . . . . 0.0 112.248 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 77.9 p -133.87 -108.74 0.23 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.679 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -159.57 118.75 2.89 Favored 'General case' 0 N--CA 1.457 -0.098 0 O-C-N 122.169 -0.332 . . . . 0.0 111.016 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.475 ' O ' HG22 ' A' ' 33' ' ' VAL . 5.3 m-85 -90.55 121.51 32.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.391 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.499 HG11 ' HD2' ' B' ' 529' ' ' ARG . 0.2 OUTLIER -160.99 -61.98 0.02 OUTLIER Pre-proline 0 N--CA 1.468 0.434 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.363 -179.415 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.476 ' CD ' ' HB ' ' A' ' 33' ' ' VAL . 3.0 Cg_exo -34.98 -28.57 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.649 2.899 . . . . 0.0 113.653 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.588 HG23 ' CG2' ' A' ' 17' ' ' THR . 28.4 m -29.73 -38.46 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.638 ' HA ' ' HB2' ' A' ' 59' ' ' ALA . 11.5 p -50.4 -24.3 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.765 0.317 . . . . 0.0 111.373 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.471 ' CE2' ' HB3' ' A' ' 34' ' ' PRO . 7.1 m-30 -66.07 -10.02 36.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.576 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -46.26 172.62 0.01 OUTLIER 'General case' 0 C--O 1.231 0.102 0 CA-C-O 120.864 0.364 . . . . 0.0 111.159 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 75.37 5.43 4.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.303 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -60.38 -174.85 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.719 0.295 . . . . 0.0 110.607 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -110.11 124.18 51.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.586 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.722 HG23 HG21 ' A' ' 52' ' ' THR . 24.0 m -118.44 124.88 73.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.014 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.72 104.82 16.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.934 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.79 HG22 ' CG2' ' A' ' 52' ' ' THR . 12.6 m -153.23 -177.24 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.931 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.447 ' HE1' ' N ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -111.96 103.71 11.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.651 -179.537 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.645 HG22 ' O ' ' A' ' 46' ' ' ILE . 2.7 mm -74.02 86.09 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.1 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.476 ' HA3' ' HA ' ' B' ' 510' ' ' ILE . . . 43.9 -94.13 0.01 OUTLIER Glycine 0 CA--C 1.519 0.313 0 CA-C-N 115.498 -0.774 . . . . 0.0 113.636 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -38.62 -87.44 0.01 OUTLIER Glycine 0 C--N 1.332 0.356 0 C-N-CA 121.607 -0.33 . . . . 0.0 113.626 -179.132 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.447 ' N ' ' HE1' ' A' ' 45' ' ' MET . 1.8 pt-20 -125.23 164.75 30.03 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 120.708 0.289 . . . . 0.0 111.024 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.41 ' HD2' ' HB2' ' A' ' 49' ' ' GLU . 52.0 Cg_exo -54.22 106.82 0.18 Allowed 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.653 2.235 . . . . 0.0 112.289 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.717 ' CE1' HG23 ' A' ' 3' ' ' THR . 4.4 t80 -172.53 147.92 1.92 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.498 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.79 ' CG2' HG22 ' A' ' 44' ' ' VAL . 0.3 OUTLIER -137.61 154.06 49.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.624 179.706 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.718 ' N ' HD13 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -131.15 177.99 7.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.877 0.37 . . . . 0.0 111.305 -179.734 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -74.09 114.8 4.67 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.161 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.519 ' H ' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -81.15 -62.97 1.5 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.019 0.437 . . . . 0.0 110.942 -179.785 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.491 ' CD2' ' HB2' ' A' ' 55' ' ' LEU . 1.9 p90 -142.94 128.89 19.55 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.185 -179.214 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -142.26 109.6 5.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.032 0.444 . . . . 0.0 110.847 179.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.536 ' O ' HD22 ' B' ' 543' ' ' LEU . 0.0 OUTLIER -155.8 131.48 9.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.316 179.524 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.638 ' HB2' ' HA ' ' A' ' 36' ' ' VAL . . . -170.93 158.44 5.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.027 0.441 . . . . 0.0 111.613 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -131.01 19.63 4.9 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.149 179.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.535 HD23 ' HB ' ' A' ' 36' ' ' VAL . 2.5 mm? -86.22 -175.51 5.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.814 0.34 . . . . 0.0 110.779 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -46.58 -31.48 2.84 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.312 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.468 ' CB ' ' CG2' ' A' ' 36' ' ' VAL . 7.2 t0 -50.52 -62.09 1.8 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.06 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.504 ' CD1' ' N ' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -168.41 137.37 2.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.975 0.417 . . . . 0.0 111.154 -179.898 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.13 -66.23 0.92 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.786 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 17.1 mmt85 -73.22 -24.9 60.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.991 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.577 HD11 ' H ' ' A' ' 59' ' ' ALA . 1.1 mt 68.52 -94.73 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.114 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.432 ' CB ' ' HD3' ' A' ' 69' ' ' PRO . 0.0 OUTLIER 166.34 -53.9 0.0 OUTLIER Pre-proline 0 N--CA 1.465 0.287 0 CA-C-O 120.722 0.296 . . . . 0.0 111.128 179.822 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.432 ' HD3' ' CB ' ' A' ' 68' ' ' ARG . 52.8 Cg_exo -52.91 -60.41 0.73 Allowed 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.662 2.242 . . . . 0.0 112.727 -179.534 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.922 HD22 ' HA ' ' B' ' 541' ' ' LEU . 0.3 OUTLIER -58.7 -31.89 68.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.031 -179.847 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.8 t -54.6 -35.63 63.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.223 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 65.3 t80 175.39 81.57 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.669 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.515 ' HG2' ' CZ ' ' A' ' 78' ' ' PHE . 94.4 Cg_endo -81.17 136.42 10.17 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.604 2.203 . . . . 0.0 112.307 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? -90.79 10.25 26.82 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.349 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.504 HG22 ' HB2' ' A' ' 73' ' ' PRO . 4.4 t -57.74 178.45 0.08 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.808 0.337 . . . . 0.0 110.737 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -123.34 7.33 9.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.535 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.655 ' O ' HG13 ' A' ' 77' ' ' VAL . 8.9 p -152.76 101.05 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 CA-C-O 120.758 0.313 . . . . 0.0 111.321 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.515 ' CZ ' ' HG2' ' A' ' 73' ' ' PRO . 3.2 m-85 -80.61 177.65 8.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.393 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.662 HD23 HG23 ' A' ' 14' ' ' VAL . 5.9 tp -138.93 108.25 6.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.047 0.451 . . . . 0.0 111.042 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.416 HG22 ' HB2' ' A' ' 110' ' ' PHE . 19.7 m -111.04 127.01 68.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.243 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.722 ' HB3' HG12 ' A' ' 14' ' ' VAL . 13.6 p -108.21 177.19 4.88 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.604 0.716 . . . . 0.0 112.51 -178.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.655 ' HZ ' ' HB2' ' A' ' 142' ' ' ALA . 2.1 p90 -176.54 124.45 0.17 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.607 -1.178 . . . . 0.0 109.467 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.514 ' HG ' " H1'" ' A' ' 185' ' ' GNP . 60.4 m -87.89 143.65 27.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.831 0.348 . . . . 0.0 111.291 -179.28 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.782 HG13 ' N ' ' A' ' 137' ' ' ILE . 51.0 t -54.72 -53.08 35.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.748 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.762 HG11 HG21 ' A' ' 125' ' ' THR . 34.3 m -52.09 110.1 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.225 179.318 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.75 ' N ' HD22 ' A' ' 129' ' ' LEU . 0.3 OUTLIER -151.46 128.38 5.44 Favored Pre-proline 0 C--N 1.33 -0.274 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.77 -179.36 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 86' ' ' SER . 82.5 Cg_endo -92.4 53.45 0.6 Allowed 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.299 2.666 . . . . 0.0 111.498 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.468 ' CA ' ' HG3' ' A' ' 133' ' ' LYS . 1.1 p 77.87 17.81 1.29 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.141 -179.485 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.769 ' O ' HG23 ' A' ' 93' ' ' VAL . 5.0 p -97.28 -23.98 15.89 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.811 0.338 . . . . 0.0 111.066 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.453 ' CZ ' HG21 ' A' ' 137' ' ' ILE . 9.7 t80 -46.96 -46.77 21.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.186 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -50.77 -52.19 43.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.183 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.93 -40.38 83.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.168 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.769 HG23 ' O ' ' A' ' 89' ' ' SER . 62.1 t -48.36 -45.42 13.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.491 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.551 ' O ' HG23 ' A' ' 98' ' ' VAL . 3.8 ptpp? -80.32 -36.81 33.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.107 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -74.61 -11.23 60.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.589 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.17 -20.49 12.33 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.58 0.228 . . . . 0.0 111.326 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.446 ' CE3' ' HA ' ' A' ' 97' ' ' TRP . 3.3 m95 -87.0 -51.61 5.92 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.712 0.291 . . . . 0.0 111.186 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 94' ' ' LYS . 57.3 t -48.51 -47.79 69.02 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.598 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 73.4 Cg_endo -76.46 -13.65 18.39 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.169 1.913 . . . . 0.0 112.492 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -89.83 -49.17 6.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.885 0.374 . . . . 0.0 110.727 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.424 HG13 HG23 ' A' ' 102' ' ' THR . 5.8 pt -56.84 -28.16 27.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.013 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.424 HG23 HG13 ' A' ' 101' ' ' ILE . 69.5 p -93.05 -25.89 17.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.93 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -63.5 -68.59 0.33 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.758 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 10.2 m80 -64.86 -51.1 63.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.795 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 2.9 m -101.57 141.15 22.01 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.811 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -51.24 155.21 6.89 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.591 2.194 . . . . 0.0 112.209 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 16.3 mttt -53.46 90.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.872 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.44 ' HB ' ' CD1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -115.65 152.43 47.26 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.918 -179.954 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -60.86 167.83 8.08 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.686 2.257 . . . . 0.0 112.415 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.738 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 1.8 p90 -155.8 159.39 39.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.738 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 1.021 HD12 HG11 ' A' ' 152' ' ' VAL . 4.2 tt -121.03 150.03 41.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.255 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.7 ' O ' HD23 ' A' ' 111' ' ' LEU . 3.8 mm? -94.05 141.71 28.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.178 179.468 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.996 HG13 HG21 ' A' ' 168' ' ' VAL . 3.1 t -122.03 145.29 28.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.183 0.516 . . . . 0.0 112.07 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -130.51 125.78 4.71 Favored Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.093 179.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.775 ' OG1' " H2'" ' A' ' 185' ' ' GNP . 0.6 OUTLIER -144.27 -44.89 0.25 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.964 0.412 . . . . 0.0 110.752 -178.854 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.741 ' OE1' " H1'" ' A' ' 185' ' ' GNP . 0.1 OUTLIER -71.33 -2.68 17.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.23 179.26 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.653 HD13 ' C ' ' A' ' 115' ' ' THR . 0.1 OUTLIER -42.29 -28.44 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 179.935 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.18 -34.7 61.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.771 0.319 . . . . 0.0 111.131 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.557 ' N ' HD22 ' A' ' 119' ' ' LEU . 2.2 mm? -69.44 -31.78 70.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.083 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.456 ' CB ' HG11 ' A' ' 84' ' ' VAL . 0.3 OUTLIER -46.11 -29.87 1.69 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.949 -179.884 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -83.84 -31.96 25.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.505 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 119' ' ' LEU . 3.5 t0 -56.54 106.86 0.74 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.618 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.415 ' O ' ' CG ' ' A' ' 127' ' ' GLU . 14.2 Cg_exo -69.19 -3.62 12.0 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.686 2.257 . . . . 0.0 112.975 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.83 -65.24 1.04 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 121.058 0.456 . . . . 0.0 109.865 179.543 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.762 HG21 HG11 ' A' ' 85' ' ' VAL . 4.1 m -56.65 -38.95 72.86 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.532 HD11 ' HB3' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -54.34 -43.1 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.753 179.203 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.459 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 1.7 mm-40 -58.31 -37.7 75.61 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.833 179.25 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 125' ' ' THR . 2.7 mptt -63.11 -30.71 71.81 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.75 HD22 ' N ' ' A' ' 86' ' ' SER . 8.0 mt -74.88 -39.22 61.63 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.102 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 127' ' ' GLU . . . -46.57 -31.49 2.84 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.85 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.0 mmtt -50.14 -34.31 21.79 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.391 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.404 ' HB2' ' O ' ' A' ' 87' ' ' PRO . 5.0 m-80 -123.3 -31.36 3.56 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.359 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.512 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 7.6 mmtt -144.79 -98.96 0.1 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 119.15 -0.452 . . . . 0.0 111.326 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.512 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 0.0 OUTLIER 132.22 -22.79 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.401 1.08 . . . . 0.0 110.503 -179.809 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 4.5 mmtt -68.75 110.82 6.62 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.726 -179.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.532 ' HB3' HD11 ' A' ' 126' ' ' ILE . 85.2 Cg_endo -81.6 123.4 4.27 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.534 2.156 . . . . 0.0 111.394 179.303 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.782 ' N ' HG13 ' A' ' 84' ' ' VAL . 1.1 mm -55.05 96.61 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.958 0.409 . . . . 0.0 110.893 -179.466 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.44 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 74.2 p -69.09 156.59 91.25 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.028 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.44 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 9.4 Cg_endo -50.75 -41.35 54.81 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.709 2.272 . . . . 0.0 112.085 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -58.85 -34.8 72.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.583 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.409 HG21 HG23 ' A' ' 137' ' ' ILE . 84.3 m -63.62 -46.49 85.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.677 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.655 ' HB2' ' HZ ' ' A' ' 82' ' ' PHE . . . -55.6 -48.74 74.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.905 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -53.48 -43.95 68.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.73 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 6.8 mttt -54.1 -61.8 2.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.704 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.663 HD21 HD11 ' A' ' 149' ' ' LEU . 0.8 OUTLIER -61.57 -37.98 85.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.649 179.748 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.478 ' HB2' ' HG ' ' A' ' 112' ' ' LEU . . . -59.45 -49.22 78.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.861 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 16.2 mtp180 -79.68 -25.14 41.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.826 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -56.93 -40.71 76.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.447 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.663 HD11 HD21 ' A' ' 145' ' ' LEU . 1.1 mt -109.95 26.11 11.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.667 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.469 ' N ' ' CD ' ' A' ' 150' ' ' LYS . 0.0 OUTLIER 37.84 57.0 1.54 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.671 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.738 ' HB1' ' O ' ' A' ' 110' ' ' PHE . . . -73.76 -82.16 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.025 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 1.021 HG11 HD12 ' A' ' 111' ' ' LEU . 55.5 t -161.96 -76.12 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.752 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.443 ' HG3' ' N ' ' A' ' 154' ' ' TYR . 1.9 ttpt -177.01 145.91 0.5 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.343 -178.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.443 ' N ' ' HG3' ' A' ' 153' ' ' LYS . 61.3 t80 -105.66 114.48 28.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.551 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.718 HG23 ' OE2' ' A' ' 171' ' ' GLU . 11.4 t -112.91 157.94 13.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.803 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.425 ' N ' HG12 ' A' ' 155' ' ' VAL . 2.6 pt-20 -97.79 118.29 34.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.065 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.452 ' HA ' ' CB ' ' A' ' 163' ' ' LYS . 22.9 m -160.63 126.42 3.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.673 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.789 ' OG ' HD12 ' A' ' 160' ' ' LEU . 0.4 OUTLIER -147.41 153.62 39.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.916 0.389 . . . . 0.0 111.745 -179.591 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -78.47 -22.07 48.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.664 179.3 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.789 HD12 ' OG ' ' A' ' 158' ' ' SER . 0.3 OUTLIER -67.39 -59.46 3.38 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.073 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.52 HG23 ' HD3' ' A' ' 163' ' ' LYS . 3.5 t -91.92 -22.49 20.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.222 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 72.13 69.86 0.15 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.865 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.52 ' HD3' HG23 ' A' ' 161' ' ' THR . 10.3 mptt -90.81 19.37 5.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.32 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 119.13 -42.21 1.83 Allowed Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.634 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.645 HD21 ' CA ' ' A' ' 19' ' ' LEU . 1.0 OUTLIER 66.35 -66.24 0.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.783 0.325 . . . . 0.0 111.359 179.904 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.423 ' O ' ' N ' ' A' ' 170' ' ' ASP . 6.2 ptpp? -58.04 -26.08 62.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.752 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.409 ' O ' ' HB2' ' A' ' 170' ' ' ASP . 0.2 OUTLIER -54.51 -69.46 0.13 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.814 0.34 . . . . 0.0 111.06 -179.717 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.996 HG21 HG13 ' A' ' 113' ' ' VAL . 13.6 p -56.15 -44.77 79.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.142 0.496 . . . . 0.0 110.69 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.559 ' HB2' HD23 ' A' ' 19' ' ' LEU . 5.6 t80 -66.85 -17.23 64.79 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.979 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' A' ' 166' ' ' LYS . 2.8 m-20 -80.95 -38.66 27.36 Favored 'General case' 0 C--N 1.334 -0.068 0 CA-C-O 120.809 0.338 . . . . 0.0 110.699 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.744 ' CD ' HD21 ' A' ' 111' ' ' LEU . 9.4 pt-20 -69.45 -27.81 65.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.936 0.398 . . . . 0.0 110.033 179.37 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.472 ' HA ' HD13 ' A' ' 111' ' ' LEU . . . -75.69 -42.23 51.58 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.911 179.459 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.546 HD13 ' HG2' ' B' ' 512' ' ' GLN . 1.7 pp -81.58 -34.44 13.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.044 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.839 HD23 HD13 ' B' ' 505' ' ' LEU . 1.2 tm? -56.36 -44.62 80.3 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.859 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.422 ' N ' HD13 ' A' ' 174' ' ' LEU . . . -51.22 -24.78 4.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.904 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.494 ' CB ' HG22 ' A' ' 4' ' ' ILE . . . -84.84 -39.27 18.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.163 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.855 HD13 ' HB ' ' B' ' 510' ' ' ILE . 31.4 mt -68.56 -24.06 64.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.869 0.366 . . . . 0.0 110.405 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.435 ' HB2' ' HB2' ' B' ' 507' ' ' ALA . 21.7 tt0 -165.52 139.27 3.76 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.543 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.419 ' HA ' ' HD3' ' A' ' 180' ' ' PRO . 43.9 Cg_endo -68.36 108.58 1.83 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.564 2.176 . . . . 0.0 112.507 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 179' ' ' PRO . 11.8 Cg_exo -70.83 -159.51 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.734 2.29 . . . . 0.0 112.185 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -145.57 146.73 30.62 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.886 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.23 -165.32 0.3 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.686 2.258 . . . . 0.0 112.287 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.5 154.6 35.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.888 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 8.2 mttt . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.297 -0.858 . . . . 0.0 110.877 -179.967 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 112.45 -0.26 . . . . 0.0 112.45 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 503' ' ' SER . . . . . . . . . . . . . 5.7 m -74.03 -69.49 0.44 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.833 0.349 . . . . 0.0 110.782 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 504' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' B' ' 509' ' ' ASP . . . 64.09 114.67 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.684 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 505' ' ' LEU . . . . . 0.839 HD13 HD23 ' A' ' 174' ' ' LEU . 0.0 OUTLIER -148.53 -52.41 0.18 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.845 0.355 . . . . 0.0 110.709 -179.922 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 506' ' ' SER . . . . . 0.41 ' CB ' ' OE1' ' A' ' 178' ' ' GLU . 1.4 m -155.19 -161.11 1.13 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.778 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 507' ' ' ALA . . . . . 0.435 ' HB2' ' HB2' ' A' ' 178' ' ' GLU . . . 55.01 -90.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.001 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 508' ' ' GLN . . . . . 0.414 ' O ' ' CB ' ' B' ' 509' ' ' ASP . 13.1 mt-30 -132.1 3.9 4.05 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.875 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 509' ' ' ASP . . . . . 0.423 ' HA ' ' HA2' ' B' ' 504' ' ' GLY . 7.8 t70 80.71 42.44 0.05 OUTLIER 'General case' 0 C--N 1.34 0.19 0 CA-C-O 121.221 0.534 . . . . 0.0 110.012 -179.347 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 510' ' ' ILE . . . . . 0.855 ' HB ' HD13 ' A' ' 177' ' ' LEU . 11.2 mt -65.3 145.28 14.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.554 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 511' ' ' SER . . . . . . . . . . . . . 27.9 t -109.37 149.2 29.86 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.205 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 512' ' ' GLN . . . . . 0.546 ' HG2' HD13 ' A' ' 173' ' ' ILE . 0.0 OUTLIER -93.69 -53.53 0.25 Allowed Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.406 179.387 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 513' ' ' PRO . . . . . 0.458 ' HD3' ' CB ' ' B' ' 512' ' ' GLN . 55.8 Cg_endo -97.73 74.79 0.08 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 123.33 2.687 . . . . 0.0 111.813 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 514' ' ' LEU . . . . . 0.44 ' CD1' ' O ' ' A' ' 45' ' ' MET . 0.7 OUTLIER -73.33 -88.28 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.6 -179.257 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 515' ' ' GLN . . . . . 0.565 ' HB2' HG12 ' A' ' 44' ' ' VAL . 0.3 OUTLIER -87.45 -159.88 0.56 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.777 0.322 . . . . 0.0 111.006 -179.669 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -54.48 -21.24 9.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.235 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 517' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 47.24 29.14 1.14 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.821 0.343 . . . . 0.0 111.129 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 518' ' ' PHE . . . . . 0.517 ' CZ ' HD12 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -150.18 91.62 1.79 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.83 -179.749 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 519' ' ' ILE . . . . . 0.459 HG12 ' HA ' ' A' ' 42' ' ' VAL . 5.3 mm -97.79 -68.89 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.442 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -117.65 -170.0 1.78 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.946 0.403 . . . . 0.0 111.005 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 521' ' ' THR . . . . . 0.421 ' OG1' ' CG ' ' A' ' 37' ' ' PHE . 15.3 t -119.32 -159.86 0.79 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.909 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 522' ' ' GLY . . . . . . . . . . . . . . . -110.57 -92.37 2.15 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.364 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 523' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -115.41 -88.29 0.58 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.643 0.259 . . . . 0.0 111.02 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 524' ' ' GLY . . . . . . . . . . . . . . . 164.47 123.9 0.68 Allowed Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.491 -0.862 . . . . 0.0 112.643 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 525' ' ' ASP . . . . . 0.406 ' HB3' ' HG ' ' A' ' 61' ' ' LEU . 0.9 OUTLIER 177.28 46.17 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.99 0.424 . . . . 0.0 110.592 179.827 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 526' ' ' SER . . . . . 0.42 ' CB ' ' HD3' ' A' ' 34' ' ' PRO . 71.8 m -104.3 100.11 9.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.068 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 527' ' ' ASP . . . . . 0.431 ' O ' HG21 ' A' ' 33' ' ' VAL . 7.2 m-20 -156.17 164.79 20.25 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.835 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -61.09 95.69 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.588 2.192 . . . . 0.0 112.133 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 529' ' ' ARG . . . . . 0.499 ' HD2' HG11 ' A' ' 33' ' ' VAL . 2.8 mtp85 -97.67 -49.77 4.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.105 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 530' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -168.8 -41.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.158 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 2.7 m 72.71 177.02 0.26 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.772 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 532' ' ' TRP . . . . . . . . . . . . . 37.1 t90 -53.01 92.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.796 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . -114.86 -61.39 0.38 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.548 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 534' ' ' PHE . . . . . 0.4 ' HA ' ' HD3' ' B' ' 535' ' ' PRO . 44.0 m-85 -78.11 139.16 60.71 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.644 0.259 . . . . 0.0 110.875 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 535' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' B' ' 534' ' ' PHE . 50.5 Cg_exo -53.79 123.86 14.45 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.557 2.172 . . . . 0.0 112.438 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 70.31 126.8 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.027 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 537' ' ' ARG . . . . . 0.437 ' CZ ' ' O3G' ' A' ' 185' ' ' GNP . 21.3 mmt180 -54.67 122.73 11.29 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.233 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 538' ' ' ILE . . . . . 0.624 ' C ' HD13 ' B' ' 538' ' ' ILE . 0.0 OUTLIER -48.17 151.05 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.152 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 539' ' ' ASP . . . . . 0.469 ' OD2' ' CD2' ' B' ' 542' ' ' TYR . 0.7 OUTLIER -38.52 104.62 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.218 0.532 . . . . 0.0 112.224 -178.58 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 540' ' ' GLU . . . . . 0.773 ' OE2' HG11 ' A' ' 8' ' ' VAL . 1.1 mm-40 -45.25 -26.54 0.51 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.529 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 541' ' ' LEU . . . . . 0.922 ' HA ' HD22 ' A' ' 70' ' ' LEU . 42.1 mt -41.21 -35.18 0.57 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.953 0.406 . . . . 0.0 111.116 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 542' ' ' TYR . . . . . 0.469 ' CD2' ' OD2' ' B' ' 539' ' ' ASP . 4.1 m-30 -104.33 -57.25 2.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.525 179.378 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 543' ' ' LEU . . . . . 0.752 HD12 ' HA ' ' B' ' 540' ' ' GLU . 0.2 OUTLIER 62.31 176.44 0.13 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.437 -179.884 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . 103.22 79.67 1.38 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.259 -0.972 . . . . 0.0 112.574 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 545' ' ' ASN . . . . . 0.43 ' HB3' ' HB2' ' B' ' 529' ' ' ARG . 2.5 m120 . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.955 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 185' ' ' GNP . . . . . 0.775 " H2'" ' OG1' ' A' ' 115' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.427 ' HE2' ' HB2' ' A' ' 1' ' ' MET . 3.3 ppp? . . . . . 0 N--CA 1.488 1.472 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.421 ' N ' ' SD ' ' A' ' 1' ' ' MET . 50.4 tt0 61.93 132.84 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.893 0.377 . . . . 0.0 110.724 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.704 HG22 ' CD2' ' A' ' 53' ' ' LEU . 0.3 OUTLIER -133.36 -161.38 1.13 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.429 -179.679 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.883 HD13 HD22 ' A' ' 53' ' ' LEU . 0.3 OUTLIER -154.91 163.37 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -179.069 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 8.2 mtmt -111.29 136.59 50.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.041 179.224 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.424 ' HB2' HD12 ' A' ' 55' ' ' LEU . 1.0 OUTLIER -108.32 138.73 44.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.063 0.459 . . . . 0.0 111.66 -179.356 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -151.11 160.41 3.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.098 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.498 HG11 ' CA ' ' A' ' 14' ' ' VAL . 3.3 m -143.24 139.95 26.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.845 0.355 . . . . 0.0 111.726 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.447 HG12 HD13 ' A' ' 70' ' ' LEU . 14.8 m -143.27 131.04 18.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.083 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.25 -110.11 3.92 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.623 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.73 -23.85 24.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.716 0.293 . . . . 0.0 110.92 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -49.43 150.56 4.32 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.617 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.773 ' O ' HG13 ' A' ' 14' ' ' VAL . . . -91.53 -56.35 3.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.549 0.214 . . . . 0.0 111.158 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.773 HG13 ' O ' ' A' ' 13' ' ' ALA . 0.0 OUTLIER 170.75 -56.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.788 179.584 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.659 ' HA2' HD13 ' A' ' 19' ' ' LEU . . . 110.25 -16.29 29.85 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.419 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.846 ' O ' HD23 ' A' ' 20' ' ' LEU . 15.4 tptm -93.44 -50.04 5.63 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.782 0.325 . . . . 0.0 111.076 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.632 HG21 ' OG1' ' A' ' 35' ' ' THR . 0.6 OUTLIER -97.81 -71.2 0.69 Allowed 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.525 -179.516 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.438 ' HA ' HG12 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -34.61 -74.18 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -178.823 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.737 HD22 ' CD1' ' A' ' 169' ' ' PHE . 7.8 mp -47.43 -39.21 15.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.058 -179.031 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.846 HD23 ' O ' ' A' ' 16' ' ' LYS . 3.1 mm? -76.9 -20.88 55.69 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.982 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.443 ' N ' ' O ' ' A' ' 17' ' ' THR . 9.1 mm -61.09 -69.64 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.439 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 74.8 m -56.55 -32.95 65.66 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.514 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.488 ' HB2' HD13 ' A' ' 165' ' ' LEU . 42.2 t80 -56.99 -68.38 0.23 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.026 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.3 m -76.65 -45.99 27.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.666 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.442 ' N ' ' O ' ' A' ' 21' ' ' ILE . 1.6 p -92.41 -155.91 0.44 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.435 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -155.75 23.8 0.39 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.776 0.322 . . . . 0.0 111.098 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.33 100.22 9.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.947 0.403 . . . . 0.0 111.39 -179.679 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.491 ' HE2' HD21 ' A' ' 119' ' ' LEU . 0.1 OUTLIER -87.86 -64.95 0.2 Allowed Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.095 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.487 ' HD3' ' CD2' ' A' ' 28' ' ' PHE . 93.0 Cg_endo -81.72 54.16 4.96 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.597 2.198 . . . . 0.0 111.983 179.341 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.414 ' O ' ' HG3' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -97.17 -84.96 0.36 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.864 -179.64 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.417 ' HA ' ' HA ' ' B' ' 531' ' ' CYS . 27.0 mt-10 -149.52 126.49 11.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.041 0.448 . . . . 0.0 111.873 -179.75 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.527 ' HA ' ' PG ' ' A' ' 185' ' ' GNP . 3.1 m-85 -105.15 93.34 4.64 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.591 178.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.569 HG23 ' CD ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -165.81 -64.56 0.01 OUTLIER Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.253 -179.177 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.569 ' CD ' HG23 ' A' ' 33' ' ' VAL . 55.2 Cg_endo -70.78 56.7 1.86 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.599 2.199 . . . . 0.0 112.891 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.632 ' OG1' HG21 ' A' ' 17' ' ' THR . 7.3 t -121.75 26.35 8.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.993 0.425 . . . . 0.0 110.52 179.523 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.768 HG22 HD23 ' A' ' 61' ' ' LEU . 1.8 t -80.46 -5.66 8.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.888 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.454 ' HB3' ' N ' ' B' ' 522' ' ' GLY . 29.5 p90 -93.98 26.54 3.17 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.785 0.326 . . . . 0.0 111.142 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.1 p30 -70.3 -19.25 63.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.12 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -100.11 11.12 40.11 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.514 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.468 ' CE1' ' HA2' ' B' ' 522' ' ' GLY . 1.0 OUTLIER -60.66 -159.42 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 120.685 0.278 . . . . 0.0 110.664 179.894 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.41 ' O ' HG12 ' B' ' 519' ' ' ILE . . . -117.82 156.26 28.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.543 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.421 HG12 ' C ' ' B' ' 517' ' ' SER . 0.5 OUTLIER -140.56 126.13 20.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.883 179.725 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.737 ' O ' HG23 ' A' ' 44' ' ' VAL . 9.9 t -85.51 104.49 15.34 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.929 0.395 . . . . 0.0 110.592 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.939 ' CG1' HD13 ' B' ' 514' ' ' LEU . 2.8 t -164.63 158.1 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.818 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.487 ' HG3' HD22 ' B' ' 514' ' ' LEU . 0.0 OUTLIER -112.75 118.83 36.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.599 178.758 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.87 HG23 HG23 ' B' ' 510' ' ' ILE . 1.4 mm -79.65 86.81 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.441 -179.185 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 54.68 -76.16 0.01 OUTLIER Glycine 0 CA--C 1.521 0.464 0 CA-C-N 115.678 -0.692 . . . . 0.0 114.353 178.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . -57.55 -95.91 0.01 OUTLIER Glycine 0 CA--C 1.518 0.272 0 C-N-CA 121.099 -0.572 . . . . 0.0 113.559 -179.042 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.438 ' HB2' ' HD2' ' A' ' 50' ' ' PRO . 0.3 OUTLIER -115.93 163.83 19.84 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-O 120.736 0.303 . . . . 0.0 111.311 -179.154 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.438 ' HD2' ' HB2' ' A' ' 49' ' ' GLU . 57.8 Cg_exo -51.6 100.38 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.483 2.122 . . . . 0.0 112.39 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.437 ' HE1' HG21 ' A' ' 3' ' ' THR . 3.5 t80 -172.2 118.61 0.39 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.227 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.774 HG21 ' HB ' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -113.95 138.64 50.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.49 179.807 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.883 HD22 HD13 ' A' ' 4' ' ' ILE . 0.3 OUTLIER -70.7 109.07 4.71 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.375 -179.463 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -61.22 94.73 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.613 179.316 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.833 HD23 ' HD3' ' A' ' 16' ' ' LYS . 0.9 OUTLIER -41.56 110.95 0.19 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.853 0.359 . . . . 0.0 111.179 -179.398 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -83.74 104.97 14.28 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.884 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.692 ' CG ' HG12 ' A' ' 14' ' ' VAL . 17.1 m-20 -131.56 174.89 9.64 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.001 -179.322 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.657 ' HA ' HD11 ' A' ' 67' ' ' LEU . 0.1 OUTLIER -144.77 143.92 30.91 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.935 -179.395 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.725 ' HB1' HD23 ' A' ' 61' ' ' LEU . . . -140.66 125.46 18.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.046 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.4 ' C ' HD22 ' A' ' 61' ' ' LEU . . . -75.66 66.19 2.41 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.728 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.768 HD23 HG22 ' A' ' 36' ' ' VAL . 3.0 mm? -121.23 -176.98 3.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.905 0.383 . . . . 0.0 110.978 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -52.79 -45.93 67.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.012 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.414 ' HB3' ' CE2' ' A' ' 64' ' ' TYR . 0.2 OUTLIER -50.68 -38.01 44.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.951 -179.959 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.726 ' HE2' HG12 ' A' ' 36' ' ' VAL . 1.4 m-85 -145.02 97.13 2.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.788 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -86.02 -37.54 18.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.211 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -97.51 4.27 50.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.781 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.731 HD23 ' O ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -62.15 133.66 55.53 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.764 0.316 . . . . 0.0 110.266 179.672 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -174.84 60.05 0.22 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.249 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.562 ' HD2' HG21 ' A' ' 58' ' ' THR . 62.4 Cg_endo -73.18 -23.23 18.24 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.567 2.178 . . . . 0.0 112.03 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.71 ' O ' HD12 ' A' ' 70' ' ' LEU . 0.3 OUTLIER -59.24 -20.19 52.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.096 -179.964 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.9 p -50.77 -42.89 58.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.169 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -160.68 69.91 2.76 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.031 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.421 ' HD3' ' O ' ' A' ' 70' ' ' LEU . 73.7 Cg_endo -75.19 149.58 36.14 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.653 2.235 . . . . 0.0 112.32 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.49 10.48 40.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.42 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.3 t -48.96 176.01 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.864 0.364 . . . . 0.0 110.897 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -109.39 -24.16 11.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.985 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.0 p -134.26 143.34 38.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.278 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.408 ' HB2' ' O ' ' A' ' 109' ' ' PRO . 0.1 OUTLIER -125.84 174.48 8.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.627 179.732 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.516 HD11 HG23 ' A' ' 113' ' ' VAL . 46.4 tp -146.51 109.28 4.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.892 0.377 . . . . 0.0 111.238 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.657 HG11 HD11 ' A' ' 101' ' ' ILE . 31.1 m -98.79 115.36 39.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.633 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 3.6 m -108.29 168.07 9.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.094 0.473 . . . . 0.0 111.655 -179.343 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.435 ' O ' ' N1 ' ' A' ' 185' ' ' GNP . 10.8 p90 -169.75 135.9 1.53 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.353 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.432 ' HA ' ' C2 ' ' A' ' 185' ' ' GNP . 4.9 p -83.17 141.17 32.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.035 0.445 . . . . 0.0 111.562 -179.19 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.782 HG12 ' O ' ' A' ' 137' ' ' ILE . 16.4 m -57.05 -31.47 37.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.243 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.74 HG11 HG21 ' A' ' 125' ' ' THR . 9.5 m -78.02 117.23 22.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.235 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.757 ' N ' HD22 ' A' ' 129' ' ' LEU . 0.4 OUTLIER -151.71 142.83 15.49 Favored Pre-proline 0 C--N 1.333 -0.151 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -179.141 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 86' ' ' SER . 69.4 Cg_endo -92.45 53.93 0.59 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 123.406 2.737 . . . . 0.0 111.614 179.117 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.445 ' CB ' ' HB2' ' A' ' 133' ' ' LYS . 0.3 OUTLIER 71.0 19.77 5.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.99 -179.297 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.711 ' O ' HG23 ' A' ' 93' ' ' VAL . 58.8 m -97.2 -21.59 17.21 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.741 0.305 . . . . 0.0 111.115 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.542 ' CZ ' HG21 ' A' ' 137' ' ' ILE . 17.4 t80 -47.48 -58.87 3.7 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.169 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.7 -39.29 36.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.868 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.419 ' O ' ' CD ' ' A' ' 96' ' ' LYS . 1.0 OUTLIER -72.52 -43.22 63.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.759 179.795 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.711 HG23 ' O ' ' A' ' 89' ' ' SER . 77.0 t -50.21 -63.47 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.051 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.81 ' HG2' HD13 ' A' ' 145' ' ' LEU . 0.0 OUTLIER -58.3 -39.32 79.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.913 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -65.81 -25.33 67.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.977 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.419 ' CD ' ' O ' ' A' ' 92' ' ' ASN . 1.4 mtpm? -100.06 -24.27 14.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.0 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.434 ' CE3' ' HA ' ' A' ' 97' ' ' TRP . 0.0 OUTLIER -67.18 -58.73 4.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.05 -179.853 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.544 HG21 HD13 ' A' ' 149' ' ' LEU . 95.4 t -45.57 -53.5 19.01 Favored Pre-proline 0 CA--C 1.532 0.26 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.814 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 51.9 Cg_endo -68.66 -14.43 39.35 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.173 1.915 . . . . 0.0 112.628 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -86.66 -35.66 19.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.87 0.367 . . . . 0.0 111.054 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.657 HD11 HG11 ' A' ' 80' ' ' VAL . 30.3 mt -78.31 -33.01 17.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.284 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.515 HG23 ' O ' ' A' ' 98' ' ' VAL . 22.9 p -84.76 -21.69 29.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.215 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 19.9 t-80 -87.63 -51.62 5.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.815 0.34 . . . . 0.0 110.96 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -80.54 -29.76 37.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.093 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -117.11 147.27 39.92 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.924 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.48 60.58 2.07 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.514 2.143 . . . . 0.0 112.288 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 59.12 67.56 0.9 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.966 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -90.84 146.79 34.6 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.744 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.408 ' O ' ' HB2' ' A' ' 78' ' ' PHE . 36.0 Cg_exo -60.7 169.17 5.89 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.505 2.137 . . . . 0.0 112.314 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.565 ' HB2' HG22 ' A' ' 80' ' ' VAL . 2.9 p90 -162.2 134.63 5.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.877 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.955 HD12 HG11 ' A' ' 152' ' ' VAL . 8.5 tt -119.93 154.53 34.3 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.997 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.596 ' N ' HD23 ' A' ' 111' ' ' LEU . 2.9 mm? -100.69 137.3 39.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.685 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 1.019 HG13 HG21 ' A' ' 168' ' ' VAL . 49.9 t -120.76 148.02 24.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.989 0.423 . . . . 0.0 111.373 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 157' ' ' CYS . . . -130.09 107.74 0.8 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.765 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.858 ' OG1' " H2'" ' A' ' 185' ' ' GNP . 0.0 OUTLIER -125.01 -41.14 2.11 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.909 0.385 . . . . 0.0 110.595 -179.106 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.736 ' HB3' HG22 ' A' ' 84' ' ' VAL . 2.1 tt0 -78.28 1.96 19.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.127 179.332 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.407 ' O ' ' CG ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -46.55 -26.23 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.094 0 CA-C-O 120.775 0.322 . . . . 0.0 111.562 179.929 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -75.52 -25.88 57.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.492 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.665 HD22 HE21 ' A' ' 116' ' ' GLN . 3.9 mp -83.95 -25.61 29.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.124 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.474 ' HB3' HG21 ' A' ' 84' ' ' VAL . 5.8 ppt_? -50.36 -25.52 3.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.978 0.418 . . . . 0.0 110.629 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -87.79 -25.82 23.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.574 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -61.33 112.19 5.5 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.767 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.418 ' O ' HG22 ' A' ' 126' ' ' ILE . 40.0 Cg_endo -67.92 -6.27 16.59 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.513 2.142 . . . . 0.0 113.114 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -77.39 -68.49 0.61 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.024 0.44 . . . . 0.0 109.929 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.74 HG21 HG11 ' A' ' 85' ' ' VAL . 4.8 m -56.71 -35.41 68.49 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.31 0.576 . . . . 0.0 109.556 179.117 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.721 HD11 ' HG3' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -57.53 -44.04 84.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.55 179.231 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' A' ' 123' ' ' PRO . 4.2 mm-40 -55.69 -36.85 67.61 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.469 179.099 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.426 ' HB2' ' O ' ' A' ' 125' ' ' THR . 0.0 OUTLIER -64.04 -31.3 72.44 Favored 'General case' 0 CA--C 1.518 -0.25 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.554 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.757 HD22 ' N ' ' A' ' 86' ' ' SER . 7.6 mt -74.0 -42.06 60.95 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.499 ' HA ' ' HB3' ' A' ' 134' ' ' GLN . . . -47.21 -28.97 2.09 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.956 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 31.4 mmtt -56.54 -34.12 66.75 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.753 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.412 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 1.7 m-80 -124.36 -31.33 3.3 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.582 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.508 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 0.0 OUTLIER -137.42 -75.6 0.41 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 121.037 -0.265 . . . . 0.0 111.306 -179.009 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.508 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 3.0 pt20 111.53 -45.21 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.607 1.163 . . . . 0.0 111.016 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.5 mttp -69.81 111.06 7.8 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.91 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.91 ' C ' HD13 ' A' ' 137' ' ' ILE . 69.9 Cg_endo -72.43 -169.89 0.52 Allowed 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.353 2.036 . . . . 0.0 111.218 178.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.91 HD13 ' C ' ' A' ' 136' ' ' PRO . 1.1 mm -114.03 97.03 5.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.904 0.383 . . . . 0.0 110.99 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.428 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 3.0 p -67.3 155.63 90.27 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.943 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.463 ' HA ' ' CE2' ' A' ' 154' ' ' TYR . 10.2 Cg_endo -51.66 -38.68 66.34 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.747 2.298 . . . . 0.0 112.098 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.422 ' HG3' ' N ' ' A' ' 141' ' ' THR . 0.0 OUTLIER -64.73 -25.96 68.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.664 179.69 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.422 ' N ' ' HG3' ' A' ' 140' ' ' GLU . 45.5 m -71.82 -47.4 53.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.787 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.492 ' O ' ' HB2' ' A' ' 146' ' ' ALA . . . -55.21 -39.2 69.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.877 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -68.04 -41.96 81.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.818 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -53.25 -60.6 3.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.867 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.81 HD13 ' HG2' ' A' ' 94' ' ' LYS . 1.6 tt -66.91 -39.8 87.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.64 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.492 ' HB2' ' O ' ' A' ' 142' ' ' ALA . . . -48.94 -50.37 35.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.927 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 19.2 mtp180 -78.76 -24.14 44.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.704 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -49.62 -34.78 19.03 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.88 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.544 HD13 HG21 ' A' ' 98' ' ' VAL . 1.6 mt -121.5 21.78 10.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.893 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.1 mttp 47.84 57.5 5.95 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.059 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.534 ' HB1' ' O ' ' A' ' 110' ' ' PHE . . . -70.58 -82.69 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.214 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.955 HG11 HD12 ' A' ' 111' ' ' LEU . 72.9 t -161.81 -73.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.842 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 179.5 146.35 0.2 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.61 -178.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.463 ' CE2' ' HA ' ' A' ' 139' ' ' PRO . 65.0 t80 -112.79 103.69 11.7 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.305 179.396 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.601 HG12 ' H ' ' A' ' 156' ' ' GLU . 0.6 OUTLIER -102.99 -179.96 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.744 -179.788 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.601 ' H ' HG12 ' A' ' 155' ' ' VAL . 0.0 OUTLIER -89.6 151.3 21.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.921 0.391 . . . . 0.0 111.099 -179.797 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.491 ' CB ' HG22 ' A' ' 115' ' ' THR . 1.9 t -128.97 169.22 14.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.883 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.497 ' O ' ' HB2' ' A' ' 159' ' ' ALA . 2.2 t -106.99 151.46 25.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.203 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.938 ' O ' HD13 ' A' ' 160' ' ' LEU . . . 172.68 -33.96 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.77 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.938 HD13 ' O ' ' A' ' 159' ' ' ALA . 0.2 OUTLIER -131.09 -44.35 1.04 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.7 179.753 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 9.7 t -100.08 -21.69 15.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.091 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.437 ' HA ' ' CB ' ' A' ' 158' ' ' SER . 1.9 tt0 72.89 77.7 0.14 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.955 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.458 ' HE3' ' CB ' ' A' ' 156' ' ' GLU . 0.0 OUTLIER -97.35 10.44 39.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.569 -179.948 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.406 ' O ' ' CB ' ' A' ' 165' ' ' LEU . . . 116.25 -50.85 0.76 Allowed Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.428 -0.892 . . . . 0.0 113.336 179.465 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.566 HD21 ' HA ' ' A' ' 19' ' ' LEU . 0.2 OUTLIER 79.54 -56.6 0.4 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.8 0.333 . . . . 0.0 110.8 -179.433 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -56.8 -21.32 27.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.791 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.409 ' OD1' HG11 ' A' ' 155' ' ' VAL . 0.6 OUTLIER -55.32 -72.18 0.07 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.014 179.889 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 1.019 HG21 HG13 ' A' ' 113' ' ' VAL . 29.0 m -57.9 -40.79 77.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.036 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.737 ' CD1' HD22 ' A' ' 19' ' ' LEU . 1.4 t80 -63.58 -34.67 78.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.734 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.41 ' HA ' ' CG1' ' A' ' 173' ' ' ILE . 13.2 m-20 -74.64 -24.89 58.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.659 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.517 ' CG ' HD11 ' A' ' 111' ' ' LEU . 5.1 tp10 -79.41 -33.41 42.69 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.59 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.582 ' N ' HD13 ' A' ' 111' ' ' LEU . . . -73.23 -35.25 66.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.685 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.537 HD12 HD12 ' A' ' 177' ' ' LEU . 1.4 pp -82.78 -32.51 9.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.891 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.807 HD13 ' CB ' ' B' ' 505' ' ' LEU . 13.6 tp -54.68 -47.34 73.75 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.211 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -47.5 -26.89 1.54 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.113 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.659 ' HB3' ' CG2' ' A' ' 4' ' ' ILE . . . -93.9 -37.12 11.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.173 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.796 ' CD1' HG21 ' B' ' 510' ' ' ILE . 43.3 mt -68.71 -24.2 64.46 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.663 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.416 ' HG3' ' N ' ' B' ' 507' ' ' ALA . 1.6 tm-20 -160.52 128.74 2.89 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.684 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.69 106.9 0.19 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.44 2.093 . . . . 0.0 112.333 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.19 176.48 9.89 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.557 2.171 . . . . 0.0 112.248 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -139.79 141.89 29.26 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.966 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.35 -165.04 0.29 Allowed 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.718 2.279 . . . . 0.0 112.227 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.08 173.87 1.01 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.018 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.289 -0.862 . . . . 0.0 110.882 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.153 0 N-CA-C 112.421 -0.272 . . . . 0.0 112.421 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 503' ' ' SER . . . . . 0.415 ' HB2' ' HA ' ' B' ' 511' ' ' SER . 0.5 OUTLIER -87.4 -80.66 0.25 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.809 0.338 . . . . 0.0 110.908 179.943 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 504' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' B' ' 509' ' ' ASP . . . 102.6 113.09 3.72 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.541 -0.838 . . . . 0.0 111.941 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 505' ' ' LEU . . . . . 0.807 ' CB ' HD13 ' A' ' 174' ' ' LEU . 0.1 OUTLIER -139.03 -42.28 0.47 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 121.053 -0.259 . . . . 0.0 111.681 -179.195 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 506' ' ' SER . . . . . 0.435 ' CB ' ' O ' ' B' ' 505' ' ' LEU . 0.4 OUTLIER 162.74 -44.98 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.668 0.27 . . . . 0.0 110.741 -179.678 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 507' ' ' ALA . . . . . 0.506 ' HB3' HG12 ' B' ' 510' ' ' ILE . . . -37.58 -35.23 0.12 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.627 0.727 . . . . 0.0 111.109 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 508' ' ' GLN . . . . . 0.493 ' O ' ' HB2' ' B' ' 509' ' ' ASP . 7.3 pt20 165.79 -37.94 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.555 -1.202 . . . . 0.0 108.634 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 509' ' ' ASP . . . . . 0.493 ' HB2' ' O ' ' B' ' 508' ' ' GLN . 13.7 t0 148.21 44.92 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 114.201 -1.363 . . . . 0.0 109.394 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 510' ' ' ILE . . . . . 0.87 HG23 HG23 ' A' ' 46' ' ' ILE . 19.9 mm -55.18 133.65 18.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.406 -179.624 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 511' ' ' SER . . . . . 0.48 ' HB3' HD11 ' B' ' 514' ' ' LEU . 30.2 t -109.59 134.82 51.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.836 179.559 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 512' ' ' GLN . . . . . 0.438 ' CB ' ' HD3' ' B' ' 513' ' ' PRO . 0.0 OUTLIER -99.47 -53.65 0.18 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.134 179.735 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 513' ' ' PRO . . . . . 0.438 ' HD3' ' CB ' ' B' ' 512' ' ' GLN . 91.0 Cg_endo -94.91 78.19 0.15 Allowed 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 123.152 2.568 . . . . 0.0 112.525 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 514' ' ' LEU . . . . . 0.939 HD13 ' CG1' ' A' ' 44' ' ' VAL . 4.7 mp -89.23 -89.88 0.14 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.227 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 515' ' ' GLN . . . . . 0.651 ' H ' HG22 ' A' ' 44' ' ' VAL . 6.4 mt-30 -93.4 47.31 1.24 Allowed 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 116.744 -0.207 . . . . 0.0 111.13 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 516' ' ' ASN . . . . . 0.546 ' HB3' ' O ' ' B' ' 515' ' ' GLN . 22.0 t-20 77.7 -38.23 0.26 Allowed 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 517' ' ' SER . . . . . 0.421 ' C ' HG12 ' A' ' 42' ' ' VAL . 0.5 OUTLIER 61.24 54.33 3.27 Favored 'General case' 0 C--O 1.232 0.15 0 O-C-N 122.24 -0.287 . . . . 0.0 111.452 179.554 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 518' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -163.54 92.73 0.72 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.894 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 519' ' ' ILE . . . . . 0.689 HD11 ' H ' ' A' ' 43' ' ' THR . 22.4 mm -71.16 -69.13 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.089 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -160.47 -170.44 2.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.94 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 521' ' ' THR . . . . . 0.454 ' O ' ' CZ ' ' A' ' 40' ' ' TYR . 13.8 t -77.32 -168.37 1.12 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.058 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 522' ' ' GLY . . . . . 0.468 ' HA2' ' CE1' ' A' ' 40' ' ' TYR . . . -121.41 -75.12 0.37 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.38 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 523' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 178.98 -88.21 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.555 0.217 . . . . 0.0 110.902 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 524' ' ' GLY . . . . . 0.506 ' HA3' HG21 ' A' ' 36' ' ' VAL . . . 46.77 -139.5 7.53 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.778 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 525' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -137.99 82.85 1.94 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.837 0.351 . . . . 0.0 110.784 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 526' ' ' SER . . . . . 0.465 ' CB ' ' HB3' ' A' ' 34' ' ' PRO . 6.5 m -72.17 95.75 1.7 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.757 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 527' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -145.96 142.42 17.78 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.016 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.21 105.29 2.0 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.671 2.248 . . . . 0.0 112.113 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 529' ' ' ARG . . . . . 0.471 ' HG3' HG11 ' A' ' 33' ' ' VAL . 2.3 mtt-85 -100.27 -55.38 2.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.307 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 530' ' ' HIS . . . . . 0.418 ' O ' ' CB ' ' B' ' 531' ' ' CYS . 0.0 OUTLIER -130.57 -38.12 1.34 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.486 -179.592 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 531' ' ' CYS . . . . . 0.418 ' CB ' ' O ' ' B' ' 530' ' ' HIS . 4.0 m 79.49 28.74 0.34 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.988 0.423 . . . . 0.0 110.604 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 532' ' ' TRP . . . . . 0.439 ' CH2' ' HG3' ' B' ' 537' ' ' ARG . 1.7 t-105 59.28 103.28 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.035 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . -114.55 -24.31 4.42 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.278 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 534' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -133.47 130.97 21.2 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.489 0.185 . . . . 0.0 110.597 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.49 -170.03 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.458 2.106 . . . . 0.0 112.504 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 68.22 120.86 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.004 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 537' ' ' ARG . . . . . 0.439 ' HG3' ' CH2' ' B' ' 532' ' ' TRP . 0.0 OUTLIER -106.23 -179.32 3.91 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 121.599 0.714 . . . . 0.0 111.259 179.916 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 538' ' ' ILE . . . . . 0.433 HG12 ' HB2' ' B' ' 542' ' ' TYR . 1.2 tt -116.02 174.47 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 CA-C-N 114.594 -1.184 . . . . 0.0 109.891 179.578 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 539' ' ' ASP . . . . . 0.469 ' HB3' HD22 ' A' ' 70' ' ' LEU . 0.3 OUTLIER -69.8 162.3 28.14 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.482 179.851 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 540' ' ' GLU . . . . . 0.427 ' CB ' ' OG1' ' A' ' 58' ' ' THR . 2.4 mt-10 -40.38 -49.08 2.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.841 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 541' ' ' LEU . . . . . . . . . . . . . 1.1 tt -42.28 -67.91 0.23 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.797 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 542' ' ' TYR . . . . . 0.433 ' HB2' HG12 ' B' ' 538' ' ' ILE . 59.2 m-85 -84.57 9.62 13.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.981 -179.17 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 543' ' ' LEU . . . . . 0.421 ' HB2' ' HA ' ' B' ' 540' ' ' GLU . 16.5 tp -44.92 -28.47 0.67 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.834 0.35 . . . . 0.0 111.283 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . -72.52 77.91 0.74 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.548 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 545' ' ' ASN . . . . . 0.461 ' HB2' HG13 ' A' ' 33' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.975 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 185' ' ' GNP . . . . . 0.858 " H2'" ' OG1' ' A' ' 115' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 188' ' ' HOH . . . . . 0.406 ' O ' ' HB2' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.431 ' HB3' ' N ' ' A' ' 49' ' ' GLU . 2.6 ppp? . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.828 0.347 . . . . 0.0 111.264 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.423 ' CG ' HD11 ' B' ' 510' ' ' ILE . 0.2 OUTLIER -129.44 141.17 51.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.52 179.464 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.807 HG23 ' CE1' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -94.06 168.78 10.72 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.983 -179.815 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.551 ' HA ' ' HB1' ' A' ' 176' ' ' ALA . 2.3 pt -151.03 154.39 8.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.659 -179.118 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -121.03 110.38 16.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.397 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.463 ' SG ' HD23 ' A' ' 55' ' ' LEU . 40.1 m -91.61 107.4 19.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.004 0.43 . . . . 0.0 111.589 -179.388 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.452 HG22 ' CZ ' ' A' ' 56' ' ' PHE . 2.9 t -138.0 113.65 10.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.254 179.334 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.78 ' CG2' HG21 ' A' ' 14' ' ' VAL . 2.4 p -87.24 150.14 3.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.308 0.575 . . . . 0.0 111.436 -179.445 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.53 ' CG2' ' CE1' ' A' ' 78' ' ' PHE . 72.5 t -155.06 130.23 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.637 179.132 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.72 148.13 4.75 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.131 -1.033 . . . . 0.0 112.711 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -58.17 -42.18 85.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.893 0.378 . . . . 0.0 110.394 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.26 -149.94 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.701 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.741 ' HB3' ' H8 ' ' A' ' 185' ' ' GNP . . . -103.1 -55.86 2.33 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.274 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.958 HG22 ' HB3' ' A' ' 81' ' ' CYS . 3.5 t 84.13 -51.52 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.264 -0.425 . . . . 0.0 109.949 -178.481 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.676 ' C ' HD12 ' A' ' 19' ' ' LEU . . . 90.49 25.48 25.67 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.857 -0.687 . . . . 0.0 113.045 179.041 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.447 ' HE2' ' N ' ' A' ' 8' ' ' VAL . 0.7 OUTLIER -38.58 -43.2 0.85 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.11 0.481 . . . . 0.0 111.017 179.749 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.534 HG22 ' CG ' ' A' ' 38' ' ' ASP . 81.9 p -98.47 -60.98 1.44 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.278 178.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.48 ' HA ' ' HB ' ' A' ' 21' ' ' ILE . 29.7 t -46.51 -32.65 3.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.014 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.865 HD13 ' CE2' ' A' ' 169' ' ' PHE . 3.3 mt -45.68 -71.99 0.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -178.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.443 HD13 ' HA ' ' A' ' 20' ' ' LEU . 3.0 mm? -64.64 -23.67 67.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.951 -179.73 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.48 ' HB ' ' HA ' ' A' ' 18' ' ' CYS . 14.6 mm -61.05 -70.95 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.945 0.403 . . . . 0.0 110.486 179.4 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.528 ' HA ' ' HA ' ' A' ' 26' ' ' ASN . 2.4 t -51.76 -34.42 39.38 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.162 -179.075 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.509 ' CE2' ' HD3' ' A' ' 166' ' ' LYS . 27.5 t80 -55.93 -45.11 78.84 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.968 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.62 -64.42 1.05 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.543 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.431 ' OG1' HG23 ' A' ' 21' ' ' ILE . 79.9 p -66.27 -37.47 85.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.582 -179.416 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.528 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 35.2 t30 67.08 56.91 0.63 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.941 -179.15 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.0 mmtt -132.91 83.25 2.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.134 0.492 . . . . 0.0 110.961 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.468 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 40.5 t80 -92.35 -45.56 0.34 Allowed Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.082 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.468 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 62.6 Cg_endo -94.86 90.22 0.11 Allowed 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.955 2.436 . . . . 0.0 112.939 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.429 ' O ' ' CB ' ' B' ' 531' ' ' CYS . 0.4 OUTLIER -150.47 -89.2 0.07 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.627 0.251 . . . . 0.0 110.855 179.616 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -159.12 126.26 4.76 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.627 -0.261 . . . . 0.0 110.427 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.512 ' CG ' ' NH2' ' B' ' 537' ' ' ARG . 3.8 m-85 -111.55 121.87 46.31 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.194 0.521 . . . . 0.0 111.283 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.686 HG11 ' HG3' ' B' ' 529' ' ' ARG . 0.0 OUTLIER -165.42 -64.55 0.01 OUTLIER Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.433 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.478 ' CD ' HG23 ' A' ' 33' ' ' VAL . 50.5 Cg_endo -69.9 58.37 1.62 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.385 2.057 . . . . 0.0 112.428 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.2 t -87.64 10.47 17.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.737 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.698 HG13 HD23 ' A' ' 61' ' ' LEU . 3.3 m -76.0 -30.03 20.33 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-O 120.865 0.364 . . . . 0.0 110.84 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.409 ' O ' ' CG ' ' A' ' 40' ' ' TYR . 0.2 OUTLIER -50.87 -25.01 4.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.017 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.534 ' CG ' HG22 ' A' ' 17' ' ' THR . 20.8 t0 -50.34 -28.29 7.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.971 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -88.99 14.52 10.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.165 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.473 ' CZ ' ' CG1' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -71.59 -169.99 0.49 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.787 0.327 . . . . 0.0 110.911 179.809 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.402 ' O ' HG12 ' B' ' 519' ' ' ILE . . . -112.16 119.92 40.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.316 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.473 ' CG1' ' CZ ' ' A' ' 40' ' ' TYR . 2.5 m -122.71 121.71 64.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.023 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.4 t -104.69 128.79 52.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.9 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.986 HG12 ' CG2' ' A' ' 52' ' ' THR . 1.0 OUTLIER -164.54 -177.45 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.871 179.895 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.611 ' H ' HG22 ' A' ' 44' ' ' VAL . 5.9 tpt -101.4 96.13 6.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.012 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.675 HG22 ' O ' ' A' ' 46' ' ' ILE . 1.6 mm -74.86 86.9 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 120.841 0.353 . . . . 0.0 110.219 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.45 ' HA3' ' HA ' ' B' ' 510' ' ' ILE . . . 33.71 -87.72 0.01 OUTLIER Glycine 0 CA--C 1.523 0.549 0 CA-C-N 115.676 -0.693 . . . . 0.0 114.327 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . -37.72 -79.17 0.04 OUTLIER Glycine 0 C--N 1.333 0.392 0 N-CA-C 113.899 0.319 . . . . 0.0 113.899 -179.292 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.482 ' N ' ' HE1' ' A' ' 45' ' ' MET . 2.7 mt-10 -140.52 156.34 69.42 Favored Pre-proline 0 C--N 1.332 -0.162 0 CA-C-O 120.808 0.337 . . . . 0.0 111.621 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -43.2 101.01 0.04 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 123.137 2.558 . . . . 0.0 112.838 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.807 ' CE1' HG23 ' A' ' 3' ' ' THR . 17.8 t80 -172.68 153.62 2.81 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.368 179.221 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.986 ' CG2' HG12 ' A' ' 44' ' ' VAL . 0.8 OUTLIER -136.88 154.11 50.57 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.961 179.53 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.643 ' N ' HD13 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -99.56 166.57 11.08 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.984 179.772 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 56' ' ' PHE . . . -115.17 87.56 0.44 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.42 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.542 ' H ' HD12 ' A' ' 55' ' ' LEU . 0.5 OUTLIER -60.34 82.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.781 0.324 . . . . 0.0 110.538 179.888 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.464 ' CG ' ' O ' ' A' ' 56' ' ' PHE . 37.4 p90 -84.36 105.5 15.24 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.571 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 56.6 p30 -98.19 -177.88 3.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.761 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.96 HG21 HD22 ' A' ' 70' ' ' LEU . 73.6 p -94.39 161.54 14.19 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.816 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.418 ' CA ' ' O ' ' B' ' 542' ' ' TYR . . . -170.84 179.84 3.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.172 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.565 ' H ' HD22 ' A' ' 61' ' ' LEU . . . -150.97 34.66 0.93 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.463 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.698 HD23 HG13 ' A' ' 36' ' ' VAL . 2.0 mm? -95.71 -173.18 2.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.863 0.363 . . . . 0.0 110.917 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -51.02 -25.54 4.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.734 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.497 ' HB2' HG11 ' A' ' 36' ' ' VAL . 0.2 OUTLIER -53.95 -54.79 34.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.798 179.866 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.411 ' CD2' ' HB3' ' A' ' 63' ' ' ASP . 4.4 m-85 -132.53 152.07 51.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.774 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -85.88 -68.27 0.75 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.205 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.8 -52.27 4.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.224 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.761 HD23 ' O ' ' A' ' 67' ' ' LEU . 7.2 tt 55.42 98.61 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.484 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.0 mmm180 -132.88 58.93 39.26 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.128 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.494 ' HD2' HD23 ' A' ' 70' ' ' LEU . 83.5 Cg_endo -83.68 -21.72 4.04 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.827 2.351 . . . . 0.0 112.172 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.96 HD22 HG21 ' A' ' 58' ' ' THR . 1.1 pt? -85.69 1.32 49.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.721 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 46.3 t -70.59 -71.16 0.26 Allowed 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.728 0.299 . . . . 0.0 111.065 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -121.85 72.55 32.76 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.861 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.411 ' HG3' ' CZ ' ' A' ' 78' ' ' PHE . 98.4 Cg_endo -78.71 140.87 16.85 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.713 2.275 . . . . 0.0 112.457 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.8 tp60 -102.11 10.39 39.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.349 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 13.6 t -59.55 -173.75 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.866 0.365 . . . . 0.0 111.055 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -136.22 7.83 3.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.503 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.501 ' CG1' ' HB3' ' A' ' 175' ' ' ALA . 64.0 t -151.14 101.15 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 CA-C-O 120.788 0.328 . . . . 0.0 111.249 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.53 ' CE1' ' CG2' ' A' ' 9' ' ' VAL . 0.1 OUTLIER -102.08 -177.85 3.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.645 179.785 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.636 HD13 ' HB3' ' A' ' 111' ' ' LEU . 21.7 tp -154.13 114.59 3.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.831 0.348 . . . . 0.0 111.633 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.609 HG23 HD13 ' A' ' 112' ' ' LEU . 2.9 m -94.61 156.22 3.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.486 179.263 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.958 ' HB3' HG22 ' A' ' 14' ' ' VAL . 22.3 p -128.98 168.93 15.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.237 0.541 . . . . 0.0 112.178 -179.203 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.649 ' HZ ' ' HB1' ' A' ' 142' ' ' ALA . 46.9 p90 179.27 123.51 0.06 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.926 179.273 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.435 ' HA ' ' C2 ' ' A' ' 185' ' ' GNP . 98.8 p -93.61 146.27 23.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.881 0.372 . . . . 0.0 111.44 -179.497 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.925 HG11 ' HG2' ' A' ' 120' ' ' ARG . 58.1 t -51.3 -73.95 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.366 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.445 ' O ' HG23 ' A' ' 85' ' ' VAL . 8.1 m -43.27 105.76 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 120.756 0.313 . . . . 0.0 110.968 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.443 ' N ' HD22 ' A' ' 129' ' ' LEU . 87.6 p -151.33 138.65 12.19 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.62 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.407 ' O ' ' CB ' ' A' ' 88' ' ' SER . 80.3 Cg_endo -91.65 53.93 0.8 Allowed 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.305 2.67 . . . . 0.0 112.026 179.475 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.461 ' CA ' ' HG3' ' A' ' 133' ' ' LYS . 0.1 OUTLIER 81.42 30.33 0.14 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.84 -179.611 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.533 ' O ' HG23 ' A' ' 93' ' ' VAL . 11.1 t -88.18 -24.42 23.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.697 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.631 ' CZ ' HG21 ' A' ' 137' ' ' ILE . 0.4 OUTLIER -50.89 -64.41 0.82 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.871 179.901 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -51.83 -37.58 52.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.936 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.413 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 3.3 m120 -67.96 -64.2 0.91 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.917 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 89' ' ' SER . 50.7 t -49.26 -46.7 18.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.368 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.791 ' HB2' HD11 ' A' ' 145' ' ' LEU . 4.5 ttpt -54.19 -59.08 5.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.276 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.415 ' O ' ' HG2' ' A' ' 99' ' ' PRO . 7.1 mt-10 -83.46 9.9 10.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.869 -179.563 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.413 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 13.7 tttt -116.86 -33.09 4.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.724 0.297 . . . . 0.0 111.067 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.558 ' O ' HG22 ' A' ' 101' ' ' ILE . 0.0 OUTLIER -94.35 -45.31 7.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.459 -179.658 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 94' ' ' LYS . 43.8 t -53.09 -44.44 97.13 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 -179.627 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.493 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 2.7 Cg_exo -76.01 -24.48 11.24 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.609 2.206 . . . . 0.0 112.641 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -88.73 -49.69 6.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.016 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.558 HG22 ' O ' ' A' ' 97' ' ' TRP . 8.9 tt -51.16 -24.55 3.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.157 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.416 HG23 HG23 ' A' ' 101' ' ' ILE . 59.3 p -97.22 -28.72 13.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.006 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 54.1 t60 -72.82 -69.29 0.42 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.926 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -62.88 -42.15 99.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.733 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 17.0 m -111.03 148.41 38.58 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.739 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -49.29 167.7 0.15 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.502 2.135 . . . . 0.0 112.21 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.6 tmtt? -83.01 54.98 2.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.799 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.4 p -76.88 156.81 82.33 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.031 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -60.45 166.52 9.43 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.653 2.235 . . . . 0.0 112.238 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.568 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 9.1 p90 -163.11 142.44 8.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.925 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.938 HD12 HG11 ' A' ' 152' ' ' VAL . 0.9 OUTLIER -108.56 159.7 16.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.983 -179.721 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.609 HD13 HG23 ' A' ' 80' ' ' VAL . 3.1 mm? -106.15 128.03 53.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.659 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.862 ' HA ' HG11 ' A' ' 168' ' ' VAL . 43.8 t -89.96 128.45 41.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.134 0.492 . . . . 0.0 111.555 -179.668 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.516 ' HA2' ' CE2' ' A' ' 154' ' ' TYR . . . -112.36 103.62 1.49 Allowed Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.253 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.666 HG23 HG12 ' A' ' 113' ' ' VAL . 0.4 OUTLIER -144.1 -153.65 0.48 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.826 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.539 ' CB ' HN22 ' A' ' 185' ' ' GNP . 0.4 OUTLIER 39.39 29.95 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.065 0.459 . . . . 0.0 111.329 179.333 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.534 HD13 ' C ' ' A' ' 115' ' ' THR . 0.0 OUTLIER -74.37 -4.3 5.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.711 179.376 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -100.28 -22.01 15.26 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.11 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.594 ' N ' HD22 ' A' ' 119' ' ' LEU . 2.1 mm? -72.85 -29.65 63.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.097 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.925 ' HG2' HG11 ' A' ' 84' ' ' VAL . 25.7 mtp180 -47.32 -35.5 8.12 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.917 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -76.32 -42.55 44.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.794 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -46.93 100.52 0.24 Allowed Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.89 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.442 ' HA ' ' CG2' ' A' ' 126' ' ' ILE . 10.5 Cg_exo -71.57 -3.76 13.7 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.737 2.291 . . . . 0.0 112.675 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.3 t -79.45 -64.11 1.26 Allowed 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.414 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 11.0 m -58.92 -40.14 83.68 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 178.761 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.48 HD13 ' O ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -53.78 -45.73 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.777 179.217 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.474 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 3.2 mm-40 -57.54 -36.08 71.15 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.068 179.385 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 125' ' ' THR . 1.4 mptt -64.75 -30.66 71.67 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.144 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.452 ' CD1' ' HA ' ' A' ' 126' ' ' ILE . 5.3 mt -74.16 -40.8 62.34 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.09 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 127' ' ' GLU . . . -42.91 -36.97 1.69 Allowed 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.438 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.3 mmtp -50.6 -29.06 9.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.974 0.416 . . . . 0.0 110.364 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.407 ' OD1' ' HB2' ' A' ' 87' ' ' PRO . 2.3 m120 -123.88 -31.09 3.45 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.732 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.516 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 4.0 mmpt? -148.86 -90.81 0.08 Allowed 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.516 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 1.2 pt20 122.24 -25.18 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.713 1.205 . . . . 0.0 110.314 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 4.5 ptmm? -69.21 110.71 6.7 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.716 -179.224 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.405 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 88.2 Cg_endo -82.01 127.69 5.5 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.574 2.182 . . . . 0.0 111.302 179.084 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.742 ' N ' HD13 ' A' ' 137' ' ' ILE . 0.9 OUTLIER -58.65 96.75 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.916 0.389 . . . . 0.0 110.792 -179.423 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.461 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 7.2 p -70.24 155.96 92.62 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.042 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.461 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 10.3 Cg_endo -51.23 -24.37 15.16 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.653 2.235 . . . . 0.0 112.175 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -79.79 -46.36 17.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.551 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 6.8 m -56.2 -45.3 79.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.669 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.649 ' HB1' ' HZ ' ' A' ' 82' ' ' PHE . . . -51.76 -51.49 55.82 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.847 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -53.97 -39.42 65.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.744 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.26 -55.81 24.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.701 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.791 HD11 ' HB2' ' A' ' 94' ' ' LYS . 1.6 tt -69.43 -36.96 77.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.572 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -54.42 -71.9 0.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.051 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.443 ' CZ ' ' HE3' ' A' ' 183' ' ' LYS . 10.0 mtt180 -61.35 -23.16 65.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.098 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -49.98 -37.16 31.18 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.855 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.484 ' CD1' HG11 ' A' ' 98' ' ' VAL . 0.6 OUTLIER -112.77 20.59 16.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.087 179.828 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.3 mttt 47.89 49.09 17.3 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.144 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.572 ' O ' HG23 ' A' ' 152' ' ' VAL . . . -65.25 -81.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.956 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.938 HG11 HD12 ' A' ' 111' ' ' LEU . 49.1 t -161.56 -75.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.732 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.449 ' O ' HD21 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -175.75 131.18 0.26 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.923 -178.822 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.516 ' CE2' ' HA2' ' A' ' 114' ' ' GLY . 11.1 t80 -104.47 103.71 13.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.15 179.429 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.56 ' HB ' HG22 ' A' ' 168' ' ' VAL . 1.4 t -102.16 164.64 3.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.141 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.4 ' H ' HG12 ' A' ' 155' ' ' VAL . 76.9 tt0 -89.86 135.78 33.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.82 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.424 ' HA ' ' HB3' ' A' ' 163' ' ' LYS . 20.4 p -178.59 129.51 0.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.922 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.651 ' HB3' HG22 ' A' ' 161' ' ' THR . 0.1 OUTLIER -125.74 140.4 52.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.172 -179.906 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.52 ' HB2' HD22 ' A' ' 165' ' ' LEU . . . -84.19 -44.32 14.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.072 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -47.77 -34.97 9.21 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.763 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.651 HG22 ' HB3' ' A' ' 158' ' ' SER . 10.6 t -116.02 -15.87 11.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.118 179.733 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.417 ' CA ' ' O ' ' A' ' 158' ' ' SER . 1.5 tt0 70.33 66.8 0.21 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.812 0.339 . . . . 0.0 110.68 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.424 ' HB3' ' HA ' ' A' ' 157' ' ' CYS . 1.0 OUTLIER -93.81 22.79 5.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.254 -179.686 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 102.36 41.98 2.28 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.48 -0.867 . . . . 0.0 113.111 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.849 HD23 ' HA ' ' A' ' 19' ' ' LEU . 1.7 tp -50.4 -25.07 3.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.864 0.364 . . . . 0.0 110.691 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.509 ' HD3' ' CE2' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -68.54 -26.08 65.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.842 179.514 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -58.33 -72.29 0.1 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.827 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.862 HG11 ' HA ' ' A' ' 113' ' ' VAL . 91.3 t -52.44 -43.63 41.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.967 0.413 . . . . 0.0 110.461 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.865 ' CE2' HD13 ' A' ' 19' ' ' LEU . 0.2 OUTLIER -62.77 -33.66 75.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.277 179.681 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.532 ' OD1' HD11 ' A' ' 173' ' ' ILE . 27.1 t0 -69.82 -25.61 63.84 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.599 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.607 ' CB ' HD11 ' A' ' 111' ' ' LEU . 4.4 mm-40 -78.75 -29.15 44.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.132 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.568 ' N ' HD13 ' A' ' 111' ' ' LEU . . . -75.1 -43.51 52.53 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.888 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.532 HD11 ' OD1' ' A' ' 170' ' ' ASP . 1.6 pp -68.75 -36.11 72.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.838 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.625 HD22 ' HB3' ' B' ' 505' ' ' LEU . 26.0 tp -55.13 -42.95 73.68 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.776 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.501 ' HB3' ' CG1' ' A' ' 77' ' ' VAL . . . -48.17 -27.01 2.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.775 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.551 ' HB1' ' HA ' ' A' ' 4' ' ' ILE . . . -86.7 -43.75 12.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.845 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.769 HD13 ' HB ' ' B' ' 510' ' ' ILE . 56.3 mt -68.73 -26.94 65.51 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.957 0.408 . . . . 0.0 110.255 179.462 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.488 ' HB2' ' HB2' ' B' ' 507' ' ' ALA . 0.1 OUTLIER -174.14 92.6 0.33 Allowed Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.721 179.788 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.439 ' HA ' ' HD2' ' A' ' 180' ' ' PRO . 86.4 Cg_exo -47.74 106.04 0.1 OUTLIER 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.645 2.23 . . . . 0.0 112.428 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 179' ' ' PRO . 41.7 Cg_endo -67.22 171.99 10.69 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.47 2.114 . . . . 0.0 112.205 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -110.19 137.79 20.67 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.979 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -79.42 -165.17 0.32 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.576 2.184 . . . . 0.0 112.272 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.443 ' HE3' ' CZ ' ' A' ' 147' ' ' ARG . 0.0 OUTLIER -135.97 97.33 3.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.925 179.992 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.166 -0.921 . . . . 0.0 110.921 -179.985 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 503' ' ' SER . . . . . . . . . . . . . 3.3 m -90.41 -75.97 0.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.744 0.307 . . . . 0.0 110.918 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 504' ' ' GLY . . . . . 0.836 ' O ' HD12 ' B' ' 505' ' ' LEU . . . 144.16 -116.84 0.99 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.368 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 505' ' ' LEU . . . . . 0.836 HD12 ' O ' ' B' ' 504' ' ' GLY . 0.1 OUTLIER 64.99 -70.6 0.09 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.786 0.327 . . . . 0.0 111.204 179.823 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 506' ' ' SER . . . . . 0.42 ' N ' ' O ' ' B' ' 504' ' ' GLY . 0.1 OUTLIER -171.92 -159.77 0.15 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.546 -179.973 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 507' ' ' ALA . . . . . 0.488 ' HB2' ' HB2' ' A' ' 178' ' ' GLU . . . 62.97 -95.71 0.05 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.469 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 508' ' ' GLN . . . . . 0.462 ' O ' ' CB ' ' B' ' 509' ' ' ASP . 28.6 mt-30 -137.28 4.04 2.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.875 179.548 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 509' ' ' ASP . . . . . 0.462 ' CB ' ' O ' ' B' ' 508' ' ' GLN . 0.1 OUTLIER 92.36 29.7 0.01 OUTLIER 'General case' 0 C--N 1.345 0.406 0 CA-C-O 121.461 0.648 . . . . 0.0 109.864 -179.127 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 510' ' ' ILE . . . . . 0.769 ' HB ' HD13 ' A' ' 177' ' ' LEU . 43.0 mt -61.58 149.48 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.393 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 511' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.23 146.62 33.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.291 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 512' ' ' GLN . . . . . 0.529 ' HA ' HD13 ' A' ' 173' ' ' ILE . 1.5 pm0 -57.79 -176.2 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.35 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 513' ' ' PRO . . . . . 0.576 ' HG3' HD21 ' A' ' 53' ' ' LEU . 50.9 Cg_exo -55.52 82.37 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.492 2.128 . . . . 0.0 111.694 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 514' ' ' LEU . . . . . 0.451 ' N ' ' O ' ' B' ' 512' ' ' GLN . 1.8 mp -46.38 171.96 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.003 -179.164 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 515' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -94.26 -168.65 1.89 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.766 179.376 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 66.22 10.49 7.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.589 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 517' ' ' SER . . . . . 0.445 ' CB ' ' HB ' ' A' ' 44' ' ' VAL . 72.5 p -133.47 80.77 1.89 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.912 0.387 . . . . 0.0 111.02 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 518' ' ' PHE . . . . . 0.429 ' HA ' HG12 ' A' ' 42' ' ' VAL . 22.6 m-85 -140.45 91.69 2.46 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.897 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 519' ' ' ILE . . . . . 0.47 ' N ' HD13 ' B' ' 519' ' ' ILE . 3.0 mm -84.97 138.12 19.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.046 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -41.89 -88.86 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.409 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 521' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 47.86 -161.59 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.873 0.368 . . . . 0.0 111.009 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 522' ' ' GLY . . . . . . . . . . . . . . . 55.24 170.33 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.47 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 523' ' ' HIS . . . . . . . . . . . . . 38.1 t-80 -156.6 -77.45 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.787 0.327 . . . . 0.0 110.876 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 524' ' ' GLY . . . . . 0.627 ' HA3' HG21 ' A' ' 36' ' ' VAL . . . 46.68 -144.62 4.33 Favored Glycine 0 N--CA 1.454 -0.164 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.722 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 525' ' ' ASP . . . . . 0.693 ' HB2' HD12 ' A' ' 61' ' ' LEU . 30.4 m-20 -119.24 81.47 1.72 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.826 0.346 . . . . 0.0 110.842 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 526' ' ' SER . . . . . 0.448 ' CA ' ' HB3' ' A' ' 34' ' ' PRO . 0.7 OUTLIER -88.43 96.25 10.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.785 179.968 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 527' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -162.08 141.28 7.28 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.795 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -57.52 97.61 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.677 2.251 . . . . 0.0 112.072 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 529' ' ' ARG . . . . . 0.686 ' HG3' HG11 ' A' ' 33' ' ' VAL . 10.4 mtp180 -100.23 -54.74 2.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.099 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 530' ' ' HIS . . . . . 0.485 ' CE1' ' HB3' ' B' ' 545' ' ' ASN . 6.2 p80 -165.47 97.45 0.68 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.831 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 531' ' ' CYS . . . . . 0.429 ' CB ' ' O ' ' A' ' 30' ' ' SER . 18.8 p -53.49 -171.65 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.068 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 532' ' ' TRP . . . . . . . . . . . . . 87.4 t90 -49.06 103.78 0.05 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.013 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . -116.39 -57.47 0.32 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.496 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 534' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -68.38 155.97 91.38 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 120.705 0.288 . . . . 0.0 110.872 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -63.34 -19.52 68.39 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.633 2.222 . . . . 0.0 112.485 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -151.66 139.01 19.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.929 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 537' ' ' ARG . . . . . 0.516 ' HD3' ' HB2' ' A' ' 13' ' ' ALA . 0.1 OUTLIER -48.07 152.23 0.85 Allowed 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.114 179.921 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 538' ' ' ILE . . . . . 0.418 ' CG2' ' HA ' ' B' ' 543' ' ' LEU . 5.6 tp -63.42 140.77 19.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.139 179.612 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 539' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -44.61 147.39 0.61 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.733 0.301 . . . . 0.0 111.162 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 540' ' ' GLU . . . . . 0.533 ' OE1' HD13 ' B' ' 543' ' ' LEU . 49.8 mm-40 -60.14 -15.86 27.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.613 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 541' ' ' LEU . . . . . 0.813 ' HA ' HD11 ' A' ' 70' ' ' LEU . 2.9 mm? -41.31 -59.59 1.5 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.99 0.424 . . . . 0.0 110.897 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 542' ' ' TYR . . . . . 0.453 ' CD1' ' HB3' ' B' ' 541' ' ' LEU . 0.1 OUTLIER -105.84 -53.63 2.61 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.578 179.41 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 543' ' ' LEU . . . . . 0.786 HD23 ' O ' ' A' ' 58' ' ' THR . 6.8 tp 57.01 31.94 20.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.936 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . -119.13 83.6 0.35 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.468 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 545' ' ' ASN . . . . . 0.486 ' HB2' HG13 ' A' ' 33' ' ' VAL . 3.6 m120 . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.211 -0.9 . . . . 0.0 110.851 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 185' ' ' GNP . . . . . 0.741 ' H8 ' ' HB3' ' A' ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.796 0.331 . . . . 0.0 111.255 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.81 144.4 47.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.388 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.645 HG23 ' CE1' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -93.86 176.34 6.38 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.925 -179.948 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 1.012 HG13 HD13 ' A' ' 53' ' ' LEU . 4.0 pt -152.27 146.36 15.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.009 0.433 . . . . 0.0 112.115 -178.723 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.608 ' O ' HG21 ' A' ' 75' ' ' THR . 13.1 tptp -134.44 95.73 3.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.399 179.429 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -110.08 119.74 40.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.979 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.417 ' HA ' ' HB3' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -104.79 145.55 13.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.14 0.495 . . . . 0.0 111.301 179.772 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.851 HG11 ' HE3' ' A' ' 16' ' ' LYS . 2.6 p -91.63 113.55 27.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.268 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.52 HG21 ' CD2' ' A' ' 78' ' ' PHE . 30.1 m -134.9 150.33 29.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.081 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 127.93 -144.46 15.22 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.508 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -103.25 -21.34 13.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.72 0.295 . . . . 0.0 110.956 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -105.02 156.33 16.87 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.611 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.47 4.78 22.93 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.811 HG21 HD23 ' A' ' 79' ' ' LEU . 1.9 m 40.99 31.07 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 120.985 0.422 . . . . 0.0 111.37 -179.305 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.435 ' O ' ' CG ' ' A' ' 19' ' ' LEU . . . 56.96 24.93 52.22 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.407 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.851 ' HE3' HG11 ' A' ' 8' ' ' VAL . 9.6 ptmt -38.31 -45.43 0.99 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.809 0.338 . . . . 0.0 111.628 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.929 HG22 HG13 ' A' ' 21' ' ' ILE . 0.2 OUTLIER -97.46 -57.43 2.25 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.49 179.341 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.522 ' HB3' ' HB1' ' A' ' 159' ' ' ALA . 46.8 m -47.65 -32.06 5.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.245 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.89 ' CD2' HD22 ' A' ' 165' ' ' LEU . 9.6 mt -47.35 -71.32 0.07 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.026 0.441 . . . . 0.0 111.079 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.629 ' H ' HD22 ' A' ' 20' ' ' LEU . 0.6 OUTLIER -87.08 -27.47 23.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.947 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.929 HG13 HG22 ' A' ' 17' ' ' THR . 46.8 mm -68.44 -52.96 31.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 179.051 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.447 ' CB ' ' O ' ' A' ' 18' ' ' CYS . 2.3 t -69.73 -37.61 76.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.519 179.665 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -51.87 -45.9 64.26 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.575 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.1 m -94.03 -48.58 6.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.566 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.441 ' N ' ' O ' ' A' ' 21' ' ' ILE . 1.3 p -96.4 -146.19 0.29 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.228 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.405 ' N ' ' OG1' ' A' ' 25' ' ' THR . 1.0 OUTLIER -163.2 34.64 0.09 Allowed 'General case' 0 C--O 1.232 0.139 0 O-C-N 122.341 -0.225 . . . . 0.0 111.365 -179.746 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.485 ' CG ' HG21 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -86.42 127.41 34.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.926 0.393 . . . . 0.0 111.067 -179.896 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.539 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . 89.0 t80 -164.04 -50.71 0.01 OUTLIER Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.035 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.539 ' HD3' ' HB3' ' A' ' 28' ' ' PHE . 88.1 Cg_endo -93.03 33.06 0.24 Allowed 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.171 1.914 . . . . 0.0 112.65 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.43 -84.8 0.58 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.772 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -159.04 147.59 18.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.697 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.473 ' HB3' ' PG ' ' A' ' 185' ' ' GNP . 9.7 m-85 -126.02 124.04 39.8 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.675 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.558 HG23 ' HD3' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -165.17 -61.76 0.01 OUTLIER Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.112 -179.763 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.558 ' HD3' HG23 ' A' ' 33' ' ' VAL . 79.5 Cg_exo -46.36 -25.78 3.5 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.382 2.054 . . . . 0.0 112.329 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.869 HG21 ' O2G' ' A' ' 185' ' ' GNP . 6.5 t -40.54 -29.51 0.09 Allowed 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.893 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.893 HG23 ' HB3' ' A' ' 59' ' ' ALA . 12.0 p -51.95 -22.25 2.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.607 -0.269 . . . . 0.0 111.394 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.479 ' CD1' ' O ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -88.68 18.34 4.76 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.494 179.899 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.403 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 25.6 t0 -58.74 -18.02 27.94 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.223 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -86.57 13.56 8.31 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.546 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.466 ' CD1' ' N ' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -60.8 179.09 0.19 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.819 0.342 . . . . 0.0 110.946 179.91 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.423 ' O ' HG12 ' B' ' 519' ' ' ILE . . . -98.05 124.94 42.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.143 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.856 HG13 ' O ' ' B' ' 517' ' ' SER . 2.8 t -119.1 146.63 23.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.737 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.4 p -129.13 112.02 13.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.867 0.365 . . . . 0.0 111.566 -179.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 1.086 HG22 HG23 ' A' ' 52' ' ' THR . 4.1 m -153.1 -176.97 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.652 179.17 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.525 ' O ' HD13 ' B' ' 514' ' ' LEU . 4.4 tpt -100.65 95.94 7.01 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.658 -179.099 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.679 HG22 ' O ' ' A' ' 46' ' ' ILE . 1.2 mm -82.23 87.32 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-O 121.382 0.61 . . . . 0.0 109.913 178.598 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.403 ' HA3' ' HA ' ' B' ' 510' ' ' ILE . . . 46.23 -90.69 0.01 OUTLIER Glycine 0 CA--C 1.522 0.494 0 CA-C-N 115.488 -0.778 . . . . 0.0 113.647 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . -36.5 -96.39 0.01 OUTLIER Glycine 0 C--N 1.335 0.477 0 N-CA-C 113.997 0.359 . . . . 0.0 113.997 -179.076 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.47 ' N ' ' HE1' ' A' ' 45' ' ' MET . 1.6 pt-20 -125.66 158.85 63.54 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 120.539 0.209 . . . . 0.0 110.555 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.402 ' HD2' ' HB2' ' A' ' 49' ' ' GLU . 88.2 Cg_exo -40.2 101.07 0.03 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.595 2.196 . . . . 0.0 112.542 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.645 ' CE1' HG23 ' A' ' 3' ' ' THR . 5.6 t80 -172.24 162.43 5.59 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.422 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' THR . . . . . 1.086 HG23 HG22 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -136.62 145.82 45.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.07 179.377 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 1.012 HD13 HG13 ' A' ' 4' ' ' ILE . 0.8 OUTLIER -83.54 179.57 7.6 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.848 179.847 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -103.14 109.93 3.59 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.236 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.38 -159.26 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.801 0.334 . . . . 0.0 110.76 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.54 ' CE1' ' CB ' ' A' ' 16' ' ' LYS . 0.1 OUTLIER -104.3 166.27 10.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.053 0.454 . . . . 0.0 111.091 -179.909 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.403 ' OD1' ' N ' ' A' ' 38' ' ' ASP . 31.0 t70 -167.63 111.2 0.66 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.444 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.736 ' HA ' HD21 ' A' ' 67' ' ' LEU . 22.5 p -144.96 126.43 14.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.044 -179.638 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.893 ' HB3' HG23 ' A' ' 36' ' ' VAL . . . -171.16 126.2 0.66 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.094 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -74.92 65.35 2.23 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.478 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.773 HD12 ' HB ' ' A' ' 36' ' ' VAL . 55.9 mt -115.88 172.97 6.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.802 0.334 . . . . 0.0 110.911 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -52.27 -37.04 54.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.815 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.464 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 1.0 OUTLIER -58.19 -62.42 1.84 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.798 179.866 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.464 ' CD2' ' HB3' ' A' ' 63' ' ' ASP . 0.3 OUTLIER -136.16 77.31 1.65 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.594 179.969 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -86.05 -16.04 39.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.491 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -83.45 -53.22 5.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.581 0.229 . . . . 0.0 111.478 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.78 HD23 HD23 ' A' ' 70' ' ' LEU . 1.6 mp 49.6 -179.73 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.487 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.409 ' N ' ' HD2' ' A' ' 69' ' ' PRO . 0.0 OUTLIER 168.25 -57.33 0.0 OUTLIER Pre-proline 0 N--CA 1.465 0.3 0 CA-C-O 120.688 0.28 . . . . 0.0 111.354 -179.992 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.412 ' O ' ' NE2' ' A' ' 74' ' ' GLN . 68.0 Cg_exo -38.12 -47.77 2.26 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.981 2.454 . . . . 0.0 113.039 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.78 HD23 HD23 ' A' ' 67' ' ' LEU . 0.3 OUTLIER -48.06 -26.9 2.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.164 -179.757 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.64 -31.75 12.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.812 0.339 . . . . 0.0 111.448 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -82.66 143.29 46.88 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.116 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.37 100.41 0.89 Allowed 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.646 2.231 . . . . 0.0 111.977 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.412 ' NE2' ' O ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -102.19 -67.55 0.87 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.514 -179.461 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.608 HG21 ' O ' ' A' ' 5' ' ' LYS . 12.4 t -84.26 -164.67 0.98 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.706 -179.281 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.411 ' O ' ' HD2' ' A' ' 109' ' ' PRO . 4.2 p30 -124.74 8.33 8.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.238 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.4 ' H ' HG23 ' A' ' 75' ' ' THR . 39.3 t -141.55 91.18 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 CA-C-O 120.758 0.313 . . . . 0.0 111.157 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.52 ' CD2' HG21 ' A' ' 9' ' ' VAL . 2.9 m-30 -80.79 -177.7 6.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.6 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.811 HD23 HG21 ' A' ' 14' ' ' VAL . 8.1 tp -143.34 108.46 4.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.262 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.71 HG11 HD13 ' A' ' 101' ' ' ILE . 21.5 m -105.61 135.09 45.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.02 179.088 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.763 ' SG ' HG12 ' A' ' 14' ' ' VAL . 9.6 m -137.38 170.7 15.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.212 0.529 . . . . 0.0 111.968 -179.134 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.564 ' HE2' HD12 ' A' ' 112' ' ' LEU . 15.0 p90 -167.77 137.29 2.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.439 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.46 ' HA ' ' C2 ' ' A' ' 185' ' ' GNP . 57.4 p -83.68 139.4 32.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.725 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.596 HG13 ' N ' ' A' ' 137' ' ' ILE . 65.6 t -48.48 -63.78 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.22 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.585 ' HA ' HD21 ' A' ' 129' ' ' LEU . 30.4 m -45.35 111.85 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-O 120.61 0.243 . . . . 0.0 110.518 179.527 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.445 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 3.4 p -149.0 140.76 14.56 Favored Pre-proline 0 C--N 1.33 -0.24 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -178.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.453 ' CA ' ' HB2' ' A' ' 132' ' ' ASN . 72.3 Cg_endo -93.07 54.3 0.44 Allowed 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 123.381 2.721 . . . . 0.0 111.797 179.322 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.452 ' CB ' ' HB2' ' A' ' 133' ' ' LYS . 0.5 OUTLIER 72.93 21.73 3.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.043 -179.554 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 43.3 p -97.48 -17.8 19.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.264 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.53 ' CE2' HG23 ' A' ' 137' ' ' ILE . 8.5 t80 -45.68 -72.86 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.743 0.306 . . . . 0.0 111.302 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -53.64 -31.2 46.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.812 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.41 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 8.3 t-20 -66.8 -58.18 5.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.953 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.428 HG13 ' N ' ' A' ' 94' ' ' LYS . 12.3 p -62.42 -41.3 91.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.256 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.784 ' HG3' HD13 ' A' ' 145' ' ' LEU . 0.8 OUTLIER -55.65 -75.33 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.832 179.951 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.423 ' O ' ' CG ' ' A' ' 99' ' ' PRO . 24.3 mm-40 -52.24 -24.01 6.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.913 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.41 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 57.4 tttt -83.62 -22.51 32.2 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.114 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.448 ' CE3' ' HA ' ' A' ' 97' ' ' TRP . 0.0 OUTLIER -82.09 -55.49 4.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.58 -179.79 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.472 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 5.0 t -41.49 -46.63 8.55 Favored Pre-proline 0 N--CA 1.466 0.358 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -179.001 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 13.7 Cg_exo -69.96 -35.02 12.81 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.72 2.28 . . . . 0.0 112.354 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.415 ' N ' ' OE1' ' A' ' 100' ' ' GLU . 1.3 mp0 -76.73 -37.63 55.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.78 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.71 HD13 HG11 ' A' ' 80' ' ' VAL . 54.8 mt -65.93 -25.36 35.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.001 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 25.1 p -93.52 -26.93 16.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.858 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -66.09 -68.04 0.4 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.816 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -59.56 -34.76 73.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.696 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.401 ' HA ' ' HD2' ' A' ' 106' ' ' PRO . 89.3 m -127.4 103.58 22.48 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.756 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 105' ' ' CYS . 29.7 Cg_endo -63.68 106.72 0.64 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.439 2.093 . . . . 0.0 112.193 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.71 82.85 0.15 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.949 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.59 100.12 16.63 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.853 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.411 ' HD2' ' O ' ' A' ' 76' ' ' ASP . 31.3 Cg_exo -59.69 158.54 27.87 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.677 2.251 . . . . 0.0 112.251 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.482 ' CE2' ' HB2' ' A' ' 151' ' ' ALA . 24.8 p90 -150.62 -176.62 5.57 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.092 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.779 HD23 ' O ' ' A' ' 112' ' ' LEU . 4.4 tt -146.27 147.63 31.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.863 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.779 ' O ' HD23 ' A' ' 111' ' ' LEU . 4.2 mm? -93.43 156.8 16.56 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.626 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.824 HG13 HG11 ' A' ' 168' ' ' VAL . 11.0 t -143.21 150.68 17.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.091 0.472 . . . . 0.0 112.227 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.419 ' O ' ' CD1' ' A' ' 117' ' ' ILE . . . -124.46 100.15 0.62 Allowed Glycine 0 C--N 1.331 0.272 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.509 179.387 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.993 ' OG1' " H2'" ' A' ' 185' ' ' GNP . 1.3 p -122.97 -2.47 8.7 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -178.56 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.607 ' CB ' HN22 ' A' ' 185' ' ' GNP . 1.6 tp-100 -111.66 10.23 21.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.115 0.483 . . . . 0.0 109.86 178.798 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.48 ' H ' HD13 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -64.36 -11.63 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.948 179.018 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -80.34 -43.22 21.54 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.852 -179.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.605 ' C ' HD12 ' A' ' 119' ' ' LEU . 4.0 pp -99.43 0.52 42.8 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -179.331 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.432 ' O ' HD13 ' A' ' 126' ' ' ILE . 0.3 OUTLIER -54.71 -27.63 41.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.002 0.429 . . . . 0.0 110.017 179.245 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -80.85 -23.91 38.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.306 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -51.27 104.65 0.44 Allowed Pre-proline 0 C--N 1.332 -0.162 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.501 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.467 ' HA ' ' CG2' ' A' ' 126' ' ' ILE . 14.3 Cg_exo -69.31 -3.52 11.88 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 122.739 2.293 . . . . 0.0 112.978 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 10.3 t -72.56 -69.36 0.41 Allowed 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 120.914 0.388 . . . . 0.0 109.969 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.766 HG22 ' CD1' ' A' ' 129' ' ' LEU . 17.2 m -58.31 -44.27 88.51 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.799 HD11 ' HB3' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -50.09 -33.93 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.093 179.694 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.56 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 3.9 mm-40 -70.88 -35.19 72.25 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.456 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.433 ' N ' ' O ' ' A' ' 125' ' ' THR . 0.1 OUTLIER -68.44 -34.85 76.71 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 177.934 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.766 ' CD1' HG22 ' A' ' 125' ' ' THR . 9.2 mp -60.76 -42.54 97.65 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.049 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' A' ' 127' ' ' GLU . . . -42.52 -36.33 1.32 Allowed 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 114.602 -1.181 . . . . 0.0 111.503 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm -55.1 -29.44 57.62 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.859 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.453 ' HB2' ' CA ' ' A' ' 87' ' ' PRO . 15.6 m120 -124.44 -32.49 3.14 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -179.489 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.512 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 1.3 ttpt -142.69 -83.13 0.18 Allowed 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 122.332 -0.23 . . . . 0.0 111.083 -179.047 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.512 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 9.9 pt20 114.94 -42.1 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.682 1.193 . . . . 0.0 111.077 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.418 ' HD2' ' HG3' ' A' ' 134' ' ' GLN . 3.2 mptt -68.61 110.1 5.3 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.112 -0.494 . . . . 0.0 112.235 -178.801 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.799 ' HB3' HD11 ' A' ' 126' ' ' ILE . 72.4 Cg_endo -75.25 148.11 33.92 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.494 2.129 . . . . 0.0 111.209 178.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.75 ' N ' HD13 ' A' ' 137' ' ' ILE . 0.7 OUTLIER -76.87 96.8 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.898 0.38 . . . . 0.0 111.053 -179.31 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 3.3 p -68.79 148.78 98.01 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.736 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.46 ' HA ' ' CE2' ' A' ' 154' ' ' TYR . 83.3 Cg_exo -45.56 -26.92 3.15 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.607 2.205 . . . . 0.0 112.382 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -77.48 -32.39 54.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.816 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.459 ' HB ' HG22 ' A' ' 137' ' ' ILE . 2.2 m -64.25 -57.55 9.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.89 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.41 ' HB2' ' HZ ' ' A' ' 82' ' ' PHE . . . -51.11 -44.15 61.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.063 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -56.14 -44.12 78.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.949 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.6 mttt -56.92 -62.91 1.41 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.786 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.784 HD13 ' HG3' ' A' ' 94' ' ' LYS . 1.0 OUTLIER -60.2 -35.9 76.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.775 179.833 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.477 ' HB2' ' HG ' ' A' ' 112' ' ' LEU . . . -51.55 -60.86 2.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.863 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 22.2 mtt180 -67.29 -22.32 65.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.885 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.617 ' HB3' HD22 ' A' ' 149' ' ' LEU . 24.2 t0 -50.25 -48.81 54.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.695 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.617 HD22 ' HB3' ' A' ' 148' ' ' ASP . 2.4 mm? -92.89 17.43 10.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.084 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 9.9 mttt 47.6 51.44 13.86 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.787 0.327 . . . . 0.0 111.021 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.482 ' HB2' ' CE2' ' A' ' 110' ' ' PHE . . . -75.73 -82.2 0.07 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.176 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.767 HG11 HD12 ' A' ' 111' ' ' LEU . 69.8 t -160.42 -74.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.928 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.41 ' HG3' ' N ' ' A' ' 154' ' ' TYR . 0.2 OUTLIER -177.52 144.43 0.39 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.65 -179.042 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.46 ' CE2' ' HA ' ' A' ' 139' ' ' PRO . 18.3 t80 -105.75 109.59 21.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.186 179.419 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.407 ' HB ' ' HB ' ' A' ' 168' ' ' VAL . 3.1 t -101.64 158.81 4.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.998 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -100.49 126.18 46.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.016 0.436 . . . . 0.0 111.666 -179.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.447 ' SG ' HG12 ' A' ' 168' ' ' VAL . 1.4 p 178.51 126.07 0.05 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.548 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.579 ' HB3' HD12 ' A' ' 160' ' ' LEU . 15.4 m -112.5 167.99 10.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.943 0.402 . . . . 0.0 111.427 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.522 ' HB1' ' HB3' ' A' ' 18' ' ' CYS . . . -98.77 -33.53 10.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.843 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.579 HD12 ' HB3' ' A' ' 158' ' ' SER . 0.9 OUTLIER -51.14 -38.69 53.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.448 179.788 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.0 t -117.33 -12.91 10.42 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.163 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 64.65 72.48 0.44 Allowed 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.818 0.342 . . . . 0.0 110.892 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.413 ' HB3' ' HA ' ' A' ' 157' ' ' CYS . 68.1 tttt -97.17 22.82 8.07 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.19 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 107.82 41.0 1.63 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.161 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.89 HD22 ' CD2' ' A' ' 19' ' ' LEU . 0.4 OUTLIER -49.26 -30.82 7.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.089 0.471 . . . . 0.0 110.632 179.596 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 22.9 pttm -68.79 -31.66 70.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.657 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -52.59 -69.28 0.12 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.546 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.824 HG11 HG13 ' A' ' 113' ' ' VAL . 12.3 p -50.29 -44.19 23.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.059 0.457 . . . . 0.0 110.441 179.435 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.522 ' CD1' ' CD1' ' A' ' 19' ' ' LEU . 2.2 t80 -59.85 -34.32 72.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.12 179.306 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.522 ' OD1' HD21 ' B' ' 505' ' ' LEU . 0.6 OUTLIER -60.7 -34.87 75.01 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.837 179.236 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.663 ' HB3' HD11 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -73.12 -30.46 63.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.2 179.229 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.451 ' CA ' HD13 ' A' ' 111' ' ' LEU . . . -76.39 -42.39 44.63 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.648 179.665 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.424 ' CG1' ' HA ' ' A' ' 170' ' ' ASP . 1.5 pp -76.97 -32.62 19.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.423 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 1.025 HD13 HD13 ' B' ' 505' ' ' LEU . 22.8 tp -53.37 -49.34 67.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.551 179.608 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.84 -22.29 62.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.783 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.588 ' HB1' ' HB ' ' A' ' 4' ' ' ILE . . . -85.4 -41.82 15.08 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.058 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.906 HD13 ' HB ' ' B' ' 510' ' ' ILE . 32.6 mt -68.78 -23.18 64.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.819 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.412 ' HB2' ' CB ' ' B' ' 507' ' ' ALA . 0.0 OUTLIER -168.3 153.56 6.5 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.784 179.934 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -52.72 124.01 14.32 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.621 2.214 . . . . 0.0 112.313 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.53 -178.43 3.37 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.538 2.159 . . . . 0.0 112.404 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -144.42 99.53 4.89 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.858 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -88.47 35.43 0.4 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 123.197 2.598 . . . . 0.0 113.038 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 17.4 pttt -56.36 157.35 5.04 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.878 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 7.2 mttm . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.898 -179.978 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.204 0 N-CA-C 112.506 -0.238 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 503' ' ' SER . . . . . . . . . . . . . 22.3 m -67.35 -78.93 0.05 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.805 0.336 . . . . 0.0 110.814 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 504' ' ' GLY . . . . . 0.418 ' CA ' ' OD2' ' B' ' 509' ' ' ASP . . . 92.71 103.53 1.54 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.278 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 505' ' ' LEU . . . . . 1.025 HD13 HD13 ' A' ' 174' ' ' LEU . 0.2 OUTLIER -164.36 47.56 0.11 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.792 0.329 . . . . 0.0 111.31 -179.614 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 506' ' ' SER . . . . . 0.481 ' O ' ' HB2' ' B' ' 507' ' ' ALA . 4.9 m 59.31 87.86 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.975 0.417 . . . . 0.0 110.022 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 507' ' ' ALA . . . . . 0.481 ' HB2' ' O ' ' B' ' 506' ' ' SER . . . 173.75 -37.68 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.242 -179.083 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 508' ' ' GLN . . . . . 0.487 ' CB ' ' CD1' ' B' ' 510' ' ' ILE . 1.3 mt-30 155.48 -20.85 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.7 -1.136 . . . . 0.0 109.994 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 509' ' ' ASP . . . . . 0.455 ' CB ' ' O ' ' B' ' 508' ' ' GLN . 8.4 t70 90.03 38.67 0.01 OUTLIER 'General case' 0 C--N 1.343 0.323 0 CA-C-O 121.309 0.576 . . . . 0.0 110.6 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 510' ' ' ILE . . . . . 0.906 ' HB ' HD13 ' A' ' 177' ' ' LEU . 1.9 mp -68.99 136.39 26.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.346 179.245 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 511' ' ' SER . . . . . 0.683 ' HB2' HD21 ' B' ' 514' ' ' LEU . 4.1 m -109.23 153.98 23.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.061 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 512' ' ' GLN . . . . . 0.492 ' CB ' ' HD3' ' B' ' 513' ' ' PRO . 0.3 OUTLIER -98.53 -68.37 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.82 179.847 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 513' ' ' PRO . . . . . 0.492 ' HD3' ' CB ' ' B' ' 512' ' ' GLN . 90.4 Cg_endo -78.64 59.55 7.27 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.4 2.067 . . . . 0.0 111.781 179.384 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 514' ' ' LEU . . . . . 0.683 HD21 ' HB2' ' B' ' 511' ' ' SER . 1.1 mt -73.34 -86.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.751 -179.235 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 515' ' ' GLN . . . . . 0.503 ' CB ' HG12 ' A' ' 44' ' ' VAL . 0.5 OUTLIER -88.1 -10.31 50.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.649 -179.529 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 53.59 24.52 4.23 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.936 0.398 . . . . 0.0 110.379 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 517' ' ' SER . . . . . 0.856 ' O ' HG13 ' A' ' 42' ' ' VAL . 75.4 m -68.28 58.8 0.08 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.618 -179.495 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 518' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -78.28 91.48 4.42 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.42 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 519' ' ' ILE . . . . . 0.423 HG12 ' O ' ' A' ' 41' ' ' ALA . 3.5 mm -76.28 157.47 5.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.251 -179.612 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -101.57 119.59 39.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.903 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 521' ' ' THR . . . . . . . . . . . . . 18.7 p -133.93 -61.99 0.78 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.829 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 522' ' ' GLY . . . . . . . . . . . . . . . -55.74 119.56 14.62 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.564 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 523' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -59.05 -83.76 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.772 0.32 . . . . 0.0 110.882 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 524' ' ' GLY . . . . . 0.5 ' HA3' HG11 ' A' ' 36' ' ' VAL . . . 67.88 167.86 4.04 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.492 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 525' ' ' ASP . . . . . 0.48 ' CG ' HD22 ' A' ' 61' ' ' LEU . 0.6 OUTLIER -85.28 83.19 8.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.83 0.348 . . . . 0.0 110.94 -179.967 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 526' ' ' SER . . . . . 0.44 ' CB ' ' HG3' ' A' ' 34' ' ' PRO . 6.4 t -83.58 95.79 8.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.694 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 527' ' ' ASP . . . . . 0.553 ' O ' HG21 ' A' ' 33' ' ' VAL . 3.2 p30 -177.52 147.36 0.66 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.995 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.74 101.56 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.685 2.257 . . . . 0.0 112.109 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 529' ' ' ARG . . . . . 0.423 ' HB2' ' HB3' ' B' ' 545' ' ' ASN . 0.1 OUTLIER -100.16 -55.3 2.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.352 -179.514 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 530' ' ' HIS . . . . . . . . . . . . . 14.2 m80 -142.3 -47.21 0.34 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.025 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 3.0 m 72.94 -172.1 0.14 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.806 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 532' ' ' TRP . . . . . . . . . . . . . 24.1 t90 -62.06 102.74 0.31 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.962 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . -122.02 -38.46 0.6 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.481 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 534' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -105.61 154.86 38.9 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 120.731 0.301 . . . . 0.0 110.932 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -67.18 125.51 13.65 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.641 2.228 . . . . 0.0 112.085 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 1.3 t0 70.84 141.35 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.768 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 537' ' ' ARG . . . . . 0.433 ' NE ' ' O3A' ' A' ' 185' ' ' GNP . 30.3 mmt180 -70.8 144.6 50.76 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.25 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 538' ' ' ILE . . . . . 0.756 HG23 HD12 ' B' ' 543' ' ' LEU . 6.2 tp -58.16 145.17 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.055 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 539' ' ' ASP . . . . . 0.449 ' O ' ' CD1' ' B' ' 543' ' ' LEU . 20.5 t0 -41.38 132.85 2.6 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.969 0.414 . . . . 0.0 112.028 -178.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 540' ' ' GLU . . . . . 0.643 ' CG ' HG22 ' A' ' 8' ' ' VAL . 0.8 OUTLIER -40.55 -27.27 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.047 179.702 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 541' ' ' LEU . . . . . 0.669 ' O ' HD21 ' A' ' 70' ' ' LEU . 5.3 mt -31.93 -69.24 0.08 Allowed 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 542' ' ' TYR . . . . . 0.458 ' CD1' ' HB3' ' B' ' 541' ' ' LEU . 0.1 OUTLIER -103.36 -63.78 1.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.317 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 543' ' ' LEU . . . . . 0.756 HD12 HG23 ' B' ' 538' ' ' ILE . 4.6 mp 65.05 141.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.866 -179.377 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . 132.62 141.86 4.74 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.487 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 545' ' ' ASN . . . . . 0.423 ' HB3' ' HB2' ' B' ' 529' ' ' ARG . 36.1 m-20 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.923 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 185' ' ' GNP . . . . . 0.993 " H2'" ' OG1' ' A' ' 115' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.516 ' HE3' ' CG2' ' A' ' 46' ' ' ILE . 7.4 tpt . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.475 0.179 . . . . 0.0 111.2 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.431 ' O ' ' CE ' ' A' ' 1' ' ' MET . 39.4 tp60 60.76 137.83 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.047 0.451 . . . . 0.0 110.917 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.598 HG21 ' HG ' ' A' ' 53' ' ' LEU . 0.2 OUTLIER -124.24 -165.95 1.43 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.609 -179.492 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.683 ' CG2' ' HB3' ' A' ' 176' ' ' ALA . 0.2 OUTLIER -150.92 138.26 13.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.581 -179.593 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.477 ' O ' HG13 ' A' ' 77' ' ' VAL . 3.6 ttmt -95.0 101.35 13.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.748 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.562 ' CB ' HD23 ' A' ' 55' ' ' LEU . 20.2 m -80.25 110.1 15.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.287 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.7 t -151.16 106.74 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.766 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.627 HG13 ' OE1' ' B' ' 540' ' ' GLU . 2.4 p -89.3 135.48 25.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.296 0.569 . . . . 0.0 111.583 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.747 HG21 ' CE2' ' A' ' 78' ' ' PHE . 2.8 m -133.41 129.44 56.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.197 178.41 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.409 ' O ' ' N ' ' B' ' 540' ' ' GLU . . . 141.69 -165.3 26.52 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.067 -1.064 . . . . 0.0 112.483 -179.106 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.7 21.87 5.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.764 0.316 . . . . 0.0 110.992 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.414 ' HA3' ' CB ' ' A' ' 81' ' ' CYS . . . -128.13 161.6 21.97 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.501 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.438 ' CB ' ' HB2' ' A' ' 18' ' ' CYS . . . -93.08 -20.1 20.87 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.4 ' CG2' ' SG ' ' A' ' 81' ' ' CYS . 4.0 m -42.41 92.67 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 CA-C-O 120.892 0.377 . . . . 0.0 111.643 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.439 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . . . -178.13 -77.97 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.76 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.508 ' O ' HD22 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -98.08 -84.1 0.39 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.927 0.394 . . . . 0.0 111.825 -179.354 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.436 ' HA ' HG12 ' A' ' 21' ' ' ILE . 4.3 p -63.33 -50.39 70.19 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.67 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.438 ' HB2' ' CB ' ' A' ' 13' ' ' ALA . 51.9 t -32.46 -70.83 0.06 Allowed 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 113.634 0.975 . . . . 0.0 113.634 -178.391 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.836 HD21 ' CE1' ' A' ' 169' ' ' PHE . 0.0 OUTLIER -58.05 -71.23 0.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -178.19 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.508 HD22 ' O ' ' A' ' 16' ' ' LYS . 0.2 OUTLIER -51.05 -65.88 0.48 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -178.283 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.512 HD11 ' CZ ' ' B' ' 518' ' ' PHE . 30.4 mm -45.6 -67.9 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.107 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.434 ' CB ' ' HB1' ' A' ' 159' ' ' ALA . 1.2 t -49.82 -26.12 3.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.961 0.41 . . . . 0.0 110.752 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -82.86 -25.34 32.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.72 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.42 HG23 ' O ' ' A' ' 20' ' ' LEU . 66.7 p -100.52 -64.21 1.06 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.243 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 40.1 p -62.41 -58.28 8.2 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.993 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 74.9 42.67 0.26 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.181 179.584 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.47 ' O ' ' CE1' ' A' ' 32' ' ' TYR . 4.2 mtmm -119.66 91.58 3.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.968 0.413 . . . . 0.0 110.928 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.48 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 9.4 t80 -89.81 -45.38 0.41 Allowed Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.872 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 88.0 Cg_endo -84.16 79.02 2.73 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.424 2.083 . . . . 0.0 113.04 -179.426 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.9 m -174.02 -94.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.879 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.41 154.74 25.46 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 120.635 0.255 . . . . 0.0 110.449 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.5 ' CE2' ' O3A' ' A' ' 185' ' ' GNP . 15.6 m-85 -133.82 93.98 3.2 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.905 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.564 ' N ' ' CD ' ' A' ' 34' ' ' PRO . 2.1 t -131.59 28.09 0.15 Allowed Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.564 ' CD ' ' N ' ' A' ' 33' ' ' VAL . 42.3 Cg_endo -86.09 -37.59 0.1 Allowed 'Trans proline' 0 C--N 1.359 1.109 0 C-N-CA 121.889 1.726 . . . . 0.0 112.496 179.605 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.472 HG21 HD21 ' B' ' 543' ' ' LEU . 1.4 m -48.46 99.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.881 -179.26 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.466 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 7.4 p 176.98 -34.95 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.825 179.17 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -109.39 35.88 3.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.582 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.449 ' CB ' ' HG2' ' A' ' 16' ' ' LYS . 18.3 m-20 -89.58 45.47 1.28 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.127 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -106.03 -16.28 14.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.077 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -60.59 174.97 0.51 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.79 0.329 . . . . 0.0 110.865 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.759 ' C ' HD12 ' B' ' 519' ' ' ILE . . . -91.99 174.48 7.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.294 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.421 ' HA ' HG13 ' B' ' 519' ' ' ILE . 30.9 m -139.32 144.67 28.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.734 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.498 ' O ' HG23 ' A' ' 44' ' ' VAL . 2.1 p -85.05 106.33 16.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.499 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.912 ' HB ' HG21 ' A' ' 52' ' ' THR . 53.9 t -158.04 153.11 6.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.158 -179.195 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.53 ' HB3' HD22 ' B' ' 514' ' ' LEU . 0.0 OUTLIER -117.73 96.31 5.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.17 179.313 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.951 HG12 HG22 ' A' ' 52' ' ' THR . 5.5 mm -71.1 88.1 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.539 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.508 ' N ' HG23 ' B' ' 510' ' ' ILE . . . 37.28 -87.85 0.01 OUTLIER Glycine 0 CA--C 1.521 0.409 0 CA-C-N 115.811 -0.631 . . . . 0.0 113.919 179.326 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . -38.88 -78.6 0.05 OUTLIER Glycine 0 C--N 1.334 0.439 0 C-N-CA 121.52 -0.371 . . . . 0.0 113.177 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.451 ' N ' ' HE1' ' A' ' 45' ' ' MET . 3.2 mt-10 -142.29 162.23 46.25 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-O 120.909 0.385 . . . . 0.0 111.373 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.42 92.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.79 2.327 . . . . 0.0 112.558 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.549 ' CE1' HG23 ' A' ' 3' ' ' THR . 0.0 OUTLIER -172.95 126.07 0.45 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.073 179.749 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.951 HG22 HG12 ' A' ' 46' ' ' ILE . 4.3 p -134.57 141.77 46.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.919 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.598 ' HG ' HG21 ' A' ' 3' ' ' THR . 5.3 mt -71.16 121.69 18.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.877 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -52.28 153.4 6.08 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.092 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.562 HD23 ' CB ' ' A' ' 6' ' ' CYS . 2.6 mp -109.79 95.04 5.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.839 0.352 . . . . 0.0 110.884 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -84.73 105.45 15.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.633 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.421 ' OD2' ' CG2' ' A' ' 35' ' ' THR . 1.5 t70 -94.44 163.77 13.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.822 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' THR . . . . . 1.087 HG21 HD22 ' A' ' 70' ' ' LEU . 6.7 p -89.44 146.38 24.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.32 -179.551 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.466 ' HB3' ' HA ' ' A' ' 36' ' ' VAL . . . -172.14 -162.78 0.22 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.677 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.455 ' H ' HD12 ' A' ' 61' ' ' LEU . . . 166.41 66.75 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.467 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.455 HD12 ' H ' ' A' ' 60' ' ' GLY . 5.8 mp -120.97 -87.01 0.65 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.727 0.299 . . . . 0.0 111.02 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.79 -31.56 11.81 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.902 0.382 . . . . 0.0 111.108 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.425 ' HB3' HG22 ' A' ' 36' ' ' VAL . 50.7 t0 -70.8 -63.25 1.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.37 -179.577 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.489 ' CD1' HD12 ' A' ' 67' ' ' LEU . 0.1 OUTLIER -118.33 160.25 21.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.805 -179.757 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -85.92 -68.35 0.74 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.807 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -96.69 -52.2 4.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.117 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.715 HD23 ' O ' ' A' ' 67' ' ' LEU . 6.5 tt 56.42 106.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.64 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.452 ' N ' ' HD3' ' A' ' 69' ' ' PRO . 1.7 ppt_? -142.47 53.33 2.87 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.321 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.452 ' HD3' ' N ' ' A' ' 68' ' ' ARG . 94.1 Cg_endo -83.95 -20.25 4.49 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.764 2.309 . . . . 0.0 112.26 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 1.087 HD22 HG21 ' A' ' 58' ' ' THR . 0.7 OUTLIER -77.76 1.0 21.49 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.925 -179.79 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.21 -61.23 2.28 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 120.908 0.385 . . . . 0.0 110.92 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.492 ' N ' ' CD1' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -159.22 56.76 0.96 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.791 179.884 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -60.94 174.44 1.77 Allowed 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.661 2.241 . . . . 0.0 112.307 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -95.68 10.57 36.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.524 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.402 HG23 ' HB3' ' A' ' 5' ' ' LYS . 98.8 m -46.51 145.21 1.88 Allowed 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.804 0.335 . . . . 0.0 111.05 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.418 ' O ' ' CG ' ' A' ' 109' ' ' PRO . 16.8 p-10 -106.4 -20.96 13.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.147 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.666 ' O ' HG13 ' A' ' 77' ' ' VAL . 7.9 p -123.55 83.96 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.827 0.346 . . . . 0.0 111.387 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.747 ' CE2' HG21 ' A' ' 9' ' ' VAL . 0.3 OUTLIER -80.79 166.3 21.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.599 179.736 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.471 HD13 ' HB3' ' A' ' 111' ' ' LEU . 4.9 tp -143.39 108.46 4.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.02 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.706 HG13 ' CB ' ' A' ' 110' ' ' PHE . 35.9 m -84.74 147.11 5.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.838 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.481 ' O ' ' CZ3' ' A' ' 97' ' ' TRP . 2.0 m -113.97 174.35 5.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.118 0.485 . . . . 0.0 111.216 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.463 ' CE1' ' O ' ' A' ' 113' ' ' VAL . 6.0 p90 179.99 -173.54 0.23 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.769 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.441 ' N ' ' CD2' ' A' ' 82' ' ' PHE . 0.3 OUTLIER -156.42 136.34 12.66 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.847 0.356 . . . . 0.0 111.349 179.958 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.538 HG13 ' N ' ' A' ' 137' ' ' ILE . 99.3 t -51.48 -40.41 24.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.827 179.534 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.623 ' O ' HG23 ' A' ' 85' ' ' VAL . 32.0 m -73.02 111.64 7.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.518 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.455 ' H ' HD13 ' A' ' 129' ' ' LEU . 83.4 p -151.28 135.27 9.51 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.743 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.417 ' HB2' ' HB2' ' A' ' 132' ' ' ASN . 74.2 Cg_endo -91.42 51.88 0.78 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.218 2.612 . . . . 0.0 111.585 179.225 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.46 ' CB ' ' CG ' ' A' ' 133' ' ' LYS . 0.1 OUTLIER 79.15 26.85 0.42 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.665 -179.426 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.922 ' O ' HG23 ' A' ' 93' ' ' VAL . 52.4 p -96.5 -25.73 15.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.999 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.411 ' CZ ' HG21 ' A' ' 137' ' ' ILE . 3.3 t80 -48.96 -54.08 17.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.075 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -49.82 -53.41 25.62 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.932 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -64.29 -47.68 78.57 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.724 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.922 HG23 ' O ' ' A' ' 89' ' ' SER . 65.9 t -51.1 -39.84 20.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.049 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.645 ' HD2' HD13 ' A' ' 145' ' ' LEU . 12.3 tttm -64.51 -50.39 67.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.847 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.403 ' O ' ' HG3' ' A' ' 99' ' ' PRO . 4.7 mt-10 -82.97 7.39 15.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.695 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.2 mttp -109.82 -26.14 9.97 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.751 0.31 . . . . 0.0 110.872 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.73 ' O ' HG22 ' A' ' 101' ' ' ILE . 5.7 m0 -94.01 -45.73 7.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.196 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.64 HG23 ' O ' ' A' ' 94' ' ' LYS . 58.5 t -49.94 -46.73 81.43 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.63 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 94.2 Cg_endo -80.74 -15.5 10.78 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.393 2.062 . . . . 0.0 112.612 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -90.11 -49.09 6.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.771 0.32 . . . . 0.0 110.901 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.73 HG22 ' O ' ' A' ' 97' ' ' TRP . 9.9 tt -62.95 -22.86 31.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.197 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.515 HG23 ' O ' ' A' ' 98' ' ' VAL . 61.2 p -91.51 -26.11 18.94 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.878 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 42.0 t60 -76.92 -57.79 3.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.895 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -65.66 -56.96 9.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.951 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.407 ' CB ' ' OG1' ' A' ' 108' ' ' THR . 60.4 m -86.65 142.94 35.16 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.976 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -69.23 60.27 1.4 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.558 2.172 . . . . 0.0 112.315 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.78 78.58 0.27 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.927 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.407 ' OG1' ' CB ' ' A' ' 105' ' ' CYS . 0.2 OUTLIER -108.52 141.12 22.59 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.813 179.847 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.418 ' CG ' ' O ' ' A' ' 76' ' ' ASP . 33.8 Cg_endo -65.53 177.91 2.46 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.507 2.138 . . . . 0.0 112.52 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.845 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 4.6 p90 -166.22 132.55 2.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.782 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.849 HD12 ' CG1' ' A' ' 152' ' ' VAL . 5.5 tt -108.94 142.0 40.21 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.678 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.438 HD12 ' CD1' ' A' ' 82' ' ' PHE . 4.2 mm? -89.59 155.03 19.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.586 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 1.091 HG13 HG21 ' A' ' 168' ' ' VAL . 2.4 t -142.12 134.17 26.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.946 0.403 . . . . 0.0 111.792 -179.448 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.784 ' O ' HD11 ' A' ' 117' ' ' ILE . . . -106.03 86.09 0.47 Allowed Glycine 0 C--N 1.332 0.338 0 C-N-CA 121.004 -0.617 . . . . 0.0 111.857 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.804 ' OG1' " H2'" ' A' ' 185' ' ' GNP . 1.0 OUTLIER -110.34 1.68 18.61 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -178.805 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.597 ' HB2' HN22 ' A' ' 185' ' ' GNP . 4.4 tp60 -96.87 -22.74 16.71 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.442 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.784 HD11 ' O ' ' A' ' 114' ' ' GLY . 0.2 OUTLIER -46.04 -25.75 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.096 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.839 178.931 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.563 ' HB3' HD13 ' A' ' 119' ' ' LEU . 4.8 t0 -53.72 -47.52 70.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.372 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.722 HD13 ' N ' ' A' ' 119' ' ' LEU . 0.0 OUTLIER -122.98 14.31 9.88 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -178.976 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.82 -28.61 3.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.897 0.379 . . . . 0.0 110.87 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.3 p30 -72.22 -22.39 61.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.094 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.421 ' O ' ' HB ' ' A' ' 126' ' ' ILE . 20.1 p-10 -48.24 104.32 0.41 Allowed Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 120.983 0.421 . . . . 0.0 110.974 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.426 ' O ' HG22 ' A' ' 126' ' ' ILE . 36.7 Cg_endo -66.49 -6.57 15.48 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.381 2.054 . . . . 0.0 113.172 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.417 ' OG ' ' N ' ' A' ' 125' ' ' THR . 54.3 p -79.78 -66.52 0.86 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.417 ' N ' ' OG ' ' A' ' 124' ' ' SER . 34.5 m -55.76 -38.06 69.34 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.499 HD11 ' HB3' ' A' ' 136' ' ' PRO . 0.1 OUTLIER -56.37 -41.68 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 115.01 -0.996 . . . . 0.0 109.803 179.229 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.449 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 1.0 OUTLIER -60.59 -37.51 81.58 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.436 179.256 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 125' ' ' THR . 0.0 OUTLIER -60.88 -31.3 70.77 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.595 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.455 HD13 ' H ' ' A' ' 86' ' ' SER . 5.1 mt -75.36 -41.68 55.9 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 177.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 127' ' ' GLU . . . -44.26 -33.9 1.73 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.99 -1.004 . . . . 0.0 111.105 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 18.0 mmtm -49.79 -33.05 15.42 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.416 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.417 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 5.1 m-80 -123.29 -31.36 3.57 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.341 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.523 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 0.8 OUTLIER -144.6 -99.17 0.1 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 119.191 -0.433 . . . . 0.0 111.571 179.793 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.523 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 2.7 pt20 129.57 -23.86 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.528 1.131 . . . . 0.0 110.313 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.2 mmtt -68.73 110.26 5.64 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.778 -179.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.499 ' HB3' HD11 ' A' ' 126' ' ' ILE . 96.1 Cg_endo -79.55 127.36 7.23 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.485 2.123 . . . . 0.0 111.239 179.16 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.734 ' N ' HD13 ' A' ' 137' ' ' ILE . 1.1 mm -56.76 95.9 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.962 0.411 . . . . 0.0 110.738 -179.462 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 47.0 p -67.65 155.65 90.81 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.087 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.455 ' HG3' HG21 ' A' ' 117' ' ' ILE . 75.3 Cg_exo -47.54 -27.85 8.1 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.461 2.107 . . . . 0.0 112.184 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -77.1 -30.53 55.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.626 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.566 ' HB ' HG22 ' A' ' 137' ' ' ILE . 5.8 m -69.58 -62.49 1.36 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.727 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.403 ' HB3' ' CZ ' ' A' ' 154' ' ' TYR . . . -52.14 -36.05 50.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.637 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -65.83 -41.53 91.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.505 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 19.4 tptp -55.11 -62.77 1.45 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.634 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.755 ' CD1' HD23 ' A' ' 149' ' ' LEU . 17.2 tp -58.31 -43.81 88.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.543 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.403 ' HB2' ' HG ' ' A' ' 112' ' ' LEU . . . -55.06 -35.3 64.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.924 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 12.3 mtt-85 -91.47 -30.87 16.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.618 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -65.12 -44.28 89.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.707 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.755 HD23 ' CD1' ' A' ' 145' ' ' LEU . 3.0 mm? -89.8 14.05 12.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.123 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 47.41 45.8 17.11 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.835 0.35 . . . . 0.0 111.002 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.845 ' HB1' ' O ' ' A' ' 110' ' ' PHE . . . -65.09 -82.22 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.198 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.849 ' CG1' HD12 ' A' ' 111' ' ' LEU . 70.7 t -161.09 -75.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.826 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.57 108.41 0.06 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.792 -178.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.449 ' CE2' ' HA ' ' A' ' 139' ' ' PRO . 19.5 t80 -80.98 114.56 19.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.425 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 3.7 t -108.87 155.12 9.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.826 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.405 ' O ' ' HB3' ' A' ' 157' ' ' CYS . 1.2 pt-20 -94.37 118.58 31.83 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.223 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.435 ' HA ' ' HB3' ' A' ' 163' ' ' LYS . 20.3 p 178.95 137.46 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.615 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.481 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 27.4 m -112.72 149.31 33.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.981 0.419 . . . . 0.0 111.221 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.853 ' HB2' HD21 ' A' ' 165' ' ' LEU . . . -83.21 -42.54 17.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.82 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.491 HD23 ' H ' ' A' ' 160' ' ' LEU . 0.1 OUTLIER -49.53 -36.5 23.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.703 179.779 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.455 HG22 ' HB2' ' A' ' 158' ' ' SER . 15.3 t -111.37 -22.48 11.3 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.685 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.413 ' N ' ' O ' ' A' ' 158' ' ' SER . 0.9 OUTLIER 73.11 62.25 0.1 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.781 -179.89 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.435 ' HB3' ' HA ' ' A' ' 157' ' ' CYS . 0.0 OUTLIER -93.08 22.59 4.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.061 -179.943 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.435 ' N ' ' HB2' ' A' ' 157' ' ' CYS . . . 133.34 35.39 0.29 Allowed Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.484 -0.865 . . . . 0.0 113.412 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.853 HD21 ' HB2' ' A' ' 159' ' ' ALA . 10.5 mt -48.88 -42.3 36.27 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.913 0.357 . . . . 0.0 110.844 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.18 -34.18 72.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.992 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.418 ' O ' ' HB2' ' A' ' 170' ' ' ASP . 0.1 OUTLIER -58.03 -72.18 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.241 -179.811 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 1.091 HG21 HG13 ' A' ' 113' ' ' VAL . 7.1 p -50.08 -46.91 24.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.981 0.42 . . . . 0.0 110.988 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.836 ' CE1' HD21 ' A' ' 19' ' ' LEU . 1.1 t80 -64.6 -33.38 75.78 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.672 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.42 ' O ' ' CB ' ' A' ' 174' ' ' LEU . 0.5 OUTLIER -56.3 -32.84 64.99 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.967 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.699 ' HB2' HD11 ' A' ' 111' ' ' LEU . 58.7 mm-40 -75.0 -36.21 61.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.887 178.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.731 ' N ' HD13 ' A' ' 111' ' ' LEU . . . -67.31 -43.41 81.72 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.623 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.494 HD13 ' HB2' ' B' ' 512' ' ' GLN . 1.7 pp -78.23 -33.14 17.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.661 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.86 HD13 HD22 ' B' ' 505' ' ' LEU . 22.0 tp -59.13 -43.62 92.01 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.634 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -54.34 -22.03 11.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.112 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.683 ' HB3' ' CG2' ' A' ' 4' ' ' ILE . . . -87.53 -37.03 17.25 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.395 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.839 HD13 ' HB ' ' B' ' 510' ' ' ILE . 94.9 mt -68.83 -27.98 66.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.962 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.11 136.73 1.93 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.981 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -57.32 112.02 1.0 Allowed 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.563 2.175 . . . . 0.0 112.302 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.53 162.1 33.55 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.625 2.217 . . . . 0.0 112.276 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -131.37 143.85 50.98 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.959 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -76.53 -165.12 0.29 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.721 2.281 . . . . 0.0 112.329 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 1.8 mmmt -71.26 83.54 0.75 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.87 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 7.7 mttt . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.979 179.992 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 502' ' ' GLY . . . . . 0.416 ' CA ' ' O ' ' B' ' 509' ' ' ASP . . . . . . . . 0 N--CA 1.489 2.195 0 N-CA-C 112.524 -0.23 . . . . 0.0 112.524 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 503' ' ' SER . . . . . . . . . . . . . 37.4 t -107.06 -74.62 0.65 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.781 0.324 . . . . 0.0 110.944 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 504' ' ' GLY . . . . . . . . . . . . . . . 116.58 103.86 2.35 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.36 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 505' ' ' LEU . . . . . 0.86 HD22 HD13 ' A' ' 174' ' ' LEU . 0.1 OUTLIER -174.55 38.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.698 0.285 . . . . 0.0 111.141 -179.871 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 506' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 68.95 34.26 3.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.127 0.489 . . . . 0.0 110.566 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 507' ' ' ALA . . . . . 0.479 ' HB3' ' CD1' ' B' ' 505' ' ' LEU . . . -137.47 35.97 2.48 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.548 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 508' ' ' GLN . . . . . 0.4 ' O ' ' HB3' ' B' ' 509' ' ' ASP . 20.4 mt-30 74.73 3.38 4.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.441 -178.555 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 509' ' ' ASP . . . . . 0.416 ' O ' ' CA ' ' B' ' 502' ' ' GLY . 16.0 t70 71.7 44.83 0.47 Allowed 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.158 0.504 . . . . 0.0 110.816 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 510' ' ' ILE . . . . . 0.839 ' HB ' HD13 ' A' ' 177' ' ' LEU . 44.5 mt -93.17 138.29 20.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.846 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 511' ' ' SER . . . . . . . . . . . . . 22.1 t -108.04 157.16 18.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.359 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 512' ' ' GLN . . . . . 0.505 ' O ' HG11 ' A' ' 44' ' ' VAL . 27.9 tp60 -110.21 -71.2 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.513 179.59 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 513' ' ' PRO . . . . . 0.478 ' CD ' ' CB ' ' B' ' 512' ' ' GLN . 73.3 Cg_endo -74.6 58.96 4.75 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.021 1.814 . . . . 0.0 111.632 179.318 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 514' ' ' LEU . . . . . 0.53 HD22 ' HB3' ' A' ' 45' ' ' MET . 2.6 mp -65.81 -86.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.65 -179.272 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 515' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -69.3 -96.1 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.218 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -127.32 -12.26 5.67 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 517' ' ' SER . . . . . 0.418 ' HA ' ' HB ' ' A' ' 42' ' ' VAL . 1.5 m 48.62 31.78 3.14 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.705 0.288 . . . . 0.0 111.135 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 518' ' ' PHE . . . . . 0.512 ' CZ ' HD11 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -163.3 91.96 0.72 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.143 -179.795 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 519' ' ' ILE . . . . . 0.759 HD12 ' C ' ' A' ' 41' ' ' ALA . 41.5 mt -64.23 -64.68 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.84 0.353 . . . . 0.0 110.755 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -126.6 -168.95 1.94 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.891 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 521' ' ' THR . . . . . . . . . . . . . 6.6 m -119.76 113.99 21.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.002 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 522' ' ' GLY . . . . . . . . . . . . . . . -107.16 120.6 6.23 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.522 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 523' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -114.58 -84.44 0.61 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.716 0.294 . . . . 0.0 110.96 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 524' ' ' GLY . . . . . . . . . . . . . . . 101.21 -44.14 1.6 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.412 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 525' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -152.01 32.95 0.54 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.862 0.363 . . . . 0.0 110.907 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 526' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.1 97.56 6.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.887 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 527' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -145.88 161.68 39.02 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.914 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.42 96.59 0.65 Allowed 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.598 2.199 . . . . 0.0 112.242 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 529' ' ' ARG . . . . . . . . . . . . . 1.9 mtp85 -96.08 -23.1 16.94 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.202 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 530' ' ' HIS . . . . . 0.41 ' O ' ' HB2' ' B' ' 531' ' ' CYS . 0.0 OUTLIER -178.76 -82.77 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.938 -179.875 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 531' ' ' CYS . . . . . 0.41 ' HB2' ' O ' ' B' ' 530' ' ' HIS . 50.1 t 178.29 -68.67 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.886 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 532' ' ' TRP . . . . . 0.521 ' CZ2' ' NH2' ' B' ' 537' ' ' ARG . 0.6 OUTLIER -126.32 -49.8 1.54 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.967 -179.908 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 533' ' ' GLY . . . . . 0.472 ' O ' ' CG ' ' B' ' 534' ' ' PHE . . . 106.4 -56.28 0.51 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.483 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 534' ' ' PHE . . . . . 0.472 ' CG ' ' O ' ' B' ' 533' ' ' GLY . 98.0 m-85 -160.67 160.72 25.5 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.76 0.314 . . . . 0.0 110.88 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -48.05 123.36 8.61 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.559 2.173 . . . . 0.0 112.274 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 2.9 t0 68.25 145.18 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.747 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 537' ' ' ARG . . . . . 0.521 ' NH2' ' CZ2' ' B' ' 532' ' ' TRP . 0.1 OUTLIER -51.94 139.19 22.93 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.036 0.446 . . . . 0.0 111.09 -179.867 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 538' ' ' ILE . . . . . 0.434 ' CG2' ' HA ' ' B' ' 543' ' ' LEU . 5.8 tp -59.38 144.94 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.959 179.181 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 539' ' ' ASP . . . . . 0.408 ' HA ' ' O ' ' A' ' 10' ' ' GLY . 8.5 m-20 -43.84 136.95 3.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.815 0.341 . . . . 0.0 111.275 -179.432 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 540' ' ' GLU . . . . . 0.704 ' HA ' HD12 ' B' ' 543' ' ' LEU . 33.1 mm-40 -52.72 -21.66 4.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.163 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 541' ' ' LEU . . . . . 0.738 ' HA ' HD21 ' A' ' 70' ' ' LEU . 1.1 mp -37.03 -63.59 0.42 Allowed 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 542' ' ' TYR . . . . . 0.412 ' O ' ' CB ' ' B' ' 543' ' ' LEU . 0.1 OUTLIER -105.16 -58.68 1.86 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.304 -179.574 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 543' ' ' LEU . . . . . 0.704 HD12 ' HA ' ' B' ' 540' ' ' GLU . 0.1 OUTLIER 81.27 -167.97 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.369 -179.225 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . 93.44 -176.3 36.77 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.497 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 545' ' ' ASN . . . . . 0.552 ' HB2' HG22 ' A' ' 33' ' ' VAL . 6.1 m120 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.279 -0.867 . . . . 0.0 110.987 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 185' ' ' GNP . . . . . 0.804 " H2'" ' OG1' ' A' ' 115' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.461 ' HE2' ' O ' ' A' ' 2' ' ' GLN . 7.9 tpt . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.769 0.319 . . . . 0.0 111.3 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.461 ' O ' ' HE2' ' A' ' 1' ' ' MET . 2.7 tt0 62.25 134.04 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.448 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.708 HG23 ' CE1' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -107.39 -166.5 1.16 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.908 -179.158 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.756 HD11 ' CD1' ' A' ' 53' ' ' LEU . 4.9 pt -156.44 162.36 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.588 -179.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.12 99.41 4.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.437 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.426 ' SG ' HD23 ' A' ' 55' ' ' LEU . 1.3 m -78.25 103.25 8.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.518 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.1 t -135.15 112.57 14.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.327 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.482 HG11 ' HG3' ' A' ' 16' ' ' LYS . 0.2 OUTLIER -103.42 138.62 27.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.299 0.571 . . . . 0.0 111.203 -179.592 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.406 ' O ' HG23 ' A' ' 9' ' ' VAL . 30.5 m -130.25 129.62 65.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.346 178.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 142.19 -172.42 24.2 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 119.867 -1.159 . . . . 0.0 112.7 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -96.5 27.48 3.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.779 0.323 . . . . 0.0 110.8 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.457 ' HA2' ' CD ' ' B' ' 537' ' ' ARG . . . -149.35 150.69 22.84 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.745 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.476 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -58.16 -54.56 45.55 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.551 0.215 . . . . 0.0 110.849 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.9 ' O ' HD21 ' A' ' 19' ' ' LEU . 0.0 OUTLIER 44.62 -87.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.472 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.528 ' HA2' HD21 ' A' ' 19' ' ' LEU . . . -102.32 23.13 35.31 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.242 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.712 ' O ' HD22 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -84.34 -163.52 0.81 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.947 0.403 . . . . 0.0 110.945 -179.823 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.452 ' HB ' ' CG1' ' A' ' 21' ' ' ILE . 6.1 p -74.84 -28.6 60.75 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.029 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.405 ' HB3' ' HB1' ' A' ' 13' ' ' ALA . 53.3 t -41.47 -30.06 0.18 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.643 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.9 HD21 ' O ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -62.83 -71.05 0.17 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.889 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.4 mt -70.07 -36.12 74.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.97 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.492 HG23 ' HB2' ' A' ' 26' ' ' ASN . 4.5 mm -58.31 -71.2 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.418 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 25' ' ' THR . 24.5 m -55.22 -34.83 64.3 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 121.098 -0.241 . . . . 0.0 110.666 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.8 ' HB2' HD13 ' A' ' 165' ' ' LEU . 49.9 t80 -52.65 -35.12 54.36 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.435 ' O ' ' HB ' ' A' ' 25' ' ' THR . 0.2 OUTLIER -100.97 -46.24 5.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.71 179.258 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.49 ' O ' ' CB ' ' A' ' 26' ' ' ASN . 6.7 t -177.83 -162.84 0.07 Allowed 'General case' 0 C--O 1.227 -0.082 0 CA-C-N 116.342 -0.39 . . . . 0.0 112.003 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.492 ' HB2' HG23 ' A' ' 21' ' ' ILE . 2.5 t30 97.6 -20.87 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.659 0.784 . . . . 0.0 110.616 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.6 mttp 60.06 146.67 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.963 0.411 . . . . 0.0 111.395 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.473 ' CD1' ' OH ' ' A' ' 32' ' ' TYR . 19.7 t80 -89.2 -47.69 0.41 Allowed Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.871 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 67.7 Cg_endo -88.29 58.14 2.71 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.793 2.328 . . . . 0.0 112.797 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.2 m -133.85 -85.53 0.43 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.823 0.344 . . . . 0.0 110.759 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -158.59 162.83 37.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.754 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.487 ' CD1' ' HB2' ' B' ' 532' ' ' TRP . 67.4 m-85 -135.22 103.56 5.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.971 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.567 HG12 HD21 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -165.31 -61.35 0.01 OUTLIER Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.341 -179.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.506 ' HD3' HG23 ' A' ' 33' ' ' VAL . 86.7 Cg_exo -42.84 -28.49 1.18 Allowed 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.371 2.048 . . . . 0.0 112.528 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.82 HG23 HD23 ' B' ' 543' ' ' LEU . 4.2 t -57.44 -20.81 32.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.192 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.964 HG21 ' HB2' ' A' ' 61' ' ' LEU . 12.6 p -52.0 -21.18 2.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.521 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.482 ' CD1' ' O ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -83.02 46.9 1.15 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.66 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.466 ' CB ' ' HB2' ' A' ' 57' ' ' ASP . 5.0 p-10 -63.66 -158.29 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.645 0.259 . . . . 0.0 110.837 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 73.73 22.48 2.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.804 0.335 . . . . 0.0 111.006 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.497 ' CE2' ' HA ' ' B' ' 520' ' ' HIS . 1.8 m-30 -60.18 129.31 41.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.77 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.443 ' O ' HG12 ' B' ' 519' ' ' ILE . . . -95.51 119.61 34.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.582 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.809 HG23 HG21 ' A' ' 52' ' ' THR . 17.5 m -117.74 159.82 17.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.986 0.422 . . . . 0.0 111.72 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.34 104.79 6.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.384 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.692 HG22 ' CG2' ' A' ' 52' ' ' THR . 10.4 m -149.04 -177.46 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.366 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.624 ' O ' HD11 ' B' ' 514' ' ' LEU . 4.7 tpt -99.07 96.62 7.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.342 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.669 HG22 ' O ' ' A' ' 46' ' ' ILE . 1.3 mm -80.44 86.66 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-O 121.33 0.586 . . . . 0.0 109.695 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.718 ' HA3' HG23 ' B' ' 510' ' ' ILE . . . 42.74 -92.42 0.01 OUTLIER Glycine 0 CA--C 1.524 0.601 0 CA-C-N 115.537 -0.756 . . . . 0.0 113.71 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . -38.55 -91.59 0.01 OUTLIER Glycine 0 CA--C 1.52 0.39 0 N-CA-C 113.988 0.355 . . . . 0.0 113.988 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.463 ' N ' ' HE1' ' A' ' 45' ' ' MET . 1.3 pt-20 -125.88 152.47 72.73 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-O 120.693 0.282 . . . . 0.0 110.932 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.401 ' N ' ' SD ' ' A' ' 45' ' ' MET . 83.0 Cg_exo -43.28 105.55 0.06 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.51 2.14 . . . . 0.0 112.266 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.708 ' CE1' HG23 ' A' ' 3' ' ' THR . 8.8 t80 -172.02 159.21 4.93 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.303 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.809 HG21 HG23 ' A' ' 42' ' ' VAL . 6.5 p -136.09 153.2 51.39 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.146 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.756 ' CD1' HD11 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -87.27 -179.19 6.37 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.919 179.807 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -128.54 103.51 0.62 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.627 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.426 HD23 ' SG ' ' A' ' 6' ' ' CYS . 0.1 OUTLIER -85.66 97.38 10.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.807 0.336 . . . . 0.0 110.254 179.702 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -84.23 105.61 15.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.694 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.807 ' OD2' HD21 ' B' ' 543' ' ' LEU . 0.6 OUTLIER -90.75 137.05 32.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.061 -179.775 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.879 ' O ' HD13 ' B' ' 543' ' ' LEU . 0.1 OUTLIER -99.03 143.38 29.37 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.278 179.807 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.901 ' HB3' HG23 ' A' ' 36' ' ' VAL . . . -153.14 177.4 10.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.923 0.392 . . . . 0.0 111.384 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.417 ' HA2' ' HA ' ' A' ' 65' ' ' ASP . . . -129.96 51.81 0.85 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.94 -0.647 . . . . 0.0 112.09 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.964 ' HB2' HG21 ' A' ' 36' ' ' VAL . 0.4 OUTLIER -120.82 -175.24 2.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.934 0.397 . . . . 0.0 111.199 -179.56 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -46.73 -40.24 13.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.347 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.439 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . 59.4 m-20 -47.25 -56.95 5.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.184 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.61 ' HB2' HD23 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -166.8 93.34 0.47 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.837 -179.855 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.417 ' HA ' ' HA2' ' A' ' 60' ' ' GLY . 0.2 OUTLIER -86.33 -7.43 58.49 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.558 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.37 -20.63 20.87 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.61 HD23 ' HB2' ' A' ' 64' ' ' TYR . 4.5 pp -51.36 160.98 0.5 Allowed 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.783 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 20.6 ttp85 -178.18 62.82 0.16 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.012 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -84.79 -23.38 2.62 Favored 'Trans proline' 0 N--CA 1.461 -0.383 0 C-N-CA 122.859 2.373 . . . . 0.0 112.581 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.71 ' O ' HD12 ' A' ' 70' ' ' LEU . 0.1 OUTLIER -71.75 -6.16 39.32 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.448 -179.672 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -48.36 -71.25 0.07 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.86 0.362 . . . . 0.0 111.097 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.405 ' N ' ' HD3' ' A' ' 73' ' ' PRO . 10.4 m-85 -140.33 62.52 20.03 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.879 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.409 ' HB2' ' CZ ' ' A' ' 78' ' ' PHE . 54.4 Cg_exo -52.36 130.58 36.55 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.685 2.257 . . . . 0.0 112.284 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -86.15 10.27 14.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.499 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 15.3 t -50.82 174.6 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.806 0.336 . . . . 0.0 110.817 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -112.3 -25.73 9.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.882 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.657 ' O ' HG13 ' A' ' 77' ' ' VAL . 8.2 p -126.57 99.14 5.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.172 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.414 ' HB2' ' O ' ' A' ' 109' ' ' PRO . 0.2 OUTLIER -80.89 176.58 9.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.61 179.826 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.559 ' CD2' ' HB1' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -127.83 108.74 10.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.077 -179.808 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.712 HG13 ' HB2' ' A' ' 110' ' ' PHE . 34.4 m -97.97 127.88 49.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.65 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.457 ' HB3' ' CG2' ' A' ' 14' ' ' VAL . 21.1 p -99.63 174.02 6.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.14 0.495 . . . . 0.0 111.632 -179.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.571 ' CZ ' ' HB2' ' A' ' 142' ' ' ALA . 8.3 p90 -179.63 -174.3 0.29 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.17 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.427 ' N ' ' CD2' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -156.08 149.89 25.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.752 0.31 . . . . 0.0 110.856 179.885 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.771 ' CG2' HG22 ' A' ' 117' ' ' ILE . 43.8 t -61.71 -41.84 92.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.345 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.689 HG13 ' CD ' ' A' ' 120' ' ' ARG . 17.6 m -59.64 114.8 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.365 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.785 ' N ' HD22 ' A' ' 129' ' ' LEU . 0.6 OUTLIER -152.02 117.47 3.08 Favored Pre-proline 0 C--N 1.329 -0.294 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.801 -179.57 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.425 ' O ' ' CB ' ' A' ' 132' ' ' ASN . 89.7 Cg_endo -94.01 53.28 0.33 Allowed 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.114 2.543 . . . . 0.0 111.288 179.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.46 ' HA ' ' HG3' ' A' ' 133' ' ' LYS . 0.2 OUTLIER 81.12 30.07 0.16 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.661 -179.253 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 73.9 m -97.2 -16.84 20.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.133 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.821 ' CE2' HD12 ' A' ' 137' ' ' ILE . 0.1 OUTLIER -43.26 -42.11 4.22 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.869 0.366 . . . . 0.0 111.403 -179.919 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -63.41 -33.6 75.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.973 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.406 ' O ' ' N ' ' A' ' 96' ' ' LYS . 7.4 m120 -75.23 -52.98 9.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.095 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.434 ' CG2' ' HA ' ' A' ' 90' ' ' PHE . 7.4 m -49.71 -44.59 20.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.233 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.454 ' O ' HG23 ' A' ' 98' ' ' VAL . 0.1 OUTLIER -65.44 -49.78 67.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.899 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -82.57 7.34 14.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.671 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.406 ' N ' ' O ' ' A' ' 92' ' ' ASN . 4.8 tttt -115.3 -27.34 7.27 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.721 0.296 . . . . 0.0 111.036 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.413 ' O ' HG22 ' A' ' 101' ' ' ILE . 1.7 m95 -94.31 -50.18 5.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.388 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.674 HG13 HD21 ' A' ' 149' ' ' LEU . 61.9 t -50.89 -46.01 87.42 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.962 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 95.3 Cg_endo -81.03 -11.21 12.38 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.377 2.051 . . . . 0.0 113.016 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.405 ' HB3' ' O ' ' A' ' 96' ' ' LYS . 1.2 tt0 -90.34 -57.0 2.99 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 120.906 0.384 . . . . 0.0 110.187 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.413 HG22 ' O ' ' A' ' 97' ' ' TRP . 20.8 tt -57.34 -27.88 29.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.084 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.76 HG22 ' HA ' ' A' ' 107' ' ' LYS . 23.2 p -86.33 -29.66 22.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.75 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -58.62 -54.84 42.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.851 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 52.9 m170 -65.54 -42.04 92.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.79 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -125.87 124.02 24.71 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.669 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -50.98 89.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.414 2.076 . . . . 0.0 112.261 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.76 ' HA ' HG22 ' A' ' 102' ' ' THR . 0.1 OUTLIER 63.29 94.54 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.911 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.428 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 0.1 OUTLIER -119.66 126.76 26.77 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.875 -179.974 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 108' ' ' THR . 37.5 Cg_exo -60.64 176.84 0.75 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.435 2.09 . . . . 0.0 112.236 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.712 ' HB2' HG13 ' A' ' 80' ' ' VAL . 32.7 p90 -165.93 176.39 7.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.852 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.632 HD12 HG11 ' A' ' 152' ' ' VAL . 1.1 tt -139.56 134.37 32.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.886 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.538 HD23 ' CB ' ' A' ' 146' ' ' ALA . 4.1 mm? -89.78 138.48 31.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.205 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 1.02 HG13 HG21 ' A' ' 168' ' ' VAL . 11.0 t -130.45 147.57 33.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.11 0.481 . . . . 0.0 112.064 -179.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -113.31 142.18 17.3 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.648 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.677 ' C ' HD13 ' A' ' 117' ' ' ILE . 0.8 OUTLIER -153.83 -61.53 0.14 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.853 0.359 . . . . 0.0 111.03 -179.622 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.445 ' N ' ' OG1' ' A' ' 115' ' ' THR . 10.5 mm100 -60.12 -20.4 58.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.026 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.771 HG22 ' CG2' ' A' ' 84' ' ' VAL . 0.2 OUTLIER -40.69 -29.13 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.867 -179.796 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -65.93 -42.19 90.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.812 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.71 HD22 HD22 ' A' ' 160' ' ' LEU . 0.1 OUTLIER -93.02 -48.16 6.64 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -179.327 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.689 ' CD ' HG13 ' A' ' 85' ' ' VAL . 1.4 mmt180 -48.15 -26.78 2.03 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.814 0.34 . . . . 0.0 111.024 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.06 -21.07 43.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.871 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.418 ' OD1' ' HD3' ' A' ' 123' ' ' PRO . 0.2 OUTLIER -64.62 153.56 87.04 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.867 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.451 ' O ' HG22 ' A' ' 126' ' ' ILE . 2.3 Cg_endo -81.35 -2.68 11.73 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.997 2.465 . . . . 0.0 112.957 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 40.7 t -81.49 -69.98 0.57 Allowed 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 120.879 0.371 . . . . 0.0 110.49 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.657 HG21 HG11 ' A' ' 85' ' ' VAL . 8.4 m -51.46 -33.77 32.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.411 0.624 . . . . 0.0 109.6 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.691 HD11 ' HB3' ' A' ' 136' ' ' PRO . 0.1 OUTLIER -58.63 -42.85 86.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.449 179.021 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.456 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 1.4 mm-40 -57.3 -35.41 69.78 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.568 179.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 125' ' ' THR . 3.9 mptt -65.66 -33.15 75.22 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.785 HD22 ' N ' ' A' ' 86' ' ' SER . 9.0 mt -73.64 -36.61 65.44 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 127' ' ' GLU . . . -49.15 -34.1 13.58 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.97 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 10.9 mmmm -47.58 -32.77 5.77 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.666 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.425 ' CB ' ' O ' ' A' ' 87' ' ' PRO . 43.4 m-80 -123.12 -31.22 3.63 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.281 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.512 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 9.3 mmtm -146.2 -95.05 0.09 Allowed 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 119.273 -0.394 . . . . 0.0 111.367 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.512 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 7.4 pt20 128.94 -21.17 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.482 1.113 . . . . 0.0 110.574 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.6 mttm -68.4 110.88 6.52 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.648 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.691 ' HB3' HD11 ' A' ' 126' ' ' ILE . 93.1 Cg_endo -82.86 130.15 5.69 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.67 2.246 . . . . 0.0 111.576 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.821 HD12 ' CE2' ' A' ' 90' ' ' PHE . 1.1 mm -62.47 96.78 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.941 0.401 . . . . 0.0 110.748 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.445 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.7 p -67.69 156.11 89.8 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.888 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.497 ' HA ' ' CE1' ' A' ' 154' ' ' TYR . 10.3 Cg_endo -51.71 -23.23 14.99 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.657 2.238 . . . . 0.0 112.023 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -86.11 -26.41 25.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.587 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.537 ' HB ' HG22 ' A' ' 137' ' ' ILE . 1.8 m -63.35 -56.84 13.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.661 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.571 ' HB2' ' CZ ' ' A' ' 82' ' ' PHE . . . -52.5 -36.96 56.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.828 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.14 -36.04 82.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.709 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.15 -56.86 13.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.815 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 50.5 tp -65.17 -36.77 85.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.764 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.538 ' CB ' HD23 ' A' ' 112' ' ' LEU . . . -57.46 -51.09 70.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.943 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 -71.64 -24.51 61.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.857 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -50.24 -41.74 50.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.832 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.674 HD21 HG13 ' A' ' 98' ' ' VAL . 1.3 mp -104.42 25.18 10.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.847 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.42 ' CD ' ' O ' ' A' ' 149' ' ' LEU . 0.0 OUTLIER 44.95 39.25 3.5 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.305 -179.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.679 ' HB1' ' O ' ' A' ' 110' ' ' PHE . . . -62.26 -81.02 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.028 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.632 HG11 HD12 ' A' ' 111' ' ' LEU . 78.4 t -159.59 -75.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.023 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.439 ' HG3' ' N ' ' A' ' 154' ' ' TYR . 0.5 OUTLIER 170.13 146.06 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.746 -178.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.497 ' CE1' ' HA ' ' A' ' 139' ' ' PRO . 10.2 t80 -100.77 113.58 26.61 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.717 HG11 ' ND2' ' A' ' 167' ' ' ASN . 1.7 t -101.6 175.73 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.629 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.628 ' H ' HG12 ' A' ' 155' ' ' VAL . 0.5 OUTLIER -88.8 145.19 25.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.021 0.439 . . . . 0.0 111.073 -179.444 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.453 ' O ' HD11 ' A' ' 117' ' ' ILE . 2.8 t -169.93 151.22 4.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.257 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.562 ' OG ' HG22 ' A' ' 161' ' ' THR . 2.4 t -160.23 123.47 3.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.072 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -92.74 20.56 6.35 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.953 179.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.71 HD22 HD22 ' A' ' 119' ' ' LEU . 0.3 OUTLIER -131.57 -44.06 1.0 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.575 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.562 HG22 ' OG ' ' A' ' 158' ' ' SER . 15.3 t -107.06 -19.51 13.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.889 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 78.05 77.78 0.07 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.098 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.424 ' HB2' ' HB2' ' A' ' 158' ' ' SER . 25.6 tptt -96.17 30.23 2.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.815 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 119.01 -58.09 0.54 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.516 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.8 HD13 ' HB2' ' A' ' 23' ' ' TYR . 0.7 OUTLIER 66.74 -73.58 0.07 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.787 0.327 . . . . 0.0 111.123 179.909 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.427 ' O ' ' N ' ' A' ' 170' ' ' ASP . 1.9 mtpt -56.9 -31.9 65.36 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.01 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.717 ' ND2' HG11 ' A' ' 155' ' ' VAL . 0.1 OUTLIER -52.31 -71.71 0.06 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.291 -179.874 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 1.02 HG21 HG13 ' A' ' 113' ' ' VAL . 13.6 p -57.06 -47.43 83.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.478 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.796 ' CD2' HD23 ' A' ' 19' ' ' LEU . 1.8 t80 -62.38 -25.79 68.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.59 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' A' ' 166' ' ' LYS . 28.4 t0 -71.58 -29.84 65.16 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.481 ' HB3' HD11 ' A' ' 111' ' ' LEU . 0.7 OUTLIER -73.67 -29.84 62.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.845 179.123 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.559 ' HB1' ' CD2' ' A' ' 79' ' ' LEU . . . -67.44 -49.67 62.66 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.835 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 1.6 pp -72.49 -32.59 42.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.11 0.481 . . . . 0.0 110.414 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.615 HD13 HD23 ' B' ' 505' ' ' LEU . 10.1 tp -46.13 -44.47 15.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.175 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.637 ' HB3' HG21 ' A' ' 77' ' ' VAL . . . -57.0 -24.24 52.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.818 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.507 ' HB1' ' HA ' ' A' ' 4' ' ' ILE . . . -94.87 -31.72 13.57 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.104 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.492 HD13 HG21 ' A' ' 4' ' ' ILE . 2.5 tp -68.27 -26.13 65.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.676 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.775 ' HB2' ' HB1' ' B' ' 507' ' ' ALA . 1.0 OUTLIER 171.24 149.3 0.17 Allowed Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.687 179.808 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . 0.437 ' HD2' ' CG ' ' A' ' 178' ' ' GLU . 16.1 Cg_endo -57.48 107.71 0.32 Allowed 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.691 2.261 . . . . 0.0 112.272 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -80.53 171.88 14.14 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.664 2.242 . . . . 0.0 112.419 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -113.62 139.56 23.52 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.872 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -76.46 -165.28 0.3 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.68 2.253 . . . . 0.0 112.342 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 10.7 mttt -134.62 80.28 1.84 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.865 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.88 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.193 0 N-CA-C 112.525 -0.23 . . . . 0.0 112.525 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 503' ' ' SER . . . . . 0.452 ' HB3' ' CD1' ' B' ' 505' ' ' LEU . 37.5 m -64.14 -78.77 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.856 0.36 . . . . 0.0 110.844 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 504' ' ' GLY . . . . . 0.847 ' C ' HD13 ' B' ' 505' ' ' LEU . . . 87.82 109.69 0.99 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.414 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 505' ' ' LEU . . . . . 0.847 HD13 ' C ' ' B' ' 504' ' ' GLY . 0.0 OUTLIER -167.17 55.12 0.08 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.701 0.286 . . . . 0.0 111.137 -179.274 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 506' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 48.48 66.44 1.07 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.917 0.389 . . . . 0.0 110.613 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 507' ' ' ALA . . . . . 0.775 ' HB1' ' HB2' ' A' ' 178' ' ' GLU . . . -175.5 53.42 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.79 -179.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 508' ' ' GLN . . . . . 0.465 ' HB3' ' O ' ' B' ' 507' ' ' ALA . 1.7 tt0 68.86 5.35 4.94 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.664 -178.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 509' ' ' ASP . . . . . 0.418 ' HA ' ' HA2' ' B' ' 504' ' ' GLY . 2.7 p30 51.54 47.1 25.45 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.449 0.643 . . . . 0.0 110.799 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 510' ' ' ILE . . . . . 0.718 HG23 ' HA3' ' A' ' 47' ' ' GLY . 80.3 mt -87.49 138.3 19.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.401 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 511' ' ' SER . . . . . . . . . . . . . 1.2 m -78.33 122.24 25.49 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.335 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 512' ' ' GLN . . . . . 0.517 ' HB2' ' HD2' ' B' ' 513' ' ' PRO . 0.0 OUTLIER -50.6 179.58 0.04 OUTLIER Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.893 179.265 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 513' ' ' PRO . . . . . 0.517 ' HD2' ' HB2' ' B' ' 512' ' ' GLN . 85.0 Cg_exo -46.12 92.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 121.78 1.653 . . . . 0.0 111.46 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 514' ' ' LEU . . . . . 0.624 HD11 ' O ' ' A' ' 45' ' ' MET . 0.0 OUTLIER -62.84 -168.33 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.27 -179.021 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 515' ' ' GLN . . . . . 0.518 ' O ' HG11 ' A' ' 44' ' ' VAL . 7.9 mt-30 -89.02 178.59 6.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.874 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 66.56 11.22 7.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.192 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 517' ' ' SER . . . . . 0.56 ' O ' HG11 ' A' ' 42' ' ' VAL . 3.4 p -100.9 65.48 1.12 Allowed 'General case' 0 N--CA 1.456 -0.139 0 CA-C-O 120.898 0.38 . . . . 0.0 110.759 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 518' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -158.06 91.86 1.14 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.644 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 519' ' ' ILE . . . . . 0.443 HG12 ' O ' ' A' ' 41' ' ' ALA . 3.5 mm -100.49 -19.02 6.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.581 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 520' ' ' HIS . . . . . 0.497 ' HA ' ' CE2' ' A' ' 40' ' ' TYR . 0.7 OUTLIER 72.91 103.12 0.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.866 0.365 . . . . 0.0 110.906 -179.737 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 521' ' ' THR . . . . . . . . . . . . . 3.2 m -143.86 57.6 1.35 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.825 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 522' ' ' GLY . . . . . . . . . . . . . . . -149.52 159.94 28.27 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.218 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 523' ' ' HIS . . . . . 0.454 ' N ' ' HB2' ' A' ' 37' ' ' PHE . 9.6 t-160 -98.68 -91.26 0.28 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.675 0.238 . . . . 0.0 110.959 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 524' ' ' GLY . . . . . 0.424 ' O ' ' CB ' ' B' ' 525' ' ' ASP . . . 45.52 -131.98 9.24 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.777 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 525' ' ' ASP . . . . . 0.424 ' CB ' ' O ' ' B' ' 524' ' ' GLY . 4.2 m-20 82.07 79.22 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.038 0.446 . . . . 0.0 111.02 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 526' ' ' SER . . . . . 0.482 ' HB3' HG11 ' A' ' 33' ' ' VAL . 0.4 OUTLIER -113.75 99.44 7.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.459 179.594 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 527' ' ' ASP . . . . . 0.411 ' HB2' ' HD2' ' B' ' 528' ' ' PRO . 0.4 OUTLIER -40.15 163.61 0.08 OUTLIER Pre-proline 0 N--CA 1.465 0.309 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.724 -179.703 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 528' ' ' PRO . . . . . 0.411 ' HD2' ' HB2' ' B' ' 527' ' ' ASP . 10.6 Cg_endo -51.08 112.05 0.7 Allowed 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 123.053 2.502 . . . . 0.0 111.988 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 529' ' ' ARG . . . . . 0.45 ' HD2' HG11 ' A' ' 33' ' ' VAL . 30.3 mtp180 -100.71 -54.1 2.91 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.258 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 530' ' ' HIS . . . . . . . . . . . . . 25.4 m-70 -137.68 10.29 2.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.587 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 3.9 m 44.99 -160.96 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.84 0.352 . . . . 0.0 111.286 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 532' ' ' TRP . . . . . 0.487 ' HB2' ' CD1' ' A' ' 32' ' ' TYR . 12.1 t-105 -132.34 92.29 3.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.867 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . -92.82 -48.87 2.82 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.526 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 534' ' ' PHE . . . . . 0.402 ' HA ' ' HD3' ' B' ' 535' ' ' PRO . 32.5 m-85 -106.87 140.21 21.15 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.658 0.266 . . . . 0.0 110.916 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 535' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' B' ' 534' ' ' PHE . 42.9 Cg_exo -56.17 -158.16 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.518 2.146 . . . . 0.0 112.303 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 69.24 61.36 0.31 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.886 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 537' ' ' ARG . . . . . 0.457 ' CD ' ' HA2' ' A' ' 12' ' ' GLY . 0.0 OUTLIER -48.75 159.56 0.23 Allowed 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.0 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 538' ' ' ILE . . . . . 0.453 ' CG1' ' HB2' ' B' ' 542' ' ' TYR . 10.3 tp -81.72 141.33 15.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.482 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 539' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -45.5 161.16 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.883 0.373 . . . . 0.0 111.221 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 540' ' ' GLU . . . . . 0.684 ' O ' HG23 ' A' ' 58' ' ' THR . 0.4 OUTLIER -61.61 -14.89 34.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.555 -179.854 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 541' ' ' LEU . . . . . 0.532 ' CB ' HD23 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -66.22 -32.77 74.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.365 0.603 . . . . 0.0 110.062 179.708 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 542' ' ' TYR . . . . . 0.453 ' HB2' ' CG1' ' B' ' 538' ' ' ILE . 40.7 m-85 -104.9 -50.76 3.19 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.17 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 543' ' ' LEU . . . . . 0.879 HD13 ' O ' ' A' ' 58' ' ' THR . 0.5 OUTLIER 72.42 -68.02 0.24 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.931 -179.678 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . -117.44 164.02 12.61 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.493 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 545' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.888 179.988 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.597 ' HE1' ' HD1' ' A' ' 51' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.418 0 N-CA-C 111.529 0.196 . . . . 0.0 111.529 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.402 ' O ' ' O ' ' A' ' 1' ' ' MET . 32.7 tp60 56.42 154.93 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.104 0.478 . . . . 0.0 111.556 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.891 ' HB ' HD22 ' A' ' 53' ' ' LEU . 0.3 OUTLIER -146.02 -168.97 3.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.034 179.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.755 ' O ' HD23 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -145.1 156.08 13.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.561 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 28.9 mttm -118.19 105.74 12.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.515 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.422 ' O ' ' N ' ' A' ' 56' ' ' PHE . 36.2 t -77.3 105.07 8.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.09 0.471 . . . . 0.0 111.934 -178.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.534 HG22 ' CB ' ' A' ' 56' ' ' PHE . 2.6 t -132.94 118.86 34.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.836 178.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.611 HG11 ' HG3' ' A' ' 16' ' ' LYS . 0.4 OUTLIER -96.69 143.41 12.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.315 0.579 . . . . 0.0 111.08 -179.235 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.83 HG21 ' CD2' ' A' ' 78' ' ' PHE . 12.6 m -140.88 129.75 24.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.482 178.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.407 ' O ' ' HB3' ' B' ' 539' ' ' ASP . . . 154.43 -143.06 9.61 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.024 -1.084 . . . . 0.0 112.734 -179.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -123.24 22.71 9.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.668 0.27 . . . . 0.0 110.953 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.434 ' CA ' ' O ' ' B' ' 536' ' ' ASP . . . -153.42 -172.45 21.62 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.406 -0.902 . . . . 0.0 113.364 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.666 ' HB2' ' HG3' ' B' ' 537' ' ' ARG . . . -63.69 -48.74 75.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.777 0.322 . . . . 0.0 111.462 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.665 HG22 ' SG ' ' A' ' 81' ' ' CYS . 61.5 t 68.37 -72.14 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.117 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.882 ' CA ' HD22 ' A' ' 19' ' ' LEU . . . -172.36 66.32 0.13 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.631 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.667 ' CD ' HD21 ' B' ' 543' ' ' LEU . 27.0 mttt -97.14 -97.56 0.2 Allowed 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 121.457 -0.097 . . . . 0.0 110.803 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.425 ' O ' HG12 ' A' ' 21' ' ' ILE . 58.3 p -98.22 -57.35 2.23 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-O 120.832 0.349 . . . . 0.0 111.177 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.402 ' HA ' ' HB ' ' A' ' 21' ' ' ILE . 14.8 p -36.17 -43.84 0.37 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.456 -179.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.967 HD23 ' CD2' ' A' ' 169' ' ' PHE . 1.8 mp -46.41 -70.96 0.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.793 0.33 . . . . 0.0 111.284 -179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.466 HD12 ' CZ ' ' B' ' 518' ' ' PHE . 14.7 mt -61.96 -25.57 67.69 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.84 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.442 HG22 ' OG1' ' A' ' 25' ' ' THR . 15.2 mm -67.2 -70.36 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.666 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.435 ' HB2' ' CD1' ' A' ' 165' ' ' LEU . 3.4 m -47.79 -28.93 2.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.082 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -66.84 -68.18 0.39 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.833 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.02 -48.11 39.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.72 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.442 ' OG1' HG22 ' A' ' 21' ' ' ILE . 13.4 p -83.2 -152.29 0.12 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.424 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -160.11 33.46 0.17 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.821 0.343 . . . . 0.0 111.033 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 13.8 mmtt -121.32 101.71 7.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.408 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.493 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . 7.9 t80 -104.87 -60.11 0.06 OUTLIER Pre-proline 0 CA--C 1.537 0.444 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.124 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.493 ' HD3' ' HB3' ' A' ' 28' ' ' PHE . 95.1 Cg_endo -84.21 48.7 2.56 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.151 1.9 . . . . 0.0 112.608 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.84 -80.79 0.43 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.029 0.442 . . . . 0.0 110.656 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.448 ' HB2' ' NE ' ' B' ' 529' ' ' ARG . 12.9 pt-20 -158.34 140.98 14.51 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.63 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.463 ' C ' HG22 ' A' ' 33' ' ' VAL . 91.7 m-85 -130.21 100.91 5.57 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.514 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.556 HG23 ' HD3' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -165.28 -63.55 0.01 OUTLIER Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.157 -179.541 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.556 ' HD3' HG23 ' A' ' 33' ' ' VAL . 74.9 Cg_exo -38.75 -29.77 0.17 Allowed 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.745 2.296 . . . . 0.0 112.905 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.947 HG23 ' OD2' ' A' ' 38' ' ' ASP . 60.9 m -56.53 85.54 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.993 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.592 HG11 ' HB2' ' A' ' 61' ' ' LEU . 2.6 t -140.5 -40.42 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.282 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.457 ' CE2' ' OD1' ' A' ' 63' ' ' ASP . 0.3 OUTLIER -91.19 25.13 2.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.966 179.698 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.947 ' OD2' HG23 ' A' ' 35' ' ' THR . 0.7 OUTLIER -57.78 -159.85 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.873 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 68.26 29.46 6.01 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.943 0.401 . . . . 0.0 110.46 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.414 ' CE1' ' O ' ' B' ' 521' ' ' THR . 0.7 OUTLIER -60.72 -160.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.852 -179.808 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.419 ' O ' HG12 ' B' ' 519' ' ' ILE . . . -122.97 123.27 40.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.466 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.481 HG13 ' C ' ' B' ' 517' ' ' SER . 3.3 t -106.76 121.7 59.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.64 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.593 ' OG1' HD11 ' B' ' 519' ' ' ILE . 6.5 p -108.79 106.84 17.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.197 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.655 ' CG2' HG21 ' A' ' 52' ' ' THR . 27.3 m -159.46 -178.91 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.916 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.651 ' O ' HD22 ' B' ' 514' ' ' LEU . 0.0 OUTLIER -98.37 103.39 15.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.844 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.571 HG22 ' O ' ' A' ' 51' ' ' TYR . 1.2 tt -95.2 106.29 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-O 121.529 0.681 . . . . 0.0 111.021 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.51 ' N ' HG23 ' B' ' 510' ' ' ILE . . . 43.61 -93.19 0.01 OUTLIER Glycine 0 CA--C 1.517 0.178 0 C-N-CA 121.001 -0.619 . . . . 0.0 113.526 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.444 ' HA3' ' CB ' ' A' ' 1' ' ' MET . . . -39.2 -86.16 0.01 OUTLIER Glycine 0 C--N 1.334 0.458 0 C-N-CA 121.393 -0.432 . . . . 0.0 113.371 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.481 ' HB3' ' HD2' ' A' ' 50' ' ' PRO . 4.0 mt-10 -144.06 177.58 1.76 Allowed Pre-proline 0 C--N 1.331 -0.205 0 CA-C-O 120.671 0.272 . . . . 0.0 111.04 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 49' ' ' GLU . 76.8 Cg_exo -51.23 92.98 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.551 2.167 . . . . 0.0 112.614 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.597 ' HD1' ' HE1' ' A' ' 1' ' ' MET . 2.8 t80 -173.29 125.96 0.42 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.386 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.655 HG21 ' CG2' ' A' ' 44' ' ' VAL . 0.1 OUTLIER -134.3 144.29 48.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.798 0.332 . . . . 0.0 111.161 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.891 HD22 ' HB ' ' A' ' 3' ' ' THR . 0.9 OUTLIER -87.69 -177.33 5.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.89 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -123.92 116.47 2.86 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.438 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.45 ' H ' HD12 ' A' ' 55' ' ' LEU . 2.2 mp -50.77 139.13 17.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.874 0.369 . . . . 0.0 110.844 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.534 ' CB ' HG22 ' A' ' 7' ' ' VAL . 7.8 t80 -85.76 135.0 33.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.311 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.452 ' CB ' ' HB2' ' A' ' 38' ' ' ASP . 0.1 OUTLIER -150.54 131.88 14.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.372 179.558 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.743 ' OG1' HD21 ' A' ' 67' ' ' LEU . 2.5 p -130.25 125.0 33.75 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.164 -179.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.72 ' HB1' ' CD1' ' A' ' 61' ' ' LEU . . . -144.19 99.68 3.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.7 179.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.09 75.79 0.25 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.684 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.72 ' CD1' ' HB1' ' A' ' 59' ' ' ALA . 4.6 mp -121.49 -95.89 0.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 121.312 -0.155 . . . . 0.0 111.207 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -99.36 -30.3 12.29 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 120.766 0.317 . . . . 0.0 111.487 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.457 ' OD1' ' CE2' ' A' ' 37' ' ' PHE . 29.7 t0 -80.57 -63.73 1.34 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.619 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.524 ' CD2' ' CD1' ' A' ' 67' ' ' LEU . 19.0 m-85 -88.27 144.53 26.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.917 0.389 . . . . 0.0 110.874 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -86.26 -62.04 1.61 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.831 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.29 -52.98 3.49 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -178.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.743 HD21 ' OG1' ' A' ' 58' ' ' THR . 0.4 OUTLIER 64.78 -151.25 0.28 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 120.596 -0.442 . . . . 0.0 109.832 -179.566 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.576 ' CB ' HD21 ' B' ' 541' ' ' LEU . 0.1 OUTLIER 78.28 41.94 0.06 OUTLIER Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 179.5 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.574 ' CG ' HG21 ' A' ' 58' ' ' THR . 88.3 Cg_endo -82.89 -21.95 4.55 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.302 2.002 . . . . 0.0 112.09 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.974 HD21 ' HA ' ' B' ' 541' ' ' LEU . 0.1 OUTLIER -60.52 -15.17 24.68 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.621 -179.677 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.33 -60.55 3.68 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.752 0.311 . . . . 0.0 110.968 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.01 65.07 74.47 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.923 0.392 . . . . 0.0 111.146 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 70' ' ' LEU . 83.6 Cg_endo -82.56 145.88 13.31 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.801 2.334 . . . . 0.0 112.189 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -96.64 10.25 39.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.48 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 11.5 t -53.05 -176.32 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.752 0.31 . . . . 0.0 110.878 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -136.5 7.35 3.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.553 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.907 HG21 ' HB2' ' A' ' 176' ' ' ALA . 4.8 t -139.03 86.76 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.725 0.298 . . . . 0.0 111.458 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.83 ' CD2' HG21 ' A' ' 9' ' ' VAL . 0.5 OUTLIER -80.85 172.01 14.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.084 179.351 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.518 HD23 HG12 ' A' ' 14' ' ' VAL . 9.8 tp -157.0 120.98 4.28 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.084 0.469 . . . . 0.0 111.812 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.485 ' HB ' ' CH2' ' A' ' 97' ' ' TRP . 0.7 OUTLIER -114.11 135.83 52.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.981 179.041 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.665 ' SG ' HG22 ' A' ' 14' ' ' VAL . 4.6 p -125.83 164.33 20.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.245 0.545 . . . . 0.0 112.283 -178.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.487 ' CE2' HD12 ' A' ' 112' ' ' LEU . 11.3 p90 -169.36 135.61 1.64 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.131 179.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 50.2 p -88.41 144.66 26.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.816 0.341 . . . . 0.0 110.943 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.743 HG13 ' N ' ' A' ' 137' ' ' ILE . 45.1 t -46.17 -63.14 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.56 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.604 ' O ' HG23 ' A' ' 85' ' ' VAL . 35.3 m -45.47 110.02 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.698 0.285 . . . . 0.0 110.829 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.623 ' N ' HD22 ' A' ' 129' ' ' LEU . 0.2 OUTLIER -151.6 131.46 6.94 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.827 -179.347 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 86' ' ' SER . 67.8 Cg_endo -92.58 53.33 0.55 Allowed 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 123.289 2.659 . . . . 0.0 111.837 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.451 ' CA ' ' HG3' ' A' ' 133' ' ' LYS . 1.0 OUTLIER 80.31 30.17 0.22 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.069 -179.745 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.729 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -95.22 -23.03 17.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.857 179.658 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.654 ' CZ ' HG21 ' A' ' 137' ' ' ILE . 0.8 OUTLIER -52.49 -58.41 6.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.93 179.924 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -58.22 -40.7 82.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.936 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -64.64 -59.21 4.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.886 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.729 HG23 ' O ' ' A' ' 89' ' ' SER . 47.1 t -51.22 -52.74 17.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.181 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.766 ' HG3' HD11 ' A' ' 145' ' ' LEU . 10.8 tmtt? -50.49 -50.43 52.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.901 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.406 ' O ' ' HG2' ' A' ' 99' ' ' PRO . 3.1 mt-10 -54.25 -42.12 69.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.183 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.72 12.23 34.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.543 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.507 ' O ' HG22 ' A' ' 101' ' ' ILE . 0.0 OUTLIER -94.47 -53.16 4.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.744 0.307 . . . . 0.0 111.087 179.918 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 1.016 HG22 HD13 ' A' ' 149' ' ' LEU . 3.5 t -60.36 -44.94 97.31 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.896 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.493 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 16.4 Cg_exo -68.31 -33.72 23.14 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.539 2.159 . . . . 0.0 112.923 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -85.73 -35.7 20.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.649 -0.25 . . . . 0.0 111.437 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.622 HD11 ' HB3' ' A' ' 110' ' ' PHE . 12.7 tt -68.75 -25.98 31.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.755 0.312 . . . . 0.0 111.056 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 68.0 p -97.18 -26.85 14.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.046 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.47 ' CG ' ' O ' ' A' ' 99' ' ' PRO . 5.1 m170 -66.68 -41.84 87.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.047 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -76.68 -24.33 53.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.103 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.414 ' O ' ' N ' ' A' ' 107' ' ' LYS . 8.0 m -137.4 123.06 12.91 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.854 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 105' ' ' CYS . 32.3 Cg_exo -58.17 79.76 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.571 2.181 . . . . 0.0 112.234 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.414 ' N ' ' O ' ' A' ' 105' ' ' CYS . 2.6 mmmp? 61.39 91.41 0.06 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.917 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.442 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 0.1 OUTLIER -122.57 138.08 28.79 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.921 179.929 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 108' ' ' THR . 31.5 Cg_exo -60.28 138.02 78.49 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.618 2.212 . . . . 0.0 112.468 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.622 ' HB3' HD11 ' A' ' 101' ' ' ILE . 1.0 OUTLIER -142.25 147.18 36.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.715 179.656 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.757 HD23 ' O ' ' A' ' 112' ' ' LEU . 0.9 OUTLIER -130.02 158.0 40.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.314 -179.678 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.757 ' O ' HD23 ' A' ' 111' ' ' LEU . 3.0 mm? -97.19 161.35 13.85 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.667 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.752 ' HA ' HG21 ' A' ' 168' ' ' VAL . 18.2 t -135.03 138.69 48.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.049 0.452 . . . . 0.0 111.889 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.432 ' HA3' ' CZ ' ' A' ' 154' ' ' TYR . . . -123.26 107.31 1.08 Allowed Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.59 179.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.746 ' C ' HD13 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -130.81 -53.18 1.06 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.852 0.358 . . . . 0.0 110.704 -179.187 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.832 ' HG2' HD13 ' A' ' 119' ' ' LEU . 1.6 tt0 -79.89 53.8 1.74 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.274 179.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.786 HD11 ' O ' ' A' ' 157' ' ' CYS . 0.1 OUTLIER -99.12 -5.8 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.006 179.834 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -77.73 -27.43 50.51 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.936 0.398 . . . . 0.0 110.536 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.832 HD13 ' HG2' ' A' ' 116' ' ' GLN . 5.0 mp -76.69 -24.36 53.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.591 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.462 ' O ' HD13 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -46.71 -29.38 1.86 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.811 179.783 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -83.79 -34.92 24.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.405 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.63 104.49 0.44 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.575 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.457 ' HA ' ' CG2' ' A' ' 126' ' ' ILE . 14.7 Cg_exo -69.06 -3.73 12.14 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.703 2.269 . . . . 0.0 113.106 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.03 -66.4 0.87 Allowed 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 121.109 0.48 . . . . 0.0 109.758 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.416 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 18.2 m -57.92 -37.92 74.94 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.482 ' HA ' HD12 ' A' ' 129' ' ' LEU . 0.0 OUTLIER -54.85 -42.95 65.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.781 179.337 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.537 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 35.6 mt-10 -60.08 -35.1 74.45 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.86 179.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 125' ' ' THR . 0.0 OUTLIER -65.38 -30.91 71.79 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.071 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.623 HD22 ' N ' ' A' ' 86' ' ' SER . 7.4 mt -73.94 -35.59 64.59 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 127' ' ' GLU . . . -46.25 -34.63 4.56 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.894 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 5.7 mmmt -47.51 -33.06 5.89 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.478 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.418 ' HB2' ' O ' ' A' ' 87' ' ' PRO . 55.7 m-80 -123.43 -31.4 3.53 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.451 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.523 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 16.7 mmtp -146.85 -97.49 0.09 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 119.208 -0.425 . . . . 0.0 111.662 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.523 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 9.2 pt20 128.99 -25.74 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.473 1.109 . . . . 0.0 110.331 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -69.36 110.63 6.64 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.761 -179.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.432 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 95.3 Cg_endo -79.53 136.97 12.71 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.514 2.143 . . . . 0.0 111.371 179.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.743 ' N ' HG13 ' A' ' 84' ' ' VAL . 0.8 OUTLIER -69.25 96.59 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.91 0.386 . . . . 0.0 110.953 -179.463 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.402 ' O ' ' HB ' ' A' ' 141' ' ' THR . 2.6 p -70.48 160.2 82.21 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.182 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.496 ' HA ' ' CE1' ' A' ' 154' ' ' TYR . 72.0 Cg_exo -48.14 -42.88 32.34 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.572 2.181 . . . . 0.0 112.213 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -67.44 -34.74 77.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.776 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.517 HG21 HG23 ' A' ' 137' ' ' ILE . 97.5 m -58.29 -55.32 36.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.904 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.511 ' CB ' ' CD2' ' A' ' 154' ' ' TYR . . . -50.9 -36.53 38.75 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.899 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -64.72 -42.59 95.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.833 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.55 -56.76 15.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.698 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.766 HD11 ' HG3' ' A' ' 94' ' ' LYS . 2.9 tt -67.92 -31.97 72.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.707 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.412 ' CA ' ' HB3' ' A' ' 151' ' ' ALA . . . -55.66 -66.02 0.49 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.931 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 16.1 mtp85 -63.52 -24.12 67.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.977 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -54.11 -40.95 67.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.2 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 1.016 HD13 HG22 ' A' ' 98' ' ' VAL . 0.5 OUTLIER -117.32 24.5 11.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.076 -179.862 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.79 59.06 2.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.786 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.514 ' HB1' ' CD2' ' A' ' 112' ' ' LEU . . . -94.22 27.92 2.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.118 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.621 ' CB ' HD12 ' A' ' 111' ' ' LEU . 92.8 t 68.94 -74.8 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.975 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.695 ' O ' HD21 ' A' ' 111' ' ' LEU . 0.2 OUTLIER 173.13 139.21 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.109 0.481 . . . . 0.0 111.394 -179.234 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.511 ' CD2' ' CB ' ' A' ' 142' ' ' ALA . 3.2 t80 -94.66 116.69 29.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.248 178.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.545 HG11 ' ND2' ' A' ' 167' ' ' ASN . 5.2 t -101.12 158.7 4.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.31 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.402 ' N ' HG12 ' A' ' 155' ' ' VAL . 3.3 tt0 -89.67 143.58 26.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.522 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.786 ' O ' HD11 ' A' ' 117' ' ' ILE . 25.3 p 178.9 179.25 0.41 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.012 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.441 ' HA ' ' HA ' ' A' ' 115' ' ' THR . 28.4 p -159.89 160.24 33.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.953 0.406 . . . . 0.0 111.308 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.475 ' HB2' HD11 ' A' ' 165' ' ' LEU . . . -113.8 -27.14 7.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.915 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.68 -37.39 41.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.782 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.405 ' O ' ' HB3' ' A' ' 162' ' ' GLN . 7.7 t -116.59 -13.69 10.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.189 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.412 ' N ' ' OG ' ' A' ' 158' ' ' SER . 0.5 OUTLIER 71.56 82.02 0.15 Allowed 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.698 0.285 . . . . 0.0 111.254 179.827 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.426 ' N ' ' OG ' ' A' ' 158' ' ' SER . 5.5 mttm -101.92 22.15 13.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.053 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 105.2 44.23 1.51 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.442 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.743 HD22 ' HG ' ' A' ' 19' ' ' LEU . 2.3 mt -46.09 -31.7 2.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.783 0.325 . . . . 0.0 111.155 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.421 ' HG3' ' N ' ' A' ' 167' ' ' ASN . 0.1 OUTLIER -66.57 -28.62 68.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.902 179.825 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.545 ' ND2' HG11 ' A' ' 155' ' ' VAL . 0.1 OUTLIER -57.48 -70.87 0.11 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.698 179.874 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.752 HG21 ' HA ' ' A' ' 113' ' ' VAL . 11.4 p -50.77 -44.27 25.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.914 0.388 . . . . 0.0 110.565 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.967 ' CD2' HD23 ' A' ' 19' ' ' LEU . 0.3 OUTLIER -63.85 -30.59 71.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.097 179.436 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.421 ' O ' HG13 ' A' ' 173' ' ' ILE . 20.4 t0 -70.65 -22.52 62.49 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.565 179.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -84.61 -35.1 22.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.248 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -67.28 -32.62 73.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.74 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.601 ' O ' HG21 ' A' ' 4' ' ' ILE . 2.0 pp -82.52 -35.11 12.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.771 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.645 ' HB2' HD22 ' B' ' 505' ' ' LEU . 9.7 tp -52.83 -43.56 66.08 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.977 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -50.65 -23.48 2.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.642 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.907 ' HB2' HG21 ' A' ' 77' ' ' VAL . . . -96.72 -34.71 11.25 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.699 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.825 HD13 ' HB ' ' B' ' 510' ' ' ILE . 96.7 mt -68.76 -24.01 64.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.797 0.332 . . . . 0.0 110.729 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -179.92 154.33 0.68 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.926 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . 0.425 ' HA ' ' HD2' ' A' ' 180' ' ' PRO . 43.8 Cg_endo -68.1 108.8 1.81 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.603 2.202 . . . . 0.0 112.256 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 179' ' ' PRO . 54.6 Cg_endo -69.55 174.08 9.84 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.531 2.154 . . . . 0.0 112.449 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -145.64 144.47 22.64 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.781 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.3 -165.14 0.27 Allowed 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.598 2.198 . . . . 0.0 112.26 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 7.6 mttm -126.71 171.67 10.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.918 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 3.4 mtpt . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.192 -0.909 . . . . 0.0 110.867 -179.961 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 502' ' ' GLY . . . . . 0.425 ' CA ' ' O ' ' B' ' 509' ' ' ASP . . . . . . . . 0 N--CA 1.488 2.116 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 503' ' ' SER . . . . . 0.401 ' HB2' ' O ' ' B' ' 510' ' ' ILE . 0.1 OUTLIER -66.49 -75.29 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.797 0.332 . . . . 0.0 110.968 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 504' ' ' GLY . . . . . 0.492 ' CA ' ' HA ' ' B' ' 509' ' ' ASP . . . 147.22 -101.33 0.23 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.0 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 505' ' ' LEU . . . . . 0.645 HD22 ' HB2' ' A' ' 174' ' ' LEU . 0.5 OUTLIER 69.39 -61.77 0.43 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 179.244 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 506' ' ' SER . . . . . 0.424 ' CB ' ' O ' ' B' ' 505' ' ' LEU . 1.1 p 165.0 -45.71 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.722 0.296 . . . . 0.0 111.108 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 507' ' ' ALA . . . . . . . . . . . . . . . -36.92 -66.51 0.23 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.947 0.88 . . . . 0.0 111.43 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 508' ' ' GLN . . . . . 0.484 ' O ' ' CB ' ' B' ' 509' ' ' ASP . 7.3 mt-30 -160.48 -45.42 0.05 OUTLIER 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.02 -1.445 . . . . 0.0 107.841 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 509' ' ' ASP . . . . . 0.492 ' HA ' ' CA ' ' B' ' 504' ' ' GLY . 3.3 p30 146.88 43.57 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 113.994 -1.457 . . . . 0.0 110.259 178.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 510' ' ' ILE . . . . . 0.825 ' HB ' HD13 ' A' ' 177' ' ' LEU . 2.3 mt -65.15 133.09 30.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.163 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 511' ' ' SER . . . . . 0.42 ' CB ' ' HG ' ' B' ' 514' ' ' LEU . 2.6 m -109.35 158.72 17.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.257 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 512' ' ' GLN . . . . . 0.505 ' CB ' ' HD3' ' B' ' 513' ' ' PRO . 0.7 OUTLIER -100.37 -65.43 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.724 179.562 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 513' ' ' PRO . . . . . 0.505 ' HD3' ' CB ' ' B' ' 512' ' ' GLN . 69.9 Cg_endo -83.81 53.49 4.11 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.549 2.166 . . . . 0.0 112.06 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 514' ' ' LEU . . . . . 0.651 HD22 ' O ' ' A' ' 45' ' ' MET . 0.7 OUTLIER -61.75 -84.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.374 -179.468 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 515' ' ' GLN . . . . . 0.433 ' HB2' HG12 ' A' ' 44' ' ' VAL . 1.6 mt-30 -78.91 -86.8 0.07 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.207 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -118.41 -32.32 4.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.779 0.323 . . . . 0.0 111.243 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 517' ' ' SER . . . . . 0.481 ' C ' HG13 ' A' ' 42' ' ' VAL . 0.4 OUTLIER 73.06 7.85 5.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.649 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 518' ' ' PHE . . . . . 0.476 ' CD1' ' O ' ' B' ' 517' ' ' SER . 6.5 m-85 -163.43 125.03 2.43 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.723 0.297 . . . . 0.0 110.901 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 519' ' ' ILE . . . . . 0.593 HD11 ' OG1' ' A' ' 43' ' ' THR . 40.1 mm -79.94 -34.37 15.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.214 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 520' ' ' HIS . . . . . 0.704 ' O ' HG23 ' B' ' 521' ' ' THR . 41.5 t-80 -163.25 -87.04 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.069 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 521' ' ' THR . . . . . 0.704 HG23 ' O ' ' B' ' 520' ' ' HIS . 0.1 OUTLIER 170.23 -172.43 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 120.848 0.356 . . . . 0.0 110.886 179.911 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 522' ' ' GLY . . . . . . . . . . . . . . . -93.23 -125.91 4.08 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.37 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 523' ' ' HIS . . . . . 0.434 ' CD2' ' C ' ' B' ' 523' ' ' HIS . 8.7 t-160 -157.47 -91.64 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.501 0.191 . . . . 0.0 110.767 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 524' ' ' GLY . . . . . . . . . . . . . . . 48.4 -178.23 0.01 OUTLIER Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.854 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 525' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 168.77 60.46 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.824 0.345 . . . . 0.0 110.809 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 526' ' ' SER . . . . . 0.42 ' OG ' ' CG1' ' A' ' 33' ' ' VAL . 12.2 t -92.34 97.01 10.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.012 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 527' ' ' ASP . . . . . 0.478 ' CB ' ' CD ' ' B' ' 528' ' ' PRO . 0.2 OUTLIER -52.72 -64.31 1.68 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.98 179.944 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 528' ' ' PRO . . . . . 0.478 ' CD ' ' CB ' ' B' ' 527' ' ' ASP . 12.8 Cg_endo -53.45 103.43 0.09 OUTLIER 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.97 2.447 . . . . 0.0 112.17 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 529' ' ' ARG . . . . . 0.522 ' HG2' HG21 ' A' ' 33' ' ' VAL . 13.7 mtt85 -100.59 -32.06 10.95 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.968 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 530' ' ' HIS . . . . . 0.503 ' CG ' ' O ' ' B' ' 530' ' ' HIS . 0.1 OUTLIER 70.5 6.47 5.82 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.116 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER 59.55 177.51 0.08 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.89 0.376 . . . . 0.0 111.034 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 532' ' ' TRP . . . . . 0.411 ' CD2' ' O ' ' B' ' 532' ' ' TRP . 72.4 t90 -75.28 73.03 2.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.844 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . -96.21 -19.0 29.52 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.491 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 534' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -88.67 156.02 50.38 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.78 0.324 . . . . 0.0 111.003 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -73.89 95.08 0.88 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.565 2.176 . . . . 0.0 112.362 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 536' ' ' ASP . . . . . 0.434 ' O ' ' CA ' ' A' ' 12' ' ' GLY . 35.4 m-20 62.97 46.91 4.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.019 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 537' ' ' ARG . . . . . 0.666 ' HG3' ' HB2' ' A' ' 13' ' ' ALA . 20.9 mmt-85 73.86 -173.89 0.14 Allowed 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.373 0.606 . . . . 0.0 111.518 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 538' ' ' ILE . . . . . 0.732 HD12 ' CB ' ' B' ' 542' ' ' TYR . 4.8 pt -106.66 -153.68 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.031 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 539' ' ' ASP . . . . . 0.418 ' N ' HG13 ' B' ' 538' ' ' ILE . 51.8 p30 -104.04 161.42 14.01 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.944 0.402 . . . . 0.0 111.35 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 540' ' ' GLU . . . . . 0.5 ' HG3' HG13 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -57.12 -23.79 49.6 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.801 179.634 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 541' ' ' LEU . . . . . 0.974 ' HA ' HD21 ' A' ' 70' ' ' LEU . 0.4 OUTLIER -60.09 -34.79 73.94 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.339 0.59 . . . . 0.0 109.884 179.794 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 542' ' ' TYR . . . . . 0.732 ' CB ' HD12 ' B' ' 538' ' ' ILE . 2.9 m-85 -102.66 -57.34 2.07 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.999 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 543' ' ' LEU . . . . . 0.667 HD21 ' CD ' ' A' ' 16' ' ' LYS . 0.2 OUTLIER 64.74 -71.41 0.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.915 179.865 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 544' ' ' GLY . . . . . 0.652 ' HA3' HD11 ' A' ' 61' ' ' LEU . . . -62.87 165.66 24.92 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.349 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 545' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.276 -0.869 . . . . 0.0 111.018 -179.907 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.505 ' HE1' ' CD1' ' A' ' 51' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.323 0.106 . . . . 0.0 111.117 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.407 ' N ' ' SD ' ' A' ' 1' ' ' MET . 13.1 tp60 56.97 151.94 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.126 0.489 . . . . 0.0 111.58 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 1.085 HG23 HG21 ' A' ' 46' ' ' ILE . 0.3 OUTLIER -154.65 -158.69 0.87 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.247 179.919 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.979 HD11 HD22 ' A' ' 53' ' ' LEU . 0.2 OUTLIER -144.82 155.57 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 CA-C-O 121.189 0.519 . . . . 0.0 111.973 -179.514 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 36.3 mttt -134.45 116.61 15.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.704 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.641 ' SG ' HG23 ' A' ' 77' ' ' VAL . 45.7 t -138.38 154.22 48.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.364 0.602 . . . . 0.0 112.52 -178.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.822 HG22 ' CB ' ' A' ' 56' ' ' PHE . 11.9 t -128.37 150.35 34.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.208 178.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.948 HG11 HG13 ' A' ' 14' ' ' VAL . 2.8 p -83.8 121.65 36.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.307 0.575 . . . . 0.0 111.707 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.705 HG12 ' HB2' ' A' ' 70' ' ' LEU . 19.2 m -129.87 129.9 66.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.928 178.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.471 ' HA2' ' CZ2' ' A' ' 97' ' ' TRP . . . 137.49 -142.8 13.79 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.194 -1.003 . . . . 0.0 112.652 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.427 ' CB ' ' O ' ' B' ' 537' ' ' ARG . 0.4 OUTLIER -122.52 26.68 8.22 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.879 0.371 . . . . 0.0 110.633 179.915 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.425 ' O ' ' CB ' ' B' ' 537' ' ' ARG . . . -86.04 -176.2 49.96 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.765 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.579 ' HB2' ' CD ' ' B' ' 537' ' ' ARG . . . -89.39 4.82 47.76 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.958 HG21 HD21 ' B' ' 543' ' ' LEU . 8.7 t 81.24 107.18 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.066 0.46 . . . . 0.0 110.651 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.504 ' HA3' ' CE1' ' A' ' 169' ' ' PHE . . . -65.32 -9.29 41.96 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.723 -0.671 . . . . 0.0 113.423 -179.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.439 ' CD ' ' HB3' ' A' ' 55' ' ' LEU . 3.1 mmtt -77.07 -51.25 11.38 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 122.395 -0.473 . . . . 0.0 111.031 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.841 HG22 ' OD1' ' A' ' 38' ' ' ASP . 0.1 OUTLIER -98.14 -44.36 6.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.596 -179.583 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.421 ' CB ' ' O ' ' A' ' 14' ' ' VAL . 44.0 t -36.12 -73.83 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.725 ' HA ' HD13 ' A' ' 165' ' ' LEU . 1.8 mp -56.53 -68.66 0.2 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.951 0.405 . . . . 0.0 111.583 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.593 HD23 ' N ' ' A' ' 20' ' ' LEU . 2.9 mt -46.38 -61.45 1.79 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.201 -178.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.442 ' HA ' HG23 ' A' ' 25' ' ' THR . 47.6 mm -49.35 -72.15 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.781 0.324 . . . . 0.0 111.191 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 27.7 t -51.2 -23.0 2.98 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.606 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.416 ' HB2' ' O ' ' A' ' 19' ' ' LEU . 85.1 t80 -75.41 -68.07 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.731 0.3 . . . . 0.0 111.382 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.4 m -75.91 -34.69 59.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.31 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.442 HG23 ' HA ' ' A' ' 21' ' ' ILE . 1.5 p -87.9 -156.12 0.34 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.882 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -151.41 21.13 0.73 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.089 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -108.59 123.51 49.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.869 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.473 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 0.4 OUTLIER -153.78 -68.25 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.411 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.632 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.473 ' CD ' ' CB ' ' A' ' 28' ' ' PHE . 74.0 Cg_endo -75.45 54.26 3.79 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.479 2.119 . . . . 0.0 112.939 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 33.9 t -145.96 -80.02 0.16 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.916 0.389 . . . . 0.0 110.976 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -158.34 159.02 35.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.45 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.413 ' CE1' ' O ' ' A' ' 28' ' ' PHE . 10.6 m-85 -128.44 93.36 3.62 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.065 0.46 . . . . 0.0 110.918 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.981 HG11 ' O ' ' B' ' 526' ' ' SER . 1.9 t -108.45 -50.01 0.08 OUTLIER Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.545 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.433 ' HD3' ' HB ' ' A' ' 33' ' ' VAL . 77.6 Cg_exo -52.01 -22.14 13.88 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.009 1.806 . . . . 0.0 112.203 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.632 ' CG2' HD23 ' B' ' 543' ' ' LEU . 27.9 m -52.3 -24.33 7.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.545 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.756 ' HB ' HD21 ' A' ' 61' ' ' LEU . 5.6 p -57.98 -25.35 25.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.164 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.494 ' CD1' ' HA3' ' B' ' 522' ' ' GLY . 0.2 OUTLIER -125.79 53.36 1.59 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.963 0.411 . . . . 0.0 110.645 179.724 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.841 ' OD1' HG22 ' A' ' 17' ' ' THR . 24.4 t70 -88.95 14.18 11.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.554 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -92.82 19.87 7.15 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.769 0.318 . . . . 0.0 110.905 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -61.95 -175.11 0.06 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.699 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -116.43 169.77 9.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.438 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.455 ' HA ' ' CG1' ' B' ' 519' ' ' ILE . 35.1 m -146.94 129.33 7.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.911 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.455 HG23 HG12 ' B' ' 519' ' ' ILE . 16.4 p -87.5 105.61 17.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.554 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.499 ' CG2' ' CG2' ' A' ' 52' ' ' THR . 19.3 m -158.93 -177.09 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.53 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.516 ' HE2' ' C ' ' A' ' 45' ' ' MET . 0.0 OUTLIER -124.85 107.54 11.01 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.795 0.295 . . . . 0.0 111.795 -179.639 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 1.085 HG21 HG23 ' A' ' 3' ' ' THR . 5.1 mm -79.96 86.13 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 26.21 90.29 0.01 OUTLIER Glycine 0 CA--C 1.526 0.731 0 O-C-N 123.64 0.587 . . . . 0.0 114.449 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 140.39 -95.51 0.2 Allowed Glycine 0 N--CA 1.454 -0.156 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.448 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.466 ' N ' ' HE1' ' A' ' 45' ' ' MET . 0.0 OUTLIER -130.31 144.99 55.46 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.791 0.329 . . . . 0.0 110.638 179.347 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_exo -34.39 102.4 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.46 2.773 . . . . 0.0 113.446 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.505 ' CD1' ' HE1' ' A' ' 1' ' ' MET . 3.1 t80 -173.4 138.22 0.69 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.159 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.499 ' CG2' ' CG2' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -134.12 153.16 51.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.112 0.482 . . . . 0.0 111.402 179.495 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.979 HD22 HD11 ' A' ' 4' ' ' ILE . 0.4 OUTLIER -80.25 109.9 15.17 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.169 -179.616 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -62.95 107.61 1.75 Allowed Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.0 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.439 ' HB3' ' CD ' ' A' ' 16' ' ' LYS . 1.4 mp -63.59 116.88 6.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.836 0.35 . . . . 0.0 110.413 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.822 ' CB ' HG22 ' A' ' 7' ' ' VAL . 0.7 OUTLIER -84.58 125.33 32.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.352 0.596 . . . . 0.0 111.751 -178.916 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.938 ' OD2' HG11 ' A' ' 14' ' ' VAL . 38.5 t0 -175.17 137.34 0.4 Allowed 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.457 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.912 ' OG1' HD21 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -155.07 160.02 40.69 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.483 -178.645 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.709 ' HB3' HD21 ' A' ' 61' ' ' LEU . . . -132.34 155.48 48.32 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.816 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.419 ' HA2' ' HB2' ' A' ' 64' ' ' TYR . . . -106.65 79.46 0.26 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.533 -0.841 . . . . 0.0 113.328 -179.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.837 HD22 ' HA2' ' B' ' 544' ' ' GLY . 0.1 OUTLIER -121.47 -87.76 0.63 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.72 0.295 . . . . 0.0 110.643 179.24 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -98.73 -26.52 14.32 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.99 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -89.4 -63.42 1.29 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.4 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.765 ' HB2' HD23 ' A' ' 67' ' ' LEU . 12.8 m-85 -96.85 146.54 24.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.958 0.409 . . . . 0.0 111.086 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -87.43 -58.5 2.56 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.402 ' O ' ' CB ' ' A' ' 67' ' ' LEU . 0.6 OUTLIER -98.35 -51.17 4.06 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -178.209 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.912 HD21 ' OG1' ' A' ' 58' ' ' THR . 0.2 OUTLIER 76.4 87.74 0.08 Allowed 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -178.636 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.475 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 34.5 ptt180 -126.59 48.19 2.94 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.563 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.525 ' HG3' HG23 ' A' ' 58' ' ' THR . 97.4 Cg_endo -79.0 -39.56 0.34 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.67 2.246 . . . . 0.0 111.875 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.945 HD23 ' CB ' ' B' ' 541' ' ' LEU . 0.1 OUTLIER -82.04 -8.45 59.67 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.038 179.959 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.4 ' O ' ' CD2' ' A' ' 104' ' ' HIS . 0.2 OUTLIER -51.8 -35.11 42.87 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.692 0.282 . . . . 0.0 111.14 -179.955 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.444 ' CZ ' ' O ' ' A' ' 104' ' ' HIS . 1.5 t80 -169.08 67.63 0.65 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.196 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.504 ' HG2' ' CE2' ' A' ' 78' ' ' PHE . 73.0 Cg_endo -75.75 142.66 25.9 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.641 2.227 . . . . 0.0 112.216 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 25.6 tp60 -101.42 10.8 40.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.608 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.679 HG23 ' CE1' ' A' ' 78' ' ' PHE . 1.2 t -47.46 167.78 0.02 OUTLIER 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.931 0.396 . . . . 0.0 111.211 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -91.49 -22.59 20.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.609 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.641 HG23 ' SG ' ' A' ' 6' ' ' CYS . 19.1 m -137.95 143.98 32.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.982 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.775 ' CE1' HG21 ' A' ' 108' ' ' THR . 3.7 m-85 -116.35 121.01 40.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.432 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.522 HD21 ' HE1' ' A' ' 169' ' ' PHE . 5.9 tp -82.38 108.18 15.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.887 0.375 . . . . 0.0 111.031 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.599 ' O ' HG23 ' A' ' 80' ' ' VAL . 19.4 m -107.87 95.6 3.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.199 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 14.3 m -95.14 155.25 16.81 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.575 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.671 ' HE1' HD12 ' A' ' 112' ' ' LEU . 23.4 p90 -153.36 128.28 9.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.462 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.1 p -83.62 136.44 34.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.0 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.796 HG13 ' N ' ' A' ' 137' ' ' ILE . 58.7 t -45.32 -54.59 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.443 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.78 HG11 HG21 ' A' ' 125' ' ' THR . 28.8 m -49.52 112.97 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.682 0.277 . . . . 0.0 110.577 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.717 ' N ' HD22 ' A' ' 129' ' ' LEU . 18.4 m -151.37 122.36 3.76 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.665 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 86' ' ' SER . 87.1 Cg_endo -93.81 56.2 0.36 Allowed 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.228 2.619 . . . . 0.0 111.599 179.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.445 ' HB3' ' HG2' ' A' ' 133' ' ' LYS . 0.9 OUTLIER 81.11 20.38 0.41 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.07 -179.449 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.95 ' O ' HG23 ' A' ' 93' ' ' VAL . 2.8 m -97.29 -27.29 14.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.827 0.346 . . . . 0.0 110.79 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -50.67 -53.86 27.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.016 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -50.18 -45.39 53.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.974 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.413 ' O ' ' N ' ' A' ' 96' ' ' LYS . 24.1 m120 -72.55 -44.58 61.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.872 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.95 HG23 ' O ' ' A' ' 89' ' ' SER . 62.0 t -51.34 -37.5 18.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.245 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.635 ' HB2' HD11 ' A' ' 145' ' ' LEU . 3.9 tttt -73.34 -49.96 24.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.886 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -82.87 6.98 16.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.562 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.413 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.1 OUTLIER -113.86 -28.47 7.39 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.713 0.292 . . . . 0.0 110.991 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.471 ' CZ2' ' HA2' ' A' ' 10' ' ' GLY . 3.1 m95 -94.32 -49.24 5.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.179 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 94' ' ' LYS . 61.8 t -48.62 -47.48 70.72 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.662 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 71.9 Cg_endo -77.9 -16.75 14.24 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.242 1.961 . . . . 0.0 112.517 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.38 -47.0 8.31 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.729 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.415 HG13 ' N ' ' A' ' 102' ' ' THR . 2.0 pt -60.21 -26.71 37.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.026 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.415 ' N ' HG13 ' A' ' 101' ' ' ILE . 27.0 p -82.56 -39.66 21.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.867 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -54.16 -48.73 70.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.799 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.444 ' O ' ' CZ ' ' A' ' 72' ' ' TYR . 0.4 OUTLIER -70.06 -26.83 64.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.715 179.852 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -143.62 99.01 5.28 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.813 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_exo -43.03 99.02 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.6 2.2 . . . . 0.0 112.484 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.5 mmtm 57.61 102.62 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.869 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.775 HG21 ' CE1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -133.13 136.76 28.01 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.862 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 108' ' ' THR . 31.3 Cg_exo -59.96 154.79 48.24 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.555 2.17 . . . . 0.0 112.292 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.564 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 3.7 p90 -165.55 140.39 4.9 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.241 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.657 HD12 ' CG1' ' A' ' 152' ' ' VAL . 1.8 tt -116.1 153.23 32.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.892 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.671 HD12 ' HE1' ' A' ' 82' ' ' PHE . 0.8 OUTLIER -98.01 161.53 13.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.833 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.916 HG13 HG21 ' A' ' 168' ' ' VAL . 10.6 t -140.53 143.59 28.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 121.08 0.467 . . . . 0.0 112.025 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -120.43 108.9 1.49 Allowed Glycine 0 C--N 1.332 0.34 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.625 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.686 HG22 ' SG ' ' A' ' 157' ' ' CYS . 0.1 OUTLIER -135.88 5.28 3.08 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.879 0.325 . . . . 0.0 111.879 -178.796 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.857 ' HG3' HD13 ' A' ' 119' ' ' LEU . 39.7 tt0 -118.32 -4.03 10.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.753 0.311 . . . . 0.0 110.459 179.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.971 HD11 ' O ' ' A' ' 157' ' ' CYS . 0.1 OUTLIER -44.88 -26.47 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.141 179.263 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -73.88 -31.5 63.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.292 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.857 HD13 ' HG3' ' A' ' 116' ' ' GLN . 3.9 mp -85.82 -23.7 27.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.359 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.609 ' CB ' HG11 ' A' ' 84' ' ' VAL . 1.0 OUTLIER -49.63 -26.18 3.43 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.961 0.41 . . . . 0.0 110.684 179.818 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -85.46 -31.66 22.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.591 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.2 107.18 0.79 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.648 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.451 ' HA ' ' CG2' ' A' ' 126' ' ' ILE . 43.1 Cg_endo -68.87 -5.91 16.76 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.493 2.129 . . . . 0.0 113.131 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.1 t -75.75 -67.22 0.69 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.78 HG21 HG11 ' A' ' 85' ' ' VAL . 3.1 m -57.81 -38.17 75.06 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.566 178.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.723 HD11 ' HB3' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -55.39 -46.36 78.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.81 179.407 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.509 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 4.8 mm-40 -56.34 -35.43 67.6 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.924 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.4 ' HA ' ' CD ' ' A' ' 131' ' ' LYS . 6.0 mptt -65.36 -31.49 72.63 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.717 HD22 ' N ' ' A' ' 86' ' ' SER . 7.1 mt -73.87 -37.82 64.63 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.509 ' HB3' ' O ' ' A' ' 127' ' ' GLU . . . -44.81 -37.97 4.19 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.224 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.4 ' CD ' ' HA ' ' A' ' 128' ' ' LYS . 0.1 OUTLIER -47.29 -32.6 4.82 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.933 179.816 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 87' ' ' PRO . 13.7 m120 -123.12 -31.36 3.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.476 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.523 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 9.3 mmmt -146.98 -100.21 0.09 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 118.993 -0.527 . . . . 0.0 111.132 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.523 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 1.4 pt20 133.29 -21.16 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.281 1.032 . . . . 0.0 110.55 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 16.1 mmtp -68.44 110.95 6.67 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.705 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.723 ' HB3' HD11 ' A' ' 126' ' ' ILE . 65.3 Cg_endo -85.48 122.27 2.37 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.832 2.355 . . . . 0.0 111.534 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.796 ' N ' HG13 ' A' ' 84' ' ' VAL . 1.2 mm -53.72 96.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.009 0.433 . . . . 0.0 110.664 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.44 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 33.8 p -68.66 155.82 92.19 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.908 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.44 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 8.6 Cg_endo -50.59 -26.24 16.42 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.699 2.266 . . . . 0.0 111.875 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -81.46 -33.4 32.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.59 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.445 ' CG2' HG23 ' A' ' 137' ' ' ILE . 89.9 m -57.62 -49.17 77.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.636 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.456 ' HB3' ' CD2' ' A' ' 154' ' ' TYR . . . -55.17 -32.79 62.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.789 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -68.14 -40.68 82.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.621 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.59 -49.93 74.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.676 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.684 HD23 ' O ' ' A' ' 145' ' ' LEU . 1.6 tt -70.08 -36.23 74.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.655 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.433 ' CB ' HD23 ' A' ' 112' ' ' LEU . . . -59.55 -58.1 10.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.965 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 38.1 mtt180 -67.86 -24.28 65.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.965 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -50.2 -36.11 29.29 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.785 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.64 23.6 7.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.86 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 37.0 mttt 45.57 59.75 3.45 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.126 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.584 ' O ' HG23 ' A' ' 152' ' ' VAL . . . -65.46 -82.39 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.212 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.657 ' CG1' HD12 ' A' ' 111' ' ' LEU . 45.1 t -161.86 -72.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.653 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 12.4 tppt? -179.8 118.9 0.06 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.883 -178.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.456 ' CD2' ' HB3' ' A' ' 142' ' ' ALA . 63.1 t80 -89.86 110.85 21.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.372 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.521 HG12 ' H ' ' A' ' 156' ' ' GLU . 2.6 t -101.61 167.46 2.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.739 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.521 ' H ' HG12 ' A' ' 155' ' ' VAL . 1.1 pm0 -106.58 119.06 38.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.123 0.487 . . . . 0.0 111.653 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.971 ' O ' HD11 ' A' ' 117' ' ' ILE . 14.8 p -140.19 -172.01 3.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.635 179.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.409 ' HB2' ' HB2' ' A' ' 163' ' ' LYS . 0.5 OUTLIER -159.1 127.95 5.31 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.459 -0.497 . . . . 0.0 111.884 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.565 ' HA ' HD11 ' A' ' 165' ' ' LEU . . . -94.67 20.33 8.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.512 178.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.702 ' N ' HD12 ' A' ' 160' ' ' LEU . 0.0 OUTLIER -129.99 -44.19 1.18 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.327 179.925 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 8.3 t -113.25 -17.84 12.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.984 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 77.45 85.75 0.08 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.2 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.409 ' HB2' ' HB2' ' A' ' 158' ' ' SER . 3.7 ttpp -107.82 22.71 15.56 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.051 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 115.44 40.73 0.84 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.793 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.725 HD13 ' HA ' ' A' ' 19' ' ' LEU . 9.2 mt -49.79 -42.79 47.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.77 0.319 . . . . 0.0 110.8 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.404 ' O ' ' HB2' ' A' ' 170' ' ' ASP . 0.5 OUTLIER -67.56 -32.02 72.5 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.423 179.418 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.22 -65.76 0.63 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.738 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.916 HG21 HG13 ' A' ' 113' ' ' VAL . 8.9 p -48.67 -43.64 13.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 121.081 0.467 . . . . 0.0 110.581 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.592 ' CE1' HD11 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -69.3 -27.03 65.04 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.079 179.221 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.404 ' HB2' ' O ' ' A' ' 166' ' ' LYS . 0.7 OUTLIER -61.57 -29.98 70.37 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.484 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.518 ' HB2' HD11 ' A' ' 111' ' ' LEU . 39.9 mm-40 -77.9 -39.7 42.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.04 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.578 ' N ' HD13 ' A' ' 111' ' ' LEU . . . -55.33 -48.22 74.5 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.579 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.558 HD12 ' CD1' ' A' ' 177' ' ' LEU . 1.4 pp -74.4 -33.69 34.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.843 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.837 HD13 ' HG ' ' B' ' 505' ' ' LEU . 21.7 tp -50.52 -68.73 0.15 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.928 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -54.44 -22.01 11.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.05 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.535 ' CB ' HG21 ' A' ' 4' ' ' ILE . . . -81.85 -45.84 14.97 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.281 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.869 ' CD2' HG21 ' B' ' 510' ' ' ILE . 2.1 mt -68.57 -25.01 64.68 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.864 0.364 . . . . 0.0 110.734 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.415 ' HB2' ' HA ' ' B' ' 507' ' ' ALA . 0.0 OUTLIER -159.57 151.63 17.17 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.727 179.928 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -53.03 139.07 62.07 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.534 2.156 . . . . 0.0 112.329 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.21 -168.71 0.59 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.546 2.164 . . . . 0.0 112.385 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -143.24 96.97 5.73 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.977 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.03 -165.0 0.26 Allowed 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.613 2.208 . . . . 0.0 112.207 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -116.33 121.03 40.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.945 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 16.4 mttp . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.884 179.979 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 502' ' ' GLY . . . . . 0.425 ' CA ' ' HB2' ' B' ' 511' ' ' SER . . . . . . . . 0 N--CA 1.49 2.272 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 503' ' ' SER . . . . . 0.403 ' N ' ' HB2' ' B' ' 511' ' ' SER . 18.5 m -77.77 -74.92 0.23 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.688 0.28 . . . . 0.0 110.908 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 504' ' ' GLY . . . . . 0.41 ' HA2' ' HA ' ' B' ' 509' ' ' ASP . . . 105.43 110.08 3.47 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.388 -0.911 . . . . 0.0 112.316 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 505' ' ' LEU . . . . . 0.837 ' HG ' HD13 ' A' ' 174' ' ' LEU . 1.4 pt? -179.93 44.89 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.755 0.312 . . . . 0.0 110.936 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 506' ' ' SER . . . . . . . . . . . . . 4.8 p 65.78 39.85 4.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.074 0.464 . . . . 0.0 110.48 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 507' ' ' ALA . . . . . 0.57 ' O ' HD13 ' B' ' 510' ' ' ILE . . . -144.25 37.56 1.26 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.657 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 508' ' ' GLN . . . . . 0.459 ' HB3' ' CD1' ' B' ' 510' ' ' ILE . 3.3 mt-30 70.04 4.29 4.75 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.09 -178.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 509' ' ' ASP . . . . . 0.41 ' HA ' ' HA2' ' B' ' 504' ' ' GLY . 52.1 t0 67.84 45.49 1.4 Allowed 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 121.012 0.434 . . . . 0.0 111.416 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 510' ' ' ILE . . . . . 0.975 HG23 HG23 ' A' ' 46' ' ' ILE . 1.7 mp -84.62 133.11 30.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.945 179.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 511' ' ' SER . . . . . 0.788 ' O ' HD13 ' A' ' 46' ' ' ILE . 40.9 t -109.28 152.78 24.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.805 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 512' ' ' GLN . . . . . 0.504 ' CB ' ' HD3' ' B' ' 513' ' ' PRO . 0.0 OUTLIER -101.3 -57.91 0.11 Allowed Pre-proline 0 CA--C 1.529 0.155 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.426 179.271 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 513' ' ' PRO . . . . . 0.504 ' HD3' ' CB ' ' B' ' 512' ' ' GLN . 49.0 Cg_endo -93.89 63.12 0.39 Allowed 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.096 2.531 . . . . 0.0 112.169 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 514' ' ' LEU . . . . . 0.442 ' CD2' ' O ' ' A' ' 45' ' ' MET . 1.3 mp -70.54 -87.49 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.599 -179.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 515' ' ' GLN . . . . . . . . . . . . . 18.8 mm100 -78.82 -86.73 0.07 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.635 0.255 . . . . 0.0 111.233 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -118.08 -36.73 3.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.856 0.36 . . . . 0.0 110.835 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 517' ' ' SER . . . . . 0.413 ' HA ' ' HB ' ' A' ' 42' ' ' VAL . 7.3 m 60.73 27.68 17.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.816 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 518' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -163.58 113.09 1.28 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.401 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 519' ' ' ILE . . . . . 0.455 HG12 HG23 ' A' ' 43' ' ' THR . 0.5 OUTLIER -137.36 111.34 8.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.124 179.483 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 80.3 m-70 60.64 174.47 0.1 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.012 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 521' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.1 136.8 28.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.812 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 522' ' ' GLY . . . . . 0.494 ' HA3' ' CD1' ' A' ' 37' ' ' PHE . . . -52.81 -174.96 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.474 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 523' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -64.0 -86.57 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.701 0.286 . . . . 0.0 110.871 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 524' ' ' GLY . . . . . 0.467 ' HA2' HG11 ' A' ' 36' ' ' VAL . . . 45.96 46.12 14.44 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.72 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 525' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -89.43 46.95 1.42 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.787 0.327 . . . . 0.0 110.958 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 526' ' ' SER . . . . . 0.981 ' O ' HG11 ' A' ' 33' ' ' VAL . 0.5 OUTLIER -87.91 100.58 13.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.67 179.784 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 527' ' ' ASP . . . . . 0.466 ' CB ' ' HD2' ' B' ' 528' ' ' PRO . 0.4 OUTLIER -43.05 167.9 0.07 OUTLIER Pre-proline 0 N--CA 1.464 0.273 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.403 -179.848 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 528' ' ' PRO . . . . . 0.466 ' HD2' ' CB ' ' B' ' 527' ' ' ASP . 9.8 Cg_endo -48.91 102.37 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.925 2.416 . . . . 0.0 111.884 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 529' ' ' ARG . . . . . 0.422 ' CG ' ' O ' ' B' ' 527' ' ' ASP . 11.1 mtp85 -100.84 -55.04 2.67 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.602 -179.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 530' ' ' HIS . . . . . 0.433 ' HB2' ' HB2' ' B' ' 545' ' ' ASN . 3.2 m-70 -148.87 94.02 2.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.405 -179.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 1.8 m -54.24 -173.75 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.606 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 532' ' ' TRP . . . . . 0.508 ' CZ2' ' HG3' ' B' ' 537' ' ' ARG . 13.2 t-105 -107.99 163.17 13.37 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.945 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . 169.86 -30.98 0.15 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.473 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 534' ' ' PHE . . . . . 0.479 ' O ' ' CZ2' ' B' ' 532' ' ' TRP . 4.2 t80 -82.35 115.54 58.47 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.507 0.194 . . . . 0.0 110.745 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -45.25 151.74 0.83 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.48 2.12 . . . . 0.0 112.5 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 65.85 135.13 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.854 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 537' ' ' ARG . . . . . 0.579 ' CD ' ' HB2' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -99.34 176.25 5.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.107 0.479 . . . . 0.0 111.159 -179.962 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 538' ' ' ILE . . . . . 0.813 HD11 ' CB ' ' B' ' 542' ' ' TYR . 0.1 OUTLIER -118.71 139.37 46.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.556 179.649 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 539' ' ' ASP . . . . . 0.701 ' HB2' HD22 ' A' ' 70' ' ' LEU . 30.6 p30 -38.84 161.23 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.086 -178.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 540' ' ' GLU . . . . . 0.729 ' HA ' HD13 ' B' ' 543' ' ' LEU . 0.9 OUTLIER -64.99 -33.44 76.05 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.056 -179.907 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 541' ' ' LEU . . . . . 0.945 ' CB ' HD23 ' A' ' 70' ' ' LEU . 4.4 tt -47.59 -29.69 3.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.105 0.479 . . . . 0.0 110.551 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 542' ' ' TYR . . . . . 0.813 ' CB ' HD11 ' B' ' 538' ' ' ILE . 6.2 m-85 -105.44 -17.08 14.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.626 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 543' ' ' LEU . . . . . 0.958 HD21 HG21 ' A' ' 14' ' ' VAL . 1.9 mp -40.11 136.54 1.15 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.89 0.376 . . . . 0.0 111.291 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 544' ' ' GLY . . . . . 0.837 ' HA2' HD22 ' A' ' 61' ' ' LEU . . . 157.8 101.68 0.18 Allowed Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.595 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 545' ' ' ASN . . . . . 0.444 ' O ' HG22 ' A' ' 33' ' ' VAL . 16.3 p30 . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.265 -0.874 . . . . 0.0 111.008 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.706 ' HE1' ' HB ' ' A' ' 46' ' ' ILE . 7.8 tpt . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.828 0.347 . . . . 0.0 111.2 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.522 ' O ' HD11 ' A' ' 177' ' ' LEU . 2.1 pt20 -155.44 111.25 3.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.898 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.82 ' O ' HG23 ' A' ' 4' ' ' ILE . 1.3 t -96.37 178.42 5.37 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.536 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.82 HG23 ' O ' ' A' ' 3' ' ' THR . 0.3 OUTLIER -165.23 159.94 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.096 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 179.874 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.659 ' N ' HD23 ' A' ' 53' ' ' LEU . 2.3 mtpt -111.65 137.47 49.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.329 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 39.8 t -121.55 142.91 49.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.041 0.448 . . . . 0.0 111.503 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.74 HG13 ' O ' ' A' ' 56' ' ' PHE . 2.8 t -135.13 120.6 30.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.486 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.869 HG13 ' HG2' ' B' ' 540' ' ' GLU . 2.4 p -84.71 149.56 4.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.209 0.528 . . . . 0.0 111.051 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.3 m -143.43 130.2 17.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.902 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.67 -140.08 8.71 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.139 -1.029 . . . . 0.0 112.584 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -123.19 27.03 7.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.857 0.361 . . . . 0.0 110.647 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.427 ' CA ' ' HB2' ' B' ' 537' ' ' ARG . . . -120.13 171.42 14.54 Favored Glycine 0 C--N 1.331 0.25 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.651 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.412 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -93.84 -25.3 17.41 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.721 0.296 . . . . 0.0 111.403 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 1.084 HG23 HD21 ' A' ' 19' ' ' LEU . 4.1 p -41.52 94.6 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.355 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.432 ' O ' ' CD1' ' A' ' 19' ' ' LEU . . . -151.21 -103.16 0.25 Allowed Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.612 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.474 ' HG3' ' CG2' ' A' ' 17' ' ' THR . 0.2 OUTLIER -97.93 -43.8 6.94 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 -179.547 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.665 HG21 HG23 ' A' ' 35' ' ' THR . 2.6 p -94.93 -53.12 3.95 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 37.2 t -32.04 -69.62 0.08 Allowed 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -178.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 1.084 HD21 HG23 ' A' ' 14' ' ' VAL . 0.5 OUTLIER -58.68 -68.09 0.3 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.393 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.503 ' H ' HD22 ' A' ' 20' ' ' LEU . 2.9 mm? -61.05 -67.44 0.4 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -178.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.527 ' O ' HG22 ' A' ' 25' ' ' THR . 1.3 tp -37.08 -54.54 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -179.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.492 ' N ' ' CG2' ' A' ' 21' ' ' ILE . 0.4 OUTLIER -67.92 -30.21 69.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.791 0.329 . . . . 0.0 110.858 -179.557 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.423 ' N ' ' O ' ' A' ' 20' ' ' LEU . 27.3 t80 -53.79 -37.95 64.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.132 0.492 . . . . 0.0 109.987 179.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.49 -31.68 11.16 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.667 179.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.527 HG22 ' O ' ' A' ' 21' ' ' ILE . 3.3 t -136.82 79.79 1.78 Allowed 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.984 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.411 ' ND2' ' OG ' ' A' ' 22' ' ' SER . 1.4 m120 -66.6 79.28 0.11 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.298 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.4 mmtm -100.29 101.04 11.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.746 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.57 ' CE1' ' CZ2' ' B' ' 532' ' ' TRP . 0.1 OUTLIER -99.28 -53.61 0.19 Allowed Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.648 -179.67 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.425 ' HD3' ' HB3' ' A' ' 28' ' ' PHE . 84.7 Cg_endo -88.54 69.95 2.69 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.76 2.307 . . . . 0.0 112.981 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -144.8 -92.68 0.1 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.667 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -159.62 158.64 31.96 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.745 0.307 . . . . 0.0 110.818 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.455 ' O ' HG22 ' A' ' 33' ' ' VAL . 53.1 m-85 -133.07 99.98 4.73 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.406 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.542 HG12 HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -162.49 -63.46 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.866 -179.398 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.477 ' CD ' ' HB ' ' A' ' 33' ' ' VAL . 2.9 Cg_exo -36.07 -29.73 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.381 2.721 . . . . 0.0 113.012 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.665 HG23 HG21 ' A' ' 17' ' ' THR . 21.2 m -63.85 71.1 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.754 0.312 . . . . 0.0 110.886 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.819 HG11 ' HA3' ' B' ' 524' ' ' GLY . 10.2 p -130.55 -3.82 2.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.471 ' CD1' ' HA3' ' B' ' 522' ' ' GLY . 0.7 OUTLIER -84.22 50.05 1.78 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.742 0.306 . . . . 0.0 111.242 -179.793 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.466 ' HA ' ' CD ' ' A' ' 16' ' ' LYS . 5.5 m-20 -58.97 -21.43 58.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.158 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -86.98 -6.21 58.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.629 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.466 ' CD1' ' O ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -60.77 157.18 15.41 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.848 0.356 . . . . 0.0 110.913 179.935 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.575 ' C ' HD12 ' B' ' 519' ' ' ILE . . . -108.07 175.72 5.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.35 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.422 ' HA ' HG13 ' B' ' 519' ' ' ILE . 12.8 m -140.57 121.71 14.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.167 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.422 ' C ' HG13 ' A' ' 44' ' ' VAL . 1.1 t -86.25 104.71 16.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.042 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.745 ' CG2' HG21 ' A' ' 52' ' ' THR . 24.9 m -158.19 -177.28 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.918 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.477 ' HE1' ' N ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -121.01 99.61 6.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.485 -179.523 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.925 ' CG1' HG23 ' A' ' 52' ' ' THR . 0.7 OUTLIER -75.93 86.02 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 178.723 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.44 ' N ' ' HE2' ' A' ' 45' ' ' MET . . . 27.91 96.26 0.01 OUTLIER Glycine 0 C--N 1.337 0.616 0 CA-C-N 115.667 -0.697 . . . . 0.0 114.275 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.468 ' N ' ' HE1' ' A' ' 45' ' ' MET . . . 137.64 -92.32 0.21 Allowed Glycine 0 CA--C 1.518 0.262 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.024 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.477 ' N ' ' HE1' ' A' ' 45' ' ' MET . 0.7 OUTLIER -137.44 138.49 24.89 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-O 120.757 0.313 . . . . 0.0 111.222 -179.828 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_exo -35.77 95.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.315 2.677 . . . . 0.0 113.079 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.532 ' CE1' ' CG2' ' A' ' 3' ' ' THR . 2.5 t80 -173.0 105.2 0.14 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.307 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.925 HG23 ' CG1' ' A' ' 46' ' ' ILE . 0.2 OUTLIER -124.06 153.64 41.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.473 -178.933 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.814 HD23 ' C ' ' A' ' 4' ' ' ILE . 6.7 tp -102.73 146.7 27.83 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.75 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.577 ' C ' HD22 ' A' ' 55' ' ' LEU . . . -78.89 -162.81 23.44 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.241 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.721 HD22 ' N ' ' A' ' 55' ' ' LEU . 1.2 mm? -121.88 114.17 20.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.813 0.34 . . . . 0.0 110.44 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.74 ' O ' HG13 ' A' ' 7' ' ' VAL . 0.9 OUTLIER -84.26 105.71 15.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.6 -179.756 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -138.65 -176.33 4.44 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.088 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.806 ' CB ' HD22 ' A' ' 67' ' ' LEU . 0.1 OUTLIER -125.63 143.33 51.07 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.943 -179.647 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.682 ' HB3' HG23 ' A' ' 36' ' ' VAL . . . -147.78 100.7 3.24 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.936 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.556 ' C ' HD22 ' A' ' 61' ' ' LEU . . . -75.66 80.9 1.01 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.63 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.646 HD23 ' HB1' ' A' ' 59' ' ' ALA . 3.1 mm? -121.3 -119.74 0.3 Allowed 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 110.577 -0.157 . . . . 0.0 110.577 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -98.53 -30.49 12.49 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-N 118.151 0.432 . . . . 0.0 111.075 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.34 -63.2 1.25 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.148 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.638 ' HB2' HD12 ' A' ' 67' ' ' LEU . 75.6 m-85 -87.67 146.34 25.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.037 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -86.5 -68.72 0.72 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.174 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.431 ' HD2' ' N ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -98.89 -50.33 4.24 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.924 -179.638 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.806 HD22 ' CB ' ' A' ' 58' ' ' THR . 0.6 OUTLIER 65.35 114.95 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.629 0.252 . . . . 0.0 110.846 -179.753 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.518 ' N ' ' HD3' ' A' ' 69' ' ' PRO . 0.5 OUTLIER -149.14 44.0 0.31 Allowed Pre-proline 0 C--N 1.329 -0.297 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 179.616 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.518 ' HD3' ' N ' ' A' ' 68' ' ' ARG . 90.6 Cg_endo -83.08 -42.98 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.344 2.029 . . . . 0.0 112.269 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.785 ' HG ' HD12 ' B' ' 541' ' ' LEU . 0.2 OUTLIER -63.08 -16.34 59.62 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.322 -179.842 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 93.9 p -46.37 -56.3 6.07 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.854 0.359 . . . . 0.0 111.274 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -156.89 65.28 3.65 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.944 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.474 ' HB2' ' CZ ' ' A' ' 78' ' ' PHE . 35.0 Cg_exo -59.59 154.62 47.26 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.542 2.161 . . . . 0.0 112.233 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 7.4 mm-40 -98.5 10.33 41.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.309 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.1 m -56.7 161.36 2.84 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.818 0.342 . . . . 0.0 110.924 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.76 7.27 30.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.487 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.779 HG11 ' HB2' ' A' ' 176' ' ' ALA . 7.5 p -156.95 91.7 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.334 -0.084 0 CA-C-O 120.859 0.361 . . . . 0.0 111.219 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.474 ' CZ ' ' HB2' ' A' ' 73' ' ' PRO . 3.1 m-85 -80.88 -177.04 6.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.622 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.51 HD21 ' CG2' ' A' ' 113' ' ' VAL . 1.1 tt -149.83 114.19 5.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.972 0.415 . . . . 0.0 111.5 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.1 t -98.6 156.4 3.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.285 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.745 ' HB3' HG11 ' A' ' 14' ' ' VAL . 1.8 p -152.04 153.08 33.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.086 0.47 . . . . 0.0 111.751 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.514 ' CE1' ' CE1' ' A' ' 90' ' ' PHE . 9.1 p90 -166.32 134.24 2.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.261 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.43 ' CB ' ' HG3' ' A' ' 116' ' ' GLN . 0.3 OUTLIER -85.34 141.72 29.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.942 -179.802 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.784 HG13 ' N ' ' A' ' 137' ' ' ILE . 57.8 t -44.47 -55.14 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.359 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.655 HG11 HG21 ' A' ' 125' ' ' THR . 34.9 m -47.81 115.71 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.732 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.801 ' N ' HD22 ' A' ' 129' ' ' LEU . 5.1 p -150.94 129.78 6.26 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.584 -179.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.425 ' O ' ' CB ' ' A' ' 132' ' ' ASN . 87.4 Cg_endo -90.83 50.37 0.85 Allowed 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.043 2.495 . . . . 0.0 111.963 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.469 ' N ' ' HB3' ' A' ' 133' ' ' LYS . 0.3 OUTLIER 76.35 14.37 2.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.522 -179.785 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.491 ' O ' HG12 ' A' ' 93' ' ' VAL . 8.4 t -97.39 -27.06 14.64 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.994 0.426 . . . . 0.0 110.583 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.514 ' CE1' ' CE1' ' A' ' 82' ' ' PHE . 59.3 t80 -51.14 -33.35 26.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.034 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.2 -48.51 28.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.191 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -69.1 -44.81 71.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.183 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.733 HG22 ' CE3' ' A' ' 97' ' ' TRP . 11.6 p -58.84 -45.31 91.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.366 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.602 ' HG3' HD13 ' A' ' 145' ' ' LEU . 9.2 mmtt -59.62 -57.32 13.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.792 0.33 . . . . 0.0 110.997 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.423 ' O ' ' CG ' ' A' ' 99' ' ' PRO . 70.0 mm-40 -62.22 -18.5 61.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.259 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.8 tmtt? -101.49 -12.42 18.55 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.489 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.733 ' CE3' HG22 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -84.27 -56.7 3.51 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.787 0.327 . . . . 0.0 111.124 -179.823 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.562 HG11 ' HG ' ' A' ' 149' ' ' LEU . 5.1 t -49.48 -46.6 78.41 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.643 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.482 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 82.1 Cg_exo -44.63 -41.23 14.47 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.458 2.105 . . . . 0.0 112.85 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.434 ' HG3' ' N ' ' A' ' 101' ' ' ILE . 2.1 pt-20 -79.51 -31.72 42.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.058 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.434 ' N ' ' HG3' ' A' ' 100' ' ' GLU . 23.0 mt -53.74 -41.71 48.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.018 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 23.1 p -93.81 -21.05 19.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.981 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.414 ' HB3' ' HA ' ' A' ' 100' ' ' GLU . 83.9 t60 -60.24 -31.46 70.22 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.936 0.398 . . . . 0.0 110.69 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 -88.64 -25.77 22.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.886 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -144.58 136.19 12.81 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.792 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -59.48 -15.28 29.52 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.598 2.199 . . . . 0.0 112.607 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -169.6 84.05 0.13 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.825 0.345 . . . . 0.0 110.906 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -108.79 101.82 45.52 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.813 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -60.4 155.17 48.31 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.493 2.128 . . . . 0.0 112.122 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.862 ' O ' HG23 ' A' ' 152' ' ' VAL . 32.1 p90 -155.99 169.4 24.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.188 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.89 HD12 ' HB ' ' A' ' 152' ' ' VAL . 0.7 OUTLIER -132.85 150.18 52.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.863 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.795 HD23 ' CB ' ' A' ' 151' ' ' ALA . 0.3 OUTLIER -98.93 161.57 13.56 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.113 -179.745 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.777 ' HA ' HG21 ' A' ' 168' ' ' VAL . 2.5 t -136.81 144.04 33.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.036 0.446 . . . . 0.0 111.805 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.5 ' HA3' ' CZ ' ' A' ' 154' ' ' TYR . . . -133.15 103.83 0.52 Allowed Glycine 0 C--N 1.33 0.233 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.697 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.491 ' HB ' ' HA ' ' A' ' 158' ' ' SER . 0.4 OUTLIER -125.01 -1.41 7.79 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -178.647 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.983 ' NE2' HD11 ' A' ' 119' ' ' LEU . 0.0 OUTLIER -99.2 -8.39 25.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.974 0.416 . . . . 0.0 110.011 178.78 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.498 ' H ' HD13 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -49.25 -24.02 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.563 178.799 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -86.13 -20.51 28.54 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.562 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.983 HD11 ' NE2' ' A' ' 116' ' ' GLN . 4.2 pp -110.89 -12.84 14.21 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.498 ' HB2' HG11 ' A' ' 84' ' ' VAL . 9.1 ptt85 -50.88 -25.33 4.43 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.911 0.386 . . . . 0.0 110.72 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -72.24 -24.86 61.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.912 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.402 ' O ' ' HB ' ' A' ' 126' ' ' ILE . 4.9 m-20 -47.0 101.27 0.26 Allowed Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.838 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.418 ' O ' ' CG ' ' A' ' 127' ' ' GLU . 17.1 Cg_exo -67.4 -6.07 15.53 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.77 2.314 . . . . 0.0 113.021 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.7 t -84.67 -67.06 0.83 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.026 0.441 . . . . 0.0 110.001 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.655 HG21 HG11 ' A' ' 85' ' ' VAL . 4.9 m -52.47 -33.84 46.42 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.381 0.61 . . . . 0.0 109.358 178.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.78 HD11 ' HG3' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -60.03 -40.83 84.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.455 179.017 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.418 ' CG ' ' O ' ' A' ' 123' ' ' PRO . 3.7 mm-40 -56.13 -35.85 67.58 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.262 178.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.403 ' HB2' ' O ' ' A' ' 125' ' ' THR . 1.9 mptp? -66.86 -32.71 74.16 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.801 HD22 ' N ' ' A' ' 86' ' ' SER . 7.3 mt -73.36 -41.55 63.28 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 177.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.49 ' HA ' ' HB3' ' A' ' 134' ' ' GLN . . . -48.88 -26.01 2.22 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.202 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 16.2 mmtp -65.6 -33.91 77.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.773 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.425 ' CB ' ' O ' ' A' ' 87' ' ' PRO . 39.1 m-80 -123.8 -30.6 3.54 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -179.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.492 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 0.0 OUTLIER -133.62 -72.53 0.5 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 120.991 -0.284 . . . . 0.0 111.424 -178.85 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.492 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 2.7 pt20 99.58 -37.4 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.959 0.903 . . . . 0.0 110.658 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.443 ' HA ' ' HD3' ' A' ' 136' ' ' PRO . 0.6 OUTLIER -69.18 107.48 2.17 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.897 -179.065 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.78 ' HG3' HD11 ' A' ' 126' ' ' ILE . 3.0 Cg_exo -80.65 134.96 10.06 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.823 2.349 . . . . 0.0 111.221 179.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.784 ' N ' HG13 ' A' ' 84' ' ' VAL . 0.8 OUTLIER -67.13 96.48 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.882 0.372 . . . . 0.0 110.817 -179.608 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 6.2 p -67.74 159.23 79.96 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.079 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -50.62 -28.99 23.76 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.636 2.224 . . . . 0.0 112.274 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -82.65 -26.72 31.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.701 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.497 ' HB ' HG22 ' A' ' 137' ' ' ILE . 8.7 m -66.66 -51.16 59.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.782 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.55 ' HB1' ' CD2' ' A' ' 154' ' ' TYR . . . -55.49 -37.98 68.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.924 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -66.54 -45.39 79.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.908 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp -54.22 -64.07 0.95 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.993 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.602 HD13 ' HG3' ' A' ' 94' ' ' LYS . 5.3 tt -60.6 -42.75 97.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.9 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.734 ' HB1' ' HB3' ' A' ' 151' ' ' ALA . . . -48.99 -61.99 1.77 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.05 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.2 mtp85 -63.51 -23.14 67.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.861 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.575 ' HB3' HD22 ' A' ' 149' ' ' LEU . 6.2 t0 -50.16 -50.95 47.42 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.827 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.575 HD22 ' HB3' ' A' ' 148' ' ' ASP . 2.0 mm? -93.65 -72.14 0.62 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.673 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 170.26 60.44 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.516 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.795 ' CB ' HD23 ' A' ' 112' ' ' LEU . . . -94.81 27.46 3.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.535 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.89 ' HB ' HD12 ' A' ' 111' ' ' LEU . 75.8 t 61.11 -74.75 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.454 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.469 ' N ' ' O ' ' A' ' 151' ' ' ALA . 1.6 ttpt -176.41 121.74 0.16 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.829 -179.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.55 ' CD2' ' HB1' ' A' ' 142' ' ' ALA . 13.2 t80 -84.97 112.38 20.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.688 179.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.409 ' CG2' ' HA ' ' A' ' 168' ' ' VAL . 3.2 t -101.28 156.11 4.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.181 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -94.19 127.58 40.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.584 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.479 ' SG ' HG12 ' A' ' 168' ' ' VAL . 1.1 p 178.62 125.12 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.305 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.491 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 37.1 m -104.53 155.76 18.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.959 0.409 . . . . 0.0 111.657 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.6 ' HB2' HD11 ' A' ' 165' ' ' LEU . . . -92.2 -52.65 4.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.592 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -48.3 -29.78 4.2 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.738 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.9 -21.97 10.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.914 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 69.19 62.46 0.3 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.804 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.443 ' HB3' ' HA ' ' A' ' 157' ' ' CYS . 0.1 OUTLIER -93.41 35.99 1.08 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.255 -179.75 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 95.21 46.56 2.79 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.21 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.858 ' CD2' HD23 ' A' ' 19' ' ' LEU . 0.4 OUTLIER -53.49 -29.88 38.31 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.988 0.423 . . . . 0.0 110.588 179.688 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 28.8 pttt -68.52 -24.54 64.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.763 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 30.7 t30 -58.25 -68.95 0.2 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.565 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.777 HG21 ' HA ' ' A' ' 113' ' ' VAL . 14.4 p -54.28 -45.81 68.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.565 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.674 ' CZ ' HD13 ' A' ' 19' ' ' LEU . 1.2 t80 -60.38 -41.02 92.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.501 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -54.91 -34.96 63.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.875 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -75.89 -26.47 57.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.174 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.688 ' HB2' HD22 ' A' ' 111' ' ' LEU . . . -63.85 -42.96 97.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.213 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.91 HD13 ' N ' ' A' ' 174' ' ' LEU . 0.0 OUTLIER -89.94 -23.45 6.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.633 -179.866 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.91 ' N ' HD13 ' A' ' 173' ' ' ILE . 2.8 tp -49.05 -43.83 41.19 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.989 0.423 . . . . 0.0 110.41 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -62.14 -27.36 68.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.995 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.779 ' HB2' HG11 ' A' ' 77' ' ' VAL . . . -87.71 -39.41 14.99 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.636 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.747 HD12 HG13 ' A' ' 4' ' ' ILE . 0.6 OUTLIER -68.61 -26.39 65.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.518 179.628 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.439 ' CB ' ' HD2' ' A' ' 179' ' ' PRO . 0.5 OUTLIER -166.82 167.72 7.64 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.651 179.861 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . 0.439 ' HD2' ' CB ' ' A' ' 178' ' ' GLU . 18.9 Cg_endo -60.27 118.77 5.69 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.541 2.161 . . . . 0.0 112.229 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.87 153.96 63.59 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.527 2.151 . . . . 0.0 112.423 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -149.63 119.92 3.96 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.822 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.01 -164.89 0.25 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.429 2.086 . . . . 0.0 112.219 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 11.9 mmtt -105.0 83.41 1.98 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.958 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.16 -0.924 . . . . 0.0 110.819 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.221 0 N-CA-C 112.525 -0.23 . . . . 0.0 112.525 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 503' ' ' SER . . . . . 0.401 ' OG ' ' HA ' ' B' ' 511' ' ' SER . 0.0 OUTLIER -111.74 -49.32 3.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.751 0.31 . . . . 0.0 111.011 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 504' ' ' GLY . . . . . 0.738 ' C ' HD22 ' B' ' 505' ' ' LEU . . . 124.78 -93.52 0.45 Allowed Glycine 0 CA--C 1.508 -0.405 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.862 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 505' ' ' LEU . . . . . 0.816 ' HB3' HD13 ' A' ' 174' ' ' LEU . 0.1 OUTLIER 74.17 0.28 3.56 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 179.45 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 506' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 52.93 23.79 3.04 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.022 0.439 . . . . 0.0 111.047 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 507' ' ' ALA . . . . . . . . . . . . . . . -107.86 -74.25 0.66 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.774 0.797 . . . . 0.0 109.506 179.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 508' ' ' GLN . . . . . 0.422 ' O ' ' HB3' ' B' ' 509' ' ' ASP . 0.0 OUTLIER -137.82 4.95 2.58 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.28 -1.327 . . . . 0.0 110.213 179.061 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 509' ' ' ASP . . . . . 0.422 ' HB3' ' O ' ' B' ' 508' ' ' GLN . 48.6 t0 72.47 38.85 0.78 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.587 0.708 . . . . 0.0 109.765 -178.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 510' ' ' ILE . . . . . 0.746 HG21 HD21 ' A' ' 177' ' ' LEU . 1.3 mt -66.34 143.72 15.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.847 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 511' ' ' SER . . . . . 0.452 ' O ' HD11 ' B' ' 514' ' ' LEU . 47.2 t -109.44 148.0 31.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.498 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 512' ' ' GLN . . . . . 0.498 ' OE1' HG21 ' A' ' 173' ' ' ILE . 0.0 OUTLIER -98.62 -67.7 0.05 OUTLIER Pre-proline 0 CA--C 1.53 0.176 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.752 179.547 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 513' ' ' PRO . . . . . 0.497 ' HD3' ' CB ' ' B' ' 512' ' ' GLN . 88.1 Cg_endo -79.16 56.95 6.24 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.456 2.104 . . . . 0.0 111.917 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 514' ' ' LEU . . . . . 0.452 HD11 ' O ' ' B' ' 511' ' ' SER . 0.9 OUTLIER -64.1 -87.01 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.39 -179.568 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 515' ' ' GLN . . . . . 0.404 ' HB2' HG12 ' A' ' 44' ' ' VAL . 4.4 mt-30 -93.07 -158.71 0.63 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.74 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 15.1 m-80 -50.37 -29.0 9.03 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.934 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 517' ' ' SER . . . . . 0.458 ' O ' ' CD1' ' B' ' 518' ' ' PHE . 0.9 OUTLIER 39.85 53.92 2.59 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.821 179.927 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 518' ' ' PHE . . . . . 0.489 ' CE2' HD12 ' A' ' 21' ' ' ILE . 6.1 m-85 -163.29 119.46 1.77 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.915 0.388 . . . . 0.0 111.438 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 519' ' ' ILE . . . . . 0.575 HD12 ' C ' ' A' ' 41' ' ' ALA . 8.9 mt -126.83 82.49 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.058 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 41.8 p-80 -54.21 101.24 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.767 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 521' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.82 31.79 1.81 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.097 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 522' ' ' GLY . . . . . 0.471 ' HA3' ' CD1' ' A' ' 37' ' ' PHE . . . -111.12 -177.83 20.42 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.409 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 523' ' ' HIS . . . . . 0.455 ' CD2' ' N ' ' B' ' 524' ' ' GLY . 34.4 t60 -117.9 -85.64 0.64 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.744 0.306 . . . . 0.0 110.956 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 524' ' ' GLY . . . . . 0.819 ' HA3' HG11 ' A' ' 36' ' ' VAL . . . 52.71 -144.4 21.87 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.604 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 525' ' ' ASP . . . . . . . . . . . . . 19.8 p30 -149.82 85.3 1.42 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.833 0.349 . . . . 0.0 110.933 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 526' ' ' SER . . . . . 0.405 ' CB ' ' HB3' ' A' ' 34' ' ' PRO . 2.4 m -74.92 95.64 3.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.662 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 527' ' ' ASP . . . . . . . . . . . . . 43.1 p-10 -153.97 150.58 22.99 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.919 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.36 100.98 0.94 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.72 2.28 . . . . 0.0 112.348 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 529' ' ' ARG . . . . . 0.509 ' HG3' HG21 ' A' ' 33' ' ' VAL . 39.7 mtp180 -100.41 -55.24 2.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.296 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 530' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -168.51 95.79 0.38 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.107 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 531' ' ' CYS . . . . . 0.412 ' O ' ' N ' ' B' ' 533' ' ' GLY . 18.3 t -49.79 130.64 21.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.014 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 532' ' ' TRP . . . . . 0.57 ' CZ2' ' CE1' ' A' ' 28' ' ' PHE . 0.0 OUTLIER 60.42 -81.84 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.933 179.893 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 533' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' B' ' 531' ' ' CYS . . . 92.3 -35.38 4.05 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.613 -0.804 . . . . 0.0 112.592 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 534' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -155.17 156.94 31.65 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.634 0.254 . . . . 0.0 110.846 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -53.21 -59.1 1.12 Allowed 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.749 2.299 . . . . 0.0 112.088 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -86.87 141.41 28.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.636 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 537' ' ' ARG . . . . . 0.427 ' HB2' ' CA ' ' A' ' 12' ' ' GLY . 25.4 mmt-85 -65.89 136.24 55.86 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.133 0.492 . . . . 0.0 111.214 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 538' ' ' ILE . . . . . 0.443 HG13 ' HB2' ' B' ' 542' ' ' TYR . 6.3 tp -59.57 143.22 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.208 179.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 539' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -44.13 143.41 1.18 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.874 0.369 . . . . 0.0 111.035 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 540' ' ' GLU . . . . . 0.869 ' HG2' HG13 ' A' ' 8' ' ' VAL . 0.3 OUTLIER -50.4 -24.39 3.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.014 -179.719 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 541' ' ' LEU . . . . . 0.785 HD12 ' HG ' ' A' ' 70' ' ' LEU . 0.1 OUTLIER -55.3 -27.04 44.21 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 121.4 0.619 . . . . 0.0 109.77 179.07 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 542' ' ' TYR . . . . . 0.443 ' HB2' HG13 ' B' ' 538' ' ' ILE . 14.2 m-85 -104.23 -63.05 1.24 Allowed 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.903 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 543' ' ' LEU . . . . . 0.403 ' HB2' ' O ' ' A' ' 58' ' ' THR . 0.3 OUTLIER 49.73 103.86 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.318 179.648 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . 118.28 -100.99 0.87 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.529 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 545' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.919 -179.884 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.426 ' HG3' ' N ' ' A' ' 2' ' ' GLN . 3.0 ptm . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.796 0.332 . . . . 0.0 111.21 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.426 ' N ' ' HG3' ' A' ' 1' ' ' MET . 0.0 OUTLIER 57.65 161.88 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.706 -179.891 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.732 HG23 ' CE1' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -129.93 -177.41 4.28 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.333 -179.786 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.515 HD11 ' CD1' ' A' ' 53' ' ' LEU . 6.0 pt -153.89 148.22 13.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.758 -179.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.1 mttt -134.0 95.7 3.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.095 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -112.31 155.29 24.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.406 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.422 HG23 HG21 ' A' ' 75' ' ' THR . 0.2 OUTLIER -137.2 159.58 36.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.309 179.667 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.824 HG12 ' CG ' ' B' ' 540' ' ' GLU . 60.1 t -90.0 113.68 26.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.997 0.427 . . . . 0.0 111.299 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.463 ' CA ' ' HG2' ' B' ' 540' ' ' GLU . 93.5 t -130.65 129.48 64.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.673 179.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 138.73 -113.19 0.92 Allowed Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.014 -1.089 . . . . 0.0 113.013 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.403 ' O ' ' HB2' ' B' ' 537' ' ' ARG . 6.9 m-20 -110.61 -53.65 2.67 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.975 ' O ' HG13 ' A' ' 14' ' ' VAL . . . -140.06 -148.48 5.18 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.176 -1.011 . . . . 0.0 113.494 -179.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.624 ' O ' HG22 ' A' ' 14' ' ' VAL . . . -41.4 -31.97 0.28 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.975 HG13 ' O ' ' A' ' 12' ' ' GLY . 6.3 m 48.08 25.52 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.966 0.412 . . . . 0.0 110.721 -178.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.936 ' CA ' HD22 ' A' ' 19' ' ' LEU . . . 83.36 26.53 43.16 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.951 -0.643 . . . . 0.0 112.723 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.68 ' CB ' HG22 ' A' ' 8' ' ' VAL . 5.6 tptm -98.19 -72.91 0.63 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.776 0.322 . . . . 0.0 111.699 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.1 p -96.06 -58.32 2.12 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.456 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.501 ' HB2' ' HB2' ' A' ' 13' ' ' ALA . 12.0 t -42.34 -46.62 4.67 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.693 0.282 . . . . 0.0 111.64 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.936 HD22 ' CA ' ' A' ' 15' ' ' GLY . 0.7 OUTLIER -47.15 -49.74 21.79 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.886 0.374 . . . . 0.0 110.724 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.568 HD21 ' CE2' ' A' ' 169' ' ' PHE . 3.7 mt -64.75 -24.18 67.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.399 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.727 HG22 ' OG1' ' A' ' 25' ' ' THR . 14.2 mm -73.99 -70.52 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.19 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 59.8 p -48.26 -27.53 2.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.742 0.306 . . . . 0.0 111.048 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -70.44 -67.36 0.5 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.742 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 89.6 m -72.23 -48.58 41.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.647 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.727 ' OG1' HG22 ' A' ' 21' ' ' ILE . 20.6 p -85.58 -151.12 0.14 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.382 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -160.28 29.39 0.17 Allowed 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.859 0.361 . . . . 0.0 111.077 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.58 104.83 9.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.281 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.486 ' CD2' ' HD3' ' A' ' 29' ' ' PRO . 0.1 OUTLIER -110.34 -61.71 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.106 -179.977 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.486 ' HD3' ' CD2' ' A' ' 28' ' ' PHE . 91.5 Cg_endo -86.61 89.35 0.67 Allowed 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.369 2.046 . . . . 0.0 113.052 -179.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.3 p -163.94 -94.74 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.395 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.51 ' CG ' ' HA ' ' B' ' 530' ' ' HIS . 0.2 OUTLIER -160.25 121.87 3.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.716 0.293 . . . . 0.0 110.818 179.684 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -101.96 94.23 5.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.934 0.397 . . . . 0.0 110.809 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.812 HG13 ' ND2' ' B' ' 545' ' ' ASN . 0.6 OUTLIER -98.73 -51.97 0.2 Allowed Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.367 -179.757 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.419 ' HD3' ' HB ' ' A' ' 33' ' ' VAL . 7.0 Cg_exo -73.9 55.94 3.47 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.812 2.341 . . . . 0.0 112.44 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.7 t -116.77 -33.68 4.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.665 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.861 ' HB ' HD13 ' A' ' 61' ' ' LEU . 7.6 p -52.6 -27.1 11.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.802 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -93.97 40.08 1.08 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.535 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.419 ' HB2' ' HB3' ' A' ' 57' ' ' ASP . 0.4 OUTLIER -93.61 36.17 1.1 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.978 -179.946 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -123.77 18.15 9.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.142 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.411 ' CD2' ' HB ' ' B' ' 521' ' ' THR . 0.2 OUTLIER -75.74 -165.39 0.44 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.789 0.328 . . . . 0.0 110.71 179.973 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.41 ' O ' HG12 ' B' ' 519' ' ' ILE . . . -96.18 161.76 13.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.164 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.503 HG23 ' OG1' ' A' ' 52' ' ' THR . 7.6 m -149.47 129.44 3.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.147 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.612 ' O ' HG23 ' A' ' 44' ' ' VAL . 5.0 t -87.9 106.13 17.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.632 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.643 HG13 ' HB2' ' B' ' 514' ' ' LEU . 1.8 t -161.1 157.86 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.726 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.48 ' HE1' ' N ' ' A' ' 48' ' ' GLY . 0.0 OUTLIER -101.74 97.61 7.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.711 -179.481 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.699 HG23 ' CG2' ' B' ' 510' ' ' ILE . 3.0 mm -77.0 86.38 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.44 ' N ' ' HE2' ' A' ' 45' ' ' MET . . . 25.63 98.63 0.01 OUTLIER Glycine 0 C--N 1.339 0.73 0 CA-C-N 115.505 -0.77 . . . . 0.0 114.435 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.48 ' N ' ' HE1' ' A' ' 45' ' ' MET . . . 128.46 -89.89 0.32 Allowed Glycine 0 CA--C 1.519 0.281 0 C-N-CA 120.596 -0.811 . . . . 0.0 113.007 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.449 ' N ' ' HE1' ' A' ' 45' ' ' MET . 1.4 pt-20 -124.73 139.85 34.26 Favored Pre-proline 0 CA--C 1.53 0.202 0 CA-C-O 120.799 0.333 . . . . 0.0 111.233 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.425 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 78.9 Cg_exo -38.12 101.26 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 123.074 2.516 . . . . 0.0 112.822 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.732 ' CE1' HG23 ' A' ' 3' ' ' THR . 2.2 t80 -172.98 154.69 2.89 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.436 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.509 HG21 ' HB ' ' A' ' 44' ' ' VAL . 0.1 OUTLIER -136.72 152.99 50.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.746 179.046 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.646 ' H ' HD13 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -74.94 161.53 29.42 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.002 -179.899 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -88.8 87.51 1.49 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.626 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.553 ' H ' HD12 ' A' ' 55' ' ' LEU . 1.1 mp -58.37 99.9 0.05 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.844 0.354 . . . . 0.0 110.664 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -84.76 105.76 15.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.997 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.419 ' HB3' ' HB2' ' A' ' 38' ' ' ASP . 30.1 t0 -104.14 129.16 51.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.84 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.884 ' O ' HD22 ' B' ' 543' ' ' LEU . 26.4 p -98.21 126.14 43.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.979 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.824 ' HB1' ' CD1' ' A' ' 61' ' ' LEU . . . -157.63 118.43 3.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.317 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.403 ' HA2' ' O ' ' A' ' 64' ' ' TYR . . . -69.36 73.85 0.42 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.286 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.861 HD13 ' HB ' ' A' ' 36' ' ' VAL . 6.7 mp -120.7 -117.26 0.31 Allowed 'General case' 0 CA--C 1.539 0.536 0 O-C-N 122.944 -0.151 . . . . 0.0 111.052 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -99.08 -31.3 11.85 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 118.069 0.395 . . . . 0.0 111.426 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.435 ' CB ' HG22 ' A' ' 36' ' ' VAL . 6.2 t0 -74.33 -63.26 1.27 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.311 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.545 ' CD2' HD21 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -115.95 133.69 55.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.718 -179.759 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.95 -69.12 0.7 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.838 0.352 . . . . 0.0 111.146 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.4 ' O ' ' HB2' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -99.44 -34.99 10.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.33 -179.885 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.597 HD13 ' HB ' ' A' ' 58' ' ' THR . 1.0 OUTLIER 70.15 123.88 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.978 -179.652 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.458 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 2.5 mpt_? -82.91 -49.26 0.77 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.147 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.458 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 83.0 Cg_exo -44.83 -58.37 1.59 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.588 2.192 . . . . 0.0 112.538 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.56 ' C ' HD12 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -51.08 -38.31 50.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.69 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.1 t -76.74 -53.78 7.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.906 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -114.32 61.57 1.12 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.638 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.428 ' N ' ' O ' ' A' ' 69' ' ' PRO . 52.1 Cg_endo -68.65 112.44 2.87 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.575 2.184 . . . . 0.0 112.466 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 15.2 tp60 -101.96 10.16 39.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.375 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.422 HG21 HG23 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -56.34 166.64 0.81 Allowed 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 120.802 0.334 . . . . 0.0 110.809 179.979 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -72.74 -26.02 61.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.707 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.632 HG11 ' HB3' ' A' ' 175' ' ' ALA . 10.3 p -164.4 116.31 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.132 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.683 ' CZ ' HG21 ' A' ' 108' ' ' THR . 0.0 OUTLIER -92.89 134.51 35.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.166 179.349 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.619 HD13 ' HB1' ' A' ' 172' ' ' ALA . 7.5 tp -70.6 108.01 4.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.095 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.516 ' O ' HG23 ' A' ' 80' ' ' VAL . 23.3 m -103.54 121.09 54.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.013 179.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.564 ' HB2' HG12 ' A' ' 14' ' ' VAL . 41.1 m -129.13 171.42 12.42 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.359 0.599 . . . . 0.0 112.493 -178.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.555 ' CZ ' ' HB2' ' A' ' 142' ' ' ALA . 41.3 p90 -140.86 -174.04 3.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.88 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.3 p -134.66 122.74 22.68 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.808 0.337 . . . . 0.0 111.071 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.66 HG11 ' HB3' ' A' ' 120' ' ' ARG . 2.9 t -57.15 170.52 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.184 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.756 HG22 ' HA ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER 61.09 105.57 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -179.287 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.531 ' N ' HD21 ' A' ' 129' ' ' LEU . 13.9 p -152.5 143.16 15.5 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-O 120.956 0.408 . . . . 0.0 112.039 -179.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.433 ' O ' ' CB ' ' A' ' 88' ' ' SER . 83.1 Cg_endo -90.84 53.36 1.01 Allowed 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.29 2.66 . . . . 0.0 111.585 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.46 ' CB ' ' HG2' ' A' ' 133' ' ' LYS . 0.3 OUTLIER 84.29 25.62 0.1 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.663 -179.533 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.964 ' O ' HG23 ' A' ' 93' ' ' VAL . 2.8 p -97.23 -25.1 15.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.992 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -53.86 -43.79 69.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.016 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -53.96 -61.71 2.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.929 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.419 ' O ' ' N ' ' A' ' 96' ' ' LYS . 30.0 m-80 -53.88 -42.31 68.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.941 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.964 HG23 ' O ' ' A' ' 89' ' ' SER . 60.1 t -47.47 -63.74 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.303 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.7 ' CG ' HD11 ' A' ' 145' ' ' LEU . 0.0 OUTLIER -51.04 -45.75 61.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.869 179.91 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.412 ' O ' ' HG3' ' A' ' 99' ' ' PRO . 0.8 OUTLIER -85.31 10.79 11.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.723 -179.952 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.2 OUTLIER -111.04 -36.18 5.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.934 0.397 . . . . 0.0 110.976 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.401 ' O ' HG23 ' A' ' 101' ' ' ILE . 33.4 m95 -94.36 -42.95 8.63 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.543 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 94' ' ' LYS . 82.3 t -53.26 -47.3 96.53 Favored Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 77.9 Cg_endo -78.95 -18.52 11.44 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.237 1.958 . . . . 0.0 112.629 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -81.61 -40.18 23.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.923 0.392 . . . . 0.0 110.492 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.498 ' CD1' ' CD2' ' A' ' 110' ' ' PHE . 32.8 pt -69.49 -29.79 43.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.904 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.543 HG23 ' O ' ' A' ' 98' ' ' VAL . 70.5 p -78.2 -32.91 50.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.697 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 -63.21 -54.76 32.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.652 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 16.2 m80 -71.65 -24.28 61.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.79 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 1.6 t -143.85 95.96 5.64 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.866 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -47.63 112.07 0.5 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.654 2.236 . . . . 0.0 112.509 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.8 mttt 49.8 99.26 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.157 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.683 HG21 ' CZ ' ' A' ' 78' ' ' PHE . 8.7 m -139.24 144.34 40.04 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.03 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.427 ' C ' HG23 ' A' ' 77' ' ' VAL . 34.2 Cg_exo -60.67 159.29 28.93 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.762 2.308 . . . . 0.0 112.829 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.498 ' CD2' ' CD1' ' A' ' 101' ' ' ILE . 2.4 p90 -165.37 148.24 7.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.556 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 1.006 HD22 ' HB2' ' A' ' 172' ' ' ALA . 1.1 tt -120.05 154.79 34.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.168 -179.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.913 HD12 ' HB2' ' A' ' 146' ' ' ALA . 13.1 mt -111.73 146.43 37.57 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.799 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.831 ' CG1' HG21 ' A' ' 168' ' ' VAL . 21.9 t -130.87 149.69 33.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.15 0.5 . . . . 0.0 111.884 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.517 ' C ' HD12 ' A' ' 117' ' ' ILE . . . -124.97 112.43 1.73 Allowed Glycine 0 N--CA 1.452 -0.247 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.407 179.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.716 ' C ' HD13 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -127.84 -54.82 1.31 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.839 0.352 . . . . 0.0 111.329 -179.009 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.474 ' HG2' HD21 ' A' ' 119' ' ' LEU . 2.0 tt0 -58.56 -17.65 23.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.26 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.871 HD11 ' O ' ' A' ' 157' ' ' CYS . 0.2 OUTLIER -44.81 -27.31 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 120.841 0.353 . . . . 0.0 111.592 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.413 ' N ' HG12 ' A' ' 117' ' ' ILE . 21.4 t0 -66.76 -35.37 79.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.688 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.633 ' C ' HD12 ' A' ' 119' ' ' LEU . 3.8 pp -99.49 -3.89 32.54 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.756 ' HA ' HG22 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -52.37 -35.67 51.87 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.977 0.418 . . . . 0.0 110.481 179.583 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -62.48 -24.17 67.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.759 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.412 ' O ' ' HB ' ' A' ' 126' ' ' ILE . 8.9 t0 -42.36 100.6 0.23 Allowed Pre-proline 0 N--CA 1.463 0.208 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.025 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.44 ' O ' ' CG ' ' A' ' 127' ' ' GLU . 37.7 Cg_endo -66.67 -8.99 22.83 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.434 2.089 . . . . 0.0 112.897 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.7 t -74.14 -67.52 0.61 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.08 0.467 . . . . 0.0 110.008 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.894 HG22 ' CD1' ' A' ' 129' ' ' LEU . 73.6 m -56.36 -47.15 79.44 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.523 HD11 ' HB3' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -46.91 -40.46 4.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.959 179.413 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.646 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 4.8 mm-40 -60.07 -39.11 84.93 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.438 ' N ' ' O ' ' A' ' 125' ' ' THR . 0.0 OUTLIER -68.67 -34.02 74.97 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.155 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.894 ' CD1' HG22 ' A' ' 125' ' ' THR . 9.8 mp -64.84 -37.75 88.66 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 177.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.646 ' HB3' ' O ' ' A' ' 127' ' ' GLU . . . -43.58 -39.16 3.34 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 114.453 -1.249 . . . . 0.0 111.567 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 6.3 mmtm -58.65 -24.8 61.91 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.579 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.426 ' CB ' ' O ' ' A' ' 87' ' ' PRO . 11.1 m-80 -124.38 -31.52 3.27 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -179.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.46 ' HG2' ' CB ' ' A' ' 88' ' ' SER . 2.2 mmtt -156.41 -63.38 0.1 Allowed 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -178.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.578 ' CD ' ' HB2' ' A' ' 130' ' ' ALA . 2.0 tt0 80.9 14.18 0.69 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.208 -178.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.402 ' HA ' ' HD2' ' A' ' 136' ' ' PRO . 35.2 mmtt -97.87 96.54 3.45 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.634 0.254 . . . . 0.0 111.175 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.523 ' HB3' HD11 ' A' ' 126' ' ' ILE . 30.9 Cg_endo -64.74 131.1 28.15 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.389 2.059 . . . . 0.0 111.738 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.659 ' O ' HG13 ' A' ' 84' ' ' VAL . 1.6 mm -67.55 96.38 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.0 0.429 . . . . 0.0 110.749 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.3 p -77.0 147.28 76.84 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.868 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.487 ' HA ' ' CE1' ' A' ' 154' ' ' TYR . 96.4 Cg_exo -43.0 -28.22 1.17 Allowed 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.584 2.189 . . . . 0.0 112.286 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -72.88 -36.55 67.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.865 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 16.6 m -54.57 -61.93 1.99 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.898 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.555 ' HB2' ' CZ ' ' A' ' 82' ' ' PHE . . . -52.04 -40.81 61.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.066 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -51.18 -45.29 61.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.821 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.4 ttpp -64.06 -49.08 73.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.812 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.7 HD11 ' CG ' ' A' ' 94' ' ' LYS . 0.9 OUTLIER -61.43 -46.77 88.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.674 179.819 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.913 ' HB2' HD12 ' A' ' 112' ' ' LEU . . . -50.93 -45.52 60.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.98 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.57 -26.6 32.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.772 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.483 ' HB3' HD22 ' A' ' 149' ' ' LEU . 25.0 t0 -53.18 -38.4 62.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.766 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.483 HD22 ' HB3' ' A' ' 148' ' ' ASP . 2.9 mm? -114.48 21.25 14.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.926 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 48.16 51.3 14.99 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.037 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.649 ' O ' HG23 ' A' ' 152' ' ' VAL . . . -66.66 -82.86 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.978 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.881 HG11 HD12 ' A' ' 111' ' ' LEU . 36.5 t -164.32 -69.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.244 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 176.65 135.76 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.134 -179.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.487 ' CE1' ' HA ' ' A' ' 139' ' ' PRO . 27.7 t80 -106.54 108.01 19.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.64 178.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.552 HG23 ' OE2' ' A' ' 171' ' ' GLU . 0.2 OUTLIER -101.32 -171.89 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.89 0.376 . . . . 0.0 111.319 -179.175 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.504 ' H ' HG12 ' A' ' 155' ' ' VAL . 8.9 mt-10 -89.73 156.51 18.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.159 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.871 ' O ' HD11 ' A' ' 117' ' ' ILE . 13.0 t 178.82 160.02 0.62 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.199 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.631 ' OG ' HG22 ' A' ' 161' ' ' THR . 8.4 t -159.69 123.56 3.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.866 0.365 . . . . 0.0 111.19 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -92.3 20.25 6.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.073 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.652 ' N ' HD12 ' A' ' 160' ' ' LEU . 0.0 OUTLIER -133.11 -44.71 0.85 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.527 179.927 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.631 HG22 ' OG ' ' A' ' 158' ' ' SER . 9.7 t -111.06 -16.08 13.57 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.993 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 75.9 85.41 0.09 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.84 0.352 . . . . 0.0 111.355 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.502 ' HG2' HG23 ' A' ' 161' ' ' THR . 22.1 mmmt -111.12 45.77 1.14 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.52 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.436 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . 128.95 -63.22 0.63 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.106 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.832 HD11 ' O ' ' A' ' 19' ' ' LEU . 0.2 OUTLIER 62.23 -74.46 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.711 0.291 . . . . 0.0 111.257 179.597 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.442 ' HB3' ' HG3' ' B' ' 513' ' ' PRO . 0.0 OUTLIER -69.76 -23.42 63.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.99 -179.961 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.548 ' ND2' HG11 ' A' ' 155' ' ' VAL . 0.2 OUTLIER -56.02 -56.07 25.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.006 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.831 HG21 ' CG1' ' A' ' 113' ' ' VAL . 16.2 m -71.27 -36.74 63.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.582 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.689 ' HB2' HD23 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -75.03 -19.52 60.0 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.853 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.72 ' OD2' HD21 ' B' ' 505' ' ' LEU . 28.7 t70 -83.06 -34.81 26.11 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.011 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.836 ' CD ' HD11 ' A' ' 111' ' ' LEU . 2.1 pt-20 -75.15 -31.66 61.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.912 0.387 . . . . 0.0 110.34 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 1.006 ' HB2' HD22 ' A' ' 111' ' ' LEU . . . -73.09 -47.81 41.23 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.586 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.424 HG12 ' O ' ' A' ' 169' ' ' PHE . 1.7 pp -64.34 -38.63 83.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.756 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.854 HD23 HD13 ' B' ' 505' ' ' LEU . 3.3 tm? -52.3 -35.4 50.43 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.921 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.632 ' HB3' HG11 ' A' ' 77' ' ' VAL . . . -51.76 -24.31 5.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.984 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.48 ' HB3' ' HB ' ' A' ' 4' ' ' ILE . . . -95.05 -36.94 11.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.106 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.921 HD13 ' HB ' ' B' ' 510' ' ' ILE . 9.6 mt -68.82 -24.34 64.37 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.844 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -172.94 128.8 0.54 Allowed Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.908 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -57.19 115.75 2.72 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.559 2.172 . . . . 0.0 112.304 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -77.47 -166.44 0.39 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.451 2.101 . . . . 0.0 112.312 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -149.08 131.55 7.84 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.891 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -80.71 -165.47 0.34 Allowed 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.667 2.245 . . . . 0.0 112.326 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 29.3 mttt -133.98 170.85 15.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.894 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 2.3 mttm . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.184 -0.913 . . . . 0.0 110.905 -179.946 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.202 0 N-CA-C 112.428 -0.269 . . . . 0.0 112.428 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 503' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.5 -162.37 0.51 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.819 0.343 . . . . 0.0 110.849 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 504' ' ' GLY . . . . . 0.844 ' O ' HD12 ' B' ' 505' ' ' LEU . . . 131.17 -101.89 0.5 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.321 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 505' ' ' LEU . . . . . 0.854 HD13 HD23 ' A' ' 174' ' ' LEU . 0.0 OUTLIER 58.96 18.08 5.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.563 0.22 . . . . 0.0 111.3 179.773 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 506' ' ' SER . . . . . 0.54 ' O ' ' HB2' ' B' ' 507' ' ' ALA . 0.7 OUTLIER 65.26 100.19 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.925 0.393 . . . . 0.0 110.649 -179.922 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 507' ' ' ALA . . . . . 0.54 ' HB2' ' O ' ' B' ' 506' ' ' SER . . . 169.15 -36.29 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.389 0.614 . . . . 0.0 110.44 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 508' ' ' GLN . . . . . 0.476 ' O ' ' CB ' ' B' ' 509' ' ' ASP . 0.5 OUTLIER 156.62 -26.36 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.394 -179.364 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 509' ' ' ASP . . . . . 0.476 ' CB ' ' O ' ' B' ' 508' ' ' GLN . 0.3 OUTLIER 98.07 32.4 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.975 0.91 . . . . 0.0 110.872 179.739 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 510' ' ' ILE . . . . . 0.921 ' HB ' HD13 ' A' ' 177' ' ' LEU . 3.3 mp -54.05 130.9 16.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.443 179.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 511' ' ' SER . . . . . 0.487 ' O ' HD12 ' B' ' 514' ' ' LEU . 0.4 OUTLIER -109.09 154.48 22.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.261 -179.459 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 512' ' ' GLN . . . . . 0.465 ' CB ' ' HD3' ' B' ' 513' ' ' PRO . 0.0 OUTLIER -97.9 -57.69 0.17 Allowed Pre-proline 0 C--N 1.333 -0.149 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.799 179.575 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 513' ' ' PRO . . . . . 0.465 ' HD3' ' CB ' ' B' ' 512' ' ' GLN . 59.9 Cg_endo -90.85 42.4 0.43 Allowed 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.905 2.404 . . . . 0.0 112.043 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 514' ' ' LEU . . . . . 0.643 ' HB2' HG13 ' A' ' 44' ' ' VAL . 0.3 OUTLIER -46.49 -85.62 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.624 -179.388 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 515' ' ' GLN . . . . . 0.617 ' H ' HG22 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -92.09 -86.52 0.23 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.124 -179.741 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -125.12 -37.15 2.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.218 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 517' ' ' SER . . . . . 0.407 ' O ' ' CG1' ' A' ' 42' ' ' VAL . 0.7 OUTLIER 63.79 29.57 14.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.962 -179.884 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 518' ' ' PHE . . . . . 0.405 ' HA ' HG12 ' A' ' 42' ' ' VAL . 1.2 m-85 -163.22 123.98 2.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.06 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 519' ' ' ILE . . . . . 0.556 HD11 ' H ' ' A' ' 43' ' ' THR . 12.1 mm -94.42 31.87 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.162 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 52.26 38.26 24.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.858 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 521' ' ' THR . . . . . 0.411 ' HB ' ' CD2' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -113.51 -172.11 2.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.845 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 522' ' ' GLY . . . . . . . . . . . . . . . 101.08 125.46 5.6 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.356 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 523' ' ' HIS . . . . . . . . . . . . . 26.4 t60 -117.86 -81.28 0.62 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.747 0.308 . . . . 0.0 110.98 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 524' ' ' GLY . . . . . . . . . . . . . . . 58.09 -106.05 0.74 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.648 -0.786 . . . . 0.0 112.619 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 525' ' ' ASP . . . . . . . . . . . . . 4.7 t0 57.77 73.77 0.45 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.754 0.311 . . . . 0.0 110.891 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 526' ' ' SER . . . . . 0.431 ' CB ' ' HB3' ' A' ' 61' ' ' LEU . 32.0 t -108.83 96.77 6.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.987 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 527' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 70.7 95.79 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.053 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -74.95 58.83 4.98 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.736 2.291 . . . . 0.0 112.472 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 529' ' ' ARG . . . . . 0.401 ' HD2' ' OD1' ' B' ' 545' ' ' ASN . 0.1 OUTLIER -53.31 -43.09 67.32 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.192 0.52 . . . . 0.0 110.122 179.519 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 530' ' ' HIS . . . . . 0.51 ' HA ' ' CG ' ' A' ' 31' ' ' GLU . 41.2 m170 64.74 51.05 1.93 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.931 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -155.99 132.1 9.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.16 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 532' ' ' TRP . . . . . 0.407 ' NE1' ' O ' ' B' ' 536' ' ' ASP . 6.6 t-105 -92.22 -22.22 19.92 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.887 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . 92.44 -136.59 13.29 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.447 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 534' ' ' PHE . . . . . 0.433 ' HB3' ' HD2' ' B' ' 535' ' ' PRO . 39.2 m-85 -81.42 165.5 43.95 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.655 0.264 . . . . 0.0 110.629 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 535' ' ' PRO . . . . . 0.433 ' HD2' ' HB3' ' B' ' 534' ' ' PHE . 48.6 Cg_exo -56.18 81.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.587 2.191 . . . . 0.0 112.377 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 536' ' ' ASP . . . . . 0.45 ' HA ' ' NH1' ' B' ' 537' ' ' ARG . 0.2 OUTLIER 171.45 -164.22 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.92 -180.0 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 537' ' ' ARG . . . . . 0.45 ' NH1' ' HA ' ' B' ' 536' ' ' ASP . 0.0 OUTLIER -125.47 155.88 39.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.148 0.499 . . . . 0.0 110.532 179.77 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 538' ' ' ILE . . . . . 0.512 HG23 ' HA ' ' B' ' 543' ' ' LEU . 6.7 tp -83.34 123.96 39.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.483 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 539' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -33.68 130.19 0.28 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.156 0.503 . . . . 0.0 112.115 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 540' ' ' GLU . . . . . 0.824 ' CG ' HG12 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -41.79 -28.35 0.15 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.254 -179.29 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 541' ' ' LEU . . . . . 0.537 ' HA ' HD21 ' A' ' 70' ' ' LEU . 0.8 OUTLIER -40.91 -50.26 3.24 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.864 0.364 . . . . 0.0 111.319 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 542' ' ' TYR . . . . . 0.406 ' CD1' ' N ' ' B' ' 542' ' ' TYR . 0.1 OUTLIER -105.35 -63.37 1.24 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.234 179.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 543' ' ' LEU . . . . . 0.884 HD22 ' O ' ' A' ' 58' ' ' THR . 0.3 OUTLIER 72.83 166.68 0.3 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.474 -179.345 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . 116.47 156.97 10.86 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.655 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 545' ' ' ASN . . . . . 0.812 ' ND2' HG13 ' A' ' 33' ' ' VAL . 5.9 p30 . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.199 -0.905 . . . . 0.0 111.098 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.4 ' HE3' ' O ' ' A' ' 2' ' ' GLN . 5.2 tpt . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.807 0.337 . . . . 0.0 111.252 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.4 ' O ' ' HE3' ' A' ' 1' ' ' MET . 0.0 OUTLIER -64.23 144.61 57.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.49 179.822 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.761 HG23 ' CE1' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -110.79 -173.82 2.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.535 -179.545 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.658 HD11 ' CD1' ' A' ' 53' ' ' LEU . 5.7 pt -154.92 127.29 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.16 -179.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.458 ' CB ' ' HB ' ' A' ' 75' ' ' THR . 5.6 mmtp -100.6 100.58 11.32 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.429 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -77.63 132.56 38.31 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.201 0.524 . . . . 0.0 112.061 -178.71 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.3 t -144.52 159.66 14.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.918 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.589 HG21 ' C ' ' A' ' 15' ' ' GLY . 48.7 t -133.72 128.57 54.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.301 0.572 . . . . 0.0 112.143 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.44 ' HA ' ' CG ' ' B' ' 540' ' ' GLU . 3.3 m -134.06 129.38 54.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.267 -0.878 . . . . 0.0 109.694 178.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 134.98 -160.3 24.26 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.247 -0.978 . . . . 0.0 112.6 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.418 ' O ' ' N ' ' B' ' 537' ' ' ARG . 6.6 p30 -122.87 27.27 7.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.642 0.258 . . . . 0.0 111.047 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -104.59 174.59 21.96 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.823 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.434 ' CA ' ' HG3' ' B' ' 537' ' ' ARG . . . -95.16 -56.38 2.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.863 0.363 . . . . 0.0 111.1 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.773 HG21 HG11 ' A' ' 113' ' ' VAL . 14.7 p -53.61 105.93 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.047 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.589 ' C ' HG21 ' A' ' 8' ' ' VAL . . . 153.01 -44.51 0.61 Allowed Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.069 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.675 ' CD ' HD11 ' B' ' 543' ' ' LEU . 9.8 mtmt -90.18 -95.24 0.11 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 120.368 0.127 . . . . 0.0 111.077 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.8 HG21 ' HA ' ' A' ' 35' ' ' THR . 61.3 p -98.44 -49.6 4.6 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 120.939 0.4 . . . . 0.0 111.482 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.436 ' O ' ' CB ' ' A' ' 22' ' ' SER . 10.2 t -36.9 -41.32 0.33 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.447 -179.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.621 ' CD2' HG23 ' A' ' 14' ' ' VAL . 6.5 mt -49.84 -73.79 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.864 0.364 . . . . 0.0 111.557 -179.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.2 mt -74.74 -30.9 61.66 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.017 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.712 HD11 ' HZ ' ' A' ' 37' ' ' PHE . 16.2 mm -66.44 -69.44 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 178.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.439 ' O ' ' ND2' ' A' ' 26' ' ' ASN . 7.4 t -49.74 -25.8 3.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.594 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -65.37 -46.59 79.52 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.447 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.58 -55.01 3.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.478 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.431 ' OG1' HG23 ' A' ' 21' ' ' ILE . 30.1 p -88.38 76.4 8.31 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.439 ' ND2' ' O ' ' A' ' 22' ' ' SER . 0.6 OUTLIER -69.52 62.28 0.16 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.436 -178.742 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.2 mtmt -121.87 90.85 3.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.599 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.495 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 2.2 t80 -90.03 -44.95 0.41 Allowed Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.749 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 86.6 Cg_endo -85.78 13.56 2.71 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.5 2.133 . . . . 0.0 113.082 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.2 m -93.68 -93.7 0.17 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.631 -0.258 . . . . 0.0 110.845 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.407 ' HB2' ' HD2' ' B' ' 529' ' ' ARG . 3.6 pt-20 -158.99 145.52 16.95 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.789 0.328 . . . . 0.0 110.786 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.417 ' O ' HG22 ' A' ' 33' ' ' VAL . 11.9 m-85 -126.23 133.61 51.44 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.669 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.74 HG11 ' O ' ' B' ' 526' ' ' SER . 0.0 OUTLIER -162.53 -56.55 0.01 OUTLIER Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.612 -179.537 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.535 ' HD3' HG23 ' A' ' 33' ' ' VAL . 51.5 Cg_exo -56.49 78.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.527 2.151 . . . . 0.0 112.686 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.8 ' HA ' HG21 ' A' ' 17' ' ' THR . 29.2 m -121.57 -5.35 9.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.253 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.651 HG22 HD13 ' A' ' 61' ' ' LEU . 0.1 OUTLIER -89.69 -3.34 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -179.863 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.712 ' HZ ' HD11 ' A' ' 21' ' ' ILE . 17.4 p90 -81.0 9.24 6.82 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.419 ' HB2' ' HB2' ' A' ' 57' ' ' ASP . 4.5 p-10 -52.39 -174.12 0.0 OUTLIER 'General case' 0 C--O 1.231 0.101 0 CA-C-O 120.778 0.323 . . . . 0.0 111.052 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.418 ' ND2' ' OH ' ' A' ' 64' ' ' TYR . 9.8 p30 48.82 25.45 1.03 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.895 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -65.16 -174.29 0.16 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.733 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.431 ' O ' ' CG1' ' B' ' 519' ' ' ILE . . . -122.93 152.01 41.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.272 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.698 HG23 HG21 ' A' ' 52' ' ' THR . 34.2 m -145.89 156.12 12.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.916 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.41 ' C ' HG13 ' A' ' 44' ' ' VAL . 0.1 OUTLIER -123.52 106.39 10.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.957 0.408 . . . . 0.0 111.239 -179.736 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.985 HG22 ' CG2' ' A' ' 52' ' ' THR . 10.7 m -156.5 -177.24 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.917 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.484 ' HE3' ' N ' ' A' ' 46' ' ' ILE . 4.8 tpt -107.01 96.1 6.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.303 -179.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.62 HD13 ' O ' ' B' ' 511' ' ' SER . 3.9 mm -76.79 86.85 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 121.036 0.446 . . . . 0.0 110.629 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.722 ' HA3' HG23 ' B' ' 510' ' ' ILE . . . 39.6 -92.73 0.01 OUTLIER Glycine 0 CA--C 1.521 0.454 0 CA-C-N 115.778 -0.647 . . . . 0.0 113.851 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . -35.59 -87.07 0.01 OUTLIER Glycine 0 C--N 1.334 0.457 0 N-CA-C 114.019 0.368 . . . . 0.0 114.019 -179.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.47 ' N ' ' HE1' ' A' ' 45' ' ' MET . 0.5 OUTLIER -133.32 159.16 73.68 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 120.705 0.288 . . . . 0.0 110.775 -179.693 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.403 ' N ' ' SD ' ' A' ' 45' ' ' MET . 86.1 Cg_exo -45.2 100.21 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.326 2.017 . . . . 0.0 112.161 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.761 ' CE1' HG23 ' A' ' 3' ' ' THR . 8.8 t80 -167.21 153.78 8.29 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.442 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.985 ' CG2' HG22 ' A' ' 44' ' ' VAL . 1.8 p -136.86 153.37 50.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.037 0.446 . . . . 0.0 111.467 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.812 HD11 ' OE1' ' B' ' 512' ' ' GLN . 0.0 OUTLIER -83.38 167.99 17.02 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.844 179.637 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.78 ' C ' HD12 ' A' ' 55' ' ' LEU . . . -105.21 -25.72 6.59 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.801 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.78 HD12 ' C ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER 52.12 92.54 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.785 0.326 . . . . 0.0 111.038 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -84.95 105.57 15.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.365 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.503 ' OD1' HG23 ' A' ' 8' ' ' VAL . 6.3 m-20 -105.95 165.99 10.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.109 0.48 . . . . 0.0 111.272 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.811 HG22 HD13 ' A' ' 67' ' ' LEU . 1.5 p -89.32 152.98 21.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.033 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.568 ' HB1' HG13 ' A' ' 36' ' ' VAL . . . -172.12 100.36 0.16 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.667 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.415 ' HA2' ' HA ' ' A' ' 65' ' ' ASP . . . -98.66 70.67 0.6 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.814 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.922 HD23 ' CB ' ' B' ' 526' ' ' SER . 6.5 mp -120.19 -107.69 0.36 Allowed 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 110.601 -0.148 . . . . 0.0 110.601 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -99.8 -24.67 14.61 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 120.775 0.322 . . . . 0.0 111.334 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.424 ' CB ' ' CG1' ' A' ' 36' ' ' VAL . 16.0 t0 -70.71 -63.41 1.1 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.676 -179.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.431 ' CD1' ' N ' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -151.66 116.25 5.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.848 0.356 . . . . 0.0 111.028 -179.54 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.415 ' HA ' ' HA2' ' A' ' 60' ' ' GLY . 0.2 OUTLIER -85.67 -13.77 47.55 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.392 179.961 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.32 -50.7 4.23 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.651 0.262 . . . . 0.0 111.656 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.811 HD13 HG22 ' A' ' 58' ' ' THR . 13.5 mt 69.82 -148.18 0.1 Allowed 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 -179.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.418 ' CB ' ' CD ' ' A' ' 69' ' ' PRO . 3.8 mtt-85 -172.55 -61.38 0.0 OUTLIER Pre-proline 0 CA--C 1.528 0.102 0 C-N-CA 120.776 -0.369 . . . . 0.0 111.883 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.418 ' CD ' ' CB ' ' A' ' 68' ' ' ARG . 50.0 Cg_exo -35.99 -60.26 0.35 Allowed 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 123.059 2.506 . . . . 0.0 113.236 -179.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.697 HD22 ' HA ' ' B' ' 541' ' ' LEU . 0.3 OUTLIER -46.88 -26.74 1.04 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.351 -179.777 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.5 t -74.6 -70.45 0.4 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.289 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -95.49 150.17 37.14 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.213 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.49 120.78 5.72 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.706 2.271 . . . . 0.0 112.531 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.415 ' NE2' ' O ' ' A' ' 69' ' ' PRO . 1.3 mp0 -102.03 -60.3 1.56 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.848 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.458 ' HB ' ' CB ' ' A' ' 5' ' ' LYS . 7.9 t -82.15 -178.71 7.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.053 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.405 ' O ' ' CG ' ' A' ' 109' ' ' PRO . 0.1 OUTLIER -104.3 7.7 35.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.382 179.899 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.655 ' O ' HG13 ' A' ' 77' ' ' VAL . 11.3 p -156.47 106.92 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.711 0.291 . . . . 0.0 111.24 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.552 ' CE1' HG21 ' A' ' 108' ' ' THR . 4.9 m-85 -83.59 -177.9 6.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.607 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.531 HD13 ' N ' ' A' ' 80' ' ' VAL . 0.2 OUTLIER -119.19 117.71 29.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.95 0.405 . . . . 0.0 111.427 -179.602 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.67 HG21 ' CD1' ' A' ' 110' ' ' PHE . 1.8 t -111.35 100.32 10.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.367 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.536 ' HB3' HG13 ' A' ' 14' ' ' VAL . 2.3 p -109.57 137.74 46.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.04 0.448 . . . . 0.0 111.538 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.756 ' CE1' HG21 ' A' ' 137' ' ' ILE . 28.7 p90 -147.18 145.22 29.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.224 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.6 m -83.29 130.58 35.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.901 0.381 . . . . 0.0 111.269 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.463 HG13 ' HB ' ' A' ' 137' ' ' ILE . 97.2 t -45.93 -73.72 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.481 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.636 ' HB ' HD21 ' A' ' 129' ' ' LEU . 5.6 m -43.64 117.75 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.332 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.469 ' N ' HD22 ' A' ' 129' ' ' LEU . 0.4 OUTLIER -151.57 136.89 10.71 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.336 -179.798 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.421 ' O ' ' CB ' ' A' ' 88' ' ' SER . 68.2 Cg_endo -92.42 52.75 0.58 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 123.212 2.608 . . . . 0.0 111.816 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.448 ' CB ' ' HG2' ' A' ' 133' ' ' LYS . 0.1 OUTLIER 80.84 26.25 0.26 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.908 -179.499 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.817 ' O ' HG23 ' A' ' 93' ' ' VAL . 43.3 t -96.78 -26.17 15.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.911 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.483 ' CE1' ' CE1' ' A' ' 82' ' ' PHE . 3.9 t80 -54.65 -46.97 74.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.983 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -52.3 -58.26 7.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.994 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.416 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.4 OUTLIER -54.39 -43.17 71.19 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.027 -179.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.817 HG23 ' O ' ' A' ' 89' ' ' SER . 60.5 t -54.35 -45.54 68.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.254 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.521 ' O ' HG23 ' A' ' 98' ' ' VAL . 14.9 tttt -59.6 -55.12 38.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.056 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.8 0.14 24.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.741 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.416 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 2.0 tttt -112.22 -22.53 10.89 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.656 0.265 . . . . 0.0 111.072 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.662 ' HZ3' HG12 ' A' ' 80' ' ' VAL . 25.2 m0 -93.06 -55.13 3.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.111 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 94' ' ' LYS . 61.1 t -43.68 -56.13 7.69 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.869 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 30.6 Cg_endo -62.67 -18.8 65.85 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.169 1.912 . . . . 0.0 112.381 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.29 -45.32 9.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.006 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.403 HG12 ' O ' ' A' ' 97' ' ' TRP . 19.7 mm -52.58 -56.92 5.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.159 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.1 p -65.25 -22.3 66.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.238 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 22.3 t-160 -64.93 -68.74 0.34 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.892 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -75.54 -27.22 58.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.004 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.459 ' HB3' ' CB ' ' A' ' 108' ' ' THR . 8.3 m -122.64 75.16 45.48 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.024 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -57.08 131.96 48.56 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.642 2.228 . . . . 0.0 112.166 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 9.7 mmtp 50.31 39.16 19.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.824 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.552 HG21 ' CE1' ' A' ' 78' ' ' PHE . 46.0 m -108.3 101.69 43.31 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.95 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.405 ' CG ' ' O ' ' A' ' 76' ' ' ASP . 36.3 Cg_exo -60.19 171.78 2.91 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.632 2.221 . . . . 0.0 112.425 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.754 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 6.6 p90 -158.52 -177.55 6.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.711 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.88 HD12 ' HB ' ' A' ' 152' ' ' VAL . 3.1 tt -142.2 152.88 43.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.828 0.347 . . . . 0.0 111.245 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.528 HD12 ' HE2' ' A' ' 82' ' ' PHE . 4.3 mm? -101.52 161.15 13.85 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.559 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.78 HG13 HG21 ' A' ' 168' ' ' VAL . 2.5 t -138.74 155.5 27.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.007 0.432 . . . . 0.0 111.743 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.474 ' C ' HD12 ' A' ' 117' ' ' ILE . . . -140.14 114.23 0.96 Allowed Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.327 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.763 ' C ' HD13 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -126.97 -49.14 1.47 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.919 0.39 . . . . 0.0 110.284 -179.676 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.584 ' CG ' HD21 ' A' ' 119' ' ' LEU . 0.7 OUTLIER -61.69 -16.28 47.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.634 179.284 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.763 HD13 ' C ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -40.58 -28.57 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 179.906 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.441 ' N ' HG12 ' A' ' 117' ' ' ILE . 2.3 p30 -66.9 -29.56 69.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.852 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.713 ' O ' HD12 ' A' ' 119' ' ' LEU . 3.6 pp -106.01 13.71 28.87 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.44 ' O ' ' CD1' ' A' ' 126' ' ' ILE . 1.8 ppt_? -66.86 -20.64 65.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.727 0.299 . . . . 0.0 110.696 179.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -85.47 -25.97 26.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.484 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -49.95 104.98 0.46 Allowed Pre-proline 0 C--N 1.332 -0.171 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.696 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.476 ' HA ' ' CG2' ' A' ' 126' ' ' ILE . 37.4 Cg_endo -66.32 -7.9 18.92 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.582 2.188 . . . . 0.0 113.174 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.38 -67.28 0.64 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.443 ' CG2' HG11 ' A' ' 85' ' ' VAL . 12.4 m -58.24 -39.41 79.04 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 178.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.828 HD11 ' HB3' ' A' ' 136' ' ' PRO . 0.1 OUTLIER -54.39 -44.68 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.684 179.176 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.538 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 11.4 mm-40 -57.84 -36.87 72.89 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.896 179.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 125' ' ' THR . 0.0 OUTLIER -63.31 -30.72 71.81 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.902 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.636 HD21 ' HB ' ' A' ' 85' ' ' VAL . 6.8 mt -74.54 -38.04 62.86 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 177.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.538 ' HB3' ' O ' ' A' ' 127' ' ' GLU . . . -45.47 -33.15 2.51 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 114.867 -1.06 . . . . 0.0 111.048 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.2 mmtp -48.95 -34.89 13.82 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.512 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.412 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 2.7 m-80 -123.2 -31.23 3.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.362 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.524 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 36.8 mmtt -143.59 -100.67 0.12 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 119.092 -0.48 . . . . 0.0 111.478 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.524 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 4.5 pt20 131.33 -22.34 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.456 1.102 . . . . 0.0 110.45 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 5.9 mmpp? -68.57 110.6 6.14 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.739 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.828 ' HB3' HD11 ' A' ' 126' ' ' ILE . 90.6 Cg_endo -80.86 134.4 9.55 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.527 2.152 . . . . 0.0 111.656 179.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.756 HG21 ' CE1' ' A' ' 82' ' ' PHE . 0.4 OUTLIER -64.34 96.6 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.323 -179.694 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.417 ' O ' ' N ' ' A' ' 141' ' ' THR . 2.9 p -68.78 145.72 97.05 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.888 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.453 ' HA ' ' CE1' ' A' ' 154' ' ' TYR . 89.1 Cg_exo -43.19 -28.21 1.34 Allowed 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.573 2.182 . . . . 0.0 112.248 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -78.75 -36.7 42.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.676 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.417 ' N ' ' O ' ' A' ' 138' ' ' THR . 6.1 m -54.88 -56.06 23.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.714 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.509 ' CB ' ' CD2' ' A' ' 154' ' ' TYR . . . -53.02 -36.56 60.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.777 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.64 -38.82 90.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.667 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 17.2 tptt -63.41 -50.59 69.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.703 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.482 HD23 ' O ' ' A' ' 145' ' ' LEU . 0.6 OUTLIER -70.23 -33.99 72.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.593 179.798 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -67.69 -44.7 77.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.894 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 60.2 mtt180 -75.14 -23.18 57.8 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.793 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -56.14 -46.88 79.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.745 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -95.54 19.7 10.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.058 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.1 mtmp? 44.82 40.39 4.25 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.428 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.754 ' HB1' ' O ' ' A' ' 110' ' ' PHE . . . -59.58 -81.72 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.866 0.365 . . . . 0.0 110.818 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.88 ' HB ' HD12 ' A' ' 111' ' ' LEU . 83.5 t -159.65 -73.82 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.833 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.413 ' HG3' HG22 ' A' ' 155' ' ' VAL . 4.1 tppt? 177.42 135.6 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.954 -179.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.517 ' OH ' HG21 ' A' ' 117' ' ' ILE . 3.3 t80 -98.06 112.49 24.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.154 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.798 HG11 ' ND2' ' A' ' 167' ' ' ASN . 0.3 OUTLIER -115.04 -172.84 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.637 -179.924 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.586 ' H ' HG12 ' A' ' 155' ' ' VAL . 2.1 mp0 -89.58 163.3 15.24 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.868 0.366 . . . . 0.0 111.145 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.751 ' CB ' HG22 ' A' ' 115' ' ' THR . 0.1 OUTLIER -133.56 -172.73 3.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.987 -179.786 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.551 ' O ' ' HB2' ' A' ' 159' ' ' ALA . 1.1 p -128.38 147.85 50.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.984 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.551 ' HB2' ' O ' ' A' ' 158' ' ' SER . . . 169.58 -57.96 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.805 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.488 HD22 HD23 ' A' ' 119' ' ' LEU . 1.2 mp -100.39 -60.07 1.59 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.62 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.438 ' CG2' ' HB3' ' A' ' 118' ' ' ASP . 13.4 t -86.04 -26.4 25.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.474 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.447 ' HA ' ' HB2' ' A' ' 158' ' ' SER . 2.8 tt0 73.39 77.11 0.13 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.16 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.422 ' CB ' ' O ' ' A' ' 157' ' ' CYS . 0.0 OUTLIER -88.19 -21.37 24.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.131 179.979 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . 142.07 -36.07 1.7 Allowed Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.491 -0.861 . . . . 0.0 112.887 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.476 HD11 ' HA ' ' A' ' 19' ' ' LEU . 0.4 OUTLIER 68.37 -63.7 0.33 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.791 0.329 . . . . 0.0 111.064 -179.796 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.407 ' O ' ' CB ' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -48.49 -30.92 5.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.264 -179.848 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.798 ' ND2' HG11 ' A' ' 155' ' ' VAL . 0.2 OUTLIER -56.46 -71.5 0.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.313 -179.707 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.78 HG21 HG13 ' A' ' 113' ' ' VAL . 8.5 p -58.48 -46.77 89.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.823 0.344 . . . . 0.0 111.061 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.503 ' N ' HG13 ' A' ' 168' ' ' VAL . 4.2 t80 -57.71 -37.39 73.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.187 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.407 ' CB ' ' O ' ' A' ' 166' ' ' LYS . 17.0 m-20 -58.83 -37.47 76.5 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.814 ' OE2' HD12 ' A' ' 174' ' ' LEU . 21.9 mm-40 -66.34 -32.29 73.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.785 179.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.528 ' HB2' HD22 ' A' ' 111' ' ' LEU . . . -66.5 -30.63 71.0 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.68 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.928 HD11 HD22 ' A' ' 177' ' ' LEU . 0.0 OUTLIER -90.55 -26.15 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.097 -0.502 . . . . 0.0 109.763 179.256 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 1.076 HD21 HD13 ' B' ' 505' ' ' LEU . 1.2 mt -49.48 -46.81 48.63 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.01 0.434 . . . . 0.0 110.612 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.573 ' HB3' HG11 ' A' ' 77' ' ' VAL . . . -60.71 -22.68 64.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.098 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -97.09 -38.22 9.83 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.219 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.928 HD22 HD11 ' A' ' 173' ' ' ILE . 2.6 tp -68.71 -21.88 64.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.868 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.448 ' HB2' ' CB ' ' B' ' 507' ' ' ALA . 0.0 OUTLIER -174.06 158.08 2.72 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.788 179.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.65 110.68 3.06 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.654 2.236 . . . . 0.0 112.262 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -83.2 164.77 14.96 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.69 2.26 . . . . 0.0 112.472 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . 0.425 ' O ' ' CG ' ' A' ' 181' ' ' GLU . 9.5 pt-20 -113.11 110.11 51.49 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.551 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.66 -164.91 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.411 2.074 . . . . 0.0 112.278 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.66 86.21 1.64 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.874 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.872 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.224 0 N-CA-C 112.56 -0.216 . . . . 0.0 112.56 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 503' ' ' SER . . . . . 0.4 ' HB2' ' O ' ' B' ' 510' ' ' ILE . 0.5 OUTLIER -76.64 -82.44 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.735 0.302 . . . . 0.0 110.909 179.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 504' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' B' ' 509' ' ' ASP . . . 93.55 104.23 1.7 Allowed Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.397 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 505' ' ' LEU . . . . . 1.076 HD13 HD21 ' A' ' 174' ' ' LEU . 0.1 OUTLIER -170.32 39.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.747 0.308 . . . . 0.0 110.982 -179.767 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 506' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 68.14 33.04 4.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.031 0.443 . . . . 0.0 110.486 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 507' ' ' ALA . . . . . 0.448 ' HB3' ' CD1' ' B' ' 505' ' ' LEU . . . -134.93 36.58 3.06 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.698 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 508' ' ' GLN . . . . . 0.407 ' O ' ' HB3' ' B' ' 509' ' ' ASP . 31.2 mt-30 74.39 3.41 4.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.551 -178.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 509' ' ' ASP . . . . . 0.408 ' HA ' ' HA2' ' B' ' 504' ' ' GLY . 22.2 t70 70.49 43.62 0.77 Allowed 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 121.024 0.44 . . . . 0.0 110.985 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 510' ' ' ILE . . . . . 0.722 HG23 ' HA3' ' A' ' 47' ' ' GLY . 66.4 mt -95.25 139.0 19.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.579 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 511' ' ' SER . . . . . 0.62 ' O ' HD13 ' A' ' 46' ' ' ILE . 34.6 t -108.28 148.12 30.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.989 0.424 . . . . 0.0 112.039 -178.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 512' ' ' GLN . . . . . 0.812 ' OE1' HD11 ' A' ' 53' ' ' LEU . 11.8 tp60 -100.06 -69.08 0.04 OUTLIER Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.998 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 513' ' ' PRO . . . . . 0.511 ' HD3' ' HB3' ' B' ' 512' ' ' GLN . 85.3 Cg_endo -78.49 73.6 5.79 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.219 1.946 . . . . 0.0 110.934 178.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 514' ' ' LEU . . . . . 0.552 HD21 ' HB3' ' B' ' 511' ' ' SER . 1.3 mp -80.38 -93.76 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -178.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 515' ' ' GLN . . . . . 0.45 ' HB2' HG12 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -69.33 -83.7 0.03 OUTLIER 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.839 0.352 . . . . 0.0 111.914 -178.707 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 516' ' ' ASN . . . . . 0.413 ' ND2' ' O ' ' B' ' 518' ' ' PHE . 48.9 t30 -120.91 -37.11 3.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.485 -178.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 517' ' ' SER . . . . . 0.474 ' O ' HG11 ' A' ' 42' ' ' VAL . 0.7 OUTLIER 55.87 26.0 9.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.854 -179.806 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 518' ' ' PHE . . . . . 0.413 ' O ' ' ND2' ' B' ' 516' ' ' ASN . 0.0 OUTLIER -162.98 106.89 1.07 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.054 -179.78 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 519' ' ' ILE . . . . . 0.431 ' CG1' ' O ' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -107.6 -84.97 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.991 179.851 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 13.7 t-160 -175.17 102.55 0.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.889 0.376 . . . . 0.0 110.899 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 521' ' ' THR . . . . . 0.414 HG22 ' H ' ' B' ' 522' ' ' GLY . 0.2 OUTLIER -150.68 178.37 9.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.769 -179.964 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 522' ' ' GLY . . . . . 0.414 ' H ' HG22 ' B' ' 521' ' ' THR . . . 58.93 161.47 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.375 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 523' ' ' HIS . . . . . 0.422 ' NE2' ' HB2' ' B' ' 525' ' ' ASP . 16.3 t-160 -137.61 -84.92 0.31 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.704 0.288 . . . . 0.0 111.126 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 524' ' ' GLY . . . . . . . . . . . . . . . 92.37 -97.54 2.29 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.379 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 525' ' ' ASP . . . . . 0.422 ' HB2' ' NE2' ' B' ' 523' ' ' HIS . 2.7 t0 75.32 78.44 0.1 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.926 0.393 . . . . 0.0 111.279 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 526' ' ' SER . . . . . 0.922 ' CB ' HD23 ' A' ' 61' ' ' LEU . 0.5 OUTLIER -117.4 98.19 6.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.723 179.545 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 527' ' ' ASP . . . . . 0.445 ' CB ' ' HD3' ' B' ' 528' ' ' PRO . 0.1 OUTLIER -44.32 -50.9 21.06 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.301 -179.807 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 528' ' ' PRO . . . . . 0.445 ' HD3' ' CB ' ' B' ' 527' ' ' ASP . 23.6 Cg_exo -68.08 118.65 5.77 Favored 'Trans proline' 0 CA--C 1.518 -0.305 0 C-N-CA 123.058 2.505 . . . . 0.0 112.108 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 529' ' ' ARG . . . . . 0.559 ' HD3' HG21 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -100.92 -37.47 8.64 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.879 -179.162 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 530' ' ' HIS . . . . . 0.48 ' CG ' ' O ' ' B' ' 530' ' ' HIS . 0.0 OUTLIER 67.71 9.62 7.21 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.012 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 531' ' ' CYS . . . . . 0.465 ' O ' ' CD2' ' B' ' 530' ' ' HIS . 1.2 m 49.1 -174.45 0.02 OUTLIER 'General case' 0 C--N 1.334 -0.093 0 CA-C-O 120.87 0.367 . . . . 0.0 111.072 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 532' ' ' TRP . . . . . . . . . . . . . 23.0 t90 -65.44 -63.16 1.16 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.864 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . 95.52 -119.11 6.09 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.377 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 534' ' ' PHE . . . . . 0.418 ' O ' ' N ' ' B' ' 536' ' ' ASP . 11.3 m-85 -119.39 151.2 50.99 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.729 0.3 . . . . 0.0 110.892 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.48 83.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.586 2.191 . . . . 0.0 112.262 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 536' ' ' ASP . . . . . 0.418 ' N ' ' O ' ' B' ' 534' ' ' PHE . 1.0 OUTLIER 172.23 80.85 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.7 179.979 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 537' ' ' ARG . . . . . 0.434 ' HG3' ' CA ' ' A' ' 13' ' ' ALA . 32.3 mmt-85 -51.78 132.92 31.81 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.116 0.484 . . . . 0.0 111.062 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 538' ' ' ILE . . . . . 0.408 HD12 ' H ' ' B' ' 539' ' ' ASP . 3.1 tp -50.9 133.53 11.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.446 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 539' ' ' ASP . . . . . 0.408 ' H ' HD12 ' B' ' 538' ' ' ILE . 62.5 m-20 -40.39 117.76 0.84 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.317 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 540' ' ' GLU . . . . . 0.783 ' HA ' HD12 ' B' ' 543' ' ' LEU . 2.8 pp20? -47.45 -24.87 0.91 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.116 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 541' ' ' LEU . . . . . 0.697 ' HA ' HD22 ' A' ' 70' ' ' LEU . 0.4 OUTLIER -38.53 -42.66 0.78 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.164 0.507 . . . . 0.0 111.012 179.435 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 542' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -105.3 -59.48 1.75 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.427 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 543' ' ' LEU . . . . . 0.783 HD12 ' HA ' ' B' ' 540' ' ' GLU . 0.1 OUTLIER 59.98 122.88 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.881 -179.911 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 544' ' ' GLY . . . . . 0.449 ' HA2' HD11 ' A' ' 61' ' ' LEU . . . 164.3 105.21 0.19 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.538 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 545' ' ' ASN . . . . . 0.439 ' HB3' ' HA ' ' B' ' 529' ' ' ARG . 10.0 m120 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.951 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.466 ' HE1' ' CD1' ' A' ' 51' ' ' TYR . 6.9 tpt . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.267 0.079 . . . . 0.0 111.082 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.43 ' N ' ' HG3' ' A' ' 1' ' ' MET . 5.7 tt0 42.22 100.08 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.294 0.568 . . . . 0.0 111.804 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.556 HG23 HG21 ' A' ' 46' ' ' ILE . 0.2 OUTLIER -104.82 -159.48 0.71 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.652 -179.889 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.701 ' O ' HD22 ' A' ' 53' ' ' LEU . 0.3 OUTLIER -156.37 163.18 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -178.653 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.519 ' HA ' HD13 ' A' ' 53' ' ' LEU . 16.2 mttp -134.45 102.36 5.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.876 179.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 32.3 m -103.07 156.2 17.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.225 0.536 . . . . 0.0 112.083 -178.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.445 HG13 ' O ' ' A' ' 56' ' ' PHE . 2.7 t -139.11 159.87 29.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.248 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.708 HG13 ' HB ' ' A' ' 14' ' ' VAL . 65.4 t -106.89 141.5 21.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.239 0.542 . . . . 0.0 111.752 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 98.0 t -156.51 129.96 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.855 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.55 -171.14 32.99 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 119.976 -1.107 . . . . 0.0 113.051 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -94.81 27.78 2.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.791 0.329 . . . . 0.0 110.852 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.635 ' O ' HG23 ' A' ' 14' ' ' VAL . . . -170.04 -170.06 33.98 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.419 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.444 ' N ' ' HB2' ' B' ' 537' ' ' ARG . . . -60.84 -30.17 69.95 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.953 0.406 . . . . 0.0 110.712 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.708 ' HB ' HG13 ' A' ' 8' ' ' VAL . 2.7 t 63.45 -71.21 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.584 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.934 ' C ' HD11 ' A' ' 19' ' ' LEU . . . 175.22 59.19 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.169 -1.015 . . . . 0.0 113.232 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.688 ' CE ' HG11 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -97.85 -85.71 0.36 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.861 0.33 . . . . 0.0 110.217 178.75 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.46 ' HB ' ' CG1' ' A' ' 21' ' ' ILE . 45.9 p -99.5 -36.64 9.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.001 0.429 . . . . 0.0 111.116 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.405 ' O ' ' CB ' ' A' ' 22' ' ' SER . 30.0 p -40.28 -36.31 0.51 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.314 -179.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.94 HD23 ' CD2' ' A' ' 165' ' ' LEU . 0.0 OUTLIER -71.15 -69.3 0.38 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.926 0.393 . . . . 0.0 110.883 -179.68 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.535 HD21 ' CD2' ' A' ' 169' ' ' PHE . 3.6 mt -55.98 -43.47 77.63 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.234 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.608 HG22 ' OG1' ' A' ' 25' ' ' THR . 42.4 mm -62.41 -66.9 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.864 0.364 . . . . 0.0 110.587 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.405 ' CB ' ' O ' ' A' ' 18' ' ' CYS . 52.3 p -46.18 -27.41 0.98 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.258 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -73.89 -68.14 0.54 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.954 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.91 -46.27 75.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.716 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.608 ' OG1' HG22 ' A' ' 21' ' ' ILE . 19.0 p -85.26 -149.1 0.12 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.308 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -161.18 30.11 0.14 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.746 0.307 . . . . 0.0 111.105 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.8 mttt -115.35 156.31 25.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.271 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.518 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . 4.1 t80 -163.67 -62.15 0.01 OUTLIER Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.726 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.518 ' HD3' ' HB3' ' A' ' 28' ' ' PHE . 63.2 Cg_endo -85.07 -16.37 5.15 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.627 2.218 . . . . 0.0 112.989 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.2 m -50.61 -87.75 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.398 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -158.12 116.86 3.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.525 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.482 ' CE1' ' HA ' ' A' ' 28' ' ' PHE . 6.6 m-85 -111.56 94.14 4.82 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.108 0.48 . . . . 0.0 110.769 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.822 HG21 ' HD3' ' B' ' 529' ' ' ARG . 2.1 t -117.25 -52.22 0.04 OUTLIER Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.23 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.472 ' O ' ' CD1' ' A' ' 37' ' ' PHE . 5.1 Cg_exo -80.14 52.99 4.54 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.501 2.134 . . . . 0.0 112.245 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.9 t -98.88 -25.22 14.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.835 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.799 HG11 ' CG ' ' B' ' 525' ' ' ASP . 7.4 p -51.0 -27.63 5.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.326 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.472 ' CD1' ' O ' ' A' ' 34' ' ' PRO . 3.4 p90 -54.79 -21.15 10.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.965 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.431 ' HB3' ' CB ' ' A' ' 57' ' ' ASP . 59.2 t0 -44.71 -29.73 0.81 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.413 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -70.29 -30.75 67.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.167 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.663 ' CE1' HG21 ' B' ' 521' ' ' THR . 8.6 m-85 -60.68 -174.07 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.86 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.681 ' O ' HD12 ' B' ' 519' ' ' ILE . . . -101.57 -179.63 4.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.087 0.47 . . . . 0.0 111.538 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.1 m -141.11 165.15 19.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.553 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.547 ' O ' HG13 ' A' ' 44' ' ' VAL . 0.7 OUTLIER -110.2 102.11 10.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.883 0.373 . . . . 0.0 111.649 -179.483 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.658 HG11 ' OG ' ' B' ' 517' ' ' SER . 30.1 m -164.81 -177.16 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.728 178.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.491 ' O ' ' HG3' ' A' ' 45' ' ' MET . 0.0 OUTLIER -128.53 101.12 6.03 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.54 0.686 . . . . 0.0 110.95 179.844 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.736 HG23 HG23 ' B' ' 510' ' ' ILE . 3.8 mm -55.49 101.6 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.478 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.454 ' O ' ' CE ' ' A' ' 45' ' ' MET . . . 29.48 -83.88 0.0 OUTLIER Glycine 0 C--N 1.337 0.626 0 N-CA-C 114.862 0.705 . . . . 0.0 114.862 178.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . -42.28 -77.32 0.08 OUTLIER Glycine 0 CA--C 1.519 0.311 0 C-N-CA 121.226 -0.511 . . . . 0.0 113.167 -179.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -143.57 164.28 31.52 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-O 120.807 0.337 . . . . 0.0 111.448 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.433 ' HA ' ' HA ' ' A' ' 45' ' ' MET . 4.2 Cg_endo -47.09 101.12 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.942 2.428 . . . . 0.0 112.309 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.494 ' HE1' HG21 ' A' ' 3' ' ' THR . 5.0 t80 -172.85 137.04 0.73 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.967 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.627 HG21 HG22 ' A' ' 44' ' ' VAL . 16.5 p -134.26 138.54 45.11 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.114 0.483 . . . . 0.0 111.369 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.701 HD22 ' O ' ' A' ' 4' ' ' ILE . 1.5 pp -74.04 178.07 5.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.752 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -111.89 86.91 0.44 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.071 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -47.62 116.81 1.58 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.854 0.359 . . . . 0.0 110.501 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.445 ' O ' HG13 ' A' ' 7' ' ' VAL . 0.8 OUTLIER -83.92 105.3 14.7 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.042 -179.374 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.805 ' OD2' HD21 ' B' ' 543' ' ' LEU . 0.1 OUTLIER -130.16 111.31 12.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.153 179.593 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.826 ' O ' HD13 ' B' ' 543' ' ' LEU . 0.6 OUTLIER -86.28 129.78 34.73 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.748 -179.512 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.643 ' HB3' HG23 ' A' ' 36' ' ' VAL . . . -135.99 114.75 12.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.909 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -67.48 63.8 0.27 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.775 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.784 HD12 ' HB ' ' A' ' 36' ' ' VAL . 9.7 mt -121.45 -171.72 2.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.834 0.349 . . . . 0.0 110.874 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.433 ' CB ' ' O ' ' B' ' 524' ' ' GLY . 0.1 OUTLIER -44.43 -45.53 9.08 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.51 -179.878 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.496 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . 5.3 m-20 -59.35 -62.99 1.47 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.163 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.496 ' CE1' ' HB3' ' A' ' 63' ' ' ASP . 0.1 OUTLIER -128.42 132.15 48.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.862 -179.68 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -86.68 -68.73 0.72 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.435 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.401 ' O ' ' HB2' ' A' ' 67' ' ' LEU . 11.1 mmt180 -98.41 -34.67 10.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.337 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.779 HD13 ' HB ' ' A' ' 58' ' ' THR . 1.2 mp 69.72 -80.07 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.058 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.556 ' CB ' ' O ' ' A' ' 67' ' ' LEU . 25.8 ttp180 113.83 -42.61 0.0 OUTLIER Pre-proline 0 N--CA 1.487 1.39 0 C-N-CA 123.89 0.876 . . . . 0.0 112.904 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 67.7 Cg_exo -41.61 -49.83 5.07 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.499 2.132 . . . . 0.0 113.182 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.783 HD22 ' N ' ' B' ' 541' ' ' LEU . 0.1 OUTLIER -53.38 -26.23 18.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.78 0.324 . . . . 0.0 110.564 -179.924 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.412 ' CB ' ' O ' ' A' ' 68' ' ' ARG . 8.5 t -50.95 -67.68 0.23 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.081 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -147.14 73.57 12.03 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.012 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -56.47 164.78 5.13 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.58 2.187 . . . . 0.0 112.202 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 54.6 tp60 -95.02 -17.53 21.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.296 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.664 HG22 ' H ' ' A' ' 77' ' ' VAL . 93.5 m -46.62 149.99 0.74 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.773 0.321 . . . . 0.0 111.201 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -90.43 -24.19 20.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.05 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.664 ' H ' HG22 ' A' ' 75' ' ' THR . 1.2 m -103.83 91.6 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.135 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -80.98 122.09 26.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.606 HD12 HG12 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -78.17 109.65 12.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.013 -179.883 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.466 HG23 HD23 ' A' ' 112' ' ' LEU . 1.8 m -106.75 121.4 59.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.379 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.67 ' HB3' HG22 ' A' ' 14' ' ' VAL . 9.0 p -95.37 161.43 14.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.319 0.581 . . . . 0.0 112.304 -178.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 1.008 ' CE1' HD22 ' A' ' 112' ' ' LEU . 14.3 p90 179.61 123.58 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.897 179.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.35 151.02 20.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.952 0.406 . . . . 0.0 111.341 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.956 HG22 ' HB3' ' A' ' 116' ' ' GLN . 1.5 m -52.52 -51.78 31.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.591 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.578 HG22 ' OE1' ' A' ' 116' ' ' GLN . 19.6 m -53.28 116.64 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.588 0.232 . . . . 0.0 110.615 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.678 ' H ' HD22 ' A' ' 129' ' ' LEU . 6.4 m -151.14 129.2 5.89 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.455 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -91.17 51.39 0.81 Allowed 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.989 2.46 . . . . 0.0 111.684 179.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.472 ' CA ' ' HB2' ' A' ' 133' ' ' LYS . 0.1 OUTLIER 75.1 15.86 2.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.21 -179.626 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.931 ' O ' HG23 ' A' ' 93' ' ' VAL . 43.8 t -97.6 -22.4 16.52 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.121 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.585 ' CZ ' HG21 ' A' ' 137' ' ' ILE . 12.0 t80 -47.07 -59.18 3.3 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.322 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -48.71 -47.18 41.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.967 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -69.89 -32.61 71.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.781 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.931 HG23 ' O ' ' A' ' 89' ' ' SER . 93.8 t -57.1 -68.51 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.964 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.838 ' HG3' HD13 ' A' ' 145' ' ' LEU . 6.9 mmtt -52.09 -52.86 48.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.745 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -57.44 -22.58 44.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.791 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -100.39 -12.38 19.46 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.355 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.421 ' O ' ' CG ' ' A' ' 100' ' ' GLU . 3.1 m0 -89.24 -56.27 3.34 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.628 0.252 . . . . 0.0 111.179 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.671 HG11 HD22 ' A' ' 149' ' ' LEU . 12.9 t -45.88 -45.44 37.57 Favored Pre-proline 0 C--N 1.329 -0.293 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.491 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 50.2 Cg_exo -54.14 -37.77 87.41 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.323 2.015 . . . . 0.0 112.523 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.445 ' HG3' ' N ' ' A' ' 101' ' ' ILE . 6.3 pt-20 -82.82 -32.53 27.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.078 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.776 HG21 ' CD1' ' A' ' 110' ' ' PHE . 19.0 mm -53.86 -35.54 27.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.892 0.377 . . . . 0.0 110.648 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 43.9 p -95.93 -22.45 17.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.055 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 13.5 t-160 -66.02 -29.01 69.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.741 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 3.5 m170 -90.93 -25.22 19.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.799 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 1.1 m -145.33 142.2 17.98 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.886 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.51 90.48 0.22 Allowed 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.535 2.157 . . . . 0.0 112.207 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 58.9 90.83 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.743 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.93 116.07 30.29 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.969 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -60.14 156.32 40.49 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.575 2.184 . . . . 0.0 112.226 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.776 ' CD1' HG21 ' A' ' 101' ' ' ILE . 3.4 p90 -145.9 147.83 32.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.943 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 1.028 HD12 HG11 ' A' ' 152' ' ' VAL . 3.7 tt -108.45 141.38 40.4 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.011 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 1.008 HD22 ' CE1' ' A' ' 82' ' ' PHE . 25.1 mt -98.71 142.94 29.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.81 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.955 HG13 HG11 ' A' ' 168' ' ' VAL . 58.1 t -121.6 142.58 37.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.98 0.419 . . . . 0.0 111.775 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -117.43 121.74 5.21 Favored Glycine 0 N--CA 1.45 -0.375 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.637 ' O ' HD12 ' A' ' 117' ' ' ILE . 1.3 p -136.63 -56.23 0.74 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.736 0.303 . . . . 0.0 111.134 -179.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.956 ' HB3' HG22 ' A' ' 84' ' ' VAL . 2.6 tt0 -59.36 -16.81 24.95 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.821 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.637 HD12 ' O ' ' A' ' 115' ' ' THR . 0.4 OUTLIER -55.15 -16.05 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 179.912 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.451 ' OD2' HG21 ' A' ' 161' ' ' THR . 1.3 t0 -82.13 -19.99 38.92 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 120.732 0.301 . . . . 0.0 111.151 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.57 ' C ' HD12 ' A' ' 119' ' ' LEU . 4.1 pp -121.35 1.72 10.21 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.908 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.806 ' HB3' HG21 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -50.05 -30.9 11.77 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.986 0.422 . . . . 0.0 110.647 179.88 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -59.84 -21.65 61.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.978 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.405 ' O ' ' HB ' ' A' ' 126' ' ' ILE . 31.8 t0 -44.79 99.84 0.22 Allowed Pre-proline 0 N--CA 1.462 0.136 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.869 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.416 ' O ' ' CG ' ' A' ' 127' ' ' GLU . 15.1 Cg_exo -68.94 -4.68 13.92 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.711 2.274 . . . . 0.0 112.968 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.3 t -83.36 -64.7 1.12 Allowed 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.541 HG21 HG11 ' A' ' 85' ' ' VAL . 32.5 m -55.84 -36.43 67.51 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.693 HG13 HD11 ' A' ' 129' ' ' LEU . 0.0 OUTLIER -58.69 -39.39 76.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.945 179.24 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.416 ' CG ' ' O ' ' A' ' 123' ' ' PRO . 8.8 mm-40 -63.71 -29.28 70.52 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.776 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.423 ' HD3' ' HA ' ' A' ' 125' ' ' THR . 1.8 mptt -74.16 -58.34 3.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.789 179.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.693 HD11 HG13 ' A' ' 126' ' ' ILE . 3.6 pp -63.22 -25.89 68.54 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.673 ' HB1' ' HG2' ' A' ' 134' ' ' GLN . . . -52.61 -41.69 63.9 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.564 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 18.0 mmtm -46.22 -24.08 0.42 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.637 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -123.04 -30.23 3.79 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.478 ' CG ' ' N ' ' A' ' 134' ' ' GLN . 0.0 OUTLIER -132.21 -72.45 0.53 Allowed 'General case' 0 CA--C 1.534 0.331 0 O-C-N 122.097 -0.377 . . . . 0.0 111.871 -178.783 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.673 ' HG2' ' HB1' ' A' ' 130' ' ' ALA . 9.5 mt-30 98.63 -46.54 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.841 0.856 . . . . 0.0 110.945 -179.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 4.2 mtpp -73.77 109.1 5.9 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.42 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.898 ' C ' HD13 ' A' ' 137' ' ' ILE . 55.8 Cg_endo -70.06 -170.8 0.44 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.087 1.858 . . . . 0.0 110.764 179.002 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.898 HD13 ' C ' ' A' ' 136' ' ' PRO . 1.2 mm -112.08 95.89 4.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.163 0.506 . . . . 0.0 111.057 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.415 HG22 ' H ' ' A' ' 138' ' ' THR . 0.1 OUTLIER -71.57 150.03 93.52 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.76 -179.981 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -44.01 -28.85 2.37 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.698 2.265 . . . . 0.0 112.383 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -71.26 -31.26 67.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.85 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.524 HG21 HG23 ' A' ' 137' ' ' ILE . 55.4 m -72.64 -50.58 24.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.905 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.55 ' HB3' ' CE2' ' A' ' 154' ' ' TYR . . . -50.28 -61.19 2.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.853 0.359 . . . . 0.0 110.792 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.45 -40.12 68.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.751 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -50.78 -61.24 2.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.705 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.838 HD13 ' HG3' ' A' ' 94' ' ' LYS . 3.6 tt -67.22 -34.0 76.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.568 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.964 ' HB2' HD12 ' A' ' 112' ' ' LEU . . . -57.2 -45.01 84.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.852 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 5.1 mtm180 -79.49 -25.6 41.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.843 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -58.24 -46.09 86.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.797 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.671 HD22 HG11 ' A' ' 98' ' ' VAL . 1.8 mt -102.05 24.18 10.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.804 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 39.07 55.14 2.13 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.758 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.611 ' HB1' ' O ' ' A' ' 110' ' ' PHE . . . -67.04 -81.62 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.056 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 1.028 HG11 HD12 ' A' ' 111' ' ' LEU . 50.9 t -160.54 -74.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.81 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.16 114.9 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.11 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.55 ' CE2' ' HB3' ' A' ' 142' ' ' ALA . 45.7 t80 -90.55 109.9 21.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.048 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.44 HG12 ' N ' ' A' ' 156' ' ' GLU . 3.6 t -101.67 161.43 3.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.393 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.44 ' N ' HG12 ' A' ' 155' ' ' VAL . 8.9 tt0 -89.7 140.33 29.68 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.098 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.589 ' O ' HD11 ' A' ' 117' ' ' ILE . 1.8 p 178.71 -175.14 0.19 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.314 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.516 ' O ' HD12 ' A' ' 165' ' ' LEU . 4.5 t -160.28 163.75 33.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.109 0.48 . . . . 0.0 111.677 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.762 ' HB2' HD11 ' A' ' 165' ' ' LEU . . . -114.82 -42.15 3.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.09 179.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.408 ' CD1' HD23 ' A' ' 119' ' ' LEU . 0.5 OUTLIER -74.43 -29.08 61.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.189 179.36 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.451 HG21 ' OD2' ' A' ' 118' ' ' ASP . 0.9 OUTLIER -111.87 -26.4 8.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.659 179.872 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.401 ' HA ' ' O ' ' A' ' 158' ' ' SER . 0.0 OUTLIER 73.52 70.57 0.12 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.232 179.844 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.409 ' HB3' ' HA ' ' A' ' 157' ' ' CYS . 12.3 mtmt -95.2 23.56 5.68 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.109 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 101.71 42.78 2.24 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.914 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.94 ' CD2' HD23 ' A' ' 19' ' ' LEU . 0.3 OUTLIER -52.29 -25.0 8.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.691 0.282 . . . . 0.0 111.042 179.911 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.405 ' HD2' ' CA ' ' B' ' 502' ' ' GLY . 22.4 pttp -69.04 -23.31 64.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.691 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.16 -70.33 0.24 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.707 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.955 HG11 HG13 ' A' ' 113' ' ' VAL . 7.5 p -52.64 -46.78 50.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.114 0.483 . . . . 0.0 110.431 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.624 ' CG ' HD22 ' A' ' 19' ' ' LEU . 2.6 t80 -57.25 -32.55 66.68 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.111 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 166' ' ' LYS . 30.9 t70 -71.22 -25.85 62.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.047 178.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.885 ' HB3' HD11 ' A' ' 111' ' ' LEU . 0.8 OUTLIER -74.16 -28.12 61.16 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.126 179.308 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.554 ' CA ' HD13 ' A' ' 111' ' ' LEU . . . -75.44 -40.74 57.21 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.709 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.636 HD12 HD12 ' A' ' 177' ' ' LEU . 1.6 pp -80.89 -33.71 13.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.916 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.807 HD13 ' CB ' ' B' ' 505' ' ' LEU . 1.0 OUTLIER -55.42 -58.59 7.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.417 179.647 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.579 ' HB1' ' HG3' ' A' ' 180' ' ' PRO . . . -49.5 -25.85 2.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.791 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.529 ' HB3' HG21 ' A' ' 4' ' ' ILE . . . -87.8 -41.19 13.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.118 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.636 HD12 HD12 ' A' ' 173' ' ' ILE . 41.8 mt -68.82 -23.68 64.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.892 0.377 . . . . 0.0 110.614 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.637 ' CB ' ' HB2' ' B' ' 507' ' ' ALA . 24.8 tt0 -168.19 142.78 2.85 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.841 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . 0.436 ' HD2' ' CG ' ' A' ' 178' ' ' GLU . 93.3 Cg_exo -44.07 115.44 0.73 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.587 2.191 . . . . 0.0 112.405 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . 0.579 ' HG3' ' HB1' ' A' ' 175' ' ' ALA . 67.6 Cg_endo -73.08 -171.76 0.86 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.452 2.101 . . . . 0.0 112.358 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . 0.4 ' HA ' ' HD3' ' A' ' 182' ' ' PRO . 41.4 mt-10 -148.83 151.59 35.45 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.787 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 181' ' ' GLU . 36.6 Cg_exo -59.45 -152.72 0.01 OUTLIER 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.706 2.271 . . . . 0.0 112.469 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.4 148.77 46.62 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.961 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.268 -0.872 . . . . 0.0 110.843 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 502' ' ' GLY . . . . . 0.405 ' CA ' ' HD2' ' A' ' 166' ' ' LYS . . . . . . . . 0 N--CA 1.488 2.165 0 N-CA-C 112.514 -0.234 . . . . 0.0 112.514 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 503' ' ' SER . . . . . . . . . . . . . 98.7 p -62.82 -170.9 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.843 0.354 . . . . 0.0 110.894 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 504' ' ' GLY . . . . . 0.702 ' C ' HD23 ' B' ' 505' ' ' LEU . . . -157.31 -106.63 0.24 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.396 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 505' ' ' LEU . . . . . 0.82 HD12 ' HB3' ' B' ' 507' ' ' ALA . 1.1 pt? 44.15 -171.77 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.114 0.483 . . . . 0.0 111.867 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 506' ' ' SER . . . . . . . . . . . . . 4.9 m -117.66 -15.69 10.14 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.106 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 507' ' ' ALA . . . . . 0.82 ' HB3' HD12 ' B' ' 505' ' ' LEU . . . -67.89 59.62 0.07 Allowed 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.087 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 508' ' ' GLN . . . . . 0.561 ' HB2' HD12 ' B' ' 510' ' ' ILE . 9.7 mt-30 69.86 3.17 4.18 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.608 -178.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 509' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' B' ' 504' ' ' GLY . 15.7 t0 46.7 53.47 10.08 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.378 0.609 . . . . 0.0 111.094 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 510' ' ' ILE . . . . . 0.736 HG23 HG23 ' A' ' 46' ' ' ILE . 0.9 OUTLIER -50.6 107.78 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.352 179.561 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 511' ' ' SER . . . . . 0.439 ' O ' HD12 ' B' ' 514' ' ' LEU . 48.2 m -61.87 86.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.91 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 512' ' ' GLN . . . . . 0.472 ' CB ' ' CD ' ' B' ' 513' ' ' PRO . 23.6 tp60 -50.89 -67.69 0.45 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.464 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 513' ' ' PRO . . . . . 0.472 ' CD ' ' CB ' ' B' ' 512' ' ' GLN . 98.3 Cg_endo -77.06 66.09 7.76 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.506 2.137 . . . . 0.0 112.13 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 514' ' ' LEU . . . . . 0.439 HD12 ' O ' ' B' ' 511' ' ' SER . 0.7 OUTLIER -73.69 138.78 44.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.847 0.356 . . . . 0.0 111.082 -179.756 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 515' ' ' GLN . . . . . 0.544 ' O ' HG12 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -52.49 143.52 15.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.927 -179.892 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 72.02 23.51 3.46 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.988 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 517' ' ' SER . . . . . 0.658 ' OG ' HG11 ' A' ' 44' ' ' VAL . 3.1 m -82.75 53.79 2.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.185 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 518' ' ' PHE . . . . . 0.467 ' CD1' ' O ' ' B' ' 517' ' ' SER . 10.4 m-85 -163.63 94.98 0.8 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.603 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 519' ' ' ILE . . . . . 0.681 HD12 ' O ' ' A' ' 41' ' ' ALA . 13.2 mt -55.87 -100.16 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.316 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 520' ' ' HIS . . . . . 0.553 ' N ' HG22 ' B' ' 519' ' ' ILE . 15.7 t-160 179.22 40.14 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.763 0.316 . . . . 0.0 110.943 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 521' ' ' THR . . . . . 0.663 HG21 ' CE1' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -112.87 -177.1 3.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.262 -179.792 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 522' ' ' GLY . . . . . . . . . . . . . . . 71.58 97.33 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.265 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 523' ' ' HIS . . . . . 0.413 ' O ' ' N ' ' B' ' 525' ' ' ASP . 15.8 p-80 -144.82 -45.77 0.23 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.821 0.343 . . . . 0.0 111.334 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 524' ' ' GLY . . . . . 0.433 ' O ' ' CB ' ' A' ' 62' ' ' GLU . . . -67.81 68.63 0.3 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.256 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 525' ' ' ASP . . . . . 0.799 ' CG ' HG11 ' A' ' 36' ' ' VAL . 0.2 OUTLIER 176.3 37.47 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.822 0.344 . . . . 0.0 110.549 -179.732 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 526' ' ' SER . . . . . 0.772 ' HA ' HG12 ' A' ' 33' ' ' VAL . 3.1 t -113.55 96.17 5.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.901 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 527' ' ' ASP . . . . . 0.52 ' CB ' ' CD ' ' B' ' 528' ' ' PRO . 0.4 OUTLIER -134.05 -70.67 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.831 179.518 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 528' ' ' PRO . . . . . 0.52 ' CD ' ' CB ' ' B' ' 527' ' ' ASP . 13.4 Cg_endo -53.97 90.07 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.671 2.247 . . . . 0.0 112.396 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 529' ' ' ARG . . . . . 0.822 ' HD3' HG21 ' A' ' 33' ' ' VAL . 0.5 OUTLIER -96.19 5.11 51.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.003 179.491 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 530' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -49.33 -53.8 20.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.751 0.31 . . . . 0.0 111.537 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER 71.23 -154.52 0.1 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.531 -179.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 532' ' ' TRP . . . . . 0.459 ' CD1' ' NH2' ' B' ' 537' ' ' ARG . 0.0 OUTLIER -41.9 142.06 0.75 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.962 0.411 . . . . 0.0 111.55 -179.86 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . -163.56 -40.45 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.308 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 534' ' ' PHE . . . . . 0.627 ' CZ ' HG22 ' B' ' 538' ' ' ILE . 4.5 p90 -133.17 161.16 65.45 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 120.679 0.276 . . . . 0.0 110.553 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 535' ' ' PRO . . . . . 0.426 ' HD2' ' HB2' ' B' ' 534' ' ' PHE . 91.0 Cg_exo -42.93 103.37 0.04 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.58 2.187 . . . . 0.0 112.49 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 1.8 t0 70.53 159.36 0.2 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.987 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 537' ' ' ARG . . . . . 0.459 ' NH2' ' CD1' ' B' ' 532' ' ' TRP . 0.0 OUTLIER -62.96 -165.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.301 0.572 . . . . 0.0 110.908 179.864 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 538' ' ' ILE . . . . . 0.627 HG22 ' CZ ' ' B' ' 534' ' ' PHE . 0.0 OUTLIER -105.5 -160.74 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.269 -0.878 . . . . 0.0 108.981 178.524 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 539' ' ' ASP . . . . . 0.476 ' N ' HG12 ' B' ' 538' ' ' ILE . 38.5 p-10 -79.83 153.13 29.32 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.329 -0.548 . . . . 0.0 111.014 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 540' ' ' GLU . . . . . 0.464 ' HG2' HD12 ' B' ' 543' ' ' LEU . 0.0 OUTLIER -52.57 -22.27 4.77 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.754 -179.389 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 541' ' ' LEU . . . . . 0.783 ' N ' HD22 ' A' ' 70' ' ' LEU . 5.4 tp -54.84 -22.31 14.13 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.175 0.512 . . . . 0.0 110.853 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 542' ' ' TYR . . . . . 0.575 ' HE1' HD23 ' B' ' 541' ' ' LEU . 3.1 m-85 -104.91 -63.86 1.18 Allowed 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.708 -178.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 543' ' ' LEU . . . . . 0.826 HD13 ' O ' ' A' ' 58' ' ' THR . 0.1 OUTLIER 62.85 46.23 5.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.879 -179.566 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . 175.67 -70.2 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.465 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 545' ' ' ASN . . . . . 0.401 ' HB2' ' HB2' ' B' ' 528' ' ' PRO . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.274 -0.87 . . . . 0.0 110.887 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.436 ' HG2' ' CG ' ' A' ' 49' ' ' GLU . 2.4 ppp? . . . . . 0 N--CA 1.488 1.448 0 CA-C-O 120.842 0.353 . . . . 0.0 111.128 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.41 ' O ' HD13 ' B' ' 510' ' ' ILE . 62.1 tp60 -161.14 125.21 3.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.313 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.972 HG23 HD22 ' A' ' 53' ' ' LEU . 13.1 t -123.65 -173.79 2.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.227 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.934 ' C ' HD23 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -153.39 156.11 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -178.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.539 ' N ' HD23 ' A' ' 53' ' ' LEU . 16.3 pttm -124.9 95.52 4.54 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.044 179.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.422 ' HB2' ' HE3' ' A' ' 16' ' ' LYS . 8.3 m -95.61 156.5 16.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.99 0.424 . . . . 0.0 111.458 -179.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.921 HG13 ' HB3' ' A' ' 56' ' ' PHE . 0.2 OUTLIER -120.12 159.65 21.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.471 179.704 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.898 HG11 ' HA2' ' A' ' 15' ' ' GLY . 6.1 p -110.36 114.37 46.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.248 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.911 HG13 ' CD ' ' B' ' 540' ' ' GLU . 81.7 t -134.6 129.75 52.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.099 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 149.53 -150.01 22.05 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.186 -1.007 . . . . 0.0 112.917 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -118.81 -13.56 9.53 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.624 0.231 . . . . 0.0 111.624 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.434 ' O ' ' NH1' ' B' ' 537' ' ' ARG . . . -50.51 -101.22 0.01 OUTLIER Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.363 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -102.5 -19.08 15.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.79 0.329 . . . . 0.0 111.032 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.678 HG12 ' O ' ' A' ' 14' ' ' VAL . 37.9 t 64.52 23.34 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.647 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.898 ' HA2' HG11 ' A' ' 8' ' ' VAL . . . -153.9 134.53 4.38 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.632 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.573 ' NZ ' HD12 ' A' ' 55' ' ' LEU . 0.4 OUTLIER -86.54 7.55 25.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.75 0.309 . . . . 0.0 110.718 179.365 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.704 HG21 HG23 ' A' ' 35' ' ' THR . 1.3 p -97.24 -45.03 6.67 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 120.938 0.399 . . . . 0.0 110.992 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 28.6 p -39.26 -45.96 1.46 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.307 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.961 HD22 ' CD1' ' A' ' 169' ' ' PHE . 1.4 mp -51.12 -50.0 59.67 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.923 0.392 . . . . 0.0 110.737 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.462 HD22 ' N ' ' A' ' 20' ' ' LEU . 3.0 mm? -73.02 -19.42 61.2 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.028 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.402 ' O ' ' N ' ' A' ' 25' ' ' THR . 17.4 mm -66.7 -71.04 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 CA-C-O 120.719 0.295 . . . . 0.0 110.7 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.3 t -61.22 -27.0 68.12 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.81 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -58.9 -62.94 1.5 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.916 0.388 . . . . 0.0 110.354 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 54.7 m -82.66 -46.53 13.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.403 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.402 ' N ' ' O ' ' A' ' 21' ' ' ILE . 14.2 p -101.23 -158.07 0.65 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.416 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -153.3 27.86 0.51 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.81 0.338 . . . . 0.0 111.114 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -96.17 73.15 2.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.046 0.45 . . . . 0.0 110.502 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.454 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . 0.3 OUTLIER -86.85 -53.1 0.41 Allowed Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.745 -179.745 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.454 ' HD3' ' HB3' ' A' ' 28' ' ' PHE . 84.0 Cg_endo -85.34 78.79 2.4 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.717 2.278 . . . . 0.0 112.757 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.417 ' O ' ' CB ' ' B' ' 531' ' ' CYS . 2.8 m -141.84 -96.18 0.13 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.815 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -159.39 133.56 7.61 Favored 'General case' 0 C--N 1.334 -0.083 0 CA-C-O 120.793 0.33 . . . . 0.0 110.977 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.445 ' OH ' ' CD1' ' B' ' 532' ' ' TRP . 3.0 m-30 -97.31 94.45 7.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.403 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.561 HG13 ' HG3' ' B' ' 529' ' ' ARG . 0.0 OUTLIER -134.2 -59.04 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.995 -179.521 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.445 ' HD2' ' H ' ' A' ' 33' ' ' VAL . 77.7 Cg_exo -52.45 -21.53 14.17 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.107 1.871 . . . . 0.0 112.21 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.704 HG23 HG21 ' A' ' 17' ' ' THR . 52.8 m -71.74 62.3 0.41 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.621 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.057 HG23 ' HB3' ' A' ' 59' ' ' ALA . 4.1 p -132.25 -39.86 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.559 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.481 ' CD2' ' HA ' ' A' ' 40' ' ' TYR . 5.6 t80 -41.13 -30.52 0.15 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.585 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.427 ' CB ' ' OH ' ' A' ' 64' ' ' TYR . 11.6 t0 66.55 -68.41 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.923 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.474 ' O ' ' CE2' ' A' ' 37' ' ' PHE . 0.7 OUTLIER -77.89 55.18 1.37 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.365 -179.928 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.481 ' HA ' ' CD2' ' A' ' 37' ' ' PHE . 6.7 m-85 -60.5 139.88 57.54 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.804 0.335 . . . . 0.0 110.464 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.437 ' O ' ' CG1' ' B' ' 519' ' ' ILE . . . -90.59 119.4 30.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.207 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.7 HG12 ' HA ' ' B' ' 518' ' ' PHE . 15.4 m -137.09 123.23 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.726 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.62 HG23 ' HB3' ' B' ' 516' ' ' ASN . 8.8 t -84.29 104.16 14.09 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.855 HG13 ' HB2' ' B' ' 514' ' ' LEU . 25.5 t -145.03 148.27 18.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.184 -178.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.496 ' HE1' ' N ' ' A' ' 49' ' ' GLU . 3.2 tpt -96.18 96.47 8.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.973 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.64 HG22 ' O ' ' A' ' 46' ' ' ILE . 1.2 mm -83.25 85.76 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 120.718 0.294 . . . . 0.0 110.578 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.443 ' N ' ' HE2' ' A' ' 45' ' ' MET . . . 30.8 94.22 0.01 OUTLIER Glycine 0 CA--C 1.524 0.644 0 CA-C-N 115.694 -0.685 . . . . 0.0 114.035 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 135.27 -97.44 0.28 Allowed Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.83 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.496 ' N ' ' HE1' ' A' ' 45' ' ' MET . 0.2 OUTLIER -119.8 129.76 25.19 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.503 0.192 . . . . 0.0 110.551 179.701 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' A' ' 45' ' ' MET . 74.8 Cg_exo -37.14 96.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.914 2.41 . . . . 0.0 112.919 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.435 ' C ' ' CD1' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -172.86 142.91 1.16 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.753 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.478 HG21 ' HB ' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -135.0 153.82 51.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.267 -178.982 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.972 HD22 HG23 ' A' ' 3' ' ' THR . 5.8 tp -95.67 136.17 36.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.768 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -64.99 142.07 44.41 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.453 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.594 ' H ' HD22 ' A' ' 55' ' ' LEU . 1.6 mm? -76.33 134.98 39.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.842 0.353 . . . . 0.0 110.505 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.921 ' HB3' HG13 ' A' ' 7' ' ' VAL . 0.9 OUTLIER -84.59 108.74 17.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.912 0.387 . . . . 0.0 110.886 -179.875 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.492 ' OD1' HD21 ' B' ' 543' ' ' LEU . 0.7 OUTLIER -140.41 142.07 35.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.138 -179.886 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.793 ' OG1' HD13 ' B' ' 543' ' ' LEU . 43.4 p -101.28 -176.66 3.22 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.105 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 1.057 ' HB3' HG23 ' A' ' 36' ' ' VAL . . . -172.44 -162.58 0.2 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.886 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -148.78 43.11 0.81 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.295 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.885 HD22 ' HB3' ' B' ' 525' ' ' ASP . 0.4 OUTLIER -121.26 -160.03 0.83 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.922 0.391 . . . . 0.0 111.364 -179.732 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -48.71 -44.84 38.49 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.387 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.485 ' HB3' ' CD1' ' A' ' 64' ' ' TYR . 0.5 OUTLIER -45.97 -61.14 1.87 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.431 -179.651 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.485 ' CD1' ' HB3' ' A' ' 63' ' ' ASP . 0.1 OUTLIER -164.31 139.44 5.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.908 0.385 . . . . 0.0 111.021 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -86.73 -68.16 0.76 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.531 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.458 ' C ' HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -87.55 -32.17 19.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.634 -179.344 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.54 HD13 ' HB ' ' A' ' 58' ' ' THR . 1.3 mp 71.16 -149.05 0.08 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.535 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.475 ' CB ' ' CD ' ' A' ' 69' ' ' PRO . 1.0 OUTLIER -159.05 -65.36 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.177 0 N-CA-C 111.717 0.265 . . . . 0.0 111.717 -179.831 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.475 ' CD ' ' CB ' ' A' ' 68' ' ' ARG . 46.1 Cg_exo -35.52 -60.26 0.33 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.039 2.493 . . . . 0.0 113.377 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.891 HD13 ' HG2' ' B' ' 540' ' ' GLU . 0.3 OUTLIER -46.62 -26.66 0.95 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.658 0.266 . . . . 0.0 111.473 -179.73 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.6 t -95.39 -6.81 40.1 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.401 ' O ' ' O ' ' A' ' 69' ' ' PRO . 23.7 m-85 -134.39 151.67 76.64 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-O 120.867 0.365 . . . . 0.0 111.474 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -80.1 51.37 3.88 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.749 2.299 . . . . 0.0 112.434 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.479 ' NE2' ' HB ' ' A' ' 75' ' ' THR . 4.1 pp0? -73.65 -30.44 62.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.0 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.617 HG21 ' HD1' ' A' ' 78' ' ' PHE . 12.1 t -70.61 -176.65 1.32 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.968 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -113.42 -21.77 10.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.904 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.628 HG13 ' HB2' ' A' ' 109' ' ' PRO . 47.8 t -150.74 112.87 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.041 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.906 ' CE2' HG21 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -80.74 176.87 9.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.707 179.912 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.405 HD22 ' HA ' ' A' ' 79' ' ' LEU . 0.2 OUTLIER -142.63 108.71 5.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.218 -179.715 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.95 HG12 ' CH2' ' A' ' 97' ' ' TRP . 20.0 m -93.57 96.06 5.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.833 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 3.9 m -82.13 177.48 8.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.077 0.465 . . . . 0.0 111.458 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.459 ' CE1' ' O ' ' A' ' 113' ' ' VAL . 19.1 p90 -179.49 -173.47 0.26 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.011 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.82 134.66 18.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.783 0.325 . . . . 0.0 110.651 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.871 HG12 ' O ' ' A' ' 137' ' ' ILE . 2.2 m -45.36 -56.76 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.567 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.632 HG22 ' OE1' ' A' ' 116' ' ' GLN . 33.7 m -54.27 113.24 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.66 ' N ' HD22 ' A' ' 129' ' ' LEU . 4.1 m -151.24 125.49 4.49 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.684 0.278 . . . . 0.0 111.721 -179.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.433 ' O ' ' CB ' ' A' ' 88' ' ' SER . 87.5 Cg_endo -92.51 54.23 0.58 Allowed 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 123.177 2.585 . . . . 0.0 111.56 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.451 ' CB ' ' HG2' ' A' ' 133' ' ' LYS . 0.1 OUTLIER 81.97 24.08 0.23 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.889 -179.413 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.425 ' O ' HG12 ' A' ' 93' ' ' VAL . 6.1 t -97.21 -26.91 14.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.747 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.716 ' CZ ' HG21 ' A' ' 137' ' ' ILE . 13.4 t80 -55.23 -41.34 71.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.89 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 19.2 mp0 -70.22 -38.84 75.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.028 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -67.6 -45.22 76.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.158 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.747 HG22 ' CD1' ' A' ' 97' ' ' TRP . 7.4 p -65.6 -48.98 80.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.488 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.526 ' N ' HG13 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -51.15 -63.18 1.21 Allowed 'General case' 0 C--O 1.235 0.31 0 CA-C-O 120.944 0.402 . . . . 0.0 110.766 179.851 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.425 ' O ' ' CD ' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -52.47 -39.73 61.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.583 179.864 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.404 ' O ' ' CG ' ' A' ' 96' ' ' LYS . 0.2 OUTLIER -88.6 9.17 24.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.274 179.753 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.95 ' CH2' HG12 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -93.06 -58.33 2.36 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.946 0.403 . . . . 0.0 110.877 -179.908 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 1.024 HG22 HD13 ' A' ' 149' ' ' LEU . 40.8 t -56.27 -44.07 99.56 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.383 -179.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.491 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 6.0 Cg_exo -74.3 -19.74 19.37 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.556 2.171 . . . . 0.0 112.921 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -90.46 -59.13 2.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.932 0.396 . . . . 0.0 111.174 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.764 HG22 ' O ' ' A' ' 97' ' ' TRP . 11.5 tt -52.17 -26.22 8.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.709 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 73.7 p -94.54 -62.09 1.39 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.177 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.423 ' CB ' ' O ' ' A' ' 99' ' ' PRO . 7.9 t60 -48.33 -43.32 33.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.222 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 34.1 m-70 -85.1 -23.59 28.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.129 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 5.3 m -146.47 75.81 12.23 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.033 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -62.19 142.37 91.54 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.638 2.226 . . . . 0.0 112.259 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.8 mmtt 63.14 56.06 1.82 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.074 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -138.28 108.06 8.03 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.651 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.628 ' HB2' HG13 ' A' ' 77' ' ' VAL . 31.2 Cg_exo -60.26 164.07 13.44 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.488 2.125 . . . . 0.0 112.354 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.947 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 0.7 OUTLIER -154.42 139.59 17.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.024 179.955 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.929 HD12 HG11 ' A' ' 152' ' ' VAL . 5.8 tt -121.58 146.31 47.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.942 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.602 ' O ' HD23 ' A' ' 111' ' ' LEU . 3.3 mm? -94.61 153.47 17.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.651 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.896 HG13 HG11 ' A' ' 168' ' ' VAL . 93.3 t -136.69 146.24 28.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.095 0.474 . . . . 0.0 111.614 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.401 ' HA3' ' OH ' ' A' ' 154' ' ' TYR . . . -126.01 104.01 0.72 Allowed Glycine 0 N--CA 1.452 -0.243 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.553 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.685 ' O ' HD12 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -120.65 -50.94 2.18 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.978 0.418 . . . . 0.0 110.701 -179.037 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.687 ' HB3' HG22 ' A' ' 84' ' ' VAL . 4.8 tt0 -67.3 -8.86 35.41 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.445 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.735 HD11 ' O ' ' A' ' 157' ' ' CYS . 0.2 OUTLIER -44.6 -26.84 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-O 120.681 0.277 . . . . 0.0 111.332 -179.865 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -64.17 -25.22 67.99 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.779 0.323 . . . . 0.0 111.048 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.543 HD12 ' N ' ' A' ' 119' ' ' LEU . 4.9 mp -95.64 -19.86 19.4 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.418 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.48 ' HB3' HG11 ' A' ' 84' ' ' VAL . 5.7 ppt_? -49.43 -26.46 3.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.946 0.403 . . . . 0.0 110.684 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.37 -27.13 29.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.519 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.417 ' N ' ' O ' ' A' ' 119' ' ' LEU . 38.0 t0 -55.1 108.02 1.04 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.599 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.4 ' O ' HG22 ' A' ' 126' ' ' ILE . 15.6 Cg_exo -68.75 -3.9 12.18 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.715 2.277 . . . . 0.0 113.034 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.78 -67.76 0.75 Allowed 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.591 HG21 HG11 ' A' ' 85' ' ' VAL . 7.2 m -56.35 -35.39 67.59 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.457 178.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.599 HD11 ' HB3' ' A' ' 136' ' ' PRO . 0.1 OUTLIER -56.37 -42.02 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.772 179.348 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.553 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 66.6 mt-10 -60.74 -35.33 76.1 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.778 179.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 125' ' ' THR . 0.2 OUTLIER -64.52 -31.66 72.97 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.094 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.66 HD22 ' N ' ' A' ' 86' ' ' SER . 8.0 mt -73.1 -35.74 66.64 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.553 ' HB3' ' O ' ' A' ' 127' ' ' GLU . . . -46.2 -34.56 4.43 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.007 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -48.11 -32.95 7.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.531 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.408 ' HB2' ' O ' ' A' ' 87' ' ' PRO . 6.2 m-80 -123.24 -31.24 3.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.416 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.521 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 17.3 mmtt -147.19 -97.96 0.09 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 119.115 -0.469 . . . . 0.0 111.399 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.521 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 7.2 pt20 130.52 -25.1 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.412 1.085 . . . . 0.0 110.297 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 60.5 mmtt -69.28 110.64 6.61 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.766 -179.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.599 ' HB3' HD11 ' A' ' 126' ' ' ILE . 83.9 Cg_endo -80.17 150.96 20.5 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.565 2.177 . . . . 0.0 111.431 179.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.871 ' O ' HG12 ' A' ' 84' ' ' VAL . 1.1 mm -81.93 96.29 3.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.106 0.479 . . . . 0.0 110.83 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.3 p -72.02 151.06 92.71 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.031 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.5 ' HA ' ' CE2' ' A' ' 154' ' ' TYR . 79.7 Cg_exo -44.09 -37.83 10.02 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.496 2.13 . . . . 0.0 112.244 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -68.6 -33.71 74.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.773 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 24.6 m -63.56 -60.58 3.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.717 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -53.15 -38.14 62.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.893 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -59.77 -46.84 87.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.812 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 22.7 tttp -61.36 -47.8 84.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.836 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.403 ' HA ' ' HB2' ' A' ' 148' ' ' ASP . 32.8 tp -67.23 -36.09 80.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.73 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.418 ' CB ' HD23 ' A' ' 112' ' ' LEU . . . -60.45 -54.33 46.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.057 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 11.2 mtp85 -73.05 -26.89 61.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.776 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.403 ' HB2' ' HA ' ' A' ' 145' ' ' LEU . 0.3 OUTLIER -51.66 -46.47 63.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.014 179.928 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 1.024 HD13 HG22 ' A' ' 98' ' ' VAL . 1.0 OUTLIER -93.36 19.61 8.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.049 -179.956 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 78.3 tttt 48.19 43.94 19.09 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.789 0.328 . . . . 0.0 110.984 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.947 ' HB1' ' O ' ' A' ' 110' ' ' PHE . . . -72.36 -81.72 0.05 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.311 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.929 HG11 HD12 ' A' ' 111' ' ' LEU . 69.4 t -160.18 -74.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.773 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt 175.84 139.65 0.06 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.776 -179.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.5 ' CE2' ' HA ' ' A' ' 139' ' ' PRO . 18.0 t80 -99.96 112.28 24.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.693 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.483 HG12 ' H ' ' A' ' 156' ' ' GLU . 3.0 t -101.24 166.03 2.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.201 -179.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.483 ' H ' HG12 ' A' ' 155' ' ' VAL . 1.3 mm-40 -89.51 150.23 22.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.12 0.486 . . . . 0.0 111.402 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.735 ' O ' HD11 ' A' ' 117' ' ' ILE . 1.6 p 178.52 -179.24 0.31 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.089 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.429 ' HB2' ' HB2' ' A' ' 163' ' ' LYS . 0.7 OUTLIER -160.14 152.49 20.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.875 0.369 . . . . 0.0 111.179 179.698 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -109.99 -28.66 8.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.923 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.619 ' H ' HD12 ' A' ' 160' ' ' LEU . 3.2 mp -83.78 -45.22 13.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.651 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -98.8 -24.31 15.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.587 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 75.34 76.9 0.1 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.108 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.429 ' HB2' ' HB2' ' A' ' 158' ' ' SER . 2.8 tttm -94.82 34.21 1.38 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.698 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . 116.34 -62.32 0.38 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.589 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.942 HD13 ' O ' ' A' ' 19' ' ' LEU . 1.9 mt 67.55 -63.03 0.31 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.745 0.307 . . . . 0.0 111.05 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.417 ' O ' ' N ' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -55.49 -27.97 51.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.075 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -52.12 -72.63 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.858 0.361 . . . . 0.0 110.687 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.896 HG11 HG13 ' A' ' 113' ' ' VAL . 7.4 p -52.69 -46.22 49.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.173 0.511 . . . . 0.0 110.29 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.961 ' CD1' HD22 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -56.97 -29.32 63.13 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.744 179.225 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.716 ' O ' HD13 ' A' ' 173' ' ' ILE . 22.5 t0 -69.08 -29.47 67.58 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.494 178.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.667 ' HB3' HD11 ' A' ' 111' ' ' LEU . 28.8 mm-40 -75.91 -24.28 55.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.972 178.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.481 ' HA ' HD13 ' A' ' 111' ' ' LEU . . . -71.01 -54.91 9.55 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.381 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.716 HD13 ' O ' ' A' ' 170' ' ' ASP . 0.2 OUTLIER -67.64 -31.97 54.82 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-O 120.896 0.379 . . . . 0.0 110.666 -179.793 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.721 HD23 HD13 ' B' ' 505' ' ' LEU . 2.5 tm? -48.6 -33.65 10.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.742 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -74.53 -25.15 59.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.053 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.673 ' HB3' HG21 ' A' ' 4' ' ' ILE . . . -97.29 -32.41 11.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.646 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.862 HD13 ' HB ' ' B' ' 510' ' ' ILE . 14.4 mt -68.66 -11.23 59.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.223 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.456 ' HB2' ' HB1' ' B' ' 507' ' ' ALA . 0.0 OUTLIER 173.01 148.79 0.21 Allowed Pre-proline 0 C--N 1.332 -0.193 0 CA-C-O 120.768 0.318 . . . . 0.0 110.94 179.761 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . 0.402 ' HA ' ' HD2' ' A' ' 180' ' ' PRO . 84.5 Cg_exo -47.26 105.52 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.618 2.212 . . . . 0.0 112.305 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 179' ' ' PRO . 57.5 Cg_endo -70.97 171.85 14.97 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.581 2.188 . . . . 0.0 112.346 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -142.11 130.73 11.93 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.805 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.74 -164.95 0.23 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.546 2.164 . . . . 0.0 112.248 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.77 78.86 4.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.902 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.187 -0.911 . . . . 0.0 110.918 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 502' ' ' GLY . . . . . 0.423 ' CA ' ' OG ' ' B' ' 511' ' ' SER . . . . . . . . 0 N--CA 1.489 2.199 0 N-CA-C 112.539 -0.224 . . . . 0.0 112.539 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 503' ' ' SER . . . . . 0.403 ' HB3' ' O ' ' B' ' 510' ' ' ILE . 26.7 t -58.83 -73.29 0.08 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.795 0.331 . . . . 0.0 110.855 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 504' ' ' GLY . . . . . 0.445 ' HA2' ' CB ' ' B' ' 509' ' ' ASP . . . 94.05 103.61 1.74 Allowed Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.393 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 505' ' ' LEU . . . . . 0.721 HD13 HD23 ' A' ' 174' ' ' LEU . 0.1 OUTLIER -174.26 57.36 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.809 0.338 . . . . 0.0 110.741 -179.62 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 506' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 46.83 58.07 5.05 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.936 0.398 . . . . 0.0 110.66 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 507' ' ' ALA . . . . . 0.456 ' HB1' ' HB2' ' A' ' 178' ' ' GLU . . . -169.56 42.06 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.894 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 508' ' ' GLN . . . . . 0.61 HE21 HD11 ' B' ' 510' ' ' ILE . 21.8 mt-30 73.65 4.53 4.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.786 -179.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 509' ' ' ASP . . . . . 0.445 ' CB ' ' HA2' ' B' ' 504' ' ' GLY . 3.0 p30 51.9 48.69 22.28 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 121.496 0.665 . . . . 0.0 110.673 -179.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 510' ' ' ILE . . . . . 0.862 ' HB ' HD13 ' A' ' 177' ' ' LEU . 37.5 mt -72.68 130.03 35.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.054 -0.975 . . . . 0.0 111.087 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 511' ' ' SER . . . . . 0.593 ' O ' HD11 ' B' ' 514' ' ' LEU . 16.5 m -77.2 135.79 38.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.3 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 512' ' ' GLN . . . . . 0.444 ' HB3' ' HD3' ' B' ' 513' ' ' PRO . 0.0 OUTLIER -97.91 -53.8 0.2 Allowed Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.092 179.744 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 513' ' ' PRO . . . . . 0.444 ' HD3' ' HB3' ' B' ' 512' ' ' GLN . 97.2 Cg_endo -90.56 59.39 1.46 Allowed 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.835 2.357 . . . . 0.0 112.231 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 514' ' ' LEU . . . . . 0.855 ' HB2' HG13 ' A' ' 44' ' ' VAL . 1.2 mp -75.21 -174.61 2.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.946 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 515' ' ' GLN . . . . . 0.596 ' O ' HG22 ' A' ' 44' ' ' VAL . 1.9 mt-30 -72.27 158.28 36.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.932 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 516' ' ' ASN . . . . . 0.62 ' HB3' HG23 ' A' ' 43' ' ' THR . 9.7 m120 59.89 24.04 13.09 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.885 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 517' ' ' SER . . . . . 0.54 ' HA ' HG21 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -41.08 -29.48 0.12 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.854 -179.737 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 518' ' ' PHE . . . . . 0.7 ' HA ' HG12 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -150.92 135.49 17.14 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.839 0.352 . . . . 0.0 111.409 -179.778 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 519' ' ' ILE . . . . . 0.437 ' CG1' ' O ' ' A' ' 41' ' ' ALA . 2.7 pt -121.21 -37.02 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.845 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -120.04 -166.84 1.35 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.672 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 521' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -151.47 54.55 0.85 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.063 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 522' ' ' GLY . . . . . 0.457 ' HA2' ' CD2' ' A' ' 37' ' ' PHE . . . 45.52 -148.0 1.89 Allowed Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.529 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 523' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -173.1 -101.36 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.641 0.221 . . . . 0.0 111.037 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 524' ' ' GLY . . . . . . . . . . . . . . . 69.13 -63.0 0.54 Allowed Glycine 0 C--N 1.337 0.619 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.4 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 525' ' ' ASP . . . . . 0.885 ' HB3' HD22 ' A' ' 61' ' ' LEU . 24.2 t70 177.29 82.59 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.874 0.369 . . . . 0.0 110.719 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 526' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.51 95.99 5.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.801 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 527' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -146.1 158.57 48.09 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.915 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -68.62 97.56 0.54 Allowed 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.626 2.217 . . . . 0.0 112.328 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 529' ' ' ARG . . . . . 0.561 ' HG3' HG13 ' A' ' 33' ' ' VAL . 0.2 OUTLIER -100.53 -53.6 3.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.971 -179.998 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 530' ' ' HIS . . . . . 0.416 ' CD2' ' O ' ' B' ' 530' ' ' HIS . 12.4 t60 -166.76 95.16 0.51 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.492 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 531' ' ' CYS . . . . . 0.417 ' CB ' ' O ' ' A' ' 30' ' ' SER . 96.5 m -55.46 160.43 2.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.943 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 532' ' ' TRP . . . . . 0.445 ' CD1' ' OH ' ' A' ' 32' ' ' TYR . 88.5 t90 -55.12 139.46 41.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.832 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . -134.53 -123.69 2.38 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.594 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 534' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.84 147.43 89.51 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.745 0.307 . . . . 0.0 110.948 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_exo -51.61 -176.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.697 2.265 . . . . 0.0 112.351 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 3.5 t70 53.64 99.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.996 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 537' ' ' ARG . . . . . 0.464 ' HB3' ' CG2' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -75.57 179.02 5.57 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.299 0.571 . . . . 0.0 110.893 179.898 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 538' ' ' ILE . . . . . 0.43 ' O ' HG21 ' A' ' 14' ' ' VAL . 1.8 pt -74.87 -154.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.984 179.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 539' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -107.58 148.19 29.61 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.726 0.298 . . . . 0.0 110.419 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 540' ' ' GLU . . . . . 0.911 ' CD ' HG13 ' A' ' 9' ' ' VAL . 12.9 pm0 -48.11 -25.58 1.51 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.036 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 541' ' ' LEU . . . . . 0.517 ' HA ' HD21 ' A' ' 70' ' ' LEU . 11.0 mt -37.5 -45.29 0.72 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.523 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 542' ' ' TYR . . . . . 0.456 ' CD1' ' N ' ' B' ' 542' ' ' TYR . 1.4 m-30 -104.73 -63.12 1.25 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.879 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 543' ' ' LEU . . . . . 0.886 HD12 ' HA ' ' B' ' 540' ' ' GLU . 0.0 OUTLIER 76.9 125.06 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.844 -179.853 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 544' ' ' GLY . . . . . 0.424 ' HA2' ' HB2' ' A' ' 32' ' ' TYR . . . 55.77 -159.08 7.56 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.483 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 545' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.207 -0.901 . . . . 0.0 110.925 179.983 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.4 tpt . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.889 0.376 . . . . 0.0 111.085 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.4 tm0? -81.78 144.1 31.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.635 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.704 HG23 ' CE1' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -93.82 -175.52 3.76 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.342 -179.639 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.977 HG13 HD13 ' A' ' 53' ' ' LEU . 5.2 pt -154.99 143.67 13.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.948 -179.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.416 ' O ' HG23 ' A' ' 75' ' ' THR . 3.2 ptpp? -134.33 95.57 3.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.131 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.499 ' SG ' HG13 ' A' ' 77' ' ' VAL . 80.5 m -118.87 153.34 34.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.059 0.457 . . . . 0.0 111.332 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.656 HG22 ' HB2' ' A' ' 56' ' ' PHE . 2.5 t -142.99 128.46 16.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.453 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.724 HG23 ' SG ' ' A' ' 81' ' ' CYS . 1.4 p -84.68 113.84 23.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.166 0.507 . . . . 0.0 111.192 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.868 HG11 ' CE1' ' A' ' 72' ' ' TYR . 1.3 m -114.74 129.75 70.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.443 178.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.482 ' HA2' ' CZ2' ' A' ' 97' ' ' TRP . . . 149.13 -170.11 29.48 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.098 -1.049 . . . . 0.0 112.808 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.435 ' O ' ' N ' ' B' ' 537' ' ' ARG . 0.4 OUTLIER -98.3 27.54 4.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.715 0.293 . . . . 0.0 110.691 179.91 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.428 ' CA ' ' HB2' ' B' ' 537' ' ' ARG . . . -126.34 170.62 18.15 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.684 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.71 ' HB1' ' HB2' ' A' ' 18' ' ' CYS . . . -98.27 -38.26 9.34 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.715 0.293 . . . . 0.0 111.344 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.816 HG11 HG21 ' A' ' 115' ' ' THR . 2.1 m -43.94 91.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.481 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.66 ' CA ' HD22 ' A' ' 19' ' ' LEU . . . -175.55 -71.43 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.934 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.441 ' CD ' ' HB3' ' A' ' 55' ' ' LEU . 8.8 mmtm -97.39 -80.67 0.44 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.007 0.432 . . . . 0.0 111.912 -179.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 1.026 HG21 HG23 ' A' ' 35' ' ' THR . 71.7 p -75.1 -69.57 0.47 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.547 -178.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.71 ' HB2' ' HB1' ' A' ' 13' ' ' ALA . 43.2 t -33.01 -43.35 0.1 Allowed 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -178.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.8 HD13 ' HA ' ' A' ' 14' ' ' VAL . 0.2 OUTLIER -60.71 -52.71 63.94 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.782 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -70.49 -24.42 62.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.842 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 27.7 mm -57.81 -71.18 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.492 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.5 m -60.87 -23.37 65.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.128 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.471 ' CE2' ' HB2' ' B' ' 513' ' ' PRO . 41.5 t80 -65.19 -68.24 0.38 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.858 0.361 . . . . 0.0 110.284 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 96.9 m -75.87 -37.58 58.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.744 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.4 p -113.12 -166.8 1.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.684 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -142.0 19.08 2.12 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.12 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.8 mmtm -93.35 95.98 9.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.021 0.438 . . . . 0.0 110.566 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.473 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . 2.6 t80 -87.01 -50.6 0.45 Allowed Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.301 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.473 ' HD3' ' HB3' ' A' ' 28' ' ' PHE . 64.9 Cg_endo -88.66 46.04 1.01 Allowed 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.842 2.361 . . . . 0.0 112.475 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.5 p -83.7 -94.36 0.07 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.127 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -158.87 124.74 4.44 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.797 0.332 . . . . 0.0 111.17 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.475 ' O ' HG22 ' A' ' 33' ' ' VAL . 4.6 m-30 -88.58 94.7 9.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.598 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.652 HG13 ' OXT' ' B' ' 545' ' ' ASN . 0.0 OUTLIER -165.03 -64.07 0.01 OUTLIER Pre-proline 0 N--CA 1.466 0.328 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.633 -179.804 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.452 ' CD ' ' HB ' ' A' ' 33' ' ' VAL . 10.3 Cg_endo -53.09 -16.98 7.25 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.889 2.393 . . . . 0.0 112.67 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 1.026 HG23 HG21 ' A' ' 17' ' ' THR . 45.4 m -36.18 -31.83 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.533 HG21 ' HA3' ' B' ' 524' ' ' GLY . 0.0 OUTLIER -44.31 -28.37 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 120.685 0.279 . . . . 0.0 111.436 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.467 ' O ' ' CG ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -78.39 57.7 1.98 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.088 179.857 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -135.05 -47.46 0.72 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.845 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -63.96 -16.88 62.55 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.265 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.66 -157.5 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.932 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.409 ' O ' HG12 ' B' ' 519' ' ' ILE . . . -90.76 162.6 14.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.068 0.461 . . . . 0.0 111.951 -179.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.588 HG13 ' C ' ' B' ' 517' ' ' SER . 4.8 t -134.86 166.58 28.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.078 179.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.69 HG22 HD13 ' B' ' 519' ' ' ILE . 9.4 t -143.82 103.8 4.1 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.904 HG22 ' CG2' ' A' ' 52' ' ' THR . 30.9 m -161.84 -177.46 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.017 178.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.499 ' O ' HD21 ' B' ' 514' ' ' LEU . 0.0 OUTLIER -105.63 100.01 9.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.61 0.243 . . . . 0.0 111.642 -179.479 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.608 HG22 ' O ' ' A' ' 46' ' ' ILE . 5.1 mm -75.01 86.59 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 178.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.458 ' HA3' ' HA ' ' B' ' 510' ' ' ILE . . . 45.76 -95.61 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.689 -0.687 . . . . 0.0 113.401 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -38.04 -90.41 0.01 OUTLIER Glycine 0 CA--C 1.52 0.355 0 N-CA-C 113.992 0.357 . . . . 0.0 113.992 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.439 ' N ' ' HE1' ' A' ' 45' ' ' MET . 0.1 OUTLIER -123.14 159.12 55.69 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.789 0.328 . . . . 0.0 111.161 -179.181 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.416 ' HD2' ' HB2' ' A' ' 49' ' ' GLU . 2.7 Cg_endo -46.15 105.06 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.792 2.328 . . . . 0.0 112.356 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.704 ' CE1' HG23 ' A' ' 3' ' ' THR . 1.7 t80 -172.27 158.72 4.53 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.328 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.904 ' CG2' HG22 ' A' ' 44' ' ' VAL . 3.3 p -136.41 153.07 51.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.154 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.977 HD13 HG13 ' A' ' 4' ' ' ILE . 0.5 OUTLIER -78.76 -174.64 4.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.629 179.61 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -114.16 76.14 0.24 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.399 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.64 HD21 ' NE2' ' B' ' 512' ' ' GLN . 0.6 OUTLIER -52.56 114.62 1.44 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.938 0.399 . . . . 0.0 110.356 179.845 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.656 ' HB2' HG22 ' A' ' 7' ' ' VAL . 77.3 m-85 -84.4 109.42 17.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.069 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.417 ' HA ' ' HG3' ' A' ' 16' ' ' LYS . 3.5 t0 -108.2 -175.76 2.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.652 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.607 HG21 ' O ' ' B' ' 540' ' ' GLU . 16.8 p -135.83 170.38 16.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.093 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.821 ' N ' HD21 ' A' ' 67' ' ' LEU . . . -171.82 167.01 6.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.111 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' B' ' 543' ' ' LEU . . . -146.14 33.73 1.46 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.306 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.694 HD13 ' OD1' ' B' ' 525' ' ' ASP . 0.0 OUTLIER -121.22 -173.68 2.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.765 0.317 . . . . 0.0 110.817 179.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -44.52 -27.76 0.5 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.697 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.465 ' OD2' ' CE1' ' A' ' 64' ' ' TYR . 45.2 t0 -47.67 -63.44 1.06 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.223 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.523 ' O ' HD23 ' A' ' 67' ' ' LEU . 0.0 OUTLIER 170.88 73.65 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.175 179.905 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -58.76 -19.9 44.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.101 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.14 -14.24 61.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.596 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.821 HD21 ' N ' ' A' ' 59' ' ' ALA . 3.6 pp -47.69 135.51 11.56 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.839 0.352 . . . . 0.0 111.087 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.479 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -139.55 48.52 1.64 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.084 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 71.0 Cg_endo -74.17 -9.58 22.03 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.451 2.101 . . . . 0.0 112.484 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.769 HD11 HD23 ' B' ' 541' ' ' LEU . 0.1 OUTLIER -78.78 1.04 24.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.641 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -55.13 -20.47 10.16 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.625 0.25 . . . . 0.0 111.437 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.868 ' CE1' HG11 ' A' ' 9' ' ' VAL . 34.2 m-85 73.59 64.84 0.31 Allowed Pre-proline 0 C--N 1.332 -0.17 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.819 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.1 -150.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.581 2.188 . . . . 0.0 111.955 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -60.39 -16.17 32.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.374 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 5' ' ' LYS . 55.3 m -42.12 133.06 3.15 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.871 0.367 . . . . 0.0 111.298 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.846 ' HA ' HG22 ' A' ' 108' ' ' THR . 0.4 OUTLIER -115.1 7.47 15.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.562 -179.82 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.758 HG21 ' HB3' ' A' ' 175' ' ' ALA . 7.9 p -145.21 79.95 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.881 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.586 ' HE1' HD12 ' A' ' 101' ' ' ILE . 1.1 p90 -92.8 124.82 37.07 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 178.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.482 HD11 ' CG2' ' A' ' 113' ' ' VAL . 12.7 tp -70.37 108.65 4.34 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.78 -178.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.659 HG21 ' CD1' ' A' ' 110' ' ' PHE . 2.1 t -80.19 156.13 4.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.696 178.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.724 ' SG ' HG23 ' A' ' 8' ' ' VAL . 2.8 m -145.77 129.75 17.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.318 0.58 . . . . 0.0 112.363 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.699 ' HE2' HD12 ' A' ' 112' ' ' LEU . 17.4 p90 -152.21 128.78 10.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.564 178.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -83.06 137.62 34.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.125 0.488 . . . . 0.0 111.76 -178.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.727 HG11 ' HB3' ' A' ' 120' ' ' ARG . 72.5 t -47.85 -78.73 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.246 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.73 HG22 ' OE1' ' A' ' 116' ' ' GLN . 29.6 m -42.8 113.95 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.086 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.537 ' C ' HD22 ' A' ' 129' ' ' LEU . 3.0 p -152.25 145.07 17.19 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.888 0.375 . . . . 0.0 111.909 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.427 ' HA ' ' HB3' ' A' ' 133' ' ' LYS . 76.9 Cg_endo -91.23 53.96 0.91 Allowed 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.226 2.618 . . . . 0.0 111.659 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.482 ' N ' ' CB ' ' A' ' 133' ' ' LYS . 0.7 OUTLIER 82.15 33.26 0.09 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.806 -179.455 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.898 ' O ' HG23 ' A' ' 93' ' ' VAL . 1.1 t -88.31 -24.75 23.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.023 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.512 ' CD1' HG13 ' A' ' 137' ' ' ILE . 2.1 t80 -51.07 -56.78 10.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.096 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -53.11 -41.9 65.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.131 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.422 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 1.8 t-20 -72.73 -53.16 12.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.975 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.898 HG23 ' O ' ' A' ' 89' ' ' SER . 46.5 t -49.81 -44.44 20.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.207 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.469 ' O ' HG23 ' A' ' 98' ' ' VAL . 30.4 tttt -62.23 -52.59 63.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.998 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.414 ' O ' ' HG3' ' A' ' 99' ' ' PRO . 70.2 mt-10 -84.51 9.38 13.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.681 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.422 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 25.7 tttp -116.12 -37.75 3.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.729 0.3 . . . . 0.0 110.725 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.482 ' CZ2' ' HA2' ' A' ' 10' ' ' GLY . 0.8 OUTLIER -94.42 -46.85 6.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.34 -179.769 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.482 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 56.9 t -51.98 -46.07 92.89 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.654 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.482 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 92.0 Cg_endo -81.1 -12.37 11.82 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.342 2.028 . . . . 0.0 112.757 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -86.61 -49.17 7.72 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.861 0.362 . . . . 0.0 110.585 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.586 HD12 ' HE1' ' A' ' 78' ' ' PHE . 32.4 pt -66.55 -28.15 42.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.879 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.425 HG23 ' O ' ' A' ' 98' ' ' VAL . 27.5 p -77.68 -33.25 53.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.579 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -64.12 -46.09 85.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.758 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 27.5 m170 -82.86 -24.15 33.37 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.758 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -142.94 95.8 6.13 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.665 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -68.81 133.13 26.51 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.594 2.196 . . . . 0.0 112.574 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 49.02 77.32 0.1 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.156 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.846 HG22 ' HA ' ' A' ' 76' ' ' ASP . 0.1 OUTLIER -139.29 115.09 8.35 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.878 179.857 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.42 162.78 13.91 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.639 2.226 . . . . 0.0 112.826 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.659 ' CD1' HG21 ' A' ' 80' ' ' VAL . 37.0 p90 -161.69 165.05 28.73 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.549 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.975 HD12 HG11 ' A' ' 152' ' ' VAL . 0.9 OUTLIER -114.96 159.62 20.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.939 0.399 . . . . 0.0 111.635 -179.562 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.737 HD22 ' C ' ' A' ' 111' ' ' LEU . 2.4 mm? -119.48 161.14 21.07 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.575 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.492 HG12 ' CG2' ' A' ' 115' ' ' THR . 3.1 t -134.4 142.85 39.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.911 0.386 . . . . 0.0 111.694 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.628 ' O ' HD13 ' A' ' 117' ' ' ILE . . . -121.76 67.77 0.45 Allowed Glycine 0 C--N 1.331 0.28 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.989 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.816 HG21 HG11 ' A' ' 14' ' ' VAL . 1.4 p -92.38 26.55 2.55 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -178.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.73 ' OE1' HG22 ' A' ' 85' ' ' VAL . 2.9 mm-40 -131.88 23.85 4.62 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.199 0.523 . . . . 0.0 109.737 179.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.725 HD11 ' N ' ' A' ' 158' ' ' SER . 0.0 OUTLIER -67.68 -9.62 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.8 179.253 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -100.43 -40.59 7.39 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.144 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.625 HD13 ' CD ' ' A' ' 116' ' ' GLN . 3.5 mp -69.54 -33.79 73.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.313 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.727 ' HB3' HG11 ' A' ' 84' ' ' VAL . 0.1 OUTLIER -47.25 -33.83 5.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.891 0.377 . . . . 0.0 110.984 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -80.13 -27.35 39.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.549 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' A' ' 119' ' ' LEU . 2.2 t70 -57.59 106.47 0.69 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.76 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -70.0 -3.83 12.95 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.643 2.229 . . . . 0.0 112.847 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.98 -67.27 0.77 Allowed 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.059 0.457 . . . . 0.0 110.0 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.416 ' O ' ' HB3' ' A' ' 128' ' ' LYS . 2.1 m -56.17 -43.58 78.51 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 178.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.88 HD11 ' HB3' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -48.28 -42.17 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.524 178.913 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.573 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 0.4 OUTLIER -55.63 -49.44 72.84 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.006 178.679 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.682 ' HD2' HD23 ' A' ' 129' ' ' LEU . 0.1 OUTLIER -54.67 -32.89 59.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.2 179.017 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.682 HD23 ' HD2' ' A' ' 128' ' ' LYS . 7.5 mt -72.41 -42.0 65.62 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.578 ' HB2' ' HG3' ' A' ' 134' ' ' GLN . . . -42.51 -30.7 0.37 Allowed 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.106 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.404 ' HG2' ' O ' ' A' ' 128' ' ' LYS . 2.9 mmmt -58.94 -39.56 81.97 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.247 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -125.16 -30.59 3.17 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.482 ' CB ' ' N ' ' A' ' 88' ' ' SER . 0.3 OUTLIER -130.51 -69.68 0.65 Allowed 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -177.719 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.578 ' HG3' ' HB2' ' A' ' 130' ' ' ALA . 2.8 tt0 87.73 -37.23 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.44 ' CB ' ' HE3' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -69.03 111.23 7.82 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 120.733 0.301 . . . . 0.0 111.505 -179.137 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.88 ' HB3' HD11 ' A' ' 126' ' ' ILE . 74.2 Cg_endo -77.5 129.68 10.33 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.544 2.163 . . . . 0.0 112.019 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.531 ' HB ' HG13 ' A' ' 84' ' ' VAL . 0.6 OUTLIER -59.42 96.9 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.94 179.904 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.42 ' O ' ' N ' ' A' ' 141' ' ' THR . 11.1 p -67.32 147.29 98.91 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.897 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_exo -40.88 -40.71 3.75 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.728 2.285 . . . . 0.0 112.318 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -69.24 -36.6 77.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.6 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.42 ' N ' ' O ' ' A' ' 138' ' ' THR . 90.6 m -55.31 -56.69 17.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.76 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.572 ' HB3' ' CE2' ' A' ' 154' ' ' TYR . . . -52.53 -39.57 61.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.81 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.98 -34.98 79.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.703 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.2 tptt -59.98 -58.63 7.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.783 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.425 ' HA ' ' HB2' ' A' ' 148' ' ' ASP . 24.1 tp -65.71 -35.98 82.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.761 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -58.11 -61.04 2.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.167 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 4.4 mtt85 -72.39 -25.44 61.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.012 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.425 ' HB2' ' HA ' ' A' ' 145' ' ' LEU . 1.8 m-20 -49.36 -41.87 40.31 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.036 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 5.9 mt -102.69 23.14 12.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.922 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 48.34 33.85 4.17 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.971 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.707 ' O ' HG23 ' A' ' 152' ' ' VAL . . . -51.96 -81.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.187 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.975 HG11 HD12 ' A' ' 111' ' ' LEU . 8.0 t -164.56 -69.21 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.894 0.378 . . . . 0.0 110.394 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 177.41 135.45 0.07 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.243 -179.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.572 ' CE2' ' HB3' ' A' ' 142' ' ' ALA . 24.7 t80 -106.75 114.7 28.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.728 178.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.622 ' HB ' HG22 ' A' ' 168' ' ' VAL . 2.8 t -101.24 151.99 5.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.733 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -99.12 118.58 36.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.4 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.512 ' N ' HD12 ' A' ' 117' ' ' ILE . 0.9 OUTLIER 178.3 125.96 0.05 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.546 179.523 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.725 ' N ' HD11 ' A' ' 117' ' ' ILE . 40.2 t -118.61 151.57 37.66 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.076 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -72.06 -38.46 69.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.942 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.514 ' H ' HD12 ' A' ' 160' ' ' LEU . 4.1 mp -52.6 -52.55 54.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.562 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 12.9 t -77.23 -42.62 36.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.562 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.404 ' O ' ' O ' ' A' ' 163' ' ' LYS . 3.1 tt0 176.71 -85.38 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.195 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.938 ' HG2' HD22 ' A' ' 165' ' ' LEU . 4.7 tttm 58.76 118.76 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.925 0.393 . . . . 0.0 110.726 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . -71.12 -10.12 68.32 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.43 -0.89 . . . . 0.0 112.523 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.938 HD22 ' HG2' ' A' ' 163' ' ' LYS . 4.0 mm? 66.95 -63.73 0.26 Allowed 'General case' 0 CA--C 1.522 -0.097 0 CA-C-O 120.702 0.287 . . . . 0.0 110.474 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.436 ' O ' ' CB ' ' A' ' 170' ' ' ASP . 1.7 ptmt -57.04 -32.14 65.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.688 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.433 ' N ' ' HG2' ' A' ' 166' ' ' LYS . 0.1 OUTLIER -53.92 -72.17 0.06 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.764 0.316 . . . . 0.0 110.617 179.832 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.622 HG22 ' HB ' ' A' ' 155' ' ' VAL . 5.9 t -63.41 -43.06 98.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.244 0.545 . . . . 0.0 110.073 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.763 ' CG ' HD23 ' A' ' 19' ' ' LEU . 0.9 OUTLIER -58.57 -24.01 59.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.603 179.539 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.443 ' HA ' ' CG1' ' A' ' 173' ' ' ILE . 27.5 t0 -76.99 -41.53 42.5 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.879 0.371 . . . . 0.0 110.038 179.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.509 ' HB3' HD11 ' A' ' 111' ' ' LEU . 13.4 mm-40 -56.59 -33.76 66.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.185 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.606 ' N ' HD13 ' A' ' 111' ' ' LEU . . . -73.54 -58.22 3.46 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.129 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.488 ' HB ' HD12 ' A' ' 4' ' ' ILE . 1.3 pp -62.66 -39.93 86.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.23 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.883 HD13 HD22 ' B' ' 505' ' ' LEU . 5.0 tp -48.03 -43.18 29.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.194 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.758 ' HB3' HG21 ' A' ' 77' ' ' VAL . . . -52.59 -23.26 6.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.071 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.49 ' HB3' ' HB ' ' A' ' 4' ' ' ILE . . . -90.88 -36.5 14.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.394 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.847 HD13 ' HB ' ' B' ' 510' ' ' ILE . 80.7 mt -68.55 -23.02 64.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.816 0.341 . . . . 0.0 110.671 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.481 ' HG3' ' HB2' ' B' ' 507' ' ' ALA . 0.6 OUTLIER -169.96 167.22 5.08 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.799 179.878 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . 0.422 ' HD2' ' CB ' ' A' ' 178' ' ' GLU . 32.4 Cg_endo -64.17 124.58 13.67 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.576 2.184 . . . . 0.0 112.251 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -74.03 164.7 33.79 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.457 2.104 . . . . 0.0 112.455 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . 0.409 ' O ' ' CG ' ' A' ' 181' ' ' GLU . 0.7 OUTLIER -117.09 114.41 38.96 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.807 179.999 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.62 -165.04 0.25 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.567 2.178 . . . . 0.0 112.321 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.48 77.66 7.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.999 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.168 -0.92 . . . . 0.0 110.787 179.99 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.122 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 503' ' ' SER . . . . . . . . . . . . . 31.0 t -105.41 -71.93 0.73 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.78 0.324 . . . . 0.0 111.034 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 504' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' B' ' 509' ' ' ASP . . . 111.93 122.49 4.14 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.126 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 505' ' ' LEU . . . . . 0.883 HD22 HD13 ' A' ' 174' ' ' LEU . 0.4 OUTLIER -173.92 -37.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.54 -179.572 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 506' ' ' SER . . . . . 0.599 ' N ' HD12 ' B' ' 505' ' ' LEU . 0.3 OUTLIER 171.46 -56.82 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.704 0.288 . . . . 0.0 110.913 -179.821 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 507' ' ' ALA . . . . . 0.481 ' HB2' ' HG3' ' A' ' 178' ' ' GLU . . . -39.9 -43.74 1.55 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.688 0.756 . . . . 0.0 111.073 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 508' ' ' GLN . . . . . 0.48 ' O ' ' CB ' ' B' ' 509' ' ' ASP . 13.5 pt20 164.99 -39.22 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.362 -1.29 . . . . 0.0 108.226 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 509' ' ' ASP . . . . . 0.48 ' CB ' ' O ' ' B' ' 508' ' ' GLN . 7.6 p30 147.25 41.44 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 113.94 -1.482 . . . . 0.0 110.197 179.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 510' ' ' ILE . . . . . 0.847 ' HB ' HD13 ' A' ' 177' ' ' LEU . 13.7 mt -72.08 126.27 32.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.263 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 511' ' ' SER . . . . . . . . . . . . . 30.3 t -109.47 141.73 41.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.288 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 512' ' ' GLN . . . . . 0.64 ' NE2' HD21 ' A' ' 55' ' ' LEU . 4.3 tp60 -92.89 -67.68 0.1 OUTLIER Pre-proline 0 CA--C 1.532 0.27 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 513' ' ' PRO . . . . . 0.492 ' HD3' ' HB3' ' B' ' 512' ' ' GLN . 92.3 Cg_endo -80.3 74.31 5.6 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.451 2.101 . . . . 0.0 111.461 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 514' ' ' LEU . . . . . 0.499 HD21 ' O ' ' A' ' 45' ' ' MET . 2.3 mp -73.45 -86.7 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.488 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 515' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -79.25 -87.76 0.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.693 -0.231 . . . . 0.0 111.052 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -117.57 -29.67 5.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.803 0.335 . . . . 0.0 111.134 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 517' ' ' SER . . . . . 0.588 ' C ' HG13 ' A' ' 42' ' ' VAL . 2.6 m 72.01 22.27 3.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.964 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 518' ' ' PHE . . . . . 0.48 ' CD1' ' O ' ' B' ' 517' ' ' SER . 12.1 m-85 -150.13 130.44 13.73 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.027 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 519' ' ' ILE . . . . . 0.69 HD13 HG22 ' A' ' 43' ' ' THR . 43.9 mm -63.62 -68.32 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.994 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -155.06 -67.41 0.13 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.061 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 521' ' ' THR . . . . . . . . . . . . . 11.2 m -163.88 157.63 18.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.101 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 522' ' ' GLY . . . . . . . . . . . . . . . -91.78 -92.08 1.39 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.333 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 523' ' ' HIS . . . . . 0.411 ' CD2' ' N ' ' B' ' 523' ' ' HIS . 0.1 OUTLIER 174.73 -98.81 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.475 0.137 . . . . 0.0 110.845 179.881 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 524' ' ' GLY . . . . . 0.533 ' HA3' HG21 ' A' ' 36' ' ' VAL . . . 42.35 -95.06 0.01 OUTLIER Glycine 0 C--N 1.338 0.658 0 C-N-CA 120.991 -0.623 . . . . 0.0 113.009 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 525' ' ' ASP . . . . . 0.694 ' OD1' HD13 ' A' ' 61' ' ' LEU . 33.2 p-10 177.46 91.65 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.815 0.34 . . . . 0.0 111.088 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 526' ' ' SER . . . . . 0.443 ' CB ' ' HB3' ' A' ' 34' ' ' PRO . 9.2 t -80.04 95.71 6.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.724 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 527' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -144.6 147.91 37.93 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.816 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.55 99.92 0.65 Allowed 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.552 2.168 . . . . 0.0 112.323 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 529' ' ' ARG . . . . . 0.614 ' HG3' HG21 ' A' ' 33' ' ' VAL . 12.6 mtp180 -100.29 -54.88 2.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.004 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 530' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -158.72 96.85 1.4 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.836 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 27.8 p -68.76 112.13 5.29 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.955 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 532' ' ' TRP . . . . . 0.504 ' CD1' ' NH2' ' B' ' 537' ' ' ARG . 22.4 t90 66.74 -68.95 0.13 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.833 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . 61.39 -80.76 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.52 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 534' ' ' PHE . . . . . 0.416 ' O ' ' NH1' ' B' ' 537' ' ' ARG . 17.7 m-85 -105.54 149.86 38.35 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.685 0.279 . . . . 0.0 110.844 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.27 -12.72 30.26 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.502 2.135 . . . . 0.0 112.555 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -112.98 120.79 42.61 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.831 0.348 . . . . 0.0 111.003 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 537' ' ' ARG . . . . . 0.504 ' NH2' ' CD1' ' B' ' 532' ' ' TRP . 11.6 mmt-85 -71.57 138.51 48.86 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.156 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 538' ' ' ILE . . . . . 0.4 HD12 ' HA ' ' B' ' 538' ' ' ILE . 4.1 tp -56.46 139.03 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.941 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 539' ' ' ASP . . . . . . . . . . . . . 34.3 p-10 -42.64 126.03 3.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.862 0.363 . . . . 0.0 111.125 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 540' ' ' GLU . . . . . 0.607 ' O ' HG21 ' A' ' 58' ' ' THR . 19.8 mm-40 -49.34 -22.58 1.15 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.077 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 541' ' ' LEU . . . . . 0.769 HD23 HD11 ' A' ' 70' ' ' LEU . 0.4 OUTLIER -35.26 -53.21 0.62 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.995 0.426 . . . . 0.0 111.62 179.81 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 542' ' ' TYR . . . . . 0.429 ' O ' ' N ' ' A' ' 59' ' ' ALA . 0.4 OUTLIER -104.8 -62.5 1.33 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.327 179.4 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 543' ' ' LEU . . . . . 0.496 HD13 ' HA ' ' B' ' 540' ' ' GLU . 3.4 tp 62.22 153.05 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.567 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . 103.26 82.73 1.65 Allowed Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.382 -0.913 . . . . 0.0 112.592 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 545' ' ' ASN . . . . . 0.652 ' OXT' HG13 ' A' ' 33' ' ' VAL . 1.1 m120 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.862 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.656 ' CE ' HG23 ' A' ' 46' ' ' ILE . 5.5 tpt . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 120.861 0.363 . . . . 0.0 111.233 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.678 ' O ' HD22 ' A' ' 177' ' ' LEU . 5.8 pt20 -167.17 138.81 3.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.753 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.941 HG23 HD12 ' A' ' 53' ' ' LEU . 13.7 t -109.94 -139.67 0.38 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.26 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.849 HG22 ' HB3' ' A' ' 176' ' ' ALA . 0.2 OUTLIER -150.55 152.54 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -178.865 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 13.1 pttt -134.0 95.61 3.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.602 178.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.409 ' O ' ' HE2' ' A' ' 16' ' ' LYS . 25.1 m -102.03 154.35 19.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.188 0.518 . . . . 0.0 111.876 -178.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.6 t -133.12 150.21 32.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.164 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.71 HG13 ' HB ' ' A' ' 14' ' ' VAL . 53.5 t -97.3 143.75 12.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.267 0.556 . . . . 0.0 111.056 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.596 HG13 ' O ' ' A' ' 8' ' ' VAL . 6.7 m -161.67 129.95 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.853 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 148.59 -178.68 26.0 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 119.882 -1.151 . . . . 0.0 112.909 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -102.46 -27.16 12.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.89 0.376 . . . . 0.0 110.593 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' B' ' 537' ' ' ARG . . . -66.9 -129.56 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.211 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -102.42 -56.95 2.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.824 0.345 . . . . 0.0 111.258 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.71 ' HB ' HG13 ' A' ' 8' ' ' VAL . 2.8 t 43.38 29.06 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.461 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.429 ' O ' HD22 ' A' ' 19' ' ' LEU . . . -64.51 89.49 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.802 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.573 ' HA ' HD22 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -52.59 -33.45 46.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.933 0.397 . . . . 0.0 110.273 179.675 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.428 HG21 ' HB2' ' A' ' 38' ' ' ASP . 39.2 p -81.15 -53.15 6.64 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.677 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 1.6 t -42.72 -38.54 2.11 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.265 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.984 HD23 ' CE1' ' A' ' 169' ' ' PHE . 0.0 OUTLIER -49.32 -58.67 4.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.545 179.668 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.662 ' H ' HD22 ' A' ' 20' ' ' LEU . 0.6 OUTLIER -70.59 -27.62 64.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.923 179.944 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.449 ' O ' ' N ' ' A' ' 25' ' ' THR . 37.3 mm -64.23 -71.43 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.242 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 9.6 t -50.0 -31.02 11.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.809 0.338 . . . . 0.0 110.717 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.406 ' CE1' ' HG2' ' A' ' 166' ' ' LYS . 46.5 t80 -63.54 -66.61 0.52 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.659 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.27 -54.63 6.77 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.73 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.449 ' N ' ' O ' ' A' ' 21' ' ' ILE . 27.4 p -78.47 -154.08 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.345 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.419 ' N ' ' ND2' ' A' ' 26' ' ' ASN . 0.1 OUTLIER -157.46 35.52 0.27 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.735 0.302 . . . . 0.0 111.088 -179.888 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -123.02 101.47 7.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.932 0.396 . . . . 0.0 111.525 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.486 ' CD2' ' HD3' ' A' ' 29' ' ' PRO . 0.4 OUTLIER -101.4 -70.04 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.726 178.92 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.486 ' HD3' ' CD2' ' A' ' 28' ' ' PHE . 95.7 Cg_endo -79.1 54.45 5.18 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.23 1.953 . . . . 0.0 111.518 178.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.02 -85.73 0.5 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.356 -179.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -147.54 118.53 7.68 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.196 0.522 . . . . 0.0 112.085 -179.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.427 ' C ' HG22 ' A' ' 33' ' ' VAL . 4.2 m-30 -99.78 94.37 6.29 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.577 178.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.474 HG11 ' HB3' ' B' ' 526' ' ' SER . 0.0 OUTLIER -163.82 -63.85 0.01 OUTLIER Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.857 -179.177 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.469 ' HD2' HG23 ' A' ' 33' ' ' VAL . 8.8 Cg_endo -50.81 -20.43 6.78 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.781 2.321 . . . . 0.0 112.328 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.661 HG23 HD23 ' B' ' 543' ' ' LEU . 8.2 t -40.92 -29.66 0.11 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.501 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.671 HG12 ' HB2' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -43.63 -29.68 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-O 120.924 0.393 . . . . 0.0 111.016 179.648 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.493 ' O ' ' CG ' ' A' ' 40' ' ' TYR . 0.8 OUTLIER -55.36 -23.48 24.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.62 179.478 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.441 ' HA ' ' CE1' ' A' ' 40' ' ' TYR . 21.9 t70 -41.67 -28.29 0.14 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.121 -0.49 . . . . 0.0 112.122 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -72.79 -1.86 18.25 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.493 ' CG ' ' O ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -60.0 -176.48 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.767 0.318 . . . . 0.0 110.651 179.856 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.421 ' O ' ' CG1' ' B' ' 519' ' ' ILE . . . -112.84 144.54 42.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.455 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.744 HG23 ' HB ' ' A' ' 52' ' ' THR . 0.8 OUTLIER -116.61 121.85 68.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.981 179.604 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.539 ' H ' HD11 ' B' ' 519' ' ' ILE . 1.7 p -111.3 106.59 15.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.749 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.727 HG21 ' HB2' ' B' ' 514' ' ' LEU . 6.4 p -164.05 148.78 2.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.283 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.702 ' O ' HD22 ' B' ' 514' ' ' LEU . 0.0 OUTLIER -74.56 104.38 5.23 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 178.773 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.73 ' HA ' HD11 ' B' ' 514' ' ' LEU . 7.8 tt -99.92 87.67 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.676 -179.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.77 -108.06 2.46 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.303 -0.862 . . . . 0.0 113.13 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -47.96 -88.88 0.01 OUTLIER Glycine 0 C--N 1.331 0.264 0 C-N-CA 121.184 -0.531 . . . . 0.0 113.342 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.458 ' N ' ' HE1' ' A' ' 45' ' ' MET . 5.0 pt-20 -126.16 170.89 8.71 Favored Pre-proline 0 CA--C 1.53 0.204 0 CA-C-O 120.627 0.251 . . . . 0.0 110.902 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.443 ' HD2' ' HB2' ' A' ' 49' ' ' GLU . 33.1 Cg_exo -60.28 107.48 0.42 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.684 2.256 . . . . 0.0 112.777 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.822 ' CE1' HG22 ' A' ' 3' ' ' THR . 6.2 t80 -172.87 104.72 0.14 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.402 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.744 ' HB ' HG23 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -122.6 128.92 51.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.844 0.354 . . . . 0.0 110.875 179.873 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.941 HD12 HG23 ' A' ' 3' ' ' THR . 11.3 mt -70.8 172.05 9.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.97 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -115.19 108.22 1.88 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.79 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.1 mp -48.73 114.55 1.0 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.842 0.353 . . . . 0.0 110.641 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -83.63 105.14 14.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.508 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.408 ' HB2' ' HB3' ' A' ' 38' ' ' ASP . 0.4 OUTLIER -99.53 -175.63 3.05 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.843 -179.87 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 1.005 HG22 HD13 ' A' ' 67' ' ' LEU . 1.2 p -136.05 167.84 20.47 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.784 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.671 ' HB2' HG12 ' A' ' 36' ' ' VAL . . . -171.2 179.99 2.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.184 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.403 ' HA2' ' CB ' ' A' ' 65' ' ' ASP . . . -151.48 31.24 0.94 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.293 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.544 HD22 ' OG ' ' B' ' 526' ' ' SER . 0.0 OUTLIER -118.45 -160.84 0.81 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.754 0.311 . . . . 0.0 110.815 -179.847 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.6 mp0 -52.82 -27.11 16.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.184 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.452 ' OD2' HD13 ' A' ' 61' ' ' LEU . 9.2 m-20 -50.49 -63.63 1.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.281 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.562 ' O ' HD23 ' A' ' 67' ' ' LEU . 0.0 OUTLIER 169.1 82.88 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.91 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.403 ' CB ' ' HA2' ' A' ' 60' ' ' GLY . 9.8 t70 -68.07 -22.32 64.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.086 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.92 -29.87 21.91 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.21 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 1.005 HD13 HG22 ' A' ' 58' ' ' THR . 4.5 pp -48.39 140.28 7.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.957 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.465 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.1 OUTLIER -150.69 50.23 0.69 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 120.893 0.377 . . . . 0.0 110.893 -179.949 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 71.6 Cg_endo -76.79 -31.29 4.13 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.657 2.238 . . . . 0.0 112.647 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.711 HD23 HD23 ' B' ' 541' ' ' LEU . 0.1 OUTLIER -66.98 -25.19 66.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.842 0.354 . . . . 0.0 110.663 -179.914 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.416 ' OG ' ' CE2' ' A' ' 72' ' ' TYR . 13.9 t -59.89 -70.59 0.16 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.942 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.416 ' CE2' ' OG ' ' A' ' 71' ' ' SER . 3.5 m-85 -123.94 67.57 42.81 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.908 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.08 140.39 31.17 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.619 2.213 . . . . 0.0 112.282 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 9.8 tp60 -101.62 10.39 40.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.451 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 84.6 m -75.87 124.61 27.61 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.811 0.338 . . . . 0.0 110.982 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -79.3 -18.32 52.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.156 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.4 t -103.71 78.91 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.224 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.669 ' CE2' HG21 ' A' ' 108' ' ' THR . 15.4 m-85 -83.19 175.15 10.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.751 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.4 HD12 ' O ' ' A' ' 111' ' ' LEU . 19.3 tp -147.63 108.9 4.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.99 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.658 ' O ' HG23 ' A' ' 80' ' ' VAL . 35.3 m -113.32 100.17 10.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.864 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.544 ' HB2' HG22 ' A' ' 14' ' ' VAL . 68.7 m -94.51 173.56 7.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.419 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.701 ' CE1' HG21 ' A' ' 137' ' ' ILE . 8.6 p90 -175.19 142.14 0.6 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.26 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.4 m -83.31 155.83 23.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.088 0.471 . . . . 0.0 111.543 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.784 HG21 ' HA ' ' A' ' 117' ' ' ILE . 15.9 t -55.01 -51.71 51.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.518 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.869 HG13 ' HD3' ' A' ' 120' ' ' ARG . 1.9 m -47.58 117.01 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.059 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -151.43 117.86 3.23 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.438 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.423 ' O ' ' CB ' ' A' ' 88' ' ' SER . 78.3 Cg_endo -90.38 49.68 0.95 Allowed 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.981 2.454 . . . . 0.0 111.969 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.466 ' CB ' ' HG2' ' A' ' 133' ' ' LYS . 0.1 OUTLIER 81.56 28.34 0.17 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.694 -179.525 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.517 ' O ' HG23 ' A' ' 93' ' ' VAL . 95.2 p -90.04 -15.94 30.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.256 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.649 ' CE1' HD12 ' A' ' 145' ' ' LEU . 0.1 OUTLIER -46.29 -51.31 14.81 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.799 0.333 . . . . 0.0 111.157 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -62.46 -36.41 82.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.822 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -72.63 -57.89 3.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.693 HG13 ' CE2' ' A' ' 97' ' ' TRP . 24.2 t -52.11 -45.48 42.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.059 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.722 ' HG3' HD11 ' A' ' 145' ' ' LEU . 0.3 OUTLIER -59.72 -50.49 73.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.811 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.408 ' O ' ' HG3' ' A' ' 99' ' ' PRO . 4.2 mt-10 -82.87 6.9 16.9 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.633 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -117.15 -30.66 5.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.804 0.335 . . . . 0.0 110.971 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.693 ' CE2' HG13 ' A' ' 93' ' ' VAL . 23.3 m0 -94.01 -51.94 4.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.176 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.474 ' HB ' ' HD3' ' A' ' 99' ' ' PRO . 85.5 t -50.5 -57.6 12.62 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.612 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.474 ' HD3' ' HB ' ' A' ' 98' ' ' VAL . 29.8 Cg_endo -62.89 -15.51 47.88 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.197 1.931 . . . . 0.0 112.422 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -89.97 -54.48 4.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.878 0.37 . . . . 0.0 110.728 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.9 tt -55.17 -30.33 24.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.9 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.747 HG22 ' HA ' ' A' ' 107' ' ' LYS . 11.2 p -85.91 -25.29 26.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.774 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -60.71 -51.04 71.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.667 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 28.4 m80 -60.99 -38.53 86.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.69 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -137.53 126.52 14.91 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.734 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -49.79 89.14 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.461 2.108 . . . . 0.0 112.248 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.747 ' HA ' HG22 ' A' ' 102' ' ' THR . 12.3 mttp 61.9 106.38 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.769 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.669 HG21 ' CE2' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -127.95 137.19 30.27 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.9 -179.944 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 108' ' ' THR . 36.2 Cg_exo -60.24 156.02 42.67 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.485 2.123 . . . . 0.0 112.478 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.766 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 1.9 p90 -158.72 148.77 19.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.75 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.803 HD11 ' HB3' ' A' ' 171' ' ' GLU . 0.5 OUTLIER -111.18 148.54 32.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.482 -179.434 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 1.018 HD12 ' HB2' ' A' ' 146' ' ' ALA . 11.6 mt -103.98 158.07 16.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.824 179.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.756 HG13 HG11 ' A' ' 168' ' ' VAL . 14.3 t -146.1 150.73 15.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.399 0.619 . . . . 0.0 112.445 -179.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -131.31 124.65 4.17 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.86 179.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.756 ' O ' HD13 ' A' ' 117' ' ' ILE . 0.9 OUTLIER -140.68 -58.51 0.52 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.908 0.354 . . . . 0.0 111.761 -178.694 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.445 ' HB3' ' CG ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -53.78 -21.84 8.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.853 0.358 . . . . 0.0 110.922 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.784 ' HA ' HG21 ' A' ' 84' ' ' VAL . 0.3 OUTLIER -41.81 -29.13 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.217 -179.859 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.641 ' CG ' HG21 ' A' ' 161' ' ' THR . 12.2 t70 -63.81 -43.16 97.09 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -178.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 1.002 HD21 HD22 ' A' ' 160' ' ' LEU . 0.3 OUTLIER -118.47 14.71 13.73 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -178.537 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.869 ' HD3' HG13 ' A' ' 85' ' ' VAL . 0.8 OUTLIER -87.18 -20.32 27.15 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.096 179.585 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.01 -18.59 35.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.85 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -46.1 122.27 6.24 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.049 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.441 ' HA ' ' CG2' ' A' ' 126' ' ' ILE . 14.0 Cg_exo -68.74 -3.52 11.43 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.576 2.184 . . . . 0.0 113.028 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 29.8 t -76.85 -71.18 0.41 Allowed 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.027 0.441 . . . . 0.0 110.247 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.697 HG21 HG11 ' A' ' 85' ' ' VAL . 95.0 m -55.68 -35.15 65.71 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.838 ' HA ' HD12 ' A' ' 129' ' ' LEU . 0.1 OUTLIER -56.68 -39.18 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.722 179.087 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.472 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 19.5 mt-10 -64.04 -31.9 73.26 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.31 178.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.479 ' O ' ' HG3' ' A' ' 131' ' ' LYS . 0.0 OUTLIER -69.69 -24.79 63.64 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.843 178.92 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.838 HD12 ' HA ' ' A' ' 126' ' ' ILE . 3.2 mt -85.02 -28.86 25.43 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 177.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' A' ' 127' ' ' GLU . . . -48.0 -39.87 20.91 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.501 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.479 ' HG3' ' O ' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -44.85 -28.75 0.69 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.884 0.373 . . . . 0.0 110.724 179.882 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.462 ' N ' ' HD2' ' A' ' 131' ' ' LYS . 52.9 m-20 -123.55 -32.03 3.41 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.391 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.512 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 52.1 mmtt -151.25 -92.73 0.06 Allowed 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.512 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 6.5 pt20 120.09 -18.09 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.783 1.233 . . . . 0.0 110.821 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.99 111.15 7.55 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.215 -0.448 . . . . 0.0 112.204 -178.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.686 ' HB3' HD11 ' A' ' 126' ' ' ILE . 96.8 Cg_endo -79.61 129.89 8.55 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.645 2.23 . . . . 0.0 111.503 179.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.722 ' N ' HD13 ' A' ' 137' ' ' ILE . 0.8 OUTLIER -58.57 96.64 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.014 0.435 . . . . 0.0 111.616 -179.331 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 16.5 p -69.32 151.61 96.84 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.462 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.496 ' HA ' ' CE1' ' A' ' 154' ' ' TYR . 4.2 Cg_endo -47.06 -25.07 3.8 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 122.809 2.339 . . . . 0.0 112.33 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -81.38 -38.66 26.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.12 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.38 -54.2 49.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.138 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.416 ' CB ' ' CD2' ' A' ' 154' ' ' TYR . . . -47.85 -43.43 28.3 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.884 0.373 . . . . 0.0 110.99 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -59.44 -40.25 86.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.589 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -55.03 -55.81 26.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.59 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.722 HD11 ' HG3' ' A' ' 94' ' ' LYS . 0.4 OUTLIER -67.73 -29.14 68.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.492 179.701 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 1.018 ' HB2' HD12 ' A' ' 112' ' ' LEU . . . -65.41 -41.24 93.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.793 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 9.0 mtp180 -85.63 -25.89 26.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.678 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -52.37 -32.62 39.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.739 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 3.5 mt -119.8 19.7 12.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.057 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 6.3 mttp 48.46 47.46 20.17 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.202 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.766 ' HB1' ' O ' ' A' ' 110' ' ' PHE . . . -63.98 -81.51 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.879 0.371 . . . . 0.0 110.865 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 151' ' ' ALA . 70.3 t -160.56 -75.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.778 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.596 ' O ' HD21 ' A' ' 111' ' ' LEU . 7.0 tppt? 173.65 116.91 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.278 -179.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.496 ' CE1' ' HA ' ' A' ' 139' ' ' PRO . 5.6 t80 -81.4 116.08 21.05 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.467 HG12 ' N ' ' A' ' 156' ' ' GLU . 12.9 t -101.4 159.35 4.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.451 -179.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.467 ' N ' HG12 ' A' ' 155' ' ' VAL . 3.6 mp0 -89.9 139.84 30.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.129 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.752 ' O ' HD11 ' A' ' 117' ' ' ILE . 3.3 p 178.71 -174.54 0.18 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.416 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.475 ' HA ' ' HA ' ' A' ' 115' ' ' THR . 24.3 p -159.99 167.87 26.95 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.937 0.399 . . . . 0.0 111.164 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -116.6 -46.11 2.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.585 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 1.002 HD22 HD21 ' A' ' 119' ' ' LEU . 0.7 OUTLIER -63.81 -33.25 75.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.402 179.557 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.641 HG21 ' CG ' ' A' ' 118' ' ' ASP . 1.3 p -113.0 -22.83 10.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.807 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.415 ' N ' ' OG ' ' A' ' 158' ' ' SER . 1.3 tt0 74.58 71.81 0.1 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.022 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.43 ' N ' ' OG ' ' A' ' 158' ' ' SER . 0.2 OUTLIER -93.96 13.63 22.2 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.501 -179.816 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 121.08 34.48 0.89 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.345 -0.931 . . . . 0.0 113.2 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.745 HD13 ' HA ' ' A' ' 19' ' ' LEU . 0.5 OUTLIER -49.58 -27.79 4.92 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.956 0.408 . . . . 0.0 110.515 179.697 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.421 ' HE2' ' N ' ' A' ' 167' ' ' ASN . 0.0 OUTLIER -73.67 -34.16 64.78 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.626 179.568 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.421 ' N ' ' HE2' ' A' ' 166' ' ' LYS . 0.6 OUTLIER -56.58 -67.61 0.29 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.421 179.601 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.756 HG11 HG13 ' A' ' 113' ' ' VAL . 14.2 p -50.63 -46.31 27.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.33 179.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.984 ' CE1' HD23 ' A' ' 19' ' ' LEU . 1.9 t80 -61.9 -31.26 71.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.732 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.412 ' N ' ' O ' ' A' ' 166' ' ' LYS . 4.6 t0 -57.42 -39.97 77.31 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.514 178.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.803 ' HB3' HD11 ' A' ' 111' ' ' LEU . 5.0 mm-40 -66.72 -35.35 79.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.612 178.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.466 ' HA ' HD12 ' A' ' 111' ' ' LEU . . . -59.83 -29.93 68.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.739 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.919 HD13 ' N ' ' A' ' 174' ' ' LEU . 0.0 OUTLIER -94.11 -43.88 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.438 179.633 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 1.027 HD23 HD13 ' B' ' 505' ' ' LEU . 3.5 tm? -52.75 -27.79 19.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.953 0.406 . . . . 0.0 110.363 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -72.04 -29.78 64.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.744 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.849 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -80.84 -37.15 30.51 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.738 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.721 HD13 ' HB ' ' B' ' 510' ' ' ILE . 58.8 mt -70.76 -24.53 62.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.635 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 29.1 tp10 -165.2 137.05 3.33 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.526 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -49.8 141.65 27.58 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.376 2.05 . . . . 0.0 112.347 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.89 171.4 18.36 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.548 2.166 . . . . 0.0 112.222 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -154.24 151.31 24.0 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.055 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.48 -164.73 0.23 Allowed 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.669 2.246 . . . . 0.0 112.271 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 8.0 pttp -87.51 152.21 22.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.863 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.188 -0.911 . . . . 0.0 110.909 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.17 0 N-CA-C 112.449 -0.26 . . . . 0.0 112.449 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 503' ' ' SER . . . . . . . . . . . . . 75.3 m -96.18 -78.52 0.46 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.889 0.376 . . . . 0.0 110.857 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 504' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' B' ' 509' ' ' ASP . . . 81.12 106.32 0.32 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.515 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 505' ' ' LEU . . . . . 1.027 HD13 HD23 ' A' ' 174' ' ' LEU . 0.1 OUTLIER -166.58 99.27 0.58 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.93 0.395 . . . . 0.0 111.063 -179.947 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 506' ' ' SER . . . . . . . . . . . . . 13.3 p 59.76 -170.95 0.13 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.005 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 507' ' ' ALA . . . . . . . . . . . . . . . 59.31 -93.21 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.725 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 508' ' ' GLN . . . . . 0.426 ' O ' ' CB ' ' B' ' 509' ' ' ASP . 20.0 mt-30 -141.29 4.84 1.83 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.048 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 509' ' ' ASP . . . . . 0.426 ' CB ' ' O ' ' B' ' 508' ' ' GLN . 8.5 t70 81.83 35.39 0.08 Allowed 'General case' 0 C--N 1.341 0.238 0 CA-C-O 121.371 0.605 . . . . 0.0 109.704 -178.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 510' ' ' ILE . . . . . 0.721 ' HB ' HD13 ' A' ' 177' ' ' LEU . 87.4 mt -64.84 156.14 5.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.579 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 511' ' ' SER . . . . . 0.472 ' HB3' HD21 ' B' ' 514' ' ' LEU . 8.7 t -109.54 167.39 10.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.098 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 512' ' ' GLN . . . . . 0.491 ' CB ' ' CD ' ' B' ' 513' ' ' PRO . 18.2 tt0 -114.2 -71.81 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.205 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 513' ' ' PRO . . . . . 0.491 ' CD ' ' CB ' ' B' ' 512' ' ' GLN . 93.5 Cg_endo -78.85 59.81 7.47 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.207 1.938 . . . . 0.0 111.29 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 514' ' ' LEU . . . . . 0.73 HD11 ' HA ' ' A' ' 46' ' ' ILE . 4.9 mt -53.31 -89.02 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.826 -178.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 515' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -92.99 -86.55 0.25 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.666 0.269 . . . . 0.0 111.255 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -127.57 -36.99 2.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.23 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 517' ' ' SER . . . . . 0.589 ' C ' HG12 ' A' ' 42' ' ' VAL . 6.4 m 72.01 22.8 3.64 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.047 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 518' ' ' PHE . . . . . 0.485 ' CD1' ' O ' ' B' ' 517' ' ' SER . 23.7 m-85 -140.99 91.79 2.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.79 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 519' ' ' ILE . . . . . 0.539 HD11 ' H ' ' A' ' 43' ' ' THR . 7.3 mm -88.89 -11.06 10.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.667 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 72.56 104.75 0.07 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.84 0.353 . . . . 0.0 110.925 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 521' ' ' THR . . . . . . . . . . . . . 1.4 m -160.91 106.5 1.41 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.818 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 522' ' ' GLY . . . . . 0.473 ' O ' ' CZ ' ' A' ' 37' ' ' PHE . . . 143.2 178.67 19.24 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.349 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 523' ' ' HIS . . . . . . . . . . . . . 22.9 t60 -104.71 -83.42 0.5 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.745 0.307 . . . . 0.0 110.867 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 524' ' ' GLY . . . . . 0.482 ' HA3' HG23 ' A' ' 36' ' ' VAL . . . 49.68 -118.65 5.76 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.638 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 525' ' ' ASP . . . . . . . . . . . . . 1.2 p30 53.41 28.53 7.61 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 121.071 0.463 . . . . 0.0 110.498 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 526' ' ' SER . . . . . 0.544 ' OG ' HD22 ' A' ' 61' ' ' LEU . 3.9 m -57.15 100.1 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.207 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 527' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -37.44 162.08 0.05 OUTLIER Pre-proline 0 N--CA 1.467 0.381 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.227 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -53.75 104.79 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.195 2.597 . . . . 0.0 112.299 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 529' ' ' ARG . . . . . . . . . . . . . 2.3 mtt-85 -100.7 -42.42 6.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.073 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 530' ' ' HIS . . . . . 0.408 ' HB2' ' CB ' ' B' ' 545' ' ' ASN . 1.4 m-70 -153.32 -44.02 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.878 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 3.6 m 70.36 -160.53 0.15 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.876 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 532' ' ' TRP . . . . . . . . . . . . . 22.9 t90 -46.19 -65.0 0.62 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.159 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . 59.71 -87.13 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.622 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 534' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -116.56 152.67 48.52 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.698 0.285 . . . . 0.0 111.018 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -55.56 176.59 0.15 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.65 2.233 . . . . 0.0 112.456 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 59.92 92.86 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.082 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 537' ' ' ARG . . . . . 0.402 ' HB2' ' O ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER -73.46 151.06 41.22 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.13 0.491 . . . . 0.0 110.844 179.829 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 538' ' ' ILE . . . . . 0.482 HG13 ' HB2' ' B' ' 542' ' ' TYR . 10.2 tp -61.18 157.22 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.262 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 539' ' ' ASP . . . . . 0.412 ' N ' HG13 ' B' ' 538' ' ' ILE . 2.3 m-20 -61.33 162.16 8.15 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.051 0.453 . . . . 0.0 111.126 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 540' ' ' GLU . . . . . 0.487 ' CG ' ' HB ' ' A' ' 8' ' ' VAL . 0.3 OUTLIER -48.22 -50.14 30.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.854 -179.633 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 541' ' ' LEU . . . . . 0.711 HD23 HD23 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -39.99 -32.51 0.16 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.324 0.583 . . . . 0.0 111.063 -179.496 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 542' ' ' TYR . . . . . 0.482 ' HB2' HG13 ' B' ' 538' ' ' ILE . 35.3 m-85 -104.45 -59.21 1.77 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.896 -179.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 543' ' ' LEU . . . . . 0.661 HD23 HG23 ' A' ' 35' ' ' THR . 2.0 tp 66.47 -67.68 0.15 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.061 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 544' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' B' ' 542' ' ' TYR . . . -89.02 139.41 15.25 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.485 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 545' ' ' ASN . . . . . 0.408 ' CB ' ' HB2' ' B' ' 530' ' ' HIS . 1.2 m-80 . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.945 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.819 ' CE ' HG23 ' A' ' 46' ' ' ILE . 1.3 tmt? . . . . . 0 N--CA 1.487 1.42 0 CA-C-O 120.84 0.352 . . . . 0.0 111.03 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 73.32 121.13 0.04 OUTLIER 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.994 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.797 HG22 ' HB2' ' A' ' 53' ' ' LEU . 0.3 OUTLIER -93.26 170.09 9.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.719 -179.345 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.779 ' O ' HD23 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -152.71 162.49 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -178.92 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.4 127.91 40.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.945 179.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 43.6 t -116.54 153.42 32.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.069 0.461 . . . . 0.0 111.906 -179.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.632 HG13 ' O ' ' A' ' 56' ' ' PHE . 1.7 t -151.11 159.51 4.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.408 179.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.873 HG13 ' HG3' ' B' ' 540' ' ' GLU . 0.9 OUTLIER -110.91 155.77 12.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.323 0.582 . . . . 0.0 111.329 -179.848 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.764 HG13 HD13 ' A' ' 70' ' ' LEU . 66.9 t -159.17 129.91 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.042 179.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 138.44 -149.06 20.35 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.183 -1.008 . . . . 0.0 112.861 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' B' ' 537' ' ' ARG . 0.4 OUTLIER -110.8 27.15 9.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.938 0.399 . . . . 0.0 110.74 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -134.68 174.26 21.12 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.439 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.431 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -80.97 -57.63 3.45 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 123.063 -0.081 . . . . 0.0 111.195 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.874 HG21 HD22 ' A' ' 79' ' ' LEU . 13.8 p 23.96 44.61 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 13' ' ' ALA . . . -125.39 -178.26 15.24 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.58 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.481 ' HG3' HD23 ' A' ' 55' ' ' LEU . 1.3 tmpt? -59.71 -17.68 36.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.585 0.231 . . . . 0.0 111.199 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.822 HG21 ' OG1' ' A' ' 35' ' ' THR . 34.1 p -79.58 -70.88 0.48 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.804 0.335 . . . . 0.0 111.463 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.418 ' N ' ' OG1' ' A' ' 17' ' ' THR . 16.5 t -62.49 -57.9 9.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.958 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.84 ' O ' HD13 ' A' ' 165' ' ' LEU . 18.7 mt -47.87 -71.76 0.06 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -178.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.432 ' N ' ' CD2' ' A' ' 20' ' ' LEU . 2.5 mm? -56.74 -60.18 3.93 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -178.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.524 HG22 ' OG1' ' A' ' 25' ' ' THR . 50.0 mm -48.2 -70.52 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 120.936 -0.305 . . . . 0.0 111.189 -179.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.43 ' CB ' ' HB1' ' A' ' 159' ' ' ALA . 19.7 m -42.2 -29.3 0.24 Allowed 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 111.582 0.215 . . . . 0.0 111.582 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.497 ' CZ ' ' HG2' ' A' ' 166' ' ' LYS . 17.5 t80 -81.45 -68.72 0.67 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.856 0.36 . . . . 0.0 110.804 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.649 HG23 HG23 ' A' ' 25' ' ' THR . 10.8 t -58.87 -46.75 87.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.128 0.489 . . . . 0.0 110.583 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.649 HG23 HG23 ' A' ' 24' ' ' THR . 18.7 p -86.42 -153.46 0.2 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.431 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -150.03 55.5 0.94 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.658 0.266 . . . . 0.0 110.985 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.7 mttt -144.22 157.56 44.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.927 0.394 . . . . 0.0 111.252 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.497 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . 0.5 OUTLIER -163.17 -64.64 0.01 OUTLIER Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.481 179.698 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.497 ' HD3' ' HB3' ' A' ' 28' ' ' PHE . 87.5 Cg_endo -81.77 57.87 6.51 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.62 2.213 . . . . 0.0 112.841 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.407 ' O ' ' N ' ' B' ' 532' ' ' TRP . 0.4 OUTLIER -131.45 -89.39 0.45 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.906 179.844 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.71 116.08 2.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.364 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -111.17 92.39 4.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.078 0.466 . . . . 0.0 111.188 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.787 HG21 ' O ' ' B' ' 527' ' ' ASP . 2.8 t -105.69 -33.55 0.19 Allowed Pre-proline 0 CA--C 1.544 0.731 0 N-CA-C 114.174 1.175 . . . . 0.0 114.174 -179.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.496 ' CD ' ' N ' ' A' ' 33' ' ' VAL . 46.6 Cg_exo -40.44 -26.5 0.22 Allowed 'Trans proline' 0 C--N 1.357 1.022 0 C-N-CA 122.361 2.041 . . . . 0.0 113.965 -178.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.955 HG21 ' CD2' ' B' ' 543' ' ' LEU . 51.4 m -54.07 88.38 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.625 0.25 . . . . 0.0 111.041 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.726 ' HB ' HD13 ' A' ' 61' ' ' LEU . 7.6 p 171.2 -32.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.7 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.409 ' CD2' ' HA3' ' B' ' 522' ' ' GLY . 0.2 OUTLIER -108.06 23.44 14.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.904 179.921 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -61.23 -16.69 47.87 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.271 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -45.54 -27.25 0.71 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.717 0.294 . . . . 0.0 111.516 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.44 ' OH ' ' CE1' ' B' ' 518' ' ' PHE . 2.7 p90 -60.27 142.53 54.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.93 0.395 . . . . 0.0 110.72 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.749 ' O ' HD12 ' B' ' 519' ' ' ILE . . . -91.17 -178.75 5.25 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.972 -179.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 42' ' ' VAL . 18.3 m -131.31 121.28 48.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.441 178.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.461 HG23 ' O ' ' A' ' 43' ' ' THR . 5.0 t -86.24 104.61 15.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.422 -179.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.472 HG12 ' HB2' ' B' ' 515' ' ' GLN . 29.5 m -161.23 144.3 4.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.177 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.91 ' O ' HD22 ' B' ' 514' ' ' LEU . 0.0 OUTLIER -77.55 96.4 4.76 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.428 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.852 ' CG1' HG23 ' B' ' 510' ' ' ILE . 5.9 tt -97.29 96.11 5.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.285 -179.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.481 ' N ' ' HE2' ' A' ' 45' ' ' MET . . . 101.91 -108.53 3.39 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.378 -0.828 . . . . 0.0 112.937 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.445 ' N ' ' HE1' ' A' ' 45' ' ' MET . . . -118.11 -22.78 3.75 Favored Glycine 0 CA--C 1.521 0.419 0 C-N-CA 120.511 -0.852 . . . . 0.0 113.375 -179.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.554 ' N ' ' HE1' ' A' ' 45' ' ' MET . 2.0 mt-10 -117.4 132.54 23.5 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.995 0.398 . . . . 0.0 111.148 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.479 ' HA ' ' HA ' ' A' ' 45' ' ' MET . 42.9 Cg_endo -68.65 90.26 0.42 Allowed 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.853 2.369 . . . . 0.0 113.839 -179.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.528 ' CD1' ' O ' ' A' ' 51' ' ' TYR . 2.3 p90 -173.41 132.18 0.47 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.728 178.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.603 HG23 ' CG2' ' A' ' 46' ' ' ILE . 0.1 OUTLIER -129.91 141.51 50.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.027 0.441 . . . . 0.0 111.354 -179.046 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.797 ' HB2' HG22 ' A' ' 3' ' ' THR . 2.1 tp -89.18 148.58 23.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.838 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -87.3 178.97 47.98 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.213 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.718 HD22 ' N ' ' A' ' 55' ' ' LEU . 0.4 OUTLIER -112.3 136.62 51.52 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.73 0.3 . . . . 0.0 110.54 179.758 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.632 ' O ' HG13 ' A' ' 7' ' ' VAL . 0.3 OUTLIER -84.38 116.34 22.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.918 -179.654 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.409 ' OD2' ' N ' ' A' ' 36' ' ' VAL . 16.0 p-10 -119.3 167.74 11.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.057 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.747 ' CB ' HD22 ' A' ' 67' ' ' LEU . 0.6 OUTLIER -154.22 139.92 18.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.984 -179.826 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -171.07 136.08 1.05 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.807 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.77 73.1 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.613 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.726 HD13 ' HB ' ' A' ' 36' ' ' VAL . 0.3 OUTLIER -121.17 -175.41 3.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.918 0.389 . . . . 0.0 111.022 179.957 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -49.76 -39.51 37.92 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.028 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.43 ' HB3' ' CG2' ' A' ' 36' ' ' VAL . 11.2 t0 -64.11 -62.7 1.46 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.102 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.937 ' CD2' HD21 ' A' ' 67' ' ' LEU . 0.5 OUTLIER -120.07 140.53 50.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.78 -179.802 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.85 -69.08 0.7 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -179.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.431 ' O ' ' HB2' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -98.65 -46.51 5.68 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 -178.939 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.937 HD21 ' CD2' ' A' ' 64' ' ' TYR . 1.2 mp 69.37 131.43 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.06 -179.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.546 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 6.9 mtp180 -130.38 36.59 0.35 Allowed Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.961 178.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.546 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 61.1 Cg_endo -84.23 -39.93 0.1 Allowed 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 122.122 1.881 . . . . 0.0 112.044 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.877 HD23 ' HB2' ' B' ' 541' ' ' LEU . 0.1 OUTLIER -83.98 -7.84 59.31 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.156 -179.802 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.9 t -49.07 -64.11 0.9 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.745 0.307 . . . . 0.0 111.026 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -159.0 55.83 0.85 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.086 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.0 160.86 46.48 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.532 2.155 . . . . 0.0 112.209 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.05 10.24 34.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.462 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.47 ' O ' HG22 ' A' ' 108' ' ' THR . 69.3 m -50.73 117.86 2.75 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.828 0.347 . . . . 0.0 110.907 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -76.12 -20.07 57.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.061 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.835 HG21 ' HB2' ' A' ' 176' ' ' ALA . 43.1 t -103.93 72.53 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.897 0.379 . . . . 0.0 111.18 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.402 ' CE2' HG21 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -80.82 172.54 13.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.559 179.822 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.874 HD22 HG21 ' A' ' 14' ' ' VAL . 1.2 tt -152.61 108.73 3.37 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.853 0.359 . . . . 0.0 111.147 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.572 ' CG2' HD22 ' A' ' 112' ' ' LEU . 2.8 m -93.1 133.1 35.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.701 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.501 ' SG ' HG12 ' A' ' 14' ' ' VAL . 1.2 p -119.17 138.16 53.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.092 0.472 . . . . 0.0 111.36 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.412 ' CZ ' ' HB2' ' A' ' 142' ' ' ALA . 39.5 p90 -135.26 -174.12 3.53 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.008 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.1 m -145.81 139.08 26.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.745 0.307 . . . . 0.0 110.797 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.804 HG21 ' HA ' ' A' ' 117' ' ' ILE . 60.1 t -53.67 -67.6 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.302 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.853 HG22 ' OE1' ' A' ' 116' ' ' GLN . 34.9 m -48.62 108.65 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.737 0.304 . . . . 0.0 110.725 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.589 ' N ' HD22 ' A' ' 129' ' ' LEU . 0.3 OUTLIER -151.55 128.9 5.62 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.687 -179.41 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 86' ' ' SER . 74.0 Cg_endo -92.56 53.36 0.56 Allowed 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 123.272 2.648 . . . . 0.0 111.723 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.43 ' CA ' ' HG3' ' A' ' 133' ' ' LYS . 0.1 OUTLIER 81.95 39.21 0.05 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.823 -179.415 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.873 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -97.25 -34.89 10.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.804 179.862 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -51.83 -37.95 53.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.827 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -50.81 -57.41 8.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.661 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.427 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 4.1 p-10 -74.93 -43.57 53.44 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.676 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.873 HG23 ' O ' ' A' ' 89' ' ' SER . 57.4 t -52.31 -31.61 15.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.991 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.622 ' O ' HG23 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -79.09 -50.92 10.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.915 -179.967 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.405 ' O ' ' HG3' ' A' ' 99' ' ' PRO . 25.2 mt-10 -82.75 6.31 18.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.648 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.427 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.6 OUTLIER -115.13 -27.81 7.18 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.754 0.312 . . . . 0.0 111.063 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.809 ' CE2' HG13 ' A' ' 93' ' ' VAL . 38.1 m0 -91.59 -44.81 8.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.02 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.622 HG23 ' O ' ' A' ' 94' ' ' LYS . 64.4 t -53.48 -46.03 98.29 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.792 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 97.4 Cg_endo -80.61 -15.22 11.08 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.334 2.023 . . . . 0.0 112.781 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -85.8 -36.14 20.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.948 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.41 HG13 ' N ' ' A' ' 102' ' ' THR . 13.8 pt -79.14 -25.53 12.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.104 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.41 ' N ' HG13 ' A' ' 101' ' ' ILE . 47.8 p -89.42 -31.63 17.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.038 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.403 ' HB2' ' O ' ' A' ' 99' ' ' PRO . 74.5 t60 -72.8 -54.97 7.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.065 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -71.07 -25.84 62.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.047 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.416 ' HB2' ' OG1' ' A' ' 108' ' ' THR . 28.5 m -132.31 95.37 21.21 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.9 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -50.2 110.69 0.41 Allowed 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.573 2.182 . . . . 0.0 112.263 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 7.6 mmpt? 50.8 92.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.906 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.47 HG22 ' O ' ' A' ' 75' ' ' THR . 0.2 OUTLIER -133.59 113.04 12.92 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.85 179.95 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.401 ' O ' ' HB2' ' A' ' 78' ' ' PHE . 31.3 Cg_exo -60.15 133.62 51.02 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.584 2.189 . . . . 0.0 112.446 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.517 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 0.8 OUTLIER -134.92 142.81 46.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.96 179.923 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.98 HD12 HG11 ' A' ' 152' ' ' VAL . 5.0 tt -110.92 141.45 44.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.197 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.795 ' O ' HD23 ' A' ' 111' ' ' LEU . 3.6 mm? -89.8 158.38 17.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.627 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.42 HG21 HG21 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -137.84 150.42 25.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.123 0.487 . . . . 0.0 111.804 -179.554 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -129.59 134.92 8.12 Favored Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.525 179.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 158' ' ' SER . 0.0 OUTLIER -155.28 -41.49 0.08 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.859 0.33 . . . . 0.0 111.088 -179.279 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.853 ' OE1' HG22 ' A' ' 85' ' ' VAL . 10.5 tt0 -71.87 -9.09 57.82 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.322 178.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.804 ' HA ' HG21 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -54.39 -20.79 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.689 -179.848 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -75.55 -35.54 60.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.383 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.617 HD21 ' HG3' ' A' ' 116' ' ' GLN . 4.3 pp -97.02 14.21 26.38 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.626 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.676 ' CB ' HG11 ' A' ' 84' ' ' VAL . 37.4 ptt85 -68.05 -27.29 66.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.951 0.405 . . . . 0.0 110.329 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -72.63 -25.68 61.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.827 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.408 ' O ' ' HB ' ' A' ' 126' ' ' ILE . 9.2 t70 -47.58 101.63 0.27 Allowed Pre-proline 0 C--N 1.332 -0.169 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.703 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -67.83 -5.85 15.46 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.745 2.297 . . . . 0.0 113.049 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.46 -65.45 1.01 Allowed 'General case' 0 C--O 1.234 0.261 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.536 HG21 HG11 ' A' ' 85' ' ' VAL . 5.0 m -55.43 -38.94 69.65 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.46 HG13 HD12 ' A' ' 129' ' ' LEU . 0.1 OUTLIER -55.53 -47.41 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.713 179.179 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.538 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 2.7 mm-40 -53.47 -35.77 60.91 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.02 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.407 ' HB2' ' O ' ' A' ' 125' ' ' THR . 1.7 mptp? -66.82 -32.09 73.14 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.589 HD22 ' N ' ' A' ' 86' ' ' SER . 6.2 mt -74.44 -36.8 63.39 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 177.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.538 ' HB3' ' O ' ' A' ' 127' ' ' GLU . . . -43.98 -42.47 6.02 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.374 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.97 -26.38 10.41 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.365 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.401 ' OD1' ' HB2' ' A' ' 87' ' ' PRO . 29.5 m120 -124.61 -31.55 3.21 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -179.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.442 ' O ' ' HB2' ' A' ' 134' ' ' GLN . 6.4 mmpt? -152.06 -63.88 0.17 Allowed 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 -178.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.532 ' HG3' ' HB2' ' A' ' 130' ' ' ALA . 2.0 tt0 81.18 15.94 0.56 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.695 0.283 . . . . 0.0 110.97 -178.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 51.6 mttm -101.17 88.66 1.13 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.97 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' ' 134' ' ' GLN . 32.8 Cg_endo -63.93 124.94 14.36 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.449 2.1 . . . . 0.0 111.859 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.688 ' N ' HD13 ' A' ' 137' ' ' ILE . 1.3 mm -60.14 97.25 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.106 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.9 p -74.34 153.83 88.05 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.807 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -47.14 -36.19 21.09 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.607 2.205 . . . . 0.0 112.324 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -67.9 -28.33 67.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.859 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.401 HG21 HG23 ' A' ' 137' ' ' ILE . 87.4 m -66.23 -53.55 35.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.841 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.557 ' HB3' ' CE2' ' A' ' 154' ' ' TYR . . . -57.7 -36.66 72.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.898 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.98 -39.95 95.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.704 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 43.9 mttt -65.16 -51.61 60.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.862 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.508 HD23 ' O ' ' A' ' 145' ' ' LEU . 0.9 OUTLIER -67.16 -40.24 86.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.803 -179.995 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -55.62 -44.81 77.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.037 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.25 -24.52 27.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.874 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -53.69 -31.57 48.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.855 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.1 mt -119.3 19.62 12.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.154 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 29.1 mmtm 48.06 42.42 16.85 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.784 0.326 . . . . 0.0 111.095 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.555 ' O ' HG23 ' A' ' 152' ' ' VAL . . . -58.18 -81.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.913 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.98 HG11 HD12 ' A' ' 111' ' ' LEU . 47.6 t -160.73 -74.67 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.747 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 179.51 128.03 0.08 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.24 -179.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.557 ' CE2' ' HB3' ' A' ' 142' ' ' ALA . 38.3 t80 -100.19 112.49 24.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.755 178.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 2.8 t -101.52 154.58 4.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.416 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -90.55 120.13 31.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.94 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.41 ' HA ' ' HB3' ' A' ' 163' ' ' LYS . 35.3 m -156.79 175.57 13.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.588 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.461 ' HA ' ' HA ' ' A' ' 115' ' ' THR . 4.6 t -158.07 145.16 17.96 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.089 0.471 . . . . 0.0 111.849 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.43 ' HB1' ' CB ' ' A' ' 22' ' ' SER . . . -104.72 -44.03 4.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.34 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.492 ' HB3' ' CE2' ' A' ' 28' ' ' PHE . 0.9 OUTLIER -62.94 -33.16 74.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.268 179.503 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -106.54 -21.74 12.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.565 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 77.9 60.48 0.03 OUTLIER 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.317 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.451 ' HB2' ' CB ' ' A' ' 158' ' ' SER . 0.5 OUTLIER -91.88 41.94 1.09 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.688 179.538 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.415 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . 104.09 -66.04 0.32 Allowed Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.719 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.84 HD13 ' O ' ' A' ' 19' ' ' LEU . 0.5 OUTLIER 66.04 -66.77 0.16 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.724 0.297 . . . . 0.0 111.308 -179.914 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.497 ' HG2' ' CZ ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -50.09 -26.22 4.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.807 0.337 . . . . 0.0 110.872 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.414 ' O ' ' HB2' ' A' ' 170' ' ' ASP . 0.4 OUTLIER -62.22 -69.05 0.27 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.425 -179.733 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.545 HG13 ' N ' ' A' ' 169' ' ' PHE . 14.0 p -54.41 -47.12 70.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.094 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.788 ' CD1' HD13 ' A' ' 19' ' ' LEU . 1.7 t80 -60.73 -31.86 71.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.338 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.766 ' O ' HD13 ' A' ' 173' ' ' ILE . 0.3 OUTLIER -62.48 -36.43 82.48 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.775 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -69.14 -28.77 66.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.633 178.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.61 ' HA ' HD13 ' A' ' 111' ' ' LEU . . . -61.04 -51.47 69.04 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.221 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.766 HD13 ' O ' ' A' ' 170' ' ' ASP . 0.1 OUTLIER -83.33 -23.65 8.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.031 -179.767 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.784 HD23 HD23 ' B' ' 505' ' ' LEU . 3.2 tm? -50.54 -48.53 57.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.048 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -51.02 -25.52 4.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.894 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.835 ' HB2' HG21 ' A' ' 77' ' ' VAL . . . -83.3 -42.77 16.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.11 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.594 HD22 HG12 ' B' ' 510' ' ' ILE . 8.3 mt -68.73 -17.54 64.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.991 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.474 ' OE2' HD11 ' A' ' 174' ' ' LEU . 0.7 OUTLIER -171.79 145.11 1.62 Allowed Pre-proline 0 C--N 1.333 -0.109 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.746 179.835 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.9 127.99 28.62 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.619 2.212 . . . . 0.0 112.224 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.85 142.23 25.16 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.444 2.096 . . . . 0.0 112.242 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -113.99 141.48 26.33 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.92 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.3 -165.1 0.29 Allowed 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.639 2.226 . . . . 0.0 112.31 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 9.4 mttm -98.98 98.25 9.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.88 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.184 -0.913 . . . . 0.0 110.96 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.133 0 N-CA-C 112.509 -0.237 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 503' ' ' SER . . . . . 0.557 ' HB3' HD11 ' B' ' 505' ' ' LEU . 71.1 m -88.06 -81.55 0.25 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.79 0.329 . . . . 0.0 111.009 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 504' ' ' GLY . . . . . 0.881 ' C ' HD13 ' B' ' 505' ' ' LEU . . . 83.76 104.01 0.55 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.326 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 505' ' ' LEU . . . . . 0.881 HD13 ' C ' ' B' ' 504' ' ' GLY . 0.0 OUTLIER -148.38 90.44 1.8 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.911 0.386 . . . . 0.0 111.077 -179.137 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 506' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 55.57 -172.92 0.06 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.082 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 507' ' ' ALA . . . . . 0.434 ' HB2' ' HB3' ' A' ' 178' ' ' GLU . . . 63.86 -93.27 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.771 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 508' ' ' GLN . . . . . 0.423 ' O ' ' CB ' ' B' ' 509' ' ' ASP . 2.6 mt-30 -133.87 3.25 3.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.018 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 509' ' ' ASP . . . . . 0.423 ' CB ' ' O ' ' B' ' 508' ' ' GLN . 8.4 t70 80.61 36.67 0.1 Allowed 'General case' 0 CA--C 1.521 -0.165 0 CA-C-O 121.167 0.508 . . . . 0.0 109.915 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 510' ' ' ILE . . . . . 0.852 HG23 ' CG1' ' A' ' 46' ' ' ILE . 1.4 mp -53.75 128.59 13.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.162 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 511' ' ' SER . . . . . 0.588 ' HB2' HD21 ' B' ' 514' ' ' LEU . 11.5 m -109.33 158.57 17.76 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.16 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 512' ' ' GLN . . . . . 0.49 ' CB ' ' HD3' ' B' ' 513' ' ' PRO . 0.1 OUTLIER -103.24 -64.25 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.883 179.661 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 513' ' ' PRO . . . . . 0.49 ' HD3' ' CB ' ' B' ' 512' ' ' GLN . 67.7 Cg_endo -85.45 53.45 3.46 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.408 2.072 . . . . 0.0 112.202 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 514' ' ' LEU . . . . . 0.91 HD22 ' O ' ' A' ' 45' ' ' MET . 1.1 mp -62.62 -81.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.176 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 515' ' ' GLN . . . . . 0.472 ' HB2' HG12 ' A' ' 44' ' ' VAL . 0.2 OUTLIER -85.91 -85.0 0.16 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.897 -179.921 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -120.66 -37.55 2.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.711 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 517' ' ' SER . . . . . 0.499 ' O ' ' CD1' ' B' ' 518' ' ' PHE . 0.9 OUTLIER 69.66 27.07 4.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.403 179.657 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 518' ' ' PHE . . . . . 0.499 ' CD1' ' O ' ' B' ' 517' ' ' SER . 24.9 m-85 -162.35 112.79 1.53 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.142 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 519' ' ' ILE . . . . . 0.749 HD12 ' O ' ' A' ' 41' ' ' ALA . 31.3 mt -78.56 -30.09 15.04 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 CA-C-O 120.806 0.336 . . . . 0.0 110.703 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 63.39 94.45 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.885 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 521' ' ' THR . . . . . . . . . . . . . 2.2 t -167.93 47.65 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.844 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 522' ' ' GLY . . . . . 0.409 ' HA3' ' CD2' ' A' ' 37' ' ' PHE . . . -155.51 165.77 32.55 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.491 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 523' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -106.32 -84.83 0.51 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.737 0.303 . . . . 0.0 110.898 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 524' ' ' GLY . . . . . 0.476 ' CA ' ' CG1' ' A' ' 36' ' ' VAL . . . 75.97 21.34 76.47 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.619 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 525' ' ' ASP . . . . . 0.543 ' O ' HG11 ' A' ' 33' ' ' VAL . 26.2 m-20 50.93 56.74 7.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.842 0.353 . . . . 0.0 110.887 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 526' ' ' SER . . . . . 0.419 ' HA ' ' HB ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -81.13 96.82 7.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.935 -179.967 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 527' ' ' ASP . . . . . 0.787 ' O ' HG21 ' A' ' 33' ' ' VAL . 1.2 m-20 -164.55 163.42 14.61 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.247 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -69.44 87.27 0.52 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 123.054 2.503 . . . . 0.0 111.734 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 529' ' ' ARG . . . . . . . . . . . . . 4.0 mtp180 -100.8 -45.67 5.39 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.527 -179.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 530' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -123.06 -42.76 2.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.057 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 3.7 m 72.72 138.81 0.05 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.924 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 532' ' ' TRP . . . . . 0.497 ' CZ2' ' HG3' ' B' ' 537' ' ' ARG . 11.2 t-105 -89.78 115.15 26.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.935 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . -110.46 -53.31 0.57 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.508 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 534' ' ' PHE . . . . . 0.475 ' O ' ' CZ2' ' B' ' 532' ' ' TRP . 32.2 m-85 -107.09 147.84 35.9 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.661 0.267 . . . . 0.0 110.881 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -67.61 -167.01 0.14 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.528 2.152 . . . . 0.0 112.298 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 70.14 102.51 0.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.945 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 537' ' ' ARG . . . . . 0.497 ' HG3' ' CZ2' ' B' ' 532' ' ' TRP . 0.0 OUTLIER -108.13 -177.11 3.24 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.391 0.615 . . . . 0.0 111.146 -179.991 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 538' ' ' ILE . . . . . 0.621 HD12 ' HB2' ' B' ' 542' ' ' TYR . 11.4 pt -114.47 -156.05 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-N 114.999 -1.001 . . . . 0.0 109.749 179.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 539' ' ' ASP . . . . . 0.68 ' HB3' HD21 ' A' ' 70' ' ' LEU . 0.3 OUTLIER -93.98 135.12 35.66 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.328 179.198 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 540' ' ' GLU . . . . . 0.873 ' HG3' HG13 ' A' ' 8' ' ' VAL . 1.4 mm-40 -41.33 -33.82 0.44 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.762 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 541' ' ' LEU . . . . . 0.877 ' HB2' HD23 ' A' ' 70' ' ' LEU . 2.4 tt -54.46 -34.36 61.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.117 0.484 . . . . 0.0 110.434 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 542' ' ' TYR . . . . . 0.621 ' HB2' HD12 ' B' ' 538' ' ' ILE . 89.4 m-85 -99.26 -6.55 27.85 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.923 -179.378 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 543' ' ' LEU . . . . . 0.955 ' CD2' HG21 ' A' ' 35' ' ' THR . 0.9 OUTLIER -50.17 167.03 0.06 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.789 0.328 . . . . 0.0 110.781 -179.786 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . 146.26 71.11 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.432 -0.89 . . . . 0.0 112.621 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 545' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.922 179.978 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.563 ' HE1' ' CD1' ' A' ' 51' ' ' TYR . 6.1 tpt . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.746 0.308 . . . . 0.0 111.263 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.432 ' O ' ' HE3' ' A' ' 1' ' ' MET . 41.3 tt0 -100.04 150.88 22.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.022 0.439 . . . . 0.0 110.864 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.679 HG23 ' HE1' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -93.46 -178.71 4.81 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.273 -179.538 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.575 ' H ' HG22 ' A' ' 3' ' ' THR . 3.8 pt -148.48 112.21 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.96 -179.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 44.8 mttt -94.85 95.83 8.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.191 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.523 ' CB ' ' CE2' ' A' ' 56' ' ' PHE . 4.0 m -121.35 136.99 54.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.666 -179.177 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.4 t -137.26 146.22 28.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.421 179.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.869 HG23 ' HB3' ' A' ' 56' ' ' PHE . 19.7 t -84.65 140.0 16.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.232 0.539 . . . . 0.0 111.668 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 96.2 t -150.66 129.81 3.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.534 179.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 135.03 -148.8 19.71 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.089 -1.053 . . . . 0.0 112.63 -179.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -122.47 23.64 9.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.825 0.345 . . . . 0.0 110.721 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.412 ' HA2' ' HB2' ' B' ' 537' ' ' ARG . . . -142.28 148.9 20.71 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.451 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -98.79 4.76 47.7 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.721 HG23 HG21 ' A' ' 115' ' ' THR . 6.8 p -43.69 -31.26 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 CA-C-O 120.692 0.282 . . . . 0.0 111.463 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.543 ' CA ' HD11 ' A' ' 19' ' ' LEU . . . -113.27 18.94 20.55 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.415 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.519 ' HA ' HG21 ' A' ' 8' ' ' VAL . 2.3 tttm -97.52 -126.49 0.15 Allowed 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 119.949 -0.072 . . . . 0.0 110.851 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.537 HG21 ' CG ' ' A' ' 38' ' ' ASP . 3.3 p -97.34 -31.08 12.58 Favored 'General case' 0 C--N 1.34 0.172 0 O-C-N 122.041 -0.412 . . . . 0.0 111.435 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.441 ' O ' ' CB ' ' A' ' 22' ' ' SER . 15.6 p -42.08 -36.38 1.13 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.903 -179.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.941 HD22 ' CG ' ' A' ' 169' ' ' PHE . 2.8 mp -48.4 -72.79 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.322 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.6 mt -78.12 -40.71 37.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.875 0.369 . . . . 0.0 110.612 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.588 HD12 ' CZ ' ' B' ' 518' ' ' PHE . 24.3 mm -62.56 -69.35 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.209 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.441 ' CB ' ' O ' ' A' ' 18' ' ' CYS . 1.5 t -52.86 -46.33 67.8 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.558 -179.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.425 ' CB ' ' O ' ' A' ' 19' ' ' LEU . 28.6 t80 -48.99 -42.66 38.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.686 0.279 . . . . 0.0 111.414 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.1 m -100.51 -64.59 1.03 Allowed 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.499 HG22 ' N ' ' A' ' 26' ' ' ASN . 97.8 m -100.55 164.64 11.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.933 0.396 . . . . 0.0 111.379 -179.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.499 ' N ' HG22 ' A' ' 25' ' ' THR . 7.1 t-20 73.89 -60.67 0.52 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.079 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 74.4 174.13 0.27 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.821 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.488 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 8.1 t80 -86.71 -46.22 0.54 Allowed Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.645 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.488 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 87.1 Cg_endo -82.99 50.8 3.47 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.501 2.134 . . . . 0.0 112.792 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.3 m -143.18 -100.46 0.12 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.79 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.416 ' O ' ' ND2' ' A' ' 26' ' ' ASN . 1.2 pt-20 -159.69 163.2 34.99 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.902 0.382 . . . . 0.0 111.073 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.474 ' O ' HG22 ' A' ' 33' ' ' VAL . 36.9 m-85 -135.21 117.09 15.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.266 179.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.659 HG11 ' HG3' ' B' ' 529' ' ' ARG . 0.0 OUTLIER -163.39 -62.87 0.01 OUTLIER Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.686 -179.471 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.449 ' HB3' ' CB ' ' B' ' 526' ' ' SER . 29.0 Cg_endo -62.9 57.33 0.15 Allowed 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.816 2.344 . . . . 0.0 113.592 -179.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.431 ' N ' ' O ' ' A' ' 33' ' ' VAL . 4.0 t -122.74 22.45 9.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.846 0.355 . . . . 0.0 110.172 178.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.71 ' CG2' HD22 ' A' ' 61' ' ' LEU . 2.3 t -73.13 -45.64 53.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.751 -179.059 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.48 ' O ' ' CD2' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -85.5 48.77 1.64 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.786 0.327 . . . . 0.0 111.303 -179.731 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.537 ' CG ' HG21 ' A' ' 17' ' ' THR . 99.4 m-20 -69.75 -16.87 63.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.111 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -86.02 11.28 11.95 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.593 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.534 ' HH ' ' HZ ' ' B' ' 518' ' ' PHE . 0.0 OUTLIER -60.25 173.81 0.61 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.821 0.343 . . . . 0.0 110.725 179.874 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.413 ' O ' HG12 ' B' ' 519' ' ' ILE . . . -92.16 147.43 22.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.174 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.529 HG12 ' HA ' ' B' ' 518' ' ' PHE . 6.7 m -134.91 147.05 29.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.887 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.705 ' N ' HD11 ' B' ' 519' ' ' ILE . 2.8 t -85.81 102.63 13.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.984 0.421 . . . . 0.0 109.911 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 1.019 HG13 HG21 ' A' ' 52' ' ' THR . 1.1 p -165.77 145.61 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.872 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.616 ' HG3' HD22 ' B' ' 514' ' ' LEU . 0.0 OUTLIER -115.75 140.33 49.31 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.424 179.521 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.604 HG23 ' CG2' ' B' ' 510' ' ' ILE . 7.8 mm -95.38 115.46 34.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-O 120.947 0.403 . . . . 0.0 111.561 -179.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.549 ' O ' ' HE1' ' A' ' 45' ' ' MET . . . 33.18 -90.35 0.01 OUTLIER Glycine 0 C--N 1.336 0.552 0 CA-C-N 115.595 -0.73 . . . . 0.0 114.223 178.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.408 ' C ' ' HE1' ' A' ' 45' ' ' MET . . . -41.14 -87.7 0.01 OUTLIER Glycine 0 C--N 1.332 0.315 0 C-N-CA 121.205 -0.522 . . . . 0.0 113.07 -179.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.407 ' CB ' ' HD2' ' A' ' 50' ' ' PRO . 1.1 mt-10 -143.51 165.36 25.53 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.406 0.103 . . . . 0.0 111.214 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.416 ' HA ' ' CB ' ' A' ' 45' ' ' MET . 39.2 Cg_exo -31.24 103.02 0.03 OUTLIER 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.619 2.879 . . . . 0.0 113.012 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.679 ' HE1' HG23 ' A' ' 3' ' ' THR . 8.7 t80 -172.53 120.67 0.41 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.772 -179.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 1.019 HG21 HG13 ' A' ' 44' ' ' VAL . 0.2 OUTLIER -135.43 155.73 50.08 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.088 -178.741 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.675 ' N ' HD13 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -115.55 156.3 26.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.186 179.973 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -62.26 109.85 2.87 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.6 -0.81 . . . . 0.0 111.875 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.22 -153.15 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.656 0.265 . . . . 0.0 110.895 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.869 ' HB3' HG23 ' A' ' 8' ' ' VAL . 9.0 m-85 -84.41 105.76 15.49 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 120.921 0.391 . . . . 0.0 111.127 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.402 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 4.3 p30 -120.74 113.06 19.64 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.939 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.593 HG22 HD13 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -154.21 125.77 7.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.87 179.86 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.884 ' HB1' ' CD1' ' A' ' 61' ' ' LEU . . . -172.52 119.86 0.39 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.992 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.4 ' HA2' ' O ' ' A' ' 64' ' ' TYR . . . -95.18 75.45 0.89 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.445 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.884 ' CD1' ' HB1' ' A' ' 59' ' ' ALA . 3.5 mp -117.46 -115.09 0.33 Allowed 'General case' 0 CA--C 1.538 0.513 0 O-C-N 122.912 -0.17 . . . . 0.0 110.872 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -98.6 -29.55 12.99 Favored 'General case' 0 N--CA 1.455 -0.182 0 O-C-N 122.073 -0.392 . . . . 0.0 111.254 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.45 ' HB3' ' CD1' ' A' ' 64' ' ' TYR . 14.8 t0 -67.38 -63.25 1.1 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.066 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.45 ' CD1' ' HB3' ' A' ' 63' ' ' ASP . 0.2 OUTLIER -124.13 137.22 54.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.674 179.966 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -87.25 -62.5 1.49 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.897 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.476 ' N ' ' CD ' ' A' ' 66' ' ' ARG . 0.3 OUTLIER -98.68 -21.09 16.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.181 -179.777 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.593 HD13 HG22 ' A' ' 58' ' ' THR . 1.7 mt 67.03 -135.38 0.13 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.297 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.467 ' CB ' ' CD ' ' A' ' 69' ' ' PRO . 1.2 mtt180 -166.06 -64.07 0.01 OUTLIER Pre-proline 0 CA--C 1.529 0.151 0 CA-C-N 118.28 0.491 . . . . 0.0 111.814 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.467 ' CD ' ' CB ' ' A' ' 68' ' ' ARG . 63.7 Cg_exo -36.96 -60.27 0.4 Allowed 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.965 2.443 . . . . 0.0 113.103 -179.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.649 ' C ' HD12 ' A' ' 70' ' ' LEU . 0.4 OUTLIER -50.08 -29.64 9.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.384 -179.752 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 68' ' ' ARG . 35.5 p -47.46 -64.76 0.7 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.759 0.314 . . . . 0.0 111.194 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.422 ' N ' ' OG ' ' A' ' 71' ' ' SER . 6.1 p90 -179.55 92.38 0.2 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.07 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.93 136.03 26.67 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.523 2.149 . . . . 0.0 112.313 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -87.4 10.91 15.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.512 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 11.7 t -70.13 -173.16 0.64 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.784 0.326 . . . . 0.0 110.933 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -124.31 7.69 8.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.431 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.986 HG11 ' HB2' ' A' ' 176' ' ' ALA . 9.0 p -129.14 78.59 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.755 0.312 . . . . 0.0 111.388 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.598 ' CZ ' HG21 ' A' ' 108' ' ' THR . 7.6 m-30 -80.7 172.43 13.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.224 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.435 ' CD2' ' HA3' ' A' ' 15' ' ' GLY . 8.1 tp -143.83 108.55 4.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.876 0.37 . . . . 0.0 111.374 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.593 ' CG1' HD12 ' A' ' 101' ' ' ILE . 4.4 m -94.52 155.12 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.18 179.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.591 ' HB3' HG12 ' A' ' 14' ' ' VAL . 2.3 m -134.85 146.21 49.03 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.194 0.521 . . . . 0.0 111.92 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.822 ' CE1' HD12 ' A' ' 112' ' ' LEU . 6.2 p90 -166.22 124.63 1.5 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.158 179.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.429 ' CB ' ' HG3' ' A' ' 116' ' ' GLN . 0.1 OUTLIER -90.24 139.26 30.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.014 0.435 . . . . 0.0 111.562 -179.244 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.956 HG22 ' CB ' ' A' ' 116' ' ' GLN . 10.2 m -63.26 -170.1 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.408 179.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.807 ' CG2' HG23 ' A' ' 84' ' ' VAL . 0.1 OUTLIER 56.19 102.11 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -179.282 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.898 ' C ' HD22 ' A' ' 129' ' ' LEU . 0.2 OUTLIER -151.26 145.9 18.49 Favored Pre-proline 0 C--N 1.325 -0.465 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.923 -179.183 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.584 ' N ' HD22 ' A' ' 129' ' ' LEU . 83.6 Cg_endo -85.73 50.04 2.51 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 123.121 2.548 . . . . 0.0 111.654 179.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.484 ' N ' ' HB3' ' A' ' 133' ' ' LYS . 2.6 t 82.9 27.8 0.11 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.877 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 44.5 t -97.3 -24.16 15.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.848 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.407 ' CZ ' HD12 ' A' ' 145' ' ' LEU . 11.2 t80 -49.56 -62.1 1.74 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.066 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -50.36 -31.16 13.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.873 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.424 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 1.4 t-20 -72.59 -63.22 1.2 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.859 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.437 HG13 ' N ' ' A' ' 94' ' ' LYS . 12.9 p -52.43 -41.74 36.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.039 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.831 ' CG ' HD11 ' A' ' 145' ' ' LEU . 0.8 OUTLIER -55.87 -62.27 1.81 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.699 179.93 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.409 ' O ' ' HG3' ' A' ' 99' ' ' PRO . 1.1 mm-40 -78.32 2.81 17.34 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.782 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.468 ' HD3' ' CZ3' ' A' ' 97' ' ' TRP . 55.9 tttt -105.24 -38.43 6.53 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.869 0.366 . . . . 0.0 110.56 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.468 ' CZ3' ' HD3' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -74.8 -49.45 20.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.15 179.967 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 94' ' ' LYS . 67.8 t -47.01 -52.3 34.57 Favored Pre-proline 0 CA--C 1.532 0.28 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.919 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 60.7 Cg_endo -72.22 -20.57 24.53 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.112 1.875 . . . . 0.0 112.385 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -84.89 -46.26 11.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.015 0.436 . . . . 0.0 110.622 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.593 HD12 ' CG1' ' A' ' 80' ' ' VAL . 5.9 tt -66.07 -26.11 37.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.906 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.46 HG22 ' HA ' ' A' ' 107' ' ' LYS . 60.3 p -91.55 -26.53 18.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.739 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.454 ' CG ' ' O ' ' A' ' 99' ' ' PRO . 1.9 m170 -67.52 -69.25 0.33 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.828 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -64.32 -42.93 96.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.634 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 4.5 m -112.59 149.21 40.79 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.603 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -49.21 162.31 0.5 Allowed 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.509 2.139 . . . . 0.0 112.269 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.46 ' HA ' HG22 ' A' ' 102' ' ' THR . 0.2 OUTLIER -81.43 56.21 2.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.801 179.921 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.598 HG21 ' CZ ' ' A' ' 78' ' ' PHE . 1.3 p -81.58 165.33 44.63 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.227 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -60.62 162.68 17.45 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.856 2.37 . . . . 0.0 112.323 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.832 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 8.8 p90 -156.07 153.83 30.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.757 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 1.023 HD12 HG11 ' A' ' 152' ' ' VAL . 4.7 tt -113.81 142.95 45.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.408 -179.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.822 HD12 ' CE1' ' A' ' 82' ' ' PHE . 3.8 mm? -99.14 158.68 15.51 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.387 179.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.957 ' CG1' HG11 ' A' ' 168' ' ' VAL . 2.6 t -141.94 146.95 22.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.166 0.507 . . . . 0.0 112.193 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.499 ' HA3' ' CZ ' ' A' ' 154' ' ' TYR . . . -122.49 92.02 0.47 Allowed Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.968 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.721 HG21 HG23 ' A' ' 14' ' ' VAL . 0.7 OUTLIER -114.34 6.76 16.18 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.281 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.956 ' CB ' HG22 ' A' ' 84' ' ' VAL . 2.3 mt-30 -110.22 25.86 11.31 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.301 0.572 . . . . 0.0 109.56 179.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.422 ' CD1' ' O ' ' A' ' 114' ' ' GLY . 0.0 OUTLIER -65.53 -10.45 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.501 179.008 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -96.9 -20.5 18.09 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.245 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.468 ' CB ' HG21 ' A' ' 85' ' ' VAL . 5.2 mp -89.02 -37.66 15.0 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.256 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.453 ' O ' HD13 ' A' ' 126' ' ' ILE . 8.2 ptm180 -48.09 -31.56 5.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.828 0.347 . . . . 0.0 110.894 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -78.58 -37.06 43.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.485 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -47.97 104.24 0.4 Allowed Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.909 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.424 ' O ' ' CG ' ' A' ' 127' ' ' GLU . 55.4 Cg_endo -70.99 -6.17 18.61 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.444 2.096 . . . . 0.0 112.898 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.93 -66.58 0.77 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.411 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 17.2 m -57.51 -40.86 79.62 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.576 HD11 ' HB3' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -52.84 -46.56 52.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.805 179.231 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.52 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 20.5 mm-40 -58.14 -33.69 69.46 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.9 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.441 ' HA ' ' CE ' ' A' ' 131' ' ' LYS . 9.9 mptt -68.99 -24.77 64.27 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 178.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.898 HD22 ' C ' ' A' ' 86' ' ' SER . 4.4 mt -79.43 -35.58 40.3 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 177.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 127' ' ' GLU . . . -39.55 -39.1 0.67 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.033 -0.985 . . . . 0.0 112.391 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.441 ' CE ' ' HA ' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -69.88 -21.63 63.31 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.793 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.422 ' CB ' ' O ' ' A' ' 87' ' ' PRO . 17.5 m120 -124.01 -31.72 3.34 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -179.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.488 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 0.0 OUTLIER -139.63 -74.68 0.36 Allowed 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 -179.303 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.488 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 1.2 pt20 99.46 -41.21 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.075 0.95 . . . . 0.0 110.806 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.421 ' N ' ' HG2' ' A' ' 134' ' ' GLN . 0.8 OUTLIER -74.33 109.03 6.02 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.438 -179.648 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.91 ' C ' HD13 ' A' ' 137' ' ' ILE . 54.4 Cg_endo -68.28 -169.35 0.25 Allowed 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.253 1.968 . . . . 0.0 111.141 179.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.91 HD13 ' C ' ' A' ' 136' ' ' PRO . 1.0 OUTLIER -115.37 96.42 4.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.028 0.442 . . . . 0.0 110.585 179.877 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.415 ' O ' ' N ' ' A' ' 141' ' ' THR . 26.3 p -69.85 144.24 93.08 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.929 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.466 ' O ' ' CE1' ' A' ' 154' ' ' TYR . 1.8 Cg_endo -42.61 -46.07 8.22 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 122.893 2.395 . . . . 0.0 112.012 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.402 ' HG2' ' OG1' ' A' ' 138' ' ' THR . 9.6 pt-20 -59.96 -32.66 71.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.417 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.415 ' N ' ' O ' ' A' ' 138' ' ' THR . 29.5 m -61.55 -53.17 59.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.686 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.526 ' CB ' ' CD2' ' A' ' 154' ' ' TYR . . . -51.91 -36.84 50.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.689 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -62.84 -40.88 98.8 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.492 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 37.4 tttp -59.38 -56.13 25.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.415 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.831 HD11 ' CG ' ' A' ' 94' ' ' LYS . 0.9 OUTLIER -62.15 -41.06 97.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.341 179.512 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.449 ' CB ' HD23 ' A' ' 112' ' ' LEU . . . -58.86 -53.19 61.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.739 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.06 -27.06 61.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.666 179.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -50.45 -45.08 55.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.709 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.11 20.73 18.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.926 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 18.9 mttt 48.67 63.55 2.05 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.091 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.832 ' HB1' ' O ' ' A' ' 110' ' ' PHE . . . -80.19 -82.29 0.11 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.959 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 1.023 HG11 HD12 ' A' ' 111' ' ' LEU . 54.9 t -162.05 -75.6 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.794 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.409 ' HE2' ' N ' ' A' ' 154' ' ' TYR . 0.0 OUTLIER -177.17 120.14 0.12 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.855 -178.831 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.526 ' CD2' ' CB ' ' A' ' 142' ' ' ALA . 12.5 t80 -89.83 114.56 26.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.296 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.48 HG21 ' HG3' ' A' ' 171' ' ' GLU . 2.8 t -111.7 154.67 13.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.032 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -93.49 119.84 33.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.021 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.571 ' O ' HG22 ' A' ' 115' ' ' THR . 1.3 m -172.49 135.71 0.73 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.808 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.434 ' CB ' ' HB ' ' A' ' 115' ' ' THR . 1.9 p -150.1 170.69 18.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.922 0.392 . . . . 0.0 111.153 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.39 -30.84 21.82 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.99 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.1 mt -51.38 -72.39 0.05 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.664 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 14.6 t -74.21 -16.81 60.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.086 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 71.07 50.84 0.3 Allowed 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.069 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.418 ' HB3' ' HA ' ' A' ' 157' ' ' CYS . 0.6 OUTLIER -68.78 -21.02 64.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.969 179.67 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 139.05 -42.45 1.25 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.388 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.702 HD22 ' HA ' ' A' ' 19' ' ' LEU . 0.3 OUTLIER 68.15 -62.18 0.37 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.796 0.332 . . . . 0.0 111.079 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.426 ' O ' ' N ' ' A' ' 170' ' ' ASP . 0.1 OUTLIER -48.12 -25.52 1.49 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.388 -179.733 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -52.34 -71.64 0.06 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.798 0.332 . . . . 0.0 110.47 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.957 HG11 ' CG1' ' A' ' 113' ' ' VAL . 14.7 p -59.24 -29.92 42.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.266 0.555 . . . . 0.0 110.184 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.941 ' CG ' HD22 ' A' ' 19' ' ' LEU . 0.6 OUTLIER -67.53 -29.8 69.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.325 179.714 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 166' ' ' LYS . 68.9 m-20 -77.28 -27.72 53.17 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.191 179.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.48 ' HG3' HG21 ' A' ' 155' ' ' VAL . 8.1 mm-40 -75.5 -28.5 59.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.316 179.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.583 ' CA ' HD13 ' A' ' 111' ' ' LEU . . . -75.02 -48.06 25.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.961 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.506 ' O ' ' HB3' ' A' ' 176' ' ' ALA . 1.3 pp -65.72 -34.71 72.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.72 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.731 HD13 ' CB ' ' B' ' 505' ' ' LEU . 1.6 tp -48.86 -58.04 5.45 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.912 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.447 ' HB3' HG23 ' A' ' 77' ' ' VAL . . . -47.87 -26.46 1.69 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.136 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.986 ' HB2' HG11 ' A' ' 77' ' ' VAL . . . -77.29 -47.85 18.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.209 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.696 ' CD2' HG21 ' B' ' 510' ' ' ILE . 3.0 mt -68.53 -23.82 64.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.881 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.431 ' HB3' ' HB2' ' B' ' 507' ' ' ALA . 0.0 OUTLIER -160.28 155.82 22.02 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.963 179.753 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.0 122.43 8.1 Favored 'Trans proline' 0 CA--C 1.529 0.253 0 C-N-CA 122.631 2.221 . . . . 0.0 112.18 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.53 175.82 5.64 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.434 2.09 . . . . 0.0 112.376 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 25.8 mp0 -144.63 96.72 5.12 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.887 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.23 -165.08 0.27 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.573 2.182 . . . . 0.0 112.235 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 5.8 mmtp -80.09 141.72 35.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.815 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.903 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.154 0 N-CA-C 112.521 -0.232 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 503' ' ' SER . . . . . . . . . . . . . 54.5 p -99.47 -160.49 0.81 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.745 0.307 . . . . 0.0 110.813 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 504' ' ' GLY . . . . . 0.407 ' HA2' ' HB2' ' B' ' 509' ' ' ASP . . . 149.23 95.81 0.15 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.331 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 505' ' ' LEU . . . . . 0.731 ' CB ' HD13 ' A' ' 174' ' ' LEU . 0.2 OUTLIER -157.43 146.51 19.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.057 0.456 . . . . 0.0 111.477 -179.698 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 506' ' ' SER . . . . . 0.482 ' O ' ' HB2' ' B' ' 507' ' ' ALA . 0.6 OUTLIER -60.05 81.83 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.728 179.579 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 507' ' ' ALA . . . . . 0.482 ' HB2' ' O ' ' B' ' 506' ' ' SER . . . 170.82 43.71 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.486 -179.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 508' ' ' GLN . . . . . 0.595 ' HB2' HD12 ' B' ' 510' ' ' ILE . 0.0 OUTLIER 75.33 3.79 4.05 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.692 -177.385 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 509' ' ' ASP . . . . . 0.407 ' HB2' ' HA2' ' B' ' 504' ' ' GLY . 3.7 p30 45.9 53.16 9.23 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.164 0.507 . . . . 0.0 111.393 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 510' ' ' ILE . . . . . 0.696 HG21 ' CD2' ' A' ' 177' ' ' LEU . 1.2 mp -52.97 143.72 4.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.104 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 511' ' ' SER . . . . . 0.532 ' O ' HD11 ' B' ' 514' ' ' LEU . 22.8 t -108.67 153.74 23.0 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.889 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 512' ' ' GLN . . . . . 0.487 ' OE1' ' CD2' ' A' ' 169' ' ' PHE . 9.6 tt0 -102.46 -70.59 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.181 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 513' ' ' PRO . . . . . 0.487 ' CD ' ' CB ' ' B' ' 512' ' ' GLN . 87.5 Cg_endo -77.54 56.59 5.63 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.279 1.986 . . . . 0.0 111.617 179.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 514' ' ' LEU . . . . . 0.898 ' HB2' HG23 ' A' ' 44' ' ' VAL . 2.1 mp -60.72 -89.99 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.623 -179.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 515' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -84.15 -159.61 0.4 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.63 0.252 . . . . 0.0 110.792 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -48.12 -27.32 2.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.834 0.35 . . . . 0.0 110.733 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 517' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 39.57 33.75 0.13 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.724 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 518' ' ' PHE . . . . . 0.588 ' CZ ' HD12 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -163.51 106.72 1.0 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.371 -179.9 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 519' ' ' ILE . . . . . 0.705 HD11 ' N ' ' A' ' 43' ' ' THR . 3.6 mm -87.13 -37.31 10.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.906 0.384 . . . . 0.0 110.842 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -167.52 -170.75 1.5 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.668 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 521' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.27 157.54 19.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.849 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 522' ' ' GLY . . . . . 0.452 ' CA ' ' HB3' ' A' ' 37' ' ' PHE . . . -61.67 -126.52 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.32 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 523' ' ' HIS . . . . . 0.482 ' CD2' ' N ' ' B' ' 524' ' ' GLY . 41.1 t60 -165.05 -88.07 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.625 0.25 . . . . 0.0 111.065 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 524' ' ' GLY . . . . . 0.482 ' N ' ' CD2' ' B' ' 523' ' ' HIS . . . 42.49 -153.39 0.19 Allowed Glycine 0 C--N 1.334 0.418 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.841 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 525' ' ' ASP . . . . . 0.518 ' OD1' HD23 ' A' ' 61' ' ' LEU . 41.0 p-10 -83.29 65.81 8.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.902 0.382 . . . . 0.0 110.655 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 526' ' ' SER . . . . . 0.449 ' CB ' ' HB3' ' A' ' 34' ' ' PRO . 53.6 p -73.19 96.12 2.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.796 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 527' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -168.24 153.36 6.47 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.003 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.62 100.81 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.684 2.256 . . . . 0.0 112.069 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 529' ' ' ARG . . . . . 0.659 ' HG3' HG11 ' A' ' 33' ' ' VAL . 7.6 mtp85 -100.71 -55.34 2.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.286 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 530' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -162.94 98.33 0.95 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.123 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 19.2 t -46.81 95.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.887 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 532' ' ' TRP . . . . . 0.445 ' CE3' ' O ' ' B' ' 533' ' ' GLY . 21.0 t90 68.48 -67.36 0.2 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.948 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 533' ' ' GLY . . . . . 0.445 ' O ' ' CE3' ' B' ' 532' ' ' TRP . . . 87.34 -122.69 6.29 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.592 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 534' ' ' PHE . . . . . 0.4 ' HB3' ' HD2' ' B' ' 535' ' ' PRO . 49.4 m-85 -95.08 155.38 39.05 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 120.738 0.304 . . . . 0.0 110.87 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 535' ' ' PRO . . . . . 0.4 ' HD2' ' HB3' ' B' ' 534' ' ' PHE . 33.9 Cg_endo -64.54 166.38 17.77 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.619 2.213 . . . . 0.0 112.302 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 64.81 97.06 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.828 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 537' ' ' ARG . . . . . 0.412 ' HB2' ' HA2' ' A' ' 12' ' ' GLY . 0.2 OUTLIER -50.59 143.14 9.79 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.047 0.451 . . . . 0.0 111.054 -179.919 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 538' ' ' ILE . . . . . 0.448 ' CG2' ' HA ' ' B' ' 543' ' ' LEU . 6.1 tp -56.17 141.84 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.912 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 539' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -43.06 143.06 0.83 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.943 0.401 . . . . 0.0 111.387 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 540' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -54.15 -20.45 6.76 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.383 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 541' ' ' LEU . . . . . 0.494 ' HA ' HD22 ' A' ' 70' ' ' LEU . 3.9 mt -41.54 -57.9 2.09 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.878 0.37 . . . . 0.0 111.348 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 542' ' ' TYR . . . . . 0.404 ' O ' ' HA ' ' A' ' 59' ' ' ALA . 1.6 m-85 -104.38 -63.54 1.2 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.804 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 543' ' ' LEU . . . . . 0.454 HD22 ' O ' ' A' ' 58' ' ' THR . 0.3 OUTLIER 67.21 152.93 0.08 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.754 -179.834 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . 120.25 -123.98 5.77 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.536 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 545' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.911 179.903 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.4 ' CE ' ' O ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.788 0.328 . . . . 0.0 111.204 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.4 ' O ' ' CE ' ' A' ' 1' ' ' MET . 6.5 tt0 54.12 170.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.715 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.771 HG23 ' CE1' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -132.28 -172.46 2.9 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.317 -179.744 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.945 HG13 HD13 ' A' ' 53' ' ' LEU . 4.5 pt -153.14 132.06 3.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.526 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -91.45 95.78 10.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.575 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.616 ' CB ' HD13 ' A' ' 55' ' ' LEU . 1.1 m -80.37 98.64 7.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.273 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.1 t -126.25 159.43 35.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.478 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.805 HG21 ' HG3' ' A' ' 16' ' ' LYS . 22.4 t -128.97 117.62 44.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.039 0.447 . . . . 0.0 111.65 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 96.7 t -123.82 129.98 74.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.917 179.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 134.17 -164.91 24.48 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.205 -0.997 . . . . 0.0 112.612 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' B' ' 539' ' ' ASP . 1.2 m-20 -98.82 25.93 6.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.837 0.351 . . . . 0.0 110.572 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -138.27 150.01 20.78 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.645 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -89.83 -14.93 33.36 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.877 HG11 HG11 ' A' ' 113' ' ' VAL . 92.2 t -43.51 102.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-O 120.903 0.382 . . . . 0.0 111.29 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.623 ' CA ' HD11 ' A' ' 19' ' ' LEU . . . 142.12 -13.02 2.58 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.624 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.805 ' HG3' HG21 ' A' ' 8' ' ' VAL . 77.0 mttt -97.61 -105.73 0.18 Allowed 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.645 0.222 . . . . 0.0 111.377 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.46 ' HB ' ' CG1' ' A' ' 21' ' ' ILE . 69.2 p -98.49 -39.32 8.81 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 -179.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.426 ' O ' ' CB ' ' A' ' 22' ' ' SER . 23.8 t -35.9 -34.19 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -179.021 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.837 HD22 ' CD2' ' A' ' 169' ' ' PHE . 0.0 OUTLIER -80.71 -70.31 0.54 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.761 0.315 . . . . 0.0 111.036 -179.746 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.676 ' H ' HD22 ' A' ' 20' ' ' LEU . 0.5 OUTLIER -50.84 -43.59 59.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.653 -179.908 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.781 HD11 ' CE2' ' B' ' 518' ' ' PHE . 32.5 mm -63.73 -64.05 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.171 179.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.426 ' CB ' ' O ' ' A' ' 18' ' ' CYS . 45.4 t -45.93 -30.17 1.67 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.958 0.408 . . . . 0.0 110.707 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -65.44 -45.24 84.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.412 179.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -87.39 -50.73 6.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.557 179.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.2 p -102.18 -158.55 0.68 Allowed 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.221 179.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -159.33 38.45 0.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.005 0.431 . . . . 0.0 110.821 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.6 98.9 8.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.92 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.469 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . 9.4 t80 -97.56 -52.04 0.21 Allowed Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.024 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.469 ' HD3' ' HB3' ' A' ' 28' ' ' PHE . 65.3 Cg_endo -90.37 26.53 0.49 Allowed 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.782 2.321 . . . . 0.0 112.62 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.57 -87.32 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.129 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.429 ' HB2' ' HD3' ' B' ' 529' ' ' ARG . 4.7 pt-20 -158.13 115.86 2.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.844 0.354 . . . . 0.0 110.737 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.439 ' O ' HG22 ' A' ' 33' ' ' VAL . 12.0 m-30 -105.83 119.5 39.32 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.759 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.508 HG23 ' HD3' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -161.86 -56.14 0.01 OUTLIER Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.145 179.863 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.508 ' HD3' HG23 ' A' ' 33' ' ' VAL . 19.1 Cg_exo -66.22 -15.52 48.61 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.469 2.112 . . . . 0.0 112.558 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.0 t -41.94 -30.67 0.28 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.907 0.384 . . . . 0.0 111.387 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.506 HG23 ' HB3' ' A' ' 59' ' ' ALA . 12.3 p -51.29 -22.47 2.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.329 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.48 ' CD1' ' O ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -81.88 48.15 1.18 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.311 179.896 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.406 ' OD2' ' N ' ' A' ' 57' ' ' ASP . 14.6 p-10 -74.13 -2.6 25.29 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.498 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -83.94 11.11 8.26 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 111.603 0.223 . . . . 0.0 111.603 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 48.7 p90 -60.27 160.96 7.7 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.74 0.305 . . . . 0.0 110.616 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.423 ' O ' ' CG1' ' B' ' 519' ' ' ILE . . . -109.89 135.99 49.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.476 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.881 HG23 HG21 ' A' ' 52' ' ' THR . 13.5 m -114.57 121.68 67.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.824 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.43 ' O ' ' CG1' ' A' ' 44' ' ' VAL . 1.6 p -91.51 103.84 16.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.524 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.67 HG22 ' CG2' ' A' ' 52' ' ' THR . 29.2 m -159.26 -177.12 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.305 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.467 ' HE1' ' N ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -112.76 97.59 6.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.511 -179.58 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 1.032 HG23 HG23 ' B' ' 510' ' ' ILE . 1.6 mm -69.54 87.67 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.504 ' HA3' HD13 ' B' ' 510' ' ' ILE . . . 39.79 -90.59 0.01 OUTLIER Glycine 0 CA--C 1.521 0.466 0 CA-C-N 116.066 -0.516 . . . . 0.0 113.53 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . -38.38 -82.76 0.01 OUTLIER Glycine 0 C--N 1.334 0.467 0 C-N-CA 121.542 -0.361 . . . . 0.0 113.502 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.467 ' N ' ' HE1' ' A' ' 45' ' ' MET . 1.9 mt-10 -135.35 165.96 32.41 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-O 120.898 0.38 . . . . 0.0 111.581 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.418 ' HD2' ' HB3' ' A' ' 49' ' ' GLU . 51.4 Cg_exo -54.28 99.74 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.769 2.313 . . . . 0.0 113.032 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.771 ' CE1' HG23 ' A' ' 3' ' ' THR . 6.2 t80 -173.24 153.06 2.37 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.667 179.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.881 HG21 HG23 ' A' ' 42' ' ' VAL . 0.8 OUTLIER -136.79 153.21 50.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.623 179.201 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.945 HD13 HG13 ' A' ' 4' ' ' ILE . 0.6 OUTLIER -80.93 -172.92 3.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.165 -179.879 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.408 ' O ' ' CE2' ' A' ' 56' ' ' PHE . . . -124.65 98.09 0.55 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.037 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.616 HD13 ' CB ' ' A' ' 6' ' ' CYS . 3.5 mm? -51.54 123.68 10.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.812 0.339 . . . . 0.0 111.053 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.408 ' CE2' ' O ' ' A' ' 54' ' ' GLY . 45.0 m-85 -113.6 118.75 35.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.786 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.433 ' HB2' ' CD ' ' A' ' 16' ' ' LYS . 35.6 p-10 -121.66 -176.57 3.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.119 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.643 ' OG1' HD22 ' B' ' 543' ' ' LEU . 75.7 p -124.52 130.83 53.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.923 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.506 ' HB3' HG23 ' A' ' 36' ' ' VAL . . . -140.93 -167.47 2.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.004 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.16 44.51 0.58 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.656 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.447 ' CD1' ' HB1' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -121.33 -158.11 0.75 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.702 0.287 . . . . 0.0 110.898 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -62.84 -34.96 78.42 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.341 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.458 ' HB3' ' CD1' ' A' ' 64' ' ' TYR . 0.5 OUTLIER -47.37 -58.0 4.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.079 -179.848 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.458 ' CD1' ' HB3' ' A' ' 63' ' ' ASP . 0.1 OUTLIER -175.2 100.58 0.08 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.721 179.778 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.24 -21.91 39.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.158 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.422 ' HG2' ' N ' ' A' ' 67' ' ' LEU . 0.1 OUTLIER -88.29 -29.1 20.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.129 -179.852 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.479 HD21 ' H ' ' A' ' 59' ' ' ALA . 20.8 mt 51.86 -153.23 0.21 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.486 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.423 ' O ' ' N ' ' A' ' 71' ' ' SER . 0.3 OUTLIER 179.56 -56.87 0.0 OUTLIER Pre-proline 0 C--N 1.333 -0.152 0 CA-C-O 120.731 0.3 . . . . 0.0 111.427 -179.992 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.406 ' HD3' ' HB3' ' A' ' 68' ' ' ARG . 85.8 Cg_exo -42.23 -27.99 0.81 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.673 2.249 . . . . 0.0 112.799 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.723 ' O ' HD12 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -85.89 -31.18 22.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.903 -179.783 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.423 ' N ' ' O ' ' A' ' 68' ' ' ARG . 35.0 t -47.45 -71.19 0.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.158 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.455 ' N ' ' CD1' ' A' ' 72' ' ' TYR . 0.0 OUTLIER 176.67 64.72 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.047 -179.855 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.98 172.9 11.99 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.51 2.14 . . . . 0.0 112.149 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 16.3 tp60 -87.98 10.2 19.71 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.495 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 12.3 t -52.35 161.13 0.7 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.783 0.325 . . . . 0.0 110.819 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -122.82 5.16 9.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.468 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.466 HG21 ' CA ' ' A' ' 176' ' ' ALA . 60.0 t -140.48 97.81 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.782 0.325 . . . . 0.0 111.117 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -95.59 -177.97 4.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.71 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.513 HD12 ' O ' ' A' ' 111' ' ' LEU . 10.7 tp -147.35 108.8 4.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.255 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.0 m -95.09 131.02 43.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.359 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 2.6 m -127.08 134.67 50.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.922 0.391 . . . . 0.0 111.42 -179.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.848 ' CE2' HD22 ' A' ' 112' ' ' LEU . 10.6 p90 -148.06 132.47 17.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.546 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.43 ' CA ' ' HG3' ' A' ' 116' ' ' GLN . 0.5 OUTLIER -83.84 133.14 34.76 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.251 -179.675 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.88 HG23 ' HB2' ' A' ' 116' ' ' GLN . 59.5 t -42.45 -67.75 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.566 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.785 HG13 ' OE1' ' A' ' 116' ' ' GLN . 28.5 m -37.03 111.17 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-O 120.75 0.31 . . . . 0.0 111.379 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.798 ' N ' HD22 ' A' ' 129' ' ' LEU . 0.1 OUTLIER -151.5 139.24 12.62 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.828 -179.064 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.426 ' O ' ' CB ' ' A' ' 132' ' ' ASN . 91.6 Cg_endo -91.02 53.19 0.93 Allowed 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 123.189 2.592 . . . . 0.0 111.681 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.474 ' CA ' ' HB2' ' A' ' 133' ' ' LYS . 0.1 OUTLIER 70.68 19.45 6.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.077 -179.521 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.568 ' O ' HG23 ' A' ' 93' ' ' VAL . 1.4 m -97.23 -23.37 16.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.964 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -47.1 -48.48 22.87 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.183 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -51.94 -40.4 60.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.991 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.412 ' HA ' ' HB2' ' A' ' 95' ' ' GLU . 0.7 OUTLIER -76.62 -36.55 57.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.933 -179.873 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 89' ' ' SER . 62.9 t -51.09 -57.25 3.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.291 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.771 ' HG2' HD13 ' A' ' 145' ' ' LEU . 3.8 mptp? -73.6 -32.35 64.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.118 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.412 ' HB2' ' HA ' ' A' ' 92' ' ' ASN . 6.3 mm-40 -64.72 -23.99 67.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.093 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 93' ' ' VAL . 13.5 ptmt -108.35 -17.67 13.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.4 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.527 ' CE2' HG13 ' A' ' 93' ' ' VAL . 34.0 m0 -76.83 -54.4 6.65 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.765 0.317 . . . . 0.0 111.078 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.531 HG11 HD22 ' A' ' 149' ' ' LEU . 42.6 t -47.18 -50.15 48.55 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.841 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 62.2 Cg_endo -72.98 -16.19 25.81 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.145 1.897 . . . . 0.0 112.549 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -85.5 -39.63 17.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.906 0.384 . . . . 0.0 110.933 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 40.8 pt -71.58 -32.93 47.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.05 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 11.0 p -80.26 -32.69 38.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.908 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -64.73 -50.09 68.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.685 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -76.03 -33.08 59.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.855 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 41.6 m -125.92 101.18 29.68 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.832 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -44.33 93.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.55 2.167 . . . . 0.0 112.49 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.2 mmmm 53.95 103.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.85 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.424 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -138.55 129.21 15.22 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.753 179.915 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 108' ' ' THR . 31.6 Cg_exo -60.2 162.82 15.91 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.448 2.099 . . . . 0.0 112.25 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.837 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 7.6 p90 -162.9 150.57 13.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.947 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.92 HD12 HG11 ' A' ' 152' ' ' VAL . 9.7 tt -120.51 150.67 40.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.063 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.98 HD12 ' HB2' ' A' ' 146' ' ' ALA . 20.0 mt -108.03 156.19 19.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.813 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.897 HG13 HG11 ' A' ' 168' ' ' VAL . 3.8 t -130.92 148.82 33.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.913 0.387 . . . . 0.0 111.44 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.53 ' O ' HD11 ' A' ' 117' ' ' ILE . . . -123.54 84.85 0.37 Allowed Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.266 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.499 ' HB ' ' HA ' ' A' ' 158' ' ' SER . 0.7 OUTLIER -106.52 7.32 30.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.657 0.265 . . . . 0.0 111.667 -179.558 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.88 ' HB2' HG23 ' A' ' 84' ' ' VAL . 0.7 OUTLIER -98.07 -17.05 19.33 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.628 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.65 HD12 ' N ' ' A' ' 117' ' ' ILE . 0.2 OUTLIER -48.75 -24.11 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.831 179.238 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.14 -22.14 58.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.163 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.651 HD11 ' CD ' ' A' ' 116' ' ' GLN . 4.5 pp -122.45 -10.04 8.46 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.623 ' HD3' HG22 ' A' ' 117' ' ' ILE . 0.7 OUTLIER -50.44 -27.18 5.99 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.942 0.401 . . . . 0.0 110.719 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -77.32 -26.62 52.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.529 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 119' ' ' LEU . 9.0 m-20 -50.81 103.92 0.4 Allowed Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.639 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.401 ' HA ' ' CG2' ' A' ' 126' ' ' ILE . 15.1 Cg_exo -68.61 -3.99 12.24 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.8 2.334 . . . . 0.0 113.047 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 26.7 t -80.88 -67.42 0.78 Allowed 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.56 HG21 HG11 ' A' ' 85' ' ' VAL . 9.0 m -56.32 -32.74 64.92 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.408 0.623 . . . . 0.0 109.355 178.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.977 HD11 ' HB3' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -61.6 -43.33 96.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.466 179.196 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.479 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 7.0 mm-40 -56.2 -34.51 66.32 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.45 178.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.429 ' HB2' ' O ' ' A' ' 125' ' ' THR . 2.2 mptt -65.95 -32.95 74.74 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.798 HD22 ' N ' ' A' ' 86' ' ' SER . 6.8 mt -71.85 -39.3 69.79 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.488 ' HA ' ' HB3' ' A' ' 134' ' ' GLN . . . -48.01 -26.71 1.89 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.094 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.7 mmtp -64.69 -32.32 73.94 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.579 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.426 ' CB ' ' O ' ' A' ' 87' ' ' PRO . 47.8 m-80 -124.2 -30.99 3.38 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -179.186 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.492 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 0.0 OUTLIER -133.63 -73.16 0.49 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.345 -178.836 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.492 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 2.3 pt20 99.28 -33.42 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.866 0.866 . . . . 0.0 111.089 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -68.61 110.46 5.93 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.774 -178.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.977 ' HB3' HD11 ' A' ' 126' ' ' ILE . 72.4 Cg_endo -76.07 123.08 7.05 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.32 2.014 . . . . 0.0 111.355 179.049 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.68 ' N ' HD13 ' A' ' 137' ' ' ILE . 0.8 OUTLIER -57.38 96.36 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.549 -179.696 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.423 HG22 ' H ' ' A' ' 138' ' ' THR . 0.5 OUTLIER -72.56 150.22 91.2 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.737 -179.808 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.488 ' HG3' HG21 ' A' ' 117' ' ' ILE . 97.8 Cg_exo -41.35 -38.34 3.61 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.682 2.255 . . . . 0.0 112.586 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -65.63 -33.36 75.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.004 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.565 HG21 HG23 ' A' ' 137' ' ' ILE . 58.5 m -60.15 -63.77 1.18 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.952 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.57 ' HB1' ' CD2' ' A' ' 154' ' ' TYR . . . -48.73 -48.16 40.78 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.807 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -58.98 -37.24 76.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.449 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -60.51 -58.38 8.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.48 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.771 HD13 ' HG2' ' A' ' 94' ' ' LYS . 0.5 OUTLIER -63.78 -33.32 75.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.393 179.574 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.98 ' HB2' HD12 ' A' ' 112' ' ' LEU . . . -65.05 -34.39 78.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.697 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -90.5 -25.31 20.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.655 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -57.01 -33.09 66.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.827 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.531 HD22 HG11 ' A' ' 98' ' ' VAL . 0.3 OUTLIER -113.07 19.49 17.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.14 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt 47.91 40.31 12.58 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.196 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.837 ' HB1' ' O ' ' A' ' 110' ' ' PHE . . . -58.4 -80.97 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.069 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.92 HG11 HD12 ' A' ' 111' ' ' LEU . 55.6 t -160.52 -75.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.744 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 176.07 126.82 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.773 -179.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.57 ' CD2' ' HB1' ' A' ' 142' ' ' ALA . 6.0 t80 -96.78 111.02 23.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.08 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 2.6 t -101.76 152.43 5.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.867 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -91.78 127.05 37.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.24 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.457 ' HA ' ' HB3' ' A' ' 163' ' ' LYS . 1.1 p 179.31 126.92 0.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.988 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.499 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 87.7 p -100.38 153.9 18.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.399 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.588 ' HB2' HD21 ' A' ' 165' ' ' LEU . . . -94.09 -35.58 12.49 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.828 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.454 ' H ' HD12 ' A' ' 160' ' ' LEU . 1.2 mp -47.5 -41.74 21.54 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.641 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.4 HG22 ' OG ' ' A' ' 158' ' ' SER . 5.0 t -112.97 -16.94 12.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.738 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.405 ' O ' ' NE2' ' A' ' 162' ' ' GLN . 0.8 OUTLIER 72.86 70.88 0.13 Allowed 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.837 179.983 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.457 ' HB3' ' HA ' ' A' ' 157' ' ' CYS . 2.1 tttm -87.84 -20.02 26.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.21 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 168.19 37.32 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.74 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.831 HD12 ' CB ' ' A' ' 19' ' ' LEU . 0.5 OUTLIER -47.82 -39.62 18.86 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.762 0.315 . . . . 0.0 110.914 179.966 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 13.8 pttp -72.61 -32.92 66.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.793 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -54.56 -70.3 0.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.597 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.897 HG11 HG13 ' A' ' 113' ' ' VAL . 7.7 p -53.7 -46.52 62.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.08 0.467 . . . . 0.0 110.358 179.525 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.837 ' CD2' HD22 ' A' ' 19' ' ' LEU . 0.8 OUTLIER -55.37 -34.09 64.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.239 179.324 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.429 ' HA ' ' CG1' ' A' ' 173' ' ' ILE . 52.5 t0 -62.13 -43.65 98.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.277 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.547 ' CB ' HD11 ' A' ' 111' ' ' LEU . 62.8 mm-40 -62.48 -28.99 70.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.367 179.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.619 ' N ' HD13 ' A' ' 111' ' ' LEU . . . -78.73 -49.21 13.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.134 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.446 ' HB ' HD12 ' A' ' 4' ' ' ILE . 1.5 pp -72.05 -36.84 58.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.344 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.833 HD13 ' O ' ' A' ' 174' ' ' LEU . 3.1 tm? -63.08 -32.67 74.1 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.969 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.69 -22.47 62.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.026 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.466 ' CA ' HG21 ' A' ' 77' ' ' VAL . . . -87.76 -31.41 19.65 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.102 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.861 HD13 HG21 ' B' ' 510' ' ' ILE . 0.3 OUTLIER -92.7 15.27 14.86 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.278 -179.87 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 176.92 98.11 0.11 Allowed Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.692 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -46.8 102.93 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.654 2.236 . . . . 0.0 112.547 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.26 170.88 19.37 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.59 2.193 . . . . 0.0 112.37 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -146.01 139.28 14.47 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.782 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -77.96 -165.27 0.32 Allowed 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.553 2.168 . . . . 0.0 112.332 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.9 153.95 32.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.879 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 2.3 mtpt . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.892 179.88 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 502' ' ' GLY . . . . . 0.837 ' N ' ' HG ' ' B' ' 511' ' ' SER . . . . . . . . 0 N--CA 1.488 2.165 0 N-CA-C 112.458 -0.257 . . . . 0.0 112.458 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 503' ' ' SER . . . . . 0.401 ' HB3' ' OD2' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -75.8 -86.62 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.714 0.292 . . . . 0.0 110.726 179.91 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 504' ' ' GLY . . . . . 0.61 ' C ' HD23 ' B' ' 505' ' ' LEU . . . 63.46 119.75 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.259 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 505' ' ' LEU . . . . . 0.726 ' N ' HD23 ' B' ' 505' ' ' LEU . 0.8 OUTLIER -173.66 115.59 0.23 Allowed 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 120.811 0.339 . . . . 0.0 111.818 -178.374 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 506' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 79.0 -74.11 0.06 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.615 179.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 507' ' ' ALA . . . . . 0.436 ' HB3' HG12 ' B' ' 510' ' ' ILE . . . -35.26 -38.14 0.09 Allowed 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.436 0.636 . . . . 0.0 111.651 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 508' ' ' GLN . . . . . 0.519 ' O ' ' CB ' ' B' ' 509' ' ' ASP . 0.9 OUTLIER 159.47 -33.86 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.768 -1.105 . . . . 0.0 108.747 -179.677 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 509' ' ' ASP . . . . . 0.519 ' CB ' ' O ' ' B' ' 508' ' ' GLN . 27.0 t70 138.13 43.35 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 O-C-N 124.957 1.411 . . . . 0.0 109.704 179.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 510' ' ' ILE . . . . . 1.032 HG23 HG23 ' A' ' 46' ' ' ILE . 21.9 mm -60.4 107.63 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.701 179.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 511' ' ' SER . . . . . 0.837 ' HG ' ' N ' ' B' ' 502' ' ' GLY . 3.9 m -101.89 130.07 48.28 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.949 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 512' ' ' GLN . . . . . 0.513 ' CB ' ' HD3' ' B' ' 513' ' ' PRO . 1.2 mm-40 -79.75 -66.87 0.25 Allowed Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.539 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 513' ' ' PRO . . . . . 0.513 ' HD3' ' CB ' ' B' ' 512' ' ' GLN . 79.0 Cg_endo -82.25 56.29 5.72 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.573 2.182 . . . . 0.0 111.84 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 514' ' ' LEU . . . . . 0.502 ' HB2' ' HB ' ' A' ' 44' ' ' VAL . 0.7 OUTLIER -55.53 -84.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.047 -179.583 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 515' ' ' GLN . . . . . 0.501 ' HB2' HG12 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -90.62 -84.81 0.23 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.828 -179.982 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -110.68 -36.8 5.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.538 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 517' ' ' SER . . . . . 0.483 ' C ' HG12 ' A' ' 42' ' ' VAL . 15.4 m 52.58 27.23 4.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.205 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 518' ' ' PHE . . . . . 0.781 ' CE2' HD11 ' A' ' 21' ' ' ILE . 0.3 OUTLIER -163.54 91.59 0.68 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.365 -179.879 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 519' ' ' ILE . . . . . 0.461 HG12 ' HA ' ' A' ' 42' ' ' VAL . 4.7 mm -101.35 131.82 48.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.858 0.361 . . . . 0.0 110.901 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -54.16 108.43 0.37 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.993 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 521' ' ' THR . . . . . . . . . . . . . 3.5 m -166.25 143.53 5.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.941 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 522' ' ' GLY . . . . . . . . . . . . . . . 128.47 179.06 15.67 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.552 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 523' ' ' HIS . . . . . . . . . . . . . 74.8 t60 -148.52 -84.12 0.1 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.808 0.337 . . . . 0.0 110.962 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 524' ' ' GLY . . . . . . . . . . . . . . . 57.81 -169.81 4.25 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.595 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 525' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -110.58 88.02 2.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.902 0.382 . . . . 0.0 110.86 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 526' ' ' SER . . . . . . . . . . . . . 35.6 p -77.44 95.59 4.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.786 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 527' ' ' ASP . . . . . 0.485 ' H ' HG11 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -174.32 -64.71 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.956 179.632 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 528' ' ' PRO . . . . . 0.484 ' CD ' ' CB ' ' B' ' 527' ' ' ASP . 20.3 Cg_endo -58.01 78.83 0.04 OUTLIER 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.971 2.447 . . . . 0.0 112.368 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 529' ' ' ARG . . . . . 0.437 ' HD3' ' CG2' ' A' ' 33' ' ' VAL . 7.0 mtt85 -82.8 -31.96 27.94 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.698 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 530' ' ' HIS . . . . . . . . . . . . . 9.4 m170 51.92 24.01 2.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.82 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 16.5 p 41.78 -163.8 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.377 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 532' ' ' TRP . . . . . 0.502 ' CZ2' ' HA ' ' B' ' 537' ' ' ARG . 34.9 t-105 -169.48 127.82 0.96 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.982 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . -159.62 35.4 0.47 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.234 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 534' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -109.66 161.62 23.45 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 120.708 0.289 . . . . 0.0 111.065 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -57.38 -57.44 1.26 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.622 2.215 . . . . 0.0 112.203 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -123.38 157.82 32.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.011 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 537' ' ' ARG . . . . . 0.502 ' HA ' ' CZ2' ' B' ' 532' ' ' TRP . 24.6 mmt180 -66.94 145.48 55.39 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.153 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 538' ' ' ILE . . . . . 0.697 HG23 HD12 ' B' ' 543' ' ' LEU . 5.8 tp -59.93 143.71 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.633 179.088 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 539' ' ' ASP . . . . . 0.611 ' HB3' HD12 ' B' ' 541' ' ' LEU . 1.1 m-20 -42.7 128.33 4.08 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.812 0.339 . . . . 0.0 111.786 -179.05 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 540' ' ' GLU . . . . . 0.492 ' HA ' ' CD1' ' B' ' 543' ' ' LEU . 41.0 mm-40 -40.95 -24.47 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.27 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 541' ' ' LEU . . . . . 0.611 HD12 ' HB3' ' B' ' 539' ' ' ASP . 0.8 OUTLIER -31.12 -69.6 0.07 Allowed 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -179.251 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 542' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -104.45 -64.74 1.08 Allowed 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -178.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 543' ' ' LEU . . . . . 0.697 HD12 HG23 ' B' ' 538' ' ' ILE . 10.2 mp 58.37 179.5 0.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.739 0.304 . . . . 0.0 110.388 -178.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . -172.91 -54.84 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.503 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 545' ' ' ASN . . . . . . . . . . . . . 42.6 p30 . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.81 179.877 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.439 ' CE ' ' HB ' ' A' ' 46' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.873 0.368 . . . . 0.0 111.107 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.432 ' O ' ' CD2' ' A' ' 177' ' ' LEU . 5.4 tt0 -174.71 130.66 0.33 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.695 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.925 HG23 HD12 ' A' ' 46' ' ' ILE . 0.6 OUTLIER -116.86 -173.7 2.44 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.246 -179.591 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.704 ' H ' HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -151.38 163.27 2.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.769 -178.541 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.65 156.23 17.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.766 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.433 ' SG ' ' CZ ' ' A' ' 169' ' ' PHE . 0.0 OUTLIER -118.57 141.51 48.52 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.278 -179.755 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.1 t -148.34 159.77 7.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.669 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.83 HG22 ' HA3' ' A' ' 15' ' ' GLY . 16.3 t -119.38 151.76 21.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.238 0.542 . . . . 0.0 111.753 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 86.2 t -156.19 130.05 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.044 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.89 -140.52 14.74 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.197 -1.002 . . . . 0.0 112.836 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' B' ' 537' ' ' ARG . 3.4 m-20 -123.23 27.85 7.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.657 0.265 . . . . 0.0 110.934 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -118.23 177.54 16.53 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.961 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.585 ' HB1' ' HB3' ' A' ' 18' ' ' CYS . . . -103.51 -26.85 12.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.775 0.322 . . . . 0.0 111.515 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.967 HG11 HG21 ' A' ' 113' ' ' VAL . 54.1 t -43.12 94.58 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 121.006 0.431 . . . . 0.0 111.418 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.83 ' HA3' HG22 ' A' ' 8' ' ' VAL . . . 132.89 -23.47 3.94 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.026 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.758 ' CG ' HG21 ' A' ' 8' ' ' VAL . 14.7 mttt -90.3 -159.13 0.58 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.767 0.318 . . . . 0.0 110.709 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.45 ' HB ' ' CG1' ' A' ' 21' ' ' ILE . 31.5 p -66.46 -44.91 81.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.392 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.585 ' HB3' ' HB1' ' A' ' 13' ' ' ALA . 43.3 t -33.26 -58.54 0.39 Allowed 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.562 HD13 ' CG ' ' A' ' 169' ' ' PHE . 13.8 mt -42.2 -67.93 0.23 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.718 -179.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.468 ' N ' ' CD2' ' A' ' 20' ' ' LEU . 1.5 mm? -72.43 -25.73 61.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.444 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.45 ' CG1' ' HB ' ' A' ' 17' ' ' THR . 20.7 mm -70.83 -68.2 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.765 0.317 . . . . 0.0 110.565 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 27.1 t -57.77 -25.74 60.92 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.983 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.811 ' HB2' HD13 ' A' ' 165' ' ' LEU . 4.4 t80 -80.1 -68.52 0.67 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.005 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 97.8 m -70.26 -48.64 55.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.031 0.444 . . . . 0.0 110.658 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.446 HG22 ' H ' ' A' ' 26' ' ' ASN . 0.2 OUTLIER -77.48 -156.04 0.08 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.646 179.876 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.446 ' H ' HG22 ' A' ' 25' ' ' THR . 0.2 OUTLIER -149.7 40.13 0.81 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.719 0.295 . . . . 0.0 110.805 -179.935 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.4 mtmt -133.51 126.88 32.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.969 0.414 . . . . 0.0 111.369 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.501 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . 3.6 t80 -163.66 -53.44 0.01 OUTLIER Pre-proline 0 CA--C 1.536 0.437 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.947 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.501 ' HD3' ' HB3' ' A' ' 28' ' ' PHE . 5.7 Cg_exo -79.55 56.44 6.05 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.774 2.316 . . . . 0.0 112.418 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.7 m -143.54 -80.03 0.2 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.755 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -157.69 162.43 38.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.593 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.464 ' OH ' ' CD1' ' A' ' 28' ' ' PHE . 9.3 m-85 -131.55 94.6 3.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.967 0.413 . . . . 0.0 111.108 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.534 HG11 ' HG3' ' B' ' 529' ' ' ARG . 0.2 OUTLIER -133.05 -56.2 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.666 179.703 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.464 ' O ' ' CZ ' ' A' ' 37' ' ' PHE . 7.8 Cg_exo -72.17 59.08 2.99 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.346 2.031 . . . . 0.0 111.983 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.588 HG23 HD23 ' B' ' 543' ' ' LEU . 5.8 t -120.53 21.89 11.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.88 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.024 HG22 HD13 ' A' ' 61' ' ' LEU . 2.4 t -83.84 -4.75 8.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.648 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.464 ' CZ ' ' O ' ' A' ' 34' ' ' PRO . 4.2 m-85 -46.03 -27.7 1.0 Allowed 'General case' 0 N--CA 1.461 0.099 0 CA-C-O 120.813 0.34 . . . . 0.0 111.108 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.419 ' HA ' ' HB3' ' A' ' 57' ' ' ASP . 6.8 t0 69.26 33.07 3.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.642 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.422 ' CB ' ' O ' ' A' ' 55' ' ' LEU . 8.3 m120 52.01 87.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.609 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.473 ' OH ' ' CZ ' ' B' ' 518' ' ' PHE . 3.2 p90 -59.98 -175.73 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.707 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.408 ' O ' HG12 ' B' ' 519' ' ' ILE . . . -90.77 160.5 15.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.055 0.455 . . . . 0.0 111.823 -179.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.494 HG12 ' C ' ' B' ' 517' ' ' SER . 3.5 m -127.25 128.19 69.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.621 179.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.701 ' H ' HD11 ' B' ' 519' ' ' ILE . 59.1 p -85.59 104.76 15.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.943 0.401 . . . . 0.0 111.17 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.767 ' CG2' HG21 ' A' ' 52' ' ' THR . 20.7 m -157.79 -177.7 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.859 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.512 ' HG3' HD22 ' B' ' 514' ' ' LEU . 0.0 OUTLIER -128.03 116.93 20.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.349 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.925 HD12 HG23 ' A' ' 3' ' ' THR . 0.8 OUTLIER -81.98 87.65 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.676 0.274 . . . . 0.0 111.668 -179.865 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 56.87 -78.08 0.01 OUTLIER Glycine 0 C--N 1.333 0.374 0 CA-C-N 116.105 -0.498 . . . . 0.0 113.776 178.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . -54.0 -99.78 0.01 OUTLIER Glycine 0 C--N 1.331 0.285 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.979 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.478 ' CA ' ' HE3' ' A' ' 45' ' ' MET . 0.6 OUTLIER -119.72 164.26 22.99 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 120.878 0.37 . . . . 0.0 111.396 -179.617 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.76 100.93 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.699 2.266 . . . . 0.0 112.596 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.464 ' CD1' ' OG1' ' A' ' 3' ' ' THR . 12.3 t80 -172.84 106.61 0.16 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.361 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.767 HG21 ' CG2' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -124.43 153.78 41.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.939 0.399 . . . . 0.0 111.038 -179.92 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.653 HD12 ' N ' ' A' ' 4' ' ' ILE . 82.7 mt -113.44 100.0 8.19 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.863 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -46.17 164.13 0.11 Allowed Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.396 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.551 ' H ' HD12 ' A' ' 55' ' ' LEU . 2.4 mp -79.66 152.87 29.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.71 0.29 . . . . 0.0 110.847 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.422 ' CB ' ' O ' ' A' ' 6' ' ' CYS . 0.3 OUTLIER -103.32 122.05 44.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.524 -179.52 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.419 ' HB3' ' HA ' ' A' ' 38' ' ' ASP . 0.2 OUTLIER -127.65 167.0 17.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.36 179.367 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.701 ' HB ' HD11 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -149.41 128.72 12.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.905 0.383 . . . . 0.0 111.122 -179.444 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.691 ' HB3' ' HA ' ' A' ' 36' ' ' VAL . . . -144.86 100.73 3.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.664 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.406 ' HA2' ' O ' ' A' ' 64' ' ' TYR . . . -70.65 83.05 0.38 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.717 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 1.024 HD13 HG22 ' A' ' 36' ' ' VAL . 3.9 mp -121.5 -108.36 0.35 Allowed 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.564 0.182 . . . . 0.0 111.027 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -99.03 -30.02 12.57 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 120.827 0.346 . . . . 0.0 111.167 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.9 -63.32 1.19 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.442 -179.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.462 ' HE1' HG12 ' A' ' 36' ' ' VAL . 0.4 OUTLIER -107.62 120.6 42.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.94 -179.624 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -87.16 -53.39 4.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 112.029 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.21 8.8 44.28 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -178.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.813 HD23 ' O ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -47.46 110.68 0.33 Allowed 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 120.728 0.299 . . . . 0.0 110.667 179.625 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.671 ' HG2' HD11 ' B' ' 541' ' ' LEU . 0.0 OUTLIER -149.97 70.92 9.45 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.235 -179.788 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.668 ' CG ' HG21 ' A' ' 58' ' ' THR . 88.9 Cg_endo -81.02 -37.07 0.33 Allowed 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.591 2.194 . . . . 0.0 112.455 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.917 ' O ' HD12 ' A' ' 70' ' ' LEU . 0.1 OUTLIER -58.83 -18.2 30.36 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.002 -179.939 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.463 ' HB3' ' CD2' ' A' ' 72' ' ' TYR . 0.3 OUTLIER -43.34 -50.44 6.7 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.389 -179.962 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.463 ' CD2' ' HB3' ' A' ' 71' ' ' SER . 5.6 p90 -165.2 70.9 1.39 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.289 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -70.01 153.36 67.85 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.881 2.387 . . . . 0.0 112.063 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 -102.42 10.28 39.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.568 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 14.1 t -57.49 178.63 0.07 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.844 0.354 . . . . 0.0 110.986 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -115.85 -18.74 10.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.282 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.5 m -118.94 91.1 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.755 0.312 . . . . 0.0 111.284 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -81.14 121.64 26.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.486 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.594 HD11 ' CG1' ' A' ' 14' ' ' VAL . 0.1 OUTLIER -83.48 108.52 16.67 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.953 0.406 . . . . 0.0 111.236 -179.675 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.719 ' O ' HD13 ' A' ' 112' ' ' LEU . 3.3 m -110.25 100.7 11.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.887 179.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -113.37 146.94 38.65 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.536 -179.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.439 ' C ' ' CD1' ' A' ' 82' ' ' PHE . 6.3 p90 -155.48 143.05 19.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.216 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.96 133.4 35.3 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.112 0.482 . . . . 0.0 111.188 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.664 HG23 ' HB2' ' A' ' 116' ' ' GLN . 89.2 t -48.5 -69.6 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.551 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.72 HG22 ' OE1' ' A' ' 116' ' ' GLN . 16.0 m -40.84 110.45 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 120.742 0.306 . . . . 0.0 111.332 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.629 ' N ' HD21 ' A' ' 129' ' ' LEU . 52.4 p -154.36 134.03 7.69 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.772 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.435 ' O ' ' HB2' ' A' ' 133' ' ' LYS . 20.0 Cg_endo -61.21 -81.76 0.01 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 121.909 1.739 . . . . 0.0 111.408 179.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.9 t -144.87 24.55 1.49 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.832 0.349 . . . . 0.0 110.966 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.518 ' O ' HG23 ' A' ' 93' ' ' VAL . 1.7 t -93.44 -21.88 19.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.176 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -48.41 -49.01 36.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.178 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -57.84 -40.6 80.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.996 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 17.5 m-20 -67.42 -50.03 61.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.903 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.606 HG13 ' CE2' ' A' ' 97' ' ' TRP . 47.2 t -51.47 -52.37 20.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.193 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.662 ' O ' HG23 ' A' ' 98' ' ' VAL . 2.3 tttp -52.31 -54.68 28.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.022 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.405 ' O ' ' HG2' ' A' ' 99' ' ' PRO . 50.7 mt-10 -78.66 3.11 17.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.829 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.5 ttmm -115.2 -19.07 10.96 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.721 0.296 . . . . 0.0 111.184 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.606 ' CE2' HG13 ' A' ' 93' ' ' VAL . 27.9 m0 -93.74 -51.4 4.93 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.199 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 94' ' ' LYS . 16.8 t -49.68 -44.98 78.71 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.706 -179.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.501 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 3.6 Cg_exo -74.88 -16.49 20.51 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.641 2.228 . . . . 0.0 112.612 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -90.19 -53.64 4.37 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.841 0.353 . . . . 0.0 110.976 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.514 ' CD1' ' CE2' ' A' ' 110' ' ' PHE . 1.0 OUTLIER -56.61 -24.2 18.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.151 179.997 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.7 p -88.8 -45.66 9.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.861 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -50.13 -32.68 16.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.959 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -79.52 -26.97 41.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.021 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -151.59 104.88 2.89 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.977 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -49.67 108.8 0.22 Allowed 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.397 2.065 . . . . 0.0 112.09 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 67.7 93.07 0.08 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.747 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.05 119.4 10.5 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.034 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -60.67 154.4 55.1 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.534 2.156 . . . . 0.0 112.438 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.514 ' CE2' ' CD1' ' A' ' 101' ' ' ILE . 1.2 p90 -151.53 147.85 27.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.864 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.807 HD12 HG11 ' A' ' 152' ' ' VAL . 0.8 OUTLIER -110.38 160.67 16.37 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.417 -179.595 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.719 HD13 ' O ' ' A' ' 80' ' ' VAL . 2.5 mm? -123.48 161.19 25.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.586 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.967 HG21 HG11 ' A' ' 14' ' ' VAL . 21.6 t -139.6 143.57 30.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.974 0.416 . . . . 0.0 111.912 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.442 ' O ' ' CD1' ' A' ' 117' ' ' ILE . . . -119.54 92.03 0.52 Allowed Glycine 0 C--N 1.331 0.297 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.005 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.604 HG22 ' SG ' ' A' ' 157' ' ' CYS . 0.6 OUTLIER -117.25 9.51 13.48 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -178.836 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.72 ' OE1' HG22 ' A' ' 85' ' ' VAL . 1.9 mm-40 -114.74 11.97 16.94 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.879 0.371 . . . . 0.0 110.323 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.763 HD11 ' O ' ' A' ' 157' ' ' CYS . 0.1 OUTLIER -57.97 -17.37 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.718 179.043 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -100.13 -17.3 17.48 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.544 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.57 HD13 ' HA ' ' A' ' 116' ' ' GLN . 5.5 mp -91.79 -32.58 15.31 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.775 0.321 . . . . 0.0 110.992 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.541 ' O ' HD13 ' A' ' 126' ' ' ILE . 1.0 OUTLIER -42.44 -52.42 4.66 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.361 -179.916 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.49 -42.59 98.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.58 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -45.37 102.79 0.31 Allowed Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.886 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.469 ' HA ' ' CG2' ' A' ' 126' ' ' ILE . 42.8 Cg_endo -68.6 -6.88 18.86 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.409 2.073 . . . . 0.0 112.947 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.34 -66.15 0.58 Allowed 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.045 0.45 . . . . 0.0 109.853 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.706 HG22 ' CD1' ' A' ' 129' ' ' LEU . 49.2 m -60.62 -49.37 77.79 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.776 HD11 ' HD3' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -47.3 -36.98 4.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.001 179.566 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.603 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 0.2 OUTLIER -62.59 -40.85 98.23 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.694 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.455 ' N ' ' O ' ' A' ' 125' ' ' THR . 0.2 OUTLIER -65.06 -33.73 76.74 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 177.992 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.706 ' CD1' HG22 ' A' ' 125' ' ' THR . 7.3 mp -68.83 -40.65 79.33 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 177.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.603 ' HB3' ' O ' ' A' ' 127' ' ' GLU . . . -44.9 -31.37 1.23 Allowed 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.587 179.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -51.41 -27.27 9.63 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.986 179.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.468 ' O ' ' CG ' ' A' ' 133' ' ' LYS . 1.2 m-80 -123.3 -34.67 3.08 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.211 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.484 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 46.7 mttt -169.65 -86.21 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 O-C-N 123.107 0.255 . . . . 0.0 111.641 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.484 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 0.1 OUTLIER 102.49 106.7 0.01 OUTLIER 'General case' 0 C--N 1.351 0.638 0 C-N-CA 124.37 1.068 . . . . 0.0 110.38 -179.284 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.5 mmtm -159.38 92.44 1.84 Allowed Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.329 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.776 ' HD3' HD11 ' A' ' 126' ' ' ILE . 21.1 Cg_endo -62.12 103.22 0.29 Allowed 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 122.252 1.968 . . . . 0.0 112.306 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.831 HG22 ' HB ' ' A' ' 141' ' ' THR . 1.5 mm -45.31 106.56 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.443 179.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.421 ' O ' ' N ' ' A' ' 141' ' ' THR . 1.6 p -67.19 141.25 96.07 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.342 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -40.42 -29.77 0.42 Allowed 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.901 2.4 . . . . 0.0 112.015 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.35 -41.12 94.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.556 179.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.831 ' HB ' HG22 ' A' ' 137' ' ' ILE . 47.0 m -57.39 -66.61 0.43 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.009 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.523 ' HB3' ' CE2' ' A' ' 154' ' ' TYR . . . -47.7 -49.31 28.27 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.887 0.375 . . . . 0.0 110.919 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -64.16 -33.92 76.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.432 179.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 15.6 tttt -73.71 -46.63 44.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.631 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 14.5 tp -68.24 -39.91 82.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.208 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -62.11 -35.82 79.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.666 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.7 mtp180 -90.32 -29.86 17.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.666 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -50.79 -29.52 11.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.733 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.5 mt -123.02 21.09 9.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.91 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 45.5 mttt 48.08 52.24 13.45 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.943 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.714 ' O ' HG23 ' A' ' 152' ' ' VAL . . . -59.17 -83.37 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.032 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.807 HG11 HD12 ' A' ' 111' ' ' LEU . 19.1 t -166.33 -68.38 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.285 179.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.04 144.04 2.06 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.144 0.497 . . . . 0.0 111.824 -179.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.523 ' CE2' ' HB3' ' A' ' 142' ' ' ALA . 37.1 t80 -135.96 102.57 5.08 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.733 ' HB ' HG22 ' A' ' 168' ' ' VAL . 2.3 t -105.93 167.87 3.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.328 -178.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.526 ' H ' HG12 ' A' ' 155' ' ' VAL . 5.5 tt0 -89.58 118.6 29.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.126 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.763 ' O ' HD11 ' A' ' 117' ' ' ILE . 17.9 p -144.92 -175.79 4.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.174 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 3.1 m -159.61 158.29 31.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.965 0.412 . . . . 0.0 111.576 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -115.44 -33.41 5.27 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.464 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.46 HD23 ' H ' ' A' ' 160' ' ' LEU . 0.2 OUTLIER -81.19 -34.85 32.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.65 179.699 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.0 t -113.0 -24.65 9.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.925 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 72.6 93.92 0.08 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.045 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -124.93 33.11 5.27 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.133 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 120.87 47.79 0.31 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.762 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.811 HD13 ' HB2' ' A' ' 23' ' ' TYR . 0.8 OUTLIER -56.52 -56.24 23.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.822 0.344 . . . . 0.0 110.745 179.838 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.403 ' O ' ' CB ' ' A' ' 170' ' ' ASP . 4.8 pttt -63.44 -29.14 70.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.805 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -51.54 -72.31 0.05 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.9 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.854 HG11 HG22 ' A' ' 113' ' ' VAL . 61.8 t -56.59 -53.36 42.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.994 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.562 ' CG ' HD13 ' A' ' 19' ' ' LEU . 3.2 t80 -53.24 -35.82 60.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.871 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.403 ' CB ' ' O ' ' A' ' 166' ' ' LYS . 5.3 m-20 -61.4 -40.34 94.02 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.915 0.388 . . . . 0.0 109.995 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.622 ' CB ' HD11 ' A' ' 111' ' ' LEU . 7.6 mm-40 -60.6 -34.89 74.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.163 179.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.513 ' CB ' HD21 ' A' ' 79' ' ' LEU . . . -62.01 -65.0 0.76 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.68 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.56 HD13 ' HG2' ' B' ' 512' ' ' GLN . 1.4 pp -59.76 -41.53 85.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.985 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.761 HD11 ' HB3' ' B' ' 506' ' ' SER . 5.2 tp -60.37 -43.77 96.25 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.006 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -54.61 -22.33 13.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.943 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -86.49 -37.78 17.92 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.122 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 1.058 HD13 HG21 ' B' ' 510' ' ' ILE . 1.9 mt -72.94 -35.88 67.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.897 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -141.79 139.46 18.42 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.949 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . 0.45 ' HA ' ' HD2' ' A' ' 180' ' ' PRO . 53.6 Cg_endo -69.83 111.61 2.87 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.545 2.163 . . . . 0.0 112.286 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . 0.45 ' HD2' ' HA ' ' A' ' 179' ' ' PRO . 33.4 Cg_endo -64.35 167.05 15.55 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.355 2.036 . . . . 0.0 112.211 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -102.79 96.38 7.61 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.142 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 180' ' ' PRO . 81.0 Cg_endo -76.64 -164.93 0.28 Allowed 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.702 2.268 . . . . 0.0 112.208 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.53 83.16 4.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.901 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 14.6 mttm . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.892 179.967 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.174 0 N-CA-C 112.435 -0.266 . . . . 0.0 112.435 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 503' ' ' SER . . . . . . . . . . . . . 1.4 m -61.39 -177.23 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.812 0.339 . . . . 0.0 110.799 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 504' ' ' GLY . . . . . 0.592 ' HA2' HD22 ' A' ' 174' ' ' LEU . . . -99.78 65.27 0.62 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.387 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 505' ' ' LEU . . . . . 0.504 ' O ' HD21 ' A' ' 174' ' ' LEU . 0.3 OUTLIER -108.92 159.89 16.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.05 0.453 . . . . 0.0 111.197 -179.971 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 506' ' ' SER . . . . . 0.761 ' HB3' HD11 ' A' ' 174' ' ' LEU . 11.3 t 165.8 -44.63 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.539 -179.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 507' ' ' ALA . . . . . 0.599 ' HB3' HG12 ' B' ' 510' ' ' ILE . . . -47.98 -28.31 2.68 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.159 178.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 508' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 167.17 -31.82 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.373 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 509' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 172.2 37.58 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.927 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 510' ' ' ILE . . . . . 1.058 HG21 HD13 ' A' ' 177' ' ' LEU . 46.9 mm -67.53 103.24 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.913 0.387 . . . . 0.0 111.286 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 511' ' ' SER . . . . . . . . . . . . . 2.1 m -101.43 131.79 47.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.921 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 512' ' ' GLN . . . . . 0.56 ' HG2' HD13 ' A' ' 173' ' ' ILE . 0.4 OUTLIER -93.41 -64.28 0.14 Allowed Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.144 -179.919 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 513' ' ' PRO . . . . . 0.49 ' HD3' ' CB ' ' B' ' 512' ' ' GLN . 89.4 Cg_endo -81.36 67.88 8.35 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.516 2.144 . . . . 0.0 112.521 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 514' ' ' LEU . . . . . 0.512 HD22 ' HG3' ' A' ' 45' ' ' MET . 0.4 OUTLIER -81.16 -85.21 0.1 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.914 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 515' ' ' GLN . . . . . 0.411 ' HB2' HG12 ' A' ' 44' ' ' VAL . 2.3 mt-30 -93.22 -158.9 0.64 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.671 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -46.97 -27.85 1.42 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.026 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 517' ' ' SER . . . . . 0.494 ' C ' HG12 ' A' ' 42' ' ' VAL . 3.0 m 40.65 42.72 1.45 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.719 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 518' ' ' PHE . . . . . 0.473 ' CZ ' ' OH ' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -163.76 91.88 0.67 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.927 -179.951 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 519' ' ' ILE . . . . . 0.701 HD11 ' H ' ' A' ' 43' ' ' THR . 6.2 mm -87.89 -33.74 6.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.748 0.309 . . . . 0.0 111.18 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 520' ' ' HIS . . . . . 0.467 ' HA ' ' CE2' ' A' ' 40' ' ' TYR . 0.7 OUTLIER 69.72 119.37 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.898 179.994 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 521' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -165.98 51.83 0.09 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.981 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 522' ' ' GLY . . . . . . . . . . . . . . . -138.26 157.62 24.51 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.445 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 523' ' ' HIS . . . . . . . . . . . . . 69.4 t60 -132.61 -84.74 0.47 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.662 0.268 . . . . 0.0 111.028 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 524' ' ' GLY . . . . . 0.408 ' HA3' ' HB ' ' A' ' 36' ' ' VAL . . . 66.22 176.67 7.14 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.465 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 525' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -75.05 87.42 2.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.89 0.376 . . . . 0.0 110.837 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 526' ' ' SER . . . . . 0.423 ' CB ' ' HB3' ' A' ' 34' ' ' PRO . 1.1 m -89.62 95.98 10.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.884 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 527' ' ' ASP . . . . . 0.496 ' O ' HG21 ' A' ' 33' ' ' VAL . 0.2 OUTLIER -159.13 145.71 12.58 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.939 179.864 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -68.83 105.59 1.35 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.705 2.27 . . . . 0.0 112.348 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 529' ' ' ARG . . . . . 0.534 ' HG3' HG11 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -100.31 -55.13 2.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.051 -179.885 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 530' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -165.89 97.63 0.64 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.846 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 95.5 m -46.27 171.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.121 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 532' ' ' TRP . . . . . 0.475 ' CZ2' ' HG3' ' B' ' 537' ' ' ARG . 0.0 OUTLIER -49.65 158.03 0.5 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.0 -179.886 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . -155.71 -56.82 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.534 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 534' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -94.35 142.73 25.25 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.742 0.306 . . . . 0.0 111.052 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.29 74.09 1.56 Allowed 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.63 2.22 . . . . 0.0 112.308 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 2.8 p30 172.73 143.56 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.671 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 537' ' ' ARG . . . . . 0.475 ' HG3' ' CZ2' ' B' ' 532' ' ' TRP . 2.0 mpt_? -92.85 179.93 5.32 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.203 0.525 . . . . 0.0 111.172 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 538' ' ' ILE . . . . . 0.648 HG23 HD12 ' B' ' 543' ' ' LEU . 5.0 tp -118.06 134.87 60.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.196 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 539' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -50.86 145.19 7.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.61 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 540' ' ' GLU . . . . . 0.415 ' HB3' ' OG1' ' A' ' 58' ' ' THR . 61.2 mt-10 -45.69 -44.72 13.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.454 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 541' ' ' LEU . . . . . 0.75 ' HB2' HD23 ' A' ' 70' ' ' LEU . 1.7 tt -48.43 -40.28 25.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.432 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 542' ' ' TYR . . . . . 0.476 ' HB2' HG13 ' B' ' 538' ' ' ILE . 63.2 m-85 -102.49 9.25 39.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.931 -179.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 543' ' ' LEU . . . . . 0.648 HD12 HG23 ' B' ' 538' ' ' ILE . 3.1 tp -58.64 95.74 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.781 0.324 . . . . 0.0 110.71 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . 176.23 89.09 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.506 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 545' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.854 179.935 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.401 ' HB2' ' HG3' ' A' ' 49' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.375 0 CA-C-O 120.761 0.315 . . . . 0.0 111.222 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -111.19 127.03 55.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.219 0.533 . . . . 0.0 110.948 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.548 HG21 ' OH ' ' A' ' 51' ' ' TYR . 36.8 m -104.19 158.2 16.61 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.739 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.836 ' CD1' HD13 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -155.25 160.34 2.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.852 -179.587 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.04 140.43 46.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.631 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.4 p -138.11 124.53 20.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.908 0.385 . . . . 0.0 111.573 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.1 t -114.04 136.57 50.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.45 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.59 HG13 ' HG2' ' B' ' 540' ' ' GLU . 2.8 p -84.84 113.52 23.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.952 0.406 . . . . 0.0 111.125 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.0 p -117.69 129.57 73.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.893 178.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.498 ' HA2' ' CE2' ' A' ' 97' ' ' TRP . . . 133.57 -160.35 23.97 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.267 -0.968 . . . . 0.0 112.455 -179.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -92.9 21.99 5.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.726 0.298 . . . . 0.0 111.047 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.407 ' HA3' ' HB2' ' A' ' 81' ' ' CYS . . . -76.14 160.2 51.05 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.538 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.458 ' O ' ' HB ' ' A' ' 14' ' ' VAL . . . -53.27 -57.3 11.0 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.489 0.185 . . . . 0.0 111.296 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.726 HG13 ' H ' ' A' ' 18' ' ' CYS . 2.6 p 154.88 94.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 O-C-N 123.75 0.656 . . . . 0.0 109.908 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.599 ' HA2' HD11 ' A' ' 19' ' ' LEU . . . -47.82 -22.79 2.11 Favored Glycine 0 CA--C 1.519 0.305 0 CA-C-N 115.844 -0.616 . . . . 0.0 113.502 -179.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.449 ' HG2' ' HB2' ' A' ' 55' ' ' LEU . 1.6 tmtm? -70.68 -59.74 2.65 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 122.544 -0.386 . . . . 0.0 111.676 -179.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.591 ' CG2' HG23 ' A' ' 35' ' ' THR . 1.2 p -97.34 -39.43 9.22 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -178.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.726 ' H ' HG13 ' A' ' 14' ' ' VAL . 44.6 t -33.74 -73.49 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.71 ' CB ' HD22 ' A' ' 165' ' ' LEU . 0.3 OUTLIER -65.34 -68.22 0.38 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.827 -179.377 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.54 HD23 ' N ' ' A' ' 20' ' ' LEU . 3.5 mt -49.0 -70.22 0.1 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.802 -179.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.474 HG22 ' O ' ' A' ' 17' ' ' THR . 1.1 tp -43.09 -48.49 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-O 120.817 0.341 . . . . 0.0 111.619 -179.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.422 ' OG ' ' ND2' ' A' ' 26' ' ' ASN . 35.2 t -62.48 -29.19 70.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.916 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.409 ' N ' ' O ' ' A' ' 20' ' ' LEU . 20.1 t80 -75.34 -37.43 60.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.949 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.616 HG23 HG23 ' A' ' 25' ' ' THR . 10.1 t -87.23 -49.8 7.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.06 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.616 HG23 HG23 ' A' ' 24' ' ' THR . 77.6 p -94.06 -61.77 1.47 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.88 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.422 ' ND2' ' OG ' ' A' ' 22' ' ' SER . 2.4 t-20 72.38 41.46 0.6 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.005 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -100.71 69.75 1.39 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.706 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.485 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 35.3 t80 -86.77 -45.59 0.54 Allowed Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.647 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.485 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 92.7 Cg_endo -82.22 73.41 5.66 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.354 2.036 . . . . 0.0 112.481 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.3 m -172.06 -85.34 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.982 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -158.29 164.57 36.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.016 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.469 ' OH ' ' CG ' ' A' ' 28' ' ' PHE . 10.2 m-85 -130.86 124.17 30.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.488 ' HB ' ' HD3' ' A' ' 34' ' ' PRO . 1.5 t -157.1 -53.61 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.772 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.488 ' HD3' ' HB ' ' A' ' 33' ' ' VAL . 5.4 Cg_exo -74.84 56.4 4.15 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.458 2.105 . . . . 0.0 112.292 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.591 HG23 ' CG2' ' A' ' 17' ' ' THR . 18.7 m -106.95 -20.64 13.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.844 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.953 HG12 ' CB ' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -42.38 -65.13 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.767 -0.197 . . . . 0.0 110.863 179.8 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.447 ' H ' HG23 ' A' ' 36' ' ' VAL . 10.8 m-85 33.92 -88.4 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.684 0.615 . . . . 0.0 112.171 179.091 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.473 ' N ' ' O ' ' A' ' 36' ' ' VAL . 96.9 m-20 65.29 -65.46 0.16 Allowed 'General case' 0 CA--C 1.527 0.087 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.584 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.437 ' N ' ' O ' ' A' ' 37' ' ' PHE . 1.1 p-10 -71.7 -4.49 27.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.772 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.485 ' CE2' ' CZ ' ' B' ' 518' ' ' PHE . 0.4 OUTLIER -59.78 95.36 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.925 0.393 . . . . 0.0 110.302 179.793 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.687 ' O ' HD13 ' B' ' 519' ' ' ILE . . . -90.36 -179.37 5.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.11 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.639 HG23 HG21 ' A' ' 52' ' ' THR . 34.5 m -144.12 161.04 15.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.083 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.8 p -125.48 105.87 9.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.173 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.911 HG22 ' CG2' ' A' ' 52' ' ' THR . 19.2 m -156.32 -177.55 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.086 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.461 ' HE1' ' N ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -100.79 97.44 8.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.532 -179.486 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 1.008 HG23 HG23 ' B' ' 510' ' ' ILE . 1.5 mm -70.91 91.08 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-O 120.824 0.345 . . . . 0.0 110.242 179.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 38.62 -91.81 0.01 OUTLIER Glycine 0 CA--C 1.519 0.337 0 CA-C-N 116.002 -0.545 . . . . 0.0 113.654 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . -39.85 -82.93 0.01 OUTLIER Glycine 0 C--N 1.333 0.374 0 C-N-CA 121.457 -0.402 . . . . 0.0 113.406 -179.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.461 ' N ' ' HE1' ' A' ' 45' ' ' MET . 2.7 mt-10 -133.99 165.7 34.75 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.786 0.327 . . . . 0.0 111.402 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.461 ' HD2' ' HB3' ' A' ' 49' ' ' GLU . 82.7 Cg_exo -48.36 104.69 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.6 2.2 . . . . 0.0 112.955 -179.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.548 ' OH ' HG21 ' A' ' 3' ' ' THR . 14.1 t80 -172.46 155.59 3.48 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.275 179.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.911 ' CG2' HG22 ' A' ' 44' ' ' VAL . 1.8 p -138.31 153.34 49.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.18 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.836 HD13 ' CD1' ' A' ' 4' ' ' ILE . 0.3 OUTLIER -110.47 99.36 8.37 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.835 179.716 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -50.97 -179.17 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.366 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.449 ' HB2' ' HG2' ' A' ' 16' ' ' LYS . 1.8 mp -139.72 97.65 3.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.853 0.359 . . . . 0.0 110.565 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -84.28 114.88 22.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.628 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.479 ' OD1' HG12 ' A' ' 8' ' ' VAL . 0.6 OUTLIER -113.97 -175.56 2.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.376 -179.883 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.483 HG22 HD13 ' A' ' 67' ' ' LEU . 18.4 p -89.67 -175.73 4.76 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.617 -179.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.953 ' CB ' HG12 ' A' ' 36' ' ' VAL . . . -172.26 168.15 5.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.553 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.411 ' H ' HD23 ' A' ' 61' ' ' LEU . . . -149.15 21.25 1.23 Allowed Glycine 0 C--N 1.329 0.189 0 C-N-CA 120.384 -0.912 . . . . 0.0 112.759 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.705 HD13 ' HB2' ' B' ' 526' ' ' SER . 0.2 OUTLIER -121.34 -171.59 2.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.568 0.223 . . . . 0.0 110.777 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -38.24 -31.2 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.877 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.686 ' HB2' HG11 ' A' ' 36' ' ' VAL . 0.2 OUTLIER -45.28 -63.18 1.0 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.143 179.875 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.68 ' O ' HD23 ' A' ' 67' ' ' LEU . 0.0 OUTLIER 166.82 77.48 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.981 179.777 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -62.48 -22.22 66.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.059 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.45 -21.74 10.7 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.311 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.69 HD21 ' N ' ' A' ' 59' ' ' ALA . 3.4 pp -48.02 141.29 6.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.794 0.33 . . . . 0.0 111.058 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.467 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 1.1 ptm180 -158.84 49.58 0.33 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.035 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.467 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 61.4 Cg_endo -74.4 -48.49 0.2 Allowed 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.451 2.1 . . . . 0.0 112.386 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.676 HD21 ' CB ' ' B' ' 541' ' ' LEU . 0.6 OUTLIER -51.27 -24.43 4.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.966 179.882 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 69.3 m -51.1 -30.13 15.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.854 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.432 ' N ' ' HD3' ' A' ' 73' ' ' PRO . 5.4 t80 177.3 65.04 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.821 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.432 ' HD3' ' N ' ' A' ' 72' ' ' TYR . 13.5 Cg_exo -69.3 154.62 69.3 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.706 2.271 . . . . 0.0 112.302 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.62 10.46 40.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.169 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.51 HG22 ' H ' ' A' ' 76' ' ' ASP . 1.4 m -49.5 172.82 0.02 OUTLIER 'General case' 0 C--N 1.334 -0.108 0 CA-C-O 120.849 0.357 . . . . 0.0 110.897 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.51 ' H ' HG22 ' A' ' 75' ' ' THR . 19.9 p-10 -113.89 -23.91 9.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.032 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.703 HG11 ' HB2' ' A' ' 176' ' ' ALA . 7.2 p -130.22 92.38 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.283 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.777 ' CE1' HG21 ' A' ' 108' ' ' THR . 15.2 m-85 -80.78 167.32 20.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.623 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 38.8 tp -141.88 109.06 5.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.976 0.417 . . . . 0.0 111.297 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.446 ' O ' HG23 ' A' ' 80' ' ' VAL . 29.1 m -96.93 126.51 49.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.583 179.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.407 ' HB2' ' HA3' ' A' ' 12' ' ' GLY . 1.6 m -116.77 158.95 23.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.161 0.505 . . . . 0.0 111.711 -179.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.565 ' CE2' HD12 ' A' ' 112' ' ' LEU . 41.7 p90 -147.15 -173.79 4.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.89 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.0 p -138.59 131.58 29.7 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.795 0.331 . . . . 0.0 111.116 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.715 HG21 ' HA ' ' A' ' 117' ' ' ILE . 60.9 t -47.57 -72.06 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.186 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.701 HG22 ' OE1' ' A' ' 116' ' ' GLN . 32.6 m -46.58 106.85 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.81 0.338 . . . . 0.0 110.527 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.536 ' N ' HD22 ' A' ' 129' ' ' LEU . 0.2 OUTLIER -149.99 137.35 11.49 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.551 -179.175 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.437 ' HB2' ' HB2' ' A' ' 132' ' ' ASN . 85.1 Cg_endo -91.76 53.29 0.75 Allowed 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.214 2.61 . . . . 0.0 111.778 179.49 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.467 ' CB ' ' HG3' ' A' ' 133' ' ' LYS . 0.1 OUTLIER 81.09 30.65 0.15 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.79 -179.534 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.72 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.9 OUTLIER -96.85 -25.94 15.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.063 179.972 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.767 ' CZ ' HG21 ' A' ' 137' ' ' ILE . 6.4 t80 -50.74 -59.85 3.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.061 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -50.19 -57.88 6.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.9 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -51.35 -62.73 1.44 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.867 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.72 HG23 ' O ' ' A' ' 89' ' ' SER . 60.3 t -44.55 -47.12 2.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.414 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.751 ' CG ' HD11 ' A' ' 145' ' ' LEU . 1.3 tmtt? -53.69 -51.01 64.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.705 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -84.0 6.59 21.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.486 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -110.52 -31.61 7.19 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.69 0.281 . . . . 0.0 111.021 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.589 ' O ' HG22 ' A' ' 101' ' ' ILE . 0.5 OUTLIER -94.11 -44.93 7.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.372 -179.722 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 94' ' ' LYS . 79.2 t -50.24 -46.41 83.21 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.575 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 97.5 Cg_endo -81.08 -15.13 10.53 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.288 1.992 . . . . 0.0 112.633 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -89.32 -44.96 9.85 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.872 0.368 . . . . 0.0 110.832 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.589 HG22 ' O ' ' A' ' 97' ' ' TRP . 7.5 tt -66.48 -30.65 50.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.145 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 38.9 p -83.19 -26.52 30.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.931 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.09 -51.5 53.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.904 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.407 ' O ' ' CE1' ' A' ' 72' ' ' TYR . 27.7 m170 -69.5 -44.31 71.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.979 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.409 ' O ' ' N ' ' A' ' 107' ' ' LYS . 0.6 OUTLIER -111.95 126.65 28.1 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.834 -179.961 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -57.63 81.23 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.475 2.117 . . . . 0.0 112.269 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.409 ' N ' ' O ' ' A' ' 105' ' ' CYS . 0.1 OUTLIER 53.44 97.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.895 -179.993 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.777 HG21 ' CE1' ' A' ' 78' ' ' PHE . 0.1 OUTLIER -117.85 141.26 28.86 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.804 179.998 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 108' ' ' THR . 31.8 Cg_exo -60.02 142.63 98.83 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.553 2.169 . . . . 0.0 112.412 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.794 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 1.9 p90 -147.78 136.27 21.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.816 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.989 HD12 HG11 ' A' ' 152' ' ' VAL . 4.8 tt -110.31 155.16 22.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.127 -179.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.656 ' O ' HD23 ' A' ' 111' ' ' LEU . 3.6 mm? -108.98 147.39 32.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.493 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.784 HG13 HG11 ' A' ' 168' ' ' VAL . 2.7 t -131.62 147.72 32.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.935 0.397 . . . . 0.0 111.855 -179.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.677 ' O ' HD12 ' A' ' 117' ' ' ILE . . . -125.55 100.64 0.6 Allowed Glycine 0 N--CA 1.453 -0.222 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.924 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.703 ' C ' HD13 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -116.18 -45.05 2.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.994 0.426 . . . . 0.0 110.894 -179.205 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.701 ' OE1' HG22 ' A' ' 85' ' ' VAL . 9.3 tt0 -64.96 -10.27 27.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.054 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.715 ' HA ' HG21 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -42.93 -27.74 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-O 120.717 0.294 . . . . 0.0 111.626 179.709 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.438 ' N ' HG12 ' A' ' 117' ' ' ILE . 1.7 m-20 -71.29 -30.16 65.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.36 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.594 HD12 ' N ' ' A' ' 119' ' ' LEU . 4.8 mp -79.91 -23.18 41.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.129 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.612 ' HB3' HG11 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -44.85 -29.22 0.76 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.934 0.397 . . . . 0.0 110.941 179.975 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.4 -38.69 34.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.549 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -46.47 103.37 0.35 Allowed Pre-proline 0 C--N 1.332 -0.192 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.918 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.43 ' O ' HG22 ' A' ' 126' ' ' ILE . 47.2 Cg_endo -69.7 -7.19 20.42 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.506 2.138 . . . . 0.0 112.934 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.3 t -77.92 -66.45 0.84 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.025 0.441 . . . . 0.0 109.945 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.416 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 5.0 m -56.73 -39.01 73.16 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.463 ' HA ' ' CD1' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -53.43 -45.45 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.854 179.309 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.514 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 3.7 mt-10 -57.44 -37.18 72.4 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.008 179.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 125' ' ' THR . 2.3 mptp? -63.67 -30.09 71.24 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.536 HD22 ' N ' ' A' ' 86' ' ' SER . 6.7 mt -74.89 -38.08 61.97 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 127' ' ' GLU . . . -44.87 -33.64 2.03 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.948 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 9.1 mmtt -49.44 -34.42 16.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.506 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.437 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 0.6 OUTLIER -123.32 -30.92 3.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.514 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.526 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 6.7 mmtt -145.46 -101.21 0.1 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 119.109 -0.472 . . . . 0.0 111.317 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.526 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 0.9 OUTLIER 133.65 -26.2 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.331 1.052 . . . . 0.0 110.249 -179.858 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 8.9 mtpp -69.0 110.7 6.55 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.715 -179.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.413 ' HB2' ' HB2' ' A' ' 120' ' ' ARG . 83.2 Cg_endo -80.34 133.72 9.81 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.682 2.254 . . . . 0.0 111.484 179.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.767 HG21 ' CZ ' ' A' ' 90' ' ' PHE . 0.8 OUTLIER -67.26 96.62 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.901 0.381 . . . . 0.0 110.871 -179.513 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.419 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.2 p -82.97 163.68 49.94 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.816 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.494 ' HA ' ' CE1' ' A' ' 154' ' ' TYR . 86.9 Cg_exo -46.15 -40.55 21.4 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.549 2.166 . . . . 0.0 112.275 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -57.56 -52.28 66.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.752 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 7.4 m -57.21 -52.09 66.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.76 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.471 ' HB1' ' CD2' ' A' ' 154' ' ' TYR . . . -54.01 -52.66 60.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.901 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -51.08 -32.52 22.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.682 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 7.4 ttpt -66.04 -61.3 2.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.76 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.751 HD11 ' CG ' ' A' ' 94' ' ' LYS . 0.7 OUTLIER -60.75 -36.45 78.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.661 179.843 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -61.84 -41.54 97.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.973 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -87.59 -25.74 23.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.746 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -67.64 -42.21 82.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.961 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.453 HD21 HG11 ' A' ' 98' ' ' VAL . 0.1 OUTLIER -93.05 16.37 12.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.258 179.912 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.7 mttm 46.88 35.02 2.94 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.768 0.318 . . . . 0.0 111.196 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.794 ' HB1' ' O ' ' A' ' 110' ' ' PHE . . . -55.64 -82.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.09 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.989 HG11 HD12 ' A' ' 111' ' ' LEU . 56.0 t -162.28 -75.67 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.711 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.425 ' HE3' ' N ' ' A' ' 154' ' ' TYR . 0.0 OUTLIER -176.56 113.54 0.1 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.801 -178.843 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.494 ' CE1' ' HA ' ' A' ' 139' ' ' PRO . 16.5 t80 -87.84 106.75 18.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.467 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.636 ' HB ' HG22 ' A' ' 168' ' ' VAL . 0.1 OUTLIER -101.74 177.07 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.448 179.745 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -99.48 118.76 36.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.8 0.333 . . . . 0.0 111.194 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.433 ' HB3' HG23 ' A' ' 168' ' ' VAL . 7.2 p -160.16 126.37 4.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.776 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.552 ' HB3' HG22 ' A' ' 161' ' ' THR . 0.3 OUTLIER -113.09 157.11 22.01 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.249 -179.728 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.505 ' CB ' HD11 ' A' ' 165' ' ' LEU . . . -107.8 -33.39 7.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.698 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.536 ' H ' HD12 ' A' ' 160' ' ' LEU . 0.4 OUTLIER -68.64 -37.19 79.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.697 179.755 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.552 HG22 ' HB3' ' A' ' 158' ' ' SER . 14.0 t -110.74 -18.78 13.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.012 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 75.76 66.54 0.06 Allowed 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 120.856 0.36 . . . . 0.0 110.975 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.417 ' HB2' ' HB2' ' A' ' 158' ' ' SER . 0.1 OUTLIER -92.26 38.1 1.0 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.244 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.414 ' O ' ' HB2' ' A' ' 167' ' ' ASN . . . 89.48 48.89 3.59 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.97 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.71 HD22 ' CB ' ' A' ' 19' ' ' LEU . 4.3 mt -47.53 -31.6 4.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.77 0.319 . . . . 0.0 111.308 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.426 ' O ' ' N ' ' A' ' 170' ' ' ASP . 36.1 pttt -70.57 -29.67 66.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.3 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.414 ' HB2' ' O ' ' A' ' 164' ' ' GLY . 2.1 t30 -52.09 -72.36 0.05 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.852 0.358 . . . . 0.0 110.94 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.784 HG11 HG13 ' A' ' 113' ' ' VAL . 57.4 t -57.69 -50.42 77.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.919 0.39 . . . . 0.0 110.584 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.676 ' CZ ' HD13 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -54.32 -29.49 47.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.463 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 166' ' ' LYS . 6.1 m-20 -72.54 -29.28 63.43 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 178.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.523 ' CB ' HD11 ' A' ' 111' ' ' LEU . 45.1 mm-40 -73.94 -31.42 63.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.237 179.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.692 ' O ' HG21 ' A' ' 77' ' ' VAL . . . -67.78 -48.13 67.23 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.796 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.656 HD12 ' CD1' ' A' ' 177' ' ' LEU . 1.1 pp -73.8 -31.82 32.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.625 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.692 HD13 ' HB3' ' B' ' 505' ' ' LEU . 4.6 tp -50.57 -53.98 26.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.789 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -50.91 -25.28 4.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.824 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.703 ' HB2' HG11 ' A' ' 77' ' ' VAL . . . -83.13 -48.68 10.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.166 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.994 HD22 HG21 ' B' ' 510' ' ' ILE . 1.0 OUTLIER -68.72 -23.62 64.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.867 179.955 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.414 ' CG ' ' HD2' ' A' ' 179' ' ' PRO . 2.4 tm-20 -152.14 142.63 15.2 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.807 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . 0.414 ' HD2' ' CG ' ' A' ' 178' ' ' GLU . 9.3 Cg_endo -52.76 117.84 4.12 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.724 2.283 . . . . 0.0 112.003 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -66.91 155.02 72.63 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.517 2.145 . . . . 0.0 112.487 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -148.01 98.13 3.83 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.804 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.21 -165.1 0.27 Allowed 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.713 2.275 . . . . 0.0 112.269 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -134.82 157.45 46.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.756 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.249 -0.882 . . . . 0.0 110.897 -179.999 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.311 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 503' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -104.65 -161.42 0.82 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.846 0.355 . . . . 0.0 110.886 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 504' ' ' GLY . . . . . 0.574 ' O ' HD22 ' A' ' 174' ' ' LEU . . . -156.92 69.58 0.27 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.727 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 505' ' ' LEU . . . . . 0.816 HD13 HD13 ' A' ' 177' ' ' LEU . 1.3 mt -133.19 -56.91 0.91 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.642 0.258 . . . . 0.0 111.254 -179.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 506' ' ' SER . . . . . 0.463 ' CB ' ' O ' ' B' ' 505' ' ' LEU . 5.2 t 88.95 -20.57 0.16 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.404 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 507' ' ' ALA . . . . . . . . . . . . . . . -51.46 -79.99 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.331 0.586 . . . . 0.0 110.494 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 508' ' ' GLN . . . . . 0.457 ' HB2' HD11 ' B' ' 510' ' ' ILE . 5.8 mt-30 -130.91 3.55 4.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.418 179.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 509' ' ' ASP . . . . . 0.441 ' CB ' ' O ' ' B' ' 508' ' ' GLN . 25.5 t0 84.41 39.03 0.03 OUTLIER 'General case' 0 C--N 1.344 0.341 0 CA-C-O 120.98 0.419 . . . . 0.0 110.946 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 510' ' ' ILE . . . . . 1.008 HG23 HG23 ' A' ' 46' ' ' ILE . 1.8 mp -68.96 73.21 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.476 179.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 511' ' ' SER . . . . . 0.415 ' O ' ' CD1' ' B' ' 514' ' ' LEU . 14.9 t -60.12 140.78 56.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.904 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 512' ' ' GLN . . . . . 0.495 ' CB ' ' HD3' ' B' ' 513' ' ' PRO . 0.7 OUTLIER -89.84 -64.03 0.19 Allowed Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.735 179.803 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 513' ' ' PRO . . . . . 0.495 ' HD3' ' CB ' ' B' ' 512' ' ' GLN . 88.6 Cg_endo -82.37 49.94 3.27 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.638 2.225 . . . . 0.0 112.463 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 514' ' ' LEU . . . . . 0.443 ' HB2' ' HB ' ' A' ' 44' ' ' VAL . 0.4 OUTLIER -52.88 -89.3 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.784 -179.79 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 515' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -93.2 -157.67 0.55 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -48.7 -29.44 4.44 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.139 0.495 . . . . 0.0 110.316 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 517' ' ' SER . . . . . 0.435 ' O ' ' CG1' ' A' ' 42' ' ' VAL . 14.2 p 38.15 59.48 1.39 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.101 179.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 518' ' ' PHE . . . . . 0.485 ' CZ ' ' CE2' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -165.06 108.41 0.86 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.734 0.302 . . . . 0.0 111.393 179.485 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 519' ' ' ILE . . . . . 0.687 HD13 ' O ' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -151.1 152.16 11.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.171 179.246 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 70.33 76.0 0.2 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.825 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 521' ' ' THR . . . . . 0.425 HG23 ' OH ' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -75.7 120.77 21.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.014 -179.951 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 522' ' ' GLY . . . . . . . . . . . . . . . -61.65 -158.26 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.389 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 523' ' ' HIS . . . . . 0.42 ' ND1' ' N ' ' B' ' 523' ' ' HIS . 0.4 OUTLIER -118.66 -83.97 0.65 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.788 0.327 . . . . 0.0 110.808 179.943 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 524' ' ' GLY . . . . . 0.444 ' CA ' HG21 ' A' ' 36' ' ' VAL . . . 67.71 122.13 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.714 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 525' ' ' ASP . . . . . 0.407 ' H ' HD12 ' A' ' 61' ' ' LEU . 18.3 m-20 -142.0 57.91 1.48 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.777 0.323 . . . . 0.0 111.067 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 526' ' ' SER . . . . . 0.705 ' HB2' HD13 ' A' ' 61' ' ' LEU . 2.9 t -78.79 96.81 5.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.754 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 527' ' ' ASP . . . . . 0.466 ' CB ' ' HD3' ' B' ' 528' ' ' PRO . 1.7 t0 -43.93 -52.52 15.05 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.679 0.276 . . . . 0.0 111.019 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 528' ' ' PRO . . . . . 0.466 ' HD3' ' CB ' ' B' ' 527' ' ' ASP . 17.7 Cg_exo -70.82 134.06 24.96 Favored 'Trans proline' 0 CA--C 1.518 -0.306 0 C-N-CA 123.125 2.55 . . . . 0.0 111.726 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 529' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -101.06 -30.02 11.84 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.986 -179.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 530' ' ' HIS . . . . . 0.502 ' CG ' ' O ' ' B' ' 530' ' ' HIS . 0.1 OUTLIER 70.35 5.02 5.16 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.399 179.712 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 1.2 m 52.76 -88.08 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.637 0.256 . . . . 0.0 111.011 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 532' ' ' TRP . . . . . 0.434 ' N ' ' O ' ' B' ' 530' ' ' HIS . 15.6 t90 -154.27 -45.33 0.09 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.855 0.36 . . . . 0.0 110.685 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . 67.89 -143.08 41.08 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.572 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 534' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -65.86 150.83 96.02 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.791 0.329 . . . . 0.0 110.896 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 535' ' ' PRO . . . . . 0.539 ' HB3' HG23 ' A' ' 85' ' ' VAL . 73.7 Cg_exo -49.35 -49.74 14.76 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.614 2.21 . . . . 0.0 112.247 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.49 109.19 11.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.78 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 537' ' ' ARG . . . . . 0.44 ' NH2' ' CE2' ' A' ' 32' ' ' TYR . 0.2 OUTLIER -50.38 143.11 9.31 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 120.989 0.423 . . . . 0.0 111.006 179.998 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 538' ' ' ILE . . . . . 0.488 HG13 ' HB2' ' B' ' 542' ' ' TYR . 7.4 tp -58.69 146.78 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.148 179.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 539' ' ' ASP . . . . . 0.41 ' HA ' ' O ' ' A' ' 10' ' ' GLY . 3.7 m-20 -46.37 140.52 4.1 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.914 0.388 . . . . 0.0 111.165 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 540' ' ' GLU . . . . . 0.59 ' HG2' HG13 ' A' ' 8' ' ' VAL . 14.0 mp0 -44.94 -27.68 0.57 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.357 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 541' ' ' LEU . . . . . 0.676 ' CB ' HD21 ' A' ' 70' ' ' LEU . 0.9 OUTLIER -55.68 -32.06 62.94 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.351 0.596 . . . . 0.0 110.147 179.615 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 542' ' ' TYR . . . . . 0.488 ' HB2' HG13 ' B' ' 538' ' ' ILE . 11.1 m-85 -105.45 0.88 27.19 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.031 -0.986 . . . . 0.0 112.171 -178.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 543' ' ' LEU . . . . . 0.71 HD21 ' HB ' ' A' ' 14' ' ' VAL . 1.6 tp -49.23 117.64 2.26 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.814 0.34 . . . . 0.0 110.679 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . 135.09 -46.83 1.02 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.505 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 545' ' ' ASN . . . . . 0.407 ' ND2' ' HB3' ' B' ' 530' ' ' HIS . 72.9 m-20 . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.253 -0.879 . . . . 0.0 111.027 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.375 0 CA-C-O 120.749 0.309 . . . . 0.0 111.216 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 57.66 160.54 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.715 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.717 HG23 ' CE1' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -119.52 -174.53 2.76 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.407 -179.632 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.609 HG23 HD23 ' A' ' 177' ' ' LEU . 25.7 pt -155.05 149.49 12.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.101 0.477 . . . . 0.0 111.991 -179.273 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 33.9 mttt -134.38 95.87 3.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.274 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -100.31 138.66 37.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.024 0.44 . . . . 0.0 111.491 -179.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.6 160.09 41.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.087 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.849 HG21 ' CG ' ' A' ' 16' ' ' LYS . 47.3 t -111.69 137.64 43.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.289 0.566 . . . . 0.0 112.184 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.547 HG13 ' O ' ' A' ' 8' ' ' VAL . 19.3 m -161.44 130.04 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.862 179.232 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 149.37 -144.01 11.56 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.238 -0.982 . . . . 0.0 112.62 -179.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.5 p30 -122.15 25.3 9.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.938 0.399 . . . . 0.0 110.825 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.401 ' HA2' ' HB2' ' B' ' 537' ' ' ARG . . . -157.36 -160.24 10.03 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.324 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.492 ' C ' HG13 ' A' ' 14' ' ' VAL . . . -79.11 -48.18 14.79 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.556 0.217 . . . . 0.0 110.836 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.722 HG12 ' HB3' ' A' ' 81' ' ' CYS . 0.6 OUTLIER 65.59 -60.04 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.403 179.55 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.655 ' HA2' HD22 ' A' ' 19' ' ' LEU . . . -165.83 30.31 0.21 Allowed Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.849 ' CG ' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -91.01 -165.32 1.33 Allowed 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 121.232 0.539 . . . . 0.0 111.359 -179.313 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.588 ' CG2' HG23 ' A' ' 35' ' ' THR . 43.6 p -38.95 -65.85 0.33 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.478 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.431 ' O ' ' CB ' ' A' ' 22' ' ' SER . 23.6 t -32.42 -43.6 0.09 Allowed 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -178.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.655 HD22 ' HA2' ' A' ' 15' ' ' GLY . 2.5 mp -56.88 -71.74 0.09 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.73 0.3 . . . . 0.0 111.269 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 20' ' ' LEU . 0.3 OUTLIER -76.55 -50.3 14.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.192 -179.741 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.732 HG22 ' HB2' ' A' ' 26' ' ' ASN . 10.9 mm -48.31 -55.79 2.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.403 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.474 ' HA ' ' CB ' ' A' ' 26' ' ' ASN . 3.1 t -64.03 -43.59 95.11 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 121.092 -0.243 . . . . 0.0 111.585 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.571 ' CG ' HD13 ' A' ' 165' ' ' LEU . 0.2 OUTLIER -45.79 -35.07 4.09 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.187 0.517 . . . . 0.0 110.16 179.6 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -101.67 -33.52 9.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.279 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 173.46 127.14 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.722 0.296 . . . . 0.0 111.039 -178.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.732 ' HB2' HG22 ' A' ' 21' ' ' ILE . 61.2 t30 178.56 -43.87 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.666 178.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.6 mtmm 65.1 142.17 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.734 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.46 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -86.68 -49.5 0.48 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.782 179.995 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.46 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 5.8 Cg_exo -79.35 52.15 4.16 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.933 2.422 . . . . 0.0 112.248 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 77.9 p -133.87 -108.74 0.23 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.679 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -159.57 118.75 2.89 Favored 'General case' 0 N--CA 1.457 -0.098 0 O-C-N 122.169 -0.332 . . . . 0.0 111.016 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.475 ' O ' HG22 ' A' ' 33' ' ' VAL . 5.3 m-85 -90.55 121.51 32.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.391 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.499 HG11 ' HD2' ' B' ' 529' ' ' ARG . 0.2 OUTLIER -160.99 -61.98 0.02 OUTLIER Pre-proline 0 N--CA 1.468 0.434 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.363 -179.415 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.476 ' CD ' ' HB ' ' A' ' 33' ' ' VAL . 3.0 Cg_exo -34.98 -28.57 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.649 2.899 . . . . 0.0 113.653 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.588 HG23 ' CG2' ' A' ' 17' ' ' THR . 28.4 m -29.73 -38.46 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.638 ' HA ' ' HB2' ' A' ' 59' ' ' ALA . 11.5 p -50.4 -24.3 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.765 0.317 . . . . 0.0 111.373 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.471 ' CE2' ' HB3' ' A' ' 34' ' ' PRO . 7.1 m-30 -66.07 -10.02 36.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.576 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -46.26 172.62 0.01 OUTLIER 'General case' 0 C--O 1.231 0.102 0 CA-C-O 120.864 0.364 . . . . 0.0 111.159 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 75.37 5.43 4.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.303 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -60.38 -174.85 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.719 0.295 . . . . 0.0 110.607 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -110.11 124.18 51.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.586 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.722 HG23 HG21 ' A' ' 52' ' ' THR . 24.0 m -118.44 124.88 73.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.014 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.72 104.82 16.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.934 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.79 HG22 ' CG2' ' A' ' 52' ' ' THR . 12.6 m -153.23 -177.24 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.931 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.447 ' HE1' ' N ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -111.96 103.71 11.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.651 -179.537 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.645 HG22 ' O ' ' A' ' 46' ' ' ILE . 2.7 mm -74.02 86.09 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.1 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.476 ' HA3' ' HA ' ' B' ' 510' ' ' ILE . . . 43.9 -94.13 0.01 OUTLIER Glycine 0 CA--C 1.519 0.313 0 CA-C-N 115.498 -0.774 . . . . 0.0 113.636 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -38.62 -87.44 0.01 OUTLIER Glycine 0 C--N 1.332 0.356 0 C-N-CA 121.607 -0.33 . . . . 0.0 113.626 -179.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.447 ' N ' ' HE1' ' A' ' 45' ' ' MET . 1.8 pt-20 -125.23 164.75 30.03 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 120.708 0.289 . . . . 0.0 111.024 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.41 ' HD2' ' HB2' ' A' ' 49' ' ' GLU . 52.0 Cg_exo -54.22 106.82 0.18 Allowed 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.653 2.235 . . . . 0.0 112.289 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.717 ' CE1' HG23 ' A' ' 3' ' ' THR . 4.4 t80 -172.53 147.92 1.92 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.498 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.79 ' CG2' HG22 ' A' ' 44' ' ' VAL . 0.3 OUTLIER -137.61 154.06 49.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.624 179.706 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.718 ' N ' HD13 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -131.15 177.99 7.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.877 0.37 . . . . 0.0 111.305 -179.734 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -74.09 114.8 4.67 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.161 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.519 ' H ' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -81.15 -62.97 1.5 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.019 0.437 . . . . 0.0 110.942 -179.785 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.491 ' CD2' ' HB2' ' A' ' 55' ' ' LEU . 1.9 p90 -142.94 128.89 19.55 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.185 -179.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -142.26 109.6 5.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.032 0.444 . . . . 0.0 110.847 179.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.536 ' O ' HD22 ' B' ' 543' ' ' LEU . 0.0 OUTLIER -155.8 131.48 9.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.316 179.524 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.638 ' HB2' ' HA ' ' A' ' 36' ' ' VAL . . . -170.93 158.44 5.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.027 0.441 . . . . 0.0 111.613 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -131.01 19.63 4.9 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.149 179.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.535 HD23 ' HB ' ' A' ' 36' ' ' VAL . 2.5 mm? -86.22 -175.51 5.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.814 0.34 . . . . 0.0 110.779 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -46.58 -31.48 2.84 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.312 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.468 ' CB ' ' CG2' ' A' ' 36' ' ' VAL . 7.2 t0 -50.52 -62.09 1.8 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.06 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.504 ' CD1' ' N ' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -168.41 137.37 2.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.975 0.417 . . . . 0.0 111.154 -179.898 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.13 -66.23 0.92 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.786 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 17.1 mmt85 -73.22 -24.9 60.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.991 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.577 HD11 ' H ' ' A' ' 59' ' ' ALA . 1.1 mt 68.52 -94.73 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.114 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.432 ' CB ' ' HD3' ' A' ' 69' ' ' PRO . 0.0 OUTLIER 166.34 -53.9 0.0 OUTLIER Pre-proline 0 N--CA 1.465 0.287 0 CA-C-O 120.722 0.296 . . . . 0.0 111.128 179.822 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.432 ' HD3' ' CB ' ' A' ' 68' ' ' ARG . 52.8 Cg_exo -52.91 -60.41 0.73 Allowed 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.662 2.242 . . . . 0.0 112.727 -179.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.922 HD22 ' HA ' ' B' ' 541' ' ' LEU . 0.3 OUTLIER -58.7 -31.89 68.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.031 -179.847 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.8 t -54.6 -35.63 63.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.223 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 65.3 t80 175.39 81.57 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.669 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.515 ' HG2' ' CZ ' ' A' ' 78' ' ' PHE . 94.4 Cg_endo -81.17 136.42 10.17 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.604 2.203 . . . . 0.0 112.307 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? -90.79 10.25 26.82 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.349 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.504 HG22 ' HB2' ' A' ' 73' ' ' PRO . 4.4 t -57.74 178.45 0.08 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.808 0.337 . . . . 0.0 110.737 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -123.34 7.33 9.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.535 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.655 ' O ' HG13 ' A' ' 77' ' ' VAL . 8.9 p -152.76 101.05 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 CA-C-O 120.758 0.313 . . . . 0.0 111.321 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.515 ' CZ ' ' HG2' ' A' ' 73' ' ' PRO . 3.2 m-85 -80.61 177.65 8.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.393 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.662 HD23 HG23 ' A' ' 14' ' ' VAL . 5.9 tp -138.93 108.25 6.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.047 0.451 . . . . 0.0 111.042 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.416 HG22 ' HB2' ' A' ' 110' ' ' PHE . 19.7 m -111.04 127.01 68.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.243 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.722 ' HB3' HG12 ' A' ' 14' ' ' VAL . 13.6 p -108.21 177.19 4.88 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.604 0.716 . . . . 0.0 112.51 -178.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.655 ' HZ ' ' HB2' ' A' ' 142' ' ' ALA . 2.1 p90 -176.54 124.45 0.17 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.607 -1.178 . . . . 0.0 109.467 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 60.4 m -87.89 143.65 27.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.831 0.348 . . . . 0.0 111.291 -179.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.782 HG13 ' N ' ' A' ' 137' ' ' ILE . 51.0 t -54.72 -53.08 35.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.748 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.762 HG11 HG21 ' A' ' 125' ' ' THR . 34.3 m -52.09 110.1 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.225 179.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.75 ' N ' HD22 ' A' ' 129' ' ' LEU . 0.3 OUTLIER -151.46 128.38 5.44 Favored Pre-proline 0 C--N 1.33 -0.274 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.77 -179.36 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 86' ' ' SER . 82.5 Cg_endo -92.4 53.45 0.6 Allowed 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.299 2.666 . . . . 0.0 111.498 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.468 ' CA ' ' HG3' ' A' ' 133' ' ' LYS . 1.1 p 77.87 17.81 1.29 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.141 -179.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.769 ' O ' HG23 ' A' ' 93' ' ' VAL . 5.0 p -97.28 -23.98 15.89 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.811 0.338 . . . . 0.0 111.066 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.453 ' CZ ' HG21 ' A' ' 137' ' ' ILE . 9.7 t80 -46.96 -46.77 21.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.186 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -50.77 -52.19 43.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.183 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.93 -40.38 83.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.168 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.769 HG23 ' O ' ' A' ' 89' ' ' SER . 62.1 t -48.36 -45.42 13.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.491 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.551 ' O ' HG23 ' A' ' 98' ' ' VAL . 3.8 ptpp? -80.32 -36.81 33.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.107 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -74.61 -11.23 60.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.589 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.17 -20.49 12.33 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.58 0.228 . . . . 0.0 111.326 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.446 ' CE3' ' HA ' ' A' ' 97' ' ' TRP . 3.3 m95 -87.0 -51.61 5.92 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.712 0.291 . . . . 0.0 111.186 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 94' ' ' LYS . 57.3 t -48.51 -47.79 69.02 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.598 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 73.4 Cg_endo -76.46 -13.65 18.39 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.169 1.913 . . . . 0.0 112.492 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -89.83 -49.17 6.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.885 0.374 . . . . 0.0 110.727 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.424 HG13 HG23 ' A' ' 102' ' ' THR . 5.8 pt -56.84 -28.16 27.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.013 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.424 HG23 HG13 ' A' ' 101' ' ' ILE . 69.5 p -93.05 -25.89 17.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.93 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -63.5 -68.59 0.33 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.758 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 10.2 m80 -64.86 -51.1 63.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.795 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 2.9 m -101.57 141.15 22.01 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.811 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -51.24 155.21 6.89 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.591 2.194 . . . . 0.0 112.209 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 16.3 mttt -53.46 90.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.872 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.44 ' HB ' ' CD1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -115.65 152.43 47.26 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.918 -179.954 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -60.86 167.83 8.08 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.686 2.257 . . . . 0.0 112.415 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.738 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 1.8 p90 -155.8 159.39 39.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.738 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 1.021 HD12 HG11 ' A' ' 152' ' ' VAL . 4.2 tt -121.03 150.03 41.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.255 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.7 ' O ' HD23 ' A' ' 111' ' ' LEU . 3.8 mm? -94.05 141.71 28.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.178 179.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.996 HG13 HG21 ' A' ' 168' ' ' VAL . 3.1 t -122.03 145.29 28.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.183 0.516 . . . . 0.0 112.07 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -130.51 125.78 4.71 Favored Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.093 179.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.653 ' C ' HD13 ' A' ' 117' ' ' ILE . 0.6 OUTLIER -144.27 -44.89 0.25 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.964 0.412 . . . . 0.0 110.752 -178.854 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.463 ' HA ' HD23 ' A' ' 119' ' ' LEU . 0.1 OUTLIER -71.33 -2.68 17.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.23 179.26 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.653 HD13 ' C ' ' A' ' 115' ' ' THR . 0.1 OUTLIER -42.29 -28.44 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 179.935 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.18 -34.7 61.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.771 0.319 . . . . 0.0 111.131 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.557 ' N ' HD22 ' A' ' 119' ' ' LEU . 2.2 mm? -69.44 -31.78 70.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.083 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.456 ' CB ' HG11 ' A' ' 84' ' ' VAL . 0.3 OUTLIER -46.11 -29.87 1.69 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.949 -179.884 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -83.84 -31.96 25.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.505 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 119' ' ' LEU . 3.5 t0 -56.54 106.86 0.74 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.618 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.415 ' O ' ' CG ' ' A' ' 127' ' ' GLU . 14.2 Cg_exo -69.19 -3.62 12.0 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.686 2.257 . . . . 0.0 112.975 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.83 -65.24 1.04 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 121.058 0.456 . . . . 0.0 109.865 179.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.762 HG21 HG11 ' A' ' 85' ' ' VAL . 4.1 m -56.65 -38.95 72.86 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.532 HD11 ' HB3' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -54.34 -43.1 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.753 179.203 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.459 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 1.7 mm-40 -58.31 -37.7 75.61 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.833 179.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 125' ' ' THR . 2.7 mptt -63.11 -30.71 71.81 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.75 HD22 ' N ' ' A' ' 86' ' ' SER . 8.0 mt -74.88 -39.22 61.63 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 127' ' ' GLU . . . -46.57 -31.49 2.84 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.85 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.0 mmtt -50.14 -34.31 21.79 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.391 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.404 ' HB2' ' O ' ' A' ' 87' ' ' PRO . 5.0 m-80 -123.3 -31.36 3.56 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.359 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.512 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 7.6 mmtt -144.79 -98.96 0.1 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 119.15 -0.452 . . . . 0.0 111.326 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.512 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 0.0 OUTLIER 132.22 -22.79 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.401 1.08 . . . . 0.0 110.503 -179.809 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 4.5 mmtt -68.75 110.82 6.62 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.726 -179.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.532 ' HB3' HD11 ' A' ' 126' ' ' ILE . 85.2 Cg_endo -81.6 123.4 4.27 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.534 2.156 . . . . 0.0 111.394 179.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.782 ' N ' HG13 ' A' ' 84' ' ' VAL . 1.1 mm -55.05 96.61 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.958 0.409 . . . . 0.0 110.893 -179.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.44 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 74.2 p -69.09 156.59 91.25 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.028 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.44 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 9.4 Cg_endo -50.75 -41.35 54.81 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.709 2.272 . . . . 0.0 112.085 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -58.85 -34.8 72.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.583 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.409 HG21 HG23 ' A' ' 137' ' ' ILE . 84.3 m -63.62 -46.49 85.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.677 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.655 ' HB2' ' HZ ' ' A' ' 82' ' ' PHE . . . -55.6 -48.74 74.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.905 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -53.48 -43.95 68.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.73 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 6.8 mttt -54.1 -61.8 2.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.704 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.663 HD21 HD11 ' A' ' 149' ' ' LEU . 0.8 OUTLIER -61.57 -37.98 85.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.649 179.748 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.478 ' HB2' ' HG ' ' A' ' 112' ' ' LEU . . . -59.45 -49.22 78.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.861 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 16.2 mtp180 -79.68 -25.14 41.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.826 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -56.93 -40.71 76.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.447 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.663 HD11 HD21 ' A' ' 145' ' ' LEU . 1.1 mt -109.95 26.11 11.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.667 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.469 ' N ' ' CD ' ' A' ' 150' ' ' LYS . 0.0 OUTLIER 37.84 57.0 1.54 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.671 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.738 ' HB1' ' O ' ' A' ' 110' ' ' PHE . . . -73.76 -82.16 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.025 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 1.021 HG11 HD12 ' A' ' 111' ' ' LEU . 55.5 t -161.96 -76.12 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.752 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.443 ' HG3' ' N ' ' A' ' 154' ' ' TYR . 1.9 ttpt -177.01 145.91 0.5 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.343 -178.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.443 ' N ' ' HG3' ' A' ' 153' ' ' LYS . 61.3 t80 -105.66 114.48 28.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.551 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.718 HG23 ' OE2' ' A' ' 171' ' ' GLU . 11.4 t -112.91 157.94 13.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.803 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.425 ' N ' HG12 ' A' ' 155' ' ' VAL . 2.6 pt-20 -97.79 118.29 34.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.065 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.452 ' HA ' ' CB ' ' A' ' 163' ' ' LYS . 22.9 m -160.63 126.42 3.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.673 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.789 ' OG ' HD12 ' A' ' 160' ' ' LEU . 0.4 OUTLIER -147.41 153.62 39.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.916 0.389 . . . . 0.0 111.745 -179.591 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -78.47 -22.07 48.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.664 179.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.789 HD12 ' OG ' ' A' ' 158' ' ' SER . 0.3 OUTLIER -67.39 -59.46 3.38 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.073 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.52 HG23 ' HD3' ' A' ' 163' ' ' LYS . 3.5 t -91.92 -22.49 20.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.222 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 72.13 69.86 0.15 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.865 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.52 ' HD3' HG23 ' A' ' 161' ' ' THR . 10.3 mptt -90.81 19.37 5.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.32 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 119.13 -42.21 1.83 Allowed Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.634 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.645 HD21 ' CA ' ' A' ' 19' ' ' LEU . 1.0 OUTLIER 66.35 -66.24 0.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.783 0.325 . . . . 0.0 111.359 179.904 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.423 ' O ' ' N ' ' A' ' 170' ' ' ASP . 6.2 ptpp? -58.04 -26.08 62.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.752 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.409 ' O ' ' HB2' ' A' ' 170' ' ' ASP . 0.2 OUTLIER -54.51 -69.46 0.13 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.814 0.34 . . . . 0.0 111.06 -179.717 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.996 HG21 HG13 ' A' ' 113' ' ' VAL . 13.6 p -56.15 -44.77 79.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.142 0.496 . . . . 0.0 110.69 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.559 ' HB2' HD23 ' A' ' 19' ' ' LEU . 5.6 t80 -66.85 -17.23 64.79 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.979 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' A' ' 166' ' ' LYS . 2.8 m-20 -80.95 -38.66 27.36 Favored 'General case' 0 C--N 1.334 -0.068 0 CA-C-O 120.809 0.338 . . . . 0.0 110.699 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.744 ' CD ' HD21 ' A' ' 111' ' ' LEU . 9.4 pt-20 -69.45 -27.81 65.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.936 0.398 . . . . 0.0 110.033 179.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.472 ' HA ' HD13 ' A' ' 111' ' ' LEU . . . -75.69 -42.23 51.58 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.911 179.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.546 HD13 ' HG2' ' B' ' 512' ' ' GLN . 1.7 pp -81.58 -34.44 13.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.044 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.839 HD23 HD13 ' B' ' 505' ' ' LEU . 1.2 tm? -56.36 -44.62 80.3 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.859 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.422 ' N ' HD13 ' A' ' 174' ' ' LEU . . . -51.22 -24.78 4.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.904 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.494 ' CB ' HG22 ' A' ' 4' ' ' ILE . . . -84.84 -39.27 18.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.163 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.855 HD13 ' HB ' ' B' ' 510' ' ' ILE . 31.4 mt -68.56 -24.06 64.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.869 0.366 . . . . 0.0 110.405 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.435 ' HB2' ' HB2' ' B' ' 507' ' ' ALA . 21.7 tt0 -165.52 139.27 3.76 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.543 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . 0.419 ' HA ' ' HD3' ' A' ' 180' ' ' PRO . 43.9 Cg_endo -68.36 108.58 1.83 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.564 2.176 . . . . 0.0 112.507 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 179' ' ' PRO . 11.8 Cg_exo -70.83 -159.51 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.734 2.29 . . . . 0.0 112.185 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -145.57 146.73 30.62 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.886 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.23 -165.32 0.3 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.686 2.258 . . . . 0.0 112.287 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.5 154.6 35.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.888 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 8.2 mttt . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.297 -0.858 . . . . 0.0 110.877 -179.967 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 112.45 -0.26 . . . . 0.0 112.45 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 503' ' ' SER . . . . . . . . . . . . . 5.7 m -74.03 -69.49 0.44 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.833 0.349 . . . . 0.0 110.782 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 504' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' B' ' 509' ' ' ASP . . . 64.09 114.67 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.684 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 505' ' ' LEU . . . . . 0.839 HD13 HD23 ' A' ' 174' ' ' LEU . 0.0 OUTLIER -148.53 -52.41 0.18 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.845 0.355 . . . . 0.0 110.709 -179.922 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 506' ' ' SER . . . . . 0.41 ' CB ' ' OE1' ' A' ' 178' ' ' GLU . 1.4 m -155.19 -161.11 1.13 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.778 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 507' ' ' ALA . . . . . 0.435 ' HB2' ' HB2' ' A' ' 178' ' ' GLU . . . 55.01 -90.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.001 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 508' ' ' GLN . . . . . 0.414 ' O ' ' CB ' ' B' ' 509' ' ' ASP . 9.9 mt-30 -132.1 3.9 4.05 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.875 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 509' ' ' ASP . . . . . 0.423 ' HA ' ' HA2' ' B' ' 504' ' ' GLY . 7.8 t70 80.71 42.44 0.05 OUTLIER 'General case' 0 C--N 1.34 0.19 0 CA-C-O 121.221 0.534 . . . . 0.0 110.012 -179.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 510' ' ' ILE . . . . . 0.855 ' HB ' HD13 ' A' ' 177' ' ' LEU . 11.2 mt -65.3 145.28 14.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.554 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 511' ' ' SER . . . . . . . . . . . . . 27.9 t -109.37 149.2 29.86 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.205 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 512' ' ' GLN . . . . . 0.546 ' HG2' HD13 ' A' ' 173' ' ' ILE . 0.0 OUTLIER -93.69 -53.53 0.25 Allowed Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.406 179.387 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 513' ' ' PRO . . . . . 0.458 ' HD3' ' CB ' ' B' ' 512' ' ' GLN . 55.8 Cg_endo -97.73 74.79 0.08 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 123.33 2.687 . . . . 0.0 111.813 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 514' ' ' LEU . . . . . 0.44 ' CD1' ' O ' ' A' ' 45' ' ' MET . 0.7 OUTLIER -73.33 -88.28 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.6 -179.257 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 515' ' ' GLN . . . . . 0.565 ' HB2' HG12 ' A' ' 44' ' ' VAL . 0.3 OUTLIER -87.45 -159.88 0.56 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.777 0.322 . . . . 0.0 111.006 -179.669 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -54.48 -21.24 9.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.235 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 517' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 47.24 29.14 1.14 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.821 0.343 . . . . 0.0 111.129 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 518' ' ' PHE . . . . . 0.517 ' CZ ' HD12 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -150.18 91.62 1.79 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.83 -179.749 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 519' ' ' ILE . . . . . 0.459 HG12 ' HA ' ' A' ' 42' ' ' VAL . 5.3 mm -97.79 -68.89 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.442 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -117.65 -170.0 1.78 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.946 0.403 . . . . 0.0 111.005 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 521' ' ' THR . . . . . 0.421 ' OG1' ' CG ' ' A' ' 37' ' ' PHE . 15.3 t -119.32 -159.86 0.79 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.909 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 522' ' ' GLY . . . . . . . . . . . . . . . -110.57 -92.37 2.15 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.364 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 523' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -115.41 -88.29 0.58 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.643 0.259 . . . . 0.0 111.02 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 524' ' ' GLY . . . . . . . . . . . . . . . 164.47 123.9 0.68 Allowed Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.491 -0.862 . . . . 0.0 112.643 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 525' ' ' ASP . . . . . 0.406 ' HB3' ' HG ' ' A' ' 61' ' ' LEU . 0.9 OUTLIER 177.28 46.17 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.99 0.424 . . . . 0.0 110.592 179.827 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 526' ' ' SER . . . . . 0.42 ' CB ' ' HD3' ' A' ' 34' ' ' PRO . 71.8 m -104.3 100.11 9.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.068 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 527' ' ' ASP . . . . . 0.431 ' O ' HG21 ' A' ' 33' ' ' VAL . 7.2 m-20 -156.17 164.79 20.25 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.835 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -61.09 95.69 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.588 2.192 . . . . 0.0 112.133 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 529' ' ' ARG . . . . . 0.499 ' HD2' HG11 ' A' ' 33' ' ' VAL . 2.8 mtp85 -97.67 -49.77 4.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.105 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 530' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -168.8 -41.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.158 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 2.7 m 72.71 177.02 0.26 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.772 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 532' ' ' TRP . . . . . . . . . . . . . 37.1 t90 -53.01 92.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.796 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . -114.86 -61.39 0.38 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.548 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 534' ' ' PHE . . . . . 0.4 ' HA ' ' HD3' ' B' ' 535' ' ' PRO . 44.0 m-85 -78.11 139.16 60.71 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.644 0.259 . . . . 0.0 110.875 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 535' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' B' ' 534' ' ' PHE . 50.5 Cg_exo -53.79 123.86 14.45 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.557 2.172 . . . . 0.0 112.438 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 70.31 126.8 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.027 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 537' ' ' ARG . . . . . 0.401 ' HB2' ' HA2' ' A' ' 12' ' ' GLY . 21.3 mmt180 -54.67 122.73 11.29 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.233 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 538' ' ' ILE . . . . . 0.624 ' C ' HD13 ' B' ' 538' ' ' ILE . 0.0 OUTLIER -48.17 151.05 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.152 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 539' ' ' ASP . . . . . 0.469 ' OD2' ' CD2' ' B' ' 542' ' ' TYR . 0.7 OUTLIER -38.52 104.62 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.218 0.532 . . . . 0.0 112.224 -178.58 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 540' ' ' GLU . . . . . 0.773 ' OE2' HG11 ' A' ' 8' ' ' VAL . 1.1 mm-40 -45.25 -26.54 0.51 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.529 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 541' ' ' LEU . . . . . 0.922 ' HA ' HD22 ' A' ' 70' ' ' LEU . 42.1 mt -41.21 -35.18 0.57 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.953 0.406 . . . . 0.0 111.116 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 542' ' ' TYR . . . . . 0.469 ' CD2' ' OD2' ' B' ' 539' ' ' ASP . 4.1 m-30 -104.33 -57.25 2.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.525 179.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 543' ' ' LEU . . . . . 0.752 HD12 ' HA ' ' B' ' 540' ' ' GLU . 0.2 OUTLIER 62.31 176.44 0.13 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.437 -179.884 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . 103.22 79.67 1.38 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.259 -0.972 . . . . 0.0 112.574 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 545' ' ' ASN . . . . . 0.43 ' HB3' ' HB2' ' B' ' 529' ' ' ARG . 2.5 m120 . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.955 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.427 ' HE2' ' HB2' ' A' ' 1' ' ' MET . 3.3 ppp? . . . . . 0 N--CA 1.488 1.472 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.421 ' N ' ' SD ' ' A' ' 1' ' ' MET . 50.4 tt0 61.93 132.84 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.893 0.377 . . . . 0.0 110.724 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.704 HG22 ' CD2' ' A' ' 53' ' ' LEU . 0.3 OUTLIER -133.36 -161.38 1.13 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.429 -179.679 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.883 HD13 HD22 ' A' ' 53' ' ' LEU . 0.3 OUTLIER -154.91 163.37 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -179.069 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 8.2 mtmt -111.29 136.59 50.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.041 179.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.424 ' HB2' HD12 ' A' ' 55' ' ' LEU . 1.0 OUTLIER -108.32 138.73 44.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.063 0.459 . . . . 0.0 111.66 -179.356 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -151.11 160.41 3.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.098 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.498 HG11 ' CA ' ' A' ' 14' ' ' VAL . 3.3 m -143.24 139.95 26.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.845 0.355 . . . . 0.0 111.726 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.447 HG12 HD13 ' A' ' 70' ' ' LEU . 14.8 m -143.27 131.04 18.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.083 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.25 -110.11 3.92 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.623 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.73 -23.85 24.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.716 0.293 . . . . 0.0 110.92 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -49.43 150.56 4.32 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.617 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.773 ' O ' HG13 ' A' ' 14' ' ' VAL . . . -91.53 -56.35 3.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.549 0.214 . . . . 0.0 111.158 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.773 HG13 ' O ' ' A' ' 13' ' ' ALA . 0.0 OUTLIER 170.75 -56.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.788 179.584 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.659 ' HA2' HD13 ' A' ' 19' ' ' LEU . . . 110.25 -16.29 29.85 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.419 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.846 ' O ' HD23 ' A' ' 20' ' ' LEU . 15.4 tptm -93.44 -50.04 5.63 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.782 0.325 . . . . 0.0 111.076 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.632 HG21 ' OG1' ' A' ' 35' ' ' THR . 0.6 OUTLIER -97.81 -71.2 0.69 Allowed 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.525 -179.516 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.438 ' HA ' HG12 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -34.61 -74.18 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -178.823 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.737 HD22 ' CD1' ' A' ' 169' ' ' PHE . 7.8 mp -47.43 -39.21 15.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.058 -179.031 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.846 HD23 ' O ' ' A' ' 16' ' ' LYS . 3.1 mm? -76.9 -20.88 55.69 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.982 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.443 ' N ' ' O ' ' A' ' 17' ' ' THR . 9.1 mm -61.09 -69.64 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 74.8 m -56.55 -32.95 65.66 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.514 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.488 ' HB2' HD13 ' A' ' 165' ' ' LEU . 42.2 t80 -56.99 -68.38 0.23 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.026 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.3 m -76.65 -45.99 27.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.666 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.442 ' N ' ' O ' ' A' ' 21' ' ' ILE . 1.6 p -92.41 -155.91 0.44 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.435 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.414 ' N ' ' ND2' ' A' ' 26' ' ' ASN . 0.1 OUTLIER -155.75 23.8 0.39 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.776 0.322 . . . . 0.0 111.098 -179.908 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.33 100.22 9.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.947 0.403 . . . . 0.0 111.39 -179.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.491 ' HE2' HD21 ' A' ' 119' ' ' LEU . 0.1 OUTLIER -87.86 -64.95 0.2 Allowed Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.095 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.487 ' HD3' ' CD2' ' A' ' 28' ' ' PHE . 93.0 Cg_endo -81.72 54.16 4.96 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.597 2.198 . . . . 0.0 111.983 179.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.414 ' O ' ' HG3' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -97.17 -84.96 0.36 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.864 -179.64 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.417 ' HA ' ' HA ' ' B' ' 531' ' ' CYS . 27.0 mt-10 -149.52 126.49 11.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.041 0.448 . . . . 0.0 111.873 -179.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.469 ' C ' HG22 ' A' ' 33' ' ' VAL . 3.1 m-85 -105.15 93.34 4.64 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.591 178.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.569 HG23 ' CD ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -165.81 -64.56 0.01 OUTLIER Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.253 -179.177 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.569 ' CD ' HG23 ' A' ' 33' ' ' VAL . 55.2 Cg_endo -70.78 56.7 1.86 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.599 2.199 . . . . 0.0 112.891 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.632 ' OG1' HG21 ' A' ' 17' ' ' THR . 7.3 t -121.75 26.35 8.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.993 0.425 . . . . 0.0 110.52 179.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.768 HG22 HD23 ' A' ' 61' ' ' LEU . 1.8 t -80.46 -5.66 8.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.888 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.454 ' HB3' ' N ' ' B' ' 522' ' ' GLY . 29.5 p90 -93.98 26.54 3.17 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.785 0.326 . . . . 0.0 111.142 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.1 p30 -70.3 -19.25 63.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.12 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -100.11 11.12 40.11 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.514 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.468 ' CE1' ' HA2' ' B' ' 522' ' ' GLY . 1.0 OUTLIER -60.66 -159.42 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 120.685 0.278 . . . . 0.0 110.664 179.894 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.41 ' O ' HG12 ' B' ' 519' ' ' ILE . . . -117.82 156.26 28.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.543 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.421 HG12 ' C ' ' B' ' 517' ' ' SER . 0.5 OUTLIER -140.56 126.13 20.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.883 179.725 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.737 ' O ' HG23 ' A' ' 44' ' ' VAL . 9.9 t -85.51 104.49 15.34 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.929 0.395 . . . . 0.0 110.592 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.939 ' CG1' HD13 ' B' ' 514' ' ' LEU . 2.8 t -164.63 158.1 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.818 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.487 ' HG3' HD22 ' B' ' 514' ' ' LEU . 0.0 OUTLIER -112.75 118.83 36.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.599 178.758 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.87 HG23 HG23 ' B' ' 510' ' ' ILE . 1.4 mm -79.65 86.81 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.441 -179.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 54.68 -76.16 0.01 OUTLIER Glycine 0 CA--C 1.521 0.464 0 CA-C-N 115.678 -0.692 . . . . 0.0 114.353 178.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . -57.55 -95.91 0.01 OUTLIER Glycine 0 CA--C 1.518 0.272 0 C-N-CA 121.099 -0.572 . . . . 0.0 113.559 -179.042 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.438 ' HB2' ' HD2' ' A' ' 50' ' ' PRO . 0.3 OUTLIER -115.93 163.83 19.84 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-O 120.736 0.303 . . . . 0.0 111.311 -179.154 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.438 ' HD2' ' HB2' ' A' ' 49' ' ' GLU . 57.8 Cg_exo -51.6 100.38 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.483 2.122 . . . . 0.0 112.39 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.437 ' HE1' HG21 ' A' ' 3' ' ' THR . 3.5 t80 -172.2 118.61 0.39 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.227 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.774 HG21 ' HB ' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -113.95 138.64 50.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.49 179.807 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.883 HD22 HD13 ' A' ' 4' ' ' ILE . 0.3 OUTLIER -70.7 109.07 4.71 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.375 -179.463 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -61.22 94.73 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.613 179.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.833 HD23 ' HD3' ' A' ' 16' ' ' LYS . 0.9 OUTLIER -41.56 110.95 0.19 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.853 0.359 . . . . 0.0 111.179 -179.398 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -83.74 104.97 14.28 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.884 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.692 ' CG ' HG12 ' A' ' 14' ' ' VAL . 17.1 m-20 -131.56 174.89 9.64 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.001 -179.322 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.657 ' HA ' HD11 ' A' ' 67' ' ' LEU . 0.1 OUTLIER -144.77 143.92 30.91 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.935 -179.395 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.725 ' HB1' HD23 ' A' ' 61' ' ' LEU . . . -140.66 125.46 18.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.046 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.4 ' C ' HD22 ' A' ' 61' ' ' LEU . . . -75.66 66.19 2.41 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.728 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.768 HD23 HG22 ' A' ' 36' ' ' VAL . 3.0 mm? -121.23 -176.98 3.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.905 0.383 . . . . 0.0 110.978 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -52.79 -45.93 67.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.012 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.414 ' HB3' ' CE2' ' A' ' 64' ' ' TYR . 0.2 OUTLIER -50.68 -38.01 44.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.951 -179.959 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.726 ' HE2' HG12 ' A' ' 36' ' ' VAL . 1.4 m-85 -145.02 97.13 2.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.788 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -86.02 -37.54 18.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.211 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -97.51 4.27 50.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.781 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.731 HD23 ' O ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -62.15 133.66 55.53 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.764 0.316 . . . . 0.0 110.266 179.672 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -174.84 60.05 0.22 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.249 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.562 ' HD2' HG21 ' A' ' 58' ' ' THR . 62.4 Cg_endo -73.18 -23.23 18.24 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.567 2.178 . . . . 0.0 112.03 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.71 ' O ' HD12 ' A' ' 70' ' ' LEU . 0.3 OUTLIER -59.24 -20.19 52.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.096 -179.964 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.9 p -50.77 -42.89 58.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.169 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -160.68 69.91 2.76 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.031 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.421 ' HD3' ' O ' ' A' ' 70' ' ' LEU . 73.7 Cg_endo -75.19 149.58 36.14 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.653 2.235 . . . . 0.0 112.32 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.49 10.48 40.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.42 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.3 t -48.96 176.01 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.864 0.364 . . . . 0.0 110.897 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -109.39 -24.16 11.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.985 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.0 p -134.26 143.34 38.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.278 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.408 ' HB2' ' O ' ' A' ' 109' ' ' PRO . 0.1 OUTLIER -125.84 174.48 8.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.627 179.732 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.516 HD11 HG23 ' A' ' 113' ' ' VAL . 46.4 tp -146.51 109.28 4.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.892 0.377 . . . . 0.0 111.238 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.657 HG11 HD11 ' A' ' 101' ' ' ILE . 31.1 m -98.79 115.36 39.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.633 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 3.6 m -108.29 168.07 9.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.094 0.473 . . . . 0.0 111.655 -179.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.41 ' CE1' HG21 ' A' ' 137' ' ' ILE . 10.8 p90 -169.75 135.9 1.53 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.353 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.421 ' CB ' ' OE1' ' A' ' 116' ' ' GLN . 4.9 p -83.17 141.17 32.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.035 0.445 . . . . 0.0 111.562 -179.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.782 HG12 ' O ' ' A' ' 137' ' ' ILE . 16.4 m -57.05 -31.47 37.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.243 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.74 HG11 HG21 ' A' ' 125' ' ' THR . 9.5 m -78.02 117.23 22.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.757 ' N ' HD22 ' A' ' 129' ' ' LEU . 0.4 OUTLIER -151.71 142.83 15.49 Favored Pre-proline 0 C--N 1.333 -0.151 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -179.141 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 86' ' ' SER . 69.4 Cg_endo -92.45 53.93 0.59 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 123.406 2.737 . . . . 0.0 111.614 179.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.445 ' CB ' ' HB2' ' A' ' 133' ' ' LYS . 0.3 OUTLIER 71.0 19.77 5.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.99 -179.297 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.711 ' O ' HG23 ' A' ' 93' ' ' VAL . 58.8 m -97.2 -21.59 17.21 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.741 0.305 . . . . 0.0 111.115 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.542 ' CZ ' HG21 ' A' ' 137' ' ' ILE . 17.4 t80 -47.48 -58.87 3.7 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.169 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.7 -39.29 36.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.868 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.419 ' O ' ' CD ' ' A' ' 96' ' ' LYS . 1.0 OUTLIER -72.52 -43.22 63.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.759 179.795 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.711 HG23 ' O ' ' A' ' 89' ' ' SER . 77.0 t -50.21 -63.47 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.051 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.81 ' HG2' HD13 ' A' ' 145' ' ' LEU . 0.0 OUTLIER -58.3 -39.32 79.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.913 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -65.81 -25.33 67.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.977 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.419 ' CD ' ' O ' ' A' ' 92' ' ' ASN . 1.4 mtpm? -100.06 -24.27 14.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.0 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.434 ' CE3' ' HA ' ' A' ' 97' ' ' TRP . 0.0 OUTLIER -67.18 -58.73 4.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.05 -179.853 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.544 HG21 HD13 ' A' ' 149' ' ' LEU . 95.4 t -45.57 -53.5 19.01 Favored Pre-proline 0 CA--C 1.532 0.26 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.814 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 51.9 Cg_endo -68.66 -14.43 39.35 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.173 1.915 . . . . 0.0 112.628 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -86.66 -35.66 19.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.87 0.367 . . . . 0.0 111.054 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.657 HD11 HG11 ' A' ' 80' ' ' VAL . 30.3 mt -78.31 -33.01 17.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.284 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.515 HG23 ' O ' ' A' ' 98' ' ' VAL . 22.9 p -84.76 -21.69 29.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.215 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 19.9 t-80 -87.63 -51.62 5.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.815 0.34 . . . . 0.0 110.96 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -80.54 -29.76 37.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.093 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -117.11 147.27 39.92 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.924 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.48 60.58 2.07 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.514 2.143 . . . . 0.0 112.288 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 59.12 67.56 0.9 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.966 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -90.84 146.79 34.6 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.744 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.408 ' O ' ' HB2' ' A' ' 78' ' ' PHE . 36.0 Cg_exo -60.7 169.17 5.89 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.505 2.137 . . . . 0.0 112.314 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.565 ' HB2' HG22 ' A' ' 80' ' ' VAL . 2.9 p90 -162.2 134.63 5.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.877 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.955 HD12 HG11 ' A' ' 152' ' ' VAL . 8.5 tt -119.93 154.53 34.3 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.997 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.596 ' N ' HD23 ' A' ' 111' ' ' LEU . 2.9 mm? -100.69 137.3 39.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.685 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 1.019 HG13 HG21 ' A' ' 168' ' ' VAL . 49.9 t -120.76 148.02 24.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.989 0.423 . . . . 0.0 111.373 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 157' ' ' CYS . . . -130.09 107.74 0.8 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.765 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.491 HG22 ' CB ' ' A' ' 157' ' ' CYS . 0.0 OUTLIER -125.01 -41.14 2.11 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.909 0.385 . . . . 0.0 110.595 -179.106 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.736 ' HB3' HG22 ' A' ' 84' ' ' VAL . 2.1 tt0 -78.28 1.96 19.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.127 179.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.407 ' O ' ' CG ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -46.55 -26.23 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.094 0 CA-C-O 120.775 0.322 . . . . 0.0 111.562 179.929 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -75.52 -25.88 57.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.492 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.665 HD22 HE21 ' A' ' 116' ' ' GLN . 3.9 mp -83.95 -25.61 29.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.124 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.474 ' HB3' HG21 ' A' ' 84' ' ' VAL . 5.8 ppt_? -50.36 -25.52 3.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.978 0.418 . . . . 0.0 110.629 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -87.79 -25.82 23.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.574 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -61.33 112.19 5.5 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.767 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.418 ' O ' HG22 ' A' ' 126' ' ' ILE . 40.0 Cg_endo -67.92 -6.27 16.59 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.513 2.142 . . . . 0.0 113.114 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -77.39 -68.49 0.61 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.024 0.44 . . . . 0.0 109.929 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.74 HG21 HG11 ' A' ' 85' ' ' VAL . 4.8 m -56.71 -35.41 68.49 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.31 0.576 . . . . 0.0 109.556 179.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.721 HD11 ' HG3' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -57.53 -44.04 84.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.55 179.231 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' A' ' 123' ' ' PRO . 4.2 mm-40 -55.69 -36.85 67.61 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.469 179.099 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.426 ' HB2' ' O ' ' A' ' 125' ' ' THR . 0.0 OUTLIER -64.04 -31.3 72.44 Favored 'General case' 0 CA--C 1.518 -0.25 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.554 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.757 HD22 ' N ' ' A' ' 86' ' ' SER . 7.6 mt -74.0 -42.06 60.95 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.499 ' HA ' ' HB3' ' A' ' 134' ' ' GLN . . . -47.21 -28.97 2.09 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.956 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 31.4 mmtt -56.54 -34.12 66.75 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.753 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.412 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 1.7 m-80 -124.36 -31.33 3.3 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.508 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 0.0 OUTLIER -137.42 -75.6 0.41 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 121.037 -0.265 . . . . 0.0 111.306 -179.009 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.508 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 3.0 pt20 111.53 -45.21 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.607 1.163 . . . . 0.0 111.016 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.5 mttp -69.81 111.06 7.8 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.91 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.91 ' C ' HD13 ' A' ' 137' ' ' ILE . 69.9 Cg_endo -72.43 -169.89 0.52 Allowed 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.353 2.036 . . . . 0.0 111.218 178.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.91 HD13 ' C ' ' A' ' 136' ' ' PRO . 1.1 mm -114.03 97.03 5.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.904 0.383 . . . . 0.0 110.99 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.428 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 3.0 p -67.3 155.63 90.27 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.943 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.463 ' HA ' ' CE2' ' A' ' 154' ' ' TYR . 10.2 Cg_endo -51.66 -38.68 66.34 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.747 2.298 . . . . 0.0 112.098 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.422 ' HG3' ' N ' ' A' ' 141' ' ' THR . 0.0 OUTLIER -64.73 -25.96 68.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.664 179.69 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.422 ' N ' ' HG3' ' A' ' 140' ' ' GLU . 45.5 m -71.82 -47.4 53.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.787 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.492 ' O ' ' HB2' ' A' ' 146' ' ' ALA . . . -55.21 -39.2 69.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.877 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -68.04 -41.96 81.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.818 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -53.25 -60.6 3.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.867 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.81 HD13 ' HG2' ' A' ' 94' ' ' LYS . 1.6 tt -66.91 -39.8 87.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.64 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.492 ' HB2' ' O ' ' A' ' 142' ' ' ALA . . . -48.94 -50.37 35.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.927 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 19.2 mtp180 -78.76 -24.14 44.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.704 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -49.62 -34.78 19.03 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.88 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.544 HD13 HG21 ' A' ' 98' ' ' VAL . 1.6 mt -121.5 21.78 10.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.893 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.1 mttp 47.84 57.5 5.95 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.059 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.534 ' HB1' ' O ' ' A' ' 110' ' ' PHE . . . -70.58 -82.69 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.214 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.955 HG11 HD12 ' A' ' 111' ' ' LEU . 72.9 t -161.81 -73.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.842 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 179.5 146.35 0.2 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.61 -178.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.463 ' CE2' ' HA ' ' A' ' 139' ' ' PRO . 65.0 t80 -112.79 103.69 11.7 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.305 179.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.601 HG12 ' H ' ' A' ' 156' ' ' GLU . 0.6 OUTLIER -102.99 -179.96 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.744 -179.788 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.601 ' H ' HG12 ' A' ' 155' ' ' VAL . 0.0 OUTLIER -89.6 151.3 21.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.921 0.391 . . . . 0.0 111.099 -179.797 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.491 ' CB ' HG22 ' A' ' 115' ' ' THR . 1.9 t -128.97 169.22 14.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.883 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.497 ' O ' ' HB2' ' A' ' 159' ' ' ALA . 2.2 t -106.99 151.46 25.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.203 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.938 ' O ' HD13 ' A' ' 160' ' ' LEU . . . 172.68 -33.96 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.77 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.938 HD13 ' O ' ' A' ' 159' ' ' ALA . 0.2 OUTLIER -131.09 -44.35 1.04 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.7 179.753 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 9.7 t -100.08 -21.69 15.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.091 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.437 ' HA ' ' CB ' ' A' ' 158' ' ' SER . 1.9 tt0 72.89 77.7 0.14 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.955 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.458 ' HE3' ' CB ' ' A' ' 156' ' ' GLU . 0.0 OUTLIER -97.35 10.44 39.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.569 -179.948 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.406 ' O ' ' CB ' ' A' ' 165' ' ' LEU . . . 116.25 -50.85 0.76 Allowed Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.428 -0.892 . . . . 0.0 113.336 179.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.566 HD21 ' HA ' ' A' ' 19' ' ' LEU . 0.2 OUTLIER 79.54 -56.6 0.4 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.8 0.333 . . . . 0.0 110.8 -179.433 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -56.8 -21.32 27.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.791 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.559 ' ND2' HG11 ' A' ' 155' ' ' VAL . 0.1 OUTLIER -55.32 -72.18 0.07 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.014 179.889 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 1.019 HG21 HG13 ' A' ' 113' ' ' VAL . 29.0 m -57.9 -40.79 77.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.036 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.737 ' CD1' HD22 ' A' ' 19' ' ' LEU . 1.4 t80 -63.58 -34.67 78.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.734 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.41 ' HA ' ' CG1' ' A' ' 173' ' ' ILE . 13.2 m-20 -74.64 -24.89 58.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.659 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.517 ' CG ' HD11 ' A' ' 111' ' ' LEU . 5.1 tp10 -79.41 -33.41 42.69 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.59 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.582 ' N ' HD13 ' A' ' 111' ' ' LEU . . . -73.23 -35.25 66.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.685 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.537 HD12 HD12 ' A' ' 177' ' ' LEU . 1.4 pp -82.78 -32.51 9.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.891 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.807 HD13 ' CB ' ' B' ' 505' ' ' LEU . 13.6 tp -54.68 -47.34 73.75 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.211 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -47.5 -26.89 1.54 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.113 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.659 ' HB3' ' CG2' ' A' ' 4' ' ' ILE . . . -93.9 -37.12 11.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.173 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.796 ' CD1' HG21 ' B' ' 510' ' ' ILE . 43.3 mt -68.71 -24.2 64.46 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.663 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.416 ' HG3' ' N ' ' B' ' 507' ' ' ALA . 1.6 tm-20 -160.52 128.74 2.89 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.684 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.69 106.9 0.19 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.44 2.093 . . . . 0.0 112.333 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.19 176.48 9.89 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.557 2.171 . . . . 0.0 112.248 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -139.79 141.89 29.26 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.966 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.35 -165.04 0.29 Allowed 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.718 2.279 . . . . 0.0 112.227 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.08 173.87 1.01 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.018 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.289 -0.862 . . . . 0.0 110.882 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.153 0 N-CA-C 112.421 -0.272 . . . . 0.0 112.421 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 503' ' ' SER . . . . . 0.415 ' HB2' ' HA ' ' B' ' 511' ' ' SER . 0.5 OUTLIER -87.4 -80.66 0.25 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.809 0.338 . . . . 0.0 110.908 179.943 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 504' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' B' ' 509' ' ' ASP . . . 102.6 113.09 3.72 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.541 -0.838 . . . . 0.0 111.941 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 505' ' ' LEU . . . . . 0.807 ' CB ' HD13 ' A' ' 174' ' ' LEU . 0.1 OUTLIER -139.03 -42.28 0.47 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 121.053 -0.259 . . . . 0.0 111.681 -179.195 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 506' ' ' SER . . . . . 0.435 ' CB ' ' O ' ' B' ' 505' ' ' LEU . 0.4 OUTLIER 162.74 -44.98 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.668 0.27 . . . . 0.0 110.741 -179.678 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 507' ' ' ALA . . . . . 0.506 ' HB3' HG12 ' B' ' 510' ' ' ILE . . . -37.58 -35.23 0.12 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.627 0.727 . . . . 0.0 111.109 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 508' ' ' GLN . . . . . 0.493 ' O ' ' HB2' ' B' ' 509' ' ' ASP . 7.3 pt20 165.79 -37.94 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.555 -1.202 . . . . 0.0 108.634 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 509' ' ' ASP . . . . . 0.493 ' HB2' ' O ' ' B' ' 508' ' ' GLN . 13.7 t0 148.21 44.92 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 114.201 -1.363 . . . . 0.0 109.394 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 510' ' ' ILE . . . . . 0.87 HG23 HG23 ' A' ' 46' ' ' ILE . 19.9 mm -55.18 133.65 18.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.406 -179.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 511' ' ' SER . . . . . 0.48 ' HB3' HD11 ' B' ' 514' ' ' LEU . 30.2 t -109.59 134.82 51.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.836 179.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 512' ' ' GLN . . . . . 0.438 ' CB ' ' HD3' ' B' ' 513' ' ' PRO . 0.0 OUTLIER -99.47 -53.65 0.18 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.134 179.735 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 513' ' ' PRO . . . . . 0.438 ' HD3' ' CB ' ' B' ' 512' ' ' GLN . 91.0 Cg_endo -94.91 78.19 0.15 Allowed 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 123.152 2.568 . . . . 0.0 112.525 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 514' ' ' LEU . . . . . 0.939 HD13 ' CG1' ' A' ' 44' ' ' VAL . 4.7 mp -89.23 -89.88 0.14 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.227 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 515' ' ' GLN . . . . . 0.651 ' H ' HG22 ' A' ' 44' ' ' VAL . 6.4 mt-30 -93.4 47.31 1.24 Allowed 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 116.744 -0.207 . . . . 0.0 111.13 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 516' ' ' ASN . . . . . 0.546 ' HB3' ' O ' ' B' ' 515' ' ' GLN . 29.2 t30 77.7 -38.23 0.26 Allowed 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 517' ' ' SER . . . . . 0.421 ' C ' HG12 ' A' ' 42' ' ' VAL . 0.5 OUTLIER 61.24 54.33 3.27 Favored 'General case' 0 C--O 1.232 0.15 0 O-C-N 122.24 -0.287 . . . . 0.0 111.452 179.554 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 518' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -163.54 92.73 0.72 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.894 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 519' ' ' ILE . . . . . 0.689 HD11 ' H ' ' A' ' 43' ' ' THR . 22.4 mm -71.16 -69.13 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.089 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -160.47 -170.44 2.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.94 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 521' ' ' THR . . . . . 0.454 ' O ' ' CZ ' ' A' ' 40' ' ' TYR . 13.8 t -77.32 -168.37 1.12 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.058 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 522' ' ' GLY . . . . . 0.468 ' HA2' ' CE1' ' A' ' 40' ' ' TYR . . . -121.41 -75.12 0.37 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.38 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 523' ' ' HIS . . . . . 0.439 ' CD2' ' C ' ' B' ' 523' ' ' HIS . 9.4 t-160 178.98 -88.21 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.555 0.217 . . . . 0.0 110.902 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 524' ' ' GLY . . . . . 0.506 ' HA3' HG21 ' A' ' 36' ' ' VAL . . . 46.77 -139.5 7.53 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.778 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 525' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -137.99 82.85 1.94 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.837 0.351 . . . . 0.0 110.784 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 526' ' ' SER . . . . . 0.465 ' CB ' ' HB3' ' A' ' 34' ' ' PRO . 6.5 m -72.17 95.75 1.7 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.757 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 527' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -145.96 142.42 17.78 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.016 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.21 105.29 2.0 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.671 2.248 . . . . 0.0 112.113 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 529' ' ' ARG . . . . . 0.471 ' HG3' HG11 ' A' ' 33' ' ' VAL . 2.3 mtt-85 -100.27 -55.38 2.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.307 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 530' ' ' HIS . . . . . 0.418 ' O ' ' CB ' ' B' ' 531' ' ' CYS . 0.0 OUTLIER -130.57 -38.12 1.34 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.486 -179.592 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 531' ' ' CYS . . . . . 0.418 ' CB ' ' O ' ' B' ' 530' ' ' HIS . 4.0 m 79.49 28.74 0.34 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.988 0.423 . . . . 0.0 110.604 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 532' ' ' TRP . . . . . 0.439 ' CH2' ' HG3' ' B' ' 537' ' ' ARG . 1.7 t-105 59.28 103.28 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.035 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . -114.55 -24.31 4.42 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.278 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 534' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -133.47 130.97 21.2 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.489 0.185 . . . . 0.0 110.597 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.49 -170.03 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.458 2.106 . . . . 0.0 112.504 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 68.22 120.86 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.004 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 537' ' ' ARG . . . . . 0.439 ' HG3' ' CH2' ' B' ' 532' ' ' TRP . 0.0 OUTLIER -106.23 -179.32 3.91 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 121.599 0.714 . . . . 0.0 111.259 179.916 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 538' ' ' ILE . . . . . 0.433 HG12 ' HB2' ' B' ' 542' ' ' TYR . 1.2 tt -116.02 174.47 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 CA-C-N 114.594 -1.184 . . . . 0.0 109.891 179.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 539' ' ' ASP . . . . . 0.469 ' HB3' HD22 ' A' ' 70' ' ' LEU . 0.3 OUTLIER -69.8 162.3 28.14 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.482 179.851 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 540' ' ' GLU . . . . . 0.427 ' CB ' ' OG1' ' A' ' 58' ' ' THR . 2.4 mt-10 -40.38 -49.08 2.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.841 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 541' ' ' LEU . . . . . . . . . . . . . 1.1 tt -42.28 -67.91 0.23 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.797 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 542' ' ' TYR . . . . . 0.433 ' HB2' HG12 ' B' ' 538' ' ' ILE . 59.2 m-85 -84.57 9.62 13.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.981 -179.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 543' ' ' LEU . . . . . 0.421 ' HB2' ' HA ' ' B' ' 540' ' ' GLU . 16.5 tp -44.92 -28.47 0.67 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.834 0.35 . . . . 0.0 111.283 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . -72.52 77.91 0.74 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.548 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 545' ' ' ASN . . . . . 0.461 ' HB2' HG13 ' A' ' 33' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.975 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.431 ' HB3' ' N ' ' A' ' 49' ' ' GLU . 2.6 ppp? . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.828 0.347 . . . . 0.0 111.264 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.423 ' CG ' HD11 ' B' ' 510' ' ' ILE . 0.2 OUTLIER -129.44 141.17 51.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.52 179.464 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.807 HG23 ' CE1' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -94.06 168.78 10.72 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.983 -179.815 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.551 ' HA ' ' HB1' ' A' ' 176' ' ' ALA . 2.3 pt -151.03 154.39 8.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.659 -179.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -121.03 110.38 16.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.397 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.463 ' SG ' HD23 ' A' ' 55' ' ' LEU . 40.1 m -91.61 107.4 19.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.004 0.43 . . . . 0.0 111.589 -179.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.452 HG22 ' CZ ' ' A' ' 56' ' ' PHE . 2.9 t -138.0 113.65 10.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.254 179.334 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.78 ' CG2' HG21 ' A' ' 14' ' ' VAL . 2.4 p -87.24 150.14 3.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.308 0.575 . . . . 0.0 111.436 -179.445 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.53 ' CG2' ' CE1' ' A' ' 78' ' ' PHE . 72.5 t -155.06 130.23 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.637 179.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.72 148.13 4.75 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.131 -1.033 . . . . 0.0 112.711 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -58.17 -42.18 85.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.893 0.378 . . . . 0.0 110.394 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.26 -149.94 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.701 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.614 ' C ' HG23 ' A' ' 14' ' ' VAL . . . -103.1 -55.86 2.33 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.958 HG22 ' HB3' ' A' ' 81' ' ' CYS . 3.5 t 84.13 -51.52 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.264 -0.425 . . . . 0.0 109.949 -178.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.676 ' C ' HD12 ' A' ' 19' ' ' LEU . . . 90.49 25.48 25.67 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.857 -0.687 . . . . 0.0 113.045 179.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.447 ' HE2' ' N ' ' A' ' 8' ' ' VAL . 0.7 OUTLIER -38.58 -43.2 0.85 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.11 0.481 . . . . 0.0 111.017 179.749 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.534 HG22 ' CG ' ' A' ' 38' ' ' ASP . 81.9 p -98.47 -60.98 1.44 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.278 178.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.48 ' HA ' ' HB ' ' A' ' 21' ' ' ILE . 29.7 t -46.51 -32.65 3.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.014 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.865 HD13 ' CE2' ' A' ' 169' ' ' PHE . 3.3 mt -45.68 -71.99 0.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -178.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.443 HD13 ' HA ' ' A' ' 20' ' ' LEU . 3.0 mm? -64.64 -23.67 67.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.951 -179.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.48 ' HB ' ' HA ' ' A' ' 18' ' ' CYS . 14.6 mm -61.05 -70.95 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.945 0.403 . . . . 0.0 110.486 179.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.528 ' HA ' ' HA ' ' A' ' 26' ' ' ASN . 2.4 t -51.76 -34.42 39.38 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.162 -179.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.509 ' CE2' ' HD3' ' A' ' 166' ' ' LYS . 27.5 t80 -55.93 -45.11 78.84 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.968 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.62 -64.42 1.05 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.543 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.431 ' OG1' HG23 ' A' ' 21' ' ' ILE . 79.9 p -66.27 -37.47 85.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.582 -179.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.528 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 1.5 t-20 67.08 56.91 0.63 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.941 -179.15 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.0 mmtt -132.91 83.25 2.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.134 0.492 . . . . 0.0 110.961 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.468 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 40.5 t80 -92.35 -45.56 0.34 Allowed Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.082 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.468 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 62.6 Cg_endo -94.86 90.22 0.11 Allowed 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.955 2.436 . . . . 0.0 112.939 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.429 ' O ' ' CB ' ' B' ' 531' ' ' CYS . 0.4 OUTLIER -150.47 -89.2 0.07 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.627 0.251 . . . . 0.0 110.855 179.616 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -159.12 126.26 4.76 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.627 -0.261 . . . . 0.0 110.427 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.512 ' CG ' ' NH2' ' B' ' 537' ' ' ARG . 3.8 m-85 -111.55 121.87 46.31 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.194 0.521 . . . . 0.0 111.283 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.686 HG11 ' HG3' ' B' ' 529' ' ' ARG . 0.0 OUTLIER -165.42 -64.55 0.01 OUTLIER Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.433 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.478 ' CD ' HG23 ' A' ' 33' ' ' VAL . 50.5 Cg_endo -69.9 58.37 1.62 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.385 2.057 . . . . 0.0 112.428 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.2 t -87.64 10.47 17.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.737 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.698 HG13 HD23 ' A' ' 61' ' ' LEU . 3.3 m -76.0 -30.03 20.33 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-O 120.865 0.364 . . . . 0.0 110.84 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.409 ' O ' ' CG ' ' A' ' 40' ' ' TYR . 0.2 OUTLIER -50.87 -25.01 4.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.017 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.534 ' CG ' HG22 ' A' ' 17' ' ' THR . 20.8 t0 -50.34 -28.29 7.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.971 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -88.99 14.52 10.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.165 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.473 ' CZ ' ' CG1' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -71.59 -169.99 0.49 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.787 0.327 . . . . 0.0 110.911 179.809 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.402 ' O ' HG12 ' B' ' 519' ' ' ILE . . . -112.16 119.92 40.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.316 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.473 ' CG1' ' CZ ' ' A' ' 40' ' ' TYR . 2.5 m -122.71 121.71 64.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.023 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.4 t -104.69 128.79 52.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.9 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.986 HG12 ' CG2' ' A' ' 52' ' ' THR . 1.0 OUTLIER -164.54 -177.45 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.871 179.895 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.611 ' H ' HG22 ' A' ' 44' ' ' VAL . 5.9 tpt -101.4 96.13 6.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.012 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.675 HG22 ' O ' ' A' ' 46' ' ' ILE . 1.6 mm -74.86 86.9 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 120.841 0.353 . . . . 0.0 110.219 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.45 ' HA3' ' HA ' ' B' ' 510' ' ' ILE . . . 33.71 -87.72 0.01 OUTLIER Glycine 0 CA--C 1.523 0.549 0 CA-C-N 115.676 -0.693 . . . . 0.0 114.327 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . -37.72 -79.17 0.04 OUTLIER Glycine 0 C--N 1.333 0.392 0 N-CA-C 113.899 0.319 . . . . 0.0 113.899 -179.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.482 ' N ' ' HE1' ' A' ' 45' ' ' MET . 2.7 mt-10 -140.52 156.34 69.42 Favored Pre-proline 0 C--N 1.332 -0.162 0 CA-C-O 120.808 0.337 . . . . 0.0 111.621 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -43.2 101.01 0.04 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 123.137 2.558 . . . . 0.0 112.838 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.807 ' CE1' HG23 ' A' ' 3' ' ' THR . 17.8 t80 -172.68 153.62 2.81 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.368 179.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.986 ' CG2' HG12 ' A' ' 44' ' ' VAL . 0.8 OUTLIER -136.88 154.11 50.57 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.961 179.53 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.643 ' N ' HD13 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -99.56 166.57 11.08 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.984 179.772 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 56' ' ' PHE . . . -115.17 87.56 0.44 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.42 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.542 ' H ' HD12 ' A' ' 55' ' ' LEU . 0.5 OUTLIER -60.34 82.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.781 0.324 . . . . 0.0 110.538 179.888 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.464 ' CG ' ' O ' ' A' ' 56' ' ' PHE . 37.4 p90 -84.36 105.5 15.24 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.571 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 56.6 p30 -98.19 -177.88 3.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.761 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.96 HG21 HD22 ' A' ' 70' ' ' LEU . 73.6 p -94.39 161.54 14.19 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.816 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.418 ' CA ' ' O ' ' B' ' 542' ' ' TYR . . . -170.84 179.84 3.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.172 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.565 ' H ' HD22 ' A' ' 61' ' ' LEU . . . -150.97 34.66 0.93 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.463 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.698 HD23 HG13 ' A' ' 36' ' ' VAL . 2.0 mm? -95.71 -173.18 2.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.863 0.363 . . . . 0.0 110.917 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -51.02 -25.54 4.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.734 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.497 ' HB2' HG11 ' A' ' 36' ' ' VAL . 0.2 OUTLIER -53.95 -54.79 34.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.798 179.866 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.411 ' CD2' ' HB3' ' A' ' 63' ' ' ASP . 4.4 m-85 -132.53 152.07 51.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.774 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -85.88 -68.27 0.75 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.205 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.8 -52.27 4.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.224 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.761 HD23 ' O ' ' A' ' 67' ' ' LEU . 7.2 tt 55.42 98.61 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.484 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.0 mmm180 -132.88 58.93 39.26 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.128 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.494 ' HD2' HD23 ' A' ' 70' ' ' LEU . 83.5 Cg_endo -83.68 -21.72 4.04 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.827 2.351 . . . . 0.0 112.172 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.96 HD22 HG21 ' A' ' 58' ' ' THR . 1.1 pt? -85.69 1.32 49.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.721 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 46.3 t -70.59 -71.16 0.26 Allowed 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.728 0.299 . . . . 0.0 111.065 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -121.85 72.55 32.76 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.861 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.411 ' HG3' ' CZ ' ' A' ' 78' ' ' PHE . 98.4 Cg_endo -78.71 140.87 16.85 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.713 2.275 . . . . 0.0 112.457 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.8 tp60 -102.11 10.39 39.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.349 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 13.6 t -59.55 -173.75 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.866 0.365 . . . . 0.0 111.055 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -136.22 7.83 3.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.503 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.501 ' CG1' ' HB3' ' A' ' 175' ' ' ALA . 64.0 t -151.14 101.15 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 CA-C-O 120.788 0.328 . . . . 0.0 111.249 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.53 ' CE1' ' CG2' ' A' ' 9' ' ' VAL . 0.1 OUTLIER -102.08 -177.85 3.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.645 179.785 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.636 HD13 ' HB3' ' A' ' 111' ' ' LEU . 21.7 tp -154.13 114.59 3.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.831 0.348 . . . . 0.0 111.633 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.609 HG23 HD13 ' A' ' 112' ' ' LEU . 2.9 m -94.61 156.22 3.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.486 179.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.958 ' HB3' HG22 ' A' ' 14' ' ' VAL . 22.3 p -128.98 168.93 15.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.237 0.541 . . . . 0.0 112.178 -179.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.649 ' HZ ' ' HB1' ' A' ' 142' ' ' ALA . 46.9 p90 179.27 123.51 0.06 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.926 179.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 98.8 p -93.61 146.27 23.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.881 0.372 . . . . 0.0 111.44 -179.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.925 HG11 ' HG2' ' A' ' 120' ' ' ARG . 58.1 t -51.3 -73.95 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.366 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.445 ' O ' HG23 ' A' ' 85' ' ' VAL . 8.1 m -43.27 105.76 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 120.756 0.313 . . . . 0.0 110.968 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.443 ' N ' HD22 ' A' ' 129' ' ' LEU . 87.6 p -151.33 138.65 12.19 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.62 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.407 ' O ' ' CB ' ' A' ' 88' ' ' SER . 80.3 Cg_endo -91.65 53.93 0.8 Allowed 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.305 2.67 . . . . 0.0 112.026 179.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.461 ' CA ' ' HG3' ' A' ' 133' ' ' LYS . 0.1 OUTLIER 81.42 30.33 0.14 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.84 -179.611 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.533 ' O ' HG23 ' A' ' 93' ' ' VAL . 11.1 t -88.18 -24.42 23.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.697 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.631 ' CZ ' HG21 ' A' ' 137' ' ' ILE . 0.4 OUTLIER -50.89 -64.41 0.82 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.871 179.901 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -51.83 -37.58 52.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.936 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.413 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 3.3 m120 -67.96 -64.2 0.91 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.917 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 89' ' ' SER . 50.7 t -49.26 -46.7 18.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.368 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.791 ' HB2' HD11 ' A' ' 145' ' ' LEU . 4.5 ttpt -54.19 -59.08 5.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.276 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.415 ' O ' ' HG2' ' A' ' 99' ' ' PRO . 7.1 mt-10 -83.46 9.9 10.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.869 -179.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.413 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 13.7 tttt -116.86 -33.09 4.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.724 0.297 . . . . 0.0 111.067 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.558 ' O ' HG22 ' A' ' 101' ' ' ILE . 0.0 OUTLIER -94.35 -45.31 7.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.459 -179.658 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 94' ' ' LYS . 43.8 t -53.09 -44.44 97.13 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 -179.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.493 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 2.7 Cg_exo -76.01 -24.48 11.24 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.609 2.206 . . . . 0.0 112.641 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -88.73 -49.69 6.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.016 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.558 HG22 ' O ' ' A' ' 97' ' ' TRP . 8.9 tt -51.16 -24.55 3.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.157 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.416 HG23 HG23 ' A' ' 101' ' ' ILE . 59.3 p -97.22 -28.72 13.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.006 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 54.1 t60 -72.82 -69.29 0.42 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.926 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -62.88 -42.15 99.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.733 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 17.0 m -111.03 148.41 38.58 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.739 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -49.29 167.7 0.15 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.502 2.135 . . . . 0.0 112.21 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.6 tmtt? -83.01 54.98 2.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.799 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.4 p -76.88 156.81 82.33 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.031 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -60.45 166.52 9.43 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.653 2.235 . . . . 0.0 112.238 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.568 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 9.1 p90 -163.11 142.44 8.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.925 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.938 HD12 HG11 ' A' ' 152' ' ' VAL . 0.9 OUTLIER -108.56 159.7 16.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.983 -179.721 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.609 HD13 HG23 ' A' ' 80' ' ' VAL . 3.1 mm? -106.15 128.03 53.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.659 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.862 ' HA ' HG11 ' A' ' 168' ' ' VAL . 43.8 t -89.96 128.45 41.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.134 0.492 . . . . 0.0 111.555 -179.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.516 ' HA2' ' CE2' ' A' ' 154' ' ' TYR . . . -112.36 103.62 1.49 Allowed Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.253 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.666 HG23 HG12 ' A' ' 113' ' ' VAL . 0.4 OUTLIER -144.1 -153.65 0.48 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.826 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.509 ' HA ' HD23 ' A' ' 119' ' ' LEU . 0.4 OUTLIER 39.39 29.95 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.065 0.459 . . . . 0.0 111.329 179.333 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.534 HD13 ' C ' ' A' ' 115' ' ' THR . 0.0 OUTLIER -74.37 -4.3 5.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.711 179.376 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -100.28 -22.01 15.26 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.11 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.594 ' N ' HD22 ' A' ' 119' ' ' LEU . 2.1 mm? -72.85 -29.65 63.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.097 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.925 ' HG2' HG11 ' A' ' 84' ' ' VAL . 25.7 mtp180 -47.32 -35.5 8.12 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.917 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -76.32 -42.55 44.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.794 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -46.93 100.52 0.24 Allowed Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.89 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.442 ' HA ' ' CG2' ' A' ' 126' ' ' ILE . 10.5 Cg_exo -71.57 -3.76 13.7 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.737 2.291 . . . . 0.0 112.675 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.3 t -79.45 -64.11 1.26 Allowed 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.414 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 11.0 m -58.92 -40.14 83.68 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 178.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.48 HD13 ' O ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -53.78 -45.73 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.777 179.217 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.474 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 3.2 mm-40 -57.54 -36.08 71.15 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.068 179.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 125' ' ' THR . 1.4 mptt -64.75 -30.66 71.67 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.452 ' CD1' ' HA ' ' A' ' 126' ' ' ILE . 5.3 mt -74.16 -40.8 62.34 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.09 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 127' ' ' GLU . . . -42.91 -36.97 1.69 Allowed 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.438 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.3 mmtp -50.6 -29.06 9.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.974 0.416 . . . . 0.0 110.364 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.407 ' OD1' ' HB2' ' A' ' 87' ' ' PRO . 2.3 m120 -123.88 -31.09 3.45 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.732 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.516 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 4.0 mmpt? -148.86 -90.81 0.08 Allowed 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.516 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 1.2 pt20 122.24 -25.18 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.713 1.205 . . . . 0.0 110.314 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 4.5 ptmm? -69.21 110.71 6.7 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.716 -179.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.405 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 88.2 Cg_endo -82.01 127.69 5.5 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.574 2.182 . . . . 0.0 111.302 179.084 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.742 ' N ' HD13 ' A' ' 137' ' ' ILE . 0.9 OUTLIER -58.65 96.75 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.916 0.389 . . . . 0.0 110.792 -179.423 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.461 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 7.2 p -70.24 155.96 92.62 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.042 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.461 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 10.3 Cg_endo -51.23 -24.37 15.16 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.653 2.235 . . . . 0.0 112.175 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -79.79 -46.36 17.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.551 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 6.8 m -56.2 -45.3 79.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.669 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.649 ' HB1' ' HZ ' ' A' ' 82' ' ' PHE . . . -51.76 -51.49 55.82 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.847 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -53.97 -39.42 65.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.744 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.26 -55.81 24.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.701 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.791 HD11 ' HB2' ' A' ' 94' ' ' LYS . 1.6 tt -69.43 -36.96 77.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.572 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -54.42 -71.9 0.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.051 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.443 ' CZ ' ' HE3' ' A' ' 183' ' ' LYS . 10.0 mtt180 -61.35 -23.16 65.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.098 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -49.98 -37.16 31.18 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.855 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.484 ' CD1' HG11 ' A' ' 98' ' ' VAL . 0.6 OUTLIER -112.77 20.59 16.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.087 179.828 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.3 mttt 47.89 49.09 17.3 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.144 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.572 ' O ' HG23 ' A' ' 152' ' ' VAL . . . -65.25 -81.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.956 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.938 HG11 HD12 ' A' ' 111' ' ' LEU . 49.1 t -161.56 -75.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.732 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.449 ' O ' HD21 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -175.75 131.18 0.26 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.923 -178.822 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.516 ' CE2' ' HA2' ' A' ' 114' ' ' GLY . 11.1 t80 -104.47 103.71 13.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.15 179.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.56 ' HB ' HG22 ' A' ' 168' ' ' VAL . 1.4 t -102.16 164.64 3.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.141 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.4 ' H ' HG12 ' A' ' 155' ' ' VAL . 76.9 tt0 -89.86 135.78 33.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.82 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.424 ' HA ' ' HB3' ' A' ' 163' ' ' LYS . 20.4 p -178.59 129.51 0.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.922 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.651 ' HB3' HG22 ' A' ' 161' ' ' THR . 0.1 OUTLIER -125.74 140.4 52.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.172 -179.906 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.52 ' HB2' HD22 ' A' ' 165' ' ' LEU . . . -84.19 -44.32 14.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.072 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -47.77 -34.97 9.21 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.763 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.651 HG22 ' HB3' ' A' ' 158' ' ' SER . 10.6 t -116.02 -15.87 11.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.118 179.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.417 ' CA ' ' O ' ' A' ' 158' ' ' SER . 1.5 tt0 70.33 66.8 0.21 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.812 0.339 . . . . 0.0 110.68 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.424 ' HB3' ' HA ' ' A' ' 157' ' ' CYS . 1.0 OUTLIER -93.81 22.79 5.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.254 -179.686 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 102.36 41.98 2.28 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.48 -0.867 . . . . 0.0 113.111 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.849 HD23 ' HA ' ' A' ' 19' ' ' LEU . 1.7 tp -50.4 -25.07 3.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.864 0.364 . . . . 0.0 110.691 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.509 ' HD3' ' CE2' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -68.54 -26.08 65.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.842 179.514 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -58.33 -72.29 0.1 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.827 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.862 HG11 ' HA ' ' A' ' 113' ' ' VAL . 91.3 t -52.44 -43.63 41.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.967 0.413 . . . . 0.0 110.461 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.865 ' CE2' HD13 ' A' ' 19' ' ' LEU . 0.2 OUTLIER -62.77 -33.66 75.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.277 179.681 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.532 ' OD1' HD11 ' A' ' 173' ' ' ILE . 27.1 t0 -69.82 -25.61 63.84 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.599 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.607 ' CB ' HD11 ' A' ' 111' ' ' LEU . 4.4 mm-40 -78.75 -29.15 44.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.132 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.568 ' N ' HD13 ' A' ' 111' ' ' LEU . . . -75.1 -43.51 52.53 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.888 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.532 HD11 ' OD1' ' A' ' 170' ' ' ASP . 1.6 pp -68.75 -36.11 72.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.838 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.625 HD22 ' HB3' ' B' ' 505' ' ' LEU . 26.0 tp -55.13 -42.95 73.68 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.776 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.501 ' HB3' ' CG1' ' A' ' 77' ' ' VAL . . . -48.17 -27.01 2.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.775 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.551 ' HB1' ' HA ' ' A' ' 4' ' ' ILE . . . -86.7 -43.75 12.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.845 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.769 HD13 ' HB ' ' B' ' 510' ' ' ILE . 56.3 mt -68.73 -26.94 65.51 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.957 0.408 . . . . 0.0 110.255 179.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.488 ' HB2' ' HB2' ' B' ' 507' ' ' ALA . 0.1 OUTLIER -174.14 92.6 0.33 Allowed Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.721 179.788 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . 0.439 ' HA ' ' HD2' ' A' ' 180' ' ' PRO . 86.4 Cg_exo -47.74 106.04 0.1 OUTLIER 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.645 2.23 . . . . 0.0 112.428 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 179' ' ' PRO . 41.7 Cg_endo -67.22 171.99 10.69 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.47 2.114 . . . . 0.0 112.205 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -110.19 137.79 20.67 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.979 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -79.42 -165.17 0.32 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.576 2.184 . . . . 0.0 112.272 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.443 ' HE3' ' CZ ' ' A' ' 147' ' ' ARG . 0.0 OUTLIER -135.97 97.33 3.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.925 179.992 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.166 -0.921 . . . . 0.0 110.921 -179.985 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 503' ' ' SER . . . . . . . . . . . . . 3.3 m -90.41 -75.97 0.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.744 0.307 . . . . 0.0 110.918 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 504' ' ' GLY . . . . . 0.836 ' O ' HD12 ' B' ' 505' ' ' LEU . . . 144.16 -116.84 0.99 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.368 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 505' ' ' LEU . . . . . 0.836 HD12 ' O ' ' B' ' 504' ' ' GLY . 0.1 OUTLIER 64.99 -70.6 0.09 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.786 0.327 . . . . 0.0 111.204 179.823 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 506' ' ' SER . . . . . 0.42 ' N ' ' O ' ' B' ' 504' ' ' GLY . 0.1 OUTLIER -171.92 -159.77 0.15 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.546 -179.973 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 507' ' ' ALA . . . . . 0.488 ' HB2' ' HB2' ' A' ' 178' ' ' GLU . . . 62.97 -95.71 0.05 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.469 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 508' ' ' GLN . . . . . 0.462 ' O ' ' CB ' ' B' ' 509' ' ' ASP . 28.6 mt-30 -137.28 4.04 2.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.875 179.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 509' ' ' ASP . . . . . 0.462 ' CB ' ' O ' ' B' ' 508' ' ' GLN . 0.1 OUTLIER 92.36 29.7 0.01 OUTLIER 'General case' 0 C--N 1.345 0.406 0 CA-C-O 121.461 0.648 . . . . 0.0 109.864 -179.127 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 510' ' ' ILE . . . . . 0.769 ' HB ' HD13 ' A' ' 177' ' ' LEU . 43.0 mt -61.58 149.48 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.393 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 511' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.23 146.62 33.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.291 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 512' ' ' GLN . . . . . 0.529 ' HA ' HD13 ' A' ' 173' ' ' ILE . 1.5 pm0 -57.79 -176.2 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.35 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 513' ' ' PRO . . . . . 0.576 ' HG3' HD21 ' A' ' 53' ' ' LEU . 50.9 Cg_exo -55.52 82.37 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.492 2.128 . . . . 0.0 111.694 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 514' ' ' LEU . . . . . 0.451 ' N ' ' O ' ' B' ' 512' ' ' GLN . 1.8 mp -46.38 171.96 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.003 -179.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 515' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -94.26 -168.65 1.89 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.766 179.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 66.22 10.49 7.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.589 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 517' ' ' SER . . . . . 0.445 ' CB ' ' HB ' ' A' ' 44' ' ' VAL . 72.5 p -133.47 80.77 1.89 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.912 0.387 . . . . 0.0 111.02 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 518' ' ' PHE . . . . . 0.429 ' HA ' HG12 ' A' ' 42' ' ' VAL . 22.6 m-85 -140.45 91.69 2.46 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.897 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 519' ' ' ILE . . . . . 0.47 ' N ' HD13 ' B' ' 519' ' ' ILE . 3.0 mm -84.97 138.12 19.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.046 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -41.89 -88.86 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.409 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 521' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 47.86 -161.59 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.873 0.368 . . . . 0.0 111.009 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 522' ' ' GLY . . . . . . . . . . . . . . . 55.24 170.33 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.47 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 523' ' ' HIS . . . . . . . . . . . . . 22.7 t60 -156.6 -77.45 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.787 0.327 . . . . 0.0 110.876 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 524' ' ' GLY . . . . . 0.627 ' HA3' HG21 ' A' ' 36' ' ' VAL . . . 46.68 -144.62 4.33 Favored Glycine 0 N--CA 1.454 -0.164 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.722 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 525' ' ' ASP . . . . . 0.693 ' HB2' HD12 ' A' ' 61' ' ' LEU . 30.4 m-20 -119.24 81.47 1.72 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.826 0.346 . . . . 0.0 110.842 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 526' ' ' SER . . . . . 0.448 ' CA ' ' HB3' ' A' ' 34' ' ' PRO . 0.7 OUTLIER -88.43 96.25 10.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.785 179.968 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 527' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -162.08 141.28 7.28 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.795 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -57.52 97.61 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.677 2.251 . . . . 0.0 112.072 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 529' ' ' ARG . . . . . 0.686 ' HG3' HG11 ' A' ' 33' ' ' VAL . 10.4 mtp180 -100.23 -54.74 2.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.099 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 530' ' ' HIS . . . . . 0.485 ' CE1' ' HB3' ' B' ' 545' ' ' ASN . 6.2 p80 -165.47 97.45 0.68 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.831 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 531' ' ' CYS . . . . . 0.429 ' CB ' ' O ' ' A' ' 30' ' ' SER . 18.8 p -53.49 -171.65 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.068 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 532' ' ' TRP . . . . . . . . . . . . . 87.4 t90 -49.06 103.78 0.05 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.013 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . -116.39 -57.47 0.32 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.496 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 534' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -68.38 155.97 91.38 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 120.705 0.288 . . . . 0.0 110.872 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -63.34 -19.52 68.39 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.633 2.222 . . . . 0.0 112.485 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -151.66 139.01 19.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.929 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 537' ' ' ARG . . . . . 0.516 ' HD3' ' HB2' ' A' ' 13' ' ' ALA . 0.1 OUTLIER -48.07 152.23 0.85 Allowed 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.114 179.921 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 538' ' ' ILE . . . . . 0.418 ' CG2' ' HA ' ' B' ' 543' ' ' LEU . 5.6 tp -63.42 140.77 19.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.139 179.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 539' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -44.61 147.39 0.61 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.733 0.301 . . . . 0.0 111.162 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 540' ' ' GLU . . . . . 0.533 ' OE1' HD13 ' B' ' 543' ' ' LEU . 49.8 mm-40 -60.14 -15.86 27.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.613 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 541' ' ' LEU . . . . . 0.813 ' HA ' HD11 ' A' ' 70' ' ' LEU . 2.9 mm? -41.31 -59.59 1.5 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.99 0.424 . . . . 0.0 110.897 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 542' ' ' TYR . . . . . 0.453 ' CD1' ' HB3' ' B' ' 541' ' ' LEU . 0.1 OUTLIER -105.84 -53.63 2.61 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.578 179.41 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 543' ' ' LEU . . . . . 0.786 HD23 ' O ' ' A' ' 58' ' ' THR . 6.8 tp 57.01 31.94 20.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.936 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . -119.13 83.6 0.35 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.468 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 545' ' ' ASN . . . . . 0.486 ' HB2' HG13 ' A' ' 33' ' ' VAL . 3.6 m120 . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.211 -0.9 . . . . 0.0 110.851 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.796 0.331 . . . . 0.0 111.255 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.81 144.4 47.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.388 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.645 HG23 ' CE1' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -93.86 176.34 6.38 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.925 -179.948 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 1.012 HG13 HD13 ' A' ' 53' ' ' LEU . 4.0 pt -152.27 146.36 15.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.009 0.433 . . . . 0.0 112.115 -178.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.608 ' O ' HG21 ' A' ' 75' ' ' THR . 13.1 tptp -134.44 95.73 3.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.399 179.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -110.08 119.74 40.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.979 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.417 ' HA ' ' HB3' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -104.79 145.55 13.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.14 0.495 . . . . 0.0 111.301 179.772 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.851 HG11 ' HE3' ' A' ' 16' ' ' LYS . 2.6 p -91.63 113.55 27.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.268 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.52 HG21 ' CD2' ' A' ' 78' ' ' PHE . 30.1 m -134.9 150.33 29.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.081 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 127.93 -144.46 15.22 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.508 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -103.25 -21.34 13.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.72 0.295 . . . . 0.0 110.956 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -105.02 156.33 16.87 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.611 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.47 4.78 22.93 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.811 HG21 HD23 ' A' ' 79' ' ' LEU . 1.9 m 40.99 31.07 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 120.985 0.422 . . . . 0.0 111.37 -179.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.435 ' O ' ' CG ' ' A' ' 19' ' ' LEU . . . 56.96 24.93 52.22 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.407 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.851 ' HE3' HG11 ' A' ' 8' ' ' VAL . 9.6 ptmt -38.31 -45.43 0.99 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.809 0.338 . . . . 0.0 111.628 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.929 HG22 HG13 ' A' ' 21' ' ' ILE . 0.2 OUTLIER -97.46 -57.43 2.25 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.49 179.341 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.522 ' HB3' ' HB1' ' A' ' 159' ' ' ALA . 46.8 m -47.65 -32.06 5.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.245 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.89 ' CD2' HD22 ' A' ' 165' ' ' LEU . 9.6 mt -47.35 -71.32 0.07 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.026 0.441 . . . . 0.0 111.079 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.629 ' H ' HD22 ' A' ' 20' ' ' LEU . 0.6 OUTLIER -87.08 -27.47 23.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.947 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.929 HG13 HG22 ' A' ' 17' ' ' THR . 46.8 mm -68.44 -52.96 31.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 179.051 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.447 ' CB ' ' O ' ' A' ' 18' ' ' CYS . 2.3 t -69.73 -37.61 76.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.519 179.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -51.87 -45.9 64.26 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.575 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.1 m -94.03 -48.58 6.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.566 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.441 ' N ' ' O ' ' A' ' 21' ' ' ILE . 1.3 p -96.4 -146.19 0.29 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.228 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.44 ' N ' ' ND2' ' A' ' 26' ' ' ASN . 0.1 OUTLIER -163.2 34.64 0.09 Allowed 'General case' 0 C--O 1.232 0.139 0 O-C-N 122.341 -0.225 . . . . 0.0 111.365 -179.746 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.485 ' CG ' HG21 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -86.42 127.41 34.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.926 0.393 . . . . 0.0 111.067 -179.896 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.539 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . 89.0 t80 -164.04 -50.71 0.01 OUTLIER Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.035 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.539 ' HD3' ' HB3' ' A' ' 28' ' ' PHE . 88.1 Cg_endo -93.03 33.06 0.24 Allowed 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.171 1.914 . . . . 0.0 112.65 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.43 -84.8 0.58 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.772 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -159.04 147.59 18.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.697 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.454 ' C ' HG22 ' A' ' 33' ' ' VAL . 9.7 m-85 -126.02 124.04 39.8 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.675 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.558 HG23 ' HD3' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -165.17 -61.76 0.01 OUTLIER Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.112 -179.763 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.558 ' HD3' HG23 ' A' ' 33' ' ' VAL . 79.5 Cg_exo -46.36 -25.78 3.5 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.382 2.054 . . . . 0.0 112.329 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.5 t -40.54 -29.51 0.09 Allowed 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.893 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.893 HG23 ' HB3' ' A' ' 59' ' ' ALA . 12.0 p -51.95 -22.25 2.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.607 -0.269 . . . . 0.0 111.394 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.479 ' CD1' ' O ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -88.68 18.34 4.76 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.494 179.899 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.403 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 25.6 t0 -58.74 -18.02 27.94 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.223 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -86.57 13.56 8.31 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.546 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.466 ' CD1' ' N ' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -60.8 179.09 0.19 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.819 0.342 . . . . 0.0 110.946 179.91 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.423 ' O ' HG12 ' B' ' 519' ' ' ILE . . . -98.05 124.94 42.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.143 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.856 HG13 ' O ' ' B' ' 517' ' ' SER . 2.8 t -119.1 146.63 23.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.737 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.4 p -129.13 112.02 13.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.867 0.365 . . . . 0.0 111.566 -179.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 1.086 HG22 HG23 ' A' ' 52' ' ' THR . 4.1 m -153.1 -176.97 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.652 179.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.525 ' O ' HD13 ' B' ' 514' ' ' LEU . 4.4 tpt -100.65 95.94 7.01 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.658 -179.099 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.679 HG22 ' O ' ' A' ' 46' ' ' ILE . 1.2 mm -82.23 87.32 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-O 121.382 0.61 . . . . 0.0 109.913 178.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.403 ' HA3' ' HA ' ' B' ' 510' ' ' ILE . . . 46.23 -90.69 0.01 OUTLIER Glycine 0 CA--C 1.522 0.494 0 CA-C-N 115.488 -0.778 . . . . 0.0 113.647 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . -36.5 -96.39 0.01 OUTLIER Glycine 0 C--N 1.335 0.477 0 N-CA-C 113.997 0.359 . . . . 0.0 113.997 -179.076 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.47 ' N ' ' HE1' ' A' ' 45' ' ' MET . 1.6 pt-20 -125.66 158.85 63.54 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 120.539 0.209 . . . . 0.0 110.555 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.402 ' HD2' ' HB2' ' A' ' 49' ' ' GLU . 88.2 Cg_exo -40.2 101.07 0.03 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.595 2.196 . . . . 0.0 112.542 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.645 ' CE1' HG23 ' A' ' 3' ' ' THR . 5.6 t80 -172.24 162.43 5.59 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.422 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 1.086 HG23 HG22 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -136.62 145.82 45.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.07 179.377 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 1.012 HD13 HG13 ' A' ' 4' ' ' ILE . 0.8 OUTLIER -83.54 179.57 7.6 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.848 179.847 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -103.14 109.93 3.59 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.236 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.38 -159.26 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.801 0.334 . . . . 0.0 110.76 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.54 ' CE1' ' CB ' ' A' ' 16' ' ' LYS . 0.1 OUTLIER -104.3 166.27 10.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.053 0.454 . . . . 0.0 111.091 -179.909 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.403 ' OD1' ' N ' ' A' ' 38' ' ' ASP . 31.0 t70 -167.63 111.2 0.66 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.444 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.736 ' HA ' HD21 ' A' ' 67' ' ' LEU . 22.5 p -144.96 126.43 14.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.044 -179.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.893 ' HB3' HG23 ' A' ' 36' ' ' VAL . . . -171.16 126.2 0.66 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.094 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -74.92 65.35 2.23 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.478 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.773 HD12 ' HB ' ' A' ' 36' ' ' VAL . 55.9 mt -115.88 172.97 6.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.802 0.334 . . . . 0.0 110.911 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -52.27 -37.04 54.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.815 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.464 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 1.0 OUTLIER -58.19 -62.42 1.84 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.798 179.866 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.464 ' CD2' ' HB3' ' A' ' 63' ' ' ASP . 0.3 OUTLIER -136.16 77.31 1.65 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.594 179.969 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -86.05 -16.04 39.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.491 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -83.45 -53.22 5.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.581 0.229 . . . . 0.0 111.478 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.78 HD23 HD23 ' A' ' 70' ' ' LEU . 1.6 mp 49.6 -179.73 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.487 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.409 ' N ' ' HD2' ' A' ' 69' ' ' PRO . 0.0 OUTLIER 168.25 -57.33 0.0 OUTLIER Pre-proline 0 N--CA 1.465 0.3 0 CA-C-O 120.688 0.28 . . . . 0.0 111.354 -179.992 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.412 ' O ' ' NE2' ' A' ' 74' ' ' GLN . 68.0 Cg_exo -38.12 -47.77 2.26 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.981 2.454 . . . . 0.0 113.039 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.78 HD23 HD23 ' A' ' 67' ' ' LEU . 0.3 OUTLIER -48.06 -26.9 2.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.164 -179.757 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.64 -31.75 12.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.812 0.339 . . . . 0.0 111.448 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -82.66 143.29 46.88 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.116 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.37 100.41 0.89 Allowed 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.646 2.231 . . . . 0.0 111.977 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.412 ' NE2' ' O ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -102.19 -67.55 0.87 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.514 -179.461 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.608 HG21 ' O ' ' A' ' 5' ' ' LYS . 12.4 t -84.26 -164.67 0.98 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.706 -179.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.411 ' O ' ' HD2' ' A' ' 109' ' ' PRO . 4.2 p30 -124.74 8.33 8.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.238 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.4 ' H ' HG23 ' A' ' 75' ' ' THR . 39.3 t -141.55 91.18 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 CA-C-O 120.758 0.313 . . . . 0.0 111.157 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.52 ' CD2' HG21 ' A' ' 9' ' ' VAL . 2.9 m-30 -80.79 -177.7 6.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.6 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.811 HD23 HG21 ' A' ' 14' ' ' VAL . 8.1 tp -143.34 108.46 4.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.262 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.71 HG11 HD13 ' A' ' 101' ' ' ILE . 21.5 m -105.61 135.09 45.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.02 179.088 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.763 ' SG ' HG12 ' A' ' 14' ' ' VAL . 9.6 m -137.38 170.7 15.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.212 0.529 . . . . 0.0 111.968 -179.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.564 ' HE2' HD12 ' A' ' 112' ' ' LEU . 15.0 p90 -167.77 137.29 2.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.439 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 57.4 p -83.68 139.4 32.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.725 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.596 HG13 ' N ' ' A' ' 137' ' ' ILE . 65.6 t -48.48 -63.78 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.22 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.585 ' HA ' HD21 ' A' ' 129' ' ' LEU . 30.4 m -45.35 111.85 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-O 120.61 0.243 . . . . 0.0 110.518 179.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.445 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 3.4 p -149.0 140.76 14.56 Favored Pre-proline 0 C--N 1.33 -0.24 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -178.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.453 ' CA ' ' HB2' ' A' ' 132' ' ' ASN . 72.3 Cg_endo -93.07 54.3 0.44 Allowed 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 123.381 2.721 . . . . 0.0 111.797 179.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.452 ' CB ' ' HB2' ' A' ' 133' ' ' LYS . 0.5 OUTLIER 72.93 21.73 3.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.043 -179.554 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 43.3 p -97.48 -17.8 19.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.264 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.53 ' CE2' HG23 ' A' ' 137' ' ' ILE . 8.5 t80 -45.68 -72.86 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.743 0.306 . . . . 0.0 111.302 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -53.64 -31.2 46.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.812 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.41 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 8.3 t-20 -66.8 -58.18 5.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.953 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.428 HG13 ' N ' ' A' ' 94' ' ' LYS . 12.3 p -62.42 -41.3 91.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.256 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.784 ' HG3' HD13 ' A' ' 145' ' ' LEU . 0.8 OUTLIER -55.65 -75.33 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.832 179.951 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.423 ' O ' ' CG ' ' A' ' 99' ' ' PRO . 24.3 mm-40 -52.24 -24.01 6.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.913 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.41 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 57.4 tttt -83.62 -22.51 32.2 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.114 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.448 ' CE3' ' HA ' ' A' ' 97' ' ' TRP . 0.0 OUTLIER -82.09 -55.49 4.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.58 -179.79 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.472 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 5.0 t -41.49 -46.63 8.55 Favored Pre-proline 0 N--CA 1.466 0.358 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -179.001 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 13.7 Cg_exo -69.96 -35.02 12.81 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.72 2.28 . . . . 0.0 112.354 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.415 ' N ' ' OE1' ' A' ' 100' ' ' GLU . 1.3 mp0 -76.73 -37.63 55.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.78 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.71 HD13 HG11 ' A' ' 80' ' ' VAL . 54.8 mt -65.93 -25.36 35.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.001 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 25.1 p -93.52 -26.93 16.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.858 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -66.09 -68.04 0.4 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.816 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -59.56 -34.76 73.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.696 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.401 ' HA ' ' HD2' ' A' ' 106' ' ' PRO . 89.3 m -127.4 103.58 22.48 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.756 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 105' ' ' CYS . 29.7 Cg_endo -63.68 106.72 0.64 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.439 2.093 . . . . 0.0 112.193 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.71 82.85 0.15 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.949 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.59 100.12 16.63 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.853 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.411 ' HD2' ' O ' ' A' ' 76' ' ' ASP . 31.3 Cg_exo -59.69 158.54 27.87 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.677 2.251 . . . . 0.0 112.251 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.482 ' CE2' ' HB2' ' A' ' 151' ' ' ALA . 24.8 p90 -150.62 -176.62 5.57 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.092 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.779 HD23 ' O ' ' A' ' 112' ' ' LEU . 4.4 tt -146.27 147.63 31.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.863 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.779 ' O ' HD23 ' A' ' 111' ' ' LEU . 4.2 mm? -93.43 156.8 16.56 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.626 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.824 HG13 HG11 ' A' ' 168' ' ' VAL . 11.0 t -143.21 150.68 17.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.091 0.472 . . . . 0.0 112.227 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.419 ' O ' ' CD1' ' A' ' 117' ' ' ILE . . . -124.46 100.15 0.62 Allowed Glycine 0 C--N 1.331 0.272 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.509 179.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.494 ' HB ' ' HA ' ' A' ' 158' ' ' SER . 1.3 p -122.97 -2.47 8.7 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -178.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.475 ' CD ' HD21 ' A' ' 119' ' ' LEU . 1.6 tp-100 -111.66 10.23 21.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.115 0.483 . . . . 0.0 109.86 178.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.48 ' H ' HD13 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -64.36 -11.63 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.948 179.018 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -80.34 -43.22 21.54 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.852 -179.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.605 ' C ' HD12 ' A' ' 119' ' ' LEU . 4.0 pp -99.43 0.52 42.8 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -179.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.432 ' O ' HD13 ' A' ' 126' ' ' ILE . 0.3 OUTLIER -54.71 -27.63 41.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.002 0.429 . . . . 0.0 110.017 179.245 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -80.85 -23.91 38.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.306 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -51.27 104.65 0.44 Allowed Pre-proline 0 C--N 1.332 -0.162 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.501 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.467 ' HA ' ' CG2' ' A' ' 126' ' ' ILE . 14.3 Cg_exo -69.31 -3.52 11.88 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 122.739 2.293 . . . . 0.0 112.978 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 10.3 t -72.56 -69.36 0.41 Allowed 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 120.914 0.388 . . . . 0.0 109.969 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.766 HG22 ' CD1' ' A' ' 129' ' ' LEU . 17.2 m -58.31 -44.27 88.51 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.799 HD11 ' HB3' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -50.09 -33.93 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.093 179.694 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.56 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 3.9 mm-40 -70.88 -35.19 72.25 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.433 ' N ' ' O ' ' A' ' 125' ' ' THR . 0.1 OUTLIER -68.44 -34.85 76.71 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 177.934 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.766 ' CD1' HG22 ' A' ' 125' ' ' THR . 9.2 mp -60.76 -42.54 97.65 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' A' ' 127' ' ' GLU . . . -42.52 -36.33 1.32 Allowed 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 114.602 -1.181 . . . . 0.0 111.503 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm -55.1 -29.44 57.62 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.859 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.453 ' HB2' ' CA ' ' A' ' 87' ' ' PRO . 29.8 m-80 -124.44 -32.49 3.14 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -179.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.512 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 1.3 ttpt -142.69 -83.13 0.18 Allowed 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 122.332 -0.23 . . . . 0.0 111.083 -179.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.512 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 9.9 pt20 114.94 -42.1 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.682 1.193 . . . . 0.0 111.077 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.418 ' HD2' ' HG3' ' A' ' 134' ' ' GLN . 3.2 mptt -68.61 110.1 5.3 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.112 -0.494 . . . . 0.0 112.235 -178.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.799 ' HB3' HD11 ' A' ' 126' ' ' ILE . 72.4 Cg_endo -75.25 148.11 33.92 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.494 2.129 . . . . 0.0 111.209 178.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.75 ' N ' HD13 ' A' ' 137' ' ' ILE . 0.7 OUTLIER -76.87 96.8 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.898 0.38 . . . . 0.0 111.053 -179.31 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 3.3 p -68.79 148.78 98.01 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.736 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.46 ' HA ' ' CE2' ' A' ' 154' ' ' TYR . 83.3 Cg_exo -45.56 -26.92 3.15 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.607 2.205 . . . . 0.0 112.382 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -77.48 -32.39 54.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.816 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.459 ' HB ' HG22 ' A' ' 137' ' ' ILE . 2.2 m -64.25 -57.55 9.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.89 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.41 ' HB2' ' HZ ' ' A' ' 82' ' ' PHE . . . -51.11 -44.15 61.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.063 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -56.14 -44.12 78.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.949 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.6 mttt -56.92 -62.91 1.41 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.786 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.784 HD13 ' HG3' ' A' ' 94' ' ' LYS . 1.0 OUTLIER -60.2 -35.9 76.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.775 179.833 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.477 ' HB2' ' HG ' ' A' ' 112' ' ' LEU . . . -51.55 -60.86 2.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.863 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 22.2 mtt180 -67.29 -22.32 65.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.885 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.617 ' HB3' HD22 ' A' ' 149' ' ' LEU . 24.2 t0 -50.25 -48.81 54.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.695 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.617 HD22 ' HB3' ' A' ' 148' ' ' ASP . 2.4 mm? -92.89 17.43 10.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.084 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 9.9 mttt 47.6 51.44 13.86 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.787 0.327 . . . . 0.0 111.021 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.482 ' HB2' ' CE2' ' A' ' 110' ' ' PHE . . . -75.73 -82.2 0.07 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.176 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.767 HG11 HD12 ' A' ' 111' ' ' LEU . 69.8 t -160.42 -74.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.928 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.41 ' HG3' ' N ' ' A' ' 154' ' ' TYR . 0.2 OUTLIER -177.52 144.43 0.39 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.65 -179.042 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.46 ' CE2' ' HA ' ' A' ' 139' ' ' PRO . 18.3 t80 -105.75 109.59 21.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.186 179.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.407 ' HB ' ' HB ' ' A' ' 168' ' ' VAL . 3.1 t -101.64 158.81 4.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.998 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -100.49 126.18 46.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.016 0.436 . . . . 0.0 111.666 -179.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.447 ' SG ' HG12 ' A' ' 168' ' ' VAL . 1.4 p 178.51 126.07 0.05 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.548 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.579 ' HB3' HD12 ' A' ' 160' ' ' LEU . 15.4 m -112.5 167.99 10.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.943 0.402 . . . . 0.0 111.427 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.522 ' HB1' ' HB3' ' A' ' 18' ' ' CYS . . . -98.77 -33.53 10.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.843 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.579 HD12 ' HB3' ' A' ' 158' ' ' SER . 0.9 OUTLIER -51.14 -38.69 53.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.448 179.788 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.0 t -117.33 -12.91 10.42 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.163 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 64.65 72.48 0.44 Allowed 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.818 0.342 . . . . 0.0 110.892 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.413 ' HB3' ' HA ' ' A' ' 157' ' ' CYS . 68.1 tttt -97.17 22.82 8.07 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.19 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 107.82 41.0 1.63 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.161 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.89 HD22 ' CD2' ' A' ' 19' ' ' LEU . 0.4 OUTLIER -49.26 -30.82 7.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.089 0.471 . . . . 0.0 110.632 179.596 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 22.9 pttm -68.79 -31.66 70.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.657 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -52.59 -69.28 0.12 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.546 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.824 HG11 HG13 ' A' ' 113' ' ' VAL . 12.3 p -50.29 -44.19 23.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.059 0.457 . . . . 0.0 110.441 179.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.522 ' CD1' ' CD1' ' A' ' 19' ' ' LEU . 2.2 t80 -59.85 -34.32 72.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.12 179.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.522 ' OD1' HD21 ' B' ' 505' ' ' LEU . 0.6 OUTLIER -60.7 -34.87 75.01 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.837 179.236 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.663 ' HB3' HD11 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -73.12 -30.46 63.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.2 179.229 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.451 ' CA ' HD13 ' A' ' 111' ' ' LEU . . . -76.39 -42.39 44.63 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.648 179.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.424 ' CG1' ' HA ' ' A' ' 170' ' ' ASP . 1.5 pp -76.97 -32.62 19.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.423 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 1.025 HD13 HD13 ' B' ' 505' ' ' LEU . 22.8 tp -53.37 -49.34 67.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.551 179.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.84 -22.29 62.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.783 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.588 ' HB1' ' HB ' ' A' ' 4' ' ' ILE . . . -85.4 -41.82 15.08 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.058 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.906 HD13 ' HB ' ' B' ' 510' ' ' ILE . 32.6 mt -68.78 -23.18 64.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.819 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.412 ' HB2' ' CB ' ' B' ' 507' ' ' ALA . 0.0 OUTLIER -168.3 153.56 6.5 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.784 179.934 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -52.72 124.01 14.32 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.621 2.214 . . . . 0.0 112.313 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.53 -178.43 3.37 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.538 2.159 . . . . 0.0 112.404 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -144.42 99.53 4.89 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.858 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -88.47 35.43 0.4 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 123.197 2.598 . . . . 0.0 113.038 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 17.4 pttt -56.36 157.35 5.04 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.878 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 7.2 mttm . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.898 -179.978 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.204 0 N-CA-C 112.506 -0.238 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 503' ' ' SER . . . . . . . . . . . . . 22.3 m -67.35 -78.93 0.05 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.805 0.336 . . . . 0.0 110.814 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 504' ' ' GLY . . . . . 0.418 ' CA ' ' OD2' ' B' ' 509' ' ' ASP . . . 92.71 103.53 1.54 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.278 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 505' ' ' LEU . . . . . 1.025 HD13 HD13 ' A' ' 174' ' ' LEU . 0.2 OUTLIER -164.36 47.56 0.11 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.792 0.329 . . . . 0.0 111.31 -179.614 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 506' ' ' SER . . . . . 0.481 ' O ' ' HB2' ' B' ' 507' ' ' ALA . 4.9 m 59.31 87.86 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.975 0.417 . . . . 0.0 110.022 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 507' ' ' ALA . . . . . 0.481 ' HB2' ' O ' ' B' ' 506' ' ' SER . . . 173.75 -37.68 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.242 -179.083 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 508' ' ' GLN . . . . . 0.487 ' CB ' ' CD1' ' B' ' 510' ' ' ILE . 1.3 mt-30 155.48 -20.85 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.7 -1.136 . . . . 0.0 109.994 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 509' ' ' ASP . . . . . 0.455 ' CB ' ' O ' ' B' ' 508' ' ' GLN . 8.4 t70 90.03 38.67 0.01 OUTLIER 'General case' 0 C--N 1.343 0.323 0 CA-C-O 121.309 0.576 . . . . 0.0 110.6 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 510' ' ' ILE . . . . . 0.906 ' HB ' HD13 ' A' ' 177' ' ' LEU . 1.9 mp -68.99 136.39 26.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.346 179.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 511' ' ' SER . . . . . 0.683 ' HB2' HD21 ' B' ' 514' ' ' LEU . 4.1 m -109.23 153.98 23.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.061 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 512' ' ' GLN . . . . . 0.492 ' CB ' ' HD3' ' B' ' 513' ' ' PRO . 1.8 mm-40 -98.53 -68.37 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.82 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 513' ' ' PRO . . . . . 0.492 ' HD3' ' CB ' ' B' ' 512' ' ' GLN . 90.4 Cg_endo -78.64 59.55 7.27 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.4 2.067 . . . . 0.0 111.781 179.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 514' ' ' LEU . . . . . 0.683 HD21 ' HB2' ' B' ' 511' ' ' SER . 1.1 mt -73.34 -86.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.751 -179.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 515' ' ' GLN . . . . . 0.503 ' CB ' HG12 ' A' ' 44' ' ' VAL . 0.5 OUTLIER -88.1 -10.31 50.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.649 -179.529 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 53.59 24.52 4.23 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.936 0.398 . . . . 0.0 110.379 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 517' ' ' SER . . . . . 0.856 ' O ' HG13 ' A' ' 42' ' ' VAL . 75.4 m -68.28 58.8 0.08 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.618 -179.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 518' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -78.28 91.48 4.42 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.42 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 519' ' ' ILE . . . . . 0.423 HG12 ' O ' ' A' ' 41' ' ' ALA . 3.5 mm -76.28 157.47 5.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.251 -179.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -101.57 119.59 39.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.903 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 521' ' ' THR . . . . . . . . . . . . . 18.7 p -133.93 -61.99 0.78 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.829 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 522' ' ' GLY . . . . . . . . . . . . . . . -55.74 119.56 14.62 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.564 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 523' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -59.05 -83.76 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.772 0.32 . . . . 0.0 110.882 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 524' ' ' GLY . . . . . 0.5 ' HA3' HG11 ' A' ' 36' ' ' VAL . . . 67.88 167.86 4.04 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.492 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 525' ' ' ASP . . . . . 0.48 ' CG ' HD22 ' A' ' 61' ' ' LEU . 0.6 OUTLIER -85.28 83.19 8.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.83 0.348 . . . . 0.0 110.94 -179.967 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 526' ' ' SER . . . . . 0.44 ' CB ' ' HG3' ' A' ' 34' ' ' PRO . 6.4 t -83.58 95.79 8.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.694 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 527' ' ' ASP . . . . . 0.553 ' O ' HG21 ' A' ' 33' ' ' VAL . 3.2 p30 -177.52 147.36 0.66 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.995 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.74 101.56 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.685 2.257 . . . . 0.0 112.109 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 529' ' ' ARG . . . . . 0.423 ' HB2' ' HB3' ' B' ' 545' ' ' ASN . 0.1 OUTLIER -100.16 -55.3 2.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.352 -179.514 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 530' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -142.3 -47.21 0.34 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.025 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 3.0 m 72.94 -172.1 0.14 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.806 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 532' ' ' TRP . . . . . . . . . . . . . 24.1 t90 -62.06 102.74 0.31 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.962 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . -122.02 -38.46 0.6 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.481 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 534' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -105.61 154.86 38.9 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 120.731 0.301 . . . . 0.0 110.932 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -67.18 125.51 13.65 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.641 2.228 . . . . 0.0 112.085 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 1.3 t0 70.84 141.35 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.768 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 537' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -70.8 144.6 50.76 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.25 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 538' ' ' ILE . . . . . 0.756 HG23 HD12 ' B' ' 543' ' ' LEU . 6.2 tp -58.16 145.17 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 539' ' ' ASP . . . . . 0.449 ' O ' ' CD1' ' B' ' 543' ' ' LEU . 20.5 t0 -41.38 132.85 2.6 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.969 0.414 . . . . 0.0 112.028 -178.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 540' ' ' GLU . . . . . 0.643 ' CG ' HG22 ' A' ' 8' ' ' VAL . 0.8 OUTLIER -40.55 -27.27 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.047 179.702 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 541' ' ' LEU . . . . . 0.669 ' O ' HD21 ' A' ' 70' ' ' LEU . 5.3 mt -31.93 -69.24 0.08 Allowed 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 542' ' ' TYR . . . . . 0.458 ' CD1' ' HB3' ' B' ' 541' ' ' LEU . 0.1 OUTLIER -103.36 -63.78 1.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.317 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 543' ' ' LEU . . . . . 0.756 HD12 HG23 ' B' ' 538' ' ' ILE . 4.6 mp 65.05 141.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.866 -179.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . 132.62 141.86 4.74 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.487 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 545' ' ' ASN . . . . . 0.423 ' HB3' ' HB2' ' B' ' 529' ' ' ARG . 36.1 m-20 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.923 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.516 ' HE3' ' CG2' ' A' ' 46' ' ' ILE . 7.4 tpt . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.475 0.179 . . . . 0.0 111.2 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.431 ' O ' ' CE ' ' A' ' 1' ' ' MET . 39.4 tp60 60.76 137.83 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.047 0.451 . . . . 0.0 110.917 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.598 HG21 ' HG ' ' A' ' 53' ' ' LEU . 0.2 OUTLIER -124.24 -165.95 1.43 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.609 -179.492 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.683 ' CG2' ' HB3' ' A' ' 176' ' ' ALA . 0.2 OUTLIER -150.92 138.26 13.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.581 -179.593 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.477 ' O ' HG13 ' A' ' 77' ' ' VAL . 3.6 ttmt -95.0 101.35 13.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.748 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.562 ' CB ' HD23 ' A' ' 55' ' ' LEU . 20.2 m -80.25 110.1 15.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.287 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.7 t -151.16 106.74 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.766 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.627 HG13 ' OE1' ' B' ' 540' ' ' GLU . 2.4 p -89.3 135.48 25.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.296 0.569 . . . . 0.0 111.583 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.747 HG21 ' CE2' ' A' ' 78' ' ' PHE . 2.8 m -133.41 129.44 56.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.197 178.41 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.409 ' O ' ' N ' ' B' ' 540' ' ' GLU . . . 141.69 -165.3 26.52 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.067 -1.064 . . . . 0.0 112.483 -179.106 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.7 21.87 5.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.764 0.316 . . . . 0.0 110.992 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.414 ' HA3' ' CB ' ' A' ' 81' ' ' CYS . . . -128.13 161.6 21.97 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.501 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.438 ' CB ' ' HB2' ' A' ' 18' ' ' CYS . . . -93.08 -20.1 20.87 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.4 ' CG2' ' SG ' ' A' ' 81' ' ' CYS . 4.0 m -42.41 92.67 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 CA-C-O 120.892 0.377 . . . . 0.0 111.643 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.439 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . . . -178.13 -77.97 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.76 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.508 ' O ' HD22 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -98.08 -84.1 0.39 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.927 0.394 . . . . 0.0 111.825 -179.354 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.436 ' HA ' HG12 ' A' ' 21' ' ' ILE . 4.3 p -63.33 -50.39 70.19 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.438 ' HB2' ' CB ' ' A' ' 13' ' ' ALA . 51.9 t -32.46 -70.83 0.06 Allowed 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 113.634 0.975 . . . . 0.0 113.634 -178.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.836 HD21 ' CE1' ' A' ' 169' ' ' PHE . 0.0 OUTLIER -58.05 -71.23 0.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -178.19 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.508 HD22 ' O ' ' A' ' 16' ' ' LYS . 0.2 OUTLIER -51.05 -65.88 0.48 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -178.283 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.512 HD11 ' CZ ' ' B' ' 518' ' ' PHE . 30.4 mm -45.6 -67.9 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.107 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.434 ' CB ' ' HB1' ' A' ' 159' ' ' ALA . 1.2 t -49.82 -26.12 3.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.961 0.41 . . . . 0.0 110.752 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -82.86 -25.34 32.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.72 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.42 HG23 ' O ' ' A' ' 20' ' ' LEU . 66.7 p -100.52 -64.21 1.06 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.243 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 40.1 p -62.41 -58.28 8.2 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.993 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.439 ' N ' ' ND2' ' A' ' 26' ' ' ASN . 0.4 OUTLIER 74.9 42.67 0.26 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.181 179.584 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.47 ' O ' ' CE1' ' A' ' 32' ' ' TYR . 4.2 mtmm -119.66 91.58 3.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.968 0.413 . . . . 0.0 110.928 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.48 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 9.4 t80 -89.81 -45.38 0.41 Allowed Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.872 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 88.0 Cg_endo -84.16 79.02 2.73 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.424 2.083 . . . . 0.0 113.04 -179.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.9 m -174.02 -94.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.879 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.41 154.74 25.46 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 120.635 0.255 . . . . 0.0 110.449 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.47 ' CE1' ' O ' ' A' ' 27' ' ' LYS . 15.6 m-85 -133.82 93.98 3.2 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.905 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.564 ' N ' ' CD ' ' A' ' 34' ' ' PRO . 2.1 t -131.59 28.09 0.15 Allowed Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.564 ' CD ' ' N ' ' A' ' 33' ' ' VAL . 42.3 Cg_endo -86.09 -37.59 0.1 Allowed 'Trans proline' 0 C--N 1.359 1.109 0 C-N-CA 121.889 1.726 . . . . 0.0 112.496 179.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.472 HG21 HD21 ' B' ' 543' ' ' LEU . 1.4 m -48.46 99.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.881 -179.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.466 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 7.4 p 176.98 -34.95 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.825 179.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -109.39 35.88 3.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.582 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.449 ' CB ' ' HG2' ' A' ' 16' ' ' LYS . 18.3 m-20 -89.58 45.47 1.28 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.127 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -106.03 -16.28 14.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.077 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -60.59 174.97 0.51 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.79 0.329 . . . . 0.0 110.865 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.759 ' C ' HD12 ' B' ' 519' ' ' ILE . . . -91.99 174.48 7.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.294 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.421 ' HA ' HG13 ' B' ' 519' ' ' ILE . 30.9 m -139.32 144.67 28.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.734 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.498 ' O ' HG23 ' A' ' 44' ' ' VAL . 2.1 p -85.05 106.33 16.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.499 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.912 ' HB ' HG21 ' A' ' 52' ' ' THR . 53.9 t -158.04 153.11 6.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.158 -179.195 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.53 ' HB3' HD22 ' B' ' 514' ' ' LEU . 0.0 OUTLIER -117.73 96.31 5.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.17 179.313 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.951 HG12 HG22 ' A' ' 52' ' ' THR . 5.5 mm -71.1 88.1 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.539 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.508 ' N ' HG23 ' B' ' 510' ' ' ILE . . . 37.28 -87.85 0.01 OUTLIER Glycine 0 CA--C 1.521 0.409 0 CA-C-N 115.811 -0.631 . . . . 0.0 113.919 179.326 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . -38.88 -78.6 0.05 OUTLIER Glycine 0 C--N 1.334 0.439 0 C-N-CA 121.52 -0.371 . . . . 0.0 113.177 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.451 ' N ' ' HE1' ' A' ' 45' ' ' MET . 3.2 mt-10 -142.29 162.23 46.25 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-O 120.909 0.385 . . . . 0.0 111.373 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.42 92.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.79 2.327 . . . . 0.0 112.558 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.549 ' CE1' HG23 ' A' ' 3' ' ' THR . 0.0 OUTLIER -172.95 126.07 0.45 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.073 179.749 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.951 HG22 HG12 ' A' ' 46' ' ' ILE . 4.3 p -134.57 141.77 46.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.919 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.598 ' HG ' HG21 ' A' ' 3' ' ' THR . 5.3 mt -71.16 121.69 18.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.877 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -52.28 153.4 6.08 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.092 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.562 HD23 ' CB ' ' A' ' 6' ' ' CYS . 2.6 mp -109.79 95.04 5.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.839 0.352 . . . . 0.0 110.884 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -84.73 105.45 15.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.633 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.421 ' OD2' ' CG2' ' A' ' 35' ' ' THR . 1.5 t70 -94.44 163.77 13.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.822 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 1.087 HG21 HD22 ' A' ' 70' ' ' LEU . 6.7 p -89.44 146.38 24.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.32 -179.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.466 ' HB3' ' HA ' ' A' ' 36' ' ' VAL . . . -172.14 -162.78 0.22 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.677 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.455 ' H ' HD12 ' A' ' 61' ' ' LEU . . . 166.41 66.75 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.467 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.455 HD12 ' H ' ' A' ' 60' ' ' GLY . 5.8 mp -120.97 -87.01 0.65 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.727 0.299 . . . . 0.0 111.02 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.79 -31.56 11.81 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.902 0.382 . . . . 0.0 111.108 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.425 ' HB3' HG22 ' A' ' 36' ' ' VAL . 50.7 t0 -70.8 -63.25 1.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.37 -179.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.489 ' CD1' HD12 ' A' ' 67' ' ' LEU . 0.1 OUTLIER -118.33 160.25 21.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.805 -179.757 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -85.92 -68.35 0.74 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.807 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -96.69 -52.2 4.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.117 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.715 HD23 ' O ' ' A' ' 67' ' ' LEU . 6.5 tt 56.42 106.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.64 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.452 ' N ' ' HD3' ' A' ' 69' ' ' PRO . 1.7 ppt_? -142.47 53.33 2.87 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.321 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.452 ' HD3' ' N ' ' A' ' 68' ' ' ARG . 94.1 Cg_endo -83.95 -20.25 4.49 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.764 2.309 . . . . 0.0 112.26 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 1.087 HD22 HG21 ' A' ' 58' ' ' THR . 0.7 OUTLIER -77.76 1.0 21.49 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.925 -179.79 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.21 -61.23 2.28 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 120.908 0.385 . . . . 0.0 110.92 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.492 ' N ' ' CD1' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -159.22 56.76 0.96 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.791 179.884 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -60.94 174.44 1.77 Allowed 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.661 2.241 . . . . 0.0 112.307 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -95.68 10.57 36.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.524 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.402 HG23 ' HB3' ' A' ' 5' ' ' LYS . 98.8 m -46.51 145.21 1.88 Allowed 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.804 0.335 . . . . 0.0 111.05 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.418 ' O ' ' CG ' ' A' ' 109' ' ' PRO . 16.8 p-10 -106.4 -20.96 13.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.147 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.666 ' O ' HG13 ' A' ' 77' ' ' VAL . 7.9 p -123.55 83.96 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.827 0.346 . . . . 0.0 111.387 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.747 ' CE2' HG21 ' A' ' 9' ' ' VAL . 0.3 OUTLIER -80.79 166.3 21.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.599 179.736 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.471 HD13 ' HB3' ' A' ' 111' ' ' LEU . 4.9 tp -143.39 108.46 4.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.02 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.706 HG13 ' CB ' ' A' ' 110' ' ' PHE . 35.9 m -84.74 147.11 5.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.838 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.481 ' O ' ' CZ3' ' A' ' 97' ' ' TRP . 2.0 m -113.97 174.35 5.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.118 0.485 . . . . 0.0 111.216 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.463 ' CE1' ' O ' ' A' ' 113' ' ' VAL . 6.0 p90 179.99 -173.54 0.23 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.769 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.441 ' N ' ' CD2' ' A' ' 82' ' ' PHE . 0.3 OUTLIER -156.42 136.34 12.66 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.847 0.356 . . . . 0.0 111.349 179.958 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.538 HG13 ' N ' ' A' ' 137' ' ' ILE . 99.3 t -51.48 -40.41 24.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.827 179.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.623 ' O ' HG23 ' A' ' 85' ' ' VAL . 32.0 m -73.02 111.64 7.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.518 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.455 ' H ' HD13 ' A' ' 129' ' ' LEU . 83.4 p -151.28 135.27 9.51 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.743 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.417 ' HB2' ' HB2' ' A' ' 132' ' ' ASN . 74.2 Cg_endo -91.42 51.88 0.78 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.218 2.612 . . . . 0.0 111.585 179.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.46 ' CB ' ' CG ' ' A' ' 133' ' ' LYS . 0.1 OUTLIER 79.15 26.85 0.42 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.665 -179.426 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.922 ' O ' HG23 ' A' ' 93' ' ' VAL . 52.4 p -96.5 -25.73 15.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.999 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.411 ' CZ ' HG21 ' A' ' 137' ' ' ILE . 3.3 t80 -48.96 -54.08 17.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.075 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -49.82 -53.41 25.62 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.932 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -64.29 -47.68 78.57 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.724 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.922 HG23 ' O ' ' A' ' 89' ' ' SER . 65.9 t -51.1 -39.84 20.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.049 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.645 ' HD2' HD13 ' A' ' 145' ' ' LEU . 12.3 tttm -64.51 -50.39 67.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.847 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.403 ' O ' ' HG3' ' A' ' 99' ' ' PRO . 4.7 mt-10 -82.97 7.39 15.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.695 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.2 mttp -109.82 -26.14 9.97 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.751 0.31 . . . . 0.0 110.872 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.73 ' O ' HG22 ' A' ' 101' ' ' ILE . 5.7 m0 -94.01 -45.73 7.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.196 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.64 HG23 ' O ' ' A' ' 94' ' ' LYS . 58.5 t -49.94 -46.73 81.43 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.63 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 94.2 Cg_endo -80.74 -15.5 10.78 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.393 2.062 . . . . 0.0 112.612 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -90.11 -49.09 6.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.771 0.32 . . . . 0.0 110.901 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.73 HG22 ' O ' ' A' ' 97' ' ' TRP . 9.9 tt -62.95 -22.86 31.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.197 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.515 HG23 ' O ' ' A' ' 98' ' ' VAL . 61.2 p -91.51 -26.11 18.94 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.878 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 42.0 t60 -76.92 -57.79 3.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.895 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -65.66 -56.96 9.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.951 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.407 ' CB ' ' OG1' ' A' ' 108' ' ' THR . 60.4 m -86.65 142.94 35.16 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.976 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -69.23 60.27 1.4 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.558 2.172 . . . . 0.0 112.315 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.78 78.58 0.27 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.927 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.407 ' OG1' ' CB ' ' A' ' 105' ' ' CYS . 0.2 OUTLIER -108.52 141.12 22.59 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.813 179.847 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.418 ' CG ' ' O ' ' A' ' 76' ' ' ASP . 33.8 Cg_endo -65.53 177.91 2.46 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.507 2.138 . . . . 0.0 112.52 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.845 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 4.6 p90 -166.22 132.55 2.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.782 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.849 HD12 ' CG1' ' A' ' 152' ' ' VAL . 5.5 tt -108.94 142.0 40.21 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.678 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.438 HD12 ' CD1' ' A' ' 82' ' ' PHE . 4.2 mm? -89.59 155.03 19.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.586 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 1.091 HG13 HG21 ' A' ' 168' ' ' VAL . 2.4 t -142.12 134.17 26.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.946 0.403 . . . . 0.0 111.792 -179.448 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.784 ' O ' HD11 ' A' ' 117' ' ' ILE . . . -106.03 86.09 0.47 Allowed Glycine 0 C--N 1.332 0.338 0 C-N-CA 121.004 -0.617 . . . . 0.0 111.857 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.481 ' HB ' ' HA ' ' A' ' 158' ' ' SER . 1.0 OUTLIER -110.34 1.68 18.61 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -178.805 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.531 ' HB3' HG23 ' A' ' 84' ' ' VAL . 4.4 tp60 -96.87 -22.74 16.71 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.784 HD11 ' O ' ' A' ' 114' ' ' GLY . 0.2 OUTLIER -46.04 -25.75 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.096 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.839 178.931 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.563 ' HB3' HD13 ' A' ' 119' ' ' LEU . 4.8 t0 -53.72 -47.52 70.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.372 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.722 HD13 ' N ' ' A' ' 119' ' ' LEU . 0.0 OUTLIER -122.98 14.31 9.88 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -178.976 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.82 -28.61 3.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.897 0.379 . . . . 0.0 110.87 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.3 p30 -72.22 -22.39 61.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.094 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.421 ' O ' ' HB ' ' A' ' 126' ' ' ILE . 20.1 p-10 -48.24 104.32 0.41 Allowed Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 120.983 0.421 . . . . 0.0 110.974 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.426 ' O ' HG22 ' A' ' 126' ' ' ILE . 36.7 Cg_endo -66.49 -6.57 15.48 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.381 2.054 . . . . 0.0 113.172 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.417 ' OG ' ' N ' ' A' ' 125' ' ' THR . 54.3 p -79.78 -66.52 0.86 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.417 ' N ' ' OG ' ' A' ' 124' ' ' SER . 34.5 m -55.76 -38.06 69.34 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.499 HD11 ' HB3' ' A' ' 136' ' ' PRO . 0.1 OUTLIER -56.37 -41.68 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 115.01 -0.996 . . . . 0.0 109.803 179.229 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.449 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 1.0 OUTLIER -60.59 -37.51 81.58 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.436 179.256 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 125' ' ' THR . 0.0 OUTLIER -60.88 -31.3 70.77 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.595 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.455 HD13 ' H ' ' A' ' 86' ' ' SER . 5.1 mt -75.36 -41.68 55.9 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 177.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 127' ' ' GLU . . . -44.26 -33.9 1.73 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.99 -1.004 . . . . 0.0 111.105 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 18.0 mmtm -49.79 -33.05 15.42 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.416 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.417 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 5.1 m-80 -123.29 -31.36 3.57 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.341 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.523 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 0.8 OUTLIER -144.6 -99.17 0.1 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 119.191 -0.433 . . . . 0.0 111.571 179.793 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.523 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 2.7 pt20 129.57 -23.86 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.528 1.131 . . . . 0.0 110.313 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.2 mmtt -68.73 110.26 5.64 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.778 -179.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.499 ' HB3' HD11 ' A' ' 126' ' ' ILE . 96.1 Cg_endo -79.55 127.36 7.23 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.485 2.123 . . . . 0.0 111.239 179.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.734 ' N ' HD13 ' A' ' 137' ' ' ILE . 1.1 mm -56.76 95.9 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.962 0.411 . . . . 0.0 110.738 -179.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 47.0 p -67.65 155.65 90.81 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.087 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.455 ' HG3' HG21 ' A' ' 117' ' ' ILE . 75.3 Cg_exo -47.54 -27.85 8.1 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.461 2.107 . . . . 0.0 112.184 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -77.1 -30.53 55.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.626 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.566 ' HB ' HG22 ' A' ' 137' ' ' ILE . 5.8 m -69.58 -62.49 1.36 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.727 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.403 ' HB3' ' CZ ' ' A' ' 154' ' ' TYR . . . -52.14 -36.05 50.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.637 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -65.83 -41.53 91.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.505 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 19.4 tptp -55.11 -62.77 1.45 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.634 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.755 ' CD1' HD23 ' A' ' 149' ' ' LEU . 17.2 tp -58.31 -43.81 88.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.543 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.403 ' HB2' ' HG ' ' A' ' 112' ' ' LEU . . . -55.06 -35.3 64.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.924 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 12.3 mtt-85 -91.47 -30.87 16.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.618 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -65.12 -44.28 89.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.707 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.755 HD23 ' CD1' ' A' ' 145' ' ' LEU . 3.0 mm? -89.8 14.05 12.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.123 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 47.41 45.8 17.11 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.835 0.35 . . . . 0.0 111.002 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.845 ' HB1' ' O ' ' A' ' 110' ' ' PHE . . . -65.09 -82.22 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.198 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.849 ' CG1' HD12 ' A' ' 111' ' ' LEU . 70.7 t -161.09 -75.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.826 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.57 108.41 0.06 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.792 -178.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.449 ' CE2' ' HA ' ' A' ' 139' ' ' PRO . 19.5 t80 -80.98 114.56 19.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.425 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 3.7 t -108.87 155.12 9.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.826 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.405 ' O ' ' HB3' ' A' ' 157' ' ' CYS . 1.2 pt-20 -94.37 118.58 31.83 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.223 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.435 ' HA ' ' HB3' ' A' ' 163' ' ' LYS . 20.3 p 178.95 137.46 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.615 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.481 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 27.4 m -112.72 149.31 33.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.981 0.419 . . . . 0.0 111.221 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.853 ' HB2' HD21 ' A' ' 165' ' ' LEU . . . -83.21 -42.54 17.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.82 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.491 HD23 ' H ' ' A' ' 160' ' ' LEU . 0.1 OUTLIER -49.53 -36.5 23.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.703 179.779 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.455 HG22 ' HB2' ' A' ' 158' ' ' SER . 15.3 t -111.37 -22.48 11.3 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.685 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.413 ' N ' ' O ' ' A' ' 158' ' ' SER . 0.9 OUTLIER 73.11 62.25 0.1 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.781 -179.89 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.435 ' HB3' ' HA ' ' A' ' 157' ' ' CYS . 0.0 OUTLIER -93.08 22.59 4.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.061 -179.943 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.435 ' N ' ' HB2' ' A' ' 157' ' ' CYS . . . 133.34 35.39 0.29 Allowed Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.484 -0.865 . . . . 0.0 113.412 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.853 HD21 ' HB2' ' A' ' 159' ' ' ALA . 10.5 mt -48.88 -42.3 36.27 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.913 0.357 . . . . 0.0 110.844 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.18 -34.18 72.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.992 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.418 ' O ' ' HB2' ' A' ' 170' ' ' ASP . 0.1 OUTLIER -58.03 -72.18 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.241 -179.811 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 1.091 HG21 HG13 ' A' ' 113' ' ' VAL . 7.1 p -50.08 -46.91 24.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.981 0.42 . . . . 0.0 110.988 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.836 ' CE1' HD21 ' A' ' 19' ' ' LEU . 1.1 t80 -64.6 -33.38 75.78 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.672 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.42 ' O ' ' CB ' ' A' ' 174' ' ' LEU . 0.5 OUTLIER -56.3 -32.84 64.99 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.967 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.699 ' HB2' HD11 ' A' ' 111' ' ' LEU . 58.7 mm-40 -75.0 -36.21 61.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.887 178.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.731 ' N ' HD13 ' A' ' 111' ' ' LEU . . . -67.31 -43.41 81.72 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.623 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.494 HD13 ' HB2' ' B' ' 512' ' ' GLN . 1.7 pp -78.23 -33.14 17.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.661 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.86 HD13 HD22 ' B' ' 505' ' ' LEU . 22.0 tp -59.13 -43.62 92.01 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.634 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -54.34 -22.03 11.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.112 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.683 ' HB3' ' CG2' ' A' ' 4' ' ' ILE . . . -87.53 -37.03 17.25 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.395 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.839 HD13 ' HB ' ' B' ' 510' ' ' ILE . 94.9 mt -68.83 -27.98 66.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.962 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.11 136.73 1.93 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.981 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -57.32 112.02 1.0 Allowed 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.563 2.175 . . . . 0.0 112.302 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.53 162.1 33.55 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.625 2.217 . . . . 0.0 112.276 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -131.37 143.85 50.98 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.959 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -76.53 -165.12 0.29 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.721 2.281 . . . . 0.0 112.329 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 1.8 mmmt -71.26 83.54 0.75 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.87 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 7.7 mttt . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.979 179.992 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 502' ' ' GLY . . . . . 0.416 ' CA ' ' O ' ' B' ' 509' ' ' ASP . . . . . . . . 0 N--CA 1.489 2.195 0 N-CA-C 112.524 -0.23 . . . . 0.0 112.524 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 503' ' ' SER . . . . . . . . . . . . . 37.4 t -107.06 -74.62 0.65 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.781 0.324 . . . . 0.0 110.944 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 504' ' ' GLY . . . . . . . . . . . . . . . 116.58 103.86 2.35 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.36 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 505' ' ' LEU . . . . . 0.86 HD22 HD13 ' A' ' 174' ' ' LEU . 0.1 OUTLIER -174.55 38.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.698 0.285 . . . . 0.0 111.141 -179.871 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 506' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 68.95 34.26 3.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.127 0.489 . . . . 0.0 110.566 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 507' ' ' ALA . . . . . 0.479 ' HB3' ' CD1' ' B' ' 505' ' ' LEU . . . -137.47 35.97 2.48 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.548 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 508' ' ' GLN . . . . . 0.4 ' O ' ' HB3' ' B' ' 509' ' ' ASP . 20.4 mt-30 74.73 3.38 4.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.441 -178.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 509' ' ' ASP . . . . . 0.416 ' O ' ' CA ' ' B' ' 502' ' ' GLY . 16.0 t70 71.7 44.83 0.47 Allowed 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.158 0.504 . . . . 0.0 110.816 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 510' ' ' ILE . . . . . 0.839 ' HB ' HD13 ' A' ' 177' ' ' LEU . 44.5 mt -93.17 138.29 20.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.846 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 511' ' ' SER . . . . . . . . . . . . . 22.1 t -108.04 157.16 18.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.359 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 512' ' ' GLN . . . . . 0.505 ' O ' HG11 ' A' ' 44' ' ' VAL . 27.9 tp60 -110.21 -71.2 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.513 179.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 513' ' ' PRO . . . . . 0.478 ' CD ' ' CB ' ' B' ' 512' ' ' GLN . 73.3 Cg_endo -74.6 58.96 4.75 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.021 1.814 . . . . 0.0 111.632 179.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 514' ' ' LEU . . . . . 0.53 HD22 ' HB3' ' A' ' 45' ' ' MET . 2.6 mp -65.81 -86.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.65 -179.272 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 515' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -69.3 -96.1 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.218 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -127.32 -12.26 5.67 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 517' ' ' SER . . . . . 0.418 ' HA ' ' HB ' ' A' ' 42' ' ' VAL . 1.5 m 48.62 31.78 3.14 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.705 0.288 . . . . 0.0 111.135 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 518' ' ' PHE . . . . . 0.512 ' CZ ' HD11 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -163.3 91.96 0.72 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.143 -179.795 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 519' ' ' ILE . . . . . 0.759 HD12 ' C ' ' A' ' 41' ' ' ALA . 41.5 mt -64.23 -64.68 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.84 0.353 . . . . 0.0 110.755 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -126.6 -168.95 1.94 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.891 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 521' ' ' THR . . . . . . . . . . . . . 6.6 m -119.76 113.99 21.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.002 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 522' ' ' GLY . . . . . . . . . . . . . . . -107.16 120.6 6.23 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.522 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 523' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -114.58 -84.44 0.61 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.716 0.294 . . . . 0.0 110.96 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 524' ' ' GLY . . . . . . . . . . . . . . . 101.21 -44.14 1.6 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.412 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 525' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -152.01 32.95 0.54 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.862 0.363 . . . . 0.0 110.907 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 526' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.1 97.56 6.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.887 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 527' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -145.88 161.68 39.02 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.914 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.42 96.59 0.65 Allowed 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.598 2.199 . . . . 0.0 112.242 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 529' ' ' ARG . . . . . . . . . . . . . 1.9 mtp85 -96.08 -23.1 16.94 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.202 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 530' ' ' HIS . . . . . 0.41 ' O ' ' HB2' ' B' ' 531' ' ' CYS . 0.0 OUTLIER -178.76 -82.77 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.938 -179.875 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 531' ' ' CYS . . . . . 0.41 ' HB2' ' O ' ' B' ' 530' ' ' HIS . 50.1 t 178.29 -68.67 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.886 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 532' ' ' TRP . . . . . 0.521 ' CZ2' ' NH2' ' B' ' 537' ' ' ARG . 0.6 OUTLIER -126.32 -49.8 1.54 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.967 -179.908 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 533' ' ' GLY . . . . . 0.472 ' O ' ' CG ' ' B' ' 534' ' ' PHE . . . 106.4 -56.28 0.51 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.483 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 534' ' ' PHE . . . . . 0.472 ' CG ' ' O ' ' B' ' 533' ' ' GLY . 98.0 m-85 -160.67 160.72 25.5 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.76 0.314 . . . . 0.0 110.88 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -48.05 123.36 8.61 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.559 2.173 . . . . 0.0 112.274 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 2.9 t0 68.25 145.18 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.747 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 537' ' ' ARG . . . . . 0.521 ' NH2' ' CZ2' ' B' ' 532' ' ' TRP . 0.1 OUTLIER -51.94 139.19 22.93 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.036 0.446 . . . . 0.0 111.09 -179.867 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 538' ' ' ILE . . . . . 0.434 ' CG2' ' HA ' ' B' ' 543' ' ' LEU . 5.8 tp -59.38 144.94 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.959 179.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 539' ' ' ASP . . . . . 0.408 ' HA ' ' O ' ' A' ' 10' ' ' GLY . 8.5 m-20 -43.84 136.95 3.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.815 0.341 . . . . 0.0 111.275 -179.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 540' ' ' GLU . . . . . 0.704 ' HA ' HD12 ' B' ' 543' ' ' LEU . 33.1 mm-40 -52.72 -21.66 4.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.163 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 541' ' ' LEU . . . . . 0.738 ' HA ' HD21 ' A' ' 70' ' ' LEU . 1.1 mp -37.03 -63.59 0.42 Allowed 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 542' ' ' TYR . . . . . 0.412 ' O ' ' CB ' ' B' ' 543' ' ' LEU . 0.1 OUTLIER -105.16 -58.68 1.86 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.304 -179.574 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 543' ' ' LEU . . . . . 0.704 HD12 ' HA ' ' B' ' 540' ' ' GLU . 0.1 OUTLIER 81.27 -167.97 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.369 -179.225 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 544' ' ' GLY . . . . . 0.42 ' O ' ' ND2' ' B' ' 545' ' ' ASN . . . 93.44 -176.3 36.77 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.497 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 545' ' ' ASN . . . . . 0.552 ' HB2' HG22 ' A' ' 33' ' ' VAL . 9.3 m-80 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.279 -0.867 . . . . 0.0 110.987 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.461 ' HE2' ' O ' ' A' ' 2' ' ' GLN . 7.9 tpt . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.769 0.319 . . . . 0.0 111.3 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.461 ' O ' ' HE2' ' A' ' 1' ' ' MET . 2.7 tt0 62.25 134.04 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.448 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.708 HG23 ' CE1' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -107.39 -166.5 1.16 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.908 -179.158 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.756 HD11 ' CD1' ' A' ' 53' ' ' LEU . 4.9 pt -156.44 162.36 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.588 -179.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.12 99.41 4.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.437 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.426 ' SG ' HD23 ' A' ' 55' ' ' LEU . 1.3 m -78.25 103.25 8.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.518 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.1 t -135.15 112.57 14.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.327 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.482 HG11 ' HG3' ' A' ' 16' ' ' LYS . 0.2 OUTLIER -103.42 138.62 27.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.299 0.571 . . . . 0.0 111.203 -179.592 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.406 ' O ' HG23 ' A' ' 9' ' ' VAL . 30.5 m -130.25 129.62 65.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.346 178.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 142.19 -172.42 24.2 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 119.867 -1.159 . . . . 0.0 112.7 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -96.5 27.48 3.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.779 0.323 . . . . 0.0 110.8 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.457 ' HA2' ' CD ' ' B' ' 537' ' ' ARG . . . -149.35 150.69 22.84 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.745 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.666 ' HB2' ' O2A' ' A' ' 185' ' ' GNP . . . -58.16 -54.56 45.55 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.551 0.215 . . . . 0.0 110.849 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.9 ' O ' HD21 ' A' ' 19' ' ' LEU . 0.0 OUTLIER 44.62 -87.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.472 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.528 ' HA2' HD21 ' A' ' 19' ' ' LEU . . . -102.32 23.13 35.31 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.242 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.712 ' O ' HD22 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -84.34 -163.52 0.81 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.947 0.403 . . . . 0.0 110.945 -179.823 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.452 ' HB ' ' CG1' ' A' ' 21' ' ' ILE . 6.1 p -74.84 -28.6 60.75 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.029 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.417 ' HB2' ' O2B' ' A' ' 185' ' ' GNP . 53.3 t -41.47 -30.06 0.18 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.643 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.9 HD21 ' O ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -62.83 -71.05 0.17 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.889 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.4 mt -70.07 -36.12 74.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.97 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.691 HG21 ' O ' ' A' ' 188' ' ' HOH . 4.5 mm -58.31 -71.2 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.418 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 25' ' ' THR . 24.5 m -55.22 -34.83 64.3 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 121.098 -0.241 . . . . 0.0 110.666 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.8 ' HB2' HD13 ' A' ' 165' ' ' LEU . 49.9 t80 -52.65 -35.12 54.36 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.435 ' O ' ' HB ' ' A' ' 25' ' ' THR . 0.2 OUTLIER -100.97 -46.24 5.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.71 179.258 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.49 ' O ' ' CB ' ' A' ' 26' ' ' ASN . 6.7 t -177.83 -162.84 0.07 Allowed 'General case' 0 C--O 1.227 -0.082 0 CA-C-N 116.342 -0.39 . . . . 0.0 112.003 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.492 ' HB2' HG23 ' A' ' 21' ' ' ILE . 2.5 t30 97.6 -20.87 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.659 0.784 . . . . 0.0 110.616 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.6 mttp 60.06 146.67 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.963 0.411 . . . . 0.0 111.395 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.473 ' CD1' ' OH ' ' A' ' 32' ' ' TYR . 19.7 t80 -89.2 -47.69 0.41 Allowed Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.871 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 67.7 Cg_endo -88.29 58.14 2.71 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.793 2.328 . . . . 0.0 112.797 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.2 m -133.85 -85.53 0.43 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.823 0.344 . . . . 0.0 110.759 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -158.59 162.83 37.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.754 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.516 ' CD2' ' O1G' ' A' ' 185' ' ' GNP . 67.4 m-85 -135.22 103.56 5.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.971 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.567 HG12 HD21 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -165.31 -61.35 0.01 OUTLIER Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.341 -179.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.506 ' HD3' HG23 ' A' ' 33' ' ' VAL . 86.7 Cg_exo -42.84 -28.49 1.18 Allowed 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.371 2.048 . . . . 0.0 112.528 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.82 HG23 HD23 ' B' ' 543' ' ' LEU . 4.2 t -57.44 -20.81 32.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.192 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.964 HG21 ' HB2' ' A' ' 61' ' ' LEU . 12.6 p -52.0 -21.18 2.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.521 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.482 ' CD1' ' O ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -83.02 46.9 1.15 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.66 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.466 ' CB ' ' HB2' ' A' ' 57' ' ' ASP . 5.0 p-10 -63.66 -158.29 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.645 0.259 . . . . 0.0 110.837 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 73.73 22.48 2.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.804 0.335 . . . . 0.0 111.006 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.497 ' CE2' ' HA ' ' B' ' 520' ' ' HIS . 1.8 m-30 -60.18 129.31 41.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.77 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.443 ' O ' HG12 ' B' ' 519' ' ' ILE . . . -95.51 119.61 34.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.582 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.809 HG23 HG21 ' A' ' 52' ' ' THR . 17.5 m -117.74 159.82 17.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.986 0.422 . . . . 0.0 111.72 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.34 104.79 6.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.384 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.692 HG22 ' CG2' ' A' ' 52' ' ' THR . 10.4 m -149.04 -177.46 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.366 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.624 ' O ' HD11 ' B' ' 514' ' ' LEU . 4.7 tpt -99.07 96.62 7.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.342 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.669 HG22 ' O ' ' A' ' 46' ' ' ILE . 1.3 mm -80.44 86.66 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-O 121.33 0.586 . . . . 0.0 109.695 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.718 ' HA3' HG23 ' B' ' 510' ' ' ILE . . . 42.74 -92.42 0.01 OUTLIER Glycine 0 CA--C 1.524 0.601 0 CA-C-N 115.537 -0.756 . . . . 0.0 113.71 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . -38.55 -91.59 0.01 OUTLIER Glycine 0 CA--C 1.52 0.39 0 N-CA-C 113.988 0.355 . . . . 0.0 113.988 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.463 ' N ' ' HE1' ' A' ' 45' ' ' MET . 1.3 pt-20 -125.88 152.47 72.73 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-O 120.693 0.282 . . . . 0.0 110.932 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.401 ' N ' ' SD ' ' A' ' 45' ' ' MET . 83.0 Cg_exo -43.28 105.55 0.06 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.51 2.14 . . . . 0.0 112.266 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.708 ' CE1' HG23 ' A' ' 3' ' ' THR . 8.8 t80 -172.02 159.21 4.93 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.303 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.809 HG21 HG23 ' A' ' 42' ' ' VAL . 6.5 p -136.09 153.2 51.39 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.146 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.756 ' CD1' HD11 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -87.27 -179.19 6.37 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.919 179.807 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -128.54 103.51 0.62 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.627 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.426 HD23 ' SG ' ' A' ' 6' ' ' CYS . 0.1 OUTLIER -85.66 97.38 10.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.807 0.336 . . . . 0.0 110.254 179.702 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -84.23 105.61 15.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.694 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.807 ' OD2' HD21 ' B' ' 543' ' ' LEU . 0.6 OUTLIER -90.75 137.05 32.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.061 -179.775 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.879 ' O ' HD13 ' B' ' 543' ' ' LEU . 0.1 OUTLIER -99.03 143.38 29.37 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.278 179.807 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.901 ' HB3' HG23 ' A' ' 36' ' ' VAL . . . -153.14 177.4 10.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.923 0.392 . . . . 0.0 111.384 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.417 ' HA2' ' HA ' ' A' ' 65' ' ' ASP . . . -129.96 51.81 0.85 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.94 -0.647 . . . . 0.0 112.09 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.964 ' HB2' HG21 ' A' ' 36' ' ' VAL . 0.4 OUTLIER -120.82 -175.24 2.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.934 0.397 . . . . 0.0 111.199 -179.56 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -46.73 -40.24 13.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.347 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.439 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . 59.4 m-20 -47.25 -56.95 5.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.184 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.61 ' HB2' HD23 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -166.8 93.34 0.47 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.837 -179.855 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.417 ' HA ' ' HA2' ' A' ' 60' ' ' GLY . 0.2 OUTLIER -86.33 -7.43 58.49 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.558 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.37 -20.63 20.87 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.61 HD23 ' HB2' ' A' ' 64' ' ' TYR . 4.5 pp -51.36 160.98 0.5 Allowed 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.783 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 20.6 ttp85 -178.18 62.82 0.16 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.012 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -84.79 -23.38 2.62 Favored 'Trans proline' 0 N--CA 1.461 -0.383 0 C-N-CA 122.859 2.373 . . . . 0.0 112.581 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.71 ' O ' HD12 ' A' ' 70' ' ' LEU . 0.1 OUTLIER -71.75 -6.16 39.32 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.448 -179.672 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -48.36 -71.25 0.07 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.86 0.362 . . . . 0.0 111.097 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.405 ' N ' ' HD3' ' A' ' 73' ' ' PRO . 10.4 m-85 -140.33 62.52 20.03 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.879 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.409 ' HB2' ' CZ ' ' A' ' 78' ' ' PHE . 54.4 Cg_exo -52.36 130.58 36.55 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.685 2.257 . . . . 0.0 112.284 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -86.15 10.27 14.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.499 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 15.3 t -50.82 174.6 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.806 0.336 . . . . 0.0 110.817 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -112.3 -25.73 9.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.882 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.657 ' O ' HG13 ' A' ' 77' ' ' VAL . 8.2 p -126.57 99.14 5.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.172 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.414 ' HB2' ' O ' ' A' ' 109' ' ' PRO . 0.2 OUTLIER -80.89 176.58 9.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.61 179.826 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.559 ' CD2' ' HB1' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -127.83 108.74 10.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.077 -179.808 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.712 HG13 ' HB2' ' A' ' 110' ' ' PHE . 34.4 m -97.97 127.88 49.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.65 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.457 ' HB3' ' CG2' ' A' ' 14' ' ' VAL . 21.1 p -99.63 174.02 6.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.14 0.495 . . . . 0.0 111.632 -179.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.571 ' CZ ' ' HB2' ' A' ' 142' ' ' ALA . 8.3 p90 -179.63 -174.3 0.29 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.17 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.427 ' N ' ' CD2' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -156.08 149.89 25.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.752 0.31 . . . . 0.0 110.856 179.885 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.771 ' CG2' HG22 ' A' ' 117' ' ' ILE . 43.8 t -61.71 -41.84 92.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.345 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.689 HG13 ' CD ' ' A' ' 120' ' ' ARG . 17.6 m -59.64 114.8 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.365 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.785 ' N ' HD22 ' A' ' 129' ' ' LEU . 0.6 OUTLIER -152.02 117.47 3.08 Favored Pre-proline 0 C--N 1.329 -0.294 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.801 -179.57 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.425 ' O ' ' CB ' ' A' ' 132' ' ' ASN . 89.7 Cg_endo -94.01 53.28 0.33 Allowed 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.114 2.543 . . . . 0.0 111.288 179.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.46 ' HA ' ' HG3' ' A' ' 133' ' ' LYS . 0.2 OUTLIER 81.12 30.07 0.16 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.661 -179.253 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 73.9 m -97.2 -16.84 20.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.133 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.821 ' CE2' HD12 ' A' ' 137' ' ' ILE . 0.1 OUTLIER -43.26 -42.11 4.22 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.869 0.366 . . . . 0.0 111.403 -179.919 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -63.41 -33.6 75.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.973 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.406 ' O ' ' N ' ' A' ' 96' ' ' LYS . 7.4 m120 -75.23 -52.98 9.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.095 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.434 ' CG2' ' HA ' ' A' ' 90' ' ' PHE . 7.4 m -49.71 -44.59 20.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.233 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.454 ' O ' HG23 ' A' ' 98' ' ' VAL . 0.1 OUTLIER -65.44 -49.78 67.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.899 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -82.57 7.34 14.85 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.671 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.406 ' N ' ' O ' ' A' ' 92' ' ' ASN . 4.8 tttt -115.3 -27.34 7.27 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.721 0.296 . . . . 0.0 111.036 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.413 ' O ' HG22 ' A' ' 101' ' ' ILE . 1.7 m95 -94.31 -50.18 5.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.388 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.674 HG13 HD21 ' A' ' 149' ' ' LEU . 61.9 t -50.89 -46.01 87.42 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.962 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 95.3 Cg_endo -81.03 -11.21 12.38 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.377 2.051 . . . . 0.0 113.016 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.405 ' HB3' ' O ' ' A' ' 96' ' ' LYS . 1.2 tt0 -90.34 -57.0 2.99 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 120.906 0.384 . . . . 0.0 110.187 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.413 HG22 ' O ' ' A' ' 97' ' ' TRP . 20.8 tt -57.34 -27.88 29.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.084 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.76 HG22 ' HA ' ' A' ' 107' ' ' LYS . 23.2 p -86.33 -29.66 22.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.75 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -58.62 -54.84 42.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.851 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 52.9 m170 -65.54 -42.04 92.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.79 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -125.87 124.02 24.71 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.669 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -50.98 89.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.414 2.076 . . . . 0.0 112.261 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.76 ' HA ' HG22 ' A' ' 102' ' ' THR . 0.1 OUTLIER 63.29 94.54 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.911 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.428 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 0.1 OUTLIER -119.66 126.76 26.77 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.875 -179.974 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 108' ' ' THR . 37.5 Cg_exo -60.64 176.84 0.75 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.435 2.09 . . . . 0.0 112.236 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.712 ' HB2' HG13 ' A' ' 80' ' ' VAL . 32.7 p90 -165.93 176.39 7.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.852 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.632 HD12 HG11 ' A' ' 152' ' ' VAL . 1.1 tt -139.56 134.37 32.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.886 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.538 HD23 ' CB ' ' A' ' 146' ' ' ALA . 4.1 mm? -89.78 138.48 31.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.205 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 1.02 HG13 HG21 ' A' ' 168' ' ' VAL . 11.0 t -130.45 147.57 33.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.11 0.481 . . . . 0.0 112.064 -179.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -113.31 142.18 17.3 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.648 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.677 ' C ' HD13 ' A' ' 117' ' ' ILE . 0.8 OUTLIER -153.83 -61.53 0.14 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.853 0.359 . . . . 0.0 111.03 -179.622 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.452 ' H ' HN22 ' A' ' 185' ' ' GNP . 10.5 mm100 -60.12 -20.4 58.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.026 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.771 HG22 ' CG2' ' A' ' 84' ' ' VAL . 0.2 OUTLIER -40.69 -29.13 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.867 -179.796 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -65.93 -42.19 90.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.812 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.71 HD22 HD22 ' A' ' 160' ' ' LEU . 0.1 OUTLIER -93.02 -48.16 6.64 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -179.327 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.689 ' CD ' HG13 ' A' ' 85' ' ' VAL . 1.4 mmt180 -48.15 -26.78 2.03 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.814 0.34 . . . . 0.0 111.024 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.06 -21.07 43.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.871 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.418 ' OD1' ' HD3' ' A' ' 123' ' ' PRO . 0.2 OUTLIER -64.62 153.56 87.04 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.867 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.451 ' O ' HG22 ' A' ' 126' ' ' ILE . 2.3 Cg_endo -81.35 -2.68 11.73 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.997 2.465 . . . . 0.0 112.957 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 40.7 t -81.49 -69.98 0.57 Allowed 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 120.879 0.371 . . . . 0.0 110.49 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.657 HG21 HG11 ' A' ' 85' ' ' VAL . 8.4 m -51.46 -33.77 32.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.411 0.624 . . . . 0.0 109.6 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.691 HD11 ' HB3' ' A' ' 136' ' ' PRO . 0.1 OUTLIER -58.63 -42.85 86.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.449 179.021 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.456 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 1.4 mm-40 -57.3 -35.41 69.78 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.568 179.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 125' ' ' THR . 3.9 mptt -65.66 -33.15 75.22 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.785 HD22 ' N ' ' A' ' 86' ' ' SER . 9.0 mt -73.64 -36.61 65.44 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 127' ' ' GLU . . . -49.15 -34.1 13.58 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.97 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 10.9 mmmm -47.58 -32.77 5.77 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.666 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.425 ' CB ' ' O ' ' A' ' 87' ' ' PRO . 43.4 m-80 -123.12 -31.22 3.63 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.281 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.512 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 9.3 mmtm -146.2 -95.05 0.09 Allowed 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 119.273 -0.394 . . . . 0.0 111.367 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.512 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 7.4 pt20 128.94 -21.17 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.482 1.113 . . . . 0.0 110.574 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.6 mttm -68.4 110.88 6.52 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.648 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.691 ' HB3' HD11 ' A' ' 126' ' ' ILE . 93.1 Cg_endo -82.86 130.15 5.69 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.67 2.246 . . . . 0.0 111.576 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.821 HD12 ' CE2' ' A' ' 90' ' ' PHE . 1.1 mm -62.47 96.78 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.941 0.401 . . . . 0.0 110.748 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.445 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.7 p -67.69 156.11 89.8 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.888 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.497 ' HA ' ' CE1' ' A' ' 154' ' ' TYR . 10.3 Cg_endo -51.71 -23.23 14.99 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.657 2.238 . . . . 0.0 112.023 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -86.11 -26.41 25.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.587 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.537 ' HB ' HG22 ' A' ' 137' ' ' ILE . 1.8 m -63.35 -56.84 13.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.661 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.571 ' HB2' ' CZ ' ' A' ' 82' ' ' PHE . . . -52.5 -36.96 56.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.828 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.14 -36.04 82.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.709 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.15 -56.86 13.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.815 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 50.5 tp -65.17 -36.77 85.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.764 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.538 ' CB ' HD23 ' A' ' 112' ' ' LEU . . . -57.46 -51.09 70.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.943 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 -71.64 -24.51 61.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.857 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -50.24 -41.74 50.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.832 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.674 HD21 HG13 ' A' ' 98' ' ' VAL . 1.3 mp -104.42 25.18 10.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.847 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.42 ' CD ' ' O ' ' A' ' 149' ' ' LEU . 0.0 OUTLIER 44.95 39.25 3.5 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.305 -179.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.679 ' HB1' ' O ' ' A' ' 110' ' ' PHE . . . -62.26 -81.02 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.028 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.632 HG11 HD12 ' A' ' 111' ' ' LEU . 78.4 t -159.59 -75.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.023 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.439 ' HG3' ' N ' ' A' ' 154' ' ' TYR . 0.5 OUTLIER 170.13 146.06 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.746 -178.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.497 ' CE1' ' HA ' ' A' ' 139' ' ' PRO . 10.2 t80 -100.77 113.58 26.61 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.717 HG11 ' ND2' ' A' ' 167' ' ' ASN . 1.7 t -101.6 175.73 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.629 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.628 ' H ' HG12 ' A' ' 155' ' ' VAL . 0.5 OUTLIER -88.8 145.19 25.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.021 0.439 . . . . 0.0 111.073 -179.444 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.453 ' O ' HD11 ' A' ' 117' ' ' ILE . 2.8 t -169.93 151.22 4.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.257 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.562 ' OG ' HG22 ' A' ' 161' ' ' THR . 2.4 t -160.23 123.47 3.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.072 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -92.74 20.56 6.35 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.953 179.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.71 HD22 HD22 ' A' ' 119' ' ' LEU . 0.3 OUTLIER -131.57 -44.06 1.0 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.575 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.562 HG22 ' OG ' ' A' ' 158' ' ' SER . 15.3 t -107.06 -19.51 13.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.889 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 78.05 77.78 0.07 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.098 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.424 ' HB2' ' HB2' ' A' ' 158' ' ' SER . 25.6 tptt -96.17 30.23 2.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.815 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 119.01 -58.09 0.54 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.516 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.8 HD13 ' HB2' ' A' ' 23' ' ' TYR . 0.7 OUTLIER 66.74 -73.58 0.07 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.787 0.327 . . . . 0.0 111.123 179.909 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.427 ' O ' ' N ' ' A' ' 170' ' ' ASP . 1.9 mtpt -56.9 -31.9 65.36 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.01 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.717 ' ND2' HG11 ' A' ' 155' ' ' VAL . 0.1 OUTLIER -52.31 -71.71 0.06 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.291 -179.874 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 1.02 HG21 HG13 ' A' ' 113' ' ' VAL . 13.6 p -57.06 -47.43 83.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.478 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.796 ' CD2' HD23 ' A' ' 19' ' ' LEU . 1.8 t80 -62.38 -25.79 68.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.59 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' A' ' 166' ' ' LYS . 28.4 t0 -71.58 -29.84 65.16 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.481 ' HB3' HD11 ' A' ' 111' ' ' LEU . 0.7 OUTLIER -73.67 -29.84 62.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.845 179.123 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.559 ' HB1' ' CD2' ' A' ' 79' ' ' LEU . . . -67.44 -49.67 62.66 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.835 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 1.6 pp -72.49 -32.59 42.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.11 0.481 . . . . 0.0 110.414 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.615 HD13 HD23 ' B' ' 505' ' ' LEU . 10.1 tp -46.13 -44.47 15.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.175 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.637 ' HB3' HG21 ' A' ' 77' ' ' VAL . . . -57.0 -24.24 52.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.818 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.507 ' HB1' ' HA ' ' A' ' 4' ' ' ILE . . . -94.87 -31.72 13.57 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.104 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.492 HD13 HG21 ' A' ' 4' ' ' ILE . 2.5 tp -68.27 -26.13 65.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.676 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.775 ' HB2' ' HB1' ' B' ' 507' ' ' ALA . 1.0 OUTLIER 171.24 149.3 0.17 Allowed Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.687 179.808 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.437 ' HD2' ' CG ' ' A' ' 178' ' ' GLU . 16.1 Cg_endo -57.48 107.71 0.32 Allowed 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.691 2.261 . . . . 0.0 112.272 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -80.53 171.88 14.14 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.664 2.242 . . . . 0.0 112.419 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -113.62 139.56 23.52 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.872 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -76.46 -165.28 0.3 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.68 2.253 . . . . 0.0 112.342 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 10.7 mttt -134.62 80.28 1.84 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.865 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.88 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.193 0 N-CA-C 112.525 -0.23 . . . . 0.0 112.525 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 503' ' ' SER . . . . . 0.452 ' HB3' ' CD1' ' B' ' 505' ' ' LEU . 37.5 m -64.14 -78.77 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.856 0.36 . . . . 0.0 110.844 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 504' ' ' GLY . . . . . 0.847 ' C ' HD13 ' B' ' 505' ' ' LEU . . . 87.82 109.69 0.99 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.414 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 505' ' ' LEU . . . . . 0.847 HD13 ' C ' ' B' ' 504' ' ' GLY . 0.0 OUTLIER -167.17 55.12 0.08 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.701 0.286 . . . . 0.0 111.137 -179.274 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 506' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 48.48 66.44 1.07 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.917 0.389 . . . . 0.0 110.613 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 507' ' ' ALA . . . . . 0.775 ' HB1' ' HB2' ' A' ' 178' ' ' GLU . . . -175.5 53.42 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.79 -179.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 508' ' ' GLN . . . . . 0.465 ' HB3' ' O ' ' B' ' 507' ' ' ALA . 1.7 tt0 68.86 5.35 4.94 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.664 -178.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 509' ' ' ASP . . . . . 0.418 ' HA ' ' HA2' ' B' ' 504' ' ' GLY . 2.7 p30 51.54 47.1 25.45 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.449 0.643 . . . . 0.0 110.799 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 510' ' ' ILE . . . . . 0.718 HG23 ' HA3' ' A' ' 47' ' ' GLY . 80.3 mt -87.49 138.3 19.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.401 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 511' ' ' SER . . . . . . . . . . . . . 1.2 m -78.33 122.24 25.49 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.335 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 512' ' ' GLN . . . . . 0.517 ' HB2' ' HD2' ' B' ' 513' ' ' PRO . 0.0 OUTLIER -50.6 179.58 0.04 OUTLIER Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.893 179.265 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 513' ' ' PRO . . . . . 0.517 ' HD2' ' HB2' ' B' ' 512' ' ' GLN . 85.0 Cg_exo -46.12 92.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 121.78 1.653 . . . . 0.0 111.46 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 514' ' ' LEU . . . . . 0.624 HD11 ' O ' ' A' ' 45' ' ' MET . 0.0 OUTLIER -62.84 -168.33 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.27 -179.021 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 515' ' ' GLN . . . . . 0.518 ' O ' HG11 ' A' ' 44' ' ' VAL . 7.9 mt-30 -89.02 178.59 6.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.874 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 66.56 11.22 7.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.192 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 517' ' ' SER . . . . . 0.56 ' O ' HG11 ' A' ' 42' ' ' VAL . 3.4 p -100.9 65.48 1.12 Allowed 'General case' 0 N--CA 1.456 -0.139 0 CA-C-O 120.898 0.38 . . . . 0.0 110.759 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 518' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -158.06 91.86 1.14 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.644 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 519' ' ' ILE . . . . . 0.443 HG12 ' O ' ' A' ' 41' ' ' ALA . 3.5 mm -100.49 -19.02 6.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.581 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 520' ' ' HIS . . . . . 0.497 ' HA ' ' CE2' ' A' ' 40' ' ' TYR . 0.7 OUTLIER 72.91 103.12 0.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.866 0.365 . . . . 0.0 110.906 -179.737 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 521' ' ' THR . . . . . . . . . . . . . 3.2 m -143.86 57.6 1.35 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.825 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 522' ' ' GLY . . . . . . . . . . . . . . . -149.52 159.94 28.27 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.218 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 523' ' ' HIS . . . . . 0.454 ' N ' ' HB2' ' A' ' 37' ' ' PHE . 9.6 t-160 -98.68 -91.26 0.28 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.675 0.238 . . . . 0.0 110.959 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 524' ' ' GLY . . . . . 0.424 ' O ' ' CB ' ' B' ' 525' ' ' ASP . . . 45.52 -131.98 9.24 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.777 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 525' ' ' ASP . . . . . 0.424 ' CB ' ' O ' ' B' ' 524' ' ' GLY . 4.2 m-20 82.07 79.22 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.038 0.446 . . . . 0.0 111.02 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 526' ' ' SER . . . . . 0.482 ' HB3' HG11 ' A' ' 33' ' ' VAL . 0.4 OUTLIER -113.75 99.44 7.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.459 179.594 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 527' ' ' ASP . . . . . 0.411 ' HB2' ' HD2' ' B' ' 528' ' ' PRO . 0.4 OUTLIER -40.15 163.61 0.08 OUTLIER Pre-proline 0 N--CA 1.465 0.309 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.724 -179.703 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 528' ' ' PRO . . . . . 0.411 ' HD2' ' HB2' ' B' ' 527' ' ' ASP . 10.6 Cg_endo -51.08 112.05 0.7 Allowed 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 123.053 2.502 . . . . 0.0 111.988 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 529' ' ' ARG . . . . . 0.45 ' HD2' HG11 ' A' ' 33' ' ' VAL . 30.3 mtp180 -100.71 -54.1 2.91 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.258 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 530' ' ' HIS . . . . . . . . . . . . . 25.4 m-70 -137.68 10.29 2.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.587 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 3.9 m 44.99 -160.96 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.84 0.352 . . . . 0.0 111.286 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 532' ' ' TRP . . . . . 0.487 ' HB2' ' CD1' ' A' ' 32' ' ' TYR . 12.1 t-105 -132.34 92.29 3.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.867 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . -92.82 -48.87 2.82 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.526 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 534' ' ' PHE . . . . . 0.402 ' HA ' ' HD3' ' B' ' 535' ' ' PRO . 32.5 m-85 -106.87 140.21 21.15 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.658 0.266 . . . . 0.0 110.916 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 535' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' B' ' 534' ' ' PHE . 42.9 Cg_exo -56.17 -158.16 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.518 2.146 . . . . 0.0 112.303 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 69.24 61.36 0.31 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.886 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 537' ' ' ARG . . . . . 0.522 ' HG2' ' PA ' ' A' ' 185' ' ' GNP . 0.0 OUTLIER -48.75 159.56 0.23 Allowed 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.0 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 538' ' ' ILE . . . . . 0.453 ' CG1' ' HB2' ' B' ' 542' ' ' TYR . 10.3 tp -81.72 141.33 15.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.482 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 539' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -45.5 161.16 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.883 0.373 . . . . 0.0 111.221 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 540' ' ' GLU . . . . . 0.684 ' O ' HG23 ' A' ' 58' ' ' THR . 0.4 OUTLIER -61.61 -14.89 34.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.555 -179.854 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 541' ' ' LEU . . . . . 0.532 ' CB ' HD23 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -66.22 -32.77 74.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.365 0.603 . . . . 0.0 110.062 179.708 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 542' ' ' TYR . . . . . 0.453 ' HB2' ' CG1' ' B' ' 538' ' ' ILE . 40.7 m-85 -104.9 -50.76 3.19 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.17 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 543' ' ' LEU . . . . . 0.879 HD13 ' O ' ' A' ' 58' ' ' THR . 0.5 OUTLIER 72.42 -68.02 0.24 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.931 -179.678 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . -117.44 164.02 12.61 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.493 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 545' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.888 179.988 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' GNP . . . . . 0.666 ' O2A' ' HB2' ' A' ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' HOH . . . . . 0.691 ' O ' HG21 ' A' ' 21' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.597 ' HE1' ' HD1' ' A' ' 51' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.418 0 N-CA-C 111.529 0.196 . . . . 0.0 111.529 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.402 ' O ' ' O ' ' A' ' 1' ' ' MET . 32.7 tp60 56.42 154.93 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.104 0.478 . . . . 0.0 111.556 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.891 ' HB ' HD22 ' A' ' 53' ' ' LEU . 0.3 OUTLIER -146.02 -168.97 3.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.034 179.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.755 ' O ' HD23 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -145.1 156.08 13.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.561 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 28.9 mttm -118.19 105.74 12.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.515 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.422 ' O ' ' N ' ' A' ' 56' ' ' PHE . 36.2 t -77.3 105.07 8.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.09 0.471 . . . . 0.0 111.934 -178.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.534 HG22 ' CB ' ' A' ' 56' ' ' PHE . 2.6 t -132.94 118.86 34.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.836 178.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.611 HG11 ' HG3' ' A' ' 16' ' ' LYS . 0.4 OUTLIER -96.69 143.41 12.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.315 0.579 . . . . 0.0 111.08 -179.235 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.83 HG21 ' CD2' ' A' ' 78' ' ' PHE . 12.6 m -140.88 129.75 24.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.482 178.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.407 ' O ' ' HB3' ' B' ' 539' ' ' ASP . . . 154.43 -143.06 9.61 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.024 -1.084 . . . . 0.0 112.734 -179.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -123.24 22.71 9.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.668 0.27 . . . . 0.0 110.953 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.434 ' CA ' ' O ' ' B' ' 536' ' ' ASP . . . -153.42 -172.45 21.62 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.406 -0.902 . . . . 0.0 113.364 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.666 ' HB2' ' HG3' ' B' ' 537' ' ' ARG . . . -63.69 -48.74 75.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.777 0.322 . . . . 0.0 111.462 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.665 HG22 ' SG ' ' A' ' 81' ' ' CYS . 61.5 t 68.37 -72.14 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.117 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.882 ' CA ' HD22 ' A' ' 19' ' ' LEU . . . -172.36 66.32 0.13 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.631 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.667 ' CD ' HD21 ' B' ' 543' ' ' LEU . 27.0 mttt -97.14 -97.56 0.2 Allowed 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 121.457 -0.097 . . . . 0.0 110.803 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.425 ' O ' HG12 ' A' ' 21' ' ' ILE . 58.3 p -98.22 -57.35 2.23 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-O 120.832 0.349 . . . . 0.0 111.177 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.446 ' CB ' ' O2A' ' A' ' 185' ' ' GNP . 14.8 p -36.17 -43.84 0.37 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.456 -179.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.967 HD23 ' CD2' ' A' ' 169' ' ' PHE . 1.8 mp -46.41 -70.96 0.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.793 0.33 . . . . 0.0 111.284 -179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.466 HD12 ' CZ ' ' B' ' 518' ' ' PHE . 14.7 mt -61.96 -25.57 67.69 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.84 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.442 HG22 ' OG1' ' A' ' 25' ' ' THR . 15.2 mm -67.2 -70.36 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.666 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.435 ' HB2' ' CD1' ' A' ' 165' ' ' LEU . 3.4 m -47.79 -28.93 2.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.082 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -66.84 -68.18 0.39 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.833 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.02 -48.11 39.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.72 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.442 ' OG1' HG22 ' A' ' 21' ' ' ILE . 13.4 p -83.2 -152.29 0.12 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.424 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -160.11 33.46 0.17 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.821 0.343 . . . . 0.0 111.033 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 13.8 mmtt -121.32 101.71 7.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.408 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.493 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . 7.9 t80 -104.87 -60.11 0.06 OUTLIER Pre-proline 0 CA--C 1.537 0.444 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.124 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.493 ' HD3' ' HB3' ' A' ' 28' ' ' PHE . 95.1 Cg_endo -84.21 48.7 2.56 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.151 1.9 . . . . 0.0 112.608 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.84 -80.79 0.43 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.029 0.442 . . . . 0.0 110.656 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.448 ' HB2' ' NE ' ' B' ' 529' ' ' ARG . 12.9 pt-20 -158.34 140.98 14.51 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.63 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.525 ' CD1' ' N3B' ' A' ' 185' ' ' GNP . 91.7 m-85 -130.21 100.91 5.57 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.514 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.556 HG23 ' HD3' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -165.28 -63.55 0.01 OUTLIER Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.157 -179.541 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.556 ' HD3' HG23 ' A' ' 33' ' ' VAL . 74.9 Cg_exo -38.75 -29.77 0.17 Allowed 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.745 2.296 . . . . 0.0 112.905 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.947 HG23 ' OD2' ' A' ' 38' ' ' ASP . 60.9 m -56.53 85.54 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.993 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.592 HG11 ' HB2' ' A' ' 61' ' ' LEU . 2.6 t -140.5 -40.42 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.282 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.457 ' CE2' ' OD1' ' A' ' 63' ' ' ASP . 0.3 OUTLIER -91.19 25.13 2.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.966 179.698 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.947 ' OD2' HG23 ' A' ' 35' ' ' THR . 0.7 OUTLIER -57.78 -159.85 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.873 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 68.26 29.46 6.01 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.943 0.401 . . . . 0.0 110.46 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.414 ' CE1' ' O ' ' B' ' 521' ' ' THR . 0.7 OUTLIER -60.72 -160.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.852 -179.808 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.419 ' O ' HG12 ' B' ' 519' ' ' ILE . . . -122.97 123.27 40.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.466 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.481 HG13 ' C ' ' B' ' 517' ' ' SER . 3.3 t -106.76 121.7 59.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.64 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.593 ' OG1' HD11 ' B' ' 519' ' ' ILE . 6.5 p -108.79 106.84 17.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.197 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.655 ' CG2' HG21 ' A' ' 52' ' ' THR . 27.3 m -159.46 -178.91 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.916 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.651 ' O ' HD22 ' B' ' 514' ' ' LEU . 0.0 OUTLIER -98.37 103.39 15.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.844 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.571 HG22 ' O ' ' A' ' 51' ' ' TYR . 1.2 tt -95.2 106.29 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-O 121.529 0.681 . . . . 0.0 111.021 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.51 ' N ' HG23 ' B' ' 510' ' ' ILE . . . 43.61 -93.19 0.01 OUTLIER Glycine 0 CA--C 1.517 0.178 0 C-N-CA 121.001 -0.619 . . . . 0.0 113.526 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.444 ' HA3' ' CB ' ' A' ' 1' ' ' MET . . . -39.2 -86.16 0.01 OUTLIER Glycine 0 C--N 1.334 0.458 0 C-N-CA 121.393 -0.432 . . . . 0.0 113.371 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.481 ' HB3' ' HD2' ' A' ' 50' ' ' PRO . 4.0 mt-10 -144.06 177.58 1.76 Allowed Pre-proline 0 C--N 1.331 -0.205 0 CA-C-O 120.671 0.272 . . . . 0.0 111.04 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 49' ' ' GLU . 76.8 Cg_exo -51.23 92.98 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.551 2.167 . . . . 0.0 112.614 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.597 ' HD1' ' HE1' ' A' ' 1' ' ' MET . 2.8 t80 -173.29 125.96 0.42 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.386 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.655 HG21 ' CG2' ' A' ' 44' ' ' VAL . 0.1 OUTLIER -134.3 144.29 48.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.798 0.332 . . . . 0.0 111.161 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.891 HD22 ' HB ' ' A' ' 3' ' ' THR . 0.9 OUTLIER -87.69 -177.33 5.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.89 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -123.92 116.47 2.86 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.438 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.45 ' H ' HD12 ' A' ' 55' ' ' LEU . 2.2 mp -50.77 139.13 17.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.874 0.369 . . . . 0.0 110.844 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.534 ' CB ' HG22 ' A' ' 7' ' ' VAL . 7.8 t80 -85.76 135.0 33.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.311 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.452 ' CB ' ' HB2' ' A' ' 38' ' ' ASP . 0.1 OUTLIER -150.54 131.88 14.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.372 179.558 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.743 ' OG1' HD21 ' A' ' 67' ' ' LEU . 2.5 p -130.25 125.0 33.75 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.164 -179.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.72 ' HB1' ' CD1' ' A' ' 61' ' ' LEU . . . -144.19 99.68 3.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.7 179.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.09 75.79 0.25 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.684 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.72 ' CD1' ' HB1' ' A' ' 59' ' ' ALA . 4.6 mp -121.49 -95.89 0.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 121.312 -0.155 . . . . 0.0 111.207 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -99.36 -30.3 12.29 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 120.766 0.317 . . . . 0.0 111.487 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.457 ' OD1' ' CE2' ' A' ' 37' ' ' PHE . 29.7 t0 -80.57 -63.73 1.34 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.619 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.524 ' CD2' ' CD1' ' A' ' 67' ' ' LEU . 19.0 m-85 -88.27 144.53 26.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.917 0.389 . . . . 0.0 110.874 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -86.26 -62.04 1.61 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.831 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.29 -52.98 3.49 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -178.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.743 HD21 ' OG1' ' A' ' 58' ' ' THR . 0.4 OUTLIER 64.78 -151.25 0.28 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 120.596 -0.442 . . . . 0.0 109.832 -179.566 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.576 ' CB ' HD21 ' B' ' 541' ' ' LEU . 0.1 OUTLIER 78.28 41.94 0.06 OUTLIER Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 179.5 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.574 ' CG ' HG21 ' A' ' 58' ' ' THR . 88.3 Cg_endo -82.89 -21.95 4.55 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.302 2.002 . . . . 0.0 112.09 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.974 HD21 ' HA ' ' B' ' 541' ' ' LEU . 0.1 OUTLIER -60.52 -15.17 24.68 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.621 -179.677 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.33 -60.55 3.68 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.752 0.311 . . . . 0.0 110.968 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.01 65.07 74.47 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.923 0.392 . . . . 0.0 111.146 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 70' ' ' LEU . 83.6 Cg_endo -82.56 145.88 13.31 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.801 2.334 . . . . 0.0 112.189 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -96.64 10.25 39.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.48 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 11.5 t -53.05 -176.32 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.752 0.31 . . . . 0.0 110.878 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -136.5 7.35 3.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.553 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.907 HG21 ' HB2' ' A' ' 176' ' ' ALA . 4.8 t -139.03 86.76 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.725 0.298 . . . . 0.0 111.458 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.83 ' CD2' HG21 ' A' ' 9' ' ' VAL . 0.5 OUTLIER -80.85 172.01 14.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.084 179.351 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.518 HD23 HG12 ' A' ' 14' ' ' VAL . 9.8 tp -157.0 120.98 4.28 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.084 0.469 . . . . 0.0 111.812 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.485 ' HB ' ' CH2' ' A' ' 97' ' ' TRP . 0.7 OUTLIER -114.11 135.83 52.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.981 179.041 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.665 ' SG ' HG22 ' A' ' 14' ' ' VAL . 4.6 p -125.83 164.33 20.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.245 0.545 . . . . 0.0 112.283 -178.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.487 ' CE2' HD12 ' A' ' 112' ' ' LEU . 11.3 p90 -169.36 135.61 1.64 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.131 179.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.439 ' HA ' ' C2 ' ' A' ' 185' ' ' GNP . 50.2 p -88.41 144.66 26.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.816 0.341 . . . . 0.0 110.943 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.743 HG13 ' N ' ' A' ' 137' ' ' ILE . 45.1 t -46.17 -63.14 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.56 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.604 ' O ' HG23 ' A' ' 85' ' ' VAL . 35.3 m -45.47 110.02 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.698 0.285 . . . . 0.0 110.829 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.623 ' N ' HD22 ' A' ' 129' ' ' LEU . 0.2 OUTLIER -151.6 131.46 6.94 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.827 -179.347 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 86' ' ' SER . 67.8 Cg_endo -92.58 53.33 0.55 Allowed 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 123.289 2.659 . . . . 0.0 111.837 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.451 ' CA ' ' HG3' ' A' ' 133' ' ' LYS . 1.0 OUTLIER 80.31 30.17 0.22 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.069 -179.745 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.729 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -95.22 -23.03 17.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.857 179.658 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.654 ' CZ ' HG21 ' A' ' 137' ' ' ILE . 0.8 OUTLIER -52.49 -58.41 6.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.93 179.924 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -58.22 -40.7 82.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.936 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -64.64 -59.21 4.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.886 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.729 HG23 ' O ' ' A' ' 89' ' ' SER . 47.1 t -51.22 -52.74 17.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.181 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.766 ' HG3' HD11 ' A' ' 145' ' ' LEU . 10.8 tmtt? -50.49 -50.43 52.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.901 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.406 ' O ' ' HG2' ' A' ' 99' ' ' PRO . 3.1 mt-10 -54.25 -42.12 69.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.183 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.72 12.23 34.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.543 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.507 ' O ' HG22 ' A' ' 101' ' ' ILE . 0.0 OUTLIER -94.47 -53.16 4.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.744 0.307 . . . . 0.0 111.087 179.918 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 1.016 HG22 HD13 ' A' ' 149' ' ' LEU . 3.5 t -60.36 -44.94 97.31 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.896 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.493 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 16.4 Cg_exo -68.31 -33.72 23.14 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.539 2.159 . . . . 0.0 112.923 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -85.73 -35.7 20.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.649 -0.25 . . . . 0.0 111.437 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.622 HD11 ' HB3' ' A' ' 110' ' ' PHE . 12.7 tt -68.75 -25.98 31.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.755 0.312 . . . . 0.0 111.056 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 68.0 p -97.18 -26.85 14.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.046 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.47 ' CG ' ' O ' ' A' ' 99' ' ' PRO . 5.1 m170 -66.68 -41.84 87.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.047 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -76.68 -24.33 53.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.103 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.414 ' O ' ' N ' ' A' ' 107' ' ' LYS . 8.0 m -137.4 123.06 12.91 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.854 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 105' ' ' CYS . 32.3 Cg_exo -58.17 79.76 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.571 2.181 . . . . 0.0 112.234 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.414 ' N ' ' O ' ' A' ' 105' ' ' CYS . 2.6 mmmp? 61.39 91.41 0.06 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.917 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.442 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 0.1 OUTLIER -122.57 138.08 28.79 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.921 179.929 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 108' ' ' THR . 31.5 Cg_exo -60.28 138.02 78.49 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.618 2.212 . . . . 0.0 112.468 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.622 ' HB3' HD11 ' A' ' 101' ' ' ILE . 1.0 OUTLIER -142.25 147.18 36.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.715 179.656 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.757 HD23 ' O ' ' A' ' 112' ' ' LEU . 0.9 OUTLIER -130.02 158.0 40.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.314 -179.678 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.757 ' O ' HD23 ' A' ' 111' ' ' LEU . 3.0 mm? -97.19 161.35 13.85 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.667 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.752 ' HA ' HG21 ' A' ' 168' ' ' VAL . 18.2 t -135.03 138.69 48.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.049 0.452 . . . . 0.0 111.889 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.432 ' HA3' ' CZ ' ' A' ' 154' ' ' TYR . . . -123.26 107.31 1.08 Allowed Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.59 179.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.849 ' OG1' " H2'" ' A' ' 185' ' ' GNP . 0.0 OUTLIER -130.81 -53.18 1.06 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.852 0.358 . . . . 0.0 110.704 -179.187 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.832 ' HG2' HD13 ' A' ' 119' ' ' LEU . 1.6 tt0 -79.89 53.8 1.74 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.274 179.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.786 HD11 ' O ' ' A' ' 157' ' ' CYS . 0.1 OUTLIER -99.12 -5.8 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.006 179.834 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -77.73 -27.43 50.51 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.936 0.398 . . . . 0.0 110.536 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.832 HD13 ' HG2' ' A' ' 116' ' ' GLN . 5.0 mp -76.69 -24.36 53.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.591 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.462 ' O ' HD13 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -46.71 -29.38 1.86 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.811 179.783 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -83.79 -34.92 24.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.405 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.63 104.49 0.44 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.575 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.457 ' HA ' ' CG2' ' A' ' 126' ' ' ILE . 14.7 Cg_exo -69.06 -3.73 12.14 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.703 2.269 . . . . 0.0 113.106 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.03 -66.4 0.87 Allowed 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 121.109 0.48 . . . . 0.0 109.758 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.416 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 18.2 m -57.92 -37.92 74.94 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.482 ' HA ' HD12 ' A' ' 129' ' ' LEU . 0.0 OUTLIER -54.85 -42.95 65.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.781 179.337 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.537 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 35.6 mt-10 -60.08 -35.1 74.45 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.86 179.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 125' ' ' THR . 0.0 OUTLIER -65.38 -30.91 71.79 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.071 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.623 HD22 ' N ' ' A' ' 86' ' ' SER . 7.4 mt -73.94 -35.59 64.59 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 127' ' ' GLU . . . -46.25 -34.63 4.56 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.894 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 5.7 mmmt -47.51 -33.06 5.89 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.478 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.418 ' HB2' ' O ' ' A' ' 87' ' ' PRO . 55.7 m-80 -123.43 -31.4 3.53 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.451 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.523 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 16.7 mmtp -146.85 -97.49 0.09 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 119.208 -0.425 . . . . 0.0 111.662 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.523 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 9.2 pt20 128.99 -25.74 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.473 1.109 . . . . 0.0 110.331 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -69.36 110.63 6.64 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.761 -179.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.432 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 95.3 Cg_endo -79.53 136.97 12.71 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.514 2.143 . . . . 0.0 111.371 179.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.743 ' N ' HG13 ' A' ' 84' ' ' VAL . 0.8 OUTLIER -69.25 96.59 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.91 0.386 . . . . 0.0 110.953 -179.463 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.402 ' O ' ' HB ' ' A' ' 141' ' ' THR . 2.6 p -70.48 160.2 82.21 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.182 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.496 ' HA ' ' CE1' ' A' ' 154' ' ' TYR . 72.0 Cg_exo -48.14 -42.88 32.34 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.572 2.181 . . . . 0.0 112.213 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -67.44 -34.74 77.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.776 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.517 HG21 HG23 ' A' ' 137' ' ' ILE . 97.5 m -58.29 -55.32 36.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.904 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.511 ' CB ' ' CD2' ' A' ' 154' ' ' TYR . . . -50.9 -36.53 38.75 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.899 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -64.72 -42.59 95.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.833 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.55 -56.76 15.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.698 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.766 HD11 ' HG3' ' A' ' 94' ' ' LYS . 2.9 tt -67.92 -31.97 72.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.707 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.412 ' CA ' ' HB3' ' A' ' 151' ' ' ALA . . . -55.66 -66.02 0.49 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.931 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 16.1 mtp85 -63.52 -24.12 67.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.977 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -54.11 -40.95 67.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.2 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 1.016 HD13 HG22 ' A' ' 98' ' ' VAL . 0.5 OUTLIER -117.32 24.5 11.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.076 -179.862 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.79 59.06 2.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.786 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.514 ' HB1' ' CD2' ' A' ' 112' ' ' LEU . . . -94.22 27.92 2.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.118 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.621 ' CB ' HD12 ' A' ' 111' ' ' LEU . 92.8 t 68.94 -74.8 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.975 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.695 ' O ' HD21 ' A' ' 111' ' ' LEU . 0.2 OUTLIER 173.13 139.21 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.109 0.481 . . . . 0.0 111.394 -179.234 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.511 ' CD2' ' CB ' ' A' ' 142' ' ' ALA . 3.2 t80 -94.66 116.69 29.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.248 178.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.545 HG11 ' ND2' ' A' ' 167' ' ' ASN . 5.2 t -101.12 158.7 4.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.31 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.402 ' N ' HG12 ' A' ' 155' ' ' VAL . 3.3 tt0 -89.67 143.58 26.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.522 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.786 ' O ' HD11 ' A' ' 117' ' ' ILE . 25.3 p 178.9 179.25 0.41 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.012 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.441 ' HA ' ' HA ' ' A' ' 115' ' ' THR . 28.4 p -159.89 160.24 33.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.953 0.406 . . . . 0.0 111.308 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.475 ' HB2' HD11 ' A' ' 165' ' ' LEU . . . -113.8 -27.14 7.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.915 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.68 -37.39 41.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.782 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.405 ' O ' ' HB3' ' A' ' 162' ' ' GLN . 7.7 t -116.59 -13.69 10.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.189 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.412 ' N ' ' OG ' ' A' ' 158' ' ' SER . 0.5 OUTLIER 71.56 82.02 0.15 Allowed 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.698 0.285 . . . . 0.0 111.254 179.827 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.426 ' N ' ' OG ' ' A' ' 158' ' ' SER . 5.5 mttm -101.92 22.15 13.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.053 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 105.2 44.23 1.51 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.442 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.743 HD22 ' HG ' ' A' ' 19' ' ' LEU . 2.3 mt -46.09 -31.7 2.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.783 0.325 . . . . 0.0 111.155 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.421 ' HG3' ' N ' ' A' ' 167' ' ' ASN . 0.1 OUTLIER -66.57 -28.62 68.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.902 179.825 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.545 ' ND2' HG11 ' A' ' 155' ' ' VAL . 0.1 OUTLIER -57.48 -70.87 0.11 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.698 179.874 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.752 HG21 ' HA ' ' A' ' 113' ' ' VAL . 11.4 p -50.77 -44.27 25.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.914 0.388 . . . . 0.0 110.565 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.967 ' CD2' HD23 ' A' ' 19' ' ' LEU . 0.3 OUTLIER -63.85 -30.59 71.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.097 179.436 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.421 ' O ' HG13 ' A' ' 173' ' ' ILE . 20.4 t0 -70.65 -22.52 62.49 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.565 179.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -84.61 -35.1 22.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.248 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -67.28 -32.62 73.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.74 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.601 ' O ' HG21 ' A' ' 4' ' ' ILE . 2.0 pp -82.52 -35.11 12.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.771 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.645 ' HB2' HD22 ' B' ' 505' ' ' LEU . 9.7 tp -52.83 -43.56 66.08 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.977 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -50.65 -23.48 2.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.642 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.907 ' HB2' HG21 ' A' ' 77' ' ' VAL . . . -96.72 -34.71 11.25 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.699 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.825 HD13 ' HB ' ' B' ' 510' ' ' ILE . 96.7 mt -68.76 -24.01 64.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.797 0.332 . . . . 0.0 110.729 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -179.92 154.33 0.68 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.926 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.425 ' HA ' ' HD2' ' A' ' 180' ' ' PRO . 43.8 Cg_endo -68.1 108.8 1.81 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.603 2.202 . . . . 0.0 112.256 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 179' ' ' PRO . 54.6 Cg_endo -69.55 174.08 9.84 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.531 2.154 . . . . 0.0 112.449 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -145.64 144.47 22.64 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.781 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.3 -165.14 0.27 Allowed 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.598 2.198 . . . . 0.0 112.26 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 7.6 mttm -126.71 171.67 10.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.918 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 3.4 mtpt . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.192 -0.909 . . . . 0.0 110.867 -179.961 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 502' ' ' GLY . . . . . 0.425 ' CA ' ' O ' ' B' ' 509' ' ' ASP . . . . . . . . 0 N--CA 1.488 2.116 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 503' ' ' SER . . . . . 0.401 ' HB2' ' O ' ' B' ' 510' ' ' ILE . 0.1 OUTLIER -66.49 -75.29 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.797 0.332 . . . . 0.0 110.968 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 504' ' ' GLY . . . . . 0.492 ' CA ' ' HA ' ' B' ' 509' ' ' ASP . . . 147.22 -101.33 0.23 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.0 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 505' ' ' LEU . . . . . 0.645 HD22 ' HB2' ' A' ' 174' ' ' LEU . 0.5 OUTLIER 69.39 -61.77 0.43 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 179.244 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 506' ' ' SER . . . . . 0.424 ' CB ' ' O ' ' B' ' 505' ' ' LEU . 1.1 p 165.0 -45.71 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.722 0.296 . . . . 0.0 111.108 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 507' ' ' ALA . . . . . . . . . . . . . . . -36.92 -66.51 0.23 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.947 0.88 . . . . 0.0 111.43 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 508' ' ' GLN . . . . . 0.484 ' O ' ' CB ' ' B' ' 509' ' ' ASP . 7.3 mt-30 -160.48 -45.42 0.05 OUTLIER 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.02 -1.445 . . . . 0.0 107.841 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 509' ' ' ASP . . . . . 0.492 ' HA ' ' CA ' ' B' ' 504' ' ' GLY . 3.3 p30 146.88 43.57 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 113.994 -1.457 . . . . 0.0 110.259 178.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 510' ' ' ILE . . . . . 0.825 ' HB ' HD13 ' A' ' 177' ' ' LEU . 2.3 mt -65.15 133.09 30.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.163 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 511' ' ' SER . . . . . 0.42 ' CB ' ' HG ' ' B' ' 514' ' ' LEU . 2.6 m -109.35 158.72 17.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.257 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 512' ' ' GLN . . . . . 0.505 ' CB ' ' HD3' ' B' ' 513' ' ' PRO . 0.7 OUTLIER -100.37 -65.43 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.724 179.562 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 513' ' ' PRO . . . . . 0.505 ' HD3' ' CB ' ' B' ' 512' ' ' GLN . 69.9 Cg_endo -83.81 53.49 4.11 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.549 2.166 . . . . 0.0 112.06 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 514' ' ' LEU . . . . . 0.651 HD22 ' O ' ' A' ' 45' ' ' MET . 0.7 OUTLIER -61.75 -84.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.374 -179.468 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 515' ' ' GLN . . . . . 0.433 ' HB2' HG12 ' A' ' 44' ' ' VAL . 1.6 mt-30 -78.91 -86.8 0.07 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.207 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -118.41 -32.32 4.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.779 0.323 . . . . 0.0 111.243 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 517' ' ' SER . . . . . 0.481 ' C ' HG13 ' A' ' 42' ' ' VAL . 0.4 OUTLIER 73.06 7.85 5.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.649 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 518' ' ' PHE . . . . . 0.476 ' CD1' ' O ' ' B' ' 517' ' ' SER . 6.5 m-85 -163.43 125.03 2.43 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 120.723 0.297 . . . . 0.0 110.901 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 519' ' ' ILE . . . . . 0.593 HD11 ' OG1' ' A' ' 43' ' ' THR . 40.1 mm -79.94 -34.37 15.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.214 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 520' ' ' HIS . . . . . 0.704 ' O ' HG23 ' B' ' 521' ' ' THR . 41.5 t-80 -163.25 -87.04 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.069 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 521' ' ' THR . . . . . 0.704 HG23 ' O ' ' B' ' 520' ' ' HIS . 0.1 OUTLIER 170.23 -172.43 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 120.848 0.356 . . . . 0.0 110.886 179.911 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 522' ' ' GLY . . . . . . . . . . . . . . . -93.23 -125.91 4.08 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.37 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 523' ' ' HIS . . . . . 0.434 ' CD2' ' C ' ' B' ' 523' ' ' HIS . 8.7 t-160 -157.47 -91.64 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.501 0.191 . . . . 0.0 110.767 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 524' ' ' GLY . . . . . . . . . . . . . . . 48.4 -178.23 0.01 OUTLIER Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.854 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 525' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 168.77 60.46 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.824 0.345 . . . . 0.0 110.809 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 526' ' ' SER . . . . . 0.42 ' OG ' ' CG1' ' A' ' 33' ' ' VAL . 12.2 t -92.34 97.01 10.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.012 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 527' ' ' ASP . . . . . 0.478 ' CB ' ' CD ' ' B' ' 528' ' ' PRO . 0.2 OUTLIER -52.72 -64.31 1.68 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.98 179.944 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 528' ' ' PRO . . . . . 0.478 ' CD ' ' CB ' ' B' ' 527' ' ' ASP . 12.8 Cg_endo -53.45 103.43 0.09 OUTLIER 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.97 2.447 . . . . 0.0 112.17 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 529' ' ' ARG . . . . . 0.522 ' HG2' HG21 ' A' ' 33' ' ' VAL . 13.7 mtt85 -100.59 -32.06 10.95 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.968 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 530' ' ' HIS . . . . . 0.503 ' CG ' ' O ' ' B' ' 530' ' ' HIS . 0.1 OUTLIER 70.5 6.47 5.82 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.116 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER 59.55 177.51 0.08 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.89 0.376 . . . . 0.0 111.034 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 532' ' ' TRP . . . . . 0.411 ' CD2' ' O ' ' B' ' 532' ' ' TRP . 72.4 t90 -75.28 73.03 2.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.844 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . -96.21 -19.0 29.52 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.491 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 534' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -88.67 156.02 50.38 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.78 0.324 . . . . 0.0 111.003 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -73.89 95.08 0.88 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.565 2.176 . . . . 0.0 112.362 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 536' ' ' ASP . . . . . 0.434 ' O ' ' CA ' ' A' ' 12' ' ' GLY . 35.4 m-20 62.97 46.91 4.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.019 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 537' ' ' ARG . . . . . 0.666 ' HG3' ' HB2' ' A' ' 13' ' ' ALA . 20.9 mmt-85 73.86 -173.89 0.14 Allowed 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.373 0.606 . . . . 0.0 111.518 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 538' ' ' ILE . . . . . 0.732 HD12 ' CB ' ' B' ' 542' ' ' TYR . 4.8 pt -106.66 -153.68 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.031 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 539' ' ' ASP . . . . . 0.418 ' N ' HG13 ' B' ' 538' ' ' ILE . 51.8 p30 -104.04 161.42 14.01 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.944 0.402 . . . . 0.0 111.35 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 540' ' ' GLU . . . . . 0.5 ' HG3' HG13 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -57.12 -23.79 49.6 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.801 179.634 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 541' ' ' LEU . . . . . 0.974 ' HA ' HD21 ' A' ' 70' ' ' LEU . 0.4 OUTLIER -60.09 -34.79 73.94 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.339 0.59 . . . . 0.0 109.884 179.794 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 542' ' ' TYR . . . . . 0.732 ' CB ' HD12 ' B' ' 538' ' ' ILE . 2.9 m-85 -102.66 -57.34 2.07 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.999 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 543' ' ' LEU . . . . . 0.667 HD21 ' CD ' ' A' ' 16' ' ' LYS . 0.2 OUTLIER 64.74 -71.41 0.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.915 179.865 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 544' ' ' GLY . . . . . 0.652 ' HA3' HD11 ' A' ' 61' ' ' LEU . . . -62.87 165.66 24.92 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.349 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 545' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.276 -0.869 . . . . 0.0 111.018 -179.907 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' GNP . . . . . 0.849 " H2'" ' OG1' ' A' ' 115' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' HOH . . . . . 0.895 ' O ' HG21 ' A' ' 35' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.505 ' HE1' ' CD1' ' A' ' 51' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.323 0.106 . . . . 0.0 111.117 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.407 ' N ' ' SD ' ' A' ' 1' ' ' MET . 13.1 tp60 56.97 151.94 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.126 0.489 . . . . 0.0 111.58 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 1.085 HG23 HG21 ' A' ' 46' ' ' ILE . 0.3 OUTLIER -154.65 -158.69 0.87 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.247 179.919 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.979 HD11 HD22 ' A' ' 53' ' ' LEU . 0.2 OUTLIER -144.82 155.57 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 CA-C-O 121.189 0.519 . . . . 0.0 111.973 -179.514 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 36.3 mttt -134.45 116.61 15.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.704 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.641 ' SG ' HG23 ' A' ' 77' ' ' VAL . 45.7 t -138.38 154.22 48.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.364 0.602 . . . . 0.0 112.52 -178.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.822 HG22 ' CB ' ' A' ' 56' ' ' PHE . 11.9 t -128.37 150.35 34.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.208 178.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.948 HG11 HG13 ' A' ' 14' ' ' VAL . 2.8 p -83.8 121.65 36.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.307 0.575 . . . . 0.0 111.707 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.705 HG12 ' HB2' ' A' ' 70' ' ' LEU . 19.2 m -129.87 129.9 66.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.928 178.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.471 ' HA2' ' CZ2' ' A' ' 97' ' ' TRP . . . 137.49 -142.8 13.79 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.194 -1.003 . . . . 0.0 112.652 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.427 ' CB ' ' O ' ' B' ' 537' ' ' ARG . 0.4 OUTLIER -122.52 26.68 8.22 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.879 0.371 . . . . 0.0 110.633 179.915 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.425 ' O ' ' CB ' ' B' ' 537' ' ' ARG . . . -86.04 -176.2 49.96 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.765 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.611 ' HB1' ' O3A' ' A' ' 185' ' ' GNP . . . -89.39 4.82 47.76 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.958 HG21 HD21 ' B' ' 543' ' ' LEU . 8.7 t 81.24 107.18 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.066 0.46 . . . . 0.0 110.651 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.504 ' HA3' ' CE1' ' A' ' 169' ' ' PHE . . . -65.32 -9.29 41.96 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.723 -0.671 . . . . 0.0 113.423 -179.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.439 ' CD ' ' HB3' ' A' ' 55' ' ' LEU . 3.1 mmtt -77.07 -51.25 11.38 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 122.395 -0.473 . . . . 0.0 111.031 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.841 HG22 ' OD1' ' A' ' 38' ' ' ASP . 0.1 OUTLIER -98.14 -44.36 6.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.596 -179.583 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.421 ' CB ' ' O ' ' A' ' 14' ' ' VAL . 44.0 t -36.12 -73.83 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.725 ' HA ' HD13 ' A' ' 165' ' ' LEU . 1.8 mp -56.53 -68.66 0.2 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.951 0.405 . . . . 0.0 111.583 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.593 HD23 ' N ' ' A' ' 20' ' ' LEU . 2.9 mt -46.38 -61.45 1.79 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.201 -178.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.442 ' HA ' HG23 ' A' ' 25' ' ' THR . 47.6 mm -49.35 -72.15 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.781 0.324 . . . . 0.0 111.191 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 27.7 t -51.2 -23.0 2.98 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.606 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.416 ' HB2' ' O ' ' A' ' 19' ' ' LEU . 85.1 t80 -75.41 -68.07 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.731 0.3 . . . . 0.0 111.382 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.4 m -75.91 -34.69 59.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.31 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.442 HG23 ' HA ' ' A' ' 21' ' ' ILE . 1.5 p -87.9 -156.12 0.34 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.882 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -151.41 21.13 0.73 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.089 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -108.59 123.51 49.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.869 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.492 ' CD1' ' O1A' ' A' ' 185' ' ' GNP . 0.4 OUTLIER -153.78 -68.25 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.411 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.632 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.473 ' CD ' ' CB ' ' A' ' 28' ' ' PHE . 74.0 Cg_endo -75.45 54.26 3.79 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.479 2.119 . . . . 0.0 112.939 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 33.9 t -145.96 -80.02 0.16 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.916 0.389 . . . . 0.0 110.976 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -158.34 159.02 35.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.45 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.522 ' CD2' ' PG ' ' A' ' 185' ' ' GNP . 10.6 m-85 -128.44 93.36 3.62 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.065 0.46 . . . . 0.0 110.918 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.981 HG11 ' O ' ' B' ' 526' ' ' SER . 1.9 t -108.45 -50.01 0.08 OUTLIER Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.545 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.433 ' HD3' ' HB ' ' A' ' 33' ' ' VAL . 77.6 Cg_exo -52.01 -22.14 13.88 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.009 1.806 . . . . 0.0 112.203 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.632 ' CG2' HD23 ' B' ' 543' ' ' LEU . 27.9 m -52.3 -24.33 7.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.545 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.756 ' HB ' HD21 ' A' ' 61' ' ' LEU . 5.6 p -57.98 -25.35 25.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.164 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.494 ' CD1' ' HA3' ' B' ' 522' ' ' GLY . 0.2 OUTLIER -125.79 53.36 1.59 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.963 0.411 . . . . 0.0 110.645 179.724 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.841 ' OD1' HG22 ' A' ' 17' ' ' THR . 24.4 t70 -88.95 14.18 11.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.554 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -92.82 19.87 7.15 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.769 0.318 . . . . 0.0 110.905 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -61.95 -175.11 0.06 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.699 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -116.43 169.77 9.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.438 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.455 ' HA ' ' CG1' ' B' ' 519' ' ' ILE . 35.1 m -146.94 129.33 7.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.911 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.455 HG23 HG12 ' B' ' 519' ' ' ILE . 16.4 p -87.5 105.61 17.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.554 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.499 ' CG2' ' CG2' ' A' ' 52' ' ' THR . 19.3 m -158.93 -177.09 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.53 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.516 ' HE2' ' C ' ' A' ' 45' ' ' MET . 0.0 OUTLIER -124.85 107.54 11.01 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.795 0.295 . . . . 0.0 111.795 -179.639 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 1.085 HG21 HG23 ' A' ' 3' ' ' THR . 5.1 mm -79.96 86.13 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 26.21 90.29 0.01 OUTLIER Glycine 0 CA--C 1.526 0.731 0 O-C-N 123.64 0.587 . . . . 0.0 114.449 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 140.39 -95.51 0.2 Allowed Glycine 0 N--CA 1.454 -0.156 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.448 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.466 ' N ' ' HE1' ' A' ' 45' ' ' MET . 0.0 OUTLIER -130.31 144.99 55.46 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.791 0.329 . . . . 0.0 110.638 179.347 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_exo -34.39 102.4 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.46 2.773 . . . . 0.0 113.446 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.505 ' CD1' ' HE1' ' A' ' 1' ' ' MET . 3.1 t80 -173.4 138.22 0.69 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.159 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.499 ' CG2' ' CG2' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -134.12 153.16 51.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.112 0.482 . . . . 0.0 111.402 179.495 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.979 HD22 HD11 ' A' ' 4' ' ' ILE . 0.4 OUTLIER -80.25 109.9 15.17 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.169 -179.616 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -62.95 107.61 1.75 Allowed Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.0 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.439 ' HB3' ' CD ' ' A' ' 16' ' ' LYS . 1.4 mp -63.59 116.88 6.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.836 0.35 . . . . 0.0 110.413 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.822 ' CB ' HG22 ' A' ' 7' ' ' VAL . 0.7 OUTLIER -84.58 125.33 32.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.352 0.596 . . . . 0.0 111.751 -178.916 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.938 ' OD2' HG11 ' A' ' 14' ' ' VAL . 38.5 t0 -175.17 137.34 0.4 Allowed 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.457 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.912 ' OG1' HD21 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -155.07 160.02 40.69 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.483 -178.645 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.709 ' HB3' HD21 ' A' ' 61' ' ' LEU . . . -132.34 155.48 48.32 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.816 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.419 ' HA2' ' HB2' ' A' ' 64' ' ' TYR . . . -106.65 79.46 0.26 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.533 -0.841 . . . . 0.0 113.328 -179.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.837 HD22 ' HA2' ' B' ' 544' ' ' GLY . 0.1 OUTLIER -121.47 -87.76 0.63 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.72 0.295 . . . . 0.0 110.643 179.24 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -98.73 -26.52 14.32 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.99 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -89.4 -63.42 1.29 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.4 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.765 ' HB2' HD23 ' A' ' 67' ' ' LEU . 12.8 m-85 -96.85 146.54 24.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.958 0.409 . . . . 0.0 111.086 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -87.43 -58.5 2.56 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.402 ' O ' ' CB ' ' A' ' 67' ' ' LEU . 0.6 OUTLIER -98.35 -51.17 4.06 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -178.209 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.912 HD21 ' OG1' ' A' ' 58' ' ' THR . 0.2 OUTLIER 76.4 87.74 0.08 Allowed 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -178.636 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.475 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 34.5 ptt180 -126.59 48.19 2.94 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.563 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.525 ' HG3' HG23 ' A' ' 58' ' ' THR . 97.4 Cg_endo -79.0 -39.56 0.34 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.67 2.246 . . . . 0.0 111.875 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.945 HD23 ' CB ' ' B' ' 541' ' ' LEU . 0.1 OUTLIER -82.04 -8.45 59.67 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.038 179.959 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.4 ' O ' ' CD2' ' A' ' 104' ' ' HIS . 0.2 OUTLIER -51.8 -35.11 42.87 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.692 0.282 . . . . 0.0 111.14 -179.955 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.444 ' CZ ' ' O ' ' A' ' 104' ' ' HIS . 1.5 t80 -169.08 67.63 0.65 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.196 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.504 ' HG2' ' CE2' ' A' ' 78' ' ' PHE . 73.0 Cg_endo -75.75 142.66 25.9 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.641 2.227 . . . . 0.0 112.216 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 25.6 tp60 -101.42 10.8 40.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.608 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.679 HG23 ' CE1' ' A' ' 78' ' ' PHE . 1.2 t -47.46 167.78 0.02 OUTLIER 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.931 0.396 . . . . 0.0 111.211 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -91.49 -22.59 20.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.609 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.641 HG23 ' SG ' ' A' ' 6' ' ' CYS . 19.1 m -137.95 143.98 32.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.982 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.775 ' CE1' HG21 ' A' ' 108' ' ' THR . 3.7 m-85 -116.35 121.01 40.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.432 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.522 HD21 ' HE1' ' A' ' 169' ' ' PHE . 5.9 tp -82.38 108.18 15.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.887 0.375 . . . . 0.0 111.031 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.599 ' O ' HG23 ' A' ' 80' ' ' VAL . 19.4 m -107.87 95.6 3.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.199 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.457 ' HB3' ' N7 ' ' A' ' 185' ' ' GNP . 14.3 m -95.14 155.25 16.81 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.575 -179.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.671 ' HE1' HD12 ' A' ' 112' ' ' LEU . 23.4 p90 -153.36 128.28 9.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.462 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.472 ' HA ' ' C2 ' ' A' ' 185' ' ' GNP . 6.1 p -83.62 136.44 34.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.0 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.796 HG13 ' N ' ' A' ' 137' ' ' ILE . 58.7 t -45.32 -54.59 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.443 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.78 HG11 HG21 ' A' ' 125' ' ' THR . 28.8 m -49.52 112.97 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.682 0.277 . . . . 0.0 110.577 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.717 ' N ' HD22 ' A' ' 129' ' ' LEU . 18.4 m -151.37 122.36 3.76 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.665 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 86' ' ' SER . 87.1 Cg_endo -93.81 56.2 0.36 Allowed 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.228 2.619 . . . . 0.0 111.599 179.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.445 ' HB3' ' HG2' ' A' ' 133' ' ' LYS . 0.9 OUTLIER 81.11 20.38 0.41 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.07 -179.449 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.95 ' O ' HG23 ' A' ' 93' ' ' VAL . 2.8 m -97.29 -27.29 14.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.827 0.346 . . . . 0.0 110.79 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -50.67 -53.86 27.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.016 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -50.18 -45.39 53.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.974 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.413 ' O ' ' N ' ' A' ' 96' ' ' LYS . 24.1 m120 -72.55 -44.58 61.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.872 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.95 HG23 ' O ' ' A' ' 89' ' ' SER . 62.0 t -51.34 -37.5 18.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.245 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.635 ' HB2' HD11 ' A' ' 145' ' ' LEU . 3.9 tttt -73.34 -49.96 24.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.886 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -82.87 6.98 16.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.562 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.413 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.1 OUTLIER -113.86 -28.47 7.39 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.713 0.292 . . . . 0.0 110.991 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.471 ' CZ2' ' HA2' ' A' ' 10' ' ' GLY . 3.1 m95 -94.32 -49.24 5.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.179 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 94' ' ' LYS . 61.8 t -48.62 -47.48 70.72 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.662 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 71.9 Cg_endo -77.9 -16.75 14.24 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.242 1.961 . . . . 0.0 112.517 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.38 -47.0 8.31 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.729 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.415 HG13 ' N ' ' A' ' 102' ' ' THR . 2.0 pt -60.21 -26.71 37.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.026 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.415 ' N ' HG13 ' A' ' 101' ' ' ILE . 27.0 p -82.56 -39.66 21.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.867 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -54.16 -48.73 70.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.799 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.444 ' O ' ' CZ ' ' A' ' 72' ' ' TYR . 0.4 OUTLIER -70.06 -26.83 64.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.715 179.852 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -143.62 99.01 5.28 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.813 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_exo -43.03 99.02 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.6 2.2 . . . . 0.0 112.484 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.5 mmtm 57.61 102.62 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.869 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.775 HG21 ' CE1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -133.13 136.76 28.01 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.862 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 108' ' ' THR . 31.3 Cg_exo -59.96 154.79 48.24 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.555 2.17 . . . . 0.0 112.292 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.564 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 3.7 p90 -165.55 140.39 4.9 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.241 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.657 HD12 ' CG1' ' A' ' 152' ' ' VAL . 1.8 tt -116.1 153.23 32.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.892 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.671 HD12 ' HE1' ' A' ' 82' ' ' PHE . 0.8 OUTLIER -98.01 161.53 13.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.833 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.916 HG13 HG21 ' A' ' 168' ' ' VAL . 10.6 t -140.53 143.59 28.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 121.08 0.467 . . . . 0.0 112.025 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -120.43 108.9 1.49 Allowed Glycine 0 C--N 1.332 0.34 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.625 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.686 HG22 ' SG ' ' A' ' 157' ' ' CYS . 0.1 OUTLIER -135.88 5.28 3.08 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.879 0.325 . . . . 0.0 111.879 -178.796 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.857 ' HG3' HD13 ' A' ' 119' ' ' LEU . 39.7 tt0 -118.32 -4.03 10.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.753 0.311 . . . . 0.0 110.459 179.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.971 HD11 ' O ' ' A' ' 157' ' ' CYS . 0.1 OUTLIER -44.88 -26.47 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.141 179.263 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -73.88 -31.5 63.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.292 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.857 HD13 ' HG3' ' A' ' 116' ' ' GLN . 3.9 mp -85.82 -23.7 27.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.359 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.609 ' CB ' HG11 ' A' ' 84' ' ' VAL . 1.0 OUTLIER -49.63 -26.18 3.43 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.961 0.41 . . . . 0.0 110.684 179.818 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -85.46 -31.66 22.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.591 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.2 107.18 0.79 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.648 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.451 ' HA ' ' CG2' ' A' ' 126' ' ' ILE . 43.1 Cg_endo -68.87 -5.91 16.76 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.493 2.129 . . . . 0.0 113.131 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.1 t -75.75 -67.22 0.69 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.78 HG21 HG11 ' A' ' 85' ' ' VAL . 3.1 m -57.81 -38.17 75.06 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.566 178.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.723 HD11 ' HB3' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -55.39 -46.36 78.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.81 179.407 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.509 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 4.8 mm-40 -56.34 -35.43 67.6 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.924 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.4 ' HA ' ' CD ' ' A' ' 131' ' ' LYS . 6.0 mptt -65.36 -31.49 72.63 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.717 HD22 ' N ' ' A' ' 86' ' ' SER . 7.1 mt -73.87 -37.82 64.63 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.509 ' HB3' ' O ' ' A' ' 127' ' ' GLU . . . -44.81 -37.97 4.19 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.224 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.4 ' CD ' ' HA ' ' A' ' 128' ' ' LYS . 0.1 OUTLIER -47.29 -32.6 4.82 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.933 179.816 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 87' ' ' PRO . 13.7 m120 -123.12 -31.36 3.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.476 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.523 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 9.3 mmmt -146.98 -100.21 0.09 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 118.993 -0.527 . . . . 0.0 111.132 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.523 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 1.4 pt20 133.29 -21.16 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.281 1.032 . . . . 0.0 110.55 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 16.1 mmtp -68.44 110.95 6.67 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.705 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.723 ' HB3' HD11 ' A' ' 126' ' ' ILE . 65.3 Cg_endo -85.48 122.27 2.37 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.832 2.355 . . . . 0.0 111.534 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.796 ' N ' HG13 ' A' ' 84' ' ' VAL . 1.2 mm -53.72 96.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.009 0.433 . . . . 0.0 110.664 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.44 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 33.8 p -68.66 155.82 92.19 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.908 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.44 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 8.6 Cg_endo -50.59 -26.24 16.42 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.699 2.266 . . . . 0.0 111.875 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -81.46 -33.4 32.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.59 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.445 ' CG2' HG23 ' A' ' 137' ' ' ILE . 89.9 m -57.62 -49.17 77.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.636 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.456 ' HB3' ' CD2' ' A' ' 154' ' ' TYR . . . -55.17 -32.79 62.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.789 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -68.14 -40.68 82.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.621 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.59 -49.93 74.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.676 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.684 HD23 ' O ' ' A' ' 145' ' ' LEU . 1.6 tt -70.08 -36.23 74.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.655 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.433 ' CB ' HD23 ' A' ' 112' ' ' LEU . . . -59.55 -58.1 10.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.965 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 38.1 mtt180 -67.86 -24.28 65.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.965 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -50.2 -36.11 29.29 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.785 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.64 23.6 7.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.86 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 37.0 mttt 45.57 59.75 3.45 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.126 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.584 ' O ' HG23 ' A' ' 152' ' ' VAL . . . -65.46 -82.39 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.212 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.657 ' CG1' HD12 ' A' ' 111' ' ' LEU . 45.1 t -161.86 -72.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.653 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 12.4 tppt? -179.8 118.9 0.06 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.883 -178.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.456 ' CD2' ' HB3' ' A' ' 142' ' ' ALA . 63.1 t80 -89.86 110.85 21.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.372 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.521 HG12 ' H ' ' A' ' 156' ' ' GLU . 2.6 t -101.61 167.46 2.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.739 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.521 ' H ' HG12 ' A' ' 155' ' ' VAL . 1.1 pm0 -106.58 119.06 38.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.123 0.487 . . . . 0.0 111.653 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.971 ' O ' HD11 ' A' ' 117' ' ' ILE . 14.8 p -140.19 -172.01 3.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.635 179.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.409 ' HB2' ' HB2' ' A' ' 163' ' ' LYS . 0.5 OUTLIER -159.1 127.95 5.31 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.459 -0.497 . . . . 0.0 111.884 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.565 ' HA ' HD11 ' A' ' 165' ' ' LEU . . . -94.67 20.33 8.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.512 178.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.702 ' N ' HD12 ' A' ' 160' ' ' LEU . 0.0 OUTLIER -129.99 -44.19 1.18 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.327 179.925 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 8.3 t -113.25 -17.84 12.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.984 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 77.45 85.75 0.08 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.2 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.409 ' HB2' ' HB2' ' A' ' 158' ' ' SER . 3.7 ttpp -107.82 22.71 15.56 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.051 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 115.44 40.73 0.84 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.793 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.725 HD13 ' HA ' ' A' ' 19' ' ' LEU . 9.2 mt -49.79 -42.79 47.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.77 0.319 . . . . 0.0 110.8 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.404 ' O ' ' HB2' ' A' ' 170' ' ' ASP . 0.5 OUTLIER -67.56 -32.02 72.5 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.423 179.418 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.22 -65.76 0.63 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.738 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.916 HG21 HG13 ' A' ' 113' ' ' VAL . 8.9 p -48.67 -43.64 13.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 121.081 0.467 . . . . 0.0 110.581 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.592 ' CE1' HD11 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -69.3 -27.03 65.04 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.079 179.221 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.404 ' HB2' ' O ' ' A' ' 166' ' ' LYS . 0.7 OUTLIER -61.57 -29.98 70.37 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.484 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.518 ' HB2' HD11 ' A' ' 111' ' ' LEU . 39.9 mm-40 -77.9 -39.7 42.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.04 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.578 ' N ' HD13 ' A' ' 111' ' ' LEU . . . -55.33 -48.22 74.5 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.579 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.558 HD12 ' CD1' ' A' ' 177' ' ' LEU . 1.4 pp -74.4 -33.69 34.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.843 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.837 HD13 ' HG ' ' B' ' 505' ' ' LEU . 21.7 tp -50.52 -68.73 0.15 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.928 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -54.44 -22.01 11.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.05 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.535 ' CB ' HG21 ' A' ' 4' ' ' ILE . . . -81.85 -45.84 14.97 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.281 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.869 ' CD2' HG21 ' B' ' 510' ' ' ILE . 2.1 mt -68.57 -25.01 64.68 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.864 0.364 . . . . 0.0 110.734 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.415 ' HB2' ' HA ' ' B' ' 507' ' ' ALA . 0.0 OUTLIER -159.57 151.63 17.17 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.727 179.928 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -53.03 139.07 62.07 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.534 2.156 . . . . 0.0 112.329 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.21 -168.71 0.59 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.546 2.164 . . . . 0.0 112.385 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -143.24 96.97 5.73 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.977 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.03 -165.0 0.26 Allowed 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.613 2.208 . . . . 0.0 112.207 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -116.33 121.03 40.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.945 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 16.4 mttp . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.884 179.979 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 502' ' ' GLY . . . . . 0.425 ' CA ' ' HB2' ' B' ' 511' ' ' SER . . . . . . . . 0 N--CA 1.49 2.272 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 503' ' ' SER . . . . . 0.403 ' N ' ' HB2' ' B' ' 511' ' ' SER . 18.5 m -77.77 -74.92 0.23 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.688 0.28 . . . . 0.0 110.908 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 504' ' ' GLY . . . . . 0.41 ' HA2' ' HA ' ' B' ' 509' ' ' ASP . . . 105.43 110.08 3.47 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.388 -0.911 . . . . 0.0 112.316 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 505' ' ' LEU . . . . . 0.837 ' HG ' HD13 ' A' ' 174' ' ' LEU . 1.4 pt? -179.93 44.89 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.755 0.312 . . . . 0.0 110.936 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 506' ' ' SER . . . . . . . . . . . . . 4.8 p 65.78 39.85 4.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.074 0.464 . . . . 0.0 110.48 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 507' ' ' ALA . . . . . 0.57 ' O ' HD13 ' B' ' 510' ' ' ILE . . . -144.25 37.56 1.26 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.657 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 508' ' ' GLN . . . . . 0.459 ' HB3' ' CD1' ' B' ' 510' ' ' ILE . 3.3 mt-30 70.04 4.29 4.75 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.09 -178.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 509' ' ' ASP . . . . . 0.41 ' HA ' ' HA2' ' B' ' 504' ' ' GLY . 52.1 t0 67.84 45.49 1.4 Allowed 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 121.012 0.434 . . . . 0.0 111.416 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 510' ' ' ILE . . . . . 0.975 HG23 HG23 ' A' ' 46' ' ' ILE . 1.7 mp -84.62 133.11 30.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.945 179.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 511' ' ' SER . . . . . 0.788 ' O ' HD13 ' A' ' 46' ' ' ILE . 40.9 t -109.28 152.78 24.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.805 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 512' ' ' GLN . . . . . 0.504 ' CB ' ' HD3' ' B' ' 513' ' ' PRO . 0.0 OUTLIER -101.3 -57.91 0.11 Allowed Pre-proline 0 CA--C 1.529 0.155 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.426 179.271 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 513' ' ' PRO . . . . . 0.504 ' HD3' ' CB ' ' B' ' 512' ' ' GLN . 49.0 Cg_endo -93.89 63.12 0.39 Allowed 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.096 2.531 . . . . 0.0 112.169 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 514' ' ' LEU . . . . . 0.442 ' CD2' ' O ' ' A' ' 45' ' ' MET . 1.3 mp -70.54 -87.49 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.599 -179.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 515' ' ' GLN . . . . . . . . . . . . . 18.8 mm100 -78.82 -86.73 0.07 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.635 0.255 . . . . 0.0 111.233 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -118.08 -36.73 3.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.856 0.36 . . . . 0.0 110.835 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 517' ' ' SER . . . . . 0.413 ' HA ' ' HB ' ' A' ' 42' ' ' VAL . 7.3 m 60.73 27.68 17.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.816 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 518' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -163.58 113.09 1.28 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.401 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 519' ' ' ILE . . . . . 0.455 HG12 HG23 ' A' ' 43' ' ' THR . 0.5 OUTLIER -137.36 111.34 8.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.124 179.483 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 80.3 m-70 60.64 174.47 0.1 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.012 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 521' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.1 136.8 28.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.812 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 522' ' ' GLY . . . . . 0.494 ' HA3' ' CD1' ' A' ' 37' ' ' PHE . . . -52.81 -174.96 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.474 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 523' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -64.0 -86.57 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.701 0.286 . . . . 0.0 110.871 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 524' ' ' GLY . . . . . 0.467 ' HA2' HG11 ' A' ' 36' ' ' VAL . . . 45.96 46.12 14.44 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.72 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 525' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -89.43 46.95 1.42 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.787 0.327 . . . . 0.0 110.958 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 526' ' ' SER . . . . . 0.981 ' O ' HG11 ' A' ' 33' ' ' VAL . 0.5 OUTLIER -87.91 100.58 13.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.67 179.784 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 527' ' ' ASP . . . . . 0.466 ' CB ' ' HD2' ' B' ' 528' ' ' PRO . 0.4 OUTLIER -43.05 167.9 0.07 OUTLIER Pre-proline 0 N--CA 1.464 0.273 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.403 -179.848 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 528' ' ' PRO . . . . . 0.466 ' HD2' ' CB ' ' B' ' 527' ' ' ASP . 9.8 Cg_endo -48.91 102.37 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.925 2.416 . . . . 0.0 111.884 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 529' ' ' ARG . . . . . 0.422 ' CG ' ' O ' ' B' ' 527' ' ' ASP . 11.1 mtp85 -100.84 -55.04 2.67 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.602 -179.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 530' ' ' HIS . . . . . 0.433 ' HB2' ' HB2' ' B' ' 545' ' ' ASN . 3.2 m-70 -148.87 94.02 2.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.405 -179.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 1.8 m -54.24 -173.75 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.606 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 532' ' ' TRP . . . . . 0.508 ' CZ2' ' HG3' ' B' ' 537' ' ' ARG . 13.2 t-105 -107.99 163.17 13.37 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.945 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . 169.86 -30.98 0.15 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.473 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 534' ' ' PHE . . . . . 0.479 ' O ' ' CZ2' ' B' ' 532' ' ' TRP . 4.2 t80 -82.35 115.54 58.47 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.507 0.194 . . . . 0.0 110.745 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -45.25 151.74 0.83 Allowed 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.48 2.12 . . . . 0.0 112.5 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 65.85 135.13 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.854 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 537' ' ' ARG . . . . . 0.579 ' CD ' ' HB2' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -99.34 176.25 5.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.107 0.479 . . . . 0.0 111.159 -179.962 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 538' ' ' ILE . . . . . 0.813 HD11 ' CB ' ' B' ' 542' ' ' TYR . 0.1 OUTLIER -118.71 139.37 46.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.556 179.649 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 539' ' ' ASP . . . . . 0.701 ' HB2' HD22 ' A' ' 70' ' ' LEU . 30.6 p30 -38.84 161.23 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.086 -178.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 540' ' ' GLU . . . . . 0.729 ' HA ' HD13 ' B' ' 543' ' ' LEU . 0.9 OUTLIER -64.99 -33.44 76.05 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.056 -179.907 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 541' ' ' LEU . . . . . 0.945 ' CB ' HD23 ' A' ' 70' ' ' LEU . 4.4 tt -47.59 -29.69 3.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.105 0.479 . . . . 0.0 110.551 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 542' ' ' TYR . . . . . 0.813 ' CB ' HD11 ' B' ' 538' ' ' ILE . 6.2 m-85 -105.44 -17.08 14.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.626 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 543' ' ' LEU . . . . . 0.958 HD21 HG21 ' A' ' 14' ' ' VAL . 1.9 mp -40.11 136.54 1.15 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.89 0.376 . . . . 0.0 111.291 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 544' ' ' GLY . . . . . 0.837 ' HA2' HD22 ' A' ' 61' ' ' LEU . . . 157.8 101.68 0.18 Allowed Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.595 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 545' ' ' ASN . . . . . 0.444 ' O ' HG22 ' A' ' 33' ' ' VAL . 16.3 p30 . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.265 -0.874 . . . . 0.0 111.008 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' GNP . . . . . 0.728 ' N3 ' " H2'" ' A' ' 185' ' ' GNP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' HOH . . . . . 0.408 ' O ' HG21 ' A' ' 14' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.706 ' HE1' ' HB ' ' A' ' 46' ' ' ILE . 7.8 tpt . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.828 0.347 . . . . 0.0 111.2 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.522 ' O ' HD11 ' A' ' 177' ' ' LEU . 2.1 pt20 -155.44 111.25 3.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.898 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.82 ' O ' HG23 ' A' ' 4' ' ' ILE . 1.3 t -96.37 178.42 5.37 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.536 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.82 HG23 ' O ' ' A' ' 3' ' ' THR . 0.3 OUTLIER -165.23 159.94 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.096 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 179.874 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.659 ' N ' HD23 ' A' ' 53' ' ' LEU . 2.3 mtpt -111.65 137.47 49.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.329 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 39.8 t -121.55 142.91 49.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.041 0.448 . . . . 0.0 111.503 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.74 HG13 ' O ' ' A' ' 56' ' ' PHE . 2.8 t -135.13 120.6 30.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.486 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.869 HG13 ' HG2' ' B' ' 540' ' ' GLU . 2.4 p -84.71 149.56 4.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.209 0.528 . . . . 0.0 111.051 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.3 m -143.43 130.2 17.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.902 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.67 -140.08 8.71 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.139 -1.029 . . . . 0.0 112.584 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -123.19 27.03 7.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.857 0.361 . . . . 0.0 110.647 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.427 ' CA ' ' HB2' ' B' ' 537' ' ' ARG . . . -120.13 171.42 14.54 Favored Glycine 0 C--N 1.331 0.25 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.651 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.412 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -93.84 -25.3 17.41 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.721 0.296 . . . . 0.0 111.403 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 1.084 HG23 HD21 ' A' ' 19' ' ' LEU . 4.1 p -41.52 94.6 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.355 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.432 ' O ' ' CD1' ' A' ' 19' ' ' LEU . . . -151.21 -103.16 0.25 Allowed Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.612 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.474 ' HG3' ' CG2' ' A' ' 17' ' ' THR . 0.2 OUTLIER -97.93 -43.8 6.94 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 -179.547 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.665 HG21 HG23 ' A' ' 35' ' ' THR . 2.6 p -94.93 -53.12 3.95 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.446 ' CB ' ' O2A' ' A' ' 185' ' ' GNP . 37.2 t -32.04 -69.62 0.08 Allowed 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -178.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 1.084 HD21 HG23 ' A' ' 14' ' ' VAL . 0.5 OUTLIER -58.68 -68.09 0.3 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.393 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.503 ' H ' HD22 ' A' ' 20' ' ' LEU . 2.9 mm? -61.05 -67.44 0.4 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -178.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.527 ' O ' HG22 ' A' ' 25' ' ' THR . 1.3 tp -37.08 -54.54 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -179.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.492 ' N ' ' CG2' ' A' ' 21' ' ' ILE . 0.4 OUTLIER -67.92 -30.21 69.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.791 0.329 . . . . 0.0 110.858 -179.557 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.423 ' N ' ' O ' ' A' ' 20' ' ' LEU . 27.3 t80 -53.79 -37.95 64.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.132 0.492 . . . . 0.0 109.987 179.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.49 -31.68 11.16 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.667 179.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.527 HG22 ' O ' ' A' ' 21' ' ' ILE . 3.3 t -136.82 79.79 1.78 Allowed 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.984 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.411 ' ND2' ' OG ' ' A' ' 22' ' ' SER . 1.4 m120 -66.6 79.28 0.11 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.298 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.4 mmtm -100.29 101.04 11.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.746 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.57 ' CE1' ' CZ2' ' B' ' 532' ' ' TRP . 0.1 OUTLIER -99.28 -53.61 0.19 Allowed Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.648 -179.67 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.425 ' HD3' ' HB3' ' A' ' 28' ' ' PHE . 84.7 Cg_endo -88.54 69.95 2.69 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.76 2.307 . . . . 0.0 112.981 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -144.8 -92.68 0.1 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.667 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -159.62 158.64 31.96 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.745 0.307 . . . . 0.0 110.818 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.455 ' O ' HG22 ' A' ' 33' ' ' VAL . 53.1 m-85 -133.07 99.98 4.73 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.406 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.542 HG12 HD12 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -162.49 -63.46 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.866 -179.398 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.477 ' CD ' ' HB ' ' A' ' 33' ' ' VAL . 2.9 Cg_exo -36.07 -29.73 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.381 2.721 . . . . 0.0 113.012 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.665 HG23 HG21 ' A' ' 17' ' ' THR . 21.2 m -63.85 71.1 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.754 0.312 . . . . 0.0 110.886 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.819 HG11 ' HA3' ' B' ' 524' ' ' GLY . 10.2 p -130.55 -3.82 2.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.471 ' CD1' ' HA3' ' B' ' 522' ' ' GLY . 0.7 OUTLIER -84.22 50.05 1.78 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.742 0.306 . . . . 0.0 111.242 -179.793 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.466 ' HA ' ' CD ' ' A' ' 16' ' ' LYS . 5.5 m-20 -58.97 -21.43 58.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.158 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -86.98 -6.21 58.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.629 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.466 ' CD1' ' O ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -60.77 157.18 15.41 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.848 0.356 . . . . 0.0 110.913 179.935 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.575 ' C ' HD12 ' B' ' 519' ' ' ILE . . . -108.07 175.72 5.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.35 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.422 ' HA ' HG13 ' B' ' 519' ' ' ILE . 12.8 m -140.57 121.71 14.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.167 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.422 ' C ' HG13 ' A' ' 44' ' ' VAL . 1.1 t -86.25 104.71 16.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.042 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.745 ' CG2' HG21 ' A' ' 52' ' ' THR . 24.9 m -158.19 -177.28 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.918 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.477 ' HE1' ' N ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -121.01 99.61 6.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.485 -179.523 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.925 ' CG1' HG23 ' A' ' 52' ' ' THR . 0.7 OUTLIER -75.93 86.02 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 178.723 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.44 ' N ' ' HE2' ' A' ' 45' ' ' MET . . . 27.91 96.26 0.01 OUTLIER Glycine 0 C--N 1.337 0.616 0 CA-C-N 115.667 -0.697 . . . . 0.0 114.275 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.468 ' N ' ' HE1' ' A' ' 45' ' ' MET . . . 137.64 -92.32 0.21 Allowed Glycine 0 CA--C 1.518 0.262 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.024 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.477 ' N ' ' HE1' ' A' ' 45' ' ' MET . 0.7 OUTLIER -137.44 138.49 24.89 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-O 120.757 0.313 . . . . 0.0 111.222 -179.828 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_exo -35.77 95.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.315 2.677 . . . . 0.0 113.079 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.532 ' CE1' ' CG2' ' A' ' 3' ' ' THR . 2.5 t80 -173.0 105.2 0.14 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.307 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.925 HG23 ' CG1' ' A' ' 46' ' ' ILE . 0.2 OUTLIER -124.06 153.64 41.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.473 -178.933 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.814 HD23 ' C ' ' A' ' 4' ' ' ILE . 6.7 tp -102.73 146.7 27.83 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.75 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.577 ' C ' HD22 ' A' ' 55' ' ' LEU . . . -78.89 -162.81 23.44 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.241 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.721 HD22 ' N ' ' A' ' 55' ' ' LEU . 1.2 mm? -121.88 114.17 20.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.813 0.34 . . . . 0.0 110.44 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.74 ' O ' HG13 ' A' ' 7' ' ' VAL . 0.9 OUTLIER -84.26 105.71 15.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.6 -179.756 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -138.65 -176.33 4.44 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.088 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.806 ' CB ' HD22 ' A' ' 67' ' ' LEU . 0.1 OUTLIER -125.63 143.33 51.07 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.943 -179.647 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.682 ' HB3' HG23 ' A' ' 36' ' ' VAL . . . -147.78 100.7 3.24 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.936 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.556 ' C ' HD22 ' A' ' 61' ' ' LEU . . . -75.66 80.9 1.01 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.63 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.646 HD23 ' HB1' ' A' ' 59' ' ' ALA . 3.1 mm? -121.3 -119.74 0.3 Allowed 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 110.577 -0.157 . . . . 0.0 110.577 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -98.53 -30.49 12.49 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-N 118.151 0.432 . . . . 0.0 111.075 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.34 -63.2 1.25 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.148 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.638 ' HB2' HD12 ' A' ' 67' ' ' LEU . 75.6 m-85 -87.67 146.34 25.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.037 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -86.5 -68.72 0.72 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.174 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.431 ' HD2' ' N ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -98.89 -50.33 4.24 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.924 -179.638 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.806 HD22 ' CB ' ' A' ' 58' ' ' THR . 0.6 OUTLIER 65.35 114.95 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.629 0.252 . . . . 0.0 110.846 -179.753 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.518 ' N ' ' HD3' ' A' ' 69' ' ' PRO . 0.5 OUTLIER -149.14 44.0 0.31 Allowed Pre-proline 0 C--N 1.329 -0.297 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 179.616 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.518 ' HD3' ' N ' ' A' ' 68' ' ' ARG . 90.6 Cg_endo -83.08 -42.98 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.344 2.029 . . . . 0.0 112.269 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.785 ' HG ' HD12 ' B' ' 541' ' ' LEU . 0.2 OUTLIER -63.08 -16.34 59.62 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.322 -179.842 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 93.9 p -46.37 -56.3 6.07 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.854 0.359 . . . . 0.0 111.274 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -156.89 65.28 3.65 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.944 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.474 ' HB2' ' CZ ' ' A' ' 78' ' ' PHE . 35.0 Cg_exo -59.59 154.62 47.26 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.542 2.161 . . . . 0.0 112.233 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 7.4 mm-40 -98.5 10.33 41.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.309 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.1 m -56.7 161.36 2.84 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.818 0.342 . . . . 0.0 110.924 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.76 7.27 30.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.487 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.779 HG11 ' HB2' ' A' ' 176' ' ' ALA . 7.5 p -156.95 91.7 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.334 -0.084 0 CA-C-O 120.859 0.361 . . . . 0.0 111.219 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.474 ' CZ ' ' HB2' ' A' ' 73' ' ' PRO . 3.1 m-85 -80.88 -177.04 6.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.622 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.51 HD21 ' CG2' ' A' ' 113' ' ' VAL . 1.1 tt -149.83 114.19 5.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.972 0.415 . . . . 0.0 111.5 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.1 t -98.6 156.4 3.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.285 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.745 ' HB3' HG11 ' A' ' 14' ' ' VAL . 1.8 p -152.04 153.08 33.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.086 0.47 . . . . 0.0 111.751 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.514 ' CE1' ' CE1' ' A' ' 90' ' ' PHE . 9.1 p90 -166.32 134.24 2.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.261 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.431 ' HA ' ' C2 ' ' A' ' 185' ' ' GNP . 0.3 OUTLIER -85.34 141.72 29.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.942 -179.802 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.784 HG13 ' N ' ' A' ' 137' ' ' ILE . 57.8 t -44.47 -55.14 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.359 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.655 HG11 HG21 ' A' ' 125' ' ' THR . 34.9 m -47.81 115.71 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.732 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.801 ' N ' HD22 ' A' ' 129' ' ' LEU . 5.1 p -150.94 129.78 6.26 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.584 -179.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.425 ' O ' ' CB ' ' A' ' 132' ' ' ASN . 87.4 Cg_endo -90.83 50.37 0.85 Allowed 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.043 2.495 . . . . 0.0 111.963 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.469 ' N ' ' HB3' ' A' ' 133' ' ' LYS . 0.3 OUTLIER 76.35 14.37 2.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.522 -179.785 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.491 ' O ' HG12 ' A' ' 93' ' ' VAL . 8.4 t -97.39 -27.06 14.64 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.994 0.426 . . . . 0.0 110.583 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.514 ' CE1' ' CE1' ' A' ' 82' ' ' PHE . 59.3 t80 -51.14 -33.35 26.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.034 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.2 -48.51 28.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.191 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -69.1 -44.81 71.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.183 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.733 HG22 ' CE3' ' A' ' 97' ' ' TRP . 11.6 p -58.84 -45.31 91.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.366 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.602 ' HG3' HD13 ' A' ' 145' ' ' LEU . 9.2 mmtt -59.62 -57.32 13.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.792 0.33 . . . . 0.0 110.997 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.423 ' O ' ' CG ' ' A' ' 99' ' ' PRO . 70.0 mm-40 -62.22 -18.5 61.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.259 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.8 tmtt? -101.49 -12.42 18.55 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.489 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.733 ' CE3' HG22 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -84.27 -56.7 3.51 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.787 0.327 . . . . 0.0 111.124 -179.823 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.562 HG11 ' HG ' ' A' ' 149' ' ' LEU . 5.1 t -49.48 -46.6 78.41 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.643 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.482 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 82.1 Cg_exo -44.63 -41.23 14.47 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.458 2.105 . . . . 0.0 112.85 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.434 ' HG3' ' N ' ' A' ' 101' ' ' ILE . 2.1 pt-20 -79.51 -31.72 42.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.058 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.434 ' N ' ' HG3' ' A' ' 100' ' ' GLU . 23.0 mt -53.74 -41.71 48.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.018 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 23.1 p -93.81 -21.05 19.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.981 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.414 ' HB3' ' HA ' ' A' ' 100' ' ' GLU . 83.9 t60 -60.24 -31.46 70.22 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.936 0.398 . . . . 0.0 110.69 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 -88.64 -25.77 22.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.886 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -144.58 136.19 12.81 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.792 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -59.48 -15.28 29.52 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.598 2.199 . . . . 0.0 112.607 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -169.6 84.05 0.13 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.825 0.345 . . . . 0.0 110.906 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -108.79 101.82 45.52 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.813 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -60.4 155.17 48.31 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.493 2.128 . . . . 0.0 112.122 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.862 ' O ' HG23 ' A' ' 152' ' ' VAL . 32.1 p90 -155.99 169.4 24.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.188 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.89 HD12 ' HB ' ' A' ' 152' ' ' VAL . 0.7 OUTLIER -132.85 150.18 52.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.863 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.795 HD23 ' CB ' ' A' ' 151' ' ' ALA . 0.3 OUTLIER -98.93 161.57 13.56 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.113 -179.745 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.777 ' HA ' HG21 ' A' ' 168' ' ' VAL . 2.5 t -136.81 144.04 33.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.036 0.446 . . . . 0.0 111.805 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.5 ' HA3' ' CZ ' ' A' ' 154' ' ' TYR . . . -133.15 103.83 0.52 Allowed Glycine 0 C--N 1.33 0.233 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.697 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.9 ' OG1' " H2'" ' A' ' 185' ' ' GNP . 0.4 OUTLIER -125.01 -1.41 7.79 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -178.647 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.983 ' NE2' HD11 ' A' ' 119' ' ' LEU . 0.0 OUTLIER -99.2 -8.39 25.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.974 0.416 . . . . 0.0 110.011 178.78 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.498 ' H ' HD13 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -49.25 -24.02 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.563 178.799 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -86.13 -20.51 28.54 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.562 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.983 HD11 ' NE2' ' A' ' 116' ' ' GLN . 4.2 pp -110.89 -12.84 14.21 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.498 ' HB2' HG11 ' A' ' 84' ' ' VAL . 9.1 ptt85 -50.88 -25.33 4.43 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.911 0.386 . . . . 0.0 110.72 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -72.24 -24.86 61.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.912 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.402 ' O ' ' HB ' ' A' ' 126' ' ' ILE . 4.9 m-20 -47.0 101.27 0.26 Allowed Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.838 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.418 ' O ' ' CG ' ' A' ' 127' ' ' GLU . 17.1 Cg_exo -67.4 -6.07 15.53 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.77 2.314 . . . . 0.0 113.021 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.7 t -84.67 -67.06 0.83 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.026 0.441 . . . . 0.0 110.001 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.655 HG21 HG11 ' A' ' 85' ' ' VAL . 4.9 m -52.47 -33.84 46.42 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.381 0.61 . . . . 0.0 109.358 178.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.78 HD11 ' HG3' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -60.03 -40.83 84.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.455 179.017 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.418 ' CG ' ' O ' ' A' ' 123' ' ' PRO . 3.7 mm-40 -56.13 -35.85 67.58 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.262 178.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.403 ' HB2' ' O ' ' A' ' 125' ' ' THR . 1.9 mptp? -66.86 -32.71 74.16 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.801 HD22 ' N ' ' A' ' 86' ' ' SER . 7.3 mt -73.36 -41.55 63.28 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 177.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.49 ' HA ' ' HB3' ' A' ' 134' ' ' GLN . . . -48.88 -26.01 2.22 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.202 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 16.2 mmtp -65.6 -33.91 77.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.773 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.425 ' CB ' ' O ' ' A' ' 87' ' ' PRO . 39.1 m-80 -123.8 -30.6 3.54 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -179.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.492 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 0.0 OUTLIER -133.62 -72.53 0.5 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 120.991 -0.284 . . . . 0.0 111.424 -178.85 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.492 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 2.7 pt20 99.58 -37.4 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.959 0.903 . . . . 0.0 110.658 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.443 ' HA ' ' HD3' ' A' ' 136' ' ' PRO . 0.6 OUTLIER -69.18 107.48 2.17 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.897 -179.065 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.78 ' HG3' HD11 ' A' ' 126' ' ' ILE . 3.0 Cg_exo -80.65 134.96 10.06 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.823 2.349 . . . . 0.0 111.221 179.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.784 ' N ' HG13 ' A' ' 84' ' ' VAL . 0.8 OUTLIER -67.13 96.48 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.882 0.372 . . . . 0.0 110.817 -179.608 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 6.2 p -67.74 159.23 79.96 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.079 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -50.62 -28.99 23.76 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.636 2.224 . . . . 0.0 112.274 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -82.65 -26.72 31.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.701 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.497 ' HB ' HG22 ' A' ' 137' ' ' ILE . 8.7 m -66.66 -51.16 59.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.782 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.55 ' HB1' ' CD2' ' A' ' 154' ' ' TYR . . . -55.49 -37.98 68.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.924 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -66.54 -45.39 79.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.908 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp -54.22 -64.07 0.95 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.993 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.602 HD13 ' HG3' ' A' ' 94' ' ' LYS . 5.3 tt -60.6 -42.75 97.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.9 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.734 ' HB1' ' HB3' ' A' ' 151' ' ' ALA . . . -48.99 -61.99 1.77 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.05 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.2 mtp85 -63.51 -23.14 67.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.861 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.575 ' HB3' HD22 ' A' ' 149' ' ' LEU . 6.2 t0 -50.16 -50.95 47.42 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.827 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.575 HD22 ' HB3' ' A' ' 148' ' ' ASP . 2.0 mm? -93.65 -72.14 0.62 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.673 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 170.26 60.44 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.516 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.795 ' CB ' HD23 ' A' ' 112' ' ' LEU . . . -94.81 27.46 3.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.535 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.89 ' HB ' HD12 ' A' ' 111' ' ' LEU . 75.8 t 61.11 -74.75 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.454 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.469 ' N ' ' O ' ' A' ' 151' ' ' ALA . 1.6 ttpt -176.41 121.74 0.16 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.829 -179.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.55 ' CD2' ' HB1' ' A' ' 142' ' ' ALA . 13.2 t80 -84.97 112.38 20.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.688 179.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.409 ' CG2' ' HA ' ' A' ' 168' ' ' VAL . 3.2 t -101.28 156.11 4.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.181 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -94.19 127.58 40.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.584 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.479 ' SG ' HG12 ' A' ' 168' ' ' VAL . 1.1 p 178.62 125.12 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.305 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.491 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 37.1 m -104.53 155.76 18.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.959 0.409 . . . . 0.0 111.657 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.6 ' HB2' HD11 ' A' ' 165' ' ' LEU . . . -92.2 -52.65 4.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.592 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -48.3 -29.78 4.2 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.738 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.9 -21.97 10.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.914 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 69.19 62.46 0.3 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.804 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.443 ' HB3' ' HA ' ' A' ' 157' ' ' CYS . 0.1 OUTLIER -93.41 35.99 1.08 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.255 -179.75 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 95.21 46.56 2.79 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.21 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.858 ' CD2' HD23 ' A' ' 19' ' ' LEU . 0.4 OUTLIER -53.49 -29.88 38.31 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.988 0.423 . . . . 0.0 110.588 179.688 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 28.8 pttt -68.52 -24.54 64.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.763 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 30.7 t30 -58.25 -68.95 0.2 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.565 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.777 HG21 ' HA ' ' A' ' 113' ' ' VAL . 14.4 p -54.28 -45.81 68.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.565 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.674 ' CZ ' HD13 ' A' ' 19' ' ' LEU . 1.2 t80 -60.38 -41.02 92.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.501 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -54.91 -34.96 63.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.875 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -75.89 -26.47 57.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.174 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.688 ' HB2' HD22 ' A' ' 111' ' ' LEU . . . -63.85 -42.96 97.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.213 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.91 HD13 ' N ' ' A' ' 174' ' ' LEU . 0.0 OUTLIER -89.94 -23.45 6.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.633 -179.866 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.91 ' N ' HD13 ' A' ' 173' ' ' ILE . 2.8 tp -49.05 -43.83 41.19 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.989 0.423 . . . . 0.0 110.41 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -62.14 -27.36 68.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.995 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.779 ' HB2' HG11 ' A' ' 77' ' ' VAL . . . -87.71 -39.41 14.99 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.636 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.747 HD12 HG13 ' A' ' 4' ' ' ILE . 0.6 OUTLIER -68.61 -26.39 65.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.518 179.628 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.439 ' CB ' ' HD2' ' A' ' 179' ' ' PRO . 0.5 OUTLIER -166.82 167.72 7.64 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.651 179.861 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.439 ' HD2' ' CB ' ' A' ' 178' ' ' GLU . 18.9 Cg_endo -60.27 118.77 5.69 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.541 2.161 . . . . 0.0 112.229 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.87 153.96 63.59 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.527 2.151 . . . . 0.0 112.423 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -149.63 119.92 3.96 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.822 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.01 -164.89 0.25 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.429 2.086 . . . . 0.0 112.219 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 11.9 mmtt -105.0 83.41 1.98 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.958 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.16 -0.924 . . . . 0.0 110.819 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.221 0 N-CA-C 112.525 -0.23 . . . . 0.0 112.525 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 503' ' ' SER . . . . . 0.401 ' OG ' ' HA ' ' B' ' 511' ' ' SER . 0.0 OUTLIER -111.74 -49.32 3.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.751 0.31 . . . . 0.0 111.011 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 504' ' ' GLY . . . . . 0.738 ' C ' HD22 ' B' ' 505' ' ' LEU . . . 124.78 -93.52 0.45 Allowed Glycine 0 CA--C 1.508 -0.405 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.862 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 505' ' ' LEU . . . . . 0.816 ' HB3' HD13 ' A' ' 174' ' ' LEU . 0.1 OUTLIER 74.17 0.28 3.56 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 179.45 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 506' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 52.93 23.79 3.04 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.022 0.439 . . . . 0.0 111.047 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 507' ' ' ALA . . . . . . . . . . . . . . . -107.86 -74.25 0.66 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.774 0.797 . . . . 0.0 109.506 179.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 508' ' ' GLN . . . . . 0.422 ' O ' ' HB3' ' B' ' 509' ' ' ASP . 0.0 OUTLIER -137.82 4.95 2.58 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.28 -1.327 . . . . 0.0 110.213 179.061 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 509' ' ' ASP . . . . . 0.422 ' HB3' ' O ' ' B' ' 508' ' ' GLN . 48.6 t0 72.47 38.85 0.78 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.587 0.708 . . . . 0.0 109.765 -178.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 510' ' ' ILE . . . . . 0.746 HG21 HD21 ' A' ' 177' ' ' LEU . 1.3 mt -66.34 143.72 15.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.847 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 511' ' ' SER . . . . . 0.452 ' O ' HD11 ' B' ' 514' ' ' LEU . 47.2 t -109.44 148.0 31.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.498 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 512' ' ' GLN . . . . . 0.498 ' OE1' HG21 ' A' ' 173' ' ' ILE . 0.0 OUTLIER -98.62 -67.7 0.05 OUTLIER Pre-proline 0 CA--C 1.53 0.176 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.752 179.547 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 513' ' ' PRO . . . . . 0.497 ' HD3' ' CB ' ' B' ' 512' ' ' GLN . 88.1 Cg_endo -79.16 56.95 6.24 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.456 2.104 . . . . 0.0 111.917 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 514' ' ' LEU . . . . . 0.452 HD11 ' O ' ' B' ' 511' ' ' SER . 0.9 OUTLIER -64.1 -87.01 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.39 -179.568 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 515' ' ' GLN . . . . . 0.404 ' HB2' HG12 ' A' ' 44' ' ' VAL . 4.4 mt-30 -93.07 -158.71 0.63 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.74 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 15.1 m-80 -50.37 -29.0 9.03 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.934 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 517' ' ' SER . . . . . 0.458 ' O ' ' CD1' ' B' ' 518' ' ' PHE . 0.9 OUTLIER 39.85 53.92 2.59 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.821 179.927 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 518' ' ' PHE . . . . . 0.489 ' CE2' HD12 ' A' ' 21' ' ' ILE . 6.1 m-85 -163.29 119.46 1.77 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.915 0.388 . . . . 0.0 111.438 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 519' ' ' ILE . . . . . 0.575 HD12 ' C ' ' A' ' 41' ' ' ALA . 8.9 mt -126.83 82.49 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.058 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 41.8 p-80 -54.21 101.24 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.767 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 521' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.82 31.79 1.81 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.097 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 522' ' ' GLY . . . . . 0.471 ' HA3' ' CD1' ' A' ' 37' ' ' PHE . . . -111.12 -177.83 20.42 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.409 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 523' ' ' HIS . . . . . 0.455 ' CD2' ' N ' ' B' ' 524' ' ' GLY . 34.4 t60 -117.9 -85.64 0.64 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.744 0.306 . . . . 0.0 110.956 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 524' ' ' GLY . . . . . 0.819 ' HA3' HG11 ' A' ' 36' ' ' VAL . . . 52.71 -144.4 21.87 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.604 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 525' ' ' ASP . . . . . . . . . . . . . 19.8 p30 -149.82 85.3 1.42 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.833 0.349 . . . . 0.0 110.933 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 526' ' ' SER . . . . . 0.405 ' CB ' ' HB3' ' A' ' 34' ' ' PRO . 2.4 m -74.92 95.64 3.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.662 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 527' ' ' ASP . . . . . . . . . . . . . 43.1 p-10 -153.97 150.58 22.99 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.919 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.36 100.98 0.94 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.72 2.28 . . . . 0.0 112.348 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 529' ' ' ARG . . . . . 0.509 ' HG3' HG21 ' A' ' 33' ' ' VAL . 39.7 mtp180 -100.41 -55.24 2.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.296 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 530' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -168.51 95.79 0.38 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.107 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 531' ' ' CYS . . . . . 0.412 ' O ' ' N ' ' B' ' 533' ' ' GLY . 18.3 t -49.79 130.64 21.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.014 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 532' ' ' TRP . . . . . 0.57 ' CZ2' ' CE1' ' A' ' 28' ' ' PHE . 0.0 OUTLIER 60.42 -81.84 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.933 179.893 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 533' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' B' ' 531' ' ' CYS . . . 92.3 -35.38 4.05 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.613 -0.804 . . . . 0.0 112.592 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 534' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -155.17 156.94 31.65 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.634 0.254 . . . . 0.0 110.846 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -53.21 -59.1 1.12 Allowed 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.749 2.299 . . . . 0.0 112.088 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -86.87 141.41 28.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.636 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 537' ' ' ARG . . . . . 0.427 ' HB2' ' CA ' ' A' ' 12' ' ' GLY . 25.4 mmt-85 -65.89 136.24 55.86 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.133 0.492 . . . . 0.0 111.214 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 538' ' ' ILE . . . . . 0.443 HG13 ' HB2' ' B' ' 542' ' ' TYR . 6.3 tp -59.57 143.22 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.208 179.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 539' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -44.13 143.41 1.18 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.874 0.369 . . . . 0.0 111.035 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 540' ' ' GLU . . . . . 0.869 ' HG2' HG13 ' A' ' 8' ' ' VAL . 0.3 OUTLIER -50.4 -24.39 3.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.014 -179.719 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 541' ' ' LEU . . . . . 0.785 HD12 ' HG ' ' A' ' 70' ' ' LEU . 0.1 OUTLIER -55.3 -27.04 44.21 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 121.4 0.619 . . . . 0.0 109.77 179.07 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 542' ' ' TYR . . . . . 0.443 ' HB2' HG13 ' B' ' 538' ' ' ILE . 14.2 m-85 -104.23 -63.05 1.24 Allowed 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.903 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 543' ' ' LEU . . . . . 0.403 ' HB2' ' O ' ' A' ' 58' ' ' THR . 0.3 OUTLIER 49.73 103.86 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.318 179.648 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . 118.28 -100.99 0.87 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.529 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 545' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.919 -179.884 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' GNP . . . . . 0.9 " H2'" ' OG1' ' A' ' 115' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.426 ' HG3' ' N ' ' A' ' 2' ' ' GLN . 3.0 ptm . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.796 0.332 . . . . 0.0 111.21 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.426 ' N ' ' HG3' ' A' ' 1' ' ' MET . 0.0 OUTLIER 57.65 161.88 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.706 -179.891 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.732 HG23 ' CE1' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -129.93 -177.41 4.28 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.333 -179.786 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.515 HD11 ' CD1' ' A' ' 53' ' ' LEU . 6.0 pt -153.89 148.22 13.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.758 -179.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.1 mttt -134.0 95.7 3.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.095 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -112.31 155.29 24.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.406 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.422 HG23 HG21 ' A' ' 75' ' ' THR . 0.2 OUTLIER -137.2 159.58 36.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.309 179.667 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.824 HG12 ' CG ' ' B' ' 540' ' ' GLU . 60.1 t -90.0 113.68 26.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.997 0.427 . . . . 0.0 111.299 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.463 ' CA ' ' HG2' ' B' ' 540' ' ' GLU . 93.5 t -130.65 129.48 64.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.673 179.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 138.73 -113.19 0.92 Allowed Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.014 -1.089 . . . . 0.0 113.013 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.403 ' O ' ' HB2' ' B' ' 537' ' ' ARG . 6.9 m-20 -110.61 -53.65 2.67 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.975 ' O ' HG13 ' A' ' 14' ' ' VAL . . . -140.06 -148.48 5.18 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.176 -1.011 . . . . 0.0 113.494 -179.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.624 ' O ' HG22 ' A' ' 14' ' ' VAL . . . -41.4 -31.97 0.28 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.975 HG13 ' O ' ' A' ' 12' ' ' GLY . 6.3 m 48.08 25.52 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.966 0.412 . . . . 0.0 110.721 -178.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.936 ' CA ' HD22 ' A' ' 19' ' ' LEU . . . 83.36 26.53 43.16 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.951 -0.643 . . . . 0.0 112.723 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.68 ' CB ' HG22 ' A' ' 8' ' ' VAL . 5.6 tptm -98.19 -72.91 0.63 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.776 0.322 . . . . 0.0 111.699 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.1 p -96.06 -58.32 2.12 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.456 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.501 ' HB2' ' HB2' ' A' ' 13' ' ' ALA . 12.0 t -42.34 -46.62 4.67 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.693 0.282 . . . . 0.0 111.64 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.936 HD22 ' CA ' ' A' ' 15' ' ' GLY . 0.7 OUTLIER -47.15 -49.74 21.79 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.886 0.374 . . . . 0.0 110.724 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.568 HD21 ' CE2' ' A' ' 169' ' ' PHE . 3.7 mt -64.75 -24.18 67.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.399 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.727 HG22 ' OG1' ' A' ' 25' ' ' THR . 14.2 mm -73.99 -70.52 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.19 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 59.8 p -48.26 -27.53 2.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.742 0.306 . . . . 0.0 111.048 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -70.44 -67.36 0.5 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.742 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 89.6 m -72.23 -48.58 41.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.647 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.727 ' OG1' HG22 ' A' ' 21' ' ' ILE . 20.6 p -85.58 -151.12 0.14 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.382 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -160.28 29.39 0.17 Allowed 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.859 0.361 . . . . 0.0 111.077 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.58 104.83 9.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.281 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.486 ' CD2' ' HD3' ' A' ' 29' ' ' PRO . 0.1 OUTLIER -110.34 -61.71 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.106 -179.977 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.486 ' HD3' ' CD2' ' A' ' 28' ' ' PHE . 91.5 Cg_endo -86.61 89.35 0.67 Allowed 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.369 2.046 . . . . 0.0 113.052 -179.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.3 p -163.94 -94.74 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.395 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.51 ' CG ' ' HA ' ' B' ' 530' ' ' HIS . 0.2 OUTLIER -160.25 121.87 3.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.716 0.293 . . . . 0.0 110.818 179.684 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.463 ' CD2' ' N3B' ' A' ' 185' ' ' GNP . 3.4 m-30 -101.96 94.23 5.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.934 0.397 . . . . 0.0 110.809 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.812 HG13 ' ND2' ' B' ' 545' ' ' ASN . 0.6 OUTLIER -98.73 -51.97 0.2 Allowed Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.367 -179.757 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.419 ' HD3' ' HB ' ' A' ' 33' ' ' VAL . 7.0 Cg_exo -73.9 55.94 3.47 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.812 2.341 . . . . 0.0 112.44 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.426 HG21 ' O2G' ' A' ' 185' ' ' GNP . 5.7 t -116.77 -33.68 4.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.665 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.861 ' HB ' HD13 ' A' ' 61' ' ' LEU . 7.6 p -52.6 -27.1 11.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.802 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -93.97 40.08 1.08 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.535 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.419 ' HB2' ' HB3' ' A' ' 57' ' ' ASP . 0.4 OUTLIER -93.61 36.17 1.1 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.978 -179.946 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -123.77 18.15 9.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.142 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.411 ' CD2' ' HB ' ' B' ' 521' ' ' THR . 0.2 OUTLIER -75.74 -165.39 0.44 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.789 0.328 . . . . 0.0 110.71 179.973 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.41 ' O ' HG12 ' B' ' 519' ' ' ILE . . . -96.18 161.76 13.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.164 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.503 HG23 ' OG1' ' A' ' 52' ' ' THR . 7.6 m -149.47 129.44 3.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.147 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.612 ' O ' HG23 ' A' ' 44' ' ' VAL . 5.0 t -87.9 106.13 17.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.632 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.643 HG13 ' HB2' ' B' ' 514' ' ' LEU . 1.8 t -161.1 157.86 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.726 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.48 ' HE1' ' N ' ' A' ' 48' ' ' GLY . 0.0 OUTLIER -101.74 97.61 7.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.711 -179.481 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.699 HG23 ' CG2' ' B' ' 510' ' ' ILE . 3.0 mm -77.0 86.38 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.44 ' N ' ' HE2' ' A' ' 45' ' ' MET . . . 25.63 98.63 0.01 OUTLIER Glycine 0 C--N 1.339 0.73 0 CA-C-N 115.505 -0.77 . . . . 0.0 114.435 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.48 ' N ' ' HE1' ' A' ' 45' ' ' MET . . . 128.46 -89.89 0.32 Allowed Glycine 0 CA--C 1.519 0.281 0 C-N-CA 120.596 -0.811 . . . . 0.0 113.007 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.449 ' N ' ' HE1' ' A' ' 45' ' ' MET . 1.4 pt-20 -124.73 139.85 34.26 Favored Pre-proline 0 CA--C 1.53 0.202 0 CA-C-O 120.799 0.333 . . . . 0.0 111.233 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.425 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 78.9 Cg_exo -38.12 101.26 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 123.074 2.516 . . . . 0.0 112.822 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.732 ' CE1' HG23 ' A' ' 3' ' ' THR . 2.2 t80 -172.98 154.69 2.89 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.436 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.509 HG21 ' HB ' ' A' ' 44' ' ' VAL . 0.1 OUTLIER -136.72 152.99 50.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.746 179.046 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.646 ' H ' HD13 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -74.94 161.53 29.42 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.002 -179.899 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -88.8 87.51 1.49 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.626 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.553 ' H ' HD12 ' A' ' 55' ' ' LEU . 1.1 mp -58.37 99.9 0.05 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.844 0.354 . . . . 0.0 110.664 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -84.76 105.76 15.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.997 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.419 ' HB3' ' HB2' ' A' ' 38' ' ' ASP . 30.1 t0 -104.14 129.16 51.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.84 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.884 ' O ' HD22 ' B' ' 543' ' ' LEU . 26.4 p -98.21 126.14 43.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.979 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.824 ' HB1' ' CD1' ' A' ' 61' ' ' LEU . . . -157.63 118.43 3.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.317 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.403 ' HA2' ' O ' ' A' ' 64' ' ' TYR . . . -69.36 73.85 0.42 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.286 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.861 HD13 ' HB ' ' A' ' 36' ' ' VAL . 6.7 mp -120.7 -117.26 0.31 Allowed 'General case' 0 CA--C 1.539 0.536 0 O-C-N 122.944 -0.151 . . . . 0.0 111.052 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -99.08 -31.3 11.85 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 118.069 0.395 . . . . 0.0 111.426 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.435 ' CB ' HG22 ' A' ' 36' ' ' VAL . 6.2 t0 -74.33 -63.26 1.27 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.311 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.545 ' CD2' HD21 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -115.95 133.69 55.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.718 -179.759 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.95 -69.12 0.7 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.838 0.352 . . . . 0.0 111.146 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.4 ' O ' ' HB2' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -99.44 -34.99 10.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.33 -179.885 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.597 HD13 ' HB ' ' A' ' 58' ' ' THR . 1.0 OUTLIER 70.15 123.88 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.978 -179.652 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.458 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 2.5 mpt_? -82.91 -49.26 0.77 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.147 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.458 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 83.0 Cg_exo -44.83 -58.37 1.59 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.588 2.192 . . . . 0.0 112.538 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.56 ' C ' HD12 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -51.08 -38.31 50.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.69 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.1 t -76.74 -53.78 7.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.906 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -114.32 61.57 1.12 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.638 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.428 ' N ' ' O ' ' A' ' 69' ' ' PRO . 52.1 Cg_endo -68.65 112.44 2.87 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.575 2.184 . . . . 0.0 112.466 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 15.2 tp60 -101.96 10.16 39.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.375 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.422 HG21 HG23 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -56.34 166.64 0.81 Allowed 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 120.802 0.334 . . . . 0.0 110.809 179.979 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -72.74 -26.02 61.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.707 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.632 HG11 ' HB3' ' A' ' 175' ' ' ALA . 10.3 p -164.4 116.31 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.132 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.683 ' CZ ' HG21 ' A' ' 108' ' ' THR . 0.0 OUTLIER -92.89 134.51 35.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.166 179.349 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.619 HD13 ' HB1' ' A' ' 172' ' ' ALA . 7.5 tp -70.6 108.01 4.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.095 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.516 ' O ' HG23 ' A' ' 80' ' ' VAL . 23.3 m -103.54 121.09 54.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.013 179.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.564 ' HB2' HG12 ' A' ' 14' ' ' VAL . 41.1 m -129.13 171.42 12.42 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.359 0.599 . . . . 0.0 112.493 -178.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.555 ' CZ ' ' HB2' ' A' ' 142' ' ' ALA . 41.3 p90 -140.86 -174.04 3.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.88 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.3 p -134.66 122.74 22.68 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.808 0.337 . . . . 0.0 111.071 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.66 HG11 ' HB3' ' A' ' 120' ' ' ARG . 2.9 t -57.15 170.52 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.184 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.756 HG22 ' HA ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER 61.09 105.57 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -179.287 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.531 ' N ' HD21 ' A' ' 129' ' ' LEU . 13.9 p -152.5 143.16 15.5 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-O 120.956 0.408 . . . . 0.0 112.039 -179.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.433 ' O ' ' CB ' ' A' ' 88' ' ' SER . 83.1 Cg_endo -90.84 53.36 1.01 Allowed 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.29 2.66 . . . . 0.0 111.585 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.46 ' CB ' ' HG2' ' A' ' 133' ' ' LYS . 0.3 OUTLIER 84.29 25.62 0.1 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.663 -179.533 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.964 ' O ' HG23 ' A' ' 93' ' ' VAL . 2.8 p -97.23 -25.1 15.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.992 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -53.86 -43.79 69.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.016 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -53.96 -61.71 2.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.929 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.419 ' O ' ' N ' ' A' ' 96' ' ' LYS . 30.0 m-80 -53.88 -42.31 68.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.941 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.964 HG23 ' O ' ' A' ' 89' ' ' SER . 60.1 t -47.47 -63.74 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.303 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.7 ' CG ' HD11 ' A' ' 145' ' ' LEU . 0.0 OUTLIER -51.04 -45.75 61.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.869 179.91 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.412 ' O ' ' HG3' ' A' ' 99' ' ' PRO . 0.8 OUTLIER -85.31 10.79 11.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.723 -179.952 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 92' ' ' ASN . 0.2 OUTLIER -111.04 -36.18 5.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.934 0.397 . . . . 0.0 110.976 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.401 ' O ' HG23 ' A' ' 101' ' ' ILE . 33.4 m95 -94.36 -42.95 8.63 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.543 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 94' ' ' LYS . 82.3 t -53.26 -47.3 96.53 Favored Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 77.9 Cg_endo -78.95 -18.52 11.44 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.237 1.958 . . . . 0.0 112.629 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -81.61 -40.18 23.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.923 0.392 . . . . 0.0 110.492 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.498 ' CD1' ' CD2' ' A' ' 110' ' ' PHE . 32.8 pt -69.49 -29.79 43.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.904 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.543 HG23 ' O ' ' A' ' 98' ' ' VAL . 70.5 p -78.2 -32.91 50.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.697 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 -63.21 -54.76 32.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.652 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 16.2 m80 -71.65 -24.28 61.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.79 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 1.6 t -143.85 95.96 5.64 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.866 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -47.63 112.07 0.5 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.654 2.236 . . . . 0.0 112.509 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.8 mttt 49.8 99.26 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.157 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.683 HG21 ' CZ ' ' A' ' 78' ' ' PHE . 8.7 m -139.24 144.34 40.04 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.03 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.427 ' C ' HG23 ' A' ' 77' ' ' VAL . 34.2 Cg_exo -60.67 159.29 28.93 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.762 2.308 . . . . 0.0 112.829 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.498 ' CD2' ' CD1' ' A' ' 101' ' ' ILE . 2.4 p90 -165.37 148.24 7.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.556 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 1.006 HD22 ' HB2' ' A' ' 172' ' ' ALA . 1.1 tt -120.05 154.79 34.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.168 -179.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.913 HD12 ' HB2' ' A' ' 146' ' ' ALA . 13.1 mt -111.73 146.43 37.57 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.799 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.831 ' CG1' HG21 ' A' ' 168' ' ' VAL . 21.9 t -130.87 149.69 33.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.15 0.5 . . . . 0.0 111.884 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.517 ' C ' HD12 ' A' ' 117' ' ' ILE . . . -124.97 112.43 1.73 Allowed Glycine 0 N--CA 1.452 -0.247 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.407 179.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.837 ' HG1' " H2'" ' A' ' 185' ' ' GNP . 0.2 OUTLIER -127.84 -54.82 1.31 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.839 0.352 . . . . 0.0 111.329 -179.009 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.474 ' HG2' HD21 ' A' ' 119' ' ' LEU . 2.0 tt0 -58.56 -17.65 23.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.26 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.871 HD11 ' O ' ' A' ' 157' ' ' CYS . 0.2 OUTLIER -44.81 -27.31 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 120.841 0.353 . . . . 0.0 111.592 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.413 ' N ' HG12 ' A' ' 117' ' ' ILE . 21.4 t0 -66.76 -35.37 79.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.688 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.633 ' C ' HD12 ' A' ' 119' ' ' LEU . 3.8 pp -99.49 -3.89 32.54 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.756 ' HA ' HG22 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -52.37 -35.67 51.87 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.977 0.418 . . . . 0.0 110.481 179.583 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -62.48 -24.17 67.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.759 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.412 ' O ' ' HB ' ' A' ' 126' ' ' ILE . 8.9 t0 -42.36 100.6 0.23 Allowed Pre-proline 0 N--CA 1.463 0.208 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.025 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.44 ' O ' ' CG ' ' A' ' 127' ' ' GLU . 37.7 Cg_endo -66.67 -8.99 22.83 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.434 2.089 . . . . 0.0 112.897 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.7 t -74.14 -67.52 0.61 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.08 0.467 . . . . 0.0 110.008 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.894 HG22 ' CD1' ' A' ' 129' ' ' LEU . 73.6 m -56.36 -47.15 79.44 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.523 HD11 ' HB3' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -46.91 -40.46 4.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.959 179.413 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.646 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 4.8 mm-40 -60.07 -39.11 84.93 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.438 ' N ' ' O ' ' A' ' 125' ' ' THR . 0.0 OUTLIER -68.67 -34.02 74.97 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.155 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.894 ' CD1' HG22 ' A' ' 125' ' ' THR . 9.8 mp -64.84 -37.75 88.66 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 177.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.646 ' HB3' ' O ' ' A' ' 127' ' ' GLU . . . -43.58 -39.16 3.34 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 114.453 -1.249 . . . . 0.0 111.567 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 6.3 mmtm -58.65 -24.8 61.91 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.579 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.426 ' CB ' ' O ' ' A' ' 87' ' ' PRO . 11.1 m-80 -124.38 -31.52 3.27 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -179.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.46 ' HG2' ' CB ' ' A' ' 88' ' ' SER . 2.2 mmtt -156.41 -63.38 0.1 Allowed 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -178.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.578 ' CD ' ' HB2' ' A' ' 130' ' ' ALA . 2.0 tt0 80.9 14.18 0.69 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.208 -178.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.402 ' HA ' ' HD2' ' A' ' 136' ' ' PRO . 35.2 mmtt -97.87 96.54 3.45 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.634 0.254 . . . . 0.0 111.175 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.523 ' HB3' HD11 ' A' ' 126' ' ' ILE . 30.9 Cg_endo -64.74 131.1 28.15 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.389 2.059 . . . . 0.0 111.738 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.659 ' O ' HG13 ' A' ' 84' ' ' VAL . 1.6 mm -67.55 96.38 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.0 0.429 . . . . 0.0 110.749 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.3 p -77.0 147.28 76.84 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.868 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.487 ' HA ' ' CE1' ' A' ' 154' ' ' TYR . 96.4 Cg_exo -43.0 -28.22 1.17 Allowed 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.584 2.189 . . . . 0.0 112.286 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -72.88 -36.55 67.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.865 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 16.6 m -54.57 -61.93 1.99 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.898 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.555 ' HB2' ' CZ ' ' A' ' 82' ' ' PHE . . . -52.04 -40.81 61.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.066 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -51.18 -45.29 61.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.821 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.4 ttpp -64.06 -49.08 73.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.812 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.7 HD11 ' CG ' ' A' ' 94' ' ' LYS . 0.9 OUTLIER -61.43 -46.77 88.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.674 179.819 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.913 ' HB2' HD12 ' A' ' 112' ' ' LEU . . . -50.93 -45.52 60.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.98 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.57 -26.6 32.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.772 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.483 ' HB3' HD22 ' A' ' 149' ' ' LEU . 25.0 t0 -53.18 -38.4 62.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.766 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.483 HD22 ' HB3' ' A' ' 148' ' ' ASP . 2.9 mm? -114.48 21.25 14.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.926 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 48.16 51.3 14.99 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.037 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.649 ' O ' HG23 ' A' ' 152' ' ' VAL . . . -66.66 -82.86 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.978 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.881 HG11 HD12 ' A' ' 111' ' ' LEU . 36.5 t -164.32 -69.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.244 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 176.65 135.76 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.134 -179.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.487 ' CE1' ' HA ' ' A' ' 139' ' ' PRO . 27.7 t80 -106.54 108.01 19.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.64 178.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.552 HG23 ' OE2' ' A' ' 171' ' ' GLU . 0.2 OUTLIER -101.32 -171.89 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.89 0.376 . . . . 0.0 111.319 -179.175 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.504 ' H ' HG12 ' A' ' 155' ' ' VAL . 8.9 mt-10 -89.73 156.51 18.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.159 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.871 ' O ' HD11 ' A' ' 117' ' ' ILE . 13.0 t 178.82 160.02 0.62 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.199 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.631 ' OG ' HG22 ' A' ' 161' ' ' THR . 8.4 t -159.69 123.56 3.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.866 0.365 . . . . 0.0 111.19 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -92.3 20.25 6.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.073 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.652 ' N ' HD12 ' A' ' 160' ' ' LEU . 0.0 OUTLIER -133.11 -44.71 0.85 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.527 179.927 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.631 HG22 ' OG ' ' A' ' 158' ' ' SER . 9.7 t -111.06 -16.08 13.57 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.993 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 75.9 85.41 0.09 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.84 0.352 . . . . 0.0 111.355 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.502 ' HG2' HG23 ' A' ' 161' ' ' THR . 22.1 mmmt -111.12 45.77 1.14 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.52 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.436 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . 128.95 -63.22 0.63 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.106 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.832 HD11 ' O ' ' A' ' 19' ' ' LEU . 0.2 OUTLIER 62.23 -74.46 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.711 0.291 . . . . 0.0 111.257 179.597 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.442 ' HB3' ' HG3' ' B' ' 513' ' ' PRO . 0.0 OUTLIER -69.76 -23.42 63.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.99 -179.961 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.548 ' ND2' HG11 ' A' ' 155' ' ' VAL . 0.2 OUTLIER -56.02 -56.07 25.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.006 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.831 HG21 ' CG1' ' A' ' 113' ' ' VAL . 16.2 m -71.27 -36.74 63.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.582 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.689 ' HB2' HD23 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -75.03 -19.52 60.0 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.853 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.72 ' OD2' HD21 ' B' ' 505' ' ' LEU . 28.7 t70 -83.06 -34.81 26.11 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.011 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.836 ' CD ' HD11 ' A' ' 111' ' ' LEU . 2.1 pt-20 -75.15 -31.66 61.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.912 0.387 . . . . 0.0 110.34 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 1.006 ' HB2' HD22 ' A' ' 111' ' ' LEU . . . -73.09 -47.81 41.23 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.586 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.424 HG12 ' O ' ' A' ' 169' ' ' PHE . 1.7 pp -64.34 -38.63 83.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.756 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.854 HD23 HD13 ' B' ' 505' ' ' LEU . 3.3 tm? -52.3 -35.4 50.43 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.921 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.632 ' HB3' HG11 ' A' ' 77' ' ' VAL . . . -51.76 -24.31 5.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.984 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.48 ' HB3' ' HB ' ' A' ' 4' ' ' ILE . . . -95.05 -36.94 11.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.106 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.921 HD13 ' HB ' ' B' ' 510' ' ' ILE . 9.6 mt -68.82 -24.34 64.37 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.844 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -172.94 128.8 0.54 Allowed Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.908 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -57.19 115.75 2.72 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.559 2.172 . . . . 0.0 112.304 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -77.47 -166.44 0.39 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.451 2.101 . . . . 0.0 112.312 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -149.08 131.55 7.84 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.891 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -80.71 -165.47 0.34 Allowed 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.667 2.245 . . . . 0.0 112.326 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 29.3 mttt -133.98 170.85 15.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.894 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 2.3 mttm . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.184 -0.913 . . . . 0.0 110.905 -179.946 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.202 0 N-CA-C 112.428 -0.269 . . . . 0.0 112.428 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 503' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.5 -162.37 0.51 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.819 0.343 . . . . 0.0 110.849 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 504' ' ' GLY . . . . . 0.844 ' O ' HD12 ' B' ' 505' ' ' LEU . . . 131.17 -101.89 0.5 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.321 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 505' ' ' LEU . . . . . 0.854 HD13 HD23 ' A' ' 174' ' ' LEU . 0.0 OUTLIER 58.96 18.08 5.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.563 0.22 . . . . 0.0 111.3 179.773 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 506' ' ' SER . . . . . 0.54 ' O ' ' HB2' ' B' ' 507' ' ' ALA . 0.7 OUTLIER 65.26 100.19 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.925 0.393 . . . . 0.0 110.649 -179.922 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 507' ' ' ALA . . . . . 0.54 ' HB2' ' O ' ' B' ' 506' ' ' SER . . . 169.15 -36.29 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.389 0.614 . . . . 0.0 110.44 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 508' ' ' GLN . . . . . 0.476 ' O ' ' CB ' ' B' ' 509' ' ' ASP . 0.5 OUTLIER 156.62 -26.36 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.394 -179.364 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 509' ' ' ASP . . . . . 0.476 ' CB ' ' O ' ' B' ' 508' ' ' GLN . 0.3 OUTLIER 98.07 32.4 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.975 0.91 . . . . 0.0 110.872 179.739 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 510' ' ' ILE . . . . . 0.921 ' HB ' HD13 ' A' ' 177' ' ' LEU . 3.3 mp -54.05 130.9 16.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.443 179.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 511' ' ' SER . . . . . 0.487 ' O ' HD12 ' B' ' 514' ' ' LEU . 0.4 OUTLIER -109.09 154.48 22.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.261 -179.459 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 512' ' ' GLN . . . . . 0.465 ' CB ' ' HD3' ' B' ' 513' ' ' PRO . 0.0 OUTLIER -97.9 -57.69 0.17 Allowed Pre-proline 0 C--N 1.333 -0.149 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.799 179.575 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 513' ' ' PRO . . . . . 0.465 ' HD3' ' CB ' ' B' ' 512' ' ' GLN . 59.9 Cg_endo -90.85 42.4 0.43 Allowed 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.905 2.404 . . . . 0.0 112.043 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 514' ' ' LEU . . . . . 0.643 ' HB2' HG13 ' A' ' 44' ' ' VAL . 0.3 OUTLIER -46.49 -85.62 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.624 -179.388 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 515' ' ' GLN . . . . . 0.617 ' H ' HG22 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -92.09 -86.52 0.23 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.124 -179.741 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -125.12 -37.15 2.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.218 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 517' ' ' SER . . . . . 0.407 ' O ' ' CG1' ' A' ' 42' ' ' VAL . 0.7 OUTLIER 63.79 29.57 14.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.962 -179.884 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 518' ' ' PHE . . . . . 0.405 ' HA ' HG12 ' A' ' 42' ' ' VAL . 1.2 m-85 -163.22 123.98 2.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.06 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 519' ' ' ILE . . . . . 0.556 HD11 ' H ' ' A' ' 43' ' ' THR . 12.1 mm -94.42 31.87 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.162 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 52.26 38.26 24.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.858 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 521' ' ' THR . . . . . 0.411 ' HB ' ' CD2' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -113.51 -172.11 2.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.845 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 522' ' ' GLY . . . . . . . . . . . . . . . 101.08 125.46 5.6 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.356 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 523' ' ' HIS . . . . . . . . . . . . . 26.4 t60 -117.86 -81.28 0.62 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.747 0.308 . . . . 0.0 110.98 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 524' ' ' GLY . . . . . . . . . . . . . . . 58.09 -106.05 0.74 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.648 -0.786 . . . . 0.0 112.619 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 525' ' ' ASP . . . . . . . . . . . . . 4.7 t0 57.77 73.77 0.45 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.754 0.311 . . . . 0.0 110.891 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 526' ' ' SER . . . . . 0.431 ' CB ' ' HB3' ' A' ' 61' ' ' LEU . 32.0 t -108.83 96.77 6.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.987 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 527' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 70.7 95.79 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.053 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -74.95 58.83 4.98 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.736 2.291 . . . . 0.0 112.472 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 529' ' ' ARG . . . . . 0.401 ' HD2' ' OD1' ' B' ' 545' ' ' ASN . 0.1 OUTLIER -53.31 -43.09 67.32 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.192 0.52 . . . . 0.0 110.122 179.519 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 530' ' ' HIS . . . . . 0.51 ' HA ' ' CG ' ' A' ' 31' ' ' GLU . 41.2 m170 64.74 51.05 1.93 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.931 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -155.99 132.1 9.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.16 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 532' ' ' TRP . . . . . 0.407 ' NE1' ' O ' ' B' ' 536' ' ' ASP . 6.6 t-105 -92.22 -22.22 19.92 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.887 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . 92.44 -136.59 13.29 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.447 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 534' ' ' PHE . . . . . 0.433 ' HB3' ' HD2' ' B' ' 535' ' ' PRO . 39.2 m-85 -81.42 165.5 43.95 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.655 0.264 . . . . 0.0 110.629 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 535' ' ' PRO . . . . . 0.433 ' HD2' ' HB3' ' B' ' 534' ' ' PHE . 48.6 Cg_exo -56.18 81.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.587 2.191 . . . . 0.0 112.377 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 536' ' ' ASP . . . . . 0.45 ' HA ' ' NH1' ' B' ' 537' ' ' ARG . 0.2 OUTLIER 171.45 -164.22 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.92 -180.0 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 537' ' ' ARG . . . . . 0.461 ' HD2' " C1'" ' A' ' 185' ' ' GNP . 0.0 OUTLIER -125.47 155.88 39.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.148 0.499 . . . . 0.0 110.532 179.77 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 538' ' ' ILE . . . . . 0.512 HG23 ' HA ' ' B' ' 543' ' ' LEU . 6.7 tp -83.34 123.96 39.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.483 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 539' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -33.68 130.19 0.28 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.156 0.503 . . . . 0.0 112.115 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 540' ' ' GLU . . . . . 0.824 ' CG ' HG12 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -41.79 -28.35 0.15 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.254 -179.29 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 541' ' ' LEU . . . . . 0.537 ' HA ' HD21 ' A' ' 70' ' ' LEU . 0.8 OUTLIER -40.91 -50.26 3.24 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.864 0.364 . . . . 0.0 111.319 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 542' ' ' TYR . . . . . 0.406 ' CD1' ' N ' ' B' ' 542' ' ' TYR . 0.1 OUTLIER -105.35 -63.37 1.24 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.234 179.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 543' ' ' LEU . . . . . 0.884 HD22 ' O ' ' A' ' 58' ' ' THR . 0.3 OUTLIER 72.83 166.68 0.3 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.474 -179.345 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . 116.47 156.97 10.86 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.655 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 545' ' ' ASN . . . . . 0.812 ' ND2' HG13 ' A' ' 33' ' ' VAL . 5.9 p30 . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.199 -0.905 . . . . 0.0 111.098 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' GNP . . . . . 0.837 " H2'" ' HG1' ' A' ' 115' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' HOH . . . . . 0.707 ' O ' HD21 ' B' ' 543' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.4 ' HE3' ' O ' ' A' ' 2' ' ' GLN . 5.2 tpt . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.807 0.337 . . . . 0.0 111.252 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.4 ' O ' ' HE3' ' A' ' 1' ' ' MET . 0.0 OUTLIER -64.23 144.61 57.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.49 179.822 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.761 HG23 ' CE1' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -110.79 -173.82 2.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.535 -179.545 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.658 HD11 ' CD1' ' A' ' 53' ' ' LEU . 5.7 pt -154.92 127.29 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.16 -179.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.458 ' CB ' ' HB ' ' A' ' 75' ' ' THR . 5.6 mmtp -100.6 100.58 11.32 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.429 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -77.63 132.56 38.31 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.201 0.524 . . . . 0.0 112.061 -178.71 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.3 t -144.52 159.66 14.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.918 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.589 HG21 ' C ' ' A' ' 15' ' ' GLY . 48.7 t -133.72 128.57 54.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.301 0.572 . . . . 0.0 112.143 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.44 ' HA ' ' CG ' ' B' ' 540' ' ' GLU . 3.3 m -134.06 129.38 54.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.267 -0.878 . . . . 0.0 109.694 178.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 134.98 -160.3 24.26 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.247 -0.978 . . . . 0.0 112.6 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.418 ' O ' ' N ' ' B' ' 537' ' ' ARG . 6.6 p30 -122.87 27.27 7.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.642 0.258 . . . . 0.0 111.047 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -104.59 174.59 21.96 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.823 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.787 ' HB3' ' H8 ' ' A' ' 185' ' ' GNP . . . -95.16 -56.38 2.75 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.863 0.363 . . . . 0.0 111.1 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.902 HG12 ' N7 ' ' A' ' 185' ' ' GNP . 14.7 p -53.61 105.93 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.047 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.589 ' C ' HG21 ' A' ' 8' ' ' VAL . . . 153.01 -44.51 0.61 Allowed Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.069 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.675 ' CD ' HD11 ' B' ' 543' ' ' LEU . 9.8 mtmt -90.18 -95.24 0.11 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 120.368 0.127 . . . . 0.0 111.077 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.8 HG21 ' HA ' ' A' ' 35' ' ' THR . 61.3 p -98.44 -49.6 4.6 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 120.939 0.4 . . . . 0.0 111.482 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.436 ' O ' ' CB ' ' A' ' 22' ' ' SER . 10.2 t -36.9 -41.32 0.33 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.447 -179.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.621 ' CD2' HG23 ' A' ' 14' ' ' VAL . 6.5 mt -49.84 -73.79 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.864 0.364 . . . . 0.0 111.557 -179.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.2 mt -74.74 -30.9 61.66 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.017 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.712 HD11 ' HZ ' ' A' ' 37' ' ' PHE . 16.2 mm -66.44 -69.44 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 178.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.439 ' O ' ' ND2' ' A' ' 26' ' ' ASN . 7.4 t -49.74 -25.8 3.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.594 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -65.37 -46.59 79.52 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.447 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.58 -55.01 3.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.478 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.431 ' OG1' HG23 ' A' ' 21' ' ' ILE . 30.1 p -88.38 76.4 8.31 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.439 ' ND2' ' O ' ' A' ' 22' ' ' SER . 0.6 OUTLIER -69.52 62.28 0.16 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.436 -178.742 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.2 mtmt -121.87 90.85 3.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.599 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.495 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 2.2 t80 -90.03 -44.95 0.41 Allowed Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.749 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 86.6 Cg_endo -85.78 13.56 2.71 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.5 2.133 . . . . 0.0 113.082 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.2 m -93.68 -93.7 0.17 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.631 -0.258 . . . . 0.0 110.845 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.407 ' HB2' ' HD2' ' B' ' 529' ' ' ARG . 3.6 pt-20 -158.99 145.52 16.95 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.789 0.328 . . . . 0.0 110.786 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.526 ' CD2' ' N3B' ' A' ' 185' ' ' GNP . 11.9 m-85 -126.23 133.61 51.44 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.669 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.74 HG11 ' O ' ' B' ' 526' ' ' SER . 0.0 OUTLIER -162.53 -56.55 0.01 OUTLIER Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.612 -179.537 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.535 ' HD3' HG23 ' A' ' 33' ' ' VAL . 51.5 Cg_exo -56.49 78.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.527 2.151 . . . . 0.0 112.686 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.8 ' HA ' HG21 ' A' ' 17' ' ' THR . 29.2 m -121.57 -5.35 9.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.253 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.651 HG22 HD13 ' A' ' 61' ' ' LEU . 0.1 OUTLIER -89.69 -3.34 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -179.863 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.712 ' HZ ' HD11 ' A' ' 21' ' ' ILE . 17.4 p90 -81.0 9.24 6.82 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.419 ' HB2' ' HB2' ' A' ' 57' ' ' ASP . 4.5 p-10 -52.39 -174.12 0.0 OUTLIER 'General case' 0 C--O 1.231 0.101 0 CA-C-O 120.778 0.323 . . . . 0.0 111.052 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.418 ' ND2' ' OH ' ' A' ' 64' ' ' TYR . 9.8 p30 48.82 25.45 1.03 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.895 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -65.16 -174.29 0.16 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.733 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.431 ' O ' ' CG1' ' B' ' 519' ' ' ILE . . . -122.93 152.01 41.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.272 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.698 HG23 HG21 ' A' ' 52' ' ' THR . 34.2 m -145.89 156.12 12.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.916 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.41 ' C ' HG13 ' A' ' 44' ' ' VAL . 0.1 OUTLIER -123.52 106.39 10.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.957 0.408 . . . . 0.0 111.239 -179.736 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.985 HG22 ' CG2' ' A' ' 52' ' ' THR . 10.7 m -156.5 -177.24 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.917 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.484 ' HE3' ' N ' ' A' ' 46' ' ' ILE . 4.8 tpt -107.01 96.1 6.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.303 -179.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.62 HD13 ' O ' ' B' ' 511' ' ' SER . 3.9 mm -76.79 86.85 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 121.036 0.446 . . . . 0.0 110.629 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.722 ' HA3' HG23 ' B' ' 510' ' ' ILE . . . 39.6 -92.73 0.01 OUTLIER Glycine 0 CA--C 1.521 0.454 0 CA-C-N 115.778 -0.647 . . . . 0.0 113.851 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . -35.59 -87.07 0.01 OUTLIER Glycine 0 C--N 1.334 0.457 0 N-CA-C 114.019 0.368 . . . . 0.0 114.019 -179.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.47 ' N ' ' HE1' ' A' ' 45' ' ' MET . 0.5 OUTLIER -133.32 159.16 73.68 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 120.705 0.288 . . . . 0.0 110.775 -179.693 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.403 ' N ' ' SD ' ' A' ' 45' ' ' MET . 86.1 Cg_exo -45.2 100.21 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.326 2.017 . . . . 0.0 112.161 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.761 ' CE1' HG23 ' A' ' 3' ' ' THR . 8.8 t80 -167.21 153.78 8.29 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.442 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.985 ' CG2' HG22 ' A' ' 44' ' ' VAL . 1.8 p -136.86 153.37 50.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.037 0.446 . . . . 0.0 111.467 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.812 HD11 ' OE1' ' B' ' 512' ' ' GLN . 0.0 OUTLIER -83.38 167.99 17.02 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.844 179.637 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.78 ' C ' HD12 ' A' ' 55' ' ' LEU . . . -105.21 -25.72 6.59 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.801 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.78 HD12 ' C ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER 52.12 92.54 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.785 0.326 . . . . 0.0 111.038 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -84.95 105.57 15.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.365 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.503 ' OD1' HG23 ' A' ' 8' ' ' VAL . 6.3 m-20 -105.95 165.99 10.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.109 0.48 . . . . 0.0 111.272 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.811 HG22 HD13 ' A' ' 67' ' ' LEU . 1.5 p -89.32 152.98 21.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.033 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.568 ' HB1' HG13 ' A' ' 36' ' ' VAL . . . -172.12 100.36 0.16 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.667 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.415 ' HA2' ' HA ' ' A' ' 65' ' ' ASP . . . -98.66 70.67 0.6 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.814 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.922 HD23 ' CB ' ' B' ' 526' ' ' SER . 6.5 mp -120.19 -107.69 0.36 Allowed 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 110.601 -0.148 . . . . 0.0 110.601 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -99.8 -24.67 14.61 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 120.775 0.322 . . . . 0.0 111.334 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.424 ' CB ' ' CG1' ' A' ' 36' ' ' VAL . 16.0 t0 -70.71 -63.41 1.1 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.676 -179.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.431 ' CD1' ' N ' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -151.66 116.25 5.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.848 0.356 . . . . 0.0 111.028 -179.54 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.415 ' HA ' ' HA2' ' A' ' 60' ' ' GLY . 0.2 OUTLIER -85.67 -13.77 47.55 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.392 179.961 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.32 -50.7 4.23 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.651 0.262 . . . . 0.0 111.656 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.811 HD13 HG22 ' A' ' 58' ' ' THR . 13.5 mt 69.82 -148.18 0.1 Allowed 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 -179.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.418 ' CB ' ' CD ' ' A' ' 69' ' ' PRO . 3.8 mtt-85 -172.55 -61.38 0.0 OUTLIER Pre-proline 0 CA--C 1.528 0.102 0 C-N-CA 120.776 -0.369 . . . . 0.0 111.883 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.418 ' CD ' ' CB ' ' A' ' 68' ' ' ARG . 50.0 Cg_exo -35.99 -60.26 0.35 Allowed 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 123.059 2.506 . . . . 0.0 113.236 -179.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.697 HD22 ' HA ' ' B' ' 541' ' ' LEU . 0.3 OUTLIER -46.88 -26.74 1.04 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.351 -179.777 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.5 t -74.6 -70.45 0.4 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.289 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -95.49 150.17 37.14 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.213 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.49 120.78 5.72 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.706 2.271 . . . . 0.0 112.531 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.415 ' NE2' ' O ' ' A' ' 69' ' ' PRO . 1.3 mp0 -102.03 -60.3 1.56 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.848 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.458 ' HB ' ' CB ' ' A' ' 5' ' ' LYS . 7.9 t -82.15 -178.71 7.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.053 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.405 ' O ' ' CG ' ' A' ' 109' ' ' PRO . 0.1 OUTLIER -104.3 7.7 35.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.382 179.899 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.655 ' O ' HG13 ' A' ' 77' ' ' VAL . 11.3 p -156.47 106.92 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.711 0.291 . . . . 0.0 111.24 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.552 ' CE1' HG21 ' A' ' 108' ' ' THR . 4.9 m-85 -83.59 -177.9 6.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.607 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.531 HD13 ' N ' ' A' ' 80' ' ' VAL . 0.2 OUTLIER -119.19 117.71 29.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.95 0.405 . . . . 0.0 111.427 -179.602 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.67 HG21 ' CD1' ' A' ' 110' ' ' PHE . 1.8 t -111.35 100.32 10.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.367 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.536 ' HB3' HG13 ' A' ' 14' ' ' VAL . 2.3 p -109.57 137.74 46.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.04 0.448 . . . . 0.0 111.538 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.756 ' CE1' HG21 ' A' ' 137' ' ' ILE . 28.7 p90 -147.18 145.22 29.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.224 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.6 m -83.29 130.58 35.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.901 0.381 . . . . 0.0 111.269 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.676 HG23 ' N2 ' ' A' ' 185' ' ' GNP . 97.2 t -45.93 -73.72 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.481 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.636 ' HB ' HD21 ' A' ' 129' ' ' LEU . 5.6 m -43.64 117.75 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.332 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.469 ' N ' HD22 ' A' ' 129' ' ' LEU . 0.4 OUTLIER -151.57 136.89 10.71 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.336 -179.798 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.421 ' O ' ' CB ' ' A' ' 88' ' ' SER . 68.2 Cg_endo -92.42 52.75 0.58 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 123.212 2.608 . . . . 0.0 111.816 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.448 ' CB ' ' HG2' ' A' ' 133' ' ' LYS . 0.1 OUTLIER 80.84 26.25 0.26 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.908 -179.499 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.817 ' O ' HG23 ' A' ' 93' ' ' VAL . 43.3 t -96.78 -26.17 15.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.911 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.483 ' CE1' ' CE1' ' A' ' 82' ' ' PHE . 3.9 t80 -54.65 -46.97 74.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.983 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -52.3 -58.26 7.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.994 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.416 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 0.4 OUTLIER -54.39 -43.17 71.19 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.027 -179.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.817 HG23 ' O ' ' A' ' 89' ' ' SER . 60.5 t -54.35 -45.54 68.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.254 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.521 ' O ' HG23 ' A' ' 98' ' ' VAL . 14.9 tttt -59.6 -55.12 38.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.056 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.8 0.14 24.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.741 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.416 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 2.0 tttt -112.22 -22.53 10.89 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.656 0.265 . . . . 0.0 111.072 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.662 ' HZ3' HG12 ' A' ' 80' ' ' VAL . 25.2 m0 -93.06 -55.13 3.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.111 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 94' ' ' LYS . 61.1 t -43.68 -56.13 7.69 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.869 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 30.6 Cg_endo -62.67 -18.8 65.85 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.169 1.912 . . . . 0.0 112.381 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.29 -45.32 9.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.006 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.403 HG12 ' O ' ' A' ' 97' ' ' TRP . 19.7 mm -52.58 -56.92 5.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.159 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.1 p -65.25 -22.3 66.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.238 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 22.3 t-160 -64.93 -68.74 0.34 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.892 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -75.54 -27.22 58.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.004 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.459 ' HB3' ' CB ' ' A' ' 108' ' ' THR . 8.3 m -122.64 75.16 45.48 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.024 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -57.08 131.96 48.56 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.642 2.228 . . . . 0.0 112.166 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 9.7 mmtp 50.31 39.16 19.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.824 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.552 HG21 ' CE1' ' A' ' 78' ' ' PHE . 46.0 m -108.3 101.69 43.31 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.95 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.405 ' CG ' ' O ' ' A' ' 76' ' ' ASP . 36.3 Cg_exo -60.19 171.78 2.91 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.632 2.221 . . . . 0.0 112.425 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.754 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 6.6 p90 -158.52 -177.55 6.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.711 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.88 HD12 ' HB ' ' A' ' 152' ' ' VAL . 3.1 tt -142.2 152.88 43.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.828 0.347 . . . . 0.0 111.245 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.528 HD12 ' HE2' ' A' ' 82' ' ' PHE . 4.3 mm? -101.52 161.15 13.85 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.559 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.78 HG13 HG21 ' A' ' 168' ' ' VAL . 2.5 t -138.74 155.5 27.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.007 0.432 . . . . 0.0 111.743 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.474 ' C ' HD12 ' A' ' 117' ' ' ILE . . . -140.14 114.23 0.96 Allowed Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.327 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.956 ' OG1' " H2'" ' A' ' 185' ' ' GNP . 0.1 OUTLIER -126.97 -49.14 1.47 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.919 0.39 . . . . 0.0 110.284 -179.676 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.584 ' CG ' HD21 ' A' ' 119' ' ' LEU . 0.7 OUTLIER -61.69 -16.28 47.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.634 179.284 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.763 HD13 ' C ' ' A' ' 115' ' ' THR . 0.2 OUTLIER -40.58 -28.57 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 179.906 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.441 ' N ' HG12 ' A' ' 117' ' ' ILE . 2.3 p30 -66.9 -29.56 69.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.852 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.713 ' O ' HD12 ' A' ' 119' ' ' LEU . 3.6 pp -106.01 13.71 28.87 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.44 ' O ' ' CD1' ' A' ' 126' ' ' ILE . 1.8 ppt_? -66.86 -20.64 65.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.727 0.299 . . . . 0.0 110.696 179.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -85.47 -25.97 26.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.484 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -49.95 104.98 0.46 Allowed Pre-proline 0 C--N 1.332 -0.171 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.696 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.476 ' HA ' ' CG2' ' A' ' 126' ' ' ILE . 37.4 Cg_endo -66.32 -7.9 18.92 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.582 2.188 . . . . 0.0 113.174 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.38 -67.28 0.64 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.443 ' CG2' HG11 ' A' ' 85' ' ' VAL . 12.4 m -58.24 -39.41 79.04 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 178.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.828 HD11 ' HB3' ' A' ' 136' ' ' PRO . 0.1 OUTLIER -54.39 -44.68 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.684 179.176 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.538 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 11.4 mm-40 -57.84 -36.87 72.89 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.896 179.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 125' ' ' THR . 0.0 OUTLIER -63.31 -30.72 71.81 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.902 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.636 HD21 ' HB ' ' A' ' 85' ' ' VAL . 6.8 mt -74.54 -38.04 62.86 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 177.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.538 ' HB3' ' O ' ' A' ' 127' ' ' GLU . . . -45.47 -33.15 2.51 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 114.867 -1.06 . . . . 0.0 111.048 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.2 mmtp -48.95 -34.89 13.82 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.512 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.412 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 2.7 m-80 -123.2 -31.23 3.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.362 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.524 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 36.8 mmtt -143.59 -100.67 0.12 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 119.092 -0.48 . . . . 0.0 111.478 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.524 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 4.5 pt20 131.33 -22.34 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.456 1.102 . . . . 0.0 110.45 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 5.9 mmpp? -68.57 110.6 6.14 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.739 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.828 ' HB3' HD11 ' A' ' 126' ' ' ILE . 90.6 Cg_endo -80.86 134.4 9.55 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.527 2.152 . . . . 0.0 111.656 179.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.756 HG21 ' CE1' ' A' ' 82' ' ' PHE . 0.4 OUTLIER -64.34 96.6 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.323 -179.694 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.417 ' O ' ' N ' ' A' ' 141' ' ' THR . 2.9 p -68.78 145.72 97.05 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.888 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.453 ' HA ' ' CE1' ' A' ' 154' ' ' TYR . 89.1 Cg_exo -43.19 -28.21 1.34 Allowed 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.573 2.182 . . . . 0.0 112.248 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -78.75 -36.7 42.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.676 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.417 ' N ' ' O ' ' A' ' 138' ' ' THR . 6.1 m -54.88 -56.06 23.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.714 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.509 ' CB ' ' CD2' ' A' ' 154' ' ' TYR . . . -53.02 -36.56 60.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.777 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.64 -38.82 90.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.667 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 17.2 tptt -63.41 -50.59 69.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.703 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.482 HD23 ' O ' ' A' ' 145' ' ' LEU . 0.6 OUTLIER -70.23 -33.99 72.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.593 179.798 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -67.69 -44.7 77.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.894 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 60.2 mtt180 -75.14 -23.18 57.8 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.793 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -56.14 -46.88 79.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.745 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -95.54 19.7 10.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.058 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.1 mtmp? 44.82 40.39 4.25 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.428 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.754 ' HB1' ' O ' ' A' ' 110' ' ' PHE . . . -59.58 -81.72 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.866 0.365 . . . . 0.0 110.818 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.88 ' HB ' HD12 ' A' ' 111' ' ' LEU . 83.5 t -159.65 -73.82 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.833 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.413 ' HG3' HG22 ' A' ' 155' ' ' VAL . 4.1 tppt? 177.42 135.6 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.954 -179.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.517 ' OH ' HG21 ' A' ' 117' ' ' ILE . 3.3 t80 -98.06 112.49 24.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.154 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.798 HG11 ' ND2' ' A' ' 167' ' ' ASN . 0.3 OUTLIER -115.04 -172.84 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.637 -179.924 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.586 ' H ' HG12 ' A' ' 155' ' ' VAL . 2.1 mp0 -89.58 163.3 15.24 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.868 0.366 . . . . 0.0 111.145 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.751 ' CB ' HG22 ' A' ' 115' ' ' THR . 0.1 OUTLIER -133.56 -172.73 3.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.987 -179.786 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.551 ' O ' ' HB2' ' A' ' 159' ' ' ALA . 1.1 p -128.38 147.85 50.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.984 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.551 ' HB2' ' O ' ' A' ' 158' ' ' SER . . . 169.58 -57.96 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.805 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.488 HD22 HD23 ' A' ' 119' ' ' LEU . 1.2 mp -100.39 -60.07 1.59 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.62 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.438 ' CG2' ' HB3' ' A' ' 118' ' ' ASP . 13.4 t -86.04 -26.4 25.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.474 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.447 ' HA ' ' HB2' ' A' ' 158' ' ' SER . 2.8 tt0 73.39 77.11 0.13 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.16 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.422 ' CB ' ' O ' ' A' ' 157' ' ' CYS . 0.0 OUTLIER -88.19 -21.37 24.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.131 179.979 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . 142.07 -36.07 1.7 Allowed Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.491 -0.861 . . . . 0.0 112.887 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.476 HD11 ' HA ' ' A' ' 19' ' ' LEU . 0.4 OUTLIER 68.37 -63.7 0.33 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.791 0.329 . . . . 0.0 111.064 -179.796 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.407 ' O ' ' CB ' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -48.49 -30.92 5.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.264 -179.848 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.798 ' ND2' HG11 ' A' ' 155' ' ' VAL . 0.2 OUTLIER -56.46 -71.5 0.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.313 -179.707 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.78 HG21 HG13 ' A' ' 113' ' ' VAL . 8.5 p -58.48 -46.77 89.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.823 0.344 . . . . 0.0 111.061 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.503 ' N ' HG13 ' A' ' 168' ' ' VAL . 4.2 t80 -57.71 -37.39 73.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.187 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.407 ' CB ' ' O ' ' A' ' 166' ' ' LYS . 17.0 m-20 -58.83 -37.47 76.5 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.814 ' OE2' HD12 ' A' ' 174' ' ' LEU . 21.9 mm-40 -66.34 -32.29 73.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.785 179.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.528 ' HB2' HD22 ' A' ' 111' ' ' LEU . . . -66.5 -30.63 71.0 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.68 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.928 HD11 HD22 ' A' ' 177' ' ' LEU . 0.0 OUTLIER -90.55 -26.15 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.097 -0.502 . . . . 0.0 109.763 179.256 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 1.076 HD21 HD13 ' B' ' 505' ' ' LEU . 1.2 mt -49.48 -46.81 48.63 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.01 0.434 . . . . 0.0 110.612 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.573 ' HB3' HG11 ' A' ' 77' ' ' VAL . . . -60.71 -22.68 64.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.098 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -97.09 -38.22 9.83 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.219 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.928 HD22 HD11 ' A' ' 173' ' ' ILE . 2.6 tp -68.71 -21.88 64.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.868 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.448 ' HB2' ' CB ' ' B' ' 507' ' ' ALA . 0.0 OUTLIER -174.06 158.08 2.72 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.788 179.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.65 110.68 3.06 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.654 2.236 . . . . 0.0 112.262 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -83.2 164.77 14.96 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.69 2.26 . . . . 0.0 112.472 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . 0.425 ' O ' ' CG ' ' A' ' 181' ' ' GLU . 9.5 pt-20 -113.11 110.11 51.49 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.551 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.66 -164.91 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.411 2.074 . . . . 0.0 112.278 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.66 86.21 1.64 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.874 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.872 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.224 0 N-CA-C 112.56 -0.216 . . . . 0.0 112.56 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 503' ' ' SER . . . . . 0.4 ' HB2' ' O ' ' B' ' 510' ' ' ILE . 0.5 OUTLIER -76.64 -82.44 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.735 0.302 . . . . 0.0 110.909 179.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 504' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' B' ' 509' ' ' ASP . . . 93.55 104.23 1.7 Allowed Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.397 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 505' ' ' LEU . . . . . 1.076 HD13 HD21 ' A' ' 174' ' ' LEU . 0.1 OUTLIER -170.32 39.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.747 0.308 . . . . 0.0 110.982 -179.767 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 506' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 68.14 33.04 4.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.031 0.443 . . . . 0.0 110.486 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 507' ' ' ALA . . . . . 0.448 ' HB3' ' CD1' ' B' ' 505' ' ' LEU . . . -134.93 36.58 3.06 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.698 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 508' ' ' GLN . . . . . 0.407 ' O ' ' HB3' ' B' ' 509' ' ' ASP . 31.2 mt-30 74.39 3.41 4.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.551 -178.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 509' ' ' ASP . . . . . 0.408 ' HA ' ' HA2' ' B' ' 504' ' ' GLY . 22.2 t70 70.49 43.62 0.77 Allowed 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 121.024 0.44 . . . . 0.0 110.985 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 510' ' ' ILE . . . . . 0.722 HG23 ' HA3' ' A' ' 47' ' ' GLY . 66.4 mt -95.25 139.0 19.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.579 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 511' ' ' SER . . . . . 0.62 ' O ' HD13 ' A' ' 46' ' ' ILE . 34.6 t -108.28 148.12 30.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.989 0.424 . . . . 0.0 112.039 -178.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 512' ' ' GLN . . . . . 0.812 ' OE1' HD11 ' A' ' 53' ' ' LEU . 11.8 tp60 -100.06 -69.08 0.04 OUTLIER Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.998 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 513' ' ' PRO . . . . . 0.511 ' HD3' ' HB3' ' B' ' 512' ' ' GLN . 85.3 Cg_endo -78.49 73.6 5.79 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.219 1.946 . . . . 0.0 110.934 178.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 514' ' ' LEU . . . . . 0.552 HD21 ' HB3' ' B' ' 511' ' ' SER . 1.3 mp -80.38 -93.76 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -178.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 515' ' ' GLN . . . . . 0.45 ' HB2' HG12 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -69.33 -83.7 0.03 OUTLIER 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.839 0.352 . . . . 0.0 111.914 -178.707 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 516' ' ' ASN . . . . . 0.413 ' ND2' ' O ' ' B' ' 518' ' ' PHE . 48.9 t30 -120.91 -37.11 3.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.485 -178.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 517' ' ' SER . . . . . 0.474 ' O ' HG11 ' A' ' 42' ' ' VAL . 0.7 OUTLIER 55.87 26.0 9.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.854 -179.806 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 518' ' ' PHE . . . . . 0.413 ' O ' ' ND2' ' B' ' 516' ' ' ASN . 0.0 OUTLIER -162.98 106.89 1.07 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.054 -179.78 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 519' ' ' ILE . . . . . 0.431 ' CG1' ' O ' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -107.6 -84.97 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.991 179.851 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 13.7 t-160 -175.17 102.55 0.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.889 0.376 . . . . 0.0 110.899 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 521' ' ' THR . . . . . 0.414 HG22 ' H ' ' B' ' 522' ' ' GLY . 0.2 OUTLIER -150.68 178.37 9.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.769 -179.964 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 522' ' ' GLY . . . . . 0.414 ' H ' HG22 ' B' ' 521' ' ' THR . . . 58.93 161.47 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.375 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 523' ' ' HIS . . . . . 0.422 ' NE2' ' HB2' ' B' ' 525' ' ' ASP . 16.3 t-160 -137.61 -84.92 0.31 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.704 0.288 . . . . 0.0 111.126 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 524' ' ' GLY . . . . . . . . . . . . . . . 92.37 -97.54 2.29 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.379 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 525' ' ' ASP . . . . . 0.422 ' HB2' ' NE2' ' B' ' 523' ' ' HIS . 2.7 t0 75.32 78.44 0.1 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.926 0.393 . . . . 0.0 111.279 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 526' ' ' SER . . . . . 0.922 ' CB ' HD23 ' A' ' 61' ' ' LEU . 0.5 OUTLIER -117.4 98.19 6.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.723 179.545 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 527' ' ' ASP . . . . . 0.445 ' CB ' ' HD3' ' B' ' 528' ' ' PRO . 0.1 OUTLIER -44.32 -50.9 21.06 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.301 -179.807 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 528' ' ' PRO . . . . . 0.445 ' HD3' ' CB ' ' B' ' 527' ' ' ASP . 23.6 Cg_exo -68.08 118.65 5.77 Favored 'Trans proline' 0 CA--C 1.518 -0.305 0 C-N-CA 123.058 2.505 . . . . 0.0 112.108 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 529' ' ' ARG . . . . . 0.559 ' HD3' HG21 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -100.92 -37.47 8.64 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.879 -179.162 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 530' ' ' HIS . . . . . 0.48 ' CG ' ' O ' ' B' ' 530' ' ' HIS . 0.0 OUTLIER 67.71 9.62 7.21 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.012 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 531' ' ' CYS . . . . . 0.465 ' O ' ' CD2' ' B' ' 530' ' ' HIS . 1.2 m 49.1 -174.45 0.02 OUTLIER 'General case' 0 C--N 1.334 -0.093 0 CA-C-O 120.87 0.367 . . . . 0.0 111.072 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 532' ' ' TRP . . . . . . . . . . . . . 23.0 t90 -65.44 -63.16 1.16 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.864 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . 95.52 -119.11 6.09 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.377 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 534' ' ' PHE . . . . . 0.418 ' O ' ' N ' ' B' ' 536' ' ' ASP . 11.3 m-85 -119.39 151.2 50.99 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.729 0.3 . . . . 0.0 110.892 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.48 83.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.586 2.191 . . . . 0.0 112.262 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 536' ' ' ASP . . . . . 0.418 ' N ' ' O ' ' B' ' 534' ' ' PHE . 1.0 OUTLIER 172.23 80.85 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.7 179.979 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 537' ' ' ARG . . . . . 0.499 ' NH2' " C4'" ' A' ' 185' ' ' GNP . 32.3 mmt-85 -51.78 132.92 31.81 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.116 0.484 . . . . 0.0 111.062 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 538' ' ' ILE . . . . . 0.408 HD12 ' H ' ' B' ' 539' ' ' ASP . 3.1 tp -50.9 133.53 11.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.446 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 539' ' ' ASP . . . . . 0.408 ' H ' HD12 ' B' ' 538' ' ' ILE . 62.5 m-20 -40.39 117.76 0.84 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.317 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 540' ' ' GLU . . . . . 0.783 ' HA ' HD12 ' B' ' 543' ' ' LEU . 2.8 pp20? -47.45 -24.87 0.91 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.116 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 541' ' ' LEU . . . . . 0.697 ' HA ' HD22 ' A' ' 70' ' ' LEU . 0.4 OUTLIER -38.53 -42.66 0.78 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.164 0.507 . . . . 0.0 111.012 179.435 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 542' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -105.3 -59.48 1.75 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.427 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 543' ' ' LEU . . . . . 0.783 HD12 ' HA ' ' B' ' 540' ' ' GLU . 0.1 OUTLIER 59.98 122.88 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.881 -179.911 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 544' ' ' GLY . . . . . 0.449 ' HA2' HD11 ' A' ' 61' ' ' LEU . . . 164.3 105.21 0.19 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.538 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 545' ' ' ASN . . . . . 0.439 ' HB3' ' HA ' ' B' ' 529' ' ' ARG . 10.0 m120 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.951 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' GNP . . . . . 0.956 " H2'" ' OG1' ' A' ' 115' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.466 ' HE1' ' CD1' ' A' ' 51' ' ' TYR . 6.9 tpt . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.267 0.079 . . . . 0.0 111.082 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.43 ' N ' ' HG3' ' A' ' 1' ' ' MET . 5.7 tt0 42.22 100.08 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.294 0.568 . . . . 0.0 111.804 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.556 HG23 HG21 ' A' ' 46' ' ' ILE . 0.2 OUTLIER -104.82 -159.48 0.71 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.652 -179.889 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.701 ' O ' HD22 ' A' ' 53' ' ' LEU . 0.3 OUTLIER -156.37 163.18 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -178.653 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.519 ' HA ' HD13 ' A' ' 53' ' ' LEU . 16.2 mttp -134.45 102.36 5.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.876 179.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 32.3 m -103.07 156.2 17.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.225 0.536 . . . . 0.0 112.083 -178.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.445 HG13 ' O ' ' A' ' 56' ' ' PHE . 2.7 t -139.11 159.87 29.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.248 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.708 HG13 ' HB ' ' A' ' 14' ' ' VAL . 65.4 t -106.89 141.5 21.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.239 0.542 . . . . 0.0 111.752 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 98.0 t -156.51 129.96 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.855 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.55 -171.14 32.99 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 119.976 -1.107 . . . . 0.0 113.051 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -94.81 27.78 2.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.791 0.329 . . . . 0.0 110.852 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.635 ' O ' HG23 ' A' ' 14' ' ' VAL . . . -170.04 -170.06 33.98 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.419 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.459 ' HB2' ' O3A' ' A' ' 185' ' ' GNP . . . -60.84 -30.17 69.95 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.953 0.406 . . . . 0.0 110.712 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.708 ' HB ' HG13 ' A' ' 8' ' ' VAL . 2.7 t 63.45 -71.21 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.584 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.934 ' C ' HD11 ' A' ' 19' ' ' LEU . . . 175.22 59.19 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.169 -1.015 . . . . 0.0 113.232 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.688 ' CE ' HG11 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -97.85 -85.71 0.36 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.861 0.33 . . . . 0.0 110.217 178.75 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.46 ' HB ' ' CG1' ' A' ' 21' ' ' ILE . 45.9 p -99.5 -36.64 9.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.001 0.429 . . . . 0.0 111.116 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.442 ' CB ' ' O1A' ' A' ' 185' ' ' GNP . 30.0 p -40.28 -36.31 0.51 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.314 -179.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.94 HD23 ' CD2' ' A' ' 165' ' ' LEU . 0.0 OUTLIER -71.15 -69.3 0.38 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.926 0.393 . . . . 0.0 110.883 -179.68 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.535 HD21 ' CD2' ' A' ' 169' ' ' PHE . 3.6 mt -55.98 -43.47 77.63 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.234 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.608 HG22 ' OG1' ' A' ' 25' ' ' THR . 42.4 mm -62.41 -66.9 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.864 0.364 . . . . 0.0 110.587 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.405 ' CB ' ' O ' ' A' ' 18' ' ' CYS . 52.3 p -46.18 -27.41 0.98 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.258 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -73.89 -68.14 0.54 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.954 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.91 -46.27 75.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.716 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.608 ' OG1' HG22 ' A' ' 21' ' ' ILE . 19.0 p -85.26 -149.1 0.12 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.308 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -161.18 30.11 0.14 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.746 0.307 . . . . 0.0 111.105 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.8 mttt -115.35 156.31 25.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.271 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.518 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . 4.1 t80 -163.67 -62.15 0.01 OUTLIER Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.726 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.518 ' HD3' ' HB3' ' A' ' 28' ' ' PHE . 63.2 Cg_endo -85.07 -16.37 5.15 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.627 2.218 . . . . 0.0 112.989 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.2 m -50.61 -87.75 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.398 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -158.12 116.86 3.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.525 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.507 ' CD2' ' O1B' ' A' ' 185' ' ' GNP . 6.6 m-85 -111.56 94.14 4.82 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.108 0.48 . . . . 0.0 110.769 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.822 HG21 ' HD3' ' B' ' 529' ' ' ARG . 2.1 t -117.25 -52.22 0.04 OUTLIER Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.23 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.472 ' O ' ' CD1' ' A' ' 37' ' ' PHE . 5.1 Cg_exo -80.14 52.99 4.54 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.501 2.134 . . . . 0.0 112.245 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.622 HG21 ' O2G' ' A' ' 185' ' ' GNP . 3.9 t -98.88 -25.22 14.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.835 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.799 HG11 ' CG ' ' B' ' 525' ' ' ASP . 7.4 p -51.0 -27.63 5.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.326 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.472 ' CD1' ' O ' ' A' ' 34' ' ' PRO . 3.4 p90 -54.79 -21.15 10.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.965 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.431 ' HB3' ' CB ' ' A' ' 57' ' ' ASP . 59.2 t0 -44.71 -29.73 0.81 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.413 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -70.29 -30.75 67.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.167 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.663 ' CE1' HG21 ' B' ' 521' ' ' THR . 8.6 m-85 -60.68 -174.07 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.86 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.681 ' O ' HD12 ' B' ' 519' ' ' ILE . . . -101.57 -179.63 4.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.087 0.47 . . . . 0.0 111.538 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.1 m -141.11 165.15 19.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.553 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.547 ' O ' HG13 ' A' ' 44' ' ' VAL . 0.7 OUTLIER -110.2 102.11 10.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.883 0.373 . . . . 0.0 111.649 -179.483 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.658 HG11 ' OG ' ' B' ' 517' ' ' SER . 30.1 m -164.81 -177.16 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.728 178.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.491 ' O ' ' HG3' ' A' ' 45' ' ' MET . 0.0 OUTLIER -128.53 101.12 6.03 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.54 0.686 . . . . 0.0 110.95 179.844 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.736 HG23 HG23 ' B' ' 510' ' ' ILE . 3.8 mm -55.49 101.6 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.478 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.454 ' O ' ' CE ' ' A' ' 45' ' ' MET . . . 29.48 -83.88 0.0 OUTLIER Glycine 0 C--N 1.337 0.626 0 N-CA-C 114.862 0.705 . . . . 0.0 114.862 178.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . -42.28 -77.32 0.08 OUTLIER Glycine 0 CA--C 1.519 0.311 0 C-N-CA 121.226 -0.511 . . . . 0.0 113.167 -179.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -143.57 164.28 31.52 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-O 120.807 0.337 . . . . 0.0 111.448 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.433 ' HA ' ' HA ' ' A' ' 45' ' ' MET . 4.2 Cg_endo -47.09 101.12 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.942 2.428 . . . . 0.0 112.309 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.494 ' HE1' HG21 ' A' ' 3' ' ' THR . 5.0 t80 -172.85 137.04 0.73 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.967 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.627 HG21 HG22 ' A' ' 44' ' ' VAL . 16.5 p -134.26 138.54 45.11 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.114 0.483 . . . . 0.0 111.369 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.701 HD22 ' O ' ' A' ' 4' ' ' ILE . 1.5 pp -74.04 178.07 5.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.752 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -111.89 86.91 0.44 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.071 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -47.62 116.81 1.58 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.854 0.359 . . . . 0.0 110.501 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.445 ' O ' HG13 ' A' ' 7' ' ' VAL . 0.8 OUTLIER -83.92 105.3 14.7 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.042 -179.374 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.805 ' OD2' HD21 ' B' ' 543' ' ' LEU . 0.1 OUTLIER -130.16 111.31 12.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.153 179.593 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.826 ' O ' HD13 ' B' ' 543' ' ' LEU . 0.6 OUTLIER -86.28 129.78 34.73 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.748 -179.512 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.643 ' HB3' HG23 ' A' ' 36' ' ' VAL . . . -135.99 114.75 12.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.909 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -67.48 63.8 0.27 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.775 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.784 HD12 ' HB ' ' A' ' 36' ' ' VAL . 9.7 mt -121.45 -171.72 2.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.834 0.349 . . . . 0.0 110.874 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.433 ' CB ' ' O ' ' B' ' 524' ' ' GLY . 0.1 OUTLIER -44.43 -45.53 9.08 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.51 -179.878 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.496 ' HB3' ' CE1' ' A' ' 64' ' ' TYR . 5.3 m-20 -59.35 -62.99 1.47 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.163 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.496 ' CE1' ' HB3' ' A' ' 63' ' ' ASP . 0.1 OUTLIER -128.42 132.15 48.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.862 -179.68 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -86.68 -68.73 0.72 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.435 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.401 ' O ' ' HB2' ' A' ' 67' ' ' LEU . 11.1 mmt180 -98.41 -34.67 10.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.337 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.779 HD13 ' HB ' ' A' ' 58' ' ' THR . 1.2 mp 69.72 -80.07 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.058 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.556 ' CB ' ' O ' ' A' ' 67' ' ' LEU . 25.8 ttp180 113.83 -42.61 0.0 OUTLIER Pre-proline 0 N--CA 1.487 1.39 0 C-N-CA 123.89 0.876 . . . . 0.0 112.904 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 67.7 Cg_exo -41.61 -49.83 5.07 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.499 2.132 . . . . 0.0 113.182 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.783 HD22 ' N ' ' B' ' 541' ' ' LEU . 0.1 OUTLIER -53.38 -26.23 18.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.78 0.324 . . . . 0.0 110.564 -179.924 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.412 ' CB ' ' O ' ' A' ' 68' ' ' ARG . 8.5 t -50.95 -67.68 0.23 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.081 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -147.14 73.57 12.03 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.012 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -56.47 164.78 5.13 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.58 2.187 . . . . 0.0 112.202 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 54.6 tp60 -95.02 -17.53 21.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.296 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.664 HG22 ' H ' ' A' ' 77' ' ' VAL . 93.5 m -46.62 149.99 0.74 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.773 0.321 . . . . 0.0 111.201 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -90.43 -24.19 20.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.05 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.664 ' H ' HG22 ' A' ' 75' ' ' THR . 1.2 m -103.83 91.6 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.135 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -80.98 122.09 26.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.606 HD12 HG12 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -78.17 109.65 12.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.013 -179.883 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.466 HG23 HD23 ' A' ' 112' ' ' LEU . 1.8 m -106.75 121.4 59.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.379 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.67 ' HB3' HG22 ' A' ' 14' ' ' VAL . 9.0 p -95.37 161.43 14.08 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.319 0.581 . . . . 0.0 112.304 -178.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 1.008 ' CE1' HD22 ' A' ' 112' ' ' LEU . 14.3 p90 179.61 123.58 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.897 179.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.35 151.02 20.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.952 0.406 . . . . 0.0 111.341 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.956 HG22 ' HB3' ' A' ' 116' ' ' GLN . 1.5 m -52.52 -51.78 31.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.591 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.578 HG22 ' OE1' ' A' ' 116' ' ' GLN . 19.6 m -53.28 116.64 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.588 0.232 . . . . 0.0 110.615 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.678 ' H ' HD22 ' A' ' 129' ' ' LEU . 6.4 m -151.14 129.2 5.89 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.455 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -91.17 51.39 0.81 Allowed 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.989 2.46 . . . . 0.0 111.684 179.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.472 ' CA ' ' HB2' ' A' ' 133' ' ' LYS . 0.1 OUTLIER 75.1 15.86 2.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.21 -179.626 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.931 ' O ' HG23 ' A' ' 93' ' ' VAL . 43.8 t -97.6 -22.4 16.52 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.121 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.585 ' CZ ' HG21 ' A' ' 137' ' ' ILE . 12.0 t80 -47.07 -59.18 3.3 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.322 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -48.71 -47.18 41.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.967 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -69.89 -32.61 71.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.781 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.931 HG23 ' O ' ' A' ' 89' ' ' SER . 93.8 t -57.1 -68.51 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.964 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.838 ' HG3' HD13 ' A' ' 145' ' ' LEU . 6.9 mmtt -52.09 -52.86 48.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.745 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -57.44 -22.58 44.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.791 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -100.39 -12.38 19.46 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.355 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.421 ' O ' ' CG ' ' A' ' 100' ' ' GLU . 3.1 m0 -89.24 -56.27 3.34 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.628 0.252 . . . . 0.0 111.179 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.671 HG11 HD22 ' A' ' 149' ' ' LEU . 12.9 t -45.88 -45.44 37.57 Favored Pre-proline 0 C--N 1.329 -0.293 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.491 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 50.2 Cg_exo -54.14 -37.77 87.41 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.323 2.015 . . . . 0.0 112.523 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.445 ' HG3' ' N ' ' A' ' 101' ' ' ILE . 6.3 pt-20 -82.82 -32.53 27.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.078 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.776 HG21 ' CD1' ' A' ' 110' ' ' PHE . 19.0 mm -53.86 -35.54 27.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.892 0.377 . . . . 0.0 110.648 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 43.9 p -95.93 -22.45 17.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.055 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 13.5 t-160 -66.02 -29.01 69.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.741 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 3.5 m170 -90.93 -25.22 19.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.799 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 1.1 m -145.33 142.2 17.98 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.886 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.51 90.48 0.22 Allowed 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.535 2.157 . . . . 0.0 112.207 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 58.9 90.83 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.743 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.93 116.07 30.29 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.969 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -60.14 156.32 40.49 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.575 2.184 . . . . 0.0 112.226 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.776 ' CD1' HG21 ' A' ' 101' ' ' ILE . 3.4 p90 -145.9 147.83 32.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.943 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 1.028 HD12 HG11 ' A' ' 152' ' ' VAL . 3.7 tt -108.45 141.38 40.4 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.011 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 1.008 HD22 ' CE1' ' A' ' 82' ' ' PHE . 25.1 mt -98.71 142.94 29.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.81 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.955 HG13 HG11 ' A' ' 168' ' ' VAL . 58.1 t -121.6 142.58 37.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.98 0.419 . . . . 0.0 111.775 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -117.43 121.74 5.21 Favored Glycine 0 N--CA 1.45 -0.375 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.855 ' OG1' " H2'" ' A' ' 185' ' ' GNP . 1.3 p -136.63 -56.23 0.74 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.736 0.303 . . . . 0.0 111.134 -179.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.956 ' HB3' HG22 ' A' ' 84' ' ' VAL . 2.6 tt0 -59.36 -16.81 24.95 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.821 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.637 HD12 ' O ' ' A' ' 115' ' ' THR . 0.4 OUTLIER -55.15 -16.05 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 179.912 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.451 ' OD2' HG21 ' A' ' 161' ' ' THR . 1.3 t0 -82.13 -19.99 38.92 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 120.732 0.301 . . . . 0.0 111.151 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.57 ' C ' HD12 ' A' ' 119' ' ' LEU . 4.1 pp -121.35 1.72 10.21 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.908 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.806 ' HB3' HG21 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -50.05 -30.9 11.77 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.986 0.422 . . . . 0.0 110.647 179.88 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -59.84 -21.65 61.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.978 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.405 ' O ' ' HB ' ' A' ' 126' ' ' ILE . 31.8 t0 -44.79 99.84 0.22 Allowed Pre-proline 0 N--CA 1.462 0.136 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.869 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.416 ' O ' ' CG ' ' A' ' 127' ' ' GLU . 15.1 Cg_exo -68.94 -4.68 13.92 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.711 2.274 . . . . 0.0 112.968 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.3 t -83.36 -64.7 1.12 Allowed 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.541 HG21 HG11 ' A' ' 85' ' ' VAL . 32.5 m -55.84 -36.43 67.51 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.693 HG13 HD11 ' A' ' 129' ' ' LEU . 0.0 OUTLIER -58.69 -39.39 76.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.945 179.24 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.416 ' CG ' ' O ' ' A' ' 123' ' ' PRO . 8.8 mm-40 -63.71 -29.28 70.52 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.776 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.423 ' HD3' ' HA ' ' A' ' 125' ' ' THR . 1.8 mptt -74.16 -58.34 3.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.789 179.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.693 HD11 HG13 ' A' ' 126' ' ' ILE . 3.6 pp -63.22 -25.89 68.54 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.673 ' HB1' ' HG2' ' A' ' 134' ' ' GLN . . . -52.61 -41.69 63.9 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.564 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 18.0 mmtm -46.22 -24.08 0.42 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.637 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -123.04 -30.23 3.79 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.478 ' CG ' ' N ' ' A' ' 134' ' ' GLN . 0.0 OUTLIER -132.21 -72.45 0.53 Allowed 'General case' 0 CA--C 1.534 0.331 0 O-C-N 122.097 -0.377 . . . . 0.0 111.871 -178.783 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.673 ' HG2' ' HB1' ' A' ' 130' ' ' ALA . 9.5 mt-30 98.63 -46.54 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.841 0.856 . . . . 0.0 110.945 -179.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 4.2 mtpp -73.77 109.1 5.9 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.42 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.898 ' C ' HD13 ' A' ' 137' ' ' ILE . 55.8 Cg_endo -70.06 -170.8 0.44 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.087 1.858 . . . . 0.0 110.764 179.002 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.898 HD13 ' C ' ' A' ' 136' ' ' PRO . 1.2 mm -112.08 95.89 4.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.163 0.506 . . . . 0.0 111.057 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.415 HG22 ' H ' ' A' ' 138' ' ' THR . 0.1 OUTLIER -71.57 150.03 93.52 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.76 -179.981 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -44.01 -28.85 2.37 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.698 2.265 . . . . 0.0 112.383 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -71.26 -31.26 67.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.85 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.524 HG21 HG23 ' A' ' 137' ' ' ILE . 55.4 m -72.64 -50.58 24.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.905 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.55 ' HB3' ' CE2' ' A' ' 154' ' ' TYR . . . -50.28 -61.19 2.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.853 0.359 . . . . 0.0 110.792 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.45 -40.12 68.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.751 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -50.78 -61.24 2.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.705 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.838 HD13 ' HG3' ' A' ' 94' ' ' LYS . 3.6 tt -67.22 -34.0 76.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.568 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.964 ' HB2' HD12 ' A' ' 112' ' ' LEU . . . -57.2 -45.01 84.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.852 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 5.1 mtm180 -79.49 -25.6 41.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.843 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -58.24 -46.09 86.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.797 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.671 HD22 HG11 ' A' ' 98' ' ' VAL . 1.8 mt -102.05 24.18 10.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.804 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 39.07 55.14 2.13 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.758 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.611 ' HB1' ' O ' ' A' ' 110' ' ' PHE . . . -67.04 -81.62 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.056 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 1.028 HG11 HD12 ' A' ' 111' ' ' LEU . 50.9 t -160.54 -74.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.81 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.16 114.9 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.11 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.55 ' CE2' ' HB3' ' A' ' 142' ' ' ALA . 45.7 t80 -90.55 109.9 21.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.048 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.44 HG12 ' N ' ' A' ' 156' ' ' GLU . 3.6 t -101.67 161.43 3.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.393 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.44 ' N ' HG12 ' A' ' 155' ' ' VAL . 8.9 tt0 -89.7 140.33 29.68 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.098 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.589 ' O ' HD11 ' A' ' 117' ' ' ILE . 1.8 p 178.71 -175.14 0.19 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.314 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.516 ' O ' HD12 ' A' ' 165' ' ' LEU . 4.5 t -160.28 163.75 33.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.109 0.48 . . . . 0.0 111.677 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.762 ' HB2' HD11 ' A' ' 165' ' ' LEU . . . -114.82 -42.15 3.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.09 179.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.408 ' CD1' HD23 ' A' ' 119' ' ' LEU . 0.5 OUTLIER -74.43 -29.08 61.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.189 179.36 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.451 HG21 ' OD2' ' A' ' 118' ' ' ASP . 0.9 OUTLIER -111.87 -26.4 8.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.659 179.872 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.401 ' HA ' ' O ' ' A' ' 158' ' ' SER . 0.0 OUTLIER 73.52 70.57 0.12 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.232 179.844 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.409 ' HB3' ' HA ' ' A' ' 157' ' ' CYS . 12.3 mtmt -95.2 23.56 5.68 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.109 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 101.71 42.78 2.24 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.914 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.94 ' CD2' HD23 ' A' ' 19' ' ' LEU . 0.3 OUTLIER -52.29 -25.0 8.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.691 0.282 . . . . 0.0 111.042 179.911 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.405 ' HD2' ' CA ' ' B' ' 502' ' ' GLY . 22.4 pttp -69.04 -23.31 64.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.691 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.16 -70.33 0.24 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.707 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.955 HG11 HG13 ' A' ' 113' ' ' VAL . 7.5 p -52.64 -46.78 50.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.114 0.483 . . . . 0.0 110.431 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.624 ' CG ' HD22 ' A' ' 19' ' ' LEU . 2.6 t80 -57.25 -32.55 66.68 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.111 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 166' ' ' LYS . 30.9 t70 -71.22 -25.85 62.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.047 178.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.885 ' HB3' HD11 ' A' ' 111' ' ' LEU . 0.8 OUTLIER -74.16 -28.12 61.16 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.126 179.308 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.554 ' CA ' HD13 ' A' ' 111' ' ' LEU . . . -75.44 -40.74 57.21 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.709 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.636 HD12 HD12 ' A' ' 177' ' ' LEU . 1.6 pp -80.89 -33.71 13.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.916 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.807 HD13 ' CB ' ' B' ' 505' ' ' LEU . 1.0 OUTLIER -55.42 -58.59 7.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.417 179.647 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.579 ' HB1' ' HG3' ' A' ' 180' ' ' PRO . . . -49.5 -25.85 2.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.791 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.529 ' HB3' HG21 ' A' ' 4' ' ' ILE . . . -87.8 -41.19 13.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.118 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.636 HD12 HD12 ' A' ' 173' ' ' ILE . 41.8 mt -68.82 -23.68 64.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.892 0.377 . . . . 0.0 110.614 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.637 ' CB ' ' HB2' ' B' ' 507' ' ' ALA . 24.8 tt0 -168.19 142.78 2.85 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.841 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.436 ' HD2' ' CG ' ' A' ' 178' ' ' GLU . 93.3 Cg_exo -44.07 115.44 0.73 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.587 2.191 . . . . 0.0 112.405 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . 0.579 ' HG3' ' HB1' ' A' ' 175' ' ' ALA . 67.6 Cg_endo -73.08 -171.76 0.86 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.452 2.101 . . . . 0.0 112.358 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . 0.4 ' HA ' ' HD3' ' A' ' 182' ' ' PRO . 41.4 mt-10 -148.83 151.59 35.45 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.787 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 181' ' ' GLU . 36.6 Cg_exo -59.45 -152.72 0.01 OUTLIER 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.706 2.271 . . . . 0.0 112.469 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.4 148.77 46.62 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.961 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.268 -0.872 . . . . 0.0 110.843 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 502' ' ' GLY . . . . . 0.405 ' CA ' ' HD2' ' A' ' 166' ' ' LYS . . . . . . . . 0 N--CA 1.488 2.165 0 N-CA-C 112.514 -0.234 . . . . 0.0 112.514 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 503' ' ' SER . . . . . . . . . . . . . 98.7 p -62.82 -170.9 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.843 0.354 . . . . 0.0 110.894 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 504' ' ' GLY . . . . . 0.702 ' C ' HD23 ' B' ' 505' ' ' LEU . . . -157.31 -106.63 0.24 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.396 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 505' ' ' LEU . . . . . 0.82 HD12 ' HB3' ' B' ' 507' ' ' ALA . 1.1 pt? 44.15 -171.77 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.114 0.483 . . . . 0.0 111.867 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 506' ' ' SER . . . . . . . . . . . . . 4.9 m -117.66 -15.69 10.14 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.106 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 507' ' ' ALA . . . . . 0.82 ' HB3' HD12 ' B' ' 505' ' ' LEU . . . -67.89 59.62 0.07 Allowed 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.087 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 508' ' ' GLN . . . . . 0.561 ' HB2' HD12 ' B' ' 510' ' ' ILE . 9.7 mt-30 69.86 3.17 4.18 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.608 -178.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 509' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' B' ' 504' ' ' GLY . 15.7 t0 46.7 53.47 10.08 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.378 0.609 . . . . 0.0 111.094 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 510' ' ' ILE . . . . . 0.736 HG23 HG23 ' A' ' 46' ' ' ILE . 0.9 OUTLIER -50.6 107.78 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.352 179.561 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 511' ' ' SER . . . . . 0.439 ' O ' HD12 ' B' ' 514' ' ' LEU . 48.2 m -61.87 86.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.91 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 512' ' ' GLN . . . . . 0.472 ' CB ' ' CD ' ' B' ' 513' ' ' PRO . 23.6 tp60 -50.89 -67.69 0.45 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.464 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 513' ' ' PRO . . . . . 0.472 ' CD ' ' CB ' ' B' ' 512' ' ' GLN . 98.3 Cg_endo -77.06 66.09 7.76 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.506 2.137 . . . . 0.0 112.13 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 514' ' ' LEU . . . . . 0.439 HD12 ' O ' ' B' ' 511' ' ' SER . 0.7 OUTLIER -73.69 138.78 44.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.847 0.356 . . . . 0.0 111.082 -179.756 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 515' ' ' GLN . . . . . 0.544 ' O ' HG12 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -52.49 143.52 15.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.927 -179.892 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 72.02 23.51 3.46 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.988 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 517' ' ' SER . . . . . 0.658 ' OG ' HG11 ' A' ' 44' ' ' VAL . 3.1 m -82.75 53.79 2.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.185 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 518' ' ' PHE . . . . . 0.467 ' CD1' ' O ' ' B' ' 517' ' ' SER . 10.4 m-85 -163.63 94.98 0.8 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.603 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 519' ' ' ILE . . . . . 0.681 HD12 ' O ' ' A' ' 41' ' ' ALA . 13.2 mt -55.87 -100.16 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.316 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 520' ' ' HIS . . . . . 0.553 ' N ' HG22 ' B' ' 519' ' ' ILE . 15.7 t-160 179.22 40.14 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.763 0.316 . . . . 0.0 110.943 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 521' ' ' THR . . . . . 0.663 HG21 ' CE1' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -112.87 -177.1 3.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.262 -179.792 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 522' ' ' GLY . . . . . . . . . . . . . . . 71.58 97.33 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.265 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 523' ' ' HIS . . . . . 0.413 ' O ' ' N ' ' B' ' 525' ' ' ASP . 15.8 p-80 -144.82 -45.77 0.23 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.821 0.343 . . . . 0.0 111.334 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 524' ' ' GLY . . . . . 0.433 ' O ' ' CB ' ' A' ' 62' ' ' GLU . . . -67.81 68.63 0.3 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.256 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 525' ' ' ASP . . . . . 0.799 ' CG ' HG11 ' A' ' 36' ' ' VAL . 0.2 OUTLIER 176.3 37.47 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.822 0.344 . . . . 0.0 110.549 -179.732 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 526' ' ' SER . . . . . 0.772 ' HA ' HG12 ' A' ' 33' ' ' VAL . 3.1 t -113.55 96.17 5.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.901 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 527' ' ' ASP . . . . . 0.52 ' CB ' ' CD ' ' B' ' 528' ' ' PRO . 0.4 OUTLIER -134.05 -70.67 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.831 179.518 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 528' ' ' PRO . . . . . 0.52 ' CD ' ' CB ' ' B' ' 527' ' ' ASP . 13.4 Cg_endo -53.97 90.07 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.671 2.247 . . . . 0.0 112.396 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 529' ' ' ARG . . . . . 0.822 ' HD3' HG21 ' A' ' 33' ' ' VAL . 0.5 OUTLIER -96.19 5.11 51.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.003 179.491 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 530' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -49.33 -53.8 20.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.751 0.31 . . . . 0.0 111.537 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER 71.23 -154.52 0.1 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.531 -179.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 532' ' ' TRP . . . . . 0.459 ' CD1' ' NH2' ' B' ' 537' ' ' ARG . 0.0 OUTLIER -41.9 142.06 0.75 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.962 0.411 . . . . 0.0 111.55 -179.86 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . -163.56 -40.45 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.308 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 534' ' ' PHE . . . . . 0.627 ' CZ ' HG22 ' B' ' 538' ' ' ILE . 4.5 p90 -133.17 161.16 65.45 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 120.679 0.276 . . . . 0.0 110.553 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 535' ' ' PRO . . . . . 0.426 ' HD2' ' HB2' ' B' ' 534' ' ' PHE . 91.0 Cg_exo -42.93 103.37 0.04 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.58 2.187 . . . . 0.0 112.49 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 1.8 t0 70.53 159.36 0.2 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.987 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 537' ' ' ARG . . . . . 0.459 ' NH2' ' CD1' ' B' ' 532' ' ' TRP . 0.0 OUTLIER -62.96 -165.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.301 0.572 . . . . 0.0 110.908 179.864 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 538' ' ' ILE . . . . . 0.627 HG22 ' CZ ' ' B' ' 534' ' ' PHE . 0.0 OUTLIER -105.5 -160.74 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.269 -0.878 . . . . 0.0 108.981 178.524 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 539' ' ' ASP . . . . . 0.476 ' N ' HG12 ' B' ' 538' ' ' ILE . 38.5 p-10 -79.83 153.13 29.32 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.329 -0.548 . . . . 0.0 111.014 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 540' ' ' GLU . . . . . 0.464 ' HG2' HD12 ' B' ' 543' ' ' LEU . 0.0 OUTLIER -52.57 -22.27 4.77 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.754 -179.389 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 541' ' ' LEU . . . . . 0.783 ' N ' HD22 ' A' ' 70' ' ' LEU . 5.4 tp -54.84 -22.31 14.13 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.175 0.512 . . . . 0.0 110.853 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 542' ' ' TYR . . . . . 0.575 ' HE1' HD23 ' B' ' 541' ' ' LEU . 3.1 m-85 -104.91 -63.86 1.18 Allowed 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.708 -178.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 543' ' ' LEU . . . . . 0.826 HD13 ' O ' ' A' ' 58' ' ' THR . 0.1 OUTLIER 62.85 46.23 5.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.879 -179.566 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . 175.67 -70.2 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.465 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 545' ' ' ASN . . . . . 0.401 ' HB2' ' HB2' ' B' ' 528' ' ' PRO . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.274 -0.87 . . . . 0.0 110.887 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' GNP . . . . . 0.855 " H2'" ' OG1' ' A' ' 115' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.436 ' HG2' ' CG ' ' A' ' 49' ' ' GLU . 2.4 ppp? . . . . . 0 N--CA 1.488 1.448 0 CA-C-O 120.842 0.353 . . . . 0.0 111.128 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.41 ' O ' HD13 ' B' ' 510' ' ' ILE . 62.1 tp60 -161.14 125.21 3.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.313 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.972 HG23 HD22 ' A' ' 53' ' ' LEU . 13.1 t -123.65 -173.79 2.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.227 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.934 ' C ' HD23 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -153.39 156.11 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -178.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.539 ' N ' HD23 ' A' ' 53' ' ' LEU . 16.3 pttm -124.9 95.52 4.54 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.044 179.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.422 ' HB2' ' HE3' ' A' ' 16' ' ' LYS . 8.3 m -95.61 156.5 16.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.99 0.424 . . . . 0.0 111.458 -179.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.921 HG13 ' HB3' ' A' ' 56' ' ' PHE . 0.2 OUTLIER -120.12 159.65 21.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.471 179.704 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.898 HG11 ' HA2' ' A' ' 15' ' ' GLY . 6.1 p -110.36 114.37 46.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.248 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.911 HG13 ' CD ' ' B' ' 540' ' ' GLU . 81.7 t -134.6 129.75 52.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.099 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 149.53 -150.01 22.05 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.186 -1.007 . . . . 0.0 112.917 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -118.81 -13.56 9.53 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.624 0.231 . . . . 0.0 111.624 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.434 ' O ' ' NH1' ' B' ' 537' ' ' ARG . . . -50.51 -101.22 0.01 OUTLIER Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.363 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.611 ' HB2' ' H8 ' ' A' ' 185' ' ' GNP . . . -102.5 -19.08 15.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.79 0.329 . . . . 0.0 111.032 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.678 HG12 ' O ' ' A' ' 14' ' ' VAL . 37.9 t 64.52 23.34 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.647 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.898 ' HA2' HG11 ' A' ' 8' ' ' VAL . . . -153.9 134.53 4.38 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.632 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.573 ' NZ ' HD12 ' A' ' 55' ' ' LEU . 0.4 OUTLIER -86.54 7.55 25.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.75 0.309 . . . . 0.0 110.718 179.365 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.704 HG21 HG23 ' A' ' 35' ' ' THR . 1.3 p -97.24 -45.03 6.67 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 120.938 0.399 . . . . 0.0 110.992 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.493 ' HB3' ' PB ' ' A' ' 185' ' ' GNP . 28.6 p -39.26 -45.96 1.46 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.307 -179.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.961 HD22 ' CD1' ' A' ' 169' ' ' PHE . 1.4 mp -51.12 -50.0 59.67 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.923 0.392 . . . . 0.0 110.737 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.462 HD22 ' N ' ' A' ' 20' ' ' LEU . 3.0 mm? -73.02 -19.42 61.2 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.028 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.424 HD11 ' O ' ' A' ' 188' ' ' HOH . 17.4 mm -66.7 -71.04 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 CA-C-O 120.719 0.295 . . . . 0.0 110.7 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.3 t -61.22 -27.0 68.12 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.81 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -58.9 -62.94 1.5 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.916 0.388 . . . . 0.0 110.354 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 54.7 m -82.66 -46.53 13.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.403 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.402 ' N ' ' O ' ' A' ' 21' ' ' ILE . 14.2 p -101.23 -158.07 0.65 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.416 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -153.3 27.86 0.51 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.81 0.338 . . . . 0.0 111.114 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -96.17 73.15 2.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.046 0.45 . . . . 0.0 110.502 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.496 ' CD1' ' O2A' ' A' ' 185' ' ' GNP . 0.3 OUTLIER -86.85 -53.1 0.41 Allowed Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.745 -179.745 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.454 ' HD3' ' HB3' ' A' ' 28' ' ' PHE . 84.0 Cg_endo -85.34 78.79 2.4 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.717 2.278 . . . . 0.0 112.757 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.417 ' O ' ' CB ' ' B' ' 531' ' ' CYS . 2.8 m -141.84 -96.18 0.13 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.815 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -159.39 133.56 7.61 Favored 'General case' 0 C--N 1.334 -0.083 0 CA-C-O 120.793 0.33 . . . . 0.0 110.977 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.527 ' CE1' ' N3B' ' A' ' 185' ' ' GNP . 3.0 m-30 -97.31 94.45 7.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.403 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.561 HG13 ' HG3' ' B' ' 529' ' ' ARG . 0.0 OUTLIER -134.2 -59.04 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.995 -179.521 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.445 ' HD2' ' H ' ' A' ' 33' ' ' VAL . 77.7 Cg_exo -52.45 -21.53 14.17 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.107 1.871 . . . . 0.0 112.21 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.704 HG23 HG21 ' A' ' 17' ' ' THR . 52.8 m -71.74 62.3 0.41 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.621 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.057 HG23 ' HB3' ' A' ' 59' ' ' ALA . 4.1 p -132.25 -39.86 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.559 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.481 ' CD2' ' HA ' ' A' ' 40' ' ' TYR . 5.6 t80 -41.13 -30.52 0.15 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.585 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.427 ' CB ' ' OH ' ' A' ' 64' ' ' TYR . 11.6 t0 66.55 -68.41 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.923 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.474 ' O ' ' CE2' ' A' ' 37' ' ' PHE . 0.7 OUTLIER -77.89 55.18 1.37 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.365 -179.928 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.481 ' HA ' ' CD2' ' A' ' 37' ' ' PHE . 6.7 m-85 -60.5 139.88 57.54 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.804 0.335 . . . . 0.0 110.464 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.437 ' O ' ' CG1' ' B' ' 519' ' ' ILE . . . -90.59 119.4 30.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.207 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.7 HG12 ' HA ' ' B' ' 518' ' ' PHE . 15.4 m -137.09 123.23 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.726 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.62 HG23 ' HB3' ' B' ' 516' ' ' ASN . 8.8 t -84.29 104.16 14.09 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.855 HG13 ' HB2' ' B' ' 514' ' ' LEU . 25.5 t -145.03 148.27 18.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.184 -178.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.496 ' HE1' ' N ' ' A' ' 49' ' ' GLU . 3.2 tpt -96.18 96.47 8.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.973 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.64 HG22 ' O ' ' A' ' 46' ' ' ILE . 1.2 mm -83.25 85.76 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 120.718 0.294 . . . . 0.0 110.578 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.443 ' N ' ' HE2' ' A' ' 45' ' ' MET . . . 30.8 94.22 0.01 OUTLIER Glycine 0 CA--C 1.524 0.644 0 CA-C-N 115.694 -0.685 . . . . 0.0 114.035 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 135.27 -97.44 0.28 Allowed Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.83 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.496 ' N ' ' HE1' ' A' ' 45' ' ' MET . 0.2 OUTLIER -119.8 129.76 25.19 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.503 0.192 . . . . 0.0 110.551 179.701 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' A' ' 45' ' ' MET . 74.8 Cg_exo -37.14 96.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.914 2.41 . . . . 0.0 112.919 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.435 ' C ' ' CD1' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -172.86 142.91 1.16 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.753 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.478 HG21 ' HB ' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -135.0 153.82 51.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.267 -178.982 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.972 HD22 HG23 ' A' ' 3' ' ' THR . 5.8 tp -95.67 136.17 36.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.768 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -64.99 142.07 44.41 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.453 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.594 ' H ' HD22 ' A' ' 55' ' ' LEU . 1.6 mm? -76.33 134.98 39.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.842 0.353 . . . . 0.0 110.505 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.921 ' HB3' HG13 ' A' ' 7' ' ' VAL . 0.9 OUTLIER -84.59 108.74 17.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.912 0.387 . . . . 0.0 110.886 -179.875 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.492 ' OD1' HD21 ' B' ' 543' ' ' LEU . 0.7 OUTLIER -140.41 142.07 35.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.138 -179.886 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.793 ' OG1' HD13 ' B' ' 543' ' ' LEU . 43.4 p -101.28 -176.66 3.22 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.105 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 1.057 ' HB3' HG23 ' A' ' 36' ' ' VAL . . . -172.44 -162.58 0.2 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.886 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -148.78 43.11 0.81 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.295 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.885 HD22 ' HB3' ' B' ' 525' ' ' ASP . 0.4 OUTLIER -121.26 -160.03 0.83 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.922 0.391 . . . . 0.0 111.364 -179.732 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -48.71 -44.84 38.49 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.387 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.485 ' HB3' ' CD1' ' A' ' 64' ' ' TYR . 0.5 OUTLIER -45.97 -61.14 1.87 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.431 -179.651 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.485 ' CD1' ' HB3' ' A' ' 63' ' ' ASP . 0.1 OUTLIER -164.31 139.44 5.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.908 0.385 . . . . 0.0 111.021 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -86.73 -68.16 0.76 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.531 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.458 ' C ' HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -87.55 -32.17 19.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.634 -179.344 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.54 HD13 ' HB ' ' A' ' 58' ' ' THR . 1.3 mp 71.16 -149.05 0.08 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.535 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.475 ' CB ' ' CD ' ' A' ' 69' ' ' PRO . 1.0 OUTLIER -159.05 -65.36 0.02 OUTLIER Pre-proline 0 CA--C 1.53 0.177 0 N-CA-C 111.717 0.265 . . . . 0.0 111.717 -179.831 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.475 ' CD ' ' CB ' ' A' ' 68' ' ' ARG . 46.1 Cg_exo -35.52 -60.26 0.33 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.039 2.493 . . . . 0.0 113.377 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.891 HD13 ' HG2' ' B' ' 540' ' ' GLU . 0.3 OUTLIER -46.62 -26.66 0.95 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.658 0.266 . . . . 0.0 111.473 -179.73 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.6 t -95.39 -6.81 40.1 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.401 ' O ' ' O ' ' A' ' 69' ' ' PRO . 23.7 m-85 -134.39 151.67 76.64 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-O 120.867 0.365 . . . . 0.0 111.474 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -80.1 51.37 3.88 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.749 2.299 . . . . 0.0 112.434 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.479 ' NE2' ' HB ' ' A' ' 75' ' ' THR . 4.1 pp0? -73.65 -30.44 62.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.0 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.617 HG21 ' HD1' ' A' ' 78' ' ' PHE . 12.1 t -70.61 -176.65 1.32 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.968 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -113.42 -21.77 10.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.904 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.628 HG13 ' HB2' ' A' ' 109' ' ' PRO . 47.8 t -150.74 112.87 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.041 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.906 ' CE2' HG21 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -80.74 176.87 9.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.707 179.912 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.405 HD22 ' HA ' ' A' ' 79' ' ' LEU . 0.2 OUTLIER -142.63 108.71 5.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.218 -179.715 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.95 HG12 ' CH2' ' A' ' 97' ' ' TRP . 20.0 m -93.57 96.06 5.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.833 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.451 ' HB3' ' N7 ' ' A' ' 185' ' ' GNP . 3.9 m -82.13 177.48 8.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.077 0.465 . . . . 0.0 111.458 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.459 ' CE1' ' O ' ' A' ' 113' ' ' VAL . 19.1 p90 -179.49 -173.47 0.26 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.011 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.82 134.66 18.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.783 0.325 . . . . 0.0 110.651 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.871 HG12 ' O ' ' A' ' 137' ' ' ILE . 2.2 m -45.36 -56.76 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.567 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.632 HG22 ' OE1' ' A' ' 116' ' ' GLN . 33.7 m -54.27 113.24 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.66 ' N ' HD22 ' A' ' 129' ' ' LEU . 4.1 m -151.24 125.49 4.49 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.684 0.278 . . . . 0.0 111.721 -179.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.433 ' O ' ' CB ' ' A' ' 88' ' ' SER . 87.5 Cg_endo -92.51 54.23 0.58 Allowed 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 123.177 2.585 . . . . 0.0 111.56 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.451 ' CB ' ' HG2' ' A' ' 133' ' ' LYS . 0.1 OUTLIER 81.97 24.08 0.23 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.889 -179.413 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.425 ' O ' HG12 ' A' ' 93' ' ' VAL . 6.1 t -97.21 -26.91 14.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.747 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.716 ' CZ ' HG21 ' A' ' 137' ' ' ILE . 13.4 t80 -55.23 -41.34 71.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.89 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 19.2 mp0 -70.22 -38.84 75.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.028 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -67.6 -45.22 76.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.158 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.747 HG22 ' CD1' ' A' ' 97' ' ' TRP . 7.4 p -65.6 -48.98 80.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.488 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.526 ' N ' HG13 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -51.15 -63.18 1.21 Allowed 'General case' 0 C--O 1.235 0.31 0 CA-C-O 120.944 0.402 . . . . 0.0 110.766 179.851 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.425 ' O ' ' CD ' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -52.47 -39.73 61.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.583 179.864 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.404 ' O ' ' CG ' ' A' ' 96' ' ' LYS . 0.2 OUTLIER -88.6 9.17 24.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.274 179.753 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.95 ' CH2' HG12 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -93.06 -58.33 2.36 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.946 0.403 . . . . 0.0 110.877 -179.908 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 1.024 HG22 HD13 ' A' ' 149' ' ' LEU . 40.8 t -56.27 -44.07 99.56 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.383 -179.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.491 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 6.0 Cg_exo -74.3 -19.74 19.37 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.556 2.171 . . . . 0.0 112.921 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -90.46 -59.13 2.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.932 0.396 . . . . 0.0 111.174 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.764 HG22 ' O ' ' A' ' 97' ' ' TRP . 11.5 tt -52.17 -26.22 8.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.709 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 73.7 p -94.54 -62.09 1.39 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.177 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.423 ' CB ' ' O ' ' A' ' 99' ' ' PRO . 7.9 t60 -48.33 -43.32 33.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.222 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 34.1 m-70 -85.1 -23.59 28.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.129 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 5.3 m -146.47 75.81 12.23 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.033 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -62.19 142.37 91.54 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.638 2.226 . . . . 0.0 112.259 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.8 mmtt 63.14 56.06 1.82 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.074 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -138.28 108.06 8.03 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.651 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.628 ' HB2' HG13 ' A' ' 77' ' ' VAL . 31.2 Cg_exo -60.26 164.07 13.44 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.488 2.125 . . . . 0.0 112.354 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.947 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 0.7 OUTLIER -154.42 139.59 17.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.024 179.955 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.929 HD12 HG11 ' A' ' 152' ' ' VAL . 5.8 tt -121.58 146.31 47.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.942 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.602 ' O ' HD23 ' A' ' 111' ' ' LEU . 3.3 mm? -94.61 153.47 17.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.651 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.896 HG13 HG11 ' A' ' 168' ' ' VAL . 93.3 t -136.69 146.24 28.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.095 0.474 . . . . 0.0 111.614 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.401 ' HA3' ' OH ' ' A' ' 154' ' ' TYR . . . -126.01 104.01 0.72 Allowed Glycine 0 N--CA 1.452 -0.243 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.553 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.964 ' OG1' " H2'" ' A' ' 185' ' ' GNP . 0.2 OUTLIER -120.65 -50.94 2.18 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.978 0.418 . . . . 0.0 110.701 -179.037 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.687 ' HB3' HG22 ' A' ' 84' ' ' VAL . 4.8 tt0 -67.3 -8.86 35.41 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.445 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.735 HD11 ' O ' ' A' ' 157' ' ' CYS . 0.2 OUTLIER -44.6 -26.84 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-O 120.681 0.277 . . . . 0.0 111.332 -179.865 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -64.17 -25.22 67.99 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.779 0.323 . . . . 0.0 111.048 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.543 HD12 ' N ' ' A' ' 119' ' ' LEU . 4.9 mp -95.64 -19.86 19.4 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.418 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.48 ' HB3' HG11 ' A' ' 84' ' ' VAL . 5.7 ppt_? -49.43 -26.46 3.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.946 0.403 . . . . 0.0 110.684 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.37 -27.13 29.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.519 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.417 ' N ' ' O ' ' A' ' 119' ' ' LEU . 38.0 t0 -55.1 108.02 1.04 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.599 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.4 ' O ' HG22 ' A' ' 126' ' ' ILE . 15.6 Cg_exo -68.75 -3.9 12.18 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.715 2.277 . . . . 0.0 113.034 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.78 -67.76 0.75 Allowed 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.591 HG21 HG11 ' A' ' 85' ' ' VAL . 7.2 m -56.35 -35.39 67.59 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.457 178.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.599 HD11 ' HB3' ' A' ' 136' ' ' PRO . 0.1 OUTLIER -56.37 -42.02 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.772 179.348 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.553 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 66.6 mt-10 -60.74 -35.33 76.1 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.778 179.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 125' ' ' THR . 0.2 OUTLIER -64.52 -31.66 72.97 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.094 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.66 HD22 ' N ' ' A' ' 86' ' ' SER . 8.0 mt -73.1 -35.74 66.64 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.553 ' HB3' ' O ' ' A' ' 127' ' ' GLU . . . -46.2 -34.56 4.43 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.007 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -48.11 -32.95 7.5 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.531 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.408 ' HB2' ' O ' ' A' ' 87' ' ' PRO . 6.2 m-80 -123.24 -31.24 3.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.416 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.521 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 17.3 mmtt -147.19 -97.96 0.09 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 119.115 -0.469 . . . . 0.0 111.399 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.521 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 7.2 pt20 130.52 -25.1 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.412 1.085 . . . . 0.0 110.297 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 60.5 mmtt -69.28 110.64 6.61 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.766 -179.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.599 ' HB3' HD11 ' A' ' 126' ' ' ILE . 83.9 Cg_endo -80.17 150.96 20.5 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.565 2.177 . . . . 0.0 111.431 179.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.871 ' O ' HG12 ' A' ' 84' ' ' VAL . 1.1 mm -81.93 96.29 3.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.106 0.479 . . . . 0.0 110.83 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.3 p -72.02 151.06 92.71 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.031 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.5 ' HA ' ' CE2' ' A' ' 154' ' ' TYR . 79.7 Cg_exo -44.09 -37.83 10.02 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.496 2.13 . . . . 0.0 112.244 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -68.6 -33.71 74.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.773 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 24.6 m -63.56 -60.58 3.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.717 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -53.15 -38.14 62.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.893 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -59.77 -46.84 87.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.812 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 22.7 tttp -61.36 -47.8 84.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.836 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.403 ' HA ' ' HB2' ' A' ' 148' ' ' ASP . 32.8 tp -67.23 -36.09 80.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.73 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.418 ' CB ' HD23 ' A' ' 112' ' ' LEU . . . -60.45 -54.33 46.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.057 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 11.2 mtp85 -73.05 -26.89 61.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.776 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.403 ' HB2' ' HA ' ' A' ' 145' ' ' LEU . 0.3 OUTLIER -51.66 -46.47 63.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.014 179.928 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 1.024 HD13 HG22 ' A' ' 98' ' ' VAL . 1.0 OUTLIER -93.36 19.61 8.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.049 -179.956 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 78.3 tttt 48.19 43.94 19.09 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.789 0.328 . . . . 0.0 110.984 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.947 ' HB1' ' O ' ' A' ' 110' ' ' PHE . . . -72.36 -81.72 0.05 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.311 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.929 HG11 HD12 ' A' ' 111' ' ' LEU . 69.4 t -160.18 -74.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.773 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt 175.84 139.65 0.06 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.776 -179.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.5 ' CE2' ' HA ' ' A' ' 139' ' ' PRO . 18.0 t80 -99.96 112.28 24.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.693 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.483 HG12 ' H ' ' A' ' 156' ' ' GLU . 3.0 t -101.24 166.03 2.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.201 -179.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.483 ' H ' HG12 ' A' ' 155' ' ' VAL . 1.3 mm-40 -89.51 150.23 22.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.12 0.486 . . . . 0.0 111.402 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.735 ' O ' HD11 ' A' ' 117' ' ' ILE . 1.6 p 178.52 -179.24 0.31 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.089 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.429 ' HB2' ' HB2' ' A' ' 163' ' ' LYS . 0.7 OUTLIER -160.14 152.49 20.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.875 0.369 . . . . 0.0 111.179 179.698 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.465 ' CB ' " H3'" ' A' ' 185' ' ' GNP . . . -109.99 -28.66 8.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.923 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.619 ' H ' HD12 ' A' ' 160' ' ' LEU . 3.2 mp -83.78 -45.22 13.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.651 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -98.8 -24.31 15.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.587 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 75.34 76.9 0.1 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.108 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.429 ' HB2' ' HB2' ' A' ' 158' ' ' SER . 2.8 tttm -94.82 34.21 1.38 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.698 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . 116.34 -62.32 0.38 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.589 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.942 HD13 ' O ' ' A' ' 19' ' ' LEU . 1.9 mt 67.55 -63.03 0.31 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.745 0.307 . . . . 0.0 111.05 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.417 ' O ' ' N ' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -55.49 -27.97 51.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.075 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -52.12 -72.63 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.858 0.361 . . . . 0.0 110.687 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.896 HG11 HG13 ' A' ' 113' ' ' VAL . 7.4 p -52.69 -46.22 49.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.173 0.511 . . . . 0.0 110.29 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.961 ' CD1' HD22 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -56.97 -29.32 63.13 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.744 179.225 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.716 ' O ' HD13 ' A' ' 173' ' ' ILE . 22.5 t0 -69.08 -29.47 67.58 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.494 178.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.667 ' HB3' HD11 ' A' ' 111' ' ' LEU . 28.8 mm-40 -75.91 -24.28 55.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.972 178.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.481 ' HA ' HD13 ' A' ' 111' ' ' LEU . . . -71.01 -54.91 9.55 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.381 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.716 HD13 ' O ' ' A' ' 170' ' ' ASP . 0.2 OUTLIER -67.64 -31.97 54.82 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-O 120.896 0.379 . . . . 0.0 110.666 -179.793 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.721 HD23 HD13 ' B' ' 505' ' ' LEU . 2.5 tm? -48.6 -33.65 10.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.742 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -74.53 -25.15 59.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.053 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.673 ' HB3' HG21 ' A' ' 4' ' ' ILE . . . -97.29 -32.41 11.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.646 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.862 HD13 ' HB ' ' B' ' 510' ' ' ILE . 14.4 mt -68.66 -11.23 59.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.223 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.456 ' HB2' ' HB1' ' B' ' 507' ' ' ALA . 0.0 OUTLIER 173.01 148.79 0.21 Allowed Pre-proline 0 C--N 1.332 -0.193 0 CA-C-O 120.768 0.318 . . . . 0.0 110.94 179.761 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.402 ' HA ' ' HD2' ' A' ' 180' ' ' PRO . 84.5 Cg_exo -47.26 105.52 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.618 2.212 . . . . 0.0 112.305 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 179' ' ' PRO . 57.5 Cg_endo -70.97 171.85 14.97 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.581 2.188 . . . . 0.0 112.346 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -142.11 130.73 11.93 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.805 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.74 -164.95 0.23 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.546 2.164 . . . . 0.0 112.248 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.77 78.86 4.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.902 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.187 -0.911 . . . . 0.0 110.918 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 502' ' ' GLY . . . . . 0.423 ' CA ' ' OG ' ' B' ' 511' ' ' SER . . . . . . . . 0 N--CA 1.489 2.199 0 N-CA-C 112.539 -0.224 . . . . 0.0 112.539 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 503' ' ' SER . . . . . 0.403 ' HB3' ' O ' ' B' ' 510' ' ' ILE . 26.7 t -58.83 -73.29 0.08 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.795 0.331 . . . . 0.0 110.855 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 504' ' ' GLY . . . . . 0.445 ' HA2' ' CB ' ' B' ' 509' ' ' ASP . . . 94.05 103.61 1.74 Allowed Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.393 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 505' ' ' LEU . . . . . 0.721 HD13 HD23 ' A' ' 174' ' ' LEU . 0.1 OUTLIER -174.26 57.36 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.809 0.338 . . . . 0.0 110.741 -179.62 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 506' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 46.83 58.07 5.05 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.936 0.398 . . . . 0.0 110.66 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 507' ' ' ALA . . . . . 0.456 ' HB1' ' HB2' ' A' ' 178' ' ' GLU . . . -169.56 42.06 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.894 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 508' ' ' GLN . . . . . 0.61 HE21 HD11 ' B' ' 510' ' ' ILE . 21.8 mt-30 73.65 4.53 4.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.786 -179.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 509' ' ' ASP . . . . . 0.445 ' CB ' ' HA2' ' B' ' 504' ' ' GLY . 3.0 p30 51.9 48.69 22.28 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 121.496 0.665 . . . . 0.0 110.673 -179.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 510' ' ' ILE . . . . . 0.862 ' HB ' HD13 ' A' ' 177' ' ' LEU . 37.5 mt -72.68 130.03 35.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.054 -0.975 . . . . 0.0 111.087 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 511' ' ' SER . . . . . 0.593 ' O ' HD11 ' B' ' 514' ' ' LEU . 16.5 m -77.2 135.79 38.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.3 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 512' ' ' GLN . . . . . 0.444 ' HB3' ' HD3' ' B' ' 513' ' ' PRO . 0.0 OUTLIER -97.91 -53.8 0.2 Allowed Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.092 179.744 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 513' ' ' PRO . . . . . 0.444 ' HD3' ' HB3' ' B' ' 512' ' ' GLN . 97.2 Cg_endo -90.56 59.39 1.46 Allowed 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.835 2.357 . . . . 0.0 112.231 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 514' ' ' LEU . . . . . 0.855 ' HB2' HG13 ' A' ' 44' ' ' VAL . 1.2 mp -75.21 -174.61 2.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.946 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 515' ' ' GLN . . . . . 0.596 ' O ' HG22 ' A' ' 44' ' ' VAL . 1.9 mt-30 -72.27 158.28 36.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.932 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 516' ' ' ASN . . . . . 0.62 ' HB3' HG23 ' A' ' 43' ' ' THR . 9.7 m120 59.89 24.04 13.09 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.885 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 517' ' ' SER . . . . . 0.54 ' HA ' HG21 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -41.08 -29.48 0.12 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.854 -179.737 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 518' ' ' PHE . . . . . 0.7 ' HA ' HG12 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -150.92 135.49 17.14 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.839 0.352 . . . . 0.0 111.409 -179.778 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 519' ' ' ILE . . . . . 0.437 ' CG1' ' O ' ' A' ' 41' ' ' ALA . 2.7 pt -121.21 -37.02 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.845 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -120.04 -166.84 1.35 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.672 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 521' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -151.47 54.55 0.85 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.063 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 522' ' ' GLY . . . . . 0.457 ' HA2' ' CD2' ' A' ' 37' ' ' PHE . . . 45.52 -148.0 1.89 Allowed Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.529 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 523' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -173.1 -101.36 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.641 0.221 . . . . 0.0 111.037 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 524' ' ' GLY . . . . . . . . . . . . . . . 69.13 -63.0 0.54 Allowed Glycine 0 C--N 1.337 0.619 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.4 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 525' ' ' ASP . . . . . 0.885 ' HB3' HD22 ' A' ' 61' ' ' LEU . 24.2 t70 177.29 82.59 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.874 0.369 . . . . 0.0 110.719 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 526' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.51 95.99 5.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.801 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 527' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -146.1 158.57 48.09 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.915 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -68.62 97.56 0.54 Allowed 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.626 2.217 . . . . 0.0 112.328 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 529' ' ' ARG . . . . . 0.561 ' HG3' HG13 ' A' ' 33' ' ' VAL . 0.2 OUTLIER -100.53 -53.6 3.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.971 -179.998 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 530' ' ' HIS . . . . . 0.416 ' CD2' ' O ' ' B' ' 530' ' ' HIS . 12.4 t60 -166.76 95.16 0.51 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.492 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 531' ' ' CYS . . . . . 0.417 ' CB ' ' O ' ' A' ' 30' ' ' SER . 96.5 m -55.46 160.43 2.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.943 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 532' ' ' TRP . . . . . 0.445 ' CD1' ' OH ' ' A' ' 32' ' ' TYR . 88.5 t90 -55.12 139.46 41.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.832 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . -134.53 -123.69 2.38 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.594 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 534' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.84 147.43 89.51 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.745 0.307 . . . . 0.0 110.948 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_exo -51.61 -176.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.697 2.265 . . . . 0.0 112.351 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 3.5 t70 53.64 99.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.996 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 537' ' ' ARG . . . . . 0.464 ' HB3' ' CG2' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -75.57 179.02 5.57 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.299 0.571 . . . . 0.0 110.893 179.898 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 538' ' ' ILE . . . . . 0.43 ' O ' HG21 ' A' ' 14' ' ' VAL . 1.8 pt -74.87 -154.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.984 179.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 539' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -107.58 148.19 29.61 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.726 0.298 . . . . 0.0 110.419 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 540' ' ' GLU . . . . . 0.911 ' CD ' HG13 ' A' ' 9' ' ' VAL . 12.9 pm0 -48.11 -25.58 1.51 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.036 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 541' ' ' LEU . . . . . 0.517 ' HA ' HD21 ' A' ' 70' ' ' LEU . 11.0 mt -37.5 -45.29 0.72 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.523 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 542' ' ' TYR . . . . . 0.456 ' CD1' ' N ' ' B' ' 542' ' ' TYR . 1.4 m-30 -104.73 -63.12 1.25 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.879 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 543' ' ' LEU . . . . . 0.886 HD12 ' HA ' ' B' ' 540' ' ' GLU . 0.0 OUTLIER 76.9 125.06 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.844 -179.853 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 544' ' ' GLY . . . . . 0.424 ' HA2' ' HB2' ' A' ' 32' ' ' TYR . . . 55.77 -159.08 7.56 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.483 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 545' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.207 -0.901 . . . . 0.0 110.925 179.983 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' GNP . . . . . 0.964 " H2'" ' OG1' ' A' ' 115' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' HOH . . . . . 0.424 ' O ' HD11 ' A' ' 21' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.4 tpt . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.889 0.376 . . . . 0.0 111.085 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.4 tm0? -81.78 144.1 31.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.635 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.704 HG23 ' CE1' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -93.82 -175.52 3.76 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.342 -179.639 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.977 HG13 HD13 ' A' ' 53' ' ' LEU . 5.2 pt -154.99 143.67 13.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.948 -179.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.416 ' O ' HG23 ' A' ' 75' ' ' THR . 3.2 ptpp? -134.33 95.57 3.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.131 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.499 ' SG ' HG13 ' A' ' 77' ' ' VAL . 80.5 m -118.87 153.34 34.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.059 0.457 . . . . 0.0 111.332 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.656 HG22 ' HB2' ' A' ' 56' ' ' PHE . 2.5 t -142.99 128.46 16.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.453 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.724 HG23 ' SG ' ' A' ' 81' ' ' CYS . 1.4 p -84.68 113.84 23.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.166 0.507 . . . . 0.0 111.192 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.868 HG11 ' CE1' ' A' ' 72' ' ' TYR . 1.3 m -114.74 129.75 70.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.443 178.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.482 ' HA2' ' CZ2' ' A' ' 97' ' ' TRP . . . 149.13 -170.11 29.48 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.098 -1.049 . . . . 0.0 112.808 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.435 ' O ' ' N ' ' B' ' 537' ' ' ARG . 0.4 OUTLIER -98.3 27.54 4.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.715 0.293 . . . . 0.0 110.691 179.91 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.428 ' CA ' ' HB2' ' B' ' 537' ' ' ARG . . . -126.34 170.62 18.15 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.684 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.719 ' HB3' H5'1 ' A' ' 185' ' ' GNP . . . -98.27 -38.26 9.34 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.715 0.293 . . . . 0.0 111.344 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.816 HG11 HG21 ' A' ' 115' ' ' THR . 2.1 m -43.94 91.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.481 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.66 ' CA ' HD22 ' A' ' 19' ' ' LEU . . . -175.55 -71.43 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.934 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.441 ' CD ' ' HB3' ' A' ' 55' ' ' LEU . 8.8 mmtm -97.39 -80.67 0.44 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.007 0.432 . . . . 0.0 111.912 -179.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 1.026 HG21 HG23 ' A' ' 35' ' ' THR . 71.7 p -75.1 -69.57 0.47 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.547 -178.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.71 ' HB2' ' HB1' ' A' ' 13' ' ' ALA . 43.2 t -33.01 -43.35 0.1 Allowed 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -178.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.8 HD13 ' HA ' ' A' ' 14' ' ' VAL . 0.2 OUTLIER -60.71 -52.71 63.94 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.782 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -70.49 -24.42 62.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.842 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 27.7 mm -57.81 -71.18 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.492 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.5 m -60.87 -23.37 65.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.128 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.471 ' CE2' ' HB2' ' B' ' 513' ' ' PRO . 41.5 t80 -65.19 -68.24 0.38 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.858 0.361 . . . . 0.0 110.284 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 96.9 m -75.87 -37.58 58.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.744 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.4 p -113.12 -166.8 1.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.684 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -142.0 19.08 2.12 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.12 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.8 mmtm -93.35 95.98 9.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.021 0.438 . . . . 0.0 110.566 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.496 ' CD1' ' O1A' ' A' ' 185' ' ' GNP . 2.6 t80 -87.01 -50.6 0.45 Allowed Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.301 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.473 ' HD3' ' HB3' ' A' ' 28' ' ' PHE . 64.9 Cg_endo -88.66 46.04 1.01 Allowed 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.842 2.361 . . . . 0.0 112.475 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.5 p -83.7 -94.36 0.07 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.127 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -158.87 124.74 4.44 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.797 0.332 . . . . 0.0 111.17 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.475 ' O ' HG22 ' A' ' 33' ' ' VAL . 4.6 m-30 -88.58 94.7 9.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.598 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.652 HG13 ' OXT' ' B' ' 545' ' ' ASN . 0.0 OUTLIER -165.03 -64.07 0.01 OUTLIER Pre-proline 0 N--CA 1.466 0.328 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.633 -179.804 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.452 ' CD ' ' HB ' ' A' ' 33' ' ' VAL . 10.3 Cg_endo -53.09 -16.98 7.25 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.889 2.393 . . . . 0.0 112.67 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 1.026 HG23 HG21 ' A' ' 17' ' ' THR . 45.4 m -36.18 -31.83 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.533 HG21 ' HA3' ' B' ' 524' ' ' GLY . 0.0 OUTLIER -44.31 -28.37 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 120.685 0.279 . . . . 0.0 111.436 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.467 ' O ' ' CG ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -78.39 57.7 1.98 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.088 179.857 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -135.05 -47.46 0.72 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.845 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -63.96 -16.88 62.55 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.265 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.66 -157.5 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.932 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.409 ' O ' HG12 ' B' ' 519' ' ' ILE . . . -90.76 162.6 14.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.068 0.461 . . . . 0.0 111.951 -179.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.588 HG13 ' C ' ' B' ' 517' ' ' SER . 4.8 t -134.86 166.58 28.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.078 179.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.69 HG22 HD13 ' B' ' 519' ' ' ILE . 9.4 t -143.82 103.8 4.1 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.904 HG22 ' CG2' ' A' ' 52' ' ' THR . 30.9 m -161.84 -177.46 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.017 178.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.499 ' O ' HD21 ' B' ' 514' ' ' LEU . 0.0 OUTLIER -105.63 100.01 9.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.61 0.243 . . . . 0.0 111.642 -179.479 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.608 HG22 ' O ' ' A' ' 46' ' ' ILE . 5.1 mm -75.01 86.59 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 178.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.458 ' HA3' ' HA ' ' B' ' 510' ' ' ILE . . . 45.76 -95.61 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.689 -0.687 . . . . 0.0 113.401 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -38.04 -90.41 0.01 OUTLIER Glycine 0 CA--C 1.52 0.355 0 N-CA-C 113.992 0.357 . . . . 0.0 113.992 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.439 ' N ' ' HE1' ' A' ' 45' ' ' MET . 0.1 OUTLIER -123.14 159.12 55.69 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.789 0.328 . . . . 0.0 111.161 -179.181 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.416 ' HD2' ' HB2' ' A' ' 49' ' ' GLU . 2.7 Cg_endo -46.15 105.06 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.792 2.328 . . . . 0.0 112.356 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.704 ' CE1' HG23 ' A' ' 3' ' ' THR . 1.7 t80 -172.27 158.72 4.53 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.328 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.904 ' CG2' HG22 ' A' ' 44' ' ' VAL . 3.3 p -136.41 153.07 51.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.154 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.977 HD13 HG13 ' A' ' 4' ' ' ILE . 0.5 OUTLIER -78.76 -174.64 4.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.629 179.61 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -114.16 76.14 0.24 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.399 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.64 HD21 ' NE2' ' B' ' 512' ' ' GLN . 0.6 OUTLIER -52.56 114.62 1.44 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.938 0.399 . . . . 0.0 110.356 179.845 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.656 ' HB2' HG22 ' A' ' 7' ' ' VAL . 77.3 m-85 -84.4 109.42 17.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.069 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.417 ' HA ' ' HG3' ' A' ' 16' ' ' LYS . 3.5 t0 -108.2 -175.76 2.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.652 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.607 HG21 ' O ' ' B' ' 540' ' ' GLU . 16.8 p -135.83 170.38 16.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.093 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.821 ' N ' HD21 ' A' ' 67' ' ' LEU . . . -171.82 167.01 6.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.111 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' B' ' 543' ' ' LEU . . . -146.14 33.73 1.46 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.306 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.694 HD13 ' OD1' ' B' ' 525' ' ' ASP . 0.0 OUTLIER -121.22 -173.68 2.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.765 0.317 . . . . 0.0 110.817 179.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -44.52 -27.76 0.5 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.697 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.465 ' OD2' ' CE1' ' A' ' 64' ' ' TYR . 45.2 t0 -47.67 -63.44 1.06 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.223 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.523 ' O ' HD23 ' A' ' 67' ' ' LEU . 0.0 OUTLIER 170.88 73.65 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.175 179.905 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -58.76 -19.9 44.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.101 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.14 -14.24 61.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.596 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.821 HD21 ' N ' ' A' ' 59' ' ' ALA . 3.6 pp -47.69 135.51 11.56 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.839 0.352 . . . . 0.0 111.087 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.479 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -139.55 48.52 1.64 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.084 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 71.0 Cg_endo -74.17 -9.58 22.03 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.451 2.101 . . . . 0.0 112.484 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.769 HD11 HD23 ' B' ' 541' ' ' LEU . 0.1 OUTLIER -78.78 1.04 24.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.641 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -55.13 -20.47 10.16 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.625 0.25 . . . . 0.0 111.437 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.868 ' CE1' HG11 ' A' ' 9' ' ' VAL . 34.2 m-85 73.59 64.84 0.31 Allowed Pre-proline 0 C--N 1.332 -0.17 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.819 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.1 -150.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.581 2.188 . . . . 0.0 111.955 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -60.39 -16.17 32.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.374 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 5' ' ' LYS . 55.3 m -42.12 133.06 3.15 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.871 0.367 . . . . 0.0 111.298 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.846 ' HA ' HG22 ' A' ' 108' ' ' THR . 0.4 OUTLIER -115.1 7.47 15.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.562 -179.82 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.758 HG21 ' HB3' ' A' ' 175' ' ' ALA . 7.9 p -145.21 79.95 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.881 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.586 ' HE1' HD12 ' A' ' 101' ' ' ILE . 1.1 p90 -92.8 124.82 37.07 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 178.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.482 HD11 ' CG2' ' A' ' 113' ' ' VAL . 12.7 tp -70.37 108.65 4.34 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.78 -178.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.659 HG21 ' CD1' ' A' ' 110' ' ' PHE . 2.1 t -80.19 156.13 4.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.696 178.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.724 ' SG ' HG23 ' A' ' 8' ' ' VAL . 2.8 m -145.77 129.75 17.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.318 0.58 . . . . 0.0 112.363 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.699 ' HE2' HD12 ' A' ' 112' ' ' LEU . 17.4 p90 -152.21 128.78 10.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.564 178.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.46 ' HA ' ' C2 ' ' A' ' 185' ' ' GNP . 0.7 OUTLIER -83.06 137.62 34.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.125 0.488 . . . . 0.0 111.76 -178.663 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.727 HG11 ' HB3' ' A' ' 120' ' ' ARG . 72.5 t -47.85 -78.73 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.246 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.73 HG22 ' OE1' ' A' ' 116' ' ' GLN . 29.6 m -42.8 113.95 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.086 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.537 ' C ' HD22 ' A' ' 129' ' ' LEU . 3.0 p -152.25 145.07 17.19 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.888 0.375 . . . . 0.0 111.909 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.427 ' HA ' ' HB3' ' A' ' 133' ' ' LYS . 76.9 Cg_endo -91.23 53.96 0.91 Allowed 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.226 2.618 . . . . 0.0 111.659 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.482 ' N ' ' CB ' ' A' ' 133' ' ' LYS . 0.7 OUTLIER 82.15 33.26 0.09 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.806 -179.455 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.898 ' O ' HG23 ' A' ' 93' ' ' VAL . 1.1 t -88.31 -24.75 23.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.023 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.512 ' CD1' HG13 ' A' ' 137' ' ' ILE . 2.1 t80 -51.07 -56.78 10.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.096 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -53.11 -41.9 65.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.131 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.422 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 1.8 t-20 -72.73 -53.16 12.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.975 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.898 HG23 ' O ' ' A' ' 89' ' ' SER . 46.5 t -49.81 -44.44 20.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.207 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.469 ' O ' HG23 ' A' ' 98' ' ' VAL . 30.4 tttt -62.23 -52.59 63.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.998 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.414 ' O ' ' HG3' ' A' ' 99' ' ' PRO . 70.2 mt-10 -84.51 9.38 13.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.681 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.422 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 25.7 tttp -116.12 -37.75 3.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.729 0.3 . . . . 0.0 110.725 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.482 ' CZ2' ' HA2' ' A' ' 10' ' ' GLY . 0.8 OUTLIER -94.42 -46.85 6.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.34 -179.769 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.482 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 56.9 t -51.98 -46.07 92.89 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.654 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.482 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 92.0 Cg_endo -81.1 -12.37 11.82 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.342 2.028 . . . . 0.0 112.757 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -86.61 -49.17 7.72 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.861 0.362 . . . . 0.0 110.585 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.586 HD12 ' HE1' ' A' ' 78' ' ' PHE . 32.4 pt -66.55 -28.15 42.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.879 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.425 HG23 ' O ' ' A' ' 98' ' ' VAL . 27.5 p -77.68 -33.25 53.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.579 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -64.12 -46.09 85.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.758 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 27.5 m170 -82.86 -24.15 33.37 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.758 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -142.94 95.8 6.13 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.665 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -68.81 133.13 26.51 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.594 2.196 . . . . 0.0 112.574 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 49.02 77.32 0.1 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.156 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.846 HG22 ' HA ' ' A' ' 76' ' ' ASP . 0.1 OUTLIER -139.29 115.09 8.35 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.878 179.857 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.42 162.78 13.91 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.639 2.226 . . . . 0.0 112.826 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.659 ' CD1' HG21 ' A' ' 80' ' ' VAL . 37.0 p90 -161.69 165.05 28.73 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.549 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.975 HD12 HG11 ' A' ' 152' ' ' VAL . 0.9 OUTLIER -114.96 159.62 20.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.939 0.399 . . . . 0.0 111.635 -179.562 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.737 HD22 ' C ' ' A' ' 111' ' ' LEU . 2.4 mm? -119.48 161.14 21.07 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.575 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.492 HG12 ' CG2' ' A' ' 115' ' ' THR . 3.1 t -134.4 142.85 39.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.911 0.386 . . . . 0.0 111.694 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.628 ' O ' HD13 ' A' ' 117' ' ' ILE . . . -121.76 67.77 0.45 Allowed Glycine 0 C--N 1.331 0.28 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.989 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.816 HG21 HG11 ' A' ' 14' ' ' VAL . 1.4 p -92.38 26.55 2.55 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -178.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.73 ' OE1' HG22 ' A' ' 85' ' ' VAL . 2.9 mm-40 -131.88 23.85 4.62 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.199 0.523 . . . . 0.0 109.737 179.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.725 HD11 ' N ' ' A' ' 158' ' ' SER . 0.0 OUTLIER -67.68 -9.62 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.8 179.253 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -100.43 -40.59 7.39 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.144 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.625 HD13 ' CD ' ' A' ' 116' ' ' GLN . 3.5 mp -69.54 -33.79 73.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.313 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.727 ' HB3' HG11 ' A' ' 84' ' ' VAL . 0.1 OUTLIER -47.25 -33.83 5.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.891 0.377 . . . . 0.0 110.984 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -80.13 -27.35 39.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.549 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' A' ' 119' ' ' LEU . 2.2 t70 -57.59 106.47 0.69 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.76 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -70.0 -3.83 12.95 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.643 2.229 . . . . 0.0 112.847 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.98 -67.27 0.77 Allowed 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.059 0.457 . . . . 0.0 110.0 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.416 ' O ' ' HB3' ' A' ' 128' ' ' LYS . 2.1 m -56.17 -43.58 78.51 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 178.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.88 HD11 ' HB3' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -48.28 -42.17 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.524 178.913 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.573 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 0.4 OUTLIER -55.63 -49.44 72.84 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.006 178.679 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.682 ' HD2' HD23 ' A' ' 129' ' ' LEU . 0.1 OUTLIER -54.67 -32.89 59.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.2 179.017 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.682 HD23 ' HD2' ' A' ' 128' ' ' LYS . 7.5 mt -72.41 -42.0 65.62 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.578 ' HB2' ' HG3' ' A' ' 134' ' ' GLN . . . -42.51 -30.7 0.37 Allowed 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.106 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.404 ' HG2' ' O ' ' A' ' 128' ' ' LYS . 2.9 mmmt -58.94 -39.56 81.97 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.247 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -125.16 -30.59 3.17 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.482 ' CB ' ' N ' ' A' ' 88' ' ' SER . 0.3 OUTLIER -130.51 -69.68 0.65 Allowed 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -177.719 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.578 ' HG3' ' HB2' ' A' ' 130' ' ' ALA . 2.8 tt0 87.73 -37.23 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.44 ' CB ' ' HE3' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -69.03 111.23 7.82 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 120.733 0.301 . . . . 0.0 111.505 -179.137 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.88 ' HB3' HD11 ' A' ' 126' ' ' ILE . 74.2 Cg_endo -77.5 129.68 10.33 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.544 2.163 . . . . 0.0 112.019 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.531 ' HB ' HG13 ' A' ' 84' ' ' VAL . 0.6 OUTLIER -59.42 96.9 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.94 179.904 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.42 ' O ' ' N ' ' A' ' 141' ' ' THR . 11.1 p -67.32 147.29 98.91 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.897 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_exo -40.88 -40.71 3.75 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.728 2.285 . . . . 0.0 112.318 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -69.24 -36.6 77.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.6 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.42 ' N ' ' O ' ' A' ' 138' ' ' THR . 90.6 m -55.31 -56.69 17.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.76 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.572 ' HB3' ' CE2' ' A' ' 154' ' ' TYR . . . -52.53 -39.57 61.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.81 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.98 -34.98 79.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.703 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.2 tptt -59.98 -58.63 7.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.783 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.425 ' HA ' ' HB2' ' A' ' 148' ' ' ASP . 24.1 tp -65.71 -35.98 82.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.761 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -58.11 -61.04 2.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.167 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 4.4 mtt85 -72.39 -25.44 61.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.012 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.425 ' HB2' ' HA ' ' A' ' 145' ' ' LEU . 1.8 m-20 -49.36 -41.87 40.31 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.036 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 5.9 mt -102.69 23.14 12.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.922 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 48.34 33.85 4.17 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.971 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.707 ' O ' HG23 ' A' ' 152' ' ' VAL . . . -51.96 -81.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.187 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.975 HG11 HD12 ' A' ' 111' ' ' LEU . 8.0 t -164.56 -69.21 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.894 0.378 . . . . 0.0 110.394 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 177.41 135.45 0.07 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.243 -179.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.572 ' CE2' ' HB3' ' A' ' 142' ' ' ALA . 24.7 t80 -106.75 114.7 28.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.728 178.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.622 ' HB ' HG22 ' A' ' 168' ' ' VAL . 2.8 t -101.24 151.99 5.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.733 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -99.12 118.58 36.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.4 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.512 ' N ' HD12 ' A' ' 117' ' ' ILE . 0.9 OUTLIER 178.3 125.96 0.05 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.546 179.523 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.725 ' N ' HD11 ' A' ' 117' ' ' ILE . 40.2 t -118.61 151.57 37.66 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.076 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -72.06 -38.46 69.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.942 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.514 ' H ' HD12 ' A' ' 160' ' ' LEU . 4.1 mp -52.6 -52.55 54.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.562 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 12.9 t -77.23 -42.62 36.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.562 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.404 ' O ' ' O ' ' A' ' 163' ' ' LYS . 3.1 tt0 176.71 -85.38 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.195 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.938 ' HG2' HD22 ' A' ' 165' ' ' LEU . 4.7 tttm 58.76 118.76 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.925 0.393 . . . . 0.0 110.726 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . -71.12 -10.12 68.32 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.43 -0.89 . . . . 0.0 112.523 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.938 HD22 ' HG2' ' A' ' 163' ' ' LYS . 4.0 mm? 66.95 -63.73 0.26 Allowed 'General case' 0 CA--C 1.522 -0.097 0 CA-C-O 120.702 0.287 . . . . 0.0 110.474 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.436 ' O ' ' CB ' ' A' ' 170' ' ' ASP . 1.7 ptmt -57.04 -32.14 65.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.688 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.433 ' N ' ' HG2' ' A' ' 166' ' ' LYS . 0.1 OUTLIER -53.92 -72.17 0.06 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.764 0.316 . . . . 0.0 110.617 179.832 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.622 HG22 ' HB ' ' A' ' 155' ' ' VAL . 5.9 t -63.41 -43.06 98.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.244 0.545 . . . . 0.0 110.073 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.763 ' CG ' HD23 ' A' ' 19' ' ' LEU . 0.9 OUTLIER -58.57 -24.01 59.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.603 179.539 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.443 ' HA ' ' CG1' ' A' ' 173' ' ' ILE . 27.5 t0 -76.99 -41.53 42.5 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.879 0.371 . . . . 0.0 110.038 179.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.509 ' HB3' HD11 ' A' ' 111' ' ' LEU . 13.4 mm-40 -56.59 -33.76 66.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.185 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.606 ' N ' HD13 ' A' ' 111' ' ' LEU . . . -73.54 -58.22 3.46 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.129 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.488 ' HB ' HD12 ' A' ' 4' ' ' ILE . 1.3 pp -62.66 -39.93 86.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.23 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.883 HD13 HD22 ' B' ' 505' ' ' LEU . 5.0 tp -48.03 -43.18 29.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.194 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.758 ' HB3' HG21 ' A' ' 77' ' ' VAL . . . -52.59 -23.26 6.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.071 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.49 ' HB3' ' HB ' ' A' ' 4' ' ' ILE . . . -90.88 -36.5 14.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.394 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.847 HD13 ' HB ' ' B' ' 510' ' ' ILE . 80.7 mt -68.55 -23.02 64.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.816 0.341 . . . . 0.0 110.671 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.481 ' HG3' ' HB2' ' B' ' 507' ' ' ALA . 0.6 OUTLIER -169.96 167.22 5.08 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.799 179.878 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.422 ' HD2' ' CB ' ' A' ' 178' ' ' GLU . 32.4 Cg_endo -64.17 124.58 13.67 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.576 2.184 . . . . 0.0 112.251 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -74.03 164.7 33.79 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.457 2.104 . . . . 0.0 112.455 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . 0.409 ' O ' ' CG ' ' A' ' 181' ' ' GLU . 0.7 OUTLIER -117.09 114.41 38.96 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.807 179.999 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.62 -165.04 0.25 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.567 2.178 . . . . 0.0 112.321 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.48 77.66 7.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.999 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.168 -0.92 . . . . 0.0 110.787 179.99 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.122 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 503' ' ' SER . . . . . . . . . . . . . 31.0 t -105.41 -71.93 0.73 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.78 0.324 . . . . 0.0 111.034 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 504' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' B' ' 509' ' ' ASP . . . 111.93 122.49 4.14 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.126 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 505' ' ' LEU . . . . . 0.883 HD22 HD13 ' A' ' 174' ' ' LEU . 0.4 OUTLIER -173.92 -37.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.54 -179.572 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 506' ' ' SER . . . . . 0.599 ' N ' HD12 ' B' ' 505' ' ' LEU . 0.3 OUTLIER 171.46 -56.82 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.704 0.288 . . . . 0.0 110.913 -179.821 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 507' ' ' ALA . . . . . 0.481 ' HB2' ' HG3' ' A' ' 178' ' ' GLU . . . -39.9 -43.74 1.55 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.688 0.756 . . . . 0.0 111.073 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 508' ' ' GLN . . . . . 0.48 ' O ' ' CB ' ' B' ' 509' ' ' ASP . 13.5 pt20 164.99 -39.22 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.362 -1.29 . . . . 0.0 108.226 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 509' ' ' ASP . . . . . 0.48 ' CB ' ' O ' ' B' ' 508' ' ' GLN . 7.6 p30 147.25 41.44 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 113.94 -1.482 . . . . 0.0 110.197 179.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 510' ' ' ILE . . . . . 0.847 ' HB ' HD13 ' A' ' 177' ' ' LEU . 13.7 mt -72.08 126.27 32.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.263 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 511' ' ' SER . . . . . . . . . . . . . 30.3 t -109.47 141.73 41.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.288 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 512' ' ' GLN . . . . . 0.64 ' NE2' HD21 ' A' ' 55' ' ' LEU . 4.3 tp60 -92.89 -67.68 0.1 OUTLIER Pre-proline 0 CA--C 1.532 0.27 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 513' ' ' PRO . . . . . 0.492 ' HD3' ' HB3' ' B' ' 512' ' ' GLN . 92.3 Cg_endo -80.3 74.31 5.6 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.451 2.101 . . . . 0.0 111.461 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 514' ' ' LEU . . . . . 0.499 HD21 ' O ' ' A' ' 45' ' ' MET . 2.3 mp -73.45 -86.7 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.488 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 515' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -79.25 -87.76 0.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.693 -0.231 . . . . 0.0 111.052 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -117.57 -29.67 5.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.803 0.335 . . . . 0.0 111.134 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 517' ' ' SER . . . . . 0.588 ' C ' HG13 ' A' ' 42' ' ' VAL . 2.6 m 72.01 22.27 3.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.964 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 518' ' ' PHE . . . . . 0.48 ' CD1' ' O ' ' B' ' 517' ' ' SER . 12.1 m-85 -150.13 130.44 13.73 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.027 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 519' ' ' ILE . . . . . 0.69 HD13 HG22 ' A' ' 43' ' ' THR . 43.9 mm -63.62 -68.32 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.994 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -155.06 -67.41 0.13 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.061 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 521' ' ' THR . . . . . . . . . . . . . 11.2 m -163.88 157.63 18.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.101 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 522' ' ' GLY . . . . . . . . . . . . . . . -91.78 -92.08 1.39 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.333 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 523' ' ' HIS . . . . . 0.411 ' CD2' ' N ' ' B' ' 523' ' ' HIS . 0.1 OUTLIER 174.73 -98.81 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.475 0.137 . . . . 0.0 110.845 179.881 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 524' ' ' GLY . . . . . 0.533 ' HA3' HG21 ' A' ' 36' ' ' VAL . . . 42.35 -95.06 0.01 OUTLIER Glycine 0 C--N 1.338 0.658 0 C-N-CA 120.991 -0.623 . . . . 0.0 113.009 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 525' ' ' ASP . . . . . 0.694 ' OD1' HD13 ' A' ' 61' ' ' LEU . 33.2 p-10 177.46 91.65 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.815 0.34 . . . . 0.0 111.088 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 526' ' ' SER . . . . . 0.443 ' CB ' ' HB3' ' A' ' 34' ' ' PRO . 9.2 t -80.04 95.71 6.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.724 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 527' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -144.6 147.91 37.93 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.816 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.55 99.92 0.65 Allowed 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.552 2.168 . . . . 0.0 112.323 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 529' ' ' ARG . . . . . 0.614 ' HG3' HG21 ' A' ' 33' ' ' VAL . 12.6 mtp180 -100.29 -54.88 2.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.004 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 530' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -158.72 96.85 1.4 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.836 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 27.8 p -68.76 112.13 5.29 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.955 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 532' ' ' TRP . . . . . 0.504 ' CD1' ' NH2' ' B' ' 537' ' ' ARG . 22.4 t90 66.74 -68.95 0.13 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.833 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . 61.39 -80.76 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.52 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 534' ' ' PHE . . . . . 0.416 ' O ' ' NH1' ' B' ' 537' ' ' ARG . 17.7 m-85 -105.54 149.86 38.35 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.685 0.279 . . . . 0.0 110.844 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.27 -12.72 30.26 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.502 2.135 . . . . 0.0 112.555 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -112.98 120.79 42.61 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.831 0.348 . . . . 0.0 111.003 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 537' ' ' ARG . . . . . 0.504 ' NH2' ' CD1' ' B' ' 532' ' ' TRP . 11.6 mmt-85 -71.57 138.51 48.86 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.156 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 538' ' ' ILE . . . . . 0.4 HD12 ' HA ' ' B' ' 538' ' ' ILE . 4.1 tp -56.46 139.03 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.941 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 539' ' ' ASP . . . . . . . . . . . . . 34.3 p-10 -42.64 126.03 3.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.862 0.363 . . . . 0.0 111.125 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 540' ' ' GLU . . . . . 0.607 ' O ' HG21 ' A' ' 58' ' ' THR . 19.8 mm-40 -49.34 -22.58 1.15 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.077 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 541' ' ' LEU . . . . . 0.769 HD23 HD11 ' A' ' 70' ' ' LEU . 0.4 OUTLIER -35.26 -53.21 0.62 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.995 0.426 . . . . 0.0 111.62 179.81 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 542' ' ' TYR . . . . . 0.429 ' O ' ' N ' ' A' ' 59' ' ' ALA . 0.4 OUTLIER -104.8 -62.5 1.33 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.327 179.4 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 543' ' ' LEU . . . . . 0.496 HD13 ' HA ' ' B' ' 540' ' ' GLU . 3.4 tp 62.22 153.05 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.567 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . 103.26 82.73 1.65 Allowed Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.382 -0.913 . . . . 0.0 112.592 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 545' ' ' ASN . . . . . 0.652 ' OXT' HG13 ' A' ' 33' ' ' VAL . 1.1 m120 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.862 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' GNP . . . . . 0.719 H5'1 ' HB3' ' A' ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.656 ' CE ' HG23 ' A' ' 46' ' ' ILE . 5.5 tpt . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 120.861 0.363 . . . . 0.0 111.233 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.678 ' O ' HD22 ' A' ' 177' ' ' LEU . 5.8 pt20 -167.17 138.81 3.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.753 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.941 HG23 HD12 ' A' ' 53' ' ' LEU . 13.7 t -109.94 -139.67 0.38 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.26 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.849 HG22 ' HB3' ' A' ' 176' ' ' ALA . 0.2 OUTLIER -150.55 152.54 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -178.865 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 13.1 pttt -134.0 95.61 3.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.602 178.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.409 ' O ' ' HE2' ' A' ' 16' ' ' LYS . 25.1 m -102.03 154.35 19.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.188 0.518 . . . . 0.0 111.876 -178.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.6 t -133.12 150.21 32.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.164 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.71 HG13 ' HB ' ' A' ' 14' ' ' VAL . 53.5 t -97.3 143.75 12.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.267 0.556 . . . . 0.0 111.056 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.596 HG13 ' O ' ' A' ' 8' ' ' VAL . 6.7 m -161.67 129.95 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.853 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 148.59 -178.68 26.0 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 119.882 -1.151 . . . . 0.0 112.909 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -102.46 -27.16 12.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.89 0.376 . . . . 0.0 110.593 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' B' ' 537' ' ' ARG . . . -66.9 -129.56 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.211 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.891 ' HB1' ' PA ' ' A' ' 185' ' ' GNP . . . -102.42 -56.95 2.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.824 0.345 . . . . 0.0 111.258 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.71 ' HB ' HG13 ' A' ' 8' ' ' VAL . 2.8 t 43.38 29.06 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.461 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.429 ' O ' HD22 ' A' ' 19' ' ' LEU . . . -64.51 89.49 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.802 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.573 ' HA ' HD22 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -52.59 -33.45 46.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.933 0.397 . . . . 0.0 110.273 179.675 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.428 HG21 ' HB2' ' A' ' 38' ' ' ASP . 39.2 p -81.15 -53.15 6.64 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.677 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.404 ' HB2' ' O2B' ' A' ' 185' ' ' GNP . 1.6 t -42.72 -38.54 2.11 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.265 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.984 HD23 ' CE1' ' A' ' 169' ' ' PHE . 0.0 OUTLIER -49.32 -58.67 4.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.545 179.668 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.662 ' H ' HD22 ' A' ' 20' ' ' LEU . 0.6 OUTLIER -70.59 -27.62 64.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.923 179.944 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.449 ' O ' ' N ' ' A' ' 25' ' ' THR . 37.3 mm -64.23 -71.43 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.242 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 9.6 t -50.0 -31.02 11.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.809 0.338 . . . . 0.0 110.717 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.406 ' CE1' ' HG2' ' A' ' 166' ' ' LYS . 46.5 t80 -63.54 -66.61 0.52 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.659 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.27 -54.63 6.77 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.73 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.449 ' N ' ' O ' ' A' ' 21' ' ' ILE . 27.4 p -78.47 -154.08 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.345 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.419 ' N ' ' ND2' ' A' ' 26' ' ' ASN . 0.1 OUTLIER -157.46 35.52 0.27 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.735 0.302 . . . . 0.0 111.088 -179.888 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -123.02 101.47 7.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.932 0.396 . . . . 0.0 111.525 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.486 ' CD2' ' HD3' ' A' ' 29' ' ' PRO . 0.4 OUTLIER -101.4 -70.04 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.726 178.92 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.486 ' HD3' ' CD2' ' A' ' 28' ' ' PHE . 95.7 Cg_endo -79.1 54.45 5.18 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.23 1.953 . . . . 0.0 111.518 178.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.02 -85.73 0.5 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.356 -179.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -147.54 118.53 7.68 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.196 0.522 . . . . 0.0 112.085 -179.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.601 ' CE2' ' PB ' ' A' ' 185' ' ' GNP . 4.2 m-30 -99.78 94.37 6.29 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.577 178.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.474 HG11 ' HB3' ' B' ' 526' ' ' SER . 0.0 OUTLIER -163.82 -63.85 0.01 OUTLIER Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.857 -179.177 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.469 ' HD2' HG23 ' A' ' 33' ' ' VAL . 8.8 Cg_endo -50.81 -20.43 6.78 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.781 2.321 . . . . 0.0 112.328 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.661 HG23 HD23 ' B' ' 543' ' ' LEU . 8.2 t -40.92 -29.66 0.11 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.501 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.671 HG12 ' HB2' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -43.63 -29.68 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-O 120.924 0.393 . . . . 0.0 111.016 179.648 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.493 ' O ' ' CG ' ' A' ' 40' ' ' TYR . 0.8 OUTLIER -55.36 -23.48 24.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.62 179.478 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.441 ' HA ' ' CE1' ' A' ' 40' ' ' TYR . 21.9 t70 -41.67 -28.29 0.14 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.121 -0.49 . . . . 0.0 112.122 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -72.79 -1.86 18.25 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.493 ' CG ' ' O ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -60.0 -176.48 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.767 0.318 . . . . 0.0 110.651 179.856 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.421 ' O ' ' CG1' ' B' ' 519' ' ' ILE . . . -112.84 144.54 42.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.455 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.744 HG23 ' HB ' ' A' ' 52' ' ' THR . 0.8 OUTLIER -116.61 121.85 68.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.981 179.604 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.539 ' H ' HD11 ' B' ' 519' ' ' ILE . 1.7 p -111.3 106.59 15.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.749 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.727 HG21 ' HB2' ' B' ' 514' ' ' LEU . 6.4 p -164.05 148.78 2.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.283 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.702 ' O ' HD22 ' B' ' 514' ' ' LEU . 0.0 OUTLIER -74.56 104.38 5.23 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 178.773 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.73 ' HA ' HD11 ' B' ' 514' ' ' LEU . 7.8 tt -99.92 87.67 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.676 -179.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.77 -108.06 2.46 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.303 -0.862 . . . . 0.0 113.13 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -47.96 -88.88 0.01 OUTLIER Glycine 0 C--N 1.331 0.264 0 C-N-CA 121.184 -0.531 . . . . 0.0 113.342 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.458 ' N ' ' HE1' ' A' ' 45' ' ' MET . 5.0 pt-20 -126.16 170.89 8.71 Favored Pre-proline 0 CA--C 1.53 0.204 0 CA-C-O 120.627 0.251 . . . . 0.0 110.902 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.443 ' HD2' ' HB2' ' A' ' 49' ' ' GLU . 33.1 Cg_exo -60.28 107.48 0.42 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.684 2.256 . . . . 0.0 112.777 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.822 ' CE1' HG22 ' A' ' 3' ' ' THR . 6.2 t80 -172.87 104.72 0.14 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.402 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.744 ' HB ' HG23 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -122.6 128.92 51.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.844 0.354 . . . . 0.0 110.875 179.873 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.941 HD12 HG23 ' A' ' 3' ' ' THR . 11.3 mt -70.8 172.05 9.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.97 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -115.19 108.22 1.88 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.79 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.1 mp -48.73 114.55 1.0 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.842 0.353 . . . . 0.0 110.641 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -83.63 105.14 14.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.508 -179.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.408 ' HB2' ' HB3' ' A' ' 38' ' ' ASP . 0.4 OUTLIER -99.53 -175.63 3.05 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.843 -179.87 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 1.005 HG22 HD13 ' A' ' 67' ' ' LEU . 1.2 p -136.05 167.84 20.47 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.784 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.671 ' HB2' HG12 ' A' ' 36' ' ' VAL . . . -171.2 179.99 2.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.184 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.403 ' HA2' ' CB ' ' A' ' 65' ' ' ASP . . . -151.48 31.24 0.94 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.293 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.544 HD22 ' OG ' ' B' ' 526' ' ' SER . 0.0 OUTLIER -118.45 -160.84 0.81 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.754 0.311 . . . . 0.0 110.815 -179.847 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.6 mp0 -52.82 -27.11 16.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.184 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.452 ' OD2' HD13 ' A' ' 61' ' ' LEU . 9.2 m-20 -50.49 -63.63 1.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.281 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.562 ' O ' HD23 ' A' ' 67' ' ' LEU . 0.0 OUTLIER 169.1 82.88 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.91 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.403 ' CB ' ' HA2' ' A' ' 60' ' ' GLY . 9.8 t70 -68.07 -22.32 64.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.086 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.92 -29.87 21.91 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.21 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 1.005 HD13 HG22 ' A' ' 58' ' ' THR . 4.5 pp -48.39 140.28 7.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.957 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.465 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.1 OUTLIER -150.69 50.23 0.69 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 120.893 0.377 . . . . 0.0 110.893 -179.949 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 71.6 Cg_endo -76.79 -31.29 4.13 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.657 2.238 . . . . 0.0 112.647 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.711 HD23 HD23 ' B' ' 541' ' ' LEU . 0.1 OUTLIER -66.98 -25.19 66.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.842 0.354 . . . . 0.0 110.663 -179.914 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.416 ' OG ' ' CE2' ' A' ' 72' ' ' TYR . 13.9 t -59.89 -70.59 0.16 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.942 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.416 ' CE2' ' OG ' ' A' ' 71' ' ' SER . 3.5 m-85 -123.94 67.57 42.81 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.908 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.08 140.39 31.17 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.619 2.213 . . . . 0.0 112.282 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 9.8 tp60 -101.62 10.39 40.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.451 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 84.6 m -75.87 124.61 27.61 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.811 0.338 . . . . 0.0 110.982 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -79.3 -18.32 52.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.156 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 42.4 t -103.71 78.91 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.224 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.669 ' CE2' HG21 ' A' ' 108' ' ' THR . 15.4 m-85 -83.19 175.15 10.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.751 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.4 HD12 ' O ' ' A' ' 111' ' ' LEU . 19.3 tp -147.63 108.9 4.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.99 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.658 ' O ' HG23 ' A' ' 80' ' ' VAL . 35.3 m -113.32 100.17 10.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.864 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.544 ' HB2' HG22 ' A' ' 14' ' ' VAL . 68.7 m -94.51 173.56 7.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.419 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.701 ' CE1' HG21 ' A' ' 137' ' ' ILE . 8.6 p90 -175.19 142.14 0.6 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.26 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.481 ' HA ' ' N2 ' ' A' ' 185' ' ' GNP . 5.4 m -83.31 155.83 23.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.088 0.471 . . . . 0.0 111.543 -179.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.784 HG21 ' HA ' ' A' ' 117' ' ' ILE . 15.9 t -55.01 -51.71 51.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.518 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.869 HG13 ' HD3' ' A' ' 120' ' ' ARG . 1.9 m -47.58 117.01 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.059 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -151.43 117.86 3.23 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.438 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.423 ' O ' ' CB ' ' A' ' 88' ' ' SER . 78.3 Cg_endo -90.38 49.68 0.95 Allowed 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.981 2.454 . . . . 0.0 111.969 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.466 ' CB ' ' HG2' ' A' ' 133' ' ' LYS . 0.1 OUTLIER 81.56 28.34 0.17 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.694 -179.525 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.517 ' O ' HG23 ' A' ' 93' ' ' VAL . 95.2 p -90.04 -15.94 30.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.256 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.649 ' CE1' HD12 ' A' ' 145' ' ' LEU . 0.1 OUTLIER -46.29 -51.31 14.81 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.799 0.333 . . . . 0.0 111.157 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -62.46 -36.41 82.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.822 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -72.63 -57.89 3.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.693 HG13 ' CE2' ' A' ' 97' ' ' TRP . 24.2 t -52.11 -45.48 42.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.059 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.722 ' HG3' HD11 ' A' ' 145' ' ' LEU . 0.3 OUTLIER -59.72 -50.49 73.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.811 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.408 ' O ' ' HG3' ' A' ' 99' ' ' PRO . 4.2 mt-10 -82.87 6.9 16.9 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.633 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -117.15 -30.66 5.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.804 0.335 . . . . 0.0 110.971 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.693 ' CE2' HG13 ' A' ' 93' ' ' VAL . 23.3 m0 -94.01 -51.94 4.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.176 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.474 ' HB ' ' HD3' ' A' ' 99' ' ' PRO . 85.5 t -50.5 -57.6 12.62 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.612 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.474 ' HD3' ' HB ' ' A' ' 98' ' ' VAL . 29.8 Cg_endo -62.89 -15.51 47.88 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.197 1.931 . . . . 0.0 112.422 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -89.97 -54.48 4.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.878 0.37 . . . . 0.0 110.728 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.9 tt -55.17 -30.33 24.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.9 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.747 HG22 ' HA ' ' A' ' 107' ' ' LYS . 11.2 p -85.91 -25.29 26.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.774 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -60.71 -51.04 71.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.667 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 28.4 m80 -60.99 -38.53 86.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.69 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -137.53 126.52 14.91 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.734 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -49.79 89.14 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.461 2.108 . . . . 0.0 112.248 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.747 ' HA ' HG22 ' A' ' 102' ' ' THR . 12.3 mttp 61.9 106.38 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.769 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.669 HG21 ' CE2' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -127.95 137.19 30.27 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.9 -179.944 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 108' ' ' THR . 36.2 Cg_exo -60.24 156.02 42.67 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.485 2.123 . . . . 0.0 112.478 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.766 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 1.9 p90 -158.72 148.77 19.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.75 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.803 HD11 ' HB3' ' A' ' 171' ' ' GLU . 0.5 OUTLIER -111.18 148.54 32.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.482 -179.434 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 1.018 HD12 ' HB2' ' A' ' 146' ' ' ALA . 11.6 mt -103.98 158.07 16.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.824 179.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.756 HG13 HG11 ' A' ' 168' ' ' VAL . 14.3 t -146.1 150.73 15.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.399 0.619 . . . . 0.0 112.445 -179.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -131.31 124.65 4.17 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.86 179.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.851 ' OG1' " H2'" ' A' ' 185' ' ' GNP . 0.9 OUTLIER -140.68 -58.51 0.52 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.908 0.354 . . . . 0.0 111.761 -178.694 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.445 ' HB3' ' CG ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -53.78 -21.84 8.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.853 0.358 . . . . 0.0 110.922 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.784 ' HA ' HG21 ' A' ' 84' ' ' VAL . 0.3 OUTLIER -41.81 -29.13 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.217 -179.859 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.641 ' CG ' HG21 ' A' ' 161' ' ' THR . 12.2 t70 -63.81 -43.16 97.09 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -178.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 1.002 HD21 HD22 ' A' ' 160' ' ' LEU . 0.3 OUTLIER -118.47 14.71 13.73 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -178.537 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.869 ' HD3' HG13 ' A' ' 85' ' ' VAL . 0.8 OUTLIER -87.18 -20.32 27.15 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.096 179.585 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.01 -18.59 35.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.85 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -46.1 122.27 6.24 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.049 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.441 ' HA ' ' CG2' ' A' ' 126' ' ' ILE . 14.0 Cg_exo -68.74 -3.52 11.43 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.576 2.184 . . . . 0.0 113.028 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 29.8 t -76.85 -71.18 0.41 Allowed 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.027 0.441 . . . . 0.0 110.247 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.697 HG21 HG11 ' A' ' 85' ' ' VAL . 95.0 m -55.68 -35.15 65.71 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.838 ' HA ' HD12 ' A' ' 129' ' ' LEU . 0.1 OUTLIER -56.68 -39.18 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.722 179.087 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.472 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 19.5 mt-10 -64.04 -31.9 73.26 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.31 178.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.479 ' O ' ' HG3' ' A' ' 131' ' ' LYS . 0.0 OUTLIER -69.69 -24.79 63.64 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.843 178.92 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.838 HD12 ' HA ' ' A' ' 126' ' ' ILE . 3.2 mt -85.02 -28.86 25.43 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 177.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' A' ' 127' ' ' GLU . . . -48.0 -39.87 20.91 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.501 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.479 ' HG3' ' O ' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -44.85 -28.75 0.69 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.884 0.373 . . . . 0.0 110.724 179.882 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.462 ' N ' ' HD2' ' A' ' 131' ' ' LYS . 52.9 m-20 -123.55 -32.03 3.41 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.391 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.512 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 52.1 mmtt -151.25 -92.73 0.06 Allowed 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.512 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 6.5 pt20 120.09 -18.09 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.783 1.233 . . . . 0.0 110.821 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.99 111.15 7.55 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.215 -0.448 . . . . 0.0 112.204 -178.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.686 ' HB3' HD11 ' A' ' 126' ' ' ILE . 96.8 Cg_endo -79.61 129.89 8.55 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.645 2.23 . . . . 0.0 111.503 179.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.722 ' N ' HD13 ' A' ' 137' ' ' ILE . 0.8 OUTLIER -58.57 96.64 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.014 0.435 . . . . 0.0 111.616 -179.331 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 16.5 p -69.32 151.61 96.84 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.462 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.496 ' HA ' ' CE1' ' A' ' 154' ' ' TYR . 4.2 Cg_endo -47.06 -25.07 3.8 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 122.809 2.339 . . . . 0.0 112.33 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -81.38 -38.66 26.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.12 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.38 -54.2 49.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.138 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.416 ' CB ' ' CD2' ' A' ' 154' ' ' TYR . . . -47.85 -43.43 28.3 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.884 0.373 . . . . 0.0 110.99 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -59.44 -40.25 86.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.589 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -55.03 -55.81 26.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.59 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.722 HD11 ' HG3' ' A' ' 94' ' ' LYS . 0.4 OUTLIER -67.73 -29.14 68.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.492 179.701 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 1.018 ' HB2' HD12 ' A' ' 112' ' ' LEU . . . -65.41 -41.24 93.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.793 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 9.0 mtp180 -85.63 -25.89 26.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.678 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -52.37 -32.62 39.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.739 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 3.5 mt -119.8 19.7 12.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.057 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 6.3 mttp 48.46 47.46 20.17 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.202 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.766 ' HB1' ' O ' ' A' ' 110' ' ' PHE . . . -63.98 -81.51 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.879 0.371 . . . . 0.0 110.865 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 151' ' ' ALA . 70.3 t -160.56 -75.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.778 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.596 ' O ' HD21 ' A' ' 111' ' ' LEU . 7.0 tppt? 173.65 116.91 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.278 -179.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.496 ' CE1' ' HA ' ' A' ' 139' ' ' PRO . 5.6 t80 -81.4 116.08 21.05 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.467 HG12 ' N ' ' A' ' 156' ' ' GLU . 12.9 t -101.4 159.35 4.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.451 -179.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.467 ' N ' HG12 ' A' ' 155' ' ' VAL . 3.6 mp0 -89.9 139.84 30.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.129 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.752 ' O ' HD11 ' A' ' 117' ' ' ILE . 3.3 p 178.71 -174.54 0.18 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.416 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.475 ' HA ' ' HA ' ' A' ' 115' ' ' THR . 24.3 p -159.99 167.87 26.95 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.937 0.399 . . . . 0.0 111.164 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -116.6 -46.11 2.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.585 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 1.002 HD22 HD21 ' A' ' 119' ' ' LEU . 0.7 OUTLIER -63.81 -33.25 75.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.402 179.557 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.641 HG21 ' CG ' ' A' ' 118' ' ' ASP . 1.3 p -113.0 -22.83 10.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.807 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.415 ' N ' ' OG ' ' A' ' 158' ' ' SER . 1.3 tt0 74.58 71.81 0.1 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.022 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.43 ' N ' ' OG ' ' A' ' 158' ' ' SER . 0.2 OUTLIER -93.96 13.63 22.2 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.501 -179.816 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 121.08 34.48 0.89 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.345 -0.931 . . . . 0.0 113.2 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.745 HD13 ' HA ' ' A' ' 19' ' ' LEU . 0.5 OUTLIER -49.58 -27.79 4.92 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.956 0.408 . . . . 0.0 110.515 179.697 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.421 ' HE2' ' N ' ' A' ' 167' ' ' ASN . 0.0 OUTLIER -73.67 -34.16 64.78 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.626 179.568 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.421 ' N ' ' HE2' ' A' ' 166' ' ' LYS . 0.6 OUTLIER -56.58 -67.61 0.29 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.421 179.601 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.756 HG11 HG13 ' A' ' 113' ' ' VAL . 14.2 p -50.63 -46.31 27.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.33 179.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.984 ' CE1' HD23 ' A' ' 19' ' ' LEU . 1.9 t80 -61.9 -31.26 71.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.732 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.412 ' N ' ' O ' ' A' ' 166' ' ' LYS . 4.6 t0 -57.42 -39.97 77.31 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.514 178.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.803 ' HB3' HD11 ' A' ' 111' ' ' LEU . 5.0 mm-40 -66.72 -35.35 79.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.612 178.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.466 ' HA ' HD12 ' A' ' 111' ' ' LEU . . . -59.83 -29.93 68.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.739 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.919 HD13 ' N ' ' A' ' 174' ' ' LEU . 0.0 OUTLIER -94.11 -43.88 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.438 179.633 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 1.027 HD23 HD13 ' B' ' 505' ' ' LEU . 3.5 tm? -52.75 -27.79 19.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.953 0.406 . . . . 0.0 110.363 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -72.04 -29.78 64.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.744 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.849 ' HB3' HG22 ' A' ' 4' ' ' ILE . . . -80.84 -37.15 30.51 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.738 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.721 HD13 ' HB ' ' B' ' 510' ' ' ILE . 58.8 mt -70.76 -24.53 62.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.635 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 29.1 tp10 -165.2 137.05 3.33 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.526 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -49.8 141.65 27.58 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.376 2.05 . . . . 0.0 112.347 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.89 171.4 18.36 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.548 2.166 . . . . 0.0 112.222 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -154.24 151.31 24.0 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.055 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.48 -164.73 0.23 Allowed 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.669 2.246 . . . . 0.0 112.271 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 8.0 pttp -87.51 152.21 22.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.863 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.188 -0.911 . . . . 0.0 110.909 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.17 0 N-CA-C 112.449 -0.26 . . . . 0.0 112.449 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 503' ' ' SER . . . . . . . . . . . . . 75.3 m -96.18 -78.52 0.46 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.889 0.376 . . . . 0.0 110.857 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 504' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' B' ' 509' ' ' ASP . . . 81.12 106.32 0.32 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.515 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 505' ' ' LEU . . . . . 1.027 HD13 HD23 ' A' ' 174' ' ' LEU . 0.1 OUTLIER -166.58 99.27 0.58 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.93 0.395 . . . . 0.0 111.063 -179.947 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 506' ' ' SER . . . . . . . . . . . . . 13.3 p 59.76 -170.95 0.13 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.005 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 507' ' ' ALA . . . . . . . . . . . . . . . 59.31 -93.21 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.725 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 508' ' ' GLN . . . . . 0.426 ' O ' ' CB ' ' B' ' 509' ' ' ASP . 20.0 mt-30 -141.29 4.84 1.83 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.048 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 509' ' ' ASP . . . . . 0.426 ' CB ' ' O ' ' B' ' 508' ' ' GLN . 8.5 t70 81.83 35.39 0.08 Allowed 'General case' 0 C--N 1.341 0.238 0 CA-C-O 121.371 0.605 . . . . 0.0 109.704 -178.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 510' ' ' ILE . . . . . 0.721 ' HB ' HD13 ' A' ' 177' ' ' LEU . 87.4 mt -64.84 156.14 5.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.579 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 511' ' ' SER . . . . . 0.472 ' HB3' HD21 ' B' ' 514' ' ' LEU . 8.7 t -109.54 167.39 10.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.098 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 512' ' ' GLN . . . . . 0.491 ' CB ' ' CD ' ' B' ' 513' ' ' PRO . 18.2 tt0 -114.2 -71.81 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.205 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 513' ' ' PRO . . . . . 0.491 ' CD ' ' CB ' ' B' ' 512' ' ' GLN . 93.5 Cg_endo -78.85 59.81 7.47 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.207 1.938 . . . . 0.0 111.29 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 514' ' ' LEU . . . . . 0.73 HD11 ' HA ' ' A' ' 46' ' ' ILE . 4.9 mt -53.31 -89.02 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.826 -178.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 515' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -92.99 -86.55 0.25 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.666 0.269 . . . . 0.0 111.255 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -127.57 -36.99 2.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.23 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 517' ' ' SER . . . . . 0.589 ' C ' HG12 ' A' ' 42' ' ' VAL . 6.4 m 72.01 22.8 3.64 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.047 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 518' ' ' PHE . . . . . 0.485 ' CD1' ' O ' ' B' ' 517' ' ' SER . 23.7 m-85 -140.99 91.79 2.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.79 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 519' ' ' ILE . . . . . 0.539 HD11 ' H ' ' A' ' 43' ' ' THR . 7.3 mm -88.89 -11.06 10.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.667 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 72.56 104.75 0.07 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.84 0.353 . . . . 0.0 110.925 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 521' ' ' THR . . . . . . . . . . . . . 1.4 m -160.91 106.5 1.41 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.818 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 522' ' ' GLY . . . . . 0.473 ' O ' ' CZ ' ' A' ' 37' ' ' PHE . . . 143.2 178.67 19.24 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.349 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 523' ' ' HIS . . . . . . . . . . . . . 22.9 t60 -104.71 -83.42 0.5 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.745 0.307 . . . . 0.0 110.867 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 524' ' ' GLY . . . . . 0.482 ' HA3' HG23 ' A' ' 36' ' ' VAL . . . 49.68 -118.65 5.76 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.638 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 525' ' ' ASP . . . . . . . . . . . . . 1.2 p30 53.41 28.53 7.61 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 121.071 0.463 . . . . 0.0 110.498 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 526' ' ' SER . . . . . 0.544 ' OG ' HD22 ' A' ' 61' ' ' LEU . 3.9 m -57.15 100.1 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.207 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 527' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -37.44 162.08 0.05 OUTLIER Pre-proline 0 N--CA 1.467 0.381 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.227 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -53.75 104.79 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.195 2.597 . . . . 0.0 112.299 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 529' ' ' ARG . . . . . . . . . . . . . 2.3 mtt-85 -100.7 -42.42 6.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.073 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 530' ' ' HIS . . . . . 0.408 ' HB2' ' CB ' ' B' ' 545' ' ' ASN . 1.4 m-70 -153.32 -44.02 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.878 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 3.6 m 70.36 -160.53 0.15 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.876 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 532' ' ' TRP . . . . . . . . . . . . . 22.9 t90 -46.19 -65.0 0.62 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.159 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . 59.71 -87.13 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.622 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 534' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -116.56 152.67 48.52 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.698 0.285 . . . . 0.0 111.018 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -55.56 176.59 0.15 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.65 2.233 . . . . 0.0 112.456 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 59.92 92.86 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.082 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 537' ' ' ARG . . . . . 0.402 ' HB2' ' O ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER -73.46 151.06 41.22 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.13 0.491 . . . . 0.0 110.844 179.829 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 538' ' ' ILE . . . . . 0.482 HG13 ' HB2' ' B' ' 542' ' ' TYR . 10.2 tp -61.18 157.22 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.262 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 539' ' ' ASP . . . . . 0.412 ' N ' HG13 ' B' ' 538' ' ' ILE . 2.3 m-20 -61.33 162.16 8.15 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.051 0.453 . . . . 0.0 111.126 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 540' ' ' GLU . . . . . 0.487 ' CG ' ' HB ' ' A' ' 8' ' ' VAL . 0.3 OUTLIER -48.22 -50.14 30.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.854 -179.633 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 541' ' ' LEU . . . . . 0.711 HD23 HD23 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -39.99 -32.51 0.16 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.324 0.583 . . . . 0.0 111.063 -179.496 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 542' ' ' TYR . . . . . 0.482 ' HB2' HG13 ' B' ' 538' ' ' ILE . 35.3 m-85 -104.45 -59.21 1.77 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.896 -179.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 543' ' ' LEU . . . . . 0.661 HD23 HG23 ' A' ' 35' ' ' THR . 2.0 tp 66.47 -67.68 0.15 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.061 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 544' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' B' ' 542' ' ' TYR . . . -89.02 139.41 15.25 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.485 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 545' ' ' ASN . . . . . 0.408 ' CB ' ' HB2' ' B' ' 530' ' ' HIS . 1.2 m-80 . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.945 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' GNP . . . . . 0.891 ' PA ' ' HB1' ' A' ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.819 ' CE ' HG23 ' A' ' 46' ' ' ILE . 1.3 tmt? . . . . . 0 N--CA 1.487 1.42 0 CA-C-O 120.84 0.352 . . . . 0.0 111.03 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 73.32 121.13 0.04 OUTLIER 'General case' 0 CA--C 1.52 -0.191 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.994 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.797 HG22 ' HB2' ' A' ' 53' ' ' LEU . 0.3 OUTLIER -93.26 170.09 9.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.719 -179.345 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.779 ' O ' HD23 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -152.71 162.49 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -178.92 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.4 127.91 40.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.945 179.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 43.6 t -116.54 153.42 32.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.069 0.461 . . . . 0.0 111.906 -179.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.632 HG13 ' O ' ' A' ' 56' ' ' PHE . 1.7 t -151.11 159.51 4.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.408 179.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.873 HG13 ' HG3' ' B' ' 540' ' ' GLU . 0.9 OUTLIER -110.91 155.77 12.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.323 0.582 . . . . 0.0 111.329 -179.848 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.764 HG13 HD13 ' A' ' 70' ' ' LEU . 66.9 t -159.17 129.91 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.042 179.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 138.44 -149.06 20.35 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.183 -1.008 . . . . 0.0 112.861 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' B' ' 537' ' ' ARG . 0.4 OUTLIER -110.8 27.15 9.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.938 0.399 . . . . 0.0 110.74 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -134.68 174.26 21.12 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.439 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.431 ' O ' ' N ' ' A' ' 15' ' ' GLY . . . -80.97 -57.63 3.45 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 123.063 -0.081 . . . . 0.0 111.195 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.874 HG21 HD22 ' A' ' 79' ' ' LEU . 13.8 p 23.96 44.61 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 13' ' ' ALA . . . -125.39 -178.26 15.24 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.58 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.481 ' HG3' HD23 ' A' ' 55' ' ' LEU . 1.3 tmpt? -59.71 -17.68 36.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.585 0.231 . . . . 0.0 111.199 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.822 HG21 ' OG1' ' A' ' 35' ' ' THR . 34.1 p -79.58 -70.88 0.48 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.804 0.335 . . . . 0.0 111.463 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.418 ' N ' ' OG1' ' A' ' 17' ' ' THR . 16.5 t -62.49 -57.9 9.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.958 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.84 ' O ' HD13 ' A' ' 165' ' ' LEU . 18.7 mt -47.87 -71.76 0.06 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -178.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.432 ' N ' ' CD2' ' A' ' 20' ' ' LEU . 2.5 mm? -56.74 -60.18 3.93 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -178.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.524 HG22 ' OG1' ' A' ' 25' ' ' THR . 50.0 mm -48.2 -70.52 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 120.936 -0.305 . . . . 0.0 111.189 -179.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.43 ' CB ' ' HB1' ' A' ' 159' ' ' ALA . 19.7 m -42.2 -29.3 0.24 Allowed 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 111.582 0.215 . . . . 0.0 111.582 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.497 ' CZ ' ' HG2' ' A' ' 166' ' ' LYS . 17.5 t80 -81.45 -68.72 0.67 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.856 0.36 . . . . 0.0 110.804 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.649 HG23 HG23 ' A' ' 25' ' ' THR . 10.8 t -58.87 -46.75 87.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.128 0.489 . . . . 0.0 110.583 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.649 HG23 HG23 ' A' ' 24' ' ' THR . 18.7 p -86.42 -153.46 0.2 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.431 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -150.03 55.5 0.94 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.658 0.266 . . . . 0.0 110.985 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.7 mttt -144.22 157.56 44.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.927 0.394 . . . . 0.0 111.252 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.497 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . 0.5 OUTLIER -163.17 -64.64 0.01 OUTLIER Pre-proline 0 CA--C 1.534 0.337 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.481 179.698 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.497 ' HD3' ' HB3' ' A' ' 28' ' ' PHE . 87.5 Cg_endo -81.77 57.87 6.51 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.62 2.213 . . . . 0.0 112.841 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.407 ' O ' ' N ' ' B' ' 532' ' ' TRP . 0.4 OUTLIER -131.45 -89.39 0.45 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.906 179.844 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.71 116.08 2.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.364 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.502 ' CD2' ' O2B' ' A' ' 185' ' ' GNP . 18.6 m-85 -111.17 92.39 4.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.078 0.466 . . . . 0.0 111.188 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.787 HG21 ' O ' ' B' ' 527' ' ' ASP . 2.8 t -105.69 -33.55 0.19 Allowed Pre-proline 0 CA--C 1.544 0.731 0 N-CA-C 114.174 1.175 . . . . 0.0 114.174 -179.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.496 ' CD ' ' N ' ' A' ' 33' ' ' VAL . 46.6 Cg_exo -40.44 -26.5 0.22 Allowed 'Trans proline' 0 C--N 1.357 1.022 0 C-N-CA 122.361 2.041 . . . . 0.0 113.965 -178.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.955 HG21 ' CD2' ' B' ' 543' ' ' LEU . 51.4 m -54.07 88.38 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.625 0.25 . . . . 0.0 111.041 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.726 ' HB ' HD13 ' A' ' 61' ' ' LEU . 7.6 p 171.2 -32.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.7 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.409 ' CD2' ' HA3' ' B' ' 522' ' ' GLY . 0.2 OUTLIER -108.06 23.44 14.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.904 179.921 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -61.23 -16.69 47.87 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.271 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -45.54 -27.25 0.71 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.717 0.294 . . . . 0.0 111.516 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.44 ' OH ' ' CE1' ' B' ' 518' ' ' PHE . 2.7 p90 -60.27 142.53 54.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.93 0.395 . . . . 0.0 110.72 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.749 ' O ' HD12 ' B' ' 519' ' ' ILE . . . -91.17 -178.75 5.25 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.972 -179.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 42' ' ' VAL . 18.3 m -131.31 121.28 48.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.441 178.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.461 HG23 ' O ' ' A' ' 43' ' ' THR . 5.0 t -86.24 104.61 15.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.422 -179.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.472 HG12 ' HB2' ' B' ' 515' ' ' GLN . 29.5 m -161.23 144.3 4.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.177 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.91 ' O ' HD22 ' B' ' 514' ' ' LEU . 0.0 OUTLIER -77.55 96.4 4.76 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.428 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.852 ' CG1' HG23 ' B' ' 510' ' ' ILE . 5.9 tt -97.29 96.11 5.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.285 -179.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.481 ' N ' ' HE2' ' A' ' 45' ' ' MET . . . 101.91 -108.53 3.39 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.378 -0.828 . . . . 0.0 112.937 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.445 ' N ' ' HE1' ' A' ' 45' ' ' MET . . . -118.11 -22.78 3.75 Favored Glycine 0 CA--C 1.521 0.419 0 C-N-CA 120.511 -0.852 . . . . 0.0 113.375 -179.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.554 ' N ' ' HE1' ' A' ' 45' ' ' MET . 2.0 mt-10 -117.4 132.54 23.5 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.995 0.398 . . . . 0.0 111.148 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.479 ' HA ' ' HA ' ' A' ' 45' ' ' MET . 42.9 Cg_endo -68.65 90.26 0.42 Allowed 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.853 2.369 . . . . 0.0 113.839 -179.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.528 ' CD1' ' O ' ' A' ' 51' ' ' TYR . 2.3 p90 -173.41 132.18 0.47 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.728 178.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.603 HG23 ' CG2' ' A' ' 46' ' ' ILE . 0.1 OUTLIER -129.91 141.51 50.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.027 0.441 . . . . 0.0 111.354 -179.046 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.797 ' HB2' HG22 ' A' ' 3' ' ' THR . 2.1 tp -89.18 148.58 23.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.838 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -87.3 178.97 47.98 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.213 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.718 HD22 ' N ' ' A' ' 55' ' ' LEU . 0.4 OUTLIER -112.3 136.62 51.52 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.73 0.3 . . . . 0.0 110.54 179.758 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.632 ' O ' HG13 ' A' ' 7' ' ' VAL . 0.3 OUTLIER -84.38 116.34 22.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.918 -179.654 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.409 ' OD2' ' N ' ' A' ' 36' ' ' VAL . 16.0 p-10 -119.3 167.74 11.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.057 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.747 ' CB ' HD22 ' A' ' 67' ' ' LEU . 0.6 OUTLIER -154.22 139.92 18.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.984 -179.826 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 35' ' ' THR . . . -171.07 136.08 1.05 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.807 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.77 73.1 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.613 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.726 HD13 ' HB ' ' A' ' 36' ' ' VAL . 0.3 OUTLIER -121.17 -175.41 3.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.918 0.389 . . . . 0.0 111.022 179.957 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -49.76 -39.51 37.92 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.028 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.43 ' HB3' ' CG2' ' A' ' 36' ' ' VAL . 11.2 t0 -64.11 -62.7 1.46 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.102 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.937 ' CD2' HD21 ' A' ' 67' ' ' LEU . 0.5 OUTLIER -120.07 140.53 50.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.78 -179.802 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.85 -69.08 0.7 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -179.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.431 ' O ' ' HB2' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -98.65 -46.51 5.68 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 -178.939 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.937 HD21 ' CD2' ' A' ' 64' ' ' TYR . 1.2 mp 69.37 131.43 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.06 -179.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.546 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 6.9 mtp180 -130.38 36.59 0.35 Allowed Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.961 178.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.546 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 61.1 Cg_endo -84.23 -39.93 0.1 Allowed 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 122.122 1.881 . . . . 0.0 112.044 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.877 HD23 ' HB2' ' B' ' 541' ' ' LEU . 0.1 OUTLIER -83.98 -7.84 59.31 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.156 -179.802 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.9 t -49.07 -64.11 0.9 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.745 0.307 . . . . 0.0 111.026 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -159.0 55.83 0.85 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.086 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.0 160.86 46.48 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.532 2.155 . . . . 0.0 112.209 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.05 10.24 34.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.462 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.47 ' O ' HG22 ' A' ' 108' ' ' THR . 69.3 m -50.73 117.86 2.75 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.828 0.347 . . . . 0.0 110.907 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -76.12 -20.07 57.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.061 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.835 HG21 ' HB2' ' A' ' 176' ' ' ALA . 43.1 t -103.93 72.53 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.897 0.379 . . . . 0.0 111.18 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.402 ' CE2' HG21 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -80.82 172.54 13.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.559 179.822 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.874 HD22 HG21 ' A' ' 14' ' ' VAL . 1.2 tt -152.61 108.73 3.37 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.853 0.359 . . . . 0.0 111.147 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.572 ' CG2' HD22 ' A' ' 112' ' ' LEU . 2.8 m -93.1 133.1 35.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.701 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.501 ' SG ' HG12 ' A' ' 14' ' ' VAL . 1.2 p -119.17 138.16 53.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.092 0.472 . . . . 0.0 111.36 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.438 ' O ' ' C2 ' ' A' ' 185' ' ' GNP . 39.5 p90 -135.26 -174.12 3.53 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.008 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.1 m -145.81 139.08 26.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.745 0.307 . . . . 0.0 110.797 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.804 HG21 ' HA ' ' A' ' 117' ' ' ILE . 60.1 t -53.67 -67.6 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.302 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.853 HG22 ' OE1' ' A' ' 116' ' ' GLN . 34.9 m -48.62 108.65 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.737 0.304 . . . . 0.0 110.725 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.589 ' N ' HD22 ' A' ' 129' ' ' LEU . 0.3 OUTLIER -151.55 128.9 5.62 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.687 -179.41 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 86' ' ' SER . 74.0 Cg_endo -92.56 53.36 0.56 Allowed 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 123.272 2.648 . . . . 0.0 111.723 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.43 ' CA ' ' HG3' ' A' ' 133' ' ' LYS . 0.1 OUTLIER 81.95 39.21 0.05 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.823 -179.415 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.873 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -97.25 -34.89 10.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.804 179.862 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -51.83 -37.95 53.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.827 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -50.81 -57.41 8.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.661 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.427 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 4.1 p-10 -74.93 -43.57 53.44 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.676 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.873 HG23 ' O ' ' A' ' 89' ' ' SER . 57.4 t -52.31 -31.61 15.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.991 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.622 ' O ' HG23 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -79.09 -50.92 10.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.915 -179.967 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.405 ' O ' ' HG3' ' A' ' 99' ' ' PRO . 25.2 mt-10 -82.75 6.31 18.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.648 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.427 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 0.6 OUTLIER -115.13 -27.81 7.18 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.754 0.312 . . . . 0.0 111.063 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.809 ' CE2' HG13 ' A' ' 93' ' ' VAL . 38.1 m0 -91.59 -44.81 8.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.02 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.622 HG23 ' O ' ' A' ' 94' ' ' LYS . 64.4 t -53.48 -46.03 98.29 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.792 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 97.4 Cg_endo -80.61 -15.22 11.08 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.334 2.023 . . . . 0.0 112.781 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -85.8 -36.14 20.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.948 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.41 HG13 ' N ' ' A' ' 102' ' ' THR . 13.8 pt -79.14 -25.53 12.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.104 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.41 ' N ' HG13 ' A' ' 101' ' ' ILE . 47.8 p -89.42 -31.63 17.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.038 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.403 ' HB2' ' O ' ' A' ' 99' ' ' PRO . 74.5 t60 -72.8 -54.97 7.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.065 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -71.07 -25.84 62.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.047 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.416 ' HB2' ' OG1' ' A' ' 108' ' ' THR . 28.5 m -132.31 95.37 21.21 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.9 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -50.2 110.69 0.41 Allowed 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.573 2.182 . . . . 0.0 112.263 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 7.6 mmpt? 50.8 92.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.906 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.47 HG22 ' O ' ' A' ' 75' ' ' THR . 0.2 OUTLIER -133.59 113.04 12.92 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.85 179.95 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.401 ' O ' ' HB2' ' A' ' 78' ' ' PHE . 31.3 Cg_exo -60.15 133.62 51.02 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.584 2.189 . . . . 0.0 112.446 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.517 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 0.8 OUTLIER -134.92 142.81 46.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.96 179.923 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.98 HD12 HG11 ' A' ' 152' ' ' VAL . 5.0 tt -110.92 141.45 44.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.197 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.795 ' O ' HD23 ' A' ' 111' ' ' LEU . 3.6 mm? -89.8 158.38 17.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.627 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.74 HG23 ' O6 ' ' A' ' 185' ' ' GNP . 0.0 OUTLIER -137.84 150.42 25.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.123 0.487 . . . . 0.0 111.804 -179.554 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -129.59 134.92 8.12 Favored Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.525 179.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.818 ' OG1' " H2'" ' A' ' 185' ' ' GNP . 0.0 OUTLIER -155.28 -41.49 0.08 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.859 0.33 . . . . 0.0 111.088 -179.279 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.853 ' OE1' HG22 ' A' ' 85' ' ' VAL . 10.5 tt0 -71.87 -9.09 57.82 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.322 178.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.804 ' HA ' HG21 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -54.39 -20.79 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.689 -179.848 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -75.55 -35.54 60.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.383 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.617 HD21 ' HG3' ' A' ' 116' ' ' GLN . 4.3 pp -97.02 14.21 26.38 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.626 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.676 ' CB ' HG11 ' A' ' 84' ' ' VAL . 37.4 ptt85 -68.05 -27.29 66.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.951 0.405 . . . . 0.0 110.329 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -72.63 -25.68 61.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.827 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.408 ' O ' ' HB ' ' A' ' 126' ' ' ILE . 9.2 t70 -47.58 101.63 0.27 Allowed Pre-proline 0 C--N 1.332 -0.169 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.703 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -67.83 -5.85 15.46 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.745 2.297 . . . . 0.0 113.049 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.46 -65.45 1.01 Allowed 'General case' 0 C--O 1.234 0.261 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.536 HG21 HG11 ' A' ' 85' ' ' VAL . 5.0 m -55.43 -38.94 69.65 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.46 HG13 HD12 ' A' ' 129' ' ' LEU . 0.1 OUTLIER -55.53 -47.41 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.713 179.179 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.538 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 2.7 mm-40 -53.47 -35.77 60.91 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.02 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.407 ' HB2' ' O ' ' A' ' 125' ' ' THR . 1.7 mptp? -66.82 -32.09 73.14 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.589 HD22 ' N ' ' A' ' 86' ' ' SER . 6.2 mt -74.44 -36.8 63.39 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 177.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.538 ' HB3' ' O ' ' A' ' 127' ' ' GLU . . . -43.98 -42.47 6.02 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.374 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.97 -26.38 10.41 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.365 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.401 ' OD1' ' HB2' ' A' ' 87' ' ' PRO . 29.5 m120 -124.61 -31.55 3.21 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -179.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.442 ' O ' ' HB2' ' A' ' 134' ' ' GLN . 6.4 mmpt? -152.06 -63.88 0.17 Allowed 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 -178.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.532 ' HG3' ' HB2' ' A' ' 130' ' ' ALA . 2.0 tt0 81.18 15.94 0.56 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.695 0.283 . . . . 0.0 110.97 -178.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 51.6 mttm -101.17 88.66 1.13 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.97 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' ' 134' ' ' GLN . 32.8 Cg_endo -63.93 124.94 14.36 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.449 2.1 . . . . 0.0 111.859 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.688 ' N ' HD13 ' A' ' 137' ' ' ILE . 1.3 mm -60.14 97.25 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.106 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.9 p -74.34 153.83 88.05 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.807 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -47.14 -36.19 21.09 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.607 2.205 . . . . 0.0 112.324 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -67.9 -28.33 67.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.859 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.401 HG21 HG23 ' A' ' 137' ' ' ILE . 87.4 m -66.23 -53.55 35.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.841 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.557 ' HB3' ' CE2' ' A' ' 154' ' ' TYR . . . -57.7 -36.66 72.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.898 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.98 -39.95 95.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.704 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 43.9 mttt -65.16 -51.61 60.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.862 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.508 HD23 ' O ' ' A' ' 145' ' ' LEU . 0.9 OUTLIER -67.16 -40.24 86.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.803 -179.995 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -55.62 -44.81 77.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.037 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.25 -24.52 27.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.874 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -53.69 -31.57 48.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.855 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.1 mt -119.3 19.62 12.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.154 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 29.1 mmtm 48.06 42.42 16.85 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.784 0.326 . . . . 0.0 111.095 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.555 ' O ' HG23 ' A' ' 152' ' ' VAL . . . -58.18 -81.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.913 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.98 HG11 HD12 ' A' ' 111' ' ' LEU . 47.6 t -160.73 -74.67 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.747 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 179.51 128.03 0.08 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.24 -179.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.557 ' CE2' ' HB3' ' A' ' 142' ' ' ALA . 38.3 t80 -100.19 112.49 24.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.755 178.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 2.8 t -101.52 154.58 4.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.416 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -90.55 120.13 31.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.94 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.41 ' HA ' ' HB3' ' A' ' 163' ' ' LYS . 35.3 m -156.79 175.57 13.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.588 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.461 ' HA ' ' HA ' ' A' ' 115' ' ' THR . 4.6 t -158.07 145.16 17.96 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.089 0.471 . . . . 0.0 111.849 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.43 ' HB1' ' CB ' ' A' ' 22' ' ' SER . . . -104.72 -44.03 4.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.34 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.492 ' HB3' ' CE2' ' A' ' 28' ' ' PHE . 0.9 OUTLIER -62.94 -33.16 74.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.268 179.503 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -106.54 -21.74 12.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.565 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 77.9 60.48 0.03 OUTLIER 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.317 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.451 ' HB2' ' CB ' ' A' ' 158' ' ' SER . 0.5 OUTLIER -91.88 41.94 1.09 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.688 179.538 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.415 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . 104.09 -66.04 0.32 Allowed Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.719 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.84 HD13 ' O ' ' A' ' 19' ' ' LEU . 0.5 OUTLIER 66.04 -66.77 0.16 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.724 0.297 . . . . 0.0 111.308 -179.914 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.497 ' HG2' ' CZ ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -50.09 -26.22 4.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.807 0.337 . . . . 0.0 110.872 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.414 ' O ' ' HB2' ' A' ' 170' ' ' ASP . 0.4 OUTLIER -62.22 -69.05 0.27 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.425 -179.733 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.545 HG13 ' N ' ' A' ' 169' ' ' PHE . 14.0 p -54.41 -47.12 70.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.094 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.788 ' CD1' HD13 ' A' ' 19' ' ' LEU . 1.7 t80 -60.73 -31.86 71.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.338 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.766 ' O ' HD13 ' A' ' 173' ' ' ILE . 0.3 OUTLIER -62.48 -36.43 82.48 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 178.775 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -69.14 -28.77 66.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.633 178.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.61 ' HA ' HD13 ' A' ' 111' ' ' LEU . . . -61.04 -51.47 69.04 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.221 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.766 HD13 ' O ' ' A' ' 170' ' ' ASP . 0.1 OUTLIER -83.33 -23.65 8.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.031 -179.767 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.784 HD23 HD23 ' B' ' 505' ' ' LEU . 3.2 tm? -50.54 -48.53 57.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.048 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -51.02 -25.52 4.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.894 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.835 ' HB2' HG21 ' A' ' 77' ' ' VAL . . . -83.3 -42.77 16.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.11 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.594 HD22 HG12 ' B' ' 510' ' ' ILE . 8.3 mt -68.73 -17.54 64.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.991 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.474 ' OE2' HD11 ' A' ' 174' ' ' LEU . 0.7 OUTLIER -171.79 145.11 1.62 Allowed Pre-proline 0 C--N 1.333 -0.109 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.746 179.835 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.9 127.99 28.62 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.619 2.212 . . . . 0.0 112.224 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.85 142.23 25.16 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.444 2.096 . . . . 0.0 112.242 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -113.99 141.48 26.33 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.92 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.3 -165.1 0.29 Allowed 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.639 2.226 . . . . 0.0 112.31 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 9.4 mttm -98.98 98.25 9.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.88 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.184 -0.913 . . . . 0.0 110.96 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.133 0 N-CA-C 112.509 -0.237 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 503' ' ' SER . . . . . 0.557 ' HB3' HD11 ' B' ' 505' ' ' LEU . 71.1 m -88.06 -81.55 0.25 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.79 0.329 . . . . 0.0 111.009 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 504' ' ' GLY . . . . . 0.881 ' C ' HD13 ' B' ' 505' ' ' LEU . . . 83.76 104.01 0.55 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.326 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 505' ' ' LEU . . . . . 0.881 HD13 ' C ' ' B' ' 504' ' ' GLY . 0.0 OUTLIER -148.38 90.44 1.8 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.911 0.386 . . . . 0.0 111.077 -179.137 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 506' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 55.57 -172.92 0.06 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.082 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 507' ' ' ALA . . . . . 0.434 ' HB2' ' HB3' ' A' ' 178' ' ' GLU . . . 63.86 -93.27 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.771 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 508' ' ' GLN . . . . . 0.423 ' O ' ' CB ' ' B' ' 509' ' ' ASP . 2.6 mt-30 -133.87 3.25 3.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.018 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 509' ' ' ASP . . . . . 0.423 ' CB ' ' O ' ' B' ' 508' ' ' GLN . 8.4 t70 80.61 36.67 0.1 Allowed 'General case' 0 CA--C 1.521 -0.165 0 CA-C-O 121.167 0.508 . . . . 0.0 109.915 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 510' ' ' ILE . . . . . 0.852 HG23 ' CG1' ' A' ' 46' ' ' ILE . 1.4 mp -53.75 128.59 13.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.162 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 511' ' ' SER . . . . . 0.588 ' HB2' HD21 ' B' ' 514' ' ' LEU . 11.5 m -109.33 158.57 17.76 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.16 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 512' ' ' GLN . . . . . 0.49 ' CB ' ' HD3' ' B' ' 513' ' ' PRO . 0.1 OUTLIER -103.24 -64.25 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.883 179.661 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 513' ' ' PRO . . . . . 0.49 ' HD3' ' CB ' ' B' ' 512' ' ' GLN . 67.7 Cg_endo -85.45 53.45 3.46 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.408 2.072 . . . . 0.0 112.202 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 514' ' ' LEU . . . . . 0.91 HD22 ' O ' ' A' ' 45' ' ' MET . 1.1 mp -62.62 -81.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.176 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 515' ' ' GLN . . . . . 0.472 ' HB2' HG12 ' A' ' 44' ' ' VAL . 0.2 OUTLIER -85.91 -85.0 0.16 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.897 -179.921 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -120.66 -37.55 2.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.711 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 517' ' ' SER . . . . . 0.499 ' O ' ' CD1' ' B' ' 518' ' ' PHE . 0.9 OUTLIER 69.66 27.07 4.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.403 179.657 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 518' ' ' PHE . . . . . 0.499 ' CD1' ' O ' ' B' ' 517' ' ' SER . 24.9 m-85 -162.35 112.79 1.53 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.142 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 519' ' ' ILE . . . . . 0.749 HD12 ' O ' ' A' ' 41' ' ' ALA . 31.3 mt -78.56 -30.09 15.04 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 CA-C-O 120.806 0.336 . . . . 0.0 110.703 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 63.39 94.45 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.885 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 521' ' ' THR . . . . . . . . . . . . . 2.2 t -167.93 47.65 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.844 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 522' ' ' GLY . . . . . 0.409 ' HA3' ' CD2' ' A' ' 37' ' ' PHE . . . -155.51 165.77 32.55 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.491 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 523' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -106.32 -84.83 0.51 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.737 0.303 . . . . 0.0 110.898 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 524' ' ' GLY . . . . . 0.476 ' CA ' ' CG1' ' A' ' 36' ' ' VAL . . . 75.97 21.34 76.47 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.619 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 525' ' ' ASP . . . . . 0.543 ' O ' HG11 ' A' ' 33' ' ' VAL . 26.2 m-20 50.93 56.74 7.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.842 0.353 . . . . 0.0 110.887 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 526' ' ' SER . . . . . 0.419 ' HA ' ' HB ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -81.13 96.82 7.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.935 -179.967 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 527' ' ' ASP . . . . . 0.787 ' O ' HG21 ' A' ' 33' ' ' VAL . 1.2 m-20 -164.55 163.42 14.61 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.247 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -69.44 87.27 0.52 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 123.054 2.503 . . . . 0.0 111.734 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 529' ' ' ARG . . . . . . . . . . . . . 4.0 mtp180 -100.8 -45.67 5.39 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.527 -179.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 530' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -123.06 -42.76 2.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.057 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 3.7 m 72.72 138.81 0.05 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.924 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 532' ' ' TRP . . . . . 0.497 ' CZ2' ' HG3' ' B' ' 537' ' ' ARG . 11.2 t-105 -89.78 115.15 26.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.935 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . -110.46 -53.31 0.57 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.508 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 534' ' ' PHE . . . . . 0.475 ' O ' ' CZ2' ' B' ' 532' ' ' TRP . 32.2 m-85 -107.09 147.84 35.9 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.661 0.267 . . . . 0.0 110.881 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -67.61 -167.01 0.14 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.528 2.152 . . . . 0.0 112.298 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 70.14 102.51 0.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.945 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 537' ' ' ARG . . . . . 0.497 ' HG3' ' CZ2' ' B' ' 532' ' ' TRP . 0.0 OUTLIER -108.13 -177.11 3.24 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.391 0.615 . . . . 0.0 111.146 -179.991 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 538' ' ' ILE . . . . . 0.621 HD12 ' HB2' ' B' ' 542' ' ' TYR . 11.4 pt -114.47 -156.05 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-N 114.999 -1.001 . . . . 0.0 109.749 179.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 539' ' ' ASP . . . . . 0.68 ' HB3' HD21 ' A' ' 70' ' ' LEU . 0.3 OUTLIER -93.98 135.12 35.66 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.328 179.198 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 540' ' ' GLU . . . . . 0.873 ' HG3' HG13 ' A' ' 8' ' ' VAL . 1.4 mm-40 -41.33 -33.82 0.44 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.762 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 541' ' ' LEU . . . . . 0.877 ' HB2' HD23 ' A' ' 70' ' ' LEU . 2.4 tt -54.46 -34.36 61.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.117 0.484 . . . . 0.0 110.434 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 542' ' ' TYR . . . . . 0.621 ' HB2' HD12 ' B' ' 538' ' ' ILE . 89.4 m-85 -99.26 -6.55 27.85 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.923 -179.378 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 543' ' ' LEU . . . . . 0.955 ' CD2' HG21 ' A' ' 35' ' ' THR . 0.9 OUTLIER -50.17 167.03 0.06 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.789 0.328 . . . . 0.0 110.781 -179.786 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . 146.26 71.11 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.432 -0.89 . . . . 0.0 112.621 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 545' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.922 179.978 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' GNP . . . . . 0.818 " H2'" ' OG1' ' A' ' 115' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.563 ' HE1' ' CD1' ' A' ' 51' ' ' TYR . 6.1 tpt . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.746 0.308 . . . . 0.0 111.263 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.432 ' O ' ' HE3' ' A' ' 1' ' ' MET . 41.3 tt0 -100.04 150.88 22.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.022 0.439 . . . . 0.0 110.864 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.679 HG23 ' HE1' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -93.46 -178.71 4.81 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.273 -179.538 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.575 ' H ' HG22 ' A' ' 3' ' ' THR . 3.8 pt -148.48 112.21 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.96 -179.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 44.8 mttt -94.85 95.83 8.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.191 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.523 ' CB ' ' CE2' ' A' ' 56' ' ' PHE . 4.0 m -121.35 136.99 54.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.666 -179.177 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.4 t -137.26 146.22 28.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.421 179.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.869 HG23 ' HB3' ' A' ' 56' ' ' PHE . 19.7 t -84.65 140.0 16.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.232 0.539 . . . . 0.0 111.668 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 96.2 t -150.66 129.81 3.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.534 179.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 135.03 -148.8 19.71 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.089 -1.053 . . . . 0.0 112.63 -179.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -122.47 23.64 9.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.825 0.345 . . . . 0.0 110.721 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.412 ' HA2' ' HB2' ' B' ' 537' ' ' ARG . . . -142.28 148.9 20.71 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.451 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.462 ' HB3' ' O3A' ' A' ' 185' ' ' GNP . . . -98.79 4.76 47.7 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.721 HG23 HG21 ' A' ' 115' ' ' THR . 6.8 p -43.69 -31.26 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 CA-C-O 120.692 0.282 . . . . 0.0 111.463 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.543 ' CA ' HD11 ' A' ' 19' ' ' LEU . . . -113.27 18.94 20.55 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.415 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.519 ' HA ' HG21 ' A' ' 8' ' ' VAL . 2.3 tttm -97.52 -126.49 0.15 Allowed 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 119.949 -0.072 . . . . 0.0 110.851 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.537 HG21 ' CG ' ' A' ' 38' ' ' ASP . 3.3 p -97.34 -31.08 12.58 Favored 'General case' 0 C--N 1.34 0.172 0 O-C-N 122.041 -0.412 . . . . 0.0 111.435 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.441 ' O ' ' CB ' ' A' ' 22' ' ' SER . 15.6 p -42.08 -36.38 1.13 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.903 -179.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.941 HD22 ' CG ' ' A' ' 169' ' ' PHE . 2.8 mp -48.4 -72.79 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.322 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.6 mt -78.12 -40.71 37.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.875 0.369 . . . . 0.0 110.612 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.588 HD12 ' CZ ' ' B' ' 518' ' ' PHE . 24.3 mm -62.56 -69.35 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.209 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.441 ' CB ' ' O ' ' A' ' 18' ' ' CYS . 1.5 t -52.86 -46.33 67.8 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.558 -179.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.425 ' CB ' ' O ' ' A' ' 19' ' ' LEU . 28.6 t80 -48.99 -42.66 38.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.686 0.279 . . . . 0.0 111.414 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.1 m -100.51 -64.59 1.03 Allowed 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.499 HG22 ' N ' ' A' ' 26' ' ' ASN . 97.8 m -100.55 164.64 11.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.933 0.396 . . . . 0.0 111.379 -179.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.499 ' N ' HG22 ' A' ' 25' ' ' THR . 7.1 t-20 73.89 -60.67 0.52 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.079 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 74.4 174.13 0.27 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.821 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.488 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 8.1 t80 -86.71 -46.22 0.54 Allowed Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.645 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.488 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 87.1 Cg_endo -82.99 50.8 3.47 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.501 2.134 . . . . 0.0 112.792 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.3 m -143.18 -100.46 0.12 Allowed 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.79 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.416 ' O ' ' ND2' ' A' ' 26' ' ' ASN . 1.2 pt-20 -159.69 163.2 34.99 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.902 0.382 . . . . 0.0 111.073 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.482 ' CE2' ' O2A' ' A' ' 185' ' ' GNP . 36.9 m-85 -135.21 117.09 15.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.266 179.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.659 HG11 ' HG3' ' B' ' 529' ' ' ARG . 0.0 OUTLIER -163.39 -62.87 0.01 OUTLIER Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.686 -179.471 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.449 ' HB3' ' CB ' ' B' ' 526' ' ' SER . 29.0 Cg_endo -62.9 57.33 0.15 Allowed 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.816 2.344 . . . . 0.0 113.592 -179.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.48 HG21 ' PG ' ' A' ' 185' ' ' GNP . 4.0 t -122.74 22.45 9.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.846 0.355 . . . . 0.0 110.172 178.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.71 ' CG2' HD22 ' A' ' 61' ' ' LEU . 2.3 t -73.13 -45.64 53.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.751 -179.059 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.48 ' O ' ' CD2' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -85.5 48.77 1.64 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.786 0.327 . . . . 0.0 111.303 -179.731 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.537 ' CG ' HG21 ' A' ' 17' ' ' THR . 99.4 m-20 -69.75 -16.87 63.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.111 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -86.02 11.28 11.95 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.593 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.534 ' HH ' ' HZ ' ' B' ' 518' ' ' PHE . 0.0 OUTLIER -60.25 173.81 0.61 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.821 0.343 . . . . 0.0 110.725 179.874 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.413 ' O ' HG12 ' B' ' 519' ' ' ILE . . . -92.16 147.43 22.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.174 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.529 HG12 ' HA ' ' B' ' 518' ' ' PHE . 6.7 m -134.91 147.05 29.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.887 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.705 ' N ' HD11 ' B' ' 519' ' ' ILE . 2.8 t -85.81 102.63 13.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.984 0.421 . . . . 0.0 109.911 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 1.019 HG13 HG21 ' A' ' 52' ' ' THR . 1.1 p -165.77 145.61 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.872 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.616 ' HG3' HD22 ' B' ' 514' ' ' LEU . 0.0 OUTLIER -115.75 140.33 49.31 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.424 179.521 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.604 HG23 ' CG2' ' B' ' 510' ' ' ILE . 7.8 mm -95.38 115.46 34.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-O 120.947 0.403 . . . . 0.0 111.561 -179.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.549 ' O ' ' HE1' ' A' ' 45' ' ' MET . . . 33.18 -90.35 0.01 OUTLIER Glycine 0 C--N 1.336 0.552 0 CA-C-N 115.595 -0.73 . . . . 0.0 114.223 178.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.408 ' C ' ' HE1' ' A' ' 45' ' ' MET . . . -41.14 -87.7 0.01 OUTLIER Glycine 0 C--N 1.332 0.315 0 C-N-CA 121.205 -0.522 . . . . 0.0 113.07 -179.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.407 ' CB ' ' HD2' ' A' ' 50' ' ' PRO . 1.1 mt-10 -143.51 165.36 25.53 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.406 0.103 . . . . 0.0 111.214 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.416 ' HA ' ' CB ' ' A' ' 45' ' ' MET . 39.2 Cg_exo -31.24 103.02 0.03 OUTLIER 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.619 2.879 . . . . 0.0 113.012 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.679 ' HE1' HG23 ' A' ' 3' ' ' THR . 8.7 t80 -172.53 120.67 0.41 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.772 -179.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 1.019 HG21 HG13 ' A' ' 44' ' ' VAL . 0.2 OUTLIER -135.43 155.73 50.08 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.088 -178.741 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.675 ' N ' HD13 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -115.55 156.3 26.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.186 179.973 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -62.26 109.85 2.87 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.6 -0.81 . . . . 0.0 111.875 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.22 -153.15 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.656 0.265 . . . . 0.0 110.895 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.869 ' HB3' HG23 ' A' ' 8' ' ' VAL . 9.0 m-85 -84.41 105.76 15.49 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 120.921 0.391 . . . . 0.0 111.127 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.402 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 4.3 p30 -120.74 113.06 19.64 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.939 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.593 HG22 HD13 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -154.21 125.77 7.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.87 179.86 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.884 ' HB1' ' CD1' ' A' ' 61' ' ' LEU . . . -172.52 119.86 0.39 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.992 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.4 ' HA2' ' O ' ' A' ' 64' ' ' TYR . . . -95.18 75.45 0.89 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.445 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.884 ' CD1' ' HB1' ' A' ' 59' ' ' ALA . 3.5 mp -117.46 -115.09 0.33 Allowed 'General case' 0 CA--C 1.538 0.513 0 O-C-N 122.912 -0.17 . . . . 0.0 110.872 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -98.6 -29.55 12.99 Favored 'General case' 0 N--CA 1.455 -0.182 0 O-C-N 122.073 -0.392 . . . . 0.0 111.254 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.45 ' HB3' ' CD1' ' A' ' 64' ' ' TYR . 14.8 t0 -67.38 -63.25 1.1 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.066 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.45 ' CD1' ' HB3' ' A' ' 63' ' ' ASP . 0.2 OUTLIER -124.13 137.22 54.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.674 179.966 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -87.25 -62.5 1.49 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.897 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.476 ' N ' ' CD ' ' A' ' 66' ' ' ARG . 0.3 OUTLIER -98.68 -21.09 16.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.181 -179.777 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.593 HD13 HG22 ' A' ' 58' ' ' THR . 1.7 mt 67.03 -135.38 0.13 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.297 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.467 ' CB ' ' CD ' ' A' ' 69' ' ' PRO . 1.2 mtt180 -166.06 -64.07 0.01 OUTLIER Pre-proline 0 CA--C 1.529 0.151 0 CA-C-N 118.28 0.491 . . . . 0.0 111.814 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.467 ' CD ' ' CB ' ' A' ' 68' ' ' ARG . 63.7 Cg_exo -36.96 -60.27 0.4 Allowed 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.965 2.443 . . . . 0.0 113.103 -179.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.649 ' C ' HD12 ' A' ' 70' ' ' LEU . 0.4 OUTLIER -50.08 -29.64 9.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.384 -179.752 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 68' ' ' ARG . 35.5 p -47.46 -64.76 0.7 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.759 0.314 . . . . 0.0 111.194 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.422 ' N ' ' OG ' ' A' ' 71' ' ' SER . 6.1 p90 -179.55 92.38 0.2 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.07 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.93 136.03 26.67 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.523 2.149 . . . . 0.0 112.313 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -87.4 10.91 15.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.512 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 11.7 t -70.13 -173.16 0.64 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.784 0.326 . . . . 0.0 110.933 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -124.31 7.69 8.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.431 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.986 HG11 ' HB2' ' A' ' 176' ' ' ALA . 9.0 p -129.14 78.59 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.755 0.312 . . . . 0.0 111.388 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.598 ' CZ ' HG21 ' A' ' 108' ' ' THR . 7.6 m-30 -80.7 172.43 13.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.224 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.435 ' CD2' ' HA3' ' A' ' 15' ' ' GLY . 8.1 tp -143.83 108.55 4.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.876 0.37 . . . . 0.0 111.374 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.593 ' CG1' HD12 ' A' ' 101' ' ' ILE . 4.4 m -94.52 155.12 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.18 179.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.591 ' HB3' HG12 ' A' ' 14' ' ' VAL . 2.3 m -134.85 146.21 49.03 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.194 0.521 . . . . 0.0 111.92 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.822 ' CE1' HD12 ' A' ' 112' ' ' LEU . 6.2 p90 -166.22 124.63 1.5 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.158 179.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.474 ' HA ' ' C2 ' ' A' ' 185' ' ' GNP . 0.1 OUTLIER -90.24 139.26 30.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.014 0.435 . . . . 0.0 111.562 -179.244 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.956 HG22 ' CB ' ' A' ' 116' ' ' GLN . 10.2 m -63.26 -170.1 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.408 179.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.807 ' CG2' HG23 ' A' ' 84' ' ' VAL . 0.1 OUTLIER 56.19 102.11 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -179.282 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.898 ' C ' HD22 ' A' ' 129' ' ' LEU . 0.2 OUTLIER -151.26 145.9 18.49 Favored Pre-proline 0 C--N 1.325 -0.465 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.923 -179.183 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.584 ' N ' HD22 ' A' ' 129' ' ' LEU . 83.6 Cg_endo -85.73 50.04 2.51 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 123.121 2.548 . . . . 0.0 111.654 179.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.484 ' N ' ' HB3' ' A' ' 133' ' ' LYS . 2.6 t 82.9 27.8 0.11 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.877 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 44.5 t -97.3 -24.16 15.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.848 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.407 ' CZ ' HD12 ' A' ' 145' ' ' LEU . 11.2 t80 -49.56 -62.1 1.74 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.066 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -50.36 -31.16 13.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.873 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.424 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 1.4 t-20 -72.59 -63.22 1.2 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.859 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.437 HG13 ' N ' ' A' ' 94' ' ' LYS . 12.9 p -52.43 -41.74 36.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.039 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.831 ' CG ' HD11 ' A' ' 145' ' ' LEU . 0.8 OUTLIER -55.87 -62.27 1.81 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.699 179.93 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.409 ' O ' ' HG3' ' A' ' 99' ' ' PRO . 1.1 mm-40 -78.32 2.81 17.34 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.782 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.468 ' HD3' ' CZ3' ' A' ' 97' ' ' TRP . 55.9 tttt -105.24 -38.43 6.53 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.869 0.366 . . . . 0.0 110.56 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.468 ' CZ3' ' HD3' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -74.8 -49.45 20.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.15 179.967 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 94' ' ' LYS . 67.8 t -47.01 -52.3 34.57 Favored Pre-proline 0 CA--C 1.532 0.28 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.919 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 60.7 Cg_endo -72.22 -20.57 24.53 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.112 1.875 . . . . 0.0 112.385 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -84.89 -46.26 11.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.015 0.436 . . . . 0.0 110.622 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.593 HD12 ' CG1' ' A' ' 80' ' ' VAL . 5.9 tt -66.07 -26.11 37.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.906 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.46 HG22 ' HA ' ' A' ' 107' ' ' LYS . 60.3 p -91.55 -26.53 18.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.739 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.454 ' CG ' ' O ' ' A' ' 99' ' ' PRO . 1.9 m170 -67.52 -69.25 0.33 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.828 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -64.32 -42.93 96.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.634 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 4.5 m -112.59 149.21 40.79 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.603 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -49.21 162.31 0.5 Allowed 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.509 2.139 . . . . 0.0 112.269 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.46 ' HA ' HG22 ' A' ' 102' ' ' THR . 0.2 OUTLIER -81.43 56.21 2.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.801 179.921 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.598 HG21 ' CZ ' ' A' ' 78' ' ' PHE . 1.3 p -81.58 165.33 44.63 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.227 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -60.62 162.68 17.45 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.856 2.37 . . . . 0.0 112.323 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.832 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 8.8 p90 -156.07 153.83 30.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.757 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 1.023 HD12 HG11 ' A' ' 152' ' ' VAL . 4.7 tt -113.81 142.95 45.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.408 -179.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.822 HD12 ' CE1' ' A' ' 82' ' ' PHE . 3.8 mm? -99.14 158.68 15.51 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.387 179.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.957 ' CG1' HG11 ' A' ' 168' ' ' VAL . 2.6 t -141.94 146.95 22.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.166 0.507 . . . . 0.0 112.193 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.499 ' HA3' ' CZ ' ' A' ' 154' ' ' TYR . . . -122.49 92.02 0.47 Allowed Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.968 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.721 HG21 HG23 ' A' ' 14' ' ' VAL . 0.7 OUTLIER -114.34 6.76 16.18 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.281 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.956 ' CB ' HG22 ' A' ' 84' ' ' VAL . 2.3 mt-30 -110.22 25.86 11.31 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.301 0.572 . . . . 0.0 109.56 179.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.422 ' CD1' ' O ' ' A' ' 114' ' ' GLY . 0.0 OUTLIER -65.53 -10.45 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.501 179.008 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -96.9 -20.5 18.09 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.245 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.468 ' CB ' HG21 ' A' ' 85' ' ' VAL . 5.2 mp -89.02 -37.66 15.0 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.256 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.453 ' O ' HD13 ' A' ' 126' ' ' ILE . 8.2 ptm180 -48.09 -31.56 5.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.828 0.347 . . . . 0.0 110.894 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -78.58 -37.06 43.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.485 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -47.97 104.24 0.4 Allowed Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.909 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.424 ' O ' ' CG ' ' A' ' 127' ' ' GLU . 55.4 Cg_endo -70.99 -6.17 18.61 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.444 2.096 . . . . 0.0 112.898 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.93 -66.58 0.77 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.411 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 17.2 m -57.51 -40.86 79.62 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.576 HD11 ' HB3' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -52.84 -46.56 52.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.805 179.231 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.52 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 20.5 mm-40 -58.14 -33.69 69.46 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.9 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.441 ' HA ' ' CE ' ' A' ' 131' ' ' LYS . 9.9 mptt -68.99 -24.77 64.27 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 178.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.898 HD22 ' C ' ' A' ' 86' ' ' SER . 4.4 mt -79.43 -35.58 40.3 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 177.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 127' ' ' GLU . . . -39.55 -39.1 0.67 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.033 -0.985 . . . . 0.0 112.391 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.441 ' CE ' ' HA ' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -69.88 -21.63 63.31 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.793 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.422 ' CB ' ' O ' ' A' ' 87' ' ' PRO . 17.5 m120 -124.01 -31.72 3.34 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -179.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.488 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 0.0 OUTLIER -139.63 -74.68 0.36 Allowed 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 -179.303 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.488 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 1.2 pt20 99.46 -41.21 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.075 0.95 . . . . 0.0 110.806 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.421 ' N ' ' HG2' ' A' ' 134' ' ' GLN . 0.8 OUTLIER -74.33 109.03 6.02 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.438 -179.648 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.91 ' C ' HD13 ' A' ' 137' ' ' ILE . 54.4 Cg_endo -68.28 -169.35 0.25 Allowed 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.253 1.968 . . . . 0.0 111.141 179.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.91 HD13 ' C ' ' A' ' 136' ' ' PRO . 1.0 OUTLIER -115.37 96.42 4.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.028 0.442 . . . . 0.0 110.585 179.877 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.415 ' O ' ' N ' ' A' ' 141' ' ' THR . 26.3 p -69.85 144.24 93.08 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.929 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.466 ' O ' ' CE1' ' A' ' 154' ' ' TYR . 1.8 Cg_endo -42.61 -46.07 8.22 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 122.893 2.395 . . . . 0.0 112.012 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.402 ' HG2' ' OG1' ' A' ' 138' ' ' THR . 9.6 pt-20 -59.96 -32.66 71.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.417 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.415 ' N ' ' O ' ' A' ' 138' ' ' THR . 29.5 m -61.55 -53.17 59.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.686 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.526 ' CB ' ' CD2' ' A' ' 154' ' ' TYR . . . -51.91 -36.84 50.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.689 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -62.84 -40.88 98.8 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.492 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 37.4 tttp -59.38 -56.13 25.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.415 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.831 HD11 ' CG ' ' A' ' 94' ' ' LYS . 0.9 OUTLIER -62.15 -41.06 97.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.341 179.512 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.449 ' CB ' HD23 ' A' ' 112' ' ' LEU . . . -58.86 -53.19 61.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.739 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.06 -27.06 61.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.666 179.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -50.45 -45.08 55.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.709 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.11 20.73 18.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.926 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 18.9 mttt 48.67 63.55 2.05 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.091 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.832 ' HB1' ' O ' ' A' ' 110' ' ' PHE . . . -80.19 -82.29 0.11 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.959 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 1.023 HG11 HD12 ' A' ' 111' ' ' LEU . 54.9 t -162.05 -75.6 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.794 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.409 ' HE2' ' N ' ' A' ' 154' ' ' TYR . 0.0 OUTLIER -177.17 120.14 0.12 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.855 -178.831 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.526 ' CD2' ' CB ' ' A' ' 142' ' ' ALA . 12.5 t80 -89.83 114.56 26.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.296 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.48 HG21 ' HG3' ' A' ' 171' ' ' GLU . 2.8 t -111.7 154.67 13.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.032 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -93.49 119.84 33.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.021 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.571 ' O ' HG22 ' A' ' 115' ' ' THR . 1.3 m -172.49 135.71 0.73 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.808 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.434 ' CB ' ' HB ' ' A' ' 115' ' ' THR . 1.9 p -150.1 170.69 18.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.922 0.392 . . . . 0.0 111.153 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.39 -30.84 21.82 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.99 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.1 mt -51.38 -72.39 0.05 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.664 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 14.6 t -74.21 -16.81 60.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.086 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 71.07 50.84 0.3 Allowed 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.069 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.418 ' HB3' ' HA ' ' A' ' 157' ' ' CYS . 0.6 OUTLIER -68.78 -21.02 64.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.969 179.67 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 139.05 -42.45 1.25 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.388 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.702 HD22 ' HA ' ' A' ' 19' ' ' LEU . 0.3 OUTLIER 68.15 -62.18 0.37 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.796 0.332 . . . . 0.0 111.079 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.426 ' O ' ' N ' ' A' ' 170' ' ' ASP . 0.1 OUTLIER -48.12 -25.52 1.49 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.388 -179.733 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -52.34 -71.64 0.06 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.798 0.332 . . . . 0.0 110.47 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.957 HG11 ' CG1' ' A' ' 113' ' ' VAL . 14.7 p -59.24 -29.92 42.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.266 0.555 . . . . 0.0 110.184 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.941 ' CG ' HD22 ' A' ' 19' ' ' LEU . 0.6 OUTLIER -67.53 -29.8 69.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.325 179.714 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 166' ' ' LYS . 68.9 m-20 -77.28 -27.72 53.17 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.191 179.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.48 ' HG3' HG21 ' A' ' 155' ' ' VAL . 8.1 mm-40 -75.5 -28.5 59.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.316 179.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.583 ' CA ' HD13 ' A' ' 111' ' ' LEU . . . -75.02 -48.06 25.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.961 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.506 ' O ' ' HB3' ' A' ' 176' ' ' ALA . 1.3 pp -65.72 -34.71 72.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.72 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.731 HD13 ' CB ' ' B' ' 505' ' ' LEU . 1.6 tp -48.86 -58.04 5.45 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.912 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.447 ' HB3' HG23 ' A' ' 77' ' ' VAL . . . -47.87 -26.46 1.69 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.136 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.986 ' HB2' HG11 ' A' ' 77' ' ' VAL . . . -77.29 -47.85 18.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.209 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.696 ' CD2' HG21 ' B' ' 510' ' ' ILE . 3.0 mt -68.53 -23.82 64.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.881 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.431 ' HB3' ' HB2' ' B' ' 507' ' ' ALA . 0.0 OUTLIER -160.28 155.82 22.02 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.963 179.753 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.0 122.43 8.1 Favored 'Trans proline' 0 CA--C 1.529 0.253 0 C-N-CA 122.631 2.221 . . . . 0.0 112.18 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.53 175.82 5.64 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.434 2.09 . . . . 0.0 112.376 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 25.8 mp0 -144.63 96.72 5.12 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.887 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.23 -165.08 0.27 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.573 2.182 . . . . 0.0 112.235 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 5.8 mmtp -80.09 141.72 35.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.815 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.903 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.154 0 N-CA-C 112.521 -0.232 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 503' ' ' SER . . . . . . . . . . . . . 54.5 p -99.47 -160.49 0.81 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.745 0.307 . . . . 0.0 110.813 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 504' ' ' GLY . . . . . 0.407 ' HA2' ' HB2' ' B' ' 509' ' ' ASP . . . 149.23 95.81 0.15 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.331 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 505' ' ' LEU . . . . . 0.731 ' CB ' HD13 ' A' ' 174' ' ' LEU . 0.2 OUTLIER -157.43 146.51 19.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.057 0.456 . . . . 0.0 111.477 -179.698 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 506' ' ' SER . . . . . 0.482 ' O ' ' HB2' ' B' ' 507' ' ' ALA . 0.6 OUTLIER -60.05 81.83 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.728 179.579 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 507' ' ' ALA . . . . . 0.482 ' HB2' ' O ' ' B' ' 506' ' ' SER . . . 170.82 43.71 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.486 -179.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 508' ' ' GLN . . . . . 0.595 ' HB2' HD12 ' B' ' 510' ' ' ILE . 0.0 OUTLIER 75.33 3.79 4.05 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.692 -177.385 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 509' ' ' ASP . . . . . 0.407 ' HB2' ' HA2' ' B' ' 504' ' ' GLY . 3.7 p30 45.9 53.16 9.23 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.164 0.507 . . . . 0.0 111.393 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 510' ' ' ILE . . . . . 0.696 HG21 ' CD2' ' A' ' 177' ' ' LEU . 1.2 mp -52.97 143.72 4.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.104 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 511' ' ' SER . . . . . 0.532 ' O ' HD11 ' B' ' 514' ' ' LEU . 22.8 t -108.67 153.74 23.0 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.889 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 512' ' ' GLN . . . . . 0.487 ' OE1' ' CD2' ' A' ' 169' ' ' PHE . 9.6 tt0 -102.46 -70.59 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.181 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 513' ' ' PRO . . . . . 0.487 ' CD ' ' CB ' ' B' ' 512' ' ' GLN . 87.5 Cg_endo -77.54 56.59 5.63 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.279 1.986 . . . . 0.0 111.617 179.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 514' ' ' LEU . . . . . 0.898 ' HB2' HG23 ' A' ' 44' ' ' VAL . 2.1 mp -60.72 -89.99 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.623 -179.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 515' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -84.15 -159.61 0.4 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.63 0.252 . . . . 0.0 110.792 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -48.12 -27.32 2.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.834 0.35 . . . . 0.0 110.733 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 517' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 39.57 33.75 0.13 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.724 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 518' ' ' PHE . . . . . 0.588 ' CZ ' HD12 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -163.51 106.72 1.0 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.371 -179.9 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 519' ' ' ILE . . . . . 0.705 HD11 ' N ' ' A' ' 43' ' ' THR . 3.6 mm -87.13 -37.31 10.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.906 0.384 . . . . 0.0 110.842 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -167.52 -170.75 1.5 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.668 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 521' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.27 157.54 19.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.849 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 522' ' ' GLY . . . . . 0.452 ' CA ' ' HB3' ' A' ' 37' ' ' PHE . . . -61.67 -126.52 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.32 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 523' ' ' HIS . . . . . 0.482 ' CD2' ' N ' ' B' ' 524' ' ' GLY . 41.1 t60 -165.05 -88.07 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.625 0.25 . . . . 0.0 111.065 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 524' ' ' GLY . . . . . 0.482 ' N ' ' CD2' ' B' ' 523' ' ' HIS . . . 42.49 -153.39 0.19 Allowed Glycine 0 C--N 1.334 0.418 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.841 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 525' ' ' ASP . . . . . 0.518 ' OD1' HD23 ' A' ' 61' ' ' LEU . 41.0 p-10 -83.29 65.81 8.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.902 0.382 . . . . 0.0 110.655 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 526' ' ' SER . . . . . 0.449 ' CB ' ' HB3' ' A' ' 34' ' ' PRO . 53.6 p -73.19 96.12 2.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.796 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 527' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -168.24 153.36 6.47 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.003 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.62 100.81 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.684 2.256 . . . . 0.0 112.069 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 529' ' ' ARG . . . . . 0.659 ' HG3' HG11 ' A' ' 33' ' ' VAL . 7.6 mtp85 -100.71 -55.34 2.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.286 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 530' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -162.94 98.33 0.95 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.123 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 19.2 t -46.81 95.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.887 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 532' ' ' TRP . . . . . 0.445 ' CE3' ' O ' ' B' ' 533' ' ' GLY . 21.0 t90 68.48 -67.36 0.2 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.948 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 533' ' ' GLY . . . . . 0.445 ' O ' ' CE3' ' B' ' 532' ' ' TRP . . . 87.34 -122.69 6.29 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.592 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 534' ' ' PHE . . . . . 0.4 ' HB3' ' HD2' ' B' ' 535' ' ' PRO . 49.4 m-85 -95.08 155.38 39.05 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 120.738 0.304 . . . . 0.0 110.87 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 535' ' ' PRO . . . . . 0.4 ' HD2' ' HB3' ' B' ' 534' ' ' PHE . 33.9 Cg_endo -64.54 166.38 17.77 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.619 2.213 . . . . 0.0 112.302 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 64.81 97.06 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.828 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 537' ' ' ARG . . . . . 0.412 ' HB2' ' HA2' ' A' ' 12' ' ' GLY . 0.2 OUTLIER -50.59 143.14 9.79 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.047 0.451 . . . . 0.0 111.054 -179.919 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 538' ' ' ILE . . . . . 0.448 ' CG2' ' HA ' ' B' ' 543' ' ' LEU . 6.1 tp -56.17 141.84 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.912 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 539' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -43.06 143.06 0.83 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.943 0.401 . . . . 0.0 111.387 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 540' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -54.15 -20.45 6.76 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.383 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 541' ' ' LEU . . . . . 0.494 ' HA ' HD22 ' A' ' 70' ' ' LEU . 3.9 mt -41.54 -57.9 2.09 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.878 0.37 . . . . 0.0 111.348 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 542' ' ' TYR . . . . . 0.404 ' O ' ' HA ' ' A' ' 59' ' ' ALA . 1.6 m-85 -104.38 -63.54 1.2 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.804 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 543' ' ' LEU . . . . . 0.454 HD22 ' O ' ' A' ' 58' ' ' THR . 0.3 OUTLIER 67.21 152.93 0.08 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.754 -179.834 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . 120.25 -123.98 5.77 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.536 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 545' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.911 179.903 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' GNP . . . . . 0.706 " H2'" ' OG1' ' A' ' 115' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.4 ' CE ' ' O ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.788 0.328 . . . . 0.0 111.204 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.4 ' O ' ' CE ' ' A' ' 1' ' ' MET . 6.5 tt0 54.12 170.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.715 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.771 HG23 ' CE1' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -132.28 -172.46 2.9 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.317 -179.744 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.945 HG13 HD13 ' A' ' 53' ' ' LEU . 4.5 pt -153.14 132.06 3.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.526 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -91.45 95.78 10.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.575 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.616 ' CB ' HD13 ' A' ' 55' ' ' LEU . 1.1 m -80.37 98.64 7.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.273 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.1 t -126.25 159.43 35.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.478 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.805 HG21 ' HG3' ' A' ' 16' ' ' LYS . 22.4 t -128.97 117.62 44.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.039 0.447 . . . . 0.0 111.65 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 96.7 t -123.82 129.98 74.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.917 179.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 134.17 -164.91 24.48 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.205 -0.997 . . . . 0.0 112.612 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' B' ' 539' ' ' ASP . 1.2 m-20 -98.82 25.93 6.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.837 0.351 . . . . 0.0 110.572 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.439 ' HA3' ' N7 ' ' A' ' 185' ' ' GNP . . . -138.27 150.01 20.78 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.645 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.668 ' HB1' ' O1B' ' A' ' 185' ' ' GNP . . . -89.83 -14.93 33.36 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -179.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.877 HG11 HG11 ' A' ' 113' ' ' VAL . 92.2 t -43.51 102.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-O 120.903 0.382 . . . . 0.0 111.29 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.623 ' CA ' HD11 ' A' ' 19' ' ' LEU . . . 142.12 -13.02 2.58 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.624 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.805 ' HG3' HG21 ' A' ' 8' ' ' VAL . 77.0 mttt -97.61 -105.73 0.18 Allowed 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.645 0.222 . . . . 0.0 111.377 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.46 ' HB ' ' CG1' ' A' ' 21' ' ' ILE . 69.2 p -98.49 -39.32 8.81 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 -179.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.426 ' O ' ' CB ' ' A' ' 22' ' ' SER . 23.8 t -35.9 -34.19 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -179.021 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.837 HD22 ' CD2' ' A' ' 169' ' ' PHE . 0.0 OUTLIER -80.71 -70.31 0.54 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.761 0.315 . . . . 0.0 111.036 -179.746 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.676 ' H ' HD22 ' A' ' 20' ' ' LEU . 0.5 OUTLIER -50.84 -43.59 59.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.653 -179.908 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.781 HD11 ' CE2' ' B' ' 518' ' ' PHE . 32.5 mm -63.73 -64.05 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.171 179.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.426 ' CB ' ' O ' ' A' ' 18' ' ' CYS . 45.4 t -45.93 -30.17 1.67 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.958 0.408 . . . . 0.0 110.707 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -65.44 -45.24 84.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.412 179.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -87.39 -50.73 6.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.557 179.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.2 p -102.18 -158.55 0.68 Allowed 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.221 179.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -159.33 38.45 0.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.005 0.431 . . . . 0.0 110.821 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.6 98.9 8.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.92 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.469 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . 9.4 t80 -97.56 -52.04 0.21 Allowed Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.024 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.469 ' HD3' ' HB3' ' A' ' 28' ' ' PHE . 65.3 Cg_endo -90.37 26.53 0.49 Allowed 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.782 2.321 . . . . 0.0 112.62 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.57 -87.32 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.129 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.429 ' HB2' ' HD3' ' B' ' 529' ' ' ARG . 4.7 pt-20 -158.13 115.86 2.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.844 0.354 . . . . 0.0 110.737 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.469 ' CE2' ' PB ' ' A' ' 185' ' ' GNP . 12.0 m-30 -105.83 119.5 39.32 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.759 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.508 HG23 ' HD3' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -161.86 -56.14 0.01 OUTLIER Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.145 179.863 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.508 ' HD3' HG23 ' A' ' 33' ' ' VAL . 19.1 Cg_exo -66.22 -15.52 48.61 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.469 2.112 . . . . 0.0 112.558 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.0 t -41.94 -30.67 0.28 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.907 0.384 . . . . 0.0 111.387 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.506 HG23 ' HB3' ' A' ' 59' ' ' ALA . 12.3 p -51.29 -22.47 2.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.329 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.48 ' CD1' ' O ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -81.88 48.15 1.18 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.311 179.896 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.406 ' OD2' ' N ' ' A' ' 57' ' ' ASP . 14.6 p-10 -74.13 -2.6 25.29 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.498 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -83.94 11.11 8.26 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 111.603 0.223 . . . . 0.0 111.603 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 48.7 p90 -60.27 160.96 7.7 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.74 0.305 . . . . 0.0 110.616 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.423 ' O ' ' CG1' ' B' ' 519' ' ' ILE . . . -109.89 135.99 49.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.476 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.881 HG23 HG21 ' A' ' 52' ' ' THR . 13.5 m -114.57 121.68 67.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.824 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.43 ' O ' ' CG1' ' A' ' 44' ' ' VAL . 1.6 p -91.51 103.84 16.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.524 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.67 HG22 ' CG2' ' A' ' 52' ' ' THR . 29.2 m -159.26 -177.12 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.305 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.467 ' HE1' ' N ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -112.76 97.59 6.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.511 -179.58 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 1.032 HG23 HG23 ' B' ' 510' ' ' ILE . 1.6 mm -69.54 87.67 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.504 ' HA3' HD13 ' B' ' 510' ' ' ILE . . . 39.79 -90.59 0.01 OUTLIER Glycine 0 CA--C 1.521 0.466 0 CA-C-N 116.066 -0.516 . . . . 0.0 113.53 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . -38.38 -82.76 0.01 OUTLIER Glycine 0 C--N 1.334 0.467 0 C-N-CA 121.542 -0.361 . . . . 0.0 113.502 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.467 ' N ' ' HE1' ' A' ' 45' ' ' MET . 1.9 mt-10 -135.35 165.96 32.41 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-O 120.898 0.38 . . . . 0.0 111.581 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.418 ' HD2' ' HB3' ' A' ' 49' ' ' GLU . 51.4 Cg_exo -54.28 99.74 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.769 2.313 . . . . 0.0 113.032 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.771 ' CE1' HG23 ' A' ' 3' ' ' THR . 6.2 t80 -173.24 153.06 2.37 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.667 179.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.881 HG21 HG23 ' A' ' 42' ' ' VAL . 0.8 OUTLIER -136.79 153.21 50.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.623 179.201 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.945 HD13 HG13 ' A' ' 4' ' ' ILE . 0.6 OUTLIER -80.93 -172.92 3.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.165 -179.879 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.408 ' O ' ' CE2' ' A' ' 56' ' ' PHE . . . -124.65 98.09 0.55 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.037 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.616 HD13 ' CB ' ' A' ' 6' ' ' CYS . 3.5 mm? -51.54 123.68 10.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.812 0.339 . . . . 0.0 111.053 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.408 ' CE2' ' O ' ' A' ' 54' ' ' GLY . 45.0 m-85 -113.6 118.75 35.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.786 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.433 ' HB2' ' CD ' ' A' ' 16' ' ' LYS . 35.6 p-10 -121.66 -176.57 3.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.119 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.643 ' OG1' HD22 ' B' ' 543' ' ' LEU . 75.7 p -124.52 130.83 53.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.923 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.506 ' HB3' HG23 ' A' ' 36' ' ' VAL . . . -140.93 -167.47 2.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.004 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.16 44.51 0.58 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.656 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.447 ' CD1' ' HB1' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -121.33 -158.11 0.75 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.702 0.287 . . . . 0.0 110.898 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -62.84 -34.96 78.42 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.341 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.458 ' HB3' ' CD1' ' A' ' 64' ' ' TYR . 0.5 OUTLIER -47.37 -58.0 4.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.079 -179.848 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.458 ' CD1' ' HB3' ' A' ' 63' ' ' ASP . 0.1 OUTLIER -175.2 100.58 0.08 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.721 179.778 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.24 -21.91 39.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.158 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.422 ' HG2' ' N ' ' A' ' 67' ' ' LEU . 0.1 OUTLIER -88.29 -29.1 20.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.129 -179.852 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.479 HD21 ' H ' ' A' ' 59' ' ' ALA . 20.8 mt 51.86 -153.23 0.21 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.486 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.423 ' O ' ' N ' ' A' ' 71' ' ' SER . 0.3 OUTLIER 179.56 -56.87 0.0 OUTLIER Pre-proline 0 C--N 1.333 -0.152 0 CA-C-O 120.731 0.3 . . . . 0.0 111.427 -179.992 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.406 ' HD3' ' HB3' ' A' ' 68' ' ' ARG . 85.8 Cg_exo -42.23 -27.99 0.81 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.673 2.249 . . . . 0.0 112.799 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.723 ' O ' HD12 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -85.89 -31.18 22.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.903 -179.783 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.423 ' N ' ' O ' ' A' ' 68' ' ' ARG . 35.0 t -47.45 -71.19 0.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.158 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.455 ' N ' ' CD1' ' A' ' 72' ' ' TYR . 0.0 OUTLIER 176.67 64.72 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.047 -179.855 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.98 172.9 11.99 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.51 2.14 . . . . 0.0 112.149 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 16.3 tp60 -87.98 10.2 19.71 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.495 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 12.3 t -52.35 161.13 0.7 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.783 0.325 . . . . 0.0 110.819 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -122.82 5.16 9.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.468 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.466 HG21 ' CA ' ' A' ' 176' ' ' ALA . 60.0 t -140.48 97.81 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.782 0.325 . . . . 0.0 111.117 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -95.59 -177.97 4.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.71 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.513 HD12 ' O ' ' A' ' 111' ' ' LEU . 10.7 tp -147.35 108.8 4.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.255 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.0 m -95.09 131.02 43.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.359 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.46 ' HB3' ' N7 ' ' A' ' 185' ' ' GNP . 2.6 m -127.08 134.67 50.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.922 0.391 . . . . 0.0 111.42 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.848 ' CE2' HD22 ' A' ' 112' ' ' LEU . 10.6 p90 -148.06 132.47 17.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.546 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.467 ' HA ' ' C2 ' ' A' ' 185' ' ' GNP . 0.5 OUTLIER -83.84 133.14 34.76 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.251 -179.675 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.88 HG23 ' HB2' ' A' ' 116' ' ' GLN . 59.5 t -42.45 -67.75 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.566 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.785 HG13 ' OE1' ' A' ' 116' ' ' GLN . 28.5 m -37.03 111.17 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-O 120.75 0.31 . . . . 0.0 111.379 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.798 ' N ' HD22 ' A' ' 129' ' ' LEU . 0.1 OUTLIER -151.5 139.24 12.62 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.828 -179.064 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.426 ' O ' ' CB ' ' A' ' 132' ' ' ASN . 91.6 Cg_endo -91.02 53.19 0.93 Allowed 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 123.189 2.592 . . . . 0.0 111.681 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.474 ' CA ' ' HB2' ' A' ' 133' ' ' LYS . 0.1 OUTLIER 70.68 19.45 6.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.077 -179.521 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.568 ' O ' HG23 ' A' ' 93' ' ' VAL . 1.4 m -97.23 -23.37 16.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.964 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -47.1 -48.48 22.87 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.183 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -51.94 -40.4 60.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.991 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.412 ' HA ' ' HB2' ' A' ' 95' ' ' GLU . 0.7 OUTLIER -76.62 -36.55 57.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.933 -179.873 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 89' ' ' SER . 62.9 t -51.09 -57.25 3.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.291 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.771 ' HG2' HD13 ' A' ' 145' ' ' LEU . 3.8 mptp? -73.6 -32.35 64.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.118 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.412 ' HB2' ' HA ' ' A' ' 92' ' ' ASN . 6.3 mm-40 -64.72 -23.99 67.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.093 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 93' ' ' VAL . 13.5 ptmt -108.35 -17.67 13.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.4 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.527 ' CE2' HG13 ' A' ' 93' ' ' VAL . 34.0 m0 -76.83 -54.4 6.65 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.765 0.317 . . . . 0.0 111.078 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.531 HG11 HD22 ' A' ' 149' ' ' LEU . 42.6 t -47.18 -50.15 48.55 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.841 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 62.2 Cg_endo -72.98 -16.19 25.81 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.145 1.897 . . . . 0.0 112.549 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -85.5 -39.63 17.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.906 0.384 . . . . 0.0 110.933 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 40.8 pt -71.58 -32.93 47.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.05 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 11.0 p -80.26 -32.69 38.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.908 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -64.73 -50.09 68.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.685 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -76.03 -33.08 59.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.855 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 41.6 m -125.92 101.18 29.68 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.832 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -44.33 93.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.55 2.167 . . . . 0.0 112.49 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.2 mmmm 53.95 103.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.85 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.424 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -138.55 129.21 15.22 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.753 179.915 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 108' ' ' THR . 31.6 Cg_exo -60.2 162.82 15.91 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.448 2.099 . . . . 0.0 112.25 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.837 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 7.6 p90 -162.9 150.57 13.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.947 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.92 HD12 HG11 ' A' ' 152' ' ' VAL . 9.7 tt -120.51 150.67 40.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.063 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.98 HD12 ' HB2' ' A' ' 146' ' ' ALA . 20.0 mt -108.03 156.19 19.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.813 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.897 HG13 HG11 ' A' ' 168' ' ' VAL . 3.8 t -130.92 148.82 33.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.913 0.387 . . . . 0.0 111.44 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.53 ' O ' HD11 ' A' ' 117' ' ' ILE . . . -123.54 84.85 0.37 Allowed Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.266 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.668 ' OG1' " H2'" ' A' ' 185' ' ' GNP . 0.7 OUTLIER -106.52 7.32 30.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.657 0.265 . . . . 0.0 111.667 -179.558 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.88 ' HB2' HG23 ' A' ' 84' ' ' VAL . 0.7 OUTLIER -98.07 -17.05 19.33 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.628 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.65 HD12 ' N ' ' A' ' 117' ' ' ILE . 0.2 OUTLIER -48.75 -24.11 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.831 179.238 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.14 -22.14 58.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.163 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.651 HD11 ' CD ' ' A' ' 116' ' ' GLN . 4.5 pp -122.45 -10.04 8.46 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.623 ' HD3' HG22 ' A' ' 117' ' ' ILE . 0.7 OUTLIER -50.44 -27.18 5.99 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.942 0.401 . . . . 0.0 110.719 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -77.32 -26.62 52.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.529 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 119' ' ' LEU . 9.0 m-20 -50.81 103.92 0.4 Allowed Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.639 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.401 ' HA ' ' CG2' ' A' ' 126' ' ' ILE . 15.1 Cg_exo -68.61 -3.99 12.24 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.8 2.334 . . . . 0.0 113.047 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 26.7 t -80.88 -67.42 0.78 Allowed 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.56 HG21 HG11 ' A' ' 85' ' ' VAL . 9.0 m -56.32 -32.74 64.92 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.408 0.623 . . . . 0.0 109.355 178.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.977 HD11 ' HB3' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -61.6 -43.33 96.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.466 179.196 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.479 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 7.0 mm-40 -56.2 -34.51 66.32 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.45 178.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.429 ' HB2' ' O ' ' A' ' 125' ' ' THR . 2.2 mptt -65.95 -32.95 74.74 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.798 HD22 ' N ' ' A' ' 86' ' ' SER . 6.8 mt -71.85 -39.3 69.79 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.488 ' HA ' ' HB3' ' A' ' 134' ' ' GLN . . . -48.01 -26.71 1.89 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.094 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.7 mmtp -64.69 -32.32 73.94 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.579 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.426 ' CB ' ' O ' ' A' ' 87' ' ' PRO . 47.8 m-80 -124.2 -30.99 3.38 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -179.186 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.492 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 0.0 OUTLIER -133.63 -73.16 0.49 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.345 -178.836 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.492 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 2.3 pt20 99.28 -33.42 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.866 0.866 . . . . 0.0 111.089 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -68.61 110.46 5.93 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.774 -178.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.977 ' HB3' HD11 ' A' ' 126' ' ' ILE . 72.4 Cg_endo -76.07 123.08 7.05 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.32 2.014 . . . . 0.0 111.355 179.049 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.68 ' N ' HD13 ' A' ' 137' ' ' ILE . 0.8 OUTLIER -57.38 96.36 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.549 -179.696 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.423 HG22 ' H ' ' A' ' 138' ' ' THR . 0.5 OUTLIER -72.56 150.22 91.2 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.737 -179.808 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.488 ' HG3' HG21 ' A' ' 117' ' ' ILE . 97.8 Cg_exo -41.35 -38.34 3.61 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.682 2.255 . . . . 0.0 112.586 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -65.63 -33.36 75.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.004 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.565 HG21 HG23 ' A' ' 137' ' ' ILE . 58.5 m -60.15 -63.77 1.18 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.952 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.57 ' HB1' ' CD2' ' A' ' 154' ' ' TYR . . . -48.73 -48.16 40.78 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.807 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -58.98 -37.24 76.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.449 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -60.51 -58.38 8.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.48 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.771 HD13 ' HG2' ' A' ' 94' ' ' LYS . 0.5 OUTLIER -63.78 -33.32 75.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.393 179.574 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.98 ' HB2' HD12 ' A' ' 112' ' ' LEU . . . -65.05 -34.39 78.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.697 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -90.5 -25.31 20.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.655 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -57.01 -33.09 66.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.827 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.531 HD22 HG11 ' A' ' 98' ' ' VAL . 0.3 OUTLIER -113.07 19.49 17.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.14 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt 47.91 40.31 12.58 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.196 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.837 ' HB1' ' O ' ' A' ' 110' ' ' PHE . . . -58.4 -80.97 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.069 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.92 HG11 HD12 ' A' ' 111' ' ' LEU . 55.6 t -160.52 -75.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.744 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 176.07 126.82 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.773 -179.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.57 ' CD2' ' HB1' ' A' ' 142' ' ' ALA . 6.0 t80 -96.78 111.02 23.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.08 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 2.6 t -101.76 152.43 5.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.867 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -91.78 127.05 37.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.24 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.457 ' HA ' ' HB3' ' A' ' 163' ' ' LYS . 1.1 p 179.31 126.92 0.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.988 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.499 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 87.7 p -100.38 153.9 18.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.399 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.588 ' HB2' HD21 ' A' ' 165' ' ' LEU . . . -94.09 -35.58 12.49 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.828 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.454 ' H ' HD12 ' A' ' 160' ' ' LEU . 1.2 mp -47.5 -41.74 21.54 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.641 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.4 HG22 ' OG ' ' A' ' 158' ' ' SER . 5.0 t -112.97 -16.94 12.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.738 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.405 ' O ' ' NE2' ' A' ' 162' ' ' GLN . 0.8 OUTLIER 72.86 70.88 0.13 Allowed 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.837 179.983 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.457 ' HB3' ' HA ' ' A' ' 157' ' ' CYS . 2.1 tttm -87.84 -20.02 26.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.21 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 168.19 37.32 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.74 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.831 HD12 ' CB ' ' A' ' 19' ' ' LEU . 0.5 OUTLIER -47.82 -39.62 18.86 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.762 0.315 . . . . 0.0 110.914 179.966 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 13.8 pttp -72.61 -32.92 66.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.793 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -54.56 -70.3 0.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.597 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.897 HG11 HG13 ' A' ' 113' ' ' VAL . 7.7 p -53.7 -46.52 62.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.08 0.467 . . . . 0.0 110.358 179.525 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.837 ' CD2' HD22 ' A' ' 19' ' ' LEU . 0.8 OUTLIER -55.37 -34.09 64.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.239 179.324 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.429 ' HA ' ' CG1' ' A' ' 173' ' ' ILE . 52.5 t0 -62.13 -43.65 98.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.277 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.547 ' CB ' HD11 ' A' ' 111' ' ' LEU . 62.8 mm-40 -62.48 -28.99 70.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.367 179.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.619 ' N ' HD13 ' A' ' 111' ' ' LEU . . . -78.73 -49.21 13.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.134 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.446 ' HB ' HD12 ' A' ' 4' ' ' ILE . 1.5 pp -72.05 -36.84 58.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.344 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.833 HD13 ' O ' ' A' ' 174' ' ' LEU . 3.1 tm? -63.08 -32.67 74.1 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.969 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.69 -22.47 62.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.026 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.466 ' CA ' HG21 ' A' ' 77' ' ' VAL . . . -87.76 -31.41 19.65 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.102 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.861 HD13 HG21 ' B' ' 510' ' ' ILE . 0.3 OUTLIER -92.7 15.27 14.86 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.278 -179.87 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 176.92 98.11 0.11 Allowed Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.692 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -46.8 102.93 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.654 2.236 . . . . 0.0 112.547 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.26 170.88 19.37 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.59 2.193 . . . . 0.0 112.37 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -146.01 139.28 14.47 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.782 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -77.96 -165.27 0.32 Allowed 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.553 2.168 . . . . 0.0 112.332 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.9 153.95 32.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.879 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 2.3 mtpt . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.892 179.88 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 502' ' ' GLY . . . . . 0.837 ' N ' ' HG ' ' B' ' 511' ' ' SER . . . . . . . . 0 N--CA 1.488 2.165 0 N-CA-C 112.458 -0.257 . . . . 0.0 112.458 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 503' ' ' SER . . . . . 0.401 ' HB3' ' OD2' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -75.8 -86.62 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.714 0.292 . . . . 0.0 110.726 179.91 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 504' ' ' GLY . . . . . 0.61 ' C ' HD23 ' B' ' 505' ' ' LEU . . . 63.46 119.75 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.259 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 505' ' ' LEU . . . . . 0.726 ' N ' HD23 ' B' ' 505' ' ' LEU . 0.8 OUTLIER -173.66 115.59 0.23 Allowed 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 120.811 0.339 . . . . 0.0 111.818 -178.374 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 506' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 79.0 -74.11 0.06 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.615 179.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 507' ' ' ALA . . . . . 0.436 ' HB3' HG12 ' B' ' 510' ' ' ILE . . . -35.26 -38.14 0.09 Allowed 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.436 0.636 . . . . 0.0 111.651 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 508' ' ' GLN . . . . . 0.519 ' O ' ' CB ' ' B' ' 509' ' ' ASP . 0.9 OUTLIER 159.47 -33.86 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.768 -1.105 . . . . 0.0 108.747 -179.677 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 509' ' ' ASP . . . . . 0.519 ' CB ' ' O ' ' B' ' 508' ' ' GLN . 27.0 t70 138.13 43.35 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 O-C-N 124.957 1.411 . . . . 0.0 109.704 179.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 510' ' ' ILE . . . . . 1.032 HG23 HG23 ' A' ' 46' ' ' ILE . 21.9 mm -60.4 107.63 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.701 179.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 511' ' ' SER . . . . . 0.837 ' HG ' ' N ' ' B' ' 502' ' ' GLY . 3.9 m -101.89 130.07 48.28 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.949 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 512' ' ' GLN . . . . . 0.513 ' CB ' ' HD3' ' B' ' 513' ' ' PRO . 1.2 mm-40 -79.75 -66.87 0.25 Allowed Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.539 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 513' ' ' PRO . . . . . 0.513 ' HD3' ' CB ' ' B' ' 512' ' ' GLN . 79.0 Cg_endo -82.25 56.29 5.72 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.573 2.182 . . . . 0.0 111.84 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 514' ' ' LEU . . . . . 0.502 ' HB2' ' HB ' ' A' ' 44' ' ' VAL . 0.7 OUTLIER -55.53 -84.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.047 -179.583 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 515' ' ' GLN . . . . . 0.501 ' HB2' HG12 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -90.62 -84.81 0.23 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.828 -179.982 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -110.68 -36.8 5.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.538 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 517' ' ' SER . . . . . 0.483 ' C ' HG12 ' A' ' 42' ' ' VAL . 15.4 m 52.58 27.23 4.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.205 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 518' ' ' PHE . . . . . 0.781 ' CE2' HD11 ' A' ' 21' ' ' ILE . 0.3 OUTLIER -163.54 91.59 0.68 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.365 -179.879 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 519' ' ' ILE . . . . . 0.461 HG12 ' HA ' ' A' ' 42' ' ' VAL . 4.7 mm -101.35 131.82 48.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.858 0.361 . . . . 0.0 110.901 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -54.16 108.43 0.37 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.993 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 521' ' ' THR . . . . . . . . . . . . . 3.5 m -166.25 143.53 5.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.941 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 522' ' ' GLY . . . . . . . . . . . . . . . 128.47 179.06 15.67 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.552 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 523' ' ' HIS . . . . . . . . . . . . . 74.8 t60 -148.52 -84.12 0.1 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.808 0.337 . . . . 0.0 110.962 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 524' ' ' GLY . . . . . . . . . . . . . . . 57.81 -169.81 4.25 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.595 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 525' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -110.58 88.02 2.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.902 0.382 . . . . 0.0 110.86 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 526' ' ' SER . . . . . . . . . . . . . 35.6 p -77.44 95.59 4.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.786 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 527' ' ' ASP . . . . . 0.485 ' H ' HG11 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -174.32 -64.71 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.956 179.632 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 528' ' ' PRO . . . . . 0.484 ' CD ' ' CB ' ' B' ' 527' ' ' ASP . 20.3 Cg_endo -58.01 78.83 0.04 OUTLIER 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.971 2.447 . . . . 0.0 112.368 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 529' ' ' ARG . . . . . 0.437 ' HD3' ' CG2' ' A' ' 33' ' ' VAL . 7.0 mtt85 -82.8 -31.96 27.94 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.698 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 530' ' ' HIS . . . . . . . . . . . . . 9.4 m170 51.92 24.01 2.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.82 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 16.5 p 41.78 -163.8 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.377 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 532' ' ' TRP . . . . . 0.502 ' CZ2' ' HA ' ' B' ' 537' ' ' ARG . 34.9 t-105 -169.48 127.82 0.96 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.982 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . -159.62 35.4 0.47 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.234 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 534' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -109.66 161.62 23.45 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 120.708 0.289 . . . . 0.0 111.065 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -57.38 -57.44 1.26 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.622 2.215 . . . . 0.0 112.203 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -123.38 157.82 32.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.011 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 537' ' ' ARG . . . . . 0.502 ' HA ' ' CZ2' ' B' ' 532' ' ' TRP . 24.6 mmt180 -66.94 145.48 55.39 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.153 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 538' ' ' ILE . . . . . 0.697 HG23 HD12 ' B' ' 543' ' ' LEU . 5.8 tp -59.93 143.71 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.633 179.088 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 539' ' ' ASP . . . . . 0.611 ' HB3' HD12 ' B' ' 541' ' ' LEU . 1.1 m-20 -42.7 128.33 4.08 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.812 0.339 . . . . 0.0 111.786 -179.05 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 540' ' ' GLU . . . . . 0.492 ' HA ' ' CD1' ' B' ' 543' ' ' LEU . 41.0 mm-40 -40.95 -24.47 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.27 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 541' ' ' LEU . . . . . 0.611 HD12 ' HB3' ' B' ' 539' ' ' ASP . 0.8 OUTLIER -31.12 -69.6 0.07 Allowed 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -179.251 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 542' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -104.45 -64.74 1.08 Allowed 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -178.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 543' ' ' LEU . . . . . 0.697 HD12 HG23 ' B' ' 538' ' ' ILE . 10.2 mp 58.37 179.5 0.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.739 0.304 . . . . 0.0 110.388 -178.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . -172.91 -54.84 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.503 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 545' ' ' ASN . . . . . . . . . . . . . 42.6 p30 . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.81 179.877 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' GNP . . . . . 0.677 ' N3 ' " H2'" ' A' ' 185' ' ' GNP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.439 ' CE ' ' HB ' ' A' ' 46' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.873 0.368 . . . . 0.0 111.107 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.432 ' O ' ' CD2' ' A' ' 177' ' ' LEU . 5.4 tt0 -174.71 130.66 0.33 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.695 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.925 HG23 HD12 ' A' ' 46' ' ' ILE . 0.6 OUTLIER -116.86 -173.7 2.44 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.246 -179.591 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.704 ' H ' HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -151.38 163.27 2.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.769 -178.541 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.65 156.23 17.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.766 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.433 ' SG ' ' CZ ' ' A' ' 169' ' ' PHE . 0.0 OUTLIER -118.57 141.51 48.52 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.278 -179.755 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.1 t -148.34 159.77 7.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.669 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.83 HG22 ' HA3' ' A' ' 15' ' ' GLY . 16.3 t -119.38 151.76 21.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.238 0.542 . . . . 0.0 111.753 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 86.2 t -156.19 130.05 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.044 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.89 -140.52 14.74 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.197 -1.002 . . . . 0.0 112.836 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' B' ' 537' ' ' ARG . 3.4 m-20 -123.23 27.85 7.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.657 0.265 . . . . 0.0 110.934 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -118.23 177.54 16.53 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.961 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.937 ' HB2' ' O2A' ' A' ' 185' ' ' GNP . . . -103.51 -26.85 12.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.775 0.322 . . . . 0.0 111.515 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.967 HG11 HG21 ' A' ' 113' ' ' VAL . 54.1 t -43.12 94.58 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 121.006 0.431 . . . . 0.0 111.418 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.83 ' HA3' HG22 ' A' ' 8' ' ' VAL . . . 132.89 -23.47 3.94 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.026 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.758 ' CG ' HG21 ' A' ' 8' ' ' VAL . 14.7 mttt -90.3 -159.13 0.58 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.767 0.318 . . . . 0.0 110.709 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.45 ' HB ' ' CG1' ' A' ' 21' ' ' ILE . 31.5 p -66.46 -44.91 81.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.392 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.585 ' HB3' ' HB1' ' A' ' 13' ' ' ALA . 43.3 t -33.26 -58.54 0.39 Allowed 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.562 HD13 ' CG ' ' A' ' 169' ' ' PHE . 13.8 mt -42.2 -67.93 0.23 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.718 -179.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.468 ' N ' ' CD2' ' A' ' 20' ' ' LEU . 1.5 mm? -72.43 -25.73 61.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.444 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.45 ' CG1' ' HB ' ' A' ' 17' ' ' THR . 20.7 mm -70.83 -68.2 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.765 0.317 . . . . 0.0 110.565 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 27.1 t -57.77 -25.74 60.92 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.983 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.811 ' HB2' HD13 ' A' ' 165' ' ' LEU . 4.4 t80 -80.1 -68.52 0.67 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.005 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 97.8 m -70.26 -48.64 55.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.031 0.444 . . . . 0.0 110.658 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.446 HG22 ' H ' ' A' ' 26' ' ' ASN . 0.2 OUTLIER -77.48 -156.04 0.08 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.646 179.876 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.446 ' H ' HG22 ' A' ' 25' ' ' THR . 0.2 OUTLIER -149.7 40.13 0.81 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.719 0.295 . . . . 0.0 110.805 -179.935 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.4 mtmt -133.51 126.88 32.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.969 0.414 . . . . 0.0 111.369 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.501 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . 3.6 t80 -163.66 -53.44 0.01 OUTLIER Pre-proline 0 CA--C 1.536 0.437 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.947 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.501 ' HD3' ' HB3' ' A' ' 28' ' ' PHE . 5.7 Cg_exo -79.55 56.44 6.05 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.774 2.316 . . . . 0.0 112.418 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.7 m -143.54 -80.03 0.2 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.755 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -157.69 162.43 38.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.593 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.528 ' CD2' ' N3B' ' A' ' 185' ' ' GNP . 9.3 m-85 -131.55 94.6 3.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.967 0.413 . . . . 0.0 111.108 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.534 HG11 ' HG3' ' B' ' 529' ' ' ARG . 0.2 OUTLIER -133.05 -56.2 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.666 179.703 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.464 ' O ' ' CZ ' ' A' ' 37' ' ' PHE . 7.8 Cg_exo -72.17 59.08 2.99 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.346 2.031 . . . . 0.0 111.983 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.588 HG23 HD23 ' B' ' 543' ' ' LEU . 5.8 t -120.53 21.89 11.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.88 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.024 HG22 HD13 ' A' ' 61' ' ' LEU . 2.4 t -83.84 -4.75 8.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.648 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.464 ' CZ ' ' O ' ' A' ' 34' ' ' PRO . 4.2 m-85 -46.03 -27.7 1.0 Allowed 'General case' 0 N--CA 1.461 0.099 0 CA-C-O 120.813 0.34 . . . . 0.0 111.108 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.419 ' HA ' ' HB3' ' A' ' 57' ' ' ASP . 6.8 t0 69.26 33.07 3.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.642 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.422 ' CB ' ' O ' ' A' ' 55' ' ' LEU . 8.3 m120 52.01 87.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.609 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.473 ' OH ' ' CZ ' ' B' ' 518' ' ' PHE . 3.2 p90 -59.98 -175.73 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.707 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.408 ' O ' HG12 ' B' ' 519' ' ' ILE . . . -90.77 160.5 15.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.055 0.455 . . . . 0.0 111.823 -179.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.494 HG12 ' C ' ' B' ' 517' ' ' SER . 3.5 m -127.25 128.19 69.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.621 179.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.701 ' H ' HD11 ' B' ' 519' ' ' ILE . 59.1 p -85.59 104.76 15.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.943 0.401 . . . . 0.0 111.17 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.767 ' CG2' HG21 ' A' ' 52' ' ' THR . 20.7 m -157.79 -177.7 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.859 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.512 ' HG3' HD22 ' B' ' 514' ' ' LEU . 0.0 OUTLIER -128.03 116.93 20.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.349 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.925 HD12 HG23 ' A' ' 3' ' ' THR . 0.8 OUTLIER -81.98 87.65 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.676 0.274 . . . . 0.0 111.668 -179.865 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 56.87 -78.08 0.01 OUTLIER Glycine 0 C--N 1.333 0.374 0 CA-C-N 116.105 -0.498 . . . . 0.0 113.776 178.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . -54.0 -99.78 0.01 OUTLIER Glycine 0 C--N 1.331 0.285 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.979 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.478 ' CA ' ' HE3' ' A' ' 45' ' ' MET . 0.6 OUTLIER -119.72 164.26 22.99 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 120.878 0.37 . . . . 0.0 111.396 -179.617 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.76 100.93 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.699 2.266 . . . . 0.0 112.596 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.464 ' CD1' ' OG1' ' A' ' 3' ' ' THR . 12.3 t80 -172.84 106.61 0.16 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.361 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.767 HG21 ' CG2' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -124.43 153.78 41.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.939 0.399 . . . . 0.0 111.038 -179.92 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.653 HD12 ' N ' ' A' ' 4' ' ' ILE . 82.7 mt -113.44 100.0 8.19 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.863 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -46.17 164.13 0.11 Allowed Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.396 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.551 ' H ' HD12 ' A' ' 55' ' ' LEU . 2.4 mp -79.66 152.87 29.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.71 0.29 . . . . 0.0 110.847 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.422 ' CB ' ' O ' ' A' ' 6' ' ' CYS . 0.3 OUTLIER -103.32 122.05 44.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.524 -179.52 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.419 ' HB3' ' HA ' ' A' ' 38' ' ' ASP . 0.2 OUTLIER -127.65 167.0 17.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.36 179.367 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.701 ' HB ' HD11 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -149.41 128.72 12.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.905 0.383 . . . . 0.0 111.122 -179.444 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.691 ' HB3' ' HA ' ' A' ' 36' ' ' VAL . . . -144.86 100.73 3.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.664 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.406 ' HA2' ' O ' ' A' ' 64' ' ' TYR . . . -70.65 83.05 0.38 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.717 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 1.024 HD13 HG22 ' A' ' 36' ' ' VAL . 3.9 mp -121.5 -108.36 0.35 Allowed 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.564 0.182 . . . . 0.0 111.027 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -99.03 -30.02 12.57 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 120.827 0.346 . . . . 0.0 111.167 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.9 -63.32 1.19 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.442 -179.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.462 ' HE1' HG12 ' A' ' 36' ' ' VAL . 0.4 OUTLIER -107.62 120.6 42.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.94 -179.624 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -87.16 -53.39 4.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 112.029 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.21 8.8 44.28 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -178.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.813 HD23 ' O ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -47.46 110.68 0.33 Allowed 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 120.728 0.299 . . . . 0.0 110.667 179.625 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.671 ' HG2' HD11 ' B' ' 541' ' ' LEU . 0.0 OUTLIER -149.97 70.92 9.45 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.235 -179.788 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.668 ' CG ' HG21 ' A' ' 58' ' ' THR . 88.9 Cg_endo -81.02 -37.07 0.33 Allowed 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.591 2.194 . . . . 0.0 112.455 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.917 ' O ' HD12 ' A' ' 70' ' ' LEU . 0.1 OUTLIER -58.83 -18.2 30.36 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.002 -179.939 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.463 ' HB3' ' CD2' ' A' ' 72' ' ' TYR . 0.3 OUTLIER -43.34 -50.44 6.7 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.389 -179.962 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.463 ' CD2' ' HB3' ' A' ' 71' ' ' SER . 5.6 p90 -165.2 70.9 1.39 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.289 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -70.01 153.36 67.85 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.881 2.387 . . . . 0.0 112.063 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 -102.42 10.28 39.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.568 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 14.1 t -57.49 178.63 0.07 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.844 0.354 . . . . 0.0 110.986 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -115.85 -18.74 10.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.282 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.5 m -118.94 91.1 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.755 0.312 . . . . 0.0 111.284 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -81.14 121.64 26.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.486 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.594 HD11 ' CG1' ' A' ' 14' ' ' VAL . 0.1 OUTLIER -83.48 108.52 16.67 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.953 0.406 . . . . 0.0 111.236 -179.675 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.719 ' O ' HD13 ' A' ' 112' ' ' LEU . 3.3 m -110.25 100.7 11.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.887 179.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.452 ' HB2' ' N7 ' ' A' ' 185' ' ' GNP . 0.5 OUTLIER -113.37 146.94 38.65 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.536 -179.187 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.466 ' O ' ' N1 ' ' A' ' 185' ' ' GNP . 6.3 p90 -155.48 143.05 19.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.216 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.416 ' HA ' ' C2 ' ' A' ' 185' ' ' GNP . 0.1 OUTLIER -81.96 133.4 35.3 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.112 0.482 . . . . 0.0 111.188 -179.472 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.664 HG23 ' HB2' ' A' ' 116' ' ' GLN . 89.2 t -48.5 -69.6 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.551 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.72 HG22 ' OE1' ' A' ' 116' ' ' GLN . 16.0 m -40.84 110.45 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 120.742 0.306 . . . . 0.0 111.332 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.629 ' N ' HD21 ' A' ' 129' ' ' LEU . 52.4 p -154.36 134.03 7.69 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.772 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.435 ' O ' ' HB2' ' A' ' 133' ' ' LYS . 20.0 Cg_endo -61.21 -81.76 0.01 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 121.909 1.739 . . . . 0.0 111.408 179.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.9 t -144.87 24.55 1.49 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.832 0.349 . . . . 0.0 110.966 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.518 ' O ' HG23 ' A' ' 93' ' ' VAL . 1.7 t -93.44 -21.88 19.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.176 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -48.41 -49.01 36.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.178 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -57.84 -40.6 80.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.996 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 17.5 m-20 -67.42 -50.03 61.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.903 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.606 HG13 ' CE2' ' A' ' 97' ' ' TRP . 47.2 t -51.47 -52.37 20.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.193 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.662 ' O ' HG23 ' A' ' 98' ' ' VAL . 2.3 tttp -52.31 -54.68 28.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.022 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.405 ' O ' ' HG2' ' A' ' 99' ' ' PRO . 50.7 mt-10 -78.66 3.11 17.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.829 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.5 ttmm -115.2 -19.07 10.96 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.721 0.296 . . . . 0.0 111.184 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.606 ' CE2' HG13 ' A' ' 93' ' ' VAL . 27.9 m0 -93.74 -51.4 4.93 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.199 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 94' ' ' LYS . 16.8 t -49.68 -44.98 78.71 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.706 -179.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.501 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 3.6 Cg_exo -74.88 -16.49 20.51 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.641 2.228 . . . . 0.0 112.612 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -90.19 -53.64 4.37 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.841 0.353 . . . . 0.0 110.976 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.514 ' CD1' ' CE2' ' A' ' 110' ' ' PHE . 1.0 OUTLIER -56.61 -24.2 18.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.151 179.997 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.7 p -88.8 -45.66 9.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.861 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -50.13 -32.68 16.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.959 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -79.52 -26.97 41.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.021 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -151.59 104.88 2.89 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.977 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -49.67 108.8 0.22 Allowed 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.397 2.065 . . . . 0.0 112.09 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 67.7 93.07 0.08 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.747 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.05 119.4 10.5 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.034 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -60.67 154.4 55.1 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.534 2.156 . . . . 0.0 112.438 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.514 ' CE2' ' CD1' ' A' ' 101' ' ' ILE . 1.2 p90 -151.53 147.85 27.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.864 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.807 HD12 HG11 ' A' ' 152' ' ' VAL . 0.8 OUTLIER -110.38 160.67 16.37 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.417 -179.595 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.719 HD13 ' O ' ' A' ' 80' ' ' VAL . 2.5 mm? -123.48 161.19 25.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.586 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.967 HG21 HG11 ' A' ' 14' ' ' VAL . 21.6 t -139.6 143.57 30.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.974 0.416 . . . . 0.0 111.912 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.442 ' O ' ' CD1' ' A' ' 117' ' ' ILE . . . -119.54 92.03 0.52 Allowed Glycine 0 C--N 1.331 0.297 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.005 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.687 ' OG1' " H2'" ' A' ' 185' ' ' GNP . 0.6 OUTLIER -117.25 9.51 13.48 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -178.836 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.72 ' OE1' HG22 ' A' ' 85' ' ' VAL . 1.9 mm-40 -114.74 11.97 16.94 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.879 0.371 . . . . 0.0 110.323 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.763 HD11 ' O ' ' A' ' 157' ' ' CYS . 0.1 OUTLIER -57.97 -17.37 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.718 179.043 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -100.13 -17.3 17.48 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.544 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.57 HD13 ' HA ' ' A' ' 116' ' ' GLN . 5.5 mp -91.79 -32.58 15.31 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.775 0.321 . . . . 0.0 110.992 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.541 ' O ' HD13 ' A' ' 126' ' ' ILE . 1.0 OUTLIER -42.44 -52.42 4.66 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.361 -179.916 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.49 -42.59 98.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.58 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -45.37 102.79 0.31 Allowed Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.886 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.469 ' HA ' ' CG2' ' A' ' 126' ' ' ILE . 42.8 Cg_endo -68.6 -6.88 18.86 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.409 2.073 . . . . 0.0 112.947 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.34 -66.15 0.58 Allowed 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.045 0.45 . . . . 0.0 109.853 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.706 HG22 ' CD1' ' A' ' 129' ' ' LEU . 49.2 m -60.62 -49.37 77.79 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.776 HD11 ' HD3' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -47.3 -36.98 4.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.001 179.566 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.603 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 0.2 OUTLIER -62.59 -40.85 98.23 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.694 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.455 ' N ' ' O ' ' A' ' 125' ' ' THR . 0.2 OUTLIER -65.06 -33.73 76.74 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 177.992 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.706 ' CD1' HG22 ' A' ' 125' ' ' THR . 7.3 mp -68.83 -40.65 79.33 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 177.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.603 ' HB3' ' O ' ' A' ' 127' ' ' GLU . . . -44.9 -31.37 1.23 Allowed 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.587 179.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -51.41 -27.27 9.63 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.986 179.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.468 ' O ' ' CG ' ' A' ' 133' ' ' LYS . 1.2 m-80 -123.3 -34.67 3.08 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.211 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.484 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 46.7 mttt -169.65 -86.21 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 O-C-N 123.107 0.255 . . . . 0.0 111.641 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.484 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 0.1 OUTLIER 102.49 106.7 0.01 OUTLIER 'General case' 0 C--N 1.351 0.638 0 C-N-CA 124.37 1.068 . . . . 0.0 110.38 -179.284 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.5 mmtm -159.38 92.44 1.84 Allowed Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.329 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.776 ' HD3' HD11 ' A' ' 126' ' ' ILE . 21.1 Cg_endo -62.12 103.22 0.29 Allowed 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 122.252 1.968 . . . . 0.0 112.306 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.831 HG22 ' HB ' ' A' ' 141' ' ' THR . 1.5 mm -45.31 106.56 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.443 179.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.421 ' O ' ' N ' ' A' ' 141' ' ' THR . 1.6 p -67.19 141.25 96.07 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.342 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -40.42 -29.77 0.42 Allowed 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.901 2.4 . . . . 0.0 112.015 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.35 -41.12 94.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.556 179.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.831 ' HB ' HG22 ' A' ' 137' ' ' ILE . 47.0 m -57.39 -66.61 0.43 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.009 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.523 ' HB3' ' CE2' ' A' ' 154' ' ' TYR . . . -47.7 -49.31 28.27 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.887 0.375 . . . . 0.0 110.919 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -64.16 -33.92 76.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.432 179.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 15.6 tttt -73.71 -46.63 44.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.631 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 14.5 tp -68.24 -39.91 82.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.208 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -62.11 -35.82 79.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.666 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.7 mtp180 -90.32 -29.86 17.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.666 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -50.79 -29.52 11.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.733 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.5 mt -123.02 21.09 9.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.91 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 45.5 mttt 48.08 52.24 13.45 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.943 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.714 ' O ' HG23 ' A' ' 152' ' ' VAL . . . -59.17 -83.37 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.032 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.807 HG11 HD12 ' A' ' 111' ' ' LEU . 19.1 t -166.33 -68.38 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.285 179.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.04 144.04 2.06 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.144 0.497 . . . . 0.0 111.824 -179.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.523 ' CE2' ' HB3' ' A' ' 142' ' ' ALA . 37.1 t80 -135.96 102.57 5.08 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.733 ' HB ' HG22 ' A' ' 168' ' ' VAL . 2.3 t -105.93 167.87 3.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.328 -178.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.526 ' H ' HG12 ' A' ' 155' ' ' VAL . 5.5 tt0 -89.58 118.6 29.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.126 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.763 ' O ' HD11 ' A' ' 117' ' ' ILE . 17.9 p -144.92 -175.79 4.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.174 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 3.1 m -159.61 158.29 31.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.965 0.412 . . . . 0.0 111.576 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -115.44 -33.41 5.27 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.464 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.46 HD23 ' H ' ' A' ' 160' ' ' LEU . 0.2 OUTLIER -81.19 -34.85 32.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.65 179.699 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.0 t -113.0 -24.65 9.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.925 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 72.6 93.92 0.08 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.045 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -124.93 33.11 5.27 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.133 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 120.87 47.79 0.31 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.762 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.811 HD13 ' HB2' ' A' ' 23' ' ' TYR . 0.8 OUTLIER -56.52 -56.24 23.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.822 0.344 . . . . 0.0 110.745 179.838 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.403 ' O ' ' CB ' ' A' ' 170' ' ' ASP . 4.8 pttt -63.44 -29.14 70.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.805 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -51.54 -72.31 0.05 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.9 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.854 HG11 HG22 ' A' ' 113' ' ' VAL . 61.8 t -56.59 -53.36 42.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.994 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.562 ' CG ' HD13 ' A' ' 19' ' ' LEU . 3.2 t80 -53.24 -35.82 60.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.871 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.403 ' CB ' ' O ' ' A' ' 166' ' ' LYS . 5.3 m-20 -61.4 -40.34 94.02 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.915 0.388 . . . . 0.0 109.995 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.622 ' CB ' HD11 ' A' ' 111' ' ' LEU . 7.6 mm-40 -60.6 -34.89 74.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.163 179.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.513 ' CB ' HD21 ' A' ' 79' ' ' LEU . . . -62.01 -65.0 0.76 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.68 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.56 HD13 ' HG2' ' B' ' 512' ' ' GLN . 1.4 pp -59.76 -41.53 85.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.985 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.761 HD11 ' HB3' ' B' ' 506' ' ' SER . 5.2 tp -60.37 -43.77 96.25 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.006 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -54.61 -22.33 13.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.943 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -86.49 -37.78 17.92 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.122 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 1.058 HD13 HG21 ' B' ' 510' ' ' ILE . 1.9 mt -72.94 -35.88 67.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.897 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -141.79 139.46 18.42 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.949 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.45 ' HA ' ' HD2' ' A' ' 180' ' ' PRO . 53.6 Cg_endo -69.83 111.61 2.87 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.545 2.163 . . . . 0.0 112.286 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . 0.45 ' HD2' ' HA ' ' A' ' 179' ' ' PRO . 33.4 Cg_endo -64.35 167.05 15.55 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.355 2.036 . . . . 0.0 112.211 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -102.79 96.38 7.61 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.142 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 180' ' ' PRO . 81.0 Cg_endo -76.64 -164.93 0.28 Allowed 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.702 2.268 . . . . 0.0 112.208 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.53 83.16 4.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.901 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 14.6 mttm . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.892 179.967 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.174 0 N-CA-C 112.435 -0.266 . . . . 0.0 112.435 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 503' ' ' SER . . . . . . . . . . . . . 1.4 m -61.39 -177.23 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.812 0.339 . . . . 0.0 110.799 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 504' ' ' GLY . . . . . 0.592 ' HA2' HD22 ' A' ' 174' ' ' LEU . . . -99.78 65.27 0.62 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.387 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 505' ' ' LEU . . . . . 0.504 ' O ' HD21 ' A' ' 174' ' ' LEU . 0.3 OUTLIER -108.92 159.89 16.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.05 0.453 . . . . 0.0 111.197 -179.971 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 506' ' ' SER . . . . . 0.761 ' HB3' HD11 ' A' ' 174' ' ' LEU . 11.3 t 165.8 -44.63 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.539 -179.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 507' ' ' ALA . . . . . 0.599 ' HB3' HG12 ' B' ' 510' ' ' ILE . . . -47.98 -28.31 2.68 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.159 178.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 508' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 167.17 -31.82 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.373 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 509' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 172.2 37.58 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.927 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 510' ' ' ILE . . . . . 1.058 HG21 HD13 ' A' ' 177' ' ' LEU . 46.9 mm -67.53 103.24 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.913 0.387 . . . . 0.0 111.286 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 511' ' ' SER . . . . . . . . . . . . . 2.1 m -101.43 131.79 47.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.921 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 512' ' ' GLN . . . . . 0.56 ' HG2' HD13 ' A' ' 173' ' ' ILE . 0.4 OUTLIER -93.41 -64.28 0.14 Allowed Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.144 -179.919 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 513' ' ' PRO . . . . . 0.49 ' HD3' ' CB ' ' B' ' 512' ' ' GLN . 89.4 Cg_endo -81.36 67.88 8.35 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.516 2.144 . . . . 0.0 112.521 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 514' ' ' LEU . . . . . 0.512 HD22 ' HG3' ' A' ' 45' ' ' MET . 0.4 OUTLIER -81.16 -85.21 0.1 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.914 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 515' ' ' GLN . . . . . 0.411 ' HB2' HG12 ' A' ' 44' ' ' VAL . 2.3 mt-30 -93.22 -158.9 0.64 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.671 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -46.97 -27.85 1.42 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.026 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 517' ' ' SER . . . . . 0.494 ' C ' HG12 ' A' ' 42' ' ' VAL . 3.0 m 40.65 42.72 1.45 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.719 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 518' ' ' PHE . . . . . 0.473 ' CZ ' ' OH ' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -163.76 91.88 0.67 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.927 -179.951 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 519' ' ' ILE . . . . . 0.701 HD11 ' H ' ' A' ' 43' ' ' THR . 6.2 mm -87.89 -33.74 6.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.748 0.309 . . . . 0.0 111.18 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 520' ' ' HIS . . . . . 0.467 ' HA ' ' CE2' ' A' ' 40' ' ' TYR . 0.7 OUTLIER 69.72 119.37 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.898 179.994 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 521' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -165.98 51.83 0.09 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.981 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 522' ' ' GLY . . . . . . . . . . . . . . . -138.26 157.62 24.51 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.445 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 523' ' ' HIS . . . . . . . . . . . . . 69.4 t60 -132.61 -84.74 0.47 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.662 0.268 . . . . 0.0 111.028 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 524' ' ' GLY . . . . . 0.408 ' HA3' ' HB ' ' A' ' 36' ' ' VAL . . . 66.22 176.67 7.14 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.465 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 525' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -75.05 87.42 2.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.89 0.376 . . . . 0.0 110.837 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 526' ' ' SER . . . . . 0.423 ' CB ' ' HB3' ' A' ' 34' ' ' PRO . 1.1 m -89.62 95.98 10.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.884 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 527' ' ' ASP . . . . . 0.496 ' O ' HG21 ' A' ' 33' ' ' VAL . 0.2 OUTLIER -159.13 145.71 12.58 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.939 179.864 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -68.83 105.59 1.35 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.705 2.27 . . . . 0.0 112.348 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 529' ' ' ARG . . . . . 0.534 ' HG3' HG11 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -100.31 -55.13 2.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.051 -179.885 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 530' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -165.89 97.63 0.64 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.846 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 95.5 m -46.27 171.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.121 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 532' ' ' TRP . . . . . 0.475 ' CZ2' ' HG3' ' B' ' 537' ' ' ARG . 0.0 OUTLIER -49.65 158.03 0.5 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.0 -179.886 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . -155.71 -56.82 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.534 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 534' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -94.35 142.73 25.25 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.742 0.306 . . . . 0.0 111.052 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.29 74.09 1.56 Allowed 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.63 2.22 . . . . 0.0 112.308 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 2.8 p30 172.73 143.56 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.671 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 537' ' ' ARG . . . . . 0.475 ' HG3' ' CZ2' ' B' ' 532' ' ' TRP . 2.0 mpt_? -92.85 179.93 5.32 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.203 0.525 . . . . 0.0 111.172 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 538' ' ' ILE . . . . . 0.648 HG23 HD12 ' B' ' 543' ' ' LEU . 5.0 tp -118.06 134.87 60.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.196 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 539' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -50.86 145.19 7.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.61 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 540' ' ' GLU . . . . . 0.415 ' HB3' ' OG1' ' A' ' 58' ' ' THR . 61.2 mt-10 -45.69 -44.72 13.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.454 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 541' ' ' LEU . . . . . 0.75 ' HB2' HD23 ' A' ' 70' ' ' LEU . 1.7 tt -48.43 -40.28 25.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.432 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 542' ' ' TYR . . . . . 0.476 ' HB2' HG13 ' B' ' 538' ' ' ILE . 63.2 m-85 -102.49 9.25 39.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.931 -179.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 543' ' ' LEU . . . . . 0.883 HD11 ' O1G' ' A' ' 185' ' ' GNP . 3.1 tp -58.64 95.74 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.781 0.324 . . . . 0.0 110.71 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . 176.23 89.09 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.506 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 545' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.854 179.935 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' GNP . . . . . 0.937 ' O2A' ' HB2' ' A' ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.401 ' HB2' ' HG3' ' A' ' 49' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.375 0 CA-C-O 120.761 0.315 . . . . 0.0 111.222 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -111.19 127.03 55.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.219 0.533 . . . . 0.0 110.948 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.548 HG21 ' OH ' ' A' ' 51' ' ' TYR . 36.8 m -104.19 158.2 16.61 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.739 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.836 ' CD1' HD13 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -155.25 160.34 2.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.852 -179.587 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.04 140.43 46.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.631 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.4 p -138.11 124.53 20.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.908 0.385 . . . . 0.0 111.573 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.1 t -114.04 136.57 50.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.45 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.59 HG13 ' HG2' ' B' ' 540' ' ' GLU . 2.8 p -84.84 113.52 23.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.952 0.406 . . . . 0.0 111.125 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.0 p -117.69 129.57 73.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.893 178.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.498 ' HA2' ' CE2' ' A' ' 97' ' ' TRP . . . 133.57 -160.35 23.97 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.267 -0.968 . . . . 0.0 112.455 -179.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -92.9 21.99 5.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.726 0.298 . . . . 0.0 111.047 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.407 ' HA3' ' HB2' ' A' ' 81' ' ' CYS . . . -76.14 160.2 51.05 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.538 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.553 ' HB1' ' O2A' ' A' ' 185' ' ' GNP . . . -53.27 -57.3 11.0 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.489 0.185 . . . . 0.0 111.296 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.726 HG13 ' H ' ' A' ' 18' ' ' CYS . 2.6 p 154.88 94.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 O-C-N 123.75 0.656 . . . . 0.0 109.908 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.599 ' HA2' HD11 ' A' ' 19' ' ' LEU . . . -47.82 -22.79 2.11 Favored Glycine 0 CA--C 1.519 0.305 0 CA-C-N 115.844 -0.616 . . . . 0.0 113.502 -179.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.449 ' HG2' ' HB2' ' A' ' 55' ' ' LEU . 1.6 tmtm? -70.68 -59.74 2.65 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 122.544 -0.386 . . . . 0.0 111.676 -179.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.591 ' CG2' HG23 ' A' ' 35' ' ' THR . 1.2 p -97.34 -39.43 9.22 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -178.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.726 ' H ' HG13 ' A' ' 14' ' ' VAL . 44.6 t -33.74 -73.49 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.71 ' CB ' HD22 ' A' ' 165' ' ' LEU . 0.3 OUTLIER -65.34 -68.22 0.38 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.827 -179.377 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.54 HD23 ' N ' ' A' ' 20' ' ' LEU . 3.5 mt -49.0 -70.22 0.1 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.802 -179.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.474 HG22 ' O ' ' A' ' 17' ' ' THR . 1.1 tp -43.09 -48.49 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-O 120.817 0.341 . . . . 0.0 111.619 -179.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.422 ' OG ' ' ND2' ' A' ' 26' ' ' ASN . 35.2 t -62.48 -29.19 70.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.916 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.409 ' N ' ' O ' ' A' ' 20' ' ' LEU . 20.1 t80 -75.34 -37.43 60.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.949 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.616 HG23 HG23 ' A' ' 25' ' ' THR . 10.1 t -87.23 -49.8 7.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.06 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.616 HG23 HG23 ' A' ' 24' ' ' THR . 77.6 p -94.06 -61.77 1.47 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.88 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.422 ' ND2' ' OG ' ' A' ' 22' ' ' SER . 2.4 t-20 72.38 41.46 0.6 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.005 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -100.71 69.75 1.39 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.706 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.508 ' CE1' " H4'" ' A' ' 185' ' ' GNP . 35.3 t80 -86.77 -45.59 0.54 Allowed Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.647 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.485 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 92.7 Cg_endo -82.22 73.41 5.66 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.354 2.036 . . . . 0.0 112.481 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.3 m -172.06 -85.34 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.982 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -158.29 164.57 36.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.016 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.513 ' CE2' ' N3B' ' A' ' 185' ' ' GNP . 10.2 m-85 -130.86 124.17 30.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.488 ' HB ' ' HD3' ' A' ' 34' ' ' PRO . 1.5 t -157.1 -53.61 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.772 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.488 ' HD3' ' HB ' ' A' ' 33' ' ' VAL . 5.4 Cg_exo -74.84 56.4 4.15 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.458 2.105 . . . . 0.0 112.292 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.591 HG23 ' CG2' ' A' ' 17' ' ' THR . 18.7 m -106.95 -20.64 13.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.844 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.953 HG12 ' CB ' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -42.38 -65.13 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.767 -0.197 . . . . 0.0 110.863 179.8 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.447 ' H ' HG23 ' A' ' 36' ' ' VAL . 10.8 m-85 33.92 -88.4 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.684 0.615 . . . . 0.0 112.171 179.091 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.473 ' N ' ' O ' ' A' ' 36' ' ' VAL . 96.9 m-20 65.29 -65.46 0.16 Allowed 'General case' 0 CA--C 1.527 0.087 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.584 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.437 ' N ' ' O ' ' A' ' 37' ' ' PHE . 1.1 p-10 -71.7 -4.49 27.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.772 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.485 ' CE2' ' CZ ' ' B' ' 518' ' ' PHE . 0.4 OUTLIER -59.78 95.36 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.925 0.393 . . . . 0.0 110.302 179.793 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.687 ' O ' HD13 ' B' ' 519' ' ' ILE . . . -90.36 -179.37 5.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.11 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.639 HG23 HG21 ' A' ' 52' ' ' THR . 34.5 m -144.12 161.04 15.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.083 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.8 p -125.48 105.87 9.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.173 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.911 HG22 ' CG2' ' A' ' 52' ' ' THR . 19.2 m -156.32 -177.55 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.086 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.461 ' HE1' ' N ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -100.79 97.44 8.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.532 -179.486 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 1.008 HG23 HG23 ' B' ' 510' ' ' ILE . 1.5 mm -70.91 91.08 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-O 120.824 0.345 . . . . 0.0 110.242 179.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 38.62 -91.81 0.01 OUTLIER Glycine 0 CA--C 1.519 0.337 0 CA-C-N 116.002 -0.545 . . . . 0.0 113.654 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . -39.85 -82.93 0.01 OUTLIER Glycine 0 C--N 1.333 0.374 0 C-N-CA 121.457 -0.402 . . . . 0.0 113.406 -179.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.461 ' N ' ' HE1' ' A' ' 45' ' ' MET . 2.7 mt-10 -133.99 165.7 34.75 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.786 0.327 . . . . 0.0 111.402 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.461 ' HD2' ' HB3' ' A' ' 49' ' ' GLU . 82.7 Cg_exo -48.36 104.69 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.6 2.2 . . . . 0.0 112.955 -179.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.548 ' OH ' HG21 ' A' ' 3' ' ' THR . 14.1 t80 -172.46 155.59 3.48 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.275 179.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.911 ' CG2' HG22 ' A' ' 44' ' ' VAL . 1.8 p -138.31 153.34 49.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.18 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.836 HD13 ' CD1' ' A' ' 4' ' ' ILE . 0.3 OUTLIER -110.47 99.36 8.37 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.835 179.716 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -50.97 -179.17 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.366 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.449 ' HB2' ' HG2' ' A' ' 16' ' ' LYS . 1.8 mp -139.72 97.65 3.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.853 0.359 . . . . 0.0 110.565 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -84.28 114.88 22.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.628 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.479 ' OD1' HG12 ' A' ' 8' ' ' VAL . 0.6 OUTLIER -113.97 -175.56 2.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.376 -179.883 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.483 HG22 HD13 ' A' ' 67' ' ' LEU . 18.4 p -89.67 -175.73 4.76 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.617 -179.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.953 ' CB ' HG12 ' A' ' 36' ' ' VAL . . . -172.26 168.15 5.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.553 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.411 ' H ' HD23 ' A' ' 61' ' ' LEU . . . -149.15 21.25 1.23 Allowed Glycine 0 C--N 1.329 0.189 0 C-N-CA 120.384 -0.912 . . . . 0.0 112.759 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.705 HD13 ' HB2' ' B' ' 526' ' ' SER . 0.2 OUTLIER -121.34 -171.59 2.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.568 0.223 . . . . 0.0 110.777 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -38.24 -31.2 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.877 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.686 ' HB2' HG11 ' A' ' 36' ' ' VAL . 0.2 OUTLIER -45.28 -63.18 1.0 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.143 179.875 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.68 ' O ' HD23 ' A' ' 67' ' ' LEU . 0.0 OUTLIER 166.82 77.48 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.981 179.777 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -62.48 -22.22 66.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.059 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.45 -21.74 10.7 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.311 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.69 HD21 ' N ' ' A' ' 59' ' ' ALA . 3.4 pp -48.02 141.29 6.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.794 0.33 . . . . 0.0 111.058 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.467 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 1.1 ptm180 -158.84 49.58 0.33 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.035 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.467 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 61.4 Cg_endo -74.4 -48.49 0.2 Allowed 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.451 2.1 . . . . 0.0 112.386 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.676 HD21 ' CB ' ' B' ' 541' ' ' LEU . 0.6 OUTLIER -51.27 -24.43 4.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.966 179.882 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 69.3 m -51.1 -30.13 15.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.854 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.432 ' N ' ' HD3' ' A' ' 73' ' ' PRO . 5.4 t80 177.3 65.04 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.821 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.432 ' HD3' ' N ' ' A' ' 72' ' ' TYR . 13.5 Cg_exo -69.3 154.62 69.3 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.706 2.271 . . . . 0.0 112.302 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.62 10.46 40.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.169 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.51 HG22 ' H ' ' A' ' 76' ' ' ASP . 1.4 m -49.5 172.82 0.02 OUTLIER 'General case' 0 C--N 1.334 -0.108 0 CA-C-O 120.849 0.357 . . . . 0.0 110.897 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.51 ' H ' HG22 ' A' ' 75' ' ' THR . 19.9 p-10 -113.89 -23.91 9.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.032 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.703 HG11 ' HB2' ' A' ' 176' ' ' ALA . 7.2 p -130.22 92.38 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.283 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.777 ' CE1' HG21 ' A' ' 108' ' ' THR . 15.2 m-85 -80.78 167.32 20.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.623 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 38.8 tp -141.88 109.06 5.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.976 0.417 . . . . 0.0 111.297 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.446 ' O ' HG23 ' A' ' 80' ' ' VAL . 29.1 m -96.93 126.51 49.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.583 179.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.407 ' HB2' ' HA3' ' A' ' 12' ' ' GLY . 1.6 m -116.77 158.95 23.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.161 0.505 . . . . 0.0 111.711 -179.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.565 ' CE2' HD12 ' A' ' 112' ' ' LEU . 41.7 p90 -147.15 -173.79 4.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.89 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.0 p -138.59 131.58 29.7 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.795 0.331 . . . . 0.0 111.116 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.715 HG21 ' HA ' ' A' ' 117' ' ' ILE . 60.9 t -47.57 -72.06 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.186 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.701 HG22 ' OE1' ' A' ' 116' ' ' GLN . 32.6 m -46.58 106.85 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.81 0.338 . . . . 0.0 110.527 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.536 ' N ' HD22 ' A' ' 129' ' ' LEU . 0.2 OUTLIER -149.99 137.35 11.49 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.551 -179.175 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.437 ' HB2' ' HB2' ' A' ' 132' ' ' ASN . 85.1 Cg_endo -91.76 53.29 0.75 Allowed 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.214 2.61 . . . . 0.0 111.778 179.49 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.467 ' CB ' ' HG3' ' A' ' 133' ' ' LYS . 0.1 OUTLIER 81.09 30.65 0.15 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.79 -179.534 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.72 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.9 OUTLIER -96.85 -25.94 15.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.063 179.972 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.767 ' CZ ' HG21 ' A' ' 137' ' ' ILE . 6.4 t80 -50.74 -59.85 3.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.061 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -50.19 -57.88 6.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.9 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -51.35 -62.73 1.44 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.867 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.72 HG23 ' O ' ' A' ' 89' ' ' SER . 60.3 t -44.55 -47.12 2.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.414 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.751 ' CG ' HD11 ' A' ' 145' ' ' LEU . 1.3 tmtt? -53.69 -51.01 64.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.705 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -84.0 6.59 21.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.486 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -110.52 -31.61 7.19 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.69 0.281 . . . . 0.0 111.021 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.589 ' O ' HG22 ' A' ' 101' ' ' ILE . 0.5 OUTLIER -94.11 -44.93 7.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.372 -179.722 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 94' ' ' LYS . 79.2 t -50.24 -46.41 83.21 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.575 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 97.5 Cg_endo -81.08 -15.13 10.53 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.288 1.992 . . . . 0.0 112.633 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -89.32 -44.96 9.85 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.872 0.368 . . . . 0.0 110.832 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.589 HG22 ' O ' ' A' ' 97' ' ' TRP . 7.5 tt -66.48 -30.65 50.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.145 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 38.9 p -83.19 -26.52 30.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.931 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.09 -51.5 53.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.904 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.407 ' O ' ' CE1' ' A' ' 72' ' ' TYR . 27.7 m170 -69.5 -44.31 71.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.979 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.409 ' O ' ' N ' ' A' ' 107' ' ' LYS . 0.6 OUTLIER -111.95 126.65 28.1 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.834 -179.961 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -57.63 81.23 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.475 2.117 . . . . 0.0 112.269 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.409 ' N ' ' O ' ' A' ' 105' ' ' CYS . 0.1 OUTLIER 53.44 97.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.895 -179.993 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.777 HG21 ' CE1' ' A' ' 78' ' ' PHE . 0.1 OUTLIER -117.85 141.26 28.86 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.804 179.998 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 108' ' ' THR . 31.8 Cg_exo -60.02 142.63 98.83 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.553 2.169 . . . . 0.0 112.412 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.794 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 1.9 p90 -147.78 136.27 21.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.816 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.989 HD12 HG11 ' A' ' 152' ' ' VAL . 4.8 tt -110.31 155.16 22.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.127 -179.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.656 ' O ' HD23 ' A' ' 111' ' ' LEU . 3.6 mm? -108.98 147.39 32.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.493 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.784 HG13 HG11 ' A' ' 168' ' ' VAL . 2.7 t -131.62 147.72 32.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.935 0.397 . . . . 0.0 111.855 -179.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.677 ' O ' HD12 ' A' ' 117' ' ' ILE . . . -125.55 100.64 0.6 Allowed Glycine 0 N--CA 1.453 -0.222 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.924 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.75 ' OG1' " H2'" ' A' ' 185' ' ' GNP . 0.1 OUTLIER -116.18 -45.05 2.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.994 0.426 . . . . 0.0 110.894 -179.205 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.701 ' OE1' HG22 ' A' ' 85' ' ' VAL . 9.3 tt0 -64.96 -10.27 27.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.054 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.715 ' HA ' HG21 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -42.93 -27.74 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-O 120.717 0.294 . . . . 0.0 111.626 179.709 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.438 ' N ' HG12 ' A' ' 117' ' ' ILE . 1.7 m-20 -71.29 -30.16 65.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.36 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.594 HD12 ' N ' ' A' ' 119' ' ' LEU . 4.8 mp -79.91 -23.18 41.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.129 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.612 ' HB3' HG11 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -44.85 -29.22 0.76 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.934 0.397 . . . . 0.0 110.941 179.975 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.4 -38.69 34.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.549 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -46.47 103.37 0.35 Allowed Pre-proline 0 C--N 1.332 -0.192 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.918 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.43 ' O ' HG22 ' A' ' 126' ' ' ILE . 47.2 Cg_endo -69.7 -7.19 20.42 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.506 2.138 . . . . 0.0 112.934 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.3 t -77.92 -66.45 0.84 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.025 0.441 . . . . 0.0 109.945 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.416 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 5.0 m -56.73 -39.01 73.16 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.463 ' HA ' ' CD1' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -53.43 -45.45 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.854 179.309 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.514 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 3.7 mt-10 -57.44 -37.18 72.4 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.008 179.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 125' ' ' THR . 2.3 mptp? -63.67 -30.09 71.24 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.536 HD22 ' N ' ' A' ' 86' ' ' SER . 6.7 mt -74.89 -38.08 61.97 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 127' ' ' GLU . . . -44.87 -33.64 2.03 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.948 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 9.1 mmtt -49.44 -34.42 16.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.506 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.437 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 0.6 OUTLIER -123.32 -30.92 3.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.514 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.526 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 6.7 mmtt -145.46 -101.21 0.1 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 119.109 -0.472 . . . . 0.0 111.317 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.526 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 0.9 OUTLIER 133.65 -26.2 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.331 1.052 . . . . 0.0 110.249 -179.858 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 8.9 mtpp -69.0 110.7 6.55 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.715 -179.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.413 ' HB2' ' HB2' ' A' ' 120' ' ' ARG . 83.2 Cg_endo -80.34 133.72 9.81 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.682 2.254 . . . . 0.0 111.484 179.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.767 HG21 ' CZ ' ' A' ' 90' ' ' PHE . 0.8 OUTLIER -67.26 96.62 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.901 0.381 . . . . 0.0 110.871 -179.513 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.419 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 2.2 p -82.97 163.68 49.94 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.816 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.494 ' HA ' ' CE1' ' A' ' 154' ' ' TYR . 86.9 Cg_exo -46.15 -40.55 21.4 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.549 2.166 . . . . 0.0 112.275 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -57.56 -52.28 66.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.752 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 7.4 m -57.21 -52.09 66.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.76 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.471 ' HB1' ' CD2' ' A' ' 154' ' ' TYR . . . -54.01 -52.66 60.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.901 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -51.08 -32.52 22.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.682 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 7.4 ttpt -66.04 -61.3 2.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.76 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.751 HD11 ' CG ' ' A' ' 94' ' ' LYS . 0.7 OUTLIER -60.75 -36.45 78.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.661 179.843 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -61.84 -41.54 97.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.973 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -87.59 -25.74 23.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.746 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -67.64 -42.21 82.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.961 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.453 HD21 HG11 ' A' ' 98' ' ' VAL . 0.1 OUTLIER -93.05 16.37 12.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.258 179.912 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.7 mttm 46.88 35.02 2.94 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.768 0.318 . . . . 0.0 111.196 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.794 ' HB1' ' O ' ' A' ' 110' ' ' PHE . . . -55.64 -82.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.09 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.989 HG11 HD12 ' A' ' 111' ' ' LEU . 56.0 t -162.28 -75.67 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.711 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.425 ' HE3' ' N ' ' A' ' 154' ' ' TYR . 0.0 OUTLIER -176.56 113.54 0.1 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.801 -178.843 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.494 ' CE1' ' HA ' ' A' ' 139' ' ' PRO . 16.5 t80 -87.84 106.75 18.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.467 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.636 ' HB ' HG22 ' A' ' 168' ' ' VAL . 0.1 OUTLIER -101.74 177.07 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.448 179.745 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -99.48 118.76 36.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.8 0.333 . . . . 0.0 111.194 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.433 ' HB3' HG23 ' A' ' 168' ' ' VAL . 7.2 p -160.16 126.37 4.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.776 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.552 ' HB3' HG22 ' A' ' 161' ' ' THR . 0.3 OUTLIER -113.09 157.11 22.01 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.249 -179.728 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.505 ' CB ' HD11 ' A' ' 165' ' ' LEU . . . -107.8 -33.39 7.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.698 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.536 ' H ' HD12 ' A' ' 160' ' ' LEU . 0.4 OUTLIER -68.64 -37.19 79.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.697 179.755 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.552 HG22 ' HB3' ' A' ' 158' ' ' SER . 14.0 t -110.74 -18.78 13.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.012 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 75.76 66.54 0.06 Allowed 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 120.856 0.36 . . . . 0.0 110.975 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.417 ' HB2' ' HB2' ' A' ' 158' ' ' SER . 0.1 OUTLIER -92.26 38.1 1.0 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.244 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.414 ' O ' ' HB2' ' A' ' 167' ' ' ASN . . . 89.48 48.89 3.59 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.97 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.71 HD22 ' CB ' ' A' ' 19' ' ' LEU . 4.3 mt -47.53 -31.6 4.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.77 0.319 . . . . 0.0 111.308 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.426 ' O ' ' N ' ' A' ' 170' ' ' ASP . 36.1 pttt -70.57 -29.67 66.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.3 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.414 ' HB2' ' O ' ' A' ' 164' ' ' GLY . 2.1 t30 -52.09 -72.36 0.05 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.852 0.358 . . . . 0.0 110.94 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.784 HG11 HG13 ' A' ' 113' ' ' VAL . 57.4 t -57.69 -50.42 77.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.919 0.39 . . . . 0.0 110.584 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.676 ' CZ ' HD13 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -54.32 -29.49 47.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.463 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 166' ' ' LYS . 6.1 m-20 -72.54 -29.28 63.43 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 178.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.523 ' CB ' HD11 ' A' ' 111' ' ' LEU . 45.1 mm-40 -73.94 -31.42 63.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.237 179.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.692 ' O ' HG21 ' A' ' 77' ' ' VAL . . . -67.78 -48.13 67.23 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.796 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.656 HD12 ' CD1' ' A' ' 177' ' ' LEU . 1.1 pp -73.8 -31.82 32.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.625 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.692 HD13 ' HB3' ' B' ' 505' ' ' LEU . 4.6 tp -50.57 -53.98 26.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.789 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -50.91 -25.28 4.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.824 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.703 ' HB2' HG11 ' A' ' 77' ' ' VAL . . . -83.13 -48.68 10.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.166 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.994 HD22 HG21 ' B' ' 510' ' ' ILE . 1.0 OUTLIER -68.72 -23.62 64.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.867 179.955 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.414 ' CG ' ' HD2' ' A' ' 179' ' ' PRO . 2.4 tm-20 -152.14 142.63 15.2 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.807 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.414 ' HD2' ' CG ' ' A' ' 178' ' ' GLU . 9.3 Cg_endo -52.76 117.84 4.12 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.724 2.283 . . . . 0.0 112.003 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -66.91 155.02 72.63 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.517 2.145 . . . . 0.0 112.487 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -148.01 98.13 3.83 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.804 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.21 -165.1 0.27 Allowed 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.713 2.275 . . . . 0.0 112.269 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -134.82 157.45 46.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.756 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.249 -0.882 . . . . 0.0 110.897 -179.999 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.311 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 503' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -104.65 -161.42 0.82 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.846 0.355 . . . . 0.0 110.886 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 504' ' ' GLY . . . . . 0.574 ' O ' HD22 ' A' ' 174' ' ' LEU . . . -156.92 69.58 0.27 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.727 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 505' ' ' LEU . . . . . 0.816 HD13 HD13 ' A' ' 177' ' ' LEU . 1.3 mt -133.19 -56.91 0.91 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.642 0.258 . . . . 0.0 111.254 -179.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 506' ' ' SER . . . . . 0.463 ' CB ' ' O ' ' B' ' 505' ' ' LEU . 5.2 t 88.95 -20.57 0.16 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.404 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 507' ' ' ALA . . . . . . . . . . . . . . . -51.46 -79.99 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.331 0.586 . . . . 0.0 110.494 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 508' ' ' GLN . . . . . 0.457 ' HB2' HD11 ' B' ' 510' ' ' ILE . 5.8 mt-30 -130.91 3.55 4.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.418 179.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 509' ' ' ASP . . . . . 0.441 ' CB ' ' O ' ' B' ' 508' ' ' GLN . 25.5 t0 84.41 39.03 0.03 OUTLIER 'General case' 0 C--N 1.344 0.341 0 CA-C-O 120.98 0.419 . . . . 0.0 110.946 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 510' ' ' ILE . . . . . 1.008 HG23 HG23 ' A' ' 46' ' ' ILE . 1.8 mp -68.96 73.21 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.476 179.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 511' ' ' SER . . . . . 0.415 ' O ' ' CD1' ' B' ' 514' ' ' LEU . 14.9 t -60.12 140.78 56.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.904 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 512' ' ' GLN . . . . . 0.495 ' CB ' ' HD3' ' B' ' 513' ' ' PRO . 0.7 OUTLIER -89.84 -64.03 0.19 Allowed Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.735 179.803 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 513' ' ' PRO . . . . . 0.495 ' HD3' ' CB ' ' B' ' 512' ' ' GLN . 88.6 Cg_endo -82.37 49.94 3.27 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.638 2.225 . . . . 0.0 112.463 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 514' ' ' LEU . . . . . 0.443 ' HB2' ' HB ' ' A' ' 44' ' ' VAL . 0.4 OUTLIER -52.88 -89.3 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.784 -179.79 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 515' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -93.2 -157.67 0.55 Allowed 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -48.7 -29.44 4.44 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.139 0.495 . . . . 0.0 110.316 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 517' ' ' SER . . . . . 0.435 ' O ' ' CG1' ' A' ' 42' ' ' VAL . 14.2 p 38.15 59.48 1.39 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.101 179.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 518' ' ' PHE . . . . . 0.485 ' CZ ' ' CE2' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -165.06 108.41 0.86 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.734 0.302 . . . . 0.0 111.393 179.485 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 519' ' ' ILE . . . . . 0.687 HD13 ' O ' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -151.1 152.16 11.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.171 179.246 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 70.33 76.0 0.2 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.825 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 521' ' ' THR . . . . . 0.425 HG23 ' OH ' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -75.7 120.77 21.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.014 -179.951 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 522' ' ' GLY . . . . . . . . . . . . . . . -61.65 -158.26 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.389 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 523' ' ' HIS . . . . . 0.42 ' ND1' ' N ' ' B' ' 523' ' ' HIS . 0.4 OUTLIER -118.66 -83.97 0.65 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.788 0.327 . . . . 0.0 110.808 179.943 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 524' ' ' GLY . . . . . 0.444 ' CA ' HG21 ' A' ' 36' ' ' VAL . . . 67.71 122.13 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.714 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 525' ' ' ASP . . . . . 0.407 ' H ' HD12 ' A' ' 61' ' ' LEU . 18.3 m-20 -142.0 57.91 1.48 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.777 0.323 . . . . 0.0 111.067 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 526' ' ' SER . . . . . 0.705 ' HB2' HD13 ' A' ' 61' ' ' LEU . 2.9 t -78.79 96.81 5.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.754 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 527' ' ' ASP . . . . . 0.466 ' CB ' ' HD3' ' B' ' 528' ' ' PRO . 1.7 t0 -43.93 -52.52 15.05 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 120.679 0.276 . . . . 0.0 111.019 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 528' ' ' PRO . . . . . 0.466 ' HD3' ' CB ' ' B' ' 527' ' ' ASP . 17.7 Cg_exo -70.82 134.06 24.96 Favored 'Trans proline' 0 CA--C 1.518 -0.306 0 C-N-CA 123.125 2.55 . . . . 0.0 111.726 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 529' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -101.06 -30.02 11.84 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.986 -179.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 530' ' ' HIS . . . . . 0.502 ' CG ' ' O ' ' B' ' 530' ' ' HIS . 0.1 OUTLIER 70.35 5.02 5.16 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.399 179.712 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 1.2 m 52.76 -88.08 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.637 0.256 . . . . 0.0 111.011 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 532' ' ' TRP . . . . . 0.434 ' N ' ' O ' ' B' ' 530' ' ' HIS . 15.6 t90 -154.27 -45.33 0.09 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.855 0.36 . . . . 0.0 110.685 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . 67.89 -143.08 41.08 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.572 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 534' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -65.86 150.83 96.02 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.791 0.329 . . . . 0.0 110.896 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 535' ' ' PRO . . . . . 0.539 ' HB3' HG23 ' A' ' 85' ' ' VAL . 73.7 Cg_exo -49.35 -49.74 14.76 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.614 2.21 . . . . 0.0 112.247 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.49 109.19 11.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.78 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 537' ' ' ARG . . . . . 0.44 ' NH2' ' CE2' ' A' ' 32' ' ' TYR . 0.2 OUTLIER -50.38 143.11 9.31 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 120.989 0.423 . . . . 0.0 111.006 179.998 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 538' ' ' ILE . . . . . 0.488 HG13 ' HB2' ' B' ' 542' ' ' TYR . 7.4 tp -58.69 146.78 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.148 179.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 539' ' ' ASP . . . . . 0.41 ' HA ' ' O ' ' A' ' 10' ' ' GLY . 3.7 m-20 -46.37 140.52 4.1 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.914 0.388 . . . . 0.0 111.165 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 540' ' ' GLU . . . . . 0.59 ' HG2' HG13 ' A' ' 8' ' ' VAL . 14.0 mp0 -44.94 -27.68 0.57 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.357 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 541' ' ' LEU . . . . . 0.676 ' CB ' HD21 ' A' ' 70' ' ' LEU . 0.9 OUTLIER -55.68 -32.06 62.94 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.351 0.596 . . . . 0.0 110.147 179.615 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 542' ' ' TYR . . . . . 0.488 ' HB2' HG13 ' B' ' 538' ' ' ILE . 11.1 m-85 -105.45 0.88 27.19 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.031 -0.986 . . . . 0.0 112.171 -178.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 543' ' ' LEU . . . . . 0.71 HD21 ' HB ' ' A' ' 14' ' ' VAL . 1.6 tp -49.23 117.64 2.26 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.814 0.34 . . . . 0.0 110.679 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . 135.09 -46.83 1.02 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.505 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 545' ' ' ASN . . . . . 0.407 ' ND2' ' HB3' ' B' ' 530' ' ' HIS . 72.9 m-20 . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.253 -0.879 . . . . 0.0 111.027 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' GNP . . . . . 0.75 " H2'" ' OG1' ' A' ' 115' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' HOH . . . . . 0.434 ' O ' HG21 ' A' ' 21' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.375 0 CA-C-O 120.749 0.309 . . . . 0.0 111.216 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 57.66 160.54 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.715 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.717 HG23 ' CE1' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -119.52 -174.53 2.76 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.407 -179.632 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.609 HG23 HD23 ' A' ' 177' ' ' LEU . 25.7 pt -155.05 149.49 12.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.101 0.477 . . . . 0.0 111.991 -179.273 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 33.9 mttt -134.38 95.87 3.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.274 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -100.31 138.66 37.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.024 0.44 . . . . 0.0 111.491 -179.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.6 160.09 41.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.087 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.849 HG21 ' CG ' ' A' ' 16' ' ' LYS . 47.3 t -111.69 137.64 43.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.289 0.566 . . . . 0.0 112.184 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.547 HG13 ' O ' ' A' ' 8' ' ' VAL . 19.3 m -161.44 130.04 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.862 179.232 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 149.37 -144.01 11.56 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.238 -0.982 . . . . 0.0 112.62 -179.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.5 p30 -122.15 25.3 9.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.938 0.399 . . . . 0.0 110.825 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.401 ' HA2' ' HB2' ' B' ' 537' ' ' ARG . . . -157.36 -160.24 10.03 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.324 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.687 ' HB2' ' O2A' ' A' ' 185' ' ' GNP . . . -79.11 -48.18 14.79 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.556 0.217 . . . . 0.0 110.836 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.722 HG12 ' HB3' ' A' ' 81' ' ' CYS . 0.6 OUTLIER 65.59 -60.04 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.403 179.55 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.655 ' HA2' HD22 ' A' ' 19' ' ' LEU . . . -165.83 30.31 0.21 Allowed Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.849 ' CG ' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -91.01 -165.32 1.33 Allowed 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 121.232 0.539 . . . . 0.0 111.359 -179.313 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.588 ' CG2' HG23 ' A' ' 35' ' ' THR . 43.6 p -38.95 -65.85 0.33 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.478 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.431 ' O ' ' CB ' ' A' ' 22' ' ' SER . 23.6 t -32.42 -43.6 0.09 Allowed 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -178.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.655 HD22 ' HA2' ' A' ' 15' ' ' GLY . 2.5 mp -56.88 -71.74 0.09 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.73 0.3 . . . . 0.0 111.269 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 20' ' ' LEU . 0.3 OUTLIER -76.55 -50.3 14.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.192 -179.741 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.732 HG22 ' HB2' ' A' ' 26' ' ' ASN . 10.9 mm -48.31 -55.79 2.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.403 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.474 ' HA ' ' CB ' ' A' ' 26' ' ' ASN . 3.1 t -64.03 -43.59 95.11 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 121.092 -0.243 . . . . 0.0 111.585 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.571 ' CG ' HD13 ' A' ' 165' ' ' LEU . 0.2 OUTLIER -45.79 -35.07 4.09 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.187 0.517 . . . . 0.0 110.16 179.6 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -101.67 -33.52 9.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.279 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 173.46 127.14 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.722 0.296 . . . . 0.0 111.039 -178.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.732 ' HB2' HG22 ' A' ' 21' ' ' ILE . 61.2 t30 178.56 -43.87 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.666 178.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.6 mtmm 65.1 142.17 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.734 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.483 ' CE2' " O3'" ' A' ' 185' ' ' GNP . 0.2 OUTLIER -86.68 -49.5 0.48 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.782 179.995 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.46 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 5.8 Cg_exo -79.35 52.15 4.16 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.933 2.422 . . . . 0.0 112.248 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 77.9 p -133.87 -108.74 0.23 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.679 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -159.57 118.75 2.89 Favored 'General case' 0 N--CA 1.457 -0.098 0 O-C-N 122.169 -0.332 . . . . 0.0 111.016 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.475 ' O ' HG22 ' A' ' 33' ' ' VAL . 5.3 m-85 -90.55 121.51 32.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.391 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.499 HG11 ' HD2' ' B' ' 529' ' ' ARG . 0.2 OUTLIER -160.99 -61.98 0.02 OUTLIER Pre-proline 0 N--CA 1.468 0.434 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.363 -179.415 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.476 ' CD ' ' HB ' ' A' ' 33' ' ' VAL . 3.0 Cg_exo -34.98 -28.57 0.05 OUTLIER 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.649 2.899 . . . . 0.0 113.653 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.588 HG23 ' CG2' ' A' ' 17' ' ' THR . 28.4 m -29.73 -38.46 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.638 ' HA ' ' HB2' ' A' ' 59' ' ' ALA . 11.5 p -50.4 -24.3 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.765 0.317 . . . . 0.0 111.373 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.471 ' CE2' ' HB3' ' A' ' 34' ' ' PRO . 7.1 m-30 -66.07 -10.02 36.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.576 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -46.26 172.62 0.01 OUTLIER 'General case' 0 C--O 1.231 0.102 0 CA-C-O 120.864 0.364 . . . . 0.0 111.159 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 75.37 5.43 4.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.303 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -60.38 -174.85 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.719 0.295 . . . . 0.0 110.607 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -110.11 124.18 51.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.586 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.722 HG23 HG21 ' A' ' 52' ' ' THR . 24.0 m -118.44 124.88 73.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.014 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.72 104.82 16.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.934 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.79 HG22 ' CG2' ' A' ' 52' ' ' THR . 12.6 m -153.23 -177.24 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.931 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.447 ' HE1' ' N ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -111.96 103.71 11.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.651 -179.537 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.645 HG22 ' O ' ' A' ' 46' ' ' ILE . 2.7 mm -74.02 86.09 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.1 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.476 ' HA3' ' HA ' ' B' ' 510' ' ' ILE . . . 43.9 -94.13 0.01 OUTLIER Glycine 0 CA--C 1.519 0.313 0 CA-C-N 115.498 -0.774 . . . . 0.0 113.636 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -38.62 -87.44 0.01 OUTLIER Glycine 0 C--N 1.332 0.356 0 C-N-CA 121.607 -0.33 . . . . 0.0 113.626 -179.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.447 ' N ' ' HE1' ' A' ' 45' ' ' MET . 1.8 pt-20 -125.23 164.75 30.03 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 120.708 0.289 . . . . 0.0 111.024 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.41 ' HD2' ' HB2' ' A' ' 49' ' ' GLU . 52.0 Cg_exo -54.22 106.82 0.18 Allowed 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.653 2.235 . . . . 0.0 112.289 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.717 ' CE1' HG23 ' A' ' 3' ' ' THR . 4.4 t80 -172.53 147.92 1.92 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.498 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.79 ' CG2' HG22 ' A' ' 44' ' ' VAL . 0.3 OUTLIER -137.61 154.06 49.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.624 179.706 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.718 ' N ' HD13 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -131.15 177.99 7.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.877 0.37 . . . . 0.0 111.305 -179.734 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -74.09 114.8 4.67 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.161 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.519 ' H ' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -81.15 -62.97 1.5 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.019 0.437 . . . . 0.0 110.942 -179.785 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.491 ' CD2' ' HB2' ' A' ' 55' ' ' LEU . 1.9 p90 -142.94 128.89 19.55 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.185 -179.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -142.26 109.6 5.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.032 0.444 . . . . 0.0 110.847 179.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.536 ' O ' HD22 ' B' ' 543' ' ' LEU . 0.0 OUTLIER -155.8 131.48 9.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.316 179.524 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.638 ' HB2' ' HA ' ' A' ' 36' ' ' VAL . . . -170.93 158.44 5.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.027 0.441 . . . . 0.0 111.613 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -131.01 19.63 4.9 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.149 179.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.535 HD23 ' HB ' ' A' ' 36' ' ' VAL . 2.5 mm? -86.22 -175.51 5.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.814 0.34 . . . . 0.0 110.779 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -46.58 -31.48 2.84 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.312 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.468 ' CB ' ' CG2' ' A' ' 36' ' ' VAL . 7.2 t0 -50.52 -62.09 1.8 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.06 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.504 ' CD1' ' N ' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -168.41 137.37 2.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.975 0.417 . . . . 0.0 111.154 -179.898 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.13 -66.23 0.92 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.786 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 17.1 mmt85 -73.22 -24.9 60.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.991 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.577 HD11 ' H ' ' A' ' 59' ' ' ALA . 1.1 mt 68.52 -94.73 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.114 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.432 ' CB ' ' HD3' ' A' ' 69' ' ' PRO . 0.0 OUTLIER 166.34 -53.9 0.0 OUTLIER Pre-proline 0 N--CA 1.465 0.287 0 CA-C-O 120.722 0.296 . . . . 0.0 111.128 179.822 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.432 ' HD3' ' CB ' ' A' ' 68' ' ' ARG . 52.8 Cg_exo -52.91 -60.41 0.73 Allowed 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.662 2.242 . . . . 0.0 112.727 -179.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.922 HD22 ' HA ' ' B' ' 541' ' ' LEU . 0.3 OUTLIER -58.7 -31.89 68.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.031 -179.847 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.8 t -54.6 -35.63 63.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.223 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 65.3 t80 175.39 81.57 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.669 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.515 ' HG2' ' CZ ' ' A' ' 78' ' ' PHE . 94.4 Cg_endo -81.17 136.42 10.17 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.604 2.203 . . . . 0.0 112.307 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? -90.79 10.25 26.82 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.349 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.504 HG22 ' HB2' ' A' ' 73' ' ' PRO . 4.4 t -57.74 178.45 0.08 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.808 0.337 . . . . 0.0 110.737 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -123.34 7.33 9.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.535 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.655 ' O ' HG13 ' A' ' 77' ' ' VAL . 8.9 p -152.76 101.05 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 CA-C-O 120.758 0.313 . . . . 0.0 111.321 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.515 ' CZ ' ' HG2' ' A' ' 73' ' ' PRO . 3.2 m-85 -80.61 177.65 8.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.393 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.662 HD23 HG23 ' A' ' 14' ' ' VAL . 5.9 tp -138.93 108.25 6.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.047 0.451 . . . . 0.0 111.042 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.416 HG22 ' HB2' ' A' ' 110' ' ' PHE . 19.7 m -111.04 127.01 68.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.243 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.722 ' HB3' HG12 ' A' ' 14' ' ' VAL . 13.6 p -108.21 177.19 4.88 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.604 0.716 . . . . 0.0 112.51 -178.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.655 ' HZ ' ' HB2' ' A' ' 142' ' ' ALA . 2.1 p90 -176.54 124.45 0.17 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.607 -1.178 . . . . 0.0 109.467 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.514 ' HG ' " H1'" ' A' ' 185' ' ' GNP . 60.4 m -87.89 143.65 27.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.831 0.348 . . . . 0.0 111.291 -179.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.782 HG13 ' N ' ' A' ' 137' ' ' ILE . 51.0 t -54.72 -53.08 35.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.748 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.762 HG11 HG21 ' A' ' 125' ' ' THR . 34.3 m -52.09 110.1 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.225 179.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.75 ' N ' HD22 ' A' ' 129' ' ' LEU . 0.3 OUTLIER -151.46 128.38 5.44 Favored Pre-proline 0 C--N 1.33 -0.274 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.77 -179.36 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 86' ' ' SER . 82.5 Cg_endo -92.4 53.45 0.6 Allowed 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.299 2.666 . . . . 0.0 111.498 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.468 ' CA ' ' HG3' ' A' ' 133' ' ' LYS . 1.1 p 77.87 17.81 1.29 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.141 -179.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.769 ' O ' HG23 ' A' ' 93' ' ' VAL . 5.0 p -97.28 -23.98 15.89 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.811 0.338 . . . . 0.0 111.066 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.453 ' CZ ' HG21 ' A' ' 137' ' ' ILE . 9.7 t80 -46.96 -46.77 21.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.186 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -50.77 -52.19 43.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.183 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.93 -40.38 83.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.168 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.769 HG23 ' O ' ' A' ' 89' ' ' SER . 62.1 t -48.36 -45.42 13.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.491 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.551 ' O ' HG23 ' A' ' 98' ' ' VAL . 3.8 ptpp? -80.32 -36.81 33.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.107 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -74.61 -11.23 60.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.589 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.17 -20.49 12.33 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.58 0.228 . . . . 0.0 111.326 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.446 ' CE3' ' HA ' ' A' ' 97' ' ' TRP . 3.3 m95 -87.0 -51.61 5.92 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.712 0.291 . . . . 0.0 111.186 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 94' ' ' LYS . 57.3 t -48.51 -47.79 69.02 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.598 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 73.4 Cg_endo -76.46 -13.65 18.39 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.169 1.913 . . . . 0.0 112.492 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -89.83 -49.17 6.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.885 0.374 . . . . 0.0 110.727 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.424 HG13 HG23 ' A' ' 102' ' ' THR . 5.8 pt -56.84 -28.16 27.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.013 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.424 HG23 HG13 ' A' ' 101' ' ' ILE . 69.5 p -93.05 -25.89 17.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.93 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -63.5 -68.59 0.33 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.758 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 10.2 m80 -64.86 -51.1 63.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.795 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 2.9 m -101.57 141.15 22.01 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.811 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -51.24 155.21 6.89 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.591 2.194 . . . . 0.0 112.209 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 16.3 mttt -53.46 90.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.872 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.44 ' HB ' ' CD1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -115.65 152.43 47.26 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.918 -179.954 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -60.86 167.83 8.08 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.686 2.257 . . . . 0.0 112.415 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.738 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 1.8 p90 -155.8 159.39 39.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.738 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 1.021 HD12 HG11 ' A' ' 152' ' ' VAL . 4.2 tt -121.03 150.03 41.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.255 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.7 ' O ' HD23 ' A' ' 111' ' ' LEU . 3.8 mm? -94.05 141.71 28.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.178 179.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.996 HG13 HG21 ' A' ' 168' ' ' VAL . 3.1 t -122.03 145.29 28.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.183 0.516 . . . . 0.0 112.07 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -130.51 125.78 4.71 Favored Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.093 179.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.775 ' OG1' " H2'" ' A' ' 185' ' ' GNP . 0.6 OUTLIER -144.27 -44.89 0.25 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.964 0.412 . . . . 0.0 110.752 -178.854 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.741 ' OE1' " H1'" ' A' ' 185' ' ' GNP . 0.1 OUTLIER -71.33 -2.68 17.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.23 179.26 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.653 HD13 ' C ' ' A' ' 115' ' ' THR . 0.1 OUTLIER -42.29 -28.44 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 179.935 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.18 -34.7 61.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.771 0.319 . . . . 0.0 111.131 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.557 ' N ' HD22 ' A' ' 119' ' ' LEU . 2.2 mm? -69.44 -31.78 70.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.083 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.456 ' CB ' HG11 ' A' ' 84' ' ' VAL . 0.3 OUTLIER -46.11 -29.87 1.69 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.949 -179.884 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -83.84 -31.96 25.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.505 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 119' ' ' LEU . 3.5 t0 -56.54 106.86 0.74 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.618 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.415 ' O ' ' CG ' ' A' ' 127' ' ' GLU . 14.2 Cg_exo -69.19 -3.62 12.0 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.686 2.257 . . . . 0.0 112.975 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.83 -65.24 1.04 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 121.058 0.456 . . . . 0.0 109.865 179.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.762 HG21 HG11 ' A' ' 85' ' ' VAL . 4.1 m -56.65 -38.95 72.86 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.532 HD11 ' HB3' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -54.34 -43.1 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.753 179.203 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.459 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 1.7 mm-40 -58.31 -37.7 75.61 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.833 179.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 125' ' ' THR . 2.7 mptt -63.11 -30.71 71.81 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.75 HD22 ' N ' ' A' ' 86' ' ' SER . 8.0 mt -74.88 -39.22 61.63 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 127' ' ' GLU . . . -46.57 -31.49 2.84 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.85 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.0 mmtt -50.14 -34.31 21.79 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.391 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.404 ' HB2' ' O ' ' A' ' 87' ' ' PRO . 5.0 m-80 -123.3 -31.36 3.56 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.359 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.512 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 7.6 mmtt -144.79 -98.96 0.1 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 119.15 -0.452 . . . . 0.0 111.326 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.512 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 0.0 OUTLIER 132.22 -22.79 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.401 1.08 . . . . 0.0 110.503 -179.809 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 4.5 mmtt -68.75 110.82 6.62 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.726 -179.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.532 ' HB3' HD11 ' A' ' 126' ' ' ILE . 85.2 Cg_endo -81.6 123.4 4.27 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.534 2.156 . . . . 0.0 111.394 179.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.782 ' N ' HG13 ' A' ' 84' ' ' VAL . 1.1 mm -55.05 96.61 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.958 0.409 . . . . 0.0 110.893 -179.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.44 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 74.2 p -69.09 156.59 91.25 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.028 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.44 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 9.4 Cg_endo -50.75 -41.35 54.81 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.709 2.272 . . . . 0.0 112.085 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -58.85 -34.8 72.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.583 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.409 HG21 HG23 ' A' ' 137' ' ' ILE . 84.3 m -63.62 -46.49 85.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.677 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.655 ' HB2' ' HZ ' ' A' ' 82' ' ' PHE . . . -55.6 -48.74 74.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.905 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -53.48 -43.95 68.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.73 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 6.8 mttt -54.1 -61.8 2.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.704 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.663 HD21 HD11 ' A' ' 149' ' ' LEU . 0.8 OUTLIER -61.57 -37.98 85.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.649 179.748 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.478 ' HB2' ' HG ' ' A' ' 112' ' ' LEU . . . -59.45 -49.22 78.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.861 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 16.2 mtp180 -79.68 -25.14 41.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.826 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -56.93 -40.71 76.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.447 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.663 HD11 HD21 ' A' ' 145' ' ' LEU . 1.1 mt -109.95 26.11 11.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.667 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.469 ' N ' ' CD ' ' A' ' 150' ' ' LYS . 0.0 OUTLIER 37.84 57.0 1.54 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.671 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.738 ' HB1' ' O ' ' A' ' 110' ' ' PHE . . . -73.76 -82.16 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.025 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 1.021 HG11 HD12 ' A' ' 111' ' ' LEU . 55.5 t -161.96 -76.12 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.752 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.443 ' HG3' ' N ' ' A' ' 154' ' ' TYR . 1.9 ttpt -177.01 145.91 0.5 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.343 -178.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.443 ' N ' ' HG3' ' A' ' 153' ' ' LYS . 61.3 t80 -105.66 114.48 28.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.551 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.718 HG23 ' OE2' ' A' ' 171' ' ' GLU . 11.4 t -112.91 157.94 13.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.803 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.425 ' N ' HG12 ' A' ' 155' ' ' VAL . 2.6 pt-20 -97.79 118.29 34.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.065 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.452 ' HA ' ' CB ' ' A' ' 163' ' ' LYS . 22.9 m -160.63 126.42 3.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.673 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.789 ' OG ' HD12 ' A' ' 160' ' ' LEU . 0.4 OUTLIER -147.41 153.62 39.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.916 0.389 . . . . 0.0 111.745 -179.591 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -78.47 -22.07 48.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.664 179.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.789 HD12 ' OG ' ' A' ' 158' ' ' SER . 0.3 OUTLIER -67.39 -59.46 3.38 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.073 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.52 HG23 ' HD3' ' A' ' 163' ' ' LYS . 3.5 t -91.92 -22.49 20.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.222 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 72.13 69.86 0.15 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.865 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.52 ' HD3' HG23 ' A' ' 161' ' ' THR . 10.3 mptt -90.81 19.37 5.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.32 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 119.13 -42.21 1.83 Allowed Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.634 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.645 HD21 ' CA ' ' A' ' 19' ' ' LEU . 1.0 OUTLIER 66.35 -66.24 0.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.783 0.325 . . . . 0.0 111.359 179.904 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.423 ' O ' ' N ' ' A' ' 170' ' ' ASP . 6.2 ptpp? -58.04 -26.08 62.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.752 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.409 ' O ' ' HB2' ' A' ' 170' ' ' ASP . 0.2 OUTLIER -54.51 -69.46 0.13 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.814 0.34 . . . . 0.0 111.06 -179.717 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.996 HG21 HG13 ' A' ' 113' ' ' VAL . 13.6 p -56.15 -44.77 79.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.142 0.496 . . . . 0.0 110.69 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.559 ' HB2' HD23 ' A' ' 19' ' ' LEU . 5.6 t80 -66.85 -17.23 64.79 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.979 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' A' ' 166' ' ' LYS . 2.8 m-20 -80.95 -38.66 27.36 Favored 'General case' 0 C--N 1.334 -0.068 0 CA-C-O 120.809 0.338 . . . . 0.0 110.699 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.744 ' CD ' HD21 ' A' ' 111' ' ' LEU . 9.4 pt-20 -69.45 -27.81 65.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.936 0.398 . . . . 0.0 110.033 179.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.472 ' HA ' HD13 ' A' ' 111' ' ' LEU . . . -75.69 -42.23 51.58 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.911 179.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.546 HD13 ' HG2' ' B' ' 512' ' ' GLN . 1.7 pp -81.58 -34.44 13.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.044 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.839 HD23 HD13 ' B' ' 505' ' ' LEU . 1.2 tm? -56.36 -44.62 80.3 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.859 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.422 ' N ' HD13 ' A' ' 174' ' ' LEU . . . -51.22 -24.78 4.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.904 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.494 ' CB ' HG22 ' A' ' 4' ' ' ILE . . . -84.84 -39.27 18.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.163 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.855 HD13 ' HB ' ' B' ' 510' ' ' ILE . 31.4 mt -68.56 -24.06 64.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.869 0.366 . . . . 0.0 110.405 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.435 ' HB2' ' HB2' ' B' ' 507' ' ' ALA . 21.7 tt0 -165.52 139.27 3.76 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.543 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.419 ' HA ' ' HD3' ' A' ' 180' ' ' PRO . 43.9 Cg_endo -68.36 108.58 1.83 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.564 2.176 . . . . 0.0 112.507 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 179' ' ' PRO . 11.8 Cg_exo -70.83 -159.51 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.734 2.29 . . . . 0.0 112.185 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -145.57 146.73 30.62 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.886 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.23 -165.32 0.3 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.686 2.258 . . . . 0.0 112.287 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.5 154.6 35.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.888 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 8.2 mttt . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.297 -0.858 . . . . 0.0 110.877 -179.967 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 112.45 -0.26 . . . . 0.0 112.45 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 503' ' ' SER . . . . . . . . . . . . . 5.7 m -74.03 -69.49 0.44 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.833 0.349 . . . . 0.0 110.782 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 504' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' B' ' 509' ' ' ASP . . . 64.09 114.67 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.684 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 505' ' ' LEU . . . . . 0.839 HD13 HD23 ' A' ' 174' ' ' LEU . 0.0 OUTLIER -148.53 -52.41 0.18 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.845 0.355 . . . . 0.0 110.709 -179.922 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 506' ' ' SER . . . . . 0.41 ' CB ' ' OE1' ' A' ' 178' ' ' GLU . 1.4 m -155.19 -161.11 1.13 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.778 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 507' ' ' ALA . . . . . 0.435 ' HB2' ' HB2' ' A' ' 178' ' ' GLU . . . 55.01 -90.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.001 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 508' ' ' GLN . . . . . 0.414 ' O ' ' CB ' ' B' ' 509' ' ' ASP . 9.9 mt-30 -132.1 3.9 4.05 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.875 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 509' ' ' ASP . . . . . 0.423 ' HA ' ' HA2' ' B' ' 504' ' ' GLY . 7.8 t70 80.71 42.44 0.05 OUTLIER 'General case' 0 C--N 1.34 0.19 0 CA-C-O 121.221 0.534 . . . . 0.0 110.012 -179.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 510' ' ' ILE . . . . . 0.855 ' HB ' HD13 ' A' ' 177' ' ' LEU . 11.2 mt -65.3 145.28 14.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.554 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 511' ' ' SER . . . . . . . . . . . . . 27.9 t -109.37 149.2 29.86 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.205 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 512' ' ' GLN . . . . . 0.546 ' HG2' HD13 ' A' ' 173' ' ' ILE . 0.0 OUTLIER -93.69 -53.53 0.25 Allowed Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.406 179.387 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 513' ' ' PRO . . . . . 0.458 ' HD3' ' CB ' ' B' ' 512' ' ' GLN . 55.8 Cg_endo -97.73 74.79 0.08 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 123.33 2.687 . . . . 0.0 111.813 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 514' ' ' LEU . . . . . 0.44 ' CD1' ' O ' ' A' ' 45' ' ' MET . 0.7 OUTLIER -73.33 -88.28 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.6 -179.257 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 515' ' ' GLN . . . . . 0.565 ' HB2' HG12 ' A' ' 44' ' ' VAL . 0.3 OUTLIER -87.45 -159.88 0.56 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.777 0.322 . . . . 0.0 111.006 -179.669 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -54.48 -21.24 9.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.235 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 517' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 47.24 29.14 1.14 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.821 0.343 . . . . 0.0 111.129 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 518' ' ' PHE . . . . . 0.517 ' CZ ' HD12 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -150.18 91.62 1.79 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.83 -179.749 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 519' ' ' ILE . . . . . 0.459 HG12 ' HA ' ' A' ' 42' ' ' VAL . 5.3 mm -97.79 -68.89 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.442 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -117.65 -170.0 1.78 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.946 0.403 . . . . 0.0 111.005 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 521' ' ' THR . . . . . 0.421 ' OG1' ' CG ' ' A' ' 37' ' ' PHE . 15.3 t -119.32 -159.86 0.79 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.909 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 522' ' ' GLY . . . . . . . . . . . . . . . -110.57 -92.37 2.15 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.364 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 523' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -115.41 -88.29 0.58 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.643 0.259 . . . . 0.0 111.02 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 524' ' ' GLY . . . . . . . . . . . . . . . 164.47 123.9 0.68 Allowed Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.491 -0.862 . . . . 0.0 112.643 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 525' ' ' ASP . . . . . 0.406 ' HB3' ' HG ' ' A' ' 61' ' ' LEU . 0.9 OUTLIER 177.28 46.17 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.99 0.424 . . . . 0.0 110.592 179.827 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 526' ' ' SER . . . . . 0.42 ' CB ' ' HD3' ' A' ' 34' ' ' PRO . 71.8 m -104.3 100.11 9.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.068 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 527' ' ' ASP . . . . . 0.431 ' O ' HG21 ' A' ' 33' ' ' VAL . 7.2 m-20 -156.17 164.79 20.25 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.835 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -61.09 95.69 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.588 2.192 . . . . 0.0 112.133 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 529' ' ' ARG . . . . . 0.499 ' HD2' HG11 ' A' ' 33' ' ' VAL . 2.8 mtp85 -97.67 -49.77 4.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.105 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 530' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -168.8 -41.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.158 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 2.7 m 72.71 177.02 0.26 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.772 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 532' ' ' TRP . . . . . . . . . . . . . 37.1 t90 -53.01 92.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.796 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . -114.86 -61.39 0.38 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.548 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 534' ' ' PHE . . . . . 0.4 ' HA ' ' HD3' ' B' ' 535' ' ' PRO . 44.0 m-85 -78.11 139.16 60.71 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.644 0.259 . . . . 0.0 110.875 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 535' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' B' ' 534' ' ' PHE . 50.5 Cg_exo -53.79 123.86 14.45 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.557 2.172 . . . . 0.0 112.438 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 70.31 126.8 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.027 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 537' ' ' ARG . . . . . 0.437 ' CZ ' ' O3G' ' A' ' 185' ' ' GNP . 21.3 mmt180 -54.67 122.73 11.29 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.233 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 538' ' ' ILE . . . . . 0.624 ' C ' HD13 ' B' ' 538' ' ' ILE . 0.0 OUTLIER -48.17 151.05 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.152 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 539' ' ' ASP . . . . . 0.469 ' OD2' ' CD2' ' B' ' 542' ' ' TYR . 0.7 OUTLIER -38.52 104.62 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.218 0.532 . . . . 0.0 112.224 -178.58 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 540' ' ' GLU . . . . . 0.773 ' OE2' HG11 ' A' ' 8' ' ' VAL . 1.1 mm-40 -45.25 -26.54 0.51 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.529 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 541' ' ' LEU . . . . . 0.922 ' HA ' HD22 ' A' ' 70' ' ' LEU . 42.1 mt -41.21 -35.18 0.57 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.953 0.406 . . . . 0.0 111.116 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 542' ' ' TYR . . . . . 0.469 ' CD2' ' OD2' ' B' ' 539' ' ' ASP . 4.1 m-30 -104.33 -57.25 2.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.525 179.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 543' ' ' LEU . . . . . 0.752 HD12 ' HA ' ' B' ' 540' ' ' GLU . 0.2 OUTLIER 62.31 176.44 0.13 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.437 -179.884 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . 103.22 79.67 1.38 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.259 -0.972 . . . . 0.0 112.574 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 545' ' ' ASN . . . . . 0.43 ' HB3' ' HB2' ' B' ' 529' ' ' ARG . 2.5 m120 . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.955 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' GNP . . . . . 0.775 " H2'" ' OG1' ' A' ' 115' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.427 ' HE2' ' HB2' ' A' ' 1' ' ' MET . 3.3 ppp? . . . . . 0 N--CA 1.488 1.472 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.421 ' N ' ' SD ' ' A' ' 1' ' ' MET . 50.4 tt0 61.93 132.84 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.893 0.377 . . . . 0.0 110.724 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.704 HG22 ' CD2' ' A' ' 53' ' ' LEU . 0.3 OUTLIER -133.36 -161.38 1.13 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.429 -179.679 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.883 HD13 HD22 ' A' ' 53' ' ' LEU . 0.3 OUTLIER -154.91 163.37 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -179.069 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 8.2 mtmt -111.29 136.59 50.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.041 179.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.424 ' HB2' HD12 ' A' ' 55' ' ' LEU . 1.0 OUTLIER -108.32 138.73 44.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.063 0.459 . . . . 0.0 111.66 -179.356 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -151.11 160.41 3.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.098 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.498 HG11 ' CA ' ' A' ' 14' ' ' VAL . 3.3 m -143.24 139.95 26.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.845 0.355 . . . . 0.0 111.726 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.447 HG12 HD13 ' A' ' 70' ' ' LEU . 14.8 m -143.27 131.04 18.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.083 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.25 -110.11 3.92 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.623 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.73 -23.85 24.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.716 0.293 . . . . 0.0 110.92 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -49.43 150.56 4.32 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.617 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.773 ' O ' HG13 ' A' ' 14' ' ' VAL . . . -91.53 -56.35 3.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.549 0.214 . . . . 0.0 111.158 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.773 HG13 ' O ' ' A' ' 13' ' ' ALA . 0.0 OUTLIER 170.75 -56.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.788 179.584 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.659 ' HA2' HD13 ' A' ' 19' ' ' LEU . . . 110.25 -16.29 29.85 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.419 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.846 ' O ' HD23 ' A' ' 20' ' ' LEU . 15.4 tptm -93.44 -50.04 5.63 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.782 0.325 . . . . 0.0 111.076 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.632 HG21 ' OG1' ' A' ' 35' ' ' THR . 0.6 OUTLIER -97.81 -71.2 0.69 Allowed 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.525 -179.516 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.438 ' HA ' HG12 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -34.61 -74.18 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -178.823 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.737 HD22 ' CD1' ' A' ' 169' ' ' PHE . 7.8 mp -47.43 -39.21 15.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.058 -179.031 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.846 HD23 ' O ' ' A' ' 16' ' ' LYS . 3.1 mm? -76.9 -20.88 55.69 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.982 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.443 ' N ' ' O ' ' A' ' 17' ' ' THR . 9.1 mm -61.09 -69.64 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 74.8 m -56.55 -32.95 65.66 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.514 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.488 ' HB2' HD13 ' A' ' 165' ' ' LEU . 42.2 t80 -56.99 -68.38 0.23 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.026 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.3 m -76.65 -45.99 27.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.666 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.442 ' N ' ' O ' ' A' ' 21' ' ' ILE . 1.6 p -92.41 -155.91 0.44 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.435 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.414 ' N ' ' ND2' ' A' ' 26' ' ' ASN . 0.1 OUTLIER -155.75 23.8 0.39 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.776 0.322 . . . . 0.0 111.098 -179.908 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.33 100.22 9.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.947 0.403 . . . . 0.0 111.39 -179.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.491 ' HE2' HD21 ' A' ' 119' ' ' LEU . 0.1 OUTLIER -87.86 -64.95 0.2 Allowed Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.095 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.487 ' HD3' ' CD2' ' A' ' 28' ' ' PHE . 93.0 Cg_endo -81.72 54.16 4.96 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.597 2.198 . . . . 0.0 111.983 179.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.414 ' O ' ' HG3' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -97.17 -84.96 0.36 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.864 -179.64 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.417 ' HA ' ' HA ' ' B' ' 531' ' ' CYS . 27.0 mt-10 -149.52 126.49 11.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.041 0.448 . . . . 0.0 111.873 -179.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.527 ' HA ' ' PG ' ' A' ' 185' ' ' GNP . 3.1 m-85 -105.15 93.34 4.64 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.591 178.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.569 HG23 ' CD ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -165.81 -64.56 0.01 OUTLIER Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.253 -179.177 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.569 ' CD ' HG23 ' A' ' 33' ' ' VAL . 55.2 Cg_endo -70.78 56.7 1.86 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.599 2.199 . . . . 0.0 112.891 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.632 ' OG1' HG21 ' A' ' 17' ' ' THR . 7.3 t -121.75 26.35 8.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.993 0.425 . . . . 0.0 110.52 179.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.768 HG22 HD23 ' A' ' 61' ' ' LEU . 1.8 t -80.46 -5.66 8.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.888 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.454 ' HB3' ' N ' ' B' ' 522' ' ' GLY . 29.5 p90 -93.98 26.54 3.17 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.785 0.326 . . . . 0.0 111.142 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.1 p30 -70.3 -19.25 63.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.12 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -100.11 11.12 40.11 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.514 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.468 ' CE1' ' HA2' ' B' ' 522' ' ' GLY . 1.0 OUTLIER -60.66 -159.42 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 120.685 0.278 . . . . 0.0 110.664 179.894 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.41 ' O ' HG12 ' B' ' 519' ' ' ILE . . . -117.82 156.26 28.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.543 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.421 HG12 ' C ' ' B' ' 517' ' ' SER . 0.5 OUTLIER -140.56 126.13 20.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.883 179.725 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.737 ' O ' HG23 ' A' ' 44' ' ' VAL . 9.9 t -85.51 104.49 15.34 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.929 0.395 . . . . 0.0 110.592 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.939 ' CG1' HD13 ' B' ' 514' ' ' LEU . 2.8 t -164.63 158.1 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.818 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.487 ' HG3' HD22 ' B' ' 514' ' ' LEU . 0.0 OUTLIER -112.75 118.83 36.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.599 178.758 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.87 HG23 HG23 ' B' ' 510' ' ' ILE . 1.4 mm -79.65 86.81 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.441 -179.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 54.68 -76.16 0.01 OUTLIER Glycine 0 CA--C 1.521 0.464 0 CA-C-N 115.678 -0.692 . . . . 0.0 114.353 178.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . -57.55 -95.91 0.01 OUTLIER Glycine 0 CA--C 1.518 0.272 0 C-N-CA 121.099 -0.572 . . . . 0.0 113.559 -179.042 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.438 ' HB2' ' HD2' ' A' ' 50' ' ' PRO . 0.3 OUTLIER -115.93 163.83 19.84 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-O 120.736 0.303 . . . . 0.0 111.311 -179.154 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.438 ' HD2' ' HB2' ' A' ' 49' ' ' GLU . 57.8 Cg_exo -51.6 100.38 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.483 2.122 . . . . 0.0 112.39 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.437 ' HE1' HG21 ' A' ' 3' ' ' THR . 3.5 t80 -172.2 118.61 0.39 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.227 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.774 HG21 ' HB ' ' A' ' 44' ' ' VAL . 0.0 OUTLIER -113.95 138.64 50.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.49 179.807 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.883 HD22 HD13 ' A' ' 4' ' ' ILE . 0.3 OUTLIER -70.7 109.07 4.71 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.375 -179.463 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -61.22 94.73 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.613 179.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.833 HD23 ' HD3' ' A' ' 16' ' ' LYS . 0.9 OUTLIER -41.56 110.95 0.19 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.853 0.359 . . . . 0.0 111.179 -179.398 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -83.74 104.97 14.28 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.884 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.692 ' CG ' HG12 ' A' ' 14' ' ' VAL . 17.1 m-20 -131.56 174.89 9.64 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.001 -179.322 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.657 ' HA ' HD11 ' A' ' 67' ' ' LEU . 0.1 OUTLIER -144.77 143.92 30.91 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.935 -179.395 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.725 ' HB1' HD23 ' A' ' 61' ' ' LEU . . . -140.66 125.46 18.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.046 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.4 ' C ' HD22 ' A' ' 61' ' ' LEU . . . -75.66 66.19 2.41 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.728 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.768 HD23 HG22 ' A' ' 36' ' ' VAL . 3.0 mm? -121.23 -176.98 3.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.905 0.383 . . . . 0.0 110.978 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -52.79 -45.93 67.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.012 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.414 ' HB3' ' CE2' ' A' ' 64' ' ' TYR . 0.2 OUTLIER -50.68 -38.01 44.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.951 -179.959 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.726 ' HE2' HG12 ' A' ' 36' ' ' VAL . 1.4 m-85 -145.02 97.13 2.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.788 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -86.02 -37.54 18.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.211 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -97.51 4.27 50.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.781 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.731 HD23 ' O ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -62.15 133.66 55.53 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.764 0.316 . . . . 0.0 110.266 179.672 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -174.84 60.05 0.22 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.249 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.562 ' HD2' HG21 ' A' ' 58' ' ' THR . 62.4 Cg_endo -73.18 -23.23 18.24 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.567 2.178 . . . . 0.0 112.03 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.71 ' O ' HD12 ' A' ' 70' ' ' LEU . 0.3 OUTLIER -59.24 -20.19 52.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.096 -179.964 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.9 p -50.77 -42.89 58.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.169 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -160.68 69.91 2.76 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.031 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.421 ' HD3' ' O ' ' A' ' 70' ' ' LEU . 73.7 Cg_endo -75.19 149.58 36.14 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.653 2.235 . . . . 0.0 112.32 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.49 10.48 40.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.42 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.3 t -48.96 176.01 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.864 0.364 . . . . 0.0 110.897 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -109.39 -24.16 11.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.985 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.0 p -134.26 143.34 38.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.278 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.408 ' HB2' ' O ' ' A' ' 109' ' ' PRO . 0.1 OUTLIER -125.84 174.48 8.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.627 179.732 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.516 HD11 HG23 ' A' ' 113' ' ' VAL . 46.4 tp -146.51 109.28 4.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.892 0.377 . . . . 0.0 111.238 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.657 HG11 HD11 ' A' ' 101' ' ' ILE . 31.1 m -98.79 115.36 39.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.633 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 3.6 m -108.29 168.07 9.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.094 0.473 . . . . 0.0 111.655 -179.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.435 ' O ' ' N1 ' ' A' ' 185' ' ' GNP . 10.8 p90 -169.75 135.9 1.53 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.353 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.432 ' HA ' ' C2 ' ' A' ' 185' ' ' GNP . 4.9 p -83.17 141.17 32.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.035 0.445 . . . . 0.0 111.562 -179.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.782 HG12 ' O ' ' A' ' 137' ' ' ILE . 16.4 m -57.05 -31.47 37.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.243 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.74 HG11 HG21 ' A' ' 125' ' ' THR . 9.5 m -78.02 117.23 22.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.757 ' N ' HD22 ' A' ' 129' ' ' LEU . 0.4 OUTLIER -151.71 142.83 15.49 Favored Pre-proline 0 C--N 1.333 -0.151 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -179.141 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 86' ' ' SER . 69.4 Cg_endo -92.45 53.93 0.59 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 123.406 2.737 . . . . 0.0 111.614 179.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.445 ' CB ' ' HB2' ' A' ' 133' ' ' LYS . 0.3 OUTLIER 71.0 19.77 5.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.99 -179.297 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.711 ' O ' HG23 ' A' ' 93' ' ' VAL . 58.8 m -97.2 -21.59 17.21 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.741 0.305 . . . . 0.0 111.115 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.542 ' CZ ' HG21 ' A' ' 137' ' ' ILE . 17.4 t80 -47.48 -58.87 3.7 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.169 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.7 -39.29 36.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.868 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.419 ' O ' ' CD ' ' A' ' 96' ' ' LYS . 1.0 OUTLIER -72.52 -43.22 63.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.759 179.795 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.711 HG23 ' O ' ' A' ' 89' ' ' SER . 77.0 t -50.21 -63.47 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.051 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.81 ' HG2' HD13 ' A' ' 145' ' ' LEU . 0.0 OUTLIER -58.3 -39.32 79.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.913 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -65.81 -25.33 67.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.977 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.419 ' CD ' ' O ' ' A' ' 92' ' ' ASN . 1.4 mtpm? -100.06 -24.27 14.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.0 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.434 ' CE3' ' HA ' ' A' ' 97' ' ' TRP . 0.0 OUTLIER -67.18 -58.73 4.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.05 -179.853 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.544 HG21 HD13 ' A' ' 149' ' ' LEU . 95.4 t -45.57 -53.5 19.01 Favored Pre-proline 0 CA--C 1.532 0.26 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.814 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 51.9 Cg_endo -68.66 -14.43 39.35 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.173 1.915 . . . . 0.0 112.628 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -86.66 -35.66 19.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.87 0.367 . . . . 0.0 111.054 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.657 HD11 HG11 ' A' ' 80' ' ' VAL . 30.3 mt -78.31 -33.01 17.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.284 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.515 HG23 ' O ' ' A' ' 98' ' ' VAL . 22.9 p -84.76 -21.69 29.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.215 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 19.9 t-80 -87.63 -51.62 5.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.815 0.34 . . . . 0.0 110.96 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -80.54 -29.76 37.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.093 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -117.11 147.27 39.92 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.924 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.48 60.58 2.07 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.514 2.143 . . . . 0.0 112.288 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 59.12 67.56 0.9 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.966 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -90.84 146.79 34.6 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.744 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.408 ' O ' ' HB2' ' A' ' 78' ' ' PHE . 36.0 Cg_exo -60.7 169.17 5.89 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.505 2.137 . . . . 0.0 112.314 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.565 ' HB2' HG22 ' A' ' 80' ' ' VAL . 2.9 p90 -162.2 134.63 5.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.877 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.955 HD12 HG11 ' A' ' 152' ' ' VAL . 8.5 tt -119.93 154.53 34.3 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.997 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.596 ' N ' HD23 ' A' ' 111' ' ' LEU . 2.9 mm? -100.69 137.3 39.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.685 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 1.019 HG13 HG21 ' A' ' 168' ' ' VAL . 49.9 t -120.76 148.02 24.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.989 0.423 . . . . 0.0 111.373 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 157' ' ' CYS . . . -130.09 107.74 0.8 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.765 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.858 ' OG1' " H2'" ' A' ' 185' ' ' GNP . 0.0 OUTLIER -125.01 -41.14 2.11 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.909 0.385 . . . . 0.0 110.595 -179.106 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.736 ' HB3' HG22 ' A' ' 84' ' ' VAL . 2.1 tt0 -78.28 1.96 19.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.127 179.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.407 ' O ' ' CG ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -46.55 -26.23 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.094 0 CA-C-O 120.775 0.322 . . . . 0.0 111.562 179.929 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -75.52 -25.88 57.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.492 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.665 HD22 HE21 ' A' ' 116' ' ' GLN . 3.9 mp -83.95 -25.61 29.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.124 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.474 ' HB3' HG21 ' A' ' 84' ' ' VAL . 5.8 ppt_? -50.36 -25.52 3.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.978 0.418 . . . . 0.0 110.629 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -87.79 -25.82 23.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.574 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -61.33 112.19 5.5 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.767 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.418 ' O ' HG22 ' A' ' 126' ' ' ILE . 40.0 Cg_endo -67.92 -6.27 16.59 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.513 2.142 . . . . 0.0 113.114 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -77.39 -68.49 0.61 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.024 0.44 . . . . 0.0 109.929 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.74 HG21 HG11 ' A' ' 85' ' ' VAL . 4.8 m -56.71 -35.41 68.49 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.31 0.576 . . . . 0.0 109.556 179.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.721 HD11 ' HG3' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -57.53 -44.04 84.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.55 179.231 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' A' ' 123' ' ' PRO . 4.2 mm-40 -55.69 -36.85 67.61 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.469 179.099 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.426 ' HB2' ' O ' ' A' ' 125' ' ' THR . 0.0 OUTLIER -64.04 -31.3 72.44 Favored 'General case' 0 CA--C 1.518 -0.25 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.554 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.757 HD22 ' N ' ' A' ' 86' ' ' SER . 7.6 mt -74.0 -42.06 60.95 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.499 ' HA ' ' HB3' ' A' ' 134' ' ' GLN . . . -47.21 -28.97 2.09 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.956 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 31.4 mmtt -56.54 -34.12 66.75 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.753 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.412 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 1.7 m-80 -124.36 -31.33 3.3 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.508 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 0.0 OUTLIER -137.42 -75.6 0.41 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 121.037 -0.265 . . . . 0.0 111.306 -179.009 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.508 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 3.0 pt20 111.53 -45.21 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.607 1.163 . . . . 0.0 111.016 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.5 mttp -69.81 111.06 7.8 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.91 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.91 ' C ' HD13 ' A' ' 137' ' ' ILE . 69.9 Cg_endo -72.43 -169.89 0.52 Allowed 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.353 2.036 . . . . 0.0 111.218 178.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.91 HD13 ' C ' ' A' ' 136' ' ' PRO . 1.1 mm -114.03 97.03 5.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.904 0.383 . . . . 0.0 110.99 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.428 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 3.0 p -67.3 155.63 90.27 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.943 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.463 ' HA ' ' CE2' ' A' ' 154' ' ' TYR . 10.2 Cg_endo -51.66 -38.68 66.34 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.747 2.298 . . . . 0.0 112.098 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.422 ' HG3' ' N ' ' A' ' 141' ' ' THR . 0.0 OUTLIER -64.73 -25.96 68.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.664 179.69 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.422 ' N ' ' HG3' ' A' ' 140' ' ' GLU . 45.5 m -71.82 -47.4 53.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.787 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.492 ' O ' ' HB2' ' A' ' 146' ' ' ALA . . . -55.21 -39.2 69.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.877 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -68.04 -41.96 81.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.818 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -53.25 -60.6 3.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.867 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.81 HD13 ' HG2' ' A' ' 94' ' ' LYS . 1.6 tt -66.91 -39.8 87.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.64 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.492 ' HB2' ' O ' ' A' ' 142' ' ' ALA . . . -48.94 -50.37 35.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.927 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 19.2 mtp180 -78.76 -24.14 44.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.704 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -49.62 -34.78 19.03 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.88 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.544 HD13 HG21 ' A' ' 98' ' ' VAL . 1.6 mt -121.5 21.78 10.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.893 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.1 mttp 47.84 57.5 5.95 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.059 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.534 ' HB1' ' O ' ' A' ' 110' ' ' PHE . . . -70.58 -82.69 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.214 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.955 HG11 HD12 ' A' ' 111' ' ' LEU . 72.9 t -161.81 -73.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.842 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 179.5 146.35 0.2 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.61 -178.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.463 ' CE2' ' HA ' ' A' ' 139' ' ' PRO . 65.0 t80 -112.79 103.69 11.7 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.305 179.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.601 HG12 ' H ' ' A' ' 156' ' ' GLU . 0.6 OUTLIER -102.99 -179.96 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.744 -179.788 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.601 ' H ' HG12 ' A' ' 155' ' ' VAL . 0.0 OUTLIER -89.6 151.3 21.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.921 0.391 . . . . 0.0 111.099 -179.797 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.491 ' CB ' HG22 ' A' ' 115' ' ' THR . 1.9 t -128.97 169.22 14.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.883 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.497 ' O ' ' HB2' ' A' ' 159' ' ' ALA . 2.2 t -106.99 151.46 25.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.203 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.938 ' O ' HD13 ' A' ' 160' ' ' LEU . . . 172.68 -33.96 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.77 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.938 HD13 ' O ' ' A' ' 159' ' ' ALA . 0.2 OUTLIER -131.09 -44.35 1.04 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.7 179.753 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 9.7 t -100.08 -21.69 15.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.091 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.437 ' HA ' ' CB ' ' A' ' 158' ' ' SER . 1.9 tt0 72.89 77.7 0.14 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.955 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.458 ' HE3' ' CB ' ' A' ' 156' ' ' GLU . 0.0 OUTLIER -97.35 10.44 39.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.569 -179.948 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.406 ' O ' ' CB ' ' A' ' 165' ' ' LEU . . . 116.25 -50.85 0.76 Allowed Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.428 -0.892 . . . . 0.0 113.336 179.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.566 HD21 ' HA ' ' A' ' 19' ' ' LEU . 0.2 OUTLIER 79.54 -56.6 0.4 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.8 0.333 . . . . 0.0 110.8 -179.433 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -56.8 -21.32 27.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.791 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.559 ' ND2' HG11 ' A' ' 155' ' ' VAL . 0.1 OUTLIER -55.32 -72.18 0.07 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.014 179.889 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 1.019 HG21 HG13 ' A' ' 113' ' ' VAL . 29.0 m -57.9 -40.79 77.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.036 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.737 ' CD1' HD22 ' A' ' 19' ' ' LEU . 1.4 t80 -63.58 -34.67 78.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.734 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.41 ' HA ' ' CG1' ' A' ' 173' ' ' ILE . 13.2 m-20 -74.64 -24.89 58.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.659 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.517 ' CG ' HD11 ' A' ' 111' ' ' LEU . 5.1 tp10 -79.41 -33.41 42.69 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.59 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.582 ' N ' HD13 ' A' ' 111' ' ' LEU . . . -73.23 -35.25 66.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.685 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.537 HD12 HD12 ' A' ' 177' ' ' LEU . 1.4 pp -82.78 -32.51 9.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.891 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.807 HD13 ' CB ' ' B' ' 505' ' ' LEU . 13.6 tp -54.68 -47.34 73.75 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.211 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -47.5 -26.89 1.54 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.113 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.659 ' HB3' ' CG2' ' A' ' 4' ' ' ILE . . . -93.9 -37.12 11.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.173 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.796 ' CD1' HG21 ' B' ' 510' ' ' ILE . 43.3 mt -68.71 -24.2 64.46 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.663 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.416 ' HG3' ' N ' ' B' ' 507' ' ' ALA . 1.6 tm-20 -160.52 128.74 2.89 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.684 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.69 106.9 0.19 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.44 2.093 . . . . 0.0 112.333 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.19 176.48 9.89 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.557 2.171 . . . . 0.0 112.248 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -139.79 141.89 29.26 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.966 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.35 -165.04 0.29 Allowed 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.718 2.279 . . . . 0.0 112.227 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.08 173.87 1.01 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.018 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.289 -0.862 . . . . 0.0 110.882 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.153 0 N-CA-C 112.421 -0.272 . . . . 0.0 112.421 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 503' ' ' SER . . . . . 0.415 ' HB2' ' HA ' ' B' ' 511' ' ' SER . 0.5 OUTLIER -87.4 -80.66 0.25 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.809 0.338 . . . . 0.0 110.908 179.943 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 504' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' B' ' 509' ' ' ASP . . . 102.6 113.09 3.72 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.541 -0.838 . . . . 0.0 111.941 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 505' ' ' LEU . . . . . 0.807 ' CB ' HD13 ' A' ' 174' ' ' LEU . 0.1 OUTLIER -139.03 -42.28 0.47 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 121.053 -0.259 . . . . 0.0 111.681 -179.195 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 506' ' ' SER . . . . . 0.435 ' CB ' ' O ' ' B' ' 505' ' ' LEU . 0.4 OUTLIER 162.74 -44.98 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.668 0.27 . . . . 0.0 110.741 -179.678 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 507' ' ' ALA . . . . . 0.506 ' HB3' HG12 ' B' ' 510' ' ' ILE . . . -37.58 -35.23 0.12 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.627 0.727 . . . . 0.0 111.109 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 508' ' ' GLN . . . . . 0.493 ' O ' ' HB2' ' B' ' 509' ' ' ASP . 7.3 pt20 165.79 -37.94 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.555 -1.202 . . . . 0.0 108.634 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 509' ' ' ASP . . . . . 0.493 ' HB2' ' O ' ' B' ' 508' ' ' GLN . 13.7 t0 148.21 44.92 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 114.201 -1.363 . . . . 0.0 109.394 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 510' ' ' ILE . . . . . 0.87 HG23 HG23 ' A' ' 46' ' ' ILE . 19.9 mm -55.18 133.65 18.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.406 -179.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 511' ' ' SER . . . . . 0.48 ' HB3' HD11 ' B' ' 514' ' ' LEU . 30.2 t -109.59 134.82 51.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.836 179.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 512' ' ' GLN . . . . . 0.438 ' CB ' ' HD3' ' B' ' 513' ' ' PRO . 0.0 OUTLIER -99.47 -53.65 0.18 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.134 179.735 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 513' ' ' PRO . . . . . 0.438 ' HD3' ' CB ' ' B' ' 512' ' ' GLN . 91.0 Cg_endo -94.91 78.19 0.15 Allowed 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 123.152 2.568 . . . . 0.0 112.525 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 514' ' ' LEU . . . . . 0.939 HD13 ' CG1' ' A' ' 44' ' ' VAL . 4.7 mp -89.23 -89.88 0.14 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.227 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 515' ' ' GLN . . . . . 0.651 ' H ' HG22 ' A' ' 44' ' ' VAL . 6.4 mt-30 -93.4 47.31 1.24 Allowed 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 116.744 -0.207 . . . . 0.0 111.13 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 516' ' ' ASN . . . . . 0.546 ' HB3' ' O ' ' B' ' 515' ' ' GLN . 29.2 t30 77.7 -38.23 0.26 Allowed 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 517' ' ' SER . . . . . 0.421 ' C ' HG12 ' A' ' 42' ' ' VAL . 0.5 OUTLIER 61.24 54.33 3.27 Favored 'General case' 0 C--O 1.232 0.15 0 O-C-N 122.24 -0.287 . . . . 0.0 111.452 179.554 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 518' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -163.54 92.73 0.72 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.894 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 519' ' ' ILE . . . . . 0.689 HD11 ' H ' ' A' ' 43' ' ' THR . 22.4 mm -71.16 -69.13 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.089 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -160.47 -170.44 2.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.94 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 521' ' ' THR . . . . . 0.454 ' O ' ' CZ ' ' A' ' 40' ' ' TYR . 13.8 t -77.32 -168.37 1.12 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.058 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 522' ' ' GLY . . . . . 0.468 ' HA2' ' CE1' ' A' ' 40' ' ' TYR . . . -121.41 -75.12 0.37 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.38 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 523' ' ' HIS . . . . . 0.439 ' CD2' ' C ' ' B' ' 523' ' ' HIS . 9.4 t-160 178.98 -88.21 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.555 0.217 . . . . 0.0 110.902 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 524' ' ' GLY . . . . . 0.506 ' HA3' HG21 ' A' ' 36' ' ' VAL . . . 46.77 -139.5 7.53 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.778 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 525' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -137.99 82.85 1.94 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.837 0.351 . . . . 0.0 110.784 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 526' ' ' SER . . . . . 0.465 ' CB ' ' HB3' ' A' ' 34' ' ' PRO . 6.5 m -72.17 95.75 1.7 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.757 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 527' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -145.96 142.42 17.78 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.016 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.21 105.29 2.0 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.671 2.248 . . . . 0.0 112.113 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 529' ' ' ARG . . . . . 0.471 ' HG3' HG11 ' A' ' 33' ' ' VAL . 2.3 mtt-85 -100.27 -55.38 2.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.307 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 530' ' ' HIS . . . . . 0.418 ' O ' ' CB ' ' B' ' 531' ' ' CYS . 0.0 OUTLIER -130.57 -38.12 1.34 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.486 -179.592 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 531' ' ' CYS . . . . . 0.418 ' CB ' ' O ' ' B' ' 530' ' ' HIS . 4.0 m 79.49 28.74 0.34 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.988 0.423 . . . . 0.0 110.604 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 532' ' ' TRP . . . . . 0.439 ' CH2' ' HG3' ' B' ' 537' ' ' ARG . 1.7 t-105 59.28 103.28 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.035 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . -114.55 -24.31 4.42 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.278 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 534' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -133.47 130.97 21.2 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.489 0.185 . . . . 0.0 110.597 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.49 -170.03 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.458 2.106 . . . . 0.0 112.504 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 68.22 120.86 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.004 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 537' ' ' ARG . . . . . 0.439 ' HG3' ' CH2' ' B' ' 532' ' ' TRP . 0.0 OUTLIER -106.23 -179.32 3.91 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 121.599 0.714 . . . . 0.0 111.259 179.916 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 538' ' ' ILE . . . . . 0.433 HG12 ' HB2' ' B' ' 542' ' ' TYR . 1.2 tt -116.02 174.47 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 CA-C-N 114.594 -1.184 . . . . 0.0 109.891 179.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 539' ' ' ASP . . . . . 0.469 ' HB3' HD22 ' A' ' 70' ' ' LEU . 0.3 OUTLIER -69.8 162.3 28.14 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.482 179.851 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 540' ' ' GLU . . . . . 0.427 ' CB ' ' OG1' ' A' ' 58' ' ' THR . 2.4 mt-10 -40.38 -49.08 2.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.841 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 541' ' ' LEU . . . . . . . . . . . . . 1.1 tt -42.28 -67.91 0.23 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.797 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 542' ' ' TYR . . . . . 0.433 ' HB2' HG12 ' B' ' 538' ' ' ILE . 59.2 m-85 -84.57 9.62 13.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.981 -179.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 543' ' ' LEU . . . . . 0.421 ' HB2' ' HA ' ' B' ' 540' ' ' GLU . 16.5 tp -44.92 -28.47 0.67 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.834 0.35 . . . . 0.0 111.283 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . -72.52 77.91 0.74 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.548 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 545' ' ' ASN . . . . . 0.461 ' HB2' HG13 ' A' ' 33' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.975 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' GNP . . . . . 0.858 " H2'" ' OG1' ' A' ' 115' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' HOH . . . . . 0.406 ' O ' ' HB2' ' A' ' 18' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.431 ' HB3' ' N ' ' A' ' 49' ' ' GLU . 2.6 ppp? . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.828 0.347 . . . . 0.0 111.264 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.423 ' CG ' HD11 ' B' ' 510' ' ' ILE . 0.2 OUTLIER -129.44 141.17 51.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.52 179.464 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.807 HG23 ' CE1' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -94.06 168.78 10.72 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.983 -179.815 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.551 ' HA ' ' HB1' ' A' ' 176' ' ' ALA . 2.3 pt -151.03 154.39 8.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.659 -179.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -121.03 110.38 16.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.397 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.463 ' SG ' HD23 ' A' ' 55' ' ' LEU . 40.1 m -91.61 107.4 19.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.004 0.43 . . . . 0.0 111.589 -179.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.452 HG22 ' CZ ' ' A' ' 56' ' ' PHE . 2.9 t -138.0 113.65 10.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.254 179.334 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.78 ' CG2' HG21 ' A' ' 14' ' ' VAL . 2.4 p -87.24 150.14 3.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.308 0.575 . . . . 0.0 111.436 -179.445 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.53 ' CG2' ' CE1' ' A' ' 78' ' ' PHE . 72.5 t -155.06 130.23 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.637 179.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.72 148.13 4.75 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.131 -1.033 . . . . 0.0 112.711 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -58.17 -42.18 85.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.893 0.378 . . . . 0.0 110.394 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.26 -149.94 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.701 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.741 ' HB3' ' H8 ' ' A' ' 185' ' ' GNP . . . -103.1 -55.86 2.33 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.958 HG22 ' HB3' ' A' ' 81' ' ' CYS . 3.5 t 84.13 -51.52 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.264 -0.425 . . . . 0.0 109.949 -178.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.676 ' C ' HD12 ' A' ' 19' ' ' LEU . . . 90.49 25.48 25.67 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.857 -0.687 . . . . 0.0 113.045 179.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.447 ' HE2' ' N ' ' A' ' 8' ' ' VAL . 0.7 OUTLIER -38.58 -43.2 0.85 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.11 0.481 . . . . 0.0 111.017 179.749 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.534 HG22 ' CG ' ' A' ' 38' ' ' ASP . 81.9 p -98.47 -60.98 1.44 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.278 178.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.48 ' HA ' ' HB ' ' A' ' 21' ' ' ILE . 29.7 t -46.51 -32.65 3.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.014 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.865 HD13 ' CE2' ' A' ' 169' ' ' PHE . 3.3 mt -45.68 -71.99 0.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -178.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.443 HD13 ' HA ' ' A' ' 20' ' ' LEU . 3.0 mm? -64.64 -23.67 67.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.951 -179.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.48 ' HB ' ' HA ' ' A' ' 18' ' ' CYS . 14.6 mm -61.05 -70.95 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.945 0.403 . . . . 0.0 110.486 179.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.528 ' HA ' ' HA ' ' A' ' 26' ' ' ASN . 2.4 t -51.76 -34.42 39.38 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.162 -179.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.509 ' CE2' ' HD3' ' A' ' 166' ' ' LYS . 27.5 t80 -55.93 -45.11 78.84 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.968 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.62 -64.42 1.05 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.543 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.431 ' OG1' HG23 ' A' ' 21' ' ' ILE . 79.9 p -66.27 -37.47 85.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.582 -179.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.528 ' HA ' ' HA ' ' A' ' 22' ' ' SER . 1.5 t-20 67.08 56.91 0.63 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.941 -179.15 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.0 mmtt -132.91 83.25 2.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.134 0.492 . . . . 0.0 110.961 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.468 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 40.5 t80 -92.35 -45.56 0.34 Allowed Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.082 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.468 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 62.6 Cg_endo -94.86 90.22 0.11 Allowed 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.955 2.436 . . . . 0.0 112.939 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.429 ' O ' ' CB ' ' B' ' 531' ' ' CYS . 0.4 OUTLIER -150.47 -89.2 0.07 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.627 0.251 . . . . 0.0 110.855 179.616 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -159.12 126.26 4.76 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.627 -0.261 . . . . 0.0 110.427 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.512 ' CG ' ' NH2' ' B' ' 537' ' ' ARG . 3.8 m-85 -111.55 121.87 46.31 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.194 0.521 . . . . 0.0 111.283 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.686 HG11 ' HG3' ' B' ' 529' ' ' ARG . 0.0 OUTLIER -165.42 -64.55 0.01 OUTLIER Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.433 179.971 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.478 ' CD ' HG23 ' A' ' 33' ' ' VAL . 50.5 Cg_endo -69.9 58.37 1.62 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.385 2.057 . . . . 0.0 112.428 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.2 t -87.64 10.47 17.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.737 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.698 HG13 HD23 ' A' ' 61' ' ' LEU . 3.3 m -76.0 -30.03 20.33 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-O 120.865 0.364 . . . . 0.0 110.84 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.409 ' O ' ' CG ' ' A' ' 40' ' ' TYR . 0.2 OUTLIER -50.87 -25.01 4.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.017 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.534 ' CG ' HG22 ' A' ' 17' ' ' THR . 20.8 t0 -50.34 -28.29 7.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.971 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -88.99 14.52 10.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.165 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.473 ' CZ ' ' CG1' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -71.59 -169.99 0.49 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.787 0.327 . . . . 0.0 110.911 179.809 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.402 ' O ' HG12 ' B' ' 519' ' ' ILE . . . -112.16 119.92 40.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.316 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.473 ' CG1' ' CZ ' ' A' ' 40' ' ' TYR . 2.5 m -122.71 121.71 64.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.023 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.4 t -104.69 128.79 52.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.9 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.986 HG12 ' CG2' ' A' ' 52' ' ' THR . 1.0 OUTLIER -164.54 -177.45 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.871 179.895 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.611 ' H ' HG22 ' A' ' 44' ' ' VAL . 5.9 tpt -101.4 96.13 6.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.012 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.675 HG22 ' O ' ' A' ' 46' ' ' ILE . 1.6 mm -74.86 86.9 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 120.841 0.353 . . . . 0.0 110.219 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.45 ' HA3' ' HA ' ' B' ' 510' ' ' ILE . . . 33.71 -87.72 0.01 OUTLIER Glycine 0 CA--C 1.523 0.549 0 CA-C-N 115.676 -0.693 . . . . 0.0 114.327 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . -37.72 -79.17 0.04 OUTLIER Glycine 0 C--N 1.333 0.392 0 N-CA-C 113.899 0.319 . . . . 0.0 113.899 -179.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.482 ' N ' ' HE1' ' A' ' 45' ' ' MET . 2.7 mt-10 -140.52 156.34 69.42 Favored Pre-proline 0 C--N 1.332 -0.162 0 CA-C-O 120.808 0.337 . . . . 0.0 111.621 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -43.2 101.01 0.04 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 123.137 2.558 . . . . 0.0 112.838 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.807 ' CE1' HG23 ' A' ' 3' ' ' THR . 17.8 t80 -172.68 153.62 2.81 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.368 179.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.986 ' CG2' HG12 ' A' ' 44' ' ' VAL . 0.8 OUTLIER -136.88 154.11 50.57 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.961 179.53 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.643 ' N ' HD13 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -99.56 166.57 11.08 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.984 179.772 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 56' ' ' PHE . . . -115.17 87.56 0.44 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.42 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.542 ' H ' HD12 ' A' ' 55' ' ' LEU . 0.5 OUTLIER -60.34 82.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.781 0.324 . . . . 0.0 110.538 179.888 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.464 ' CG ' ' O ' ' A' ' 56' ' ' PHE . 37.4 p90 -84.36 105.5 15.24 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.571 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 56.6 p30 -98.19 -177.88 3.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.761 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.96 HG21 HD22 ' A' ' 70' ' ' LEU . 73.6 p -94.39 161.54 14.19 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.816 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.418 ' CA ' ' O ' ' B' ' 542' ' ' TYR . . . -170.84 179.84 3.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.172 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.565 ' H ' HD22 ' A' ' 61' ' ' LEU . . . -150.97 34.66 0.93 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.463 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.698 HD23 HG13 ' A' ' 36' ' ' VAL . 2.0 mm? -95.71 -173.18 2.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.863 0.363 . . . . 0.0 110.917 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -51.02 -25.54 4.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.734 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.497 ' HB2' HG11 ' A' ' 36' ' ' VAL . 0.2 OUTLIER -53.95 -54.79 34.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.798 179.866 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.411 ' CD2' ' HB3' ' A' ' 63' ' ' ASP . 4.4 m-85 -132.53 152.07 51.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.774 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -85.88 -68.27 0.75 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.205 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.8 -52.27 4.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.224 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.761 HD23 ' O ' ' A' ' 67' ' ' LEU . 7.2 tt 55.42 98.61 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.484 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.0 mmm180 -132.88 58.93 39.26 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.128 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.494 ' HD2' HD23 ' A' ' 70' ' ' LEU . 83.5 Cg_endo -83.68 -21.72 4.04 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.827 2.351 . . . . 0.0 112.172 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.96 HD22 HG21 ' A' ' 58' ' ' THR . 1.1 pt? -85.69 1.32 49.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.721 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 46.3 t -70.59 -71.16 0.26 Allowed 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.728 0.299 . . . . 0.0 111.065 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -121.85 72.55 32.76 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.861 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.411 ' HG3' ' CZ ' ' A' ' 78' ' ' PHE . 98.4 Cg_endo -78.71 140.87 16.85 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.713 2.275 . . . . 0.0 112.457 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.8 tp60 -102.11 10.39 39.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.349 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 13.6 t -59.55 -173.75 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.866 0.365 . . . . 0.0 111.055 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -136.22 7.83 3.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.503 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.501 ' CG1' ' HB3' ' A' ' 175' ' ' ALA . 64.0 t -151.14 101.15 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 CA-C-O 120.788 0.328 . . . . 0.0 111.249 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.53 ' CE1' ' CG2' ' A' ' 9' ' ' VAL . 0.1 OUTLIER -102.08 -177.85 3.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.645 179.785 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.636 HD13 ' HB3' ' A' ' 111' ' ' LEU . 21.7 tp -154.13 114.59 3.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.831 0.348 . . . . 0.0 111.633 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.609 HG23 HD13 ' A' ' 112' ' ' LEU . 2.9 m -94.61 156.22 3.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.486 179.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.958 ' HB3' HG22 ' A' ' 14' ' ' VAL . 22.3 p -128.98 168.93 15.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.237 0.541 . . . . 0.0 112.178 -179.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.649 ' HZ ' ' HB1' ' A' ' 142' ' ' ALA . 46.9 p90 179.27 123.51 0.06 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.926 179.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.435 ' HA ' ' C2 ' ' A' ' 185' ' ' GNP . 98.8 p -93.61 146.27 23.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.881 0.372 . . . . 0.0 111.44 -179.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.925 HG11 ' HG2' ' A' ' 120' ' ' ARG . 58.1 t -51.3 -73.95 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.366 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.445 ' O ' HG23 ' A' ' 85' ' ' VAL . 8.1 m -43.27 105.76 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 120.756 0.313 . . . . 0.0 110.968 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.443 ' N ' HD22 ' A' ' 129' ' ' LEU . 87.6 p -151.33 138.65 12.19 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.62 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.407 ' O ' ' CB ' ' A' ' 88' ' ' SER . 80.3 Cg_endo -91.65 53.93 0.8 Allowed 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.305 2.67 . . . . 0.0 112.026 179.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.461 ' CA ' ' HG3' ' A' ' 133' ' ' LYS . 0.1 OUTLIER 81.42 30.33 0.14 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.84 -179.611 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.533 ' O ' HG23 ' A' ' 93' ' ' VAL . 11.1 t -88.18 -24.42 23.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.697 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.631 ' CZ ' HG21 ' A' ' 137' ' ' ILE . 0.4 OUTLIER -50.89 -64.41 0.82 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.871 179.901 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -51.83 -37.58 52.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.936 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.413 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 3.3 m120 -67.96 -64.2 0.91 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.917 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 89' ' ' SER . 50.7 t -49.26 -46.7 18.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.368 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.791 ' HB2' HD11 ' A' ' 145' ' ' LEU . 4.5 ttpt -54.19 -59.08 5.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.276 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.415 ' O ' ' HG2' ' A' ' 99' ' ' PRO . 7.1 mt-10 -83.46 9.9 10.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.869 -179.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.413 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 13.7 tttt -116.86 -33.09 4.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.724 0.297 . . . . 0.0 111.067 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.558 ' O ' HG22 ' A' ' 101' ' ' ILE . 0.0 OUTLIER -94.35 -45.31 7.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.459 -179.658 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 94' ' ' LYS . 43.8 t -53.09 -44.44 97.13 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 -179.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.493 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 2.7 Cg_exo -76.01 -24.48 11.24 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.609 2.206 . . . . 0.0 112.641 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -88.73 -49.69 6.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.016 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.558 HG22 ' O ' ' A' ' 97' ' ' TRP . 8.9 tt -51.16 -24.55 3.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.157 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.416 HG23 HG23 ' A' ' 101' ' ' ILE . 59.3 p -97.22 -28.72 13.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.006 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 54.1 t60 -72.82 -69.29 0.42 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.926 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -62.88 -42.15 99.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.733 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 17.0 m -111.03 148.41 38.58 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.739 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -49.29 167.7 0.15 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.502 2.135 . . . . 0.0 112.21 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.6 tmtt? -83.01 54.98 2.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.799 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.4 p -76.88 156.81 82.33 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.031 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -60.45 166.52 9.43 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.653 2.235 . . . . 0.0 112.238 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.568 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 9.1 p90 -163.11 142.44 8.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.925 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.938 HD12 HG11 ' A' ' 152' ' ' VAL . 0.9 OUTLIER -108.56 159.7 16.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.983 -179.721 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.609 HD13 HG23 ' A' ' 80' ' ' VAL . 3.1 mm? -106.15 128.03 53.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.659 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.862 ' HA ' HG11 ' A' ' 168' ' ' VAL . 43.8 t -89.96 128.45 41.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.134 0.492 . . . . 0.0 111.555 -179.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.516 ' HA2' ' CE2' ' A' ' 154' ' ' TYR . . . -112.36 103.62 1.49 Allowed Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.253 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.666 HG23 HG12 ' A' ' 113' ' ' VAL . 0.4 OUTLIER -144.1 -153.65 0.48 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.826 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.539 ' CB ' HN22 ' A' ' 185' ' ' GNP . 0.4 OUTLIER 39.39 29.95 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.065 0.459 . . . . 0.0 111.329 179.333 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.534 HD13 ' C ' ' A' ' 115' ' ' THR . 0.0 OUTLIER -74.37 -4.3 5.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.711 179.376 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -100.28 -22.01 15.26 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.11 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.594 ' N ' HD22 ' A' ' 119' ' ' LEU . 2.1 mm? -72.85 -29.65 63.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.097 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.925 ' HG2' HG11 ' A' ' 84' ' ' VAL . 25.7 mtp180 -47.32 -35.5 8.12 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.917 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -76.32 -42.55 44.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.794 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -46.93 100.52 0.24 Allowed Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.89 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.442 ' HA ' ' CG2' ' A' ' 126' ' ' ILE . 10.5 Cg_exo -71.57 -3.76 13.7 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.737 2.291 . . . . 0.0 112.675 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.3 t -79.45 -64.11 1.26 Allowed 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.414 ' O ' ' HB2' ' A' ' 128' ' ' LYS . 11.0 m -58.92 -40.14 83.68 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 178.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.48 HD13 ' O ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -53.78 -45.73 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.777 179.217 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.474 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 3.2 mm-40 -57.54 -36.08 71.15 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.068 179.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 125' ' ' THR . 1.4 mptt -64.75 -30.66 71.67 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.452 ' CD1' ' HA ' ' A' ' 126' ' ' ILE . 5.3 mt -74.16 -40.8 62.34 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.09 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 127' ' ' GLU . . . -42.91 -36.97 1.69 Allowed 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.438 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.3 mmtp -50.6 -29.06 9.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.974 0.416 . . . . 0.0 110.364 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.407 ' OD1' ' HB2' ' A' ' 87' ' ' PRO . 2.3 m120 -123.88 -31.09 3.45 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.732 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.516 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 4.0 mmpt? -148.86 -90.81 0.08 Allowed 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.516 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 1.2 pt20 122.24 -25.18 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.713 1.205 . . . . 0.0 110.314 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 4.5 ptmm? -69.21 110.71 6.7 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.716 -179.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.405 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 88.2 Cg_endo -82.01 127.69 5.5 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.574 2.182 . . . . 0.0 111.302 179.084 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.742 ' N ' HD13 ' A' ' 137' ' ' ILE . 0.9 OUTLIER -58.65 96.75 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.916 0.389 . . . . 0.0 110.792 -179.423 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.461 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 7.2 p -70.24 155.96 92.62 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.042 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.461 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 10.3 Cg_endo -51.23 -24.37 15.16 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.653 2.235 . . . . 0.0 112.175 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -79.79 -46.36 17.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.551 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 6.8 m -56.2 -45.3 79.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.669 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.649 ' HB1' ' HZ ' ' A' ' 82' ' ' PHE . . . -51.76 -51.49 55.82 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.847 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -53.97 -39.42 65.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.744 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.26 -55.81 24.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.701 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.791 HD11 ' HB2' ' A' ' 94' ' ' LYS . 1.6 tt -69.43 -36.96 77.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.572 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -54.42 -71.9 0.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.051 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.443 ' CZ ' ' HE3' ' A' ' 183' ' ' LYS . 10.0 mtt180 -61.35 -23.16 65.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.098 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -49.98 -37.16 31.18 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.855 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.484 ' CD1' HG11 ' A' ' 98' ' ' VAL . 0.6 OUTLIER -112.77 20.59 16.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.087 179.828 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.3 mttt 47.89 49.09 17.3 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.144 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.572 ' O ' HG23 ' A' ' 152' ' ' VAL . . . -65.25 -81.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.956 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.938 HG11 HD12 ' A' ' 111' ' ' LEU . 49.1 t -161.56 -75.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.732 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.449 ' O ' HD21 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -175.75 131.18 0.26 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.923 -178.822 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.516 ' CE2' ' HA2' ' A' ' 114' ' ' GLY . 11.1 t80 -104.47 103.71 13.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.15 179.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.56 ' HB ' HG22 ' A' ' 168' ' ' VAL . 1.4 t -102.16 164.64 3.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.141 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.4 ' H ' HG12 ' A' ' 155' ' ' VAL . 76.9 tt0 -89.86 135.78 33.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.82 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.424 ' HA ' ' HB3' ' A' ' 163' ' ' LYS . 20.4 p -178.59 129.51 0.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.922 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.651 ' HB3' HG22 ' A' ' 161' ' ' THR . 0.1 OUTLIER -125.74 140.4 52.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.172 -179.906 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.52 ' HB2' HD22 ' A' ' 165' ' ' LEU . . . -84.19 -44.32 14.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.072 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -47.77 -34.97 9.21 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.763 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.651 HG22 ' HB3' ' A' ' 158' ' ' SER . 10.6 t -116.02 -15.87 11.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.118 179.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.417 ' CA ' ' O ' ' A' ' 158' ' ' SER . 1.5 tt0 70.33 66.8 0.21 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.812 0.339 . . . . 0.0 110.68 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.424 ' HB3' ' HA ' ' A' ' 157' ' ' CYS . 1.0 OUTLIER -93.81 22.79 5.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.254 -179.686 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 102.36 41.98 2.28 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.48 -0.867 . . . . 0.0 113.111 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.849 HD23 ' HA ' ' A' ' 19' ' ' LEU . 1.7 tp -50.4 -25.07 3.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.864 0.364 . . . . 0.0 110.691 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.509 ' HD3' ' CE2' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -68.54 -26.08 65.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.842 179.514 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -58.33 -72.29 0.1 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.827 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.862 HG11 ' HA ' ' A' ' 113' ' ' VAL . 91.3 t -52.44 -43.63 41.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.967 0.413 . . . . 0.0 110.461 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.865 ' CE2' HD13 ' A' ' 19' ' ' LEU . 0.2 OUTLIER -62.77 -33.66 75.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.277 179.681 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.532 ' OD1' HD11 ' A' ' 173' ' ' ILE . 27.1 t0 -69.82 -25.61 63.84 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.599 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.607 ' CB ' HD11 ' A' ' 111' ' ' LEU . 4.4 mm-40 -78.75 -29.15 44.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.132 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.568 ' N ' HD13 ' A' ' 111' ' ' LEU . . . -75.1 -43.51 52.53 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.888 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.532 HD11 ' OD1' ' A' ' 170' ' ' ASP . 1.6 pp -68.75 -36.11 72.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.838 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.625 HD22 ' HB3' ' B' ' 505' ' ' LEU . 26.0 tp -55.13 -42.95 73.68 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.776 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.501 ' HB3' ' CG1' ' A' ' 77' ' ' VAL . . . -48.17 -27.01 2.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.775 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.551 ' HB1' ' HA ' ' A' ' 4' ' ' ILE . . . -86.7 -43.75 12.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.845 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.769 HD13 ' HB ' ' B' ' 510' ' ' ILE . 56.3 mt -68.73 -26.94 65.51 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.957 0.408 . . . . 0.0 110.255 179.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.488 ' HB2' ' HB2' ' B' ' 507' ' ' ALA . 0.1 OUTLIER -174.14 92.6 0.33 Allowed Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.721 179.788 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.439 ' HA ' ' HD2' ' A' ' 180' ' ' PRO . 86.4 Cg_exo -47.74 106.04 0.1 OUTLIER 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.645 2.23 . . . . 0.0 112.428 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 179' ' ' PRO . 41.7 Cg_endo -67.22 171.99 10.69 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.47 2.114 . . . . 0.0 112.205 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -110.19 137.79 20.67 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.979 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -79.42 -165.17 0.32 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.576 2.184 . . . . 0.0 112.272 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.443 ' HE3' ' CZ ' ' A' ' 147' ' ' ARG . 0.0 OUTLIER -135.97 97.33 3.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.925 179.992 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.166 -0.921 . . . . 0.0 110.921 -179.985 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 503' ' ' SER . . . . . . . . . . . . . 3.3 m -90.41 -75.97 0.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.744 0.307 . . . . 0.0 110.918 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 504' ' ' GLY . . . . . 0.836 ' O ' HD12 ' B' ' 505' ' ' LEU . . . 144.16 -116.84 0.99 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.368 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 505' ' ' LEU . . . . . 0.836 HD12 ' O ' ' B' ' 504' ' ' GLY . 0.1 OUTLIER 64.99 -70.6 0.09 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.786 0.327 . . . . 0.0 111.204 179.823 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 506' ' ' SER . . . . . 0.42 ' N ' ' O ' ' B' ' 504' ' ' GLY . 0.1 OUTLIER -171.92 -159.77 0.15 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.546 -179.973 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 507' ' ' ALA . . . . . 0.488 ' HB2' ' HB2' ' A' ' 178' ' ' GLU . . . 62.97 -95.71 0.05 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.469 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 508' ' ' GLN . . . . . 0.462 ' O ' ' CB ' ' B' ' 509' ' ' ASP . 28.6 mt-30 -137.28 4.04 2.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.875 179.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 509' ' ' ASP . . . . . 0.462 ' CB ' ' O ' ' B' ' 508' ' ' GLN . 0.1 OUTLIER 92.36 29.7 0.01 OUTLIER 'General case' 0 C--N 1.345 0.406 0 CA-C-O 121.461 0.648 . . . . 0.0 109.864 -179.127 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 510' ' ' ILE . . . . . 0.769 ' HB ' HD13 ' A' ' 177' ' ' LEU . 43.0 mt -61.58 149.48 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.393 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 511' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.23 146.62 33.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.291 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 512' ' ' GLN . . . . . 0.529 ' HA ' HD13 ' A' ' 173' ' ' ILE . 1.5 pm0 -57.79 -176.2 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.35 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 513' ' ' PRO . . . . . 0.576 ' HG3' HD21 ' A' ' 53' ' ' LEU . 50.9 Cg_exo -55.52 82.37 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.492 2.128 . . . . 0.0 111.694 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 514' ' ' LEU . . . . . 0.451 ' N ' ' O ' ' B' ' 512' ' ' GLN . 1.8 mp -46.38 171.96 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.003 -179.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 515' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -94.26 -168.65 1.89 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.766 179.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 66.22 10.49 7.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.589 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 517' ' ' SER . . . . . 0.445 ' CB ' ' HB ' ' A' ' 44' ' ' VAL . 72.5 p -133.47 80.77 1.89 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.912 0.387 . . . . 0.0 111.02 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 518' ' ' PHE . . . . . 0.429 ' HA ' HG12 ' A' ' 42' ' ' VAL . 22.6 m-85 -140.45 91.69 2.46 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.897 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 519' ' ' ILE . . . . . 0.47 ' N ' HD13 ' B' ' 519' ' ' ILE . 3.0 mm -84.97 138.12 19.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.046 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -41.89 -88.86 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.409 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 521' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 47.86 -161.59 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.873 0.368 . . . . 0.0 111.009 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 522' ' ' GLY . . . . . . . . . . . . . . . 55.24 170.33 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.47 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 523' ' ' HIS . . . . . . . . . . . . . 22.7 t60 -156.6 -77.45 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.787 0.327 . . . . 0.0 110.876 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 524' ' ' GLY . . . . . 0.627 ' HA3' HG21 ' A' ' 36' ' ' VAL . . . 46.68 -144.62 4.33 Favored Glycine 0 N--CA 1.454 -0.164 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.722 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 525' ' ' ASP . . . . . 0.693 ' HB2' HD12 ' A' ' 61' ' ' LEU . 30.4 m-20 -119.24 81.47 1.72 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.826 0.346 . . . . 0.0 110.842 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 526' ' ' SER . . . . . 0.448 ' CA ' ' HB3' ' A' ' 34' ' ' PRO . 0.7 OUTLIER -88.43 96.25 10.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.785 179.968 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 527' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -162.08 141.28 7.28 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.795 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -57.52 97.61 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.677 2.251 . . . . 0.0 112.072 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 529' ' ' ARG . . . . . 0.686 ' HG3' HG11 ' A' ' 33' ' ' VAL . 10.4 mtp180 -100.23 -54.74 2.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.099 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 530' ' ' HIS . . . . . 0.485 ' CE1' ' HB3' ' B' ' 545' ' ' ASN . 6.2 p80 -165.47 97.45 0.68 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.831 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 531' ' ' CYS . . . . . 0.429 ' CB ' ' O ' ' A' ' 30' ' ' SER . 18.8 p -53.49 -171.65 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.068 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 532' ' ' TRP . . . . . . . . . . . . . 87.4 t90 -49.06 103.78 0.05 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.013 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . -116.39 -57.47 0.32 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.496 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 534' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -68.38 155.97 91.38 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 120.705 0.288 . . . . 0.0 110.872 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -63.34 -19.52 68.39 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.633 2.222 . . . . 0.0 112.485 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -151.66 139.01 19.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.929 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 537' ' ' ARG . . . . . 0.516 ' HD3' ' HB2' ' A' ' 13' ' ' ALA . 0.1 OUTLIER -48.07 152.23 0.85 Allowed 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.114 179.921 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 538' ' ' ILE . . . . . 0.418 ' CG2' ' HA ' ' B' ' 543' ' ' LEU . 5.6 tp -63.42 140.77 19.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.139 179.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 539' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -44.61 147.39 0.61 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.733 0.301 . . . . 0.0 111.162 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 540' ' ' GLU . . . . . 0.533 ' OE1' HD13 ' B' ' 543' ' ' LEU . 49.8 mm-40 -60.14 -15.86 27.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.613 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 541' ' ' LEU . . . . . 0.813 ' HA ' HD11 ' A' ' 70' ' ' LEU . 2.9 mm? -41.31 -59.59 1.5 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.99 0.424 . . . . 0.0 110.897 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 542' ' ' TYR . . . . . 0.453 ' CD1' ' HB3' ' B' ' 541' ' ' LEU . 0.1 OUTLIER -105.84 -53.63 2.61 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.578 179.41 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 543' ' ' LEU . . . . . 0.786 HD23 ' O ' ' A' ' 58' ' ' THR . 6.8 tp 57.01 31.94 20.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.936 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . -119.13 83.6 0.35 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.468 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 545' ' ' ASN . . . . . 0.486 ' HB2' HG13 ' A' ' 33' ' ' VAL . 3.6 m120 . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.211 -0.9 . . . . 0.0 110.851 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' GNP . . . . . 0.741 ' H8 ' ' HB3' ' A' ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.796 0.331 . . . . 0.0 111.255 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.81 144.4 47.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.388 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.645 HG23 ' CE1' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -93.86 176.34 6.38 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.925 -179.948 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 1.012 HG13 HD13 ' A' ' 53' ' ' LEU . 4.0 pt -152.27 146.36 15.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.009 0.433 . . . . 0.0 112.115 -178.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.608 ' O ' HG21 ' A' ' 75' ' ' THR . 13.1 tptp -134.44 95.73 3.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.399 179.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -110.08 119.74 40.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.979 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.417 ' HA ' ' HB3' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -104.79 145.55 13.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.14 0.495 . . . . 0.0 111.301 179.772 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.851 HG11 ' HE3' ' A' ' 16' ' ' LYS . 2.6 p -91.63 113.55 27.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.268 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.52 HG21 ' CD2' ' A' ' 78' ' ' PHE . 30.1 m -134.9 150.33 29.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.081 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 127.93 -144.46 15.22 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.508 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -103.25 -21.34 13.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.72 0.295 . . . . 0.0 110.956 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -105.02 156.33 16.87 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.611 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.47 4.78 22.93 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.811 HG21 HD23 ' A' ' 79' ' ' LEU . 1.9 m 40.99 31.07 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 120.985 0.422 . . . . 0.0 111.37 -179.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.435 ' O ' ' CG ' ' A' ' 19' ' ' LEU . . . 56.96 24.93 52.22 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.407 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.851 ' HE3' HG11 ' A' ' 8' ' ' VAL . 9.6 ptmt -38.31 -45.43 0.99 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.809 0.338 . . . . 0.0 111.628 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.929 HG22 HG13 ' A' ' 21' ' ' ILE . 0.2 OUTLIER -97.46 -57.43 2.25 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.49 179.341 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.522 ' HB3' ' HB1' ' A' ' 159' ' ' ALA . 46.8 m -47.65 -32.06 5.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.245 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.89 ' CD2' HD22 ' A' ' 165' ' ' LEU . 9.6 mt -47.35 -71.32 0.07 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.026 0.441 . . . . 0.0 111.079 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.629 ' H ' HD22 ' A' ' 20' ' ' LEU . 0.6 OUTLIER -87.08 -27.47 23.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.947 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.929 HG13 HG22 ' A' ' 17' ' ' THR . 46.8 mm -68.44 -52.96 31.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 179.051 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.447 ' CB ' ' O ' ' A' ' 18' ' ' CYS . 2.3 t -69.73 -37.61 76.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.519 179.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -51.87 -45.9 64.26 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.575 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.1 m -94.03 -48.58 6.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.566 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.441 ' N ' ' O ' ' A' ' 21' ' ' ILE . 1.3 p -96.4 -146.19 0.29 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.228 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.44 ' N ' ' ND2' ' A' ' 26' ' ' ASN . 0.1 OUTLIER -163.2 34.64 0.09 Allowed 'General case' 0 C--O 1.232 0.139 0 O-C-N 122.341 -0.225 . . . . 0.0 111.365 -179.746 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.485 ' CG ' HG21 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -86.42 127.41 34.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.926 0.393 . . . . 0.0 111.067 -179.896 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.539 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . 89.0 t80 -164.04 -50.71 0.01 OUTLIER Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.035 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.539 ' HD3' ' HB3' ' A' ' 28' ' ' PHE . 88.1 Cg_endo -93.03 33.06 0.24 Allowed 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.171 1.914 . . . . 0.0 112.65 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.43 -84.8 0.58 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.772 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -159.04 147.59 18.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.697 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.473 ' HB3' ' PG ' ' A' ' 185' ' ' GNP . 9.7 m-85 -126.02 124.04 39.8 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.675 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.558 HG23 ' HD3' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -165.17 -61.76 0.01 OUTLIER Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.112 -179.763 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.558 ' HD3' HG23 ' A' ' 33' ' ' VAL . 79.5 Cg_exo -46.36 -25.78 3.5 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.382 2.054 . . . . 0.0 112.329 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.869 HG21 ' O2G' ' A' ' 185' ' ' GNP . 6.5 t -40.54 -29.51 0.09 Allowed 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.893 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.893 HG23 ' HB3' ' A' ' 59' ' ' ALA . 12.0 p -51.95 -22.25 2.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.607 -0.269 . . . . 0.0 111.394 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.479 ' CD1' ' O ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -88.68 18.34 4.76 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.494 179.899 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.403 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 25.6 t0 -58.74 -18.02 27.94 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.223 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -86.57 13.56 8.31 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.546 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.466 ' CD1' ' N ' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -60.8 179.09 0.19 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.819 0.342 . . . . 0.0 110.946 179.91 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.423 ' O ' HG12 ' B' ' 519' ' ' ILE . . . -98.05 124.94 42.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.143 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.856 HG13 ' O ' ' B' ' 517' ' ' SER . 2.8 t -119.1 146.63 23.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.737 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.4 p -129.13 112.02 13.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.867 0.365 . . . . 0.0 111.566 -179.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 1.086 HG22 HG23 ' A' ' 52' ' ' THR . 4.1 m -153.1 -176.97 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.652 179.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.525 ' O ' HD13 ' B' ' 514' ' ' LEU . 4.4 tpt -100.65 95.94 7.01 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.658 -179.099 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.679 HG22 ' O ' ' A' ' 46' ' ' ILE . 1.2 mm -82.23 87.32 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-O 121.382 0.61 . . . . 0.0 109.913 178.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.403 ' HA3' ' HA ' ' B' ' 510' ' ' ILE . . . 46.23 -90.69 0.01 OUTLIER Glycine 0 CA--C 1.522 0.494 0 CA-C-N 115.488 -0.778 . . . . 0.0 113.647 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . -36.5 -96.39 0.01 OUTLIER Glycine 0 C--N 1.335 0.477 0 N-CA-C 113.997 0.359 . . . . 0.0 113.997 -179.076 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.47 ' N ' ' HE1' ' A' ' 45' ' ' MET . 1.6 pt-20 -125.66 158.85 63.54 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 120.539 0.209 . . . . 0.0 110.555 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.402 ' HD2' ' HB2' ' A' ' 49' ' ' GLU . 88.2 Cg_exo -40.2 101.07 0.03 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.595 2.196 . . . . 0.0 112.542 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.645 ' CE1' HG23 ' A' ' 3' ' ' THR . 5.6 t80 -172.24 162.43 5.59 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.422 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 1.086 HG23 HG22 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -136.62 145.82 45.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.07 179.377 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 1.012 HD13 HG13 ' A' ' 4' ' ' ILE . 0.8 OUTLIER -83.54 179.57 7.6 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.848 179.847 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -103.14 109.93 3.59 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.236 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.38 -159.26 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.801 0.334 . . . . 0.0 110.76 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.54 ' CE1' ' CB ' ' A' ' 16' ' ' LYS . 0.1 OUTLIER -104.3 166.27 10.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.053 0.454 . . . . 0.0 111.091 -179.909 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.403 ' OD1' ' N ' ' A' ' 38' ' ' ASP . 31.0 t70 -167.63 111.2 0.66 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.444 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.736 ' HA ' HD21 ' A' ' 67' ' ' LEU . 22.5 p -144.96 126.43 14.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.044 -179.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.893 ' HB3' HG23 ' A' ' 36' ' ' VAL . . . -171.16 126.2 0.66 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.094 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -74.92 65.35 2.23 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.478 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.773 HD12 ' HB ' ' A' ' 36' ' ' VAL . 55.9 mt -115.88 172.97 6.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.802 0.334 . . . . 0.0 110.911 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -52.27 -37.04 54.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.815 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.464 ' HB3' ' CD2' ' A' ' 64' ' ' TYR . 1.0 OUTLIER -58.19 -62.42 1.84 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.798 179.866 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.464 ' CD2' ' HB3' ' A' ' 63' ' ' ASP . 0.3 OUTLIER -136.16 77.31 1.65 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.594 179.969 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -86.05 -16.04 39.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.491 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -83.45 -53.22 5.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.581 0.229 . . . . 0.0 111.478 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.78 HD23 HD23 ' A' ' 70' ' ' LEU . 1.6 mp 49.6 -179.73 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.487 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.409 ' N ' ' HD2' ' A' ' 69' ' ' PRO . 0.0 OUTLIER 168.25 -57.33 0.0 OUTLIER Pre-proline 0 N--CA 1.465 0.3 0 CA-C-O 120.688 0.28 . . . . 0.0 111.354 -179.992 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.412 ' O ' ' NE2' ' A' ' 74' ' ' GLN . 68.0 Cg_exo -38.12 -47.77 2.26 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.981 2.454 . . . . 0.0 113.039 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.78 HD23 HD23 ' A' ' 67' ' ' LEU . 0.3 OUTLIER -48.06 -26.9 2.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.164 -179.757 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.64 -31.75 12.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.812 0.339 . . . . 0.0 111.448 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -82.66 143.29 46.88 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.116 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.37 100.41 0.89 Allowed 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.646 2.231 . . . . 0.0 111.977 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.412 ' NE2' ' O ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -102.19 -67.55 0.87 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.514 -179.461 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.608 HG21 ' O ' ' A' ' 5' ' ' LYS . 12.4 t -84.26 -164.67 0.98 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.706 -179.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.411 ' O ' ' HD2' ' A' ' 109' ' ' PRO . 4.2 p30 -124.74 8.33 8.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.238 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.4 ' H ' HG23 ' A' ' 75' ' ' THR . 39.3 t -141.55 91.18 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 CA-C-O 120.758 0.313 . . . . 0.0 111.157 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.52 ' CD2' HG21 ' A' ' 9' ' ' VAL . 2.9 m-30 -80.79 -177.7 6.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.6 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.811 HD23 HG21 ' A' ' 14' ' ' VAL . 8.1 tp -143.34 108.46 4.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.262 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.71 HG11 HD13 ' A' ' 101' ' ' ILE . 21.5 m -105.61 135.09 45.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.02 179.088 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.763 ' SG ' HG12 ' A' ' 14' ' ' VAL . 9.6 m -137.38 170.7 15.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.212 0.529 . . . . 0.0 111.968 -179.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.564 ' HE2' HD12 ' A' ' 112' ' ' LEU . 15.0 p90 -167.77 137.29 2.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.439 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.46 ' HA ' ' C2 ' ' A' ' 185' ' ' GNP . 57.4 p -83.68 139.4 32.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.725 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.596 HG13 ' N ' ' A' ' 137' ' ' ILE . 65.6 t -48.48 -63.78 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.22 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.585 ' HA ' HD21 ' A' ' 129' ' ' LEU . 30.4 m -45.35 111.85 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-O 120.61 0.243 . . . . 0.0 110.518 179.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.445 ' HA ' ' HD3' ' A' ' 87' ' ' PRO . 3.4 p -149.0 140.76 14.56 Favored Pre-proline 0 C--N 1.33 -0.24 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -178.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.453 ' CA ' ' HB2' ' A' ' 132' ' ' ASN . 72.3 Cg_endo -93.07 54.3 0.44 Allowed 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 123.381 2.721 . . . . 0.0 111.797 179.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.452 ' CB ' ' HB2' ' A' ' 133' ' ' LYS . 0.5 OUTLIER 72.93 21.73 3.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.043 -179.554 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 43.3 p -97.48 -17.8 19.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.264 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.53 ' CE2' HG23 ' A' ' 137' ' ' ILE . 8.5 t80 -45.68 -72.86 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.743 0.306 . . . . 0.0 111.302 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -53.64 -31.2 46.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.812 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.41 ' O ' ' CB ' ' A' ' 96' ' ' LYS . 8.3 t-20 -66.8 -58.18 5.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.953 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.428 HG13 ' N ' ' A' ' 94' ' ' LYS . 12.3 p -62.42 -41.3 91.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.256 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.784 ' HG3' HD13 ' A' ' 145' ' ' LEU . 0.8 OUTLIER -55.65 -75.33 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.832 179.951 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.423 ' O ' ' CG ' ' A' ' 99' ' ' PRO . 24.3 mm-40 -52.24 -24.01 6.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.913 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.41 ' CB ' ' O ' ' A' ' 92' ' ' ASN . 57.4 tttt -83.62 -22.51 32.2 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.114 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.448 ' CE3' ' HA ' ' A' ' 97' ' ' TRP . 0.0 OUTLIER -82.09 -55.49 4.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.58 -179.79 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.472 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 5.0 t -41.49 -46.63 8.55 Favored Pre-proline 0 N--CA 1.466 0.358 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -179.001 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 13.7 Cg_exo -69.96 -35.02 12.81 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.72 2.28 . . . . 0.0 112.354 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.415 ' N ' ' OE1' ' A' ' 100' ' ' GLU . 1.3 mp0 -76.73 -37.63 55.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.78 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.71 HD13 HG11 ' A' ' 80' ' ' VAL . 54.8 mt -65.93 -25.36 35.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.001 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 25.1 p -93.52 -26.93 16.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.858 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -66.09 -68.04 0.4 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.816 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -59.56 -34.76 73.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.696 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.401 ' HA ' ' HD2' ' A' ' 106' ' ' PRO . 89.3 m -127.4 103.58 22.48 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.756 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 105' ' ' CYS . 29.7 Cg_endo -63.68 106.72 0.64 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.439 2.093 . . . . 0.0 112.193 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.71 82.85 0.15 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.949 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.59 100.12 16.63 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.853 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.411 ' HD2' ' O ' ' A' ' 76' ' ' ASP . 31.3 Cg_exo -59.69 158.54 27.87 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.677 2.251 . . . . 0.0 112.251 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.482 ' CE2' ' HB2' ' A' ' 151' ' ' ALA . 24.8 p90 -150.62 -176.62 5.57 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.092 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.779 HD23 ' O ' ' A' ' 112' ' ' LEU . 4.4 tt -146.27 147.63 31.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.863 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.779 ' O ' HD23 ' A' ' 111' ' ' LEU . 4.2 mm? -93.43 156.8 16.56 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.626 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.824 HG13 HG11 ' A' ' 168' ' ' VAL . 11.0 t -143.21 150.68 17.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.091 0.472 . . . . 0.0 112.227 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.419 ' O ' ' CD1' ' A' ' 117' ' ' ILE . . . -124.46 100.15 0.62 Allowed Glycine 0 C--N 1.331 0.272 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.509 179.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.993 ' OG1' " H2'" ' A' ' 185' ' ' GNP . 1.3 p -122.97 -2.47 8.7 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -178.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.607 ' CB ' HN22 ' A' ' 185' ' ' GNP . 1.6 tp-100 -111.66 10.23 21.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.115 0.483 . . . . 0.0 109.86 178.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.48 ' H ' HD13 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -64.36 -11.63 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.948 179.018 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -80.34 -43.22 21.54 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.852 -179.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.605 ' C ' HD12 ' A' ' 119' ' ' LEU . 4.0 pp -99.43 0.52 42.8 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -179.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.432 ' O ' HD13 ' A' ' 126' ' ' ILE . 0.3 OUTLIER -54.71 -27.63 41.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.002 0.429 . . . . 0.0 110.017 179.245 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -80.85 -23.91 38.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.306 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -51.27 104.65 0.44 Allowed Pre-proline 0 C--N 1.332 -0.162 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.501 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.467 ' HA ' ' CG2' ' A' ' 126' ' ' ILE . 14.3 Cg_exo -69.31 -3.52 11.88 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 122.739 2.293 . . . . 0.0 112.978 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 10.3 t -72.56 -69.36 0.41 Allowed 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 120.914 0.388 . . . . 0.0 109.969 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.766 HG22 ' CD1' ' A' ' 129' ' ' LEU . 17.2 m -58.31 -44.27 88.51 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.799 HD11 ' HB3' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -50.09 -33.93 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.093 179.694 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.56 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 3.9 mm-40 -70.88 -35.19 72.25 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.433 ' N ' ' O ' ' A' ' 125' ' ' THR . 0.1 OUTLIER -68.44 -34.85 76.71 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 177.934 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.766 ' CD1' HG22 ' A' ' 125' ' ' THR . 9.2 mp -60.76 -42.54 97.65 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' A' ' 127' ' ' GLU . . . -42.52 -36.33 1.32 Allowed 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 114.602 -1.181 . . . . 0.0 111.503 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm -55.1 -29.44 57.62 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.859 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.453 ' HB2' ' CA ' ' A' ' 87' ' ' PRO . 29.8 m-80 -124.44 -32.49 3.14 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -179.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.512 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 1.3 ttpt -142.69 -83.13 0.18 Allowed 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 122.332 -0.23 . . . . 0.0 111.083 -179.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.512 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 9.9 pt20 114.94 -42.1 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.682 1.193 . . . . 0.0 111.077 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.418 ' HD2' ' HG3' ' A' ' 134' ' ' GLN . 3.2 mptt -68.61 110.1 5.3 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.112 -0.494 . . . . 0.0 112.235 -178.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.799 ' HB3' HD11 ' A' ' 126' ' ' ILE . 72.4 Cg_endo -75.25 148.11 33.92 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.494 2.129 . . . . 0.0 111.209 178.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.75 ' N ' HD13 ' A' ' 137' ' ' ILE . 0.7 OUTLIER -76.87 96.8 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.898 0.38 . . . . 0.0 111.053 -179.31 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 3.3 p -68.79 148.78 98.01 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.736 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.46 ' HA ' ' CE2' ' A' ' 154' ' ' TYR . 83.3 Cg_exo -45.56 -26.92 3.15 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.607 2.205 . . . . 0.0 112.382 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -77.48 -32.39 54.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.816 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.459 ' HB ' HG22 ' A' ' 137' ' ' ILE . 2.2 m -64.25 -57.55 9.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.89 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.41 ' HB2' ' HZ ' ' A' ' 82' ' ' PHE . . . -51.11 -44.15 61.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.063 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -56.14 -44.12 78.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.949 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.6 mttt -56.92 -62.91 1.41 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.786 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.784 HD13 ' HG3' ' A' ' 94' ' ' LYS . 1.0 OUTLIER -60.2 -35.9 76.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.775 179.833 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.477 ' HB2' ' HG ' ' A' ' 112' ' ' LEU . . . -51.55 -60.86 2.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.863 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 22.2 mtt180 -67.29 -22.32 65.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.885 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.617 ' HB3' HD22 ' A' ' 149' ' ' LEU . 24.2 t0 -50.25 -48.81 54.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.695 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.617 HD22 ' HB3' ' A' ' 148' ' ' ASP . 2.4 mm? -92.89 17.43 10.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.084 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 9.9 mttt 47.6 51.44 13.86 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.787 0.327 . . . . 0.0 111.021 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.482 ' HB2' ' CE2' ' A' ' 110' ' ' PHE . . . -75.73 -82.2 0.07 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.176 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.767 HG11 HD12 ' A' ' 111' ' ' LEU . 69.8 t -160.42 -74.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.928 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.41 ' HG3' ' N ' ' A' ' 154' ' ' TYR . 0.2 OUTLIER -177.52 144.43 0.39 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.65 -179.042 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.46 ' CE2' ' HA ' ' A' ' 139' ' ' PRO . 18.3 t80 -105.75 109.59 21.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.186 179.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.407 ' HB ' ' HB ' ' A' ' 168' ' ' VAL . 3.1 t -101.64 158.81 4.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.998 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -100.49 126.18 46.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.016 0.436 . . . . 0.0 111.666 -179.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.447 ' SG ' HG12 ' A' ' 168' ' ' VAL . 1.4 p 178.51 126.07 0.05 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.548 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.579 ' HB3' HD12 ' A' ' 160' ' ' LEU . 15.4 m -112.5 167.99 10.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.943 0.402 . . . . 0.0 111.427 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.522 ' HB1' ' HB3' ' A' ' 18' ' ' CYS . . . -98.77 -33.53 10.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.843 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.579 HD12 ' HB3' ' A' ' 158' ' ' SER . 0.9 OUTLIER -51.14 -38.69 53.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.448 179.788 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.0 t -117.33 -12.91 10.42 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.163 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 64.65 72.48 0.44 Allowed 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.818 0.342 . . . . 0.0 110.892 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.413 ' HB3' ' HA ' ' A' ' 157' ' ' CYS . 68.1 tttt -97.17 22.82 8.07 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.19 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 107.82 41.0 1.63 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.161 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.89 HD22 ' CD2' ' A' ' 19' ' ' LEU . 0.4 OUTLIER -49.26 -30.82 7.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.089 0.471 . . . . 0.0 110.632 179.596 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 22.9 pttm -68.79 -31.66 70.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.657 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -52.59 -69.28 0.12 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.546 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.824 HG11 HG13 ' A' ' 113' ' ' VAL . 12.3 p -50.29 -44.19 23.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.059 0.457 . . . . 0.0 110.441 179.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.522 ' CD1' ' CD1' ' A' ' 19' ' ' LEU . 2.2 t80 -59.85 -34.32 72.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.12 179.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.522 ' OD1' HD21 ' B' ' 505' ' ' LEU . 0.6 OUTLIER -60.7 -34.87 75.01 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.837 179.236 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.663 ' HB3' HD11 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -73.12 -30.46 63.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.2 179.229 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.451 ' CA ' HD13 ' A' ' 111' ' ' LEU . . . -76.39 -42.39 44.63 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.648 179.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.424 ' CG1' ' HA ' ' A' ' 170' ' ' ASP . 1.5 pp -76.97 -32.62 19.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.423 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 1.025 HD13 HD13 ' B' ' 505' ' ' LEU . 22.8 tp -53.37 -49.34 67.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.551 179.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.84 -22.29 62.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.783 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.588 ' HB1' ' HB ' ' A' ' 4' ' ' ILE . . . -85.4 -41.82 15.08 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.058 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.906 HD13 ' HB ' ' B' ' 510' ' ' ILE . 32.6 mt -68.78 -23.18 64.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.819 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.412 ' HB2' ' CB ' ' B' ' 507' ' ' ALA . 0.0 OUTLIER -168.3 153.56 6.5 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.784 179.934 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -52.72 124.01 14.32 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.621 2.214 . . . . 0.0 112.313 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.53 -178.43 3.37 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.538 2.159 . . . . 0.0 112.404 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -144.42 99.53 4.89 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.858 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -88.47 35.43 0.4 Allowed 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 123.197 2.598 . . . . 0.0 113.038 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 17.4 pttt -56.36 157.35 5.04 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.878 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 7.2 mttm . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.898 -179.978 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 502' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.204 0 N-CA-C 112.506 -0.238 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 503' ' ' SER . . . . . . . . . . . . . 22.3 m -67.35 -78.93 0.05 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.805 0.336 . . . . 0.0 110.814 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 504' ' ' GLY . . . . . 0.418 ' CA ' ' OD2' ' B' ' 509' ' ' ASP . . . 92.71 103.53 1.54 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.278 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 505' ' ' LEU . . . . . 1.025 HD13 HD13 ' A' ' 174' ' ' LEU . 0.2 OUTLIER -164.36 47.56 0.11 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.792 0.329 . . . . 0.0 111.31 -179.614 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 506' ' ' SER . . . . . 0.481 ' O ' ' HB2' ' B' ' 507' ' ' ALA . 4.9 m 59.31 87.86 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.975 0.417 . . . . 0.0 110.022 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 507' ' ' ALA . . . . . 0.481 ' HB2' ' O ' ' B' ' 506' ' ' SER . . . 173.75 -37.68 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.242 -179.083 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 508' ' ' GLN . . . . . 0.487 ' CB ' ' CD1' ' B' ' 510' ' ' ILE . 1.3 mt-30 155.48 -20.85 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.7 -1.136 . . . . 0.0 109.994 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 509' ' ' ASP . . . . . 0.455 ' CB ' ' O ' ' B' ' 508' ' ' GLN . 8.4 t70 90.03 38.67 0.01 OUTLIER 'General case' 0 C--N 1.343 0.323 0 CA-C-O 121.309 0.576 . . . . 0.0 110.6 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 510' ' ' ILE . . . . . 0.906 ' HB ' HD13 ' A' ' 177' ' ' LEU . 1.9 mp -68.99 136.39 26.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.346 179.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 511' ' ' SER . . . . . 0.683 ' HB2' HD21 ' B' ' 514' ' ' LEU . 4.1 m -109.23 153.98 23.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.061 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 512' ' ' GLN . . . . . 0.492 ' CB ' ' HD3' ' B' ' 513' ' ' PRO . 1.8 mm-40 -98.53 -68.37 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.82 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 513' ' ' PRO . . . . . 0.492 ' HD3' ' CB ' ' B' ' 512' ' ' GLN . 90.4 Cg_endo -78.64 59.55 7.27 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.4 2.067 . . . . 0.0 111.781 179.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 514' ' ' LEU . . . . . 0.683 HD21 ' HB2' ' B' ' 511' ' ' SER . 1.1 mt -73.34 -86.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.751 -179.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 515' ' ' GLN . . . . . 0.503 ' CB ' HG12 ' A' ' 44' ' ' VAL . 0.5 OUTLIER -88.1 -10.31 50.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.649 -179.529 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 53.59 24.52 4.23 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.936 0.398 . . . . 0.0 110.379 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 517' ' ' SER . . . . . 0.856 ' O ' HG13 ' A' ' 42' ' ' VAL . 75.4 m -68.28 58.8 0.08 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.618 -179.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 518' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -78.28 91.48 4.42 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.42 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 519' ' ' ILE . . . . . 0.423 HG12 ' O ' ' A' ' 41' ' ' ALA . 3.5 mm -76.28 157.47 5.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.251 -179.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -101.57 119.59 39.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.903 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 521' ' ' THR . . . . . . . . . . . . . 18.7 p -133.93 -61.99 0.78 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.829 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 522' ' ' GLY . . . . . . . . . . . . . . . -55.74 119.56 14.62 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.564 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 523' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -59.05 -83.76 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.772 0.32 . . . . 0.0 110.882 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 524' ' ' GLY . . . . . 0.5 ' HA3' HG11 ' A' ' 36' ' ' VAL . . . 67.88 167.86 4.04 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.492 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 525' ' ' ASP . . . . . 0.48 ' CG ' HD22 ' A' ' 61' ' ' LEU . 0.6 OUTLIER -85.28 83.19 8.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.83 0.348 . . . . 0.0 110.94 -179.967 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 526' ' ' SER . . . . . 0.44 ' CB ' ' HG3' ' A' ' 34' ' ' PRO . 6.4 t -83.58 95.79 8.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.694 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 527' ' ' ASP . . . . . 0.553 ' O ' HG21 ' A' ' 33' ' ' VAL . 3.2 p30 -177.52 147.36 0.66 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.995 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.74 101.56 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.685 2.257 . . . . 0.0 112.109 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 529' ' ' ARG . . . . . 0.423 ' HB2' ' HB3' ' B' ' 545' ' ' ASN . 0.1 OUTLIER -100.16 -55.3 2.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.352 -179.514 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 530' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -142.3 -47.21 0.34 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.025 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 531' ' ' CYS . . . . . . . . . . . . . 3.0 m 72.94 -172.1 0.14 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.806 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 532' ' ' TRP . . . . . . . . . . . . . 24.1 t90 -62.06 102.74 0.31 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.962 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 533' ' ' GLY . . . . . . . . . . . . . . . -122.02 -38.46 0.6 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.481 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 534' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -105.61 154.86 38.9 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 120.731 0.301 . . . . 0.0 110.932 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -67.18 125.51 13.65 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.641 2.228 . . . . 0.0 112.085 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 1.3 t0 70.84 141.35 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.768 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 537' ' ' ARG . . . . . 0.433 ' NE ' ' O3A' ' A' ' 185' ' ' GNP . 30.3 mmt180 -70.8 144.6 50.76 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.25 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 538' ' ' ILE . . . . . 0.756 HG23 HD12 ' B' ' 543' ' ' LEU . 6.2 tp -58.16 145.17 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 539' ' ' ASP . . . . . 0.449 ' O ' ' CD1' ' B' ' 543' ' ' LEU . 20.5 t0 -41.38 132.85 2.6 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.969 0.414 . . . . 0.0 112.028 -178.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 540' ' ' GLU . . . . . 0.643 ' CG ' HG22 ' A' ' 8' ' ' VAL . 0.8 OUTLIER -40.55 -27.27 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.047 179.702 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 541' ' ' LEU . . . . . 0.669 ' O ' HD21 ' A' ' 70' ' ' LEU . 5.3 mt -31.93 -69.24 0.08 Allowed 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 542' ' ' TYR . . . . . 0.458 ' CD1' ' HB3' ' B' ' 541' ' ' LEU . 0.1 OUTLIER -103.36 -63.78 1.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.317 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 543' ' ' LEU . . . . . 0.756 HD12 HG23 ' B' ' 538' ' ' ILE . 4.6 mp 65.05 141.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.866 -179.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 544' ' ' GLY . . . . . . . . . . . . . . . 132.62 141.86 4.74 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.487 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 545' ' ' ASN . . . . . 0.423 ' HB3' ' HB2' ' B' ' 529' ' ' ARG . 36.1 m-20 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.923 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' GNP . . . . . 0.993 " H2'" ' OG1' ' A' ' 115' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.516 ' HE3' ' CG2' ' A' ' 46' ' ' ILE . 7.4 tpt . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.475 0.179 . . . . 0.0 111.2 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.431 ' O ' ' CE ' ' A' ' 1' ' ' MET . 39.4 tp60 60.76 137.83 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.047 0.451 . . . . 0.0 110.917 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.598 HG21 ' HG ' ' A' ' 53' ' ' LEU . 0.2 OUTLIER -124.24 -165.95 1.43 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.609 -179.492 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.683 ' CG2' ' HB3' ' A' ' 176' ' ' ALA . 0.2 OUTLIER -150.92 138.26 13.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.581 -179.593 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.477 ' O ' HG13 ' A' ' 77' ' ' VAL . 3.6 ttmt -95.0 101.35 13.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.748 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.562 ' CB ' HD23 ' A' ' 55' ' ' LEU . 20.2 m -80.25 110.1 15.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.287 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.7 t -151.16 106.74 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.766 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.627 HG13 ' OE1' ' B' ' 540' ' ' GLU . 2.4 p -89.3 135.48 25.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.296 0.569 . . . . 0.0 111.583 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.747 HG21 ' CE2' ' A' ' 78' ' ' PHE . 2.8 m -133.41 129.44 56.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.197 178.41 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.409 ' O ' ' N ' ' B' ' 540' ' ' GLU . . . 141.69 -165.3 26.52 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.067 -1.064 . . . . 0.0 112.483 -179.106 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.7 21.87 5.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.764 0.316 . . . . 0.0 110.992 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.414 ' HA3' ' CB ' ' A' ' 81' ' ' CYS . . . -128.13 161.6 21.97 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.501 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.438 ' CB ' ' HB2' ' A' ' 18' ' ' CYS . . . -93.08 -20.1 20.87 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.4 ' CG2' ' SG ' ' A' ' 81' ' ' CYS . 4.0 m -42.41 92.67 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 CA-C-O 120.892 0.377 . . . . 0.0 111.643 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.439 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . . . -178.13 -77.97 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.76 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.508 ' O ' HD22 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -98.08 -84.1 0.39 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.927 0.394 . . . . 0.0 111.825 -179.354 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.436 ' HA ' HG12 ' A' ' 21' ' ' ILE . 4.3 p -63.33 -50.39 70.19 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.438 ' HB2' ' CB ' ' A' ' 13' ' ' ALA . 51.9 t -32.46 -70.83 0.06 Allowed 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 113.634 0.975 . . . . 0.0 113.634 -178.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.836 HD21 ' CE1' ' A' ' 169' ' ' PHE . 0.0 OUTLIER -58.05 -71.23 0.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -178.19 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.508 HD22 ' O ' ' A' ' 16' ' ' LYS . 0.2 OUTLIER -51.05 -65.88 0.48 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -178.283 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.512 HD11 ' CZ ' ' B' ' 518' ' ' PHE . 30.4 mm -45.6 -67.9 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.107 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.434 ' CB ' ' HB1' ' A' ' 159' ' ' ALA . 1.2 t -49.82 -26.12 3.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.961 0.41 . . . . 0.0 110.752 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -82.86 -25.34 32.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.72 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.42 HG23 ' O ' ' A' ' 20' ' ' LEU . 66.7 p -100.52 -64.21 1.06 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.243 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 40.1 p -62.41 -58.28 8.2 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.993 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.439 ' N ' ' ND2' ' A' ' 26' ' ' ASN . 0.4 OUTLIER 74.9 42.67 0.26 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.181 179.584 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.47 ' O ' ' CE1' ' A' ' 32' ' ' TYR . 4.2 mtmm -119.66 91.58 3.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.968 0.413 . . . . 0.0 110.928 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.48 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 9.4 t80 -89.81 -45.38 0.41 Allowed Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.872 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 88.0 Cg_endo -84.16 79.02 2.73 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.424 2.083 . . . . 0.0 113.04 -179.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.9 m -174.02 -94.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.879 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.41 154.74 25.46 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 120.635 0.255 . . . . 0.0 110.449 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.5 ' CE2' ' O3A' ' A' ' 185' ' ' GNP . 15.6 m-85 -133.82 93.98 3.2 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.905 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.564 ' N ' ' CD ' ' A' ' 34' ' ' PRO . 2.1 t -131.59 28.09 0.15 Allowed Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.564 ' CD ' ' N ' ' A' ' 33' ' ' VAL . 42.3 Cg_endo -86.09 -37.59 0.1 Allowed 'Trans proline' 0 C--N 1.359 1.109 0 C-N-CA 121.889 1.726 . . . . 0.0 112.496 179.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.472 HG21 HD21 ' B' ' 543' ' ' LEU . 1.4 m -48.46 99.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.881 -179.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.466 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 7.4 p 176.98 -34.95 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.825 179.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -109.39 35.88 3.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.582 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.449 ' CB ' ' HG2' ' A' ' 16' ' ' LYS . 18.3 m-20 -89.58 45.47 1.28 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.127 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -106.03 -16.28 14.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.077 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -60.59 174.97 0.51 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.79 0.329 . . . . 0.0 110.865 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.759 ' C ' HD12 ' B' ' 519' ' ' ILE . . . -91.99 174.48 7.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.294 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.421 ' HA ' HG13 ' B' ' 519' ' ' ILE . 30.9 m -139.32 144.67 28.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.734 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.498 ' O ' HG23 ' A' ' 44' ' ' VAL . 2.1 p -85.05 106.33 16.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.499 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.912 ' HB ' HG21 ' A' ' 52' ' ' THR . 53.9 t -158.04 153.11 6.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.158 -179.195 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.53 ' HB3' HD22 ' B' ' 514' ' ' LEU . 0.0 OUTLIER -117.73 96.31 5.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.17 179.313 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.951 HG12 HG22 ' A' ' 52' ' ' THR . 5.5 mm -71.1 88.1 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.539 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.508 ' N ' HG23 ' B' ' 510' ' ' ILE . . . 37.28 -87.85 0.01 OUTLIER Glycine 0 CA--C 1.521 0.409 0 CA-C-N 115.811 -0.631 . . . . 0.0 113.919 179.326 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . -38.88 -78.6 0.05 OUTLIER Glycine 0 C--N 1.334 0.439 0 C-N-CA 121.52 -0.371 . . . . 0.0 113.177 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.451 ' N ' ' HE1' ' A' ' 45' ' ' MET . 3.2 mt-10 -142.29 162.23 46.25 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-O 120.909 0.385 . . . . 0.0 111.373 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.42 92.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.79 2.327 . . . . 0.0 112.558 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.549 ' CE1' HG23 ' A' ' 3' ' ' THR . 0.0 OUTLIER -172.95 126.07 0.45 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.073 179.749 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.951 HG22 HG12 ' A' ' 46' ' ' ILE . 4.3 p -134.57 141.77 46.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.919 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.598 ' HG ' HG21 ' A' ' 3' ' ' THR . 5.3 mt -71.16 121.69 18.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.877 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -52.28 153.4 6.08 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.092 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.562 HD23 ' CB ' ' A' ' 6' ' ' CYS . 2.6 mp -109.79 95.04 5.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.839 0.352 . . . . 0.0 110.884 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -84.73 105.45 15.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.633 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.421 ' OD2' ' CG2' ' A' ' 35' ' ' THR . 1.5 t70 -94.44 163.77 13.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.822 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 1.087 HG21 HD22 ' A' ' 70' ' ' LEU . 6.7 p -89.44 146.38 24.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.32 -179.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.466 ' HB3' ' HA ' ' A' ' 36' ' ' VAL . . . -172.14 -162.78 0.22 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.677 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.455 ' H ' HD12 ' A' ' 61' ' ' LEU . . . 166.41 66.75 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.467 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.455 HD12 ' H ' ' A' ' 60' ' ' GLY . 5.8 mp -120.97 -87.01 0.65 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.727 0.299 . . . . 0.0 111.02 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.79 -31.56 11.81 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.902 0.382 . . . . 0.0 111.108 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.425 ' HB3' HG22 ' A' ' 36' ' ' VAL . 50.7 t0 -70.8 -63.25 1.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.37 -179.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.489 ' CD1' HD12 ' A' ' 67' ' ' LEU . 0.1 OUTLIER -118.33 160.25 21.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.805 -179.757 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -85.92 -68.35 0.74 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.807 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -96.69 -52.2 4.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.117 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.715 HD23 ' O ' ' A' ' 67' ' ' LEU . 6.5 tt 56.42 106.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.64 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.452 ' N ' ' HD3' ' A' ' 69' ' ' PRO . 1.7 ppt_? -142.47 53.33 2.87 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.321 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.452 ' HD3' ' N ' ' A' ' 68' ' ' ARG . 94.1 Cg_endo -83.95 -20.25 4.49 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.764 2.309 . . . . 0.0 112.26 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 1.087 HD22 HG21 ' A' ' 58' ' ' THR . 0.7 OUTLIER -77.76 1.0 21.49 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.925 -179.79 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.21 -61.23 2.28 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 120.908 0.385 . . . . 0.0 110.92 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.492 ' N ' ' CD1' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -159.22 56.76 0.96 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.791 179.884 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -60.94 174.44 1.77 Allowed 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.661 2.241 . . . . 0.0 112.307 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -95.68 10.57 36.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.524 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.402 HG23 ' HB3' ' A' ' 5' ' ' LYS . 98.8 m -46.51 145.21 1.88 Allowed 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.804 0.335 . . . . 0.0 111.05 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.418 ' O ' ' CG ' ' A' ' 109' ' ' PRO . 16.8 p-10 -106.4 -20.96 13.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.147 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.666 ' O ' HG13 ' A' ' 77' ' ' VAL . 7.9 p -123.55 83.96 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.827 0.346 . . . . 0.0 111.387 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.747 ' CE2' HG21 ' A' ' 9' ' ' VAL . 0.3 OUTLIER -80.79 166.3 21.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.599 179.736 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.471 HD13 ' HB3' ' A' ' 111' ' ' LEU . 4.9 tp -143.39 108.46 4.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.02 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.706 HG13 ' CB ' ' A' ' 110' ' ' PHE . 35.9 m -84.74 147.11 5.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.838 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.481 ' O ' ' CZ3' ' A' ' 97' ' ' TRP . 2.0 m -113.97 174.35 5.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.118 0.485 . . . . 0.0 111.216 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.463 ' CE1' ' O ' ' A' ' 113' ' ' VAL . 6.0 p90 179.99 -173.54 0.23 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.769 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.441 ' N ' ' CD2' ' A' ' 82' ' ' PHE . 0.3 OUTLIER -156.42 136.34 12.66 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.847 0.356 . . . . 0.0 111.349 179.958 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.538 HG13 ' N ' ' A' ' 137' ' ' ILE . 99.3 t -51.48 -40.41 24.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.827 179.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.623 ' O ' HG23 ' A' ' 85' ' ' VAL . 32.0 m -73.02 111.64 7.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.518 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.455 ' H ' HD13 ' A' ' 129' ' ' LEU . 83.4 p -151.28 135.27 9.51 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.743 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.417 ' HB2' ' HB2' ' A' ' 132' ' ' ASN . 74.2 Cg_endo -91.42 51.88 0.78 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.218 2.612 . . . . 0.0 111.585 179.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.46 ' CB ' ' CG ' ' A' ' 133' ' ' LYS . 0.1 OUTLIER 79.15 26.85 0.42 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.665 -179.426 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.922 ' O ' HG23 ' A' ' 93' ' ' VAL . 52.4 p -96.5 -25.73 15.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.999 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.411 ' CZ ' HG21 ' A' ' 137' ' ' ILE . 3.3 t80 -48.96 -54.08 17.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.075 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -49.82 -53.41 25.62 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.932 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -64.29 -47.68 78.57 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.724 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.922 HG23 ' O ' ' A' ' 89' ' ' SER . 65.9 t -51.1 -39.84 20.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.049 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.645 ' HD2' HD13 ' A' ' 145' ' ' LEU . 12.3 tttm -64.51 -50.39 67.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.847 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.403 ' O ' ' HG3' ' A' ' 99' ' ' PRO . 4.7 mt-10 -82.97 7.39 15.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.695 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.2 mttp -109.82 -26.14 9.97 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.751 0.31 . . . . 0.0 110.872 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.73 ' O ' HG22 ' A' ' 101' ' ' ILE . 5.7 m0 -94.01 -45.73 7.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.196 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.64 HG23 ' O ' ' A' ' 94' ' ' LYS . 58.5 t -49.94 -46.73 81.43 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.63 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 94.2 Cg_endo -80.74 -15.5 10.78 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.393 2.062 . . . . 0.0 112.612 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -90.11 -49.09 6.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.771 0.32 . . . . 0.0 110.901 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.73 HG22 ' O ' ' A' ' 97' ' ' TRP . 9.9 tt -62.95 -22.86 31.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.197 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.515 HG23 ' O ' ' A' ' 98' ' ' VAL . 61.2 p -91.51 -26.11 18.94 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.878 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 42.0 t60 -76.92 -57.79 3.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.895 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -65.66 -56.96 9.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.951 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.407 ' CB ' ' OG1' ' A' ' 108' ' ' THR . 60.4 m -86.65 142.94 35.16 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.976 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -69.23 60.27 1.4 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.558 2.172 . . . . 0.0 112.315 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.78 78.58 0.27 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.927 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.407 ' OG1' ' CB ' ' A' ' 105' ' ' CYS . 0.2 OUTLIER -108.52 141.12 22.59 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.813 179.847 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.418 ' CG ' ' O ' ' A' ' 76' ' ' ASP . 33.8 Cg_endo -65.53 177.91 2.46 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.507 2.138 . . . . 0.0 112.52 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.845 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 4.6 p90 -166.22 132.55 2.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.782 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.849 HD12 ' CG1' ' A' ' 152' ' ' VAL . 5.5 tt -108.94 142.0 40.21 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.678 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.438 HD12 ' CD1' ' A' ' 82' ' ' PHE . 4.2 mm? -89.59 155.03 19.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.586 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 1.091 HG13 HG21 ' A' ' 168' ' ' VAL . 2.4 t -142.12 134.17 26.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.946 0.403 . . . . 0.0 111.792 -179.448 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.784 ' O ' HD11 ' A' ' 117' ' ' ILE . . . -106.03 86.09 0.47 Allowed Glycine 0 C--N 1.332 0.338 0 C-N-CA 121.004 -0.617 . . . . 0.0 111.857 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.804 ' OG1' " H2'" ' A' ' 185' ' ' GNP . 1.0 OUTLIER -110.34 1.68 18.61 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -178.805 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.597 ' HB2' HN22 ' A' ' 185' ' ' GNP . 4.4 tp60 -96.87 -22.74 16.71 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.784 HD11 ' O ' ' A' ' 114' ' ' GLY . 0.2 OUTLIER -46.04 -25.75 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.096 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.839 178.931 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.563 ' HB3' HD13 ' A' ' 119' ' ' LEU . 4.8 t0 -53.72 -47.52 70.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.372 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.722 HD13 ' N ' ' A' ' 119' ' ' LEU . 0.0 OUTLIER -122.98 14.31 9.88 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -178.976 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.82 -28.61 3.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.897 0.379 . . . . 0.0 110.87 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.3 p30 -72.22 -22.39 61.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.094 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.421 ' O ' ' HB ' ' A' ' 126' ' ' ILE . 20.1 p-10 -48.24 104.32 0.41 Allowed Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 120.983 0.421 . . . . 0.0 110.974 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.426 ' O ' HG22 ' A' ' 126' ' ' ILE . 36.7 Cg_endo -66.49 -6.57 15.48 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.381 2.054 . . . . 0.0 113.172 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.417 ' OG ' ' N ' ' A' ' 125' ' ' THR . 54.3 p -79.78 -66.52 0.86 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.417 ' N ' ' OG ' ' A' ' 124' ' ' SER . 34.5 m -55.76 -38.06 69.34 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.499 HD11 ' HB3' ' A' ' 136' ' ' PRO . 0.1 OUTLIER -56.37 -41.68 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 115.01 -0.996 . . . . 0.0 109.803 179.229 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.449 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 1.0 OUTLIER -60.59 -37.51 81.58 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.436 179.256 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 125' ' ' THR . 0.0 OUTLIER -60.88 -31.3 70.77 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.595 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.455 HD13 ' H ' ' A' ' 86' ' ' SER . 5.1 mt -75.36 -41.68 55.9 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 177.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 127' ' ' GLU . . . -44.26 -33.9 1.73 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.99 -1.004 . . . . 0.0 111.105 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 18.0 mmtm -49.79 -33.05 15.42 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.416 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.417 ' HB2' ' HB2' ' A' ' 87' ' ' PRO . 5.1 m-80 -123.29 -31.36 3.57 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.341 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.523 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 0.8 OUTLIER -144.6 -99.17 0.1 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 119.191 -0.433 . . . . 0.0 111.571 179.793 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.523 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 2.7 pt20 129.57 -23.86 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.528 1.131 . . . . 0.0 110.313 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.2 mmtt -68.73 110.26 5.64 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.778 -179.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.499 ' HB3' HD11 ' A' ' 126' ' ' ILE . 96.1 Cg_endo -79.55 127.36 7.23 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.485 2.123 . . . . 0.0 111.239 179.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.734 ' N ' HD13 ' A' ' 137' ' ' ILE . 1.1 mm -56.76 95.9 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.962 0.411 . . . . 0.0 110.738 -179.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 47.0 p -67.65 155.65 90.81 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.087 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.455 ' HG3' HG21 ' A' ' 117' ' ' ILE . 75.3 Cg_exo -47.54 -27.85 8.1 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.461 2.107 . . . . 0.0 112.184 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -77.1 -30.53 55.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.626 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.566 ' HB ' HG22 ' A' ' 137' ' ' ILE . 5.8 m -69.58 -62.49 1.36 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.727 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.403 ' HB3' ' CZ ' ' A' ' 154' ' ' TYR . . . -52.14 -36.05 50.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.637 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -65.83 -41.53 91.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.505 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 19.4 tptp -55.11 -62.77 1.45 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.634 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.755 ' CD1' HD23 ' A' ' 149' ' ' LEU . 17.2 tp -58.31 -43.81 88.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.543 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.403 ' HB2' ' HG ' ' A' ' 112' ' ' LEU . . . -55.06 -35.3 64.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.924 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 12.3 mtt-85 -91.47 -30.87 16.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.618 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -65.12 -44.28 89.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.707 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.755 HD23 ' CD1' ' A' ' 145' ' ' LEU . 3.0 mm? -89.8 14.05 12.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.123 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 47.41 45.8 17.11 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.835 0.35 . . . . 0.0 111.002 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.845 ' HB1' ' O ' ' A' ' 110' ' ' PHE . . . -65.09 -82.22 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.198 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.849 ' CG1' HD12 ' A' ' 111' ' ' LEU . 70.7 t -161.09 -75.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.826 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.57 108.41 0.06 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.792 -178.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.449 ' CE2' ' HA ' ' A' ' 139' ' ' PRO . 19.5 t80 -80.98 114.56 19.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.425 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 3.7 t -108.87 155.12 9.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.826 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.405 ' O ' ' HB3' ' A' ' 157' ' ' CYS . 1.2 pt-20 -94.37 118.58 31.83 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.223 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.435 ' HA ' ' HB3' ' A' ' 163' ' ' LYS . 20.3 p 178.95 137.46 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.615 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.481 ' HA ' ' HB ' ' A' ' 115' ' ' THR . 27.4 m -112.72 149.31 33.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.981 0.419 . . . . 0.0 111.221 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.853 ' HB2' HD21 ' A' ' 165' ' ' LEU . . . -83.21 -42.54 17.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.82 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.491 HD23 ' H ' ' A' ' 160' ' ' LEU . 0.1 OUTLIER -49.53 -36.5 23.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.703 179.779 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.455 HG22 ' HB2' ' A' ' 158' ' ' SER . 15.3 t -111.37 -22.48 11.3 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.685 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.413 ' N ' ' O ' ' A' ' 158' ' ' SER . 0.9 OUTLIER 73.11 62.25 0.1 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.781 -179.89 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.435 ' HB3' ' HA ' ' A' ' 157' ' ' CYS . 0.0 OUTLIER -93.08 22.59 4.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.061 -179.943 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.435 ' N ' ' HB2' ' A' ' 157' ' ' CYS . . . 133.34 35.39 0.29 Allowed Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.484 -0.865 . . . . 0.0 113.412 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.853 HD21 ' HB2' ' A' ' 159' ' ' ALA . 10.5 mt -48.88 -42.3 36.27 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.913 0.357 . . . . 0.0 110.844 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.18 -34.18 72.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.992 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.418 ' O ' ' HB2' ' A' ' 170' ' ' ASP . 0.1 OUTLIER -58.03 -72.18 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.241 -179.811 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 1.091 HG21 HG13 ' A' ' 113' ' ' VAL . 7.1 p -50.08 -46.91 24.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.981 0.42 . . . . 0.0 110.988 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.836 ' CE1' HD21 ' A' ' 19' ' ' LEU . 1.1 t80 -64.6 -33.38 75.78 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.672 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.42 ' O ' ' CB ' ' A' ' 174' ' ' LEU . 0.5 OUTLIER -56.3 -32.84 64.99 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 178.967 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.699 ' HB2' HD11 ' A' ' 111' ' ' LEU . 58.7 mm-40 -75.0 -36.21 61.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.887 178.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.731 ' N ' HD13 ' A' ' 111' ' ' LEU . . . -67.31 -43.41 81.72 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.623 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.494 HD13 ' HB2' ' B' ' 512' ' ' GLN . 1.7 pp -78.23 -33.14 17.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.661 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.86 HD13 HD22 ' B' ' 505' ' ' LEU . 22.0 tp -59.13 -43.62 92.01 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.634 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -54.34 -22.03 11.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.112 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.683 ' HB3' ' CG2' ' A' ' 4' ' ' ILE . . . -87.53 -37.03 17.25 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.395 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.839 HD13 ' HB ' ' B' ' 510' ' ' ILE . 94.9 mt -68.83 -27.98 66.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.962 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.11 136.73 1.93 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.981 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -57.32 112.02 1.0 Allowed 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.563 2.175 . . . . 0.0 112.302 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.53 162.1 33.55 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.625 2.217 . . . . 0.0 112.276 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -131.37 143.85 50.98 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.959 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -76.53 -165.12 0.29 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.721 2.281 . . . . 0.0 112.329 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 1.8 mmmt -71.26 83.54 0.75 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.87 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 7.7 mttt . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.979 179.992 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 502' ' ' GLY . . . . . 0.416 ' CA ' ' O ' ' B' ' 509' ' ' ASP . . . . . . . . 0 N--CA 1.489 2.195 0 N-CA-C 112.524 -0.23 . . . . 0.0 112.524 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 503' ' ' SER . . . . . . . . . . . . . 37.4 t -107.06 -74.62 0.65 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.781 0.324 . . . . 0.0 110.944 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 504' ' ' GLY . . . . . . . . . . . . . . . 116.58 103.86 2.35 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.36 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 505' ' ' LEU . . . . . 0.86 HD22 HD13 ' A' ' 174' ' ' LEU . 0.1 OUTLIER -174.55 38.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.698 0.285 . . . . 0.0 111.141 -179.871 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 506' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 68.95 34.26 3.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.127 0.489 . . . . 0.0 110.566 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 507' ' ' ALA . . . . . 0.479 ' HB3' ' CD1' ' B' ' 505' ' ' LEU . . . -137.47 35.97 2.48 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.548 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 508' ' ' GLN . . . . . 0.4 ' O ' ' HB3' ' B' ' 509' ' ' ASP . 20.4 mt-30 74.73 3.38 4.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.441 -178.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 509' ' ' ASP . . . . . 0.416 ' O ' ' CA ' ' B' ' 502' ' ' GLY . 16.0 t70 71.7 44.83 0.47 Allowed 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.158 0.504 . . . . 0.0 110.816 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 510' ' ' ILE . . . . . 0.839 ' HB ' HD13 ' A' ' 177' ' ' LEU . 44.5 mt -93.17 138.29 20.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.846 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 511' ' ' SER . . . . . . . . . . . . . 22.1 t -108.04 157.16 18.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.359 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 512' ' ' GLN . . . . . 0.505 ' O ' HG11 ' A' ' 44' ' ' VAL . 27.9 tp60 -110.21 -71.2 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.513 179.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 513' ' ' PRO . . . . . 0.478 ' CD ' ' CB ' ' B' ' 512' ' ' GLN . 73.3 Cg_endo -74.6 58.96 4.75 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.021 1.814 . . . . 0.0 111.632 179.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 514' ' ' LEU . . . . . 0.53 HD22 ' HB3' ' A' ' 45' ' ' MET . 2.6 mp -65.81 -86.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.65 -179.272 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 515' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -69.3 -96.1 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.218 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 516' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -127.32 -12.26 5.67 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 517' ' ' SER . . . . . 0.418 ' HA ' ' HB ' ' A' ' 42' ' ' VAL . 1.5 m 48.62 31.78 3.14 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.705 0.288 . . . . 0.0 111.135 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 518' ' ' PHE . . . . . 0.512 ' CZ ' HD11 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -163.3 91.96 0.72 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.143 -179.795 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 519' ' ' ILE . . . . . 0.759 HD12 ' C ' ' A' ' 41' ' ' ALA . 41.5 mt -64.23 -64.68 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.84 0.353 . . . . 0.0 110.755 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 520' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -126.6 -168.95 1.94 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.891 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 521' ' ' THR . . . . . . . . . . . . . 6.6 m -119.76 113.99 21.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.002 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 522' ' ' GLY . . . . . . . . . . . . . . . -107.16 120.6 6.23 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.522 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 523' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -114.58 -84.44 0.61 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.716 0.294 . . . . 0.0 110.96 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 524' ' ' GLY . . . . . . . . . . . . . . . 101.21 -44.14 1.6 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.412 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 525' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -152.01 32.95 0.54 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.862 0.363 . . . . 0.0 110.907 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 526' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.1 97.56 6.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.887 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 527' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -145.88 161.68 39.02 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.914 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 528' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.42 96.59 0.65 Allowed 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.598 2.199 . . . . 0.0 112.242 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 529' ' ' ARG . . . . . . . . . . . . . 1.9 mtp85 -96.08 -23.1 16.94 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.202 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 530' ' ' HIS . . . . . 0.41 ' O ' ' HB2' ' B' ' 531' ' ' CYS . 0.0 OUTLIER -178.76 -82.77 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.938 -179.875 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 531' ' ' CYS . . . . . 0.41 ' HB2' ' O ' ' B' ' 530' ' ' HIS . 50.1 t 178.29 -68.67 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.886 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 532' ' ' TRP . . . . . 0.521 ' CZ2' ' NH2' ' B' ' 537' ' ' ARG . 0.6 OUTLIER -126.32 -49.8 1.54 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.967 -179.908 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 533' ' ' GLY . . . . . 0.472 ' O ' ' CG ' ' B' ' 534' ' ' PHE . . . 106.4 -56.28 0.51 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.483 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 534' ' ' PHE . . . . . 0.472 ' CG ' ' O ' ' B' ' 533' ' ' GLY . 98.0 m-85 -160.67 160.72 25.5 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.76 0.314 . . . . 0.0 110.88 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 535' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -48.05 123.36 8.61 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.559 2.173 . . . . 0.0 112.274 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 536' ' ' ASP . . . . . . . . . . . . . 2.9 t0 68.25 145.18 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.747 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 537' ' ' ARG . . . . . 0.521 ' NH2' ' CZ2' ' B' ' 532' ' ' TRP . 0.1 OUTLIER -51.94 139.19 22.93 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.036 0.446 . . . . 0.0 111.09 -179.867 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 538' ' ' ILE . . . . . 0.434 ' CG2' ' HA ' ' B' ' 543' ' ' LEU . 5.8 tp -59.38 144.94 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.959 179.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 539' ' ' ASP . . . . . 0.408 ' HA ' ' O ' ' A' ' 10' ' ' GLY . 8.5 m-20 -43.84 136.95 3.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.815 0.341 . . . . 0.0 111.275 -179.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 540' ' ' GLU . . . . . 0.704 ' HA ' HD12 ' B' ' 543' ' ' LEU . 33.1 mm-40 -52.72 -21.66 4.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.163 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 541' ' ' LEU . . . . . 0.738 ' HA ' HD21 ' A' ' 70' ' ' LEU . 1.1 mp -37.03 -63.59 0.42 Allowed 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 542' ' ' TYR . . . . . 0.412 ' O ' ' CB ' ' B' ' 543' ' ' LEU . 0.1 OUTLIER -105.16 -58.68 1.86 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.304 -179.574 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 543' ' ' LEU . . . . . 0.704 HD12 ' HA ' ' B' ' 540' ' ' GLU . 0.1 OUTLIER 81.27 -167.97 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.369 -179.225 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 544' ' ' GLY . . . . . 0.42 ' O ' ' ND2' ' B' ' 545' ' ' ASN . . . 93.44 -176.3 36.77 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.497 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 545' ' ' ASN . . . . . 0.552 ' HB2' HG22 ' A' ' 33' ' ' VAL . 9.3 m-80 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.279 -0.867 . . . . 0.0 110.987 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' GNP . . . . . 0.804 " H2'" ' OG1' ' A' ' 115' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_